variant_id,rs_id,chr,position,gene,variant_type,nucleotide_change,risk_allele,odds_ratio,confidence_interval_low,confidence_interval_high,p_value,risk_classification,european_freq,east_asian_freq,african_freq,south_asian_freq,csf_abeta_effect,csf_tau_effect,pet_amyloid_effect,cognitive_impact,clinvar_classification,acmg_classification,age_onset_effect,disease_progression,therapeutic_relevance
AD-SNP00001,rs258755,15,177868013,SORL1,Insertion,-,-,0.56,0.33,0.87,0.0017169,Moderate,0.039,0.08,0.075,0.606,Variable effect (p=0.014),Significant decrease (p=0.005),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00002,rs175989,15,5236445,BIN1,Insertion,-,-,1.28,0.94,1.63,0.0103673,High,0.034,0.326,0.202,0.238,Significant increase (p=0.035),Mild increase (p=0.005),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP00003,rs920229,19,112115638,SORL1,SNP (A/G),(A/,A,0.87,0.51,1.27,0.01141025,Moderate,0.249,0.269,0.251,0.031,Variable effect (p=0.046),Mild increase (p=0.028),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00004,rs669926,11,60497316,SORL1,SNP (A/G),(A/,A,0.56,0.19,0.87,0.00667344,Moderate,0.015,0.169,0.409,0.207,Mild decrease (p=0.029),Variable effect (p=0.031),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00005,rs504912,7,151930762,SORL1,Deletion,-,-,1.67,1.41,1.97,0.03849828,Protective,0.362,0.032,0.224,0.182,Mild increase (p=0.01),No significant pattern (p=0.033),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP00006,rs540058,7,223268910,APP,SNP (G/T),(G/,G,1.04,0.66,1.42,0.02336586,High,0.18,0.01,0.064,0.546,Significant increase (p=0.043),Variable effect (p=0.024),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP00007,rs789384,5,164392366,PICALM,SNP (G/T),(G/,G,0.69,0.43,0.97,0.01161177,Moderate,0.137,0.162,0.082,0.419,Mild increase (p=0.046),Mild decrease (p=0.048),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00008,rs543503,12,162554107,PSEN2,SNP (G/T),(G/,G,1.9,1.64,2.11,0.05203083,High,0.16,0.027,0.094,0.519,Significant decrease (p=0.009),No significant pattern (p=0.047),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00009,rs105148,11,74773697,SORL1,SNP (C/G),(C/,C,1.53,1.17,1.87,0.02059541,Low,0.061,0.043,0.482,0.214,Mild decrease (p=0.024),No significant pattern (p=0.014),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00010,rs752528,7,30618068,BIN1,SNP (C/T),(C/,C,1.06,0.71,1.38,0.00580697,High,0.387,0.143,0.154,0.116,Significant increase (p=0.012),No significant pattern (p=0.023),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00011,rs805871,22,64868587,CR1,SNP (A/C),(A/,A,1.32,0.97,1.52,0.01568439,Moderate,0.015,0.202,0.187,0.397,Mild decrease (p=0.042),Significant decrease (p=0.032),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00012,rs158282,19,184303190,APP,SNP (C/G),(C/,C,0.5,0.24,0.8,0.0257495,Moderate,0.132,0.482,0.117,0.068,Significant increase (p=0.023),Mild decrease (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00013,rs420719,22,182479690,SORL1,SNP (C/T),(C/,C,0.9,0.55,1.19,0.00609993,High,0.234,0.028,0.247,0.29,Mild increase (p=0.046),Significant increase (p=0.003),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00014,rs114332,3,105064306,PSEN2,SNP (A/C),(A/,A,1.96,1.72,2.22,0.04132639,Low,0.192,0.407,0.114,0.087,Significant increase (p=0.036),No significant pattern (p=0.018),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00015,rs431132,21,243579376,APOE,SNP (A/C),(A/,A,0.88,0.5,1.2,0.00058782,Low,0.128,0.033,0.42,0.218,Mild increase (p=0.023),Significant decrease (p=0.009),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00016,rs644218,11,219628274,SORL1,SNP (A/T),(A/,A,1.6,1.31,1.94,0.02111897,Low,0.116,0.308,0.001,0.374,Mild increase (p=0.036),Mild decrease (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP00017,rs244805,5,11778602,APOE,SNP (G/T),(G/,G,1.13,0.84,1.35,0.07721247,Moderate,0.06,0.229,0.215,0.296,Significant increase (p=0.015),No significant pattern (p=0.031),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00018,rs314648,14,152991164,PSEN2,Deletion,-,-,2.09,1.81,2.33,0.07034367,Low,0.391,0.156,0.174,0.079,Variable effect (p=0.014),Variable effect (p=0.036),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00019,rs477010,17,76567315,CR1,SNP (A/T),(A/,A,1.25,0.98,1.53,0.0328495,Low,0.054,0.534,0.101,0.111,Mild decrease (p=0.025),Significant decrease (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP00020,rs777115,16,160957051,ABCA7,SNP (A/G),(A/,A,0.76,0.37,1.1,0.06067641,High,0.249,0.127,0.221,0.203,Variable effect (p=0.005),Mild decrease (p=0.011),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00021,rs372675,17,103447048,APOE,SNP (A/C),(A/,A,0.61,0.35,0.88,0.00184848,High,0.21,0.385,0.192,0.013,Significant increase (p=0.048),Mild increase (p=0.015),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00022,rs561561,7,21142948,ABCA7,SNP (A/G),(A/,A,1.29,0.96,1.53,0.01247225,Moderate,0.06,0.12,0.334,0.286,Mild increase (p=0.041),Variable effect (p=0.009),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00023,rs397725,17,70403928,TREM2,SNP (C/T),(C/,C,1.08,0.72,1.31,0.03851688,High,0.038,0.216,0.053,0.494,Significant decrease (p=0.046),No significant pattern (p=0.036),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00024,rs439988,20,104084340,MS4A6A,SNP (A/C),(A/,A,1.59,1.27,1.96,0.07078228,Moderate,0.077,0.346,0.314,0.063,Mild decrease (p=0.041),Variable effect (p=0.014),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP00025,rs491987,1,44025791,APP,SNP (A/T),(A/,A,0.6,0.37,0.93,0.01937993,Low,0.19,0.068,0.458,0.084,Significant decrease (p=0.035),Mild increase (p=0.019),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00026,rs566509,18,83529554,SORL1,SNP (C/G),(C/,C,0.64,0.37,0.9,0.15592579,High,0.289,0.006,0.373,0.131,Significant increase (p=0.018),No significant pattern (p=0.009),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00027,rs950121,4,81154891,EPHA1,SNP (A/T),(A/,A,1.28,0.89,1.67,0.12920867,High,0.224,0.209,0.262,0.105,Variable effect (p=0.006),No significant pattern (p=0.009),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00028,rs598935,13,54712042,EPHA1,SNP (C/G),(C/,C,1.69,1.47,1.94,0.0354866,Low,0.059,0.044,0.417,0.28,Significant increase (p=0.037),Significant decrease (p=0.029),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00029,rs227312,1,131513522,CR1,SNP (G/T),(G/,G,0.92,0.6,1.14,0.03585985,Moderate,0.053,0.216,0.337,0.194,No significant pattern (p=0.013),No significant pattern (p=0.035),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00030,rs941543,20,36607740,APP,Deletion,-,-,0.36,0.1,0.71,0.02197659,Protective,0.047,0.031,0.521,0.201,Significant increase (p=0.026),Variable effect (p=0.025),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00031,rs831439,17,236009421,APP,SNP (G/T),(G/,G,0.52,0.27,0.87,0.00047657,Low,0.158,0.049,0.407,0.187,Mild increase (p=0.012),Significant decrease (p=0.042),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00032,rs453040,9,39265512,PSEN2,Insertion,-,-,1.01,0.65,1.35,0.00527796,Moderate,0.306,0.012,0.207,0.274,Variable effect (p=0.024),Significant increase (p=0.033),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00033,rs970426,7,6872031,PSEN2,SNP (A/G),(A/,A,0.47,0.16,0.83,0.0646608,Moderate,0.304,0.381,0.063,0.052,Mild increase (p=0.04),Significant decrease (p=0.019),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00034,rs766317,1,194505584,ABCA7,Deletion,-,-,1.33,0.99,1.67,0.00332001,Moderate,0.26,0.273,0.164,0.104,Variable effect (p=0.034),Significant decrease (p=0.046),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00035,rs158448,15,5167036,TREM2,SNP (C/G),(C/,C,1.28,0.9,1.61,0.04454131,Protective,0.029,0.123,0.534,0.114,Significant decrease (p=0.019),Significant increase (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00036,rs233299,9,201858837,EPHA1,SNP (A/T),(A/,A,1.07,0.74,1.42,0.04255854,Moderate,0.301,0.132,0.038,0.329,Significant decrease (p=0.008),Significant decrease (p=0.007),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00037,rs837773,3,118728811,APOE,SNP (C/T),(C/,C,0.83,0.49,1.16,0.02021698,Moderate,0.104,0.178,0.008,0.51,Significant decrease (p=0.041),Variable effect (p=0.027),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00038,rs158816,21,173991305,CD2AP,SNP (C/T),(C/,C,1.22,0.91,1.44,0.05503248,Moderate,0.083,0.024,0.414,0.28,Mild increase (p=0.004),Variable effect (p=0.045),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00039,rs134282,17,134701016,PICALM,SNP (G/T),(G/,G,1.69,1.32,1.9,0.06565676,Unknown,0.17,0.081,0.416,0.133,No significant pattern (p=0.033),Mild increase (p=0.045),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00040,rs213858,5,71255542,SORL1,Deletion,-,-,1.18,0.85,1.53,0.0652123,Low,0.064,0.471,0.018,0.247,Variable effect (p=0.016),Significant decrease (p=0.027),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00041,rs931164,9,230526790,CD33,SNP (A/G),(A/,A,1.18,0.84,1.48,0.04419966,High,0.324,0.212,0.243,0.021,Variable effect (p=0.036),Significant increase (p=0.005),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00042,rs874860,10,179203156,ABCA7,Insertion,-,-,0.56,0.31,0.82,0.00528409,Moderate,0.19,0.295,0.213,0.103,Mild increase (p=0.036),Mild increase (p=0.016),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00043,rs449321,2,153129865,APOE,SNP (C/G),(C/,C,1.71,1.5,2.1,0.02001338,Moderate,0.409,0.052,0.251,0.087,Mild decrease (p=0.026),Mild increase (p=0.022),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00044,rs149582,17,4627290,SORL1,SNP (C/T),(C/,C,1.99,1.59,2.28,0.00576175,High,0.259,0.179,0.055,0.307,Variable effect (p=0.04),Mild decrease (p=0.012),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00045,rs596951,13,158045099,PTK2B,SNP (A/G),(A/,A,0.62,0.39,0.84,0.01728292,High,0.025,0.317,0.455,0.003,Mild decrease (p=0.041),No significant pattern (p=0.015),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP00046,rs727064,18,172699761,EPHA1,SNP (A/T),(A/,A,2.16,1.86,2.56,0.0344321,Low,0.121,0.16,0.063,0.456,Mild decrease (p=0.021),Variable effect (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00047,rs865450,9,45727932,PICALM,Insertion,-,-,0.66,0.31,0.88,0.00703224,Low,0.075,0.12,0.064,0.54,Significant decrease (p=0.036),Variable effect (p=0.013),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00048,rs247115,1,81594924,CR1,SNP (A/T),(A/,A,1.13,0.91,1.43,0.09836266,High,0.196,0.139,0.213,0.252,Mild decrease (p=0.023),No significant pattern (p=0.007),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00049,rs742278,21,128402974,CLU,Insertion,-,-,1.02,0.79,1.34,0.06156571,High,0.3,0.111,0.007,0.382,No significant pattern (p=0.042),Mild decrease (p=0.042),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00050,rs774878,10,105254901,PSEN2,SNP (A/C),(A/,A,1.23,0.88,1.54,0.0229855,Low,0.003,0.344,0.295,0.158,No significant pattern (p=0.044),Variable effect (p=0.039),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP00051,rs177667,8,108269938,CD33,SNP (A/C),(A/,A,0.66,0.33,0.97,0.07590788,High,0.456,0.04,0.069,0.235,Significant decrease (p=0.009),Significant decrease (p=0.036),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP00052,rs510775,12,109989673,CLU,SNP (A/C),(A/,A,0.86,0.65,1.12,0.00801734,Low,0.054,0.344,0.356,0.047,Significant increase (p=0.043),Significant decrease (p=0.008),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP00053,rs200274,9,54821828,SORL1,SNP (C/G),(C/,C,1.78,1.39,2.09,0.03015463,Moderate,0.537,0.023,0.17,0.07,Significant decrease (p=0.047),Mild decrease (p=0.011),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP00054,rs297607,20,184856863,MS4A6A,SNP (A/C),(A/,A,2.58,2.32,2.86,0.02992124,High,0.473,0.141,0.112,0.074,Significant increase (p=0.04),Variable effect (p=0.026),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00055,rs805740,16,226770384,MS4A6A,SNP (A/G),(A/,A,1.28,0.91,1.51,0.01043742,Protective,0.001,0.212,0.57,0.018,Significant decrease (p=0.028),Variable effect (p=0.047),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00056,rs996627,7,144159629,APP,Deletion,-,-,0.69,0.39,0.91,0.01093214,Moderate,0.056,0.367,0.156,0.221,Mild increase (p=0.034),Significant increase (p=0.047),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00057,rs358649,2,122513988,CD33,SNP (C/G),(C/,C,1.35,1.02,1.74,0.0767025,Moderate,0.127,0.299,0.326,0.048,Significant decrease (p=0.049),Variable effect (p=0.033),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00058,rs590523,17,181099646,MS4A6A,SNP (C/T),(C/,C,1.12,0.77,1.34,0.04073834,Moderate,0.049,0.084,0.465,0.202,Mild decrease (p=0.049),No significant pattern (p=0.032),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00059,rs961710,1,243291237,TREM2,SNP (A/C),(A/,A,1.4,1.17,1.61,0.01283582,Moderate,0.09,0.341,0.003,0.366,No significant pattern (p=0.048),Variable effect (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00060,rs596983,18,47419910,ABCA7,SNP (A/C),(A/,A,0.61,0.23,0.95,0.04224487,Moderate,0.014,0.165,0.04,0.581,Mild increase (p=0.012),Mild increase (p=0.024),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00061,rs704983,8,114588545,BIN1,SNP (A/C),(A/,A,1.78,1.4,2.0,0.04646533,High,0.267,0.233,0.11,0.19,Mild decrease (p=0.035),Mild increase (p=0.01),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00062,rs558109,2,237026558,APP,Insertion,-,-,0.75,0.47,0.98,0.07836762,High,0.039,0.307,0.249,0.204,Variable effect (p=0.033),Significant decrease (p=0.015),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00063,rs677542,11,161103211,APP,SNP (G/T),(G/,G,0.74,0.43,0.97,0.14373908,High,0.121,0.473,0.072,0.134,Mild decrease (p=0.04),Mild increase (p=0.027),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00064,rs975720,14,244515931,CD33,Insertion,-,-,1.58,1.29,1.98,0.02862101,High,0.337,0.137,0.104,0.221,Significant decrease (p=0.016),Variable effect (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP00065,rs368001,19,246186984,CD33,SNP (A/C),(A/,A,1.25,0.88,1.63,0.0860069,Unknown,0.167,0.055,0.286,0.291,Mild increase (p=0.007),Mild decrease (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00066,rs291067,20,245188415,CD2AP,SNP (C/G),(C/,C,0.97,0.74,1.28,0.00297562,Protective,0.134,0.025,0.082,0.559,Mild increase (p=0.004),No significant pattern (p=0.019),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00067,rs593323,8,143946426,APOE,SNP (C/T),(C/,C,1.61,1.24,1.9,0.00904173,High,0.598,0.086,0.09,0.025,Variable effect (p=0.023),Mild decrease (p=0.034),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00068,rs799982,5,118471426,CD2AP,SNP (A/T),(A/,A,0.68,0.29,1.07,0.02496784,Moderate,0.09,0.301,0.202,0.207,No significant pattern (p=0.01),Mild decrease (p=0.013),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00069,rs411053,14,51184753,CLU,SNP (C/T),(C/,C,1.27,1.06,1.64,0.00092318,Protective,0.252,0.417,0.063,0.067,Mild decrease (p=0.033),Mild decrease (p=0.035),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00070,rs295896,16,150066558,EPHA1,SNP (C/T),(C/,C,1.39,1.16,1.69,0.00194457,Moderate,0.171,0.071,0.525,0.034,Mild decrease (p=0.036),Significant decrease (p=0.022),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP00071,rs452282,11,94613694,SORL1,SNP (A/C),(A/,A,0.95,0.61,1.17,0.05202861,Moderate,0.109,0.493,0.163,0.035,Mild decrease (p=0.028),Significant increase (p=0.005),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00072,rs594787,9,229856791,CD33,SNP (C/G),(C/,C,1.98,1.67,2.33,0.00206807,Moderate,0.357,0.251,0.058,0.134,Significant decrease (p=0.018),No significant pattern (p=0.033),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00073,rs916862,17,14907867,EPHA1,SNP (A/C),(A/,A,0.99,0.79,1.28,0.00110788,High,0.034,0.073,0.065,0.628,Significant decrease (p=0.005),Mild increase (p=0.014),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00074,rs166580,22,80769640,EPHA1,SNP (C/T),(C/,C,0.84,0.52,1.05,0.04349035,High,0.008,0.225,0.509,0.058,Variable effect (p=0.001),Significant decrease (p=0.021),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP00075,rs396149,5,154603697,PTK2B,SNP (G/T),(G/,G,1.05,0.78,1.34,0.06681114,Unknown,0.024,0.338,0.422,0.016,Mild decrease (p=0.05),No significant pattern (p=0.016),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00076,rs823543,9,125546678,APOE,SNP (C/G),(C/,C,0.85,0.61,1.23,0.015719,Moderate,0.031,0.024,0.085,0.659,No significant pattern (p=0.043),Significant decrease (p=0.035),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00077,rs151974,5,233032274,BIN1,SNP (C/G),(C/,C,0.8,0.44,1.02,0.00351756,High,0.145,0.011,0.111,0.533,Significant decrease (p=0.025),Significant decrease (p=0.028),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP00078,rs423253,14,62551312,APP,Insertion,-,-,1.43,1.17,1.78,0.00641482,Unknown,0.13,0.007,0.444,0.219,No significant pattern (p=0.033),Mild decrease (p=0.005),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00079,rs464755,4,240202886,ABCA7,SNP (A/C),(A/,A,1.12,0.73,1.43,0.00599842,Protective,0.025,0.433,0.162,0.179,Variable effect (p=0.023),Mild decrease (p=0.042),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00080,rs649911,7,18414045,ABCA7,SNP (A/T),(A/,A,0.72,0.49,1.1,0.01649019,High,0.105,0.014,0.551,0.13,No significant pattern (p=0.009),Mild decrease (p=0.013),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00081,rs195036,3,243710182,CLU,SNP (C/T),(C/,C,1.26,0.99,1.5,0.02014891,High,0.321,0.057,0.192,0.229,Significant increase (p=0.04),Mild decrease (p=0.009),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00082,rs629068,18,44710510,CD33,SNP (G/T),(G/,G,0.4,0.1,0.66,0.00267847,Low,0.587,0.085,0.047,0.081,No significant pattern (p=0.025),Significant decrease (p=0.019),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00083,rs601798,6,65841020,EPHA1,Insertion,-,-,0.58,0.25,0.97,0.01268521,Moderate,0.1,0.002,0.219,0.479,Significant increase (p=0.018),Mild decrease (p=0.033),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00084,rs704111,17,65858708,CD2AP,Deletion,-,-,1.5,1.13,1.78,0.00902567,Unknown,0.013,0.455,0.111,0.222,Significant increase (p=0.016),Significant decrease (p=0.015),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00085,rs824542,11,59270536,TREM2,SNP (C/G),(C/,C,0.58,0.24,0.84,0.01307538,High,0.094,0.135,0.375,0.196,Mild decrease (p=0.046),Mild decrease (p=0.004),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP00086,rs735340,3,158875565,APP,Insertion,-,-,0.83,0.59,1.09,0.03647348,Protective,0.03,0.494,0.135,0.14,Significant increase (p=0.013),Variable effect (p=0.002),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00087,rs558266,21,121797249,MS4A6A,SNP (G/T),(G/,G,0.51,0.28,0.76,0.00596593,Moderate,0.212,0.311,0.129,0.148,Significant increase (p=0.004),Mild decrease (p=0.014),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00088,rs969630,3,165327341,CLU,Deletion,-,-,0.79,0.58,1.13,0.03794265,High,0.571,0.026,0.151,0.052,Significant increase (p=0.047),Significant decrease (p=0.023),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00089,rs399973,13,84772829,BIN1,Insertion,-,-,1.42,1.05,1.81,0.00703353,Moderate,0.035,0.199,0.278,0.289,Variable effect (p=0.003),Variable effect (p=0.019),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP00090,rs926793,1,225067854,ABCA7,SNP (A/C),(A/,A,1.08,0.69,1.36,0.03668563,Moderate,0.062,0.346,0.155,0.236,Significant increase (p=0.004),Significant decrease (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP00091,rs115579,12,46490069,CD33,SNP (C/T),(C/,C,1.24,0.85,1.59,0.12257405,Low,0.045,0.348,0.115,0.292,Mild increase (p=0.048),Mild increase (p=0.046),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00092,rs375426,15,232179771,TREM2,SNP (A/C),(A/,A,1.24,0.85,1.56,0.00891048,High,0.134,0.192,0.438,0.035,No significant pattern (p=0.022),Significant decrease (p=0.017),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00093,rs502862,9,52215926,MS4A6A,SNP (A/T),(A/,A,1.53,1.26,1.79,0.00476444,High,0.18,0.219,0.251,0.15,Significant decrease (p=0.006),Significant increase (p=0.048),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00094,rs612584,9,75169800,PICALM,SNP (A/G),(A/,A,1.5,1.15,1.87,0.00174332,Low,0.092,0.091,0.235,0.382,Significant increase (p=0.044),No significant pattern (p=0.024),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00095,rs632112,4,67675311,PICALM,Deletion,-,-,0.69,0.44,0.95,0.10094278,Moderate,0.43,0.296,0.004,0.069,Significant decrease (p=0.018),Mild decrease (p=0.005),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00096,rs717080,16,46738776,TREM2,SNP (A/C),(A/,A,0.66,0.4,1.02,0.07366856,High,0.214,0.196,0.215,0.175,Significant increase (p=0.011),Variable effect (p=0.014),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00097,rs272236,12,93287415,EPHA1,SNP (G/T),(G/,G,2.01,1.66,2.37,0.0070094,High,0.049,0.399,0.186,0.165,Significant decrease (p=0.007),No significant pattern (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00098,rs408896,3,106036982,CD33,SNP (A/C),(A/,A,0.63,0.37,1.03,0.00855511,Moderate,0.276,0.004,0.384,0.135,Significant increase (p=0.032),Variable effect (p=0.025),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP00099,rs345882,6,216059868,CR1,SNP (C/G),(C/,C,0.79,0.47,1.01,0.00516027,High,0.304,0.321,0.005,0.17,Significant decrease (p=0.011),Mild increase (p=0.008),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00100,rs455327,13,196398802,SORL1,SNP (A/T),(A/,A,0.61,0.39,0.89,0.01373267,Low,0.009,0.52,0.104,0.167,Significant increase (p=0.012),No significant pattern (p=0.043),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00101,rs613622,4,190873407,SORL1,SNP (A/G),(A/,A,0.97,0.76,1.31,0.06496825,Moderate,0.081,0.009,0.561,0.149,Mild increase (p=0.029),Mild increase (p=0.019),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00102,rs934840,5,234409437,CD33,SNP (C/T),(C/,C,0.75,0.47,1.14,0.07493193,Moderate,0.158,0.41,0.188,0.043,No significant pattern (p=0.015),Significant decrease (p=0.02),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00103,rs775807,15,218549375,CD2AP,SNP (G/T),(G/,G,0.75,0.4,0.98,0.03711495,Moderate,0.046,0.092,0.417,0.244,No significant pattern (p=0.031),Mild increase (p=0.002),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00104,rs991258,8,174969954,CD2AP,SNP (G/T),(G/,G,1.04,0.82,1.33,0.0207362,High,0.127,0.205,0.048,0.42,Significant increase (p=0.005),Significant decrease (p=0.05),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP00105,rs863551,22,230635451,TREM2,SNP (C/T),(C/,C,1.79,1.5,2.17,0.00388218,Low,0.207,0.05,0.03,0.513,Significant decrease (p=0.035),Significant decrease (p=0.009),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00106,rs866670,11,89077774,APOE,SNP (C/G),(C/,C,0.53,0.22,0.79,0.0101313,Low,0.481,0.045,0.19,0.083,Significant decrease (p=0.002),Significant increase (p=0.02),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00107,rs173857,16,65332372,APP,Deletion,-,-,0.64,0.29,0.98,0.00523524,Moderate,0.393,0.019,0.033,0.355,Variable effect (p=0.012),Significant increase (p=0.039),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP00108,rs341736,21,223293298,SORL1,SNP (G/T),(G/,G,0.5,0.18,0.86,0.00729404,High,0.081,0.575,0.115,0.029,Mild decrease (p=0.006),Significant increase (p=0.042),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00109,rs284176,10,88668651,TREM2,SNP (C/T),(C/,C,1.26,0.94,1.56,0.00257929,High,0.063,0.067,0.428,0.242,Significant increase (p=0.024),Mild decrease (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00110,rs395917,12,163235395,PSEN2,SNP (G/T),(G/,G,0.74,0.48,1.12,0.09299322,Low,0.195,0.262,0.228,0.115,No significant pattern (p=0.022),Mild decrease (p=0.012),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00111,rs523417,3,90764038,MS4A6A,Deletion,-,-,1.73,1.51,1.96,0.01512741,High,0.109,0.006,0.669,0.016,Significant increase (p=0.019),Significant increase (p=0.017),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00112,rs957264,16,85786211,PICALM,SNP (C/G),(C/,C,0.74,0.53,1.1,0.01018439,High,0.103,0.052,0.507,0.137,Mild increase (p=0.012),No significant pattern (p=0.02),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00113,rs822605,2,97799399,CR1,SNP (C/T),(C/,C,1.42,1.12,1.68,0.08929669,Moderate,0.318,0.109,0.089,0.284,Mild increase (p=0.04),Significant decrease (p=0.031),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00114,rs187449,18,246844116,CD33,SNP (A/C),(A/,A,0.97,0.64,1.36,0.04697968,Low,0.181,0.289,0.17,0.16,Variable effect (p=0.049),Mild decrease (p=0.025),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP00115,rs425963,20,46367510,SORL1,SNP (A/G),(A/,A,1.22,0.86,1.57,0.00130921,Low,0.201,0.39,0.117,0.092,Variable effect (p=0.036),Mild increase (p=0.022),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00116,rs546908,21,85381357,CD2AP,SNP (A/C),(A/,A,1.52,1.17,1.87,0.02681614,High,0.053,0.393,0.179,0.175,Variable effect (p=0.022),Variable effect (p=0.006),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00117,rs371945,18,27451359,PSEN2,SNP (A/C),(A/,A,0.55,0.34,0.91,0.01658976,Low,0.157,0.285,0.177,0.182,Significant decrease (p=0.008),Significant decrease (p=0.037),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00118,rs622096,2,156760494,APOE,SNP (C/G),(C/,C,1.69,1.36,1.97,0.08857473,High,0.04,0.136,0.209,0.415,Significant decrease (p=0.023),Mild decrease (p=0.024),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00119,rs689164,6,133922361,ABCA7,SNP (A/G),(A/,A,0.61,0.33,0.82,0.00893819,Moderate,0.148,0.162,0.349,0.141,Mild decrease (p=0.029),Variable effect (p=0.027),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00120,rs278928,15,125657862,BIN1,SNP (A/C),(A/,A,0.9,0.69,1.22,0.04148264,Moderate,0.261,0.344,0.151,0.044,Significant increase (p=0.028),Mild increase (p=0.013),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00121,rs585913,6,2711391,APOE,SNP (C/G),(C/,C,0.88,0.55,1.23,0.0827745,High,0.197,0.287,0.275,0.041,Mild increase (p=0.024),Mild increase (p=0.014),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00122,rs783351,17,40431505,APP,SNP (C/G),(C/,C,0.78,0.48,1.1,0.00146275,Moderate,0.155,0.231,0.374,0.04,Significant increase (p=0.03),Variable effect (p=0.006),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00123,rs189738,3,132819986,CD33,Insertion,-,-,1.15,0.88,1.54,0.04706258,Moderate,0.116,0.201,0.301,0.183,Significant decrease (p=0.028),Mild decrease (p=0.029),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00124,rs921410,17,186207961,MS4A6A,Insertion,-,-,0.7,0.4,0.92,0.01307961,Low,0.234,0.264,0.261,0.041,Significant increase (p=0.024),Mild decrease (p=0.04),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00125,rs806954,12,192437811,CR1,SNP (C/G),(C/,C,1.39,1.15,1.65,0.07230381,High,0.169,0.076,0.367,0.188,Mild decrease (p=0.036),Significant decrease (p=0.045),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP00126,rs424423,12,170229593,ABCA7,Deletion,-,-,1.29,0.98,1.65,0.0505943,High,0.035,0.084,0.489,0.193,Significant increase (p=0.007),Variable effect (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00127,rs764422,2,141948950,CD2AP,Insertion,-,-,0.73,0.36,1.07,0.01772579,Moderate,0.222,0.045,0.476,0.056,No significant pattern (p=0.017),Significant increase (p=0.026),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP00128,rs691897,6,162861093,PICALM,SNP (A/T),(A/,A,1.0,0.77,1.23,0.00981607,High,0.179,0.081,0.443,0.097,Significant increase (p=0.025),Mild increase (p=0.047),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00129,rs272023,1,45606221,CD2AP,Deletion,-,-,1.21,0.86,1.45,0.00652137,Low,0.246,0.003,0.04,0.511,Variable effect (p=0.024),Variable effect (p=0.021),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00130,rs665274,4,187650682,CD2AP,SNP (A/T),(A/,A,1.58,1.24,1.83,0.0117453,Moderate,0.092,0.138,0.451,0.119,No significant pattern (p=0.008),Mild increase (p=0.026),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00131,rs227050,9,53126384,PSEN2,SNP (G/T),(G/,G,3.05,2.77,3.39,0.0865643,Moderate,0.003,0.062,0.688,0.046,Significant increase (p=0.03),Mild decrease (p=0.015),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00132,rs589700,8,211206064,SORL1,Deletion,-,-,0.47,0.17,0.78,0.00743096,Low,0.014,0.568,0.132,0.087,Variable effect (p=0.013),Variable effect (p=0.032),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00133,rs832241,13,62365328,TREM2,SNP (A/G),(A/,A,0.66,0.4,1.03,0.09320003,Moderate,0.135,0.018,0.219,0.427,Variable effect (p=0.008),Significant increase (p=0.023),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00134,rs402744,6,80012000,CLU,SNP (A/C),(A/,A,1.7,1.44,2.05,0.00021728,High,0.295,0.145,0.349,0.01,Variable effect (p=0.047),Significant decrease (p=0.011),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00135,rs613656,22,3189002,APP,SNP (G/T),(G/,G,0.88,0.59,1.26,0.01690543,Protective,0.109,0.171,0.169,0.35,Significant increase (p=0.039),Significant decrease (p=0.034),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP00136,rs419586,16,10054985,BIN1,SNP (C/G),(C/,C,0.53,0.21,0.8,0.00564234,Moderate,0.262,0.143,0.094,0.302,Variable effect (p=0.046),Significant increase (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP00137,rs222304,11,165381483,EPHA1,SNP (C/T),(C/,C,0.4,0.1,0.7,0.0052749,Low,0.365,0.101,0.014,0.321,Mild increase (p=0.03),Significant increase (p=0.024),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00138,rs421613,1,171879022,PSEN2,SNP (A/T),(A/,A,1.86,1.47,2.07,0.00411891,High,0.431,0.106,0.19,0.073,Significant decrease (p=0.047),Variable effect (p=0.023),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00139,rs450675,19,125362831,MS4A6A,SNP (C/G),(C/,C,0.81,0.54,1.13,0.03676852,Moderate,0.192,0.114,0.247,0.247,Significant decrease (p=0.048),Significant increase (p=0.041),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00140,rs886967,14,13395532,CLU,Deletion,-,-,1.36,1.08,1.57,0.0293026,Moderate,0.045,0.428,0.042,0.284,Significant decrease (p=0.017),Mild decrease (p=0.012),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00141,rs597553,14,232936312,MS4A6A,SNP (A/G),(A/,A,0.58,0.24,0.85,0.00022453,Low,0.194,0.264,0.287,0.056,Mild increase (p=0.046),Significant increase (p=0.018),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00142,rs571886,22,1900058,TREM2,Deletion,-,-,0.48,0.21,0.87,0.01547156,Low,0.15,0.33,0.183,0.137,No significant pattern (p=0.025),Variable effect (p=0.043),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP00143,rs830219,13,145239257,CD33,SNP (C/T),(C/,C,2.8,2.58,3.13,0.02160379,Unknown,0.39,0.144,0.06,0.206,Mild decrease (p=0.025),Mild decrease (p=0.045),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00144,rs938330,5,213269286,ABCA7,Deletion,-,-,1.7,1.44,1.93,0.15469777,High,0.201,0.106,0.449,0.045,Significant increase (p=0.024),Significant decrease (p=0.022),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00145,rs279552,11,7422676,PSEN2,Insertion,-,-,1.01,0.79,1.37,0.01497923,Protective,0.105,0.324,0.166,0.206,Significant increase (p=0.029),Significant decrease (p=0.049),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00146,rs721943,2,181632336,PICALM,SNP (A/T),(A/,A,2.65,2.36,2.94,0.00550799,Protective,0.206,0.279,0.018,0.298,Significant increase (p=0.037),Mild decrease (p=0.007),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00147,rs759682,18,149423383,APOE,SNP (A/C),(A/,A,0.9,0.68,1.15,0.01167788,Low,0.05,0.086,0.284,0.379,Significant decrease (p=0.039),Mild increase (p=0.03),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP00148,rs974614,6,130666154,PTK2B,SNP (A/T),(A/,A,0.75,0.47,1.12,0.01531573,Low,0.037,0.355,0.207,0.201,No significant pattern (p=0.041),Variable effect (p=0.048),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00149,rs283893,10,84630919,TREM2,SNP (G/T),(G/,G,0.95,0.66,1.24,0.05496138,Unknown,0.263,0.088,0.294,0.155,Mild decrease (p=0.004),Significant increase (p=0.039),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00150,rs794474,3,226418052,PSEN2,SNP (A/T),(A/,A,0.86,0.51,1.09,0.0240712,Moderate,0.084,0.025,0.191,0.5,Mild increase (p=0.023),Significant increase (p=0.015),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP00151,rs238525,22,159133761,APOE,SNP (A/C),(A/,A,0.59,0.27,0.84,0.03110804,High,0.317,0.116,0.131,0.235,Significant decrease (p=0.013),Variable effect (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00152,rs567988,5,89186595,CR1,SNP (C/G),(C/,C,0.44,0.17,0.83,0.00018591,Low,0.322,0.125,0.208,0.145,Variable effect (p=0.048),Significant decrease (p=0.005),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00153,rs722866,17,156313394,MS4A6A,Deletion,-,-,1.2,0.87,1.5,0.01006601,Protective,0.07,0.267,0.275,0.188,Mild increase (p=0.025),Significant increase (p=0.012),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00154,rs445138,1,11929828,CLU,SNP (A/C),(A/,A,1.27,1.01,1.5,0.04542582,High,0.092,0.131,0.394,0.184,Significant decrease (p=0.014),Significant increase (p=0.006),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00155,rs543659,10,122893104,APOE,SNP (C/G),(C/,C,0.58,0.3,0.8,0.00089542,Low,0.23,0.037,0.456,0.077,Mild increase (p=0.016),Mild increase (p=0.02),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00156,rs487645,9,236579094,PICALM,SNP (A/T),(A/,A,0.89,0.59,1.27,0.01962649,High,0.087,0.126,0.172,0.415,Mild decrease (p=0.01),Mild increase (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP00157,rs639723,22,186689920,BIN1,SNP (A/G),(A/,A,1.23,0.86,1.58,0.01536122,Moderate,0.061,0.346,0.288,0.105,Significant increase (p=0.005),Significant decrease (p=0.041),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00158,rs333606,19,83388324,APP,SNP (A/T),(A/,A,0.65,0.26,0.95,0.06793119,High,0.016,0.459,0.289,0.036,No significant pattern (p=0.003),Significant increase (p=0.029),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP00159,rs239064,12,167750650,PTK2B,Insertion,-,-,1.5,1.22,1.88,0.02294115,Unknown,0.132,0.339,0.193,0.135,No significant pattern (p=0.033),Mild decrease (p=0.033),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00160,rs163170,6,173183570,SORL1,SNP (A/C),(A/,A,2.11,1.76,2.45,0.0425048,Unknown,0.017,0.23,0.055,0.498,No significant pattern (p=0.011),Significant decrease (p=0.021),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00161,rs320023,1,65009112,TREM2,SNP (G/T),(G/,G,1.56,1.34,1.88,0.00818377,Moderate,0.349,0.059,0.19,0.202,Mild increase (p=0.031),Variable effect (p=0.021),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00162,rs373721,9,159509874,SORL1,Insertion,-,-,1.45,1.18,1.65,0.00583968,Moderate,0.057,0.21,0.366,0.167,Variable effect (p=0.045),Significant increase (p=0.04),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00163,rs422956,11,51366674,APOE,SNP (C/G),(C/,C,1.21,0.96,1.52,0.04418242,High,0.122,0.291,0.195,0.192,Significant decrease (p=0.019),Significant decrease (p=0.007),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP00164,rs510416,5,29392660,CD2AP,SNP (A/G),(A/,A,0.26,0.1,0.62,0.07073394,Moderate,0.367,0.112,0.214,0.108,No significant pattern (p=0.036),Variable effect (p=0.011),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP00165,rs881335,17,76211752,SORL1,SNP (A/C),(A/,A,0.91,0.59,1.18,0.03990842,Moderate,0.191,0.032,0.204,0.373,Variable effect (p=0.015),Mild increase (p=0.044),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00166,rs608271,7,48135632,PTK2B,SNP (C/G),(C/,C,0.91,0.64,1.13,0.00147562,High,0.517,0.137,0.07,0.076,Mild decrease (p=0.042),No significant pattern (p=0.039),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00167,rs467699,7,225633994,PTK2B,SNP (A/C),(A/,A,0.73,0.37,1.03,0.04743213,Low,0.25,0.365,0.181,0.004,Variable effect (p=0.007),Mild increase (p=0.01),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00168,rs720407,4,155863508,APP,SNP (G/T),(G/,G,0.75,0.42,1.09,0.01317078,Moderate,0.27,0.392,0.011,0.127,Significant decrease (p=0.038),Variable effect (p=0.035),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00169,rs934956,22,161946601,PICALM,Deletion,-,-,0.52,0.32,0.85,0.03576155,High,0.357,0.417,0.02,0.006,Variable effect (p=0.021),No significant pattern (p=0.022),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00170,rs372245,4,120595408,SORL1,SNP (G/T),(G/,G,0.95,0.73,1.21,0.05627454,Low,0.504,0.006,0.03,0.26,Mild increase (p=0.02),Significant increase (p=0.011),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00171,rs140195,16,155310317,MS4A6A,SNP (A/C),(A/,A,1.32,1.1,1.58,0.03093725,Moderate,0.561,0.085,0.042,0.112,Mild decrease (p=0.006),Significant increase (p=0.024),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP00172,rs440972,10,196468193,MS4A6A,SNP (A/C),(A/,A,0.59,0.33,0.88,0.11798426,High,0.248,0.097,0.379,0.076,Variable effect (p=0.019),Mild decrease (p=0.002),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00173,rs878096,17,113830631,CR1,Insertion,-,-,1.13,0.81,1.38,0.00394972,Moderate,0.007,0.281,0.48,0.032,Variable effect (p=0.005),Variable effect (p=0.034),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00174,rs118813,15,223279413,EPHA1,SNP (C/T),(C/,C,0.73,0.48,1.01,0.11616569,Low,0.192,0.252,0.059,0.296,Variable effect (p=0.003),Significant increase (p=0.03),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00175,rs512315,10,131486393,MS4A6A,SNP (A/G),(A/,A,1.31,1.04,1.61,0.03792462,Moderate,0.409,0.113,0.057,0.221,Variable effect (p=0.014),Mild decrease (p=0.032),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00176,rs803991,13,25636696,SORL1,SNP (A/C),(A/,A,1.61,1.27,1.99,0.0264697,High,0.187,0.152,0.215,0.246,No significant pattern (p=0.046),Significant decrease (p=0.024),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00177,rs593693,17,166047271,BIN1,Deletion,-,-,1.0,0.63,1.27,0.05692767,Moderate,0.328,0.332,0.039,0.102,Significant decrease (p=0.03),Mild decrease (p=0.042),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00178,rs102195,2,131765656,PTK2B,SNP (A/T),(A/,A,1.1,0.7,1.43,0.04014169,Moderate,0.154,0.286,0.333,0.027,Variable effect (p=0.018),Mild decrease (p=0.048),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00179,rs295621,21,190127170,TREM2,SNP (A/C),(A/,A,0.75,0.55,1.05,0.00294042,Low,0.162,0.301,0.02,0.317,Mild decrease (p=0.004),Variable effect (p=0.014),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00180,rs699358,16,195445093,CR1,SNP (C/T),(C/,C,1.55,1.25,1.81,0.04683967,High,0.345,0.184,0.265,0.006,Significant increase (p=0.023),No significant pattern (p=0.003),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00181,rs993970,12,145490807,SORL1,SNP (C/T),(C/,C,2.54,2.16,2.82,0.04120438,Moderate,0.085,0.247,0.141,0.328,Significant decrease (p=0.013),Mild increase (p=0.049),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00182,rs619863,13,234451908,ABCA7,Insertion,-,-,0.78,0.47,1.09,0.02297901,Low,0.217,0.48,0.029,0.074,Significant decrease (p=0.022),Significant increase (p=0.025),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00183,rs272821,17,74782164,SORL1,SNP (G/T),(G/,G,1.88,1.66,2.23,0.00923883,Moderate,0.022,0.004,0.012,0.761,Mild decrease (p=0.037),Significant increase (p=0.044),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00184,rs419273,13,237114661,APP,SNP (G/T),(G/,G,0.66,0.28,0.91,0.04756508,Unknown,0.248,0.456,0.005,0.091,Significant increase (p=0.036),No significant pattern (p=0.029),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00185,rs945109,22,127401267,TREM2,Insertion,-,-,1.05,0.67,1.27,0.01234345,Low,0.153,0.067,0.022,0.558,Mild decrease (p=0.024),Significant increase (p=0.015),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00186,rs137286,18,223853168,MS4A6A,SNP (A/G),(A/,A,1.04,0.66,1.26,0.00469191,Moderate,0.016,0.226,0.393,0.166,Variable effect (p=0.026),Variable effect (p=0.031),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00187,rs951770,6,123607488,BIN1,Deletion,-,-,1.14,0.84,1.41,0.02178249,High,0.198,0.152,0.385,0.065,Mild increase (p=0.008),Mild decrease (p=0.044),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00188,rs116112,18,100723548,PICALM,SNP (A/C),(A/,A,0.86,0.51,1.14,0.05580554,Low,0.258,0.177,0.11,0.255,Mild decrease (p=0.004),No significant pattern (p=0.023),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00189,rs699581,18,103513363,PSEN2,SNP (G/T),(G/,G,1.6,1.33,1.95,0.02058217,Moderate,0.073,0.107,0.428,0.192,Significant increase (p=0.021),Mild increase (p=0.024),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00190,rs138463,17,231227636,CD33,SNP (C/T),(C/,C,1.21,0.99,1.46,0.00505102,Low,0.234,0.034,0.143,0.389,Significant increase (p=0.015),Mild increase (p=0.034),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00191,rs473679,16,185957682,CD33,SNP (A/G),(A/,A,0.39,0.16,0.72,0.03160865,Moderate,0.504,0.003,0.089,0.204,Mild increase (p=0.045),Significant increase (p=0.035),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00192,rs307328,16,174084501,ABCA7,Insertion,-,-,1.26,1.04,1.6,0.06114684,Moderate,0.323,0.021,0.431,0.025,Mild increase (p=0.014),Significant increase (p=0.001),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP00193,rs146977,20,38180754,ABCA7,SNP (A/G),(A/,A,1.04,0.67,1.38,0.01324865,High,0.017,0.445,0.199,0.139,Significant decrease (p=0.012),Significant decrease (p=0.014),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00194,rs351494,13,71522658,APP,SNP (A/G),(A/,A,0.49,0.13,0.88,0.00272619,Moderate,0.214,0.156,0.138,0.291,Mild decrease (p=0.042),Significant increase (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00195,rs326855,10,19164286,APP,SNP (A/C),(A/,A,1.87,1.58,2.16,0.00797583,High,0.271,0.119,0.045,0.366,Mild increase (p=0.013),Significant increase (p=0.023),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00196,rs472897,18,228498701,APP,SNP (A/C),(A/,A,0.73,0.43,0.94,0.00034104,High,0.43,0.011,0.067,0.292,Variable effect (p=0.023),Significant increase (p=0.035),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00197,rs988067,2,97626094,EPHA1,SNP (A/T),(A/,A,1.05,0.7,1.42,0.01114693,Protective,0.53,0.129,0.04,0.101,Mild increase (p=0.033),Variable effect (p=0.008),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00198,rs717870,13,183538001,BIN1,SNP (A/G),(A/,A,0.85,0.64,1.18,0.14412788,High,0.108,0.177,0.166,0.349,Significant decrease (p=0.006),Significant decrease (p=0.047),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00199,rs711911,22,96379009,CD33,SNP (C/T),(C/,C,0.66,0.45,1.02,0.03128049,Low,0.387,0.369,0.039,0.004,Significant increase (p=0.023),No significant pattern (p=0.038),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00200,rs219679,9,150411044,PTK2B,SNP (A/C),(A/,A,1.22,0.96,1.57,0.08268816,High,0.02,0.287,0.202,0.29,Significant decrease (p=0.031),Significant increase (p=0.016),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00201,rs581161,3,195175343,CLU,SNP (C/T),(C/,C,3.12,2.9,3.52,0.15234481,Low,0.107,0.193,0.107,0.394,No significant pattern (p=0.003),Significant increase (p=0.042),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00202,rs942841,14,227069690,PICALM,SNP (C/T),(C/,C,1.17,0.82,1.4,0.08810537,High,0.078,0.065,0.148,0.509,No significant pattern (p=0.04),Significant decrease (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00203,rs824255,17,93966083,PICALM,SNP (G/T),(G/,G,0.96,0.73,1.17,0.00272533,Low,0.119,0.075,0.156,0.451,No significant pattern (p=0.047),Significant decrease (p=0.024),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00204,rs498336,11,113465593,CLU,SNP (C/G),(C/,C,0.86,0.64,1.26,0.02479395,Moderate,0.4,0.03,0.202,0.168,No significant pattern (p=0.008),Significant increase (p=0.049),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP00205,rs919247,12,89331991,CD33,Insertion,-,-,0.92,0.63,1.31,0.04423012,High,0.048,0.075,0.242,0.435,No significant pattern (p=0.011),Significant increase (p=0.003),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00206,rs160098,20,157360448,PICALM,Insertion,-,-,0.91,0.57,1.19,0.0313541,Low,0.389,0.136,0.088,0.187,Variable effect (p=0.032),Variable effect (p=0.038),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00207,rs574934,22,95324111,APOE,SNP (A/C),(A/,A,2.05,1.73,2.26,0.00579043,High,0.542,0.143,0.047,0.069,Mild increase (p=0.033),Variable effect (p=0.02),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00208,rs194712,17,131123597,CD33,SNP (G/T),(G/,G,1.48,1.14,1.7,0.068608,Moderate,0.229,0.233,0.318,0.021,Mild increase (p=0.014),Mild increase (p=0.006),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00209,rs837447,22,167227913,CLU,Deletion,-,-,1.9,1.64,2.24,0.04080922,High,0.16,0.225,0.066,0.35,Mild decrease (p=0.002),Significant increase (p=0.041),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00210,rs767236,13,171213596,EPHA1,SNP (A/T),(A/,A,0.98,0.67,1.38,0.02612586,Moderate,0.155,0.066,0.349,0.229,Mild increase (p=0.049),Mild decrease (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00211,rs377591,20,68776859,PSEN2,SNP (A/G),(A/,A,1.56,1.16,1.88,0.05092014,Protective,0.431,0.204,0.094,0.071,Significant decrease (p=0.035),Significant increase (p=0.023),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00212,rs626141,19,190088371,PSEN2,SNP (A/C),(A/,A,3.1,2.9,3.31,0.00825676,Unknown,0.318,0.269,0.051,0.162,Significant increase (p=0.028),Variable effect (p=0.025),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00213,rs491739,18,248247866,CD2AP,SNP (A/G),(A/,A,0.73,0.45,0.96,0.0183595,Protective,0.1,0.17,0.237,0.293,Mild decrease (p=0.01),No significant pattern (p=0.042),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00214,rs484730,19,227372806,BIN1,Insertion,-,-,0.98,0.73,1.2,0.00326872,Moderate,0.111,0.077,0.232,0.38,Variable effect (p=0.023),Significant increase (p=0.047),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00215,rs459004,4,177341216,CD2AP,Insertion,-,-,0.58,0.2,0.89,0.0147387,Low,0.002,0.375,0.06,0.363,Significant decrease (p=0.011),Significant increase (p=0.04),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00216,rs225553,13,173229234,CLU,SNP (A/G),(A/,A,1.46,1.13,1.76,0.00909608,Low,0.01,0.728,0.054,0.007,Variable effect (p=0.01),Significant decrease (p=0.031),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00217,rs661550,8,114664687,PSEN2,SNP (C/T),(C/,C,1.2,0.87,1.6,0.01587709,Low,0.173,0.317,0.12,0.189,Mild decrease (p=0.035),Significant increase (p=0.026),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP00218,rs826325,11,161275768,APP,Deletion,-,-,0.55,0.25,0.91,0.02541964,Moderate,0.292,0.015,0.158,0.335,Mild increase (p=0.025),Significant increase (p=0.018),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00219,rs270893,9,74641244,SORL1,SNP (A/G),(A/,A,1.24,0.97,1.54,0.03764297,Low,0.101,0.181,0.268,0.25,Variable effect (p=0.005),Significant decrease (p=0.014),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00220,rs316265,8,176754901,TREM2,SNP (C/G),(C/,C,1.13,0.86,1.42,0.02232996,Unknown,0.009,0.015,0.544,0.231,Variable effect (p=0.042),Mild decrease (p=0.013),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00221,rs883912,11,129782833,PICALM,SNP (A/G),(A/,A,1.01,0.69,1.27,0.03475221,Moderate,0.185,0.408,0.198,0.009,Mild decrease (p=0.038),Significant increase (p=0.003),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00222,rs712243,3,120739137,BIN1,SNP (A/T),(A/,A,1.11,0.75,1.46,0.00196293,Moderate,0.122,0.124,0.27,0.284,Significant decrease (p=0.006),Significant decrease (p=0.027),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00223,rs700557,3,14938353,CD33,SNP (C/G),(C/,C,1.92,1.65,2.29,0.0520802,Moderate,0.194,0.177,0.343,0.086,Variable effect (p=0.031),No significant pattern (p=0.037),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00224,rs130972,10,244613708,MS4A6A,SNP (G/T),(G/,G,0.92,0.64,1.25,0.02003369,Moderate,0.142,0.328,0.099,0.232,Mild decrease (p=0.04),Mild decrease (p=0.042),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP00225,rs317294,8,116316793,TREM2,SNP (C/T),(C/,C,0.59,0.21,0.97,0.01235539,Low,0.43,0.195,0.082,0.093,Variable effect (p=0.013),Variable effect (p=0.045),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP00226,rs804744,15,236406473,EPHA1,SNP (A/T),(A/,A,0.91,0.55,1.3,0.00127778,Moderate,0.281,0.014,0.279,0.226,Mild decrease (p=0.013),Mild decrease (p=0.037),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00227,rs323099,6,98080724,PTK2B,Deletion,-,-,1.38,1.01,1.71,0.06581364,High,0.241,0.276,0.009,0.275,Mild increase (p=0.038),Significant increase (p=0.045),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00228,rs770380,2,226927330,EPHA1,Deletion,-,-,0.8,0.46,1.08,0.01969244,Moderate,0.034,0.084,0.358,0.324,No significant pattern (p=0.035),Variable effect (p=0.023),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00229,rs380541,22,27470023,PICALM,SNP (A/C),(A/,A,0.98,0.75,1.24,0.01327858,Moderate,0.186,0.391,0.052,0.171,Variable effect (p=0.049),Significant increase (p=0.024),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00230,rs127407,8,105790053,BIN1,SNP (C/G),(C/,C,0.71,0.36,1.05,0.10191683,High,0.121,0.27,0.129,0.28,Significant increase (p=0.019),Significant decrease (p=0.031),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00231,rs281055,2,225101405,ABCA7,SNP (C/G),(C/,C,0.46,0.13,0.8,0.02106707,Moderate,0.085,0.0,0.059,0.656,No significant pattern (p=0.039),Mild decrease (p=0.014),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP00232,rs408185,3,204316591,EPHA1,Deletion,-,-,3.0,2.76,3.36,0.00050938,Low,0.131,0.146,0.208,0.315,Significant decrease (p=0.024),Significant increase (p=0.025),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00233,rs928492,2,73050844,CD33,SNP (C/T),(C/,C,0.62,0.36,0.84,0.00619322,Low,0.333,0.097,0.175,0.195,Significant decrease (p=0.048),Mild decrease (p=0.036),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00234,rs221952,19,202968110,CD2AP,SNP (C/G),(C/,C,1.41,1.21,1.69,0.05720515,Low,0.282,0.145,0.082,0.291,No significant pattern (p=0.041),Variable effect (p=0.001),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00235,rs472993,21,86884798,EPHA1,SNP (A/C),(A/,A,0.95,0.71,1.33,0.00400597,Moderate,0.017,0.451,0.279,0.054,No significant pattern (p=0.049),Mild decrease (p=0.046),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00236,rs324032,14,132676008,APP,SNP (A/G),(A/,A,0.9,0.64,1.2,0.00544214,High,0.083,0.369,0.321,0.027,Mild increase (p=0.04),Significant decrease (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00237,rs138247,17,211096984,PSEN2,SNP (A/G),(A/,A,1.36,1.0,1.58,0.08003013,Moderate,0.379,0.337,0.011,0.073,Mild increase (p=0.016),No significant pattern (p=0.019),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00238,rs414042,3,121382324,CD33,SNP (G/T),(G/,G,0.62,0.28,0.82,0.01538252,Low,0.142,0.418,0.043,0.196,Mild increase (p=0.015),No significant pattern (p=0.007),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00239,rs454772,5,163742776,PICALM,SNP (A/G),(A/,A,1.18,0.96,1.56,0.03354661,Low,0.543,0.108,0.066,0.084,Significant decrease (p=0.006),No significant pattern (p=0.002),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00240,rs803415,6,232168623,EPHA1,SNP (A/C),(A/,A,0.32,0.1,0.53,0.04628404,Moderate,0.014,0.032,0.449,0.305,Mild decrease (p=0.008),Variable effect (p=0.008),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00241,rs481835,1,5446803,PICALM,SNP (C/T),(C/,C,0.83,0.58,1.14,0.05371162,Low,0.361,0.016,0.308,0.115,No significant pattern (p=0.035),Mild increase (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00242,rs698054,1,211249276,CR1,SNP (C/G),(C/,C,1.13,0.73,1.44,0.01320918,Low,0.236,0.1,0.096,0.368,Significant increase (p=0.014),Significant increase (p=0.017),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00243,rs634401,10,15413993,EPHA1,Deletion,-,-,0.95,0.61,1.21,0.02340156,Low,0.208,0.005,0.183,0.403,Mild decrease (p=0.043),Mild decrease (p=0.004),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00244,rs559320,22,210269628,TREM2,Insertion,-,-,0.54,0.28,0.8,0.01583237,High,0.224,0.381,0.02,0.175,No significant pattern (p=0.004),Mild decrease (p=0.039),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00245,rs401183,15,22093384,PICALM,SNP (C/T),(C/,C,1.45,1.2,1.76,0.03617646,Low,0.2,0.356,0.116,0.128,Significant decrease (p=0.005),Variable effect (p=0.047),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00246,rs943107,17,231088505,EPHA1,Deletion,-,-,1.14,0.91,1.38,0.01094087,Moderate,0.301,0.248,0.101,0.15,Mild increase (p=0.05),Variable effect (p=0.015),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00247,rs411892,13,59972914,CLU,SNP (A/C),(A/,A,0.92,0.61,1.29,0.00281756,Moderate,0.063,0.576,0.041,0.121,Mild increase (p=0.031),Variable effect (p=0.006),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00248,rs807632,10,59518034,CR1,Deletion,-,-,3.04,2.67,3.39,0.00247934,Low,0.388,0.011,0.335,0.065,Mild increase (p=0.036),Significant increase (p=0.003),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00249,rs345299,21,52650464,PSEN2,Insertion,-,-,0.56,0.24,0.81,0.03279867,Protective,0.17,0.223,0.036,0.372,Mild increase (p=0.038),Variable effect (p=0.017),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00250,rs161465,19,114084705,CD2AP,SNP (A/G),(A/,A,1.57,1.32,1.81,0.03251539,High,0.135,0.187,0.407,0.071,Significant decrease (p=0.045),Variable effect (p=0.023),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00251,rs974837,16,188762040,TREM2,SNP (G/T),(G/,G,0.59,0.35,0.83,0.0080879,High,0.234,0.143,0.06,0.364,Mild decrease (p=0.027),Significant decrease (p=0.006),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00252,rs691490,11,177788046,ABCA7,SNP (A/G),(A/,A,0.73,0.48,1.13,0.07969471,High,0.27,0.084,0.054,0.392,Mild increase (p=0.009),Mild increase (p=0.009),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00253,rs750894,21,175333280,TREM2,SNP (A/T),(A/,A,1.53,1.27,1.91,0.03366073,High,0.108,0.192,0.339,0.161,Significant decrease (p=0.026),Significant increase (p=0.045),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00254,rs288440,8,7448814,CD33,SNP (C/G),(C/,C,1.55,1.22,1.84,0.03396695,High,0.012,0.08,0.149,0.559,Variable effect (p=0.042),Mild decrease (p=0.046),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP00255,rs547140,21,199116057,ABCA7,SNP (A/C),(A/,A,0.71,0.41,1.07,0.00029532,Low,0.024,0.138,0.137,0.5,Mild decrease (p=0.01),Significant decrease (p=0.022),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00256,rs177254,3,125974312,MS4A6A,SNP (C/T),(C/,C,0.82,0.56,1.14,0.04357687,Moderate,0.082,0.199,0.167,0.352,Significant decrease (p=0.024),Significant decrease (p=0.002),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00257,rs261932,4,184693906,CR1,Deletion,-,-,0.42,0.1,0.67,0.07852773,Protective,0.093,0.006,0.047,0.654,Significant increase (p=0.035),Significant increase (p=0.026),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00258,rs882200,15,58919688,ABCA7,SNP (G/T),(G/,G,0.56,0.29,0.93,0.0258838,High,0.346,0.104,0.215,0.135,Significant decrease (p=0.01),Significant increase (p=0.037),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00259,rs166293,9,142172843,APOE,Deletion,-,-,1.3,1.03,1.58,0.03441249,Protective,0.319,0.268,0.076,0.136,Mild decrease (p=0.016),Significant decrease (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00260,rs411388,4,12361315,MS4A6A,SNP (A/T),(A/,A,1.05,0.76,1.27,0.00829543,Unknown,0.11,0.296,0.198,0.196,Mild increase (p=0.041),Variable effect (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP00261,rs365703,16,138126018,EPHA1,SNP (A/C),(A/,A,1.77,1.48,2.13,0.02044852,Moderate,0.091,0.277,0.301,0.13,Mild decrease (p=0.018),Significant increase (p=0.013),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00262,rs341229,15,169457382,EPHA1,SNP (A/C),(A/,A,0.74,0.54,1.1,0.01547345,Low,0.48,0.042,0.043,0.235,No significant pattern (p=0.038),Mild decrease (p=0.03),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00263,rs413185,9,81734883,APP,SNP (A/C),(A/,A,0.74,0.53,1.06,0.00359347,Moderate,0.076,0.281,0.408,0.036,Significant decrease (p=0.044),Mild decrease (p=0.048),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00264,rs774313,12,209656307,APOE,SNP (C/G),(C/,C,1.09,0.71,1.34,0.01338563,Moderate,0.095,0.197,0.186,0.323,Significant increase (p=0.044),Significant increase (p=0.031),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00265,rs308128,3,193732185,EPHA1,SNP (G/T),(G/,G,1.05,0.67,1.25,0.04657346,High,0.162,0.155,0.389,0.094,Mild increase (p=0.047),No significant pattern (p=0.031),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00266,rs704522,22,211894810,SORL1,SNP (C/T),(C/,C,0.56,0.34,0.91,0.09920412,Moderate,0.382,0.136,0.102,0.18,No significant pattern (p=0.005),Mild decrease (p=0.027),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00267,rs630837,18,124107666,TREM2,SNP (G/T),(G/,G,1.34,1.02,1.61,0.06004629,Moderate,0.127,0.294,0.209,0.17,Significant increase (p=0.029),Mild decrease (p=0.032),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00268,rs732993,14,175894464,EPHA1,SNP (A/C),(A/,A,1.36,1.04,1.57,0.03179311,Protective,0.049,0.166,0.339,0.246,Significant increase (p=0.002),Mild decrease (p=0.045),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00269,rs303873,18,53706567,CD33,Insertion,-,-,0.72,0.43,1.05,0.01247786,Unknown,0.232,0.034,0.259,0.276,Mild decrease (p=0.041),No significant pattern (p=0.036),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP00270,rs903560,8,154438790,CD2AP,SNP (G/T),(G/,G,0.7,0.32,1.04,0.02425907,High,0.086,0.307,0.124,0.284,Variable effect (p=0.04),No significant pattern (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00271,rs319086,12,147132654,MS4A6A,SNP (C/G),(C/,C,0.99,0.6,1.34,0.00547185,Moderate,0.476,0.023,0.274,0.027,No significant pattern (p=0.048),No significant pattern (p=0.016),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00272,rs598818,5,11072213,CLU,Deletion,-,-,0.51,0.21,0.78,0.05009483,Moderate,0.06,0.036,0.419,0.285,No significant pattern (p=0.038),No significant pattern (p=0.03),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00273,rs956039,17,149529237,CLU,Deletion,-,-,1.14,0.88,1.5,0.00617637,High,0.059,0.236,0.161,0.343,Significant decrease (p=0.013),Significant increase (p=0.021),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP00274,rs371453,22,76124519,PTK2B,SNP (G/T),(G/,G,1.09,0.89,1.31,0.02409585,High,0.051,0.361,0.215,0.173,Significant increase (p=0.023),Significant increase (p=0.045),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00275,rs480476,22,236974911,CD33,SNP (G/T),(G/,G,1.21,0.92,1.47,0.07026373,High,0.338,0.061,0.375,0.026,Mild increase (p=0.039),Significant increase (p=0.029),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP00276,rs560912,3,196369091,PICALM,SNP (C/G),(C/,C,0.83,0.49,1.13,0.07093572,Moderate,0.307,0.335,0.132,0.026,No significant pattern (p=0.05),Mild increase (p=0.046),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00277,rs708864,13,103564576,MS4A6A,Deletion,-,-,2.2,1.96,2.43,0.00199608,Moderate,0.104,0.213,0.124,0.359,Significant decrease (p=0.029),Mild increase (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00278,rs316603,14,162857674,PICALM,Insertion,-,-,0.79,0.4,1.03,0.0954735,High,0.582,0.167,0.02,0.03,Mild increase (p=0.039),Mild decrease (p=0.012),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP00279,rs457006,22,107396231,APP,SNP (A/T),(A/,A,0.27,0.1,0.57,0.0564053,Protective,0.48,0.083,0.147,0.091,Significant decrease (p=0.007),Mild decrease (p=0.046),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00280,rs319275,21,182384041,ABCA7,SNP (A/C),(A/,A,1.33,1.07,1.57,0.01193775,High,0.14,0.336,0.163,0.161,Mild decrease (p=0.028),Mild increase (p=0.008),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00281,rs300149,15,59596612,APOE,SNP (C/G),(C/,C,1.47,1.11,1.81,0.06200315,Low,0.165,0.092,0.091,0.451,No significant pattern (p=0.023),Significant increase (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00282,rs880609,7,30192925,ABCA7,SNP (A/C),(A/,A,1.33,1.1,1.58,0.00886794,Unknown,0.25,0.121,0.222,0.208,Significant increase (p=0.013),Significant increase (p=0.03),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00283,rs684895,9,222372295,MS4A6A,Insertion,-,-,0.86,0.52,1.18,0.0182341,High,0.127,0.312,0.049,0.312,Significant decrease (p=0.036),No significant pattern (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00284,rs938518,15,172241474,CD33,Insertion,-,-,0.64,0.38,1.0,0.02721306,High,0.244,0.008,0.248,0.3,Variable effect (p=0.005),No significant pattern (p=0.022),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00285,rs689595,15,175784339,APOE,SNP (G/T),(G/,G,0.76,0.4,1.02,0.01412308,Low,0.067,0.18,0.051,0.502,Significant decrease (p=0.027),Mild decrease (p=0.043),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00286,rs747435,20,136244832,PTK2B,SNP (A/T),(A/,A,0.93,0.57,1.22,0.08588701,Protective,0.038,0.055,0.21,0.497,Significant decrease (p=0.043),No significant pattern (p=0.02),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00287,rs794543,14,200387563,PTK2B,Deletion,-,-,1.14,0.91,1.51,0.00169494,High,0.349,0.189,0.057,0.205,Variable effect (p=0.018),Significant increase (p=0.01),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP00288,rs573893,15,206267307,PSEN2,Deletion,-,-,1.48,1.2,1.74,0.0550054,Moderate,0.302,0.42,0.07,0.008,Variable effect (p=0.003),Variable effect (p=0.01),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00289,rs475157,17,221694528,BIN1,SNP (G/T),(G/,G,1.63,1.4,1.84,0.01344625,Low,0.205,0.155,0.141,0.299,No significant pattern (p=0.005),Mild increase (p=0.035),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00290,rs184577,18,94634699,CR1,Deletion,-,-,0.84,0.48,1.12,0.08543396,Moderate,0.036,0.294,0.419,0.052,No significant pattern (p=0.05),Variable effect (p=0.025),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00291,rs805469,12,210738910,CR1,Deletion,-,-,0.96,0.58,1.17,0.05698651,Low,0.079,0.5,0.006,0.214,Variable effect (p=0.004),Mild increase (p=0.036),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00292,rs580336,13,144096381,BIN1,SNP (A/C),(A/,A,1.3,1.03,1.66,0.04640456,Low,0.081,0.27,0.025,0.424,Mild increase (p=0.035),Mild increase (p=0.031),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00293,rs638099,19,43254427,PTK2B,SNP (C/G),(C/,C,0.79,0.53,1.1,0.02282518,High,0.259,0.061,0.348,0.133,Variable effect (p=0.024),Significant increase (p=0.048),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00294,rs773388,4,247434371,CLU,Insertion,-,-,0.89,0.64,1.29,0.10839871,Protective,0.008,0.075,0.213,0.504,Mild decrease (p=0.022),Variable effect (p=0.046),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00295,rs899612,6,232527224,CLU,SNP (A/G),(A/,A,0.54,0.17,0.81,0.02509358,Low,0.299,0.188,0.277,0.036,Mild increase (p=0.044),Mild decrease (p=0.012),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00296,rs635470,8,144257137,CLU,SNP (A/T),(A/,A,0.68,0.3,0.92,0.0285402,Protective,0.183,0.397,0.191,0.029,Significant decrease (p=0.005),Significant decrease (p=0.008),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00297,rs273806,1,189841909,ABCA7,SNP (A/T),(A/,A,1.64,1.24,1.97,0.00958548,Low,0.003,0.613,0.148,0.036,No significant pattern (p=0.012),Significant decrease (p=0.01),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP00298,rs442616,1,17721021,APOE,SNP (G/T),(G/,G,0.56,0.24,0.86,0.02659914,Unknown,0.117,0.088,0.552,0.043,Significant increase (p=0.039),Mild increase (p=0.011),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP00299,rs803284,17,105247173,PICALM,SNP (A/T),(A/,A,0.64,0.43,0.88,0.05381466,Low,0.107,0.421,0.156,0.116,Mild increase (p=0.036),Variable effect (p=0.011),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00300,rs999681,15,97613479,PICALM,SNP (A/C),(A/,A,1.0,0.75,1.34,0.00670608,Unknown,0.069,0.008,0.045,0.678,Variable effect (p=0.003),Mild decrease (p=0.031),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00301,rs212150,9,178758852,CD33,Deletion,-,-,1.18,0.84,1.52,0.00756945,High,0.123,0.571,0.063,0.042,Mild decrease (p=0.048),Mild increase (p=0.012),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00302,rs907832,9,108814659,PICALM,SNP (A/T),(A/,A,0.57,0.32,0.95,0.02460532,Moderate,0.314,0.099,0.26,0.127,Significant decrease (p=0.025),Significant decrease (p=0.021),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00303,rs970581,17,15257250,SORL1,SNP (C/T),(C/,C,0.72,0.39,0.95,0.01065543,Protective,0.023,0.363,0.36,0.053,No significant pattern (p=0.003),Significant decrease (p=0.016),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00304,rs892954,15,205871330,BIN1,Insertion,-,-,0.39,0.1,0.74,0.0047273,Moderate,0.271,0.38,0.112,0.038,Mild decrease (p=0.033),Variable effect (p=0.035),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP00305,rs117486,3,192818299,APOE,Deletion,-,-,1.18,0.84,1.44,0.01137939,Low,0.531,0.224,0.003,0.042,Significant decrease (p=0.005),Mild decrease (p=0.02),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00306,rs427233,9,82267457,MS4A6A,SNP (C/T),(C/,C,0.95,0.59,1.22,0.01141567,Protective,0.118,0.348,0.126,0.208,Significant increase (p=0.028),Significant decrease (p=0.042),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00307,rs845581,21,205649957,SORL1,SNP (C/T),(C/,C,0.81,0.57,1.08,0.04528101,High,0.265,0.019,0.076,0.441,Variable effect (p=0.004),Mild increase (p=0.03),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00308,rs772542,6,72518081,APOE,SNP (G/T),(G/,G,1.21,0.85,1.52,0.0309845,Low,0.214,0.508,0.017,0.061,Variable effect (p=0.02),Mild decrease (p=0.02),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00309,rs188768,15,244683529,PSEN2,SNP (G/T),(G/,G,1.65,1.43,1.93,0.03588959,Moderate,0.024,0.093,0.344,0.339,Variable effect (p=0.034),Mild decrease (p=0.047),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00310,rs788768,20,207075926,ABCA7,SNP (C/T),(C/,C,0.81,0.45,1.09,0.06388371,Unknown,0.02,0.352,0.201,0.227,Significant increase (p=0.032),Variable effect (p=0.006),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00311,rs984769,7,66751441,CD2AP,Insertion,-,-,1.85,1.54,2.18,0.05048882,Moderate,0.481,0.208,0.103,0.008,Significant decrease (p=0.015),Variable effect (p=0.031),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00312,rs126542,1,135037813,PICALM,Insertion,-,-,1.26,1.05,1.55,0.03800212,Protective,0.079,0.301,0.001,0.419,No significant pattern (p=0.037),Significant decrease (p=0.011),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00313,rs613492,11,20477594,CD33,SNP (A/G),(A/,A,1.32,0.96,1.6,0.09865621,Moderate,0.107,0.039,0.332,0.322,Variable effect (p=0.029),Significant increase (p=0.027),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00314,rs651260,18,78828004,CR1,Insertion,-,-,2.35,2.04,2.62,0.04691134,Low,0.079,0.25,0.021,0.45,No significant pattern (p=0.043),Significant increase (p=0.036),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP00315,rs108713,7,101786052,PICALM,SNP (A/C),(A/,A,0.89,0.59,1.12,0.01064056,Protective,0.523,0.072,0.161,0.045,Variable effect (p=0.004),No significant pattern (p=0.013),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00316,rs441125,21,233729491,PSEN2,SNP (A/C),(A/,A,0.77,0.37,1.01,0.00094415,High,0.088,0.396,0.262,0.054,Mild increase (p=0.027),Variable effect (p=0.034),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00317,rs920220,20,153634971,PTK2B,SNP (A/T),(A/,A,0.98,0.65,1.27,0.00201053,High,0.179,0.041,0.412,0.168,No significant pattern (p=0.009),No significant pattern (p=0.009),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP00318,rs487074,18,186474875,CR1,Insertion,-,-,1.01,0.68,1.22,0.01548933,High,0.033,0.265,0.083,0.419,Significant increase (p=0.007),Significant increase (p=0.008),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00319,rs998498,18,223172179,ABCA7,SNP (G/T),(G/,G,1.13,0.88,1.38,0.04774731,Protective,0.351,0.248,0.11,0.09,Mild increase (p=0.024),Significant increase (p=0.015),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00320,rs899407,13,100010113,ABCA7,SNP (A/T),(A/,A,2.35,2.11,2.56,0.03513629,Low,0.09,0.014,0.55,0.146,Mild decrease (p=0.003),No significant pattern (p=0.029),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00321,rs187942,12,173744774,CD33,SNP (A/C),(A/,A,0.83,0.55,1.14,0.02773822,Moderate,0.612,0.182,0.001,0.006,Variable effect (p=0.045),Significant decrease (p=0.005),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00322,rs395552,14,120182125,ABCA7,SNP (C/G),(C/,C,0.75,0.48,0.99,0.04915061,High,0.304,0.105,0.291,0.1,Significant decrease (p=0.036),Mild increase (p=0.025),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP00323,rs374807,8,46662718,APP,SNP (A/G),(A/,A,1.38,1.02,1.61,0.06007217,Moderate,0.246,0.419,0.104,0.032,No significant pattern (p=0.022),No significant pattern (p=0.011),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00324,rs620520,17,97792171,APOE,SNP (C/G),(C/,C,1.26,0.89,1.57,0.0478657,Moderate,0.04,0.109,0.366,0.285,Mild decrease (p=0.041),Significant decrease (p=0.031),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00325,rs570096,6,107254181,EPHA1,SNP (A/C),(A/,A,0.68,0.41,0.91,0.00524025,High,0.002,0.122,0.081,0.595,Variable effect (p=0.029),No significant pattern (p=0.04),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00326,rs143176,13,178609355,CD33,SNP (A/G),(A/,A,0.78,0.48,1.15,0.02584917,Moderate,0.093,0.063,0.514,0.129,Variable effect (p=0.026),Variable effect (p=0.046),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00327,rs928093,5,129950601,APOE,SNP (G/T),(G/,G,0.71,0.35,1.08,0.01731887,Unknown,0.19,0.04,0.562,0.008,Variable effect (p=0.003),No significant pattern (p=0.025),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00328,rs946090,5,190896814,TREM2,SNP (A/C),(A/,A,1.21,0.97,1.56,0.02162903,Low,0.136,0.247,0.086,0.332,Significant decrease (p=0.028),Significant increase (p=0.035),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00329,rs168272,21,33330831,PSEN2,SNP (A/T),(A/,A,1.23,0.96,1.5,0.04256548,High,0.425,0.042,0.075,0.258,Mild increase (p=0.05),Variable effect (p=0.044),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00330,rs460997,15,114149839,EPHA1,SNP (A/G),(A/,A,0.99,0.64,1.21,0.00060474,Moderate,0.194,0.213,0.066,0.326,Significant decrease (p=0.001),Mild increase (p=0.004),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00331,rs642248,16,197999815,APP,Insertion,-,-,0.79,0.51,1.19,0.14870049,High,0.101,0.549,0.148,0.001,Mild increase (p=0.017),Mild decrease (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00332,rs937771,13,58115063,BIN1,SNP (A/G),(A/,A,1.18,0.97,1.43,0.07108181,Low,0.247,0.21,0.181,0.162,Significant increase (p=0.033),No significant pattern (p=0.023),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP00333,rs771124,2,221999576,CR1,Deletion,-,-,1.51,1.18,1.83,0.00837726,High,0.292,0.001,0.008,0.499,Significant decrease (p=0.001),Variable effect (p=0.047),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00334,rs666310,2,153961782,SORL1,Deletion,-,-,0.62,0.35,0.96,0.00470695,Moderate,0.393,0.005,0.171,0.232,Mild increase (p=0.001),Significant increase (p=0.024),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00335,rs377892,12,230332945,PSEN2,SNP (A/C),(A/,A,0.67,0.36,0.98,0.01579591,High,0.027,0.311,0.325,0.137,No significant pattern (p=0.04),Mild increase (p=0.018),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00336,rs598511,20,128735332,APOE,Deletion,-,-,0.52,0.15,0.81,0.01298895,Moderate,0.243,0.145,0.255,0.157,Mild increase (p=0.03),No significant pattern (p=0.007),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00337,rs381626,6,178373796,ABCA7,Deletion,-,-,0.85,0.64,1.07,0.00177154,Moderate,0.048,0.004,0.556,0.193,Significant increase (p=0.002),No significant pattern (p=0.026),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00338,rs821108,3,91853017,APP,SNP (A/G),(A/,A,2.18,1.97,2.53,0.02407627,High,0.073,0.148,0.301,0.278,Variable effect (p=0.007),Variable effect (p=0.023),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00339,rs304603,11,115632356,PICALM,SNP (A/C),(A/,A,0.44,0.23,0.8,0.05775253,Moderate,0.533,0.003,0.027,0.237,Significant increase (p=0.024),Significant increase (p=0.049),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00340,rs639370,2,114698592,PTK2B,SNP (A/T),(A/,A,1.49,1.1,1.88,0.03421758,Low,0.372,0.198,0.0,0.229,Mild increase (p=0.05),Significant increase (p=0.032),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00341,rs936043,3,197300914,CLU,SNP (C/T),(C/,C,0.62,0.27,0.94,0.04548857,Moderate,0.429,0.007,0.002,0.362,Mild increase (p=0.043),Variable effect (p=0.042),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00342,rs820325,16,165071372,ABCA7,SNP (C/G),(C/,C,0.75,0.54,1.15,0.07795494,High,0.053,0.107,0.637,0.004,Significant decrease (p=0.03),Mild decrease (p=0.049),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00343,rs241680,13,223872436,MS4A6A,SNP (G/T),(G/,G,1.35,1.05,1.65,0.00248166,Moderate,0.528,0.056,0.025,0.191,Significant increase (p=0.011),Variable effect (p=0.01),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP00344,rs602288,21,137917776,CR1,Insertion,-,-,2.7,2.32,2.9,0.0508274,Low,0.278,0.118,0.381,0.023,Significant increase (p=0.001),Significant decrease (p=0.038),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00345,rs577896,11,247502845,APP,SNP (A/T),(A/,A,1.8,1.51,2.07,0.00337023,High,0.059,0.227,0.429,0.085,Significant decrease (p=0.035),Significant increase (p=0.043),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00346,rs907557,22,224144297,APOE,SNP (G/T),(G/,G,0.57,0.25,0.87,0.01781027,Moderate,0.376,0.136,0.221,0.067,Mild increase (p=0.032),Mild increase (p=0.028),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP00347,rs476526,11,74346190,EPHA1,SNP (C/T),(C/,C,1.01,0.75,1.4,0.02189616,High,0.073,0.169,0.22,0.338,Variable effect (p=0.041),Variable effect (p=0.004),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP00348,rs538863,18,57346577,CR1,SNP (C/G),(C/,C,0.62,0.24,0.91,0.00830555,Unknown,0.019,0.399,0.359,0.022,Mild increase (p=0.031),Variable effect (p=0.036),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00349,rs555816,5,172424050,APOE,SNP (A/C),(A/,A,1.44,1.21,1.75,0.00364503,Moderate,0.065,0.23,0.338,0.167,Mild decrease (p=0.05),Variable effect (p=0.019),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP00350,rs606632,12,189368840,APOE,SNP (C/T),(C/,C,0.78,0.41,1.11,0.0689738,Moderate,0.032,0.081,0.518,0.169,Variable effect (p=0.045),Significant increase (p=0.011),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00351,rs781271,9,234106197,ABCA7,SNP (A/G),(A/,A,0.47,0.15,0.77,0.05898994,Moderate,0.182,0.192,0.404,0.022,Mild increase (p=0.022),Mild increase (p=0.013),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00352,rs938792,2,206904452,APP,SNP (C/G),(C/,C,0.75,0.46,1.14,0.01692061,High,0.18,0.279,0.042,0.299,No significant pattern (p=0.013),Mild increase (p=0.015),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00353,rs546775,13,157395573,ABCA7,SNP (G/T),(G/,G,1.26,0.9,1.52,0.01898595,High,0.355,0.343,0.028,0.074,Mild decrease (p=0.018),Mild decrease (p=0.004),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00354,rs582943,2,216437922,PSEN2,SNP (A/T),(A/,A,2.2,1.86,2.42,0.07327348,Protective,0.051,0.366,0.221,0.162,No significant pattern (p=0.009),Variable effect (p=0.033),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00355,rs212750,6,35375600,APOE,SNP (G/T),(G/,G,0.73,0.39,1.05,0.0217929,Low,0.015,0.12,0.171,0.495,Variable effect (p=0.009),Significant increase (p=0.043),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00356,rs107852,17,182468485,MS4A6A,SNP (A/G),(A/,A,1.36,1.03,1.65,0.02159172,Low,0.16,0.26,0.235,0.145,Mild increase (p=0.039),No significant pattern (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00357,rs552434,15,203548245,ABCA7,SNP (C/G),(C/,C,0.83,0.44,1.1,0.01847139,High,0.424,0.183,0.115,0.077,Variable effect (p=0.006),Mild increase (p=0.005),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00358,rs276926,4,90454486,MS4A6A,SNP (A/G),(A/,A,1.51,1.13,1.88,0.00742776,Moderate,0.303,0.051,0.41,0.035,Significant increase (p=0.03),Significant increase (p=0.034),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00359,rs125241,17,171758212,APOE,SNP (A/G),(A/,A,0.44,0.1,0.82,0.00936985,Protective,0.152,0.292,0.084,0.272,Mild increase (p=0.033),Variable effect (p=0.049),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00360,rs853797,3,117954791,CLU,SNP (C/T),(C/,C,1.14,0.86,1.37,0.05620087,Moderate,0.094,0.303,0.11,0.293,Significant decrease (p=0.007),Significant decrease (p=0.005),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00361,rs261721,19,155390827,SORL1,SNP (C/G),(C/,C,1.15,0.8,1.54,0.02111346,High,0.186,0.081,0.035,0.498,Variable effect (p=0.035),Significant decrease (p=0.019),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP00362,rs877485,12,15137624,CR1,SNP (A/G),(A/,A,0.77,0.39,1.1,0.00193744,Unknown,0.212,0.036,0.024,0.529,Mild decrease (p=0.017),Mild decrease (p=0.035),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP00363,rs438131,13,115172881,CD33,SNP (C/T),(C/,C,1.02,0.72,1.36,0.06858774,Protective,0.199,0.4,0.021,0.181,No significant pattern (p=0.041),Mild increase (p=0.039),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00364,rs767398,20,246565498,APP,Insertion,-,-,0.75,0.51,0.99,0.00093734,Unknown,0.028,0.421,0.285,0.066,No significant pattern (p=0.046),Mild increase (p=0.027),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP00365,rs236055,1,221798622,CR1,SNP (G/T),(G/,G,0.97,0.61,1.31,0.00752281,High,0.063,0.005,0.329,0.404,Mild increase (p=0.015),Mild increase (p=0.007),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00366,rs643896,1,246106662,TREM2,SNP (A/T),(A/,A,0.57,0.35,0.78,0.0037104,Moderate,0.37,0.218,0.094,0.118,Significant decrease (p=0.036),No significant pattern (p=0.023),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP00367,rs129818,13,136290482,CLU,SNP (A/T),(A/,A,1.42,1.14,1.67,0.08549782,Moderate,0.125,0.291,0.361,0.024,Mild decrease (p=0.007),Variable effect (p=0.019),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00368,rs548389,14,8012037,BIN1,SNP (C/T),(C/,C,0.84,0.47,1.09,0.06964352,Low,0.143,0.036,0.325,0.296,Mild decrease (p=0.006),Mild decrease (p=0.004),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00369,rs972321,19,81657356,PTK2B,SNP (C/T),(C/,C,0.96,0.6,1.23,0.02851765,Moderate,0.067,0.344,0.125,0.264,Mild decrease (p=0.04),Significant decrease (p=0.003),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00370,rs311013,14,28832920,CD33,SNP (C/T),(C/,C,0.76,0.47,1.12,0.04933049,High,0.194,0.486,0.034,0.086,No significant pattern (p=0.041),Significant increase (p=0.03),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00371,rs288072,13,56645776,APP,SNP (C/T),(C/,C,1.19,0.92,1.55,0.00807528,Low,0.262,0.048,0.119,0.372,Significant increase (p=0.005),Significant decrease (p=0.005),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00372,rs473959,22,48055317,CD2AP,SNP (A/T),(A/,A,1.21,0.9,1.5,0.03177124,High,0.149,0.055,0.061,0.535,Variable effect (p=0.002),Mild increase (p=0.002),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00373,rs237483,12,123008002,SORL1,SNP (C/T),(C/,C,1.08,0.85,1.42,0.01782227,High,0.125,0.013,0.304,0.359,Significant increase (p=0.01),Mild decrease (p=0.03),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00374,rs771911,18,167253112,CD33,SNP (C/G),(C/,C,0.86,0.52,1.24,0.06200445,Moderate,0.047,0.647,0.098,0.008,Mild decrease (p=0.046),No significant pattern (p=0.022),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00375,rs218265,11,128767622,SORL1,Deletion,-,-,1.33,0.98,1.56,0.03456587,High,0.019,0.601,0.108,0.072,Significant increase (p=0.035),Significant increase (p=0.011),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00376,rs180661,13,158198420,ABCA7,SNP (A/T),(A/,A,1.75,1.53,2.01,0.01964856,Low,0.21,0.26,0.077,0.252,Variable effect (p=0.007),Significant decrease (p=0.016),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00377,rs410355,15,172397263,APOE,Deletion,-,-,0.95,0.61,1.29,0.02319102,High,0.076,0.12,0.572,0.032,Mild decrease (p=0.002),Mild increase (p=0.018),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00378,rs908392,4,21047648,CD2AP,SNP (C/T),(C/,C,0.54,0.22,0.87,0.00283767,Low,0.011,0.183,0.485,0.121,Mild increase (p=0.012),Mild increase (p=0.017),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00379,rs144832,8,160214021,TREM2,SNP (A/C),(A/,A,0.74,0.43,1.0,0.04411906,Low,0.061,0.024,0.675,0.04,Significant decrease (p=0.038),Variable effect (p=0.015),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00380,rs856608,3,97667484,PSEN2,SNP (G/T),(G/,G,1.33,1.04,1.71,0.12632515,High,0.054,0.469,0.072,0.205,Significant increase (p=0.017),Variable effect (p=0.027),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00381,rs673720,2,27115187,APP,SNP (C/G),(C/,C,1.85,1.62,2.09,0.00626838,Low,0.282,0.053,0.163,0.301,Mild decrease (p=0.014),No significant pattern (p=0.023),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00382,rs285649,20,216217975,PSEN2,SNP (C/T),(C/,C,0.63,0.35,0.99,0.02637694,Low,0.113,0.281,0.167,0.238,Variable effect (p=0.019),No significant pattern (p=0.002),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00383,rs788540,11,22541572,TREM2,SNP (G/T),(G/,G,1.33,1.08,1.61,0.00041946,Low,0.066,0.346,0.025,0.364,No significant pattern (p=0.017),Mild increase (p=0.027),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP00384,rs984639,6,176818886,BIN1,SNP (A/C),(A/,A,6.62,6.22,6.88,0.01713219,Low,0.136,0.055,0.546,0.063,Significant decrease (p=0.038),Significant increase (p=0.032),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00385,rs638161,9,75379306,ABCA7,SNP (A/T),(A/,A,2.02,1.75,2.28,0.00645653,High,0.239,0.003,0.535,0.022,No significant pattern (p=0.043),Variable effect (p=0.03),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00386,rs902569,9,196170815,PICALM,SNP (A/G),(A/,A,0.57,0.24,0.79,0.03165204,Moderate,0.024,0.043,0.167,0.566,Mild decrease (p=0.048),Significant decrease (p=0.042),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP00387,rs575035,22,28111075,APOE,SNP (G/T),(G/,G,1.65,1.25,1.95,0.03651135,Unknown,0.034,0.195,0.241,0.33,Significant decrease (p=0.013),Mild increase (p=0.036),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00388,rs217922,22,65563209,CR1,SNP (A/T),(A/,A,0.87,0.67,1.2,0.12910477,Protective,0.255,0.081,0.047,0.416,Mild decrease (p=0.017),Mild increase (p=0.034),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00389,rs876581,21,120824874,APOE,Deletion,-,-,3.31,2.96,3.55,0.00564091,Moderate,0.541,0.124,0.026,0.109,Significant increase (p=0.042),No significant pattern (p=0.031),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00390,rs227530,4,248002973,ABCA7,Insertion,-,-,0.5,0.28,0.82,0.08689625,Moderate,0.047,0.062,0.46,0.231,Significant decrease (p=0.039),Significant increase (p=0.015),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00391,rs668944,7,145829874,PTK2B,SNP (A/T),(A/,A,1.99,1.63,2.35,0.03741808,Moderate,0.188,0.519,0.076,0.017,Variable effect (p=0.006),No significant pattern (p=0.003),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00392,rs932882,5,226119390,CLU,SNP (A/C),(A/,A,0.51,0.25,0.85,0.1414634,Moderate,0.013,0.344,0.26,0.183,Mild decrease (p=0.044),Significant increase (p=0.02),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00393,rs640658,21,213731285,PICALM,SNP (C/T),(C/,C,2.1,1.76,2.36,0.01450202,Moderate,0.051,0.699,0.017,0.033,Significant decrease (p=0.046),Significant increase (p=0.028),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00394,rs178183,5,86821698,APP,SNP (C/T),(C/,C,1.85,1.54,2.16,0.00306483,Unknown,0.484,0.063,0.019,0.234,Significant decrease (p=0.034),Mild decrease (p=0.024),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00395,rs901010,4,61433273,SORL1,SNP (A/G),(A/,A,0.47,0.1,0.71,0.03312487,Moderate,0.225,0.096,0.479,0.001,Significant increase (p=0.008),Significant increase (p=0.021),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00396,rs316113,3,84271907,CR1,SNP (A/G),(A/,A,1.01,0.63,1.36,0.04535731,Low,0.272,0.091,0.194,0.243,Significant increase (p=0.043),No significant pattern (p=0.011),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00397,rs402062,3,19675586,MS4A6A,SNP (C/T),(C/,C,0.69,0.31,1.01,0.0020336,High,0.091,0.258,0.099,0.352,No significant pattern (p=0.029),Significant decrease (p=0.048),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00398,rs257857,22,41461502,BIN1,SNP (A/C),(A/,A,0.9,0.54,1.14,0.02743826,Moderate,0.307,0.054,0.407,0.032,Significant decrease (p=0.004),Variable effect (p=0.007),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00399,rs507268,13,182614453,APP,Insertion,-,-,0.51,0.18,0.85,0.00827082,High,0.184,0.222,0.292,0.101,No significant pattern (p=0.03),Mild decrease (p=0.049),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00400,rs193563,19,198098602,PTK2B,SNP (C/G),(C/,C,0.52,0.25,0.76,0.00028694,High,0.043,0.156,0.407,0.194,Mild increase (p=0.011),Significant decrease (p=0.024),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP00401,rs465118,2,207572867,EPHA1,SNP (C/G),(C/,C,0.53,0.25,0.79,0.00855929,Moderate,0.09,0.409,0.291,0.01,Mild decrease (p=0.03),No significant pattern (p=0.012),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00402,rs290167,21,188674645,CLU,SNP (A/G),(A/,A,2.53,2.32,2.79,0.01480065,High,0.201,0.458,0.081,0.06,No significant pattern (p=0.02),Variable effect (p=0.041),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00403,rs921068,22,168050996,PICALM,SNP (A/G),(A/,A,0.42,0.1,0.74,0.02803213,Protective,0.18,0.387,0.132,0.102,Significant decrease (p=0.03),Mild decrease (p=0.048),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00404,rs157989,15,62245965,CD33,SNP (A/G),(A/,A,0.97,0.69,1.25,0.01296562,Moderate,0.013,0.427,0.128,0.232,Mild increase (p=0.05),Variable effect (p=0.003),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP00405,rs699409,22,151723987,APOE,SNP (C/T),(C/,C,1.02,0.62,1.35,0.04771367,Protective,0.124,0.03,0.417,0.23,Mild increase (p=0.02),Mild increase (p=0.007),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00406,rs673900,7,177073362,EPHA1,SNP (C/G),(C/,C,1.46,1.16,1.78,0.04906253,High,0.58,0.172,0.04,0.008,Mild increase (p=0.048),No significant pattern (p=0.002),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00407,rs471357,2,122814504,CD2AP,SNP (A/C),(A/,A,1.27,1.06,1.65,0.03602585,Low,0.365,0.133,0.04,0.262,Significant increase (p=0.013),Mild decrease (p=0.049),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00408,rs152715,17,58417891,APOE,SNP (G/T),(G/,G,0.98,0.76,1.35,0.06584982,Low,0.207,0.132,0.409,0.052,Significant decrease (p=0.046),Mild decrease (p=0.002),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00409,rs968473,5,219545605,APOE,Insertion,-,-,1.27,1.06,1.49,0.05698046,High,0.378,0.029,0.04,0.353,Significant increase (p=0.022),Significant increase (p=0.03),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP00410,rs227336,11,19355496,CD33,Deletion,-,-,1.46,1.09,1.81,0.00807782,Moderate,0.311,0.196,0.117,0.176,Significant increase (p=0.018),No significant pattern (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00411,rs928515,3,197306416,TREM2,Deletion,-,-,0.55,0.34,0.87,0.02374599,High,0.109,0.101,0.434,0.156,Mild increase (p=0.026),Variable effect (p=0.034),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00412,rs510739,6,98276669,BIN1,SNP (G/T),(G/,G,1.0,0.66,1.4,0.00426727,Protective,0.132,0.054,0.207,0.407,No significant pattern (p=0.025),Significant decrease (p=0.026),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP00413,rs886531,7,37827473,PICALM,SNP (A/G),(A/,A,1.24,1.0,1.48,0.0181574,Moderate,0.421,0.315,0.026,0.039,Mild decrease (p=0.015),Significant decrease (p=0.034),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00414,rs404170,22,82918837,EPHA1,SNP (A/C),(A/,A,1.65,1.26,2.0,0.02293669,Moderate,0.171,0.577,0.009,0.042,No significant pattern (p=0.025),Variable effect (p=0.025),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00415,rs121045,3,59277072,BIN1,SNP (G/T),(G/,G,1.16,0.78,1.54,0.0327956,High,0.107,0.244,0.239,0.21,Significant increase (p=0.011),Mild decrease (p=0.046),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00416,rs245463,12,154955227,PSEN2,SNP (A/G),(A/,A,1.0,0.61,1.21,0.021445,Low,0.068,0.282,0.002,0.448,Variable effect (p=0.036),Significant decrease (p=0.027),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00417,rs948873,10,70437339,MS4A6A,Deletion,-,-,1.58,1.3,1.88,0.03144921,Unknown,0.004,0.211,0.468,0.117,Significant increase (p=0.041),No significant pattern (p=0.014),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00418,rs898786,3,25205212,PICALM,SNP (A/G),(A/,A,0.3,0.1,0.64,0.0179391,Moderate,0.367,0.037,0.095,0.3,No significant pattern (p=0.004),No significant pattern (p=0.012),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00419,rs709842,2,246002205,EPHA1,SNP (A/C),(A/,A,0.88,0.64,1.21,0.02817971,Moderate,0.233,0.319,0.066,0.182,Significant increase (p=0.03),Variable effect (p=0.046),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00420,rs883495,14,32997321,ABCA7,SNP (C/G),(C/,C,1.04,0.76,1.27,0.04087057,Moderate,0.151,0.267,0.311,0.072,No significant pattern (p=0.025),Variable effect (p=0.027),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00421,rs973409,14,205663699,CD33,Deletion,-,-,0.97,0.62,1.22,0.00226763,Moderate,0.311,0.1,0.279,0.11,Mild increase (p=0.049),No significant pattern (p=0.014),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP00422,rs925310,20,54552923,PSEN2,SNP (C/G),(C/,C,1.35,1.07,1.58,0.02070719,Low,0.082,0.183,0.119,0.416,Variable effect (p=0.031),Significant increase (p=0.032),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP00423,rs862380,22,150412593,PICALM,SNP (C/G),(C/,C,0.81,0.61,1.13,0.00956314,Moderate,0.054,0.389,0.299,0.058,Significant decrease (p=0.038),Variable effect (p=0.045),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00424,rs948910,17,117495319,CD33,SNP (C/T),(C/,C,1.11,0.81,1.32,0.04368908,High,0.216,0.124,0.306,0.154,Significant decrease (p=0.032),Significant decrease (p=0.013),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00425,rs355885,5,119291418,EPHA1,SNP (C/G),(C/,C,1.51,1.14,1.87,0.00429302,High,0.034,0.451,0.245,0.069,Mild increase (p=0.035),Mild decrease (p=0.046),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00426,rs809043,9,92249115,MS4A6A,SNP (G/T),(G/,G,0.56,0.18,0.76,0.08510231,Low,0.417,0.047,0.28,0.056,Mild increase (p=0.026),Variable effect (p=0.006),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00427,rs807328,13,47899628,MS4A6A,SNP (C/T),(C/,C,0.32,0.1,0.66,0.02773291,Moderate,0.128,0.069,0.003,0.6,Significant increase (p=0.047),Variable effect (p=0.023),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00428,rs607882,16,134683727,APP,SNP (G/T),(G/,G,0.84,0.47,1.21,0.00178539,Unknown,0.147,0.342,0.148,0.162,Significant decrease (p=0.006),Mild decrease (p=0.037),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00429,rs843806,2,115040043,PTK2B,Insertion,-,-,1.37,1.13,1.59,0.01240111,High,0.088,0.031,0.39,0.291,Mild increase (p=0.048),No significant pattern (p=0.043),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00430,rs579953,6,17844839,CLU,SNP (C/T),(C/,C,0.71,0.4,0.99,0.02926687,High,0.171,0.313,0.305,0.01,Mild decrease (p=0.029),Significant increase (p=0.045),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00431,rs998961,11,83985279,PTK2B,SNP (G/T),(G/,G,1.24,0.89,1.51,0.00386907,Moderate,0.02,0.159,0.319,0.302,No significant pattern (p=0.004),Mild increase (p=0.033),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00432,rs829892,20,128825380,CD2AP,SNP (C/T),(C/,C,1.21,0.98,1.51,0.01590121,Protective,0.1,0.078,0.429,0.194,Mild increase (p=0.015),Significant increase (p=0.003),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00433,rs685809,14,179356382,CR1,SNP (A/G),(A/,A,1.24,0.88,1.6,0.00521236,Moderate,0.202,0.179,0.214,0.206,Mild increase (p=0.039),Mild increase (p=0.045),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00434,rs396210,14,144433569,CR1,SNP (G/T),(G/,G,1.44,1.22,1.79,0.04952784,High,0.224,0.198,0.102,0.276,Variable effect (p=0.049),Significant decrease (p=0.014),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00435,rs203004,1,87457165,SORL1,SNP (C/T),(C/,C,1.34,0.95,1.55,0.01758094,Moderate,0.517,0.175,0.065,0.043,Mild increase (p=0.032),No significant pattern (p=0.017),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00436,rs642983,12,70939619,SORL1,SNP (C/T),(C/,C,1.77,1.48,2.16,0.06112804,Moderate,0.086,0.246,0.295,0.174,No significant pattern (p=0.045),Mild increase (p=0.044),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00437,rs394242,14,157547509,PICALM,Deletion,-,-,1.43,1.15,1.75,0.03367842,Moderate,0.024,0.675,0.053,0.048,No significant pattern (p=0.022),Significant increase (p=0.048),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00438,rs962995,15,174937613,MS4A6A,SNP (A/G),(A/,A,1.67,1.39,2.0,0.02917136,High,0.003,0.115,0.611,0.071,Significant increase (p=0.036),Mild increase (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00439,rs359653,20,106981542,CD33,Deletion,-,-,0.64,0.39,0.89,0.02980689,Low,0.02,0.437,0.188,0.155,Mild decrease (p=0.008),Significant increase (p=0.002),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00440,rs180290,10,7321589,EPHA1,Insertion,-,-,1.21,0.92,1.55,0.01446731,Protective,0.47,0.094,0.229,0.007,No significant pattern (p=0.009),Significant increase (p=0.042),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00441,rs972055,19,185766270,SORL1,SNP (A/C),(A/,A,1.55,1.19,1.89,0.00635833,Moderate,0.46,0.094,0.216,0.03,Significant decrease (p=0.018),Variable effect (p=0.028),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00442,rs752430,12,68957782,SORL1,SNP (A/G),(A/,A,2.76,2.46,3.04,0.00830855,Moderate,0.367,0.139,0.237,0.057,Variable effect (p=0.003),Significant decrease (p=0.034),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00443,rs889163,2,37293354,SORL1,SNP (C/G),(C/,C,1.77,1.44,2.0,0.05589113,Moderate,0.24,0.2,0.284,0.076,Significant increase (p=0.021),Mild increase (p=0.036),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00444,rs427498,16,66782556,PSEN2,SNP (C/T),(C/,C,1.58,1.38,1.98,0.06748018,Moderate,0.025,0.381,0.285,0.109,Variable effect (p=0.012),Mild decrease (p=0.045),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00445,rs967755,19,74071290,APOE,SNP (G/T),(G/,G,1.16,0.83,1.47,0.03179468,Moderate,0.141,0.047,0.533,0.079,No significant pattern (p=0.001),Significant decrease (p=0.009),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00446,rs711160,12,56158745,PSEN2,SNP (C/T),(C/,C,1.81,1.56,2.02,0.02445125,Moderate,0.176,0.003,0.364,0.258,Variable effect (p=0.013),Mild increase (p=0.026),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00447,rs935528,17,1836621,TREM2,SNP (A/T),(A/,A,2.58,2.25,2.88,0.02072813,Moderate,0.038,0.143,0.01,0.61,Variable effect (p=0.03),Significant decrease (p=0.049),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00448,rs422247,19,120975239,PSEN2,SNP (A/C),(A/,A,0.71,0.38,0.91,0.01936417,Moderate,0.37,0.091,0.24,0.1,Mild increase (p=0.03),Mild increase (p=0.013),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00449,rs283457,3,7478109,BIN1,SNP (A/T),(A/,A,1.23,0.97,1.6,0.06914328,High,0.243,0.352,0.119,0.086,Mild increase (p=0.008),Mild decrease (p=0.009),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP00450,rs523391,22,187673140,BIN1,SNP (A/C),(A/,A,1.25,1.04,1.56,0.02573616,High,0.159,0.14,0.388,0.113,Mild increase (p=0.001),No significant pattern (p=0.046),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP00451,rs381576,9,136317375,CLU,SNP (C/T),(C/,C,1.51,1.28,1.72,0.00871294,Low,0.177,0.261,0.29,0.073,Variable effect (p=0.018),Significant decrease (p=0.027),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00452,rs146955,6,39424760,TREM2,Deletion,-,-,0.63,0.41,0.93,0.01354489,Low,0.03,0.267,0.139,0.364,Mild increase (p=0.021),Mild decrease (p=0.041),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00453,rs338325,14,91618507,TREM2,SNP (A/C),(A/,A,0.96,0.6,1.31,0.08861462,Moderate,0.186,0.219,0.003,0.392,Mild decrease (p=0.042),Mild increase (p=0.029),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00454,rs282095,19,115081225,PSEN2,Insertion,-,-,1.54,1.14,1.8,0.11230687,Moderate,0.018,0.009,0.525,0.248,Variable effect (p=0.001),Mild decrease (p=0.006),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00455,rs933403,17,58515670,EPHA1,SNP (G/T),(G/,G,0.93,0.73,1.19,0.04115019,Moderate,0.525,0.082,0.141,0.052,Mild increase (p=0.015),Significant increase (p=0.005),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00456,rs906297,13,54262163,PSEN2,SNP (G/T),(G/,G,2.56,2.22,2.81,0.00612535,Low,0.366,0.206,0.054,0.175,Significant decrease (p=0.03),Mild decrease (p=0.014),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00457,rs688037,7,29359893,PTK2B,Insertion,-,-,2.05,1.78,2.31,0.02910602,High,0.107,0.056,0.225,0.413,No significant pattern (p=0.026),Significant increase (p=0.004),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP00458,rs394567,13,124530623,CD2AP,Deletion,-,-,0.25,0.1,0.49,0.12366679,Moderate,0.169,0.476,0.031,0.124,Significant increase (p=0.023),Mild increase (p=0.043),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00459,rs261423,22,126932402,BIN1,SNP (G/T),(G/,G,0.49,0.27,0.8,0.00328821,High,0.232,0.317,0.018,0.233,Mild increase (p=0.043),Mild increase (p=0.035),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00460,rs553279,14,63563124,PSEN2,SNP (A/G),(A/,A,1.07,0.72,1.34,0.09823964,Protective,0.369,0.008,0.379,0.045,Mild decrease (p=0.028),Significant increase (p=0.037),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00461,rs143217,2,209238346,PSEN2,SNP (A/G),(A/,A,1.98,1.76,2.35,0.00152979,High,0.077,0.209,0.469,0.045,Significant increase (p=0.005),Significant increase (p=0.002),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00462,rs977146,19,82899285,APP,SNP (A/C),(A/,A,0.53,0.32,0.84,0.01793069,Moderate,0.216,0.323,0.096,0.164,Significant increase (p=0.026),Significant increase (p=0.048),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00463,rs926134,18,131675667,CR1,Insertion,-,-,0.93,0.72,1.32,0.00757963,Unknown,0.629,0.011,0.103,0.057,Significant decrease (p=0.024),Mild decrease (p=0.002),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00464,rs495591,7,231229325,CR1,SNP (C/G),(C/,C,1.32,1.12,1.62,0.00159476,Protective,0.314,0.379,0.025,0.082,Significant decrease (p=0.024),Variable effect (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00465,rs417455,5,75598554,ABCA7,SNP (A/C),(A/,A,0.75,0.53,1.05,0.00572551,Low,0.077,0.159,0.301,0.263,Mild increase (p=0.033),Mild increase (p=0.016),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00466,rs245907,7,151311584,APP,SNP (C/G),(C/,C,0.72,0.36,1.06,0.02002828,Low,0.154,0.322,0.251,0.072,Variable effect (p=0.027),No significant pattern (p=0.042),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00467,rs766065,11,246621050,CLU,SNP (G/T),(G/,G,2.44,2.2,2.77,0.02303626,Moderate,0.046,0.086,0.281,0.387,Mild increase (p=0.042),Significant increase (p=0.025),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00468,rs147491,5,79941051,PICALM,SNP (A/T),(A/,A,0.94,0.6,1.32,0.02646845,Protective,0.428,0.201,0.03,0.141,Mild increase (p=0.002),Variable effect (p=0.006),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00469,rs730855,8,47226018,APP,SNP (C/T),(C/,C,1.66,1.27,2.05,0.08320787,High,0.086,0.017,0.629,0.067,Variable effect (p=0.034),Significant increase (p=0.008),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00470,rs122267,11,4823232,PTK2B,SNP (C/G),(C/,C,0.93,0.69,1.15,0.02495599,Moderate,0.102,0.4,0.121,0.177,Mild increase (p=0.042),Mild increase (p=0.03),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00471,rs120465,14,127933244,TREM2,SNP (A/C),(A/,A,0.93,0.7,1.19,0.00881606,High,0.021,0.397,0.362,0.02,Variable effect (p=0.041),Mild increase (p=0.028),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00472,rs483295,13,10847719,CD2AP,SNP (G/T),(G/,G,1.12,0.77,1.36,0.04421838,Moderate,0.332,0.071,0.318,0.079,Significant increase (p=0.02),Mild increase (p=0.043),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00473,rs146479,14,62756420,BIN1,SNP (C/T),(C/,C,0.47,0.1,0.71,0.00747677,Low,0.309,0.264,0.086,0.141,Significant decrease (p=0.002),Variable effect (p=0.002),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP00474,rs844012,12,129816361,CD33,SNP (A/C),(A/,A,0.81,0.57,1.11,0.00680989,Low,0.002,0.589,0.021,0.188,Significant decrease (p=0.026),Significant decrease (p=0.011),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00475,rs368480,21,168427681,EPHA1,Deletion,-,-,1.15,0.94,1.51,0.02578913,High,0.25,0.139,0.296,0.115,Mild increase (p=0.034),Mild increase (p=0.028),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP00476,rs200187,1,73514836,ABCA7,SNP (A/C),(A/,A,1.71,1.41,2.08,0.02535142,High,0.475,0.018,0.303,0.004,Mild increase (p=0.011),Significant increase (p=0.046),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00477,rs491201,6,124171672,CD33,SNP (C/G),(C/,C,1.1,0.72,1.34,0.02317323,Protective,0.003,0.048,0.619,0.13,Significant decrease (p=0.007),No significant pattern (p=0.025),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP00478,rs412371,2,44899609,PTK2B,SNP (A/T),(A/,A,0.54,0.16,0.88,0.00750833,Low,0.059,0.132,0.577,0.033,Significant increase (p=0.005),Significant increase (p=0.023),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00479,rs493454,14,210256348,CD2AP,SNP (A/T),(A/,A,1.15,0.9,1.52,0.0417086,High,0.302,0.257,0.185,0.057,Mild decrease (p=0.038),Variable effect (p=0.024),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00480,rs879984,6,208315649,PICALM,SNP (C/T),(C/,C,2.86,2.65,3.09,0.01863945,Moderate,0.102,0.054,0.54,0.105,Significant increase (p=0.044),Significant increase (p=0.03),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00481,rs690795,5,210106285,CD2AP,SNP (A/T),(A/,A,0.29,0.1,0.6,0.00417309,Unknown,0.321,0.2,0.024,0.255,Mild decrease (p=0.036),Significant decrease (p=0.023),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00482,rs331763,18,247259416,APP,SNP (A/T),(A/,A,0.79,0.48,1.01,0.01846298,Low,0.209,0.128,0.243,0.219,Significant increase (p=0.031),Variable effect (p=0.005),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00483,rs949366,13,212635900,CD33,SNP (G/T),(G/,G,1.84,1.63,2.05,0.01543374,Moderate,0.087,0.487,0.009,0.217,Variable effect (p=0.042),Mild decrease (p=0.009),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00484,rs563976,18,141827368,ABCA7,Deletion,-,-,0.5,0.27,0.75,0.00535617,Moderate,0.394,0.279,0.091,0.036,Significant increase (p=0.018),Mild increase (p=0.022),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00485,rs875685,2,132331554,APP,SNP (A/C),(A/,A,0.93,0.55,1.29,0.03336491,High,0.069,0.116,0.449,0.166,Mild increase (p=0.009),Mild decrease (p=0.031),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00486,rs405376,6,117070057,SORL1,SNP (G/T),(G/,G,0.68,0.44,0.9,0.07473008,Unknown,0.098,0.054,0.046,0.602,Significant decrease (p=0.002),Variable effect (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00487,rs259344,6,132275250,EPHA1,Insertion,-,-,0.62,0.24,0.91,0.02236052,High,0.398,0.236,0.034,0.132,Mild increase (p=0.049),Significant decrease (p=0.014),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00488,rs560635,18,207325952,CD33,SNP (A/T),(A/,A,0.71,0.49,0.97,0.06232936,High,0.027,0.513,0.027,0.234,Mild decrease (p=0.017),Mild increase (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00489,rs274966,1,82554717,PTK2B,Insertion,-,-,1.33,0.99,1.61,0.01773129,Unknown,0.139,0.038,0.267,0.356,Mild increase (p=0.046),Significant decrease (p=0.01),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00490,rs102669,22,40683688,EPHA1,SNP (A/T),(A/,A,0.6,0.24,0.9,0.01719674,High,0.192,0.354,0.091,0.162,Mild increase (p=0.014),No significant pattern (p=0.039),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00491,rs122225,6,199082691,SORL1,Insertion,-,-,0.77,0.54,1.12,0.11232182,High,0.013,0.086,0.682,0.018,Mild decrease (p=0.031),No significant pattern (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00492,rs686775,3,115444913,CD2AP,Insertion,-,-,1.23,0.89,1.45,0.01386868,Moderate,0.282,0.088,0.426,0.004,Mild increase (p=0.049),Mild increase (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00493,rs826252,16,27199371,PTK2B,Deletion,-,-,1.62,1.34,1.89,0.07006391,Protective,0.151,0.114,0.158,0.377,Variable effect (p=0.001),Mild increase (p=0.043),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00494,rs615491,2,37482445,EPHA1,SNP (C/G),(C/,C,2.12,1.78,2.48,0.06964868,Moderate,0.328,0.149,0.069,0.254,No significant pattern (p=0.005),No significant pattern (p=0.028),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00495,rs419262,8,219348175,CLU,SNP (A/C),(A/,A,1.1,0.85,1.47,0.00871224,Low,0.021,0.395,0.38,0.003,Mild increase (p=0.021),Mild increase (p=0.014),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00496,rs536074,11,17200779,MS4A6A,SNP (G/T),(G/,G,1.65,1.42,1.87,0.0466818,Protective,0.46,0.005,0.176,0.159,No significant pattern (p=0.013),Mild decrease (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00497,rs748458,21,216919425,APP,SNP (C/G),(C/,C,1.27,0.9,1.49,0.06021669,High,0.208,0.089,0.245,0.258,Variable effect (p=0.041),No significant pattern (p=0.01),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP00498,rs427486,16,149825067,CR1,SNP (C/G),(C/,C,1.02,0.78,1.31,0.01444087,High,0.526,0.109,0.12,0.045,Mild increase (p=0.035),Mild increase (p=0.007),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP00499,rs736137,18,231391946,PTK2B,Insertion,-,-,1.29,0.95,1.56,0.0693699,High,0.549,0.018,0.011,0.222,Significant increase (p=0.022),Significant decrease (p=0.01),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00500,rs378170,1,107478491,PICALM,SNP (A/G),(A/,A,1.19,0.88,1.48,0.05975801,Protective,0.142,0.366,0.183,0.109,Mild increase (p=0.034),Variable effect (p=0.041),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00501,rs312022,16,169165128,CD33,SNP (A/C),(A/,A,0.32,0.1,0.61,0.05784078,High,0.334,0.228,0.008,0.23,Mild decrease (p=0.008),Mild decrease (p=0.019),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00502,rs520961,8,228745162,CD33,SNP (C/T),(C/,C,0.49,0.29,0.73,0.00728735,High,0.154,0.055,0.447,0.144,Mild decrease (p=0.022),Significant decrease (p=0.048),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00503,rs278558,21,209420791,PTK2B,SNP (A/T),(A/,A,1.37,1.0,1.58,0.00866199,Low,0.117,0.229,0.385,0.069,Significant increase (p=0.026),Mild increase (p=0.022),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00504,rs411944,6,134960060,TREM2,Insertion,-,-,1.5,1.29,1.84,0.0072857,Moderate,0.358,0.36,0.024,0.058,Mild decrease (p=0.038),Significant increase (p=0.022),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00505,rs474319,9,161594295,TREM2,SNP (C/G),(C/,C,0.62,0.26,0.84,0.03675285,Low,0.121,0.294,0.14,0.246,Variable effect (p=0.026),Variable effect (p=0.021),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00506,rs102972,15,4635008,CR1,SNP (C/T),(C/,C,0.96,0.57,1.32,0.05145829,Protective,0.034,0.231,0.111,0.425,No significant pattern (p=0.049),Mild increase (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP00507,rs315032,17,246282059,SORL1,Insertion,-,-,1.05,0.72,1.43,0.05473112,Moderate,0.161,0.32,0.253,0.066,No significant pattern (p=0.028),Mild decrease (p=0.015),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00508,rs617665,11,241978826,PSEN2,SNP (A/G),(A/,A,3.49,3.16,3.89,0.00544256,High,0.057,0.244,0.419,0.08,Variable effect (p=0.032),Variable effect (p=0.044),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00509,rs876527,7,162330774,BIN1,SNP (A/T),(A/,A,0.7,0.32,0.92,0.14688625,High,0.078,0.638,0.041,0.043,Mild increase (p=0.023),Significant increase (p=0.007),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00510,rs906899,16,130999694,CD33,SNP (G/T),(G/,G,1.45,1.21,1.78,0.01704112,Protective,0.044,0.095,0.285,0.376,No significant pattern (p=0.008),Mild decrease (p=0.038),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00511,rs862207,4,114583770,APP,SNP (G/T),(G/,G,1.35,1.04,1.65,0.03946702,High,0.081,0.618,0.092,0.008,Variable effect (p=0.015),Mild increase (p=0.002),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00512,rs800230,5,27935703,APOE,SNP (C/G),(C/,C,1.21,0.9,1.42,0.12755824,Moderate,0.339,0.018,0.419,0.024,Mild increase (p=0.011),Significant increase (p=0.024),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00513,rs999138,21,177139705,CR1,Insertion,-,-,1.84,1.58,2.06,0.0365917,Moderate,0.357,0.161,0.251,0.031,Mild decrease (p=0.002),Mild decrease (p=0.004),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00514,rs945149,22,196980672,CD33,SNP (C/G),(C/,C,0.68,0.28,1.03,0.0823236,Moderate,0.109,0.133,0.071,0.488,Variable effect (p=0.018),Variable effect (p=0.031),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00515,rs375189,14,208724687,BIN1,SNP (A/G),(A/,A,1.7,1.48,1.95,0.0323056,Low,0.047,0.4,0.31,0.043,Significant increase (p=0.024),Mild decrease (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00516,rs962774,17,146816386,APOE,SNP (G/T),(G/,G,2.93,2.6,3.15,0.02484107,Low,0.141,0.054,0.415,0.19,No significant pattern (p=0.047),Mild decrease (p=0.034),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00517,rs934195,11,30042326,PSEN2,SNP (C/G),(C/,C,0.54,0.19,0.83,0.02130232,Low,0.149,0.322,0.044,0.285,Mild increase (p=0.049),Significant decrease (p=0.013),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00518,rs362819,11,169969281,APOE,SNP (A/G),(A/,A,1.44,1.09,1.76,0.00105648,Moderate,0.228,0.106,0.409,0.058,Significant increase (p=0.036),Significant increase (p=0.045),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP00519,rs430935,10,93704568,BIN1,SNP (G/T),(G/,G,0.97,0.68,1.18,0.01936761,Low,0.223,0.013,0.133,0.431,Significant decrease (p=0.016),No significant pattern (p=0.029),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP00520,rs157752,8,42606900,PSEN2,SNP (A/C),(A/,A,0.4,0.19,0.72,0.16088655,High,0.179,0.007,0.145,0.468,Mild decrease (p=0.049),Significant increase (p=0.039),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP00521,rs389616,20,3720861,EPHA1,Deletion,-,-,0.8,0.51,1.04,0.0489666,High,0.224,0.114,0.303,0.159,Significant increase (p=0.01),No significant pattern (p=0.031),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP00522,rs497435,16,125828847,TREM2,SNP (C/G),(C/,C,3.03,2.76,3.28,0.04946689,Low,0.448,0.033,0.267,0.053,Mild decrease (p=0.027),No significant pattern (p=0.01),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00523,rs110401,16,87731779,ABCA7,SNP (C/T),(C/,C,0.81,0.51,1.14,0.02642442,Moderate,0.084,0.138,0.173,0.405,Mild decrease (p=0.047),No significant pattern (p=0.025),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00524,rs701399,8,91387325,CD33,SNP (C/T),(C/,C,1.33,1.11,1.55,0.02158517,Moderate,0.428,0.022,0.033,0.317,Mild increase (p=0.003),No significant pattern (p=0.032),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00525,rs753124,7,232946437,BIN1,Insertion,-,-,1.16,0.9,1.39,0.0853379,Protective,0.102,0.09,0.098,0.51,Significant increase (p=0.029),Significant increase (p=0.027),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00526,rs955382,1,207029055,CD33,Insertion,-,-,1.55,1.26,1.75,0.01088108,Moderate,0.097,0.539,0.027,0.137,Significant increase (p=0.029),No significant pattern (p=0.034),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00527,rs805282,7,50348926,APP,Deletion,-,-,0.63,0.25,1.02,0.03012134,High,0.058,0.088,0.261,0.393,Significant increase (p=0.041),Variable effect (p=0.029),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00528,rs821657,7,70104295,PTK2B,SNP (G/T),(G/,G,1.32,1.1,1.63,0.01014855,Moderate,0.22,0.303,0.252,0.024,Mild decrease (p=0.021),Mild decrease (p=0.018),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00529,rs115261,8,95171439,APP,SNP (C/G),(C/,C,2.49,2.16,2.72,0.01028963,Low,0.269,0.031,0.432,0.068,Mild increase (p=0.011),Mild increase (p=0.005),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00530,rs677272,20,197718197,ABCA7,SNP (G/T),(G/,G,1.18,0.81,1.41,0.00187808,Moderate,0.28,0.147,0.016,0.358,Mild increase (p=0.031),Significant decrease (p=0.022),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00531,rs307510,14,86551459,PSEN2,SNP (C/T),(C/,C,1.02,0.81,1.32,0.01033122,Moderate,0.142,0.061,0.564,0.033,Significant increase (p=0.024),Significant decrease (p=0.015),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00532,rs977717,19,227814982,SORL1,SNP (C/G),(C/,C,1.07,0.84,1.41,0.07423382,Moderate,0.53,0.069,0.04,0.161,Significant increase (p=0.009),Significant decrease (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00533,rs255372,9,52835344,APOE,Deletion,-,-,0.93,0.53,1.24,0.06673756,Low,0.093,0.199,0.07,0.438,Significant decrease (p=0.025),Mild decrease (p=0.023),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00534,rs594825,19,46115529,APOE,SNP (C/T),(C/,C,1.42,1.08,1.64,0.02388923,Moderate,0.147,0.221,0.09,0.342,Mild decrease (p=0.019),No significant pattern (p=0.002),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00535,rs612598,10,14605106,EPHA1,SNP (A/T),(A/,A,0.93,0.59,1.29,0.03351032,High,0.221,0.009,0.503,0.066,Significant increase (p=0.017),Mild increase (p=0.035),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP00536,rs378577,12,158395985,PTK2B,Insertion,-,-,0.6,0.22,0.95,0.12792725,High,0.048,0.371,0.232,0.149,No significant pattern (p=0.006),Significant decrease (p=0.043),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP00537,rs429699,8,6188291,MS4A6A,SNP (C/T),(C/,C,1.55,1.23,1.83,0.01820741,High,0.139,0.361,0.15,0.151,Mild decrease (p=0.004),Significant decrease (p=0.003),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00538,rs596388,21,11371245,CLU,SNP (A/G),(A/,A,0.58,0.19,0.86,0.02157637,Moderate,0.073,0.13,0.248,0.35,Variable effect (p=0.043),Variable effect (p=0.013),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00539,rs439512,10,36770041,BIN1,SNP (C/T),(C/,C,0.61,0.34,0.94,0.03884802,Unknown,0.174,0.111,0.378,0.136,No significant pattern (p=0.018),Variable effect (p=0.024),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00540,rs881074,10,3362172,PTK2B,SNP (G/T),(G/,G,0.69,0.43,1.04,0.14776425,High,0.124,0.298,0.14,0.238,Significant decrease (p=0.023),Significant increase (p=0.038),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00541,rs987464,17,241663513,BIN1,SNP (A/T),(A/,A,0.75,0.5,1.01,0.003707,High,0.011,0.333,0.38,0.076,Significant decrease (p=0.002),Mild decrease (p=0.01),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00542,rs588320,4,119309792,SORL1,Insertion,-,-,1.45,1.19,1.8,0.04054274,Low,0.234,0.237,0.047,0.282,Mild increase (p=0.038),Significant increase (p=0.034),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00543,rs781625,19,85016808,PSEN2,Deletion,-,-,1.06,0.8,1.28,0.08404819,High,0.623,0.037,0.114,0.026,Variable effect (p=0.036),Variable effect (p=0.007),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00544,rs709849,6,160501186,APOE,Insertion,-,-,0.8,0.47,1.01,0.02052437,Low,0.153,0.055,0.277,0.315,Significant increase (p=0.046),Variable effect (p=0.002),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00545,rs148044,22,8173846,PICALM,SNP (G/T),(G/,G,0.86,0.5,1.26,0.0475361,Low,0.049,0.057,0.077,0.617,Significant increase (p=0.006),Mild increase (p=0.028),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00546,rs937898,21,193790800,PICALM,SNP (G/T),(G/,G,1.16,0.92,1.48,0.00325907,High,0.152,0.268,0.184,0.196,Significant increase (p=0.02),Variable effect (p=0.031),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00547,rs448103,20,8817267,PSEN2,SNP (A/G),(A/,A,0.59,0.32,0.82,0.00546341,Low,0.05,0.318,0.118,0.314,No significant pattern (p=0.004),Mild decrease (p=0.045),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00548,rs426658,4,240072484,TREM2,Insertion,-,-,1.13,0.82,1.47,0.0563834,Low,0.194,0.032,0.347,0.227,Significant decrease (p=0.016),Significant decrease (p=0.018),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP00549,rs679220,10,136900570,CD33,SNP (C/G),(C/,C,1.55,1.3,1.77,0.00366962,High,0.059,0.152,0.38,0.208,Mild decrease (p=0.044),Mild decrease (p=0.031),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00550,rs591446,10,43262649,BIN1,SNP (A/T),(A/,A,1.33,0.96,1.61,0.01592085,High,0.371,0.002,0.111,0.316,Significant increase (p=0.014),Significant decrease (p=0.037),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00551,rs599792,13,90756098,SORL1,SNP (C/G),(C/,C,0.7,0.4,0.97,0.02697366,Protective,0.41,0.127,0.242,0.021,Significant decrease (p=0.03),No significant pattern (p=0.014),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00552,rs239142,18,236423398,BIN1,Insertion,-,-,1.52,1.15,1.72,0.00121015,High,0.267,0.187,0.214,0.132,No significant pattern (p=0.002),Variable effect (p=0.034),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP00553,rs735210,21,166646327,ABCA7,SNP (A/G),(A/,A,0.57,0.29,0.89,0.02633498,High,0.42,0.138,0.076,0.166,Significant decrease (p=0.023),Mild increase (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP00554,rs903804,18,193654231,PSEN2,SNP (A/C),(A/,A,1.16,0.91,1.51,0.03630427,Protective,0.132,0.446,0.135,0.087,Variable effect (p=0.042),Significant decrease (p=0.018),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00555,rs205499,9,193200007,CD33,SNP (A/C),(A/,A,1.42,1.05,1.68,0.05207264,Low,0.068,0.401,0.015,0.316,Significant increase (p=0.04),Variable effect (p=0.039),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00556,rs861229,16,41775138,ABCA7,SNP (A/T),(A/,A,3.98,3.66,4.23,0.01423541,High,0.461,0.076,0.215,0.048,Mild decrease (p=0.007),Significant decrease (p=0.017),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00557,rs698195,9,71523107,CD33,SNP (C/G),(C/,C,1.06,0.81,1.29,0.01597316,High,0.141,0.504,0.149,0.006,Mild increase (p=0.022),Significant increase (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP00558,rs916080,2,150955361,ABCA7,Deletion,-,-,0.97,0.66,1.35,0.00222664,Low,0.365,0.037,0.28,0.119,Mild decrease (p=0.023),Mild decrease (p=0.039),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP00559,rs195230,18,8253671,PTK2B,SNP (C/G),(C/,C,1.79,1.58,2.07,0.00862116,Low,0.341,0.436,0.008,0.015,Variable effect (p=0.008),Significant increase (p=0.048),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00560,rs462746,1,116842052,PICALM,SNP (A/T),(A/,A,2.19,1.93,2.42,0.02280661,Moderate,0.133,0.119,0.303,0.245,Variable effect (p=0.001),Significant increase (p=0.032),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00561,rs937161,8,238281957,BIN1,SNP (G/T),(G/,G,1.02,0.76,1.4,0.00859427,Moderate,0.304,0.33,0.1,0.066,No significant pattern (p=0.045),Mild decrease (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00562,rs190490,7,231634645,PICALM,Insertion,-,-,2.04,1.78,2.3,0.00705733,High,0.038,0.378,0.085,0.299,Significant increase (p=0.017),Variable effect (p=0.014),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP00563,rs295760,4,139710431,CR1,SNP (C/G),(C/,C,0.39,0.14,0.69,0.05101578,High,0.286,0.199,0.085,0.23,Mild decrease (p=0.046),Significant increase (p=0.034),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00564,rs997385,8,29382366,PICALM,Deletion,-,-,1.61,1.38,1.99,0.00159902,High,0.01,0.221,0.495,0.073,No significant pattern (p=0.036),Mild increase (p=0.002),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00565,rs339198,20,44613425,PSEN2,SNP (G/T),(G/,G,1.2,0.93,1.46,0.01975985,Protective,0.036,0.6,0.042,0.123,No significant pattern (p=0.014),Mild increase (p=0.004),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP00566,rs862424,1,9325993,APOE,SNP (C/T),(C/,C,0.3,0.1,0.52,0.01334699,High,0.037,0.105,0.387,0.271,Mild decrease (p=0.007),Variable effect (p=0.05),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00567,rs688876,15,148784819,CLU,Insertion,-,-,1.06,0.84,1.44,0.01691279,Unknown,0.369,0.075,0.036,0.319,Mild decrease (p=0.049),Mild increase (p=0.024),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00568,rs315538,19,123284591,APP,SNP (C/G),(C/,C,2.59,2.35,2.96,0.02914833,High,0.227,0.415,0.061,0.097,Variable effect (p=0.02),Mild decrease (p=0.001),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00569,rs887797,6,46565256,ABCA7,Deletion,-,-,0.7,0.45,0.99,0.08865545,Protective,0.127,0.421,0.033,0.218,Mild increase (p=0.008),Significant decrease (p=0.019),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00570,rs488321,12,236746732,MS4A6A,SNP (C/G),(C/,C,0.9,0.52,1.12,0.01669017,Moderate,0.147,0.068,0.534,0.051,No significant pattern (p=0.015),Significant increase (p=0.035),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00571,rs396646,22,5117043,CD2AP,SNP (C/T),(C/,C,1.36,1.01,1.76,0.07218456,Moderate,0.226,0.154,0.369,0.052,Significant decrease (p=0.004),Mild decrease (p=0.021),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00572,rs522585,9,66461284,ABCA7,SNP (A/G),(A/,A,0.57,0.28,0.94,0.02691405,Low,0.107,0.2,0.285,0.208,Mild increase (p=0.028),Variable effect (p=0.009),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00573,rs364326,16,80929058,SORL1,SNP (A/T),(A/,A,1.89,1.53,2.15,0.06076009,High,0.463,0.001,0.104,0.232,Significant decrease (p=0.034),Significant increase (p=0.037),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00574,rs572611,8,68733164,CLU,Deletion,-,-,0.65,0.32,0.97,0.12767839,Moderate,0.294,0.103,0.147,0.257,Variable effect (p=0.049),Mild increase (p=0.011),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00575,rs444536,14,171928975,TREM2,Insertion,-,-,0.5,0.24,0.7,0.00520575,Low,0.096,0.057,0.414,0.232,Mild increase (p=0.008),Significant decrease (p=0.008),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00576,rs555111,20,33251225,APP,SNP (A/C),(A/,A,1.1,0.78,1.47,0.12199514,High,0.046,0.58,0.084,0.09,Mild increase (p=0.015),Significant decrease (p=0.036),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00577,rs689772,6,109621773,BIN1,Insertion,-,-,2.13,1.86,2.34,0.01712275,Moderate,0.144,0.04,0.005,0.611,Significant decrease (p=0.007),No significant pattern (p=0.035),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00578,rs194274,4,34167739,CD2AP,SNP (A/C),(A/,A,1.09,0.82,1.36,0.00382046,Low,0.142,0.317,0.322,0.018,Significant decrease (p=0.026),Mild decrease (p=0.004),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00579,rs412940,19,1356405,APOE,Deletion,-,-,1.38,1.11,1.62,0.07233214,High,0.235,0.366,0.141,0.058,No significant pattern (p=0.027),Significant increase (p=0.039),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00580,rs183883,18,211119300,PTK2B,SNP (A/T),(A/,A,1.27,0.9,1.55,0.00127852,High,0.48,0.197,0.066,0.057,Mild decrease (p=0.033),Mild increase (p=0.021),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00581,rs234733,20,126271960,TREM2,SNP (A/T),(A/,A,0.85,0.47,1.14,0.05071752,Moderate,0.073,0.386,0.053,0.288,No significant pattern (p=0.03),Variable effect (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00582,rs643503,8,219317249,TREM2,SNP (A/C),(A/,A,0.82,0.55,1.19,0.08237114,Low,0.114,0.026,0.545,0.116,Mild increase (p=0.002),No significant pattern (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00583,rs443480,13,220659284,SORL1,Deletion,-,-,0.35,0.1,0.55,0.00805241,Low,0.124,0.016,0.425,0.234,Mild increase (p=0.002),Variable effect (p=0.033),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00584,rs151721,20,68710809,EPHA1,SNP (G/T),(G/,G,0.8,0.5,1.1,0.03055585,Moderate,0.255,0.127,0.138,0.281,Significant decrease (p=0.032),Variable effect (p=0.049),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00585,rs969714,14,22268953,APOE,SNP (A/G),(A/,A,0.51,0.15,0.85,0.01211889,Moderate,0.001,0.319,0.153,0.328,Significant decrease (p=0.004),Significant increase (p=0.018),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00586,rs955272,1,25969242,PTK2B,SNP (C/T),(C/,C,0.94,0.71,1.3,0.00922924,High,0.147,0.179,0.039,0.434,Significant increase (p=0.036),No significant pattern (p=0.016),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP00587,rs254963,15,178704506,CLU,Insertion,-,-,2.0,1.63,2.33,0.00890121,Moderate,0.011,0.04,0.673,0.076,Mild decrease (p=0.023),Mild decrease (p=0.026),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP00588,rs830383,9,50010138,BIN1,SNP (A/C),(A/,A,0.59,0.24,0.85,0.00498319,High,0.323,0.011,0.231,0.235,Significant decrease (p=0.018),Variable effect (p=0.031),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00589,rs952284,20,68849248,CLU,Insertion,-,-,0.73,0.35,1.03,0.00690518,High,0.524,0.073,0.162,0.041,Mild decrease (p=0.007),Significant decrease (p=0.033),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00590,rs899433,13,110697868,CD33,SNP (G/T),(G/,G,0.3,0.1,0.69,0.05466675,Protective,0.047,0.278,0.127,0.347,No significant pattern (p=0.015),No significant pattern (p=0.013),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00591,rs409261,19,207227904,PSEN2,SNP (C/T),(C/,C,1.84,1.5,2.24,0.0391867,High,0.146,0.077,0.083,0.494,Significant decrease (p=0.036),No significant pattern (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00592,rs181772,6,80067677,SORL1,SNP (C/G),(C/,C,1.28,0.92,1.54,0.01051298,Moderate,0.157,0.016,0.179,0.448,Variable effect (p=0.016),Mild decrease (p=0.029),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00593,rs253306,15,92214874,SORL1,SNP (A/T),(A/,A,1.69,1.32,1.91,0.03363137,Low,0.091,0.016,0.658,0.036,Significant increase (p=0.016),Significant increase (p=0.007),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00594,rs461142,16,187421194,CD2AP,Insertion,-,-,1.56,1.23,1.83,0.04372027,Moderate,0.207,0.251,0.213,0.128,Mild increase (p=0.025),Significant decrease (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00595,rs850275,11,85882785,SORL1,Insertion,-,-,0.73,0.4,1.09,0.01063286,High,0.029,0.236,0.105,0.43,Significant decrease (p=0.012),Variable effect (p=0.015),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00596,rs965850,20,125969945,CD2AP,Insertion,-,-,0.63,0.3,0.98,0.00221679,High,0.517,0.186,0.054,0.043,Significant increase (p=0.037),Mild increase (p=0.029),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00597,rs489694,3,172369630,CD2AP,Insertion,-,-,0.88,0.49,1.08,0.02115016,High,0.345,0.147,0.175,0.133,Mild decrease (p=0.015),Mild increase (p=0.033),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00598,rs929543,18,6939295,APP,Deletion,-,-,1.33,0.96,1.57,0.07930402,Low,0.008,0.495,0.138,0.159,No significant pattern (p=0.016),Mild decrease (p=0.031),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00599,rs690966,11,84548669,ABCA7,SNP (A/G),(A/,A,1.01,0.63,1.24,0.06071918,Moderate,0.127,0.437,0.21,0.026,No significant pattern (p=0.02),Significant decrease (p=0.031),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00600,rs557899,12,150173177,PTK2B,SNP (G/T),(G/,G,1.13,0.88,1.36,0.08964708,Low,0.381,0.138,0.159,0.122,Variable effect (p=0.041),Variable effect (p=0.024),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00601,rs627137,14,175709316,ABCA7,SNP (C/G),(C/,C,0.91,0.52,1.11,0.04260239,High,0.339,0.167,0.227,0.067,Mild increase (p=0.049),Significant increase (p=0.029),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00602,rs811495,22,160976380,CR1,SNP (C/T),(C/,C,0.59,0.31,0.91,0.02630549,Protective,0.017,0.092,0.336,0.355,Mild decrease (p=0.022),No significant pattern (p=0.018),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00603,rs372082,11,179857199,CLU,SNP (C/T),(C/,C,0.95,0.72,1.32,0.07602969,Moderate,0.019,0.542,0.142,0.096,No significant pattern (p=0.018),Significant decrease (p=0.006),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00604,rs316088,14,198766545,APOE,SNP (C/T),(C/,C,1.59,1.22,1.99,0.01725657,Moderate,0.025,0.06,0.382,0.333,Significant increase (p=0.027),Mild decrease (p=0.002),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00605,rs107586,20,130542431,CLU,Deletion,-,-,0.47,0.11,0.68,0.04838127,Low,0.225,0.207,0.32,0.047,Mild decrease (p=0.006),Mild decrease (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00606,rs191463,15,139025793,PTK2B,SNP (A/C),(A/,A,1.79,1.59,2.17,0.04688277,High,0.031,0.393,0.375,0.002,Mild decrease (p=0.033),Significant decrease (p=0.022),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00607,rs139012,12,161238239,APP,SNP (C/G),(C/,C,1.53,1.23,1.86,0.0195587,Moderate,0.176,0.53,0.08,0.015,Significant increase (p=0.011),Significant increase (p=0.027),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP00608,rs629007,9,205519954,PTK2B,SNP (C/G),(C/,C,1.33,1.02,1.58,0.02795199,Moderate,0.226,0.115,0.181,0.278,Mild decrease (p=0.003),No significant pattern (p=0.034),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00609,rs528149,11,108957739,PSEN2,SNP (C/G),(C/,C,1.64,1.26,2.03,0.00569628,Low,0.283,0.255,0.137,0.125,Mild decrease (p=0.029),Mild decrease (p=0.045),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00610,rs809133,7,106475187,CLU,Deletion,-,-,1.5,1.21,1.89,0.00616349,High,0.261,0.161,0.266,0.113,Mild decrease (p=0.003),No significant pattern (p=0.032),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00611,rs603294,11,105287387,APOE,Deletion,-,-,0.59,0.29,0.81,0.02441575,Moderate,0.288,0.017,0.265,0.23,Significant increase (p=0.033),Significant increase (p=0.019),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00612,rs243499,14,204397830,TREM2,SNP (C/T),(C/,C,1.48,1.18,1.72,0.1574229,Protective,0.021,0.355,0.119,0.305,Significant decrease (p=0.004),Significant decrease (p=0.039),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00613,rs662076,18,24429806,EPHA1,SNP (A/C),(A/,A,1.23,0.85,1.52,0.10744245,Moderate,0.232,0.051,0.415,0.102,Significant increase (p=0.006),Significant increase (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00614,rs895397,8,57413940,EPHA1,SNP (A/T),(A/,A,1.94,1.63,2.22,0.0295202,Moderate,0.075,0.057,0.35,0.318,Mild decrease (p=0.005),No significant pattern (p=0.004),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00615,rs581728,14,152163858,CR1,Insertion,-,-,1.26,0.97,1.47,0.15048536,Low,0.223,0.248,0.002,0.327,Mild increase (p=0.047),Mild increase (p=0.011),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00616,rs418157,2,86294312,APOE,SNP (A/T),(A/,A,1.15,0.78,1.53,0.02904288,Moderate,0.24,0.057,0.029,0.475,Variable effect (p=0.038),Variable effect (p=0.017),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00617,rs180331,21,136122273,BIN1,Deletion,-,-,1.09,0.72,1.47,0.01330873,Low,0.369,0.37,0.025,0.036,No significant pattern (p=0.017),Mild decrease (p=0.012),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00618,rs938282,12,131718024,APP,Insertion,-,-,1.36,0.99,1.62,0.02643474,Moderate,0.192,0.104,0.079,0.424,Significant increase (p=0.044),Variable effect (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00619,rs483572,11,41974951,APOE,SNP (C/T),(C/,C,1.54,1.31,1.88,0.02140423,Low,0.095,0.224,0.464,0.017,No significant pattern (p=0.032),Mild increase (p=0.034),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP00620,rs499594,19,122936952,CR1,SNP (A/T),(A/,A,1.44,1.2,1.69,0.01202866,Moderate,0.423,0.033,0.344,0.0,No significant pattern (p=0.045),Significant increase (p=0.03),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00621,rs758880,9,153570492,APOE,SNP (C/G),(C/,C,0.68,0.35,1.08,0.01795971,High,0.082,0.066,0.053,0.599,Significant increase (p=0.035),Mild decrease (p=0.044),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00622,rs986029,9,200215268,CLU,SNP (A/C),(A/,A,1.12,0.88,1.34,0.05989786,Protective,0.059,0.225,0.049,0.467,Mild increase (p=0.036),Mild decrease (p=0.028),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00623,rs176434,14,42643546,APOE,SNP (C/G),(C/,C,0.95,0.64,1.35,0.00209925,Moderate,0.494,0.093,0.122,0.091,Significant increase (p=0.025),Significant decrease (p=0.043),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00624,rs773601,10,37337192,PTK2B,SNP (A/C),(A/,A,1.02,0.79,1.42,0.05227761,Moderate,0.098,0.574,0.058,0.07,Mild increase (p=0.016),Mild decrease (p=0.022),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00625,rs761482,2,51488224,PTK2B,SNP (G/T),(G/,G,0.77,0.42,1.02,0.00581588,Moderate,0.115,0.555,0.053,0.077,Variable effect (p=0.001),Significant increase (p=0.037),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00626,rs570558,8,43762346,BIN1,SNP (A/C),(A/,A,1.77,1.38,2.12,0.00785008,High,0.417,0.001,0.334,0.048,Mild decrease (p=0.045),Variable effect (p=0.029),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00627,rs997720,4,155771424,ABCA7,SNP (G/T),(G/,G,0.87,0.6,1.25,0.07651608,Moderate,0.322,0.17,0.026,0.282,Significant increase (p=0.015),Significant increase (p=0.003),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00628,rs322746,20,26445860,APOE,SNP (A/T),(A/,A,0.64,0.4,0.88,0.1124873,Moderate,0.039,0.474,0.125,0.163,Variable effect (p=0.006),Mild decrease (p=0.041),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00629,rs682477,2,237439450,TREM2,SNP (G/T),(G/,G,0.61,0.29,0.96,0.00841445,Moderate,0.237,0.439,0.087,0.037,Variable effect (p=0.022),Variable effect (p=0.05),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00630,rs317837,22,31050327,APP,Deletion,-,-,0.54,0.26,0.84,0.0400143,High,0.062,0.059,0.497,0.181,No significant pattern (p=0.029),Significant increase (p=0.025),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00631,rs800813,4,168335805,APP,SNP (A/C),(A/,A,1.53,1.25,1.91,0.00729021,High,0.374,0.101,0.316,0.008,Mild increase (p=0.04),Variable effect (p=0.032),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00632,rs482266,12,242122568,CLU,SNP (C/G),(C/,C,1.42,1.12,1.74,0.02568378,Low,0.064,0.053,0.275,0.408,Mild increase (p=0.026),Significant increase (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP00633,rs825405,4,125246513,PTK2B,SNP (A/C),(A/,A,1.47,1.19,1.74,0.04060576,Low,0.1,0.315,0.155,0.231,Mild increase (p=0.016),No significant pattern (p=0.01),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00634,rs967310,8,82893373,EPHA1,SNP (A/G),(A/,A,1.14,0.77,1.35,0.08621781,Moderate,0.195,0.299,0.188,0.118,Mild increase (p=0.008),Significant decrease (p=0.023),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00635,rs972488,3,71350965,MS4A6A,Insertion,-,-,0.51,0.14,0.82,0.03667281,Moderate,0.021,0.387,0.335,0.057,Mild decrease (p=0.038),No significant pattern (p=0.004),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00636,rs122648,15,63447775,TREM2,SNP (G/T),(G/,G,1.99,1.79,2.38,0.01425956,High,0.09,0.092,0.155,0.464,Significant decrease (p=0.013),Variable effect (p=0.012),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00637,rs591553,21,85539772,ABCA7,Insertion,-,-,2.26,2.03,2.52,0.01871772,High,0.208,0.266,0.027,0.299,Variable effect (p=0.016),Mild increase (p=0.042),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00638,rs679973,5,219564864,APP,SNP (A/T),(A/,A,0.74,0.42,0.98,0.0066291,Low,0.044,0.145,0.366,0.244,Variable effect (p=0.021),No significant pattern (p=0.03),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP00639,rs541051,9,90664567,ABCA7,Insertion,-,-,0.59,0.33,0.81,0.00798774,Moderate,0.28,0.167,0.276,0.077,No significant pattern (p=0.03),Mild decrease (p=0.015),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00640,rs941304,12,164504544,ABCA7,SNP (A/G),(A/,A,1.72,1.37,1.92,0.00597273,Moderate,0.149,0.126,0.232,0.293,Variable effect (p=0.035),Significant decrease (p=0.007),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP00641,rs399476,11,114591019,PTK2B,Deletion,-,-,0.48,0.1,0.68,0.06371316,Moderate,0.343,0.039,0.1,0.318,Variable effect (p=0.003),Mild increase (p=0.012),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00642,rs556973,6,127890842,BIN1,SNP (G/T),(G/,G,1.22,0.91,1.54,0.00717474,Unknown,0.016,0.401,0.329,0.054,Significant increase (p=0.05),No significant pattern (p=0.019),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00643,rs905224,8,162993802,PTK2B,Deletion,-,-,0.73,0.51,0.94,0.03844984,High,0.169,0.155,0.34,0.137,Significant increase (p=0.002),Significant increase (p=0.039),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP00644,rs215754,20,208376015,PICALM,SNP (A/C),(A/,A,1.35,1.12,1.62,0.01479756,Moderate,0.214,0.208,0.028,0.35,No significant pattern (p=0.045),Significant decrease (p=0.011),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00645,rs415729,4,95876182,CD2AP,SNP (A/T),(A/,A,1.23,0.93,1.51,0.00127946,Low,0.297,0.381,0.035,0.087,No significant pattern (p=0.01),Variable effect (p=0.038),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP00646,rs758452,4,176153913,CR1,SNP (C/G),(C/,C,0.96,0.69,1.2,0.02460872,Moderate,0.095,0.286,0.135,0.285,No significant pattern (p=0.026),Significant increase (p=0.022),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00647,rs805362,17,52706657,ABCA7,SNP (C/T),(C/,C,0.65,0.37,0.86,0.0372907,Unknown,0.104,0.449,0.187,0.06,Mild decrease (p=0.031),Significant decrease (p=0.001),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00648,rs647655,20,24713068,APOE,SNP (G/T),(G/,G,1.13,0.8,1.52,0.06978137,Moderate,0.11,0.057,0.354,0.279,Mild decrease (p=0.035),Mild increase (p=0.049),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00649,rs858264,11,93672822,CLU,SNP (A/G),(A/,A,2.11,1.73,2.34,0.06519448,Moderate,0.073,0.144,0.223,0.36,Mild increase (p=0.039),Variable effect (p=0.047),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00650,rs235878,8,195506928,CR1,SNP (C/G),(C/,C,1.19,0.98,1.46,0.00956972,High,0.299,0.164,0.31,0.027,Significant increase (p=0.011),No significant pattern (p=0.044),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00651,rs721435,14,241877152,PTK2B,SNP (A/T),(A/,A,1.41,1.04,1.75,0.01409812,High,0.089,0.377,0.131,0.203,Significant increase (p=0.013),Variable effect (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00652,rs942474,9,82145741,BIN1,SNP (C/G),(C/,C,1.82,1.47,2.14,0.07460239,Low,0.018,0.478,0.031,0.272,Variable effect (p=0.017),Variable effect (p=0.032),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00653,rs206287,7,131692613,APP,SNP (C/G),(C/,C,1.57,1.18,1.81,0.01112569,Unknown,0.172,0.239,0.063,0.327,Significant decrease (p=0.002),No significant pattern (p=0.025),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP00654,rs784795,10,199440161,EPHA1,SNP (C/G),(C/,C,0.83,0.51,1.21,0.01158181,High,0.133,0.413,0.101,0.152,Variable effect (p=0.012),Variable effect (p=0.033),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00655,rs214228,4,177382657,APP,SNP (C/G),(C/,C,0.93,0.67,1.27,0.0213307,Low,0.138,0.034,0.513,0.115,Mild increase (p=0.019),Mild decrease (p=0.039),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00656,rs974602,22,58397963,TREM2,SNP (A/C),(A/,A,1.94,1.6,2.2,0.07585661,Low,0.341,0.019,0.032,0.408,Significant decrease (p=0.006),Significant increase (p=0.043),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00657,rs716961,5,157708725,PTK2B,SNP (A/C),(A/,A,0.94,0.55,1.18,0.05317161,Protective,0.189,0.138,0.432,0.042,Significant decrease (p=0.02),Mild increase (p=0.003),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00658,rs229891,4,214630200,SORL1,SNP (A/G),(A/,A,0.63,0.32,1.03,0.03099187,High,0.358,0.109,0.232,0.101,Significant increase (p=0.039),No significant pattern (p=0.032),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP00659,rs748356,20,149007760,PTK2B,SNP (A/G),(A/,A,1.68,1.37,2.06,0.03481143,Moderate,0.142,0.276,0.165,0.217,Variable effect (p=0.037),Mild decrease (p=0.008),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00660,rs228269,20,172995940,EPHA1,SNP (A/G),(A/,A,1.79,1.41,2.07,0.0127745,Protective,0.162,0.581,0.017,0.039,No significant pattern (p=0.021),Mild decrease (p=0.039),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00661,rs202002,17,150845939,CR1,SNP (C/T),(C/,C,0.48,0.15,0.68,0.03818002,High,0.034,0.137,0.1,0.529,Mild increase (p=0.039),Significant decrease (p=0.022),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00662,rs195514,8,55909009,SORL1,SNP (C/T),(C/,C,1.07,0.78,1.28,0.08221426,Low,0.272,0.004,0.165,0.359,Mild decrease (p=0.001),Mild decrease (p=0.013),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00663,rs246025,19,123264905,APOE,Deletion,-,-,0.4,0.16,0.64,0.0139004,Moderate,0.073,0.263,0.159,0.304,Significant decrease (p=0.007),Variable effect (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00664,rs662586,16,133076145,CR1,Insertion,-,-,0.76,0.51,1.01,0.01213879,Low,0.346,0.209,0.23,0.016,No significant pattern (p=0.012),Mild increase (p=0.024),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP00665,rs845962,6,24010964,ABCA7,SNP (C/T),(C/,C,0.6,0.31,0.8,0.02403056,High,0.46,0.089,0.05,0.201,Variable effect (p=0.04),No significant pattern (p=0.046),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00666,rs157278,19,214677390,CD33,SNP (C/G),(C/,C,0.5,0.3,0.81,0.0068634,Moderate,0.06,0.178,0.165,0.398,Mild increase (p=0.028),Mild increase (p=0.036),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00667,rs589302,8,33095437,ABCA7,SNP (A/C),(A/,A,0.88,0.61,1.1,0.01476069,Low,0.377,0.012,0.331,0.08,No significant pattern (p=0.029),No significant pattern (p=0.048),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00668,rs848945,22,95858801,ABCA7,SNP (A/C),(A/,A,0.88,0.66,1.27,0.05828632,Moderate,0.028,0.347,0.276,0.149,Mild increase (p=0.021),No significant pattern (p=0.027),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00669,rs580869,5,186216384,ABCA7,SNP (G/T),(G/,G,1.81,1.45,2.05,0.01719542,Low,0.028,0.326,0.278,0.169,Mild increase (p=0.002),Variable effect (p=0.043),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00670,rs413111,18,234470711,PICALM,SNP (A/C),(A/,A,0.55,0.19,0.92,0.00846957,Unknown,0.421,0.069,0.298,0.011,Mild decrease (p=0.017),Significant decrease (p=0.014),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00671,rs767852,19,63065832,APP,SNP (A/G),(A/,A,1.32,0.95,1.71,0.04216941,Protective,0.025,0.184,0.016,0.576,Mild decrease (p=0.049),Significant decrease (p=0.039),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00672,rs933684,7,240423676,CR1,SNP (A/T),(A/,A,0.17,0.1,0.43,0.00063992,Low,0.198,0.227,0.293,0.083,Significant decrease (p=0.027),Significant increase (p=0.041),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00673,rs696011,2,224184354,PSEN2,SNP (C/G),(C/,C,0.73,0.43,1.07,0.10418376,Protective,0.068,0.304,0.241,0.187,Mild increase (p=0.046),Variable effect (p=0.015),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00674,rs319947,19,182243566,MS4A6A,SNP (C/T),(C/,C,1.55,1.32,1.79,0.05875844,Protective,0.101,0.254,0.19,0.255,Mild increase (p=0.024),Mild decrease (p=0.005),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP00675,rs934393,15,22266184,ABCA7,SNP (A/G),(A/,A,0.74,0.44,0.99,0.09659566,High,0.04,0.51,0.106,0.143,Significant increase (p=0.028),Mild decrease (p=0.045),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP00676,rs674637,16,234717866,CR1,SNP (A/C),(A/,A,0.99,0.72,1.2,0.00381987,Moderate,0.235,0.219,0.074,0.272,Mild increase (p=0.044),Significant decrease (p=0.001),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00677,rs485703,20,174768652,MS4A6A,SNP (A/T),(A/,A,3.29,2.99,3.67,0.01056897,Protective,0.237,0.388,0.014,0.161,Mild increase (p=0.036),Variable effect (p=0.019),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00678,rs400012,4,241907850,CD2AP,Deletion,-,-,0.82,0.6,1.16,0.11727,High,0.022,0.103,0.24,0.436,Mild decrease (p=0.013),Mild decrease (p=0.014),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP00679,rs824910,8,73089314,TREM2,SNP (A/G),(A/,A,0.43,0.16,0.76,0.02656171,High,0.006,0.097,0.246,0.451,Significant decrease (p=0.03),Significant decrease (p=0.043),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00680,rs350409,13,129581299,PTK2B,SNP (G/T),(G/,G,0.5,0.24,0.73,0.00864413,Protective,0.191,0.131,0.052,0.426,No significant pattern (p=0.035),Mild decrease (p=0.04),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00681,rs618618,15,140193370,PICALM,SNP (A/C),(A/,A,1.85,1.54,2.07,0.03230227,Moderate,0.074,0.075,0.545,0.106,Significant increase (p=0.034),Significant decrease (p=0.041),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00682,rs903635,11,36739381,SORL1,Insertion,-,-,2.02,1.79,2.31,0.0113,High,0.181,0.199,0.017,0.402,Significant decrease (p=0.037),Mild increase (p=0.005),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00683,rs417850,18,145587345,TREM2,SNP (A/C),(A/,A,1.37,1.02,1.6,0.04150219,Moderate,0.492,0.033,0.044,0.231,Mild increase (p=0.036),No significant pattern (p=0.003),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00684,rs355711,1,44698611,TREM2,Insertion,-,-,2.08,1.8,2.46,0.01999922,Low,0.201,0.391,0.136,0.072,No significant pattern (p=0.043),Mild decrease (p=0.006),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00685,rs509502,1,49479288,PICALM,SNP (C/T),(C/,C,0.84,0.49,1.07,0.02855693,Unknown,0.326,0.311,0.136,0.027,Mild increase (p=0.01),Mild decrease (p=0.016),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00686,rs584947,14,147880584,TREM2,SNP (C/G),(C/,C,0.74,0.54,1.02,0.06469504,High,0.459,0.145,0.162,0.034,Significant increase (p=0.025),Significant decrease (p=0.027),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00687,rs486235,13,218100881,ABCA7,SNP (C/T),(C/,C,0.83,0.55,1.16,0.0255172,Moderate,0.283,0.056,0.273,0.188,No significant pattern (p=0.038),No significant pattern (p=0.029),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00688,rs358828,12,107339346,CLU,SNP (G/T),(G/,G,1.44,1.04,1.83,0.04708116,Low,0.24,0.054,0.251,0.255,Variable effect (p=0.03),Variable effect (p=0.009),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00689,rs295666,10,199249473,TREM2,Deletion,-,-,1.1,0.72,1.42,0.01120469,Protective,0.411,0.184,0.121,0.084,Mild decrease (p=0.021),Mild decrease (p=0.008),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00690,rs286291,19,70603518,CD2AP,SNP (C/G),(C/,C,2.64,2.27,2.91,0.03686221,Moderate,0.35,0.279,0.139,0.031,Mild decrease (p=0.046),No significant pattern (p=0.012),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00691,rs583475,15,222684518,EPHA1,SNP (G/T),(G/,G,1.05,0.83,1.42,0.04908053,Moderate,0.149,0.452,0.134,0.065,No significant pattern (p=0.022),Mild increase (p=0.015),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00692,rs585354,13,46300156,BIN1,SNP (C/G),(C/,C,1.97,1.59,2.18,0.01597821,Moderate,0.173,0.13,0.205,0.293,Significant increase (p=0.027),Significant increase (p=0.011),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00693,rs913217,12,22399600,EPHA1,SNP (A/G),(A/,A,1.63,1.38,1.99,0.02602938,High,0.542,0.033,0.116,0.109,Significant decrease (p=0.021),No significant pattern (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00694,rs521466,19,225390935,CR1,SNP (G/T),(G/,G,1.78,1.47,2.14,0.04592042,High,0.29,0.116,0.026,0.368,Significant decrease (p=0.021),Mild decrease (p=0.049),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00695,rs252788,6,229834316,APOE,SNP (A/C),(A/,A,1.44,1.08,1.81,0.02367437,Moderate,0.072,0.361,0.082,0.284,Mild increase (p=0.044),Variable effect (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00696,rs762740,19,95424470,PTK2B,SNP (A/G),(A/,A,1.26,0.97,1.49,0.05268932,Moderate,0.197,0.348,0.255,0.001,Mild decrease (p=0.039),No significant pattern (p=0.003),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00697,rs524480,4,207250205,SORL1,SNP (A/G),(A/,A,0.59,0.3,0.89,0.03498522,Low,0.093,0.019,0.278,0.41,Mild increase (p=0.04),Variable effect (p=0.026),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP00698,rs171852,4,3795626,APP,Insertion,-,-,1.84,1.61,2.04,0.05488421,High,0.228,0.097,0.389,0.086,No significant pattern (p=0.018),Mild decrease (p=0.026),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00699,rs894638,3,68847615,APP,SNP (G/T),(G/,G,0.64,0.3,0.88,0.00998537,Unknown,0.215,0.324,0.257,0.004,Significant decrease (p=0.005),Significant increase (p=0.044),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00700,rs473210,10,15049067,PTK2B,SNP (A/C),(A/,A,0.74,0.53,0.99,0.03679616,Low,0.221,0.14,0.071,0.368,No significant pattern (p=0.047),Mild decrease (p=0.013),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00701,rs573189,3,9818061,TREM2,SNP (C/G),(C/,C,0.8,0.44,1.19,0.00952689,Moderate,0.102,0.078,0.18,0.44,Significant decrease (p=0.033),Mild decrease (p=0.003),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00702,rs420140,11,144174517,APP,SNP (G/T),(G/,G,0.71,0.49,1.08,0.06767457,High,0.09,0.098,0.481,0.131,No significant pattern (p=0.03),Significant decrease (p=0.044),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP00703,rs153041,11,100213211,CR1,SNP (A/T),(A/,A,0.89,0.51,1.12,0.0352572,High,0.27,0.1,0.086,0.344,Mild decrease (p=0.037),Mild decrease (p=0.009),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00704,rs238477,6,82928766,ABCA7,Deletion,-,-,5.05,4.84,5.32,0.07008073,Protective,0.385,0.149,0.117,0.148,No significant pattern (p=0.036),No significant pattern (p=0.009),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00705,rs363750,6,126093005,CD2AP,SNP (A/C),(A/,A,1.95,1.58,2.21,0.07833746,Moderate,0.013,0.342,0.088,0.358,No significant pattern (p=0.028),Significant decrease (p=0.028),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00706,rs904392,7,85450689,PSEN2,SNP (A/C),(A/,A,1.1,0.86,1.36,0.02437744,High,0.087,0.112,0.432,0.168,Significant increase (p=0.02),Significant decrease (p=0.008),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00707,rs654700,2,139180540,CD2AP,SNP (C/G),(C/,C,1.39,1.16,1.69,0.06516327,High,0.28,0.206,0.188,0.126,No significant pattern (p=0.029),Variable effect (p=0.014),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00708,rs816959,9,247103238,MS4A6A,Insertion,-,-,0.98,0.75,1.32,0.02841438,Low,0.197,0.242,0.239,0.122,Variable effect (p=0.01),Mild decrease (p=0.038),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00709,rs194520,13,11887320,CR1,SNP (C/G),(C/,C,0.7,0.42,0.96,0.21271481,Low,0.298,0.051,0.244,0.207,Mild increase (p=0.047),Significant decrease (p=0.027),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00710,rs753758,9,208030998,CR1,SNP (C/G),(C/,C,0.86,0.49,1.08,0.00743298,High,0.133,0.036,0.07,0.561,Mild decrease (p=0.009),No significant pattern (p=0.049),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00711,rs491114,17,121103237,APP,SNP (A/T),(A/,A,1.9,1.51,2.14,0.00226633,Moderate,0.23,0.012,0.556,0.003,Significant increase (p=0.011),Mild decrease (p=0.022),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00712,rs426532,2,246265843,APOE,Insertion,-,-,0.5,0.12,0.71,0.02257862,Protective,0.462,0.234,0.042,0.062,No significant pattern (p=0.049),Significant decrease (p=0.009),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00713,rs705614,16,115153144,CD33,SNP (G/T),(G/,G,0.53,0.28,0.78,0.03625365,Protective,0.522,0.134,0.032,0.112,Significant decrease (p=0.013),Mild decrease (p=0.027),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00714,rs484823,20,132886577,APP,SNP (A/G),(A/,A,0.87,0.5,1.11,0.00277181,Low,0.006,0.359,0.35,0.084,Significant decrease (p=0.012),No significant pattern (p=0.05),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00715,rs744673,7,12518942,CLU,Deletion,-,-,1.64,1.29,1.88,0.0355456,Moderate,0.113,0.239,0.002,0.446,Mild decrease (p=0.04),Mild decrease (p=0.008),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00716,rs366761,7,53433204,PTK2B,SNP (C/T),(C/,C,0.87,0.52,1.11,0.06139693,Moderate,0.207,0.461,0.112,0.021,No significant pattern (p=0.016),Mild decrease (p=0.044),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00717,rs678876,17,233542973,APP,Deletion,-,-,1.71,1.4,1.99,0.10612723,Protective,0.125,0.604,0.051,0.02,Mild increase (p=0.013),No significant pattern (p=0.007),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00718,rs112878,16,167896387,CD33,SNP (A/C),(A/,A,2.67,2.45,2.89,0.03381128,Moderate,0.501,0.15,0.106,0.043,Significant increase (p=0.033),Mild decrease (p=0.018),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00719,rs729754,15,48490792,BIN1,Deletion,-,-,1.63,1.25,1.83,0.00371743,High,0.114,0.238,0.195,0.253,Mild increase (p=0.016),Significant increase (p=0.045),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00720,rs910409,4,236776170,ABCA7,SNP (C/G),(C/,C,0.38,0.12,0.65,0.00805993,Low,0.094,0.553,0.138,0.015,Significant decrease (p=0.036),Variable effect (p=0.003),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00721,rs620064,20,234560221,EPHA1,SNP (C/T),(C/,C,0.49,0.2,0.87,0.04409429,Moderate,0.458,0.021,0.234,0.087,Variable effect (p=0.048),Mild decrease (p=0.003),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00722,rs719207,8,170516531,CR1,SNP (A/T),(A/,A,0.89,0.51,1.13,0.02931741,High,0.155,0.218,0.322,0.105,Significant decrease (p=0.017),Variable effect (p=0.022),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00723,rs170316,16,80715783,SORL1,Insertion,-,-,1.05,0.73,1.43,0.01119406,Protective,0.049,0.069,0.042,0.641,Mild decrease (p=0.04),Variable effect (p=0.024),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00724,rs516262,10,244255469,MS4A6A,SNP (G/T),(G/,G,1.41,1.18,1.8,0.0025312,Moderate,0.03,0.071,0.042,0.656,Mild increase (p=0.005),No significant pattern (p=0.047),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00725,rs953998,11,173080870,TREM2,SNP (C/T),(C/,C,2.17,1.91,2.57,0.0207533,Moderate,0.089,0.156,0.413,0.142,No significant pattern (p=0.015),Significant decrease (p=0.023),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP00726,rs147358,5,145584134,TREM2,SNP (G/T),(G/,G,0.79,0.48,1.08,0.01234213,Moderate,0.002,0.074,0.594,0.13,No significant pattern (p=0.007),Mild decrease (p=0.029),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00727,rs989397,16,233903728,TREM2,SNP (G/T),(G/,G,0.92,0.64,1.13,0.0289889,Protective,0.069,0.406,0.19,0.135,Mild increase (p=0.026),Mild increase (p=0.004),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00728,rs635911,14,53188600,BIN1,Insertion,-,-,0.71,0.39,0.99,0.00822004,High,0.033,0.042,0.372,0.352,Mild increase (p=0.025),Mild increase (p=0.017),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00729,rs736816,16,148291189,SORL1,SNP (A/C),(A/,A,0.8,0.42,1.09,0.02473136,Moderate,0.261,0.19,0.098,0.251,No significant pattern (p=0.045),Significant increase (p=0.01),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00730,rs535600,13,214724309,PICALM,SNP (C/T),(C/,C,1.18,0.82,1.49,0.05666124,Moderate,0.09,0.424,0.268,0.018,Mild increase (p=0.044),Mild decrease (p=0.042),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00731,rs359639,14,129429168,CD33,SNP (A/G),(A/,A,1.14,0.76,1.48,0.00108304,High,0.064,0.271,0.039,0.425,Significant increase (p=0.013),Significant increase (p=0.037),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00732,rs306281,20,47026472,PICALM,Deletion,-,-,1.57,1.21,1.93,0.09375816,Low,0.03,0.454,0.105,0.212,Significant decrease (p=0.003),Significant decrease (p=0.024),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00733,rs407901,14,150491464,SORL1,SNP (C/G),(C/,C,1.23,0.9,1.44,0.02302307,Moderate,0.0,0.171,0.164,0.464,Variable effect (p=0.032),Mild decrease (p=0.025),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00734,rs722562,10,132041013,PTK2B,Deletion,-,-,1.75,1.37,2.0,0.07451212,Protective,0.11,0.181,0.342,0.167,Variable effect (p=0.044),Significant decrease (p=0.004),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00735,rs135031,7,25727284,CD2AP,SNP (C/T),(C/,C,0.73,0.51,1.02,0.00605411,Moderate,0.204,0.389,0.006,0.201,Mild increase (p=0.004),Variable effect (p=0.01),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00736,rs224991,16,34434324,APOE,SNP (G/T),(G/,G,0.71,0.34,0.95,0.00625536,Low,0.48,0.096,0.091,0.134,No significant pattern (p=0.044),Variable effect (p=0.031),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00737,rs593259,2,59335580,CD33,SNP (A/C),(A/,A,0.94,0.64,1.31,0.04797405,Unknown,0.332,0.106,0.323,0.039,Significant increase (p=0.009),Mild decrease (p=0.005),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00738,rs482663,3,106326629,SORL1,SNP (C/T),(C/,C,0.86,0.62,1.16,0.04862093,High,0.068,0.024,0.156,0.552,Variable effect (p=0.046),Mild increase (p=0.038),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00739,rs606824,6,197557005,CLU,Insertion,-,-,0.93,0.57,1.2,0.01286572,Unknown,0.405,0.169,0.146,0.079,Variable effect (p=0.044),Significant decrease (p=0.04),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP00740,rs503879,1,91225745,ABCA7,Deletion,-,-,1.67,1.36,1.88,0.01574045,Unknown,0.355,0.297,0.129,0.019,No significant pattern (p=0.024),Significant decrease (p=0.025),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP00741,rs384592,1,111072387,PICALM,SNP (C/T),(C/,C,0.61,0.36,0.85,0.05223903,Low,0.069,0.197,0.242,0.292,Significant increase (p=0.036),Significant increase (p=0.023),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00742,rs765340,16,63666000,PICALM,SNP (A/G),(A/,A,1.35,1.07,1.57,0.00213325,Moderate,0.238,0.109,0.38,0.073,Significant increase (p=0.018),No significant pattern (p=0.002),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00743,rs877029,11,230593196,PTK2B,SNP (A/C),(A/,A,1.91,1.64,2.21,0.06260441,Protective,0.024,0.172,0.515,0.089,Mild decrease (p=0.04),Mild decrease (p=0.014),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00744,rs739905,8,50020766,SORL1,Deletion,-,-,0.9,0.62,1.2,0.01451644,Moderate,0.278,0.128,0.031,0.363,Mild decrease (p=0.006),Variable effect (p=0.017),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00745,rs880096,6,26144165,ABCA7,SNP (A/G),(A/,A,0.6,0.34,0.81,0.02157863,High,0.331,0.081,0.081,0.307,Significant decrease (p=0.038),Significant decrease (p=0.017),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00746,rs883356,13,44801592,PSEN2,Deletion,-,-,1.01,0.7,1.24,0.13239768,High,0.316,0.191,0.009,0.284,Significant decrease (p=0.016),Significant increase (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00747,rs335019,13,221251675,APP,Deletion,-,-,0.59,0.33,0.92,0.00542637,High,0.057,0.428,0.285,0.029,Mild decrease (p=0.015),Variable effect (p=0.035),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00748,rs489796,11,148739180,CD2AP,Insertion,-,-,2.89,2.66,3.2,0.04412975,Low,0.008,0.278,0.064,0.451,Significant increase (p=0.005),Significant increase (p=0.042),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00749,rs310722,16,234823948,MS4A6A,SNP (A/G),(A/,A,1.53,1.22,1.73,0.0216087,Moderate,0.061,0.372,0.288,0.08,Significant decrease (p=0.024),Significant increase (p=0.031),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00750,rs653072,11,50068866,CD33,SNP (A/G),(A/,A,0.53,0.26,0.91,0.01418447,High,0.258,0.297,0.06,0.185,Significant decrease (p=0.049),Significant decrease (p=0.029),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00751,rs793283,4,159245304,PTK2B,SNP (G/T),(G/,G,1.15,0.83,1.46,0.04289933,High,0.448,0.214,0.019,0.119,Significant decrease (p=0.034),No significant pattern (p=0.021),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00752,rs471055,2,52597536,EPHA1,SNP (A/G),(A/,A,0.99,0.72,1.37,0.01767258,Moderate,0.251,0.173,0.147,0.23,Variable effect (p=0.037),Variable effect (p=0.031),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00753,rs953391,10,14600141,PTK2B,SNP (A/T),(A/,A,1.27,1.04,1.58,0.0226051,Low,0.206,0.058,0.445,0.092,Significant increase (p=0.02),Mild decrease (p=0.047),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00754,rs675123,16,213728493,CD2AP,SNP (A/T),(A/,A,0.51,0.16,0.73,0.09461152,High,0.152,0.053,0.056,0.539,Variable effect (p=0.042),Significant decrease (p=0.049),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00755,rs441096,15,114772417,SORL1,SNP (A/G),(A/,A,0.67,0.36,1.01,0.01116864,Low,0.404,0.036,0.238,0.121,Significant increase (p=0.032),Variable effect (p=0.013),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00756,rs498966,19,132098416,MS4A6A,SNP (A/C),(A/,A,0.68,0.37,1.02,0.00794246,Moderate,0.165,0.04,0.129,0.466,Mild increase (p=0.022),Mild decrease (p=0.034),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00757,rs474806,7,137411458,CD33,Deletion,-,-,3.09,2.77,3.41,0.00908524,High,0.097,0.082,0.062,0.558,Mild increase (p=0.042),Significant decrease (p=0.038),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00758,rs128392,22,86336824,PSEN2,Insertion,-,-,0.52,0.3,0.76,0.07913951,Low,0.125,0.021,0.425,0.229,No significant pattern (p=0.044),Mild increase (p=0.034),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00759,rs712563,5,73075933,MS4A6A,SNP (C/G),(C/,C,1.53,1.23,1.92,0.0244018,Moderate,0.239,0.469,0.06,0.032,Variable effect (p=0.02),Significant decrease (p=0.006),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00760,rs616884,11,145070329,CD33,SNP (C/T),(C/,C,1.07,0.84,1.3,0.00250942,Low,0.084,0.185,0.469,0.062,Variable effect (p=0.048),Mild decrease (p=0.049),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00761,rs262366,18,220703752,CD2AP,SNP (A/T),(A/,A,1.01,0.73,1.37,0.10449167,Low,0.296,0.299,0.195,0.011,Significant increase (p=0.043),Variable effect (p=0.007),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00762,rs257156,19,24478810,CR1,SNP (C/T),(C/,C,2.0,1.68,2.35,0.008143,Protective,0.068,0.181,0.247,0.305,Significant increase (p=0.002),Significant increase (p=0.035),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00763,rs386383,16,43186160,ABCA7,SNP (C/G),(C/,C,1.85,1.5,2.09,0.01300516,Low,0.251,0.449,0.036,0.065,Mild decrease (p=0.015),Significant increase (p=0.043),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00764,rs376716,16,84682370,APOE,SNP (G/T),(G/,G,1.15,0.9,1.37,0.04113187,Moderate,0.193,0.321,0.136,0.151,Mild decrease (p=0.018),Mild decrease (p=0.043),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00765,rs539449,15,102781026,BIN1,SNP (C/G),(C/,C,0.6,0.29,0.86,0.01429344,High,0.281,0.258,0.177,0.084,Mild decrease (p=0.015),Significant increase (p=0.026),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00766,rs908171,2,56935812,PSEN2,SNP (A/C),(A/,A,2.42,2.18,2.62,0.01691535,High,0.084,0.16,0.138,0.418,No significant pattern (p=0.004),Mild decrease (p=0.044),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00767,rs739256,5,158857101,EPHA1,Insertion,-,-,0.61,0.26,0.82,0.03855759,Unknown,0.021,0.287,0.295,0.197,Significant decrease (p=0.049),Mild decrease (p=0.033),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP00768,rs924825,5,54082942,ABCA7,SNP (A/G),(A/,A,0.53,0.14,0.76,0.0142943,High,0.274,0.112,0.158,0.255,Significant decrease (p=0.016),Mild decrease (p=0.012),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP00769,rs501860,9,99274771,SORL1,Insertion,-,-,0.77,0.41,1.11,0.03762218,Low,0.032,0.411,0.104,0.253,Variable effect (p=0.048),No significant pattern (p=0.006),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00770,rs604429,10,69435883,CD33,SNP (C/G),(C/,C,1.49,1.16,1.86,0.00781458,High,0.01,0.199,0.466,0.125,Mild decrease (p=0.01),No significant pattern (p=0.006),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00771,rs465348,2,107255024,CR1,SNP (C/G),(C/,C,1.55,1.19,1.81,0.04142997,Low,0.13,0.291,0.136,0.243,Significant increase (p=0.019),Significant decrease (p=0.007),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00772,rs485186,22,91316446,SORL1,SNP (A/G),(A/,A,0.33,0.1,0.7,0.10388591,High,0.373,0.09,0.097,0.24,Mild increase (p=0.008),Mild decrease (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00773,rs715891,18,13705157,PSEN2,SNP (C/T),(C/,C,0.89,0.53,1.13,0.02857121,Protective,0.205,0.33,0.172,0.093,No significant pattern (p=0.042),Mild increase (p=0.025),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00774,rs154252,15,110086834,EPHA1,Insertion,-,-,0.62,0.4,0.82,0.01557141,Protective,0.124,0.045,0.05,0.581,Mild increase (p=0.003),Mild increase (p=0.004),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00775,rs462783,7,5499551,SORL1,SNP (C/G),(C/,C,0.71,0.51,0.99,0.05889872,Moderate,0.259,0.172,0.276,0.093,Mild increase (p=0.034),Significant increase (p=0.016),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP00776,rs781212,2,52455088,PTK2B,SNP (A/G),(A/,A,1.0,0.62,1.29,0.02490152,Unknown,0.231,0.152,0.262,0.154,Variable effect (p=0.024),Variable effect (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00777,rs496265,2,97962997,PICALM,SNP (A/T),(A/,A,0.98,0.71,1.19,0.05059098,Protective,0.082,0.424,0.039,0.256,Variable effect (p=0.026),Mild increase (p=0.041),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00778,rs680663,19,14415871,PSEN2,SNP (C/T),(C/,C,1.22,1.02,1.45,0.07842314,Moderate,0.281,0.071,0.354,0.094,Mild increase (p=0.027),Variable effect (p=0.046),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00779,rs315616,3,58756818,APOE,Deletion,-,-,0.36,0.14,0.73,0.01063241,Low,0.016,0.611,0.066,0.106,Significant decrease (p=0.032),Significant decrease (p=0.038),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00780,rs176615,3,104149168,PICALM,SNP (A/T),(A/,A,0.49,0.28,0.81,0.00153221,Moderate,0.018,0.093,0.074,0.615,Significant increase (p=0.023),No significant pattern (p=0.034),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00781,rs557457,15,34390587,APP,SNP (G/T),(G/,G,1.06,0.78,1.45,0.09382994,Moderate,0.343,0.047,0.14,0.27,Mild decrease (p=0.025),Mild decrease (p=0.015),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00782,rs959871,3,206237272,PICALM,SNP (C/T),(C/,C,1.22,0.89,1.45,0.00278792,Low,0.062,0.046,0.205,0.487,Significant decrease (p=0.004),Significant decrease (p=0.001),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP00783,rs137974,13,158693220,BIN1,SNP (A/C),(A/,A,0.97,0.71,1.21,0.0580704,Unknown,0.055,0.369,0.071,0.305,Mild decrease (p=0.041),Variable effect (p=0.014),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00784,rs752201,4,157472847,PICALM,SNP (G/T),(G/,G,1.21,0.85,1.48,0.05258616,Moderate,0.154,0.497,0.093,0.057,No significant pattern (p=0.011),Significant decrease (p=0.012),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00785,rs192028,21,25504584,APOE,SNP (A/C),(A/,A,1.01,0.65,1.25,0.01337986,Low,0.02,0.534,0.114,0.131,Variable effect (p=0.015),No significant pattern (p=0.009),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00786,rs890554,17,11808740,BIN1,Insertion,-,-,0.58,0.2,0.97,0.06630171,Unknown,0.574,0.034,0.035,0.158,Mild increase (p=0.024),Mild decrease (p=0.031),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00787,rs507302,1,114756127,PICALM,Deletion,-,-,1.12,0.86,1.33,0.02169945,Moderate,0.378,0.081,0.327,0.014,Significant increase (p=0.05),Significant increase (p=0.02),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00788,rs228780,19,170084559,ABCA7,SNP (G/T),(G/,G,1.52,1.25,1.77,0.0631778,Unknown,0.125,0.18,0.485,0.011,Mild increase (p=0.009),No significant pattern (p=0.036),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP00789,rs963612,10,65639551,CD2AP,SNP (A/G),(A/,A,0.94,0.72,1.27,0.00176996,Moderate,0.178,0.111,0.256,0.255,Mild increase (p=0.017),Mild decrease (p=0.008),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00790,rs138572,11,28343778,APP,Deletion,-,-,1.42,1.02,1.65,0.00359117,Moderate,0.343,0.068,0.135,0.254,Mild increase (p=0.006),No significant pattern (p=0.047),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00791,rs737520,13,173480723,ABCA7,Insertion,-,-,1.72,1.35,2.03,0.03241065,Low,0.114,0.243,0.355,0.088,Significant increase (p=0.014),Variable effect (p=0.05),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00792,rs290392,22,223585987,ABCA7,SNP (A/T),(A/,A,0.61,0.23,0.89,0.03536509,High,0.148,0.121,0.52,0.011,Significant decrease (p=0.041),Significant increase (p=0.02),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00793,rs563528,4,99705050,APP,SNP (C/G),(C/,C,1.77,1.56,2.09,0.00612135,Moderate,0.082,0.511,0.022,0.184,No significant pattern (p=0.042),Mild decrease (p=0.012),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00794,rs142412,17,191504407,CLU,SNP (A/C),(A/,A,0.71,0.32,1.04,0.01594122,Low,0.059,0.22,0.517,0.004,Mild decrease (p=0.011),Mild increase (p=0.005),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP00795,rs604290,12,157644637,CR1,Deletion,-,-,0.49,0.21,0.81,0.02128928,Protective,0.359,0.116,0.287,0.038,Mild increase (p=0.021),Mild increase (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00796,rs639187,5,232962786,BIN1,Insertion,-,-,0.55,0.21,0.83,0.03203786,Low,0.063,0.066,0.633,0.038,Significant increase (p=0.028),Variable effect (p=0.018),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP00797,rs606037,6,14132061,PSEN2,SNP (A/G),(A/,A,0.82,0.56,1.04,0.00564815,Moderate,0.342,0.248,0.157,0.053,Mild increase (p=0.035),Mild decrease (p=0.035),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00798,rs348279,16,183070982,PTK2B,SNP (C/G),(C/,C,0.95,0.64,1.33,0.09715555,High,0.28,0.065,0.019,0.435,No significant pattern (p=0.028),Mild decrease (p=0.044),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00799,rs811448,7,186279916,CLU,SNP (A/C),(A/,A,1.77,1.41,2.01,0.00104369,Moderate,0.164,0.116,0.504,0.016,Mild decrease (p=0.041),Mild increase (p=0.048),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00800,rs235100,11,48076901,BIN1,Insertion,-,-,1.48,1.14,1.83,0.05242139,Moderate,0.298,0.225,0.128,0.149,Mild increase (p=0.017),Mild increase (p=0.004),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00801,rs391228,9,110762671,EPHA1,SNP (G/T),(G/,G,0.75,0.51,1.12,0.01826572,Moderate,0.227,0.038,0.478,0.057,Mild decrease (p=0.001),Mild decrease (p=0.039),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00802,rs886719,5,202214033,PICALM,SNP (G/T),(G/,G,0.42,0.1,0.76,0.02066069,High,0.238,0.102,0.375,0.085,Significant increase (p=0.018),Significant increase (p=0.018),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00803,rs726998,14,196257947,EPHA1,Insertion,-,-,1.58,1.32,1.86,0.01677056,Unknown,0.548,0.157,0.083,0.011,Mild increase (p=0.028),Mild increase (p=0.028),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00804,rs453028,15,72256797,CD33,SNP (G/T),(G/,G,0.71,0.43,0.96,0.06551688,Moderate,0.005,0.346,0.146,0.304,Variable effect (p=0.009),Mild increase (p=0.008),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00805,rs291261,8,148424551,CD2AP,SNP (A/G),(A/,A,0.58,0.27,0.86,0.01932555,High,0.063,0.472,0.083,0.182,No significant pattern (p=0.03),Variable effect (p=0.031),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00806,rs859787,21,129055589,CR1,SNP (G/T),(G/,G,1.04,0.71,1.31,0.05565659,Protective,0.255,0.274,0.069,0.201,Significant increase (p=0.048),Mild increase (p=0.05),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00807,rs133198,11,109614892,BIN1,SNP (C/T),(C/,C,0.68,0.3,1.08,0.01143967,High,0.337,0.267,0.002,0.194,Significant decrease (p=0.035),Mild increase (p=0.024),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00808,rs508821,21,133398486,PTK2B,SNP (A/T),(A/,A,1.15,0.94,1.42,0.01397383,High,0.207,0.045,0.518,0.031,Variable effect (p=0.016),Variable effect (p=0.049),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00809,rs623650,17,246723292,PSEN2,SNP (G/T),(G/,G,1.0,0.77,1.35,0.02915485,High,0.284,0.207,0.269,0.041,Mild decrease (p=0.049),Significant increase (p=0.049),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00810,rs162811,14,57476764,CLU,SNP (C/G),(C/,C,0.37,0.1,0.65,0.04685541,Moderate,0.051,0.595,0.136,0.017,Mild increase (p=0.034),Variable effect (p=0.015),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00811,rs688107,13,119211061,TREM2,SNP (C/G),(C/,C,0.85,0.52,1.19,0.01037425,Low,0.072,0.257,0.235,0.236,Significant decrease (p=0.041),Mild increase (p=0.045),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP00812,rs568046,15,31759336,CLU,SNP (A/C),(A/,A,0.56,0.23,0.78,0.01898467,High,0.356,0.028,0.305,0.111,Mild increase (p=0.005),No significant pattern (p=0.023),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00813,rs162721,6,175726751,CR1,SNP (A/T),(A/,A,0.93,0.66,1.23,0.0222806,High,0.053,0.051,0.611,0.085,Mild increase (p=0.041),Mild increase (p=0.034),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00814,rs219453,7,98395038,CR1,SNP (C/G),(C/,C,2.29,2.04,2.68,0.00542445,High,0.116,0.558,0.043,0.083,Significant decrease (p=0.05),Variable effect (p=0.038),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00815,rs633050,20,222870956,CLU,SNP (A/C),(A/,A,1.69,1.35,2.08,0.02774367,Moderate,0.177,0.134,0.239,0.25,Variable effect (p=0.039),Mild increase (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00816,rs130867,8,181206855,PICALM,SNP (A/T),(A/,A,1.9,1.56,2.25,0.01506868,High,0.132,0.01,0.17,0.488,Significant increase (p=0.033),Significant increase (p=0.026),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00817,rs479194,5,100241801,BIN1,SNP (C/T),(C/,C,1.71,1.37,2.07,0.02649825,Moderate,0.348,0.077,0.038,0.337,Variable effect (p=0.007),Mild decrease (p=0.03),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00818,rs812623,18,54435972,PICALM,SNP (A/T),(A/,A,0.59,0.3,0.95,0.03035752,Low,0.239,0.241,0.114,0.205,No significant pattern (p=0.034),Mild decrease (p=0.026),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00819,rs952558,3,77883021,CD33,SNP (G/T),(G/,G,1.32,1.11,1.69,0.05733119,Unknown,0.119,0.537,0.111,0.033,No significant pattern (p=0.032),Variable effect (p=0.02),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00820,rs143325,15,145970321,CLU,SNP (A/C),(A/,A,0.44,0.1,0.78,0.02192086,Unknown,0.462,0.049,0.09,0.199,Mild decrease (p=0.047),Significant increase (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00821,rs981923,17,31461709,CD33,SNP (G/T),(G/,G,0.72,0.45,1.02,0.10975341,Protective,0.115,0.113,0.093,0.479,Mild increase (p=0.028),Variable effect (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00822,rs979977,4,20492261,BIN1,SNP (C/G),(C/,C,0.63,0.26,0.89,0.04211167,Protective,0.534,0.008,0.239,0.018,Significant decrease (p=0.009),Mild increase (p=0.014),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00823,rs456862,19,150914104,TREM2,SNP (A/T),(A/,A,0.86,0.47,1.25,0.04134728,High,0.525,0.06,0.049,0.167,Mild decrease (p=0.006),Mild increase (p=0.028),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00824,rs681108,8,196934851,SORL1,SNP (A/G),(A/,A,0.84,0.63,1.06,0.04579211,Moderate,0.359,0.23,0.046,0.165,Significant decrease (p=0.01),Mild increase (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00825,rs193765,8,197667894,EPHA1,Deletion,-,-,1.96,1.58,2.2,0.00076083,High,0.018,0.117,0.626,0.039,Mild increase (p=0.018),No significant pattern (p=0.002),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00826,rs299144,13,178980435,SORL1,SNP (G/T),(G/,G,2.26,1.94,2.54,0.0025545,High,0.123,0.026,0.386,0.265,Mild decrease (p=0.033),No significant pattern (p=0.037),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP00827,rs757763,18,244900339,BIN1,SNP (A/T),(A/,A,1.24,0.89,1.63,0.08441829,Moderate,0.063,0.539,0.01,0.188,Mild increase (p=0.039),No significant pattern (p=0.003),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00828,rs935091,21,116768379,SORL1,SNP (C/G),(C/,C,0.68,0.4,1.0,0.00919619,Moderate,0.304,0.203,0.225,0.067,Mild increase (p=0.03),Mild increase (p=0.02),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP00829,rs914500,7,40356259,APOE,SNP (C/G),(C/,C,1.84,1.55,2.24,0.00038597,High,0.019,0.163,0.295,0.323,Mild decrease (p=0.033),Significant decrease (p=0.043),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00830,rs537547,10,239341367,ABCA7,SNP (A/T),(A/,A,1.38,1.04,1.72,0.04289979,Unknown,0.149,0.154,0.371,0.125,Mild decrease (p=0.022),Mild increase (p=0.039),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP00831,rs935460,4,199501098,CD33,SNP (G/T),(G/,G,1.26,0.86,1.47,0.10456254,Low,0.057,0.383,0.302,0.057,No significant pattern (p=0.026),Mild increase (p=0.037),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP00832,rs595904,5,155841332,ABCA7,Insertion,-,-,1.51,1.18,1.88,0.04728541,High,0.188,0.457,0.135,0.02,Significant increase (p=0.034),Mild increase (p=0.03),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00833,rs478662,15,137469840,SORL1,SNP (A/C),(A/,A,1.9,1.56,2.18,0.04039336,Moderate,0.024,0.517,0.219,0.04,Significant decrease (p=0.003),Significant increase (p=0.026),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00834,rs715684,6,247228234,CLU,Insertion,-,-,1.25,0.95,1.56,0.00807235,Protective,0.034,0.689,0.031,0.046,Significant increase (p=0.032),No significant pattern (p=0.015),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP00835,rs599841,6,74224395,CR1,Insertion,-,-,1.66,1.27,1.91,0.01660174,Protective,0.026,0.028,0.731,0.015,Mild decrease (p=0.034),Variable effect (p=0.035),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00836,rs346939,17,186811355,MS4A6A,SNP (A/G),(A/,A,1.02,0.68,1.29,0.03914735,High,0.63,0.066,0.055,0.049,Mild increase (p=0.041),Mild decrease (p=0.044),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00837,rs130038,13,230794651,APP,SNP (A/T),(A/,A,1.33,1.12,1.68,0.09354633,High,0.481,0.038,0.214,0.066,Variable effect (p=0.011),Significant increase (p=0.003),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00838,rs289259,14,12522409,CD33,Insertion,-,-,1.1,0.87,1.35,0.02916552,Moderate,0.17,0.08,0.265,0.285,Significant decrease (p=0.012),Variable effect (p=0.048),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00839,rs316186,1,84388717,PICALM,SNP (A/T),(A/,A,1.97,1.75,2.34,0.0149516,Low,0.094,0.596,0.063,0.047,Mild decrease (p=0.029),Significant increase (p=0.034),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00840,rs827719,5,222284164,PSEN2,SNP (A/T),(A/,A,0.77,0.52,1.09,0.01632207,Low,0.174,0.08,0.131,0.415,No significant pattern (p=0.024),Significant increase (p=0.05),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00841,rs955804,2,198032265,BIN1,Deletion,-,-,0.92,0.52,1.21,0.04952764,Unknown,0.289,0.252,0.245,0.014,Mild increase (p=0.006),Variable effect (p=0.039),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00842,rs253429,6,6904298,CD33,SNP (A/G),(A/,A,1.11,0.89,1.42,2.36e-06,Unknown,0.138,0.505,0.028,0.128,Mild decrease (p=0.037),No significant pattern (p=0.014),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00843,rs838079,20,181688135,TREM2,SNP (A/G),(A/,A,1.23,1.01,1.43,0.03956676,Moderate,0.483,0.235,0.037,0.044,Variable effect (p=0.012),Mild decrease (p=0.009),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00844,rs800789,18,214038648,BIN1,SNP (A/T),(A/,A,1.19,0.94,1.45,0.00302237,High,0.027,0.355,0.042,0.375,Significant decrease (p=0.02),Variable effect (p=0.048),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00845,rs712556,13,55305102,MS4A6A,SNP (G/T),(G/,G,1.06,0.75,1.32,0.00076026,High,0.206,0.492,0.023,0.079,Variable effect (p=0.012),Variable effect (p=0.002),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00846,rs482398,8,54420643,PTK2B,SNP (G/T),(G/,G,2.38,2.02,2.77,0.01148218,High,0.02,0.369,0.152,0.258,Variable effect (p=0.046),Mild decrease (p=0.05),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00847,rs865348,5,20976574,APOE,Insertion,-,-,0.9,0.68,1.25,0.05324447,Protective,0.562,0.199,0.025,0.014,No significant pattern (p=0.014),Significant increase (p=0.024),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP00848,rs250716,8,93467100,MS4A6A,SNP (G/T),(G/,G,1.09,0.87,1.49,0.03727863,Moderate,0.458,0.288,0.006,0.047,Significant increase (p=0.004),No significant pattern (p=0.008),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00849,rs670507,15,64895449,PICALM,SNP (C/T),(C/,C,1.28,1.05,1.65,0.01546072,Moderate,0.332,0.263,0.033,0.172,Significant increase (p=0.048),Significant increase (p=0.027),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00850,rs824683,5,21109264,MS4A6A,SNP (A/G),(A/,A,0.81,0.52,1.01,0.00279199,High,0.155,0.142,0.307,0.197,Significant decrease (p=0.034),Significant increase (p=0.024),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00851,rs696703,10,6222820,APOE,SNP (C/T),(C/,C,1.65,1.29,1.99,0.00923851,High,0.208,0.304,0.183,0.106,No significant pattern (p=0.034),Variable effect (p=0.013),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00852,rs522546,12,116723662,APP,SNP (C/G),(C/,C,1.29,0.99,1.5,0.04159422,Moderate,0.389,0.053,0.219,0.139,Significant increase (p=0.028),Significant decrease (p=0.017),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00853,rs505958,12,185222169,TREM2,SNP (A/C),(A/,A,1.44,1.09,1.76,0.00919813,High,0.212,0.287,0.027,0.275,Variable effect (p=0.014),Mild increase (p=0.02),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00854,rs637280,21,101061067,ABCA7,SNP (C/G),(C/,C,1.27,1.0,1.58,0.09479754,High,0.232,0.078,0.379,0.112,No significant pattern (p=0.046),Significant decrease (p=0.009),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00855,rs339631,14,20862284,BIN1,SNP (C/G),(C/,C,0.78,0.57,1.08,0.01639228,High,0.225,0.045,0.256,0.275,No significant pattern (p=0.033),Mild decrease (p=0.005),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00856,rs937759,3,52667427,PICALM,Insertion,-,-,1.2,0.82,1.57,0.01611143,Moderate,0.009,0.104,0.327,0.359,No significant pattern (p=0.041),Significant decrease (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00857,rs895202,15,136386047,CD33,SNP (A/C),(A/,A,1.24,0.87,1.54,0.0361923,Moderate,0.035,0.05,0.596,0.119,Variable effect (p=0.026),Mild increase (p=0.027),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00858,rs816767,3,164744599,APP,SNP (C/G),(C/,C,1.75,1.49,2.12,0.04217849,High,0.019,0.385,0.054,0.342,Significant increase (p=0.011),Significant increase (p=0.022),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00859,rs100572,14,206548768,CD33,Deletion,-,-,2.66,2.46,2.97,0.00441688,High,0.017,0.27,0.4,0.113,Mild increase (p=0.045),Mild decrease (p=0.034),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00860,rs117331,5,64500915,PSEN2,SNP (C/G),(C/,C,0.74,0.48,0.95,0.01002055,High,0.069,0.332,0.321,0.078,Significant decrease (p=0.007),Mild increase (p=0.03),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00861,rs365301,11,17251171,EPHA1,Insertion,-,-,1.41,1.03,1.73,0.04083487,Moderate,0.048,0.133,0.301,0.319,Mild increase (p=0.01),Significant increase (p=0.007),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00862,rs793116,19,126073882,EPHA1,SNP (A/C),(A/,A,0.87,0.63,1.25,0.13846474,Moderate,0.07,0.018,0.278,0.434,Significant increase (p=0.021),Mild decrease (p=0.018),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00863,rs994388,16,10598058,SORL1,SNP (A/G),(A/,A,1.66,1.41,2.05,0.02447869,Moderate,0.639,0.034,0.047,0.08,Mild increase (p=0.012),No significant pattern (p=0.032),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00864,rs702555,8,82339326,EPHA1,SNP (A/T),(A/,A,1.02,0.76,1.26,0.13796926,Low,0.594,0.006,0.052,0.148,Mild increase (p=0.01),Mild increase (p=0.041),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00865,rs205569,10,135536629,EPHA1,SNP (A/G),(A/,A,2.46,2.18,2.73,0.01815559,Moderate,0.082,0.055,0.079,0.584,Significant decrease (p=0.034),No significant pattern (p=0.04),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00866,rs231938,13,99480763,MS4A6A,SNP (A/C),(A/,A,2.07,1.82,2.33,0.01912386,Low,0.657,0.066,0.002,0.075,No significant pattern (p=0.019),Significant decrease (p=0.026),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00867,rs597623,5,16820684,PSEN2,SNP (A/C),(A/,A,0.7,0.49,1.09,0.00147524,Protective,0.106,0.608,0.052,0.034,Significant increase (p=0.04),Significant decrease (p=0.042),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00868,rs578206,20,24959136,MS4A6A,SNP (A/G),(A/,A,0.64,0.32,0.98,0.00408216,Moderate,0.487,0.01,0.01,0.293,Mild increase (p=0.004),Significant increase (p=0.02),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00869,rs956426,6,15934797,EPHA1,SNP (C/T),(C/,C,0.41,0.1,0.79,0.05262154,Moderate,0.357,0.047,0.217,0.179,Variable effect (p=0.035),No significant pattern (p=0.041),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00870,rs459586,18,183196625,CLU,Deletion,-,-,1.2,0.89,1.49,0.01567961,Moderate,0.038,0.223,0.436,0.103,Significant decrease (p=0.013),Significant decrease (p=0.036),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00871,rs713817,16,197493654,CD2AP,Deletion,-,-,0.97,0.73,1.17,0.09656382,Moderate,0.127,0.124,0.253,0.295,Mild increase (p=0.016),Mild decrease (p=0.018),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00872,rs634152,18,188037607,BIN1,Deletion,-,-,0.85,0.53,1.11,0.10911784,Moderate,0.186,0.352,0.104,0.158,Mild decrease (p=0.004),Mild increase (p=0.013),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00873,rs525896,4,83095293,SORL1,SNP (A/C),(A/,A,2.0,1.75,2.26,0.0196337,High,0.189,0.074,0.528,0.009,Variable effect (p=0.017),No significant pattern (p=0.002),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00874,rs298166,20,91590267,PSEN2,SNP (A/G),(A/,A,1.8,1.49,2.06,0.09502251,Unknown,0.098,0.057,0.563,0.082,Significant increase (p=0.042),Significant decrease (p=0.033),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00875,rs424062,17,20761070,APP,Insertion,-,-,1.43,1.05,1.74,0.02688403,High,0.364,0.334,0.083,0.02,Significant decrease (p=0.001),Significant decrease (p=0.034),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00876,rs342387,4,135791130,APP,SNP (A/T),(A/,A,1.22,0.94,1.47,0.02308911,Moderate,0.235,0.016,0.128,0.422,Significant decrease (p=0.05),Significant decrease (p=0.002),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00877,rs756769,13,117393520,MS4A6A,Insertion,-,-,1.44,1.13,1.81,0.03344764,Moderate,0.139,0.44,0.017,0.203,Significant increase (p=0.004),Significant increase (p=0.029),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00878,rs759797,6,167215841,PTK2B,SNP (C/G),(C/,C,1.52,1.29,1.84,0.0404094,Unknown,0.07,0.3,0.221,0.209,Significant increase (p=0.029),Mild decrease (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00879,rs852867,13,225482933,PSEN2,SNP (G/T),(G/,G,0.59,0.36,0.86,0.01933778,Moderate,0.22,0.366,0.114,0.1,Mild increase (p=0.04),Mild increase (p=0.028),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00880,rs182464,14,86834369,PSEN2,SNP (A/T),(A/,A,0.91,0.59,1.24,0.05331826,High,0.015,0.209,0.291,0.284,Mild increase (p=0.022),Mild decrease (p=0.004),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP00881,rs246039,21,40207471,PICALM,SNP (A/C),(A/,A,0.82,0.53,1.21,0.00409224,Moderate,0.097,0.622,0.013,0.068,Variable effect (p=0.009),Mild decrease (p=0.036),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00882,rs854664,1,219217831,BIN1,SNP (A/G),(A/,A,2.21,1.85,2.43,0.00339588,Protective,0.117,0.238,0.443,0.002,Variable effect (p=0.047),Mild increase (p=0.035),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00883,rs544563,6,160995654,CD33,SNP (C/T),(C/,C,0.9,0.64,1.29,0.03164836,High,0.233,0.281,0.154,0.133,Significant decrease (p=0.044),Mild decrease (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00884,rs205449,15,70699357,PICALM,Deletion,-,-,0.95,0.65,1.33,0.02877765,Moderate,0.396,0.069,0.038,0.297,Mild increase (p=0.018),Variable effect (p=0.004),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP00885,rs139771,12,157798409,MS4A6A,SNP (A/C),(A/,A,1.03,0.72,1.36,0.0334696,Moderate,0.091,0.207,0.154,0.348,Mild decrease (p=0.009),Significant increase (p=0.017),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00886,rs431546,21,68796690,CR1,SNP (G/T),(G/,G,0.25,0.1,0.47,0.00069274,High,0.284,0.275,0.24,0.001,No significant pattern (p=0.039),No significant pattern (p=0.003),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00887,rs235960,1,176081317,SORL1,Deletion,-,-,0.78,0.54,1.06,0.01987151,Protective,0.314,0.183,0.002,0.301,No significant pattern (p=0.004),No significant pattern (p=0.026),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00888,rs982158,13,7531558,SORL1,SNP (A/T),(A/,A,2.02,1.77,2.23,0.02610506,Moderate,0.238,0.291,0.241,0.03,Significant decrease (p=0.05),Mild increase (p=0.028),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00889,rs571932,22,11633834,APP,SNP (C/G),(C/,C,1.05,0.74,1.41,0.00632644,Protective,0.006,0.014,0.104,0.675,Mild decrease (p=0.032),No significant pattern (p=0.033),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00890,rs257300,6,187798663,CD33,SNP (A/T),(A/,A,0.59,0.35,0.97,0.04240282,Moderate,0.266,0.062,0.095,0.377,Mild decrease (p=0.031),Mild decrease (p=0.004),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00891,rs686434,17,138674044,CD33,Insertion,-,-,1.9,1.51,2.2,0.02637409,High,0.413,0.029,0.354,0.005,Variable effect (p=0.028),Variable effect (p=0.037),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00892,rs962216,21,194240833,MS4A6A,SNP (C/G),(C/,C,1.11,0.82,1.32,0.08193817,Moderate,0.479,0.212,0.015,0.095,Mild increase (p=0.016),No significant pattern (p=0.012),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP00893,rs337386,8,226900110,CLU,SNP (A/G),(A/,A,1.55,1.25,1.92,0.00552591,Moderate,0.026,0.157,0.085,0.532,No significant pattern (p=0.043),Mild increase (p=0.04),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP00894,rs189340,19,104834650,EPHA1,SNP (C/T),(C/,C,2.08,1.73,2.36,0.06472516,High,0.522,0.044,0.219,0.016,Variable effect (p=0.012),No significant pattern (p=0.024),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP00895,rs211937,12,155181438,APOE,SNP (A/C),(A/,A,0.92,0.59,1.18,0.00252878,High,0.186,0.19,0.228,0.196,Mild increase (p=0.042),Mild decrease (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00896,rs522204,16,235697430,APP,SNP (G/T),(G/,G,1.0,0.73,1.22,0.00188163,Low,0.268,0.079,0.408,0.046,Variable effect (p=0.031),Mild decrease (p=0.048),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP00897,rs489535,15,1743078,CR1,SNP (G/T),(G/,G,2.2,1.89,2.46,0.01253932,Protective,0.109,0.325,0.334,0.032,Mild increase (p=0.028),Significant increase (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00898,rs840559,16,152986971,CD33,SNP (A/G),(A/,A,0.88,0.48,1.28,0.0421674,Moderate,0.301,0.118,0.367,0.014,Mild decrease (p=0.023),No significant pattern (p=0.033),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP00899,rs125795,21,241713571,SORL1,SNP (C/T),(C/,C,0.57,0.35,0.89,0.02779404,Moderate,0.245,0.187,0.363,0.005,Variable effect (p=0.029),Significant increase (p=0.042),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00900,rs415326,22,45355790,CR1,SNP (G/T),(G/,G,1.18,0.78,1.46,0.00341338,Moderate,0.365,0.18,0.194,0.06,Variable effect (p=0.029),Significant increase (p=0.008),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00901,rs882743,5,203554017,MS4A6A,Insertion,-,-,0.78,0.41,1.03,0.02130281,High,0.119,0.373,0.081,0.226,Mild increase (p=0.025),Mild increase (p=0.016),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00902,rs698848,3,238584105,APP,SNP (A/G),(A/,A,1.43,1.22,1.82,0.00866853,Moderate,0.209,0.084,0.191,0.316,Significant increase (p=0.044),Mild decrease (p=0.015),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00903,rs277972,22,178711001,CD33,SNP (A/G),(A/,A,0.4,0.1,0.79,0.02862876,High,0.382,0.08,0.338,0.0,No significant pattern (p=0.012),Significant decrease (p=0.002),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP00904,rs915989,4,79219316,MS4A6A,Deletion,-,-,1.22,1.02,1.48,0.0193008,Unknown,0.011,0.314,0.356,0.119,No significant pattern (p=0.04),Variable effect (p=0.008),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP00905,rs499673,3,107876410,MS4A6A,SNP (A/C),(A/,A,0.54,0.21,0.83,0.00067555,High,0.315,0.195,0.07,0.22,Significant decrease (p=0.047),Mild increase (p=0.039),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00906,rs308594,12,176310655,CD2AP,SNP (C/T),(C/,C,0.61,0.25,0.92,0.03047614,Low,0.065,0.295,0.031,0.409,Significant increase (p=0.036),Mild decrease (p=0.01),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00907,rs930172,17,54104079,CLU,SNP (A/T),(A/,A,0.78,0.47,1.03,0.06636741,Low,0.085,0.239,0.022,0.454,Mild increase (p=0.05),Mild increase (p=0.003),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00908,rs649905,1,99858167,CD33,SNP (C/G),(C/,C,1.56,1.32,1.84,0.02796156,Low,0.004,0.094,0.142,0.56,Variable effect (p=0.006),Variable effect (p=0.011),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00909,rs411923,21,36685944,CD33,SNP (C/T),(C/,C,1.21,0.87,1.42,0.00982084,Moderate,0.035,0.064,0.338,0.364,Mild increase (p=0.044),Significant increase (p=0.05),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00910,rs564304,14,225350195,PTK2B,SNP (C/T),(C/,C,0.99,0.67,1.34,0.01005037,High,0.195,0.106,0.161,0.338,Mild decrease (p=0.046),Significant increase (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00911,rs384171,20,116900892,MS4A6A,Insertion,-,-,0.52,0.16,0.73,0.00812922,Moderate,0.024,0.093,0.005,0.678,No significant pattern (p=0.046),Variable effect (p=0.035),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00912,rs872870,2,111587911,BIN1,Deletion,-,-,2.18,1.87,2.48,0.06473992,Moderate,0.0,0.151,0.224,0.425,Significant decrease (p=0.006),Significant decrease (p=0.003),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP00913,rs468187,4,118420958,MS4A6A,Insertion,-,-,1.32,0.95,1.54,0.02232522,Low,0.132,0.364,0.193,0.111,Mild increase (p=0.028),Variable effect (p=0.047),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00914,rs676795,10,117657379,APP,Insertion,-,-,1.41,1.16,1.78,0.01556656,Low,0.332,0.07,0.107,0.291,Significant increase (p=0.045),No significant pattern (p=0.009),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00915,rs733137,17,228934559,ABCA7,SNP (C/T),(C/,C,0.89,0.63,1.29,0.01318847,High,0.257,0.259,0.222,0.063,Significant increase (p=0.038),Mild increase (p=0.003),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00916,rs476175,20,248437437,CD33,SNP (C/T),(C/,C,2.59,2.3,2.85,0.00595176,Moderate,0.161,0.15,0.147,0.342,Variable effect (p=0.032),Mild increase (p=0.024),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00917,rs622366,22,150702673,PICALM,SNP (C/T),(C/,C,1.67,1.29,1.92,0.00445301,Protective,0.509,0.206,0.045,0.039,No significant pattern (p=0.041),No significant pattern (p=0.019),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00918,rs571022,11,181430952,PICALM,SNP (C/G),(C/,C,1.29,0.99,1.69,0.0147702,Moderate,0.117,0.672,0.01,0.002,Mild decrease (p=0.004),Significant decrease (p=0.001),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00919,rs604532,13,125965282,PSEN2,SNP (A/T),(A/,A,0.95,0.59,1.34,0.05396817,Moderate,0.33,0.124,0.099,0.247,No significant pattern (p=0.042),Mild increase (p=0.004),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP00920,rs516404,5,6835074,PSEN2,SNP (A/C),(A/,A,1.78,1.43,2.0,0.00061861,Unknown,0.516,0.166,0.102,0.015,Mild decrease (p=0.021),Mild decrease (p=0.006),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00921,rs795220,1,202253573,SORL1,Deletion,-,-,1.25,1.03,1.58,0.07976389,High,0.147,0.067,0.319,0.267,Mild increase (p=0.04),No significant pattern (p=0.028),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP00922,rs341847,22,237365512,CLU,SNP (C/G),(C/,C,0.83,0.63,1.06,0.03844514,Moderate,0.016,0.701,0.05,0.033,Significant decrease (p=0.046),Mild decrease (p=0.033),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00923,rs646258,8,50202186,MS4A6A,Insertion,-,-,0.62,0.34,1.0,0.01785013,High,0.474,0.12,0.109,0.097,Variable effect (p=0.028),Mild increase (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP00924,rs491954,6,11695065,MS4A6A,SNP (A/C),(A/,A,2.12,1.72,2.46,0.08919369,High,0.058,0.05,0.571,0.122,Mild decrease (p=0.011),Mild decrease (p=0.012),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP00925,rs780019,6,34303352,ABCA7,SNP (G/T),(G/,G,0.89,0.56,1.13,0.05984346,High,0.23,0.065,0.368,0.136,Variable effect (p=0.038),Mild increase (p=0.002),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00926,rs970759,6,229346454,PSEN2,SNP (A/G),(A/,A,0.66,0.32,0.89,0.1401926,Moderate,0.056,0.348,0.338,0.057,No significant pattern (p=0.041),Significant increase (p=0.047),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00927,rs101162,4,67076380,SORL1,SNP (A/G),(A/,A,1.39,1.08,1.68,0.011608,High,0.232,0.312,0.091,0.165,Mild increase (p=0.033),Significant decrease (p=0.023),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00928,rs851510,7,182028728,PSEN2,SNP (A/C),(A/,A,1.5,1.28,1.88,0.07145854,Protective,0.025,0.678,0.088,0.008,Significant increase (p=0.016),Significant decrease (p=0.037),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00929,rs347018,13,221964506,APOE,Deletion,-,-,1.18,0.88,1.55,0.00500869,Moderate,0.309,0.164,0.198,0.128,Mild decrease (p=0.01),Significant decrease (p=0.037),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00930,rs365646,20,232796908,EPHA1,SNP (C/T),(C/,C,0.68,0.46,0.91,0.00788283,Low,0.023,0.704,0.059,0.014,Significant increase (p=0.002),Mild decrease (p=0.039),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00931,rs182310,19,66923624,PICALM,SNP (A/T),(A/,A,0.58,0.22,0.88,0.00717616,Moderate,0.164,0.165,0.463,0.007,No significant pattern (p=0.031),No significant pattern (p=0.018),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00932,rs872118,15,231069596,SORL1,SNP (G/T),(G/,G,1.53,1.19,1.74,0.01389501,Moderate,0.437,0.014,0.272,0.077,Mild decrease (p=0.026),Significant increase (p=0.03),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00933,rs236676,10,67808296,CD33,Deletion,-,-,0.37,0.1,0.72,0.01599776,High,0.437,0.009,0.081,0.273,Significant decrease (p=0.015),Significant increase (p=0.027),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00934,rs976438,22,77336543,PTK2B,SNP (A/G),(A/,A,1.46,1.12,1.85,0.04288834,Protective,0.408,0.026,0.173,0.193,Significant increase (p=0.037),Significant increase (p=0.031),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00935,rs384713,13,109233232,PSEN2,SNP (A/G),(A/,A,1.15,0.85,1.4,0.0109436,Moderate,0.411,0.269,0.059,0.062,Significant increase (p=0.021),No significant pattern (p=0.034),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00936,rs485853,12,74276756,PTK2B,SNP (C/G),(C/,C,0.78,0.58,1.06,0.03581996,Moderate,0.175,0.032,0.268,0.324,Variable effect (p=0.041),Variable effect (p=0.03),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP00937,rs368002,18,134232053,CR1,SNP (A/G),(A/,A,1.39,1.14,1.77,0.01404975,Unknown,0.051,0.564,0.153,0.032,Mild decrease (p=0.005),Variable effect (p=0.048),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP00938,rs393347,3,85051468,ABCA7,SNP (A/C),(A/,A,0.81,0.59,1.08,0.02580779,Moderate,0.028,0.216,0.54,0.016,Significant decrease (p=0.009),Variable effect (p=0.016),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00939,rs287118,3,205465787,SORL1,SNP (C/T),(C/,C,1.14,0.91,1.35,0.08813424,Moderate,0.266,0.333,0.014,0.186,Significant decrease (p=0.021),Significant increase (p=0.033),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00940,rs657283,17,157701630,SORL1,SNP (A/C),(A/,A,0.67,0.32,0.97,0.04809018,Unknown,0.1,0.049,0.283,0.368,Mild decrease (p=0.047),Variable effect (p=0.039),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00941,rs941204,7,247371339,APOE,SNP (A/G),(A/,A,1.36,1.09,1.57,0.02646621,Unknown,0.362,0.061,0.26,0.116,No significant pattern (p=0.012),Mild decrease (p=0.045),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP00942,rs919331,17,97760441,SORL1,Insertion,-,-,0.99,0.77,1.22,0.0200981,Low,0.016,0.026,0.446,0.312,Variable effect (p=0.012),Variable effect (p=0.034),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00943,rs260865,21,234719534,MS4A6A,Insertion,-,-,0.89,0.54,1.23,0.00051931,Moderate,0.307,0.184,0.17,0.139,Variable effect (p=0.019),No significant pattern (p=0.038),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00944,rs914683,2,143297718,CD2AP,SNP (C/T),(C/,C,0.89,0.51,1.21,0.05644957,Moderate,0.149,0.303,0.157,0.19,Variable effect (p=0.008),Mild increase (p=0.041),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00945,rs782067,5,86616504,CR1,SNP (A/C),(A/,A,1.55,1.29,1.83,0.02293062,Moderate,0.467,0.299,0.008,0.025,Variable effect (p=0.023),Significant decrease (p=0.048),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00946,rs904623,17,60774193,EPHA1,SNP (A/T),(A/,A,0.77,0.53,1.14,0.0424023,High,0.42,0.313,0.015,0.053,Significant increase (p=0.029),Significant decrease (p=0.015),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00947,rs692324,15,90802496,ABCA7,SNP (A/G),(A/,A,0.49,0.27,0.85,0.04156478,High,0.035,0.094,0.205,0.467,Variable effect (p=0.047),Variable effect (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00948,rs368866,9,120614583,TREM2,SNP (G/T),(G/,G,0.65,0.35,0.99,0.00933684,Moderate,0.224,0.379,0.01,0.187,Significant increase (p=0.016),Mild increase (p=0.023),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00949,rs237310,19,38460455,PICALM,SNP (C/G),(C/,C,0.79,0.56,1.12,0.08350462,Moderate,0.483,0.071,0.196,0.051,Mild increase (p=0.02),No significant pattern (p=0.045),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00950,rs534962,19,231117615,BIN1,SNP (C/G),(C/,C,0.73,0.43,0.95,0.04518817,High,0.151,0.23,0.253,0.166,Mild increase (p=0.046),Significant decrease (p=0.01),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00951,rs513648,18,46763111,ABCA7,Insertion,-,-,0.85,0.58,1.1,0.00121108,Low,0.008,0.224,0.106,0.462,Significant increase (p=0.045),Significant decrease (p=0.046),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00952,rs777024,1,43604142,BIN1,SNP (A/T),(A/,A,0.59,0.34,0.98,0.07634729,Moderate,0.029,0.093,0.428,0.25,Mild decrease (p=0.036),No significant pattern (p=0.036),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00953,rs896899,17,8358472,PTK2B,SNP (A/C),(A/,A,1.12,0.82,1.45,0.0216369,Moderate,0.148,0.199,0.331,0.123,Mild decrease (p=0.03),Variable effect (p=0.01),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00954,rs940650,12,140963288,EPHA1,Deletion,-,-,0.7,0.45,1.01,0.14836625,High,0.088,0.527,0.067,0.117,Significant decrease (p=0.047),Mild increase (p=0.02),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00955,rs178652,9,181048253,PTK2B,SNP (C/T),(C/,C,1.1,0.89,1.47,0.00979706,Moderate,0.065,0.491,0.187,0.057,Significant increase (p=0.044),No significant pattern (p=0.048),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP00956,rs371534,9,171700061,PTK2B,SNP (G/T),(G/,G,1.41,1.12,1.79,0.00903966,Unknown,0.15,0.288,0.242,0.12,Mild increase (p=0.043),Significant increase (p=0.003),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00957,rs821237,10,136913538,MS4A6A,SNP (A/G),(A/,A,1.23,1.02,1.5,0.00047574,Moderate,0.264,0.056,0.214,0.266,Significant decrease (p=0.036),Variable effect (p=0.007),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP00958,rs647631,11,138355390,EPHA1,Deletion,-,-,0.41,0.1,0.76,0.05981397,Moderate,0.335,0.021,0.227,0.217,Mild decrease (p=0.012),Mild decrease (p=0.034),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00959,rs651580,15,113981297,TREM2,SNP (C/G),(C/,C,0.4,0.1,0.62,0.00543744,Moderate,0.135,0.294,0.061,0.309,Mild increase (p=0.028),Significant increase (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP00960,rs593837,18,7744171,CR1,SNP (C/T),(C/,C,0.88,0.65,1.12,0.13763272,High,0.279,0.057,0.334,0.13,Variable effect (p=0.027),Significant increase (p=0.014),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP00961,rs452353,10,35925237,PSEN2,Deletion,-,-,0.94,0.57,1.26,0.0028898,High,0.011,0.441,0.161,0.188,Mild decrease (p=0.015),Mild decrease (p=0.013),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00962,rs333281,16,6386913,MS4A6A,Deletion,-,-,0.89,0.58,1.22,0.02370803,High,0.387,0.11,0.277,0.025,Mild decrease (p=0.024),Significant increase (p=0.046),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP00963,rs115924,9,188007211,EPHA1,Deletion,-,-,0.8,0.53,1.07,0.02311994,Moderate,0.436,0.053,0.198,0.113,Significant decrease (p=0.024),Mild decrease (p=0.033),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP00964,rs207714,22,224278673,APOE,Insertion,-,-,0.83,0.59,1.13,0.00282839,High,0.168,0.485,0.088,0.059,Significant decrease (p=0.025),Mild decrease (p=0.036),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00965,rs801133,11,44520063,MS4A6A,SNP (G/T),(G/,G,1.49,1.23,1.7,0.09503196,Protective,0.022,0.389,0.097,0.292,Variable effect (p=0.043),Mild decrease (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP00966,rs568553,2,43871327,PICALM,Deletion,-,-,0.58,0.38,0.89,0.01624134,Low,0.364,0.207,0.225,0.004,Variable effect (p=0.019),Mild increase (p=0.007),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00967,rs148329,7,191861459,MS4A6A,SNP (C/G),(C/,C,1.02,0.75,1.3,0.04563708,Low,0.18,0.425,0.137,0.058,No significant pattern (p=0.027),Variable effect (p=0.034),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00968,rs851010,19,129780345,EPHA1,SNP (A/G),(A/,A,1.88,1.51,2.08,0.01101144,Moderate,0.095,0.663,0.013,0.028,Mild increase (p=0.007),Significant increase (p=0.029),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP00969,rs222637,17,130109445,SORL1,SNP (A/G),(A/,A,0.86,0.51,1.21,0.00841436,High,0.378,0.228,0.116,0.079,No significant pattern (p=0.034),Mild increase (p=0.039),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP00970,rs174118,21,15586769,CD33,SNP (A/C),(A/,A,0.87,0.49,1.1,0.00182242,Low,0.024,0.07,0.224,0.482,Mild decrease (p=0.025),Mild increase (p=0.005),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP00971,rs334424,21,195631146,PSEN2,SNP (G/T),(G/,G,1.18,0.9,1.54,0.0202473,Low,0.253,0.467,0.022,0.058,Variable effect (p=0.02),Mild decrease (p=0.048),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP00972,rs299282,3,170749083,CD2AP,Insertion,-,-,1.99,1.59,2.38,0.00625683,High,0.043,0.565,0.158,0.034,Mild increase (p=0.014),Mild increase (p=0.004),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP00973,rs551249,12,245014688,PSEN2,SNP (A/G),(A/,A,0.55,0.19,0.77,0.03635157,Low,0.372,0.258,0.111,0.06,Mild decrease (p=0.02),Mild increase (p=0.043),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP00974,rs533771,16,158747345,CD33,Insertion,-,-,1.77,1.55,2.08,0.04095237,Moderate,0.245,0.015,0.327,0.213,Mild increase (p=0.02),Significant increase (p=0.014),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00975,rs876209,7,130250432,PTK2B,SNP (A/T),(A/,A,1.65,1.42,2.01,0.03094639,High,0.174,0.023,0.523,0.08,Significant decrease (p=0.006),Significant increase (p=0.007),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP00976,rs709128,7,190512606,TREM2,Deletion,-,-,1.15,0.84,1.36,0.00060567,High,0.28,0.099,0.3,0.12,Mild increase (p=0.032),Significant decrease (p=0.039),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP00977,rs881044,19,201151406,APP,SNP (C/T),(C/,C,1.13,0.75,1.44,0.03165287,Moderate,0.103,0.256,0.403,0.039,No significant pattern (p=0.001),No significant pattern (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP00978,rs749457,10,176982953,APOE,SNP (A/T),(A/,A,2.04,1.68,2.3,0.03113404,Low,0.035,0.342,0.095,0.328,Variable effect (p=0.006),No significant pattern (p=0.038),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP00979,rs814743,19,16160750,PSEN2,SNP (A/T),(A/,A,1.26,0.89,1.59,0.00389019,Moderate,0.473,0.059,0.23,0.038,No significant pattern (p=0.026),Mild increase (p=0.044),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP00980,rs415193,6,5704604,CR1,SNP (C/G),(C/,C,0.95,0.74,1.26,0.04429762,Low,0.356,0.291,0.149,0.004,Mild increase (p=0.016),Significant decrease (p=0.004),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP00981,rs313330,8,177403689,SORL1,SNP (C/G),(C/,C,1.72,1.34,1.99,0.00567876,Moderate,0.073,0.278,0.415,0.035,Significant increase (p=0.003),Variable effect (p=0.042),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00982,rs875942,22,144033569,PSEN2,SNP (A/G),(A/,A,0.55,0.29,0.9,0.07568404,High,0.005,0.103,0.117,0.575,No significant pattern (p=0.032),Significant increase (p=0.028),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP00983,rs401665,16,151485298,CD33,SNP (A/G),(A/,A,1.83,1.56,2.07,0.00121142,High,0.094,0.033,0.039,0.634,Significant increase (p=0.018),Mild increase (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP00984,rs858577,6,141670516,PSEN2,Insertion,-,-,2.17,1.85,2.4,0.0233666,High,0.015,0.435,0.188,0.163,No significant pattern (p=0.033),Significant decrease (p=0.043),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00985,rs255680,21,80814824,CR1,Insertion,-,-,0.84,0.49,1.19,0.00666701,High,0.302,0.066,0.102,0.331,Variable effect (p=0.04),Mild decrease (p=0.042),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP00986,rs359393,3,155060665,SORL1,SNP (A/C),(A/,A,1.33,1.01,1.62,0.03692481,High,0.017,0.405,0.002,0.376,Mild increase (p=0.026),Variable effect (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP00987,rs713003,5,144417338,APP,SNP (A/T),(A/,A,0.88,0.56,1.16,0.02612415,High,0.366,0.123,0.04,0.27,Variable effect (p=0.043),Variable effect (p=0.007),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP00988,rs425207,18,127104715,CD2AP,Insertion,-,-,0.97,0.58,1.17,0.00216813,High,0.412,0.011,0.166,0.212,Mild decrease (p=0.036),Mild decrease (p=0.041),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00989,rs963698,18,174481972,PICALM,SNP (G/T),(G/,G,1.0,0.6,1.36,0.03796653,High,0.301,0.117,0.377,0.005,Mild decrease (p=0.021),No significant pattern (p=0.002),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP00990,rs432300,14,191605060,EPHA1,SNP (G/T),(G/,G,2.11,1.81,2.46,0.0391222,High,0.115,0.1,0.394,0.191,Mild increase (p=0.006),Significant increase (p=0.035),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP00991,rs417871,15,31375231,CD33,Deletion,-,-,1.19,0.86,1.58,0.00368117,Low,0.183,0.522,0.075,0.02,Significant increase (p=0.032),No significant pattern (p=0.006),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP00992,rs938136,10,127685009,MS4A6A,SNP (A/C),(A/,A,0.78,0.5,1.04,0.07754647,Low,0.32,0.043,0.328,0.108,Variable effect (p=0.016),No significant pattern (p=0.014),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP00993,rs712047,22,218159099,TREM2,SNP (C/G),(C/,C,1.88,1.68,2.19,0.03042572,Moderate,0.15,0.018,0.319,0.313,Mild decrease (p=0.023),Mild increase (p=0.022),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00994,rs185128,2,137099871,MS4A6A,SNP (C/G),(C/,C,0.86,0.53,1.15,0.02256683,Moderate,0.15,0.196,0.06,0.394,Significant decrease (p=0.033),Mild increase (p=0.031),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP00995,rs150722,9,41688074,APP,SNP (C/T),(C/,C,0.72,0.48,0.94,0.0146142,Moderate,0.071,0.111,0.324,0.294,Mild decrease (p=0.012),No significant pattern (p=0.039),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP00996,rs586067,22,121291965,TREM2,SNP (C/G),(C/,C,1.03,0.66,1.34,0.02975001,High,0.513,0.038,0.149,0.1,Variable effect (p=0.021),Significant increase (p=0.018),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP00997,rs569841,6,225483427,PSEN2,SNP (A/T),(A/,A,0.64,0.3,0.99,0.0134316,Moderate,0.413,0.275,0.055,0.058,Variable effect (p=0.032),Mild decrease (p=0.004),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP00998,rs322235,21,210358552,MS4A6A,Insertion,-,-,1.13,0.91,1.39,0.00283275,Moderate,0.378,0.011,0.02,0.391,Mild increase (p=0.037),Significant increase (p=0.044),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP00999,rs255807,11,193452105,SORL1,SNP (A/T),(A/,A,2.32,2.09,2.63,0.0667834,Protective,0.383,0.09,0.006,0.321,Significant increase (p=0.007),Variable effect (p=0.023),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01000,rs392050,8,156030401,TREM2,SNP (G/T),(G/,G,0.98,0.63,1.22,0.04215356,Moderate,0.162,0.209,0.344,0.085,Mild increase (p=0.008),Variable effect (p=0.035),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01001,rs357286,6,167420871,CLU,Insertion,-,-,0.91,0.61,1.24,0.02994231,High,0.12,0.37,0.164,0.145,Significant decrease (p=0.008),Significant increase (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01002,rs950980,11,169196118,MS4A6A,Deletion,-,-,2.61,2.24,2.85,0.01410931,Moderate,0.169,0.322,0.307,0.002,Mild decrease (p=0.005),No significant pattern (p=0.005),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01003,rs378503,1,64629569,APP,Insertion,-,-,1.33,1.09,1.65,0.02914409,Moderate,0.122,0.311,0.226,0.141,No significant pattern (p=0.049),No significant pattern (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01004,rs222647,2,138485527,TREM2,Deletion,-,-,0.78,0.44,1.14,0.01264238,Moderate,0.369,0.071,0.199,0.161,Mild decrease (p=0.043),Mild increase (p=0.039),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP01005,rs873347,6,32195492,ABCA7,SNP (C/G),(C/,C,0.85,0.6,1.07,0.00915496,Moderate,0.381,0.161,0.003,0.255,No significant pattern (p=0.016),Mild increase (p=0.021),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01006,rs237663,1,199703154,MS4A6A,Deletion,-,-,1.92,1.72,2.17,0.02715244,High,0.197,0.055,0.257,0.291,Significant decrease (p=0.038),Mild increase (p=0.027),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01007,rs840791,15,11227456,PICALM,SNP (A/T),(A/,A,0.76,0.47,1.03,0.02138246,Low,0.607,0.007,0.117,0.069,Significant increase (p=0.046),Mild increase (p=0.035),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01008,rs299225,18,97107077,CR1,SNP (G/T),(G/,G,2.43,2.05,2.67,0.13726215,Low,0.006,0.618,0.043,0.133,Mild increase (p=0.021),Mild increase (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01009,rs601716,2,77359581,BIN1,Insertion,-,-,1.34,1.04,1.64,0.03821687,Moderate,0.26,0.178,0.343,0.019,Significant decrease (p=0.004),Mild increase (p=0.047),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01010,rs373015,5,89120868,APOE,Insertion,-,-,0.66,0.35,0.99,0.13750777,Low,0.081,0.172,0.004,0.544,Mild increase (p=0.011),No significant pattern (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP01011,rs809115,17,114669547,PICALM,SNP (A/C),(A/,A,0.75,0.48,1.02,0.01900445,Moderate,0.163,0.088,0.365,0.184,Variable effect (p=0.012),Significant increase (p=0.011),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01012,rs245522,6,122373000,TREM2,SNP (A/T),(A/,A,0.9,0.64,1.18,0.00568225,Unknown,0.001,0.385,0.126,0.289,Significant decrease (p=0.043),Mild decrease (p=0.013),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01013,rs978810,4,98627341,PICALM,Deletion,-,-,1.26,1.05,1.53,0.07456242,High,0.12,0.256,0.072,0.352,Significant increase (p=0.024),Significant decrease (p=0.031),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01014,rs784839,2,46155115,CD2AP,SNP (A/T),(A/,A,0.65,0.41,0.97,0.01644735,Unknown,0.122,0.272,0.078,0.328,No significant pattern (p=0.005),Mild increase (p=0.018),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01015,rs227366,4,100245322,APOE,SNP (G/T),(G/,G,1.49,1.21,1.71,0.08199475,High,0.176,0.388,0.202,0.034,Significant increase (p=0.029),Variable effect (p=0.005),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01016,rs988966,14,70415149,BIN1,Deletion,-,-,1.06,0.78,1.31,0.0784056,Moderate,0.089,0.217,0.166,0.327,Variable effect (p=0.018),Mild decrease (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP01017,rs427401,2,203133540,MS4A6A,SNP (A/C),(A/,A,1.67,1.33,2.04,0.01915467,Moderate,0.655,0.021,0.105,0.019,Mild decrease (p=0.043),Significant increase (p=0.04),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP01018,rs666152,7,155042287,SORL1,SNP (A/G),(A/,A,0.82,0.58,1.09,0.00327212,Moderate,0.282,0.103,0.106,0.31,Mild increase (p=0.019),Significant increase (p=0.003),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01019,rs263213,6,17385637,CD33,Insertion,-,-,1.16,0.84,1.44,0.01758895,Moderate,0.41,0.103,0.013,0.275,No significant pattern (p=0.008),Mild increase (p=0.035),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01020,rs393473,5,158935898,TREM2,Insertion,-,-,1.01,0.69,1.38,0.00088245,High,0.277,0.079,0.037,0.408,Significant decrease (p=0.048),Significant increase (p=0.046),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01021,rs588371,1,222666205,CD2AP,SNP (C/G),(C/,C,0.45,0.1,0.82,0.02413692,High,0.174,0.335,0.069,0.222,Significant decrease (p=0.031),Mild increase (p=0.02),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP01022,rs642702,15,196395744,TREM2,Insertion,-,-,0.99,0.64,1.22,0.00895457,Protective,0.133,0.406,0.085,0.177,No significant pattern (p=0.012),Significant increase (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP01023,rs432830,20,209192599,CR1,SNP (C/T),(C/,C,1.14,0.92,1.35,0.01944333,Moderate,0.063,0.566,0.122,0.049,Significant increase (p=0.041),Mild decrease (p=0.045),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01024,rs276627,16,16970428,CR1,Deletion,-,-,0.74,0.37,0.97,0.0140371,Moderate,0.298,0.102,0.003,0.397,Significant increase (p=0.037),Variable effect (p=0.025),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP01025,rs840010,19,21800164,TREM2,SNP (A/C),(A/,A,0.92,0.64,1.19,0.044963,Moderate,0.193,0.146,0.343,0.118,Variable effect (p=0.011),Significant decrease (p=0.04),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01026,rs171946,6,60599484,SORL1,Deletion,-,-,1.36,1.08,1.58,0.00193504,High,0.093,0.27,0.011,0.425,No significant pattern (p=0.02),Mild increase (p=0.04),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP01027,rs944656,19,122436330,CD2AP,SNP (C/G),(C/,C,1.57,1.24,1.91,0.00639814,High,0.234,0.346,0.056,0.164,Significant decrease (p=0.016),Variable effect (p=0.035),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01028,rs825656,16,56671478,PTK2B,SNP (C/T),(C/,C,1.1,0.79,1.49,0.08024505,High,0.075,0.433,0.041,0.25,No significant pattern (p=0.005),No significant pattern (p=0.041),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01029,rs688173,15,168022977,PSEN2,SNP (A/C),(A/,A,1.3,0.91,1.59,0.0719718,Moderate,0.251,0.163,0.314,0.072,No significant pattern (p=0.007),Mild increase (p=0.012),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01030,rs606622,21,89623269,TREM2,SNP (C/T),(C/,C,1.9,1.64,2.14,0.04760357,High,0.15,0.342,0.129,0.178,Mild decrease (p=0.002),Mild decrease (p=0.018),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01031,rs556305,2,118619615,MS4A6A,Deletion,-,-,1.56,1.19,1.85,0.15823373,High,0.1,0.118,0.281,0.301,No significant pattern (p=0.017),Mild decrease (p=0.002),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01032,rs866709,17,128949531,PICALM,Insertion,-,-,1.11,0.86,1.42,0.01593631,Low,0.217,0.305,0.266,0.012,Mild decrease (p=0.021),Mild increase (p=0.012),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01033,rs895320,20,89639101,PTK2B,SNP (C/T),(C/,C,0.61,0.24,0.84,0.03802905,Moderate,0.104,0.141,0.317,0.238,Mild increase (p=0.002),Mild increase (p=0.023),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01034,rs443372,5,235964643,APOE,SNP (C/T),(C/,C,0.83,0.56,1.16,0.00772672,Moderate,0.084,0.193,0.056,0.467,Mild decrease (p=0.014),Mild increase (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01035,rs855953,7,149345487,PSEN2,Insertion,-,-,1.56,1.35,1.84,0.0807918,High,0.243,0.103,0.242,0.212,Significant increase (p=0.008),Significant increase (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP01036,rs415852,3,91171653,MS4A6A,SNP (A/T),(A/,A,0.79,0.54,1.02,0.00339567,Moderate,0.06,0.1,0.321,0.319,Variable effect (p=0.042),No significant pattern (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01037,rs127726,8,204214370,APP,SNP (A/G),(A/,A,0.66,0.41,0.9,0.00648682,High,0.151,0.135,0.047,0.466,Variable effect (p=0.023),Mild increase (p=0.026),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP01038,rs433728,20,36118220,PICALM,SNP (G/T),(G/,G,0.7,0.5,0.95,0.01308034,High,0.151,0.52,0.006,0.123,Significant increase (p=0.005),Variable effect (p=0.032),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01039,rs775763,22,148183538,SORL1,Insertion,-,-,0.84,0.63,1.07,0.03800474,Low,0.0,0.322,0.111,0.367,Mild increase (p=0.013),Mild decrease (p=0.019),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP01040,rs630206,4,215353020,PICALM,Deletion,-,-,0.98,0.76,1.23,0.05452955,Low,0.159,0.075,0.167,0.399,Significant decrease (p=0.018),Mild increase (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP01041,rs945709,22,71553660,PICALM,SNP (A/C),(A/,A,0.45,0.1,0.84,0.03114366,High,0.119,0.099,0.534,0.048,Mild increase (p=0.018),Variable effect (p=0.037),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01042,rs886923,10,42724134,BIN1,SNP (A/G),(A/,A,0.65,0.43,0.88,0.00125392,High,0.027,0.072,0.57,0.13,Mild increase (p=0.033),No significant pattern (p=0.012),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01043,rs653977,20,59450297,CD33,SNP (A/G),(A/,A,0.96,0.7,1.24,0.00760657,High,0.021,0.181,0.463,0.135,Mild decrease (p=0.049),Mild increase (p=0.008),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01044,rs489025,9,119405969,ABCA7,Insertion,-,-,0.52,0.18,0.74,0.0203286,Low,0.354,0.045,0.389,0.012,Variable effect (p=0.022),Significant decrease (p=0.042),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01045,rs671862,1,4406743,PSEN2,SNP (G/T),(G/,G,1.34,1.12,1.69,0.08212716,High,0.253,0.239,0.262,0.045,Significant increase (p=0.008),Significant increase (p=0.021),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01046,rs672050,20,147589336,BIN1,SNP (A/C),(A/,A,2.21,1.91,2.47,0.02903422,High,0.307,0.096,0.164,0.232,No significant pattern (p=0.026),Significant decrease (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP01047,rs288966,15,207312501,APP,SNP (A/G),(A/,A,0.96,0.62,1.25,0.00882383,Low,0.043,0.252,0.301,0.204,Significant decrease (p=0.017),Significant increase (p=0.008),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP01048,rs757562,20,111245330,ABCA7,SNP (G/T),(G/,G,0.87,0.54,1.21,0.04488771,Moderate,0.065,0.134,0.504,0.098,Significant increase (p=0.019),No significant pattern (p=0.001),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01049,rs985842,9,117545599,CD2AP,SNP (A/G),(A/,A,0.95,0.67,1.22,0.03256281,Moderate,0.173,0.454,0.085,0.087,Mild increase (p=0.012),Mild decrease (p=0.045),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01050,rs311360,22,149524562,TREM2,SNP (A/C),(A/,A,1.1,0.74,1.42,0.00643582,Protective,0.171,0.155,0.004,0.47,Variable effect (p=0.024),Mild decrease (p=0.029),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP01051,rs473154,7,32564411,PTK2B,SNP (A/T),(A/,A,0.4,0.12,0.62,0.0486021,Low,0.322,0.247,0.089,0.142,Significant increase (p=0.018),Mild increase (p=0.001),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01052,rs650239,1,121221847,APOE,SNP (A/T),(A/,A,1.42,1.09,1.69,0.00511353,High,0.338,0.121,0.085,0.257,No significant pattern (p=0.041),Mild increase (p=0.04),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01053,rs298298,19,141507798,MS4A6A,Insertion,-,-,1.64,1.26,1.92,0.00260529,Moderate,0.09,0.496,0.111,0.103,Variable effect (p=0.005),No significant pattern (p=0.028),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01054,rs191891,19,164498687,PSEN2,SNP (A/G),(A/,A,0.92,0.67,1.14,0.03314575,Protective,0.018,0.371,0.294,0.117,No significant pattern (p=0.009),No significant pattern (p=0.037),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01055,rs630159,2,62391346,CLU,SNP (C/G),(C/,C,0.53,0.28,0.78,0.02253017,Moderate,0.103,0.185,0.357,0.154,No significant pattern (p=0.022),Mild increase (p=0.013),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01056,rs906469,7,3601697,CR1,SNP (A/C),(A/,A,1.14,0.92,1.41,0.06133528,High,0.303,0.037,0.186,0.273,Significant decrease (p=0.032),Variable effect (p=0.043),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01057,rs308551,17,228835596,PSEN2,SNP (A/G),(A/,A,1.57,1.21,1.96,0.01382806,Unknown,0.348,0.197,0.18,0.074,Variable effect (p=0.036),No significant pattern (p=0.011),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP01058,rs234894,13,224029523,BIN1,SNP (A/C),(A/,A,0.43,0.1,0.8,0.01732864,Moderate,0.365,0.077,0.266,0.091,Mild decrease (p=0.015),Variable effect (p=0.018),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01059,rs381808,9,48436788,ABCA7,Insertion,-,-,0.68,0.45,1.07,0.0413605,Low,0.201,0.053,0.374,0.173,Variable effect (p=0.026),Significant decrease (p=0.006),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP01060,rs557112,16,97669536,CD33,SNP (C/T),(C/,C,0.44,0.11,0.81,0.02580871,Low,0.043,0.08,0.32,0.358,Mild increase (p=0.043),Variable effect (p=0.009),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01061,rs644136,10,53322408,APOE,SNP (C/G),(C/,C,0.96,0.64,1.32,0.03594499,Protective,0.224,0.109,0.144,0.323,Mild increase (p=0.044),Significant increase (p=0.044),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01062,rs369207,8,219515767,APOE,SNP (A/G),(A/,A,2.02,1.74,2.26,0.04353852,Moderate,0.034,0.354,0.267,0.145,No significant pattern (p=0.032),Mild increase (p=0.021),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01063,rs480460,20,109538156,CLU,SNP (C/G),(C/,C,0.82,0.45,1.09,0.0607866,Low,0.196,0.286,0.235,0.083,Mild increase (p=0.04),Mild decrease (p=0.004),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01064,rs138240,5,129717588,CD33,SNP (C/T),(C/,C,2.22,2.01,2.55,0.00617788,Protective,0.024,0.163,0.6,0.013,Significant increase (p=0.005),Mild increase (p=0.038),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01065,rs138304,13,172562941,CD2AP,SNP (A/G),(A/,A,1.82,1.46,2.12,0.00930233,Moderate,0.453,0.003,0.291,0.053,Mild increase (p=0.046),Significant increase (p=0.035),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01066,rs691101,15,155083901,EPHA1,SNP (C/T),(C/,C,0.88,0.54,1.21,0.01719074,High,0.228,0.289,0.185,0.098,Mild increase (p=0.023),Significant decrease (p=0.03),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01067,rs281919,1,190931405,APOE,Insertion,-,-,0.83,0.46,1.05,0.12441775,High,0.098,0.375,0.15,0.177,Significant decrease (p=0.034),No significant pattern (p=0.044),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01068,rs745212,12,2030300,CD33,SNP (C/T),(C/,C,1.19,0.81,1.4,0.02558814,High,0.22,0.152,0.25,0.177,Mild increase (p=0.029),Mild increase (p=0.008),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP01069,rs786557,2,198921148,EPHA1,SNP (A/C),(A/,A,2.84,2.5,3.13,0.03564895,High,0.291,0.034,0.353,0.121,Significant increase (p=0.037),Mild decrease (p=0.03),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01070,rs588783,4,124442235,APOE,Insertion,-,-,0.9,0.62,1.14,0.01277729,Moderate,0.177,0.428,0.174,0.021,Mild decrease (p=0.017),No significant pattern (p=0.043),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01071,rs880766,13,201386422,PICALM,SNP (C/T),(C/,C,1.58,1.32,1.82,0.01492247,High,0.006,0.007,0.123,0.664,Significant decrease (p=0.044),Mild decrease (p=0.004),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01072,rs372143,19,222237309,CD2AP,Deletion,-,-,0.65,0.37,0.9,0.00924849,High,0.634,0.067,0.001,0.099,No significant pattern (p=0.027),Mild increase (p=0.034),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01073,rs726467,20,191357386,PICALM,SNP (G/T),(G/,G,0.84,0.5,1.04,0.08312243,Moderate,0.188,0.019,0.105,0.487,Mild increase (p=0.031),Variable effect (p=0.033),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01074,rs892289,1,119743238,CD33,Insertion,-,-,1.46,1.2,1.73,0.00680951,High,0.078,0.126,0.27,0.327,Significant decrease (p=0.049),Variable effect (p=0.042),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01075,rs900704,4,172707425,MS4A6A,SNP (A/T),(A/,A,2.47,2.21,2.72,0.03052232,Moderate,0.46,0.168,0.17,0.001,Mild decrease (p=0.032),Mild decrease (p=0.047),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01076,rs904002,14,18952077,EPHA1,SNP (C/T),(C/,C,1.19,0.83,1.53,0.00676497,Moderate,0.158,0.377,0.009,0.255,Mild increase (p=0.002),Significant decrease (p=0.023),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01077,rs599426,21,34364280,PSEN2,SNP (C/G),(C/,C,0.83,0.44,1.13,0.06931296,High,0.316,0.05,0.065,0.369,Mild decrease (p=0.035),No significant pattern (p=0.041),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01078,rs406877,12,31560839,BIN1,SNP (A/C),(A/,A,1.36,1.14,1.74,0.0659613,High,0.075,0.038,0.06,0.627,No significant pattern (p=0.003),Significant increase (p=0.03),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01079,rs987955,7,61081477,APOE,Insertion,-,-,0.43,0.12,0.7,0.02722603,High,0.045,0.693,0.055,0.007,Significant increase (p=0.032),Significant increase (p=0.049),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01080,rs898457,3,223501844,CD2AP,SNP (A/G),(A/,A,0.87,0.61,1.09,0.08306802,Moderate,0.028,0.05,0.487,0.234,No significant pattern (p=0.049),Significant increase (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01081,rs404280,18,50104328,CLU,SNP (A/G),(A/,A,0.74,0.42,0.98,0.08251075,Low,0.116,0.283,0.082,0.319,Variable effect (p=0.04),No significant pattern (p=0.045),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01082,rs658512,9,34808334,CD2AP,SNP (G/T),(G/,G,1.24,0.89,1.53,0.17055439,Low,0.533,0.112,0.07,0.084,Significant decrease (p=0.04),Significant increase (p=0.019),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01083,rs246088,11,124804123,ABCA7,Insertion,-,-,1.58,1.23,1.86,0.05216457,High,0.265,0.192,0.236,0.106,Variable effect (p=0.015),Variable effect (p=0.016),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01084,rs365596,13,183661354,EPHA1,SNP (A/C),(A/,A,0.9,0.64,1.22,0.12455615,Unknown,0.082,0.547,0.109,0.061,Significant decrease (p=0.048),Mild decrease (p=0.002),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01085,rs257426,15,54414338,PSEN2,Insertion,-,-,1.48,1.14,1.75,0.04175443,Moderate,0.108,0.095,0.042,0.555,Mild decrease (p=0.018),Mild increase (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01086,rs963362,19,188442690,EPHA1,SNP (A/C),(A/,A,0.94,0.6,1.15,0.00442938,Low,0.417,0.35,0.029,0.004,No significant pattern (p=0.01),Significant increase (p=0.022),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01087,rs265128,11,191714693,SORL1,Deletion,-,-,1.42,1.18,1.69,0.04316594,Protective,0.166,0.61,0.016,0.009,Significant increase (p=0.037),Significant decrease (p=0.029),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01088,rs334500,15,151893641,BIN1,SNP (A/T),(A/,A,1.06,0.76,1.45,0.05432049,Moderate,0.497,0.165,0.038,0.1,Mild increase (p=0.046),Significant decrease (p=0.036),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01089,rs959119,3,235291505,BIN1,SNP (C/T),(C/,C,0.35,0.1,0.68,0.06240751,High,0.226,0.442,0.094,0.038,Variable effect (p=0.041),Significant decrease (p=0.029),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01090,rs270156,12,161331076,PICALM,SNP (G/T),(G/,G,0.77,0.48,1.02,0.0249518,Low,0.345,0.252,0.025,0.178,Significant increase (p=0.015),No significant pattern (p=0.022),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP01091,rs720713,21,108019238,TREM2,SNP (A/G),(A/,A,1.89,1.63,2.23,0.02902758,Moderate,0.259,0.281,0.188,0.073,Mild increase (p=0.005),Significant decrease (p=0.007),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP01092,rs530463,8,149122653,CD2AP,SNP (A/C),(A/,A,0.4,0.1,0.74,0.06420382,Moderate,0.047,0.104,0.153,0.495,Mild decrease (p=0.026),Mild decrease (p=0.021),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01093,rs812936,13,212529203,CLU,Deletion,-,-,1.03,0.78,1.24,0.10480342,Moderate,0.345,0.207,0.046,0.202,Significant increase (p=0.016),Mild increase (p=0.014),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP01094,rs835525,4,27038041,BIN1,Insertion,-,-,0.38,0.17,0.69,0.03663671,Low,0.161,0.019,0.539,0.081,Significant decrease (p=0.033),Variable effect (p=0.001),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01095,rs860897,5,213213510,ABCA7,SNP (A/T),(A/,A,0.99,0.78,1.28,0.03797516,Moderate,0.102,0.092,0.408,0.199,Significant decrease (p=0.045),No significant pattern (p=0.048),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01096,rs319353,18,163861846,PTK2B,SNP (A/G),(A/,A,1.36,1.01,1.75,0.07399357,Low,0.577,0.078,0.049,0.096,Mild decrease (p=0.048),Variable effect (p=0.044),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01097,rs846089,22,133905530,ABCA7,SNP (C/T),(C/,C,0.81,0.52,1.16,0.02627315,Low,0.425,0.18,0.16,0.035,Significant decrease (p=0.011),No significant pattern (p=0.022),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01098,rs187220,16,42060611,CR1,SNP (A/T),(A/,A,1.17,0.81,1.39,0.00515119,Moderate,0.076,0.116,0.168,0.441,Mild increase (p=0.028),Variable effect (p=0.017),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01099,rs582234,4,134818812,PICALM,Deletion,-,-,1.06,0.68,1.42,0.01951374,Moderate,0.122,0.286,0.098,0.294,Mild decrease (p=0.041),Mild decrease (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP01100,rs742455,22,43982547,CD2AP,SNP (A/C),(A/,A,0.99,0.74,1.32,0.05788312,High,0.004,0.182,0.533,0.081,Mild decrease (p=0.029),Variable effect (p=0.009),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01101,rs262016,22,244287801,CD2AP,SNP (A/T),(A/,A,0.78,0.49,1.01,0.00084865,High,0.406,0.046,0.068,0.28,Significant decrease (p=0.027),Significant decrease (p=0.001),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01102,rs642449,21,46392064,BIN1,SNP (C/T),(C/,C,0.36,0.15,0.74,0.01423317,Moderate,0.517,0.265,0.009,0.009,Significant increase (p=0.027),No significant pattern (p=0.026),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01103,rs877901,16,89059260,TREM2,Deletion,-,-,0.71,0.44,1.1,0.04500654,High,0.089,0.315,0.337,0.059,No significant pattern (p=0.046),Mild decrease (p=0.013),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01104,rs282380,18,123522556,SORL1,SNP (A/T),(A/,A,3.24,2.89,3.6,0.04569864,Low,0.031,0.241,0.22,0.308,Significant increase (p=0.029),Variable effect (p=0.035),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01105,rs609964,18,79389248,PICALM,SNP (A/C),(A/,A,1.48,1.26,1.79,0.05515678,Moderate,0.397,0.142,0.177,0.085,Variable effect (p=0.011),No significant pattern (p=0.042),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01106,rs565365,12,81682743,EPHA1,SNP (G/T),(G/,G,0.73,0.48,1.06,0.00701915,High,0.461,0.006,0.049,0.284,No significant pattern (p=0.048),Significant increase (p=0.028),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01107,rs141546,17,32312413,ABCA7,SNP (A/G),(A/,A,0.54,0.22,0.81,0.04582256,Moderate,0.344,0.124,0.018,0.313,Significant decrease (p=0.021),Mild increase (p=0.044),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP01108,rs554641,14,87498666,CR1,SNP (C/G),(C/,C,1.45,1.25,1.76,0.04557019,High,0.434,0.336,0.019,0.011,No significant pattern (p=0.012),No significant pattern (p=0.01),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01109,rs905842,21,193611794,MS4A6A,SNP (A/C),(A/,A,1.57,1.32,1.95,0.02879179,Moderate,0.061,0.705,0.012,0.022,Significant decrease (p=0.036),No significant pattern (p=0.001),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01110,rs982698,11,203225726,CR1,SNP (C/G),(C/,C,1.11,0.87,1.41,0.07704685,High,0.444,0.059,0.08,0.217,No significant pattern (p=0.05),Significant decrease (p=0.008),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01111,rs758657,7,244433057,PSEN2,Deletion,-,-,1.55,1.16,1.89,0.00221172,Moderate,0.058,0.169,0.038,0.535,Variable effect (p=0.029),Mild increase (p=0.033),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01112,rs686402,22,119527574,CR1,Insertion,-,-,1.13,0.91,1.45,0.01233224,High,0.177,0.086,0.432,0.105,No significant pattern (p=0.003),Significant increase (p=0.013),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP01113,rs551015,15,112380937,PICALM,Deletion,-,-,3.72,3.4,4.04,0.11663393,High,0.051,0.439,0.144,0.165,Significant increase (p=0.032),No significant pattern (p=0.038),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01114,rs442674,8,189084046,PICALM,Insertion,-,-,0.26,0.1,0.51,0.01912113,Low,0.671,0.018,0.043,0.068,Variable effect (p=0.013),Significant increase (p=0.034),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01115,rs302363,17,236019258,MS4A6A,SNP (C/G),(C/,C,0.38,0.1,0.66,0.00506796,High,0.146,0.21,0.29,0.154,Mild increase (p=0.042),Mild decrease (p=0.023),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01116,rs418414,22,68651955,PSEN2,SNP (C/T),(C/,C,1.8,1.55,2.18,0.0027947,Low,0.248,0.318,0.23,0.005,Mild decrease (p=0.049),Mild decrease (p=0.048),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01117,rs448346,1,127750229,SORL1,SNP (C/G),(C/,C,0.42,0.14,0.63,0.00268921,Moderate,0.516,0.073,0.068,0.144,Significant increase (p=0.002),Variable effect (p=0.025),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01118,rs783794,11,245845369,MS4A6A,SNP (A/C),(A/,A,0.82,0.43,1.09,0.01303154,High,0.054,0.006,0.207,0.533,No significant pattern (p=0.005),Mild decrease (p=0.037),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP01119,rs192954,2,121488576,CD33,SNP (C/G),(C/,C,1.09,0.72,1.37,0.00033487,Moderate,0.029,0.32,0.115,0.336,No significant pattern (p=0.048),Significant increase (p=0.04),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01120,rs245938,7,230763809,PSEN2,SNP (A/T),(A/,A,2.79,2.4,3.03,0.01568124,Protective,0.152,0.019,0.047,0.581,Significant increase (p=0.007),Significant decrease (p=0.046),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP01121,rs451606,7,150177453,CR1,SNP (G/T),(G/,G,1.07,0.77,1.35,0.08726554,Moderate,0.096,0.008,0.365,0.331,Significant decrease (p=0.019),No significant pattern (p=0.017),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01122,rs311692,22,201163371,ABCA7,Insertion,-,-,0.88,0.6,1.25,0.03323401,Low,0.159,0.147,0.052,0.442,Mild increase (p=0.012),Mild increase (p=0.002),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01123,rs597344,17,217382395,ABCA7,SNP (A/C),(A/,A,1.65,1.38,1.9,0.07507684,Moderate,0.146,0.062,0.527,0.064,Significant increase (p=0.021),Significant increase (p=0.002),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01124,rs247655,7,94096136,CD33,Deletion,-,-,1.18,0.88,1.4,0.01944909,Moderate,0.062,0.12,0.315,0.303,Mild decrease (p=0.008),Significant decrease (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP01125,rs467795,13,98922651,APP,Insertion,-,-,1.62,1.39,1.84,0.01251017,Unknown,0.236,0.261,0.266,0.038,Variable effect (p=0.049),Significant increase (p=0.044),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01126,rs727621,3,159207690,SORL1,Insertion,-,-,1.21,0.9,1.43,0.01869017,Low,0.181,0.153,0.459,0.006,Mild decrease (p=0.045),No significant pattern (p=0.022),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP01127,rs686704,12,106303851,TREM2,Deletion,-,-,0.58,0.21,0.83,0.04165413,Unknown,0.083,0.398,0.142,0.177,Mild increase (p=0.002),Significant increase (p=0.027),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01128,rs667600,9,48440520,TREM2,Deletion,-,-,1.45,1.24,1.67,0.00025487,Low,0.253,0.077,0.226,0.244,Significant increase (p=0.02),Mild increase (p=0.02),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP01129,rs870914,22,44813569,CD33,SNP (C/T),(C/,C,1.7,1.42,1.9,0.0369723,High,0.077,0.498,0.022,0.202,No significant pattern (p=0.036),No significant pattern (p=0.043),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP01130,rs308807,1,228966033,CD2AP,SNP (A/T),(A/,A,0.71,0.46,0.95,0.02531016,Low,0.429,0.16,0.203,0.008,Variable effect (p=0.032),No significant pattern (p=0.02),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP01131,rs999604,13,142889333,PSEN2,SNP (G/T),(G/,G,1.4,1.14,1.64,0.05820388,Low,0.23,0.126,0.209,0.236,Variable effect (p=0.026),Variable effect (p=0.039),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP01132,rs657698,2,3802931,APOE,Insertion,-,-,0.8,0.46,1.05,0.06948518,High,0.444,0.063,0.004,0.289,No significant pattern (p=0.004),Variable effect (p=0.046),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01133,rs891819,7,24703882,SORL1,SNP (C/T),(C/,C,0.41,0.1,0.68,0.02540998,High,0.134,0.161,0.35,0.154,Significant decrease (p=0.026),No significant pattern (p=0.016),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01134,rs920915,12,145333195,ABCA7,SNP (A/C),(A/,A,1.27,0.89,1.56,0.06735782,High,0.027,0.496,0.155,0.123,Significant decrease (p=0.018),Mild increase (p=0.037),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01135,rs581751,17,6109484,CD33,Insertion,-,-,1.24,0.98,1.6,0.03575738,Low,0.365,0.112,0.262,0.061,Significant increase (p=0.037),Variable effect (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01136,rs893059,3,111056891,CLU,SNP (G/T),(G/,G,0.85,0.62,1.24,0.19378878,Moderate,0.056,0.061,0.607,0.076,Significant increase (p=0.018),No significant pattern (p=0.042),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01137,rs662173,18,151230303,BIN1,Insertion,-,-,1.64,1.3,1.86,0.00747765,Protective,0.094,0.401,0.212,0.093,Variable effect (p=0.026),No significant pattern (p=0.041),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01138,rs905421,21,23104812,EPHA1,SNP (A/C),(A/,A,0.51,0.22,0.72,0.00026817,High,0.341,0.1,0.063,0.296,Mild decrease (p=0.009),Mild decrease (p=0.039),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01139,rs827406,22,178955485,MS4A6A,SNP (A/G),(A/,A,1.11,0.88,1.5,0.00122015,Moderate,0.014,0.4,0.136,0.25,No significant pattern (p=0.033),No significant pattern (p=0.035),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01140,rs135540,6,247648329,EPHA1,SNP (C/T),(C/,C,0.67,0.37,1.02,0.00516023,Protective,0.538,0.044,0.101,0.118,No significant pattern (p=0.009),Significant decrease (p=0.04),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01141,rs367736,20,229866862,APOE,SNP (C/T),(C/,C,1.33,1.06,1.63,0.0001254,High,0.411,0.011,0.023,0.355,Significant decrease (p=0.002),No significant pattern (p=0.018),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP01142,rs210859,19,119875519,APP,Deletion,-,-,0.79,0.4,0.99,0.00276527,Moderate,0.388,0.011,0.079,0.322,No significant pattern (p=0.027),Significant decrease (p=0.015),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01143,rs438718,18,244896903,PSEN2,Deletion,-,-,3.8,3.54,4.17,0.00073973,Low,0.028,0.246,0.055,0.47,Variable effect (p=0.042),Significant decrease (p=0.031),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01144,rs389282,13,143598542,CLU,SNP (G/T),(G/,G,1.76,1.37,1.99,0.00544856,Low,0.06,0.214,0.132,0.394,Significant increase (p=0.026),Mild increase (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01145,rs277540,10,8167743,ABCA7,SNP (A/G),(A/,A,1.2,0.84,1.41,0.00954433,Low,0.027,0.24,0.403,0.13,No significant pattern (p=0.048),Significant decrease (p=0.006),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01146,rs166349,21,150758397,PTK2B,SNP (A/G),(A/,A,0.8,0.44,1.08,0.00442228,Protective,0.12,0.49,0.149,0.041,Mild decrease (p=0.037),Mild increase (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01147,rs718964,5,93945319,EPHA1,SNP (C/G),(C/,C,2.16,1.82,2.36,0.0564959,Protective,0.019,0.378,0.054,0.349,Variable effect (p=0.047),Significant increase (p=0.045),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP01148,rs962149,20,103891882,CD33,SNP (A/T),(A/,A,0.38,0.1,0.67,0.0803717,Moderate,0.125,0.643,0.029,0.003,Significant increase (p=0.041),Mild decrease (p=0.004),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01149,rs884219,16,236426749,APOE,SNP (C/G),(C/,C,1.69,1.36,1.91,0.05331676,Moderate,0.14,0.258,0.315,0.088,Mild decrease (p=0.016),No significant pattern (p=0.02),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01150,rs314770,4,35825201,PSEN2,SNP (C/G),(C/,C,0.93,0.62,1.29,0.02359327,Unknown,0.009,0.236,0.026,0.529,Mild increase (p=0.021),Mild increase (p=0.005),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP01151,rs961421,16,97300434,APP,SNP (A/C),(A/,A,1.14,0.82,1.45,0.00302949,Low,0.184,0.32,0.269,0.028,Significant decrease (p=0.044),Mild decrease (p=0.039),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP01152,rs696601,14,194485209,CD33,SNP (A/C),(A/,A,1.01,0.7,1.23,0.00522739,Low,0.429,0.127,0.055,0.189,Variable effect (p=0.015),No significant pattern (p=0.019),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01153,rs485277,12,208443492,PICALM,Insertion,-,-,2.69,2.44,3.02,0.01168101,High,0.335,0.002,0.202,0.261,Significant increase (p=0.012),Significant increase (p=0.043),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01154,rs213928,21,151237672,CLU,SNP (C/G),(C/,C,2.09,1.83,2.45,0.04028924,Moderate,0.15,0.338,0.181,0.131,Variable effect (p=0.037),Significant increase (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01155,rs919849,20,193886978,MS4A6A,SNP (C/T),(C/,C,0.28,0.1,0.63,0.03979512,Low,0.07,0.611,0.053,0.066,No significant pattern (p=0.012),Significant increase (p=0.032),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP01156,rs226199,16,9769581,CLU,SNP (A/T),(A/,A,2.6,2.24,2.91,0.00462628,Moderate,0.102,0.273,0.31,0.115,Mild increase (p=0.008),No significant pattern (p=0.017),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01157,rs292839,17,124568586,APP,Deletion,-,-,1.5,1.15,1.72,0.12164217,Moderate,0.084,0.538,0.074,0.105,Mild decrease (p=0.026),Significant decrease (p=0.014),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP01158,rs559737,8,52189828,APOE,Insertion,-,-,1.17,0.95,1.48,0.01221859,Low,0.384,0.135,0.224,0.057,Mild increase (p=0.034),Significant increase (p=0.002),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP01159,rs384630,16,161443856,SORL1,Deletion,-,-,1.14,0.93,1.49,0.07196757,Moderate,0.124,0.002,0.005,0.669,No significant pattern (p=0.032),Mild increase (p=0.005),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01160,rs592029,18,241631801,BIN1,SNP (C/T),(C/,C,0.59,0.32,0.91,0.08621991,High,0.516,0.068,0.032,0.184,Significant increase (p=0.009),Mild increase (p=0.007),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01161,rs780999,4,101108042,MS4A6A,SNP (A/C),(A/,A,1.62,1.41,1.87,0.02197494,High,0.069,0.389,0.232,0.109,Significant increase (p=0.025),Mild decrease (p=0.032),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01162,rs260345,18,174238020,BIN1,SNP (C/T),(C/,C,1.22,0.9,1.57,0.04984379,Moderate,0.04,0.346,0.012,0.402,Mild decrease (p=0.032),Variable effect (p=0.014),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP01163,rs308495,4,138140851,APOE,SNP (A/G),(A/,A,0.57,0.32,0.83,0.03578471,High,0.126,0.205,0.292,0.176,Variable effect (p=0.017),Significant increase (p=0.019),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01164,rs838410,19,65232677,PICALM,SNP (G/T),(G/,G,1.29,0.99,1.54,0.05134812,Low,0.62,0.01,0.034,0.136,Mild decrease (p=0.018),Variable effect (p=0.041),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01165,rs449503,11,220258295,APOE,SNP (C/G),(C/,C,0.74,0.5,1.1,0.01568103,Moderate,0.495,0.125,0.045,0.134,Mild increase (p=0.028),Mild decrease (p=0.013),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01166,rs628512,1,247511498,TREM2,Insertion,-,-,1.38,1.11,1.78,0.04029614,Moderate,0.161,0.159,0.15,0.33,Mild decrease (p=0.047),Variable effect (p=0.004),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01167,rs762840,11,74524799,PTK2B,SNP (A/T),(A/,A,1.48,1.11,1.68,0.00314565,High,0.021,0.458,0.282,0.039,Significant increase (p=0.019),Significant increase (p=0.024),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01168,rs384029,14,81775173,ABCA7,SNP (G/T),(G/,G,0.83,0.47,1.17,0.00872101,High,0.092,0.451,0.123,0.134,Variable effect (p=0.006),Significant increase (p=0.01),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01169,rs882959,2,182178983,MS4A6A,Deletion,-,-,1.07,0.84,1.27,0.01093847,Low,0.176,0.054,0.49,0.081,Variable effect (p=0.036),Variable effect (p=0.006),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01170,rs344581,21,107475082,TREM2,SNP (A/T),(A/,A,3.15,2.83,3.44,0.03150846,High,0.489,0.048,0.203,0.061,Significant increase (p=0.017),Mild decrease (p=0.036),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01171,rs487509,6,51329946,APP,SNP (G/T),(G/,G,0.92,0.69,1.26,0.01867199,High,0.214,0.273,0.133,0.181,Variable effect (p=0.034),Mild decrease (p=0.007),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01172,rs412331,1,217951251,APP,SNP (C/G),(C/,C,1.05,0.78,1.33,0.01825635,Moderate,0.538,0.048,0.205,0.01,Mild decrease (p=0.038),Variable effect (p=0.006),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01173,rs681635,16,209116160,BIN1,SNP (G/T),(G/,G,1.7,1.34,2.03,0.06097117,Moderate,0.001,0.505,0.1,0.194,Mild increase (p=0.023),Variable effect (p=0.038),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01174,rs452313,17,223141242,CR1,Deletion,-,-,0.9,0.5,1.25,0.00947405,Moderate,0.145,0.362,0.257,0.036,Variable effect (p=0.013),Mild increase (p=0.044),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01175,rs664025,17,23632258,APOE,SNP (A/G),(A/,A,0.62,0.29,0.94,0.01723643,Low,0.028,0.368,0.3,0.104,No significant pattern (p=0.025),No significant pattern (p=0.024),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01176,rs990438,4,27787096,PICALM,SNP (A/T),(A/,A,1.01,0.75,1.3,0.02084087,Low,0.199,0.364,0.177,0.06,No significant pattern (p=0.004),Significant increase (p=0.009),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01177,rs226970,14,1603230,BIN1,Deletion,-,-,1.83,1.48,2.19,0.04943974,High,0.177,0.094,0.408,0.12,Variable effect (p=0.025),Mild increase (p=0.025),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01178,rs891183,6,213842111,CD33,SNP (A/C),(A/,A,2.14,1.91,2.4,0.00058431,High,0.268,0.297,0.184,0.052,Mild increase (p=0.031),Variable effect (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01179,rs176842,17,162962062,MS4A6A,SNP (C/T),(C/,C,2.73,2.45,3.1,0.00056281,Moderate,0.451,0.166,0.078,0.105,No significant pattern (p=0.023),Significant increase (p=0.021),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01180,rs278541,19,118028911,BIN1,SNP (A/T),(A/,A,0.52,0.15,0.84,0.03089854,Low,0.309,0.076,0.294,0.12,Significant increase (p=0.031),Significant decrease (p=0.003),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01181,rs546561,4,127933639,BIN1,Insertion,-,-,1.55,1.28,1.89,0.10185249,Low,0.139,0.285,0.045,0.332,Mild decrease (p=0.037),Mild decrease (p=0.005),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP01182,rs741928,7,147686945,CD33,Deletion,-,-,1.18,0.87,1.45,0.05036461,Moderate,0.073,0.381,0.156,0.19,Mild decrease (p=0.018),Significant decrease (p=0.014),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01183,rs457415,7,57870105,CR1,SNP (G/T),(G/,G,1.64,1.36,1.89,0.02630713,High,0.019,0.543,0.058,0.18,Mild increase (p=0.007),Mild increase (p=0.048),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01184,rs356235,11,116915312,BIN1,SNP (C/G),(C/,C,0.57,0.19,0.92,0.01663129,High,0.063,0.354,0.071,0.312,Significant increase (p=0.003),Mild increase (p=0.025),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01185,rs932207,14,131438900,TREM2,SNP (A/C),(A/,A,0.9,0.62,1.1,0.02009993,High,0.174,0.254,0.008,0.364,Variable effect (p=0.039),Mild decrease (p=0.035),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01186,rs911283,22,103343151,APP,SNP (A/T),(A/,A,0.31,0.1,0.55,0.02824768,Protective,0.111,0.016,0.19,0.482,Significant decrease (p=0.027),Significant increase (p=0.013),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01187,rs224103,18,65223375,PTK2B,SNP (C/T),(C/,C,1.06,0.79,1.43,0.05553316,Protective,0.054,0.293,0.428,0.026,Variable effect (p=0.049),Mild increase (p=0.017),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP01188,rs864272,21,184161945,PTK2B,SNP (A/G),(A/,A,1.66,1.39,1.93,0.03132962,High,0.038,0.286,0.466,0.01,Variable effect (p=0.047),Mild decrease (p=0.018),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01189,rs617815,14,236429746,ABCA7,Deletion,-,-,0.49,0.14,0.87,0.02239517,Protective,0.267,0.06,0.128,0.346,Mild decrease (p=0.002),Significant increase (p=0.001),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01190,rs279706,9,67760007,PSEN2,SNP (A/C),(A/,A,1.11,0.85,1.45,0.01435641,High,0.093,0.099,0.201,0.407,Mild decrease (p=0.009),Significant decrease (p=0.014),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP01191,rs517525,11,38289038,EPHA1,SNP (A/T),(A/,A,1.48,1.25,1.79,0.00383669,Low,0.014,0.137,0.579,0.07,Significant decrease (p=0.019),Variable effect (p=0.043),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP01192,rs753930,19,13601697,TREM2,SNP (A/T),(A/,A,0.67,0.31,1.01,0.00624802,Low,0.106,0.237,0.129,0.329,Variable effect (p=0.026),No significant pattern (p=0.044),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01193,rs599546,10,234900763,ABCA7,SNP (C/T),(C/,C,1.78,1.48,2.06,0.03798351,Moderate,0.166,0.061,0.57,0.004,Mild decrease (p=0.04),Significant increase (p=0.01),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01194,rs378497,11,201701616,ABCA7,Deletion,-,-,1.12,0.74,1.47,0.01497066,High,0.359,0.336,0.01,0.095,Significant increase (p=0.018),Variable effect (p=0.004),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01195,rs681635,9,55485348,CD2AP,SNP (C/G),(C/,C,1.49,1.18,1.7,0.01822723,Moderate,0.068,0.142,0.342,0.248,Variable effect (p=0.01),Mild decrease (p=0.016),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01196,rs125346,20,191454758,CD2AP,SNP (A/T),(A/,A,1.05,0.85,1.3,0.07501447,High,0.122,0.394,0.229,0.054,Mild increase (p=0.016),Significant decrease (p=0.022),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01197,rs289250,7,206362959,BIN1,SNP (A/G),(A/,A,1.31,1.05,1.59,0.02822165,Unknown,0.277,0.218,0.259,0.047,Significant decrease (p=0.025),Mild increase (p=0.022),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01198,rs908188,19,55539045,APOE,SNP (C/G),(C/,C,1.0,0.68,1.39,0.00855108,High,0.185,0.256,0.205,0.153,Variable effect (p=0.017),Significant increase (p=0.022),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01199,rs408616,15,170945286,PTK2B,SNP (C/T),(C/,C,1.01,0.73,1.39,0.02086102,Low,0.205,0.093,0.326,0.176,Mild increase (p=0.005),Mild increase (p=0.013),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01200,rs291744,1,171868610,PSEN2,SNP (A/T),(A/,A,1.64,1.37,2.01,0.03014594,High,0.043,0.367,0.233,0.156,No significant pattern (p=0.001),No significant pattern (p=0.024),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01201,rs883553,16,106511649,PICALM,SNP (G/T),(G/,G,0.9,0.55,1.13,0.05190604,Moderate,0.526,0.094,0.148,0.031,Variable effect (p=0.026),Significant increase (p=0.01),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01202,rs858656,14,37273780,CR1,Deletion,-,-,2.61,2.39,2.97,0.0595868,Moderate,0.34,0.212,0.07,0.178,Significant decrease (p=0.025),Mild decrease (p=0.007),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01203,rs428989,4,226646349,PSEN2,SNP (C/G),(C/,C,1.12,0.78,1.38,1.183e-05,Low,0.262,0.002,0.314,0.222,No significant pattern (p=0.01),No significant pattern (p=0.036),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01204,rs611962,20,218808403,CD2AP,SNP (A/T),(A/,A,1.91,1.59,2.15,0.00310783,Moderate,0.09,0.282,0.299,0.128,Mild decrease (p=0.044),Significant increase (p=0.027),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01205,rs437626,13,168995600,PSEN2,SNP (G/T),(G/,G,1.17,0.77,1.41,0.04283836,High,0.151,0.356,0.267,0.026,Significant increase (p=0.042),No significant pattern (p=0.022),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01206,rs632915,17,114156800,CD33,SNP (A/C),(A/,A,0.56,0.27,0.9,0.02814362,Moderate,0.053,0.469,0.031,0.247,No significant pattern (p=0.035),Significant increase (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01207,rs882266,3,112142698,APP,Deletion,-,-,1.02,0.81,1.35,0.00212828,Moderate,0.077,0.212,0.3,0.212,Significant decrease (p=0.007),No significant pattern (p=0.012),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01208,rs489708,7,94230410,PICALM,SNP (A/C),(A/,A,0.97,0.77,1.36,0.05541887,High,0.389,0.257,0.044,0.11,Mild increase (p=0.024),Mild increase (p=0.045),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01209,rs198922,20,185957713,PSEN2,SNP (A/G),(A/,A,0.85,0.63,1.07,0.08385314,Low,0.144,0.054,0.007,0.595,Significant increase (p=0.021),No significant pattern (p=0.026),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01210,rs481540,13,55051493,MS4A6A,SNP (A/G),(A/,A,0.61,0.38,0.84,0.0102991,High,0.051,0.156,0.47,0.123,Mild decrease (p=0.036),Mild increase (p=0.038),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01211,rs297180,22,16718014,CD2AP,SNP (A/T),(A/,A,0.73,0.4,0.96,0.02439824,Low,0.33,0.237,0.228,0.004,Mild decrease (p=0.042),Mild increase (p=0.032),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01212,rs563477,11,142335969,CD2AP,SNP (A/T),(A/,A,1.01,0.69,1.28,0.01273404,Low,0.167,0.087,0.352,0.194,No significant pattern (p=0.01),Mild decrease (p=0.035),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01213,rs109205,13,218276049,EPHA1,SNP (A/G),(A/,A,1.07,0.81,1.37,0.00176317,Moderate,0.442,0.055,0.071,0.232,Variable effect (p=0.045),Variable effect (p=0.005),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01214,rs351200,3,200171801,PICALM,SNP (G/T),(G/,G,0.29,0.1,0.68,0.10544145,Unknown,0.09,0.437,0.239,0.033,Significant increase (p=0.026),Variable effect (p=0.046),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01215,rs192757,21,89910345,CD2AP,Deletion,-,-,0.83,0.5,1.15,0.0137394,Low,0.162,0.298,0.106,0.234,Significant decrease (p=0.019),No significant pattern (p=0.032),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01216,rs786858,22,221114043,EPHA1,Insertion,-,-,0.64,0.28,0.98,0.02367038,High,0.348,0.092,0.315,0.045,Significant increase (p=0.034),Mild increase (p=0.011),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01217,rs628888,5,196916109,APP,Insertion,-,-,1.35,0.98,1.7,0.00026824,Moderate,0.004,0.081,0.497,0.218,Mild decrease (p=0.042),Mild decrease (p=0.011),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01218,rs168790,1,59189591,MS4A6A,Insertion,-,-,1.02,0.74,1.3,0.08075855,Protective,0.126,0.024,0.52,0.131,Mild decrease (p=0.023),Mild increase (p=0.021),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01219,rs229583,21,10454897,EPHA1,Deletion,-,-,0.53,0.25,0.83,0.01408574,Moderate,0.186,0.333,0.029,0.252,Significant increase (p=0.036),Significant decrease (p=0.034),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01220,rs750471,14,145455237,APOE,Insertion,-,-,0.67,0.45,0.93,0.04186966,Moderate,0.478,0.05,0.157,0.114,No significant pattern (p=0.04),Mild decrease (p=0.019),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01221,rs764537,21,177415023,ABCA7,SNP (G/T),(G/,G,1.12,0.77,1.49,0.00920357,Low,0.167,0.317,0.217,0.1,Significant decrease (p=0.004),Variable effect (p=0.02),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01222,rs496588,18,63710862,BIN1,Insertion,-,-,0.45,0.22,0.74,0.02118248,Low,0.037,0.644,0.075,0.044,Significant decrease (p=0.005),Mild increase (p=0.014),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP01223,rs150983,17,60678411,PSEN2,Insertion,-,-,2.78,2.48,3.01,0.0368605,Low,0.016,0.143,0.613,0.028,No significant pattern (p=0.044),No significant pattern (p=0.045),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01224,rs685647,9,128222553,CR1,Deletion,-,-,1.59,1.3,1.83,0.03783859,Moderate,0.14,0.132,0.408,0.12,Mild decrease (p=0.017),Mild increase (p=0.035),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01225,rs986568,13,74564795,APOE,Insertion,-,-,1.25,0.96,1.53,0.01691834,High,0.52,0.088,0.06,0.132,No significant pattern (p=0.019),Significant increase (p=0.015),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01226,rs294917,7,8250237,PTK2B,Insertion,-,-,1.58,1.21,1.91,0.05992053,Moderate,0.157,0.585,0.034,0.025,Mild decrease (p=0.01),No significant pattern (p=0.026),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01227,rs642473,3,7515208,PSEN2,SNP (A/T),(A/,A,0.83,0.61,1.07,0.064947,Low,0.293,0.127,0.234,0.146,No significant pattern (p=0.031),Variable effect (p=0.038),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP01228,rs475729,14,161162586,PTK2B,Deletion,-,-,0.55,0.34,0.85,0.00023178,High,0.03,0.106,0.002,0.663,Mild increase (p=0.013),Significant increase (p=0.026),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01229,rs597789,20,134518925,TREM2,SNP (G/T),(G/,G,0.83,0.45,1.17,0.00876233,High,0.051,0.266,0.289,0.193,Significant decrease (p=0.036),Mild decrease (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01230,rs193684,10,147512606,PTK2B,SNP (G/T),(G/,G,0.82,0.47,1.19,0.02286838,High,0.592,0.072,0.057,0.079,No significant pattern (p=0.013),Significant decrease (p=0.002),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP01231,rs523802,5,72700691,CLU,SNP (C/G),(C/,C,1.42,1.16,1.7,0.12256093,High,0.011,0.486,0.113,0.19,Mild increase (p=0.027),Significant increase (p=0.044),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP01232,rs155070,2,71709754,APOE,SNP (C/G),(C/,C,0.91,0.59,1.23,0.02297633,High,0.302,0.447,0.01,0.04,Mild increase (p=0.024),Variable effect (p=0.028),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01233,rs660792,14,14997399,BIN1,SNP (C/G),(C/,C,1.16,0.79,1.47,0.00620234,Unknown,0.368,0.119,0.166,0.146,Mild increase (p=0.044),Significant decrease (p=0.05),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP01234,rs855731,18,77234616,PSEN2,SNP (A/G),(A/,A,0.58,0.23,0.94,0.0416684,Moderate,0.114,0.043,0.394,0.249,Mild increase (p=0.012),Mild increase (p=0.025),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01235,rs517318,1,174147005,APOE,Deletion,-,-,1.07,0.71,1.28,0.03623388,Moderate,0.107,0.248,0.27,0.175,No significant pattern (p=0.031),Mild decrease (p=0.009),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01236,rs748988,22,178805497,TREM2,Deletion,-,-,0.66,0.45,0.99,0.02013009,High,0.665,0.042,0.016,0.077,Mild decrease (p=0.037),Mild increase (p=0.038),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01237,rs969020,15,75151836,CD2AP,SNP (C/T),(C/,C,0.6,0.32,0.96,0.00039693,Moderate,0.265,0.254,0.243,0.038,Significant increase (p=0.017),Mild decrease (p=0.021),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP01238,rs215727,8,221630754,TREM2,Deletion,-,-,1.04,0.81,1.28,0.04753235,High,0.083,0.101,0.191,0.425,Mild increase (p=0.002),Mild increase (p=0.009),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01239,rs293338,6,42117205,CR1,SNP (A/C),(A/,A,0.89,0.64,1.1,0.00040966,High,0.065,0.128,0.281,0.327,Mild decrease (p=0.002),Mild decrease (p=0.03),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01240,rs243477,16,122884408,PTK2B,SNP (A/T),(A/,A,0.69,0.41,1.02,0.01814684,Moderate,0.489,0.037,0.029,0.245,Variable effect (p=0.022),Significant increase (p=0.044),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01241,rs730041,3,21744371,APOE,SNP (A/T),(A/,A,0.81,0.6,1.14,0.01094308,Low,0.166,0.131,0.26,0.243,No significant pattern (p=0.015),Mild decrease (p=0.038),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01242,rs552759,4,180613906,CD2AP,Insertion,-,-,0.45,0.1,0.72,0.01663826,Moderate,0.047,0.432,0.08,0.241,Variable effect (p=0.041),Significant decrease (p=0.003),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01243,rs231565,5,36543853,MS4A6A,Deletion,-,-,0.45,0.25,0.78,0.02265002,Moderate,0.145,0.233,0.217,0.205,Significant increase (p=0.028),Mild increase (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01244,rs250913,6,51827977,CLU,SNP (C/G),(C/,C,1.22,0.96,1.52,0.028279,High,0.299,0.187,0.253,0.062,Significant increase (p=0.042),Mild increase (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01245,rs108334,17,173759617,APP,Insertion,-,-,1.86,1.56,2.11,0.10865571,Low,0.457,0.24,0.091,0.012,Mild decrease (p=0.009),Variable effect (p=0.011),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01246,rs487301,13,159154501,TREM2,SNP (C/G),(C/,C,1.26,0.93,1.64,0.0156494,High,0.087,0.429,0.048,0.236,Mild decrease (p=0.041),Variable effect (p=0.028),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01247,rs241319,21,168090115,PTK2B,SNP (C/G),(C/,C,0.62,0.27,0.84,0.01016332,Low,0.415,0.043,0.009,0.333,Significant decrease (p=0.004),Mild decrease (p=0.043),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01248,rs425123,18,223143319,ABCA7,SNP (A/C),(A/,A,0.53,0.23,0.85,0.02013702,Moderate,0.291,0.016,0.042,0.451,Significant decrease (p=0.01),Significant decrease (p=0.018),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01249,rs267234,16,197401416,CD33,SNP (A/C),(A/,A,0.74,0.45,0.99,0.05437342,Low,0.371,0.318,0.085,0.027,Significant decrease (p=0.037),Variable effect (p=0.043),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01250,rs212909,12,220635115,APOE,SNP (A/T),(A/,A,0.55,0.29,0.87,0.07622808,Moderate,0.334,0.087,0.213,0.166,Mild decrease (p=0.009),Significant decrease (p=0.043),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01251,rs745480,9,4444583,CR1,SNP (A/G),(A/,A,1.05,0.84,1.32,0.06222649,Moderate,0.149,0.4,0.013,0.238,Mild decrease (p=0.002),Variable effect (p=0.006),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01252,rs239921,4,4372880,ABCA7,SNP (A/C),(A/,A,0.96,0.62,1.35,0.0203588,Protective,0.238,0.061,0.348,0.153,Significant decrease (p=0.005),Variable effect (p=0.034),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01253,rs146661,6,131759562,MS4A6A,Insertion,-,-,0.58,0.26,0.8,0.02376066,High,0.094,0.159,0.113,0.434,Mild decrease (p=0.049),Variable effect (p=0.017),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01254,rs522700,22,228941128,SORL1,Insertion,-,-,0.88,0.65,1.27,0.03809828,High,0.09,0.037,0.021,0.652,Variable effect (p=0.023),Mild decrease (p=0.014),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01255,rs542469,2,165957884,PSEN2,SNP (C/G),(C/,C,0.65,0.35,1.04,0.02258859,High,0.274,0.255,0.143,0.128,Variable effect (p=0.045),No significant pattern (p=0.04),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01256,rs309594,1,23289603,CR1,SNP (C/T),(C/,C,1.95,1.72,2.33,0.00483228,Unknown,0.522,0.03,0.164,0.084,Significant increase (p=0.018),Mild increase (p=0.009),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP01257,rs134464,13,28816394,APP,Deletion,-,-,0.62,0.39,0.83,0.01608414,High,0.239,0.013,0.191,0.358,Mild decrease (p=0.033),No significant pattern (p=0.021),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01258,rs735831,20,203105081,APOE,SNP (A/T),(A/,A,0.78,0.47,1.17,0.00166919,High,0.102,0.287,0.194,0.217,Significant increase (p=0.028),Variable effect (p=0.025),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01259,rs131912,8,14410066,CR1,Insertion,-,-,1.1,0.82,1.39,0.0052592,Moderate,0.121,0.293,0.336,0.05,Mild increase (p=0.038),Significant decrease (p=0.037),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01260,rs250545,16,70471304,CD2AP,SNP (C/G),(C/,C,1.24,0.92,1.53,0.06851662,Moderate,0.534,0.142,0.07,0.054,Mild increase (p=0.022),Significant decrease (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP01261,rs478559,15,233689171,EPHA1,SNP (A/G),(A/,A,2.35,2.1,2.68,0.0720689,High,0.479,0.056,0.099,0.166,Mild increase (p=0.044),Mild increase (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01262,rs509742,19,231888108,PSEN2,Insertion,-,-,0.78,0.4,1.01,0.0046786,Moderate,0.304,0.007,0.081,0.408,Variable effect (p=0.047),Variable effect (p=0.024),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01263,rs888429,6,226880204,CLU,SNP (C/G),(C/,C,0.9,0.62,1.14,0.03242458,High,0.249,0.167,0.287,0.097,Mild decrease (p=0.048),No significant pattern (p=0.023),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP01264,rs392818,8,87946231,CD2AP,Insertion,-,-,0.82,0.59,1.21,0.04104473,Moderate,0.08,0.005,0.143,0.573,No significant pattern (p=0.027),No significant pattern (p=0.05),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP01265,rs781004,22,240794157,CD33,SNP (C/T),(C/,C,1.01,0.73,1.23,0.02119093,High,0.107,0.334,0.301,0.058,Mild increase (p=0.026),No significant pattern (p=0.047),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP01266,rs367442,10,74379943,BIN1,Insertion,-,-,0.45,0.15,0.84,0.04085637,Moderate,0.08,0.249,0.412,0.059,Significant increase (p=0.046),Variable effect (p=0.027),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01267,rs624328,16,87537652,PICALM,SNP (G/T),(G/,G,0.75,0.44,1.07,0.08904468,Low,0.112,0.06,0.213,0.414,No significant pattern (p=0.031),Variable effect (p=0.028),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01268,rs712945,17,53616079,CLU,Deletion,-,-,0.71,0.38,1.03,0.04637723,Low,0.014,0.162,0.614,0.01,Significant increase (p=0.014),Mild increase (p=0.028),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01269,rs986049,18,215873594,SORL1,SNP (G/T),(G/,G,2.47,2.22,2.71,0.02665395,High,0.155,0.262,0.316,0.067,Mild increase (p=0.023),Significant increase (p=0.025),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01270,rs953646,6,47581101,MS4A6A,SNP (A/C),(A/,A,0.99,0.67,1.19,0.02675338,Low,0.189,0.332,0.134,0.144,No significant pattern (p=0.025),Variable effect (p=0.048),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01271,rs433802,6,14622323,MS4A6A,Deletion,-,-,0.76,0.51,0.98,0.01216121,Moderate,0.05,0.134,0.259,0.358,Mild increase (p=0.011),Mild decrease (p=0.011),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01272,rs811866,1,197929479,PTK2B,Deletion,-,-,1.48,1.13,1.8,0.03523106,Moderate,0.188,0.324,0.191,0.097,Significant decrease (p=0.049),Significant increase (p=0.015),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01273,rs990084,14,196370491,SORL1,Insertion,-,-,1.69,1.33,2.03,0.113746,Protective,0.041,0.267,0.195,0.297,Significant increase (p=0.045),Significant increase (p=0.027),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP01274,rs771749,5,135174522,APP,Deletion,-,-,0.98,0.63,1.31,0.05276172,Low,0.259,0.08,0.221,0.239,Mild increase (p=0.048),Significant increase (p=0.029),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01275,rs498017,7,155213799,CD33,SNP (C/G),(C/,C,1.03,0.7,1.25,0.00440399,Moderate,0.102,0.298,0.391,0.01,Significant increase (p=0.021),Significant decrease (p=0.005),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01276,rs662963,6,180240310,TREM2,SNP (A/T),(A/,A,1.74,1.47,2.14,0.02876584,Protective,0.051,0.16,0.421,0.168,No significant pattern (p=0.006),Variable effect (p=0.002),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01277,rs991253,22,67903971,PTK2B,SNP (C/G),(C/,C,0.61,0.27,0.89,0.03709705,Moderate,0.192,0.097,0.122,0.389,No significant pattern (p=0.006),Significant decrease (p=0.016),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01278,rs913232,11,245527280,EPHA1,Insertion,-,-,1.26,0.95,1.53,0.01393504,Moderate,0.025,0.531,0.12,0.124,Variable effect (p=0.031),Significant increase (p=0.003),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01279,rs317152,16,219060793,PTK2B,Deletion,-,-,1.41,1.05,1.65,0.0034708,Low,0.011,0.359,0.078,0.352,Significant increase (p=0.013),Variable effect (p=0.01),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01280,rs277512,21,238617464,PSEN2,SNP (C/T),(C/,C,1.33,0.98,1.67,0.02140563,Moderate,0.277,0.246,0.022,0.255,Significant decrease (p=0.029),Mild increase (p=0.042),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01281,rs768238,16,59387080,TREM2,SNP (C/G),(C/,C,1.32,1.09,1.59,0.00384608,Moderate,0.539,0.074,0.181,0.006,Mild increase (p=0.023),No significant pattern (p=0.002),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01282,rs195532,1,89429233,CD33,SNP (G/T),(G/,G,0.45,0.1,0.67,0.00855663,High,0.054,0.211,0.307,0.227,Significant increase (p=0.044),Mild increase (p=0.046),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP01283,rs905766,13,10443391,MS4A6A,SNP (A/C),(A/,A,1.16,0.77,1.43,0.01533764,Moderate,0.155,0.179,0.44,0.026,Significant increase (p=0.049),Mild increase (p=0.023),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01284,rs911563,18,65754648,CD33,SNP (A/T),(A/,A,0.87,0.53,1.24,0.01025671,Moderate,0.03,0.343,0.174,0.253,Mild decrease (p=0.021),No significant pattern (p=0.027),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01285,rs878713,14,186162040,CLU,SNP (G/T),(G/,G,1.45,1.12,1.65,0.11970947,Moderate,0.251,0.009,0.102,0.438,Significant decrease (p=0.023),Significant increase (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP01286,rs850383,19,140185644,EPHA1,SNP (A/G),(A/,A,2.78,2.4,3.07,0.01413985,Low,0.229,0.017,0.183,0.371,Mild decrease (p=0.026),Significant increase (p=0.047),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01287,rs133381,20,118261819,PICALM,SNP (C/G),(C/,C,0.64,0.33,0.86,0.00356066,High,0.448,0.1,0.225,0.027,Variable effect (p=0.039),Variable effect (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01288,rs592011,5,35534514,MS4A6A,SNP (C/T),(C/,C,1.0,0.8,1.29,0.10556137,Moderate,0.009,0.132,0.057,0.601,No significant pattern (p=0.033),Significant increase (p=0.031),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01289,rs454755,19,190842803,PSEN2,SNP (G/T),(G/,G,1.51,1.23,1.85,0.05987406,High,0.46,0.063,0.068,0.208,Significant decrease (p=0.048),Significant decrease (p=0.021),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01290,rs158639,20,191430804,CLU,SNP (A/T),(A/,A,1.23,0.94,1.54,0.01424982,Moderate,0.165,0.012,0.12,0.503,Variable effect (p=0.032),Significant decrease (p=0.034),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP01291,rs313690,10,225711247,SORL1,SNP (C/G),(C/,C,1.34,1.0,1.67,0.02866842,Protective,0.025,0.114,0.349,0.313,Significant decrease (p=0.027),No significant pattern (p=0.022),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP01292,rs635252,21,175828980,EPHA1,SNP (C/G),(C/,C,1.22,0.86,1.51,0.05531483,Moderate,0.323,0.127,0.332,0.019,Significant decrease (p=0.012),Mild increase (p=0.043),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP01293,rs926564,17,206331766,APOE,Insertion,-,-,1.67,1.42,1.95,0.10217101,High,0.131,0.345,0.151,0.173,Mild decrease (p=0.05),Mild increase (p=0.047),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01294,rs515520,12,8243382,CR1,SNP (A/T),(A/,A,1.82,1.54,2.03,0.07129535,Moderate,0.068,0.146,0.313,0.273,Mild decrease (p=0.01),Mild decrease (p=0.004),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01295,rs302855,8,229034287,APOE,SNP (A/G),(A/,A,0.33,0.1,0.59,0.00190156,Moderate,0.378,0.08,0.263,0.08,No significant pattern (p=0.036),Variable effect (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01296,rs400662,14,119505183,EPHA1,SNP (A/T),(A/,A,0.65,0.41,0.92,0.19634004,Low,0.136,0.361,0.142,0.161,No significant pattern (p=0.04),Significant decrease (p=0.036),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01297,rs346985,22,10046542,APOE,SNP (A/T),(A/,A,1.03,0.75,1.33,0.01283275,Low,0.015,0.099,0.518,0.168,Significant decrease (p=0.012),Significant increase (p=0.048),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01298,rs314409,9,98941017,CD2AP,SNP (A/C),(A/,A,1.34,0.94,1.57,0.02666162,Low,0.519,0.148,0.123,0.011,Significant decrease (p=0.016),Mild decrease (p=0.029),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01299,rs504693,19,128241703,APP,SNP (A/G),(A/,A,2.15,1.87,2.41,0.02608392,High,0.185,0.438,0.099,0.078,Mild increase (p=0.023),Significant increase (p=0.021),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP01300,rs386355,9,216910337,CD33,SNP (A/G),(A/,A,0.22,0.1,0.62,0.00690249,High,0.312,0.136,0.227,0.125,Significant increase (p=0.006),Mild decrease (p=0.022),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01301,rs509389,5,3292679,PICALM,SNP (C/G),(C/,C,1.01,0.75,1.28,0.04350719,Moderate,0.1,0.089,0.112,0.499,Significant increase (p=0.013),Significant increase (p=0.019),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01302,rs964821,1,19259057,CR1,SNP (C/G),(C/,C,1.1,0.77,1.32,0.05340514,High,0.228,0.283,0.208,0.081,Mild increase (p=0.033),No significant pattern (p=0.021),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01303,rs840660,6,154623481,SORL1,SNP (A/C),(A/,A,1.09,0.85,1.41,0.02925312,Unknown,0.213,0.147,0.011,0.429,Variable effect (p=0.003),Variable effect (p=0.021),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01304,rs323979,11,197043542,MS4A6A,Insertion,-,-,0.66,0.28,0.99,0.02013676,Moderate,0.357,0.231,0.099,0.113,Significant increase (p=0.016),No significant pattern (p=0.011),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01305,rs493991,1,158431337,PICALM,Insertion,-,-,1.46,1.12,1.75,0.05164566,Protective,0.055,0.106,0.615,0.023,Mild increase (p=0.037),Mild decrease (p=0.022),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01306,rs353106,17,148058736,CD2AP,SNP (G/T),(G/,G,0.54,0.18,0.91,0.0083294,High,0.284,0.136,0.136,0.244,Mild decrease (p=0.002),Mild decrease (p=0.028),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01307,rs585901,12,108992330,APP,SNP (G/T),(G/,G,1.06,0.86,1.36,0.0518481,Low,0.336,0.21,0.238,0.017,Significant decrease (p=0.031),No significant pattern (p=0.041),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01308,rs827725,22,233894463,CLU,SNP (A/G),(A/,A,0.79,0.4,1.18,0.05973362,Moderate,0.219,0.145,0.233,0.202,Variable effect (p=0.021),Significant increase (p=0.039),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01309,rs763699,20,31866098,CR1,SNP (C/G),(C/,C,0.88,0.67,1.09,0.00795451,Moderate,0.164,0.212,0.413,0.011,Significant increase (p=0.043),Variable effect (p=0.04),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01310,rs678816,19,134246280,SORL1,Deletion,-,-,1.49,1.09,1.78,0.11286863,High,0.591,0.19,0.001,0.018,Variable effect (p=0.01),Significant decrease (p=0.047),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01311,rs845146,7,87238943,CD2AP,SNP (G/T),(G/,G,0.98,0.76,1.34,0.00090217,Protective,0.501,0.142,0.006,0.151,Mild increase (p=0.003),No significant pattern (p=0.003),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01312,rs944658,13,69582201,APP,SNP (A/C),(A/,A,1.6,1.26,1.83,0.04988141,Low,0.17,0.182,0.396,0.052,Significant decrease (p=0.016),Mild increase (p=0.005),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01313,rs112239,13,215084973,PICALM,SNP (A/T),(A/,A,2.65,2.42,2.96,0.06759324,High,0.35,0.069,0.197,0.184,Variable effect (p=0.033),Significant decrease (p=0.041),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01314,rs551279,10,78707458,PICALM,SNP (A/G),(A/,A,0.73,0.44,1.04,0.02508207,High,0.117,0.158,0.125,0.399,Significant increase (p=0.032),No significant pattern (p=0.024),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01315,rs991740,22,187424673,TREM2,Insertion,-,-,1.48,1.12,1.78,0.01599181,High,0.196,0.142,0.414,0.049,Variable effect (p=0.022),No significant pattern (p=0.015),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01316,rs562016,3,152780058,APOE,SNP (A/T),(A/,A,1.22,0.88,1.45,0.12123298,High,0.335,0.156,0.208,0.1,No significant pattern (p=0.001),Significant decrease (p=0.032),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01317,rs730926,17,178337058,CR1,Insertion,-,-,1.16,0.85,1.41,0.04088245,Unknown,0.006,0.361,0.355,0.078,Variable effect (p=0.021),Significant decrease (p=0.037),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01318,rs518187,9,203447587,APOE,Deletion,-,-,1.51,1.11,1.9,0.09209186,Moderate,0.176,0.121,0.194,0.31,Mild decrease (p=0.043),Mild increase (p=0.005),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP01319,rs452992,20,25130624,CR1,Insertion,-,-,1.51,1.29,1.71,0.02066423,Low,0.077,0.165,0.529,0.029,No significant pattern (p=0.005),Significant decrease (p=0.025),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01320,rs108896,19,81219950,CR1,SNP (C/T),(C/,C,1.02,0.81,1.22,0.00743607,High,0.183,0.056,0.433,0.128,Mild decrease (p=0.014),No significant pattern (p=0.018),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01321,rs362625,13,122027793,CD2AP,SNP (A/T),(A/,A,0.87,0.54,1.16,0.01150981,Moderate,0.121,0.48,0.005,0.195,Significant decrease (p=0.014),Significant increase (p=0.003),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP01322,rs295826,14,134604150,ABCA7,Deletion,-,-,1.91,1.6,2.16,0.00156174,Moderate,0.082,0.253,0.423,0.042,Mild decrease (p=0.016),Mild increase (p=0.037),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01323,rs933541,10,197464037,APP,SNP (A/C),(A/,A,1.23,0.85,1.52,0.00466763,Moderate,0.318,0.131,0.234,0.116,Significant decrease (p=0.02),Variable effect (p=0.035),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01324,rs373284,6,163022661,APP,SNP (A/C),(A/,A,0.9,0.67,1.17,0.09197587,High,0.162,0.085,0.161,0.392,Mild decrease (p=0.024),Variable effect (p=0.006),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01325,rs504733,3,27397950,APOE,SNP (G/T),(G/,G,1.23,1.0,1.62,0.01910869,Protective,0.36,0.064,0.257,0.118,No significant pattern (p=0.022),Mild increase (p=0.033),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01326,rs274944,22,190904736,CLU,SNP (G/T),(G/,G,1.38,1.13,1.6,0.02434487,Unknown,0.077,0.306,0.281,0.136,Significant decrease (p=0.011),Mild increase (p=0.038),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP01327,rs912879,18,20573539,CD33,SNP (A/C),(A/,A,1.53,1.23,1.73,0.01699896,Moderate,0.288,0.333,0.116,0.064,Significant increase (p=0.011),Mild decrease (p=0.044),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01328,rs363450,18,54792571,CLU,SNP (G/T),(G/,G,1.22,0.99,1.45,0.02176277,Protective,0.004,0.359,0.287,0.149,Variable effect (p=0.042),Significant decrease (p=0.033),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01329,rs253793,18,1853189,BIN1,SNP (G/T),(G/,G,0.91,0.55,1.2,0.01424703,High,0.375,0.035,0.277,0.113,No significant pattern (p=0.02),Significant increase (p=0.041),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01330,rs778646,1,11820932,APOE,SNP (A/T),(A/,A,0.53,0.27,0.78,0.00849391,High,0.312,0.315,0.126,0.046,Mild decrease (p=0.002),No significant pattern (p=0.02),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01331,rs131385,15,171913890,PICALM,SNP (C/T),(C/,C,0.46,0.23,0.82,0.01377923,High,0.333,0.03,0.128,0.309,Variable effect (p=0.044),No significant pattern (p=0.007),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01332,rs448934,18,80606029,ABCA7,Deletion,-,-,0.88,0.51,1.14,0.02932997,Moderate,0.019,0.295,0.266,0.22,Mild increase (p=0.022),Significant increase (p=0.044),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01333,rs280021,10,18389429,SORL1,SNP (A/G),(A/,A,1.06,0.69,1.3,0.0616853,Moderate,0.282,0.253,0.26,0.005,Variable effect (p=0.02),Significant increase (p=0.006),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01334,rs398143,8,109183616,MS4A6A,SNP (A/G),(A/,A,0.15,0.1,0.51,0.00097907,Protective,0.129,0.292,0.187,0.191,Variable effect (p=0.043),Variable effect (p=0.001),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01335,rs800363,21,150234763,EPHA1,SNP (A/C),(A/,A,1.02,0.68,1.41,0.01207516,Low,0.152,0.06,0.247,0.341,Variable effect (p=0.042),No significant pattern (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01336,rs773821,16,245115594,CD2AP,SNP (C/T),(C/,C,1.38,1.0,1.71,0.04651558,Moderate,0.172,0.001,0.029,0.598,Significant increase (p=0.048),No significant pattern (p=0.018),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01337,rs515122,22,189231393,CLU,SNP (C/T),(C/,C,0.74,0.5,1.08,0.05255431,High,0.056,0.307,0.138,0.3,Variable effect (p=0.042),Mild increase (p=0.022),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01338,rs628931,18,60734964,CR1,SNP (A/C),(A/,A,1.77,1.42,2.07,0.01498294,Low,0.04,0.347,0.299,0.115,Mild increase (p=0.014),No significant pattern (p=0.045),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01339,rs590300,14,183567990,APOE,Insertion,-,-,0.56,0.23,0.85,0.03424353,Low,0.358,0.364,0.016,0.062,Significant increase (p=0.016),Significant increase (p=0.016),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01340,rs145007,13,174660540,CLU,Insertion,-,-,0.75,0.36,1.15,0.00420647,Moderate,0.151,0.075,0.465,0.109,Mild increase (p=0.018),Mild increase (p=0.015),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP01341,rs199404,6,146514620,APP,SNP (C/G),(C/,C,1.61,1.37,1.86,0.00949855,Moderate,0.125,0.405,0.219,0.051,No significant pattern (p=0.002),No significant pattern (p=0.029),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01342,rs957883,17,228958693,CR1,SNP (A/T),(A/,A,0.87,0.64,1.25,0.02227629,Moderate,0.238,0.081,0.007,0.474,Significant increase (p=0.028),Mild decrease (p=0.034),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01343,rs950232,3,36211816,APP,Deletion,-,-,1.48,1.12,1.7,0.00735009,Moderate,0.143,0.038,0.363,0.256,Significant decrease (p=0.012),Mild decrease (p=0.044),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01344,rs586116,5,122257291,BIN1,SNP (G/T),(G/,G,0.91,0.57,1.13,0.01368965,Moderate,0.353,0.24,0.141,0.066,Significant increase (p=0.039),Significant decrease (p=0.018),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01345,rs847478,19,126263879,PSEN2,SNP (G/T),(G/,G,0.96,0.69,1.33,0.03113968,Moderate,0.216,0.136,0.315,0.133,Significant decrease (p=0.036),Significant increase (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01346,rs542450,19,214646681,SORL1,SNP (C/G),(C/,C,0.45,0.18,0.66,0.02630913,Protective,0.222,0.341,0.154,0.083,Mild decrease (p=0.001),No significant pattern (p=0.005),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01347,rs332737,15,155040539,APP,SNP (C/T),(C/,C,0.44,0.23,0.75,0.00064222,Low,0.214,0.354,0.067,0.166,Variable effect (p=0.02),Significant decrease (p=0.04),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP01348,rs522315,11,54407151,CD33,SNP (C/G),(C/,C,1.02,0.71,1.31,0.02089151,Moderate,0.165,0.097,0.447,0.091,No significant pattern (p=0.019),Significant decrease (p=0.049),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01349,rs342371,7,70724746,APP,SNP (A/C),(A/,A,1.29,0.97,1.54,0.05770645,Moderate,0.127,0.503,0.02,0.15,Significant increase (p=0.032),Significant decrease (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01350,rs779909,10,187959230,CLU,SNP (C/G),(C/,C,1.95,1.73,2.28,0.05459046,Low,0.082,0.025,0.013,0.68,Mild increase (p=0.016),No significant pattern (p=0.027),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP01351,rs148986,13,136386945,EPHA1,Deletion,-,-,1.57,1.29,1.8,0.02458329,Moderate,0.006,0.529,0.113,0.152,Mild increase (p=0.022),Variable effect (p=0.048),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01352,rs213914,19,96741726,CLU,SNP (C/T),(C/,C,0.35,0.1,0.72,0.03764172,High,0.178,0.319,0.281,0.022,Significant decrease (p=0.04),Mild increase (p=0.01),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP01353,rs622783,7,137784831,EPHA1,Insertion,-,-,0.68,0.37,0.99,0.05614135,High,0.397,0.062,0.235,0.106,Variable effect (p=0.017),Significant decrease (p=0.005),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01354,rs338119,1,172620460,APP,SNP (A/G),(A/,A,1.1,0.88,1.32,0.03161499,Protective,0.148,0.432,0.021,0.2,Variable effect (p=0.019),No significant pattern (p=0.046),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP01355,rs372431,18,144674037,BIN1,SNP (A/C),(A/,A,1.58,1.34,1.82,0.00971226,Low,0.232,0.194,0.206,0.168,No significant pattern (p=0.028),Significant increase (p=0.007),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01356,rs887650,19,90689211,APOE,SNP (G/T),(G/,G,1.22,0.83,1.49,0.0059452,High,0.176,0.006,0.108,0.51,Mild decrease (p=0.046),No significant pattern (p=0.022),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01357,rs510924,1,75888050,MS4A6A,SNP (C/T),(C/,C,0.62,0.29,0.87,0.04822704,Moderate,0.295,0.149,0.255,0.1,Mild decrease (p=0.036),Mild increase (p=0.024),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01358,rs971313,16,30989797,SORL1,SNP (A/T),(A/,A,0.9,0.58,1.2,0.01203844,Unknown,0.008,0.203,0.498,0.091,Mild decrease (p=0.007),No significant pattern (p=0.042),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP01359,rs865631,20,122054115,PTK2B,Insertion,-,-,0.57,0.3,0.89,0.03547619,High,0.244,0.144,0.04,0.372,Significant increase (p=0.029),Mild increase (p=0.017),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01360,rs485048,3,141889508,APOE,SNP (G/T),(G/,G,1.15,0.92,1.54,0.04449867,Protective,0.41,0.022,0.327,0.041,Significant increase (p=0.035),Significant decrease (p=0.006),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01361,rs454746,1,214372123,SORL1,Insertion,-,-,1.5,1.16,1.83,0.00244486,Moderate,0.212,0.056,0.487,0.044,Significant increase (p=0.039),Variable effect (p=0.032),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01362,rs927817,15,33530381,APP,SNP (C/G),(C/,C,1.52,1.18,1.86,0.02588736,High,0.435,0.153,0.127,0.085,Mild decrease (p=0.03),Mild increase (p=0.003),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01363,rs411348,19,217361429,APOE,SNP (A/T),(A/,A,0.82,0.43,1.04,0.03019447,Moderate,0.139,0.374,0.095,0.192,Variable effect (p=0.003),Variable effect (p=0.013),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP01364,rs926925,22,30143764,EPHA1,SNP (C/G),(C/,C,1.95,1.66,2.27,0.10004332,Moderate,0.123,0.338,0.159,0.181,Significant increase (p=0.047),Mild decrease (p=0.022),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01365,rs612455,9,55887121,APP,SNP (G/T),(G/,G,0.92,0.64,1.31,0.01392293,Moderate,0.247,0.078,0.41,0.065,Variable effect (p=0.015),No significant pattern (p=0.01),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01366,rs797654,15,178870283,MS4A6A,SNP (C/G),(C/,C,0.99,0.77,1.29,0.08037902,High,0.271,0.109,0.219,0.201,Mild increase (p=0.048),Significant decrease (p=0.04),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01367,rs901913,13,77816575,EPHA1,SNP (A/C),(A/,A,0.9,0.51,1.2,0.03105628,Moderate,0.033,0.37,0.035,0.362,Mild decrease (p=0.029),Variable effect (p=0.023),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01368,rs447370,12,241694327,APP,SNP (G/T),(G/,G,2.33,1.93,2.64,0.00671202,Moderate,0.096,0.194,0.082,0.428,Significant decrease (p=0.032),Variable effect (p=0.038),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP01369,rs532314,5,216303298,CD2AP,SNP (C/G),(C/,C,1.09,0.86,1.47,0.09696208,Low,0.014,0.294,0.195,0.297,Significant increase (p=0.03),Variable effect (p=0.006),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01370,rs254795,20,140779071,MS4A6A,SNP (C/G),(C/,C,1.17,0.83,1.39,0.06545384,Moderate,0.001,0.18,0.03,0.589,Variable effect (p=0.048),Mild increase (p=0.033),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01371,rs422362,10,100911281,EPHA1,SNP (G/T),(G/,G,3.64,3.33,4.01,0.01114571,Moderate,0.014,0.261,0.507,0.018,No significant pattern (p=0.005),Mild decrease (p=0.037),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01372,rs917255,7,201653940,CLU,SNP (A/T),(A/,A,0.72,0.36,1.1,0.01813246,Moderate,0.575,0.173,0.034,0.018,No significant pattern (p=0.024),Mild increase (p=0.025),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP01373,rs801896,13,8926679,CR1,SNP (C/T),(C/,C,0.24,0.1,0.51,0.05587404,Moderate,0.245,0.078,0.036,0.441,No significant pattern (p=0.01),Mild increase (p=0.028),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01374,rs547726,10,3656375,ABCA7,Insertion,-,-,0.78,0.53,1.13,0.10288902,Moderate,0.108,0.015,0.561,0.116,Mild decrease (p=0.05),No significant pattern (p=0.001),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01375,rs664026,17,205118312,MS4A6A,SNP (C/T),(C/,C,0.75,0.53,0.99,0.00615961,Moderate,0.092,0.64,0.03,0.038,Significant decrease (p=0.006),Mild increase (p=0.013),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01376,rs743917,21,53815878,SORL1,SNP (G/T),(G/,G,0.71,0.4,1.11,0.04048724,Moderate,0.128,0.311,0.277,0.084,Significant increase (p=0.019),Variable effect (p=0.021),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP01377,rs980408,19,245629587,ABCA7,SNP (C/G),(C/,C,0.5,0.23,0.81,0.00634882,High,0.144,0.271,0.186,0.198,Significant increase (p=0.029),No significant pattern (p=0.019),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP01378,rs280668,22,205686837,CD2AP,Insertion,-,-,1.22,0.94,1.56,0.00445572,Protective,0.164,0.268,0.289,0.079,Variable effect (p=0.047),Variable effect (p=0.012),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP01379,rs813443,7,8971365,EPHA1,SNP (C/G),(C/,C,0.78,0.56,1.16,0.03935994,High,0.664,0.015,0.112,0.009,Mild decrease (p=0.013),Mild decrease (p=0.032),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01380,rs872731,3,32506266,APP,SNP (A/T),(A/,A,0.92,0.56,1.15,0.09686218,High,0.008,0.547,0.043,0.202,Mild decrease (p=0.046),No significant pattern (p=0.024),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP01381,rs156370,18,145902362,CD33,SNP (A/G),(A/,A,0.98,0.69,1.29,0.00293425,Moderate,0.271,0.036,0.307,0.185,Significant increase (p=0.023),Mild decrease (p=0.019),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01382,rs670272,17,77537008,MS4A6A,SNP (C/T),(C/,C,2.05,1.83,2.25,0.0144777,Low,0.334,0.111,0.247,0.108,No significant pattern (p=0.027),Significant increase (p=0.046),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP01383,rs726346,14,91233552,APOE,SNP (G/T),(G/,G,1.32,1.01,1.52,0.00362814,Unknown,0.071,0.288,0.33,0.11,Mild decrease (p=0.032),Mild decrease (p=0.047),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01384,rs873165,6,21871267,APOE,SNP (A/C),(A/,A,0.99,0.69,1.37,0.00504731,High,0.004,0.249,0.321,0.226,No significant pattern (p=0.005),Mild increase (p=0.025),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01385,rs974410,18,1334195,CR1,SNP (G/T),(G/,G,0.57,0.31,0.78,0.00969737,High,0.043,0.339,0.181,0.236,Mild increase (p=0.047),No significant pattern (p=0.013),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01386,rs669741,15,240708680,SORL1,SNP (G/T),(G/,G,1.45,1.08,1.65,0.00544449,Moderate,0.311,0.122,0.246,0.121,Mild increase (p=0.003),Significant decrease (p=0.001),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01387,rs427029,15,239831801,EPHA1,SNP (A/C),(A/,A,2.19,1.97,2.42,0.06275216,High,0.38,0.117,0.149,0.154,Mild decrease (p=0.019),No significant pattern (p=0.011),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01388,rs320930,19,88197204,CD33,Insertion,-,-,1.55,1.27,1.82,0.051413,Moderate,0.14,0.056,0.002,0.602,Mild increase (p=0.002),Significant increase (p=0.012),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01389,rs312168,11,44671709,EPHA1,SNP (C/G),(C/,C,0.86,0.61,1.25,0.00241032,Moderate,0.064,0.099,0.605,0.031,Mild increase (p=0.034),Variable effect (p=0.034),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP01390,rs323939,7,191998375,CLU,SNP (A/T),(A/,A,0.83,0.55,1.05,0.05257623,High,0.464,0.031,0.302,0.003,Mild increase (p=0.012),Significant decrease (p=0.038),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01391,rs114632,2,115415892,PICALM,SNP (G/T),(G/,G,1.38,1.08,1.75,0.02907696,High,0.636,0.076,0.052,0.036,Mild increase (p=0.01),No significant pattern (p=0.031),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01392,rs197932,17,109398538,CLU,Insertion,-,-,2.35,2.04,2.7,0.04521313,Moderate,0.065,0.161,0.455,0.119,Significant increase (p=0.021),Significant increase (p=0.013),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP01393,rs218941,6,19468857,APOE,Insertion,-,-,1.3,1.1,1.69,0.02632293,High,0.065,0.18,0.157,0.397,Significant increase (p=0.04),Mild increase (p=0.022),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP01394,rs263889,7,204601248,PICALM,SNP (A/G),(A/,A,0.68,0.48,0.97,0.00172303,High,0.421,0.308,0.034,0.037,Mild decrease (p=0.006),Mild increase (p=0.044),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP01395,rs157751,20,144978199,BIN1,SNP (C/G),(C/,C,1.64,1.43,1.87,0.0038499,Protective,0.155,0.445,0.154,0.046,Mild increase (p=0.018),Mild decrease (p=0.023),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP01396,rs799263,16,41076854,BIN1,SNP (A/C),(A/,A,0.69,0.42,0.89,0.04537325,Unknown,0.337,0.103,0.017,0.344,Mild decrease (p=0.031),Significant decrease (p=0.039),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01397,rs549365,8,198343864,EPHA1,SNP (C/G),(C/,C,1.54,1.19,1.8,0.00728784,Low,0.133,0.38,0.277,0.011,Significant increase (p=0.046),Significant decrease (p=0.028),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01398,rs232541,18,19145861,CD33,SNP (C/G),(C/,C,1.03,0.77,1.25,0.04193377,Low,0.054,0.258,0.101,0.387,Mild decrease (p=0.002),Significant decrease (p=0.023),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01399,rs177148,4,220351180,SORL1,SNP (C/G),(C/,C,0.69,0.4,0.92,0.02259305,Low,0.392,0.104,0.237,0.067,Variable effect (p=0.016),Significant increase (p=0.004),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01400,rs185824,15,79093789,BIN1,SNP (A/C),(A/,A,0.61,0.4,0.83,0.01032911,Low,0.096,0.022,0.534,0.148,Significant increase (p=0.005),Mild increase (p=0.042),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP01401,rs434910,5,33848839,PSEN2,Deletion,-,-,1.28,1.03,1.65,0.00162685,Low,0.361,0.1,0.317,0.022,Significant decrease (p=0.002),Mild increase (p=0.004),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01402,rs890702,11,239020933,PTK2B,SNP (G/T),(G/,G,0.77,0.5,1.06,0.0368941,High,0.435,0.241,0.082,0.042,Mild increase (p=0.011),Significant decrease (p=0.017),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01403,rs119956,9,159006536,TREM2,SNP (C/G),(C/,C,0.84,0.61,1.19,0.00581149,Moderate,0.294,0.105,0.159,0.242,No significant pattern (p=0.018),Mild decrease (p=0.015),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01404,rs136019,21,52994700,PSEN2,SNP (C/G),(C/,C,0.99,0.71,1.33,0.04679724,High,0.026,0.07,0.271,0.433,No significant pattern (p=0.004),Significant increase (p=0.028),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01405,rs472286,2,185002192,ABCA7,Deletion,-,-,0.88,0.53,1.16,0.02521996,Low,0.189,0.179,0.23,0.202,Significant decrease (p=0.017),Mild decrease (p=0.038),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01406,rs716393,18,66639326,CR1,SNP (A/G),(A/,A,1.69,1.32,2.02,0.01034911,High,0.147,0.026,0.602,0.025,Mild increase (p=0.016),Significant increase (p=0.047),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01407,rs604046,14,224803471,APP,SNP (C/G),(C/,C,0.94,0.6,1.32,0.02680436,Moderate,0.077,0.487,0.209,0.027,No significant pattern (p=0.01),Mild increase (p=0.038),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01408,rs840232,7,40555050,APOE,SNP (A/G),(A/,A,0.57,0.37,0.77,2.937e-05,High,0.629,0.025,0.123,0.024,Mild decrease (p=0.016),No significant pattern (p=0.049),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01409,rs383203,4,114235099,PICALM,SNP (C/G),(C/,C,0.39,0.15,0.59,0.00348911,Protective,0.134,0.07,0.484,0.112,Variable effect (p=0.035),Mild increase (p=0.029),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01410,rs237513,4,207833960,APOE,SNP (C/G),(C/,C,0.64,0.39,0.88,0.02276368,High,0.368,0.175,0.015,0.243,No significant pattern (p=0.008),Variable effect (p=0.016),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01411,rs714837,8,98838171,CD2AP,Deletion,-,-,1.68,1.41,1.91,0.05066713,High,0.485,0.164,0.029,0.122,Significant decrease (p=0.031),Significant decrease (p=0.044),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01412,rs953076,9,105615617,CLU,SNP (C/G),(C/,C,1.84,1.55,2.16,0.01852398,High,0.032,0.397,0.369,0.002,Mild increase (p=0.033),Mild decrease (p=0.01),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01413,rs651440,18,189250811,ABCA7,SNP (G/T),(G/,G,1.26,1.02,1.5,0.0037811,High,0.068,0.525,0.112,0.095,Significant increase (p=0.046),Significant decrease (p=0.035),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01414,rs993611,5,147652818,CLU,SNP (C/G),(C/,C,1.01,0.65,1.38,0.03322923,Moderate,0.461,0.046,0.015,0.277,Mild increase (p=0.027),Significant decrease (p=0.03),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01415,rs429738,13,29671860,APOE,SNP (G/T),(G/,G,0.99,0.78,1.31,0.00821566,Moderate,0.267,0.233,0.232,0.067,Mild increase (p=0.02),Mild increase (p=0.002),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01416,rs625031,18,147171311,CLU,SNP (C/T),(C/,C,1.61,1.33,1.95,0.00462112,Moderate,0.313,0.279,0.133,0.076,Significant decrease (p=0.037),Mild decrease (p=0.046),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01417,rs913504,16,93394879,PTK2B,Insertion,-,-,1.08,0.77,1.41,0.01963299,Low,0.289,0.197,0.171,0.143,No significant pattern (p=0.027),Variable effect (p=0.04),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01418,rs477903,5,142461173,SORL1,Insertion,-,-,1.34,1.02,1.62,0.03109193,High,0.106,0.48,0.163,0.051,Mild increase (p=0.008),Mild increase (p=0.009),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01419,rs163030,18,139997843,CR1,Deletion,-,-,0.96,0.68,1.26,0.08063824,Low,0.147,0.032,0.488,0.133,Mild decrease (p=0.014),No significant pattern (p=0.003),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP01420,rs356000,16,73346691,BIN1,SNP (C/T),(C/,C,1.52,1.25,1.83,0.01896768,Low,0.153,0.275,0.107,0.265,No significant pattern (p=0.008),Mild increase (p=0.015),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP01421,rs285884,15,190431113,CLU,SNP (A/C),(A/,A,0.68,0.33,0.91,0.06747737,Low,0.014,0.253,0.47,0.062,Significant increase (p=0.025),Mild increase (p=0.003),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01422,rs911918,17,15462366,BIN1,SNP (C/T),(C/,C,1.48,1.14,1.78,0.04020582,Moderate,0.086,0.572,0.011,0.13,Significant increase (p=0.042),Variable effect (p=0.026),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01423,rs303425,19,96718191,CR1,SNP (C/T),(C/,C,0.4,0.1,0.64,0.02902477,Moderate,0.114,0.036,0.342,0.308,Mild decrease (p=0.016),Significant increase (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01424,rs685319,14,98553824,APP,SNP (A/G),(A/,A,1.27,0.93,1.64,0.02191466,Moderate,0.53,0.133,0.085,0.053,Mild decrease (p=0.014),Significant decrease (p=0.018),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01425,rs136152,16,134919137,ABCA7,Deletion,-,-,1.08,0.86,1.35,0.02704545,Moderate,0.346,0.002,0.127,0.326,Mild increase (p=0.01),No significant pattern (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01426,rs782525,22,10347092,APP,SNP (C/G),(C/,C,0.65,0.44,0.98,0.07665244,Moderate,0.175,0.045,0.294,0.286,Significant decrease (p=0.024),Significant increase (p=0.043),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP01427,rs892543,22,242457411,SORL1,SNP (G/T),(G/,G,0.71,0.35,1.11,0.03486674,High,0.384,0.041,0.196,0.18,Mild increase (p=0.042),Variable effect (p=0.035),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01428,rs393584,19,68421980,APP,SNP (A/G),(A/,A,0.38,0.1,0.71,0.02561162,Moderate,0.039,0.53,0.174,0.056,Mild increase (p=0.048),Significant increase (p=0.046),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01429,rs483061,14,94817446,ABCA7,SNP (C/G),(C/,C,1.38,1.18,1.76,0.01342101,Low,0.162,0.112,0.428,0.097,Variable effect (p=0.019),No significant pattern (p=0.014),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01430,rs568257,4,112387051,APOE,SNP (A/T),(A/,A,1.46,1.18,1.8,0.02923634,Moderate,0.005,0.106,0.005,0.684,Mild increase (p=0.027),Variable effect (p=0.049),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01431,rs784771,7,211347479,SORL1,SNP (A/G),(A/,A,1.35,1.07,1.69,0.00429524,High,0.255,0.235,0.278,0.032,Significant decrease (p=0.026),Variable effect (p=0.004),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP01432,rs826742,22,93516762,CLU,SNP (A/G),(A/,A,0.72,0.41,1.02,0.0277876,High,0.009,0.103,0.574,0.114,Mild decrease (p=0.032),Mild increase (p=0.031),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01433,rs616187,5,52281456,PSEN2,SNP (A/G),(A/,A,0.42,0.14,0.63,0.00117323,High,0.151,0.224,0.172,0.252,Significant decrease (p=0.046),Variable effect (p=0.024),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01434,rs964894,11,105958528,TREM2,SNP (C/G),(C/,C,0.9,0.57,1.19,0.03094758,Protective,0.028,0.33,0.029,0.412,Variable effect (p=0.03),Significant increase (p=0.046),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01435,rs235020,1,32957186,EPHA1,SNP (C/T),(C/,C,0.99,0.6,1.36,0.00186454,High,0.399,0.026,0.036,0.338,No significant pattern (p=0.016),Significant decrease (p=0.004),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01436,rs985707,17,46188539,ABCA7,SNP (A/C),(A/,A,1.23,0.95,1.43,0.02379877,Protective,0.045,0.054,0.097,0.603,No significant pattern (p=0.042),No significant pattern (p=0.034),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01437,rs637965,8,60575067,CLU,Insertion,-,-,0.58,0.35,0.85,0.01352277,High,0.092,0.2,0.118,0.39,No significant pattern (p=0.034),Mild decrease (p=0.017),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01438,rs815652,4,218836569,CLU,SNP (A/C),(A/,A,0.74,0.44,1.07,0.0458806,High,0.166,0.129,0.341,0.163,Mild decrease (p=0.037),Variable effect (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP01439,rs310259,22,207290191,EPHA1,SNP (C/G),(C/,C,1.14,0.75,1.5,0.03624964,Moderate,0.101,0.414,0.125,0.16,Mild increase (p=0.042),Variable effect (p=0.005),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01440,rs523198,12,201568142,PICALM,Deletion,-,-,0.34,0.14,0.66,0.07334598,Moderate,0.228,0.44,0.102,0.03,Significant increase (p=0.005),Significant increase (p=0.037),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP01441,rs255880,7,157921313,CD2AP,SNP (C/T),(C/,C,0.84,0.61,1.23,0.09608908,Low,0.069,0.125,0.338,0.268,No significant pattern (p=0.028),Mild increase (p=0.029),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01442,rs988307,14,141312538,APOE,Insertion,-,-,0.71,0.4,0.93,0.0465713,High,0.022,0.487,0.16,0.131,Mild decrease (p=0.025),Significant decrease (p=0.016),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01443,rs509671,15,25492962,CR1,Insertion,-,-,0.51,0.21,0.76,0.06798761,Moderate,0.045,0.441,0.147,0.167,No significant pattern (p=0.048),Variable effect (p=0.032),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01444,rs913524,14,41325244,PTK2B,Insertion,-,-,1.72,1.33,2.11,0.05250203,High,0.052,0.104,0.43,0.213,Mild increase (p=0.008),Mild increase (p=0.003),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP01445,rs140944,22,106278097,APP,SNP (A/C),(A/,A,0.86,0.55,1.21,0.00492051,High,0.586,0.138,0.038,0.038,Mild decrease (p=0.041),Significant increase (p=0.011),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01446,rs488873,9,115196102,BIN1,SNP (G/T),(G/,G,1.19,0.97,1.41,0.14730346,Moderate,0.278,0.189,0.205,0.128,No significant pattern (p=0.034),Variable effect (p=0.003),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01447,rs934226,12,96547473,PSEN2,SNP (C/T),(C/,C,3.77,3.44,4.12,0.00639204,High,0.252,0.298,0.217,0.034,Significant increase (p=0.017),Variable effect (p=0.031),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP01448,rs222727,4,167314795,PICALM,Insertion,-,-,0.94,0.54,1.14,0.01047956,Unknown,0.393,0.196,0.029,0.182,Variable effect (p=0.027),No significant pattern (p=0.012),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP01449,rs417122,20,107049600,BIN1,Insertion,-,-,0.94,0.66,1.25,0.12073514,High,0.385,0.11,0.168,0.137,Mild increase (p=0.018),Significant increase (p=0.007),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01450,rs560161,7,123994836,APP,Deletion,-,-,0.61,0.21,0.84,0.04743714,High,0.013,0.001,0.141,0.645,No significant pattern (p=0.008),Mild increase (p=0.028),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP01451,rs109681,16,208782617,PSEN2,SNP (G/T),(G/,G,0.92,0.66,1.19,0.0128426,Unknown,0.194,0.296,0.136,0.174,No significant pattern (p=0.041),Mild decrease (p=0.032),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01452,rs931802,15,44867045,PTK2B,SNP (C/T),(C/,C,0.72,0.39,0.96,0.03019263,Moderate,0.137,0.077,0.34,0.246,No significant pattern (p=0.034),Significant increase (p=0.044),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01453,rs579436,22,21833841,PSEN2,SNP (C/G),(C/,C,0.65,0.35,1.03,0.04187881,Moderate,0.025,0.119,0.141,0.515,Variable effect (p=0.008),Significant increase (p=0.038),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01454,rs489314,5,73722629,EPHA1,SNP (C/G),(C/,C,2.63,2.26,2.84,0.00099642,Protective,0.043,0.466,0.054,0.238,Significant decrease (p=0.016),Mild decrease (p=0.041),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01455,rs988714,6,58956395,PTK2B,SNP (G/T),(G/,G,0.64,0.37,0.91,0.04032161,Moderate,0.232,0.454,0.097,0.018,No significant pattern (p=0.039),Significant increase (p=0.048),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01456,rs803207,14,45629857,PICALM,SNP (A/G),(A/,A,1.07,0.77,1.46,0.03238789,Moderate,0.308,0.149,0.262,0.081,Mild increase (p=0.011),Variable effect (p=0.016),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP01457,rs142229,1,197550684,SORL1,SNP (G/T),(G/,G,1.0,0.73,1.36,0.00267067,Moderate,0.332,0.239,0.009,0.22,Mild decrease (p=0.035),Significant decrease (p=0.035),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01458,rs575802,14,182608054,APOE,SNP (A/C),(A/,A,0.61,0.34,0.99,0.03970647,High,0.082,0.402,0.107,0.209,Mild increase (p=0.005),Variable effect (p=0.007),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01459,rs970141,11,193551958,PICALM,SNP (G/T),(G/,G,0.69,0.41,1.01,0.08734576,Low,0.074,0.165,0.384,0.177,No significant pattern (p=0.029),Mild increase (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01460,rs902286,2,33743985,CLU,SNP (C/T),(C/,C,0.85,0.53,1.19,0.02611526,Moderate,0.408,0.059,0.118,0.216,Significant decrease (p=0.046),Mild decrease (p=0.031),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01461,rs465948,1,229491306,PICALM,SNP (G/T),(G/,G,0.62,0.33,0.83,0.01365297,Low,0.593,0.033,0.167,0.008,Significant increase (p=0.02),Variable effect (p=0.03),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01462,rs503149,4,188018921,PICALM,SNP (C/T),(C/,C,1.86,1.47,2.2,0.02267884,Protective,0.394,0.009,0.255,0.141,No significant pattern (p=0.018),Variable effect (p=0.035),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01463,rs904392,7,219735763,PTK2B,SNP (A/T),(A/,A,1.33,0.98,1.57,0.0264208,Moderate,0.04,0.53,0.118,0.113,Mild increase (p=0.045),Variable effect (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01464,rs536286,19,210933421,PTK2B,SNP (C/T),(C/,C,1.76,1.37,2.13,0.04725431,Low,0.312,0.141,0.33,0.018,Significant decrease (p=0.004),Variable effect (p=0.036),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01465,rs607466,15,113231365,APOE,SNP (A/C),(A/,A,2.41,2.13,2.65,0.07902735,Moderate,0.065,0.183,0.049,0.503,Significant decrease (p=0.005),Significant increase (p=0.027),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01466,rs333677,6,193726526,BIN1,SNP (C/T),(C/,C,1.14,0.92,1.38,0.01168656,Moderate,0.101,0.064,0.207,0.428,Significant increase (p=0.022),Significant decrease (p=0.038),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01467,rs227579,22,17932772,SORL1,Deletion,-,-,1.57,1.27,1.8,0.01588682,High,0.31,0.203,0.08,0.206,Mild increase (p=0.006),Significant increase (p=0.028),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01468,rs507011,2,154773241,ABCA7,Insertion,-,-,1.44,1.2,1.7,0.00274927,High,0.142,0.362,0.067,0.229,No significant pattern (p=0.003),Mild decrease (p=0.027),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01469,rs241005,11,123296131,EPHA1,SNP (C/G),(C/,C,1.35,1.0,1.56,0.0990172,High,0.116,0.244,0.112,0.328,No significant pattern (p=0.035),No significant pattern (p=0.03),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP01470,rs230933,16,158256496,APP,SNP (A/G),(A/,A,1.02,0.69,1.31,0.05369486,Low,0.528,0.02,0.013,0.239,Mild increase (p=0.014),Significant increase (p=0.007),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP01471,rs662695,20,192014976,ABCA7,SNP (C/G),(C/,C,1.3,1.01,1.54,0.00781718,Moderate,0.144,0.079,0.358,0.219,Variable effect (p=0.049),Mild decrease (p=0.036),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01472,rs460552,22,63091689,BIN1,SNP (G/T),(G/,G,0.57,0.28,0.94,0.0084164,Protective,0.128,0.256,0.012,0.404,No significant pattern (p=0.024),Variable effect (p=0.025),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01473,rs600978,16,55037236,PTK2B,SNP (A/G),(A/,A,0.95,0.6,1.2,0.03556842,Moderate,0.154,0.148,0.052,0.446,Significant increase (p=0.044),Significant increase (p=0.049),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01474,rs256589,22,205528956,CD2AP,SNP (A/G),(A/,A,1.17,0.89,1.44,0.03201799,High,0.195,0.027,0.488,0.091,Mild increase (p=0.05),Variable effect (p=0.012),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01475,rs212352,2,197921816,APOE,Insertion,-,-,0.58,0.28,0.85,0.00108932,High,0.537,0.048,0.051,0.164,Significant decrease (p=0.002),No significant pattern (p=0.008),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01476,rs234714,9,45307006,ABCA7,SNP (C/T),(C/,C,0.4,0.1,0.64,0.05532749,Moderate,0.149,0.063,0.01,0.578,Mild decrease (p=0.029),Significant increase (p=0.031),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01477,rs310921,22,45067488,SORL1,SNP (A/G),(A/,A,0.83,0.59,1.2,0.02970092,Moderate,0.278,0.049,0.38,0.093,Variable effect (p=0.024),Variable effect (p=0.027),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01478,rs491426,11,55733201,CD33,SNP (A/T),(A/,A,0.81,0.48,1.16,0.02797632,High,0.174,0.276,0.164,0.186,Significant decrease (p=0.032),Significant increase (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01479,rs600771,16,110004426,TREM2,Insertion,-,-,2.38,2.15,2.61,0.05156216,Moderate,0.065,0.006,0.494,0.236,Significant decrease (p=0.023),Variable effect (p=0.016),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01480,rs108994,13,175315983,BIN1,SNP (C/T),(C/,C,0.61,0.32,1.0,0.02116387,High,0.009,0.103,0.359,0.329,No significant pattern (p=0.023),Variable effect (p=0.027),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01481,rs599912,13,63666128,CLU,SNP (A/C),(A/,A,0.96,0.73,1.35,0.0037978,Protective,0.028,0.292,0.307,0.173,Mild increase (p=0.011),Variable effect (p=0.023),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP01482,rs911343,13,97595877,PSEN2,SNP (G/T),(G/,G,0.74,0.52,1.05,0.0120458,Unknown,0.16,0.295,0.021,0.325,Mild increase (p=0.046),Mild increase (p=0.025),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01483,rs178563,2,55683277,TREM2,SNP (A/T),(A/,A,1.92,1.57,2.29,0.05224598,High,0.087,0.247,0.339,0.126,Variable effect (p=0.03),Significant increase (p=0.04),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01484,rs525813,2,135295562,BIN1,SNP (G/T),(G/,G,1.06,0.81,1.42,0.00789887,High,0.058,0.009,0.093,0.64,Mild decrease (p=0.041),Significant increase (p=0.04),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01485,rs520371,20,159248703,MS4A6A,SNP (A/G),(A/,A,2.27,2.0,2.58,0.06414819,Moderate,0.533,0.168,0.018,0.081,Mild increase (p=0.037),Mild increase (p=0.017),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01486,rs405563,17,50257009,ABCA7,SNP (A/G),(A/,A,0.73,0.46,0.95,0.01005463,Low,0.154,0.034,0.116,0.496,Mild decrease (p=0.033),Variable effect (p=0.023),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01487,rs715866,21,183217044,APP,Deletion,-,-,1.39,1.12,1.75,0.04802062,High,0.0,0.217,0.079,0.504,No significant pattern (p=0.034),Significant decrease (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01488,rs599995,4,174544168,PTK2B,SNP (A/C),(A/,A,0.39,0.1,0.6,0.01131897,Protective,0.07,0.144,0.176,0.41,No significant pattern (p=0.044),No significant pattern (p=0.038),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01489,rs896705,13,52377360,MS4A6A,SNP (G/T),(G/,G,0.49,0.11,0.87,0.00096933,High,0.443,0.081,0.04,0.237,Variable effect (p=0.032),No significant pattern (p=0.006),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01490,rs834487,13,162918293,EPHA1,SNP (A/T),(A/,A,0.58,0.32,0.85,0.01697259,Moderate,0.143,0.431,0.169,0.057,Mild increase (p=0.009),Mild decrease (p=0.049),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01491,rs445791,5,61654359,EPHA1,SNP (A/C),(A/,A,1.03,0.72,1.34,0.00659977,Unknown,0.288,0.114,0.362,0.037,Variable effect (p=0.031),Mild increase (p=0.029),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01492,rs280712,15,57341713,PICALM,Deletion,-,-,0.69,0.42,1.05,0.00595304,High,0.299,0.238,0.13,0.134,Significant increase (p=0.031),Significant increase (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP01493,rs867671,8,189692612,PTK2B,SNP (C/G),(C/,C,1.01,0.65,1.32,0.02226857,Low,0.41,0.099,0.247,0.044,Variable effect (p=0.005),Mild increase (p=0.016),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01494,rs971041,15,35017927,APOE,Insertion,-,-,0.47,0.27,0.75,0.02619564,Low,0.124,0.302,0.24,0.134,Mild decrease (p=0.039),Significant increase (p=0.001),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01495,rs418801,16,64422380,CLU,SNP (A/T),(A/,A,2.65,2.28,2.98,0.04576736,Protective,0.373,0.317,0.057,0.054,Mild decrease (p=0.013),No significant pattern (p=0.007),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01496,rs568261,4,188797678,CD33,SNP (C/G),(C/,C,0.43,0.2,0.67,0.01000033,Protective,0.225,0.213,0.145,0.217,Significant increase (p=0.04),No significant pattern (p=0.005),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01497,rs102925,15,122412794,CD33,SNP (C/G),(C/,C,1.51,1.16,1.87,0.03220256,High,0.138,0.136,0.385,0.142,Significant decrease (p=0.049),Mild decrease (p=0.039),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP01498,rs228347,11,165910163,ABCA7,SNP (A/C),(A/,A,0.92,0.67,1.16,0.01576355,High,0.481,0.004,0.284,0.031,Variable effect (p=0.014),Variable effect (p=0.011),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01499,rs729337,3,117179715,CD2AP,SNP (G/T),(G/,G,0.67,0.31,1.05,0.0423534,Unknown,0.367,0.277,0.065,0.091,Mild decrease (p=0.008),Significant decrease (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01500,rs591769,4,81739377,CLU,SNP (G/T),(G/,G,1.09,0.76,1.39,0.01633314,Low,0.246,0.101,0.031,0.423,Mild decrease (p=0.025),Variable effect (p=0.002),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01501,rs741273,22,9470649,APOE,SNP (A/C),(A/,A,0.97,0.61,1.27,0.00399821,Protective,0.034,0.122,0.144,0.5,Significant decrease (p=0.002),No significant pattern (p=0.026),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01502,rs502506,8,214517375,CLU,Insertion,-,-,1.19,0.79,1.4,0.12571542,Protective,0.168,0.082,0.297,0.254,Mild decrease (p=0.048),Mild increase (p=0.006),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01503,rs492021,22,26865445,TREM2,SNP (C/T),(C/,C,1.03,0.76,1.36,0.05260877,Moderate,0.327,0.031,0.166,0.276,No significant pattern (p=0.032),No significant pattern (p=0.033),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01504,rs810569,8,83692163,CLU,SNP (G/T),(G/,G,1.0,0.74,1.22,0.00159185,Moderate,0.058,0.086,0.382,0.273,Mild increase (p=0.022),Significant increase (p=0.004),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01505,rs230151,17,206385357,MS4A6A,Deletion,-,-,1.18,0.95,1.57,0.05450354,Low,0.044,0.574,0.034,0.149,Significant increase (p=0.027),Mild increase (p=0.043),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01506,rs583596,5,205185328,PTK2B,SNP (C/T),(C/,C,0.67,0.33,1.04,0.08206616,Moderate,0.22,0.332,0.124,0.124,Significant increase (p=0.01),Significant decrease (p=0.047),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01507,rs248061,10,116304572,SORL1,SNP (G/T),(G/,G,1.13,0.85,1.52,0.00461416,High,0.353,0.174,0.242,0.032,Mild decrease (p=0.05),Significant increase (p=0.016),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01508,rs693237,15,26174245,CD2AP,SNP (G/T),(G/,G,1.15,0.9,1.42,0.08346851,Moderate,0.308,0.113,0.239,0.14,Variable effect (p=0.029),Mild increase (p=0.03),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01509,rs377871,17,32669977,CR1,SNP (A/C),(A/,A,1.61,1.21,1.88,0.00493261,Low,0.206,0.366,0.016,0.212,No significant pattern (p=0.037),Mild decrease (p=0.038),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01510,rs782081,4,65669629,TREM2,Insertion,-,-,1.07,0.76,1.31,0.03422373,Low,0.237,0.254,0.184,0.125,Variable effect (p=0.03),Mild decrease (p=0.026),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01511,rs459805,17,62721172,EPHA1,Insertion,-,-,0.66,0.3,1.05,0.08517978,Unknown,0.019,0.088,0.028,0.665,Significant increase (p=0.048),Significant increase (p=0.009),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01512,rs166011,22,159540754,SORL1,Insertion,-,-,0.83,0.59,1.19,0.08849153,Low,0.123,0.17,0.292,0.215,Significant increase (p=0.002),Mild decrease (p=0.049),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01513,rs986866,15,85890753,APP,Deletion,-,-,0.43,0.15,0.69,0.00604641,High,0.116,0.414,0.042,0.229,Mild decrease (p=0.038),No significant pattern (p=0.004),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP01514,rs233939,7,98098929,APOE,SNP (A/T),(A/,A,0.81,0.6,1.11,0.08175196,Moderate,0.082,0.138,0.201,0.379,Significant increase (p=0.002),No significant pattern (p=0.012),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01515,rs494988,19,155208022,APP,SNP (A/T),(A/,A,1.23,0.85,1.46,0.02121736,Protective,0.034,0.097,0.068,0.6,Mild increase (p=0.036),Significant increase (p=0.017),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01516,rs785907,19,34136754,EPHA1,SNP (G/T),(G/,G,1.16,0.89,1.41,0.04070456,Protective,0.256,0.149,0.202,0.193,Significant increase (p=0.04),No significant pattern (p=0.005),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP01517,rs560846,14,141741918,EPHA1,SNP (A/T),(A/,A,2.04,1.84,2.32,0.03416374,High,0.169,0.059,0.226,0.346,Significant decrease (p=0.045),Significant decrease (p=0.047),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01518,rs759375,22,157754484,MS4A6A,SNP (A/G),(A/,A,1.06,0.86,1.27,0.03139268,High,0.146,0.4,0.242,0.012,Significant decrease (p=0.038),Significant decrease (p=0.025),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01519,rs367299,11,58802498,APP,Insertion,-,-,0.69,0.35,0.9,0.02742351,Low,0.462,0.081,0.168,0.09,Mild decrease (p=0.042),No significant pattern (p=0.026),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01520,rs970378,21,56540614,APOE,SNP (C/G),(C/,C,1.24,0.91,1.54,0.01294962,High,0.047,0.028,0.682,0.043,Mild increase (p=0.045),Mild decrease (p=0.004),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01521,rs973025,1,120259380,SORL1,SNP (C/T),(C/,C,1.9,1.67,2.21,0.04716351,Low,0.027,0.414,0.353,0.005,Significant decrease (p=0.025),Significant decrease (p=0.022),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01522,rs658227,18,34436683,CD33,Insertion,-,-,1.35,1.0,1.59,0.0062222,High,0.159,0.105,0.407,0.13,No significant pattern (p=0.009),Significant decrease (p=0.041),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01523,rs779453,21,160180577,PTK2B,Deletion,-,-,0.4,0.1,0.7,0.05026498,High,0.115,0.092,0.035,0.557,Mild increase (p=0.036),Significant decrease (p=0.027),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP01524,rs789701,13,176656144,APOE,SNP (A/C),(A/,A,1.1,0.72,1.37,0.02168223,High,0.143,0.062,0.316,0.278,Significant decrease (p=0.038),No significant pattern (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP01525,rs162578,15,109965707,PTK2B,SNP (G/T),(G/,G,0.76,0.37,1.09,0.07039438,High,0.377,0.272,0.106,0.045,Mild decrease (p=0.04),Significant increase (p=0.044),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP01526,rs935413,3,111170620,APP,SNP (A/G),(A/,A,0.47,0.12,0.69,0.00661214,High,0.264,0.052,0.372,0.112,No significant pattern (p=0.034),Mild decrease (p=0.047),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP01527,rs421796,7,113374736,PICALM,SNP (A/C),(A/,A,0.76,0.51,1.11,0.08173458,Protective,0.128,0.558,0.058,0.055,Significant increase (p=0.029),No significant pattern (p=0.034),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP01528,rs592456,17,167384982,BIN1,SNP (C/T),(C/,C,1.54,1.19,1.82,0.0721219,Moderate,0.62,0.118,0.029,0.033,No significant pattern (p=0.027),Mild increase (p=0.044),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01529,rs323716,22,203625881,CD33,SNP (C/G),(C/,C,0.76,0.55,1.05,0.03409884,High,0.179,0.238,0.198,0.185,Mild decrease (p=0.017),Mild decrease (p=0.031),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01530,rs582596,19,44277742,ABCA7,Insertion,-,-,1.03,0.66,1.37,0.03689115,Moderate,0.092,0.458,0.117,0.133,Mild increase (p=0.025),Mild decrease (p=0.013),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01531,rs363124,1,230272423,APOE,SNP (C/G),(C/,C,2.2,1.97,2.48,0.02036585,Moderate,0.025,0.046,0.059,0.669,No significant pattern (p=0.027),Mild increase (p=0.011),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01532,rs570655,22,149362955,ABCA7,SNP (A/T),(A/,A,0.94,0.7,1.27,0.00074827,Low,0.014,0.139,0.33,0.316,Mild decrease (p=0.013),Significant increase (p=0.012),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP01533,rs154414,22,171786810,CR1,SNP (C/G),(C/,C,1.23,0.89,1.45,0.02961185,Moderate,0.464,0.278,0.013,0.044,Significant decrease (p=0.014),No significant pattern (p=0.031),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01534,rs423566,16,130789690,PSEN2,SNP (A/C),(A/,A,0.77,0.38,1.14,0.01223782,Protective,0.298,0.052,0.362,0.088,Significant increase (p=0.017),Significant decrease (p=0.042),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP01535,rs966981,19,134629672,PICALM,Insertion,-,-,0.43,0.21,0.68,0.13513828,Protective,0.11,0.133,0.229,0.327,Variable effect (p=0.035),Significant increase (p=0.032),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01536,rs998603,12,118306303,BIN1,SNP (G/T),(G/,G,0.76,0.39,1.1,0.0065055,Low,0.007,0.175,0.073,0.545,Variable effect (p=0.043),Mild increase (p=0.008),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01537,rs245554,17,197370173,CLU,SNP (C/T),(C/,C,0.98,0.69,1.2,0.02530954,Moderate,0.174,0.433,0.11,0.083,No significant pattern (p=0.041),Significant increase (p=0.042),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01538,rs101173,6,27366029,TREM2,SNP (G/T),(G/,G,0.38,0.1,0.59,0.00253603,High,0.321,0.131,0.072,0.276,Significant increase (p=0.033),Mild decrease (p=0.003),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP01539,rs227321,5,50366948,SORL1,Deletion,-,-,0.69,0.32,0.94,0.00728217,High,0.02,0.536,0.179,0.065,Mild decrease (p=0.027),Variable effect (p=0.049),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01540,rs418887,7,229025308,ABCA7,Insertion,-,-,2.65,2.26,2.87,0.0161278,Low,0.163,0.219,0.041,0.377,Variable effect (p=0.038),No significant pattern (p=0.01),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01541,rs660385,14,95562088,PTK2B,Deletion,-,-,1.71,1.45,2.05,0.05016921,High,0.047,0.229,0.289,0.234,Variable effect (p=0.007),No significant pattern (p=0.045),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01542,rs202504,17,136878419,PICALM,SNP (C/G),(C/,C,0.61,0.36,0.89,0.00143857,Moderate,0.079,0.111,0.428,0.182,Mild decrease (p=0.043),Mild increase (p=0.047),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01543,rs221369,20,143020779,PTK2B,SNP (C/T),(C/,C,1.9,1.53,2.28,0.00086942,Protective,0.172,0.052,0.362,0.214,No significant pattern (p=0.034),No significant pattern (p=0.034),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01544,rs428313,18,126138563,SORL1,SNP (C/T),(C/,C,0.8,0.54,1.16,0.02904897,Protective,0.332,0.14,0.196,0.133,Variable effect (p=0.033),Mild decrease (p=0.016),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01545,rs519485,6,219102174,MS4A6A,SNP (C/T),(C/,C,0.74,0.39,1.12,0.03425021,Low,0.233,0.496,0.029,0.042,Significant increase (p=0.002),Mild decrease (p=0.025),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01546,rs886665,3,23736317,APP,SNP (A/T),(A/,A,1.01,0.63,1.3,0.07434094,Moderate,0.049,0.071,0.598,0.082,Mild decrease (p=0.013),Significant decrease (p=0.05),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01547,rs678926,17,95466666,TREM2,Deletion,-,-,1.21,0.91,1.56,0.03472059,Moderate,0.517,0.163,0.094,0.026,Mild decrease (p=0.014),Significant decrease (p=0.023),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01548,rs464042,18,88234017,MS4A6A,Deletion,-,-,0.98,0.76,1.25,0.02532966,High,0.032,0.283,0.452,0.032,No significant pattern (p=0.033),No significant pattern (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01549,rs262553,17,148287288,CLU,SNP (C/G),(C/,C,1.47,1.1,1.85,0.02555612,Moderate,0.03,0.265,0.033,0.472,Mild decrease (p=0.014),Mild decrease (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01550,rs604682,21,42348821,MS4A6A,Deletion,-,-,0.69,0.34,0.93,0.0078894,Moderate,0.108,0.018,0.559,0.115,No significant pattern (p=0.016),Significant increase (p=0.048),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01551,rs326047,20,180394102,CD33,SNP (A/T),(A/,A,1.37,1.08,1.72,0.01217471,High,0.165,0.172,0.135,0.328,Variable effect (p=0.022),Variable effect (p=0.039),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01552,rs391451,14,180055846,BIN1,Insertion,-,-,3.15,2.86,3.52,0.01546285,High,0.012,0.562,0.179,0.047,Variable effect (p=0.027),Significant increase (p=0.05),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP01553,rs660141,12,63576157,APP,SNP (C/T),(C/,C,1.09,0.75,1.29,0.00434323,Protective,0.181,0.18,0.35,0.089,Variable effect (p=0.009),Mild increase (p=0.043),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP01554,rs130326,19,187713275,CR1,Insertion,-,-,0.33,0.12,0.54,0.00761253,Moderate,0.068,0.537,0.071,0.124,Mild decrease (p=0.033),Mild decrease (p=0.022),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01555,rs748024,4,64066621,PICALM,SNP (A/T),(A/,A,0.71,0.48,1.05,0.08597001,Moderate,0.143,0.177,0.005,0.476,Variable effect (p=0.04),Variable effect (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01556,rs162881,8,52568368,MS4A6A,Deletion,-,-,0.56,0.16,0.89,0.00918711,Low,0.288,0.218,0.041,0.253,No significant pattern (p=0.002),Variable effect (p=0.024),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP01557,rs876713,14,233539529,ABCA7,SNP (A/G),(A/,A,0.8,0.44,1.1,0.0743787,Moderate,0.593,0.17,0.004,0.033,Mild increase (p=0.038),Mild increase (p=0.036),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01558,rs480559,3,101654371,EPHA1,Deletion,-,-,1.94,1.67,2.2,0.027472,High,0.439,0.215,0.026,0.12,Significant decrease (p=0.03),Significant increase (p=0.022),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01559,rs876272,16,183380266,PTK2B,Deletion,-,-,2.37,2.05,2.6,0.00227962,Low,0.323,0.24,0.236,0.001,Mild decrease (p=0.038),Significant increase (p=0.011),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01560,rs258007,4,166567093,CLU,SNP (C/T),(C/,C,0.54,0.25,0.87,0.03133397,Low,0.368,0.175,0.024,0.234,Significant decrease (p=0.039),Significant decrease (p=0.022),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01561,rs829238,6,170492439,PTK2B,SNP (G/T),(G/,G,1.39,1.12,1.61,0.18180629,Moderate,0.069,0.148,0.229,0.355,Significant decrease (p=0.037),Mild decrease (p=0.011),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01562,rs621943,17,212272284,PICALM,Deletion,-,-,1.68,1.28,1.9,0.00197022,High,0.16,0.197,0.098,0.345,Variable effect (p=0.008),No significant pattern (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP01563,rs107573,1,4106627,CD2AP,SNP (A/T),(A/,A,0.79,0.43,1.0,0.0449788,Low,0.127,0.134,0.444,0.095,Significant increase (p=0.048),No significant pattern (p=0.009),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01564,rs746335,2,171861076,BIN1,SNP (C/G),(C/,C,0.72,0.51,0.96,0.01017323,High,0.065,0.345,0.096,0.294,Variable effect (p=0.024),Significant increase (p=0.043),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01565,rs369419,16,244041028,SORL1,Insertion,-,-,1.0,0.74,1.26,0.00335539,Moderate,0.339,0.075,0.297,0.089,Significant increase (p=0.026),Variable effect (p=0.045),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP01566,rs773215,17,57906486,PSEN2,SNP (A/T),(A/,A,0.66,0.3,0.87,0.01639888,Moderate,0.419,0.135,0.233,0.013,No significant pattern (p=0.019),Mild increase (p=0.028),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01567,rs880608,22,173463091,CLU,Insertion,-,-,1.04,0.72,1.34,0.04072811,Moderate,0.24,0.382,0.074,0.105,Mild increase (p=0.042),Significant decrease (p=0.049),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01568,rs624386,14,138895879,CD33,Deletion,-,-,0.36,0.11,0.7,0.01877041,Unknown,0.005,0.034,0.241,0.521,Significant increase (p=0.013),Mild decrease (p=0.003),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01569,rs932666,16,180961210,TREM2,SNP (C/G),(C/,C,1.26,1.02,1.48,0.00274783,Moderate,0.093,0.14,0.379,0.188,Significant increase (p=0.01),Significant decrease (p=0.011),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01570,rs554940,1,103989158,CD2AP,Deletion,-,-,0.57,0.27,0.82,0.01109105,Moderate,0.509,0.079,0.006,0.206,No significant pattern (p=0.038),Significant decrease (p=0.045),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01571,rs696735,18,178029221,PICALM,SNP (A/G),(A/,A,0.69,0.39,1.06,0.00128581,Low,0.497,0.15,0.035,0.118,Significant decrease (p=0.05),Mild increase (p=0.042),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP01572,rs796764,18,108005696,APP,SNP (A/C),(A/,A,0.68,0.32,0.95,0.00173567,Protective,0.011,0.02,0.656,0.113,No significant pattern (p=0.038),No significant pattern (p=0.003),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01573,rs888572,6,232251392,TREM2,SNP (G/T),(G/,G,2.03,1.75,2.27,0.04721262,Moderate,0.083,0.013,0.641,0.063,Mild increase (p=0.031),Significant decrease (p=0.015),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01574,rs121648,7,221649765,MS4A6A,SNP (G/T),(G/,G,1.11,0.73,1.4,0.04915726,High,0.19,0.514,0.089,0.007,Mild decrease (p=0.016),No significant pattern (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01575,rs192141,7,220378410,PSEN2,SNP (G/T),(G/,G,2.23,1.91,2.46,0.0254719,High,0.01,0.016,0.358,0.416,Mild increase (p=0.05),Mild increase (p=0.024),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01576,rs759131,1,110079203,EPHA1,SNP (G/T),(G/,G,0.99,0.66,1.2,0.0440396,Low,0.032,0.556,0.121,0.091,Variable effect (p=0.003),Mild decrease (p=0.004),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP01577,rs102361,13,244689798,CR1,Insertion,-,-,1.16,0.84,1.49,0.00034391,Protective,0.407,0.114,0.03,0.249,Significant decrease (p=0.039),Mild decrease (p=0.003),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01578,rs352020,16,39202919,CR1,SNP (G/T),(G/,G,0.83,0.48,1.08,0.00584388,Protective,0.285,0.073,0.177,0.266,Mild increase (p=0.018),Variable effect (p=0.034),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP01579,rs936657,4,12652959,TREM2,SNP (G/T),(G/,G,0.83,0.54,1.1,0.00428817,High,0.015,0.383,0.146,0.256,Mild increase (p=0.009),Significant decrease (p=0.027),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01580,rs164307,6,177486470,ABCA7,SNP (A/T),(A/,A,0.53,0.14,0.78,0.04674397,Low,0.062,0.145,0.397,0.196,No significant pattern (p=0.03),Significant decrease (p=0.018),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP01581,rs536915,18,44744096,PTK2B,SNP (C/G),(C/,C,0.64,0.29,1.02,0.01604739,Moderate,0.002,0.233,0.046,0.519,Variable effect (p=0.028),Significant increase (p=0.007),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01582,rs395797,1,234056030,ABCA7,SNP (C/G),(C/,C,0.72,0.32,0.98,0.08976183,Moderate,0.113,0.241,0.039,0.407,Mild decrease (p=0.035),Variable effect (p=0.006),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01583,rs727268,13,43096460,APOE,Deletion,-,-,1.92,1.58,2.19,0.01218444,Low,0.095,0.059,0.4,0.246,Variable effect (p=0.014),Mild increase (p=0.027),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01584,rs853134,18,205740702,MS4A6A,SNP (G/T),(G/,G,0.82,0.43,1.17,0.12334228,Moderate,0.164,0.264,0.32,0.052,Significant decrease (p=0.022),No significant pattern (p=0.019),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01585,rs533057,20,135697142,PTK2B,SNP (A/T),(A/,A,0.57,0.3,0.93,0.00228953,Low,0.208,0.256,0.213,0.123,Mild decrease (p=0.042),No significant pattern (p=0.026),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01586,rs752135,20,94918224,CD2AP,SNP (A/T),(A/,A,0.73,0.47,0.99,0.07767954,Moderate,0.074,0.434,0.286,0.007,Mild increase (p=0.027),No significant pattern (p=0.003),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP01587,rs700152,6,125312467,CD33,Insertion,-,-,0.72,0.49,1.05,0.05685507,Moderate,0.41,0.071,0.233,0.087,Mild decrease (p=0.049),Significant decrease (p=0.026),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01588,rs804675,8,140348653,TREM2,SNP (A/G),(A/,A,0.52,0.18,0.83,0.13041396,High,0.051,0.212,0.243,0.294,Mild increase (p=0.023),Variable effect (p=0.033),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01589,rs993287,10,81247290,EPHA1,SNP (A/T),(A/,A,1.45,1.23,1.66,0.01560308,High,0.676,0.014,0.108,0.003,Mild decrease (p=0.035),Significant increase (p=0.03),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01590,rs172432,13,193314992,APP,SNP (C/T),(C/,C,0.75,0.49,1.13,0.0679415,Low,0.245,0.134,0.238,0.183,Mild decrease (p=0.017),Mild increase (p=0.022),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01591,rs873981,8,204205492,APP,SNP (C/T),(C/,C,0.7,0.47,1.07,0.00181522,Low,0.232,0.317,0.043,0.208,Mild increase (p=0.04),Significant decrease (p=0.026),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01592,rs107127,2,181868529,CD2AP,SNP (G/T),(G/,G,0.78,0.44,1.1,0.02413289,High,0.262,0.195,0.262,0.082,Mild decrease (p=0.038),No significant pattern (p=0.046),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01593,rs220030,2,127465278,ABCA7,SNP (C/G),(C/,C,1.33,1.02,1.57,0.09097088,Low,0.258,0.039,0.473,0.03,Mild increase (p=0.049),Mild increase (p=0.038),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP01594,rs164729,10,51292123,CD2AP,SNP (C/G),(C/,C,2.63,2.26,2.9,0.07861845,Moderate,0.12,0.146,0.405,0.129,Variable effect (p=0.003),Significant increase (p=0.028),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01595,rs778465,9,189697160,BIN1,SNP (C/G),(C/,C,1.42,1.06,1.63,0.06139283,Moderate,0.168,0.488,0.083,0.061,No significant pattern (p=0.008),Significant increase (p=0.004),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01596,rs177247,22,107248820,SORL1,SNP (C/T),(C/,C,0.93,0.72,1.18,0.02162128,Low,0.079,0.011,0.154,0.556,Variable effect (p=0.032),Mild increase (p=0.01),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP01597,rs969748,10,75865099,PSEN2,SNP (A/C),(A/,A,1.08,0.78,1.46,0.0086591,High,0.021,0.222,0.222,0.334,Mild increase (p=0.037),Significant increase (p=0.003),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01598,rs251641,8,24380153,PICALM,SNP (A/C),(A/,A,1.51,1.21,1.73,0.00159948,Low,0.447,0.096,0.181,0.076,Variable effect (p=0.016),Mild decrease (p=0.012),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01599,rs176592,16,178143386,APOE,Deletion,-,-,1.4,1.18,1.67,0.03219433,Low,0.525,0.038,0.214,0.023,No significant pattern (p=0.028),Significant increase (p=0.009),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01600,rs673206,11,107009108,CD2AP,SNP (G/T),(G/,G,2.75,2.36,3.03,0.01354372,Protective,0.186,0.376,0.154,0.084,Mild increase (p=0.034),Significant decrease (p=0.027),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01601,rs642862,12,203231767,PTK2B,SNP (A/C),(A/,A,0.92,0.65,1.22,0.02032187,Unknown,0.226,0.061,0.415,0.099,Significant increase (p=0.014),Significant decrease (p=0.014),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01602,rs961004,3,242338937,PTK2B,SNP (A/G),(A/,A,0.69,0.37,1.01,0.05915287,Low,0.034,0.047,0.202,0.518,Variable effect (p=0.007),Significant increase (p=0.025),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01603,rs639117,2,80716629,CD33,SNP (A/T),(A/,A,1.55,1.3,1.77,0.05919766,High,0.005,0.165,0.615,0.016,Significant increase (p=0.013),Significant decrease (p=0.042),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01604,rs417132,17,147796131,PTK2B,Deletion,-,-,0.75,0.35,1.14,0.02665859,Moderate,0.486,0.02,0.023,0.271,No significant pattern (p=0.016),Mild increase (p=0.022),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01605,rs415628,12,247177124,CD33,SNP (C/G),(C/,C,0.49,0.19,0.85,0.01102714,High,0.153,0.084,0.209,0.354,No significant pattern (p=0.04),Mild decrease (p=0.011),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01606,rs544451,4,60644244,BIN1,SNP (C/G),(C/,C,1.56,1.3,1.95,0.0630522,Moderate,0.299,0.07,0.158,0.273,Mild decrease (p=0.048),Significant increase (p=0.019),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP01607,rs407298,14,46068050,APOE,Deletion,-,-,0.66,0.39,1.0,0.10057132,Low,0.204,0.234,0.114,0.248,Mild decrease (p=0.022),Mild increase (p=0.044),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01608,rs315832,5,227695743,APOE,SNP (A/G),(A/,A,0.89,0.56,1.24,0.0002955,High,0.044,0.023,0.535,0.198,Mild decrease (p=0.015),No significant pattern (p=0.035),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01609,rs713194,15,99153453,CD2AP,Deletion,-,-,0.62,0.36,1.02,0.0101083,Unknown,0.058,0.009,0.493,0.241,Significant decrease (p=0.024),Mild increase (p=0.022),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01610,rs505286,14,208539272,PICALM,SNP (A/G),(A/,A,0.97,0.6,1.29,0.0331731,High,0.109,0.523,0.045,0.123,Mild decrease (p=0.044),Mild decrease (p=0.008),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP01611,rs579174,1,108176900,ABCA7,SNP (A/T),(A/,A,0.86,0.49,1.24,0.14955555,High,0.038,0.425,0.27,0.067,No significant pattern (p=0.01),Significant decrease (p=0.048),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01612,rs213799,1,40284174,APP,SNP (A/T),(A/,A,1.02,0.7,1.4,0.00344253,High,0.3,0.026,0.224,0.25,Mild decrease (p=0.016),Significant increase (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01613,rs926122,18,105026579,MS4A6A,Deletion,-,-,0.79,0.47,1.08,0.00538483,Protective,0.169,0.225,0.116,0.29,Mild decrease (p=0.037),Variable effect (p=0.026),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP01614,rs734678,16,234246121,CLU,SNP (C/T),(C/,C,1.19,0.84,1.46,0.00019018,Protective,0.264,0.274,0.218,0.043,Significant decrease (p=0.041),Mild decrease (p=0.023),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01615,rs167892,8,87143342,BIN1,SNP (A/T),(A/,A,0.55,0.29,0.92,0.03784173,Low,0.2,0.148,0.077,0.375,Mild decrease (p=0.048),Significant decrease (p=0.011),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01616,rs190081,1,9773596,MS4A6A,Insertion,-,-,0.66,0.39,0.97,0.06547298,Low,0.015,0.39,0.156,0.239,Mild decrease (p=0.012),Mild increase (p=0.031),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP01617,rs668364,10,74085746,CLU,Deletion,-,-,0.96,0.7,1.22,0.01962684,Moderate,0.491,0.236,0.014,0.059,Mild increase (p=0.02),Variable effect (p=0.036),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01618,rs456188,16,12405175,CLU,SNP (A/G),(A/,A,0.86,0.64,1.11,0.05974964,Moderate,0.424,0.065,0.083,0.228,Mild decrease (p=0.038),No significant pattern (p=0.027),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01619,rs772181,21,238778967,CLU,SNP (A/C),(A/,A,0.61,0.24,0.9,0.00302308,Low,0.489,0.102,0.101,0.108,Significant decrease (p=0.048),Mild increase (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01620,rs366009,8,184766187,TREM2,SNP (A/C),(A/,A,0.4,0.2,0.67,0.06252394,Moderate,0.013,0.264,0.091,0.432,Variable effect (p=0.004),Significant increase (p=0.02),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01621,rs697191,6,81321536,APP,Deletion,-,-,0.9,0.68,1.14,0.05241508,High,0.068,0.05,0.007,0.676,Significant decrease (p=0.04),Mild increase (p=0.046),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01622,rs316161,14,79257820,PTK2B,Insertion,-,-,0.98,0.69,1.34,0.01557663,Unknown,0.309,0.322,0.058,0.11,No significant pattern (p=0.007),Variable effect (p=0.005),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01623,rs452145,16,135479912,APP,Insertion,-,-,1.38,1.15,1.64,0.06034773,Moderate,0.028,0.003,0.515,0.254,Mild increase (p=0.049),Significant increase (p=0.044),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP01624,rs568609,8,168309943,MS4A6A,SNP (C/G),(C/,C,0.97,0.59,1.22,0.00283369,High,0.331,0.246,0.214,0.009,Mild decrease (p=0.022),No significant pattern (p=0.032),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01625,rs484305,19,60350731,APP,SNP (G/T),(G/,G,0.54,0.31,0.9,0.07611589,Low,0.053,0.082,0.631,0.034,Significant increase (p=0.002),No significant pattern (p=0.035),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01626,rs954727,8,218299547,APOE,SNP (A/C),(A/,A,0.67,0.28,0.95,0.03460643,High,0.198,0.083,0.372,0.147,No significant pattern (p=0.02),Significant decrease (p=0.031),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01627,rs613947,10,119032844,SORL1,SNP (A/G),(A/,A,1.32,0.97,1.68,0.04971129,Protective,0.027,0.085,0.445,0.243,Significant increase (p=0.018),Significant increase (p=0.043),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01628,rs488841,16,112359152,APP,SNP (A/G),(A/,A,1.71,1.51,1.92,0.00182122,Low,0.148,0.047,0.587,0.018,Significant decrease (p=0.015),Significant decrease (p=0.029),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01629,rs691929,17,64056545,PICALM,SNP (C/T),(C/,C,0.67,0.33,1.06,0.03258452,High,0.366,0.1,0.232,0.102,Mild decrease (p=0.028),Variable effect (p=0.024),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01630,rs513022,6,1210527,APOE,Deletion,-,-,0.71,0.4,1.0,0.03304743,High,0.092,0.176,0.376,0.155,Significant decrease (p=0.039),Significant increase (p=0.048),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01631,rs540985,2,78634030,BIN1,SNP (C/G),(C/,C,1.09,0.85,1.3,0.05691057,High,0.25,0.126,0.407,0.017,Variable effect (p=0.004),Variable effect (p=0.039),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01632,rs996983,3,27101159,BIN1,SNP (G/T),(G/,G,1.4,1.09,1.67,0.00679735,High,0.078,0.551,0.128,0.043,Variable effect (p=0.034),Variable effect (p=0.023),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01633,rs377940,7,91097597,EPHA1,Insertion,-,-,2.15,1.84,2.38,0.00101536,Low,0.224,0.377,0.197,0.002,No significant pattern (p=0.033),No significant pattern (p=0.016),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01634,rs297496,3,29414354,PSEN2,SNP (A/G),(A/,A,1.91,1.69,2.14,0.00575926,High,0.041,0.308,0.297,0.155,Variable effect (p=0.004),Mild decrease (p=0.04),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01635,rs552323,15,218227167,EPHA1,SNP (A/G),(A/,A,1.22,0.98,1.49,0.06361955,High,0.236,0.383,0.019,0.161,Variable effect (p=0.045),Significant increase (p=0.026),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP01636,rs300520,9,234582363,CLU,SNP (A/T),(A/,A,1.87,1.53,2.22,0.02706024,Low,0.532,0.023,0.148,0.097,Mild increase (p=0.008),Significant decrease (p=0.015),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP01637,rs187661,5,193186296,APOE,SNP (A/G),(A/,A,0.83,0.54,1.2,0.0032368,Unknown,0.28,0.069,0.188,0.262,Significant decrease (p=0.007),Significant decrease (p=0.018),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01638,rs278793,20,158357497,APP,SNP (G/T),(G/,G,0.7,0.32,0.99,0.07281578,Unknown,0.149,0.275,0.119,0.258,Mild increase (p=0.047),Significant increase (p=0.045),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01639,rs298678,17,71161971,CD33,SNP (C/G),(C/,C,0.73,0.52,1.01,0.06007163,Moderate,0.065,0.029,0.148,0.559,Significant increase (p=0.004),Significant increase (p=0.018),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01640,rs959875,1,10848795,ABCA7,SNP (G/T),(G/,G,1.18,0.81,1.41,0.0057949,Moderate,0.172,0.014,0.122,0.492,Mild decrease (p=0.005),No significant pattern (p=0.036),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01641,rs433669,15,242689569,CD2AP,SNP (A/C),(A/,A,1.24,0.96,1.45,0.00542451,Protective,0.074,0.05,0.235,0.441,Variable effect (p=0.021),Mild increase (p=0.046),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01642,rs981470,21,149540154,CD2AP,SNP (C/T),(C/,C,0.93,0.7,1.23,0.03840632,Moderate,0.537,0.111,0.103,0.049,Significant increase (p=0.04),Mild decrease (p=0.007),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01643,rs800505,6,56313739,EPHA1,SNP (A/G),(A/,A,1.25,0.93,1.52,0.07732863,Low,0.014,0.511,0.1,0.174,No significant pattern (p=0.018),Significant decrease (p=0.025),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP01644,rs526627,17,100356747,TREM2,SNP (G/T),(G/,G,1.47,1.17,1.73,0.00128767,High,0.491,0.033,0.129,0.147,No significant pattern (p=0.02),Mild decrease (p=0.037),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP01645,rs216199,17,20976634,ABCA7,SNP (C/G),(C/,C,2.58,2.2,2.85,0.00135095,Moderate,0.651,0.045,0.085,0.019,Mild increase (p=0.016),Significant decrease (p=0.019),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01646,rs428840,7,164713511,MS4A6A,SNP (G/T),(G/,G,1.17,0.83,1.4,0.01747456,Protective,0.09,0.031,0.569,0.11,Variable effect (p=0.034),Variable effect (p=0.021),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01647,rs468171,16,66509193,EPHA1,SNP (A/T),(A/,A,0.64,0.42,0.99,0.0410629,Moderate,0.02,0.58,0.07,0.13,No significant pattern (p=0.036),Mild increase (p=0.012),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP01648,rs937439,8,85142596,PICALM,SNP (A/G),(A/,A,0.64,0.38,1.02,0.06211064,High,0.082,0.329,0.197,0.192,Significant decrease (p=0.037),Significant increase (p=0.005),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01649,rs151608,17,195472403,CD33,SNP (G/T),(G/,G,1.67,1.42,2.06,0.04422545,Moderate,0.255,0.338,0.104,0.103,Significant decrease (p=0.022),Significant increase (p=0.031),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01650,rs593059,4,231913853,SORL1,SNP (A/T),(A/,A,0.57,0.18,0.88,1.974e-05,High,0.262,0.23,0.197,0.111,Significant increase (p=0.024),Mild increase (p=0.045),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01651,rs212302,7,136082081,ABCA7,Insertion,-,-,1.12,0.87,1.45,0.0004247,Protective,0.107,0.041,0.303,0.35,Mild decrease (p=0.015),Mild increase (p=0.025),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP01652,rs385602,19,186447787,MS4A6A,SNP (A/C),(A/,A,1.98,1.65,2.3,0.0185515,Low,0.128,0.14,0.04,0.493,Mild increase (p=0.042),Mild decrease (p=0.029),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01653,rs625795,16,36297209,CLU,SNP (A/C),(A/,A,1.9,1.68,2.16,0.03716683,Moderate,0.392,0.098,0.153,0.157,Mild decrease (p=0.021),No significant pattern (p=0.022),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01654,rs547942,16,43840216,PTK2B,Deletion,-,-,0.57,0.3,0.87,0.00353466,Protective,0.253,0.117,0.251,0.179,Significant decrease (p=0.022),Significant increase (p=0.012),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01655,rs250292,1,158788927,SORL1,SNP (C/G),(C/,C,0.91,0.65,1.29,0.03954492,Unknown,0.145,0.019,0.331,0.305,Mild increase (p=0.017),Variable effect (p=0.045),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01656,rs981063,20,47913876,CD33,Deletion,-,-,1.13,0.86,1.44,0.01147536,High,0.09,0.194,0.147,0.369,Mild increase (p=0.004),Significant increase (p=0.003),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01657,rs152625,1,192748346,CR1,SNP (A/T),(A/,A,1.23,0.91,1.52,0.03414798,Low,0.103,0.278,0.14,0.279,Variable effect (p=0.006),Variable effect (p=0.019),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01658,rs556621,3,230418601,PSEN2,SNP (A/T),(A/,A,0.66,0.35,0.86,0.03933033,High,0.142,0.044,0.568,0.046,Mild decrease (p=0.003),Significant decrease (p=0.023),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP01659,rs544970,14,232458123,PICALM,Insertion,-,-,0.85,0.46,1.22,0.06406359,High,0.292,0.159,0.22,0.128,Mild increase (p=0.019),Significant decrease (p=0.046),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01660,rs349615,9,97846015,CD2AP,SNP (G/T),(G/,G,1.79,1.47,2.19,0.0419987,Moderate,0.313,0.181,0.263,0.043,No significant pattern (p=0.025),Variable effect (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP01661,rs245828,5,126598505,MS4A6A,SNP (C/G),(C/,C,3.31,2.95,3.58,0.00680792,Moderate,0.147,0.227,0.148,0.278,Significant decrease (p=0.013),Significant decrease (p=0.005),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP01662,rs333463,17,216790178,CLU,SNP (G/T),(G/,G,1.26,1.06,1.48,0.00947898,Unknown,0.027,0.149,0.241,0.383,Variable effect (p=0.005),No significant pattern (p=0.041),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP01663,rs809999,10,86893359,APP,Insertion,-,-,0.76,0.41,1.0,0.01241437,Low,0.262,0.425,0.097,0.016,No significant pattern (p=0.028),Mild increase (p=0.02),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01664,rs202452,16,248645629,PTK2B,SNP (C/T),(C/,C,0.63,0.38,0.85,0.09801571,Low,0.098,0.056,0.391,0.254,No significant pattern (p=0.005),No significant pattern (p=0.012),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01665,rs170692,5,228488849,PTK2B,SNP (A/T),(A/,A,2.33,2.05,2.66,0.01451083,High,0.006,0.225,0.392,0.177,Significant increase (p=0.035),Mild decrease (p=0.021),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01666,rs582041,20,211453023,PSEN2,SNP (C/G),(C/,C,0.96,0.57,1.26,0.00096336,High,0.132,0.429,0.063,0.176,Mild decrease (p=0.024),Significant decrease (p=0.037),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01667,rs841518,3,186118341,EPHA1,SNP (A/C),(A/,A,0.82,0.58,1.07,0.0359334,Moderate,0.139,0.307,0.249,0.104,Mild increase (p=0.048),Mild decrease (p=0.017),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01668,rs448914,8,145581260,APP,SNP (C/T),(C/,C,1.65,1.34,1.99,0.06725413,Moderate,0.076,0.706,0.009,0.009,Mild increase (p=0.048),Significant increase (p=0.034),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01669,rs587626,8,234483408,CD33,SNP (A/T),(A/,A,0.67,0.28,0.94,0.03573078,High,0.059,0.218,0.229,0.294,No significant pattern (p=0.032),Significant decrease (p=0.019),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01670,rs638534,2,183221006,CD2AP,Deletion,-,-,1.0,0.68,1.28,0.04894953,Moderate,0.141,0.029,0.57,0.06,Significant increase (p=0.002),Significant decrease (p=0.027),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01671,rs919361,21,207566608,PICALM,SNP (C/G),(C/,C,1.45,1.06,1.75,0.03526225,Moderate,0.169,0.004,0.075,0.552,Mild increase (p=0.038),Variable effect (p=0.046),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01672,rs228986,5,198700411,PICALM,SNP (C/G),(C/,C,0.81,0.42,1.19,0.01038151,Moderate,0.237,0.33,0.18,0.054,Significant increase (p=0.005),Significant increase (p=0.002),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP01673,rs224086,6,39999971,MS4A6A,SNP (A/C),(A/,A,0.8,0.56,1.05,0.0193637,Moderate,0.246,0.428,0.112,0.014,Significant increase (p=0.017),Mild increase (p=0.046),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01674,rs753051,21,91016925,CR1,SNP (G/T),(G/,G,0.97,0.58,1.31,0.01312935,High,0.56,0.096,0.093,0.051,Significant decrease (p=0.024),Significant decrease (p=0.028),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01675,rs347696,8,22733607,SORL1,SNP (C/G),(C/,C,1.05,0.77,1.37,0.0148206,Low,0.019,0.09,0.398,0.294,No significant pattern (p=0.032),Significant decrease (p=0.028),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01676,rs242133,3,62921079,CLU,Deletion,-,-,0.38,0.18,0.63,0.01080488,Low,0.051,0.046,0.072,0.631,Variable effect (p=0.02),No significant pattern (p=0.03),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01677,rs302510,22,167456299,TREM2,SNP (G/T),(G/,G,1.08,0.69,1.42,0.03013461,Low,0.078,0.523,0.181,0.018,Mild decrease (p=0.017),Mild increase (p=0.007),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01678,rs274261,17,196019235,APOE,SNP (C/T),(C/,C,0.79,0.4,1.18,0.00468753,Moderate,0.042,0.197,0.348,0.212,Variable effect (p=0.032),Significant increase (p=0.021),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01679,rs347314,8,87638810,CLU,Deletion,-,-,0.96,0.64,1.27,0.01060071,Moderate,0.268,0.339,0.17,0.023,Mild increase (p=0.029),No significant pattern (p=0.047),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01680,rs936576,5,158178429,CLU,SNP (C/G),(C/,C,0.78,0.43,1.07,0.00370629,Low,0.184,0.372,0.027,0.217,Variable effect (p=0.003),Mild increase (p=0.042),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01681,rs836238,1,193649267,PTK2B,SNP (C/G),(C/,C,1.15,0.83,1.47,0.01460105,High,0.469,0.023,0.024,0.284,Significant increase (p=0.008),Significant decrease (p=0.024),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01682,rs568611,16,164904752,APP,SNP (A/T),(A/,A,0.8,0.47,1.18,0.00486788,Moderate,0.0,0.15,0.636,0.013,Mild increase (p=0.034),Significant increase (p=0.026),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01683,rs693256,7,212113632,APP,Insertion,-,-,1.43,1.16,1.75,0.01047045,Moderate,0.18,0.174,0.179,0.267,Significant increase (p=0.019),Mild decrease (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01684,rs733121,21,41547656,APOE,SNP (A/C),(A/,A,1.23,0.94,1.57,0.03209186,High,0.239,0.338,0.205,0.018,Significant decrease (p=0.012),Significant increase (p=0.02),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01685,rs263943,20,99765620,TREM2,Deletion,-,-,1.16,0.86,1.47,0.01788266,Moderate,0.329,0.124,0.127,0.219,Variable effect (p=0.036),Significant increase (p=0.006),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP01686,rs133052,8,217724530,MS4A6A,SNP (C/G),(C/,C,1.55,1.28,1.94,0.12592739,Protective,0.031,0.295,0.19,0.283,Mild decrease (p=0.05),Mild decrease (p=0.048),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP01687,rs462315,22,71008051,TREM2,SNP (A/G),(A/,A,0.86,0.5,1.17,0.01603051,Moderate,0.286,0.146,0.042,0.325,Mild decrease (p=0.031),No significant pattern (p=0.009),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01688,rs765839,1,68100724,PICALM,SNP (A/G),(A/,A,1.97,1.73,2.2,0.03209701,Moderate,0.462,0.3,0.022,0.016,No significant pattern (p=0.036),Significant increase (p=0.045),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01689,rs649035,18,236146641,APOE,SNP (A/C),(A/,A,1.0,0.77,1.29,0.03061494,Moderate,0.075,0.002,0.141,0.582,Variable effect (p=0.035),No significant pattern (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01690,rs365839,11,191776187,PSEN2,SNP (G/T),(G/,G,1.48,1.17,1.76,0.00722671,Moderate,0.505,0.055,0.107,0.133,Mild decrease (p=0.009),No significant pattern (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01691,rs994671,10,20697252,APOE,Insertion,-,-,0.92,0.72,1.31,0.00936048,High,0.266,0.042,0.467,0.025,Significant decrease (p=0.041),Significant increase (p=0.025),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01692,rs584214,10,158757801,SORL1,SNP (C/G),(C/,C,0.46,0.16,0.78,0.01072714,High,0.276,0.176,0.017,0.331,Mild decrease (p=0.041),Significant increase (p=0.041),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01693,rs520041,2,82772277,SORL1,SNP (A/G),(A/,A,0.96,0.7,1.24,0.03506387,Protective,0.061,0.359,0.002,0.379,Significant decrease (p=0.009),No significant pattern (p=0.037),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP01694,rs811158,1,150733289,PTK2B,SNP (A/T),(A/,A,0.64,0.36,0.98,0.01450935,Low,0.003,0.071,0.589,0.137,Mild decrease (p=0.024),Significant decrease (p=0.02),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01695,rs195549,12,128252782,APOE,SNP (C/G),(C/,C,1.92,1.68,2.3,0.09028841,Moderate,0.163,0.182,0.291,0.164,Variable effect (p=0.002),No significant pattern (p=0.015),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01696,rs600395,3,239008471,PTK2B,SNP (A/G),(A/,A,1.49,1.19,1.78,0.0212782,Unknown,0.478,0.035,0.284,0.004,Significant increase (p=0.05),Mild increase (p=0.032),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01697,rs929084,20,93782440,TREM2,SNP (C/G),(C/,C,1.32,1.07,1.52,0.02467605,Moderate,0.38,0.269,0.098,0.053,Significant decrease (p=0.016),Mild increase (p=0.02),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01698,rs509507,6,170066017,PSEN2,Insertion,-,-,1.81,1.44,2.09,0.02480302,High,0.163,0.044,0.228,0.365,Significant decrease (p=0.033),Mild increase (p=0.014),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01699,rs742153,6,123779185,APP,SNP (A/T),(A/,A,0.75,0.5,1.0,0.02645923,Low,0.061,0.143,0.018,0.578,No significant pattern (p=0.028),No significant pattern (p=0.026),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP01700,rs730852,12,209498071,CD2AP,Deletion,-,-,0.43,0.13,0.78,0.0056257,High,0.009,0.516,0.252,0.023,No significant pattern (p=0.016),Significant increase (p=0.036),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01701,rs264282,13,157999074,CLU,Insertion,-,-,1.25,0.88,1.51,0.07731104,Protective,0.413,0.196,0.024,0.167,No significant pattern (p=0.018),Mild decrease (p=0.02),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01702,rs114759,4,221739149,PTK2B,SNP (G/T),(G/,G,0.79,0.59,1.02,0.0617479,High,0.457,0.106,0.051,0.186,No significant pattern (p=0.02),Variable effect (p=0.011),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP01703,rs417531,18,42539761,CD33,SNP (C/T),(C/,C,0.63,0.23,0.85,0.05777256,Moderate,0.14,0.076,0.263,0.322,Significant decrease (p=0.048),Significant increase (p=0.049),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP01704,rs840060,19,154835912,PICALM,SNP (C/G),(C/,C,1.18,0.9,1.51,0.01308782,Moderate,0.407,0.136,0.039,0.218,Mild increase (p=0.005),Mild increase (p=0.015),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP01705,rs238559,9,219233918,PSEN2,SNP (A/G),(A/,A,1.03,0.64,1.3,0.04571452,High,0.16,0.082,0.513,0.046,Significant decrease (p=0.012),No significant pattern (p=0.005),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01706,rs489677,17,203093125,CD2AP,SNP (G/T),(G/,G,0.55,0.28,0.79,0.0010228,High,0.412,0.067,0.028,0.292,Mild decrease (p=0.004),Mild increase (p=0.041),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01707,rs374441,5,30855483,PTK2B,SNP (G/T),(G/,G,0.88,0.63,1.28,0.04589861,Protective,0.149,0.265,0.009,0.377,No significant pattern (p=0.027),Significant increase (p=0.044),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01708,rs167106,22,28834445,CD33,SNP (C/T),(C/,C,1.11,0.78,1.42,0.0960211,High,0.148,0.326,0.303,0.024,Variable effect (p=0.01),Mild decrease (p=0.019),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP01709,rs872009,13,81131754,CR1,Deletion,-,-,1.34,1.07,1.62,0.05718545,Unknown,0.669,0.057,0.073,0.001,Significant decrease (p=0.014),No significant pattern (p=0.002),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01710,rs445373,8,27816139,APOE,SNP (A/G),(A/,A,0.77,0.37,1.15,0.03695518,Moderate,0.068,0.155,0.47,0.106,Mild increase (p=0.038),Mild decrease (p=0.036),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01711,rs467477,11,49074218,APOE,SNP (G/T),(G/,G,2.01,1.67,2.4,0.00465189,Low,0.156,0.329,0.033,0.282,No significant pattern (p=0.014),Mild increase (p=0.017),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01712,rs179740,12,7111625,MS4A6A,SNP (A/G),(A/,A,1.69,1.48,1.95,0.04402915,Protective,0.1,0.169,0.146,0.385,Mild decrease (p=0.029),No significant pattern (p=0.046),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01713,rs563616,11,91598182,CR1,SNP (A/G),(A/,A,1.21,0.93,1.42,0.04280266,Low,0.434,0.007,0.148,0.211,Variable effect (p=0.008),No significant pattern (p=0.006),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP01714,rs220481,17,175457791,PICALM,Deletion,-,-,0.72,0.33,0.96,0.01113774,Moderate,0.257,0.182,0.077,0.284,Mild decrease (p=0.03),Variable effect (p=0.027),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01715,rs447404,18,6074592,APP,SNP (A/G),(A/,A,1.75,1.43,2.11,0.04004601,Low,0.082,0.504,0.096,0.118,Significant decrease (p=0.032),Variable effect (p=0.035),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP01716,rs495443,17,117052433,CR1,SNP (A/C),(A/,A,1.01,0.77,1.33,0.03586891,Low,0.096,0.012,0.413,0.278,Mild decrease (p=0.042),Significant increase (p=0.041),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP01717,rs647829,13,10745912,CD33,SNP (C/T),(C/,C,0.97,0.77,1.36,0.03980544,Low,0.098,0.159,0.495,0.049,Mild decrease (p=0.02),Mild decrease (p=0.014),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP01718,rs325347,6,120871738,SORL1,SNP (C/T),(C/,C,0.49,0.18,0.87,0.00228636,High,0.294,0.142,0.135,0.23,No significant pattern (p=0.029),Mild increase (p=0.01),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01719,rs883866,15,236681668,APP,SNP (A/T),(A/,A,2.21,1.86,2.45,0.01011162,Protective,0.387,0.129,0.259,0.026,Mild decrease (p=0.024),Mild decrease (p=0.04),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01720,rs237246,16,171371749,CD33,SNP (G/T),(G/,G,1.93,1.69,2.16,0.04714542,Low,0.075,0.016,0.478,0.231,Variable effect (p=0.021),Significant decrease (p=0.044),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01721,rs232370,6,51371644,PSEN2,Insertion,-,-,0.61,0.21,0.98,0.03848729,High,0.326,0.293,0.148,0.034,No significant pattern (p=0.025),Mild decrease (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP01722,rs119062,22,72886234,APP,Deletion,-,-,2.29,2.03,2.59,0.09522219,Moderate,0.213,0.289,0.065,0.233,Significant decrease (p=0.025),Mild increase (p=0.015),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01723,rs998267,18,111136523,CD2AP,SNP (G/T),(G/,G,0.93,0.59,1.24,0.1317984,Protective,0.06,0.724,0.009,0.007,Mild increase (p=0.032),Mild decrease (p=0.005),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01724,rs182822,6,138276544,APP,SNP (C/T),(C/,C,0.6,0.26,0.94,0.00141005,Moderate,0.029,0.286,0.193,0.292,Significant increase (p=0.023),Variable effect (p=0.017),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP01725,rs445232,9,12479469,APP,SNP (A/G),(A/,A,0.69,0.31,1.06,0.01086466,Moderate,0.003,0.062,0.528,0.207,No significant pattern (p=0.014),Mild increase (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01726,rs129890,9,169573187,CLU,SNP (G/T),(G/,G,1.33,0.98,1.73,0.03077126,Low,0.415,0.014,0.142,0.229,Mild decrease (p=0.027),Mild decrease (p=0.034),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01727,rs195441,17,246148707,CD33,SNP (G/T),(G/,G,0.41,0.18,0.76,0.07253413,Protective,0.136,0.114,0.122,0.428,Significant increase (p=0.008),Significant decrease (p=0.012),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01728,rs710385,17,20811892,TREM2,SNP (A/T),(A/,A,0.51,0.24,0.86,0.0275568,High,0.103,0.264,0.083,0.35,Significant increase (p=0.044),Mild increase (p=0.024),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01729,rs211978,9,229456856,TREM2,Insertion,-,-,1.12,0.74,1.42,0.03263638,Low,0.212,0.33,0.005,0.253,No significant pattern (p=0.048),Mild increase (p=0.011),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01730,rs530397,1,196579284,CLU,SNP (A/G),(A/,A,1.65,1.4,2.04,0.03580276,Low,0.205,0.211,0.291,0.092,Mild increase (p=0.038),Variable effect (p=0.01),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01731,rs750421,4,130597554,SORL1,SNP (A/G),(A/,A,1.3,0.96,1.5,0.03354159,Protective,0.11,0.274,0.362,0.054,Significant increase (p=0.009),Mild decrease (p=0.031),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01732,rs967970,2,223254181,MS4A6A,SNP (G/T),(G/,G,1.58,1.36,1.93,0.05533133,Low,0.121,0.127,0.293,0.26,Variable effect (p=0.05),Variable effect (p=0.01),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01733,rs550335,6,124071430,MS4A6A,SNP (C/G),(C/,C,1.43,1.11,1.71,0.0397045,Moderate,0.464,0.147,0.023,0.166,Variable effect (p=0.033),Significant increase (p=0.015),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01734,rs788650,9,215023498,BIN1,Deletion,-,-,0.53,0.21,0.87,0.09904127,Protective,0.179,0.117,0.004,0.5,No significant pattern (p=0.033),Significant increase (p=0.037),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01735,rs345218,7,149301295,BIN1,SNP (A/T),(A/,A,0.58,0.37,0.96,0.03346132,Low,0.401,0.052,0.324,0.024,Significant decrease (p=0.027),Significant decrease (p=0.029),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01736,rs111945,18,36496793,MS4A6A,SNP (A/T),(A/,A,1.12,0.75,1.37,0.00530982,Low,0.245,0.11,0.184,0.261,Variable effect (p=0.04),Mild decrease (p=0.049),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01737,rs674767,20,29151666,CLU,SNP (A/C),(A/,A,0.61,0.37,0.91,0.03922456,Moderate,0.227,0.107,0.16,0.307,Significant increase (p=0.024),No significant pattern (p=0.018),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01738,rs657169,9,110393169,PICALM,SNP (C/G),(C/,C,1.58,1.35,1.86,0.0334357,Moderate,0.128,0.52,0.069,0.084,Variable effect (p=0.005),Variable effect (p=0.026),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01739,rs443645,9,14170822,CR1,SNP (C/G),(C/,C,0.56,0.28,0.85,0.00137112,High,0.009,0.228,0.257,0.306,Mild decrease (p=0.042),Mild increase (p=0.044),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01740,rs405942,21,163417999,SORL1,Deletion,-,-,1.44,1.17,1.76,0.0056869,Low,0.665,0.045,0.068,0.022,Variable effect (p=0.007),Variable effect (p=0.019),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01741,rs895558,12,242432469,CD2AP,Deletion,-,-,0.41,0.19,0.68,0.07775628,Moderate,0.121,0.076,0.521,0.082,Mild decrease (p=0.014),Significant increase (p=0.025),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP01742,rs451446,12,47208327,MS4A6A,Insertion,-,-,1.69,1.29,2.01,0.04475073,Moderate,0.197,0.192,0.272,0.14,Significant decrease (p=0.005),No significant pattern (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP01743,rs918667,22,48026681,PICALM,SNP (A/T),(A/,A,0.61,0.26,0.89,0.00388799,Moderate,0.032,0.663,0.04,0.064,Variable effect (p=0.003),Mild increase (p=0.042),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01744,rs941005,14,47451317,APOE,SNP (A/G),(A/,A,1.15,0.81,1.36,0.00291574,High,0.016,0.134,0.624,0.027,Mild decrease (p=0.039),No significant pattern (p=0.025),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01745,rs658460,16,163198127,SORL1,SNP (C/G),(C/,C,0.97,0.72,1.34,0.03849598,Moderate,0.367,0.066,0.052,0.315,Significant decrease (p=0.026),Significant increase (p=0.023),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01746,rs123437,13,217181386,PTK2B,SNP (C/G),(C/,C,1.71,1.34,1.97,0.03492087,High,0.075,0.115,0.205,0.404,Mild decrease (p=0.006),Mild decrease (p=0.005),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01747,rs962747,21,41980154,SORL1,SNP (A/G),(A/,A,1.03,0.82,1.32,0.05276849,High,0.101,0.001,0.112,0.586,Mild decrease (p=0.033),Significant decrease (p=0.048),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP01748,rs169761,19,149625849,PTK2B,Deletion,-,-,1.17,0.87,1.45,0.00543539,Moderate,0.328,0.128,0.311,0.033,Mild increase (p=0.039),Significant increase (p=0.038),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01749,rs346317,10,202800806,CD2AP,SNP (A/C),(A/,A,1.0,0.72,1.3,0.0025034,Protective,0.194,0.292,0.273,0.041,Significant decrease (p=0.032),Significant decrease (p=0.009),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01750,rs271476,10,41653635,BIN1,SNP (C/T),(C/,C,1.85,1.59,2.23,0.01194838,Protective,0.24,0.217,0.075,0.268,Mild increase (p=0.039),Significant decrease (p=0.03),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01751,rs831382,2,10452528,SORL1,SNP (G/T),(G/,G,1.1,0.83,1.41,0.01628129,High,0.3,0.399,0.095,0.007,Mild increase (p=0.025),Significant decrease (p=0.01),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP01752,rs647132,12,189925654,BIN1,SNP (A/C),(A/,A,0.63,0.4,0.89,0.01010588,Moderate,0.096,0.145,0.258,0.301,No significant pattern (p=0.019),Variable effect (p=0.04),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01753,rs475153,4,51306175,APP,Insertion,-,-,0.75,0.36,0.99,0.01815203,High,0.539,0.025,0.087,0.149,Mild decrease (p=0.038),No significant pattern (p=0.047),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP01754,rs391483,6,67931165,TREM2,Insertion,-,-,1.6,1.35,1.85,0.03284049,Low,0.077,0.34,0.06,0.323,Mild decrease (p=0.007),Significant decrease (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01755,rs412738,14,204169051,TREM2,SNP (A/T),(A/,A,1.47,1.14,1.8,0.02063037,Moderate,0.433,0.016,0.085,0.266,Mild increase (p=0.022),Variable effect (p=0.036),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01756,rs658576,13,190606569,BIN1,SNP (G/T),(G/,G,1.15,0.78,1.47,0.03093299,High,0.113,0.072,0.586,0.029,Significant increase (p=0.029),Significant decrease (p=0.033),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01757,rs608916,17,208081973,CLU,SNP (G/T),(G/,G,1.96,1.73,2.3,0.06801235,Protective,0.172,0.065,0.488,0.075,Significant increase (p=0.044),Mild increase (p=0.026),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01758,rs663041,16,50994003,ABCA7,SNP (G/T),(G/,G,1.97,1.59,2.27,0.02937563,Moderate,0.06,0.191,0.315,0.233,Significant increase (p=0.02),Variable effect (p=0.029),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01759,rs446475,5,61401094,PICALM,SNP (G/T),(G/,G,0.99,0.74,1.32,0.00804456,Low,0.18,0.005,0.521,0.094,Mild decrease (p=0.017),Significant increase (p=0.037),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01760,rs595760,21,20997769,APP,SNP (C/G),(C/,C,1.29,1.01,1.68,0.00780887,Low,0.467,0.073,0.053,0.207,Significant decrease (p=0.018),Variable effect (p=0.022),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01761,rs369642,8,130326902,APOE,SNP (C/G),(C/,C,1.04,0.69,1.32,0.02031525,Moderate,0.038,0.368,0.126,0.268,No significant pattern (p=0.027),Mild decrease (p=0.04),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01762,rs873357,13,190867172,CD33,SNP (A/C),(A/,A,2.22,1.96,2.43,0.04672045,High,0.087,0.622,0.053,0.038,Significant decrease (p=0.003),Significant decrease (p=0.008),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01763,rs197374,11,65155538,PSEN2,Deletion,-,-,2.48,2.1,2.8,5.326e-05,Low,0.039,0.003,0.216,0.542,No significant pattern (p=0.033),Mild decrease (p=0.014),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01764,rs413188,21,135520857,MS4A6A,Deletion,-,-,0.71,0.38,0.92,0.01738299,Moderate,0.002,0.381,0.051,0.367,Variable effect (p=0.007),Mild increase (p=0.033),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01765,rs522708,12,217220442,PSEN2,SNP (A/C),(A/,A,1.03,0.63,1.42,7.848e-05,Moderate,0.368,0.038,0.39,0.004,Significant decrease (p=0.021),No significant pattern (p=0.003),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01766,rs722664,21,103493733,MS4A6A,Insertion,-,-,0.95,0.69,1.23,0.02770283,Moderate,0.106,0.152,0.005,0.537,Significant decrease (p=0.031),Variable effect (p=0.014),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP01767,rs621293,22,149424683,BIN1,SNP (A/T),(A/,A,2.58,2.34,2.84,0.06171812,High,0.09,0.011,0.674,0.025,Variable effect (p=0.018),Significant decrease (p=0.039),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01768,rs281173,15,152869231,PSEN2,SNP (C/G),(C/,C,0.66,0.34,1.05,0.04043197,Protective,0.051,0.484,0.099,0.166,Variable effect (p=0.021),Significant decrease (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01769,rs336933,1,144145377,PSEN2,Insertion,-,-,2.23,1.88,2.53,0.00283145,Moderate,0.09,0.596,0.089,0.024,Significant decrease (p=0.012),Mild increase (p=0.008),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01770,rs748253,11,155125077,CD33,SNP (G/T),(G/,G,1.37,0.99,1.57,0.00990388,High,0.366,0.25,0.112,0.072,Mild decrease (p=0.007),Mild increase (p=0.023),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01771,rs325644,19,46305840,SORL1,SNP (C/G),(C/,C,1.03,0.65,1.38,0.03508791,High,0.019,0.059,0.591,0.131,Variable effect (p=0.027),Significant increase (p=0.029),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01772,rs258838,13,121169578,CLU,Insertion,-,-,0.86,0.48,1.13,0.00765744,High,0.593,0.059,0.082,0.066,No significant pattern (p=0.04),Variable effect (p=0.013),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01773,rs354486,6,4339924,APP,SNP (A/G),(A/,A,0.84,0.59,1.09,0.05157986,Protective,0.49,0.198,0.028,0.084,Significant decrease (p=0.021),Significant decrease (p=0.037),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP01774,rs900712,5,37025681,MS4A6A,SNP (A/T),(A/,A,0.93,0.58,1.15,0.03324038,High,0.221,0.509,0.001,0.068,Variable effect (p=0.001),Variable effect (p=0.05),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01775,rs185898,22,163490705,APOE,Deletion,-,-,1.65,1.35,1.86,0.01727825,Low,0.019,0.279,0.454,0.048,Significant increase (p=0.046),Mild increase (p=0.041),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01776,rs715783,7,177575178,PTK2B,SNP (A/T),(A/,A,1.05,0.82,1.44,0.11777053,Unknown,0.164,0.428,0.173,0.034,No significant pattern (p=0.05),Significant increase (p=0.016),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01777,rs925960,11,56901973,CD2AP,SNP (C/T),(C/,C,0.39,0.1,0.66,0.02126362,Moderate,0.451,0.181,0.165,0.004,Variable effect (p=0.012),Variable effect (p=0.05),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01778,rs712959,11,40714630,ABCA7,SNP (C/G),(C/,C,2.01,1.76,2.23,0.01287029,Moderate,0.336,0.049,0.201,0.214,Mild increase (p=0.01),Mild decrease (p=0.02),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01779,rs168137,11,220846246,BIN1,SNP (A/T),(A/,A,0.93,0.61,1.3,0.0635438,Protective,0.06,0.075,0.397,0.269,Significant decrease (p=0.044),Mild increase (p=0.022),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP01780,rs508082,14,219431039,CLU,Insertion,-,-,1.41,1.06,1.77,0.07048956,Unknown,0.336,0.184,0.125,0.154,Mild increase (p=0.044),Mild increase (p=0.042),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01781,rs156383,8,205083558,CD33,SNP (A/T),(A/,A,0.79,0.54,1.05,0.0215689,Moderate,0.308,0.241,0.036,0.216,Mild decrease (p=0.019),Significant increase (p=0.036),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01782,rs155758,19,65210860,CLU,SNP (G/T),(G/,G,0.51,0.25,0.75,0.01043279,Low,0.219,0.142,0.381,0.057,Significant increase (p=0.016),Significant increase (p=0.048),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01783,rs926874,12,22499650,EPHA1,SNP (C/T),(C/,C,0.77,0.51,1.05,0.02720869,Protective,0.117,0.198,0.028,0.457,Significant increase (p=0.039),No significant pattern (p=0.037),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01784,rs805524,13,100728093,PSEN2,SNP (C/T),(C/,C,1.67,1.37,1.9,0.07167129,High,0.172,0.099,0.193,0.336,No significant pattern (p=0.042),Significant increase (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP01785,rs992248,16,77036903,PSEN2,SNP (A/C),(A/,A,1.11,0.72,1.47,0.05988998,High,0.357,0.122,0.037,0.285,Significant increase (p=0.025),Mild decrease (p=0.047),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01786,rs270784,21,136773025,CLU,SNP (A/T),(A/,A,1.1,0.83,1.31,0.01609411,High,0.466,0.275,0.057,0.002,Significant increase (p=0.043),Significant increase (p=0.002),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01787,rs671349,12,65196491,APOE,SNP (G/T),(G/,G,0.4,0.1,0.66,0.0396255,Low,0.131,0.016,0.273,0.38,Significant increase (p=0.02),Significant increase (p=0.011),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP01788,rs117341,8,132367807,EPHA1,SNP (A/T),(A/,A,0.81,0.48,1.06,0.11042284,Moderate,0.378,0.128,0.191,0.103,No significant pattern (p=0.045),Significant increase (p=0.042),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP01789,rs276590,4,175511126,MS4A6A,SNP (G/T),(G/,G,0.96,0.59,1.27,0.07281333,Moderate,0.013,0.592,0.095,0.1,Mild increase (p=0.006),Significant increase (p=0.026),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01790,rs132662,9,120520091,EPHA1,SNP (A/C),(A/,A,0.38,0.1,0.65,0.05358555,Moderate,0.051,0.012,0.419,0.318,No significant pattern (p=0.025),Mild increase (p=0.007),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01791,rs242731,22,129014776,CD2AP,Deletion,-,-,1.89,1.58,2.28,0.0153755,Moderate,0.046,0.005,0.229,0.521,Variable effect (p=0.022),Variable effect (p=0.004),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01792,rs824474,10,136092557,PSEN2,SNP (A/G),(A/,A,0.34,0.1,0.7,0.00145248,High,0.478,0.186,0.084,0.052,Significant decrease (p=0.038),Significant increase (p=0.023),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01793,rs854129,10,216505339,APOE,SNP (C/G),(C/,C,0.68,0.31,0.94,0.06319742,Moderate,0.148,0.034,0.453,0.166,Significant increase (p=0.026),No significant pattern (p=0.011),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01794,rs988361,16,85248834,PSEN2,Insertion,-,-,0.97,0.63,1.24,0.0105279,Protective,0.044,0.131,0.104,0.521,Mild increase (p=0.046),Mild decrease (p=0.013),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01795,rs598878,22,99826491,CLU,SNP (A/C),(A/,A,0.73,0.51,1.04,0.00601016,Low,0.428,0.141,0.224,0.007,Mild increase (p=0.011),Significant increase (p=0.022),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP01796,rs542703,4,119431954,CR1,Insertion,-,-,0.76,0.38,0.99,0.00851586,Low,0.429,0.103,0.027,0.241,Mild decrease (p=0.04),Variable effect (p=0.04),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP01797,rs275265,16,64475199,CD33,SNP (G/T),(G/,G,1.11,0.89,1.35,0.02946964,Low,0.105,0.341,0.262,0.092,Mild decrease (p=0.037),Variable effect (p=0.009),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01798,rs529038,3,232856405,CLU,SNP (C/T),(C/,C,0.64,0.26,0.86,0.04617157,Moderate,0.204,0.453,0.076,0.066,Significant increase (p=0.001),Variable effect (p=0.019),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01799,rs523611,18,187911912,MS4A6A,Insertion,-,-,0.43,0.1,0.8,0.0126996,Moderate,0.043,0.355,0.193,0.208,Significant increase (p=0.005),No significant pattern (p=0.002),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01800,rs508493,9,108907931,CLU,Deletion,-,-,0.72,0.4,1.07,0.04659685,Unknown,0.32,0.19,0.194,0.096,Variable effect (p=0.031),Mild decrease (p=0.048),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01801,rs416701,11,181859543,CD2AP,SNP (A/G),(A/,A,0.53,0.2,0.86,0.01976151,Moderate,0.016,0.527,0.237,0.02,Significant decrease (p=0.033),Significant decrease (p=0.024),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01802,rs455368,18,18781112,CLU,SNP (A/T),(A/,A,1.69,1.4,2.0,0.00827948,High,0.613,0.069,0.115,0.003,Mild increase (p=0.043),Mild decrease (p=0.004),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01803,rs551658,1,131641870,CD2AP,SNP (C/G),(C/,C,0.54,0.19,0.8,0.02881086,Moderate,0.277,0.143,0.257,0.123,Mild increase (p=0.023),Significant increase (p=0.025),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01804,rs943223,11,157220534,CD33,SNP (A/C),(A/,A,0.97,0.68,1.32,0.01169267,Moderate,0.0,0.059,0.583,0.157,Significant decrease (p=0.045),Variable effect (p=0.001),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01805,rs104236,15,1050482,SORL1,Deletion,-,-,0.82,0.5,1.22,0.02757234,High,0.281,0.01,0.066,0.444,Variable effect (p=0.018),Mild increase (p=0.033),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01806,rs302021,14,24627967,CR1,SNP (G/T),(G/,G,2.17,1.83,2.55,0.00208952,Low,0.163,0.409,0.033,0.195,No significant pattern (p=0.002),Mild increase (p=0.026),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01807,rs513548,18,126950290,EPHA1,SNP (C/G),(C/,C,1.82,1.51,2.09,0.07945043,High,0.245,0.054,0.456,0.046,Variable effect (p=0.003),Significant decrease (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01808,rs488467,14,223785450,SORL1,SNP (A/G),(A/,A,1.19,0.96,1.4,0.10349705,High,0.304,0.073,0.408,0.015,No significant pattern (p=0.031),No significant pattern (p=0.014),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01809,rs176671,5,169886981,APOE,Insertion,-,-,0.63,0.39,0.96,0.0044544,High,0.459,0.006,0.165,0.17,Mild decrease (p=0.014),No significant pattern (p=0.046),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01810,rs232772,13,64657925,CD2AP,SNP (A/T),(A/,A,1.4,1.07,1.61,0.02806327,High,0.128,0.242,0.299,0.132,Mild increase (p=0.045),No significant pattern (p=0.019),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01811,rs446387,7,78183820,PICALM,SNP (A/T),(A/,A,0.93,0.63,1.23,0.04324309,High,0.068,0.24,0.22,0.272,Mild decrease (p=0.017),Mild decrease (p=0.023),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP01812,rs154482,4,32558601,SORL1,SNP (C/G),(C/,C,2.05,1.82,2.42,0.0588292,Moderate,0.286,0.098,0.158,0.258,Significant increase (p=0.033),Significant increase (p=0.041),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01813,rs976505,7,182390832,PTK2B,SNP (A/G),(A/,A,2.33,1.95,2.55,0.00305999,Moderate,0.107,0.318,0.044,0.331,Mild increase (p=0.044),Significant increase (p=0.046),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01814,rs443391,6,148623670,PTK2B,Deletion,-,-,0.7,0.31,0.99,0.12579539,Low,0.572,0.028,0.161,0.04,Significant decrease (p=0.038),Variable effect (p=0.048),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01815,rs635835,10,59732149,PTK2B,SNP (G/T),(G/,G,1.38,1.14,1.77,0.01424582,Moderate,0.479,0.157,0.003,0.161,No significant pattern (p=0.04),Significant decrease (p=0.026),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01816,rs188530,19,202801618,PSEN2,Insertion,-,-,0.96,0.66,1.22,0.15595897,Moderate,0.276,0.011,0.147,0.366,No significant pattern (p=0.023),No significant pattern (p=0.038),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01817,rs388304,17,194796360,ABCA7,SNP (A/C),(A/,A,1.56,1.2,1.89,0.16982001,High,0.218,0.45,0.056,0.077,Significant increase (p=0.014),Mild increase (p=0.009),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01818,rs995295,11,118243193,PSEN2,SNP (C/G),(C/,C,1.31,1.04,1.61,0.01024542,Low,0.119,0.195,0.291,0.195,Variable effect (p=0.02),Mild decrease (p=0.001),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP01819,rs186226,21,95720105,APP,SNP (C/T),(C/,C,0.66,0.4,1.0,0.00781353,Low,0.535,0.171,0.036,0.058,No significant pattern (p=0.009),No significant pattern (p=0.04),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01820,rs879840,4,157147371,BIN1,Insertion,-,-,0.84,0.5,1.17,0.00262803,Low,0.114,0.314,0.077,0.295,Mild increase (p=0.02),Mild increase (p=0.032),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01821,rs879675,1,99833007,CD33,SNP (A/C),(A/,A,0.6,0.32,0.97,0.12010352,Moderate,0.437,0.113,0.144,0.105,Variable effect (p=0.046),No significant pattern (p=0.023),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01822,rs682470,12,34193917,CR1,SNP (A/C),(A/,A,0.94,0.66,1.23,0.01125625,High,0.036,0.114,0.196,0.455,Mild increase (p=0.036),Variable effect (p=0.028),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01823,rs387997,22,14893256,PSEN2,Deletion,-,-,0.72,0.42,1.11,0.01141568,High,0.289,0.186,0.151,0.174,No significant pattern (p=0.005),Mild increase (p=0.046),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01824,rs988018,4,117432031,CD2AP,SNP (A/C),(A/,A,1.05,0.66,1.27,0.01016891,High,0.13,0.602,0.013,0.055,Variable effect (p=0.023),Significant increase (p=0.044),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01825,rs424740,5,84933204,PSEN2,Deletion,-,-,1.35,1.07,1.68,0.01119895,Low,0.333,0.309,0.013,0.145,Variable effect (p=0.014),Variable effect (p=0.025),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01826,rs547926,12,176882850,APOE,SNP (G/T),(G/,G,0.96,0.69,1.27,0.01181074,Moderate,0.479,0.119,0.188,0.015,Mild decrease (p=0.01),No significant pattern (p=0.029),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01827,rs423990,4,143065020,CR1,SNP (A/T),(A/,A,0.89,0.51,1.22,0.00893588,Protective,0.187,0.245,0.063,0.304,No significant pattern (p=0.041),Mild increase (p=0.019),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP01828,rs171489,19,83505205,APOE,SNP (A/G),(A/,A,0.91,0.7,1.21,0.00693621,Low,0.113,0.074,0.343,0.27,Significant decrease (p=0.002),Variable effect (p=0.034),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP01829,rs498974,15,82312311,TREM2,SNP (C/T),(C/,C,0.85,0.55,1.05,0.13153972,High,0.105,0.535,0.006,0.154,Significant increase (p=0.002),Mild increase (p=0.033),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01830,rs400323,17,51156482,CR1,Deletion,-,-,1.22,0.95,1.45,0.01501748,Unknown,0.356,0.154,0.038,0.252,Significant decrease (p=0.042),Significant increase (p=0.004),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP01831,rs680073,20,1556166,MS4A6A,SNP (C/T),(C/,C,0.96,0.73,1.18,0.06795224,High,0.112,0.556,0.034,0.098,No significant pattern (p=0.01),No significant pattern (p=0.004),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01832,rs338806,14,176754608,PICALM,SNP (A/G),(A/,A,0.47,0.17,0.7,0.02805506,Moderate,0.169,0.091,0.002,0.537,No significant pattern (p=0.033),Significant increase (p=0.042),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01833,rs806733,14,105599639,BIN1,SNP (G/T),(G/,G,1.34,1.13,1.65,0.01869787,Low,0.012,0.498,0.13,0.16,Variable effect (p=0.014),Significant decrease (p=0.046),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01834,rs703352,15,135315262,CD33,SNP (G/T),(G/,G,0.76,0.44,0.99,0.01164893,High,0.032,0.157,0.553,0.057,Mild increase (p=0.012),Significant decrease (p=0.033),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01835,rs855119,11,9863770,PICALM,SNP (C/T),(C/,C,1.27,0.98,1.52,0.05718396,High,0.005,0.221,0.195,0.379,Variable effect (p=0.025),No significant pattern (p=0.046),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01836,rs195873,14,225417300,CD2AP,SNP (A/G),(A/,A,1.63,1.4,1.85,0.01213891,Protective,0.13,0.46,0.128,0.083,Significant decrease (p=0.028),Mild decrease (p=0.041),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP01837,rs404769,1,28556975,CLU,Insertion,-,-,0.48,0.14,0.78,0.01796982,Moderate,0.091,0.081,0.297,0.332,Mild increase (p=0.05),Significant increase (p=0.01),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01838,rs247370,21,176704793,TREM2,SNP (A/T),(A/,A,0.83,0.53,1.12,0.00875956,High,0.041,0.359,0.012,0.388,Mild decrease (p=0.015),Mild increase (p=0.022),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01839,rs415499,9,73800401,CLU,SNP (A/T),(A/,A,0.95,0.62,1.25,0.02680031,High,0.062,0.113,0.368,0.257,Variable effect (p=0.023),Significant increase (p=0.004),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP01840,rs532225,22,235059626,APOE,Deletion,-,-,1.1,0.87,1.46,0.04452812,High,0.026,0.376,0.164,0.234,No significant pattern (p=0.024),Significant increase (p=0.014),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01841,rs777248,11,183898358,BIN1,Deletion,-,-,2.29,1.9,2.67,0.00465138,Moderate,0.284,0.099,0.172,0.245,Significant increase (p=0.019),Variable effect (p=0.007),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01842,rs958983,19,208725855,CR1,Insertion,-,-,1.08,0.79,1.32,0.01400534,Protective,0.135,0.196,0.199,0.269,Mild decrease (p=0.018),Variable effect (p=0.006),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01843,rs767755,8,99844003,MS4A6A,Deletion,-,-,0.43,0.21,0.7,0.09735803,Moderate,0.368,0.271,0.024,0.137,Mild increase (p=0.033),Significant increase (p=0.012),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01844,rs283663,13,147287107,PSEN2,Insertion,-,-,0.48,0.22,0.79,0.04280519,Moderate,0.315,0.066,0.135,0.284,Significant increase (p=0.018),Variable effect (p=0.019),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP01845,rs108391,3,84647430,MS4A6A,SNP (A/T),(A/,A,1.48,1.26,1.86,0.00878832,Moderate,0.046,0.172,0.164,0.419,No significant pattern (p=0.025),Significant decrease (p=0.022),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP01846,rs928860,6,27860491,CD33,SNP (A/T),(A/,A,0.5,0.12,0.74,0.10338045,Low,0.315,0.02,0.105,0.36,Mild increase (p=0.02),No significant pattern (p=0.041),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01847,rs881909,7,15830066,BIN1,SNP (A/T),(A/,A,0.52,0.21,0.75,0.10994695,Moderate,0.103,0.081,0.14,0.476,Mild decrease (p=0.012),Mild decrease (p=0.05),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01848,rs550518,13,107874256,BIN1,SNP (A/C),(A/,A,0.4,0.1,0.7,0.13301461,Moderate,0.125,0.326,0.117,0.232,Variable effect (p=0.045),Significant increase (p=0.033),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01849,rs116861,13,243769472,SORL1,SNP (G/T),(G/,G,1.39,1.12,1.76,0.10137043,Moderate,0.037,0.349,0.075,0.339,Mild decrease (p=0.042),Mild decrease (p=0.021),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01850,rs958739,15,129951143,MS4A6A,SNP (C/T),(C/,C,1.25,0.87,1.64,0.07222362,Moderate,0.235,0.002,0.175,0.387,Mild decrease (p=0.044),Significant decrease (p=0.01),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP01851,rs874029,9,81185872,PSEN2,SNP (A/C),(A/,A,1.52,1.23,1.78,0.06693909,Moderate,0.132,0.402,0.18,0.086,No significant pattern (p=0.035),Mild increase (p=0.01),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP01852,rs202511,10,22998159,BIN1,SNP (G/T),(G/,G,0.84,0.5,1.08,0.06388214,Moderate,0.277,0.028,0.15,0.345,Significant decrease (p=0.042),Mild increase (p=0.049),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01853,rs175250,2,106734726,SORL1,SNP (A/T),(A/,A,3.25,3.04,3.6,0.01588371,Moderate,0.002,0.322,0.117,0.36,Mild increase (p=0.047),Significant increase (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP01854,rs427031,5,132580768,PTK2B,SNP (A/T),(A/,A,1.16,0.91,1.38,0.05515714,High,0.667,0.022,0.055,0.056,Significant increase (p=0.03),Mild decrease (p=0.026),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01855,rs451388,13,178662020,APOE,SNP (A/G),(A/,A,1.39,1.12,1.7,0.07003809,Protective,0.276,0.185,0.044,0.295,Significant decrease (p=0.038),Significant increase (p=0.02),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01856,rs439014,4,207230112,PSEN2,SNP (A/G),(A/,A,1.06,0.82,1.33,0.01084437,Moderate,0.059,0.58,0.035,0.125,Significant increase (p=0.012),Significant decrease (p=0.018),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01857,rs286950,22,207186496,MS4A6A,Deletion,-,-,0.9,0.65,1.14,0.00644162,Low,0.257,0.292,0.1,0.151,Significant decrease (p=0.04),No significant pattern (p=0.029),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01858,rs671589,18,173331024,PSEN2,Deletion,-,-,0.64,0.36,1.0,0.02550593,Moderate,0.182,0.285,0.32,0.013,Mild increase (p=0.025),Mild increase (p=0.023),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01859,rs582574,4,62802481,PICALM,SNP (A/C),(A/,A,0.42,0.15,0.77,0.01361599,High,0.264,0.135,0.104,0.298,Significant increase (p=0.031),Variable effect (p=0.023),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01860,rs501085,13,184777785,BIN1,SNP (C/G),(C/,C,1.58,1.22,1.97,0.00978226,Moderate,0.033,0.055,0.558,0.155,Variable effect (p=0.038),No significant pattern (p=0.006),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01861,rs633383,7,224852200,SORL1,SNP (A/T),(A/,A,2.02,1.81,2.33,0.01695189,Unknown,0.076,0.237,0.255,0.232,Mild increase (p=0.019),Mild decrease (p=0.032),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01862,rs637248,15,66549913,ABCA7,SNP (A/G),(A/,A,0.89,0.57,1.12,0.03815156,Moderate,0.011,0.165,0.166,0.458,Mild increase (p=0.031),Significant increase (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP01863,rs870953,7,185153180,CLU,Insertion,-,-,1.12,0.74,1.49,0.02160483,Moderate,0.017,0.048,0.697,0.038,Significant increase (p=0.002),Significant decrease (p=0.026),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP01864,rs610518,10,203813789,APP,SNP (A/T),(A/,A,1.02,0.7,1.26,0.04488985,High,0.221,0.473,0.077,0.029,Significant increase (p=0.019),Significant decrease (p=0.029),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01865,rs714781,10,158194623,PICALM,SNP (A/G),(A/,A,0.5,0.29,0.75,0.0090097,Protective,0.099,0.3,0.184,0.217,Significant decrease (p=0.025),Significant increase (p=0.01),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01866,rs756089,8,221216643,EPHA1,SNP (A/G),(A/,A,0.38,0.1,0.65,0.0779105,Moderate,0.052,0.372,0.365,0.011,Mild increase (p=0.038),Significant increase (p=0.008),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01867,rs644044,7,90107598,PSEN2,SNP (C/G),(C/,C,0.47,0.25,0.78,0.08933055,High,0.171,0.135,0.355,0.14,No significant pattern (p=0.04),No significant pattern (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01868,rs517006,18,177289327,PSEN2,SNP (A/G),(A/,A,0.56,0.21,0.79,0.00126303,High,0.284,0.234,0.142,0.14,Mild increase (p=0.035),Significant increase (p=0.006),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP01869,rs418812,5,237526579,ABCA7,SNP (G/T),(G/,G,1.22,0.98,1.58,0.037407,Moderate,0.09,0.244,0.011,0.455,Significant increase (p=0.006),Mild decrease (p=0.011),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP01870,rs805502,2,190407378,BIN1,Insertion,-,-,2.08,1.83,2.29,0.01587401,Low,0.0,0.104,0.409,0.287,Mild increase (p=0.005),Significant increase (p=0.046),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01871,rs105473,11,156083254,MS4A6A,SNP (A/C),(A/,A,1.08,0.87,1.38,0.01286252,High,0.335,0.218,0.103,0.145,No significant pattern (p=0.024),No significant pattern (p=0.015),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01872,rs603528,3,234566526,TREM2,SNP (C/T),(C/,C,2.24,2.0,2.55,0.03698487,Moderate,0.022,0.362,0.379,0.036,Mild decrease (p=0.01),Variable effect (p=0.044),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01873,rs538165,17,81935343,CR1,Deletion,-,-,1.14,0.93,1.42,0.06738597,Low,0.021,0.178,0.587,0.014,Significant decrease (p=0.03),Mild increase (p=0.034),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01874,rs608585,17,140925271,MS4A6A,SNP (A/T),(A/,A,0.68,0.3,0.99,0.11422604,Moderate,0.208,0.163,0.19,0.24,Significant increase (p=0.033),Mild decrease (p=0.017),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP01875,rs708555,1,246355039,MS4A6A,SNP (A/C),(A/,A,0.94,0.69,1.21,0.03673535,High,0.228,0.077,0.267,0.227,Significant decrease (p=0.017),Variable effect (p=0.014),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01876,rs393781,8,5483732,CD2AP,SNP (C/T),(C/,C,0.6,0.35,0.98,0.04568798,Protective,0.437,0.071,0.046,0.245,Mild decrease (p=0.022),Mild decrease (p=0.015),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01877,rs891686,5,194603594,EPHA1,SNP (A/C),(A/,A,0.88,0.64,1.17,0.00631591,Low,0.567,0.057,0.004,0.172,No significant pattern (p=0.012),Mild decrease (p=0.037),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP01878,rs132634,12,122057981,APOE,Deletion,-,-,1.62,1.35,2.01,0.07094795,Moderate,0.409,0.273,0.087,0.03,Mild decrease (p=0.013),No significant pattern (p=0.044),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01879,rs437253,11,45327861,APP,Deletion,-,-,1.85,1.45,2.07,0.05821622,High,0.094,0.119,0.183,0.403,Mild decrease (p=0.017),Variable effect (p=0.012),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01880,rs515014,16,39626205,PICALM,Deletion,-,-,0.69,0.45,1.09,0.01020275,Moderate,0.45,0.093,0.211,0.045,Variable effect (p=0.036),Variable effect (p=0.026),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01881,rs818710,22,164535551,CD2AP,SNP (A/T),(A/,A,1.08,0.68,1.3,0.02324907,High,0.281,0.222,0.111,0.185,Significant increase (p=0.036),Mild decrease (p=0.043),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP01882,rs445823,10,143688774,TREM2,SNP (C/G),(C/,C,0.78,0.55,1.16,0.01133921,Moderate,0.482,0.066,0.061,0.19,Mild decrease (p=0.045),Mild decrease (p=0.034),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01883,rs942343,3,131801097,CLU,Insertion,-,-,1.54,1.19,1.77,0.01592591,Moderate,0.251,0.316,0.191,0.043,Variable effect (p=0.031),Variable effect (p=0.006),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01884,rs383889,8,23707407,PTK2B,SNP (A/T),(A/,A,0.66,0.41,0.9,0.06549103,Moderate,0.283,0.173,0.251,0.094,Significant decrease (p=0.046),Significant increase (p=0.026),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP01885,rs220665,21,134301945,TREM2,SNP (A/G),(A/,A,0.84,0.52,1.21,0.01287453,Low,0.236,0.339,0.181,0.044,Mild increase (p=0.043),Significant increase (p=0.038),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01886,rs650842,18,31987237,SORL1,SNP (G/T),(G/,G,0.62,0.32,0.91,0.00506634,Moderate,0.443,0.041,0.175,0.141,Significant increase (p=0.005),Mild decrease (p=0.022),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01887,rs429394,4,65133610,CLU,SNP (G/T),(G/,G,0.82,0.45,1.13,0.01810944,Moderate,0.04,0.197,0.223,0.339,Mild increase (p=0.036),Mild increase (p=0.037),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01888,rs536546,3,198967830,CD33,SNP (A/T),(A/,A,0.9,0.58,1.14,0.01203322,Moderate,0.004,0.508,0.217,0.071,Mild increase (p=0.021),Significant decrease (p=0.002),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01889,rs474001,17,114779297,EPHA1,SNP (A/T),(A/,A,1.17,0.8,1.47,0.03352049,High,0.18,0.287,0.244,0.089,Mild increase (p=0.036),Variable effect (p=0.008),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01890,rs827487,2,166118841,ABCA7,Insertion,-,-,4.84,4.45,5.19,0.07842061,Moderate,0.073,0.09,0.333,0.303,Variable effect (p=0.046),Variable effect (p=0.021),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01891,rs423085,11,178529480,PTK2B,SNP (A/C),(A/,A,0.5,0.29,0.77,0.00657332,Moderate,0.259,0.215,0.033,0.293,No significant pattern (p=0.014),Variable effect (p=0.044),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01892,rs670244,21,143444332,CR1,SNP (C/G),(C/,C,0.57,0.32,0.81,0.0400297,High,0.278,0.357,0.147,0.019,Mild decrease (p=0.045),No significant pattern (p=0.004),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01893,rs684404,7,149469072,MS4A6A,SNP (A/C),(A/,A,0.98,0.61,1.32,0.05691071,Moderate,0.359,0.288,0.117,0.036,Mild increase (p=0.005),Variable effect (p=0.033),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP01894,rs713331,15,24930971,CD2AP,SNP (A/G),(A/,A,0.72,0.4,0.96,0.04640269,Moderate,0.202,0.167,0.119,0.313,Mild decrease (p=0.039),Variable effect (p=0.05),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP01895,rs355757,14,129791460,ABCA7,SNP (A/C),(A/,A,2.48,2.19,2.77,0.03839259,Moderate,0.361,0.058,0.221,0.16,Mild decrease (p=0.021),Variable effect (p=0.021),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01896,rs528993,9,51467052,BIN1,Insertion,-,-,1.62,1.23,1.86,0.06535679,Moderate,0.293,0.183,0.035,0.289,No significant pattern (p=0.005),Mild increase (p=0.012),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01897,rs281787,11,141600211,CLU,SNP (A/C),(A/,A,1.17,0.87,1.44,0.01597291,High,0.282,0.001,0.09,0.427,Variable effect (p=0.004),Mild decrease (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01898,rs845178,6,53321911,APP,Insertion,-,-,0.31,0.1,0.57,0.14431931,Protective,0.188,0.042,0.256,0.314,Significant decrease (p=0.014),Mild decrease (p=0.047),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP01899,rs419232,13,66325510,CR1,Insertion,-,-,1.94,1.6,2.21,0.00412753,High,0.085,0.509,0.19,0.015,No significant pattern (p=0.031),No significant pattern (p=0.005),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP01900,rs515330,1,176710047,CLU,SNP (A/T),(A/,A,2.29,2.02,2.5,0.08026534,High,0.008,0.45,0.195,0.147,Significant decrease (p=0.037),Variable effect (p=0.002),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01901,rs846716,19,92141770,APP,SNP (A/T),(A/,A,1.14,0.9,1.36,0.03767199,Unknown,0.511,0.014,0.026,0.249,Significant decrease (p=0.027),No significant pattern (p=0.027),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01902,rs226159,4,59060136,EPHA1,SNP (A/G),(A/,A,1.17,0.77,1.53,0.02058428,High,0.283,0.113,0.222,0.182,Significant decrease (p=0.044),Significant decrease (p=0.037),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01903,rs448011,3,80631496,APP,Insertion,-,-,1.01,0.77,1.34,0.09563141,High,0.045,0.552,0.14,0.062,No significant pattern (p=0.023),Variable effect (p=0.031),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01904,rs295002,17,242287819,PTK2B,SNP (A/T),(A/,A,1.05,0.79,1.28,0.032283,Protective,0.264,0.274,0.182,0.08,Variable effect (p=0.046),Significant increase (p=0.033),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01905,rs529375,12,14342846,EPHA1,SNP (C/T),(C/,C,1.74,1.45,2.0,0.01016263,Moderate,0.084,0.057,0.577,0.082,Mild decrease (p=0.044),Significant decrease (p=0.007),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP01906,rs817585,2,92095946,MS4A6A,SNP (G/T),(G/,G,0.9,0.67,1.24,0.00973832,Low,0.039,0.063,0.112,0.586,Variable effect (p=0.022),Significant increase (p=0.042),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP01907,rs182002,4,118758153,TREM2,Insertion,-,-,0.85,0.46,1.18,0.00293354,Protective,0.243,0.063,0.364,0.13,Variable effect (p=0.018),Significant increase (p=0.048),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01908,rs602144,12,105244577,CR1,SNP (C/T),(C/,C,0.83,0.45,1.13,0.00870954,Moderate,0.234,0.428,0.067,0.071,No significant pattern (p=0.041),Significant increase (p=0.029),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP01909,rs593352,10,63225127,PICALM,Deletion,-,-,2.02,1.64,2.24,0.00931038,High,0.101,0.223,0.237,0.239,Mild increase (p=0.02),Significant increase (p=0.046),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP01910,rs821931,17,37327783,BIN1,Insertion,-,-,1.64,1.39,2.04,0.00136543,Low,0.3,0.005,0.289,0.206,Mild decrease (p=0.043),Significant decrease (p=0.029),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP01911,rs590401,2,161154008,ABCA7,Deletion,-,-,1.1,0.76,1.4,0.08778898,Low,0.065,0.364,0.319,0.052,Variable effect (p=0.027),No significant pattern (p=0.008),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01912,rs615680,6,43499261,APOE,Insertion,-,-,0.48,0.24,0.72,0.00923931,Low,0.0,0.327,0.219,0.253,Mild increase (p=0.008),No significant pattern (p=0.03),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01913,rs937447,19,43646068,CD33,SNP (C/G),(C/,C,0.95,0.73,1.21,0.03597841,Moderate,0.147,0.413,0.124,0.116,Significant decrease (p=0.018),Significant decrease (p=0.014),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01914,rs945738,10,245478320,MS4A6A,Insertion,-,-,1.36,1.13,1.63,0.02494928,Protective,0.177,0.237,0.002,0.384,Mild decrease (p=0.036),Mild increase (p=0.003),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP01915,rs730430,3,213338813,CLU,SNP (G/T),(G/,G,1.6,1.32,1.89,0.0612045,High,0.094,0.011,0.263,0.432,Mild decrease (p=0.005),Variable effect (p=0.032),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP01916,rs588105,15,140829325,PICALM,SNP (G/T),(G/,G,2.82,2.5,3.03,0.00144777,High,0.462,0.158,0.119,0.061,Mild increase (p=0.047),Mild decrease (p=0.036),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01917,rs493076,17,20673884,ABCA7,SNP (G/T),(G/,G,1.12,0.91,1.48,0.04129547,High,0.001,0.442,0.124,0.232,Significant increase (p=0.03),Mild decrease (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01918,rs213158,16,44431017,CLU,SNP (A/T),(A/,A,0.74,0.38,1.07,0.00261687,High,0.299,0.26,0.032,0.209,No significant pattern (p=0.01),Variable effect (p=0.044),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01919,rs610802,6,45434442,CD33,SNP (A/T),(A/,A,0.97,0.65,1.36,0.09332208,High,0.031,0.026,0.367,0.375,Significant decrease (p=0.048),Significant increase (p=0.044),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP01920,rs792478,5,175476924,CLU,SNP (A/T),(A/,A,0.35,0.1,0.56,0.030616,Moderate,0.059,0.198,0.223,0.32,Mild decrease (p=0.011),Variable effect (p=0.048),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP01921,rs796332,9,246302600,PSEN2,SNP (G/T),(G/,G,0.7,0.37,0.95,0.03117164,High,0.294,0.08,0.267,0.159,Significant decrease (p=0.043),No significant pattern (p=0.05),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP01922,rs321644,17,118986367,PTK2B,SNP (A/T),(A/,A,0.58,0.34,0.82,0.01030723,High,0.532,0.073,0.095,0.099,Mild decrease (p=0.038),Significant increase (p=0.026),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01923,rs987725,3,208814631,PSEN2,SNP (A/G),(A/,A,0.52,0.13,0.84,0.00224512,High,0.14,0.254,0.323,0.083,Variable effect (p=0.011),Significant increase (p=0.002),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01924,rs599446,6,225467388,PICALM,Deletion,-,-,0.51,0.29,0.79,0.00443697,Protective,0.199,0.032,0.33,0.239,Variable effect (p=0.025),Variable effect (p=0.021),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01925,rs898796,4,234556333,PICALM,SNP (A/T),(A/,A,1.18,0.86,1.46,0.02189521,Moderate,0.519,0.197,0.081,0.002,Significant decrease (p=0.04),Mild decrease (p=0.021),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01926,rs184352,19,135952509,MS4A6A,Insertion,-,-,2.84,2.63,3.17,0.00636725,High,0.246,0.242,0.074,0.237,Significant increase (p=0.044),No significant pattern (p=0.017),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01927,rs424533,9,48921689,APP,SNP (A/T),(A/,A,0.63,0.26,0.93,0.05239661,Unknown,0.248,0.344,0.106,0.102,Mild increase (p=0.034),Mild increase (p=0.023),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01928,rs232739,5,9984538,APP,Insertion,-,-,0.62,0.32,0.94,0.0136699,High,0.288,0.023,0.173,0.316,Mild increase (p=0.024),Mild decrease (p=0.024),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01929,rs415109,9,141928736,CR1,SNP (A/C),(A/,A,1.34,1.09,1.55,0.01750939,Unknown,0.306,0.211,0.158,0.124,Variable effect (p=0.002),Significant increase (p=0.042),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01930,rs272123,15,154355691,MS4A6A,SNP (A/C),(A/,A,0.78,0.43,1.02,0.10459907,High,0.118,0.022,0.085,0.574,Variable effect (p=0.008),Mild increase (p=0.032),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01931,rs323943,5,229874990,APP,Insertion,-,-,0.59,0.37,0.91,0.00320114,High,0.415,0.025,0.252,0.108,Mild decrease (p=0.04),Significant decrease (p=0.035),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01932,rs333325,13,60497180,CLU,Deletion,-,-,1.1,0.85,1.46,0.06044574,High,0.137,0.026,0.189,0.449,Significant increase (p=0.048),Significant increase (p=0.043),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01933,rs184629,17,108082854,TREM2,SNP (C/G),(C/,C,0.83,0.46,1.08,0.00672912,Protective,0.143,0.396,0.156,0.105,Variable effect (p=0.012),No significant pattern (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01934,rs713910,17,219944446,CR1,SNP (A/G),(A/,A,1.28,0.94,1.59,0.0391791,Moderate,0.314,0.209,0.064,0.213,Significant decrease (p=0.045),Significant decrease (p=0.05),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01935,rs951749,4,212887410,APP,Deletion,-,-,1.86,1.65,2.17,0.06103475,Moderate,0.178,0.181,0.35,0.092,Mild increase (p=0.002),Mild increase (p=0.02),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01936,rs650326,8,70646433,APOE,SNP (A/T),(A/,A,0.82,0.48,1.18,0.05433872,Low,0.129,0.099,0.241,0.331,Significant increase (p=0.031),Significant increase (p=0.011),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01937,rs371115,20,202289530,APOE,Deletion,-,-,2.85,2.46,3.15,0.04221385,Moderate,0.229,0.208,0.053,0.311,Mild increase (p=0.046),Variable effect (p=0.019),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP01938,rs440574,10,113682497,SORL1,SNP (C/G),(C/,C,0.44,0.1,0.64,0.01013704,Moderate,0.053,0.302,0.329,0.116,Mild decrease (p=0.012),Variable effect (p=0.003),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01939,rs973259,21,74930399,APOE,SNP (G/T),(G/,G,0.74,0.38,1.12,0.01933992,Moderate,0.11,0.205,0.218,0.268,Variable effect (p=0.039),Variable effect (p=0.016),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01940,rs846739,17,89653402,BIN1,Insertion,-,-,3.53,3.23,3.73,0.01192551,High,0.361,0.076,0.174,0.19,No significant pattern (p=0.042),Significant increase (p=0.037),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01941,rs789307,17,133352717,APOE,SNP (G/T),(G/,G,1.58,1.36,1.94,0.03176764,High,0.236,0.215,0.347,0.002,Significant increase (p=0.017),Significant increase (p=0.04),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01942,rs101714,11,45830398,APP,SNP (C/T),(C/,C,1.37,1.1,1.71,0.01347885,Moderate,0.13,0.166,0.487,0.017,Mild increase (p=0.013),Significant decrease (p=0.04),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP01943,rs767647,8,242946696,EPHA1,SNP (A/T),(A/,A,3.85,3.48,4.06,0.00013247,High,0.074,0.191,0.433,0.102,Mild decrease (p=0.022),Variable effect (p=0.049),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01944,rs674523,18,80344500,EPHA1,SNP (C/G),(C/,C,0.51,0.26,0.71,0.0579235,High,0.288,0.157,0.306,0.048,Mild decrease (p=0.024),Mild increase (p=0.013),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01945,rs571744,3,214288516,BIN1,SNP (A/G),(A/,A,1.03,0.8,1.27,0.00453132,Low,0.091,0.179,0.083,0.446,No significant pattern (p=0.038),Mild increase (p=0.015),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01946,rs909503,13,159198891,CLU,Deletion,-,-,1.99,1.72,2.3,0.01968249,Low,0.157,0.248,0.152,0.243,Significant decrease (p=0.042),Significant increase (p=0.008),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01947,rs336458,11,167480329,CLU,SNP (C/T),(C/,C,0.84,0.56,1.17,0.12166629,High,0.341,0.268,0.176,0.015,Significant increase (p=0.029),Significant decrease (p=0.03),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP01948,rs267610,8,224916634,EPHA1,SNP (A/G),(A/,A,0.9,0.55,1.14,0.01049461,Moderate,0.16,0.097,0.225,0.317,No significant pattern (p=0.023),No significant pattern (p=0.018),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01949,rs850998,8,217527056,APP,SNP (A/T),(A/,A,1.58,1.18,1.94,0.06926653,High,0.045,0.431,0.217,0.106,No significant pattern (p=0.043),No significant pattern (p=0.006),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01950,rs968197,19,242703509,EPHA1,SNP (C/G),(C/,C,1.16,0.85,1.38,0.03263437,Protective,0.561,0.133,0.03,0.076,Mild decrease (p=0.03),Significant increase (p=0.029),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01951,rs135644,13,92562430,TREM2,Insertion,-,-,0.25,0.1,0.51,0.01761388,Moderate,0.216,0.1,0.474,0.009,Significant increase (p=0.013),Significant increase (p=0.041),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP01952,rs156574,8,244877136,CLU,SNP (G/T),(G/,G,0.88,0.56,1.17,0.04599951,Moderate,0.42,0.002,0.191,0.187,Mild increase (p=0.047),Significant decrease (p=0.031),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP01953,rs758664,14,169181518,PICALM,SNP (C/T),(C/,C,1.58,1.18,1.92,0.11915427,High,0.235,0.239,0.004,0.321,Significant decrease (p=0.007),No significant pattern (p=0.044),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP01954,rs410640,1,72974249,PICALM,SNP (A/C),(A/,A,0.73,0.4,1.0,0.03735618,Moderate,0.075,0.506,0.157,0.062,No significant pattern (p=0.046),Significant increase (p=0.031),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01955,rs835998,10,23606877,TREM2,SNP (A/T),(A/,A,0.77,0.49,1.01,0.04102064,Protective,0.226,0.241,0.026,0.307,No significant pattern (p=0.009),Significant increase (p=0.016),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP01956,rs533824,4,182564931,APP,Insertion,-,-,1.11,0.77,1.44,0.11635921,Low,0.683,0.047,0.043,0.026,Variable effect (p=0.043),Mild decrease (p=0.05),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01957,rs765135,12,98015268,PSEN2,SNP (A/G),(A/,A,0.87,0.48,1.15,0.00616088,Protective,0.1,0.102,0.436,0.163,Variable effect (p=0.041),Significant decrease (p=0.008),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP01958,rs850516,7,168998241,ABCA7,SNP (C/T),(C/,C,0.82,0.61,1.22,0.01541932,High,0.427,0.002,0.011,0.36,Mild increase (p=0.005),No significant pattern (p=0.019),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01959,rs650702,9,203842798,CD33,SNP (C/T),(C/,C,0.28,0.1,0.67,0.05106712,Moderate,0.219,0.039,0.27,0.272,Mild increase (p=0.001),Significant increase (p=0.028),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01960,rs765761,13,77189649,CD33,SNP (G/T),(G/,G,0.8,0.57,1.16,0.00311179,Unknown,0.26,0.227,0.208,0.105,Mild increase (p=0.042),Mild increase (p=0.008),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP01961,rs888422,5,26955604,APOE,Insertion,-,-,1.09,0.73,1.32,0.00707896,Protective,0.227,0.144,0.136,0.293,No significant pattern (p=0.007),Mild increase (p=0.027),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP01962,rs755666,13,155313675,PICALM,SNP (C/G),(C/,C,1.43,1.08,1.83,0.11874753,Moderate,0.143,0.012,0.031,0.614,Mild decrease (p=0.019),Significant increase (p=0.038),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP01963,rs974787,7,217857165,CD33,Insertion,-,-,0.65,0.35,1.01,0.00148519,Moderate,0.133,0.333,0.072,0.262,Significant increase (p=0.014),Variable effect (p=0.004),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP01964,rs308650,4,57717003,CLU,SNP (A/C),(A/,A,0.94,0.59,1.3,0.0035984,Low,0.274,0.229,0.282,0.016,Mild decrease (p=0.028),Mild increase (p=0.018),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP01965,rs317061,18,126813431,CLU,SNP (G/T),(G/,G,0.95,0.64,1.17,0.0277103,Low,0.209,0.132,0.226,0.233,Mild increase (p=0.003),No significant pattern (p=0.037),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP01966,rs662324,13,57886136,PICALM,SNP (C/G),(C/,C,1.54,1.32,1.8,0.02021696,High,0.045,0.232,0.303,0.22,Significant decrease (p=0.033),Mild decrease (p=0.036),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP01967,rs612012,15,64348592,CR1,SNP (C/T),(C/,C,0.7,0.36,0.98,0.01573695,High,0.075,0.098,0.105,0.523,Variable effect (p=0.022),Significant increase (p=0.027),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP01968,rs143183,2,245345615,CD33,SNP (A/T),(A/,A,1.5,1.15,1.85,0.05971169,High,0.3,0.246,0.237,0.017,Mild decrease (p=0.018),Variable effect (p=0.008),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP01969,rs108254,8,91873155,PSEN2,Insertion,-,-,2.09,1.73,2.36,0.05550769,Moderate,0.249,0.132,0.239,0.18,Variable effect (p=0.025),Significant increase (p=0.036),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01970,rs653317,16,75301446,CD33,SNP (C/T),(C/,C,1.3,1.05,1.69,0.01383579,High,0.186,0.37,0.154,0.09,Mild decrease (p=0.015),Significant increase (p=0.023),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01971,rs512748,19,205848943,TREM2,SNP (G/T),(G/,G,0.61,0.23,0.91,0.03372321,Protective,0.169,0.598,0.005,0.027,Significant decrease (p=0.042),No significant pattern (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP01972,rs325871,18,135629943,ABCA7,SNP (C/T),(C/,C,2.13,1.83,2.44,0.00144681,Low,0.235,0.053,0.362,0.149,No significant pattern (p=0.023),Mild decrease (p=0.026),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01973,rs984619,19,82463824,PSEN2,Deletion,-,-,0.34,0.1,0.63,0.00370265,Moderate,0.081,0.423,0.094,0.203,Mild increase (p=0.025),Mild decrease (p=0.028),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01974,rs977723,9,167099006,SORL1,Insertion,-,-,1.07,0.73,1.37,0.00591884,High,0.105,0.181,0.368,0.146,No significant pattern (p=0.041),Mild increase (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP01975,rs948350,8,235477733,ABCA7,SNP (C/G),(C/,C,0.39,0.16,0.67,0.08751709,High,0.599,0.023,0.101,0.076,Mild decrease (p=0.029),Variable effect (p=0.023),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01976,rs350405,7,181575751,CD2AP,SNP (A/T),(A/,A,0.74,0.37,1.07,0.02115591,Moderate,0.473,0.023,0.093,0.211,Variable effect (p=0.025),No significant pattern (p=0.032),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01977,rs271883,2,147043196,APOE,SNP (A/G),(A/,A,0.77,0.56,1.04,0.00201345,Low,0.003,0.65,0.042,0.105,Significant increase (p=0.009),Mild decrease (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP01978,rs105324,17,7929437,TREM2,SNP (A/C),(A/,A,0.93,0.72,1.23,0.07154752,Moderate,0.126,0.31,0.188,0.175,Significant decrease (p=0.036),Mild decrease (p=0.032),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP01979,rs326508,6,214273413,BIN1,SNP (A/C),(A/,A,0.62,0.34,0.99,0.00862914,High,0.08,0.19,0.524,0.006,Mild decrease (p=0.041),Mild increase (p=0.009),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01980,rs222744,3,87130118,CD2AP,SNP (A/C),(A/,A,0.73,0.53,1.09,0.00578161,Unknown,0.291,0.041,0.077,0.391,Mild increase (p=0.024),Significant decrease (p=0.046),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01981,rs541249,8,77476958,BIN1,SNP (C/G),(C/,C,0.69,0.45,0.93,0.00874859,Protective,0.248,0.281,0.211,0.06,Variable effect (p=0.05),Mild decrease (p=0.014),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP01982,rs749043,16,52467822,PSEN2,SNP (A/G),(A/,A,1.08,0.77,1.4,0.06806095,Moderate,0.216,0.197,0.129,0.257,Mild decrease (p=0.007),No significant pattern (p=0.034),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP01983,rs575090,16,120711329,EPHA1,SNP (C/T),(C/,C,0.74,0.39,1.05,0.04424599,Moderate,0.236,0.003,0.12,0.44,Mild increase (p=0.026),Significant increase (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01984,rs617268,4,5393552,MS4A6A,SNP (C/G),(C/,C,0.69,0.38,0.93,0.02679278,Moderate,0.0,0.131,0.607,0.062,Mild decrease (p=0.033),Variable effect (p=0.032),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP01985,rs572399,10,200378940,BIN1,Deletion,-,-,0.56,0.35,0.82,0.06080337,Moderate,0.102,0.468,0.075,0.155,Mild increase (p=0.04),Mild increase (p=0.026),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP01986,rs691512,12,210510862,APP,SNP (G/T),(G/,G,0.57,0.36,0.87,0.0167046,Moderate,0.034,0.105,0.4,0.261,Mild increase (p=0.013),Significant decrease (p=0.033),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP01987,rs406628,7,204526398,CD33,SNP (G/T),(G/,G,1.31,1.03,1.56,0.01671984,High,0.034,0.692,0.042,0.032,Significant increase (p=0.043),Mild increase (p=0.006),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP01988,rs718137,22,233742586,BIN1,Insertion,-,-,1.42,1.19,1.8,0.05373041,High,0.192,0.322,0.125,0.161,Mild increase (p=0.047),Significant increase (p=0.006),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP01989,rs677410,3,6591436,CLU,SNP (A/C),(A/,A,0.98,0.68,1.37,0.03256192,Low,0.117,0.241,0.308,0.133,Mild increase (p=0.022),Variable effect (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP01990,rs893196,11,197745826,CR1,SNP (C/T),(C/,C,1.28,0.89,1.6,0.02062798,High,0.461,0.061,0.07,0.208,No significant pattern (p=0.032),Significant increase (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01991,rs113569,19,189061015,PICALM,SNP (A/G),(A/,A,0.5,0.22,0.79,0.09413511,High,0.284,0.182,0.334,0.0,Mild increase (p=0.003),Significant increase (p=0.016),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP01992,rs573342,2,137535006,SORL1,SNP (A/C),(A/,A,0.79,0.42,1.13,0.01822281,Unknown,0.095,0.204,0.099,0.402,Mild increase (p=0.031),Significant increase (p=0.005),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP01993,rs290307,19,134832776,CD33,SNP (C/T),(C/,C,1.13,0.8,1.48,0.03452983,Low,0.195,0.157,0.383,0.065,Significant increase (p=0.02),Mild decrease (p=0.049),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP01994,rs288443,13,121216252,TREM2,SNP (A/T),(A/,A,1.43,1.14,1.71,0.01812668,High,0.16,0.168,0.045,0.427,Significant increase (p=0.031),No significant pattern (p=0.05),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP01995,rs118627,6,199958147,MS4A6A,Insertion,-,-,3.04,2.76,3.27,0.0563849,Moderate,0.069,0.053,0.64,0.038,Variable effect (p=0.036),Mild decrease (p=0.03),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP01996,rs689916,18,157488503,CD2AP,SNP (A/C),(A/,A,1.51,1.17,1.73,0.00213085,High,0.094,0.081,0.314,0.311,Significant increase (p=0.049),Significant increase (p=0.033),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP01997,rs547429,10,80261492,EPHA1,SNP (C/G),(C/,C,1.25,1.01,1.58,0.04547797,High,0.392,0.308,0.066,0.034,Mild increase (p=0.005),Mild decrease (p=0.044),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP01998,rs608221,17,180323381,PTK2B,SNP (G/T),(G/,G,0.97,0.68,1.35,0.03220533,Unknown,0.057,0.25,0.069,0.424,Variable effect (p=0.014),No significant pattern (p=0.016),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP01999,rs987153,13,26782115,PICALM,Deletion,-,-,0.6,0.22,0.87,0.04169018,Moderate,0.026,0.286,0.309,0.178,Significant decrease (p=0.002),No significant pattern (p=0.026),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02000,rs506570,5,164141000,CD33,SNP (A/C),(A/,A,1.6,1.25,1.95,0.01074427,Moderate,0.37,0.199,0.219,0.012,No significant pattern (p=0.036),Mild increase (p=0.023),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02001,rs452892,8,222805639,CLU,SNP (C/G),(C/,C,1.15,0.94,1.55,0.01969924,High,0.387,0.197,0.181,0.035,Significant decrease (p=0.005),Mild increase (p=0.05),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02002,rs117052,3,149970601,CD2AP,SNP (A/C),(A/,A,0.76,0.42,1.03,0.04055074,Low,0.356,0.117,0.098,0.229,Significant decrease (p=0.037),Mild decrease (p=0.028),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02003,rs818908,8,165287680,ABCA7,SNP (A/T),(A/,A,0.83,0.49,1.22,0.02249353,High,0.542,0.168,0.035,0.056,Mild increase (p=0.034),No significant pattern (p=0.018),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02004,rs148207,3,48446417,CLU,SNP (A/T),(A/,A,1.02,0.72,1.4,0.02296243,Unknown,0.542,0.114,0.086,0.059,Significant increase (p=0.042),Significant increase (p=0.039),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02005,rs251851,9,226678751,PSEN2,SNP (G/T),(G/,G,0.68,0.29,0.96,0.02536282,Moderate,0.103,0.212,0.223,0.263,No significant pattern (p=0.015),Variable effect (p=0.007),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02006,rs763093,2,25722095,APP,SNP (A/T),(A/,A,1.13,0.73,1.4,0.00375931,Unknown,0.136,0.507,0.014,0.143,Mild decrease (p=0.012),Mild increase (p=0.038),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02007,rs798314,6,242815131,CLU,Deletion,-,-,1.08,0.77,1.28,0.03478883,Moderate,0.062,0.184,0.393,0.161,Significant increase (p=0.04),Mild decrease (p=0.048),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP02008,rs401537,1,121307608,PICALM,SNP (A/C),(A/,A,2.32,2.09,2.58,0.01338514,Protective,0.025,0.34,0.264,0.171,Significant decrease (p=0.026),Mild increase (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02009,rs833552,21,197097733,TREM2,SNP (C/G),(C/,C,1.71,1.36,2.01,0.00949272,Moderate,0.459,0.119,0.035,0.188,No significant pattern (p=0.046),No significant pattern (p=0.012),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP02010,rs143682,1,13409804,SORL1,Insertion,-,-,0.41,0.16,0.63,0.03155514,Protective,0.327,0.21,0.106,0.157,Significant decrease (p=0.024),Mild increase (p=0.012),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02011,rs350121,12,7242099,CD2AP,SNP (A/T),(A/,A,1.06,0.78,1.44,0.04016024,Moderate,0.574,0.055,0.142,0.029,Significant increase (p=0.029),Variable effect (p=0.047),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02012,rs160294,16,83772841,SORL1,SNP (C/T),(C/,C,1.13,0.81,1.34,0.0147429,Moderate,0.262,0.204,0.326,0.008,Significant increase (p=0.008),Variable effect (p=0.032),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02013,rs803736,18,105042718,TREM2,SNP (C/T),(C/,C,1.14,0.79,1.36,0.00395033,High,0.01,0.513,0.137,0.14,Significant increase (p=0.049),Significant decrease (p=0.037),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02014,rs209129,2,136481943,BIN1,SNP (G/T),(G/,G,1.5,1.1,1.88,0.05051906,Low,0.057,0.266,0.106,0.371,Significant increase (p=0.013),Mild decrease (p=0.022),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02015,rs213976,18,168445001,APP,Deletion,-,-,2.23,1.98,2.46,0.04352384,Low,0.083,0.45,0.187,0.081,Mild increase (p=0.038),Mild increase (p=0.044),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02016,rs949553,21,66802311,CLU,Deletion,-,-,0.71,0.46,1.0,0.02014798,Protective,0.01,0.668,0.079,0.043,Mild increase (p=0.021),Significant increase (p=0.012),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP02017,rs138938,9,7895097,PICALM,SNP (A/T),(A/,A,1.14,0.86,1.47,0.02348843,High,0.197,0.334,0.179,0.09,Variable effect (p=0.009),Mild increase (p=0.037),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02018,rs164582,11,225864175,CR1,SNP (C/T),(C/,C,1.11,0.73,1.32,0.06664012,Low,0.256,0.159,0.336,0.049,Mild increase (p=0.004),No significant pattern (p=0.037),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02019,rs844414,2,38477179,MS4A6A,SNP (C/T),(C/,C,1.1,0.71,1.38,0.00840152,Moderate,0.003,0.246,0.302,0.249,Variable effect (p=0.004),Variable effect (p=0.026),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02020,rs727645,20,62032662,PTK2B,SNP (G/T),(G/,G,1.04,0.66,1.41,0.0097398,Moderate,0.307,0.001,0.097,0.395,Mild decrease (p=0.008),Variable effect (p=0.014),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP02021,rs355476,11,187378699,EPHA1,SNP (A/T),(A/,A,0.76,0.55,1.12,0.02491461,High,0.451,0.132,0.057,0.16,Significant decrease (p=0.023),Mild decrease (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02022,rs653445,20,224772848,PTK2B,SNP (C/T),(C/,C,1.02,0.69,1.33,0.00877526,High,0.207,0.049,0.339,0.205,Variable effect (p=0.041),Significant increase (p=0.029),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02023,rs281421,1,185090748,BIN1,Insertion,-,-,0.52,0.28,0.74,0.01988359,Moderate,0.091,0.289,0.21,0.211,Significant decrease (p=0.039),Mild increase (p=0.01),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02024,rs670356,18,192415804,TREM2,SNP (A/T),(A/,A,0.57,0.35,0.91,0.02458791,Low,0.004,0.082,0.197,0.516,Significant increase (p=0.022),Mild decrease (p=0.014),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP02025,rs861522,5,106189174,MS4A6A,SNP (G/T),(G/,G,1.92,1.62,2.31,0.03554311,Moderate,0.287,0.194,0.229,0.091,Significant increase (p=0.038),Variable effect (p=0.02),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02026,rs133816,14,79806674,PTK2B,SNP (C/G),(C/,C,0.6,0.3,0.9,0.09399419,Low,0.246,0.075,0.437,0.041,No significant pattern (p=0.002),Mild decrease (p=0.025),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02027,rs116556,12,196470513,SORL1,SNP (C/T),(C/,C,0.77,0.52,1.04,0.03127562,Low,0.245,0.12,0.337,0.098,Mild increase (p=0.022),Variable effect (p=0.036),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02028,rs530005,16,112342103,TREM2,Insertion,-,-,0.55,0.3,0.94,0.01311176,High,0.317,0.089,0.126,0.268,Mild decrease (p=0.013),Mild decrease (p=0.037),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP02029,rs268376,11,11892005,APP,SNP (A/C),(A/,A,0.84,0.54,1.23,0.0275824,Moderate,0.161,0.588,0.049,0.002,No significant pattern (p=0.016),No significant pattern (p=0.024),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02030,rs923670,13,158041878,BIN1,SNP (C/G),(C/,C,0.74,0.37,1.1,0.06798952,Moderate,0.041,0.072,0.044,0.644,Significant increase (p=0.039),No significant pattern (p=0.034),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02031,rs180234,10,182491601,PTK2B,SNP (A/C),(A/,A,0.87,0.65,1.2,0.13783671,Moderate,0.003,0.301,0.465,0.03,Variable effect (p=0.048),No significant pattern (p=0.024),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP02032,rs204864,20,189980792,PSEN2,SNP (G/T),(G/,G,1.32,1.05,1.62,0.04806977,Moderate,0.013,0.27,0.369,0.147,Significant increase (p=0.015),No significant pattern (p=0.036),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02033,rs338631,16,29004505,SORL1,SNP (C/T),(C/,C,0.84,0.46,1.2,0.01069464,High,0.056,0.448,0.236,0.06,Variable effect (p=0.04),Mild decrease (p=0.03),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02034,rs952400,11,159949278,MS4A6A,Insertion,-,-,0.82,0.45,1.06,0.00096307,High,0.095,0.112,0.026,0.567,Mild increase (p=0.008),Mild increase (p=0.025),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02035,rs518317,6,115806952,PTK2B,SNP (A/C),(A/,A,1.1,0.77,1.39,0.00090641,Moderate,0.36,0.235,0.062,0.143,Mild increase (p=0.042),Mild decrease (p=0.025),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP02036,rs399047,15,159868333,PSEN2,SNP (A/T),(A/,A,1.32,1.06,1.6,0.07656402,High,0.065,0.273,0.374,0.088,No significant pattern (p=0.038),No significant pattern (p=0.001),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02037,rs809690,8,240643382,CD2AP,SNP (A/C),(A/,A,0.78,0.53,0.99,0.02042592,Unknown,0.023,0.136,0.343,0.298,Mild increase (p=0.045),Mild increase (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP02038,rs887803,7,210853239,CD33,SNP (A/C),(A/,A,1.53,1.28,1.81,0.00749827,Moderate,0.147,0.139,0.021,0.493,Significant increase (p=0.03),Mild increase (p=0.009),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02039,rs613305,3,88096218,TREM2,Insertion,-,-,0.78,0.57,1.15,0.01513322,Protective,0.106,0.211,0.398,0.085,Significant decrease (p=0.024),No significant pattern (p=0.018),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02040,rs808360,13,195668972,PTK2B,SNP (A/C),(A/,A,1.5,1.24,1.84,0.00489076,Moderate,0.194,0.041,0.27,0.295,Significant increase (p=0.047),No significant pattern (p=0.018),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02041,rs381842,13,65707028,CD33,SNP (G/T),(G/,G,0.68,0.39,1.07,0.00744895,Low,0.038,0.051,0.067,0.644,Significant decrease (p=0.048),Significant decrease (p=0.039),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02042,rs953104,9,212439606,APP,SNP (G/T),(G/,G,1.05,0.75,1.26,0.00549506,Moderate,0.264,0.044,0.49,0.002,Significant decrease (p=0.014),Mild increase (p=0.025),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02043,rs241287,22,245918728,EPHA1,Deletion,-,-,0.5,0.1,0.87,0.02223451,High,0.058,0.445,0.252,0.045,Significant increase (p=0.016),Mild decrease (p=0.034),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02044,rs914012,1,138365487,ABCA7,SNP (G/T),(G/,G,1.43,1.22,1.78,0.08610677,Moderate,0.016,0.015,0.114,0.655,Significant decrease (p=0.032),Variable effect (p=0.014),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02045,rs551609,22,211726746,EPHA1,Deletion,-,-,1.42,1.16,1.75,0.00759283,Unknown,0.04,0.626,0.035,0.1,Significant increase (p=0.022),Significant increase (p=0.013),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP02046,rs869815,3,90758746,CLU,SNP (G/T),(G/,G,1.28,0.91,1.52,0.02080315,Low,0.038,0.047,0.441,0.274,Mild increase (p=0.005),Variable effect (p=0.019),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02047,rs880472,22,72130040,CR1,Insertion,-,-,0.6,0.28,0.82,0.01138225,Moderate,0.235,0.001,0.153,0.41,Mild increase (p=0.009),Significant increase (p=0.004),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02048,rs382710,20,20385699,MS4A6A,Insertion,-,-,1.77,1.48,2.08,0.02404735,Unknown,0.005,0.416,0.169,0.21,Variable effect (p=0.045),Mild increase (p=0.041),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02049,rs877575,9,149259306,CD2AP,SNP (G/T),(G/,G,1.05,0.7,1.36,0.00062385,High,0.124,0.238,0.244,0.194,Variable effect (p=0.04),Mild decrease (p=0.03),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02050,rs228502,12,239188600,PTK2B,SNP (A/C),(A/,A,0.59,0.24,0.99,0.01238608,Moderate,0.085,0.0,0.565,0.15,Mild decrease (p=0.04),No significant pattern (p=0.039),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02051,rs193025,5,12244261,PICALM,SNP (A/C),(A/,A,1.29,1.02,1.61,0.01643313,High,0.04,0.072,0.388,0.3,Mild increase (p=0.033),Mild increase (p=0.016),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02052,rs794115,9,61108449,MS4A6A,SNP (C/G),(C/,C,0.79,0.51,1.12,0.13382462,Low,0.155,0.356,0.036,0.253,Significant increase (p=0.008),No significant pattern (p=0.004),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02053,rs499678,6,25318752,CLU,SNP (G/T),(G/,G,3.06,2.69,3.4,0.01782831,Moderate,0.219,0.016,0.251,0.314,No significant pattern (p=0.047),Significant increase (p=0.028),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02054,rs570089,13,236088484,CD33,SNP (A/C),(A/,A,2.94,2.61,3.15,0.01212263,Low,0.112,0.452,0.085,0.151,Mild increase (p=0.024),Significant decrease (p=0.045),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02055,rs241727,16,114850137,MS4A6A,SNP (A/G),(A/,A,1.52,1.27,1.85,0.00058202,High,0.253,0.055,0.083,0.408,Variable effect (p=0.014),Mild increase (p=0.036),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP02056,rs308710,4,40305362,ABCA7,Insertion,-,-,0.92,0.71,1.14,0.00592337,Moderate,0.168,0.539,0.032,0.06,Variable effect (p=0.038),Significant increase (p=0.05),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02057,rs740998,16,125615029,CD33,SNP (A/C),(A/,A,1.22,0.82,1.54,0.06258288,Moderate,0.303,0.156,0.184,0.157,Mild increase (p=0.041),Mild increase (p=0.003),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP02058,rs577109,3,110030622,APOE,SNP (C/G),(C/,C,0.91,0.65,1.15,0.01836461,High,0.093,0.235,0.196,0.275,No significant pattern (p=0.034),Mild decrease (p=0.046),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02059,rs577951,3,16685519,MS4A6A,SNP (A/T),(A/,A,1.2,0.88,1.42,0.04370253,Protective,0.048,0.129,0.384,0.238,No significant pattern (p=0.048),Mild decrease (p=0.006),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP02060,rs141433,20,85338441,CD33,SNP (A/T),(A/,A,2.34,2.13,2.7,0.01365843,Moderate,0.22,0.02,0.238,0.322,Mild increase (p=0.019),Significant increase (p=0.008),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP02061,rs212963,2,106873456,APOE,SNP (C/G),(C/,C,0.66,0.41,0.89,0.01276364,High,0.299,0.212,0.144,0.145,Mild decrease (p=0.003),No significant pattern (p=0.028),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP02062,rs339712,8,226819331,PICALM,SNP (A/T),(A/,A,0.59,0.24,0.79,0.03202796,Moderate,0.559,0.011,0.005,0.225,Significant increase (p=0.03),Significant decrease (p=0.01),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP02063,rs589992,7,18766284,MS4A6A,SNP (C/T),(C/,C,0.96,0.67,1.35,0.02891425,Moderate,0.098,0.296,0.146,0.259,Mild decrease (p=0.009),Variable effect (p=0.045),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02064,rs241122,3,13780569,APP,SNP (A/T),(A/,A,0.94,0.57,1.24,0.00860637,Moderate,0.421,0.183,0.117,0.079,Significant increase (p=0.011),Significant increase (p=0.024),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02065,rs195019,19,101872938,CR1,SNP (A/G),(A/,A,0.78,0.39,1.06,0.07055667,Unknown,0.229,0.216,0.128,0.228,Mild decrease (p=0.015),Variable effect (p=0.041),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02066,rs886725,17,58402304,BIN1,SNP (A/T),(A/,A,1.04,0.65,1.35,0.04671339,Low,0.164,0.348,0.019,0.269,Mild increase (p=0.026),Mild decrease (p=0.024),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02067,rs396953,20,182088965,CD2AP,SNP (C/T),(C/,C,1.6,1.24,1.83,0.00306655,High,0.001,0.142,0.631,0.026,Variable effect (p=0.017),Variable effect (p=0.012),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02068,rs355672,11,185094267,EPHA1,SNP (A/T),(A/,A,0.54,0.19,0.82,0.01987384,Moderate,0.058,0.085,0.413,0.245,Mild decrease (p=0.005),Significant increase (p=0.014),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02069,rs222221,6,203326801,CD2AP,SNP (A/T),(A/,A,0.85,0.57,1.19,0.00904782,Protective,0.25,0.362,0.142,0.046,Variable effect (p=0.038),No significant pattern (p=0.025),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02070,rs538097,20,41670335,TREM2,SNP (C/T),(C/,C,0.91,0.59,1.24,0.01845254,Moderate,0.029,0.108,0.092,0.57,Significant decrease (p=0.01),Variable effect (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02071,rs205918,8,156541065,PSEN2,SNP (G/T),(G/,G,0.62,0.37,0.9,0.00059327,Moderate,0.274,0.028,0.101,0.398,Mild increase (p=0.024),Significant decrease (p=0.04),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02072,rs496008,8,5720922,CLU,Deletion,-,-,1.29,0.93,1.64,0.07664471,Moderate,0.003,0.666,0.13,0.001,Significant decrease (p=0.035),No significant pattern (p=0.019),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02073,rs953023,10,183112298,APP,SNP (A/T),(A/,A,3.74,3.44,3.99,0.01661662,High,0.143,0.217,0.038,0.402,Variable effect (p=0.048),Significant increase (p=0.024),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP02074,rs836009,13,224787889,CLU,SNP (A/G),(A/,A,0.84,0.63,1.08,0.05411455,Low,0.19,0.446,0.126,0.037,Significant increase (p=0.011),Significant decrease (p=0.031),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02075,rs896787,6,84783448,CLU,Deletion,-,-,1.05,0.77,1.34,0.00925823,Moderate,0.031,0.35,0.149,0.27,No significant pattern (p=0.023),Significant decrease (p=0.05),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP02076,rs376166,1,85963664,EPHA1,SNP (G/T),(G/,G,0.65,0.26,0.99,0.01086884,Moderate,0.026,0.635,0.137,0.001,Mild decrease (p=0.011),Variable effect (p=0.006),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02077,rs127406,2,143456217,ABCA7,SNP (C/T),(C/,C,1.18,0.9,1.45,0.02567155,High,0.248,0.084,0.36,0.108,Significant increase (p=0.032),Significant increase (p=0.029),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP02078,rs589059,4,207814591,CLU,SNP (C/G),(C/,C,0.51,0.21,0.9,0.01107516,Low,0.194,0.314,0.291,0.001,Mild increase (p=0.013),No significant pattern (p=0.041),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02079,rs787587,8,90113731,APOE,SNP (A/C),(A/,A,1.67,1.44,1.89,0.00044619,Moderate,0.153,0.143,0.226,0.278,Significant increase (p=0.036),Significant increase (p=0.005),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP02080,rs592271,10,239210817,APP,SNP (G/T),(G/,G,0.44,0.1,0.7,0.09465059,Unknown,0.108,0.071,0.555,0.067,Significant increase (p=0.028),Variable effect (p=0.002),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP02081,rs901082,12,241537110,PICALM,SNP (C/G),(C/,C,0.54,0.29,0.91,0.0022639,Moderate,0.168,0.14,0.159,0.333,Mild increase (p=0.04),Significant decrease (p=0.018),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP02082,rs816042,2,107590055,EPHA1,SNP (G/T),(G/,G,1.21,0.99,1.49,0.00218393,Unknown,0.252,0.13,0.116,0.302,Mild increase (p=0.011),Significant decrease (p=0.033),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02083,rs940768,17,205976426,APOE,SNP (C/T),(C/,C,0.56,0.27,0.87,0.03655474,Moderate,0.307,0.36,0.036,0.097,Significant increase (p=0.017),Mild increase (p=0.036),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02084,rs517454,2,16148023,CD33,SNP (A/C),(A/,A,2.24,1.95,2.59,0.00266154,Moderate,0.137,0.131,0.134,0.397,Variable effect (p=0.046),No significant pattern (p=0.036),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02085,rs818625,5,97305346,APOE,Deletion,-,-,0.33,0.1,0.6,0.10119741,High,0.279,0.471,0.027,0.023,Significant decrease (p=0.048),Significant decrease (p=0.01),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP02086,rs521479,2,240767573,APP,Insertion,-,-,1.96,1.63,2.27,0.06258309,High,0.016,0.104,0.194,0.485,Mild increase (p=0.005),Mild decrease (p=0.006),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP02087,rs227210,4,154888967,EPHA1,SNP (G/T),(G/,G,0.95,0.6,1.32,0.04634765,Low,0.18,0.302,0.148,0.171,No significant pattern (p=0.009),Mild increase (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02088,rs941775,12,12952268,ABCA7,SNP (C/T),(C/,C,0.55,0.27,0.9,0.06454648,Moderate,0.297,0.133,0.064,0.306,Significant increase (p=0.011),Mild decrease (p=0.004),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02089,rs272519,18,110346240,PTK2B,Deletion,-,-,0.7,0.35,0.96,0.01767634,Moderate,0.368,0.368,0.062,0.003,Variable effect (p=0.029),Mild decrease (p=0.012),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02090,rs342577,7,13809651,PICALM,SNP (A/T),(A/,A,1.44,1.21,1.72,0.01296452,Moderate,0.021,0.191,0.358,0.23,Significant decrease (p=0.038),Mild increase (p=0.014),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02091,rs609805,11,122512990,CD33,SNP (C/T),(C/,C,0.93,0.6,1.21,0.12879118,Moderate,0.227,0.159,0.073,0.341,No significant pattern (p=0.047),Variable effect (p=0.029),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02092,rs139181,21,97837082,SORL1,SNP (C/G),(C/,C,0.69,0.34,1.04,0.0584514,High,0.07,0.066,0.178,0.486,Significant increase (p=0.006),Significant decrease (p=0.013),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02093,rs867650,10,83239660,PSEN2,SNP (A/T),(A/,A,1.4,1.1,1.75,0.02733765,Protective,0.128,0.467,0.168,0.037,No significant pattern (p=0.002),Mild increase (p=0.002),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02094,rs282269,9,170130957,PICALM,SNP (C/G),(C/,C,0.95,0.7,1.2,0.03387618,High,0.273,0.427,0.009,0.092,Significant decrease (p=0.036),No significant pattern (p=0.013),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02095,rs922724,5,242268986,ABCA7,Deletion,-,-,0.74,0.43,1.05,0.03438481,Moderate,0.551,0.057,0.014,0.177,Significant decrease (p=0.024),No significant pattern (p=0.023),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02096,rs560525,1,72310121,CD33,SNP (A/T),(A/,A,1.23,0.89,1.48,0.00398306,Low,0.195,0.144,0.257,0.204,Mild increase (p=0.022),Variable effect (p=0.041),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP02097,rs934019,12,195655027,CR1,SNP (C/T),(C/,C,1.55,1.19,1.81,0.0285258,Low,0.19,0.215,0.143,0.252,Variable effect (p=0.034),Significant increase (p=0.048),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02098,rs991292,21,168822869,EPHA1,Insertion,-,-,1.06,0.73,1.36,0.03827559,Moderate,0.321,0.11,0.074,0.295,Mild increase (p=0.005),Mild decrease (p=0.045),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02099,rs372155,20,52493525,APP,SNP (A/C),(A/,A,0.39,0.12,0.62,0.01465493,High,0.605,0.0,0.123,0.072,Mild decrease (p=0.041),Mild increase (p=0.004),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02100,rs672425,15,97086600,EPHA1,Insertion,-,-,0.53,0.27,0.8,0.00387384,Moderate,0.355,0.016,0.202,0.228,Variable effect (p=0.047),Significant increase (p=0.037),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02101,rs175028,9,66739847,APOE,SNP (A/C),(A/,A,0.51,0.21,0.81,0.02083833,High,0.137,0.533,0.0,0.129,No significant pattern (p=0.036),Significant decrease (p=0.018),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP02102,rs515791,19,179125448,ABCA7,Deletion,-,-,0.69,0.42,1.07,0.04095902,Moderate,0.054,0.251,0.124,0.371,Significant decrease (p=0.029),No significant pattern (p=0.031),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02103,rs183164,14,226034860,EPHA1,Deletion,-,-,1.04,0.72,1.32,0.07127313,Moderate,0.303,0.352,0.008,0.137,Significant increase (p=0.025),Mild increase (p=0.029),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02104,rs353002,9,219578128,APP,Deletion,-,-,1.88,1.65,2.26,0.0121803,Low,0.142,0.214,0.014,0.43,Variable effect (p=0.003),Significant increase (p=0.02),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02105,rs984511,3,243043459,CD33,SNP (A/C),(A/,A,0.42,0.1,0.69,0.00626368,Low,0.254,0.073,0.137,0.336,Significant increase (p=0.024),Variable effect (p=0.033),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP02106,rs835400,5,124697532,MS4A6A,SNP (A/T),(A/,A,1.62,1.36,1.93,0.01448569,High,0.257,0.482,0.027,0.034,Significant increase (p=0.028),No significant pattern (p=0.04),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP02107,rs475858,22,188547516,PICALM,SNP (C/G),(C/,C,1.06,0.75,1.32,0.00255662,Moderate,0.326,0.02,0.399,0.055,No significant pattern (p=0.031),No significant pattern (p=0.031),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02108,rs434885,21,1002947,CD33,SNP (A/T),(A/,A,0.55,0.29,0.81,0.00906686,High,0.423,0.09,0.202,0.085,Mild increase (p=0.044),Significant decrease (p=0.021),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02109,rs232304,22,196371072,CD2AP,SNP (C/G),(C/,C,0.43,0.18,0.82,0.04143502,Protective,0.061,0.342,0.046,0.351,Mild increase (p=0.019),Significant decrease (p=0.037),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02110,rs638235,19,168182607,CD33,SNP (A/G),(A/,A,2.7,2.35,3.04,0.03502425,Protective,0.445,0.014,0.258,0.083,Significant increase (p=0.032),No significant pattern (p=0.037),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02111,rs540133,4,202293401,MS4A6A,SNP (A/C),(A/,A,1.48,1.2,1.83,0.07847366,Moderate,0.242,0.315,0.047,0.195,No significant pattern (p=0.017),Significant increase (p=0.008),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP02112,rs647370,15,223581921,MS4A6A,SNP (A/T),(A/,A,1.06,0.79,1.43,0.08689099,Moderate,0.222,0.414,0.109,0.055,Mild decrease (p=0.016),No significant pattern (p=0.029),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02113,rs124856,3,100600635,ABCA7,SNP (G/T),(G/,G,1.69,1.48,2.0,0.01160539,High,0.171,0.232,0.153,0.244,Mild decrease (p=0.043),Mild decrease (p=0.006),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02114,rs495091,2,175451872,PICALM,SNP (C/G),(C/,C,1.34,1.08,1.55,0.0136157,Moderate,0.195,0.025,0.53,0.05,No significant pattern (p=0.023),Mild increase (p=0.011),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02115,rs806662,18,121455731,PSEN2,SNP (C/G),(C/,C,1.53,1.31,1.84,0.03017794,Moderate,0.358,0.276,0.164,0.002,Mild increase (p=0.04),Significant decrease (p=0.027),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02116,rs216230,22,174102601,CD33,SNP (C/T),(C/,C,1.16,0.85,1.5,0.02261757,Unknown,0.177,0.578,0.039,0.006,Significant increase (p=0.025),Mild decrease (p=0.036),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02117,rs805546,2,80556528,BIN1,SNP (C/T),(C/,C,1.07,0.69,1.3,0.00478068,Moderate,0.363,0.017,0.004,0.416,Variable effect (p=0.048),Significant increase (p=0.012),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02118,rs624827,2,187234922,PTK2B,SNP (A/C),(A/,A,1.33,1.03,1.58,0.02372516,Low,0.293,0.251,0.186,0.071,Variable effect (p=0.004),Significant increase (p=0.016),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02119,rs789302,3,93547945,BIN1,Deletion,-,-,0.72,0.52,1.07,0.00339628,Moderate,0.237,0.228,0.112,0.222,No significant pattern (p=0.004),Significant decrease (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02120,rs104793,10,93077364,ABCA7,SNP (C/T),(C/,C,1.16,0.88,1.42,0.0122688,High,0.093,0.465,0.049,0.193,Significant decrease (p=0.009),Mild decrease (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP02121,rs850173,5,40042162,PSEN2,SNP (C/T),(C/,C,1.24,0.93,1.61,0.00723239,High,0.129,0.281,0.223,0.167,Significant increase (p=0.002),Variable effect (p=0.02),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP02122,rs902221,19,161412453,BIN1,SNP (A/G),(A/,A,0.78,0.45,1.04,0.05231464,Low,0.281,0.252,0.143,0.124,Significant increase (p=0.045),Mild increase (p=0.036),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02123,rs352789,13,71616963,CD33,SNP (A/G),(A/,A,1.17,0.95,1.43,0.06831875,High,0.144,0.374,0.076,0.206,Variable effect (p=0.024),Significant increase (p=0.008),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP02124,rs807411,9,108619060,MS4A6A,SNP (A/C),(A/,A,1.06,0.73,1.33,0.03073405,Unknown,0.169,0.185,0.143,0.303,Significant decrease (p=0.044),Mild decrease (p=0.035),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP02125,rs595547,8,11188295,EPHA1,SNP (A/C),(A/,A,1.03,0.63,1.27,0.01186064,Moderate,0.525,0.227,0.022,0.026,Significant increase (p=0.026),Mild increase (p=0.044),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02126,rs243725,14,96270899,CD2AP,SNP (A/T),(A/,A,1.04,0.69,1.42,0.00243831,High,0.186,0.245,0.247,0.122,Significant increase (p=0.024),Significant decrease (p=0.022),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02127,rs892295,21,79383108,APOE,SNP (A/G),(A/,A,0.54,0.2,0.92,0.04388482,Moderate,0.079,0.126,0.572,0.023,Significant increase (p=0.016),Significant decrease (p=0.019),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02128,rs696308,4,108045025,TREM2,SNP (C/G),(C/,C,0.74,0.46,1.1,0.00579044,Low,0.653,0.11,0.021,0.016,Mild decrease (p=0.038),Mild decrease (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02129,rs619263,9,33327703,ABCA7,SNP (G/T),(G/,G,0.84,0.49,1.05,0.00124035,Moderate,0.018,0.224,0.428,0.13,Significant decrease (p=0.018),Mild increase (p=0.038),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02130,rs848304,14,62750053,MS4A6A,SNP (C/T),(C/,C,0.32,0.1,0.6,0.00822211,Protective,0.275,0.311,0.146,0.068,Significant decrease (p=0.025),Significant decrease (p=0.015),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02131,rs643753,12,133172974,APP,Deletion,-,-,0.53,0.29,0.74,0.07882367,Moderate,0.203,0.392,0.019,0.186,Mild decrease (p=0.007),Mild decrease (p=0.009),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02132,rs573987,6,155882323,CD2AP,SNP (A/C),(A/,A,0.87,0.48,1.18,0.02765366,Protective,0.022,0.046,0.077,0.656,Mild increase (p=0.027),Significant increase (p=0.03),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP02133,rs372273,20,196449136,CLU,SNP (A/T),(A/,A,0.6,0.22,0.99,0.08275176,Moderate,0.132,0.567,0.047,0.054,No significant pattern (p=0.031),Mild decrease (p=0.025),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02134,rs915526,16,227288026,PSEN2,SNP (C/G),(C/,C,0.43,0.14,0.78,0.02434533,High,0.084,0.005,0.067,0.644,Mild decrease (p=0.032),Significant decrease (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02135,rs922574,9,154696657,CR1,SNP (A/T),(A/,A,0.98,0.62,1.36,0.12915598,Low,0.014,0.265,0.212,0.308,No significant pattern (p=0.026),Significant decrease (p=0.026),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02136,rs594451,5,64653867,TREM2,SNP (G/T),(G/,G,0.6,0.38,0.86,0.03798366,Protective,0.282,0.107,0.339,0.072,Mild increase (p=0.047),Mild decrease (p=0.016),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02137,rs157608,6,109231412,EPHA1,Deletion,-,-,0.43,0.13,0.82,0.07229479,Moderate,0.106,0.043,0.513,0.138,Mild decrease (p=0.01),Significant increase (p=0.021),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP02138,rs904635,11,87026308,PTK2B,SNP (C/G),(C/,C,0.58,0.34,0.93,0.05810006,Moderate,0.164,0.043,0.337,0.255,Variable effect (p=0.042),No significant pattern (p=0.009),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02139,rs166744,12,203752270,CLU,Deletion,-,-,1.23,0.95,1.46,0.00013599,Moderate,0.251,0.421,0.03,0.098,Significant increase (p=0.023),Significant increase (p=0.011),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02140,rs308585,5,208304881,PSEN2,SNP (A/C),(A/,A,0.61,0.38,0.99,0.03261618,Low,0.197,0.158,0.362,0.083,Mild increase (p=0.038),Variable effect (p=0.031),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02141,rs550763,6,130424267,PICALM,SNP (A/T),(A/,A,0.96,0.69,1.3,0.01774128,Protective,0.003,0.029,0.604,0.164,Mild decrease (p=0.04),Mild increase (p=0.024),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02142,rs445936,8,183847829,MS4A6A,Insertion,-,-,1.51,1.27,1.83,0.02041009,Low,0.176,0.062,0.021,0.541,Significant increase (p=0.023),Significant decrease (p=0.034),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP02143,rs186201,5,21445810,CD33,SNP (A/C),(A/,A,0.83,0.44,1.12,0.00536487,Moderate,0.233,0.212,0.254,0.1,Variable effect (p=0.023),Mild increase (p=0.035),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02144,rs878584,18,113966036,CD2AP,Deletion,-,-,0.56,0.29,0.84,0.12504434,Protective,0.076,0.666,0.044,0.014,Mild decrease (p=0.017),Mild increase (p=0.006),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02145,rs115345,4,34652256,EPHA1,SNP (G/T),(G/,G,0.8,0.6,1.15,0.02897621,Low,0.292,0.292,0.129,0.086,Variable effect (p=0.049),No significant pattern (p=0.015),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02146,rs265890,11,88223956,PICALM,SNP (G/T),(G/,G,2.49,2.28,2.85,0.0196827,High,0.032,0.405,0.123,0.239,Significant increase (p=0.011),Mild increase (p=0.008),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02147,rs494756,12,75088442,CR1,SNP (C/G),(C/,C,0.78,0.43,1.11,0.01271241,Moderate,0.524,0.12,0.053,0.102,No significant pattern (p=0.049),Mild increase (p=0.048),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02148,rs586482,22,123174086,PTK2B,SNP (C/T),(C/,C,0.39,0.1,0.65,0.00784653,Low,0.074,0.102,0.609,0.015,Mild decrease (p=0.015),Variable effect (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02149,rs419506,9,75254729,BIN1,SNP (C/G),(C/,C,1.22,0.97,1.59,0.01098621,Unknown,0.272,0.069,0.153,0.306,Mild increase (p=0.013),Mild increase (p=0.033),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP02150,rs121571,13,177460249,MS4A6A,SNP (C/T),(C/,C,1.02,0.72,1.35,0.02832312,Moderate,0.115,0.059,0.182,0.444,Significant decrease (p=0.024),Significant decrease (p=0.008),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02151,rs193735,11,160068979,PTK2B,SNP (C/G),(C/,C,0.59,0.37,0.9,0.04037714,High,0.028,0.482,0.15,0.14,Variable effect (p=0.012),No significant pattern (p=0.03),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02152,rs705758,6,141175624,PSEN2,SNP (A/C),(A/,A,0.79,0.49,1.13,0.01184827,High,0.469,0.194,0.019,0.118,Variable effect (p=0.035),No significant pattern (p=0.024),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP02153,rs723008,10,248858919,PICALM,SNP (G/T),(G/,G,0.99,0.71,1.31,0.00145333,High,0.016,0.293,0.162,0.329,Mild increase (p=0.039),Significant increase (p=0.022),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02154,rs833232,8,152898499,PTK2B,Insertion,-,-,0.78,0.49,1.14,0.08837258,Moderate,0.168,0.128,0.476,0.027,No significant pattern (p=0.024),Significant decrease (p=0.047),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02155,rs625161,16,55994570,CLU,SNP (G/T),(G/,G,1.06,0.82,1.45,0.05266035,High,0.151,0.205,0.141,0.302,Variable effect (p=0.016),Significant increase (p=0.028),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02156,rs415556,9,224898453,MS4A6A,SNP (A/T),(A/,A,0.95,0.57,1.27,0.10510654,High,0.08,0.146,0.008,0.566,Mild increase (p=0.004),Variable effect (p=0.036),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02157,rs486564,8,112553490,CD2AP,SNP (C/G),(C/,C,0.79,0.55,1.04,0.02520876,High,0.273,0.046,0.354,0.127,Mild decrease (p=0.023),Significant decrease (p=0.002),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP02158,rs452720,18,225030029,CR1,SNP (A/G),(A/,A,0.46,0.16,0.79,0.00742221,High,0.07,0.148,0.324,0.258,Significant increase (p=0.044),No significant pattern (p=0.009),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02159,rs639310,14,185151022,MS4A6A,SNP (A/T),(A/,A,0.99,0.77,1.25,0.00981903,Moderate,0.354,0.255,0.144,0.046,Mild decrease (p=0.013),No significant pattern (p=0.021),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP02160,rs836441,10,92960498,APOE,SNP (C/T),(C/,C,0.96,0.56,1.34,0.0559776,High,0.099,0.108,0.529,0.064,Mild decrease (p=0.02),Mild decrease (p=0.049),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02161,rs639774,17,246577594,BIN1,SNP (A/T),(A/,A,1.49,1.27,1.81,0.10015313,Moderate,0.418,0.101,0.22,0.062,Mild decrease (p=0.012),Significant decrease (p=0.002),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02162,rs761624,12,111052023,PSEN2,SNP (C/T),(C/,C,1.08,0.86,1.43,0.01823753,High,0.431,0.097,0.184,0.088,No significant pattern (p=0.011),Mild increase (p=0.02),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02163,rs112806,10,45315584,CR1,SNP (G/T),(G/,G,1.61,1.29,1.98,0.00406161,High,0.338,0.05,0.225,0.186,Significant increase (p=0.022),Significant decrease (p=0.032),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP02164,rs878708,18,199094445,PTK2B,Insertion,-,-,1.07,0.76,1.45,0.00326184,Moderate,0.217,0.229,0.216,0.139,Variable effect (p=0.024),Mild decrease (p=0.022),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP02165,rs740557,6,195236652,PICALM,SNP (C/T),(C/,C,2.61,2.29,2.89,0.00024215,High,0.216,0.063,0.281,0.24,Significant increase (p=0.032),No significant pattern (p=0.023),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02166,rs918646,14,138691118,APP,SNP (G/T),(G/,G,1.04,0.75,1.41,0.00188822,Unknown,0.058,0.274,0.004,0.464,No significant pattern (p=0.049),Variable effect (p=0.046),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02167,rs622298,8,168518487,EPHA1,Deletion,-,-,0.56,0.27,0.77,0.01237,Moderate,0.069,0.412,0.249,0.071,Mild increase (p=0.018),Mild decrease (p=0.027),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP02168,rs451089,6,237381811,CLU,SNP (A/G),(A/,A,1.12,0.9,1.5,0.04537191,Low,0.083,0.555,0.157,0.005,Variable effect (p=0.001),Variable effect (p=0.017),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02169,rs466966,12,134490232,CD33,SNP (G/T),(G/,G,0.36,0.14,0.67,0.05891081,Low,0.011,0.044,0.692,0.053,Mild increase (p=0.029),Significant increase (p=0.021),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP02170,rs870089,14,96328787,ABCA7,Insertion,-,-,1.35,1.05,1.72,0.09154278,High,0.178,0.053,0.036,0.532,Variable effect (p=0.001),Variable effect (p=0.004),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02171,rs151598,11,170236099,CD2AP,SNP (G/T),(G/,G,0.84,0.53,1.14,0.02954791,Moderate,0.088,0.024,0.302,0.387,Mild increase (p=0.007),No significant pattern (p=0.03),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP02172,rs567354,14,26835859,PICALM,SNP (A/G),(A/,A,1.04,0.82,1.31,0.00269121,High,0.048,0.418,0.042,0.292,Mild increase (p=0.027),No significant pattern (p=0.037),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02173,rs647843,18,182944320,SORL1,SNP (C/G),(C/,C,1.3,0.94,1.57,0.00441425,Low,0.092,0.264,0.036,0.407,No significant pattern (p=0.029),Mild increase (p=0.033),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02174,rs339609,16,87777298,MS4A6A,SNP (A/T),(A/,A,0.51,0.25,0.72,0.12697009,Moderate,0.096,0.263,0.368,0.074,Significant increase (p=0.047),No significant pattern (p=0.02),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP02175,rs334935,19,150372282,APOE,SNP (G/T),(G/,G,0.68,0.29,0.91,0.08432431,Moderate,0.345,0.327,0.089,0.039,No significant pattern (p=0.043),Mild decrease (p=0.004),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02176,rs439978,2,181030105,EPHA1,SNP (A/T),(A/,A,0.43,0.14,0.78,0.01588088,Moderate,0.12,0.109,0.155,0.415,Significant increase (p=0.041),Significant increase (p=0.004),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02177,rs441137,22,232041221,CR1,SNP (C/T),(C/,C,1.37,0.98,1.67,0.03183917,High,0.267,0.017,0.042,0.474,Significant decrease (p=0.038),Mild increase (p=0.017),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP02178,rs955255,3,97153568,PICALM,SNP (G/T),(G/,G,0.91,0.69,1.13,0.03241026,Moderate,0.331,0.102,0.325,0.042,Significant decrease (p=0.039),Significant increase (p=0.017),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02179,rs731018,12,62262985,TREM2,SNP (A/C),(A/,A,0.54,0.29,0.77,0.09030648,Low,0.1,0.25,0.391,0.058,No significant pattern (p=0.046),Significant increase (p=0.016),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02180,rs932470,8,40688087,APP,SNP (A/G),(A/,A,1.31,0.99,1.54,0.03646452,Protective,0.296,0.158,0.096,0.25,Mild decrease (p=0.04),Significant increase (p=0.04),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02181,rs997297,13,160080827,CLU,SNP (C/T),(C/,C,0.81,0.59,1.08,0.0104079,Low,0.152,0.312,0.317,0.018,Mild increase (p=0.047),Mild increase (p=0.033),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02182,rs859476,3,19709335,CD2AP,Insertion,-,-,0.23,0.1,0.52,0.01865485,Low,0.547,0.166,0.035,0.051,Significant decrease (p=0.042),Significant increase (p=0.01),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02183,rs254954,13,214057063,CLU,SNP (C/T),(C/,C,0.98,0.63,1.35,0.0110425,High,0.128,0.162,0.371,0.139,Significant increase (p=0.041),Significant increase (p=0.043),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02184,rs966173,15,176224575,APP,SNP (A/G),(A/,A,0.71,0.49,1.08,0.00684164,Low,0.476,0.09,0.161,0.073,Significant decrease (p=0.024),Mild increase (p=0.008),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP02185,rs364224,5,172586616,SORL1,SNP (C/G),(C/,C,1.3,0.91,1.55,0.08437159,High,0.266,0.076,0.311,0.147,Significant increase (p=0.046),Variable effect (p=0.035),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02186,rs852853,5,126638784,SORL1,SNP (C/T),(C/,C,2.02,1.68,2.31,0.06901179,Low,0.081,0.58,0.068,0.072,No significant pattern (p=0.01),Significant decrease (p=0.023),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP02187,rs920676,17,109813546,CLU,SNP (G/T),(G/,G,1.39,1.06,1.7,0.00824032,Low,0.049,0.438,0.278,0.035,No significant pattern (p=0.024),No significant pattern (p=0.029),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02188,rs356686,3,52121813,CD2AP,SNP (C/T),(C/,C,1.88,1.5,2.18,0.04659564,Moderate,0.275,0.019,0.219,0.287,Significant increase (p=0.027),Mild decrease (p=0.036),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02189,rs700437,21,86300600,CLU,SNP (C/G),(C/,C,0.96,0.68,1.3,0.016878,Moderate,0.007,0.009,0.368,0.416,No significant pattern (p=0.011),Mild decrease (p=0.005),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02190,rs700306,12,43666062,APP,SNP (G/T),(G/,G,1.72,1.51,2.03,0.03949282,High,0.193,0.037,0.523,0.046,No significant pattern (p=0.048),Variable effect (p=0.006),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02191,rs468241,2,53380265,BIN1,SNP (C/T),(C/,C,0.89,0.62,1.17,0.16655786,Moderate,0.317,0.127,0.309,0.047,Significant decrease (p=0.025),Significant increase (p=0.027),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02192,rs164730,6,164531585,TREM2,SNP (C/T),(C/,C,0.47,0.15,0.78,0.00814367,Low,0.144,0.12,0.46,0.076,Significant increase (p=0.007),Significant decrease (p=0.039),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02193,rs595183,16,199846561,CD33,SNP (G/T),(G/,G,0.6,0.3,0.84,0.01261572,High,0.028,0.644,0.119,0.009,Mild decrease (p=0.036),No significant pattern (p=0.017),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02194,rs407108,9,49841449,CLU,SNP (A/T),(A/,A,0.84,0.59,1.19,0.01669441,High,0.177,0.122,0.357,0.144,Significant decrease (p=0.02),No significant pattern (p=0.04),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02195,rs600378,17,152588198,MS4A6A,SNP (G/T),(G/,G,1.15,0.93,1.42,0.04694323,Moderate,0.292,0.114,0.233,0.161,Mild decrease (p=0.017),Significant increase (p=0.027),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02196,rs719041,7,24829882,ABCA7,Deletion,-,-,0.7,0.42,1.0,0.00806714,High,0.107,0.363,0.2,0.13,Variable effect (p=0.004),Mild increase (p=0.038),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02197,rs404339,17,216281353,CLU,Insertion,-,-,0.61,0.29,1.0,0.05653645,High,0.44,0.098,0.085,0.177,Variable effect (p=0.018),Variable effect (p=0.044),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02198,rs828906,18,126612243,BIN1,SNP (A/T),(A/,A,1.04,0.74,1.28,0.04719423,Unknown,0.01,0.331,0.433,0.026,Significant decrease (p=0.038),Mild increase (p=0.013),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02199,rs267336,19,222917238,BIN1,SNP (C/T),(C/,C,1.01,0.67,1.26,0.00111191,High,0.043,0.129,0.038,0.59,Significant increase (p=0.029),Significant decrease (p=0.009),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP02200,rs425795,18,5531093,BIN1,SNP (C/G),(C/,C,0.67,0.44,0.99,0.03558676,High,0.094,0.32,0.005,0.381,Mild increase (p=0.043),Mild increase (p=0.022),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02201,rs516844,22,241473246,PSEN2,Deletion,-,-,1.01,0.69,1.32,0.04455902,Moderate,0.093,0.392,0.202,0.113,Significant decrease (p=0.04),No significant pattern (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02202,rs327281,1,70754226,APP,Insertion,-,-,1.78,1.4,2.04,0.00329875,Unknown,0.113,0.343,0.304,0.04,Mild increase (p=0.008),Variable effect (p=0.02),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP02203,rs815944,5,140518760,CD33,SNP (A/C),(A/,A,1.43,1.06,1.8,0.00091274,High,0.33,0.008,0.172,0.29,No significant pattern (p=0.013),No significant pattern (p=0.034),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02204,rs739712,1,37660735,PTK2B,SNP (C/G),(C/,C,1.23,0.94,1.47,0.06945989,High,0.284,0.16,0.17,0.186,Mild increase (p=0.048),Variable effect (p=0.033),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP02205,rs825397,17,42410287,ABCA7,SNP (A/G),(A/,A,0.38,0.16,0.59,0.00383912,Moderate,0.01,0.694,0.075,0.02,Mild decrease (p=0.021),Significant increase (p=0.033),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02206,rs249951,3,167945101,SORL1,SNP (C/T),(C/,C,0.6,0.29,0.9,0.02087431,High,0.474,0.018,0.273,0.035,Mild increase (p=0.015),Mild decrease (p=0.025),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02207,rs936907,13,49061030,EPHA1,SNP (A/T),(A/,A,1.7,1.44,2.0,0.04374109,Moderate,0.137,0.336,0.22,0.107,Significant decrease (p=0.045),Mild decrease (p=0.025),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02208,rs666361,6,163229902,APP,SNP (A/C),(A/,A,0.7,0.41,1.07,0.00207041,Low,0.164,0.357,0.214,0.064,Mild increase (p=0.033),Mild decrease (p=0.017),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP02209,rs509843,4,26055999,APP,SNP (A/C),(A/,A,0.47,0.21,0.67,0.00063492,High,0.084,0.012,0.31,0.394,Significant increase (p=0.02),Significant increase (p=0.02),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP02210,rs223906,8,148589740,PSEN2,SNP (C/G),(C/,C,0.96,0.56,1.32,0.06520594,Protective,0.085,0.336,0.179,0.2,Mild decrease (p=0.006),Significant increase (p=0.016),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02211,rs134560,8,192374195,MS4A6A,SNP (C/T),(C/,C,1.19,0.98,1.45,0.0227112,High,0.113,0.633,0.001,0.054,Significant decrease (p=0.034),Variable effect (p=0.033),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02212,rs387228,1,116245364,CD33,SNP (C/T),(C/,C,0.87,0.54,1.22,0.00144642,Moderate,0.074,0.128,0.024,0.574,Mild increase (p=0.044),Significant increase (p=0.041),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02213,rs817765,12,98671407,CLU,SNP (C/G),(C/,C,0.64,0.38,1.0,0.01072665,High,0.17,0.139,0.029,0.462,No significant pattern (p=0.014),Mild increase (p=0.022),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02214,rs699541,2,178654780,PICALM,Deletion,-,-,1.93,1.65,2.14,0.02063557,Moderate,0.201,0.113,0.238,0.247,Variable effect (p=0.012),No significant pattern (p=0.004),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP02215,rs996992,3,118989582,CD2AP,SNP (C/G),(C/,C,1.6,1.35,1.8,0.13430256,High,0.043,0.608,0.034,0.115,Variable effect (p=0.013),Significant decrease (p=0.004),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02216,rs557890,6,171626962,APOE,SNP (A/G),(A/,A,0.28,0.1,0.63,0.0028044,High,0.1,0.282,0.084,0.334,Variable effect (p=0.042),Significant increase (p=0.026),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02217,rs254329,15,176728532,CD33,Insertion,-,-,0.72,0.34,1.08,0.06302335,Moderate,0.301,0.068,0.192,0.239,Significant decrease (p=0.04),Significant increase (p=0.03),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02218,rs779686,2,185073457,TREM2,Insertion,-,-,1.24,1.01,1.62,0.06381929,High,0.205,0.366,0.165,0.064,Mild decrease (p=0.006),Significant increase (p=0.045),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02219,rs734951,2,76300598,APOE,SNP (A/T),(A/,A,1.58,1.31,1.83,0.01177052,Low,0.006,0.126,0.54,0.128,Significant increase (p=0.044),Significant increase (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP02220,rs643911,3,83146514,PICALM,Insertion,-,-,2.56,2.3,2.85,0.00768252,High,0.193,0.233,0.019,0.355,Significant decrease (p=0.002),Variable effect (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02221,rs231077,1,147359638,APP,SNP (C/T),(C/,C,0.27,0.1,0.53,0.0099099,Moderate,0.029,0.356,0.021,0.394,No significant pattern (p=0.003),Mild decrease (p=0.004),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02222,rs230558,4,238161658,APOE,SNP (A/G),(A/,A,0.63,0.3,1.01,0.00878208,High,0.2,0.084,0.186,0.331,Variable effect (p=0.025),Mild decrease (p=0.026),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02223,rs664689,22,97122553,CR1,SNP (C/G),(C/,C,1.41,1.19,1.68,0.00271124,Moderate,0.058,0.31,0.072,0.36,Mild increase (p=0.006),Mild increase (p=0.019),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02224,rs713394,22,146332476,PSEN2,SNP (G/T),(G/,G,1.03,0.68,1.39,0.03680908,Protective,0.465,0.032,0.264,0.039,Mild decrease (p=0.045),Significant increase (p=0.047),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02225,rs114009,6,60172102,APP,SNP (A/C),(A/,A,0.81,0.49,1.02,0.00247961,Moderate,0.063,0.126,0.171,0.44,Significant increase (p=0.002),Significant increase (p=0.021),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02226,rs750367,21,125370050,BIN1,Deletion,-,-,0.84,0.59,1.17,0.05548755,Protective,0.132,0.345,0.285,0.037,Mild decrease (p=0.033),Variable effect (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02227,rs443746,14,131604388,APP,SNP (A/C),(A/,A,3.06,2.68,3.3,0.00514969,Moderate,0.063,0.541,0.163,0.033,No significant pattern (p=0.009),Significant increase (p=0.019),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02228,rs294336,7,225230157,PICALM,Insertion,-,-,0.83,0.51,1.06,0.00498942,High,0.172,0.52,0.08,0.029,Mild increase (p=0.024),Significant increase (p=0.047),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02229,rs958665,22,102803890,PICALM,SNP (A/G),(A/,A,0.77,0.53,1.16,0.01389554,Low,0.305,0.004,0.14,0.351,Mild decrease (p=0.041),Significant increase (p=0.031),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02230,rs321589,7,157345950,CLU,SNP (C/T),(C/,C,0.75,0.45,1.03,0.08208704,Moderate,0.26,0.025,0.276,0.238,Mild increase (p=0.032),Significant decrease (p=0.016),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP02231,rs591979,17,66343723,BIN1,SNP (A/G),(A/,A,0.39,0.1,0.7,2.264e-05,High,0.037,0.383,0.005,0.375,Significant decrease (p=0.043),No significant pattern (p=0.007),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02232,rs765507,2,184500748,CD2AP,SNP (G/T),(G/,G,1.53,1.31,1.74,0.05589083,Moderate,0.117,0.086,0.388,0.209,Significant decrease (p=0.035),Mild increase (p=0.032),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02233,rs550075,8,80330000,PSEN2,SNP (A/T),(A/,A,1.35,1.11,1.57,0.01480403,High,0.027,0.185,0.176,0.412,No significant pattern (p=0.032),Variable effect (p=0.045),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP02234,rs330505,10,167797024,CD33,SNP (A/G),(A/,A,2.68,2.42,3.05,0.04481907,Moderate,0.427,0.072,0.267,0.034,Mild increase (p=0.007),Significant decrease (p=0.026),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02235,rs596480,17,126577076,APOE,SNP (A/G),(A/,A,2.05,1.81,2.44,0.02101737,Moderate,0.078,0.25,0.022,0.449,Mild decrease (p=0.007),Variable effect (p=0.035),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02236,rs317620,21,172435367,ABCA7,SNP (A/G),(A/,A,1.94,1.6,2.23,0.06014683,Moderate,0.419,0.08,0.22,0.082,Mild increase (p=0.05),Mild decrease (p=0.024),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02237,rs467153,12,229201268,MS4A6A,SNP (A/G),(A/,A,1.06,0.74,1.39,0.08538302,High,0.078,0.355,0.08,0.287,Mild increase (p=0.002),Significant decrease (p=0.002),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP02238,rs114705,12,72197287,APOE,Deletion,-,-,0.67,0.46,1.07,0.00653491,High,0.037,0.453,0.193,0.117,Significant decrease (p=0.041),Variable effect (p=0.022),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP02239,rs348941,3,13261934,ABCA7,Deletion,-,-,0.55,0.26,0.76,0.08865604,Protective,0.224,0.032,0.445,0.099,Significant increase (p=0.018),Significant increase (p=0.007),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02240,rs683477,1,183600478,PTK2B,SNP (C/T),(C/,C,0.97,0.74,1.24,0.05273864,Moderate,0.018,0.294,0.194,0.295,Mild decrease (p=0.037),No significant pattern (p=0.008),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02241,rs965804,19,53466796,CD33,Insertion,-,-,0.3,0.1,0.64,0.03816506,Moderate,0.124,0.132,0.098,0.446,Significant decrease (p=0.044),Mild decrease (p=0.004),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02242,rs709725,7,59189160,EPHA1,SNP (G/T),(G/,G,0.81,0.44,1.15,0.01636672,High,0.195,0.174,0.419,0.012,Mild increase (p=0.016),No significant pattern (p=0.018),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02243,rs679924,3,72245547,CR1,SNP (G/T),(G/,G,0.35,0.1,0.64,0.0053901,Low,0.333,0.022,0.255,0.19,Significant decrease (p=0.039),Significant decrease (p=0.03),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02244,rs438105,4,24283623,EPHA1,Insertion,-,-,0.33,0.1,0.56,0.04751264,Moderate,0.024,0.243,0.018,0.514,No significant pattern (p=0.037),Mild increase (p=0.005),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02245,rs459890,22,110237043,PICALM,SNP (A/T),(A/,A,0.7,0.3,0.93,0.01690706,Low,0.517,0.153,0.048,0.082,Mild decrease (p=0.017),Significant decrease (p=0.005),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02246,rs639086,2,158671659,PSEN2,SNP (G/T),(G/,G,0.87,0.47,1.26,0.01841799,High,0.716,0.002,0.078,0.004,Mild increase (p=0.038),Significant increase (p=0.02),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02247,rs430479,21,194144757,PICALM,Insertion,-,-,0.73,0.47,1.11,0.01663047,Moderate,0.256,0.266,0.235,0.042,Mild increase (p=0.035),Mild decrease (p=0.017),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02248,rs631300,22,108713946,CD2AP,Insertion,-,-,0.27,0.1,0.49,0.03747348,Moderate,0.098,0.174,0.388,0.14,No significant pattern (p=0.013),Variable effect (p=0.042),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02249,rs957094,2,2260545,MS4A6A,SNP (A/C),(A/,A,0.86,0.52,1.14,0.00325475,High,0.222,0.162,0.406,0.01,Significant increase (p=0.045),Mild decrease (p=0.032),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02250,rs399936,5,67757824,CLU,SNP (A/C),(A/,A,0.24,0.1,0.45,0.00474026,Protective,0.028,0.033,0.074,0.664,No significant pattern (p=0.025),Mild increase (p=0.031),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02251,rs529395,2,208522859,BIN1,SNP (G/T),(G/,G,0.93,0.54,1.32,0.02264378,Moderate,0.407,0.062,0.261,0.07,Significant increase (p=0.025),Significant increase (p=0.012),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02252,rs466530,2,125176034,APP,Deletion,-,-,0.93,0.64,1.19,0.00964852,Moderate,0.542,0.135,0.083,0.039,Mild increase (p=0.032),Significant increase (p=0.009),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02253,rs752396,11,138778519,EPHA1,SNP (G/T),(G/,G,1.11,0.8,1.34,0.1078464,Moderate,0.067,0.391,0.142,0.2,Variable effect (p=0.036),No significant pattern (p=0.002),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02254,rs861099,18,235752571,TREM2,SNP (C/G),(C/,C,0.52,0.24,0.91,9.688e-05,High,0.372,0.253,0.131,0.044,Mild increase (p=0.032),No significant pattern (p=0.049),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02255,rs941826,9,35838986,EPHA1,SNP (G/T),(G/,G,0.95,0.7,1.29,0.00585029,Unknown,0.293,0.137,0.347,0.023,Variable effect (p=0.001),Mild decrease (p=0.031),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02256,rs730905,9,189330859,MS4A6A,SNP (G/T),(G/,G,0.57,0.27,0.83,0.00171053,Moderate,0.219,0.22,0.004,0.357,Mild increase (p=0.008),Mild increase (p=0.05),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP02257,rs300811,21,148976299,TREM2,Deletion,-,-,1.49,1.26,1.78,0.01106494,Low,0.157,0.004,0.453,0.186,Mild increase (p=0.023),Significant decrease (p=0.006),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02258,rs522008,1,155518992,PTK2B,SNP (A/C),(A/,A,0.99,0.74,1.36,0.01369886,High,0.225,0.22,0.263,0.091,Mild increase (p=0.019),Significant increase (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02259,rs105398,15,30763420,APOE,Insertion,-,-,0.66,0.4,1.05,0.00310029,Moderate,0.179,0.554,0.034,0.033,Mild increase (p=0.047),Significant increase (p=0.031),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02260,rs798225,15,192106878,SORL1,SNP (A/C),(A/,A,0.5,0.2,0.74,0.01675733,Moderate,0.281,0.083,0.332,0.104,No significant pattern (p=0.024),Mild decrease (p=0.022),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02261,rs393027,10,67123742,CR1,SNP (C/G),(C/,C,1.12,0.78,1.43,0.01572601,Moderate,0.138,0.284,0.106,0.271,Mild decrease (p=0.017),Mild decrease (p=0.006),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP02262,rs967458,14,123009850,MS4A6A,SNP (A/T),(A/,A,0.82,0.44,1.17,0.0725465,Moderate,0.245,0.035,0.392,0.128,No significant pattern (p=0.032),Variable effect (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02263,rs262189,18,73441474,PTK2B,SNP (A/G),(A/,A,0.48,0.24,0.73,0.0091927,Moderate,0.009,0.428,0.037,0.326,Significant decrease (p=0.03),Mild increase (p=0.02),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP02264,rs890860,7,96853845,APOE,Deletion,-,-,1.21,0.81,1.42,0.08806626,High,0.556,0.064,0.104,0.076,Significant decrease (p=0.013),Mild increase (p=0.011),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02265,rs866244,13,3845320,APP,SNP (C/G),(C/,C,0.76,0.53,1.06,0.03873574,Moderate,0.269,0.145,0.208,0.178,Mild increase (p=0.044),Mild decrease (p=0.021),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02266,rs614850,17,120508461,APP,SNP (G/T),(G/,G,1.33,1.13,1.6,0.01524739,High,0.195,0.417,0.163,0.025,No significant pattern (p=0.006),No significant pattern (p=0.005),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02267,rs892329,5,26860331,CLU,SNP (G/T),(G/,G,1.38,1.06,1.69,0.04706206,Low,0.229,0.16,0.117,0.294,No significant pattern (p=0.02),Mild decrease (p=0.031),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02268,rs597433,17,213337577,EPHA1,Insertion,-,-,0.86,0.62,1.1,0.00445967,Low,0.305,0.123,0.231,0.141,Significant decrease (p=0.004),Significant increase (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP02269,rs261139,12,190845608,APP,SNP (C/T),(C/,C,0.78,0.43,1.1,0.00101824,Moderate,0.037,0.483,0.087,0.193,Significant decrease (p=0.011),Significant decrease (p=0.036),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02270,rs668164,4,207629856,ABCA7,Deletion,-,-,1.24,0.95,1.48,0.00407508,High,0.116,0.379,0.227,0.078,Significant increase (p=0.042),Significant decrease (p=0.01),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02271,rs951440,15,89593330,MS4A6A,SNP (A/T),(A/,A,1.86,1.64,2.11,0.05591755,Low,0.132,0.191,0.454,0.023,No significant pattern (p=0.015),No significant pattern (p=0.014),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02272,rs571345,19,50586059,APP,SNP (C/G),(C/,C,1.79,1.44,2.11,0.06234785,Moderate,0.238,0.037,0.183,0.342,No significant pattern (p=0.048),Significant decrease (p=0.03),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02273,rs929241,20,64086950,PICALM,SNP (C/G),(C/,C,1.14,0.76,1.36,0.05570158,High,0.375,0.299,0.093,0.033,Mild increase (p=0.003),No significant pattern (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02274,rs903083,22,42263248,SORL1,Deletion,-,-,1.05,0.72,1.34,0.01110023,Moderate,0.142,0.307,0.21,0.141,Mild decrease (p=0.049),Significant decrease (p=0.022),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02275,rs871764,16,239354232,ABCA7,SNP (C/G),(C/,C,0.63,0.36,0.98,0.00736262,High,0.057,0.343,0.305,0.095,No significant pattern (p=0.043),Mild increase (p=0.044),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02276,rs931554,12,49791083,APOE,Deletion,-,-,1.75,1.47,2.05,0.03332713,High,0.063,0.23,0.084,0.424,Variable effect (p=0.003),Mild increase (p=0.048),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02277,rs563902,12,134921352,ABCA7,SNP (A/T),(A/,A,2.26,1.98,2.47,0.01260061,Moderate,0.327,0.334,0.061,0.078,Mild decrease (p=0.003),Variable effect (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02278,rs468868,15,134370114,PTK2B,Insertion,-,-,1.8,1.47,2.17,0.03449487,Low,0.411,0.147,0.112,0.129,Mild decrease (p=0.038),Mild decrease (p=0.024),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP02279,rs282275,2,17413588,PICALM,SNP (A/G),(A/,A,2.12,1.87,2.47,0.08901638,Moderate,0.236,0.341,0.025,0.198,Significant increase (p=0.026),Significant decrease (p=0.043),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02280,rs336103,22,188247296,PICALM,SNP (C/T),(C/,C,1.35,1.13,1.67,0.02140893,Moderate,0.088,0.405,0.065,0.241,Variable effect (p=0.032),Variable effect (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP02281,rs339015,9,189078080,APOE,SNP (C/G),(C/,C,0.85,0.53,1.15,0.00768015,Moderate,0.117,0.395,0.094,0.194,Variable effect (p=0.031),Mild decrease (p=0.024),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02282,rs611732,20,117683298,BIN1,Insertion,-,-,1.44,1.18,1.81,0.03943078,High,0.02,0.439,0.165,0.176,No significant pattern (p=0.022),Significant decrease (p=0.028),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02283,rs693815,5,218325629,APOE,SNP (C/T),(C/,C,0.44,0.22,0.68,0.00217343,High,0.131,0.412,0.224,0.034,Significant increase (p=0.037),Mild decrease (p=0.003),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02284,rs381940,4,101529240,CLU,SNP (A/T),(A/,A,0.87,0.55,1.19,0.0146089,Low,0.293,0.118,0.245,0.143,Mild increase (p=0.003),Significant increase (p=0.049),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP02285,rs887168,6,89170281,PTK2B,SNP (C/G),(C/,C,0.92,0.68,1.18,0.09015945,Low,0.035,0.602,0.019,0.144,Variable effect (p=0.037),Significant increase (p=0.014),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02286,rs717372,3,119040883,CLU,SNP (A/G),(A/,A,1.19,0.83,1.43,0.05529356,Moderate,0.223,0.233,0.308,0.036,No significant pattern (p=0.018),Significant decrease (p=0.009),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02287,rs962999,10,246301450,CD33,SNP (C/G),(C/,C,0.82,0.6,1.19,0.00321538,Low,0.086,0.035,0.624,0.055,Significant decrease (p=0.048),Variable effect (p=0.015),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02288,rs776993,16,137955445,PSEN2,SNP (C/G),(C/,C,1.21,0.87,1.54,0.01954221,High,0.173,0.105,0.437,0.085,Mild increase (p=0.006),Significant increase (p=0.022),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02289,rs847401,11,80373963,APP,SNP (A/T),(A/,A,1.48,1.25,1.88,0.02076537,Protective,0.109,0.364,0.045,0.282,Mild increase (p=0.023),Significant increase (p=0.017),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02290,rs887527,17,65454137,EPHA1,Insertion,-,-,0.98,0.65,1.19,0.00362596,Moderate,0.04,0.185,0.512,0.063,Significant increase (p=0.003),Mild increase (p=0.042),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02291,rs290075,19,48028991,SORL1,SNP (C/G),(C/,C,1.4,1.1,1.77,0.07069382,Low,0.035,0.045,0.35,0.37,No significant pattern (p=0.031),No significant pattern (p=0.015),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02292,rs623628,19,179135115,EPHA1,SNP (A/T),(A/,A,0.85,0.57,1.11,0.02500612,Protective,0.33,0.024,0.442,0.004,Mild increase (p=0.035),Mild decrease (p=0.037),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP02293,rs693630,12,102034027,BIN1,SNP (C/G),(C/,C,1.1,0.87,1.33,0.0014981,Moderate,0.333,0.074,0.167,0.226,Significant increase (p=0.002),No significant pattern (p=0.015),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02294,rs641008,10,9964066,MS4A6A,Deletion,-,-,0.88,0.6,1.15,0.08130436,High,0.251,0.225,0.033,0.291,Mild increase (p=0.001),Significant increase (p=0.015),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02295,rs680411,10,5422123,APP,SNP (G/T),(G/,G,1.29,1.07,1.62,0.2088936,Low,0.383,0.011,0.024,0.382,Variable effect (p=0.041),Mild decrease (p=0.011),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02296,rs476644,18,215671093,CD33,SNP (C/G),(C/,C,1.04,0.67,1.41,0.00118942,Low,0.192,0.395,0.111,0.101,No significant pattern (p=0.037),No significant pattern (p=0.024),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02297,rs692996,21,2423181,CD33,Insertion,-,-,1.43,1.11,1.73,0.02937639,Moderate,0.075,0.182,0.385,0.158,No significant pattern (p=0.025),Significant decrease (p=0.022),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02298,rs718359,12,61123619,CD33,SNP (A/T),(A/,A,3.05,2.79,3.31,0.06212003,Moderate,0.148,0.449,0.021,0.182,Significant increase (p=0.006),Mild increase (p=0.05),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02299,rs447500,8,143556080,BIN1,SNP (G/T),(G/,G,1.09,0.84,1.37,0.00448305,Low,0.052,0.009,0.259,0.48,Variable effect (p=0.037),Significant increase (p=0.026),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02300,rs334085,21,85641236,BIN1,Insertion,-,-,2.4,2.18,2.8,0.02932752,High,0.106,0.057,0.555,0.082,Significant decrease (p=0.049),No significant pattern (p=0.038),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02301,rs824447,22,79062713,TREM2,Deletion,-,-,1.92,1.52,2.2,0.01815842,Moderate,0.044,0.154,0.089,0.513,Significant increase (p=0.007),Variable effect (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP02302,rs514465,11,62736575,APP,Insertion,-,-,0.39,0.14,0.68,0.04114744,Moderate,0.376,0.129,0.128,0.168,Variable effect (p=0.017),Significant decrease (p=0.045),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02303,rs390599,6,39210462,CLU,SNP (A/T),(A/,A,0.73,0.46,0.95,0.02108737,High,0.381,0.354,0.037,0.027,Mild increase (p=0.03),No significant pattern (p=0.035),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02304,rs391941,3,122300779,CR1,Deletion,-,-,1.9,1.58,2.2,0.00331891,Moderate,0.121,0.045,0.628,0.005,Significant increase (p=0.034),Variable effect (p=0.031),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02305,rs952434,5,209651726,ABCA7,SNP (A/C),(A/,A,0.5,0.15,0.7,0.00760241,Low,0.06,0.18,0.497,0.063,No significant pattern (p=0.024),Significant decrease (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP02306,rs108695,10,187335289,APOE,SNP (C/G),(C/,C,0.67,0.3,0.96,0.01775774,Protective,0.185,0.103,0.32,0.191,Mild increase (p=0.029),Variable effect (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP02307,rs675027,11,87089717,TREM2,Insertion,-,-,1.7,1.38,2.09,0.02542131,Low,0.064,0.202,0.45,0.083,No significant pattern (p=0.013),Mild increase (p=0.012),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02308,rs756170,11,218762383,ABCA7,SNP (A/C),(A/,A,1.54,1.22,1.93,0.03003149,Moderate,0.018,0.053,0.62,0.11,Significant decrease (p=0.046),Mild increase (p=0.023),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02309,rs908798,12,182987951,BIN1,SNP (A/T),(A/,A,1.06,0.71,1.42,0.03164913,Moderate,0.389,0.28,0.027,0.104,Mild increase (p=0.006),Mild increase (p=0.024),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02310,rs894618,1,120906567,APP,SNP (C/T),(C/,C,1.22,0.94,1.57,0.05027022,Moderate,0.29,0.18,0.107,0.223,Mild increase (p=0.016),Mild decrease (p=0.013),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02311,rs505679,15,60351696,PSEN2,SNP (A/G),(A/,A,1.24,0.93,1.6,0.00679599,Moderate,0.163,0.083,0.037,0.518,Significant decrease (p=0.021),Significant decrease (p=0.019),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02312,rs112508,18,136241333,CR1,SNP (C/T),(C/,C,0.32,0.1,0.58,0.01877258,High,0.283,0.197,0.064,0.256,Variable effect (p=0.007),Variable effect (p=0.026),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02313,rs226938,11,89090736,CD2AP,SNP (G/T),(G/,G,1.53,1.13,1.89,0.10270338,Low,0.026,0.073,0.317,0.384,Significant decrease (p=0.03),Variable effect (p=0.003),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP02314,rs865234,19,128980694,MS4A6A,SNP (A/T),(A/,A,1.49,1.23,1.7,0.0025758,Moderate,0.154,0.094,0.155,0.398,No significant pattern (p=0.02),No significant pattern (p=0.041),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02315,rs818363,4,157723326,APP,Insertion,-,-,0.78,0.43,1.05,0.01805519,Moderate,0.194,0.369,0.182,0.055,Mild decrease (p=0.003),Mild increase (p=0.044),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP02316,rs213896,12,32878956,PSEN2,SNP (C/T),(C/,C,1.09,0.86,1.45,0.08806553,High,0.129,0.254,0.15,0.267,Significant increase (p=0.023),Significant decrease (p=0.046),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP02317,rs239784,22,224285295,APOE,SNP (A/G),(A/,A,1.04,0.77,1.31,0.0470918,High,0.002,0.167,0.237,0.395,Mild increase (p=0.011),Variable effect (p=0.029),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02318,rs804590,6,164370028,SORL1,SNP (A/C),(A/,A,0.95,0.73,1.26,0.02185467,High,0.111,0.141,0.026,0.521,Significant decrease (p=0.02),Significant increase (p=0.034),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02319,rs178684,14,132543982,PICALM,SNP (A/T),(A/,A,1.21,0.91,1.5,0.05477278,Moderate,0.004,0.039,0.328,0.428,Significant decrease (p=0.034),Mild decrease (p=0.047),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02320,rs620088,5,244685261,PSEN2,SNP (A/G),(A/,A,0.93,0.66,1.16,0.0106569,Unknown,0.294,0.027,0.428,0.05,No significant pattern (p=0.014),Mild increase (p=0.034),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02321,rs250157,12,149091158,CD2AP,SNP (A/T),(A/,A,2.59,2.38,2.87,0.0694579,Protective,0.4,0.056,0.107,0.238,No significant pattern (p=0.007),Mild increase (p=0.045),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02322,rs714633,14,227179559,BIN1,SNP (G/T),(G/,G,1.5,1.15,1.76,0.08351794,High,0.053,0.161,0.334,0.252,No significant pattern (p=0.023),Mild increase (p=0.009),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02323,rs473035,1,46744821,BIN1,SNP (C/G),(C/,C,1.47,1.12,1.72,0.05151512,Low,0.283,0.434,0.057,0.026,Variable effect (p=0.004),Significant decrease (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02324,rs293999,13,166608744,APOE,SNP (C/G),(C/,C,1.11,0.8,1.37,0.0720467,Unknown,0.118,0.162,0.368,0.153,Significant decrease (p=0.01),Significant decrease (p=0.027),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP02325,rs905607,18,119237084,PSEN2,SNP (A/G),(A/,A,1.41,1.03,1.76,0.01567321,Moderate,0.056,0.332,0.233,0.18,No significant pattern (p=0.013),Significant decrease (p=0.008),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02326,rs799788,8,245019065,SORL1,Deletion,-,-,0.73,0.41,1.06,0.0029459,High,0.098,0.417,0.219,0.066,Mild decrease (p=0.016),Significant increase (p=0.025),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02327,rs279302,8,138098930,MS4A6A,SNP (C/G),(C/,C,0.84,0.56,1.18,0.02241452,High,0.01,0.057,0.22,0.513,Mild increase (p=0.003),Mild increase (p=0.022),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02328,rs359758,15,68910071,APOE,SNP (A/C),(A/,A,0.9,0.56,1.1,0.02868731,Low,0.335,0.204,0.162,0.1,Mild increase (p=0.042),Significant decrease (p=0.01),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02329,rs524085,1,170754410,BIN1,SNP (A/T),(A/,A,1.07,0.8,1.38,0.07904105,Low,0.266,0.213,0.107,0.214,Significant decrease (p=0.031),No significant pattern (p=0.03),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02330,rs402026,18,158243016,CLU,SNP (G/T),(G/,G,2.33,1.98,2.68,0.02944356,High,0.589,0.08,0.128,0.003,No significant pattern (p=0.004),Significant decrease (p=0.038),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP02331,rs481886,17,58750919,PSEN2,Insertion,-,-,1.19,0.8,1.51,0.01865601,Low,0.172,0.281,0.285,0.062,Variable effect (p=0.048),Variable effect (p=0.049),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02332,rs548587,14,221118526,EPHA1,SNP (A/T),(A/,A,2.51,2.12,2.83,0.01691859,Moderate,0.139,0.153,0.099,0.409,Significant increase (p=0.036),Mild increase (p=0.048),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02333,rs652779,10,166844743,APOE,Insertion,-,-,1.43,1.08,1.66,0.07294569,Unknown,0.192,0.062,0.037,0.508,Mild increase (p=0.046),Mild decrease (p=0.033),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02334,rs828963,9,14708753,APP,SNP (A/G),(A/,A,0.44,0.2,0.76,0.01259183,Moderate,0.475,0.155,0.091,0.079,Significant decrease (p=0.029),Mild decrease (p=0.026),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP02335,rs120922,2,153122115,PICALM,Deletion,-,-,1.04,0.82,1.32,0.00239961,Moderate,0.123,0.387,0.008,0.283,Mild increase (p=0.004),No significant pattern (p=0.027),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02336,rs507675,11,101041272,ABCA7,SNP (C/T),(C/,C,1.26,0.99,1.51,0.03257355,Moderate,0.122,0.436,0.192,0.05,Mild increase (p=0.006),Significant increase (p=0.048),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02337,rs293782,22,45928615,APP,SNP (C/G),(C/,C,0.73,0.42,1.01,0.03354203,Moderate,0.145,0.089,0.209,0.357,Variable effect (p=0.028),Mild increase (p=0.029),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02338,rs430411,14,207917921,PICALM,Deletion,-,-,0.95,0.73,1.23,0.03130252,Moderate,0.439,0.228,0.107,0.026,Significant increase (p=0.002),No significant pattern (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP02339,rs919779,7,148711323,CLU,SNP (A/T),(A/,A,0.78,0.57,1.05,0.01943743,Low,0.118,0.346,0.111,0.225,Significant increase (p=0.005),Significant decrease (p=0.036),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP02340,rs269740,3,164467643,EPHA1,SNP (A/C),(A/,A,0.59,0.24,0.86,0.0074951,Unknown,0.151,0.461,0.068,0.12,Mild increase (p=0.006),Mild decrease (p=0.02),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP02341,rs377781,3,96358059,CLU,SNP (C/T),(C/,C,1.41,1.19,1.69,0.00532132,High,0.012,0.418,0.245,0.125,Significant decrease (p=0.032),No significant pattern (p=0.007),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02342,rs765367,8,9042727,CD33,SNP (A/C),(A/,A,0.88,0.6,1.2,0.04103538,Low,0.027,0.188,0.128,0.457,Variable effect (p=0.041),Mild increase (p=0.025),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02343,rs893042,13,228861579,ABCA7,SNP (A/C),(A/,A,0.84,0.54,1.12,0.02005998,Moderate,0.168,0.006,0.586,0.041,Mild increase (p=0.029),Significant decrease (p=0.045),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02344,rs874775,19,245339191,CD33,SNP (A/C),(A/,A,1.13,0.78,1.38,0.03317229,Low,0.489,0.226,0.02,0.064,Mild increase (p=0.044),No significant pattern (p=0.015),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02345,rs891610,5,205185908,APP,SNP (G/T),(G/,G,1.0,0.79,1.22,0.00053514,Moderate,0.038,0.09,0.049,0.622,Significant decrease (p=0.03),Mild increase (p=0.043),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02346,rs851866,5,50174931,PICALM,SNP (C/T),(C/,C,1.67,1.37,1.9,0.06030835,High,0.064,0.579,0.078,0.078,Significant increase (p=0.031),No significant pattern (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02347,rs429261,16,34275355,BIN1,SNP (A/T),(A/,A,0.38,0.13,0.66,0.05448834,Moderate,0.013,0.148,0.144,0.494,No significant pattern (p=0.016),Significant increase (p=0.048),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP02348,rs245084,6,210551778,CD33,SNP (A/T),(A/,A,0.7,0.37,1.01,0.00317016,High,0.016,0.034,0.065,0.685,Significant decrease (p=0.011),Mild decrease (p=0.023),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02349,rs721704,1,1603522,CR1,Deletion,-,-,0.85,0.47,1.13,0.04575569,High,0.331,0.141,0.189,0.138,Mild decrease (p=0.047),Significant increase (p=0.026),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02350,rs427144,5,225953629,CD33,Deletion,-,-,0.86,0.57,1.11,0.00228798,Low,0.313,0.095,0.269,0.123,No significant pattern (p=0.003),Significant decrease (p=0.037),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02351,rs237713,4,129447035,CR1,SNP (A/G),(A/,A,1.0,0.62,1.32,0.02120774,Moderate,0.042,0.235,0.294,0.23,Significant increase (p=0.044),Mild decrease (p=0.041),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02352,rs850783,13,245279458,PICALM,Deletion,-,-,1.85,1.56,2.06,0.04563129,Low,0.422,0.097,0.267,0.014,Variable effect (p=0.016),Significant decrease (p=0.041),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02353,rs603139,18,89913497,PICALM,SNP (A/C),(A/,A,0.77,0.46,1.0,0.02167725,Moderate,0.37,0.083,0.011,0.336,Significant decrease (p=0.042),Mild increase (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02354,rs389394,10,162103373,ABCA7,Deletion,-,-,0.55,0.26,0.93,0.03386496,Protective,0.18,0.041,0.316,0.262,Significant decrease (p=0.013),Significant increase (p=0.034),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02355,rs515173,3,233395878,APP,SNP (C/T),(C/,C,0.79,0.46,1.15,0.01528605,Low,0.063,0.092,0.555,0.09,Significant decrease (p=0.005),Significant decrease (p=0.006),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02356,rs727140,20,30925737,CR1,SNP (C/G),(C/,C,0.93,0.62,1.21,0.04941626,High,0.379,0.347,0.062,0.011,Variable effect (p=0.015),Significant increase (p=0.01),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02357,rs185904,7,131427820,APP,SNP (A/C),(A/,A,0.69,0.37,1.02,0.00724409,Moderate,0.051,0.022,0.709,0.017,Mild increase (p=0.022),No significant pattern (p=0.003),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02358,rs933475,22,10570528,CD33,SNP (A/T),(A/,A,1.17,0.94,1.41,0.1694198,Moderate,0.489,0.051,0.241,0.019,Mild decrease (p=0.015),Mild increase (p=0.046),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02359,rs651846,19,51499615,CD33,Deletion,-,-,0.45,0.1,0.82,0.04786566,Unknown,0.185,0.419,0.011,0.185,Mild decrease (p=0.011),Significant increase (p=0.015),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02360,rs980860,19,121996687,EPHA1,SNP (C/T),(C/,C,0.54,0.27,0.91,0.00825502,High,0.004,0.563,0.03,0.202,Significant decrease (p=0.004),Mild increase (p=0.022),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP02361,rs126989,22,105582744,SORL1,SNP (A/C),(A/,A,1.84,1.57,2.15,0.03656229,High,0.068,0.122,0.092,0.519,Mild decrease (p=0.007),Significant increase (p=0.04),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02362,rs542522,5,11304494,ABCA7,SNP (A/C),(A/,A,1.23,0.91,1.56,0.0286433,Low,0.08,0.299,0.268,0.153,Mild decrease (p=0.022),Mild increase (p=0.001),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02363,rs704141,16,172862332,CR1,SNP (C/T),(C/,C,0.84,0.59,1.11,0.20323112,Low,0.339,0.142,0.098,0.221,Mild decrease (p=0.013),Significant increase (p=0.041),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02364,rs390158,17,49934491,SORL1,SNP (A/G),(A/,A,1.44,1.19,1.67,0.00758688,Moderate,0.172,0.134,0.385,0.108,Significant increase (p=0.033),Significant increase (p=0.036),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02365,rs333355,14,221173308,TREM2,SNP (G/T),(G/,G,0.9,0.6,1.24,0.03032433,High,0.245,0.044,0.044,0.466,Mild decrease (p=0.016),Variable effect (p=0.016),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02366,rs623558,12,204377524,ABCA7,SNP (A/C),(A/,A,0.88,0.57,1.17,0.03219419,High,0.125,0.156,0.35,0.169,No significant pattern (p=0.003),Significant increase (p=0.011),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02367,rs247921,15,198679207,EPHA1,SNP (C/G),(C/,C,0.68,0.29,1.04,0.00657426,High,0.128,0.142,0.466,0.064,Variable effect (p=0.008),Variable effect (p=0.034),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP02368,rs168004,15,87518631,CLU,SNP (A/T),(A/,A,0.67,0.38,0.9,0.00517847,Unknown,0.199,0.044,0.045,0.511,Mild decrease (p=0.031),No significant pattern (p=0.003),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02369,rs487492,7,203881894,BIN1,SNP (G/T),(G/,G,1.28,1.08,1.65,0.00088303,Protective,0.026,0.108,0.089,0.577,Mild increase (p=0.029),Significant decrease (p=0.035),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02370,rs436328,22,92031638,MS4A6A,SNP (A/T),(A/,A,1.34,1.12,1.61,0.00541992,High,0.169,0.059,0.369,0.203,No significant pattern (p=0.042),Variable effect (p=0.022),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP02371,rs413108,13,80612755,EPHA1,SNP (C/T),(C/,C,0.81,0.57,1.07,0.05752751,High,0.205,0.213,0.357,0.025,Significant increase (p=0.026),Mild decrease (p=0.029),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02372,rs500844,13,230592449,PTK2B,SNP (A/C),(A/,A,1.94,1.68,2.24,0.01566822,High,0.232,0.011,0.05,0.507,Significant increase (p=0.041),No significant pattern (p=0.044),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02373,rs771660,14,218683711,SORL1,Deletion,-,-,0.74,0.45,1.08,0.01848067,Moderate,0.073,0.424,0.012,0.292,No significant pattern (p=0.014),Significant increase (p=0.017),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02374,rs142326,9,193129057,CLU,Deletion,-,-,0.58,0.38,0.89,0.01539092,Moderate,0.443,0.159,0.087,0.111,Mild increase (p=0.009),Significant decrease (p=0.009),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02375,rs654139,12,217483484,BIN1,SNP (A/T),(A/,A,3.13,2.77,3.44,0.04431365,Low,0.134,0.164,0.28,0.222,Mild increase (p=0.046),No significant pattern (p=0.043),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP02376,rs821702,12,207967116,APOE,SNP (A/C),(A/,A,0.57,0.22,0.93,0.0513162,Moderate,0.135,0.262,0.082,0.321,No significant pattern (p=0.033),No significant pattern (p=0.038),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP02377,rs458311,7,231115299,CR1,SNP (A/T),(A/,A,0.46,0.15,0.74,0.09066295,Low,0.606,0.028,0.156,0.01,Mild increase (p=0.048),Variable effect (p=0.038),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02378,rs434664,2,32141857,PTK2B,Insertion,-,-,1.08,0.82,1.3,0.02344563,Moderate,0.33,0.24,0.198,0.032,No significant pattern (p=0.041),Variable effect (p=0.003),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02379,rs974231,8,193145889,EPHA1,SNP (A/T),(A/,A,1.36,1.01,1.59,0.00077042,Moderate,0.368,0.166,0.24,0.025,Variable effect (p=0.036),No significant pattern (p=0.04),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02380,rs740607,21,125113412,TREM2,Insertion,-,-,0.53,0.29,0.9,0.05995804,Moderate,0.014,0.287,0.427,0.072,Significant decrease (p=0.011),Significant decrease (p=0.007),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP02381,rs154040,5,114369288,APP,SNP (G/T),(G/,G,1.14,0.86,1.52,0.05014224,Protective,0.025,0.65,0.11,0.015,Mild decrease (p=0.046),Mild increase (p=0.011),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02382,rs930655,5,153145322,APP,Deletion,-,-,0.39,0.1,0.69,0.00396277,Low,0.197,0.34,0.006,0.258,No significant pattern (p=0.017),Variable effect (p=0.045),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02383,rs797085,4,235996694,SORL1,SNP (G/T),(G/,G,0.73,0.49,1.01,0.00466195,Low,0.379,0.164,0.169,0.088,Significant increase (p=0.028),Variable effect (p=0.047),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02384,rs519461,7,90787138,CD33,SNP (G/T),(G/,G,1.15,0.75,1.35,0.11584855,Moderate,0.265,0.153,0.37,0.013,Significant decrease (p=0.048),Mild decrease (p=0.049),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP02385,rs697144,5,189208847,TREM2,SNP (C/T),(C/,C,0.69,0.3,1.01,0.04221556,Low,0.131,0.146,0.004,0.519,Variable effect (p=0.006),Variable effect (p=0.037),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02386,rs723364,14,131732392,SORL1,SNP (A/G),(A/,A,0.95,0.71,1.16,0.10471372,Moderate,0.14,0.082,0.435,0.143,Significant increase (p=0.023),Significant increase (p=0.021),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02387,rs862886,12,69842598,TREM2,SNP (A/T),(A/,A,2.37,2.16,2.77,0.00189003,Low,0.427,0.054,0.304,0.014,No significant pattern (p=0.032),Variable effect (p=0.047),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02388,rs356641,10,17576773,EPHA1,SNP (A/T),(A/,A,2.08,1.83,2.38,0.00144417,High,0.316,0.011,0.013,0.46,Variable effect (p=0.011),Mild decrease (p=0.049),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02389,rs335664,14,181531143,PSEN2,Deletion,-,-,0.64,0.36,0.94,0.07323957,Low,0.025,0.353,0.072,0.35,Significant increase (p=0.024),Mild decrease (p=0.036),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02390,rs559401,8,141917699,APOE,SNP (C/G),(C/,C,1.3,0.94,1.65,0.03433562,Moderate,0.221,0.33,0.207,0.041,Variable effect (p=0.037),Variable effect (p=0.034),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02391,rs295669,10,220010810,CD33,SNP (C/G),(C/,C,0.46,0.24,0.71,0.03536333,High,0.325,0.082,0.117,0.276,Mild increase (p=0.047),No significant pattern (p=0.042),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02392,rs132694,16,183726621,ABCA7,SNP (C/T),(C/,C,0.58,0.25,0.81,0.10322381,Protective,0.23,0.249,0.008,0.312,Variable effect (p=0.045),Variable effect (p=0.02),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02393,rs606059,10,132871471,EPHA1,Insertion,-,-,1.73,1.41,1.96,0.03889475,Moderate,0.158,0.176,0.071,0.396,Mild decrease (p=0.014),Mild decrease (p=0.019),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02394,rs579418,13,107183088,PSEN2,SNP (G/T),(G/,G,1.22,0.93,1.49,0.02790103,Unknown,0.206,0.017,0.339,0.239,No significant pattern (p=0.012),No significant pattern (p=0.027),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02395,rs987191,19,57208099,APP,SNP (C/G),(C/,C,0.81,0.53,1.11,0.06387124,Moderate,0.098,0.191,0.217,0.294,Significant increase (p=0.006),Mild increase (p=0.035),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02396,rs180764,16,129781745,PTK2B,SNP (A/G),(A/,A,1.15,0.91,1.39,0.07789993,Protective,0.006,0.34,0.398,0.056,Mild decrease (p=0.006),Mild decrease (p=0.033),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02397,rs871744,18,132327082,PSEN2,SNP (A/G),(A/,A,1.38,0.98,1.66,0.0531047,High,0.13,0.032,0.458,0.18,Significant increase (p=0.034),Significant decrease (p=0.016),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02398,rs138864,7,108968102,TREM2,SNP (C/G),(C/,C,0.86,0.61,1.12,0.01819712,High,0.085,0.051,0.111,0.554,Significant decrease (p=0.032),Significant increase (p=0.043),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02399,rs250875,1,191927257,SORL1,SNP (A/T),(A/,A,1.16,0.79,1.5,0.00588794,Low,0.222,0.26,0.057,0.261,No significant pattern (p=0.045),Mild increase (p=0.039),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02400,rs483790,8,172660343,TREM2,SNP (A/T),(A/,A,0.79,0.41,1.18,0.0136998,Moderate,0.023,0.168,0.4,0.209,No significant pattern (p=0.047),Mild increase (p=0.033),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02401,rs924115,20,207022005,APOE,Insertion,-,-,0.67,0.32,0.93,0.06991473,Low,0.287,0.042,0.177,0.295,Significant increase (p=0.016),Significant increase (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02402,rs264155,20,38067575,MS4A6A,SNP (C/G),(C/,C,2.17,1.86,2.39,0.03114322,Protective,0.042,0.067,0.645,0.045,No significant pattern (p=0.03),Mild decrease (p=0.037),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02403,rs758385,20,95107467,APP,SNP (A/T),(A/,A,0.7,0.49,0.97,0.02957329,Low,0.146,0.083,0.521,0.05,Significant decrease (p=0.029),Mild decrease (p=0.007),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02404,rs693470,14,116601244,BIN1,SNP (C/T),(C/,C,2.15,1.9,2.44,0.07827216,Unknown,0.404,0.083,0.082,0.231,Significant decrease (p=0.013),Mild decrease (p=0.019),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP02405,rs134402,15,137040585,CR1,SNP (G/T),(G/,G,1.64,1.26,1.94,0.00147041,Moderate,0.099,0.072,0.464,0.165,Significant decrease (p=0.016),No significant pattern (p=0.016),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02406,rs832202,10,92392486,ABCA7,SNP (C/G),(C/,C,0.97,0.68,1.26,0.03525536,Moderate,0.113,0.057,0.341,0.29,Significant decrease (p=0.007),Significant decrease (p=0.004),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02407,rs775143,3,153570563,EPHA1,SNP (A/T),(A/,A,0.66,0.36,1.0,0.00401021,Low,0.472,0.012,0.133,0.183,Mild decrease (p=0.007),No significant pattern (p=0.005),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP02408,rs834133,2,190433585,PSEN2,SNP (G/T),(G/,G,0.81,0.6,1.07,0.02979145,Low,0.2,0.387,0.115,0.099,Significant decrease (p=0.033),Significant decrease (p=0.034),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02409,rs776063,21,122724702,APOE,SNP (A/G),(A/,A,0.96,0.75,1.27,0.05499573,Moderate,0.252,0.38,0.074,0.093,Significant increase (p=0.023),Variable effect (p=0.032),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02410,rs407602,18,134714894,MS4A6A,SNP (A/G),(A/,A,0.77,0.53,1.04,0.03601467,Moderate,0.42,0.164,0.017,0.198,Significant increase (p=0.043),No significant pattern (p=0.019),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02411,rs834152,1,111253315,PSEN2,SNP (G/T),(G/,G,0.56,0.27,0.77,0.02757172,Low,0.029,0.203,0.419,0.148,Variable effect (p=0.028),Mild increase (p=0.023),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02412,rs353575,18,102960554,APP,SNP (G/T),(G/,G,0.75,0.39,1.02,0.02692048,Low,0.032,0.408,0.233,0.127,No significant pattern (p=0.049),Mild increase (p=0.006),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP02413,rs614983,7,165975832,BIN1,SNP (C/G),(C/,C,0.6,0.22,0.82,0.02264928,Moderate,0.541,0.027,0.214,0.018,Mild decrease (p=0.044),Variable effect (p=0.049),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02414,rs309215,6,84774887,CLU,Deletion,-,-,0.75,0.48,1.09,0.04986698,Moderate,0.043,0.262,0.206,0.288,Mild decrease (p=0.016),Significant decrease (p=0.05),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02415,rs633360,10,30012412,CR1,Insertion,-,-,2.33,1.96,2.66,0.06192356,Low,0.079,0.348,0.187,0.186,Mild increase (p=0.021),Mild increase (p=0.048),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02416,rs847143,18,156348221,APOE,SNP (C/T),(C/,C,0.92,0.58,1.19,0.02630273,High,0.276,0.1,0.205,0.219,No significant pattern (p=0.027),Significant increase (p=0.009),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP02417,rs731782,21,239631365,PTK2B,Deletion,-,-,1.36,1.11,1.61,0.03113664,Protective,0.041,0.199,0.296,0.264,Mild decrease (p=0.012),Significant decrease (p=0.014),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02418,rs442281,17,113810947,APOE,SNP (A/G),(A/,A,1.52,1.18,1.88,0.00235153,Low,0.106,0.103,0.083,0.509,Variable effect (p=0.029),No significant pattern (p=0.049),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02419,rs399910,6,247666341,CR1,Insertion,-,-,0.89,0.6,1.28,0.05050839,Low,0.1,0.336,0.313,0.051,Significant increase (p=0.048),No significant pattern (p=0.006),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02420,rs205894,1,142109233,CD33,Insertion,-,-,1.61,1.38,1.86,0.00136611,Protective,0.21,0.06,0.394,0.137,Variable effect (p=0.035),Significant decrease (p=0.002),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02421,rs686674,6,7964745,CD33,SNP (A/G),(A/,A,1.78,1.57,2.14,0.1350534,Moderate,0.136,0.118,0.476,0.07,Mild decrease (p=0.048),Mild increase (p=0.007),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02422,rs487001,19,225661783,PTK2B,SNP (G/T),(G/,G,1.2,0.93,1.58,0.02350283,Moderate,0.208,0.064,0.316,0.212,Significant decrease (p=0.016),Variable effect (p=0.036),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02423,rs260868,21,181724057,SORL1,SNP (A/T),(A/,A,1.64,1.26,1.95,0.0357786,Moderate,0.242,0.129,0.151,0.278,Mild decrease (p=0.042),No significant pattern (p=0.024),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02424,rs419148,1,22859164,PSEN2,SNP (A/G),(A/,A,0.46,0.21,0.82,0.03422616,Low,0.093,0.049,0.558,0.1,Significant decrease (p=0.042),Significant increase (p=0.025),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02425,rs928606,13,123987142,CLU,SNP (A/C),(A/,A,1.96,1.72,2.35,0.02551605,Moderate,0.12,0.274,0.234,0.172,Significant decrease (p=0.03),Mild decrease (p=0.025),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02426,rs699413,14,167552705,CD2AP,Deletion,-,-,0.64,0.26,0.99,0.01463963,Low,0.15,0.521,0.115,0.013,Mild increase (p=0.041),Mild increase (p=0.005),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02427,rs241119,12,52173137,CR1,Insertion,-,-,1.34,0.96,1.61,0.02510022,High,0.013,0.299,0.071,0.418,No significant pattern (p=0.006),Mild decrease (p=0.002),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02428,rs160753,18,131559268,APOE,Insertion,-,-,2.35,2.11,2.69,0.0233983,Moderate,0.037,0.073,0.31,0.379,Variable effect (p=0.003),Significant decrease (p=0.024),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02429,rs473656,2,107900517,CD2AP,SNP (C/G),(C/,C,1.65,1.26,1.88,0.00088819,Low,0.014,0.524,0.22,0.042,Variable effect (p=0.039),Mild decrease (p=0.042),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02430,rs865841,16,231042909,CLU,SNP (C/T),(C/,C,1.14,0.78,1.47,0.02016478,Moderate,0.618,0.014,0.134,0.034,Significant decrease (p=0.034),Significant increase (p=0.043),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02431,rs788526,10,96872959,PTK2B,SNP (A/G),(A/,A,0.5,0.2,0.79,0.06404068,Protective,0.061,0.581,0.101,0.057,No significant pattern (p=0.043),Significant decrease (p=0.022),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02432,rs438556,14,225015687,MS4A6A,SNP (A/C),(A/,A,1.33,1.0,1.53,0.06995444,High,0.126,0.056,0.559,0.059,Variable effect (p=0.011),Mild decrease (p=0.017),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02433,rs312287,17,81350245,PICALM,SNP (C/T),(C/,C,1.05,0.68,1.31,0.02377443,Moderate,0.417,0.122,0.077,0.184,Mild increase (p=0.025),Mild decrease (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02434,rs116741,3,101823649,ABCA7,SNP (A/C),(A/,A,1.57,1.28,1.9,0.01158833,Moderate,0.042,0.21,0.072,0.475,Significant increase (p=0.047),Variable effect (p=0.006),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02435,rs363031,15,92960263,PTK2B,SNP (C/G),(C/,C,1.41,1.15,1.74,0.02916755,High,0.04,0.204,0.301,0.255,Variable effect (p=0.015),Significant decrease (p=0.018),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02436,rs982794,16,195652186,MS4A6A,SNP (C/G),(C/,C,1.97,1.6,2.33,0.03880799,Moderate,0.242,0.046,0.195,0.316,No significant pattern (p=0.023),Significant increase (p=0.018),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02437,rs342076,10,95557050,PICALM,SNP (C/G),(C/,C,0.7,0.35,1.04,0.00631677,Moderate,0.224,0.455,0.116,0.005,Mild increase (p=0.043),Variable effect (p=0.02),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP02438,rs591428,11,188302822,MS4A6A,Deletion,-,-,1.91,1.62,2.3,0.01246357,Moderate,0.137,0.287,0.335,0.041,Mild increase (p=0.031),Mild decrease (p=0.042),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02439,rs245230,13,84792016,APOE,SNP (A/T),(A/,A,0.59,0.36,0.97,0.06656962,Protective,0.324,0.027,0.308,0.141,No significant pattern (p=0.009),Variable effect (p=0.012),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP02440,rs130624,15,100781439,CD33,Insertion,-,-,0.5,0.23,0.73,0.03793994,Low,0.451,0.051,0.213,0.085,Mild decrease (p=0.015),Mild increase (p=0.043),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02441,rs874570,4,201140045,APOE,Deletion,-,-,1.11,0.71,1.35,0.0985201,Moderate,0.376,0.041,0.269,0.114,Mild increase (p=0.025),Mild decrease (p=0.023),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02442,rs121698,14,49038301,PICALM,SNP (G/T),(G/,G,1.4,1.05,1.69,0.09106122,High,0.114,0.211,0.133,0.341,Significant decrease (p=0.003),Variable effect (p=0.035),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02443,rs850473,22,206869681,BIN1,SNP (A/C),(A/,A,0.95,0.63,1.25,0.03359569,High,0.291,0.155,0.267,0.087,Mild decrease (p=0.018),Mild increase (p=0.031),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02444,rs474716,6,185117017,MS4A6A,SNP (G/T),(G/,G,1.01,0.62,1.37,0.00480751,High,0.294,0.056,0.388,0.063,Mild increase (p=0.002),Significant decrease (p=0.02),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02445,rs522739,7,116434901,MS4A6A,SNP (A/T),(A/,A,2.06,1.66,2.29,0.01634945,High,0.087,0.247,0.204,0.262,Variable effect (p=0.042),Significant decrease (p=0.03),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02446,rs622015,14,81611522,ABCA7,SNP (C/G),(C/,C,1.62,1.32,1.86,0.00313698,Moderate,0.023,0.468,0.156,0.154,Significant increase (p=0.032),Significant increase (p=0.026),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02447,rs718912,10,200073391,PICALM,Insertion,-,-,3.17,2.88,3.53,0.00994114,Moderate,0.208,0.183,0.065,0.344,Mild decrease (p=0.033),No significant pattern (p=0.001),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP02448,rs407053,2,147118646,APOE,SNP (C/G),(C/,C,1.13,0.75,1.48,0.01432476,Protective,0.179,0.088,0.434,0.099,Significant decrease (p=0.039),Mild decrease (p=0.02),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02449,rs867968,9,97510159,SORL1,SNP (C/T),(C/,C,1.07,0.85,1.36,0.07567728,Moderate,0.106,0.289,0.224,0.181,Mild increase (p=0.048),Variable effect (p=0.023),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02450,rs596164,10,177926902,EPHA1,SNP (A/C),(A/,A,0.95,0.66,1.27,0.02589813,Low,0.031,0.095,0.549,0.125,Significant increase (p=0.009),Variable effect (p=0.04),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02451,rs488530,14,198168978,ABCA7,Deletion,-,-,0.91,0.55,1.3,0.00551686,Moderate,0.033,0.072,0.459,0.236,No significant pattern (p=0.005),Mild decrease (p=0.043),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02452,rs137074,20,101120660,APP,SNP (A/T),(A/,A,2.17,1.87,2.47,0.02702888,Moderate,0.078,0.278,0.191,0.253,Significant decrease (p=0.024),Mild increase (p=0.047),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02453,rs727281,5,136510819,MS4A6A,SNP (C/G),(C/,C,0.66,0.37,1.04,0.01407044,High,0.163,0.285,0.193,0.159,Significant increase (p=0.016),Significant decrease (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02454,rs514505,18,220851255,CD2AP,SNP (A/C),(A/,A,1.02,0.73,1.33,0.02668469,Protective,0.05,0.024,0.589,0.137,Significant increase (p=0.011),Mild increase (p=0.015),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02455,rs620368,17,85814971,EPHA1,SNP (A/C),(A/,A,1.77,1.55,2.06,0.01239239,Unknown,0.351,0.005,0.361,0.083,Significant decrease (p=0.049),Significant increase (p=0.013),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP02456,rs964982,5,92307324,MS4A6A,Deletion,-,-,0.51,0.12,0.8,0.03475611,Moderate,0.5,0.172,0.099,0.03,Significant decrease (p=0.015),Significant decrease (p=0.03),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02457,rs597217,3,15006766,CLU,SNP (C/G),(C/,C,1.62,1.31,1.97,0.01078644,Low,0.284,0.041,0.103,0.371,No significant pattern (p=0.048),Significant decrease (p=0.004),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02458,rs567450,17,210723824,CD2AP,SNP (A/C),(A/,A,1.37,1.07,1.71,0.03603214,Low,0.08,0.095,0.496,0.129,Significant decrease (p=0.015),Mild decrease (p=0.018),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02459,rs562278,21,100874864,TREM2,SNP (A/T),(A/,A,0.47,0.1,0.68,0.04804033,Protective,0.346,0.14,0.197,0.117,Mild increase (p=0.007),Variable effect (p=0.023),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02460,rs748306,19,101414139,APOE,SNP (A/C),(A/,A,0.56,0.29,0.93,0.05317371,High,0.203,0.477,0.025,0.094,No significant pattern (p=0.03),Mild decrease (p=0.041),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02461,rs932913,13,7382323,APP,SNP (A/G),(A/,A,1.3,0.94,1.66,0.16319373,Moderate,0.318,0.423,0.045,0.014,Significant decrease (p=0.048),Significant decrease (p=0.045),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02462,rs147776,18,5680649,CD33,SNP (A/G),(A/,A,0.43,0.1,0.66,0.05618991,Low,0.165,0.013,0.203,0.42,Variable effect (p=0.005),Significant decrease (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02463,rs942516,8,103206181,APOE,Insertion,-,-,1.1,0.86,1.5,0.00190282,Moderate,0.285,0.089,0.134,0.293,Mild increase (p=0.01),Mild decrease (p=0.044),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02464,rs738572,2,194071872,APP,SNP (C/G),(C/,C,1.99,1.65,2.35,0.03139737,Protective,0.322,0.109,0.325,0.044,Mild decrease (p=0.049),Significant increase (p=0.007),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP02465,rs349346,13,103002885,APOE,Deletion,-,-,1.83,1.43,2.05,0.00276294,Moderate,0.087,0.094,0.413,0.206,No significant pattern (p=0.025),Variable effect (p=0.049),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP02466,rs996466,13,91911674,CR1,SNP (C/T),(C/,C,1.81,1.55,2.2,0.01771354,Protective,0.0,0.177,0.315,0.308,Variable effect (p=0.027),No significant pattern (p=0.042),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02467,rs758360,9,214205564,MS4A6A,SNP (A/C),(A/,A,3.27,3.03,3.57,0.00639619,Low,0.062,0.278,0.31,0.151,Significant decrease (p=0.032),Variable effect (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02468,rs100760,10,229148606,SORL1,SNP (C/T),(C/,C,1.26,0.89,1.51,0.07939455,High,0.077,0.065,0.538,0.121,No significant pattern (p=0.017),Mild decrease (p=0.032),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02469,rs832646,5,160052714,PICALM,Deletion,-,-,1.06,0.74,1.38,0.03190162,Moderate,0.36,0.031,0.214,0.195,Mild increase (p=0.019),No significant pattern (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02470,rs771188,7,72462416,PICALM,SNP (A/G),(A/,A,0.65,0.33,0.94,0.012068,Moderate,0.392,0.009,0.25,0.15,No significant pattern (p=0.035),Variable effect (p=0.043),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02471,rs726619,4,208926695,EPHA1,Insertion,-,-,1.72,1.41,2.04,0.05124146,High,0.215,0.219,0.126,0.24,Significant increase (p=0.009),Mild increase (p=0.013),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02472,rs132315,17,147024684,MS4A6A,SNP (C/T),(C/,C,0.72,0.33,1.01,0.00075887,High,0.07,0.41,0.207,0.113,No significant pattern (p=0.021),No significant pattern (p=0.048),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP02473,rs510886,1,241306128,APOE,Insertion,-,-,1.02,0.78,1.34,0.08180247,High,0.01,0.141,0.352,0.297,Significant increase (p=0.024),No significant pattern (p=0.039),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02474,rs431034,14,110089195,EPHA1,SNP (A/T),(A/,A,0.89,0.53,1.1,0.08031784,Unknown,0.081,0.221,0.469,0.029,Mild increase (p=0.011),Mild decrease (p=0.041),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02475,rs524458,2,204345704,PICALM,SNP (C/T),(C/,C,0.43,0.1,0.67,0.16967723,Low,0.059,0.433,0.178,0.13,Mild decrease (p=0.049),Variable effect (p=0.007),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02476,rs350854,21,8872632,APP,SNP (C/T),(C/,C,2.15,1.87,2.51,0.03300231,High,0.009,0.184,0.086,0.521,Significant decrease (p=0.003),Mild increase (p=0.013),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02477,rs709881,7,112226125,PTK2B,SNP (A/G),(A/,A,0.92,0.56,1.3,0.08558163,Protective,0.117,0.564,0.06,0.058,Significant decrease (p=0.009),Mild decrease (p=0.024),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02478,rs811478,2,188307825,PTK2B,SNP (A/C),(A/,A,1.11,0.79,1.47,0.06394024,Low,0.123,0.372,0.157,0.148,Mild decrease (p=0.025),Mild increase (p=0.025),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02479,rs410059,7,147031491,APOE,SNP (C/T),(C/,C,0.81,0.53,1.09,0.02036087,Low,0.47,0.0,0.217,0.112,Significant decrease (p=0.024),Mild decrease (p=0.026),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02480,rs193257,13,164891845,ABCA7,SNP (G/T),(G/,G,1.34,1.14,1.59,0.00067285,High,0.255,0.064,0.252,0.228,No significant pattern (p=0.028),Significant increase (p=0.027),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02481,rs994655,5,61443680,APP,Insertion,-,-,0.69,0.4,1.06,0.00070243,Protective,0.555,0.06,0.058,0.127,Significant increase (p=0.038),Mild decrease (p=0.032),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02482,rs321874,5,96445782,ABCA7,Insertion,-,-,2.34,2.08,2.54,0.09655437,Unknown,0.021,0.428,0.083,0.268,Significant decrease (p=0.029),Variable effect (p=0.044),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02483,rs210108,16,233049499,CLU,SNP (C/T),(C/,C,1.75,1.39,2.0,0.01775825,High,0.323,0.161,0.131,0.185,No significant pattern (p=0.048),Mild decrease (p=0.047),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02484,rs228097,5,111276033,PSEN2,SNP (A/G),(A/,A,0.29,0.1,0.54,0.04270565,Low,0.214,0.281,0.192,0.113,Mild increase (p=0.046),Significant decrease (p=0.033),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02485,rs828582,21,101242390,CD33,SNP (A/T),(A/,A,1.5,1.22,1.8,0.01090742,Moderate,0.261,0.137,0.133,0.269,Mild increase (p=0.028),Significant decrease (p=0.045),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02486,rs438368,3,190510723,PSEN2,Insertion,-,-,1.92,1.67,2.16,0.01036334,High,0.281,0.137,0.221,0.16,Variable effect (p=0.022),No significant pattern (p=0.008),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP02487,rs108654,11,68470365,MS4A6A,Insertion,-,-,1.69,1.38,1.93,0.01459041,High,0.337,0.082,0.137,0.244,Mild decrease (p=0.001),Mild increase (p=0.044),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02488,rs974471,9,46070927,TREM2,SNP (A/G),(A/,A,0.55,0.29,0.8,0.02574979,Moderate,0.427,0.189,0.058,0.126,Mild increase (p=0.02),Significant increase (p=0.002),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02489,rs467644,5,214399150,CR1,SNP (G/T),(G/,G,1.44,1.21,1.77,0.00210383,High,0.084,0.609,0.077,0.029,Significant decrease (p=0.036),Mild increase (p=0.01),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP02490,rs416737,19,90662691,ABCA7,SNP (C/G),(C/,C,1.65,1.37,1.89,0.0120655,Protective,0.209,0.264,0.218,0.109,No significant pattern (p=0.04),Mild increase (p=0.025),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02491,rs856678,16,116048970,SORL1,SNP (A/G),(A/,A,0.6,0.32,0.82,0.05227024,High,0.16,0.479,0.082,0.08,Significant increase (p=0.033),Mild increase (p=0.03),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02492,rs968426,6,27838835,CD2AP,SNP (A/C),(A/,A,0.54,0.27,0.87,0.02660436,High,0.196,0.002,0.258,0.344,Significant increase (p=0.044),Significant decrease (p=0.033),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02493,rs947360,15,76008065,PSEN2,Insertion,-,-,0.96,0.6,1.33,0.02544965,Moderate,0.014,0.326,0.374,0.085,Significant decrease (p=0.044),Significant increase (p=0.023),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP02494,rs828590,1,112865372,PICALM,Insertion,-,-,0.88,0.51,1.18,0.01428503,Moderate,0.279,0.194,0.282,0.045,Mild increase (p=0.029),No significant pattern (p=0.047),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02495,rs386839,16,115314717,APOE,SNP (A/C),(A/,A,2.12,1.75,2.46,0.03480885,Low,0.134,0.298,0.36,0.008,Mild decrease (p=0.047),Significant decrease (p=0.032),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02496,rs374416,14,150807960,EPHA1,Insertion,-,-,0.74,0.36,1.0,0.03624578,Low,0.315,0.068,0.392,0.024,Variable effect (p=0.002),Mild decrease (p=0.004),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP02497,rs312419,20,101625758,CR1,SNP (A/T),(A/,A,0.81,0.49,1.04,0.06160877,Moderate,0.229,0.205,0.292,0.075,Significant increase (p=0.046),Variable effect (p=0.039),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02498,rs131465,13,7729224,MS4A6A,SNP (C/T),(C/,C,0.83,0.55,1.05,0.02186217,Low,0.005,0.077,0.711,0.007,Significant increase (p=0.004),No significant pattern (p=0.038),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02499,rs948323,18,26347756,EPHA1,SNP (G/T),(G/,G,1.34,1.07,1.64,0.03794649,Moderate,0.397,0.248,0.101,0.054,Mild increase (p=0.034),No significant pattern (p=0.011),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02500,rs922571,14,82199661,CR1,SNP (C/G),(C/,C,0.92,0.69,1.24,0.02502651,High,0.011,0.146,0.355,0.287,No significant pattern (p=0.017),Significant increase (p=0.021),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02501,rs628121,18,8267929,APP,SNP (G/T),(G/,G,0.46,0.13,0.84,0.05018321,Low,0.147,0.261,0.198,0.194,Mild decrease (p=0.019),Significant increase (p=0.017),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02502,rs845416,22,234300770,CLU,Insertion,-,-,1.01,0.7,1.28,0.11726059,High,0.077,0.098,0.34,0.284,Variable effect (p=0.011),Mild increase (p=0.049),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02503,rs842636,18,106027574,EPHA1,SNP (C/T),(C/,C,0.81,0.42,1.07,0.01469115,Low,0.324,0.144,0.134,0.199,Significant increase (p=0.003),Mild decrease (p=0.033),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02504,rs158802,15,47081803,MS4A6A,SNP (A/G),(A/,A,0.92,0.62,1.31,0.00583343,Low,0.061,0.14,0.413,0.186,No significant pattern (p=0.042),Significant decrease (p=0.032),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP02505,rs487446,16,167299515,APOE,SNP (A/C),(A/,A,2.03,1.66,2.37,0.1566725,Protective,0.023,0.077,0.355,0.345,Variable effect (p=0.029),Mild decrease (p=0.012),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02506,rs689964,20,203142094,MS4A6A,SNP (C/T),(C/,C,0.19,0.1,0.52,0.00066515,Low,0.228,0.449,0.11,0.013,Mild increase (p=0.014),Significant increase (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02507,rs940911,13,177709260,BIN1,SNP (A/C),(A/,A,1.66,1.28,2.05,0.00857381,High,0.377,0.267,0.147,0.009,Significant decrease (p=0.017),Significant decrease (p=0.028),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02508,rs513179,15,213927194,SORL1,Insertion,-,-,0.81,0.49,1.1,0.0266552,Moderate,0.233,0.007,0.491,0.069,No significant pattern (p=0.013),Significant decrease (p=0.043),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02509,rs950973,1,94958251,SORL1,Insertion,-,-,1.77,1.43,2.0,0.02140681,Protective,0.113,0.244,0.132,0.311,Mild increase (p=0.023),Significant increase (p=0.039),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02510,rs539945,8,174073781,PSEN2,SNP (A/T),(A/,A,2.29,2.08,2.52,0.00226123,Moderate,0.452,0.009,0.163,0.177,Significant decrease (p=0.033),Significant increase (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP02511,rs239142,8,34482993,APOE,SNP (A/C),(A/,A,0.94,0.72,1.27,0.02248852,Low,0.286,0.03,0.285,0.199,Mild decrease (p=0.025),No significant pattern (p=0.028),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP02512,rs250838,9,65898668,CLU,SNP (A/C),(A/,A,0.7,0.46,1.0,0.00589043,Protective,0.185,0.251,0.046,0.318,Mild decrease (p=0.002),Significant increase (p=0.047),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02513,rs100886,13,128386330,EPHA1,SNP (C/T),(C/,C,0.98,0.62,1.29,0.05392932,High,0.173,0.046,0.103,0.478,Mild decrease (p=0.047),Significant decrease (p=0.022),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02514,rs146714,22,144285662,PICALM,SNP (A/G),(A/,A,2.91,2.69,3.17,0.00835401,High,0.232,0.258,0.279,0.031,Mild decrease (p=0.001),Variable effect (p=0.032),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02515,rs406240,4,95398004,APP,SNP (A/T),(A/,A,1.26,1.05,1.59,0.03294223,Moderate,0.04,0.143,0.173,0.444,Variable effect (p=0.018),Significant increase (p=0.041),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP02516,rs592698,20,244193243,BIN1,SNP (C/T),(C/,C,1.26,1.04,1.65,0.0409655,Low,0.234,0.186,0.26,0.119,Mild decrease (p=0.049),Variable effect (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP02517,rs862884,22,225452872,PSEN2,SNP (G/T),(G/,G,1.54,1.19,1.83,0.0208259,Low,0.005,0.757,0.034,0.004,Significant decrease (p=0.033),No significant pattern (p=0.019),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02518,rs408257,14,196349299,PSEN2,SNP (A/C),(A/,A,1.95,1.68,2.16,0.0054127,Moderate,0.089,0.174,0.17,0.367,Significant decrease (p=0.024),Variable effect (p=0.005),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP02519,rs261043,8,3702625,PTK2B,SNP (A/C),(A/,A,0.63,0.38,0.94,0.03583854,High,0.107,0.147,0.085,0.461,Significant increase (p=0.006),Variable effect (p=0.038),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02520,rs404565,22,193749189,CR1,SNP (G/T),(G/,G,0.86,0.49,1.1,0.01241493,High,0.385,0.057,0.354,0.003,No significant pattern (p=0.037),No significant pattern (p=0.005),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP02521,rs227923,22,236335448,CD2AP,SNP (A/C),(A/,A,0.49,0.2,0.85,0.05205779,Moderate,0.077,0.008,0.25,0.465,Significant decrease (p=0.036),Mild decrease (p=0.043),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP02522,rs386517,14,71907874,ABCA7,SNP (A/T),(A/,A,1.17,0.85,1.38,0.02617667,Moderate,0.172,0.204,0.367,0.057,Significant increase (p=0.016),Significant increase (p=0.019),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02523,rs277692,11,172413890,TREM2,Deletion,-,-,0.52,0.27,0.78,0.00862113,High,0.304,0.272,0.168,0.056,Variable effect (p=0.012),Mild decrease (p=0.006),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02524,rs204846,13,246374098,SORL1,SNP (G/T),(G/,G,1.01,0.63,1.3,0.02772129,Protective,0.089,0.216,0.019,0.475,Mild increase (p=0.002),No significant pattern (p=0.043),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02525,rs400623,20,211694597,TREM2,Deletion,-,-,1.35,1.02,1.69,0.05362024,High,0.18,0.308,0.245,0.067,Mild increase (p=0.004),Mild increase (p=0.043),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02526,rs776158,8,100323177,PTK2B,Insertion,-,-,1.41,1.09,1.79,0.04837919,Moderate,0.211,0.431,0.017,0.141,No significant pattern (p=0.036),Mild increase (p=0.012),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02527,rs181951,11,97530866,CR1,Insertion,-,-,0.53,0.22,0.81,0.01065773,Moderate,0.023,0.072,0.203,0.502,Mild increase (p=0.024),Mild increase (p=0.044),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02528,rs922440,10,164891227,APP,SNP (A/T),(A/,A,0.2,0.1,0.53,0.01642862,Moderate,0.036,0.049,0.186,0.529,Significant increase (p=0.01),Mild increase (p=0.044),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP02529,rs410185,5,181987606,CLU,SNP (A/G),(A/,A,0.63,0.31,0.96,0.03642568,High,0.2,0.144,0.307,0.149,Variable effect (p=0.021),Significant decrease (p=0.024),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02530,rs279394,19,132230023,PTK2B,SNP (A/T),(A/,A,1.13,0.78,1.39,0.00814989,Moderate,0.158,0.199,0.01,0.434,Significant decrease (p=0.034),Mild decrease (p=0.025),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02531,rs476336,5,110780839,EPHA1,SNP (C/G),(C/,C,1.17,0.8,1.46,0.02639485,High,0.204,0.442,0.094,0.06,Significant increase (p=0.032),Significant increase (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02532,rs820425,3,176801781,PSEN2,SNP (A/T),(A/,A,3.23,2.96,3.58,0.02345333,Moderate,0.022,0.362,0.086,0.33,Significant decrease (p=0.015),Mild decrease (p=0.006),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02533,rs749796,9,162128755,SORL1,Deletion,-,-,0.59,0.27,0.84,0.0162756,Moderate,0.325,0.098,0.047,0.33,No significant pattern (p=0.045),Significant increase (p=0.019),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP02534,rs706674,7,77967158,CD33,SNP (C/G),(C/,C,1.79,1.41,2.03,0.05030109,Protective,0.019,0.267,0.155,0.359,Variable effect (p=0.009),Variable effect (p=0.047),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP02535,rs207251,14,120622607,ABCA7,SNP (C/G),(C/,C,1.33,0.95,1.59,0.02243538,Low,0.122,0.296,0.29,0.092,Significant decrease (p=0.039),Variable effect (p=0.037),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP02536,rs165175,8,243866623,TREM2,SNP (A/T),(A/,A,1.28,0.99,1.66,0.01701747,High,0.32,0.108,0.184,0.188,Mild increase (p=0.034),Variable effect (p=0.018),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP02537,rs237085,7,246341937,CD33,SNP (A/T),(A/,A,1.09,0.8,1.3,0.08502001,High,0.206,0.291,0.084,0.219,No significant pattern (p=0.023),Mild decrease (p=0.027),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02538,rs543561,13,26304601,CD33,SNP (G/T),(G/,G,0.63,0.25,0.84,0.01685016,High,0.236,0.185,0.263,0.116,Mild decrease (p=0.028),Significant decrease (p=0.038),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02539,rs236980,15,43907076,PTK2B,Insertion,-,-,0.78,0.53,1.02,0.07592681,Protective,0.312,0.191,0.203,0.095,Significant decrease (p=0.03),No significant pattern (p=0.006),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02540,rs873206,17,217487933,PTK2B,SNP (C/G),(C/,C,1.61,1.39,1.84,0.00879049,Moderate,0.514,0.159,0.038,0.089,No significant pattern (p=0.045),No significant pattern (p=0.036),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02541,rs604506,22,88660406,APP,SNP (A/G),(A/,A,0.9,0.69,1.11,0.0121748,Moderate,0.58,0.043,0.153,0.024,Significant increase (p=0.013),Significant increase (p=0.026),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02542,rs182971,5,156905010,CLU,SNP (C/G),(C/,C,0.85,0.47,1.13,0.01185839,High,0.15,0.099,0.526,0.025,Significant increase (p=0.028),No significant pattern (p=0.004),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02543,rs788427,18,115789712,ABCA7,SNP (A/T),(A/,A,1.15,0.78,1.38,0.00919101,Moderate,0.012,0.167,0.434,0.187,Mild decrease (p=0.046),Significant increase (p=0.032),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP02544,rs135172,13,190089664,APP,SNP (A/T),(A/,A,0.53,0.28,0.78,0.12821828,Protective,0.016,0.078,0.168,0.537,Variable effect (p=0.043),No significant pattern (p=0.045),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02545,rs343291,14,174394291,BIN1,Insertion,-,-,0.44,0.1,0.82,0.00589678,Moderate,0.503,0.033,0.093,0.171,Significant decrease (p=0.033),Significant increase (p=0.008),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02546,rs541362,6,14035933,CD2AP,SNP (C/T),(C/,C,0.85,0.61,1.19,0.01346962,High,0.103,0.102,0.488,0.106,Variable effect (p=0.03),No significant pattern (p=0.009),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02547,rs492268,6,42063546,CR1,SNP (A/G),(A/,A,2.01,1.8,2.35,0.001817,Low,0.239,0.068,0.091,0.402,Significant decrease (p=0.016),Mild increase (p=0.01),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02548,rs301038,8,141235900,CLU,Insertion,-,-,1.11,0.8,1.39,0.00432746,Moderate,0.611,0.027,0.072,0.09,No significant pattern (p=0.034),Variable effect (p=0.044),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02549,rs791793,9,111430985,ABCA7,SNP (A/G),(A/,A,1.8,1.52,2.07,0.01232637,Low,0.334,0.005,0.059,0.402,Mild increase (p=0.015),Variable effect (p=0.011),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02550,rs286352,17,180322441,BIN1,SNP (A/C),(A/,A,1.24,0.86,1.6,0.00515006,Protective,0.259,0.021,0.039,0.481,Significant increase (p=0.035),Variable effect (p=0.025),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP02551,rs137980,7,190134597,EPHA1,Insertion,-,-,0.82,0.6,1.22,0.00937859,Protective,0.079,0.17,0.089,0.462,Mild decrease (p=0.024),Variable effect (p=0.017),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02552,rs780447,19,242784070,CD2AP,SNP (A/C),(A/,A,0.66,0.38,0.9,0.04050282,High,0.043,0.048,0.009,0.7,Mild decrease (p=0.029),Significant decrease (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02553,rs680873,13,106774602,APOE,SNP (A/T),(A/,A,0.69,0.35,1.06,0.01162592,High,0.474,0.048,0.025,0.254,Significant increase (p=0.045),Mild increase (p=0.035),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02554,rs295224,1,63109731,CR1,SNP (A/G),(A/,A,0.56,0.21,0.94,0.06698289,Protective,0.252,0.432,0.091,0.024,No significant pattern (p=0.029),Mild decrease (p=0.024),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02555,rs441577,15,47843095,ABCA7,SNP (A/T),(A/,A,0.8,0.42,1.08,0.01099406,Protective,0.244,0.004,0.102,0.45,Variable effect (p=0.045),Significant increase (p=0.03),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02556,rs862143,9,200820476,CR1,SNP (C/G),(C/,C,1.86,1.53,2.09,0.03596146,Moderate,0.404,0.034,0.198,0.164,Mild increase (p=0.043),Variable effect (p=0.017),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02557,rs816684,13,83533698,APP,SNP (A/C),(A/,A,0.98,0.59,1.33,0.02334415,High,0.432,0.123,0.171,0.074,Mild increase (p=0.044),Significant increase (p=0.022),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02558,rs734582,15,113618814,SORL1,SNP (A/T),(A/,A,1.1,0.89,1.47,0.01644884,Moderate,0.04,0.371,0.318,0.071,Mild decrease (p=0.045),Variable effect (p=0.036),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP02559,rs988793,21,131401246,CD33,SNP (A/G),(A/,A,1.52,1.18,1.84,0.00476516,Moderate,0.25,0.314,0.069,0.168,Significant increase (p=0.018),Significant decrease (p=0.009),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02560,rs258375,19,109025796,TREM2,SNP (A/C),(A/,A,0.73,0.52,0.97,0.02701912,Moderate,0.026,0.081,0.503,0.19,No significant pattern (p=0.04),Variable effect (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02561,rs581700,7,61374121,CLU,SNP (G/T),(G/,G,1.05,0.74,1.34,0.01748788,Moderate,0.452,0.016,0.272,0.06,Variable effect (p=0.019),Mild increase (p=0.009),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02562,rs900488,17,27287045,PICALM,SNP (A/T),(A/,A,0.74,0.51,1.1,0.00035856,High,0.126,0.165,0.121,0.389,Significant increase (p=0.021),Mild decrease (p=0.027),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02563,rs257470,9,84149945,SORL1,SNP (C/T),(C/,C,0.27,0.1,0.59,0.01448946,Low,0.103,0.379,0.15,0.168,Significant increase (p=0.012),Significant decrease (p=0.012),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02564,rs596652,13,228147502,TREM2,SNP (A/G),(A/,A,1.14,0.93,1.44,0.02458337,High,0.193,0.292,0.248,0.066,Significant increase (p=0.015),Variable effect (p=0.02),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02565,rs229253,4,19580801,TREM2,SNP (A/T),(A/,A,0.74,0.36,1.1,0.10298919,Protective,0.056,0.226,0.396,0.121,Variable effect (p=0.034),Mild increase (p=0.042),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02566,rs662321,21,147505455,ABCA7,SNP (A/C),(A/,A,1.44,1.13,1.7,0.01012003,Low,0.092,0.346,0.309,0.053,No significant pattern (p=0.008),Significant increase (p=0.019),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02567,rs273449,15,74565897,APP,SNP (C/G),(C/,C,0.81,0.43,1.05,0.02600517,Protective,0.372,0.063,0.225,0.14,Variable effect (p=0.013),Significant decrease (p=0.016),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02568,rs350718,5,54794687,PSEN2,SNP (A/C),(A/,A,1.87,1.57,2.27,0.00720338,Moderate,0.109,0.476,0.046,0.169,Significant decrease (p=0.023),Significant increase (p=0.031),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP02569,rs372279,19,124419067,PTK2B,SNP (C/T),(C/,C,0.72,0.44,0.94,0.01758479,Protective,0.084,0.642,0.006,0.069,Mild decrease (p=0.033),Significant increase (p=0.048),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02570,rs510211,17,54927811,TREM2,SNP (C/G),(C/,C,0.89,0.5,1.12,0.01307747,Low,0.163,0.266,0.19,0.181,Mild decrease (p=0.023),Mild increase (p=0.032),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02571,rs355819,10,75195177,PICALM,Deletion,-,-,1.89,1.64,2.24,0.04706563,Protective,0.402,0.148,0.027,0.223,Significant decrease (p=0.01),No significant pattern (p=0.041),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP02572,rs434453,7,29027510,APP,SNP (C/T),(C/,C,1.63,1.32,1.87,0.00035698,Unknown,0.104,0.358,0.239,0.098,Mild increase (p=0.036),Variable effect (p=0.037),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02573,rs838375,18,67216205,BIN1,SNP (A/T),(A/,A,0.92,0.65,1.14,0.03707993,Low,0.049,0.348,0.32,0.083,Significant decrease (p=0.022),Variable effect (p=0.021),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02574,rs296301,5,209964406,CD33,SNP (A/T),(A/,A,0.83,0.56,1.16,0.12901351,Moderate,0.058,0.016,0.101,0.626,Significant decrease (p=0.013),No significant pattern (p=0.028),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP02575,rs776948,9,69761433,MS4A6A,SNP (C/T),(C/,C,2.02,1.8,2.39,0.03398982,High,0.023,0.004,0.71,0.062,Significant increase (p=0.015),Mild increase (p=0.009),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02576,rs468919,11,180896737,BIN1,SNP (A/C),(A/,A,0.95,0.55,1.32,0.03483284,Unknown,0.561,0.087,0.018,0.134,Significant decrease (p=0.039),Significant increase (p=0.049),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02577,rs806636,15,232422433,TREM2,SNP (G/T),(G/,G,1.38,1.05,1.68,0.02920327,High,0.19,0.104,0.465,0.041,Variable effect (p=0.018),Variable effect (p=0.011),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02578,rs485425,3,39066963,EPHA1,SNP (A/C),(A/,A,2.11,1.85,2.5,0.00111824,Low,0.097,0.102,0.297,0.304,Significant increase (p=0.044),Variable effect (p=0.039),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02579,rs148877,4,247661332,PICALM,SNP (G/T),(G/,G,1.33,1.03,1.71,0.09978387,Moderate,0.168,0.219,0.297,0.116,Variable effect (p=0.03),No significant pattern (p=0.018),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02580,rs723206,15,84803720,CLU,SNP (G/T),(G/,G,1.01,0.65,1.35,0.03060021,Low,0.139,0.114,0.386,0.161,Significant increase (p=0.011),Significant increase (p=0.025),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP02581,rs819552,19,245886701,CD2AP,SNP (A/G),(A/,A,0.95,0.73,1.28,0.04131368,High,0.299,0.272,0.008,0.222,No significant pattern (p=0.048),Mild increase (p=0.027),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02582,rs517932,10,242141152,TREM2,Deletion,-,-,0.99,0.74,1.36,0.00980885,Moderate,0.059,0.417,0.277,0.047,Variable effect (p=0.002),Mild increase (p=0.015),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02583,rs129818,5,35687119,EPHA1,Deletion,-,-,1.03,0.81,1.27,0.03836865,High,0.59,0.072,0.082,0.056,Mild decrease (p=0.003),Significant decrease (p=0.014),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02584,rs407282,3,56819256,APOE,SNP (C/T),(C/,C,1.2,0.91,1.44,0.01165636,Moderate,0.318,0.034,0.212,0.237,Mild decrease (p=0.013),Mild increase (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP02585,rs167722,14,80775489,PICALM,SNP (C/T),(C/,C,1.24,1.02,1.52,0.06534573,Low,0.174,0.152,0.424,0.051,Mild increase (p=0.046),Significant increase (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP02586,rs693169,21,124435003,ABCA7,SNP (A/T),(A/,A,0.48,0.19,0.72,0.16458441,Moderate,0.107,0.456,0.099,0.138,Variable effect (p=0.011),Significant decrease (p=0.027),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02587,rs842893,6,68891247,PTK2B,SNP (C/G),(C/,C,0.58,0.18,0.82,0.03398675,High,0.31,0.206,0.197,0.087,Variable effect (p=0.009),No significant pattern (p=0.037),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02588,rs788289,16,207788504,CD2AP,Deletion,-,-,0.79,0.51,1.18,0.04881837,High,0.281,0.127,0.288,0.105,No significant pattern (p=0.031),No significant pattern (p=0.011),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02589,rs831292,13,96881364,PICALM,Deletion,-,-,0.56,0.25,0.93,0.04542246,Moderate,0.281,0.399,0.047,0.072,Mild increase (p=0.045),Variable effect (p=0.033),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02590,rs819808,12,16325491,CR1,SNP (A/T),(A/,A,0.72,0.35,1.01,0.12473969,High,0.237,0.504,0.006,0.053,Mild decrease (p=0.002),Mild decrease (p=0.031),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02591,rs846395,2,49581122,TREM2,SNP (A/C),(A/,A,0.51,0.21,0.8,0.0810498,Low,0.121,0.25,0.104,0.326,Mild increase (p=0.032),Variable effect (p=0.044),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP02592,rs667707,7,17975746,APP,SNP (G/T),(G/,G,1.95,1.7,2.25,0.0411464,Unknown,0.323,0.11,0.122,0.245,Significant decrease (p=0.026),Mild increase (p=0.021),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02593,rs120042,21,172115853,MS4A6A,SNP (A/T),(A/,A,1.94,1.63,2.18,0.05962701,High,0.33,0.086,0.01,0.374,Variable effect (p=0.036),Mild increase (p=0.026),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02594,rs524166,2,70345385,MS4A6A,SNP (C/T),(C/,C,1.72,1.48,2.01,0.00397648,Unknown,0.041,0.637,0.117,0.004,Mild increase (p=0.019),Variable effect (p=0.015),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP02595,rs288613,8,107875134,CR1,Insertion,-,-,1.18,0.79,1.57,0.01038512,Moderate,0.303,0.072,0.128,0.298,Mild increase (p=0.045),Significant increase (p=0.04),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP02596,rs822199,1,22984384,CD2AP,SNP (A/T),(A/,A,1.27,1.01,1.51,0.0391488,High,0.055,0.007,0.65,0.088,Variable effect (p=0.046),Variable effect (p=0.031),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02597,rs969768,20,28674999,ABCA7,SNP (C/T),(C/,C,1.4,1.1,1.72,0.05063237,High,0.161,0.464,0.032,0.143,Significant decrease (p=0.02),Variable effect (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02598,rs904007,6,106133572,SORL1,SNP (A/C),(A/,A,0.83,0.59,1.21,0.07106537,Moderate,0.039,0.021,0.155,0.585,No significant pattern (p=0.027),Variable effect (p=0.004),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02599,rs247678,7,203083369,APOE,SNP (C/G),(C/,C,1.71,1.4,2.01,0.02650594,High,0.106,0.105,0.021,0.567,Variable effect (p=0.042),Significant decrease (p=0.006),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02600,rs208157,9,135383482,CR1,SNP (C/G),(C/,C,1.02,0.66,1.37,0.01873307,Low,0.223,0.289,0.184,0.104,Mild increase (p=0.006),Significant increase (p=0.038),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02601,rs680514,7,189907385,CD2AP,Deletion,-,-,2.52,2.32,2.8,0.01910684,High,0.205,0.268,0.245,0.082,Significant increase (p=0.003),Significant increase (p=0.012),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02602,rs369988,4,210057272,MS4A6A,SNP (C/T),(C/,C,0.67,0.4,0.9,0.03086935,Moderate,0.195,0.042,0.131,0.432,Significant increase (p=0.019),No significant pattern (p=0.02),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02603,rs538843,4,101191724,CD2AP,SNP (C/G),(C/,C,1.45,1.09,1.83,0.04718527,Protective,0.095,0.211,0.424,0.069,Significant decrease (p=0.034),Significant decrease (p=0.037),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02604,rs832307,13,221657424,SORL1,SNP (A/G),(A/,A,1.67,1.44,1.93,0.01544396,High,0.117,0.269,0.069,0.345,Variable effect (p=0.046),Significant increase (p=0.028),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02605,rs445397,22,103064394,CD33,Deletion,-,-,0.6,0.34,0.87,0.04702116,High,0.15,0.023,0.052,0.576,Mild increase (p=0.02),Mild increase (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP02606,rs783372,19,162589608,APP,Insertion,-,-,0.75,0.43,1.07,0.08268384,Low,0.101,0.359,0.097,0.242,Mild decrease (p=0.035),No significant pattern (p=0.023),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02607,rs389793,18,216960836,SORL1,SNP (C/T),(C/,C,1.32,1.09,1.58,0.01459562,Low,0.27,0.319,0.184,0.028,Variable effect (p=0.007),Mild increase (p=0.035),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02608,rs127998,12,214734953,PSEN2,Deletion,-,-,1.34,1.08,1.67,0.0097231,High,0.052,0.043,0.237,0.468,Variable effect (p=0.004),Mild increase (p=0.007),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02609,rs260647,21,232049998,CR1,SNP (C/T),(C/,C,1.2,0.86,1.55,0.00682821,Low,0.041,0.083,0.473,0.202,Significant increase (p=0.026),Mild increase (p=0.035),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02610,rs334173,8,81839036,BIN1,SNP (A/T),(A/,A,2.04,1.74,2.43,0.04133791,Low,0.002,0.41,0.046,0.341,Mild decrease (p=0.003),Mild increase (p=0.047),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02611,rs105530,10,15583288,CD33,SNP (A/T),(A/,A,1.02,0.72,1.25,0.01116781,Low,0.415,0.27,0.09,0.025,Variable effect (p=0.039),Mild decrease (p=0.049),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02612,rs622167,4,126137524,PICALM,SNP (C/G),(C/,C,0.75,0.46,1.0,0.02178767,Moderate,0.097,0.323,0.321,0.059,Significant increase (p=0.022),No significant pattern (p=0.009),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02613,rs503354,21,138261150,CR1,SNP (A/T),(A/,A,0.26,0.1,0.51,0.02894122,Protective,0.006,0.13,0.59,0.074,Mild increase (p=0.011),Mild decrease (p=0.003),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02614,rs804582,4,199737646,PTK2B,SNP (C/G),(C/,C,2.46,2.14,2.81,0.03125724,Low,0.029,0.07,0.02,0.681,Mild decrease (p=0.024),Significant decrease (p=0.026),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02615,rs224698,2,84330313,CLU,SNP (A/C),(A/,A,0.82,0.6,1.21,0.00250168,High,0.039,0.019,0.416,0.327,Mild decrease (p=0.042),Significant increase (p=0.05),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP02616,rs181200,16,44664763,CLU,SNP (C/T),(C/,C,1.79,1.55,2.06,0.00442251,High,0.052,0.139,0.394,0.216,Mild increase (p=0.03),Significant increase (p=0.049),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02617,rs821682,4,167477714,MS4A6A,SNP (C/T),(C/,C,1.01,0.72,1.22,0.00980176,Protective,0.051,0.475,0.128,0.146,Mild decrease (p=0.035),No significant pattern (p=0.045),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02618,rs639854,21,176160982,CR1,Deletion,-,-,1.47,1.17,1.8,0.07784446,Moderate,0.024,0.506,0.183,0.087,Mild increase (p=0.01),Significant decrease (p=0.008),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP02619,rs773420,7,153869288,APP,SNP (A/T),(A/,A,1.39,1.01,1.71,0.08643506,Moderate,0.377,0.223,0.162,0.039,Mild increase (p=0.04),Variable effect (p=0.043),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02620,rs221834,21,131219380,PICALM,Deletion,-,-,0.86,0.55,1.19,0.04594124,Moderate,0.047,0.516,0.005,0.231,Variable effect (p=0.042),Significant increase (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02621,rs696382,3,41498720,EPHA1,Deletion,-,-,2.23,1.92,2.52,0.11972753,Low,0.096,0.29,0.055,0.358,No significant pattern (p=0.032),Significant increase (p=0.028),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP02622,rs717151,6,190410756,CD33,Insertion,-,-,3.09,2.76,3.35,0.00186861,Moderate,0.318,0.157,0.316,0.009,No significant pattern (p=0.048),Mild decrease (p=0.03),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP02623,rs654828,1,78003758,PSEN2,Deletion,-,-,1.52,1.24,1.75,0.07347991,Moderate,0.375,0.302,0.065,0.057,Mild decrease (p=0.049),Significant increase (p=0.02),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02624,rs246838,7,11336785,ABCA7,SNP (C/T),(C/,C,0.61,0.22,1.0,0.00626289,High,0.115,0.107,0.454,0.123,No significant pattern (p=0.033),Mild increase (p=0.003),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02625,rs352409,2,109272378,BIN1,SNP (A/C),(A/,A,1.2,0.99,1.45,0.01646973,High,0.147,0.371,0.092,0.19,Mild decrease (p=0.044),Significant increase (p=0.018),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02626,rs471336,16,117437096,CD2AP,Insertion,-,-,1.59,1.22,1.81,0.02800993,High,0.525,0.164,0.027,0.083,Mild increase (p=0.047),Mild increase (p=0.009),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02627,rs934284,14,224567174,PTK2B,SNP (A/C),(A/,A,2.43,2.08,2.69,0.00478164,High,0.142,0.133,0.422,0.102,Mild decrease (p=0.014),Significant decrease (p=0.039),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02628,rs316912,11,65006862,APP,Insertion,-,-,0.51,0.21,0.81,0.01208839,Moderate,0.224,0.001,0.176,0.4,Mild increase (p=0.005),Mild increase (p=0.045),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02629,rs992394,17,241170048,BIN1,SNP (G/T),(G/,G,0.94,0.55,1.29,0.00515887,Low,0.223,0.173,0.068,0.336,Significant increase (p=0.005),No significant pattern (p=0.03),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02630,rs758027,10,76067878,EPHA1,SNP (A/T),(A/,A,1.03,0.7,1.37,0.00313587,Moderate,0.081,0.135,0.379,0.205,Variable effect (p=0.022),Mild decrease (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02631,rs118347,9,180874297,PTK2B,SNP (A/C),(A/,A,1.12,0.84,1.5,0.00736612,Low,0.073,0.117,0.486,0.125,Significant decrease (p=0.033),Mild increase (p=0.011),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02632,rs470359,15,31753713,BIN1,SNP (C/G),(C/,C,0.92,0.53,1.15,0.00548315,High,0.111,0.254,0.223,0.212,Mild decrease (p=0.049),Mild decrease (p=0.039),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02633,rs203289,8,102858526,PSEN2,SNP (A/T),(A/,A,1.1,0.78,1.34,0.04043777,High,0.177,0.251,0.32,0.053,Mild increase (p=0.025),Mild decrease (p=0.016),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02634,rs546133,13,210101195,APOE,SNP (C/T),(C/,C,0.67,0.3,1.06,0.05117963,Moderate,0.16,0.002,0.498,0.14,Variable effect (p=0.011),Mild decrease (p=0.014),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02635,rs860738,19,62401208,EPHA1,SNP (A/G),(A/,A,0.47,0.18,0.67,0.10179714,Moderate,0.518,0.007,0.06,0.215,Mild increase (p=0.008),Significant increase (p=0.003),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02636,rs961814,11,39496328,EPHA1,SNP (A/C),(A/,A,0.55,0.35,0.89,0.01344938,Low,0.04,0.191,0.568,0.001,Variable effect (p=0.013),Variable effect (p=0.011),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP02637,rs527493,21,7127252,EPHA1,Insertion,-,-,0.8,0.54,1.18,0.05423826,Protective,0.363,0.017,0.335,0.085,Significant decrease (p=0.005),Mild decrease (p=0.003),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02638,rs901562,17,40903084,TREM2,Deletion,-,-,0.5,0.22,0.88,0.02025755,High,0.081,0.464,0.229,0.027,Significant increase (p=0.023),Significant increase (p=0.049),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02639,rs986130,7,5955655,APOE,SNP (A/C),(A/,A,1.64,1.38,1.92,0.02987776,Moderate,0.022,0.208,0.449,0.122,Variable effect (p=0.007),No significant pattern (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02640,rs523964,1,24155062,APP,SNP (C/G),(C/,C,0.62,0.32,0.9,0.00387654,Moderate,0.205,0.135,0.404,0.056,No significant pattern (p=0.023),Mild decrease (p=0.008),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02641,rs966101,4,61786835,ABCA7,SNP (C/T),(C/,C,1.42,1.16,1.82,0.01746459,High,0.231,0.037,0.221,0.311,Significant decrease (p=0.035),Mild increase (p=0.05),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02642,rs181944,10,19284369,SORL1,Deletion,-,-,2.67,2.37,3.05,0.05856261,Moderate,0.373,0.272,0.001,0.154,Variable effect (p=0.026),Variable effect (p=0.008),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP02643,rs706269,1,76900583,PICALM,SNP (C/G),(C/,C,2.12,1.84,2.36,0.04565056,Low,0.369,0.191,0.138,0.101,Variable effect (p=0.047),Mild decrease (p=0.03),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02644,rs807632,2,161372057,PICALM,SNP (G/T),(G/,G,3.88,3.55,4.23,0.02692013,High,0.158,0.147,0.315,0.18,No significant pattern (p=0.024),No significant pattern (p=0.016),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02645,rs130463,3,216670839,CLU,SNP (C/T),(C/,C,2.85,2.58,3.07,0.01138681,High,0.268,0.043,0.18,0.309,Mild increase (p=0.05),Mild decrease (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP02646,rs762484,5,178083530,CR1,SNP (C/G),(C/,C,0.93,0.72,1.27,0.01005826,Low,0.025,0.587,0.185,0.003,Significant decrease (p=0.045),Mild increase (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02647,rs769617,21,160255315,MS4A6A,SNP (G/T),(G/,G,0.95,0.71,1.16,0.0242442,High,0.043,0.406,0.074,0.277,Mild increase (p=0.035),No significant pattern (p=0.025),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02648,rs247848,9,201315346,MS4A6A,SNP (A/G),(A/,A,1.04,0.66,1.27,0.00749431,Moderate,0.423,0.034,0.021,0.322,Significant increase (p=0.032),Mild increase (p=0.037),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02649,rs826002,1,10203778,BIN1,SNP (A/T),(A/,A,0.78,0.44,1.17,0.01094881,High,0.342,0.269,0.173,0.016,No significant pattern (p=0.019),Variable effect (p=0.028),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02650,rs410978,16,59966618,PTK2B,SNP (G/T),(G/,G,1.47,1.13,1.76,0.11326656,Low,0.016,0.186,0.182,0.416,Mild increase (p=0.026),Significant increase (p=0.035),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02651,rs948426,7,178969219,SORL1,Deletion,-,-,1.1,0.71,1.49,0.04765053,Moderate,0.295,0.277,0.003,0.225,No significant pattern (p=0.025),No significant pattern (p=0.038),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02652,rs777935,10,194753666,APOE,Deletion,-,-,1.41,1.12,1.66,0.09163209,Moderate,0.295,0.188,0.141,0.176,Significant decrease (p=0.027),Mild decrease (p=0.03),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02653,rs545314,22,56039437,CD33,Deletion,-,-,1.04,0.75,1.41,0.00288431,High,0.017,0.099,0.669,0.015,Significant increase (p=0.008),Significant decrease (p=0.033),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP02654,rs786338,7,172309978,APP,SNP (A/T),(A/,A,0.55,0.22,0.8,0.01764672,High,0.043,0.348,0.291,0.119,Variable effect (p=0.019),Mild increase (p=0.008),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02655,rs984719,6,42773887,MS4A6A,Insertion,-,-,1.01,0.74,1.26,0.16245231,High,0.349,0.092,0.312,0.047,Mild decrease (p=0.032),Significant increase (p=0.043),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP02656,rs834024,9,141160059,ABCA7,Insertion,-,-,1.03,0.75,1.24,0.00642187,High,0.124,0.007,0.355,0.314,Mild increase (p=0.007),Significant decrease (p=0.006),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02657,rs128212,13,227143444,CD33,SNP (C/G),(C/,C,0.75,0.48,1.0,0.03197621,High,0.221,0.258,0.138,0.184,Significant increase (p=0.007),Mild increase (p=0.034),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02658,rs194978,5,19160555,PTK2B,SNP (C/T),(C/,C,0.98,0.59,1.27,0.04279612,Low,0.142,0.007,0.268,0.383,Significant decrease (p=0.036),Significant increase (p=0.036),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02659,rs175906,2,131854810,CD33,SNP (C/T),(C/,C,1.42,1.08,1.67,0.02388507,Low,0.178,0.266,0.108,0.247,Variable effect (p=0.016),Mild decrease (p=0.026),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP02660,rs671597,11,184186220,CD33,SNP (C/G),(C/,C,1.38,1.09,1.72,0.04390053,Protective,0.086,0.198,0.343,0.174,Mild increase (p=0.008),Significant decrease (p=0.034),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02661,rs292352,10,121039662,CR1,Insertion,-,-,0.41,0.1,0.65,0.03211254,Low,0.449,0.047,0.041,0.263,No significant pattern (p=0.046),Significant increase (p=0.019),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02662,rs710641,4,203706954,CD33,SNP (C/G),(C/,C,1.29,0.91,1.6,0.01265366,Protective,0.031,0.372,0.396,0.001,Mild decrease (p=0.023),No significant pattern (p=0.006),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02663,rs746255,12,159021027,PICALM,SNP (A/C),(A/,A,1.31,0.95,1.52,0.05271094,Low,0.344,0.001,0.107,0.348,No significant pattern (p=0.05),Mild increase (p=0.02),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02664,rs343711,13,174837002,ABCA7,Insertion,-,-,0.98,0.71,1.28,0.05925286,Protective,0.128,0.601,0.065,0.006,No significant pattern (p=0.037),Mild decrease (p=0.027),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02665,rs282127,18,188244003,CLU,SNP (A/C),(A/,A,1.42,1.02,1.72,0.01129727,Moderate,0.155,0.024,0.463,0.158,Variable effect (p=0.039),Significant increase (p=0.025),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02666,rs947889,13,183959107,CD33,SNP (A/T),(A/,A,0.52,0.21,0.82,0.10216568,Low,0.071,0.242,0.136,0.351,Variable effect (p=0.004),Variable effect (p=0.017),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP02667,rs118797,16,114120117,CD2AP,Insertion,-,-,1.08,0.8,1.4,0.02964475,Protective,0.067,0.146,0.045,0.543,Mild decrease (p=0.04),No significant pattern (p=0.046),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02668,rs886151,18,34119021,MS4A6A,Deletion,-,-,1.04,0.81,1.31,0.03524723,Low,0.071,0.129,0.045,0.554,Variable effect (p=0.049),No significant pattern (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02669,rs939674,16,147250987,APP,SNP (A/T),(A/,A,1.49,1.27,1.73,0.01668709,High,0.431,0.309,0.04,0.019,Significant decrease (p=0.036),Significant increase (p=0.026),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP02670,rs161756,20,176318974,TREM2,Deletion,-,-,1.31,1.04,1.58,0.01738285,Protective,0.112,0.17,0.133,0.385,No significant pattern (p=0.036),Significant increase (p=0.008),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02671,rs392402,21,49710901,SORL1,SNP (G/T),(G/,G,0.78,0.56,1.1,0.02494531,Low,0.245,0.244,0.089,0.222,Significant increase (p=0.041),No significant pattern (p=0.036),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP02672,rs399438,21,12749194,MS4A6A,SNP (C/T),(C/,C,0.86,0.59,1.15,0.02955018,Low,0.277,0.295,0.079,0.149,Mild decrease (p=0.002),Variable effect (p=0.018),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP02673,rs108118,20,147414315,MS4A6A,SNP (A/C),(A/,A,1.45,1.14,1.66,0.02118399,Moderate,0.08,0.185,0.534,0.001,Variable effect (p=0.006),No significant pattern (p=0.024),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP02674,rs678807,20,118250737,APOE,Deletion,-,-,0.53,0.17,0.84,0.03070114,Low,0.466,0.056,0.095,0.183,Significant increase (p=0.049),Mild increase (p=0.028),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02675,rs853763,2,164467785,MS4A6A,Insertion,-,-,0.53,0.27,0.8,0.03771832,Low,0.188,0.024,0.122,0.465,Variable effect (p=0.019),Significant increase (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02676,rs552331,3,237030357,CD2AP,SNP (A/C),(A/,A,1.17,0.9,1.41,0.19060489,Moderate,0.27,0.25,0.076,0.205,Mild decrease (p=0.029),Variable effect (p=0.044),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02677,rs326881,17,57096352,MS4A6A,Deletion,-,-,0.65,0.25,1.04,0.02011335,High,0.152,0.284,0.303,0.061,Significant increase (p=0.02),Significant increase (p=0.03),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP02678,rs475561,3,28045675,CD33,Insertion,-,-,1.77,1.51,2.12,0.01260664,Moderate,0.099,0.131,0.372,0.198,No significant pattern (p=0.033),No significant pattern (p=0.046),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP02679,rs225020,5,125155088,PTK2B,SNP (A/C),(A/,A,0.46,0.1,0.67,0.01712159,Low,0.467,0.209,0.085,0.038,Significant increase (p=0.045),Significant decrease (p=0.007),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP02680,rs204402,2,58602407,APP,SNP (C/G),(C/,C,1.64,1.33,2.02,0.00963156,High,0.165,0.355,0.249,0.031,Mild decrease (p=0.025),Mild decrease (p=0.043),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02681,rs757859,10,61354986,MS4A6A,SNP (C/G),(C/,C,1.03,0.65,1.25,0.06178401,High,0.25,0.231,0.189,0.131,Mild increase (p=0.015),Mild decrease (p=0.015),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02682,rs975168,16,90672758,TREM2,SNP (A/T),(A/,A,0.43,0.14,0.71,0.00382423,Moderate,0.182,0.194,0.085,0.338,Significant increase (p=0.018),Mild increase (p=0.042),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02683,rs254125,18,71608657,MS4A6A,SNP (A/C),(A/,A,0.87,0.63,1.2,0.02026836,Moderate,0.08,0.549,0.121,0.05,Significant increase (p=0.002),Mild decrease (p=0.008),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP02684,rs647536,12,228413861,MS4A6A,SNP (C/T),(C/,C,0.77,0.55,1.11,0.02434452,Protective,0.266,0.058,0.234,0.242,No significant pattern (p=0.019),No significant pattern (p=0.035),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02685,rs873888,16,188890000,CD2AP,SNP (C/T),(C/,C,0.61,0.34,0.91,0.03714701,High,0.549,0.002,0.034,0.215,Mild increase (p=0.033),Mild decrease (p=0.031),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02686,rs655441,17,178050053,ABCA7,Insertion,-,-,2.16,1.81,2.36,0.00899163,Low,0.083,0.214,0.291,0.212,Significant decrease (p=0.012),Mild decrease (p=0.032),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02687,rs473566,11,108881057,PTK2B,SNP (A/T),(A/,A,0.8,0.41,1.09,0.00577542,High,0.055,0.433,0.011,0.301,Mild increase (p=0.015),Mild decrease (p=0.032),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02688,rs278194,16,157399417,PTK2B,Insertion,-,-,0.93,0.62,1.17,0.00362258,High,0.524,0.097,0.01,0.169,Mild increase (p=0.024),Significant decrease (p=0.046),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02689,rs537041,22,65580596,CD2AP,SNP (A/G),(A/,A,1.26,0.98,1.64,0.08440836,Moderate,0.053,0.467,0.151,0.128,No significant pattern (p=0.023),Variable effect (p=0.018),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02690,rs619497,9,89603323,BIN1,SNP (C/G),(C/,C,1.17,0.97,1.52,0.025149,High,0.084,0.139,0.363,0.214,Significant decrease (p=0.018),Variable effect (p=0.026),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02691,rs541510,10,158963584,CR1,SNP (C/G),(C/,C,1.71,1.35,2.07,0.05431377,Low,0.238,0.017,0.284,0.261,Variable effect (p=0.029),Mild increase (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02692,rs711041,1,225546782,BIN1,Deletion,-,-,0.89,0.59,1.1,0.014163,High,0.108,0.112,0.04,0.541,Variable effect (p=0.016),Significant increase (p=0.028),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02693,rs363492,5,46388476,PSEN2,SNP (C/G),(C/,C,1.58,1.2,1.85,0.09103289,Moderate,0.056,0.142,0.519,0.084,Variable effect (p=0.012),Significant increase (p=0.042),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02694,rs819212,14,21314296,EPHA1,SNP (A/T),(A/,A,1.02,0.68,1.27,0.01353473,Low,0.024,0.013,0.188,0.575,No significant pattern (p=0.025),Significant decrease (p=0.005),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP02695,rs504195,8,70844405,SORL1,SNP (C/T),(C/,C,0.68,0.43,0.88,0.02648327,Moderate,0.377,0.328,0.04,0.056,Significant increase (p=0.011),Variable effect (p=0.047),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02696,rs517064,17,43704003,CLU,SNP (A/T),(A/,A,1.18,0.91,1.41,0.05935146,Moderate,0.292,0.286,0.094,0.129,Significant increase (p=0.007),Mild decrease (p=0.006),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02697,rs665278,16,75443753,EPHA1,Deletion,-,-,0.85,0.46,1.16,0.01108201,Low,0.066,0.24,0.205,0.288,Mild decrease (p=0.002),No significant pattern (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02698,rs980383,18,99822043,TREM2,SNP (A/T),(A/,A,0.7,0.32,1.01,0.00370486,Protective,0.144,0.347,0.236,0.073,Variable effect (p=0.05),Mild increase (p=0.012),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02699,rs484022,8,104381322,PICALM,SNP (A/T),(A/,A,1.22,0.88,1.53,0.01876107,Protective,0.238,0.059,0.222,0.281,Mild decrease (p=0.046),Significant decrease (p=0.043),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02700,rs574652,16,28781129,CR1,Insertion,-,-,0.77,0.39,1.15,0.01914367,High,0.061,0.173,0.217,0.349,Mild increase (p=0.047),Significant decrease (p=0.012),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02701,rs593934,17,33585683,PICALM,SNP (C/G),(C/,C,0.55,0.3,0.9,0.00816726,Moderate,0.259,0.015,0.311,0.215,Mild increase (p=0.009),Mild decrease (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02702,rs576604,19,72101665,APOE,SNP (C/T),(C/,C,2.22,2.0,2.55,0.0068415,High,0.001,0.25,0.246,0.303,Mild increase (p=0.042),Mild increase (p=0.015),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02703,rs624647,15,15200070,APP,SNP (A/C),(A/,A,1.61,1.28,1.95,0.05287368,High,0.106,0.014,0.219,0.461,Significant decrease (p=0.009),Significant decrease (p=0.014),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02704,rs740825,13,21961680,CD33,Deletion,-,-,0.62,0.37,0.84,0.01350568,Moderate,0.121,0.22,0.336,0.124,Mild decrease (p=0.026),Significant increase (p=0.048),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02705,rs896515,18,239673899,PSEN2,SNP (A/C),(A/,A,1.1,0.86,1.34,0.00119951,Moderate,0.211,0.17,0.341,0.078,Mild decrease (p=0.028),Significant decrease (p=0.022),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02706,rs459348,9,52046565,MS4A6A,Deletion,-,-,1.0,0.68,1.23,0.00320452,High,0.049,0.372,0.09,0.29,No significant pattern (p=0.024),Variable effect (p=0.027),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02707,rs349658,13,228755441,CLU,SNP (C/G),(C/,C,0.71,0.44,1.01,0.04520215,Low,0.436,0.033,0.215,0.116,Mild increase (p=0.048),Variable effect (p=0.039),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02708,rs812628,6,85964664,CR1,SNP (G/T),(G/,G,0.72,0.37,0.97,0.01926739,High,0.022,0.043,0.346,0.39,Mild increase (p=0.048),No significant pattern (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02709,rs915368,6,86094874,APP,SNP (A/G),(A/,A,0.53,0.26,0.78,0.01247523,High,0.599,0.13,0.016,0.056,Mild decrease (p=0.009),Significant increase (p=0.009),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP02710,rs151700,6,126505613,EPHA1,SNP (C/T),(C/,C,0.8,0.55,1.02,5.394e-05,High,0.062,0.241,0.209,0.288,Variable effect (p=0.032),Significant decrease (p=0.025),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02711,rs790795,21,98498668,ABCA7,Insertion,-,-,1.43,1.05,1.74,0.04529574,High,0.1,0.4,0.004,0.296,Mild decrease (p=0.044),Significant increase (p=0.018),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02712,rs524694,6,4593101,CD33,Deletion,-,-,0.64,0.4,0.98,0.00520586,Protective,0.104,0.147,0.474,0.075,Significant increase (p=0.038),Mild increase (p=0.006),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02713,rs349091,20,1647433,APOE,SNP (C/G),(C/,C,1.57,1.35,1.88,0.00519602,Moderate,0.34,0.094,0.282,0.084,Mild decrease (p=0.025),No significant pattern (p=0.021),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02714,rs135523,5,181186067,ABCA7,SNP (G/T),(G/,G,1.45,1.19,1.69,0.03126023,High,0.149,0.069,0.202,0.38,Significant decrease (p=0.034),Variable effect (p=0.002),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP02715,rs190931,2,100633206,SORL1,Insertion,-,-,0.42,0.1,0.63,0.02036076,High,0.27,0.072,0.446,0.012,Significant decrease (p=0.02),No significant pattern (p=0.036),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02716,rs696684,2,51716150,PICALM,SNP (A/T),(A/,A,0.61,0.28,0.92,0.13257172,Low,0.231,0.187,0.228,0.153,Mild increase (p=0.01),Significant increase (p=0.02),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02717,rs288226,7,104040776,TREM2,SNP (A/C),(A/,A,1.96,1.6,2.23,0.01464385,Moderate,0.353,0.084,0.32,0.043,Mild decrease (p=0.035),Variable effect (p=0.035),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02718,rs294269,7,141907613,CD33,SNP (A/C),(A/,A,0.64,0.4,1.0,0.04892311,High,0.048,0.257,0.248,0.247,Significant decrease (p=0.045),No significant pattern (p=0.004),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02719,rs399040,2,18034815,TREM2,SNP (A/T),(A/,A,0.84,0.62,1.08,0.0442914,High,0.534,0.225,0.022,0.019,Significant increase (p=0.011),No significant pattern (p=0.032),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02720,rs452278,8,153794964,SORL1,SNP (C/T),(C/,C,0.94,0.55,1.28,0.04724605,High,0.393,0.037,0.155,0.215,Variable effect (p=0.049),Mild decrease (p=0.025),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02721,rs496927,11,227314691,CR1,SNP (G/T),(G/,G,0.75,0.45,1.01,0.00414216,Low,0.048,0.187,0.493,0.073,Variable effect (p=0.012),Variable effect (p=0.049),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02722,rs323623,12,100616241,PICALM,SNP (A/T),(A/,A,2.12,1.85,2.49,0.01263442,Protective,0.222,0.245,0.167,0.166,Mild decrease (p=0.024),Significant increase (p=0.01),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP02723,rs322007,15,110744672,SORL1,SNP (C/G),(C/,C,1.18,0.85,1.5,0.03857957,High,0.295,0.169,0.332,0.004,Significant increase (p=0.024),Mild decrease (p=0.009),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02724,rs354012,8,199912527,PSEN2,Deletion,-,-,0.76,0.49,1.16,0.01359902,High,0.46,0.109,0.003,0.228,Significant increase (p=0.031),Significant increase (p=0.037),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02725,rs294077,15,140548196,BIN1,SNP (A/T),(A/,A,2.61,2.28,2.94,0.00197661,High,0.073,0.087,0.348,0.292,Mild increase (p=0.016),Significant decrease (p=0.008),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02726,rs393979,12,76407588,CD33,SNP (A/T),(A/,A,0.63,0.27,0.92,0.02467429,Moderate,0.203,0.05,0.254,0.293,Mild decrease (p=0.017),Mild increase (p=0.019),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02727,rs332811,11,223594028,SORL1,SNP (C/G),(C/,C,1.56,1.24,1.85,0.03311108,Unknown,0.095,0.056,0.613,0.036,No significant pattern (p=0.034),Variable effect (p=0.033),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02728,rs525901,8,30960377,PICALM,SNP (G/T),(G/,G,0.75,0.47,1.01,0.04857527,High,0.0,0.219,0.067,0.514,No significant pattern (p=0.005),Variable effect (p=0.002),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP02729,rs120614,1,54336630,PTK2B,SNP (C/T),(C/,C,0.95,0.73,1.23,0.06300099,High,0.072,0.033,0.062,0.634,No significant pattern (p=0.033),No significant pattern (p=0.031),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP02730,rs873531,9,119738254,BIN1,Deletion,-,-,2.71,2.48,3.06,0.01373042,Moderate,0.086,0.457,0.077,0.18,Mild increase (p=0.033),Significant decrease (p=0.021),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02731,rs132501,3,210017687,CD2AP,SNP (G/T),(G/,G,1.45,1.24,1.77,0.1074927,High,0.095,0.249,0.179,0.277,Variable effect (p=0.008),Significant increase (p=0.004),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02732,rs630359,11,122795580,PSEN2,Deletion,-,-,1.53,1.14,1.87,0.0392381,Moderate,0.232,0.017,0.295,0.256,Mild increase (p=0.012),Variable effect (p=0.02),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02733,rs263643,20,113851594,BIN1,SNP (A/C),(A/,A,0.88,0.64,1.2,0.00722105,Moderate,0.64,0.127,0.029,0.004,No significant pattern (p=0.031),Variable effect (p=0.033),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02734,rs139094,8,76054493,SORL1,SNP (G/T),(G/,G,1.04,0.81,1.33,0.0026625,Moderate,0.009,0.271,0.117,0.403,Mild increase (p=0.014),Variable effect (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02735,rs452654,8,13355799,CLU,SNP (A/T),(A/,A,0.85,0.46,1.06,0.04917065,Moderate,0.241,0.13,0.239,0.191,Mild decrease (p=0.013),Mild increase (p=0.045),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02736,rs415377,18,171371006,SORL1,SNP (C/G),(C/,C,0.64,0.25,1.03,0.06140659,Low,0.239,0.477,0.035,0.048,No significant pattern (p=0.029),No significant pattern (p=0.046),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02737,rs492828,14,193145616,SORL1,SNP (C/T),(C/,C,1.7,1.46,2.08,0.05815632,Moderate,0.056,0.097,0.036,0.611,No significant pattern (p=0.008),Significant increase (p=0.019),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02738,rs540099,2,207713051,PICALM,Insertion,-,-,1.32,0.97,1.72,0.02566539,Moderate,0.283,0.437,0.01,0.07,Mild increase (p=0.003),Significant increase (p=0.038),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02739,rs812180,12,44517820,ABCA7,SNP (A/C),(A/,A,1.46,1.06,1.77,0.02415823,Protective,0.108,0.219,0.018,0.455,Mild decrease (p=0.031),Mild decrease (p=0.039),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02740,rs633499,3,142141305,CLU,SNP (A/C),(A/,A,0.79,0.48,1.03,0.00117278,Moderate,0.036,0.194,0.282,0.289,Variable effect (p=0.03),Mild decrease (p=0.037),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02741,rs191430,19,18247696,CD33,SNP (G/T),(G/,G,1.71,1.4,1.97,0.00673864,Low,0.048,0.464,0.131,0.157,Variable effect (p=0.032),Variable effect (p=0.043),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02742,rs453076,13,246806773,ABCA7,SNP (C/G),(C/,C,2.61,2.4,2.99,0.00284649,Low,0.052,0.271,0.459,0.018,Significant increase (p=0.001),Significant decrease (p=0.019),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02743,rs670920,21,109599182,TREM2,SNP (A/T),(A/,A,1.4,1.14,1.72,0.02273524,Low,0.499,0.038,0.056,0.207,Mild decrease (p=0.008),Variable effect (p=0.005),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02744,rs206530,12,152024277,SORL1,Insertion,-,-,0.82,0.57,1.15,0.01792608,Unknown,0.005,0.497,0.083,0.215,Mild decrease (p=0.05),Mild increase (p=0.046),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02745,rs724366,8,215138582,EPHA1,SNP (C/T),(C/,C,1.8,1.43,2.14,0.03717261,Low,0.299,0.31,0.11,0.081,Mild increase (p=0.015),Mild increase (p=0.045),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02746,rs872829,20,192889555,MS4A6A,Deletion,-,-,0.77,0.46,0.98,0.01856918,Low,0.189,0.098,0.14,0.372,Variable effect (p=0.019),Variable effect (p=0.049),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02747,rs333342,13,105482033,CD2AP,SNP (C/G),(C/,C,1.55,1.29,1.79,0.00743827,High,0.011,0.171,0.014,0.604,No significant pattern (p=0.047),Variable effect (p=0.032),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02748,rs136263,2,70011459,CR1,Insertion,-,-,1.01,0.67,1.23,0.00077635,Low,0.143,0.386,0.235,0.035,Significant increase (p=0.003),Significant decrease (p=0.011),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02749,rs271692,2,146519719,APOE,SNP (A/T),(A/,A,0.65,0.45,1.03,0.0706193,Moderate,0.459,0.101,0.03,0.21,Significant increase (p=0.045),Mild decrease (p=0.037),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02750,rs431193,4,107424375,SORL1,SNP (A/C),(A/,A,1.31,1.09,1.7,0.01860494,Moderate,0.165,0.163,0.259,0.213,Variable effect (p=0.034),Significant increase (p=0.035),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02751,rs150844,2,173127582,MS4A6A,Insertion,-,-,0.49,0.23,0.7,0.04053405,Unknown,0.062,0.153,0.199,0.386,Significant increase (p=0.048),Mild increase (p=0.029),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02752,rs181891,11,16289024,EPHA1,Deletion,-,-,0.59,0.32,0.92,0.00671761,Low,0.165,0.15,0.023,0.462,No significant pattern (p=0.022),Variable effect (p=0.026),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP02753,rs643870,5,126084840,PSEN2,SNP (A/G),(A/,A,1.23,1.0,1.54,0.07629765,Moderate,0.066,0.479,0.096,0.159,No significant pattern (p=0.027),Significant increase (p=0.045),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP02754,rs765262,3,229556719,PICALM,SNP (A/C),(A/,A,0.84,0.6,1.11,0.02922282,High,0.345,0.14,0.149,0.166,Mild increase (p=0.047),Variable effect (p=0.035),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP02755,rs538186,2,53777054,CR1,SNP (G/T),(G/,G,0.46,0.26,0.7,0.02612229,Moderate,0.223,0.313,0.104,0.159,Significant increase (p=0.038),Mild decrease (p=0.039),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02756,rs617242,10,49081477,CLU,SNP (G/T),(G/,G,0.97,0.74,1.27,0.03509756,Moderate,0.309,0.018,0.407,0.066,Variable effect (p=0.004),Mild increase (p=0.001),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02757,rs913546,21,162218704,PTK2B,SNP (C/G),(C/,C,1.64,1.28,1.95,0.02004881,Moderate,0.067,0.186,0.036,0.511,Mild increase (p=0.027),Mild decrease (p=0.027),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02758,rs106308,18,170508321,BIN1,SNP (C/G),(C/,C,0.95,0.65,1.24,0.0042806,Moderate,0.139,0.161,0.43,0.07,Mild increase (p=0.024),Mild increase (p=0.022),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP02759,rs619018,20,121793323,SORL1,SNP (A/T),(A/,A,1.27,0.96,1.58,0.01249758,Low,0.133,0.49,0.052,0.125,Mild decrease (p=0.032),Mild increase (p=0.003),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02760,rs932171,14,164915477,SORL1,SNP (A/T),(A/,A,1.14,0.87,1.36,0.01890721,Moderate,0.277,0.206,0.014,0.303,Mild increase (p=0.018),Mild decrease (p=0.018),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP02761,rs256814,22,50251638,ABCA7,Deletion,-,-,1.03,0.81,1.41,0.05965282,Moderate,0.002,0.397,0.364,0.036,Variable effect (p=0.03),Mild decrease (p=0.017),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP02762,rs244356,7,230833407,PSEN2,Insertion,-,-,1.68,1.39,2.04,0.02186325,Moderate,0.216,0.135,0.168,0.282,No significant pattern (p=0.016),Variable effect (p=0.006),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02763,rs640816,17,177133130,CD2AP,SNP (C/T),(C/,C,1.55,1.21,1.83,0.03605352,High,0.296,0.176,0.177,0.151,Mild decrease (p=0.05),Variable effect (p=0.046),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02764,rs428406,16,52410898,PTK2B,SNP (G/T),(G/,G,1.16,0.8,1.47,0.00078797,Moderate,0.077,0.035,0.317,0.372,Mild increase (p=0.039),Significant decrease (p=0.038),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02765,rs872690,18,244719185,CD2AP,Deletion,-,-,1.18,0.81,1.44,0.02105475,High,0.556,0.044,0.134,0.066,Variable effect (p=0.037),Variable effect (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02766,rs861072,7,220412321,EPHA1,SNP (A/T),(A/,A,0.68,0.41,0.93,0.00283352,High,0.145,0.158,0.138,0.359,Mild increase (p=0.005),No significant pattern (p=0.049),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02767,rs602288,12,25433524,PICALM,SNP (A/C),(A/,A,1.27,0.98,1.56,0.01743158,Moderate,0.04,0.389,0.232,0.14,Mild increase (p=0.011),Mild increase (p=0.039),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02768,rs139182,13,135020365,SORL1,SNP (A/T),(A/,A,1.45,1.2,1.73,0.00917743,Moderate,0.205,0.502,0.035,0.057,Significant decrease (p=0.037),Significant increase (p=0.003),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02769,rs825895,19,109714686,TREM2,Deletion,-,-,0.96,0.6,1.17,0.00324702,Protective,0.166,0.151,0.449,0.035,Significant increase (p=0.049),Significant decrease (p=0.022),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02770,rs460574,18,72851999,TREM2,Deletion,-,-,1.33,1.01,1.57,0.01343416,High,0.167,0.125,0.422,0.085,Significant decrease (p=0.005),Mild increase (p=0.021),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02771,rs717977,11,191844793,APOE,SNP (A/C),(A/,A,0.77,0.55,1.16,0.0249282,Protective,0.108,0.05,0.528,0.114,Significant decrease (p=0.045),Significant decrease (p=0.007),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02772,rs213407,8,226280587,EPHA1,SNP (A/G),(A/,A,0.81,0.44,1.2,0.01100534,High,0.184,0.251,0.291,0.075,Mild decrease (p=0.036),Mild increase (p=0.041),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02773,rs730337,5,238000872,SORL1,SNP (A/G),(A/,A,0.65,0.39,0.94,0.04317096,High,0.089,0.163,0.03,0.518,Mild increase (p=0.026),Mild decrease (p=0.014),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02774,rs794692,8,8227814,CD2AP,Deletion,-,-,1.11,0.88,1.37,0.0155013,High,0.309,0.246,0.208,0.037,Mild decrease (p=0.005),Mild increase (p=0.013),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02775,rs649369,22,114566573,CLU,SNP (C/T),(C/,C,2.09,1.88,2.43,0.00885876,Moderate,0.255,0.395,0.132,0.019,Variable effect (p=0.032),Significant increase (p=0.029),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02776,rs424490,5,166609085,BIN1,SNP (A/T),(A/,A,1.75,1.47,2.11,0.08673199,Unknown,0.33,0.063,0.169,0.238,No significant pattern (p=0.045),Mild increase (p=0.041),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP02777,rs438936,8,70583370,BIN1,Deletion,-,-,1.09,0.75,1.35,0.1169123,High,0.115,0.218,0.312,0.154,Significant increase (p=0.022),Significant decrease (p=0.041),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP02778,rs137901,8,136774302,EPHA1,Deletion,-,-,1.54,1.28,1.76,0.00590234,Low,0.345,0.185,0.087,0.183,No significant pattern (p=0.019),Significant increase (p=0.027),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP02779,rs808216,6,112534091,CLU,SNP (A/T),(A/,A,0.77,0.47,0.99,0.06283975,Moderate,0.453,0.153,0.151,0.043,Significant decrease (p=0.021),Significant decrease (p=0.046),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02780,rs795623,8,43504251,ABCA7,Insertion,-,-,0.96,0.57,1.21,0.02509744,High,0.125,0.054,0.115,0.506,Mild decrease (p=0.038),Mild decrease (p=0.024),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02781,rs356937,10,170755830,APOE,Insertion,-,-,0.98,0.66,1.26,0.01288305,Unknown,0.081,0.051,0.588,0.08,Variable effect (p=0.034),Mild increase (p=0.031),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP02782,rs389317,20,63765290,ABCA7,SNP (A/G),(A/,A,2.06,1.71,2.42,0.04829368,High,0.053,0.147,0.11,0.489,Variable effect (p=0.048),Significant increase (p=0.005),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02783,rs833016,8,161524459,CR1,SNP (A/C),(A/,A,1.85,1.47,2.16,0.02131252,High,0.006,0.071,0.524,0.2,No significant pattern (p=0.036),Mild decrease (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02784,rs624296,12,182023352,EPHA1,SNP (G/T),(G/,G,1.92,1.58,2.29,0.00266333,Moderate,0.007,0.559,0.032,0.202,Significant decrease (p=0.033),Mild increase (p=0.021),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02785,rs324323,9,230815714,BIN1,SNP (C/T),(C/,C,1.35,1.04,1.61,0.04414396,Protective,0.72,0.004,0.074,0.002,No significant pattern (p=0.024),Significant increase (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP02786,rs965144,9,10442781,CLU,SNP (A/T),(A/,A,0.51,0.19,0.91,0.00449458,Low,0.077,0.381,0.07,0.273,Mild decrease (p=0.044),Mild decrease (p=0.021),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02787,rs720446,3,58726489,APP,SNP (A/T),(A/,A,1.16,0.93,1.54,0.00994828,Low,0.227,0.4,0.092,0.081,No significant pattern (p=0.014),No significant pattern (p=0.041),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02788,rs281173,2,42552192,APP,SNP (C/G),(C/,C,1.06,0.67,1.33,0.10703532,High,0.102,0.178,0.421,0.099,Variable effect (p=0.035),Mild increase (p=0.025),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02789,rs503876,8,159735980,CD33,Insertion,-,-,1.95,1.7,2.27,0.00985724,Protective,0.249,0.132,0.083,0.335,No significant pattern (p=0.002),No significant pattern (p=0.033),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02790,rs755217,16,52587689,CR1,SNP (A/T),(A/,A,0.36,0.1,0.7,0.16055043,Moderate,0.109,0.348,0.1,0.243,Significant increase (p=0.041),Mild increase (p=0.01),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02791,rs209817,11,197448465,TREM2,SNP (A/C),(A/,A,0.9,0.56,1.21,0.10672051,Low,0.084,0.487,0.007,0.222,Variable effect (p=0.025),Mild increase (p=0.04),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP02792,rs336943,1,215143326,PSEN2,SNP (A/G),(A/,A,0.99,0.78,1.24,0.02089213,High,0.289,0.0,0.153,0.357,No significant pattern (p=0.015),Variable effect (p=0.006),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02793,rs970695,7,158201070,TREM2,SNP (A/T),(A/,A,1.62,1.32,1.93,0.00680244,High,0.036,0.428,0.124,0.212,Mild increase (p=0.048),No significant pattern (p=0.024),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02794,rs370336,9,155053954,EPHA1,Deletion,-,-,1.02,0.72,1.29,0.0181677,Moderate,0.07,0.281,0.356,0.094,Significant decrease (p=0.004),Mild decrease (p=0.035),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02795,rs523642,4,146453428,EPHA1,SNP (C/G),(C/,C,1.38,1.05,1.6,0.02652386,Low,0.03,0.059,0.452,0.259,Variable effect (p=0.034),Significant decrease (p=0.044),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP02796,rs584881,19,26933860,BIN1,SNP (C/G),(C/,C,2.56,2.2,2.87,0.03803248,Low,0.268,0.266,0.006,0.26,Mild increase (p=0.015),Significant decrease (p=0.041),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP02797,rs641290,5,129835104,MS4A6A,SNP (G/T),(G/,G,0.58,0.21,0.88,0.04596126,Moderate,0.069,0.536,0.061,0.134,Mild decrease (p=0.032),Mild decrease (p=0.042),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02798,rs437531,5,51931989,EPHA1,SNP (G/T),(G/,G,1.21,0.89,1.49,0.01587066,Moderate,0.332,0.052,0.369,0.047,No significant pattern (p=0.045),Variable effect (p=0.045),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP02799,rs208888,1,220513237,APOE,SNP (A/C),(A/,A,0.75,0.46,1.03,0.04624122,Low,0.015,0.288,0.302,0.194,No significant pattern (p=0.016),Significant decrease (p=0.008),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02800,rs721560,19,103664843,CLU,SNP (A/G),(A/,A,0.93,0.6,1.27,0.12403925,Moderate,0.254,0.237,0.262,0.047,Variable effect (p=0.011),No significant pattern (p=0.009),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02801,rs241567,2,75744333,MS4A6A,SNP (A/G),(A/,A,1.11,0.78,1.44,0.0908592,Protective,0.048,0.515,0.029,0.208,Variable effect (p=0.011),No significant pattern (p=0.002),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02802,rs190608,21,171965697,BIN1,SNP (A/T),(A/,A,0.76,0.52,1.05,0.02725719,Low,0.02,0.442,0.284,0.054,No significant pattern (p=0.006),Mild decrease (p=0.019),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02803,rs843261,3,163857704,CLU,SNP (A/C),(A/,A,0.9,0.52,1.15,0.04879461,Moderate,0.017,0.29,0.145,0.348,Mild decrease (p=0.027),Significant increase (p=0.024),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02804,rs777372,1,38136043,CLU,SNP (G/T),(G/,G,0.63,0.38,0.89,0.00872787,Low,0.206,0.013,0.262,0.319,Mild decrease (p=0.006),Significant increase (p=0.041),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02805,rs290275,1,66883527,CD33,SNP (A/G),(A/,A,0.56,0.27,0.88,0.00214344,Protective,0.034,0.252,0.216,0.299,Mild decrease (p=0.039),Variable effect (p=0.037),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02806,rs339946,10,204263906,APOE,SNP (C/G),(C/,C,0.99,0.64,1.24,0.00568126,High,0.55,0.025,0.059,0.165,Mild decrease (p=0.028),No significant pattern (p=0.042),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02807,rs330245,12,221926799,APOE,SNP (A/T),(A/,A,1.2,0.93,1.58,0.00262959,Protective,0.031,0.028,0.371,0.37,Significant decrease (p=0.041),Significant decrease (p=0.038),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02808,rs786524,12,47940074,SORL1,SNP (A/C),(A/,A,0.94,0.7,1.21,0.01191032,Low,0.117,0.421,0.002,0.26,No significant pattern (p=0.024),Mild increase (p=0.037),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02809,rs597027,12,68259687,BIN1,Deletion,-,-,1.76,1.52,1.99,0.02304502,High,0.318,0.163,0.275,0.045,Mild increase (p=0.041),Significant increase (p=0.017),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02810,rs638913,15,36161497,MS4A6A,SNP (A/T),(A/,A,1.69,1.38,1.97,0.01504168,High,0.0,0.054,0.142,0.604,No significant pattern (p=0.003),Significant decrease (p=0.012),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02811,rs292426,20,122269059,PICALM,SNP (A/T),(A/,A,0.79,0.54,1.02,0.05098217,Moderate,0.053,0.065,0.665,0.018,Mild decrease (p=0.044),No significant pattern (p=0.02),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02812,rs789081,7,128906984,PTK2B,SNP (A/C),(A/,A,1.86,1.63,2.13,0.00058618,High,0.147,0.015,0.334,0.303,Mild increase (p=0.029),Variable effect (p=0.032),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02813,rs640121,11,168062580,CD33,SNP (C/T),(C/,C,1.24,0.84,1.46,0.04055275,Protective,0.205,0.08,0.235,0.28,No significant pattern (p=0.002),Significant increase (p=0.008),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02814,rs438996,12,6225063,CD33,SNP (C/T),(C/,C,2.96,2.58,3.24,0.01814716,Low,0.158,0.524,0.105,0.013,Significant decrease (p=0.046),Variable effect (p=0.027),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02815,rs939351,11,48307191,TREM2,SNP (A/C),(A/,A,0.47,0.22,0.73,0.00294033,Low,0.039,0.2,0.541,0.02,No significant pattern (p=0.033),Mild decrease (p=0.032),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02816,rs385369,6,32291485,TREM2,SNP (A/C),(A/,A,1.41,1.07,1.78,0.11524306,Moderate,0.273,0.117,0.274,0.137,Mild decrease (p=0.022),Significant increase (p=0.035),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02817,rs585358,7,27104475,APOE,SNP (C/T),(C/,C,0.49,0.1,0.83,0.00708179,High,0.02,0.079,0.369,0.332,Mild increase (p=0.037),Significant decrease (p=0.003),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP02818,rs853770,21,246062554,PSEN2,Deletion,-,-,0.67,0.47,0.98,0.04946325,Moderate,0.179,0.008,0.531,0.083,Significant decrease (p=0.029),Variable effect (p=0.046),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02819,rs242436,11,166998412,BIN1,SNP (G/T),(G/,G,0.9,0.59,1.2,0.02489607,Moderate,0.179,0.188,0.189,0.243,Mild increase (p=0.033),Mild decrease (p=0.023),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02820,rs732054,6,7001763,MS4A6A,SNP (C/G),(C/,C,1.17,0.87,1.57,0.00610197,Low,0.075,0.216,0.078,0.43,Variable effect (p=0.027),Significant increase (p=0.042),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP02821,rs941084,16,113203035,SORL1,Insertion,-,-,0.39,0.14,0.6,0.02621897,Unknown,0.263,0.239,0.093,0.204,Mild increase (p=0.002),No significant pattern (p=0.008),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02822,rs916710,13,237797242,CR1,Insertion,-,-,1.58,1.36,1.83,0.15384277,Protective,0.271,0.108,0.311,0.111,Mild increase (p=0.003),Significant increase (p=0.028),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02823,rs150347,10,244721072,APP,SNP (A/C),(A/,A,2.34,2.07,2.71,0.04291722,High,0.138,0.113,0.442,0.107,No significant pattern (p=0.047),Mild increase (p=0.012),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02824,rs206771,1,35838146,APOE,SNP (A/G),(A/,A,0.46,0.1,0.71,0.03597739,Low,0.191,0.276,0.235,0.098,Significant decrease (p=0.027),Significant decrease (p=0.016),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02825,rs879667,21,203805832,CD2AP,Deletion,-,-,0.49,0.25,0.89,0.05273683,Protective,0.004,0.034,0.275,0.486,Significant increase (p=0.046),Significant increase (p=0.018),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP02826,rs761931,20,139529843,ABCA7,SNP (A/C),(A/,A,0.52,0.19,0.84,0.00474303,Low,0.024,0.043,0.425,0.308,Mild increase (p=0.047),Significant increase (p=0.04),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02827,rs728793,22,162488732,SORL1,Insertion,-,-,0.47,0.16,0.75,0.00374898,High,0.121,0.615,0.055,0.009,Variable effect (p=0.017),Significant decrease (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02828,rs473496,12,94146742,ABCA7,SNP (A/T),(A/,A,1.64,1.34,1.93,0.00303009,Moderate,0.047,0.129,0.497,0.128,Significant increase (p=0.036),Significant decrease (p=0.026),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02829,rs450246,15,206957537,BIN1,SNP (C/G),(C/,C,4.13,3.76,4.49,0.08688512,Unknown,0.381,0.134,0.204,0.081,No significant pattern (p=0.016),Variable effect (p=0.003),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02830,rs501906,20,68788026,CR1,Deletion,-,-,1.32,0.92,1.57,0.04849109,High,0.075,0.369,0.102,0.254,Variable effect (p=0.004),No significant pattern (p=0.028),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02831,rs271657,14,130119678,CR1,SNP (G/T),(G/,G,0.78,0.41,1.15,0.06297643,Low,0.007,0.132,0.012,0.649,No significant pattern (p=0.002),No significant pattern (p=0.025),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02832,rs484163,10,194055750,CR1,Deletion,-,-,1.12,0.82,1.42,0.02505827,Low,0.245,0.187,0.219,0.149,Significant decrease (p=0.016),Significant decrease (p=0.03),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02833,rs704295,15,106801244,CD2AP,SNP (C/G),(C/,C,1.01,0.65,1.37,0.00527239,Low,0.173,0.16,0.309,0.158,Mild decrease (p=0.017),Mild decrease (p=0.032),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP02834,rs819701,22,115102404,PICALM,SNP (G/T),(G/,G,1.25,0.88,1.49,0.01482326,Low,0.043,0.694,0.055,0.008,Mild increase (p=0.006),No significant pattern (p=0.02),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02835,rs689904,2,105203731,ABCA7,SNP (C/G),(C/,C,0.5,0.2,0.83,0.01504794,Moderate,0.67,0.119,0.002,0.009,Significant decrease (p=0.033),Significant increase (p=0.022),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02836,rs465346,10,79876860,APOE,SNP (A/G),(A/,A,2.51,2.15,2.76,0.00273359,High,0.363,0.18,0.253,0.004,Significant increase (p=0.001),Variable effect (p=0.004),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02837,rs525418,3,31866057,SORL1,SNP (C/T),(C/,C,1.4,1.16,1.67,0.03807926,Moderate,0.619,0.021,0.032,0.128,No significant pattern (p=0.01),Mild increase (p=0.033),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02838,rs632619,10,103590779,APP,Insertion,-,-,0.95,0.65,1.15,0.06101758,Low,0.384,0.129,0.101,0.186,No significant pattern (p=0.009),Mild increase (p=0.024),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP02839,rs656246,4,230535291,EPHA1,SNP (A/G),(A/,A,0.68,0.38,1.05,0.01059602,Low,0.061,0.161,0.101,0.477,Variable effect (p=0.046),No significant pattern (p=0.018),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02840,rs834740,1,57996750,TREM2,SNP (C/G),(C/,C,1.0,0.73,1.38,0.02722541,High,0.08,0.276,0.067,0.376,Variable effect (p=0.035),No significant pattern (p=0.018),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02841,rs442992,2,162353878,CD2AP,SNP (A/G),(A/,A,0.64,0.31,1.03,0.03894539,Protective,0.13,0.186,0.455,0.03,Significant increase (p=0.015),Significant increase (p=0.035),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02842,rs673064,2,128049950,PICALM,SNP (C/G),(C/,C,1.11,0.91,1.33,0.03764411,High,0.078,0.405,0.183,0.133,Mild decrease (p=0.024),Significant increase (p=0.044),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP02843,rs215210,5,153256036,MS4A6A,SNP (C/T),(C/,C,0.8,0.43,1.02,0.03034613,Moderate,0.54,0.023,0.212,0.025,Mild decrease (p=0.01),Significant increase (p=0.04),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02844,rs701422,13,139273486,TREM2,Insertion,-,-,1.35,1.0,1.74,0.01279643,High,0.36,0.02,0.248,0.172,Significant increase (p=0.02),Variable effect (p=0.017),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02845,rs477403,21,36728312,SORL1,SNP (C/T),(C/,C,1.14,0.77,1.38,0.03373092,Moderate,0.316,0.084,0.131,0.269,Mild increase (p=0.002),Mild decrease (p=0.035),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02846,rs691758,22,157385140,APOE,SNP (A/G),(A/,A,1.19,0.92,1.5,0.0375648,High,0.057,0.116,0.437,0.19,No significant pattern (p=0.046),No significant pattern (p=0.027),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02847,rs347387,17,236631467,EPHA1,SNP (A/C),(A/,A,0.67,0.41,0.91,2.566e-05,Low,0.0,0.12,0.242,0.438,Mild decrease (p=0.049),No significant pattern (p=0.03),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02848,rs197418,9,34704246,MS4A6A,SNP (G/T),(G/,G,1.18,0.79,1.52,0.04582152,Low,0.248,0.083,0.026,0.443,Variable effect (p=0.018),Variable effect (p=0.022),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP02849,rs541490,5,107762491,ABCA7,SNP (C/G),(C/,C,0.91,0.53,1.31,0.03049564,Unknown,0.327,0.189,0.08,0.204,Significant increase (p=0.002),No significant pattern (p=0.042),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02850,rs340306,19,122287821,EPHA1,Deletion,-,-,0.72,0.33,0.96,0.00216864,Moderate,0.164,0.102,0.188,0.345,Variable effect (p=0.005),Significant decrease (p=0.03),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02851,rs258202,1,214716440,PTK2B,Deletion,-,-,0.87,0.66,1.17,0.02331877,Moderate,0.05,0.198,0.316,0.236,Variable effect (p=0.047),Mild decrease (p=0.022),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02852,rs139238,16,72536883,CD33,SNP (C/T),(C/,C,0.8,0.6,1.03,0.06730212,High,0.191,0.189,0.416,0.003,Significant increase (p=0.034),Variable effect (p=0.019),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02853,rs864214,3,198001796,PICALM,SNP (A/G),(A/,A,0.87,0.65,1.19,0.01076817,Moderate,0.192,0.035,0.378,0.194,No significant pattern (p=0.008),Significant increase (p=0.046),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02854,rs406495,10,147858235,MS4A6A,SNP (C/G),(C/,C,1.33,1.06,1.64,0.02649578,Unknown,0.071,0.037,0.423,0.269,Variable effect (p=0.017),Mild decrease (p=0.018),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02855,rs124822,12,49166628,CLU,SNP (A/T),(A/,A,0.8,0.58,1.06,0.01326597,Low,0.336,0.215,0.085,0.165,No significant pattern (p=0.015),Mild increase (p=0.032),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02856,rs934775,13,203037815,MS4A6A,Deletion,-,-,1.12,0.78,1.47,0.01308874,High,0.317,0.249,0.014,0.22,Mild decrease (p=0.043),No significant pattern (p=0.047),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02857,rs308461,10,181664106,APOE,SNP (C/G),(C/,C,0.99,0.78,1.32,0.00536395,Moderate,0.433,0.054,0.265,0.048,Mild increase (p=0.009),No significant pattern (p=0.047),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP02858,rs363099,15,84378650,APP,Insertion,-,-,1.75,1.47,1.95,0.00879067,Unknown,0.034,0.102,0.663,0.002,Significant decrease (p=0.035),No significant pattern (p=0.008),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02859,rs137336,2,228843357,EPHA1,SNP (A/T),(A/,A,0.65,0.25,0.89,0.01494965,Moderate,0.099,0.099,0.145,0.458,Significant increase (p=0.032),Significant increase (p=0.022),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP02860,rs604939,3,223266733,BIN1,SNP (C/G),(C/,C,0.68,0.47,1.02,0.02978918,Moderate,0.164,0.364,0.222,0.049,No significant pattern (p=0.029),Variable effect (p=0.004),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02861,rs126383,16,17285889,APOE,SNP (C/T),(C/,C,1.89,1.65,2.27,0.00526525,High,0.125,0.071,0.115,0.489,No significant pattern (p=0.038),Significant decrease (p=0.032),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02862,rs735609,17,112256368,APOE,SNP (G/T),(G/,G,0.39,0.1,0.66,0.11872831,Moderate,0.162,0.546,0.013,0.08,Variable effect (p=0.044),No significant pattern (p=0.035),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP02863,rs813613,19,215714020,APOE,SNP (C/G),(C/,C,1.6,1.36,1.98,0.02745657,Protective,0.232,0.183,0.029,0.356,Variable effect (p=0.026),Mild decrease (p=0.011),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP02864,rs833375,5,234096601,CLU,SNP (C/T),(C/,C,0.48,0.16,0.82,0.069234,Moderate,0.103,0.162,0.045,0.49,Mild increase (p=0.038),Mild decrease (p=0.001),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02865,rs392252,7,121906838,CD33,SNP (A/C),(A/,A,0.73,0.36,0.97,0.0405128,High,0.105,0.113,0.376,0.206,No significant pattern (p=0.04),Significant increase (p=0.002),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02866,rs270769,3,213260510,ABCA7,SNP (C/T),(C/,C,0.79,0.48,1.01,0.0196487,High,0.071,0.505,0.049,0.175,Variable effect (p=0.039),Mild increase (p=0.005),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP02867,rs154125,19,43735265,PICALM,Insertion,-,-,0.88,0.52,1.19,0.01838805,Moderate,0.123,0.128,0.376,0.173,No significant pattern (p=0.027),Significant increase (p=0.012),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP02868,rs422910,20,183547523,CD33,SNP (C/T),(C/,C,1.37,1.11,1.7,0.09180939,High,0.454,0.051,0.022,0.274,Significant increase (p=0.027),Significant decrease (p=0.012),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP02869,rs335783,13,209260982,APP,SNP (A/C),(A/,A,1.49,1.15,1.88,0.11307266,High,0.074,0.041,0.536,0.149,No significant pattern (p=0.029),Mild decrease (p=0.005),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02870,rs128239,1,53543990,EPHA1,Insertion,-,-,0.49,0.26,0.73,0.00182603,Moderate,0.54,0.095,0.114,0.051,Significant increase (p=0.014),Variable effect (p=0.002),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02871,rs771265,20,124946317,PTK2B,Deletion,-,-,0.33,0.1,0.69,0.05091223,Moderate,0.13,0.428,0.08,0.162,Variable effect (p=0.022),No significant pattern (p=0.013),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02872,rs610669,22,244861787,PTK2B,Deletion,-,-,2.67,2.36,2.91,0.03816572,High,0.409,0.132,0.076,0.183,Significant increase (p=0.006),Mild decrease (p=0.049),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02873,rs435107,2,34264419,SORL1,Deletion,-,-,0.71,0.32,0.91,0.00056658,High,0.554,0.012,0.213,0.021,No significant pattern (p=0.018),Mild decrease (p=0.038),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02874,rs155716,21,71670046,APP,SNP (C/T),(C/,C,2.49,2.26,2.78,0.05601417,Moderate,0.178,0.25,0.076,0.296,Variable effect (p=0.045),No significant pattern (p=0.045),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02875,rs680403,19,25323709,EPHA1,SNP (C/T),(C/,C,0.88,0.6,1.26,0.00907013,Low,0.253,0.302,0.221,0.024,Variable effect (p=0.028),Significant increase (p=0.008),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02876,rs963332,10,89583222,MS4A6A,Insertion,-,-,0.53,0.21,0.77,0.03634156,High,0.073,0.187,0.403,0.138,Mild increase (p=0.014),Mild increase (p=0.031),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02877,rs424806,7,211800350,PICALM,SNP (C/T),(C/,C,1.65,1.35,1.9,0.05758084,Moderate,0.206,0.456,0.125,0.013,Variable effect (p=0.038),Mild increase (p=0.033),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02878,rs589143,5,145593657,PTK2B,Insertion,-,-,1.32,0.97,1.68,0.00918433,Low,0.296,0.417,0.085,0.002,Significant increase (p=0.019),Mild decrease (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02879,rs197507,1,235512512,SORL1,SNP (A/G),(A/,A,1.57,1.28,1.88,0.01673984,High,0.293,0.217,0.044,0.246,Mild decrease (p=0.004),Mild decrease (p=0.046),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02880,rs211400,3,222963450,SORL1,SNP (A/T),(A/,A,0.77,0.56,1.02,0.02738201,High,0.473,0.206,0.041,0.08,Variable effect (p=0.05),Significant decrease (p=0.046),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02881,rs181274,22,46601103,CD33,Insertion,-,-,1.36,1.05,1.7,0.02015041,Moderate,0.157,0.309,0.034,0.3,No significant pattern (p=0.029),Significant increase (p=0.008),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP02882,rs149690,9,198008357,CLU,SNP (A/T),(A/,A,1.54,1.14,1.89,0.0091515,Moderate,0.438,0.133,0.176,0.053,Significant increase (p=0.012),Significant increase (p=0.015),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02883,rs126099,4,142435075,SORL1,SNP (C/T),(C/,C,1.05,0.73,1.43,0.00610391,High,0.011,0.401,0.174,0.214,No significant pattern (p=0.011),No significant pattern (p=0.022),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02884,rs594486,1,130504376,ABCA7,SNP (A/T),(A/,A,1.23,0.94,1.52,0.02650391,Protective,0.527,0.074,0.183,0.015,Significant increase (p=0.046),No significant pattern (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP02885,rs753565,3,146989463,PICALM,SNP (A/T),(A/,A,1.01,0.67,1.29,0.03995046,High,0.292,0.443,0.038,0.027,No significant pattern (p=0.009),Mild decrease (p=0.04),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02886,rs886111,17,220469355,PTK2B,Deletion,-,-,1.87,1.58,2.26,0.03808845,High,0.229,0.013,0.281,0.278,No significant pattern (p=0.014),Significant increase (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP02887,rs171877,8,157108874,APP,SNP (A/G),(A/,A,1.16,0.89,1.4,0.00313157,High,0.359,0.087,0.234,0.12,Significant decrease (p=0.033),Significant increase (p=0.027),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02888,rs640071,9,111310596,SORL1,Insertion,-,-,1.11,0.83,1.37,0.02414352,Moderate,0.37,0.305,0.027,0.098,No significant pattern (p=0.015),Mild increase (p=0.005),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP02889,rs454906,17,200337408,MS4A6A,SNP (A/G),(A/,A,0.7,0.3,0.98,0.02706149,High,0.179,0.154,0.389,0.077,Mild decrease (p=0.024),Significant decrease (p=0.009),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP02890,rs541053,11,28690877,CD2AP,SNP (C/T),(C/,C,1.47,1.21,1.78,0.03704317,Low,0.099,0.581,0.034,0.086,Mild decrease (p=0.029),Significant increase (p=0.04),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP02891,rs977742,11,62348158,PTK2B,Insertion,-,-,1.42,1.16,1.67,0.00024876,Unknown,0.236,0.297,0.201,0.067,No significant pattern (p=0.009),Variable effect (p=0.013),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP02892,rs202916,9,160125029,BIN1,SNP (C/G),(C/,C,0.91,0.67,1.14,0.02651299,Moderate,0.314,0.037,0.071,0.378,Significant decrease (p=0.009),Significant increase (p=0.04),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP02893,rs834337,13,179793434,APOE,SNP (A/T),(A/,A,2.56,2.21,2.8,0.01633264,Moderate,0.596,0.156,0.035,0.012,Variable effect (p=0.026),Significant decrease (p=0.04),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP02894,rs670005,15,203703416,APOE,SNP (G/T),(G/,G,1.05,0.76,1.38,0.02676642,Low,0.059,0.403,0.232,0.105,Significant decrease (p=0.021),No significant pattern (p=0.035),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02895,rs764547,10,232921319,CD33,SNP (A/C),(A/,A,0.6,0.28,0.8,0.08019251,Moderate,0.093,0.493,0.088,0.126,Mild decrease (p=0.038),No significant pattern (p=0.027),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02896,rs631462,11,8894960,CD33,SNP (A/C),(A/,A,0.45,0.1,0.79,0.02676964,Moderate,0.015,0.25,0.009,0.526,Mild increase (p=0.026),Variable effect (p=0.038),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02897,rs747605,1,3337280,CLU,SNP (G/T),(G/,G,1.45,1.17,1.66,0.05862981,Low,0.063,0.57,0.132,0.035,Mild increase (p=0.037),Significant decrease (p=0.015),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP02898,rs603933,22,9942990,CLU,SNP (C/T),(C/,C,0.97,0.64,1.33,0.0188138,Moderate,0.121,0.586,0.076,0.017,Significant increase (p=0.014),Mild decrease (p=0.044),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP02899,rs693978,7,148405657,PICALM,SNP (G/T),(G/,G,1.91,1.62,2.28,0.03713058,High,0.063,0.089,0.367,0.28,Variable effect (p=0.008),No significant pattern (p=0.033),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02900,rs369388,2,152149830,PICALM,SNP (G/T),(G/,G,2.03,1.67,2.41,0.00165521,Moderate,0.216,0.039,0.436,0.11,No significant pattern (p=0.003),Variable effect (p=0.018),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02901,rs693336,21,203331550,CD33,SNP (A/G),(A/,A,1.17,0.94,1.42,0.07580366,Moderate,0.218,0.036,0.064,0.481,Significant decrease (p=0.01),Significant decrease (p=0.019),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02902,rs497120,7,237049199,PSEN2,SNP (C/G),(C/,C,0.83,0.51,1.07,0.05582872,Unknown,0.406,0.13,0.059,0.205,Significant decrease (p=0.015),Mild decrease (p=0.005),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02903,rs838900,7,140203895,CLU,SNP (A/C),(A/,A,0.98,0.71,1.31,0.03684874,High,0.019,0.36,0.009,0.412,Mild decrease (p=0.005),Significant decrease (p=0.049),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02904,rs897170,20,193225947,PICALM,Insertion,-,-,0.75,0.53,1.09,0.0063622,Moderate,0.512,0.181,0.093,0.014,Variable effect (p=0.01),Significant increase (p=0.046),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02905,rs592457,6,129037558,CD2AP,SNP (G/T),(G/,G,0.8,0.51,1.14,0.03170252,High,0.219,0.115,0.379,0.087,Significant decrease (p=0.019),Mild decrease (p=0.002),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP02906,rs129809,21,174323902,ABCA7,SNP (C/G),(C/,C,1.34,1.09,1.68,0.00312046,Low,0.048,0.395,0.215,0.141,No significant pattern (p=0.031),Mild increase (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02907,rs732601,8,34731855,CD33,Deletion,-,-,1.5,1.18,1.79,0.01055558,Moderate,0.407,0.104,0.272,0.017,Variable effect (p=0.015),No significant pattern (p=0.013),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02908,rs969237,6,5786044,ABCA7,Deletion,-,-,0.8,0.58,1.02,0.01420092,High,0.13,0.125,0.425,0.119,Significant decrease (p=0.025),Mild decrease (p=0.024),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02909,rs991740,15,122225792,BIN1,SNP (G/T),(G/,G,0.32,0.1,0.71,0.01662889,High,0.126,0.434,0.123,0.117,Mild decrease (p=0.034),Mild increase (p=0.033),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02910,rs259056,3,26252079,PTK2B,SNP (A/C),(A/,A,1.26,0.89,1.48,0.04994937,High,0.221,0.075,0.332,0.172,Significant decrease (p=0.032),Significant decrease (p=0.027),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP02911,rs779538,15,205644360,CD33,SNP (A/T),(A/,A,0.71,0.47,0.91,0.00273574,Low,0.046,0.487,0.192,0.075,Variable effect (p=0.023),Significant increase (p=0.011),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP02912,rs443470,20,218464419,APP,SNP (C/T),(C/,C,1.86,1.55,2.14,0.00243094,Moderate,0.252,0.224,0.212,0.112,Variable effect (p=0.042),Significant increase (p=0.017),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02913,rs651022,14,97064091,CD2AP,SNP (C/T),(C/,C,1.04,0.66,1.43,0.0313827,High,0.151,0.179,0.105,0.365,Significant increase (p=0.044),Significant decrease (p=0.013),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02914,rs818037,13,102279032,CD33,SNP (A/G),(A/,A,0.45,0.17,0.68,0.02501787,Moderate,0.027,0.411,0.108,0.254,Significant increase (p=0.013),Mild increase (p=0.046),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP02915,rs346882,14,78954290,CD33,SNP (G/T),(G/,G,1.04,0.67,1.32,0.07118447,Moderate,0.073,0.286,0.374,0.067,Significant decrease (p=0.025),Mild increase (p=0.041),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02916,rs527769,8,199610300,BIN1,SNP (C/G),(C/,C,0.43,0.1,0.77,0.03841709,Moderate,0.211,0.067,0.091,0.431,Significant increase (p=0.042),No significant pattern (p=0.037),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02917,rs864270,18,209139905,PICALM,SNP (A/T),(A/,A,0.54,0.32,0.81,0.01305802,Moderate,0.415,0.282,0.074,0.028,Mild decrease (p=0.015),Significant increase (p=0.027),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02918,rs715926,19,50599712,BIN1,Insertion,-,-,0.93,0.64,1.16,0.01377226,Moderate,0.097,0.233,0.302,0.168,Mild increase (p=0.041),Significant increase (p=0.004),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02919,rs790607,16,68428915,PICALM,SNP (A/T),(A/,A,1.48,1.24,1.76,0.03350886,Moderate,0.207,0.044,0.523,0.027,Significant decrease (p=0.036),Mild increase (p=0.041),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02920,rs174185,19,72431091,MS4A6A,SNP (A/C),(A/,A,0.44,0.21,0.75,0.01132719,Low,0.339,0.004,0.193,0.264,Variable effect (p=0.043),No significant pattern (p=0.013),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02921,rs312524,6,220360861,BIN1,SNP (A/T),(A/,A,1.64,1.37,1.89,0.02301839,Low,0.012,0.117,0.626,0.045,No significant pattern (p=0.021),No significant pattern (p=0.012),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP02922,rs579187,4,200454443,CD33,SNP (A/G),(A/,A,0.41,0.1,0.77,0.09040596,Moderate,0.403,0.329,0.044,0.024,Mild decrease (p=0.035),Mild decrease (p=0.016),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP02923,rs399435,4,105467573,APOE,SNP (A/G),(A/,A,1.41,1.14,1.62,0.0845641,Low,0.027,0.582,0.175,0.016,No significant pattern (p=0.036),Significant decrease (p=0.002),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP02924,rs651718,15,23970457,EPHA1,Deletion,-,-,1.85,1.57,2.05,0.0212216,High,0.276,0.062,0.102,0.361,Mild increase (p=0.01),Significant increase (p=0.04),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02925,rs821496,1,49781437,SORL1,SNP (A/C),(A/,A,0.7,0.43,1.07,0.0755963,Moderate,0.348,0.352,0.019,0.081,Significant increase (p=0.028),No significant pattern (p=0.044),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02926,rs975742,22,140503836,CD33,SNP (C/T),(C/,C,1.07,0.84,1.36,0.01204583,High,0.246,0.258,0.235,0.061,Significant increase (p=0.004),Significant decrease (p=0.02),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02927,rs968067,6,121296004,APOE,SNP (A/T),(A/,A,0.55,0.17,0.91,0.07839048,Moderate,0.218,0.008,0.314,0.26,Significant increase (p=0.02),Mild increase (p=0.039),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02928,rs617637,20,200606208,BIN1,Insertion,-,-,0.65,0.41,0.89,0.01648031,Low,0.148,0.319,0.109,0.224,Significant increase (p=0.031),Significant increase (p=0.028),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP02929,rs664151,3,80174205,CR1,SNP (G/T),(G/,G,0.46,0.18,0.74,0.02569037,Unknown,0.658,0.053,0.087,0.001,Variable effect (p=0.003),Mild decrease (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02930,rs380591,14,71533951,APP,SNP (A/C),(A/,A,1.88,1.67,2.21,0.04938998,Moderate,0.073,0.0,0.604,0.123,Mild decrease (p=0.01),Mild decrease (p=0.024),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP02931,rs795785,20,94253071,APP,Insertion,-,-,1.22,1.01,1.5,0.02839365,Moderate,0.201,0.125,0.341,0.133,Mild decrease (p=0.018),Mild increase (p=0.011),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP02932,rs941697,20,135340412,MS4A6A,SNP (A/T),(A/,A,2.36,2.03,2.66,0.10479777,Protective,0.172,0.201,0.401,0.026,No significant pattern (p=0.032),Significant increase (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02933,rs689648,10,10276299,CD2AP,Insertion,-,-,1.12,0.74,1.34,0.02272334,Moderate,0.018,0.3,0.465,0.017,No significant pattern (p=0.019),Mild increase (p=0.025),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02934,rs431823,16,119911265,PSEN2,SNP (A/G),(A/,A,0.56,0.26,0.78,0.23724717,Moderate,0.29,0.143,0.011,0.356,Significant decrease (p=0.032),No significant pattern (p=0.022),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02935,rs990249,18,124654267,ABCA7,SNP (C/T),(C/,C,2.3,1.91,2.62,0.05345453,High,0.182,0.387,0.102,0.13,Mild increase (p=0.044),Variable effect (p=0.042),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP02936,rs244698,17,141132633,BIN1,SNP (G/T),(G/,G,1.08,0.73,1.35,0.03810745,High,0.047,0.228,0.457,0.067,Mild decrease (p=0.027),Significant decrease (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02937,rs596351,14,54468461,TREM2,SNP (C/G),(C/,C,0.69,0.45,1.02,0.00258877,High,0.084,0.005,0.103,0.608,Significant increase (p=0.022),Variable effect (p=0.044),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP02938,rs827631,6,188759190,CLU,SNP (A/G),(A/,A,1.13,0.92,1.45,0.12921515,Low,0.216,0.095,0.247,0.243,Significant decrease (p=0.016),Significant increase (p=0.029),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02939,rs193691,7,72043546,PSEN2,SNP (C/T),(C/,C,0.32,0.1,0.52,0.05940438,High,0.236,0.227,0.099,0.237,Significant increase (p=0.042),Significant decrease (p=0.009),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP02940,rs124006,8,22139673,PICALM,SNP (A/C),(A/,A,0.87,0.51,1.16,0.00392354,High,0.442,0.234,0.077,0.047,Mild increase (p=0.018),Variable effect (p=0.024),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02941,rs972400,10,217922520,PICALM,SNP (A/T),(A/,A,1.48,1.25,1.82,0.00794783,Protective,0.203,0.434,0.031,0.132,Significant decrease (p=0.028),Significant increase (p=0.01),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02942,rs412613,19,157832003,PTK2B,Deletion,-,-,1.41,1.11,1.66,0.03333249,Moderate,0.185,0.34,0.1,0.174,No significant pattern (p=0.024),Mild increase (p=0.019),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02943,rs856765,16,190940730,CLU,SNP (A/G),(A/,A,1.47,1.18,1.74,0.00503378,Moderate,0.404,0.053,0.305,0.039,Mild increase (p=0.034),Mild increase (p=0.04),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02944,rs753731,13,133430716,CD33,Insertion,-,-,1.93,1.58,2.27,0.01838558,Moderate,0.096,0.402,0.185,0.117,Mild decrease (p=0.034),Significant decrease (p=0.018),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP02945,rs996055,2,3301423,CLU,SNP (C/T),(C/,C,1.75,1.49,2.02,0.02489791,Low,0.257,0.107,0.307,0.129,Mild increase (p=0.006),Variable effect (p=0.015),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02946,rs216841,4,147892574,EPHA1,Deletion,-,-,1.36,1.04,1.74,0.04707857,Moderate,0.134,0.023,0.594,0.048,Variable effect (p=0.038),Variable effect (p=0.042),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP02947,rs202053,18,90507285,ABCA7,SNP (C/T),(C/,C,0.52,0.15,0.91,0.02227214,Moderate,0.103,0.386,0.256,0.055,Mild decrease (p=0.025),Mild decrease (p=0.011),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP02948,rs343927,6,98998162,SORL1,SNP (A/C),(A/,A,1.65,1.43,1.88,0.00026749,Moderate,0.124,0.295,0.101,0.28,Mild decrease (p=0.025),Mild decrease (p=0.002),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP02949,rs305903,20,16007658,MS4A6A,SNP (A/T),(A/,A,1.47,1.11,1.73,0.06978439,Low,0.602,0.104,0.05,0.043,Mild decrease (p=0.045),Mild increase (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02950,rs495137,15,108481487,EPHA1,SNP (G/T),(G/,G,0.83,0.5,1.11,0.00826158,Low,0.024,0.168,0.542,0.065,Mild decrease (p=0.025),Mild increase (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP02951,rs348589,10,181978436,MS4A6A,SNP (C/G),(C/,C,1.22,0.85,1.43,0.03144712,High,0.035,0.548,0.068,0.149,Mild increase (p=0.043),Significant increase (p=0.025),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP02952,rs414679,15,53721151,PSEN2,Insertion,-,-,0.4,0.1,0.64,0.00911419,High,0.242,0.361,0.136,0.062,No significant pattern (p=0.023),Significant decrease (p=0.015),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP02953,rs370254,1,127386583,CLU,SNP (A/T),(A/,A,2.25,1.91,2.5,0.0110584,Protective,0.264,0.122,0.368,0.046,Mild decrease (p=0.045),No significant pattern (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02954,rs942298,19,185466824,EPHA1,SNP (G/T),(G/,G,1.68,1.43,1.92,0.00945392,Moderate,0.133,0.376,0.265,0.026,Mild decrease (p=0.012),Mild decrease (p=0.008),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02955,rs652806,6,131034247,CD2AP,SNP (C/G),(C/,C,0.71,0.33,0.98,0.01528629,Low,0.07,0.533,0.026,0.171,Variable effect (p=0.008),No significant pattern (p=0.012),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP02956,rs250012,7,28712978,CR1,SNP (A/C),(A/,A,0.64,0.31,0.84,0.05786418,High,0.112,0.141,0.114,0.433,Mild increase (p=0.018),Variable effect (p=0.049),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP02957,rs850284,8,4570234,TREM2,SNP (G/T),(G/,G,0.67,0.34,0.9,0.03521526,High,0.357,0.084,0.203,0.156,Mild decrease (p=0.009),Variable effect (p=0.009),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP02958,rs340611,16,194633407,MS4A6A,SNP (G/T),(G/,G,0.82,0.6,1.16,0.01063547,Protective,0.074,0.166,0.544,0.015,Variable effect (p=0.011),Mild decrease (p=0.008),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02959,rs296971,15,182502966,ABCA7,SNP (G/T),(G/,G,1.28,0.93,1.51,0.01618913,Unknown,0.245,0.02,0.322,0.213,Mild increase (p=0.014),Mild increase (p=0.028),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02960,rs891629,10,8367499,CD2AP,SNP (A/G),(A/,A,0.45,0.22,0.69,0.00397333,Protective,0.312,0.173,0.039,0.276,Mild increase (p=0.024),Mild increase (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP02961,rs731101,11,140636302,APP,SNP (A/T),(A/,A,2.51,2.21,2.79,0.1266966,High,0.24,0.395,0.106,0.059,Variable effect (p=0.025),Variable effect (p=0.041),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02962,rs687490,18,199476233,CD2AP,SNP (G/T),(G/,G,1.5,1.26,1.73,0.00367768,Moderate,0.153,0.321,0.168,0.158,No significant pattern (p=0.012),Significant increase (p=0.014),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP02963,rs934779,7,195220148,PTK2B,SNP (A/G),(A/,A,0.82,0.44,1.05,0.00054191,Low,0.258,0.398,0.049,0.095,Mild increase (p=0.018),Variable effect (p=0.038),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP02964,rs345755,2,78059075,APOE,SNP (A/C),(A/,A,0.2,0.1,0.42,0.01082188,Low,0.549,0.093,0.074,0.084,No significant pattern (p=0.045),Significant decrease (p=0.003),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP02965,rs375047,20,107797606,CD2AP,Deletion,-,-,0.74,0.51,0.96,0.00710309,High,0.043,0.024,0.186,0.547,Significant decrease (p=0.043),Significant increase (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02966,rs146013,16,222506522,CR1,SNP (G/T),(G/,G,2.0,1.7,2.25,0.0067404,Low,0.216,0.323,0.011,0.251,Variable effect (p=0.002),Significant increase (p=0.028),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02967,rs807513,4,247505815,PSEN2,SNP (A/T),(A/,A,2.32,1.99,2.57,0.00644525,Moderate,0.335,0.043,0.159,0.264,Significant increase (p=0.035),No significant pattern (p=0.026),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP02968,rs826581,3,147409517,APP,Insertion,-,-,2.38,2.16,2.73,0.00706645,Moderate,0.422,0.071,0.089,0.218,Significant decrease (p=0.032),Significant decrease (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02969,rs626274,9,142050494,MS4A6A,Deletion,-,-,1.12,0.76,1.33,0.00493898,High,0.177,0.068,0.344,0.211,Significant increase (p=0.041),Significant decrease (p=0.02),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP02970,rs822224,18,34781019,EPHA1,SNP (C/G),(C/,C,1.82,1.58,2.12,0.0269564,High,0.031,0.581,0.075,0.113,No significant pattern (p=0.01),Variable effect (p=0.008),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02971,rs945975,20,161676854,PTK2B,SNP (C/G),(C/,C,1.68,1.31,1.9,0.01935357,Protective,0.139,0.339,0.066,0.256,No significant pattern (p=0.041),Mild decrease (p=0.04),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02972,rs447167,6,86513476,CLU,Insertion,-,-,0.75,0.42,1.07,0.01341449,Unknown,0.109,0.317,0.188,0.186,Variable effect (p=0.011),Significant increase (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02973,rs441870,22,131708966,PICALM,Insertion,-,-,0.43,0.22,0.73,0.00131061,Low,0.351,0.225,0.149,0.074,No significant pattern (p=0.015),No significant pattern (p=0.014),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02974,rs831741,18,226916561,CD33,SNP (G/T),(G/,G,0.67,0.3,0.9,0.00866772,Moderate,0.494,0.003,0.299,0.004,Significant increase (p=0.032),Mild decrease (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02975,rs646874,20,176555176,PTK2B,SNP (G/T),(G/,G,0.55,0.17,0.84,0.04555505,Unknown,0.501,0.058,0.081,0.16,Mild increase (p=0.014),Variable effect (p=0.011),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP02976,rs545656,11,54393271,ABCA7,Insertion,-,-,0.4,0.12,0.64,0.01147489,Low,0.087,0.222,0.041,0.451,Variable effect (p=0.004),Significant decrease (p=0.013),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP02977,rs868265,21,148171882,CR1,SNP (A/G),(A/,A,0.72,0.48,0.99,0.00246983,Protective,0.171,0.314,0.256,0.058,Significant decrease (p=0.038),No significant pattern (p=0.034),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP02978,rs654235,22,212295347,CD2AP,SNP (A/T),(A/,A,1.02,0.76,1.4,0.00554731,Protective,0.008,0.44,0.289,0.063,No significant pattern (p=0.034),Variable effect (p=0.038),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP02979,rs291695,14,150815091,BIN1,Deletion,-,-,0.91,0.56,1.2,0.01219992,Low,0.029,0.409,0.138,0.224,Mild increase (p=0.014),Variable effect (p=0.004),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02980,rs762184,6,34353815,SORL1,Deletion,-,-,1.09,0.85,1.37,0.18007327,High,0.072,0.181,0.476,0.072,Significant decrease (p=0.049),Significant increase (p=0.028),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP02981,rs511097,1,102214425,CR1,SNP (A/T),(A/,A,1.07,0.85,1.41,0.02219842,High,0.072,0.121,0.581,0.026,No significant pattern (p=0.027),Mild decrease (p=0.028),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP02982,rs188020,13,145192833,APOE,SNP (A/T),(A/,A,1.33,1.01,1.62,0.06640683,High,0.435,0.254,0.063,0.047,Significant increase (p=0.041),Mild decrease (p=0.024),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02983,rs474686,11,146404887,PSEN2,SNP (G/T),(G/,G,2.21,1.93,2.54,0.0228614,Moderate,0.694,0.084,0.014,0.008,Variable effect (p=0.04),Mild increase (p=0.016),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP02984,rs579530,8,152643905,TREM2,SNP (A/C),(A/,A,0.66,0.33,0.88,0.05438333,Low,0.228,0.022,0.482,0.069,Significant increase (p=0.043),Variable effect (p=0.028),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP02985,rs886467,9,144405555,PSEN2,Insertion,-,-,1.21,0.93,1.54,0.0045838,Unknown,0.096,0.365,0.204,0.134,Significant increase (p=0.011),Mild decrease (p=0.002),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02986,rs751255,16,71319494,CD33,SNP (A/C),(A/,A,0.71,0.44,0.95,0.00824495,High,0.192,0.27,0.256,0.082,Mild decrease (p=0.047),No significant pattern (p=0.046),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP02987,rs356149,20,186014262,EPHA1,Deletion,-,-,0.5,0.22,0.84,0.01980933,Moderate,0.289,0.151,0.252,0.108,Mild increase (p=0.038),Significant decrease (p=0.04),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP02988,rs703672,22,187441181,CLU,SNP (C/T),(C/,C,1.08,0.72,1.31,0.03825994,Moderate,0.265,0.172,0.039,0.324,Significant decrease (p=0.039),Significant decrease (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP02989,rs806903,13,215767047,PSEN2,Deletion,-,-,1.15,0.9,1.51,0.01196293,Low,0.147,0.132,0.467,0.054,Mild increase (p=0.007),Mild decrease (p=0.02),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP02990,rs344458,19,28211259,ABCA7,SNP (A/C),(A/,A,1.52,1.23,1.9,0.00051943,Low,0.033,0.157,0.178,0.432,Significant increase (p=0.034),No significant pattern (p=0.019),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP02991,rs551178,3,230282114,CD2AP,SNP (A/G),(A/,A,1.83,1.44,2.09,0.01093383,Low,0.069,0.154,0.101,0.476,Mild increase (p=0.037),No significant pattern (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP02992,rs198120,22,33370994,PSEN2,Insertion,-,-,0.98,0.77,1.27,0.00579477,High,0.18,0.533,0.086,0.001,Variable effect (p=0.039),Significant increase (p=0.05),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP02993,rs114580,11,170934035,ABCA7,SNP (A/C),(A/,A,0.45,0.2,0.66,0.01114417,Unknown,0.364,0.123,0.121,0.192,Significant increase (p=0.026),Mild increase (p=0.046),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP02994,rs557886,20,83603052,ABCA7,Insertion,-,-,1.59,1.3,1.97,0.07181252,Unknown,0.338,0.066,0.006,0.39,Significant decrease (p=0.048),No significant pattern (p=0.047),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP02995,rs750741,13,84808117,CD2AP,SNP (A/C),(A/,A,0.88,0.58,1.26,0.07217254,Low,0.116,0.011,0.572,0.101,Significant increase (p=0.024),Variable effect (p=0.022),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP02996,rs291958,18,109963396,CD2AP,SNP (C/G),(C/,C,0.76,0.48,1.15,0.00832326,Protective,0.46,0.118,0.18,0.042,Significant increase (p=0.012),Significant decrease (p=0.033),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP02997,rs439431,22,157648615,APOE,SNP (C/T),(C/,C,1.06,0.74,1.32,0.03205436,Moderate,0.122,0.301,0.302,0.075,Significant decrease (p=0.012),Mild increase (p=0.047),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP02998,rs507256,9,110822002,TREM2,SNP (A/T),(A/,A,0.6,0.34,0.89,0.0129243,Low,0.616,0.055,0.026,0.103,Variable effect (p=0.029),Mild decrease (p=0.032),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP02999,rs401417,8,121621946,SORL1,SNP (G/T),(G/,G,0.89,0.51,1.09,0.00905994,High,0.058,0.043,0.659,0.04,Mild increase (p=0.005),Significant increase (p=0.043),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03000,rs461678,20,157167348,CR1,SNP (A/G),(A/,A,0.67,0.29,0.87,0.01822251,High,0.214,0.004,0.296,0.287,Variable effect (p=0.014),No significant pattern (p=0.046),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03001,rs997143,20,100859766,PTK2B,SNP (C/T),(C/,C,0.36,0.15,0.64,0.0143343,Moderate,0.533,0.062,0.174,0.031,Significant increase (p=0.006),Mild decrease (p=0.02),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03002,rs659741,16,7853119,BIN1,Insertion,-,-,1.45,1.14,1.81,0.01394866,High,0.279,0.38,0.039,0.102,Variable effect (p=0.04),Significant decrease (p=0.037),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03003,rs540299,12,157917780,MS4A6A,SNP (C/G),(C/,C,0.55,0.18,0.82,0.04399362,Moderate,0.192,0.047,0.201,0.359,Mild increase (p=0.042),Variable effect (p=0.027),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03004,rs741600,3,134401789,BIN1,SNP (A/C),(A/,A,0.64,0.42,0.86,0.07631216,High,0.426,0.052,0.161,0.161,No significant pattern (p=0.023),Mild decrease (p=0.018),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03005,rs816077,19,48996330,SORL1,Insertion,-,-,1.14,0.83,1.5,0.01527676,High,0.05,0.02,0.382,0.348,Mild increase (p=0.005),Mild increase (p=0.009),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03006,rs261536,12,52897245,APOE,SNP (G/T),(G/,G,0.71,0.42,0.94,0.03395175,Moderate,0.211,0.066,0.467,0.057,No significant pattern (p=0.018),Mild increase (p=0.048),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03007,rs202383,14,170613089,TREM2,SNP (C/G),(C/,C,3.92,3.63,4.17,0.00527027,Moderate,0.109,0.46,0.225,0.006,Significant increase (p=0.014),Variable effect (p=0.035),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03008,rs176067,17,55280075,PICALM,Deletion,-,-,2.49,2.28,2.87,0.00376764,Moderate,0.045,0.054,0.35,0.351,Variable effect (p=0.049),Mild increase (p=0.033),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03009,rs984780,16,149658452,CR1,SNP (C/G),(C/,C,2.29,1.99,2.65,0.02285991,Moderate,0.09,0.182,0.384,0.144,Significant decrease (p=0.005),Mild decrease (p=0.027),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03010,rs277803,1,74000129,EPHA1,Insertion,-,-,0.55,0.23,0.93,0.01636728,Moderate,0.254,0.147,0.316,0.083,Significant increase (p=0.036),Mild increase (p=0.04),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03011,rs831328,11,24552330,PSEN2,Deletion,-,-,1.12,0.73,1.37,0.04058341,Protective,0.365,0.31,0.103,0.022,Variable effect (p=0.011),No significant pattern (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03012,rs267281,16,234774126,APOE,SNP (A/C),(A/,A,0.95,0.59,1.26,0.03084017,Moderate,0.421,0.128,0.217,0.034,Variable effect (p=0.038),Mild decrease (p=0.033),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP03013,rs416729,10,198869076,APP,SNP (C/T),(C/,C,0.68,0.32,1.03,0.05878612,Protective,0.042,0.214,0.539,0.004,Mild decrease (p=0.043),Mild increase (p=0.022),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03014,rs482074,5,47305883,APP,SNP (A/G),(A/,A,0.96,0.67,1.34,0.03599816,Low,0.191,0.135,0.184,0.29,Variable effect (p=0.042),Variable effect (p=0.014),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03015,rs748008,16,141506753,SORL1,SNP (A/G),(A/,A,0.89,0.64,1.17,0.01670695,High,0.191,0.097,0.366,0.147,No significant pattern (p=0.041),Significant decrease (p=0.05),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03016,rs887542,14,211089167,BIN1,SNP (A/G),(A/,A,1.29,1.01,1.66,0.08278346,Moderate,0.418,0.199,0.084,0.099,No significant pattern (p=0.049),Variable effect (p=0.006),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP03017,rs124446,20,199668149,EPHA1,Deletion,-,-,2.02,1.76,2.27,0.0032771,Low,0.01,0.088,0.648,0.054,Mild increase (p=0.011),Significant decrease (p=0.044),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03018,rs412719,19,142697352,APOE,SNP (A/G),(A/,A,0.95,0.7,1.17,0.03441801,High,0.009,0.698,0.004,0.088,No significant pattern (p=0.021),Variable effect (p=0.014),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03019,rs137750,17,24686338,CR1,SNP (A/T),(A/,A,2.11,1.72,2.33,0.04233918,Protective,0.431,0.135,0.199,0.035,Significant decrease (p=0.014),Variable effect (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03020,rs341774,7,236077289,CR1,Deletion,-,-,0.5,0.11,0.75,0.06579236,Moderate,0.416,0.148,0.199,0.037,Significant increase (p=0.019),Mild decrease (p=0.03),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP03021,rs495636,20,35215043,PICALM,Deletion,-,-,1.24,0.99,1.49,0.00053402,Low,0.325,0.134,0.082,0.258,Variable effect (p=0.049),Mild increase (p=0.005),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03022,rs492917,21,91453706,EPHA1,SNP (A/T),(A/,A,1.2,0.86,1.48,0.06040929,Protective,0.267,0.315,0.182,0.036,Mild decrease (p=0.012),Significant increase (p=0.007),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03023,rs107302,5,178347697,APOE,SNP (A/T),(A/,A,0.87,0.54,1.14,0.01933995,Moderate,0.194,0.31,0.198,0.099,No significant pattern (p=0.015),Mild increase (p=0.038),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03024,rs872236,18,88677610,PICALM,SNP (C/T),(C/,C,1.76,1.53,2.14,0.06655382,Moderate,0.228,0.196,0.172,0.204,Mild increase (p=0.02),Mild increase (p=0.016),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03025,rs619196,8,248735878,CD33,SNP (G/T),(G/,G,0.85,0.5,1.23,0.01554702,Moderate,0.153,0.194,0.093,0.36,Significant decrease (p=0.004),Mild increase (p=0.027),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03026,rs515153,14,245623597,CD2AP,SNP (A/C),(A/,A,0.76,0.43,1.04,0.01451499,Moderate,0.13,0.148,0.251,0.271,Variable effect (p=0.019),Mild decrease (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03027,rs931495,14,139752301,APP,Deletion,-,-,0.62,0.4,0.94,0.00202309,High,0.342,0.129,0.309,0.019,Variable effect (p=0.008),Mild increase (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03028,rs301765,22,32761216,PTK2B,SNP (A/G),(A/,A,0.66,0.29,0.87,0.08548286,Moderate,0.254,0.084,0.029,0.433,Significant decrease (p=0.02),No significant pattern (p=0.046),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03029,rs918205,8,103394144,CR1,SNP (A/T),(A/,A,1.37,1.14,1.73,0.04366971,High,0.22,0.121,0.013,0.447,Mild increase (p=0.015),Mild decrease (p=0.036),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03030,rs604625,14,186280476,EPHA1,SNP (G/T),(G/,G,0.31,0.1,0.61,0.05037767,Moderate,0.347,0.252,0.049,0.152,Mild increase (p=0.035),Mild decrease (p=0.02),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03031,rs133856,10,33418138,PSEN2,SNP (A/T),(A/,A,0.87,0.58,1.18,0.00298302,High,0.065,0.151,0.163,0.421,Significant increase (p=0.035),No significant pattern (p=0.009),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03032,rs345419,7,140848082,CD33,SNP (C/T),(C/,C,0.59,0.36,0.81,0.04394509,Low,0.697,0.023,0.049,0.032,Significant decrease (p=0.002),Mild decrease (p=0.003),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03033,rs971675,1,105081976,ABCA7,SNP (G/T),(G/,G,0.46,0.23,0.78,0.0141941,Moderate,0.635,0.097,0.019,0.049,No significant pattern (p=0.012),No significant pattern (p=0.003),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP03034,rs644228,5,154239643,BIN1,SNP (G/T),(G/,G,0.81,0.42,1.13,0.00660288,Moderate,0.003,0.242,0.072,0.484,Significant decrease (p=0.01),Mild increase (p=0.039),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03035,rs850069,15,147811089,BIN1,SNP (C/G),(C/,C,1.48,1.1,1.73,0.03338218,High,0.161,0.262,0.089,0.288,Variable effect (p=0.016),Significant increase (p=0.037),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP03036,rs569966,20,59571541,ABCA7,SNP (G/T),(G/,G,2.57,2.32,2.96,0.07344819,Protective,0.57,0.02,0.056,0.154,Significant increase (p=0.036),No significant pattern (p=0.042),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03037,rs114130,7,93631151,ABCA7,SNP (C/G),(C/,C,0.76,0.54,1.1,0.02789376,Protective,0.203,0.22,0.02,0.356,Mild decrease (p=0.038),Significant increase (p=0.009),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03038,rs577567,1,216050005,EPHA1,Insertion,-,-,0.94,0.63,1.16,0.05361584,Low,0.065,0.294,0.2,0.241,Mild decrease (p=0.016),Significant increase (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03039,rs629621,9,208257425,TREM2,SNP (A/T),(A/,A,1.09,0.84,1.48,0.04606025,Low,0.304,0.159,0.083,0.254,Mild increase (p=0.003),Mild decrease (p=0.019),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03040,rs535757,22,216454402,EPHA1,SNP (G/T),(G/,G,1.37,0.98,1.75,0.09934846,Moderate,0.368,0.024,0.192,0.216,Significant increase (p=0.032),Mild increase (p=0.005),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03041,rs568422,18,41345582,CD33,Insertion,-,-,1.6,1.36,1.95,0.02013292,High,0.468,0.015,0.111,0.205,Variable effect (p=0.024),Significant increase (p=0.031),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03042,rs991016,16,148094661,MS4A6A,SNP (A/C),(A/,A,0.82,0.47,1.04,0.05629803,High,0.449,0.135,0.107,0.11,Significant decrease (p=0.012),No significant pattern (p=0.024),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03043,rs583595,13,182666063,TREM2,SNP (A/C),(A/,A,1.12,0.74,1.39,0.00708195,Moderate,0.178,0.07,0.317,0.235,Significant increase (p=0.002),Variable effect (p=0.019),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03044,rs800813,21,146279711,MS4A6A,SNP (C/G),(C/,C,1.03,0.72,1.41,0.02082218,Moderate,0.069,0.413,0.011,0.307,Mild increase (p=0.008),No significant pattern (p=0.01),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03045,rs733872,1,127244918,EPHA1,Deletion,-,-,4.03,3.65,4.3,0.01390085,Moderate,0.046,0.228,0.438,0.088,Significant increase (p=0.022),Variable effect (p=0.042),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03046,rs873815,18,221911629,CD2AP,SNP (A/G),(A/,A,1.6,1.26,1.91,0.03403267,Protective,0.066,0.461,0.25,0.024,Variable effect (p=0.002),Mild decrease (p=0.041),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP03047,rs474075,10,213545987,CD33,Deletion,-,-,1.09,0.77,1.29,0.00321347,High,0.02,0.447,0.133,0.2,Mild increase (p=0.049),Mild increase (p=0.032),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03048,rs503865,10,70907258,PICALM,SNP (G/T),(G/,G,0.67,0.31,0.89,0.07548252,Moderate,0.228,0.398,0.13,0.044,No significant pattern (p=0.049),Significant decrease (p=0.048),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03049,rs715432,4,32727670,PSEN2,SNP (A/T),(A/,A,1.33,1.1,1.7,0.01420757,Low,0.049,0.152,0.49,0.109,Mild decrease (p=0.031),No significant pattern (p=0.016),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03050,rs825387,15,20359722,ABCA7,SNP (A/C),(A/,A,1.13,0.77,1.45,0.03765283,Moderate,0.197,0.103,0.316,0.185,Significant increase (p=0.044),Variable effect (p=0.002),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03051,rs226691,4,95662584,CR1,SNP (A/C),(A/,A,0.36,0.1,0.71,0.03865304,High,0.479,0.042,0.096,0.183,Mild increase (p=0.035),Significant decrease (p=0.003),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03052,rs498251,1,41050100,PTK2B,SNP (C/T),(C/,C,1.17,0.88,1.49,0.02835202,Unknown,0.106,0.068,0.16,0.466,Variable effect (p=0.007),Significant increase (p=0.005),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03053,rs567993,5,28311387,CLU,Insertion,-,-,1.09,0.69,1.34,0.05343699,Low,0.253,0.127,0.41,0.011,Variable effect (p=0.014),Significant increase (p=0.013),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03054,rs703951,2,32925690,BIN1,SNP (C/G),(C/,C,0.79,0.48,1.1,0.0657683,Unknown,0.024,0.381,0.365,0.03,Mild increase (p=0.027),Significant decrease (p=0.023),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03055,rs309006,16,90673158,BIN1,SNP (A/G),(A/,A,0.76,0.55,1.07,0.00371884,High,0.456,0.304,0.028,0.011,Mild increase (p=0.039),Variable effect (p=0.004),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03056,rs669060,19,28158754,TREM2,Deletion,-,-,0.6,0.4,0.92,0.03535254,High,0.562,0.054,0.041,0.142,Mild decrease (p=0.044),Significant increase (p=0.029),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03057,rs734084,12,51715396,PSEN2,SNP (C/G),(C/,C,0.77,0.55,1.06,0.02001103,Low,0.403,0.056,0.061,0.281,Significant decrease (p=0.041),Significant decrease (p=0.01),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03058,rs241087,10,169368519,APOE,SNP (C/G),(C/,C,0.41,0.11,0.69,0.03565161,High,0.093,0.188,0.112,0.408,Significant decrease (p=0.01),Mild increase (p=0.037),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03059,rs178646,16,169740361,SORL1,SNP (A/T),(A/,A,2.07,1.74,2.46,0.0714289,Moderate,0.186,0.266,0.218,0.131,No significant pattern (p=0.026),Mild increase (p=0.004),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03060,rs457862,16,58395414,CR1,SNP (A/C),(A/,A,1.14,0.74,1.41,0.01093686,Protective,0.639,0.099,0.022,0.04,Significant decrease (p=0.043),No significant pattern (p=0.005),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03061,rs998706,13,127200531,CD33,SNP (A/C),(A/,A,1.36,1.05,1.67,0.06781256,Protective,0.176,0.131,0.033,0.46,Significant decrease (p=0.012),Significant increase (p=0.046),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03062,rs653886,8,220054066,CD2AP,SNP (C/G),(C/,C,1.12,0.85,1.41,0.02847894,Moderate,0.292,0.17,0.261,0.077,Variable effect (p=0.014),Mild decrease (p=0.027),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03063,rs265021,4,184883217,CD2AP,SNP (A/T),(A/,A,0.78,0.4,1.01,0.00386945,Protective,0.48,0.065,0.215,0.04,Variable effect (p=0.017),Significant increase (p=0.047),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03064,rs734373,13,5837739,CD2AP,SNP (C/G),(C/,C,0.63,0.41,0.93,0.00079155,Low,0.002,0.153,0.462,0.183,Mild decrease (p=0.018),No significant pattern (p=0.043),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03065,rs425211,5,79673331,APOE,SNP (G/T),(G/,G,0.75,0.51,0.96,0.01118621,Moderate,0.172,0.099,0.161,0.368,Mild increase (p=0.01),Variable effect (p=0.036),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP03066,rs642358,5,84633800,APOE,SNP (A/C),(A/,A,1.33,1.0,1.61,0.05471555,Moderate,0.259,0.017,0.508,0.017,Significant increase (p=0.048),No significant pattern (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP03067,rs956530,7,13103473,APOE,SNP (A/C),(A/,A,1.07,0.8,1.36,0.0622529,Protective,0.141,0.308,0.054,0.297,No significant pattern (p=0.048),Significant decrease (p=0.023),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP03068,rs147678,8,54903636,APOE,SNP (A/T),(A/,A,0.74,0.52,1.01,0.0417746,High,0.326,0.231,0.017,0.227,Mild decrease (p=0.021),Significant increase (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03069,rs233202,2,110412667,MS4A6A,SNP (A/T),(A/,A,1.23,0.84,1.48,0.01870571,Low,0.311,0.245,0.112,0.132,Mild increase (p=0.039),Mild increase (p=0.003),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03070,rs652102,13,97297473,ABCA7,SNP (A/C),(A/,A,3.05,2.82,3.36,0.01019855,Low,0.075,0.245,0.126,0.354,Significant increase (p=0.02),Significant increase (p=0.007),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03071,rs870767,7,39142871,BIN1,Insertion,-,-,0.86,0.53,1.09,0.00303306,Moderate,0.172,0.066,0.128,0.434,Mild decrease (p=0.014),Significant decrease (p=0.048),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03072,rs677625,9,37041605,APOE,SNP (A/G),(A/,A,1.4,1.18,1.8,0.00125547,High,0.425,0.218,0.108,0.049,Significant decrease (p=0.043),Variable effect (p=0.042),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03073,rs365962,11,196618332,CR1,SNP (C/G),(C/,C,2.06,1.83,2.3,0.0194141,High,0.432,0.172,0.093,0.103,Mild increase (p=0.034),No significant pattern (p=0.015),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03074,rs185423,19,77816533,CLU,Deletion,-,-,1.19,0.89,1.49,0.02061203,High,0.177,0.074,0.081,0.468,No significant pattern (p=0.002),Significant increase (p=0.049),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03075,rs848898,19,30212715,BIN1,SNP (A/G),(A/,A,1.0,0.77,1.34,0.00617999,Protective,0.371,0.188,0.03,0.211,Mild increase (p=0.002),Significant decrease (p=0.045),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP03076,rs999707,17,184480206,APOE,SNP (C/G),(C/,C,1.14,0.87,1.47,0.05069779,High,0.208,0.295,0.021,0.276,Significant decrease (p=0.017),Mild decrease (p=0.036),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03077,rs103801,19,22897370,CR1,Insertion,-,-,0.75,0.41,1.14,0.05751903,Moderate,0.083,0.249,0.381,0.086,Mild increase (p=0.037),Significant decrease (p=0.047),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03078,rs294784,16,142430686,CR1,SNP (A/T),(A/,A,0.62,0.38,0.92,0.07313388,Protective,0.167,0.182,0.04,0.41,No significant pattern (p=0.024),No significant pattern (p=0.014),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03079,rs179624,8,139687166,SORL1,Insertion,-,-,1.05,0.83,1.43,0.07811932,Low,0.208,0.047,0.285,0.261,Significant decrease (p=0.016),No significant pattern (p=0.048),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03080,rs498518,2,32221633,CD33,SNP (A/C),(A/,A,0.66,0.37,0.99,0.0002696,Moderate,0.287,0.059,0.268,0.187,No significant pattern (p=0.019),Variable effect (p=0.048),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03081,rs564959,22,74980042,APP,Deletion,-,-,1.26,1.03,1.57,0.02354046,Protective,0.238,0.074,0.335,0.153,Significant decrease (p=0.043),Significant increase (p=0.005),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03082,rs430229,18,54387819,EPHA1,SNP (G/T),(G/,G,0.52,0.31,0.74,0.01195731,Protective,0.039,0.182,0.541,0.037,Significant increase (p=0.013),No significant pattern (p=0.037),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03083,rs864610,18,152359722,PSEN2,Insertion,-,-,1.11,0.85,1.48,0.04648175,Low,0.076,0.089,0.535,0.1,No significant pattern (p=0.009),Mild increase (p=0.033),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP03084,rs643334,6,244882986,CD2AP,Insertion,-,-,1.24,0.94,1.48,0.04850845,Low,0.536,0.112,0.102,0.05,Mild decrease (p=0.021),Mild increase (p=0.021),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03085,rs812596,19,80366214,SORL1,SNP (C/G),(C/,C,1.14,0.76,1.49,0.02116111,Moderate,0.035,0.451,0.199,0.114,Mild increase (p=0.001),Variable effect (p=0.048),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03086,rs570940,2,127391275,TREM2,Deletion,-,-,1.47,1.21,1.73,0.02499668,High,0.042,0.666,0.047,0.044,Variable effect (p=0.024),Significant decrease (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03087,rs466160,17,166594750,CD33,SNP (G/T),(G/,G,2.8,2.46,3.02,0.0034168,High,0.233,0.199,0.021,0.347,Mild decrease (p=0.025),No significant pattern (p=0.033),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03088,rs653717,7,231614133,CLU,SNP (G/T),(G/,G,0.42,0.1,0.66,0.0663628,Low,0.109,0.012,0.364,0.315,Significant increase (p=0.01),Mild increase (p=0.04),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03089,rs570600,12,204500850,TREM2,SNP (C/T),(C/,C,0.67,0.29,0.97,0.08335199,Low,0.152,0.615,0.012,0.021,Significant increase (p=0.048),Variable effect (p=0.048),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03090,rs465935,15,40389540,BIN1,SNP (A/G),(A/,A,1.13,0.8,1.48,0.00531554,Low,0.509,0.083,0.055,0.153,No significant pattern (p=0.002),Mild increase (p=0.039),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03091,rs235253,6,209919956,CR1,Insertion,-,-,0.94,0.6,1.16,0.02513082,Moderate,0.001,0.483,0.196,0.119,Mild decrease (p=0.05),Significant decrease (p=0.015),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03092,rs663367,5,75930160,PSEN2,SNP (A/C),(A/,A,1.88,1.58,2.17,0.0382415,Moderate,0.225,0.474,0.086,0.015,Significant decrease (p=0.016),Significant decrease (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03093,rs676184,19,81120265,APOE,SNP (A/C),(A/,A,0.95,0.67,1.17,0.05962083,Low,0.199,0.058,0.376,0.168,Significant decrease (p=0.013),Significant increase (p=0.05),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP03094,rs564704,14,136056791,CR1,SNP (G/T),(G/,G,0.49,0.23,0.71,0.00108747,High,0.267,0.209,0.003,0.321,No significant pattern (p=0.023),Significant increase (p=0.038),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03095,rs442450,10,143757533,APP,Insertion,-,-,1.69,1.39,2.0,0.03800966,High,0.012,0.325,0.272,0.192,Significant decrease (p=0.008),No significant pattern (p=0.045),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03096,rs245671,4,133477222,PICALM,SNP (A/G),(A/,A,1.56,1.27,1.9,0.01429969,Protective,0.164,0.187,0.356,0.093,Variable effect (p=0.042),Significant increase (p=0.009),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03097,rs705227,11,248672118,BIN1,SNP (G/T),(G/,G,0.53,0.16,0.89,0.1298877,Protective,0.279,0.121,0.175,0.225,Significant decrease (p=0.008),No significant pattern (p=0.038),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03098,rs337493,13,122320416,PSEN2,Insertion,-,-,0.41,0.19,0.73,0.00363599,Moderate,0.062,0.217,0.226,0.296,Mild increase (p=0.034),Significant increase (p=0.025),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03099,rs268215,2,234213359,CLU,SNP (A/C),(A/,A,1.04,0.81,1.34,0.00072341,High,0.127,0.09,0.477,0.106,Mild increase (p=0.049),Significant increase (p=0.041),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03100,rs534289,4,134211904,EPHA1,SNP (A/T),(A/,A,1.09,0.86,1.47,0.12534036,Unknown,0.443,0.163,0.011,0.183,Significant increase (p=0.011),Significant decrease (p=0.017),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03101,rs473412,10,140607406,TREM2,Deletion,-,-,1.62,1.41,1.96,0.00306483,High,0.312,0.123,0.011,0.354,Mild increase (p=0.023),Significant decrease (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03102,rs177715,1,35233295,CR1,Insertion,-,-,0.67,0.29,0.9,0.00420557,Protective,0.136,0.318,0.075,0.271,No significant pattern (p=0.033),Significant increase (p=0.032),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP03103,rs783970,18,90682027,EPHA1,SNP (A/G),(A/,A,3.73,3.51,4.09,0.02350802,Unknown,0.157,0.07,0.284,0.29,No significant pattern (p=0.026),Mild increase (p=0.01),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03104,rs875376,15,38037379,MS4A6A,Insertion,-,-,0.65,0.27,1.02,0.00399806,Moderate,0.317,0.147,0.143,0.193,Mild decrease (p=0.008),Mild increase (p=0.003),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03105,rs931191,12,221862482,BIN1,Deletion,-,-,0.76,0.42,1.12,0.01831972,Moderate,0.012,0.173,0.492,0.124,Significant decrease (p=0.041),Variable effect (p=0.036),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03106,rs364739,21,208349031,APOE,SNP (A/C),(A/,A,0.95,0.56,1.3,0.03793756,Moderate,0.169,0.511,0.093,0.027,No significant pattern (p=0.023),Mild decrease (p=0.02),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03107,rs292601,12,204935284,ABCA7,SNP (A/G),(A/,A,0.73,0.52,1.01,0.00100032,Protective,0.316,0.057,0.231,0.196,Significant increase (p=0.009),Mild increase (p=0.027),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03108,rs223307,12,106022297,EPHA1,SNP (C/G),(C/,C,0.51,0.17,0.82,0.01912498,High,0.007,0.584,0.058,0.15,Variable effect (p=0.035),Variable effect (p=0.003),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03109,rs790818,17,187939601,PSEN2,Deletion,-,-,1.42,1.07,1.7,0.02221865,High,0.295,0.386,0.047,0.072,Significant decrease (p=0.018),Mild decrease (p=0.02),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP03110,rs535049,7,217020060,CR1,SNP (C/G),(C/,C,0.6,0.3,0.85,0.009303,Moderate,0.116,0.002,0.645,0.037,Significant decrease (p=0.028),Significant increase (p=0.03),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03111,rs857306,10,129885641,BIN1,SNP (A/C),(A/,A,1.42,1.07,1.64,0.01055344,Low,0.393,0.127,0.274,0.007,Mild increase (p=0.012),Significant decrease (p=0.011),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03112,rs884492,8,85106856,CR1,SNP (G/T),(G/,G,2.42,2.07,2.69,0.03324479,Low,0.131,0.313,0.089,0.267,No significant pattern (p=0.034),Significant decrease (p=0.032),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03113,rs300769,10,102411599,ABCA7,Insertion,-,-,0.45,0.15,0.76,0.02237523,High,0.321,0.215,0.247,0.017,Significant decrease (p=0.011),Mild increase (p=0.025),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03114,rs339383,18,2741592,MS4A6A,Insertion,-,-,1.21,0.92,1.6,0.02288797,Moderate,0.034,0.081,0.238,0.447,Mild increase (p=0.047),Significant decrease (p=0.046),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03115,rs200721,1,41452346,APOE,SNP (A/T),(A/,A,0.59,0.27,0.8,0.01492494,Moderate,0.078,0.354,0.127,0.241,Significant increase (p=0.031),No significant pattern (p=0.043),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP03116,rs659152,1,56272415,CR1,SNP (C/G),(C/,C,0.61,0.3,0.83,0.0100423,Unknown,0.345,0.071,0.229,0.155,Mild increase (p=0.049),Mild decrease (p=0.046),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03117,rs751450,22,4023414,CR1,SNP (G/T),(G/,G,0.89,0.63,1.11,0.00166137,Low,0.068,0.342,0.324,0.065,Mild increase (p=0.031),No significant pattern (p=0.015),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03118,rs240291,3,55148483,APP,SNP (C/T),(C/,C,0.99,0.62,1.33,0.00147786,Moderate,0.064,0.184,0.169,0.384,Significant increase (p=0.023),Mild increase (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03119,rs162181,22,14801189,PICALM,Deletion,-,-,0.99,0.6,1.31,0.03262177,Moderate,0.139,0.185,0.267,0.209,No significant pattern (p=0.007),Mild increase (p=0.042),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03120,rs909976,21,46445229,PSEN2,Deletion,-,-,0.67,0.31,0.95,0.01142678,Unknown,0.138,0.182,0.177,0.304,No significant pattern (p=0.047),Mild decrease (p=0.039),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP03121,rs622992,8,93154679,MS4A6A,SNP (G/T),(G/,G,1.14,0.87,1.38,4.741e-05,Moderate,0.102,0.207,0.148,0.342,Mild decrease (p=0.012),No significant pattern (p=0.022),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03122,rs867279,2,90999377,PTK2B,SNP (C/T),(C/,C,0.88,0.67,1.08,0.08585999,High,0.063,0.368,0.179,0.191,Significant increase (p=0.021),Variable effect (p=0.029),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03123,rs515093,18,159351519,EPHA1,Insertion,-,-,0.75,0.54,0.97,0.02508256,Moderate,0.415,0.161,0.133,0.091,No significant pattern (p=0.013),Mild increase (p=0.007),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03124,rs946056,5,113472315,CR1,SNP (C/T),(C/,C,0.71,0.44,1.04,0.00057648,Moderate,0.296,0.067,0.184,0.253,Significant decrease (p=0.022),Significant decrease (p=0.026),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03125,rs445216,10,120236895,ABCA7,SNP (C/G),(C/,C,1.13,0.84,1.44,0.00217953,Moderate,0.077,0.017,0.127,0.58,Significant decrease (p=0.034),Variable effect (p=0.029),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03126,rs790420,17,49276697,CLU,SNP (C/T),(C/,C,0.82,0.55,1.03,0.00346544,Protective,0.183,0.182,0.337,0.098,Mild increase (p=0.033),Significant increase (p=0.038),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP03127,rs746960,15,17878480,MS4A6A,Insertion,-,-,0.37,0.1,0.7,0.00597389,Moderate,0.25,0.048,0.439,0.063,Significant decrease (p=0.042),No significant pattern (p=0.029),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03128,rs606441,15,135720020,EPHA1,SNP (C/G),(C/,C,0.81,0.6,1.05,0.05390855,Low,0.278,0.158,0.049,0.315,Variable effect (p=0.011),No significant pattern (p=0.02),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03129,rs344776,9,184568532,TREM2,Deletion,-,-,1.29,1.06,1.53,0.03223776,High,0.086,0.101,0.172,0.44,Significant decrease (p=0.038),No significant pattern (p=0.016),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03130,rs554403,20,128799752,CLU,SNP (C/T),(C/,C,1.17,0.83,1.47,0.01228219,High,0.126,0.05,0.157,0.467,No significant pattern (p=0.021),Significant decrease (p=0.022),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03131,rs981169,2,45172940,APP,SNP (C/G),(C/,C,3.22,2.95,3.57,0.01121626,Protective,0.493,0.073,0.226,0.008,Mild increase (p=0.05),Mild increase (p=0.017),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP03132,rs950653,5,83237146,PICALM,SNP (A/T),(A/,A,0.64,0.4,0.93,0.01239673,High,0.099,0.378,0.242,0.081,Significant decrease (p=0.007),Mild increase (p=0.023),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03133,rs133624,21,74479616,MS4A6A,SNP (C/G),(C/,C,1.12,0.82,1.49,0.03321369,Protective,0.065,0.489,0.158,0.087,Significant decrease (p=0.015),Significant decrease (p=0.037),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03134,rs327856,6,132667286,PICALM,SNP (A/G),(A/,A,1.09,0.89,1.4,0.02426977,Moderate,0.504,0.166,0.078,0.053,Mild increase (p=0.036),Significant decrease (p=0.01),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP03135,rs559592,8,240485692,ABCA7,Insertion,-,-,2.24,1.84,2.48,0.01605767,High,0.098,0.19,0.146,0.365,No significant pattern (p=0.041),No significant pattern (p=0.007),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP03136,rs138542,19,90582743,CR1,SNP (C/T),(C/,C,1.9,1.66,2.1,0.02108948,Low,0.159,0.355,0.119,0.167,Mild increase (p=0.035),No significant pattern (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03137,rs437384,7,134365568,MS4A6A,SNP (G/T),(G/,G,1.45,1.12,1.79,0.01712033,High,0.165,0.175,0.222,0.238,Variable effect (p=0.027),Significant decrease (p=0.021),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03138,rs222781,3,26562764,BIN1,SNP (A/T),(A/,A,1.37,1.12,1.64,0.09280127,Moderate,0.076,0.157,0.211,0.357,Mild increase (p=0.034),Mild decrease (p=0.002),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03139,rs499468,19,182642508,TREM2,SNP (G/T),(G/,G,0.81,0.6,1.05,0.04859427,Low,0.138,0.276,0.288,0.098,No significant pattern (p=0.022),Significant increase (p=0.03),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03140,rs674607,10,138432456,APP,SNP (A/G),(A/,A,1.2,0.84,1.48,0.08948257,Low,0.358,0.107,0.118,0.216,No significant pattern (p=0.031),Significant decrease (p=0.007),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03141,rs615270,22,229302743,ABCA7,Insertion,-,-,0.83,0.52,1.14,0.04413851,Moderate,0.029,0.382,0.139,0.25,Mild increase (p=0.013),Variable effect (p=0.048),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP03142,rs843089,14,15800095,ABCA7,Insertion,-,-,1.36,1.09,1.71,0.01837915,High,0.239,0.019,0.416,0.126,Variable effect (p=0.007),Significant decrease (p=0.022),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03143,rs760495,22,93950085,TREM2,Deletion,-,-,1.53,1.15,1.77,0.04745865,High,0.474,0.207,0.065,0.054,Mild decrease (p=0.014),Mild decrease (p=0.009),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03144,rs607931,13,74618780,PICALM,Insertion,-,-,0.86,0.52,1.18,0.01366091,Moderate,0.349,0.129,0.142,0.181,Variable effect (p=0.01),Mild increase (p=0.048),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03145,rs132381,11,128681619,PSEN2,Insertion,-,-,0.39,0.1,0.69,0.09983584,Moderate,0.35,0.184,0.226,0.04,Mild decrease (p=0.049),Significant increase (p=0.016),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03146,rs364316,14,68290658,PICALM,Deletion,-,-,1.54,1.15,1.82,0.02137141,Moderate,0.039,0.307,0.157,0.297,Mild increase (p=0.009),Mild decrease (p=0.043),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03147,rs807303,6,71630223,SORL1,Deletion,-,-,0.51,0.19,0.9,0.15787164,Protective,0.418,0.028,0.301,0.053,Significant increase (p=0.009),Variable effect (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03148,rs147786,19,222592348,SORL1,SNP (A/G),(A/,A,1.78,1.47,2.04,0.01525766,High,0.071,0.12,0.038,0.571,Significant increase (p=0.028),No significant pattern (p=0.023),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03149,rs349401,15,50543170,PTK2B,SNP (A/G),(A/,A,0.89,0.6,1.21,0.0257585,Moderate,0.124,0.314,0.073,0.289,Significant increase (p=0.015),Mild increase (p=0.039),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03150,rs175302,18,198381705,CD2AP,SNP (A/T),(A/,A,1.08,0.68,1.3,0.00361996,Moderate,0.087,0.512,0.051,0.15,Mild increase (p=0.044),Significant decrease (p=0.021),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03151,rs534822,17,202738478,MS4A6A,SNP (A/T),(A/,A,0.33,0.1,0.57,0.00439668,High,0.027,0.382,0.164,0.228,Mild decrease (p=0.015),Significant decrease (p=0.005),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03152,rs719318,11,169239252,PSEN2,Insertion,-,-,2.65,2.4,2.94,0.00489934,Low,0.168,0.458,0.075,0.099,Variable effect (p=0.004),No significant pattern (p=0.049),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03153,rs909947,8,12103936,MS4A6A,SNP (C/G),(C/,C,0.74,0.38,0.99,0.02891572,Low,0.523,0.101,0.078,0.097,No significant pattern (p=0.014),Mild decrease (p=0.012),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03154,rs176864,11,59414160,APP,SNP (A/C),(A/,A,0.63,0.34,0.92,0.05352148,Moderate,0.044,0.201,0.477,0.078,No significant pattern (p=0.048),Variable effect (p=0.036),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03155,rs907368,7,246674818,BIN1,SNP (A/G),(A/,A,1.6,1.34,1.87,0.0063255,Moderate,0.46,0.045,0.13,0.166,Mild increase (p=0.023),Significant increase (p=0.017),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03156,rs253942,12,96820329,APOE,SNP (A/T),(A/,A,0.62,0.34,0.97,0.043117,Moderate,0.206,0.312,0.074,0.208,Variable effect (p=0.019),No significant pattern (p=0.04),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03157,rs161331,12,50235956,MS4A6A,SNP (A/T),(A/,A,1.71,1.45,1.98,0.02224839,High,0.1,0.022,0.504,0.174,Variable effect (p=0.015),Mild increase (p=0.034),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03158,rs657091,22,204296522,EPHA1,SNP (C/G),(C/,C,1.63,1.36,1.88,0.02211986,Moderate,0.024,0.059,0.251,0.467,Mild decrease (p=0.032),Variable effect (p=0.049),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP03159,rs794001,21,171773550,TREM2,SNP (C/G),(C/,C,0.77,0.46,1.12,0.00819933,Moderate,0.015,0.202,0.499,0.085,Significant increase (p=0.027),No significant pattern (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03160,rs214934,19,90607853,ABCA7,SNP (G/T),(G/,G,0.94,0.71,1.3,0.01300626,Low,0.381,0.198,0.07,0.151,Significant decrease (p=0.001),Variable effect (p=0.009),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03161,rs734877,11,121648435,MS4A6A,SNP (C/T),(C/,C,1.64,1.28,1.97,0.09162597,Low,0.329,0.081,0.102,0.288,Mild increase (p=0.003),Significant decrease (p=0.027),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03162,rs447970,7,56027551,ABCA7,SNP (C/G),(C/,C,0.76,0.43,1.04,0.06539172,Protective,0.321,0.322,0.15,0.008,Mild decrease (p=0.005),Variable effect (p=0.021),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03163,rs942020,6,136212181,BIN1,SNP (C/G),(C/,C,1.79,1.5,2.0,0.0585837,Moderate,0.166,0.072,0.427,0.135,Mild decrease (p=0.002),Mild decrease (p=0.008),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03164,rs962130,5,238650506,CR1,Insertion,-,-,0.79,0.47,1.14,0.0241449,Unknown,0.297,0.033,0.164,0.306,Mild decrease (p=0.04),Significant decrease (p=0.029),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03165,rs151349,15,86902869,CLU,Deletion,-,-,0.99,0.61,1.22,0.02768443,Unknown,0.129,0.008,0.451,0.212,Significant increase (p=0.031),Mild decrease (p=0.011),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03166,rs331899,17,88767639,EPHA1,SNP (G/T),(G/,G,1.4,1.02,1.64,0.03146458,Moderate,0.338,0.109,0.112,0.241,No significant pattern (p=0.034),Variable effect (p=0.018),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03167,rs739097,14,61268288,BIN1,SNP (A/G),(A/,A,2.11,1.88,2.49,0.03831763,Moderate,0.085,0.115,0.358,0.243,Significant decrease (p=0.003),Mild decrease (p=0.045),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03168,rs805573,16,70213702,BIN1,SNP (A/T),(A/,A,1.16,0.9,1.4,0.03097635,Protective,0.247,0.23,0.3,0.023,No significant pattern (p=0.042),Significant increase (p=0.009),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03169,rs832837,1,218419929,TREM2,Insertion,-,-,2.47,2.09,2.82,0.06487493,High,0.217,0.516,0.052,0.015,Mild decrease (p=0.048),Mild decrease (p=0.033),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03170,rs996108,7,62038085,ABCA7,SNP (G/T),(G/,G,0.94,0.62,1.18,0.00296796,High,0.459,0.009,0.152,0.18,Mild decrease (p=0.047),Mild decrease (p=0.046),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03171,rs111520,12,160299986,EPHA1,SNP (G/T),(G/,G,0.46,0.22,0.71,0.1347084,Low,0.067,0.229,0.35,0.153,Variable effect (p=0.005),Variable effect (p=0.047),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03172,rs938872,11,31821669,CD33,SNP (A/T),(A/,A,0.66,0.31,1.02,0.00848314,Low,0.221,0.518,0.035,0.026,No significant pattern (p=0.039),No significant pattern (p=0.008),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03173,rs598918,14,139110112,APP,SNP (C/T),(C/,C,0.88,0.49,1.24,0.00940884,Moderate,0.31,0.031,0.083,0.376,Mild increase (p=0.005),Mild increase (p=0.036),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03174,rs353189,4,167493620,SORL1,Deletion,-,-,0.43,0.1,0.78,0.02015454,Moderate,0.155,0.412,0.117,0.116,Variable effect (p=0.02),Variable effect (p=0.004),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03175,rs202711,19,150655598,BIN1,Deletion,-,-,3.39,3.02,3.69,0.02092389,High,0.251,0.065,0.313,0.171,No significant pattern (p=0.029),Variable effect (p=0.008),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03176,rs378872,1,102196285,ABCA7,SNP (G/T),(G/,G,1.15,0.87,1.39,0.02327504,Moderate,0.106,0.355,0.052,0.286,Significant decrease (p=0.007),Mild increase (p=0.025),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03177,rs673528,8,222962474,PICALM,Deletion,-,-,0.53,0.28,0.86,0.03002053,High,0.569,0.146,0.028,0.057,Mild increase (p=0.001),Mild increase (p=0.004),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03178,rs307901,14,236925001,CLU,Insertion,-,-,0.97,0.7,1.18,0.02179532,Moderate,0.306,0.046,0.374,0.074,Variable effect (p=0.044),Significant decrease (p=0.035),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03179,rs574914,22,211657325,PICALM,SNP (A/G),(A/,A,2.53,2.19,2.79,0.03663033,Unknown,0.006,0.343,0.088,0.363,Significant decrease (p=0.045),Mild increase (p=0.036),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP03180,rs824842,9,48377230,EPHA1,Insertion,-,-,1.62,1.24,1.87,0.10414701,High,0.341,0.217,0.242,0.0,Significant increase (p=0.041),Significant increase (p=0.027),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03181,rs477883,1,52225209,APOE,SNP (A/T),(A/,A,1.01,0.66,1.23,0.11667073,Moderate,0.598,0.136,0.005,0.061,Mild decrease (p=0.031),No significant pattern (p=0.031),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03182,rs775828,11,232839692,BIN1,SNP (A/T),(A/,A,1.11,0.82,1.37,0.0302237,High,0.16,0.285,0.052,0.303,Significant increase (p=0.033),Significant decrease (p=0.008),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03183,rs885176,11,199428920,CR1,SNP (C/T),(C/,C,0.63,0.42,0.96,0.03389487,High,0.09,0.533,0.031,0.146,Mild decrease (p=0.047),Variable effect (p=0.023),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03184,rs865536,19,181060836,APOE,SNP (C/G),(C/,C,1.13,0.73,1.48,0.00284388,Unknown,0.165,0.05,0.28,0.305,Significant increase (p=0.026),Mild decrease (p=0.018),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03185,rs318393,16,11725225,CLU,SNP (A/C),(A/,A,1.16,0.93,1.42,0.04371087,Low,0.067,0.395,0.17,0.168,Mild decrease (p=0.049),Mild decrease (p=0.02),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03186,rs777271,18,18185163,CD2AP,Insertion,-,-,0.4,0.1,0.71,0.01586199,Low,0.006,0.528,0.023,0.243,Mild decrease (p=0.009),Significant increase (p=0.004),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03187,rs408639,3,61434045,PTK2B,SNP (A/G),(A/,A,3.06,2.74,3.43,0.01475796,High,0.141,0.169,0.185,0.305,Significant decrease (p=0.021),Mild increase (p=0.038),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP03188,rs332102,21,129438132,CD2AP,SNP (A/G),(A/,A,1.25,0.9,1.57,0.01946105,High,0.006,0.24,0.127,0.427,Mild increase (p=0.012),Mild increase (p=0.035),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03189,rs364871,21,22448546,TREM2,Deletion,-,-,0.38,0.17,0.77,0.07826641,Protective,0.471,0.034,0.24,0.054,Mild increase (p=0.003),Significant increase (p=0.029),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03190,rs118049,22,110695879,SORL1,SNP (C/T),(C/,C,0.81,0.61,1.04,0.01370291,Low,0.219,0.22,0.335,0.026,Variable effect (p=0.046),No significant pattern (p=0.028),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03191,rs599945,10,105241753,MS4A6A,SNP (C/T),(C/,C,1.19,0.86,1.53,0.01315854,Moderate,0.273,0.184,0.262,0.081,No significant pattern (p=0.013),Significant decrease (p=0.009),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP03192,rs248583,1,66972900,SORL1,SNP (A/T),(A/,A,0.83,0.61,1.06,0.07044492,Low,0.072,0.27,0.358,0.099,No significant pattern (p=0.035),No significant pattern (p=0.026),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03193,rs310891,2,95418161,CD2AP,SNP (G/T),(G/,G,1.68,1.38,2.06,9.558e-05,Moderate,0.023,0.02,0.655,0.103,No significant pattern (p=0.047),Mild increase (p=0.049),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03194,rs406877,15,74408460,CR1,SNP (C/G),(C/,C,1.08,0.84,1.31,0.04058317,High,0.112,0.035,0.022,0.631,No significant pattern (p=0.014),No significant pattern (p=0.019),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03195,rs186220,19,156167855,CD33,Deletion,-,-,0.84,0.54,1.05,0.01659328,Protective,0.175,0.112,0.483,0.03,Mild increase (p=0.026),Mild increase (p=0.034),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP03196,rs834387,3,115101200,CD33,SNP (A/T),(A/,A,0.84,0.6,1.06,0.00271695,Moderate,0.131,0.112,0.011,0.546,Mild increase (p=0.025),Mild increase (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP03197,rs384552,21,213650484,PSEN2,Insertion,-,-,1.76,1.45,2.07,0.05787934,Protective,0.565,0.101,0.023,0.111,Mild increase (p=0.007),Mild increase (p=0.026),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03198,rs477852,22,98234041,CD2AP,SNP (A/C),(A/,A,1.21,1.0,1.57,0.02321503,High,0.102,0.575,0.05,0.073,Variable effect (p=0.036),No significant pattern (p=0.009),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03199,rs472904,7,146220337,ABCA7,Deletion,-,-,1.24,0.85,1.58,0.0993442,Moderate,0.4,0.009,0.371,0.02,Mild decrease (p=0.024),Mild increase (p=0.049),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03200,rs934228,21,165792761,ABCA7,SNP (G/T),(G/,G,1.13,0.88,1.49,0.01194783,High,0.071,0.488,0.137,0.104,Variable effect (p=0.031),Mild decrease (p=0.024),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03201,rs447877,11,67947595,MS4A6A,Deletion,-,-,1.19,0.91,1.45,0.00509421,Moderate,0.065,0.027,0.568,0.14,Significant increase (p=0.032),Significant decrease (p=0.044),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03202,rs758225,19,200866897,BIN1,Insertion,-,-,1.05,0.77,1.39,0.03571137,Low,0.442,0.037,0.291,0.03,Mild decrease (p=0.033),Variable effect (p=0.046),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03203,rs820664,4,37067420,CLU,SNP (A/T),(A/,A,1.11,0.74,1.37,0.01701543,High,0.097,0.393,0.302,0.009,Mild increase (p=0.006),Mild increase (p=0.024),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03204,rs665815,14,239182406,PSEN2,Deletion,-,-,1.46,1.11,1.73,0.03291268,High,0.084,0.005,0.476,0.235,Significant increase (p=0.046),Significant increase (p=0.013),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03205,rs114528,5,172431804,CLU,SNP (G/T),(G/,G,1.2,0.82,1.51,0.07077892,Unknown,0.259,0.469,0.019,0.054,Significant increase (p=0.024),No significant pattern (p=0.044),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03206,rs240045,13,124028316,APP,SNP (A/C),(A/,A,0.81,0.53,1.2,0.01665168,Moderate,0.171,0.136,0.13,0.363,Mild increase (p=0.017),Mild decrease (p=0.02),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03207,rs719905,13,122082950,CLU,SNP (G/T),(G/,G,1.07,0.77,1.34,0.00450165,Low,0.04,0.513,0.097,0.149,Variable effect (p=0.021),No significant pattern (p=0.022),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03208,rs710617,20,71201298,CD33,SNP (A/C),(A/,A,0.54,0.24,0.74,0.01209361,Moderate,0.282,0.383,0.092,0.043,Variable effect (p=0.036),Significant decrease (p=0.039),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03209,rs682112,7,126021710,TREM2,SNP (A/G),(A/,A,1.65,1.25,1.93,0.04230211,Protective,0.01,0.028,0.725,0.037,Mild decrease (p=0.041),No significant pattern (p=0.008),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03210,rs248261,10,182388139,CD2AP,Deletion,-,-,0.45,0.21,0.85,0.01385475,Low,0.317,0.396,0.071,0.016,Mild increase (p=0.046),No significant pattern (p=0.035),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03211,rs232972,9,200342087,APP,SNP (G/T),(G/,G,1.11,0.72,1.44,0.04511611,Moderate,0.037,0.237,0.134,0.392,Significant increase (p=0.012),Significant increase (p=0.003),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03212,rs312796,1,61120700,ABCA7,SNP (C/T),(C/,C,1.0,0.7,1.22,0.10119375,High,0.254,0.486,0.03,0.029,Mild decrease (p=0.046),Significant decrease (p=0.043),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03213,rs649184,7,17842921,APOE,SNP (A/T),(A/,A,0.6,0.37,0.99,0.01047273,Protective,0.22,0.274,0.117,0.189,Significant increase (p=0.001),Mild increase (p=0.006),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03214,rs670692,1,226978895,CR1,SNP (C/T),(C/,C,2.56,2.26,2.88,0.04926007,Moderate,0.152,0.336,0.152,0.161,Significant increase (p=0.001),Variable effect (p=0.049),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03215,rs116634,13,202465232,PICALM,SNP (A/T),(A/,A,1.95,1.63,2.17,0.01444677,Protective,0.212,0.394,0.05,0.145,No significant pattern (p=0.012),Mild decrease (p=0.024),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03216,rs806257,2,56561739,APP,SNP (A/G),(A/,A,0.79,0.55,1.0,0.06232627,Low,0.199,0.286,0.005,0.31,Variable effect (p=0.003),Significant decrease (p=0.022),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03217,rs414570,6,185609855,APOE,Insertion,-,-,0.59,0.39,0.9,0.00663184,High,0.337,0.296,0.046,0.122,Significant increase (p=0.036),Significant decrease (p=0.046),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03218,rs143049,10,234434392,CLU,Deletion,-,-,0.57,0.37,0.89,0.0218447,Protective,0.13,0.071,0.234,0.365,Mild increase (p=0.008),Mild increase (p=0.039),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03219,rs256939,10,78629878,ABCA7,Deletion,-,-,0.71,0.31,0.91,0.01902728,Low,0.061,0.476,0.157,0.106,Variable effect (p=0.037),Variable effect (p=0.01),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03220,rs594355,19,96852517,ABCA7,SNP (G/T),(G/,G,1.21,0.94,1.47,0.10239307,Low,0.35,0.019,0.261,0.17,Significant increase (p=0.035),Variable effect (p=0.006),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03221,rs664857,14,63772087,MS4A6A,SNP (A/T),(A/,A,1.24,0.97,1.47,0.03013809,Moderate,0.647,0.056,0.018,0.079,Significant increase (p=0.045),Mild decrease (p=0.007),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03222,rs429131,8,40552923,PSEN2,SNP (C/T),(C/,C,1.63,1.3,1.89,0.0216686,Low,0.07,0.192,0.069,0.469,No significant pattern (p=0.022),Variable effect (p=0.019),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03223,rs231547,19,110803828,BIN1,SNP (G/T),(G/,G,2.28,2.06,2.66,0.03002693,Moderate,0.03,0.445,0.014,0.311,Mild decrease (p=0.028),Mild decrease (p=0.045),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03224,rs252112,8,192994226,CD33,SNP (G/T),(G/,G,1.76,1.41,1.97,0.01841603,Protective,0.278,0.334,0.162,0.026,Significant increase (p=0.007),Significant increase (p=0.008),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03225,rs235408,15,230840325,EPHA1,SNP (A/T),(A/,A,1.26,1.02,1.59,0.12485291,Protective,0.369,0.004,0.23,0.197,Mild increase (p=0.036),Variable effect (p=0.013),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03226,rs217210,16,59112399,TREM2,Deletion,-,-,1.07,0.7,1.33,0.01676074,High,0.013,0.047,0.661,0.079,Significant decrease (p=0.047),Significant decrease (p=0.011),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03227,rs313974,4,78018296,CD33,SNP (G/T),(G/,G,3.3,2.96,3.51,0.00487547,Low,0.076,0.381,0.217,0.126,Significant increase (p=0.021),Variable effect (p=0.04),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03228,rs624519,3,207145330,APP,SNP (A/G),(A/,A,1.2,0.8,1.46,0.01941639,Moderate,0.155,0.232,0.284,0.13,Significant increase (p=0.029),Significant increase (p=0.025),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03229,rs784706,8,145936455,SORL1,SNP (A/G),(A/,A,0.82,0.52,1.21,0.01089082,Moderate,0.032,0.045,0.548,0.175,Mild increase (p=0.033),Mild increase (p=0.03),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP03230,rs176914,17,227910683,SORL1,SNP (A/T),(A/,A,1.35,1.06,1.64,0.02318831,Protective,0.651,0.048,0.017,0.084,No significant pattern (p=0.008),Variable effect (p=0.036),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03231,rs888896,9,160419350,SORL1,SNP (A/G),(A/,A,2.72,2.49,2.95,0.00480638,Unknown,0.008,0.608,0.022,0.162,Significant decrease (p=0.018),Significant increase (p=0.029),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03232,rs268072,15,236803521,APP,SNP (G/T),(G/,G,0.86,0.48,1.14,0.03735626,Moderate,0.411,0.019,0.138,0.232,Significant increase (p=0.039),Significant decrease (p=0.036),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP03233,rs516086,12,141380658,PTK2B,SNP (C/T),(C/,C,1.84,1.53,2.18,0.09990447,Low,0.047,0.311,0.182,0.26,Variable effect (p=0.035),No significant pattern (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP03234,rs101865,10,231686804,PSEN2,SNP (C/G),(C/,C,2.99,2.72,3.28,0.01286436,Protective,0.431,0.222,0.057,0.09,Variable effect (p=0.037),Significant increase (p=0.018),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03235,rs717156,16,20224232,MS4A6A,Insertion,-,-,0.58,0.31,0.88,0.03648366,High,0.499,0.155,0.116,0.03,Significant increase (p=0.047),Variable effect (p=0.019),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03236,rs444972,15,189761577,CR1,SNP (A/G),(A/,A,1.34,1.1,1.59,0.02697259,Unknown,0.254,0.355,0.042,0.15,Variable effect (p=0.029),Mild decrease (p=0.036),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03237,rs804365,4,164682306,APP,SNP (G/T),(G/,G,1.75,1.39,2.12,0.00985283,High,0.083,0.112,0.29,0.315,No significant pattern (p=0.046),Significant decrease (p=0.026),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03238,rs313944,8,171846823,CLU,SNP (C/T),(C/,C,0.69,0.34,0.89,0.00965564,Low,0.107,0.1,0.042,0.551,Mild increase (p=0.048),Mild increase (p=0.017),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP03239,rs665354,2,35155678,PTK2B,SNP (A/G),(A/,A,0.94,0.65,1.21,0.010687,High,0.12,0.01,0.404,0.266,No significant pattern (p=0.019),Mild increase (p=0.036),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP03240,rs577614,11,219503263,APP,SNP (A/C),(A/,A,1.1,0.77,1.31,0.00623197,Moderate,0.1,0.124,0.387,0.189,Mild increase (p=0.032),Significant increase (p=0.028),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03241,rs552659,13,126755812,ABCA7,SNP (A/T),(A/,A,0.87,0.63,1.23,0.00957047,High,0.142,0.026,0.266,0.365,Variable effect (p=0.034),Mild increase (p=0.021),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03242,rs959922,22,30073371,CLU,SNP (G/T),(G/,G,2.16,1.88,2.44,0.04736112,Protective,0.27,0.254,0.119,0.157,Significant decrease (p=0.04),Variable effect (p=0.019),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03243,rs974029,22,14936347,PSEN2,SNP (A/C),(A/,A,1.92,1.67,2.3,0.07106697,High,0.004,0.199,0.294,0.303,Significant increase (p=0.043),Mild decrease (p=0.031),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03244,rs303627,22,14638739,CD2AP,SNP (A/C),(A/,A,0.67,0.36,0.93,0.00816685,High,0.072,0.016,0.008,0.703,Mild decrease (p=0.029),Significant decrease (p=0.043),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03245,rs368183,5,22847161,CR1,SNP (A/T),(A/,A,0.97,0.64,1.3,0.00558211,High,0.381,0.192,0.111,0.116,Significant increase (p=0.017),No significant pattern (p=0.035),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03246,rs281565,12,120134262,SORL1,SNP (A/G),(A/,A,1.85,1.59,2.16,0.01099638,Moderate,0.495,0.113,0.19,0.003,No significant pattern (p=0.003),Significant increase (p=0.029),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03247,rs491201,16,110142959,CD33,Deletion,-,-,0.83,0.53,1.19,0.02532322,High,0.077,0.194,0.46,0.07,Significant increase (p=0.016),Significant decrease (p=0.008),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03248,rs729011,15,163168676,TREM2,Deletion,-,-,0.26,0.1,0.53,0.00130483,Moderate,0.024,0.14,0.449,0.187,Variable effect (p=0.022),Mild increase (p=0.014),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03249,rs573606,22,187756701,ABCA7,SNP (A/T),(A/,A,0.66,0.43,1.0,0.07212827,Protective,0.171,0.24,0.137,0.251,Mild increase (p=0.036),No significant pattern (p=0.032),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP03250,rs177279,21,24048987,SORL1,SNP (C/G),(C/,C,1.25,1.0,1.59,0.01189327,Moderate,0.095,0.084,0.585,0.037,Significant increase (p=0.022),Mild increase (p=0.041),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03251,rs807092,3,152421678,EPHA1,SNP (C/T),(C/,C,2.37,2.02,2.62,0.19162822,High,0.631,0.091,0.069,0.009,Significant increase (p=0.039),No significant pattern (p=0.03),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03252,rs728107,7,221370841,BIN1,Deletion,-,-,2.15,1.8,2.45,0.06391719,Low,0.137,0.368,0.002,0.292,Significant decrease (p=0.027),No significant pattern (p=0.028),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP03253,rs995651,5,120686050,SORL1,Insertion,-,-,2.0,1.78,2.26,0.02807445,Low,0.131,0.426,0.137,0.105,Mild increase (p=0.045),Significant decrease (p=0.02),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP03254,rs982742,5,104288037,ABCA7,Insertion,-,-,1.53,1.21,1.92,0.01315006,Low,0.173,0.291,0.016,0.321,Mild decrease (p=0.024),Significant increase (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03255,rs935075,11,22744187,CLU,SNP (G/T),(G/,G,1.45,1.13,1.81,0.01337496,Protective,0.233,0.497,0.01,0.06,Significant decrease (p=0.013),Significant decrease (p=0.032),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03256,rs297664,22,212873018,MS4A6A,SNP (G/T),(G/,G,3.5,3.3,3.71,0.00355088,Moderate,0.073,0.645,0.036,0.047,Significant decrease (p=0.003),No significant pattern (p=0.006),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03257,rs468479,8,145225123,PTK2B,Insertion,-,-,1.16,0.85,1.51,0.07835507,High,0.26,0.112,0.097,0.331,Variable effect (p=0.023),Variable effect (p=0.02),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03258,rs103903,3,56005110,PTK2B,SNP (G/T),(G/,G,1.38,1.13,1.67,0.05963637,Low,0.299,0.13,0.218,0.153,No significant pattern (p=0.036),Mild decrease (p=0.017),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03259,rs888760,15,154845977,TREM2,Insertion,-,-,0.65,0.39,0.86,0.02188506,Low,0.11,0.167,0.502,0.021,Significant decrease (p=0.016),Variable effect (p=0.007),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03260,rs995700,2,225775503,APP,SNP (C/T),(C/,C,0.79,0.57,1.14,0.03038173,Moderate,0.02,0.092,0.123,0.564,Mild decrease (p=0.032),Mild decrease (p=0.01),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03261,rs899573,10,100257061,MS4A6A,SNP (C/G),(C/,C,0.59,0.21,0.89,0.01410346,Unknown,0.266,0.04,0.22,0.274,No significant pattern (p=0.032),No significant pattern (p=0.022),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03262,rs518611,19,183810015,PSEN2,SNP (A/C),(A/,A,1.36,1.07,1.57,0.0144195,High,0.582,0.091,0.025,0.102,Variable effect (p=0.045),Variable effect (p=0.02),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03263,rs353030,12,118727726,MS4A6A,SNP (C/G),(C/,C,0.84,0.49,1.17,0.07042787,High,0.057,0.232,0.222,0.288,No significant pattern (p=0.023),Significant decrease (p=0.023),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03264,rs289223,19,20974251,ABCA7,SNP (A/T),(A/,A,0.6,0.36,0.86,0.00719391,Moderate,0.097,0.371,0.078,0.253,Variable effect (p=0.029),Mild decrease (p=0.017),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03265,rs795001,7,144097636,APOE,Deletion,-,-,0.7,0.35,0.99,0.00861851,Low,0.326,0.068,0.138,0.268,Mild decrease (p=0.01),Significant decrease (p=0.029),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03266,rs262345,22,200431309,ABCA7,SNP (C/G),(C/,C,1.16,0.94,1.37,0.07171252,Moderate,0.234,0.036,0.374,0.156,Variable effect (p=0.012),Variable effect (p=0.033),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03267,rs626367,20,137065557,EPHA1,SNP (A/G),(A/,A,1.07,0.86,1.43,0.02706031,Moderate,0.109,0.096,0.123,0.472,Variable effect (p=0.044),Significant increase (p=0.015),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03268,rs713925,11,230852594,BIN1,SNP (A/G),(A/,A,0.77,0.43,1.16,0.00613333,Unknown,0.138,0.349,0.04,0.273,Variable effect (p=0.033),Mild decrease (p=0.013),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03269,rs254219,21,2352382,SORL1,SNP (G/T),(G/,G,0.76,0.53,1.08,0.03947782,Moderate,0.194,0.519,0.047,0.039,Significant decrease (p=0.024),Mild increase (p=0.03),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03270,rs748877,11,144188026,CD33,Insertion,-,-,0.5,0.21,0.78,0.07828287,High,0.287,0.304,0.063,0.146,Significant increase (p=0.03),Significant increase (p=0.008),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03271,rs270009,2,77217140,BIN1,SNP (G/T),(G/,G,0.94,0.6,1.17,0.07893297,Moderate,0.125,0.409,0.0,0.266,Significant decrease (p=0.045),Significant increase (p=0.045),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03272,rs235569,21,9366012,CLU,SNP (A/G),(A/,A,1.0,0.68,1.34,0.02223308,High,0.075,0.233,0.188,0.303,Variable effect (p=0.048),Mild decrease (p=0.05),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP03273,rs402908,4,182602187,CD2AP,Deletion,-,-,0.67,0.35,0.87,0.00480107,High,0.102,0.443,0.021,0.234,No significant pattern (p=0.008),Significant decrease (p=0.018),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03274,rs311360,9,234105940,APP,SNP (A/T),(A/,A,0.52,0.19,0.88,0.08431325,High,0.153,0.388,0.065,0.193,Mild increase (p=0.015),Significant decrease (p=0.02),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP03275,rs164457,19,79199425,BIN1,SNP (C/G),(C/,C,1.54,1.15,1.77,0.00908499,Unknown,0.106,0.467,0.006,0.221,Mild decrease (p=0.006),Significant increase (p=0.007),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03276,rs472340,19,223112512,PSEN2,SNP (A/C),(A/,A,0.8,0.55,1.01,0.00572995,Moderate,0.103,0.463,0.101,0.132,Variable effect (p=0.008),Mild decrease (p=0.048),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03277,rs342732,10,187755945,BIN1,SNP (C/T),(C/,C,1.13,0.76,1.42,0.01251448,Moderate,0.548,0.104,0.079,0.069,Significant decrease (p=0.009),Mild increase (p=0.039),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP03278,rs875207,18,12933390,ABCA7,Deletion,-,-,0.63,0.36,0.99,0.00213778,High,0.197,0.058,0.036,0.509,Variable effect (p=0.049),Significant increase (p=0.004),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03279,rs173148,19,210588105,CLU,Deletion,-,-,1.2,0.97,1.59,0.1622721,Moderate,0.561,0.088,0.134,0.018,No significant pattern (p=0.046),Variable effect (p=0.024),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03280,rs157095,3,207361077,PSEN2,SNP (G/T),(G/,G,1.07,0.74,1.37,0.06353339,Moderate,0.155,0.14,0.424,0.081,Mild decrease (p=0.019),Variable effect (p=0.021),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03281,rs250077,1,205545223,SORL1,SNP (A/C),(A/,A,1.52,1.24,1.87,0.02400482,High,0.448,0.004,0.111,0.237,Variable effect (p=0.01),Significant increase (p=0.008),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03282,rs739332,1,154881637,MS4A6A,SNP (A/C),(A/,A,0.56,0.22,0.92,0.01396448,High,0.254,0.297,0.044,0.205,Significant increase (p=0.045),Variable effect (p=0.014),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03283,rs225117,12,132919919,CD33,SNP (A/G),(A/,A,1.33,0.99,1.69,0.06259102,High,0.247,0.245,0.196,0.113,Variable effect (p=0.022),No significant pattern (p=0.043),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03284,rs195131,4,80684797,MS4A6A,SNP (A/G),(A/,A,0.85,0.5,1.24,0.02630945,Low,0.038,0.313,0.08,0.369,Mild decrease (p=0.017),Variable effect (p=0.045),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03285,rs511840,4,60860287,PTK2B,Deletion,-,-,1.1,0.83,1.49,0.12118988,Low,0.078,0.12,0.533,0.07,Mild increase (p=0.046),Variable effect (p=0.024),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03286,rs271251,5,21755849,CLU,Deletion,-,-,1.49,1.21,1.69,0.10423625,Moderate,0.138,0.422,0.237,0.004,Mild decrease (p=0.024),Significant decrease (p=0.034),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03287,rs791707,11,63197255,CD2AP,Insertion,-,-,0.76,0.43,1.03,0.00697352,Moderate,0.482,0.133,0.135,0.05,Mild increase (p=0.044),Significant increase (p=0.023),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03288,rs907025,8,74637634,CD2AP,SNP (A/T),(A/,A,0.58,0.24,0.98,0.02490178,Low,0.254,0.151,0.263,0.133,Mild decrease (p=0.035),Significant increase (p=0.003),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP03289,rs221397,14,156157154,CD33,SNP (G/T),(G/,G,0.47,0.22,0.72,0.0364757,Low,0.267,0.516,0.011,0.006,Significant increase (p=0.004),Mild decrease (p=0.013),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03290,rs552593,10,139021845,APOE,SNP (C/G),(C/,C,1.0,0.62,1.3,0.01336072,Moderate,0.159,0.13,0.126,0.385,Significant increase (p=0.043),No significant pattern (p=0.012),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03291,rs475683,21,92761381,PTK2B,SNP (A/G),(A/,A,1.66,1.43,2.0,0.09177263,Low,0.258,0.149,0.236,0.157,Significant decrease (p=0.026),No significant pattern (p=0.038),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03292,rs552626,9,99428754,SORL1,SNP (A/G),(A/,A,0.55,0.21,0.92,0.02086525,High,0.165,0.344,0.238,0.053,Mild increase (p=0.022),Significant increase (p=0.003),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03293,rs482587,14,152632667,CR1,SNP (C/T),(C/,C,3.11,2.77,3.4,0.01231607,High,0.169,0.173,0.106,0.352,Mild increase (p=0.05),Mild decrease (p=0.043),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03294,rs976756,18,239420767,TREM2,SNP (C/G),(C/,C,0.89,0.6,1.24,0.0301804,Low,0.067,0.191,0.225,0.317,Significant increase (p=0.044),No significant pattern (p=0.011),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03295,rs159907,5,131355403,PICALM,SNP (A/G),(A/,A,1.5,1.16,1.81,0.00212068,Moderate,0.022,0.272,0.068,0.439,Mild decrease (p=0.015),Significant decrease (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP03296,rs300974,6,171180450,CD2AP,Insertion,-,-,0.89,0.51,1.12,0.03267958,High,0.151,0.182,0.003,0.463,Significant decrease (p=0.041),Significant increase (p=0.014),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03297,rs652376,5,54777763,CR1,Insertion,-,-,1.2,0.93,1.42,0.01315247,Protective,0.069,0.543,0.148,0.041,Variable effect (p=0.047),Significant decrease (p=0.041),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03298,rs353931,18,165489726,PSEN2,SNP (C/G),(C/,C,0.95,0.67,1.2,0.02892677,Unknown,0.018,0.015,0.556,0.211,No significant pattern (p=0.014),Mild decrease (p=0.033),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03299,rs102778,2,70942652,APOE,SNP (A/T),(A/,A,0.82,0.49,1.09,0.06514561,High,0.26,0.421,0.085,0.034,Significant decrease (p=0.036),Significant decrease (p=0.014),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03300,rs455001,8,84477228,APOE,SNP (C/G),(C/,C,1.12,0.73,1.33,0.07154038,Low,0.149,0.043,0.152,0.456,Mild increase (p=0.005),Variable effect (p=0.021),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03301,rs910336,3,22495059,PSEN2,SNP (A/T),(A/,A,1.46,1.19,1.68,0.14829067,Protective,0.013,0.375,0.192,0.219,Variable effect (p=0.011),Variable effect (p=0.019),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP03302,rs365570,3,169110814,PSEN2,Insertion,-,-,1.38,0.99,1.7,0.13344032,Low,0.175,0.327,0.079,0.22,Significant decrease (p=0.05),Mild increase (p=0.021),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP03303,rs770576,12,152243897,ABCA7,SNP (A/T),(A/,A,1.82,1.42,2.15,0.00372065,Low,0.058,0.156,0.142,0.444,Mild decrease (p=0.044),Variable effect (p=0.036),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03304,rs635079,22,112992091,APOE,SNP (A/C),(A/,A,1.24,0.85,1.46,0.01099944,Low,0.043,0.218,0.438,0.101,Mild increase (p=0.046),Variable effect (p=0.048),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03305,rs639533,9,126619228,CR1,SNP (G/T),(G/,G,0.27,0.1,0.64,0.001543,Moderate,0.032,0.512,0.24,0.016,No significant pattern (p=0.026),Variable effect (p=0.019),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03306,rs786085,14,193955410,BIN1,Insertion,-,-,1.08,0.73,1.37,0.00734664,Protective,0.298,0.018,0.294,0.19,Significant increase (p=0.045),Significant decrease (p=0.037),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03307,rs174934,22,206423417,MS4A6A,SNP (A/C),(A/,A,0.51,0.16,0.86,0.00937439,Protective,0.318,0.355,0.03,0.098,Significant decrease (p=0.049),Variable effect (p=0.049),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP03308,rs638009,21,29934437,PICALM,SNP (A/T),(A/,A,1.64,1.43,1.96,0.2222802,Moderate,0.638,0.07,0.073,0.019,Variable effect (p=0.028),No significant pattern (p=0.05),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03309,rs837388,2,164641437,BIN1,Insertion,-,-,0.79,0.43,1.0,0.04573863,Moderate,0.123,0.236,0.141,0.299,No significant pattern (p=0.034),Mild increase (p=0.004),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03310,rs355340,19,96193157,CLU,SNP (C/G),(C/,C,1.27,0.96,1.64,0.05783908,Low,0.041,0.398,0.174,0.188,No significant pattern (p=0.011),Mild increase (p=0.035),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03311,rs273883,1,204773461,APP,Insertion,-,-,1.19,0.93,1.53,0.03615817,High,0.1,0.241,0.349,0.11,No significant pattern (p=0.036),Mild decrease (p=0.026),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03312,rs614756,2,113032756,CLU,SNP (A/C),(A/,A,1.42,1.04,1.64,0.01196327,Moderate,0.613,0.011,0.089,0.087,Variable effect (p=0.021),Variable effect (p=0.028),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03313,rs628031,10,106227394,MS4A6A,SNP (A/T),(A/,A,0.74,0.39,1.03,0.02151203,Low,0.043,0.021,0.201,0.534,No significant pattern (p=0.02),Mild decrease (p=0.049),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03314,rs598653,10,219899085,CD2AP,Deletion,-,-,2.12,1.78,2.39,0.03839159,Moderate,0.323,0.079,0.303,0.095,Variable effect (p=0.021),No significant pattern (p=0.019),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03315,rs367427,22,134811966,APP,SNP (A/G),(A/,A,0.71,0.33,0.97,0.04013124,Low,0.264,0.218,0.019,0.3,Mild decrease (p=0.009),Significant increase (p=0.009),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03316,rs261188,1,24415594,PICALM,Insertion,-,-,0.76,0.5,1.11,0.01827528,Low,0.098,0.2,0.422,0.08,No significant pattern (p=0.045),Significant decrease (p=0.018),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03317,rs337879,4,160511818,SORL1,SNP (A/T),(A/,A,2.29,1.99,2.57,0.01370503,Low,0.409,0.259,0.031,0.101,Mild increase (p=0.038),Significant decrease (p=0.032),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP03318,rs775273,22,9559206,TREM2,SNP (C/G),(C/,C,0.46,0.18,0.75,0.00501067,Low,0.38,0.033,0.24,0.147,Variable effect (p=0.019),Mild increase (p=0.037),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03319,rs680074,20,14589322,MS4A6A,Deletion,-,-,2.09,1.75,2.44,0.03067842,High,0.044,0.516,0.156,0.084,No significant pattern (p=0.017),Significant decrease (p=0.012),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP03320,rs369754,16,240490146,CR1,SNP (A/T),(A/,A,0.7,0.44,0.95,0.08720691,Moderate,0.171,0.213,0.369,0.047,Significant increase (p=0.038),Variable effect (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03321,rs418733,6,148441753,CR1,Insertion,-,-,0.76,0.45,1.08,0.00429435,Moderate,0.074,0.111,0.239,0.377,Significant increase (p=0.027),Significant increase (p=0.01),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03322,rs753069,6,63776644,TREM2,Deletion,-,-,1.06,0.83,1.32,0.02254623,Protective,0.072,0.277,0.135,0.316,Significant decrease (p=0.023),Mild increase (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03323,rs513671,17,85866855,APOE,SNP (C/G),(C/,C,0.71,0.39,0.97,0.01129899,Moderate,0.003,0.107,0.59,0.1,Variable effect (p=0.003),Mild increase (p=0.03),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03324,rs478771,8,220162659,PTK2B,SNP (C/T),(C/,C,1.96,1.73,2.29,0.0024542,High,0.138,0.232,0.044,0.387,Significant increase (p=0.041),Variable effect (p=0.014),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP03325,rs870307,18,184637666,APOE,Deletion,-,-,0.74,0.37,1.09,0.004395,Moderate,0.126,0.104,0.508,0.062,Mild decrease (p=0.001),Significant increase (p=0.049),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03326,rs805532,6,227416570,APP,SNP (G/T),(G/,G,1.98,1.73,2.25,0.1063534,Low,0.006,0.364,0.282,0.147,Significant increase (p=0.04),Significant decrease (p=0.014),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03327,rs351431,4,153223104,PTK2B,SNP (A/C),(A/,A,1.51,1.26,1.86,0.00871207,Low,0.392,0.071,0.262,0.075,Significant decrease (p=0.032),Variable effect (p=0.006),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03328,rs343386,18,248727799,APOE,SNP (A/C),(A/,A,0.92,0.57,1.16,0.0207007,Unknown,0.254,0.472,0.038,0.035,No significant pattern (p=0.033),Mild decrease (p=0.043),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03329,rs252701,5,101273422,MS4A6A,SNP (A/C),(A/,A,1.45,1.05,1.84,0.03074081,High,0.28,0.299,0.142,0.08,Variable effect (p=0.049),No significant pattern (p=0.008),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03330,rs366035,20,207219727,BIN1,SNP (A/C),(A/,A,1.73,1.39,2.08,0.00090035,Moderate,0.274,0.147,0.272,0.107,Mild increase (p=0.005),Mild decrease (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03331,rs717078,9,145329992,TREM2,SNP (C/T),(C/,C,2.35,2.11,2.74,0.00742872,Moderate,0.121,0.098,0.541,0.04,Variable effect (p=0.033),Significant increase (p=0.041),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03332,rs828415,4,101140205,TREM2,Insertion,-,-,1.45,1.17,1.7,0.0081318,Low,0.022,0.01,0.368,0.4,No significant pattern (p=0.002),Mild increase (p=0.014),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03333,rs379668,16,53367029,SORL1,SNP (C/T),(C/,C,0.98,0.71,1.36,0.01348737,Low,0.544,0.066,0.031,0.16,Variable effect (p=0.021),Significant decrease (p=0.006),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03334,rs430080,17,29583309,CR1,SNP (A/G),(A/,A,0.82,0.49,1.2,0.0410128,Moderate,0.456,0.094,0.201,0.048,Mild increase (p=0.042),Variable effect (p=0.022),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03335,rs963252,11,154545371,PTK2B,SNP (G/T),(G/,G,1.77,1.47,1.98,0.06894818,Moderate,0.13,0.044,0.018,0.608,Significant increase (p=0.029),No significant pattern (p=0.014),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP03336,rs430862,1,101341638,EPHA1,SNP (A/T),(A/,A,0.44,0.1,0.69,0.02509097,High,0.111,0.325,0.181,0.183,Significant increase (p=0.008),No significant pattern (p=0.042),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03337,rs349888,19,49103427,CD33,Insertion,-,-,2.14,1.75,2.4,0.02679258,Moderate,0.186,0.292,0.07,0.252,Mild increase (p=0.043),Mild increase (p=0.049),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP03338,rs989490,6,57255388,CD33,SNP (C/G),(C/,C,0.96,0.69,1.36,0.00663636,Low,0.021,0.11,0.393,0.276,Variable effect (p=0.048),Significant decrease (p=0.036),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03339,rs950727,5,202317177,CLU,Insertion,-,-,1.1,0.88,1.44,0.03664296,Low,0.191,0.496,0.05,0.063,Significant increase (p=0.027),Variable effect (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03340,rs270314,7,14692202,APOE,Deletion,-,-,1.24,0.95,1.52,0.1505527,High,0.397,0.188,0.065,0.15,Mild decrease (p=0.007),No significant pattern (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03341,rs279808,14,159835128,ABCA7,SNP (C/T),(C/,C,1.01,0.71,1.3,0.00316533,Moderate,0.499,0.109,0.16,0.032,No significant pattern (p=0.01),Significant increase (p=0.034),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03342,rs630907,3,53282961,CR1,SNP (A/G),(A/,A,1.89,1.56,2.16,0.0338239,Low,0.144,0.526,0.063,0.067,Variable effect (p=0.007),Mild decrease (p=0.036),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03343,rs519110,14,150937981,BIN1,SNP (G/T),(G/,G,0.58,0.27,0.87,0.02894313,Moderate,0.044,0.419,0.202,0.134,Mild increase (p=0.046),Mild decrease (p=0.034),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03344,rs660187,4,79768271,ABCA7,SNP (A/C),(A/,A,1.12,0.85,1.41,0.03308476,Low,0.364,0.269,0.077,0.09,Significant increase (p=0.046),Significant increase (p=0.048),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03345,rs187020,4,131525119,ABCA7,SNP (A/T),(A/,A,0.51,0.29,0.83,0.08069919,Low,0.11,0.081,0.369,0.24,Significant increase (p=0.013),Variable effect (p=0.009),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03346,rs539926,6,28138439,CD2AP,SNP (A/G),(A/,A,1.01,0.66,1.34,0.06793145,High,0.267,0.1,0.34,0.093,Variable effect (p=0.039),Variable effect (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03347,rs642479,3,2712501,CLU,Deletion,-,-,0.71,0.48,0.92,0.00306973,Moderate,0.389,0.349,0.032,0.031,No significant pattern (p=0.05),Significant decrease (p=0.023),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP03348,rs479776,8,235451136,PSEN2,SNP (G/T),(G/,G,2.36,2.03,2.75,0.01569105,Moderate,0.248,0.399,0.04,0.112,Significant decrease (p=0.017),Significant decrease (p=0.001),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03349,rs159967,20,134985065,EPHA1,SNP (C/T),(C/,C,0.79,0.54,1.1,0.04007095,Protective,0.244,0.113,0.08,0.363,Mild increase (p=0.014),Significant increase (p=0.001),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03350,rs387655,4,124829427,APP,SNP (C/T),(C/,C,0.47,0.17,0.85,0.02196122,High,0.021,0.304,0.175,0.3,No significant pattern (p=0.002),No significant pattern (p=0.017),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03351,rs188716,16,32299512,APOE,SNP (G/T),(G/,G,0.72,0.51,1.11,0.02339196,High,0.072,0.043,0.526,0.159,Mild decrease (p=0.049),Mild decrease (p=0.036),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03352,rs997018,8,235678394,CR1,SNP (A/C),(A/,A,1.33,1.1,1.65,0.0018669,Moderate,0.028,0.191,0.119,0.462,Significant decrease (p=0.039),Mild decrease (p=0.042),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03353,rs858561,8,154903647,CD2AP,SNP (A/C),(A/,A,0.37,0.1,0.61,0.00258968,Moderate,0.068,0.201,0.298,0.233,Mild increase (p=0.002),Mild increase (p=0.042),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03354,rs749393,10,161869186,CLU,SNP (C/G),(C/,C,0.57,0.21,0.92,0.0579206,Moderate,0.379,0.035,0.175,0.21,Variable effect (p=0.038),Variable effect (p=0.025),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03355,rs503104,11,114269529,CR1,SNP (C/T),(C/,C,1.14,0.93,1.39,0.06830971,High,0.047,0.34,0.015,0.397,Variable effect (p=0.016),Mild increase (p=0.02),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03356,rs357325,7,195103703,EPHA1,SNP (G/T),(G/,G,5.33,5.06,5.7,0.02554613,Moderate,0.025,0.14,0.455,0.18,Mild increase (p=0.039),Mild decrease (p=0.043),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP03357,rs518888,15,205920629,EPHA1,Insertion,-,-,0.74,0.49,1.02,0.02041292,Unknown,0.098,0.533,0.159,0.01,No significant pattern (p=0.004),Variable effect (p=0.009),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP03358,rs749471,4,96344610,CR1,SNP (C/T),(C/,C,1.08,0.84,1.4,0.01703913,High,0.272,0.232,0.115,0.181,Significant decrease (p=0.025),Variable effect (p=0.004),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03359,rs266684,4,134492119,TREM2,SNP (A/T),(A/,A,0.89,0.52,1.11,0.00606296,Low,0.033,0.104,0.336,0.327,Significant decrease (p=0.047),Variable effect (p=0.038),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03360,rs672564,18,185910524,EPHA1,SNP (A/G),(A/,A,0.44,0.18,0.7,0.01848234,Moderate,0.01,0.461,0.262,0.066,Significant decrease (p=0.023),Significant decrease (p=0.031),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03361,rs308704,16,178135621,BIN1,SNP (C/G),(C/,C,0.56,0.21,0.93,0.0085101,Protective,0.006,0.245,0.387,0.162,Mild decrease (p=0.029),Mild increase (p=0.035),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP03362,rs924258,15,66319100,CD33,SNP (G/T),(G/,G,2.47,2.12,2.82,0.02631701,Protective,0.248,0.207,0.044,0.301,Significant decrease (p=0.011),Significant increase (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03363,rs639784,22,74762004,BIN1,SNP (A/G),(A/,A,1.05,0.69,1.31,0.00037038,High,0.026,0.411,0.224,0.139,Significant decrease (p=0.03),Significant decrease (p=0.029),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03364,rs863650,15,164946361,BIN1,SNP (C/G),(C/,C,0.48,0.24,0.76,0.02518909,High,0.677,0.105,0.008,0.01,Mild increase (p=0.02),Mild decrease (p=0.048),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03365,rs803756,8,202601057,CD33,SNP (C/T),(C/,C,1.08,0.83,1.44,0.08200069,Moderate,0.018,0.662,0.045,0.074,Mild decrease (p=0.03),Mild increase (p=0.011),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03366,rs352301,2,93154681,MS4A6A,SNP (A/G),(A/,A,1.4,1.08,1.76,0.01291593,High,0.512,0.207,0.047,0.034,Significant decrease (p=0.017),Significant increase (p=0.013),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03367,rs800131,5,159763829,PTK2B,Insertion,-,-,0.92,0.57,1.22,0.0665,Protective,0.07,0.032,0.143,0.554,Significant increase (p=0.014),Significant decrease (p=0.046),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03368,rs935463,12,212827552,BIN1,SNP (A/C),(A/,A,0.92,0.65,1.13,0.02113739,High,0.008,0.195,0.37,0.228,Mild decrease (p=0.01),Significant decrease (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03369,rs984116,9,54004142,SORL1,SNP (G/T),(G/,G,3.41,3.21,3.71,0.00308333,Moderate,0.225,0.136,0.421,0.018,Significant decrease (p=0.011),Significant decrease (p=0.021),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03370,rs410599,4,186830302,SORL1,SNP (C/T),(C/,C,0.5,0.3,0.71,0.01266253,High,0.154,0.006,0.165,0.475,No significant pattern (p=0.042),No significant pattern (p=0.018),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03371,rs346546,10,70321181,PTK2B,SNP (C/T),(C/,C,0.99,0.73,1.36,0.00042315,High,0.106,0.037,0.601,0.057,Mild decrease (p=0.043),No significant pattern (p=0.034),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03372,rs115774,5,92871289,TREM2,SNP (A/C),(A/,A,0.92,0.67,1.32,0.04508858,Moderate,0.093,0.052,0.649,0.005,Variable effect (p=0.039),Significant decrease (p=0.005),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP03373,rs705718,18,54334633,APP,SNP (C/T),(C/,C,1.02,0.68,1.31,0.00941886,Low,0.246,0.004,0.151,0.399,Significant increase (p=0.005),Mild increase (p=0.036),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03374,rs650339,3,218300411,SORL1,SNP (G/T),(G/,G,1.0,0.72,1.39,0.07211458,High,0.169,0.12,0.023,0.488,Mild increase (p=0.046),Significant increase (p=0.032),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03375,rs179991,20,97433233,ABCA7,SNP (A/T),(A/,A,0.43,0.22,0.77,0.03270355,High,0.113,0.117,0.459,0.111,No significant pattern (p=0.022),No significant pattern (p=0.023),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03376,rs310281,16,44130586,CD33,SNP (A/T),(A/,A,1.56,1.31,1.79,0.04024665,High,0.017,0.039,0.351,0.393,Mild decrease (p=0.01),Mild decrease (p=0.024),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03377,rs544080,19,241514408,PICALM,SNP (C/G),(C/,C,0.45,0.12,0.69,0.05660484,Unknown,0.273,0.311,0.118,0.098,Variable effect (p=0.041),Significant decrease (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03378,rs726602,21,95384244,ABCA7,SNP (G/T),(G/,G,0.53,0.27,0.82,0.02165518,Moderate,0.17,0.044,0.43,0.156,Variable effect (p=0.03),Mild decrease (p=0.045),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03379,rs764849,7,132924304,EPHA1,SNP (G/T),(G/,G,2.46,2.09,2.85,0.02173853,Protective,0.117,0.433,0.072,0.178,Mild decrease (p=0.009),Mild decrease (p=0.036),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03380,rs628700,7,18882467,MS4A6A,SNP (A/T),(A/,A,0.61,0.34,0.94,0.00252884,Moderate,0.065,0.378,0.283,0.074,Significant increase (p=0.036),Mild decrease (p=0.029),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03381,rs848996,19,83880427,EPHA1,SNP (A/G),(A/,A,1.69,1.34,2.0,0.0291681,Moderate,0.303,0.047,0.375,0.075,Variable effect (p=0.021),Significant increase (p=0.039),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03382,rs961548,15,30963694,PSEN2,SNP (C/T),(C/,C,1.86,1.5,2.16,0.00553636,Moderate,0.023,0.265,0.298,0.214,Mild increase (p=0.004),Significant decrease (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP03383,rs687528,6,139404212,EPHA1,Deletion,-,-,0.72,0.36,0.98,0.03663796,High,0.213,0.139,0.426,0.023,Significant increase (p=0.043),Variable effect (p=0.024),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP03384,rs857121,5,147209206,CD2AP,SNP (A/C),(A/,A,0.64,0.3,0.85,0.02713103,Moderate,0.105,0.01,0.532,0.154,No significant pattern (p=0.024),Variable effect (p=0.015),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03385,rs153153,3,140071334,CD33,Insertion,-,-,1.26,0.97,1.54,0.06746125,Moderate,0.486,0.065,0.073,0.176,No significant pattern (p=0.048),Mild decrease (p=0.03),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03386,rs544808,17,195362630,BIN1,SNP (C/G),(C/,C,1.77,1.55,2.09,0.01613379,Moderate,0.023,0.671,0.09,0.016,Mild increase (p=0.03),Significant increase (p=0.021),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03387,rs699748,13,13475546,APP,SNP (C/T),(C/,C,1.33,1.08,1.57,0.02349192,Moderate,0.113,0.148,0.433,0.107,Mild increase (p=0.026),Significant decrease (p=0.028),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03388,rs226708,12,22239569,PSEN2,SNP (A/G),(A/,A,0.87,0.66,1.21,0.01058765,Low,0.193,0.299,0.063,0.244,Significant increase (p=0.004),Mild decrease (p=0.009),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03389,rs977160,21,22859532,CD2AP,SNP (C/T),(C/,C,2.06,1.72,2.37,0.02926841,High,0.041,0.316,0.211,0.231,Variable effect (p=0.048),No significant pattern (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03390,rs252442,5,95340976,CD33,SNP (C/G),(C/,C,1.32,1.06,1.69,0.04576716,Low,0.101,0.359,0.036,0.304,Mild decrease (p=0.002),Significant decrease (p=0.028),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03391,rs730404,12,72457574,CD33,SNP (C/T),(C/,C,2.01,1.74,2.28,0.03214598,Moderate,0.164,0.301,0.297,0.039,Significant increase (p=0.042),Significant decrease (p=0.02),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03392,rs155780,14,14834672,ABCA7,SNP (C/T),(C/,C,1.1,0.77,1.45,0.02179212,High,0.057,0.477,0.071,0.195,Significant increase (p=0.016),Mild increase (p=0.034),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP03393,rs361694,5,229133221,CLU,Deletion,-,-,1.17,0.89,1.39,0.0228003,Low,0.131,0.129,0.411,0.129,Variable effect (p=0.012),Significant increase (p=0.015),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP03394,rs460031,21,63181500,APOE,SNP (A/C),(A/,A,0.43,0.2,0.68,0.02383493,Moderate,0.254,0.31,0.127,0.109,Mild increase (p=0.025),Variable effect (p=0.005),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03395,rs979464,14,109057139,CLU,Deletion,-,-,1.29,0.97,1.54,0.03237151,Unknown,0.04,0.352,0.019,0.39,Significant decrease (p=0.013),Significant increase (p=0.015),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03396,rs138191,7,136915702,BIN1,SNP (G/T),(G/,G,1.8,1.55,2.11,0.01254485,Moderate,0.443,0.162,0.131,0.064,Mild increase (p=0.014),Significant decrease (p=0.007),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03397,rs163929,10,158945072,PICALM,SNP (G/T),(G/,G,2.74,2.36,2.99,0.00654585,Low,0.124,0.33,0.038,0.308,Significant decrease (p=0.019),Significant increase (p=0.044),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03398,rs342278,3,4152543,PTK2B,SNP (G/T),(G/,G,1.25,0.99,1.49,0.01407512,Moderate,0.534,0.157,0.064,0.045,Significant increase (p=0.038),Significant decrease (p=0.008),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP03399,rs174475,6,127226178,CLU,SNP (A/G),(A/,A,0.86,0.54,1.12,0.07104516,Moderate,0.199,0.069,0.228,0.304,Mild increase (p=0.018),Variable effect (p=0.019),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03400,rs132884,19,210033102,SORL1,Insertion,-,-,1.35,1.0,1.67,0.01351016,High,0.016,0.156,0.117,0.511,Significant increase (p=0.026),No significant pattern (p=0.027),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03401,rs929857,5,76407762,APOE,Insertion,-,-,0.4,0.1,0.76,0.00613948,Moderate,0.009,0.478,0.122,0.19,Significant decrease (p=0.005),No significant pattern (p=0.006),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03402,rs691770,3,21232633,CR1,SNP (A/G),(A/,A,0.68,0.37,1.06,0.01145875,Moderate,0.033,0.107,0.633,0.026,Mild decrease (p=0.045),Significant increase (p=0.014),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03403,rs272833,21,16274461,BIN1,SNP (C/T),(C/,C,2.0,1.79,2.27,0.00406951,Moderate,0.163,0.242,0.37,0.025,Mild increase (p=0.024),Mild decrease (p=0.011),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03404,rs323625,9,237932393,PICALM,Deletion,-,-,0.74,0.38,1.06,0.01644035,Low,0.457,0.182,0.152,0.008,Variable effect (p=0.027),No significant pattern (p=0.005),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03405,rs755905,18,157592060,APOE,SNP (G/T),(G/,G,0.95,0.71,1.31,0.00258052,Protective,0.085,0.109,0.166,0.44,Mild increase (p=0.04),Variable effect (p=0.005),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03406,rs637976,10,8108932,ABCA7,Insertion,-,-,0.78,0.57,1.03,0.01825104,Low,0.517,0.072,0.026,0.185,Significant decrease (p=0.046),Variable effect (p=0.016),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03407,rs730146,4,206777396,APOE,SNP (A/G),(A/,A,0.65,0.28,0.96,0.02029834,Low,0.422,0.23,0.072,0.076,Variable effect (p=0.03),No significant pattern (p=0.035),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03408,rs912725,4,189080650,APP,SNP (A/T),(A/,A,1.1,0.75,1.4,0.054032,High,0.07,0.545,0.02,0.164,Significant increase (p=0.034),Significant decrease (p=0.015),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03409,rs778848,6,164484990,SORL1,SNP (G/T),(G/,G,0.62,0.26,0.88,1.018e-05,Unknown,0.07,0.097,0.039,0.595,Mild decrease (p=0.017),Variable effect (p=0.013),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03410,rs682840,6,217776944,CD2AP,Deletion,-,-,1.09,0.88,1.32,0.00904031,Low,0.357,0.131,0.132,0.18,Significant decrease (p=0.016),Significant increase (p=0.001),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP03411,rs184294,14,124400500,CR1,Insertion,-,-,0.32,0.1,0.68,0.0240623,High,0.274,0.007,0.204,0.316,No significant pattern (p=0.004),Significant increase (p=0.017),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03412,rs226399,17,35307613,CD2AP,SNP (C/T),(C/,C,1.09,0.79,1.47,0.01931639,Protective,0.184,0.365,0.053,0.198,Mild decrease (p=0.006),No significant pattern (p=0.024),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03413,rs224106,1,206547069,EPHA1,Deletion,-,-,1.25,1.0,1.49,0.0560447,Moderate,0.011,0.493,0.145,0.151,No significant pattern (p=0.03),Mild increase (p=0.012),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03414,rs731010,17,118651212,CD33,Deletion,-,-,2.43,2.19,2.8,0.00783532,Moderate,0.381,0.131,0.088,0.2,Variable effect (p=0.002),No significant pattern (p=0.042),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03415,rs857476,22,227624493,ABCA7,SNP (G/T),(G/,G,1.13,0.88,1.45,0.01062193,Unknown,0.045,0.189,0.421,0.145,No significant pattern (p=0.036),Significant increase (p=0.022),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03416,rs898524,19,200436420,CD33,SNP (A/G),(A/,A,0.77,0.42,1.08,0.00652347,Unknown,0.19,0.061,0.283,0.266,No significant pattern (p=0.006),Significant decrease (p=0.029),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03417,rs729695,9,152451848,TREM2,SNP (G/T),(G/,G,1.74,1.51,1.97,0.03637505,Moderate,0.229,0.46,0.05,0.062,No significant pattern (p=0.005),Variable effect (p=0.049),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03418,rs640750,5,75088753,TREM2,Deletion,-,-,1.62,1.35,1.84,0.00458604,Moderate,0.046,0.031,0.175,0.549,Mild increase (p=0.021),Mild decrease (p=0.026),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03419,rs928618,2,117041580,PICALM,SNP (A/G),(A/,A,0.62,0.41,0.94,0.00576441,Low,0.082,0.256,0.327,0.135,Significant increase (p=0.018),Variable effect (p=0.026),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03420,rs643070,17,229879674,APP,Deletion,-,-,0.58,0.19,0.93,0.007455,High,0.151,0.065,0.185,0.399,Variable effect (p=0.046),Mild increase (p=0.017),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03421,rs265356,8,60899019,APP,SNP (A/G),(A/,A,0.73,0.51,1.04,0.01015252,Moderate,0.118,0.317,0.267,0.097,Significant increase (p=0.042),Mild decrease (p=0.013),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03422,rs611104,7,242614930,PICALM,Deletion,-,-,1.04,0.83,1.42,0.00072967,Moderate,0.086,0.34,0.014,0.361,Significant decrease (p=0.018),Variable effect (p=0.037),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03423,rs109283,16,227560208,SORL1,SNP (C/G),(C/,C,1.79,1.57,2.17,0.00972212,Unknown,0.473,0.151,0.012,0.164,Mild increase (p=0.032),Mild decrease (p=0.044),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03424,rs415402,15,46535439,SORL1,SNP (A/C),(A/,A,1.85,1.58,2.16,0.06801289,Unknown,0.089,0.039,0.48,0.192,Significant decrease (p=0.045),Significant increase (p=0.012),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03425,rs912781,10,55161379,CD2AP,SNP (A/C),(A/,A,1.25,0.88,1.62,0.18019772,Unknown,0.028,0.325,0.079,0.368,Significant increase (p=0.014),Mild increase (p=0.02),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03426,rs141131,18,210713499,CLU,SNP (C/T),(C/,C,0.68,0.31,1.05,0.05437866,Low,0.179,0.107,0.472,0.042,Variable effect (p=0.048),Variable effect (p=0.046),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03427,rs506521,1,102440062,TREM2,Deletion,-,-,0.85,0.64,1.06,0.00058058,High,0.264,0.356,0.124,0.056,Significant increase (p=0.019),Mild increase (p=0.018),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03428,rs384601,20,89193460,PSEN2,Insertion,-,-,1.33,0.97,1.69,0.01416733,Protective,0.054,0.236,0.107,0.403,No significant pattern (p=0.029),Mild increase (p=0.018),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03429,rs931172,12,95543913,CD2AP,Insertion,-,-,0.69,0.49,1.02,0.01389208,High,0.147,0.066,0.008,0.579,Mild decrease (p=0.028),Variable effect (p=0.025),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03430,rs859875,15,101413773,SORL1,Deletion,-,-,0.36,0.12,0.65,0.01356523,Protective,0.396,0.07,0.172,0.163,Mild decrease (p=0.014),Variable effect (p=0.037),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03431,rs107189,20,31078162,MS4A6A,SNP (A/G),(A/,A,0.5,0.14,0.85,0.00377197,Moderate,0.339,0.071,0.206,0.184,Mild decrease (p=0.019),Mild increase (p=0.04),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03432,rs255411,13,184099237,CD33,Insertion,-,-,0.7,0.48,1.06,0.03649209,Low,0.348,0.121,0.12,0.211,Significant increase (p=0.009),Mild decrease (p=0.024),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03433,rs767360,22,90524768,CD2AP,SNP (A/T),(A/,A,1.1,0.78,1.36,0.0156694,Moderate,0.006,0.122,0.668,0.005,Mild decrease (p=0.048),Mild decrease (p=0.04),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03434,rs324543,5,178847655,MS4A6A,SNP (C/T),(C/,C,1.15,0.87,1.54,0.00298715,Protective,0.108,0.448,0.009,0.235,Mild increase (p=0.011),Variable effect (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03435,rs300817,8,126871226,ABCA7,SNP (C/G),(C/,C,0.89,0.55,1.15,0.0095892,Moderate,0.131,0.107,0.306,0.256,Significant decrease (p=0.033),Significant increase (p=0.03),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03436,rs630694,2,214018336,PICALM,SNP (C/G),(C/,C,1.48,1.14,1.76,0.05535734,Moderate,0.218,0.178,0.001,0.403,Mild decrease (p=0.049),Significant decrease (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03437,rs238094,3,73819906,CD33,SNP (G/T),(G/,G,0.6,0.23,0.99,0.00593411,High,0.353,0.257,0.155,0.034,Mild decrease (p=0.045),No significant pattern (p=0.013),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03438,rs854978,5,26379557,SORL1,Deletion,-,-,1.13,0.81,1.33,0.03175474,Moderate,0.038,0.053,0.079,0.63,Significant increase (p=0.032),Significant increase (p=0.008),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03439,rs398535,14,169395316,CLU,SNP (C/G),(C/,C,0.8,0.53,1.08,0.00842649,Unknown,0.101,0.08,0.213,0.406,Mild increase (p=0.029),Significant increase (p=0.011),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03440,rs380436,14,158255810,CR1,Insertion,-,-,1.17,0.84,1.39,0.02042949,Low,0.174,0.082,0.523,0.021,No significant pattern (p=0.017),Significant decrease (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03441,rs147149,20,156793502,CD33,SNP (C/T),(C/,C,1.62,1.41,1.87,0.02758965,High,0.07,0.057,0.572,0.102,Mild increase (p=0.008),Variable effect (p=0.048),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03442,rs943767,10,161060883,CLU,Deletion,-,-,1.98,1.66,2.37,0.00225985,Unknown,0.289,0.03,0.216,0.265,Significant increase (p=0.035),No significant pattern (p=0.035),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03443,rs879866,22,29085401,TREM2,SNP (A/C),(A/,A,0.93,0.62,1.2,0.00613785,Moderate,0.21,0.224,0.185,0.181,Mild decrease (p=0.049),Significant increase (p=0.006),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03444,rs289711,22,60888812,BIN1,SNP (A/G),(A/,A,1.11,0.77,1.42,0.00048986,Low,0.444,0.004,0.224,0.128,Significant decrease (p=0.036),No significant pattern (p=0.014),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03445,rs882221,21,230155092,CR1,SNP (G/T),(G/,G,0.93,0.55,1.19,0.00567936,Low,0.093,0.604,0.021,0.081,Mild increase (p=0.008),No significant pattern (p=0.043),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03446,rs845324,10,199260997,APP,SNP (A/T),(A/,A,0.39,0.1,0.61,0.06506726,High,0.024,0.089,0.169,0.518,Significant increase (p=0.017),Mild decrease (p=0.041),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03447,rs857540,6,45513300,CR1,SNP (C/T),(C/,C,1.08,0.7,1.31,0.02719724,High,0.161,0.187,0.197,0.255,Variable effect (p=0.011),Mild decrease (p=0.039),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP03448,rs864717,20,12745172,CD33,SNP (A/T),(A/,A,0.7,0.3,1.1,0.01465618,Low,0.133,0.353,0.174,0.14,Mild increase (p=0.025),Mild decrease (p=0.04),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03449,rs337583,8,191704067,PSEN2,Deletion,-,-,1.42,1.1,1.73,0.02313901,Low,0.216,0.116,0.275,0.193,No significant pattern (p=0.001),No significant pattern (p=0.045),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03450,rs951432,4,85011516,CD2AP,SNP (G/T),(G/,G,0.56,0.19,0.82,0.06774914,Moderate,0.037,0.563,0.156,0.043,Mild increase (p=0.005),Mild increase (p=0.039),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03451,rs462165,21,199073517,ABCA7,SNP (C/G),(C/,C,1.15,0.82,1.49,0.10542033,High,0.587,0.083,0.057,0.073,Mild decrease (p=0.023),No significant pattern (p=0.033),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03452,rs304897,22,149915754,PSEN2,SNP (A/C),(A/,A,0.7,0.49,1.03,0.05960876,Moderate,0.134,0.492,0.157,0.018,Variable effect (p=0.027),No significant pattern (p=0.048),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03453,rs271893,3,22966594,CD33,SNP (G/T),(G/,G,1.06,0.82,1.34,0.02507207,High,0.033,0.22,0.222,0.325,Significant decrease (p=0.05),Mild increase (p=0.037),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03454,rs989126,8,239606441,CR1,SNP (C/G),(C/,C,1.46,1.17,1.78,0.00886113,Moderate,0.236,0.235,0.298,0.031,Variable effect (p=0.035),Significant increase (p=0.038),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03455,rs945300,12,135324156,CD2AP,Deletion,-,-,0.81,0.42,1.15,0.05447997,High,0.189,0.24,0.344,0.027,Significant decrease (p=0.044),Significant decrease (p=0.024),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03456,rs968300,14,7917716,PICALM,Insertion,-,-,1.28,0.94,1.67,0.01970006,Unknown,0.522,0.127,0.079,0.073,Variable effect (p=0.021),No significant pattern (p=0.021),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03457,rs598778,22,54736913,CLU,Deletion,-,-,0.67,0.31,0.89,0.16006445,Low,0.582,0.084,0.063,0.071,Mild increase (p=0.043),Mild increase (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03458,rs452122,22,104355557,PSEN2,SNP (C/G),(C/,C,0.6,0.32,0.87,0.00151564,Low,0.185,0.332,0.142,0.141,Mild increase (p=0.025),Mild increase (p=0.038),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03459,rs903652,3,73978511,PSEN2,SNP (C/T),(C/,C,0.89,0.58,1.12,0.00622907,High,0.072,0.713,0.011,0.004,Mild increase (p=0.009),Mild decrease (p=0.026),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03460,rs339004,22,20772680,PSEN2,Deletion,-,-,1.55,1.18,1.84,0.01734939,Protective,0.525,0.1,0.152,0.023,Significant decrease (p=0.021),Significant decrease (p=0.007),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP03461,rs141123,8,42116843,EPHA1,SNP (G/T),(G/,G,1.53,1.22,1.89,0.00754338,Moderate,0.05,0.32,0.1,0.33,No significant pattern (p=0.028),Mild decrease (p=0.02),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03462,rs225395,4,106466029,SORL1,Insertion,-,-,1.11,0.88,1.5,0.02467483,Protective,0.026,0.435,0.335,0.004,No significant pattern (p=0.01),Mild increase (p=0.011),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03463,rs587609,2,201817945,TREM2,SNP (C/G),(C/,C,1.39,1.03,1.64,0.01633917,High,0.24,0.121,0.008,0.431,Mild decrease (p=0.024),Significant decrease (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03464,rs147204,1,134110156,EPHA1,SNP (C/G),(C/,C,0.73,0.37,0.97,0.02084769,Moderate,0.103,0.489,0.026,0.182,Mild decrease (p=0.006),Significant increase (p=0.041),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP03465,rs579406,21,51462292,APP,SNP (C/G),(C/,C,1.3,1.06,1.69,0.01567385,Moderate,0.285,0.098,0.308,0.108,Mild decrease (p=0.006),No significant pattern (p=0.033),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP03466,rs881071,15,104318181,APP,SNP (A/G),(A/,A,0.39,0.1,0.67,0.06876091,Moderate,0.0,0.147,0.614,0.038,Significant decrease (p=0.035),Significant decrease (p=0.037),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03467,rs705615,18,31990950,CD33,SNP (A/G),(A/,A,1.92,1.67,2.21,0.02615872,High,0.214,0.454,0.066,0.066,No significant pattern (p=0.014),Variable effect (p=0.043),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03468,rs374935,7,105782687,APP,SNP (A/T),(A/,A,2.92,2.71,3.25,0.03445222,Low,0.279,0.02,0.073,0.428,Significant decrease (p=0.04),Significant increase (p=0.029),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03469,rs585960,8,207447523,PICALM,SNP (A/T),(A/,A,1.8,1.49,2.17,0.03421169,Unknown,0.401,0.129,0.236,0.034,No significant pattern (p=0.018),No significant pattern (p=0.03),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03470,rs849888,18,52636753,MS4A6A,SNP (G/T),(G/,G,1.39,1.11,1.75,0.03199263,Protective,0.369,0.16,0.229,0.041,Mild increase (p=0.009),Significant increase (p=0.021),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03471,rs176229,1,73406248,PTK2B,SNP (C/T),(C/,C,0.5,0.1,0.71,0.0132099,High,0.149,0.046,0.036,0.569,No significant pattern (p=0.046),No significant pattern (p=0.007),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03472,rs434589,8,158986801,PTK2B,SNP (A/G),(A/,A,0.54,0.27,0.85,0.02635631,Unknown,0.119,0.248,0.33,0.103,Mild decrease (p=0.003),Variable effect (p=0.025),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03473,rs514277,2,61420477,BIN1,SNP (G/T),(G/,G,1.6,1.31,1.94,0.00498571,Low,0.366,0.177,0.155,0.102,Significant increase (p=0.01),No significant pattern (p=0.042),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP03474,rs835695,6,226194920,BIN1,Insertion,-,-,0.43,0.1,0.68,0.04718302,Low,0.025,0.303,0.465,0.007,Mild increase (p=0.01),Variable effect (p=0.022),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03475,rs969344,16,100650528,SORL1,SNP (C/T),(C/,C,1.57,1.31,1.82,0.03986097,Low,0.085,0.549,0.016,0.15,Variable effect (p=0.031),Mild decrease (p=0.016),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03476,rs251146,22,53645335,APOE,Insertion,-,-,1.47,1.1,1.81,0.02469083,High,0.287,0.119,0.37,0.023,Mild decrease (p=0.02),Significant decrease (p=0.048),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03477,rs220399,21,148012131,APP,SNP (A/C),(A/,A,0.93,0.56,1.16,0.08368653,Moderate,0.259,0.062,0.352,0.127,No significant pattern (p=0.041),Variable effect (p=0.002),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03478,rs289046,13,228417352,TREM2,SNP (C/T),(C/,C,1.78,1.49,2.1,0.02612321,Moderate,0.255,0.032,0.074,0.439,Mild decrease (p=0.018),Mild increase (p=0.039),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03479,rs733838,21,11011500,CR1,SNP (C/T),(C/,C,0.93,0.55,1.23,0.00242727,Moderate,0.134,0.414,0.009,0.244,No significant pattern (p=0.038),No significant pattern (p=0.025),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03480,rs602696,6,191545493,PICALM,SNP (A/C),(A/,A,0.41,0.13,0.75,0.0067868,High,0.307,0.051,0.21,0.232,Significant decrease (p=0.048),Significant decrease (p=0.045),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03481,rs864091,1,44644488,MS4A6A,SNP (C/T),(C/,C,0.69,0.41,1.09,0.00716332,Moderate,0.141,0.083,0.142,0.434,Significant decrease (p=0.036),Mild increase (p=0.037),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03482,rs639014,17,7776158,PICALM,SNP (G/T),(G/,G,0.81,0.48,1.21,0.05033133,Moderate,0.044,0.378,0.157,0.221,Variable effect (p=0.03),Variable effect (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03483,rs619267,1,244739683,ABCA7,SNP (C/G),(C/,C,1.37,1.11,1.62,0.10755165,High,0.118,0.101,0.271,0.31,Significant increase (p=0.022),No significant pattern (p=0.009),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03484,rs531185,9,247913640,ABCA7,Insertion,-,-,0.98,0.66,1.28,0.00518269,High,0.458,0.101,0.098,0.143,Significant increase (p=0.033),No significant pattern (p=0.006),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP03485,rs711684,8,190899241,SORL1,SNP (A/T),(A/,A,0.71,0.33,1.04,0.09948006,Moderate,0.109,0.452,0.156,0.084,Significant increase (p=0.014),No significant pattern (p=0.006),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03486,rs272424,12,247605882,APP,SNP (G/T),(G/,G,1.49,1.22,1.71,0.01289509,High,0.21,0.053,0.492,0.044,Significant decrease (p=0.027),Variable effect (p=0.042),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03487,rs415100,6,38537391,CD33,Insertion,-,-,0.5,0.17,0.8,0.02520271,High,0.422,0.285,0.063,0.029,Mild decrease (p=0.006),No significant pattern (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03488,rs324905,4,86031033,CLU,SNP (G/T),(G/,G,0.99,0.79,1.25,0.0131556,High,0.196,0.126,0.051,0.426,No significant pattern (p=0.044),No significant pattern (p=0.03),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03489,rs977231,4,242517874,SORL1,SNP (A/C),(A/,A,0.35,0.1,0.66,0.00978107,Moderate,0.038,0.036,0.457,0.269,Variable effect (p=0.045),Variable effect (p=0.046),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03490,rs522022,4,207452324,PTK2B,SNP (A/C),(A/,A,0.56,0.3,0.83,0.06076727,Moderate,0.401,0.061,0.3,0.038,Significant increase (p=0.03),Variable effect (p=0.012),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03491,rs126785,8,15580971,ABCA7,SNP (C/G),(C/,C,0.5,0.16,0.89,0.08586735,High,0.071,0.307,0.371,0.051,Variable effect (p=0.02),Significant decrease (p=0.017),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03492,rs124830,1,24865569,MS4A6A,SNP (C/G),(C/,C,0.74,0.49,1.1,0.02466977,Protective,0.092,0.162,0.31,0.236,Mild decrease (p=0.006),Variable effect (p=0.047),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03493,rs534922,14,245047790,BIN1,SNP (C/G),(C/,C,0.96,0.75,1.32,0.04690095,High,0.353,0.252,0.073,0.122,Mild decrease (p=0.044),Variable effect (p=0.037),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP03494,rs414266,14,117772069,CR1,SNP (A/C),(A/,A,3.45,3.07,3.84,0.01641981,Low,0.333,0.005,0.328,0.134,Significant increase (p=0.024),Variable effect (p=0.007),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03495,rs679579,14,172187618,TREM2,Deletion,-,-,1.01,0.73,1.31,0.04962012,High,0.464,0.068,0.158,0.111,Significant increase (p=0.029),Mild increase (p=0.024),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03496,rs655256,19,210616010,PTK2B,SNP (C/T),(C/,C,1.46,1.21,1.67,0.04350218,Moderate,0.217,0.224,0.25,0.109,Significant increase (p=0.002),Significant increase (p=0.013),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03497,rs290038,12,194966157,CD33,SNP (A/C),(A/,A,0.69,0.41,1.04,0.02935563,Moderate,0.047,0.186,0.253,0.314,Significant increase (p=0.035),Significant increase (p=0.034),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP03498,rs631865,2,83921092,APP,SNP (A/G),(A/,A,1.01,0.69,1.3,0.04545297,Moderate,0.03,0.185,0.467,0.118,Significant increase (p=0.028),No significant pattern (p=0.039),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03499,rs514008,10,182049827,ABCA7,SNP (C/T),(C/,C,1.89,1.69,2.21,0.01705459,High,0.134,0.133,0.289,0.244,Variable effect (p=0.016),Mild decrease (p=0.029),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03500,rs775636,22,242136675,CLU,SNP (A/G),(A/,A,1.16,0.93,1.55,0.00428689,High,0.321,0.007,0.145,0.327,Mild increase (p=0.032),Variable effect (p=0.044),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP03501,rs887383,6,54947069,PSEN2,Insertion,-,-,0.73,0.43,1.12,0.03960059,Protective,0.0,0.119,0.584,0.097,Significant increase (p=0.002),No significant pattern (p=0.029),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP03502,rs713375,7,188319117,CD33,SNP (G/T),(G/,G,1.41,1.09,1.76,0.10473542,Moderate,0.016,0.452,0.294,0.038,Variable effect (p=0.039),Mild decrease (p=0.039),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03503,rs373963,15,103152898,EPHA1,SNP (C/T),(C/,C,0.63,0.41,0.88,0.00049578,Unknown,0.038,0.55,0.041,0.172,No significant pattern (p=0.046),Significant decrease (p=0.043),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03504,rs575934,9,121927458,MS4A6A,SNP (A/G),(A/,A,0.45,0.11,0.71,0.04116528,High,0.083,0.471,0.224,0.023,Variable effect (p=0.022),Significant increase (p=0.048),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03505,rs385879,16,108079993,PICALM,SNP (G/T),(G/,G,0.57,0.34,0.88,0.00880174,Low,0.09,0.316,0.039,0.355,Significant decrease (p=0.011),Significant increase (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03506,rs576576,6,197249624,CD2AP,SNP (A/G),(A/,A,0.74,0.35,0.96,0.00339839,High,0.349,0.032,0.197,0.222,Significant increase (p=0.014),Mild decrease (p=0.004),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP03507,rs440319,20,220443581,PICALM,SNP (A/T),(A/,A,0.78,0.55,1.01,0.03431109,Low,0.483,0.009,0.242,0.067,Significant decrease (p=0.034),Mild decrease (p=0.04),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03508,rs693907,12,19873876,PTK2B,SNP (G/T),(G/,G,0.69,0.35,1.05,0.03798444,Moderate,0.114,0.062,0.457,0.167,No significant pattern (p=0.046),Significant decrease (p=0.018),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03509,rs513414,22,163284448,CD2AP,SNP (G/T),(G/,G,1.23,0.93,1.51,0.0177556,Moderate,0.3,0.168,0.235,0.097,Variable effect (p=0.006),Mild decrease (p=0.049),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03510,rs937302,19,244095841,CD33,Insertion,-,-,1.31,1.01,1.57,0.0265166,Moderate,0.365,0.268,0.107,0.061,Variable effect (p=0.025),Mild decrease (p=0.046),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03511,rs344306,14,63040912,CD33,Deletion,-,-,0.91,0.69,1.15,0.00646057,Moderate,0.241,0.268,0.045,0.246,Variable effect (p=0.008),Significant increase (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03512,rs497618,7,119513358,SORL1,SNP (A/T),(A/,A,1.33,1.05,1.58,0.00824125,Low,0.001,0.286,0.035,0.479,Significant increase (p=0.008),Mild decrease (p=0.046),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03513,rs796667,10,12795239,PICALM,SNP (A/C),(A/,A,2.14,1.89,2.44,0.00269609,High,0.012,0.587,0.066,0.134,Variable effect (p=0.021),Mild increase (p=0.019),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03514,rs351093,14,165896200,CR1,SNP (C/G),(C/,C,2.19,1.83,2.49,0.00184403,High,0.576,0.011,0.202,0.011,Variable effect (p=0.011),Significant increase (p=0.003),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03515,rs273499,14,186956796,CLU,SNP (A/G),(A/,A,0.79,0.58,1.12,0.0051998,High,0.38,0.026,0.32,0.074,No significant pattern (p=0.041),No significant pattern (p=0.048),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03516,rs155732,18,1640893,APOE,SNP (A/G),(A/,A,2.27,1.88,2.58,0.00040912,Unknown,0.258,0.165,0.165,0.212,Significant increase (p=0.044),Variable effect (p=0.033),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03517,rs530209,8,194196592,SORL1,SNP (G/T),(G/,G,1.31,0.97,1.54,0.02877647,High,0.439,0.241,0.073,0.047,Significant increase (p=0.024),Significant decrease (p=0.013),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03518,rs384908,10,233299936,ABCA7,SNP (G/T),(G/,G,1.3,0.91,1.63,0.03145893,Moderate,0.053,0.438,0.115,0.193,No significant pattern (p=0.013),Variable effect (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03519,rs316237,6,10759632,PICALM,SNP (A/T),(A/,A,0.91,0.54,1.16,0.00233946,Low,0.151,0.097,0.118,0.434,Mild increase (p=0.009),Mild decrease (p=0.01),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03520,rs909384,21,196830778,APP,SNP (A/C),(A/,A,0.92,0.59,1.21,0.00329932,Moderate,0.108,0.214,0.035,0.442,Significant decrease (p=0.035),Mild increase (p=0.043),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03521,rs250080,4,99860866,CD33,SNP (A/T),(A/,A,0.45,0.1,0.69,0.00047339,Moderate,0.172,0.055,0.504,0.069,Variable effect (p=0.028),Variable effect (p=0.043),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03522,rs484466,11,19223467,CLU,SNP (C/G),(C/,C,0.5,0.22,0.75,0.04060256,Protective,0.359,0.141,0.268,0.033,Significant increase (p=0.036),No significant pattern (p=0.043),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03523,rs723661,16,45503941,CR1,SNP (G/T),(G/,G,0.83,0.52,1.21,0.02787418,Moderate,0.195,0.072,0.069,0.463,No significant pattern (p=0.016),Mild increase (p=0.023),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03524,rs808643,14,13339016,CLU,SNP (C/G),(C/,C,1.05,0.76,1.26,0.01010726,Unknown,0.027,0.181,0.439,0.153,Mild increase (p=0.05),No significant pattern (p=0.002),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03525,rs784642,3,11107806,PTK2B,SNP (A/G),(A/,A,1.32,1.08,1.62,0.01762094,High,0.185,0.192,0.308,0.115,Significant increase (p=0.018),Mild decrease (p=0.049),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03526,rs368736,6,115266547,CD2AP,SNP (A/G),(A/,A,1.65,1.39,2.05,0.08238871,Moderate,0.047,0.192,0.404,0.158,Variable effect (p=0.004),Significant decrease (p=0.003),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03527,rs817604,6,242329580,EPHA1,Deletion,-,-,0.56,0.32,0.94,0.00658588,Moderate,0.106,0.047,0.572,0.075,Mild increase (p=0.042),Variable effect (p=0.027),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03528,rs484685,10,1998483,PSEN2,SNP (A/G),(A/,A,1.39,1.08,1.66,0.06846889,Moderate,0.661,0.055,0.019,0.065,No significant pattern (p=0.027),No significant pattern (p=0.025),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03529,rs919457,18,221766270,TREM2,SNP (A/T),(A/,A,1.24,0.89,1.62,0.03772796,High,0.325,0.396,0.066,0.012,Mild increase (p=0.027),Mild increase (p=0.027),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03530,rs847440,4,146157767,EPHA1,SNP (C/G),(C/,C,0.56,0.25,0.87,0.05599951,Protective,0.095,0.388,0.08,0.237,No significant pattern (p=0.036),Mild decrease (p=0.011),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03531,rs185377,8,134132106,MS4A6A,SNP (G/T),(G/,G,0.79,0.4,1.12,0.00384701,Moderate,0.276,0.292,0.119,0.114,Variable effect (p=0.047),Significant decrease (p=0.025),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03532,rs462936,14,228123216,ABCA7,SNP (A/C),(A/,A,0.97,0.72,1.36,0.03651881,High,0.036,0.427,0.298,0.04,Mild increase (p=0.042),Significant increase (p=0.045),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03533,rs563274,15,219884373,SORL1,SNP (C/T),(C/,C,0.31,0.1,0.51,0.11429633,Moderate,0.113,0.108,0.146,0.432,Variable effect (p=0.015),Mild decrease (p=0.029),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03534,rs432945,16,80374973,APOE,SNP (C/T),(C/,C,2.45,2.16,2.74,0.02247354,Low,0.28,0.157,0.332,0.031,Significant increase (p=0.018),Mild decrease (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03535,rs527874,13,233559750,APP,SNP (C/G),(C/,C,2.99,2.62,3.21,0.03383971,Unknown,0.029,0.182,0.037,0.553,Mild increase (p=0.022),Variable effect (p=0.044),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03536,rs188744,9,120994857,BIN1,SNP (A/G),(A/,A,0.58,0.37,0.88,0.03119806,Moderate,0.111,0.347,0.251,0.091,Mild decrease (p=0.036),Significant decrease (p=0.046),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03537,rs223090,21,158751698,CD33,Insertion,-,-,0.88,0.58,1.08,0.01232453,Moderate,0.003,0.159,0.46,0.178,Significant increase (p=0.016),Significant decrease (p=0.009),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP03538,rs151834,3,85724958,PICALM,SNP (C/T),(C/,C,1.63,1.39,1.85,0.07274848,Moderate,0.678,0.074,0.046,0.002,Significant increase (p=0.008),No significant pattern (p=0.033),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03539,rs366150,10,194480113,EPHA1,SNP (C/T),(C/,C,0.95,0.56,1.26,0.00994581,Moderate,0.414,0.102,0.277,0.007,No significant pattern (p=0.004),Variable effect (p=0.028),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03540,rs362484,21,19212476,SORL1,SNP (A/G),(A/,A,2.02,1.66,2.25,0.00625156,Moderate,0.432,0.1,0.181,0.086,Mild decrease (p=0.037),Variable effect (p=0.026),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03541,rs616287,2,113298389,MS4A6A,SNP (A/C),(A/,A,3.24,3.03,3.5,0.0732241,Protective,0.607,0.082,0.109,0.001,Mild decrease (p=0.035),Mild increase (p=0.023),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03542,rs133218,12,182921954,ABCA7,SNP (C/T),(C/,C,1.76,1.47,2.15,0.02339328,High,0.085,0.221,0.276,0.219,Variable effect (p=0.007),Variable effect (p=0.007),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03543,rs712090,20,17026617,EPHA1,Insertion,-,-,1.58,1.29,1.9,0.02129537,Moderate,0.219,0.343,0.116,0.122,No significant pattern (p=0.047),No significant pattern (p=0.039),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP03544,rs576918,14,100285884,CLU,SNP (A/C),(A/,A,1.81,1.47,2.18,0.08822046,Moderate,0.035,0.293,0.212,0.26,Significant decrease (p=0.035),Significant increase (p=0.005),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03545,rs644398,5,190369737,CD2AP,SNP (G/T),(G/,G,0.81,0.49,1.09,0.03131933,High,0.149,0.185,0.422,0.045,No significant pattern (p=0.011),Variable effect (p=0.017),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03546,rs483407,13,99192514,CD2AP,SNP (G/T),(G/,G,0.93,0.71,1.16,0.00318055,Moderate,0.384,0.039,0.193,0.185,Significant increase (p=0.013),Significant decrease (p=0.041),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03547,rs879503,4,56182328,BIN1,SNP (G/T),(G/,G,0.91,0.53,1.19,0.0218756,Moderate,0.058,0.159,0.017,0.566,Mild increase (p=0.033),Mild increase (p=0.019),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03548,rs619669,7,53988958,CR1,SNP (C/T),(C/,C,2.0,1.66,2.33,0.02578002,Protective,0.207,0.259,0.295,0.04,Mild increase (p=0.005),Mild decrease (p=0.023),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03549,rs917746,19,109322362,TREM2,SNP (C/T),(C/,C,1.46,1.06,1.73,8.424e-05,High,0.431,0.045,0.232,0.093,Variable effect (p=0.029),Mild decrease (p=0.016),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03550,rs475052,18,114326527,APP,SNP (C/T),(C/,C,0.6,0.22,0.83,0.03337339,Moderate,0.574,0.057,0.056,0.113,No significant pattern (p=0.009),No significant pattern (p=0.009),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03551,rs499454,21,6109964,BIN1,SNP (A/T),(A/,A,0.65,0.39,1.02,0.02116935,High,0.327,0.197,0.153,0.124,Mild decrease (p=0.007),Variable effect (p=0.032),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03552,rs826523,18,193132484,CD33,SNP (C/T),(C/,C,0.83,0.54,1.05,0.04357024,High,0.123,0.178,0.395,0.104,Significant decrease (p=0.015),Significant increase (p=0.007),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03553,rs626593,11,89115666,BIN1,SNP (A/C),(A/,A,0.47,0.21,0.72,0.07785835,Protective,0.142,0.363,0.078,0.216,No significant pattern (p=0.01),Variable effect (p=0.013),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP03554,rs673661,19,90665878,PSEN2,SNP (A/T),(A/,A,1.11,0.9,1.44,0.00782504,Moderate,0.119,0.007,0.582,0.092,No significant pattern (p=0.019),Variable effect (p=0.041),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03555,rs377356,4,220953412,ABCA7,SNP (C/T),(C/,C,0.85,0.59,1.22,0.01101288,Low,0.005,0.027,0.106,0.662,Mild increase (p=0.006),Mild increase (p=0.016),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03556,rs691585,8,145402763,CR1,Deletion,-,-,0.9,0.7,1.25,0.00617969,Moderate,0.466,0.006,0.044,0.284,Mild decrease (p=0.008),No significant pattern (p=0.043),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03557,rs455136,11,84568028,TREM2,SNP (C/T),(C/,C,1.54,1.33,1.89,0.03742302,Moderate,0.045,0.151,0.451,0.153,Significant increase (p=0.027),Mild increase (p=0.05),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03558,rs368430,22,189378520,TREM2,SNP (A/C),(A/,A,0.51,0.21,0.86,0.02687375,Protective,0.083,0.276,0.343,0.098,Significant decrease (p=0.033),Mild increase (p=0.031),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03559,rs637439,8,206066644,CR1,Insertion,-,-,0.63,0.36,0.86,0.00796062,High,0.236,0.05,0.159,0.355,Significant increase (p=0.023),Significant increase (p=0.009),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP03560,rs493079,22,124046009,MS4A6A,SNP (A/T),(A/,A,0.43,0.1,0.67,0.09351809,Low,0.035,0.059,0.567,0.139,No significant pattern (p=0.018),Variable effect (p=0.032),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP03561,rs130020,12,45901635,APP,SNP (A/G),(A/,A,0.62,0.31,0.85,0.00396587,Low,0.018,0.502,0.262,0.017,Variable effect (p=0.01),Significant increase (p=0.008),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03562,rs657152,2,199092905,APOE,SNP (C/G),(C/,C,1.24,0.94,1.55,0.12417493,Low,0.28,0.013,0.079,0.428,Significant increase (p=0.046),No significant pattern (p=0.02),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03563,rs375658,5,155392089,APOE,SNP (G/T),(G/,G,0.61,0.27,0.93,0.11104274,Low,0.519,0.026,0.065,0.19,No significant pattern (p=0.017),Mild increase (p=0.026),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03564,rs725024,17,23189995,ABCA7,SNP (A/C),(A/,A,0.81,0.45,1.18,0.01921823,Unknown,0.096,0.332,0.371,0.001,Variable effect (p=0.004),Mild decrease (p=0.02),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03565,rs932521,20,55307123,SORL1,Insertion,-,-,0.8,0.54,1.16,0.02935261,High,0.375,0.124,0.042,0.259,Significant increase (p=0.02),Mild increase (p=0.048),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03566,rs293865,15,82884280,PTK2B,SNP (C/T),(C/,C,1.09,0.7,1.42,0.01042357,Low,0.324,0.072,0.027,0.376,No significant pattern (p=0.034),Mild decrease (p=0.024),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03567,rs875620,1,159797360,PTK2B,SNP (G/T),(G/,G,0.49,0.24,0.79,0.00253254,Moderate,0.011,0.183,0.376,0.231,No significant pattern (p=0.037),Mild decrease (p=0.028),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03568,rs486052,19,52232615,MS4A6A,SNP (C/G),(C/,C,0.82,0.53,1.13,0.00748203,Low,0.263,0.191,0.186,0.16,Significant decrease (p=0.009),Mild decrease (p=0.03),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03569,rs979515,9,85099178,PTK2B,SNP (A/G),(A/,A,1.44,1.16,1.81,0.00643797,Moderate,0.266,0.023,0.44,0.071,Mild decrease (p=0.009),Mild decrease (p=0.005),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03570,rs550865,11,16065881,PSEN2,SNP (G/T),(G/,G,0.77,0.39,0.97,0.04512373,High,0.089,0.079,0.392,0.24,Significant increase (p=0.008),Significant increase (p=0.01),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03571,rs176142,7,231008628,CD33,SNP (C/G),(C/,C,0.56,0.23,0.85,0.03591732,Protective,0.146,0.157,0.005,0.492,Significant increase (p=0.026),No significant pattern (p=0.01),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03572,rs188269,5,168398897,TREM2,SNP (A/T),(A/,A,0.42,0.1,0.62,0.12079734,Protective,0.662,0.004,0.133,0.001,Variable effect (p=0.005),Variable effect (p=0.018),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03573,rs763438,9,40253143,CLU,SNP (G/T),(G/,G,2.23,1.83,2.43,0.02720551,Protective,0.407,0.262,0.104,0.027,Significant increase (p=0.029),No significant pattern (p=0.003),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03574,rs728816,4,34158704,APOE,SNP (G/T),(G/,G,0.66,0.36,0.87,0.07194572,Moderate,0.006,0.497,0.145,0.152,Mild decrease (p=0.029),Significant decrease (p=0.048),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03575,rs666957,5,112330836,SORL1,SNP (A/C),(A/,A,0.81,0.46,1.18,0.00660699,Low,0.5,0.07,0.117,0.112,Mild increase (p=0.028),Mild increase (p=0.048),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03576,rs216073,5,87175795,MS4A6A,SNP (A/G),(A/,A,0.82,0.54,1.02,0.00823333,High,0.113,0.029,0.218,0.441,No significant pattern (p=0.005),Significant increase (p=0.011),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03577,rs248148,16,78247112,EPHA1,SNP (A/T),(A/,A,0.58,0.31,0.81,0.00466148,High,0.191,0.283,0.31,0.016,Mild increase (p=0.023),No significant pattern (p=0.006),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03578,rs889007,18,88449184,TREM2,SNP (C/T),(C/,C,1.07,0.78,1.47,0.04965852,Protective,0.06,0.136,0.392,0.212,Significant decrease (p=0.038),Significant increase (p=0.007),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03579,rs183524,4,176864853,PTK2B,SNP (A/G),(A/,A,1.88,1.52,2.2,0.02825829,Moderate,0.056,0.004,0.523,0.218,Mild decrease (p=0.002),Significant increase (p=0.013),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03580,rs576472,16,53565402,CLU,SNP (A/C),(A/,A,0.61,0.31,0.97,0.00373585,Moderate,0.489,0.048,0.018,0.245,Mild decrease (p=0.032),Variable effect (p=0.031),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP03581,rs850318,10,3261297,SORL1,SNP (A/G),(A/,A,0.5,0.18,0.83,0.01793641,Low,0.249,0.044,0.043,0.464,Mild increase (p=0.031),No significant pattern (p=0.048),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03582,rs244877,22,85258842,BIN1,SNP (G/T),(G/,G,0.99,0.67,1.35,0.04747416,Protective,0.146,0.175,0.444,0.036,Variable effect (p=0.028),Significant decrease (p=0.035),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03583,rs131198,3,3863175,PTK2B,SNP (A/T),(A/,A,0.98,0.78,1.34,0.02219712,Low,0.101,0.039,0.165,0.494,Variable effect (p=0.04),Variable effect (p=0.007),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03584,rs663087,19,205100342,MS4A6A,Deletion,-,-,1.8,1.52,2.18,0.07381517,Moderate,0.095,0.15,0.401,0.155,Mild increase (p=0.007),Significant increase (p=0.047),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03585,rs511564,14,225496491,ABCA7,SNP (C/T),(C/,C,1.46,1.13,1.83,0.00863324,Moderate,0.42,0.313,0.062,0.005,Significant increase (p=0.017),Significant decrease (p=0.016),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03586,rs413300,17,96657319,ABCA7,Insertion,-,-,0.83,0.51,1.04,0.04826408,Unknown,0.254,0.058,0.178,0.31,No significant pattern (p=0.041),Mild increase (p=0.049),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP03587,rs294978,11,93155000,CD33,SNP (A/G),(A/,A,1.44,1.15,1.7,0.03668976,High,0.002,0.346,0.252,0.2,No significant pattern (p=0.037),Significant decrease (p=0.024),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP03588,rs489834,19,239511170,PTK2B,SNP (A/T),(A/,A,1.0,0.77,1.4,0.00130386,High,0.017,0.062,0.674,0.047,Significant increase (p=0.037),Mild decrease (p=0.029),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03589,rs251421,9,139380839,CR1,Insertion,-,-,0.87,0.53,1.08,0.0220683,Moderate,0.164,0.515,0.004,0.117,Significant increase (p=0.02),Significant decrease (p=0.023),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03590,rs275152,5,208645473,CLU,SNP (A/G),(A/,A,1.48,1.19,1.83,0.05423743,Moderate,0.152,0.03,0.6,0.018,Variable effect (p=0.018),Mild increase (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03591,rs171318,16,78754334,MS4A6A,SNP (A/C),(A/,A,0.77,0.57,1.16,0.03042438,Protective,0.031,0.421,0.005,0.343,Mild decrease (p=0.039),No significant pattern (p=0.036),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03592,rs518007,5,242020720,PSEN2,SNP (C/G),(C/,C,0.95,0.61,1.32,0.00716847,Low,0.207,0.072,0.195,0.326,Significant decrease (p=0.017),Mild decrease (p=0.047),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03593,rs359877,8,212790667,PSEN2,SNP (G/T),(G/,G,0.58,0.35,0.89,0.11960364,Low,0.408,0.178,0.003,0.211,Significant increase (p=0.004),Mild increase (p=0.015),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03594,rs581155,10,66222301,APP,SNP (C/G),(C/,C,1.11,0.9,1.34,0.01438809,High,0.149,0.17,0.453,0.028,Mild decrease (p=0.046),Mild decrease (p=0.035),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP03595,rs260164,12,83197792,APP,Insertion,-,-,0.76,0.46,0.97,0.03886214,Protective,0.078,0.471,0.144,0.107,No significant pattern (p=0.027),Significant decrease (p=0.032),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03596,rs573304,11,240345938,BIN1,SNP (A/C),(A/,A,0.85,0.45,1.11,0.06929224,Moderate,0.088,0.348,0.158,0.206,Mild increase (p=0.001),No significant pattern (p=0.031),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03597,rs958390,2,241675819,ABCA7,SNP (G/T),(G/,G,1.3,1.04,1.58,0.00234237,Moderate,0.368,0.067,0.108,0.258,Variable effect (p=0.039),No significant pattern (p=0.026),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03598,rs161700,21,42460266,MS4A6A,SNP (C/T),(C/,C,2.12,1.82,2.35,0.09020739,High,0.193,0.035,0.16,0.412,Variable effect (p=0.029),Significant decrease (p=0.017),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03599,rs211507,22,63125286,CD2AP,SNP (C/T),(C/,C,0.89,0.66,1.15,0.02495901,High,0.162,0.359,0.263,0.016,Variable effect (p=0.018),No significant pattern (p=0.02),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03600,rs396721,2,61973189,PICALM,Deletion,-,-,2.03,1.82,2.32,0.00570485,High,0.214,0.239,0.232,0.114,No significant pattern (p=0.046),Variable effect (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03601,rs378430,2,39260895,EPHA1,SNP (G/T),(G/,G,0.96,0.69,1.22,0.04294623,Moderate,0.095,0.053,0.043,0.61,No significant pattern (p=0.01),Variable effect (p=0.001),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP03602,rs361152,17,160022914,PSEN2,SNP (C/G),(C/,C,0.92,0.59,1.15,0.03472148,High,0.05,0.125,0.435,0.19,Mild decrease (p=0.027),Mild decrease (p=0.022),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03603,rs979747,4,86260027,PSEN2,SNP (C/T),(C/,C,1.15,0.86,1.52,0.05358388,High,0.292,0.149,0.284,0.075,Mild increase (p=0.045),Mild increase (p=0.027),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03604,rs160776,18,168636938,ABCA7,Insertion,-,-,1.05,0.7,1.33,0.06527667,Unknown,0.097,0.414,0.147,0.142,Mild increase (p=0.002),Significant increase (p=0.047),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03605,rs968538,8,22311725,SORL1,SNP (A/T),(A/,A,0.7,0.37,1.03,0.01473425,Unknown,0.098,0.399,0.001,0.301,Mild decrease (p=0.044),Significant increase (p=0.018),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP03606,rs498439,2,89662256,PSEN2,SNP (C/G),(C/,C,0.58,0.23,0.98,0.00753307,Moderate,0.092,0.311,0.302,0.094,Mild decrease (p=0.012),Mild decrease (p=0.021),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03607,rs416419,9,197775638,EPHA1,SNP (G/T),(G/,G,1.12,0.8,1.43,0.10844043,Moderate,0.004,0.501,0.161,0.134,Mild increase (p=0.022),Mild decrease (p=0.04),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP03608,rs413180,15,225506759,EPHA1,Insertion,-,-,1.0,0.74,1.34,0.05322928,Moderate,0.45,0.121,0.077,0.151,Mild increase (p=0.006),No significant pattern (p=0.031),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03609,rs423320,21,129329638,CD33,SNP (C/T),(C/,C,0.43,0.17,0.76,0.08063074,Moderate,0.205,0.115,0.241,0.24,Variable effect (p=0.004),No significant pattern (p=0.018),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03610,rs287463,11,55102217,PICALM,SNP (C/G),(C/,C,1.52,1.15,1.9,0.01076221,Low,0.282,0.117,0.325,0.076,Variable effect (p=0.028),Mild increase (p=0.021),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP03611,rs442176,5,168891452,CR1,SNP (C/G),(C/,C,1.15,0.85,1.51,0.01202112,High,0.174,0.18,0.398,0.047,Mild increase (p=0.018),Variable effect (p=0.025),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP03612,rs545167,6,155252086,MS4A6A,SNP (A/C),(A/,A,1.33,0.96,1.64,0.01563206,High,0.508,0.077,0.188,0.027,Mild increase (p=0.031),Mild decrease (p=0.02),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03613,rs871781,11,117461608,APOE,SNP (A/T),(A/,A,0.32,0.1,0.67,0.00326912,Low,0.27,0.295,0.195,0.04,Mild decrease (p=0.011),No significant pattern (p=0.026),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03614,rs120510,12,187474148,TREM2,SNP (G/T),(G/,G,1.25,0.9,1.58,0.04467029,Moderate,0.366,0.295,0.134,0.005,Mild increase (p=0.035),Mild decrease (p=0.04),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03615,rs728434,6,87480168,APP,SNP (C/T),(C/,C,1.26,0.98,1.51,0.02238962,High,0.17,0.427,0.169,0.034,Significant increase (p=0.036),Mild decrease (p=0.021),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03616,rs699363,18,159242053,APOE,Deletion,-,-,1.93,1.56,2.29,0.04335519,Moderate,0.195,0.012,0.001,0.592,Significant increase (p=0.023),Significant decrease (p=0.021),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03617,rs209710,22,178990862,PICALM,SNP (A/G),(A/,A,1.12,0.86,1.45,0.05939946,Low,0.079,0.377,0.217,0.127,Variable effect (p=0.049),Significant increase (p=0.038),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03618,rs260949,18,177755267,APP,Deletion,-,-,0.43,0.1,0.76,0.00506687,Moderate,0.094,0.33,0.058,0.317,Mild decrease (p=0.029),Significant increase (p=0.024),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03619,rs820062,21,51165163,APOE,SNP (C/G),(C/,C,0.29,0.1,0.55,0.00967663,High,0.46,0.162,0.136,0.042,No significant pattern (p=0.011),No significant pattern (p=0.044),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03620,rs830264,7,108815808,MS4A6A,Insertion,-,-,1.44,1.14,1.79,0.0162321,Moderate,0.334,0.13,0.167,0.169,Mild decrease (p=0.022),Significant increase (p=0.005),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03621,rs930544,6,109535882,PTK2B,SNP (A/C),(A/,A,0.93,0.56,1.19,0.01189769,Moderate,0.296,0.046,0.28,0.179,No significant pattern (p=0.001),Significant increase (p=0.004),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03622,rs794434,4,245962362,SORL1,SNP (G/T),(G/,G,2.06,1.69,2.37,0.01914452,High,0.067,0.094,0.564,0.075,Mild increase (p=0.001),Significant increase (p=0.027),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03623,rs116018,7,105288021,PTK2B,Deletion,-,-,1.57,1.26,1.88,0.02154281,Protective,0.496,0.041,0.09,0.174,Mild increase (p=0.023),Significant decrease (p=0.031),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03624,rs329606,17,205570681,PSEN2,SNP (A/G),(A/,A,0.79,0.58,1.03,0.02980833,High,0.087,0.013,0.597,0.103,Significant decrease (p=0.01),Significant decrease (p=0.03),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03625,rs500190,7,73875864,TREM2,SNP (C/T),(C/,C,0.94,0.59,1.32,0.03925305,Protective,0.13,0.366,0.267,0.037,Significant increase (p=0.046),Significant decrease (p=0.05),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03626,rs375447,13,14342547,EPHA1,SNP (C/G),(C/,C,2.69,2.46,3.05,0.00460178,Low,0.031,0.34,0.195,0.234,Significant decrease (p=0.045),Mild increase (p=0.014),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03627,rs853970,10,235584985,BIN1,SNP (A/G),(A/,A,0.3,0.1,0.61,0.05225742,High,0.575,0.053,0.02,0.152,Significant decrease (p=0.022),Significant increase (p=0.005),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03628,rs626551,18,9357629,CR1,SNP (A/T),(A/,A,0.72,0.37,0.96,0.03544616,High,0.221,0.159,0.107,0.313,No significant pattern (p=0.021),Mild increase (p=0.046),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03629,rs490272,6,9773670,CD33,SNP (A/T),(A/,A,1.03,0.79,1.29,0.13436944,Low,0.468,0.01,0.245,0.077,Mild increase (p=0.037),Mild increase (p=0.002),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03630,rs499045,17,85000470,CD33,SNP (C/G),(C/,C,1.68,1.3,1.94,0.01671016,Unknown,0.376,0.053,0.169,0.201,Significant decrease (p=0.019),Mild decrease (p=0.017),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03631,rs683668,9,98317123,TREM2,Insertion,-,-,1.34,0.99,1.7,0.02103788,Low,0.271,0.44,0.003,0.086,Mild decrease (p=0.047),Mild increase (p=0.036),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03632,rs559380,11,9367985,TREM2,SNP (A/G),(A/,A,1.35,1.12,1.66,0.00540174,Low,0.325,0.302,0.145,0.028,No significant pattern (p=0.018),Variable effect (p=0.005),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03633,rs178883,4,215954376,CLU,SNP (C/G),(C/,C,1.43,1.18,1.71,0.02264027,High,0.054,0.108,0.222,0.416,Mild increase (p=0.042),Significant increase (p=0.029),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP03634,rs499847,15,11399739,CR1,SNP (G/T),(G/,G,2.19,1.97,2.44,0.03038798,Unknown,0.196,0.301,0.139,0.164,No significant pattern (p=0.022),Mild decrease (p=0.022),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03635,rs124974,10,202701150,SORL1,Deletion,-,-,0.54,0.27,0.87,0.004299,Moderate,0.255,0.139,0.223,0.183,Significant increase (p=0.049),Mild decrease (p=0.006),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP03636,rs941467,15,82921231,CLU,SNP (A/T),(A/,A,1.08,0.76,1.35,0.03589683,Moderate,0.151,0.499,0.099,0.05,Significant decrease (p=0.022),Significant decrease (p=0.012),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03637,rs313184,17,91384509,APOE,SNP (G/T),(G/,G,1.63,1.34,1.9,0.02051027,Low,0.111,0.321,0.262,0.106,No significant pattern (p=0.033),Significant decrease (p=0.046),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03638,rs168503,3,37703684,PICALM,SNP (A/T),(A/,A,1.57,1.19,1.81,0.03215062,Moderate,0.199,0.219,0.145,0.237,Variable effect (p=0.029),Significant decrease (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03639,rs448457,6,217510843,APP,Deletion,-,-,1.22,0.86,1.55,0.04314518,High,0.271,0.257,0.03,0.241,Significant increase (p=0.002),Significant decrease (p=0.011),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03640,rs348030,5,13586527,CD2AP,SNP (C/G),(C/,C,1.22,0.98,1.49,0.0134314,High,0.22,0.112,0.045,0.423,Mild increase (p=0.03),Mild increase (p=0.046),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03641,rs688846,11,158300618,PTK2B,SNP (A/T),(A/,A,1.04,0.84,1.28,0.00462592,Low,0.087,0.019,0.206,0.488,Significant increase (p=0.015),Significant decrease (p=0.007),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03642,rs138900,14,93362434,PICALM,SNP (A/T),(A/,A,0.96,0.76,1.31,0.01101177,High,0.232,0.043,0.285,0.24,Significant decrease (p=0.046),Significant increase (p=0.038),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP03643,rs600328,15,88116851,MS4A6A,SNP (G/T),(G/,G,0.8,0.53,1.13,0.02548063,High,0.216,0.514,0.069,0.0,Mild increase (p=0.005),Significant increase (p=0.037),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03644,rs390954,14,28407945,APP,Deletion,-,-,1.18,0.89,1.56,0.07119609,High,0.607,0.038,0.043,0.111,Mild decrease (p=0.008),Mild increase (p=0.009),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03645,rs753555,22,107213902,CR1,SNP (A/G),(A/,A,1.28,1.01,1.54,0.03131533,High,0.035,0.123,0.33,0.312,Mild increase (p=0.048),Variable effect (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03646,rs821989,4,181602843,MS4A6A,Insertion,-,-,1.13,0.79,1.43,0.02625229,Moderate,0.049,0.254,0.315,0.181,Mild increase (p=0.025),Mild decrease (p=0.046),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP03647,rs478878,16,114469173,APP,SNP (G/T),(G/,G,0.4,0.12,0.78,0.13899688,Moderate,0.001,0.482,0.26,0.057,Mild decrease (p=0.006),Variable effect (p=0.042),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03648,rs308077,22,162083705,CR1,SNP (G/T),(G/,G,0.45,0.15,0.77,0.01452427,Moderate,0.206,0.041,0.122,0.431,Significant decrease (p=0.011),Significant increase (p=0.044),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03649,rs285265,17,186182902,APOE,SNP (A/G),(A/,A,1.01,0.68,1.23,0.01936835,High,0.099,0.157,0.37,0.175,Significant increase (p=0.003),Significant increase (p=0.029),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03650,rs869124,3,136285798,MS4A6A,Deletion,-,-,0.93,0.54,1.22,0.04642219,High,0.416,0.231,0.129,0.024,Mild increase (p=0.021),Mild increase (p=0.034),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03651,rs132559,12,243548518,CD33,SNP (C/T),(C/,C,0.88,0.64,1.14,0.00404843,Low,0.004,0.595,0.151,0.05,Significant decrease (p=0.037),Significant decrease (p=0.043),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03652,rs970951,17,216305242,CD2AP,Deletion,-,-,1.57,1.21,1.95,0.03414363,Moderate,0.04,0.122,0.04,0.598,Mild increase (p=0.046),Significant decrease (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03653,rs475646,18,11746082,BIN1,Deletion,-,-,0.79,0.56,1.07,0.01569395,Protective,0.495,0.035,0.223,0.047,Variable effect (p=0.041),Significant increase (p=0.038),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03654,rs179814,4,34345147,PICALM,SNP (A/C),(A/,A,1.81,1.61,2.02,0.02765306,High,0.154,0.238,0.122,0.286,Mild decrease (p=0.035),Variable effect (p=0.005),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03655,rs272229,10,11734944,SORL1,Insertion,-,-,0.95,0.6,1.32,0.02746183,Low,0.052,0.612,0.03,0.106,Mild increase (p=0.034),Significant increase (p=0.045),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03656,rs522772,18,65931697,BIN1,SNP (A/T),(A/,A,1.02,0.67,1.34,0.00405565,Protective,0.405,0.123,0.166,0.106,Mild increase (p=0.03),Significant increase (p=0.007),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03657,rs632043,17,66465829,EPHA1,SNP (A/C),(A/,A,1.01,0.75,1.41,0.01997963,High,0.051,0.294,0.012,0.443,Significant decrease (p=0.027),No significant pattern (p=0.014),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03658,rs189960,17,246792753,SORL1,SNP (C/T),(C/,C,1.8,1.44,2.05,0.01595489,Unknown,0.548,0.155,0.096,0.0,No significant pattern (p=0.035),Mild increase (p=0.015),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03659,rs273903,15,55058451,CD2AP,SNP (C/T),(C/,C,1.88,1.49,2.21,0.03006882,Moderate,0.174,0.135,0.144,0.348,Mild decrease (p=0.017),Variable effect (p=0.022),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03660,rs976203,10,244032456,EPHA1,SNP (A/T),(A/,A,0.68,0.39,0.97,0.01816555,High,0.118,0.135,0.209,0.338,Mild increase (p=0.025),Mild increase (p=0.015),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03661,rs285901,9,235812962,TREM2,SNP (C/T),(C/,C,1.37,1.15,1.59,0.00537235,Moderate,0.163,0.151,0.348,0.138,Significant decrease (p=0.007),Mild increase (p=0.008),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03662,rs822365,13,9162053,PICALM,SNP (A/T),(A/,A,0.47,0.16,0.77,0.01278513,High,0.16,0.06,0.521,0.058,Significant increase (p=0.035),Mild decrease (p=0.043),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03663,rs648314,2,58883545,APP,Insertion,-,-,0.82,0.54,1.03,0.01579901,Protective,0.049,0.302,0.366,0.083,Variable effect (p=0.008),Significant decrease (p=0.005),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03664,rs723194,21,191077842,SORL1,SNP (A/C),(A/,A,1.44,1.15,1.75,0.01523427,High,0.284,0.008,0.208,0.3,Significant increase (p=0.02),Mild increase (p=0.045),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP03665,rs799208,18,102457482,APP,Deletion,-,-,0.39,0.13,0.67,0.02321797,High,0.224,0.158,0.092,0.326,Significant increase (p=0.034),No significant pattern (p=0.044),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03666,rs205188,13,224555690,APOE,SNP (C/G),(C/,C,1.08,0.7,1.37,0.01613307,Protective,0.033,0.222,0.513,0.032,No significant pattern (p=0.046),Variable effect (p=0.005),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03667,rs995346,5,217166217,PICALM,Insertion,-,-,0.72,0.36,1.08,5.832e-05,High,0.184,0.33,0.021,0.266,No significant pattern (p=0.032),Variable effect (p=0.017),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03668,rs557965,20,13263941,CR1,SNP (G/T),(G/,G,0.73,0.46,1.01,0.03728503,High,0.067,0.252,0.318,0.163,Mild decrease (p=0.026),Mild increase (p=0.049),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03669,rs162710,14,42370187,ABCA7,SNP (A/C),(A/,A,1.1,0.89,1.41,0.13495152,Low,0.251,0.436,0.11,0.003,No significant pattern (p=0.027),Variable effect (p=0.014),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03670,rs758382,17,238940172,CD33,SNP (C/T),(C/,C,0.48,0.18,0.75,0.04044202,High,0.144,0.505,0.12,0.031,Significant decrease (p=0.006),Significant decrease (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03671,rs342300,1,204032454,EPHA1,SNP (C/T),(C/,C,0.55,0.26,0.78,0.04255907,Low,0.048,0.241,0.497,0.014,Mild increase (p=0.003),Variable effect (p=0.014),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03672,rs259390,6,6473595,SORL1,Insertion,-,-,0.68,0.3,1.0,0.01395925,Low,0.31,0.004,0.15,0.337,Mild increase (p=0.015),Mild increase (p=0.032),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03673,rs355637,8,119129030,APP,SNP (G/T),(G/,G,0.93,0.72,1.18,0.08741771,High,0.247,0.034,0.209,0.309,No significant pattern (p=0.005),Mild increase (p=0.021),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03674,rs444476,3,188043117,MS4A6A,SNP (A/T),(A/,A,0.42,0.22,0.72,0.05790579,Low,0.284,0.172,0.037,0.307,Mild decrease (p=0.047),Significant increase (p=0.035),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03675,rs837555,8,206501043,PTK2B,Insertion,-,-,1.08,0.87,1.46,0.03536977,High,0.336,0.217,0.131,0.116,Significant increase (p=0.02),Mild increase (p=0.048),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03676,rs669923,17,202975682,APOE,SNP (C/G),(C/,C,1.1,0.73,1.43,0.0133693,High,0.029,0.001,0.205,0.564,Mild decrease (p=0.05),Significant increase (p=0.04),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03677,rs282625,15,110343012,SORL1,Deletion,-,-,0.41,0.15,0.69,0.00048316,High,0.31,0.084,0.188,0.218,Mild increase (p=0.032),Mild decrease (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03678,rs734969,14,240960151,PSEN2,Insertion,-,-,1.15,0.87,1.55,0.03486844,High,0.047,0.262,0.015,0.475,Mild decrease (p=0.01),No significant pattern (p=0.016),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03679,rs376935,11,113767769,BIN1,SNP (G/T),(G/,G,1.25,1.01,1.57,0.00161731,Moderate,0.488,0.162,0.064,0.086,Significant increase (p=0.023),Variable effect (p=0.041),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03680,rs933110,3,188945935,APOE,SNP (A/G),(A/,A,0.79,0.4,1.14,0.05376517,Low,0.297,0.196,0.206,0.101,Variable effect (p=0.043),Significant increase (p=0.029),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03681,rs450181,22,85629546,TREM2,Insertion,-,-,1.19,0.95,1.51,0.00372644,High,0.133,0.167,0.234,0.265,No significant pattern (p=0.03),Mild decrease (p=0.007),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03682,rs272997,17,85898511,BIN1,SNP (C/T),(C/,C,1.07,0.81,1.34,0.00608513,High,0.539,0.176,0.059,0.027,Variable effect (p=0.013),Variable effect (p=0.022),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03683,rs976303,4,7029783,TREM2,SNP (C/T),(C/,C,0.42,0.2,0.65,0.07036711,Protective,0.021,0.172,0.037,0.57,No significant pattern (p=0.024),Mild decrease (p=0.005),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03684,rs890276,16,203668792,APOE,SNP (A/C),(A/,A,2.3,1.99,2.57,0.05189283,High,0.668,0.03,0.029,0.073,Significant increase (p=0.011),Significant increase (p=0.017),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03685,rs201435,18,26603328,CD2AP,SNP (A/C),(A/,A,1.78,1.53,2.14,0.03989492,Moderate,0.032,0.471,0.151,0.146,No significant pattern (p=0.008),Significant increase (p=0.018),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03686,rs793220,8,178210514,APOE,SNP (C/T),(C/,C,1.13,0.74,1.43,0.02765439,High,0.08,0.475,0.105,0.14,Significant increase (p=0.033),Variable effect (p=0.022),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP03687,rs112233,13,240932894,TREM2,SNP (A/C),(A/,A,0.67,0.33,1.06,0.01165591,High,0.089,0.261,0.127,0.322,No significant pattern (p=0.045),Mild decrease (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03688,rs527422,22,83009285,BIN1,SNP (A/T),(A/,A,0.86,0.55,1.21,0.03422035,High,0.123,0.128,0.047,0.502,Significant increase (p=0.031),Mild decrease (p=0.014),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP03689,rs320689,5,240875507,CD2AP,SNP (A/G),(A/,A,1.54,1.2,1.79,0.03762693,High,0.013,0.067,0.371,0.348,Mild increase (p=0.021),Significant decrease (p=0.039),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03690,rs792716,6,125779919,EPHA1,SNP (A/C),(A/,A,0.66,0.46,0.92,0.01767102,Moderate,0.305,0.162,0.302,0.032,Significant decrease (p=0.029),Mild decrease (p=0.012),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03691,rs957286,14,22654435,TREM2,SNP (A/T),(A/,A,1.55,1.29,1.77,0.07344459,High,0.058,0.371,0.329,0.043,No significant pattern (p=0.047),Significant increase (p=0.035),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP03692,rs914148,19,19511426,MS4A6A,Insertion,-,-,0.84,0.57,1.13,0.0017034,High,0.236,0.037,0.4,0.128,Significant increase (p=0.042),Mild increase (p=0.042),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03693,rs628204,8,76530997,EPHA1,SNP (G/T),(G/,G,0.93,0.68,1.25,0.0180127,Moderate,0.191,0.303,0.199,0.106,Significant decrease (p=0.014),Mild increase (p=0.008),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03694,rs387030,5,234535789,CD2AP,Insertion,-,-,1.93,1.55,2.22,0.01161372,High,0.256,0.293,0.237,0.014,Significant increase (p=0.003),Mild decrease (p=0.004),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03695,rs739920,12,61676932,MS4A6A,Insertion,-,-,1.23,1.0,1.58,0.07609514,Moderate,0.006,0.318,0.3,0.175,Mild increase (p=0.035),No significant pattern (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03696,rs259962,22,99848114,PSEN2,SNP (A/G),(A/,A,0.51,0.3,0.89,0.01044516,Moderate,0.265,0.166,0.027,0.341,Significant increase (p=0.018),Variable effect (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03697,rs916180,20,227026722,PICALM,SNP (G/T),(G/,G,0.55,0.21,0.89,0.00701554,Low,0.235,0.163,0.098,0.304,Significant increase (p=0.005),Significant increase (p=0.008),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03698,rs620023,9,7767613,CD2AP,SNP (G/T),(G/,G,1.45,1.12,1.85,0.01502896,Protective,0.073,0.389,0.034,0.304,Variable effect (p=0.008),Significant decrease (p=0.011),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03699,rs769022,16,1261060,APP,Insertion,-,-,1.62,1.4,1.94,0.01900243,High,0.085,0.324,0.057,0.334,Mild decrease (p=0.005),Mild increase (p=0.021),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03700,rs216758,5,107891091,SORL1,SNP (C/T),(C/,C,1.38,1.06,1.74,0.11651242,High,0.061,0.082,0.113,0.544,Significant decrease (p=0.039),Mild decrease (p=0.039),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03701,rs956389,8,151244035,EPHA1,SNP (C/T),(C/,C,0.5,0.11,0.72,0.00590987,Unknown,0.735,0.033,0.026,0.006,Variable effect (p=0.007),Mild decrease (p=0.026),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03702,rs518064,14,53695700,ABCA7,SNP (G/T),(G/,G,2.0,1.72,2.31,0.00982668,Moderate,0.133,0.084,0.419,0.164,Significant decrease (p=0.028),Significant increase (p=0.029),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03703,rs853904,1,177972541,CD33,SNP (A/G),(A/,A,1.82,1.55,2.15,0.03450817,High,0.137,0.513,0.11,0.04,Mild decrease (p=0.034),Significant increase (p=0.016),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03704,rs852204,21,45664466,PSEN2,SNP (A/T),(A/,A,1.16,0.86,1.38,0.03075712,Unknown,0.491,0.071,0.086,0.153,No significant pattern (p=0.031),Mild decrease (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP03705,rs608230,22,175638479,APP,Deletion,-,-,0.86,0.64,1.19,0.09133497,High,0.078,0.47,0.168,0.084,Variable effect (p=0.021),Significant decrease (p=0.045),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03706,rs281530,3,216568295,CLU,SNP (G/T),(G/,G,0.97,0.65,1.26,0.014573,High,0.539,0.054,0.084,0.123,Variable effect (p=0.037),Significant increase (p=0.027),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03707,rs591286,22,132461441,PTK2B,SNP (C/G),(C/,C,0.67,0.28,0.93,0.01814138,High,0.021,0.37,0.003,0.405,Mild decrease (p=0.006),Mild decrease (p=0.024),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03708,rs101634,9,212591745,ABCA7,Deletion,-,-,1.03,0.67,1.26,0.02727403,High,0.021,0.254,0.299,0.226,Significant decrease (p=0.013),Significant decrease (p=0.006),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP03709,rs399375,14,134103703,PSEN2,SNP (G/T),(G/,G,2.78,2.47,3.13,0.13921927,Low,0.113,0.089,0.038,0.56,Variable effect (p=0.024),Mild decrease (p=0.034),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03710,rs550589,4,31250054,PTK2B,SNP (A/C),(A/,A,3.0,2.7,3.25,0.00994786,High,0.074,0.47,0.011,0.244,Significant decrease (p=0.023),No significant pattern (p=0.02),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03711,rs858631,8,177439313,BIN1,Insertion,-,-,0.78,0.46,1.0,0.03429926,Moderate,0.254,0.291,0.098,0.157,Significant increase (p=0.026),Variable effect (p=0.046),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP03712,rs221939,4,64994980,APOE,SNP (G/T),(G/,G,1.17,0.92,1.4,0.0148265,Low,0.079,0.365,0.301,0.055,Variable effect (p=0.045),Significant increase (p=0.031),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03713,rs697766,5,24996936,CLU,SNP (G/T),(G/,G,1.69,1.46,1.92,0.00824559,Low,0.055,0.516,0.052,0.177,Significant increase (p=0.037),Mild increase (p=0.046),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03714,rs592131,8,132713208,APP,Deletion,-,-,0.43,0.1,0.74,0.07778199,Moderate,0.317,0.018,0.126,0.339,Significant increase (p=0.003),No significant pattern (p=0.041),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP03715,rs115987,12,139718149,CLU,SNP (C/T),(C/,C,0.69,0.47,0.96,0.00640049,Unknown,0.1,0.361,0.328,0.011,Mild increase (p=0.009),Mild increase (p=0.043),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03716,rs761342,15,35675393,CR1,SNP (A/C),(A/,A,1.25,0.99,1.46,0.095809,Low,0.152,0.588,0.008,0.052,Significant increase (p=0.037),Mild increase (p=0.013),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03717,rs308514,1,198066580,PTK2B,Insertion,-,-,0.74,0.36,0.97,0.0617118,High,0.417,0.016,0.16,0.208,Mild increase (p=0.033),Mild decrease (p=0.033),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03718,rs404522,14,105867282,SORL1,SNP (A/C),(A/,A,1.41,1.16,1.67,0.01040476,Moderate,0.039,0.1,0.123,0.538,Significant decrease (p=0.036),Variable effect (p=0.039),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03719,rs948334,15,121129990,CD33,SNP (C/T),(C/,C,0.84,0.54,1.21,0.02505088,High,0.027,0.271,0.011,0.492,Mild increase (p=0.045),Significant decrease (p=0.022),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP03720,rs302225,6,65852318,BIN1,SNP (G/T),(G/,G,0.87,0.61,1.13,0.00614787,High,0.108,0.034,0.39,0.268,Significant increase (p=0.02),Significant decrease (p=0.011),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03721,rs373803,22,194815420,PTK2B,Deletion,-,-,0.6,0.31,0.83,0.01642481,Moderate,0.337,0.011,0.138,0.314,Significant decrease (p=0.025),Mild increase (p=0.048),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03722,rs977373,12,107346843,BIN1,SNP (A/T),(A/,A,0.96,0.65,1.21,0.08321854,Low,0.042,0.561,0.097,0.1,Mild increase (p=0.017),Significant decrease (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03723,rs620390,9,160821195,APOE,SNP (A/T),(A/,A,0.87,0.58,1.08,0.04918078,Protective,0.125,0.352,0.007,0.316,Variable effect (p=0.02),Mild increase (p=0.034),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03724,rs947037,9,112125533,CD33,Insertion,-,-,0.77,0.4,1.0,0.02836121,Low,0.405,0.017,0.057,0.321,Mild increase (p=0.009),Significant decrease (p=0.028),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03725,rs366497,18,192406338,CD2AP,SNP (A/T),(A/,A,1.07,0.78,1.4,0.09639269,Moderate,0.499,0.149,0.094,0.058,Mild decrease (p=0.004),Mild decrease (p=0.008),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03726,rs534545,13,56082019,MS4A6A,SNP (A/T),(A/,A,1.0,0.78,1.33,0.00187327,Moderate,0.323,0.036,0.408,0.034,Mild decrease (p=0.024),Significant decrease (p=0.015),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03727,rs415311,21,238069815,APOE,Insertion,-,-,0.88,0.63,1.1,0.0730272,High,0.417,0.273,0.108,0.002,Variable effect (p=0.002),Variable effect (p=0.006),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03728,rs380113,11,21349992,CD2AP,SNP (A/C),(A/,A,2.36,2.09,2.6,0.00736281,Protective,0.0,0.049,0.216,0.535,Mild increase (p=0.02),Significant increase (p=0.005),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03729,rs313695,13,203661416,MS4A6A,Deletion,-,-,1.68,1.29,2.05,0.02817743,High,0.298,0.442,0.033,0.027,Significant decrease (p=0.011),Mild increase (p=0.007),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03730,rs195739,1,231542453,SORL1,SNP (A/T),(A/,A,1.77,1.53,2.1,0.03360346,Moderate,0.135,0.073,0.215,0.377,Significant decrease (p=0.011),Mild decrease (p=0.025),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03731,rs242364,5,44161281,APOE,Deletion,-,-,1.07,0.87,1.42,0.00995926,High,0.353,0.272,0.123,0.052,No significant pattern (p=0.047),Significant increase (p=0.036),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03732,rs139113,12,59254522,PICALM,Insertion,-,-,0.51,0.17,0.78,0.00635513,Low,0.341,0.283,0.076,0.1,Mild increase (p=0.05),Mild decrease (p=0.018),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03733,rs578624,12,178243596,MS4A6A,SNP (C/G),(C/,C,1.41,1.12,1.7,0.10200695,Moderate,0.283,0.095,0.037,0.386,Variable effect (p=0.043),Mild increase (p=0.013),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03734,rs395096,13,192553834,APOE,Insertion,-,-,0.69,0.45,1.03,0.00015863,High,0.013,0.667,0.05,0.07,Mild increase (p=0.016),Mild increase (p=0.042),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP03735,rs787939,2,112604772,APP,SNP (A/C),(A/,A,3.41,3.16,3.69,0.01831199,Low,0.078,0.078,0.236,0.408,Mild decrease (p=0.016),Mild decrease (p=0.01),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03736,rs980481,4,182972156,MS4A6A,SNP (G/T),(G/,G,0.52,0.21,0.86,0.02533665,Moderate,0.092,0.335,0.276,0.096,Mild increase (p=0.034),Mild decrease (p=0.038),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03737,rs703025,6,93414006,CD33,SNP (A/G),(A/,A,1.78,1.45,2.09,0.01511161,Moderate,0.1,0.123,0.119,0.458,Mild increase (p=0.006),Significant decrease (p=0.013),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03738,rs420877,15,98319194,APP,SNP (A/G),(A/,A,0.72,0.33,1.03,0.04239313,Moderate,0.27,0.124,0.398,0.008,Variable effect (p=0.016),Variable effect (p=0.032),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03739,rs145768,3,6064034,APP,SNP (A/G),(A/,A,1.33,1.05,1.53,0.04071437,High,0.24,0.274,0.239,0.047,Significant decrease (p=0.01),Variable effect (p=0.015),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03740,rs294798,19,195983695,BIN1,SNP (G/T),(G/,G,0.59,0.36,0.94,0.00373327,Protective,0.382,0.204,0.111,0.103,Mild increase (p=0.038),Significant decrease (p=0.009),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03741,rs680081,13,99868306,EPHA1,SNP (G/T),(G/,G,1.84,1.63,2.1,0.05053087,Moderate,0.043,0.054,0.468,0.235,Significant decrease (p=0.026),Significant decrease (p=0.014),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03742,rs818964,7,3622711,CLU,Insertion,-,-,1.21,0.93,1.6,0.01209909,High,0.389,0.31,0.048,0.053,Mild increase (p=0.002),Significant decrease (p=0.025),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03743,rs584944,18,45636556,MS4A6A,SNP (A/T),(A/,A,0.69,0.37,0.93,0.07622305,Moderate,0.48,0.124,0.12,0.076,Variable effect (p=0.011),Mild increase (p=0.006),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03744,rs823989,16,48162233,APP,SNP (G/T),(G/,G,1.56,1.18,1.84,0.0530921,High,0.228,0.376,0.042,0.155,Variable effect (p=0.01),Significant increase (p=0.035),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03745,rs242219,4,186945486,CR1,Insertion,-,-,0.64,0.27,0.87,0.01536366,High,0.14,0.158,0.399,0.103,Mild increase (p=0.01),Mild increase (p=0.041),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03746,rs898274,20,224004780,ABCA7,SNP (A/C),(A/,A,0.4,0.17,0.68,0.0523025,High,0.657,0.095,0.033,0.014,Mild increase (p=0.038),Mild decrease (p=0.037),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03747,rs632924,20,166427139,PTK2B,SNP (C/T),(C/,C,0.77,0.38,1.12,0.0123714,Moderate,0.0,0.174,0.151,0.474,Mild increase (p=0.046),Mild decrease (p=0.045),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP03748,rs143331,2,70231330,CD2AP,Deletion,-,-,1.01,0.77,1.41,0.00564147,Low,0.538,0.028,0.189,0.045,Mild decrease (p=0.028),Mild decrease (p=0.034),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03749,rs272673,21,20580960,CD33,SNP (A/G),(A/,A,0.51,0.18,0.86,0.02614662,Moderate,0.059,0.074,0.482,0.184,Mild decrease (p=0.03),Significant increase (p=0.035),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03750,rs255828,5,155919873,PICALM,SNP (C/G),(C/,C,0.66,0.4,0.95,0.11046515,Low,0.449,0.174,0.073,0.104,Significant increase (p=0.03),Significant decrease (p=0.004),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03751,rs571076,2,184953425,PICALM,SNP (A/T),(A/,A,1.18,0.92,1.46,0.00357002,Moderate,0.184,0.061,0.059,0.496,Mild decrease (p=0.01),Mild decrease (p=0.042),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03752,rs455812,11,190417809,BIN1,Deletion,-,-,2.22,1.86,2.6,0.01503296,Low,0.054,0.522,0.008,0.216,Significant increase (p=0.011),Mild decrease (p=0.043),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03753,rs503865,12,210699905,PICALM,Deletion,-,-,0.71,0.39,1.02,0.02456479,Moderate,0.033,0.498,0.229,0.04,Mild decrease (p=0.018),Significant increase (p=0.044),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03754,rs759130,8,48128390,TREM2,Deletion,-,-,1.89,1.63,2.22,0.01835781,Moderate,0.48,0.099,0.105,0.116,No significant pattern (p=0.015),Mild increase (p=0.046),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP03755,rs535827,19,111730809,APP,SNP (G/T),(G/,G,0.81,0.49,1.09,0.01554046,Moderate,0.08,0.426,0.001,0.293,Mild decrease (p=0.005),Variable effect (p=0.004),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03756,rs531398,6,138353701,CD2AP,SNP (C/G),(C/,C,1.26,1.05,1.59,0.04520388,Moderate,0.213,0.06,0.109,0.418,Mild increase (p=0.043),Mild decrease (p=0.041),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP03757,rs583552,19,140734942,PSEN2,Deletion,-,-,1.24,0.87,1.45,0.00246982,Low,0.161,0.314,0.019,0.306,Significant increase (p=0.014),Significant decrease (p=0.046),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03758,rs585457,22,215377417,CD2AP,SNP (A/T),(A/,A,1.07,0.72,1.37,0.04696868,Moderate,0.421,0.133,0.062,0.185,No significant pattern (p=0.04),Mild increase (p=0.004),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03759,rs523877,13,244188152,CR1,SNP (A/G),(A/,A,1.27,1.01,1.64,0.08230755,High,0.249,0.484,0.027,0.04,No significant pattern (p=0.014),Significant increase (p=0.007),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03760,rs819048,5,170099064,CD2AP,SNP (C/T),(C/,C,1.06,0.74,1.32,0.00771406,High,0.028,0.291,0.443,0.038,Significant increase (p=0.01),Mild increase (p=0.037),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03761,rs862439,1,148316118,MS4A6A,SNP (G/T),(G/,G,0.68,0.44,0.97,0.00580704,High,0.095,0.192,0.206,0.307,Mild increase (p=0.029),No significant pattern (p=0.007),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03762,rs185164,4,245626575,CD33,SNP (C/G),(C/,C,1.73,1.4,2.12,0.09113806,Low,0.087,0.4,0.284,0.029,No significant pattern (p=0.016),Significant decrease (p=0.016),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03763,rs231055,5,156624891,BIN1,SNP (C/T),(C/,C,1.07,0.81,1.41,0.02174157,Low,0.345,0.163,0.167,0.125,Significant decrease (p=0.047),Significant increase (p=0.001),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03764,rs581566,20,33278216,PSEN2,SNP (A/T),(A/,A,0.88,0.67,1.21,0.01944108,Low,0.463,0.055,0.247,0.035,No significant pattern (p=0.021),Mild decrease (p=0.002),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP03765,rs717961,22,201007650,PTK2B,SNP (A/G),(A/,A,2.09,1.72,2.44,0.02792445,Protective,0.126,0.037,0.115,0.522,Significant decrease (p=0.026),No significant pattern (p=0.008),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03766,rs428045,7,100493784,PTK2B,Insertion,-,-,0.62,0.31,0.98,0.12762755,High,0.124,0.358,0.261,0.057,Variable effect (p=0.043),No significant pattern (p=0.03),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03767,rs505365,12,72486346,PSEN2,SNP (C/G),(C/,C,1.14,0.91,1.37,0.11159698,Moderate,0.176,0.144,0.178,0.301,No significant pattern (p=0.047),Significant decrease (p=0.049),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03768,rs219741,12,74134095,CLU,SNP (A/C),(A/,A,0.83,0.55,1.06,0.04117411,Moderate,0.162,0.01,0.084,0.544,Variable effect (p=0.011),No significant pattern (p=0.03),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03769,rs800153,10,35109169,APOE,SNP (A/C),(A/,A,2.26,2.05,2.59,0.03165498,Moderate,0.053,0.438,0.253,0.056,Significant increase (p=0.04),Significant increase (p=0.034),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03770,rs783016,3,126244916,MS4A6A,SNP (C/G),(C/,C,0.96,0.72,1.16,0.03877048,Low,0.422,0.175,0.021,0.181,No significant pattern (p=0.032),Mild increase (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03771,rs944476,14,55239074,MS4A6A,SNP (A/G),(A/,A,1.33,0.99,1.56,0.00252346,Moderate,0.003,0.736,0.03,0.031,Variable effect (p=0.024),Mild increase (p=0.03),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03772,rs666632,1,84287608,MS4A6A,SNP (C/T),(C/,C,0.36,0.15,0.64,0.01950014,Protective,0.237,0.068,0.103,0.392,No significant pattern (p=0.022),Significant decrease (p=0.043),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03773,rs973384,10,163249616,CD2AP,SNP (C/G),(C/,C,0.5,0.14,0.85,0.01141807,Moderate,0.306,0.033,0.454,0.007,Variable effect (p=0.048),Mild decrease (p=0.028),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03774,rs891551,21,182840565,CD2AP,SNP (C/T),(C/,C,1.23,0.84,1.57,0.00609119,Unknown,0.007,0.215,0.386,0.191,Variable effect (p=0.027),Significant decrease (p=0.048),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03775,rs260415,21,45554922,CR1,SNP (A/C),(A/,A,0.6,0.33,0.97,0.02640401,Moderate,0.108,0.471,0.181,0.04,Variable effect (p=0.004),Mild decrease (p=0.044),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03776,rs535864,3,191342463,PSEN2,SNP (G/T),(G/,G,0.55,0.26,0.87,0.0165826,Moderate,0.393,0.005,0.217,0.186,Variable effect (p=0.003),Significant decrease (p=0.047),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03777,rs787398,11,147273694,SORL1,Insertion,-,-,1.46,1.19,1.84,0.07634,Low,0.162,0.516,0.113,0.009,Significant decrease (p=0.024),Significant decrease (p=0.002),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03778,rs728650,14,235640372,TREM2,SNP (G/T),(G/,G,1.36,1.09,1.72,0.06924445,High,0.384,0.304,0.043,0.069,No significant pattern (p=0.009),Mild increase (p=0.05),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03779,rs580919,7,219975864,EPHA1,SNP (A/C),(A/,A,0.97,0.64,1.35,0.01039795,High,0.367,0.079,0.176,0.178,Significant decrease (p=0.023),Significant decrease (p=0.014),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03780,rs854408,9,244978174,CLU,SNP (G/T),(G/,G,1.27,0.97,1.49,0.01229308,Moderate,0.035,0.077,0.19,0.499,Mild increase (p=0.008),Mild increase (p=0.04),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03781,rs204214,13,179667595,TREM2,SNP (C/G),(C/,C,1.22,0.87,1.43,0.04452128,Moderate,0.03,0.505,0.215,0.049,Significant decrease (p=0.039),Variable effect (p=0.033),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03782,rs870689,10,151237665,APOE,SNP (A/T),(A/,A,0.55,0.26,0.87,0.00768411,Moderate,0.253,0.089,0.109,0.349,Variable effect (p=0.038),Significant increase (p=0.036),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03783,rs921426,17,73795353,TREM2,Insertion,-,-,0.72,0.47,0.94,0.01202129,Moderate,0.627,0.031,0.089,0.053,Mild increase (p=0.001),Significant increase (p=0.032),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03784,rs449857,11,60459288,CD33,SNP (C/T),(C/,C,0.83,0.49,1.07,0.03796036,Low,0.112,0.392,0.112,0.184,Mild decrease (p=0.008),Significant increase (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03785,rs689320,4,223164838,SORL1,Deletion,-,-,0.33,0.1,0.64,0.04375351,Moderate,0.045,0.484,0.139,0.132,Mild decrease (p=0.004),Significant decrease (p=0.047),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03786,rs112611,17,189799053,APOE,SNP (A/C),(A/,A,0.59,0.31,0.79,0.00854775,High,0.016,0.136,0.016,0.632,No significant pattern (p=0.046),Significant increase (p=0.049),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03787,rs969604,13,3315137,CD33,SNP (G/T),(G/,G,1.28,1.05,1.49,0.00733816,High,0.199,0.25,0.323,0.028,Variable effect (p=0.038),Mild increase (p=0.016),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03788,rs537532,1,239407987,PTK2B,SNP (C/T),(C/,C,1.57,1.24,1.78,0.07177798,Protective,0.281,0.092,0.005,0.422,No significant pattern (p=0.024),Mild increase (p=0.009),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03789,rs502420,19,159262719,CR1,SNP (A/G),(A/,A,0.71,0.51,0.99,0.00062016,Low,0.036,0.089,0.162,0.513,Mild decrease (p=0.009),Mild decrease (p=0.013),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03790,rs492209,21,41309352,ABCA7,Insertion,-,-,1.72,1.33,2.02,0.00750843,High,0.001,0.202,0.122,0.474,Variable effect (p=0.025),Significant increase (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03791,rs236706,7,21285717,APOE,SNP (C/G),(C/,C,0.81,0.51,1.06,0.00097711,High,0.069,0.269,0.374,0.088,Mild increase (p=0.014),No significant pattern (p=0.009),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP03792,rs709168,7,140045342,CR1,SNP (A/T),(A/,A,0.84,0.58,1.16,0.08558288,Protective,0.071,0.392,0.313,0.024,Significant decrease (p=0.031),Significant increase (p=0.042),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03793,rs612451,5,97726068,MS4A6A,SNP (A/G),(A/,A,0.9,0.57,1.2,0.04179646,Moderate,0.36,0.149,0.15,0.141,Mild decrease (p=0.042),Mild increase (p=0.015),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03794,rs195307,1,140295668,BIN1,SNP (G/T),(G/,G,1.14,0.94,1.53,0.00222473,Moderate,0.225,0.151,0.322,0.102,Mild decrease (p=0.029),Mild decrease (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03795,rs793022,14,181024831,CD2AP,Insertion,-,-,1.07,0.69,1.34,0.0129117,High,0.114,0.402,0.183,0.1,Mild increase (p=0.046),Mild decrease (p=0.014),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03796,rs591625,3,170798134,CD33,SNP (C/G),(C/,C,0.69,0.43,1.06,0.01248523,Protective,0.132,0.249,0.066,0.353,Significant decrease (p=0.029),Mild decrease (p=0.01),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03797,rs938794,17,95609075,PTK2B,Insertion,-,-,0.93,0.58,1.19,0.02055002,High,0.104,0.187,0.435,0.073,Mild increase (p=0.012),Mild increase (p=0.038),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03798,rs594784,8,231226117,APOE,SNP (C/T),(C/,C,0.33,0.1,0.64,0.0209667,Low,0.034,0.114,0.127,0.525,No significant pattern (p=0.013),Significant increase (p=0.005),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03799,rs180459,22,6393113,PICALM,SNP (C/T),(C/,C,2.97,2.67,3.21,0.00167951,Moderate,0.06,0.364,0.313,0.064,Mild increase (p=0.032),Significant decrease (p=0.02),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03800,rs668812,9,222774201,APP,Deletion,-,-,1.12,0.83,1.38,0.01860741,Moderate,0.31,0.056,0.161,0.273,Significant decrease (p=0.032),Mild increase (p=0.008),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03801,rs962685,17,164640997,CLU,SNP (G/T),(G/,G,0.78,0.51,1.02,0.19666657,Moderate,0.351,0.076,0.125,0.247,No significant pattern (p=0.006),Variable effect (p=0.043),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03802,rs267712,2,34039600,APOE,Insertion,-,-,0.74,0.37,1.13,0.00292886,Protective,0.271,0.101,0.229,0.199,Mild increase (p=0.03),Significant decrease (p=0.029),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03803,rs234716,8,119832326,SORL1,SNP (G/T),(G/,G,2.0,1.67,2.21,0.03733491,High,0.021,0.019,0.63,0.13,Significant increase (p=0.047),Mild increase (p=0.03),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03804,rs928267,5,106216981,PICALM,SNP (C/G),(C/,C,2.16,1.85,2.37,0.01761204,High,0.031,0.407,0.228,0.134,Mild increase (p=0.014),Mild decrease (p=0.032),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03805,rs682232,7,200349755,PICALM,Insertion,-,-,0.68,0.45,1.01,0.02628659,Protective,0.542,0.039,0.027,0.192,Mild increase (p=0.022),Significant decrease (p=0.008),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03806,rs893716,8,31233821,BIN1,SNP (G/T),(G/,G,1.07,0.73,1.34,0.04084323,Low,0.577,0.012,0.096,0.115,Significant decrease (p=0.041),Mild increase (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP03807,rs210974,16,176723945,CD2AP,SNP (C/T),(C/,C,1.52,1.3,1.89,0.0892222,Low,0.549,0.161,0.09,0.001,Mild decrease (p=0.005),Significant decrease (p=0.014),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03808,rs575656,14,69454326,APP,SNP (A/T),(A/,A,2.92,2.58,3.28,0.00406314,High,0.655,0.012,0.09,0.043,Variable effect (p=0.05),Mild increase (p=0.046),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03809,rs805049,20,58723850,EPHA1,SNP (A/T),(A/,A,0.79,0.55,1.09,0.0163339,Low,0.38,0.074,0.197,0.148,Mild increase (p=0.013),Mild increase (p=0.029),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03810,rs968582,15,223433930,ABCA7,SNP (A/C),(A/,A,2.96,2.71,3.16,0.00954577,Moderate,0.382,0.02,0.314,0.084,Significant decrease (p=0.023),Variable effect (p=0.021),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03811,rs999895,2,158289392,MS4A6A,Insertion,-,-,3.59,3.35,3.91,0.00266738,Protective,0.285,0.067,0.435,0.013,Mild increase (p=0.017),Variable effect (p=0.021),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03812,rs118928,21,114434539,TREM2,SNP (C/G),(C/,C,1.92,1.59,2.25,0.00136819,Moderate,0.521,0.083,0.083,0.114,Significant increase (p=0.028),Mild increase (p=0.023),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03813,rs738317,12,69184085,CD33,SNP (C/G),(C/,C,0.99,0.73,1.25,0.03438337,Protective,0.344,0.209,0.15,0.097,Significant increase (p=0.011),Mild decrease (p=0.009),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03814,rs578834,10,151594357,APOE,SNP (A/G),(A/,A,0.39,0.1,0.7,0.01454169,Low,0.161,0.255,0.282,0.102,Significant increase (p=0.037),Variable effect (p=0.012),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03815,rs251289,9,248299138,PICALM,Insertion,-,-,0.95,0.71,1.17,0.03064446,Low,0.348,0.001,0.408,0.043,Mild decrease (p=0.029),Variable effect (p=0.011),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03816,rs638507,6,63877284,CR1,SNP (A/G),(A/,A,0.71,0.49,1.1,0.04396343,High,0.314,0.066,0.033,0.387,Variable effect (p=0.036),Mild increase (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03817,rs899485,15,70655145,CLU,Insertion,-,-,1.14,0.84,1.51,0.00539485,High,0.051,0.11,0.454,0.185,Significant decrease (p=0.03),Variable effect (p=0.019),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03818,rs903936,8,159682672,ABCA7,SNP (C/G),(C/,C,1.06,0.68,1.39,0.07400736,High,0.327,0.288,0.173,0.012,Significant increase (p=0.022),Significant decrease (p=0.011),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03819,rs365532,7,132859822,CR1,SNP (A/G),(A/,A,1.11,0.78,1.31,0.01317308,Protective,0.281,0.103,0.01,0.406,Significant increase (p=0.01),Significant increase (p=0.034),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03820,rs985944,19,130986256,PSEN2,SNP (C/T),(C/,C,0.74,0.4,0.97,0.02571024,Protective,0.235,0.109,0.415,0.041,Variable effect (p=0.044),No significant pattern (p=0.024),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03821,rs305353,11,42198214,ABCA7,Insertion,-,-,1.74,1.51,2.07,0.03771613,Low,0.312,0.001,0.367,0.121,Mild decrease (p=0.049),No significant pattern (p=0.004),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03822,rs326537,6,193004113,APOE,SNP (C/G),(C/,C,1.01,0.71,1.23,0.0048048,High,0.182,0.026,0.403,0.189,Variable effect (p=0.049),No significant pattern (p=0.043),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03823,rs500597,16,158999597,TREM2,SNP (A/G),(A/,A,1.54,1.3,1.9,0.01439485,Low,0.39,0.044,0.087,0.279,No significant pattern (p=0.015),Significant decrease (p=0.036),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03824,rs826282,10,46983407,CD33,SNP (C/G),(C/,C,0.45,0.11,0.84,0.0172588,Low,0.136,0.385,0.229,0.05,No significant pattern (p=0.039),Mild decrease (p=0.015),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP03825,rs624269,3,66855789,CD2AP,SNP (C/G),(C/,C,1.07,0.77,1.4,0.00454887,Low,0.385,0.206,0.174,0.035,Mild increase (p=0.028),No significant pattern (p=0.019),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03826,rs553615,2,125421040,CLU,SNP (A/C),(A/,A,2.24,1.87,2.52,0.02041191,Moderate,0.129,0.024,0.597,0.05,Mild decrease (p=0.019),Significant increase (p=0.008),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP03827,rs306745,22,111897475,MS4A6A,SNP (G/T),(G/,G,0.84,0.46,1.17,0.00150262,Low,0.037,0.256,0.224,0.284,Variable effect (p=0.046),Mild decrease (p=0.039),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP03828,rs826626,4,1327032,CD2AP,SNP (A/G),(A/,A,0.75,0.55,1.04,0.04271555,Protective,0.044,0.613,0.119,0.024,Mild increase (p=0.034),Significant increase (p=0.022),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03829,rs255748,7,61314995,PSEN2,SNP (C/G),(C/,C,0.6,0.31,0.98,0.01519535,Moderate,0.122,0.413,0.098,0.167,No significant pattern (p=0.013),Significant increase (p=0.022),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03830,rs606330,8,213011640,ABCA7,SNP (A/G),(A/,A,0.97,0.68,1.24,0.00363411,Moderate,0.181,0.122,0.083,0.414,No significant pattern (p=0.016),Mild decrease (p=0.029),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03831,rs610664,22,159568047,CD2AP,SNP (G/T),(G/,G,0.93,0.66,1.22,0.01164218,High,0.149,0.056,0.163,0.432,Mild decrease (p=0.041),Significant increase (p=0.044),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03832,rs997076,2,7916772,BIN1,SNP (A/C),(A/,A,0.66,0.43,0.97,0.04890574,Moderate,0.192,0.406,0.005,0.196,Significant decrease (p=0.018),No significant pattern (p=0.027),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03833,rs476766,17,163249309,MS4A6A,SNP (G/T),(G/,G,0.72,0.44,1.0,0.10027219,Moderate,0.08,0.172,0.343,0.205,No significant pattern (p=0.001),No significant pattern (p=0.05),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03834,rs463992,3,91088600,MS4A6A,SNP (C/T),(C/,C,1.29,1.0,1.55,0.02654177,High,0.197,0.34,0.118,0.145,Significant decrease (p=0.032),Significant decrease (p=0.035),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03835,rs178077,3,99168768,APP,SNP (G/T),(G/,G,0.9,0.64,1.21,0.00911527,Low,0.205,0.02,0.528,0.048,Significant increase (p=0.009),Mild decrease (p=0.034),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03836,rs155543,7,102108165,PICALM,SNP (C/G),(C/,C,1.0,0.68,1.21,0.07943711,High,0.367,0.037,0.313,0.082,Variable effect (p=0.046),Significant decrease (p=0.044),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03837,rs698389,8,61922251,BIN1,Deletion,-,-,1.16,0.92,1.5,0.00124241,Unknown,0.46,0.049,0.017,0.275,Significant increase (p=0.024),Mild decrease (p=0.033),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03838,rs477209,12,124377526,CD2AP,SNP (C/T),(C/,C,0.72,0.43,0.93,0.00171746,Moderate,0.24,0.107,0.205,0.248,Significant increase (p=0.031),Mild increase (p=0.039),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03839,rs108889,11,69779033,PTK2B,SNP (A/C),(A/,A,0.75,0.4,1.06,0.00284906,Moderate,0.187,0.466,0.079,0.068,Variable effect (p=0.017),Variable effect (p=0.006),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03840,rs583659,19,126478250,PSEN2,SNP (A/C),(A/,A,0.93,0.54,1.16,0.00154166,Moderate,0.375,0.274,0.132,0.019,Variable effect (p=0.004),Significant decrease (p=0.04),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03841,rs667788,19,206986914,PTK2B,SNP (A/C),(A/,A,1.59,1.26,1.79,0.10003694,High,0.387,0.001,0.291,0.121,No significant pattern (p=0.049),Mild decrease (p=0.023),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03842,rs754928,7,151635158,MS4A6A,SNP (A/T),(A/,A,0.6,0.27,0.92,0.06512813,Low,0.114,0.203,0.408,0.075,No significant pattern (p=0.004),No significant pattern (p=0.04),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03843,rs391477,12,74956972,TREM2,SNP (G/T),(G/,G,0.71,0.45,0.94,0.00590387,Moderate,0.17,0.049,0.376,0.205,No significant pattern (p=0.008),No significant pattern (p=0.003),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03844,rs660977,17,102969448,TREM2,SNP (C/G),(C/,C,2.08,1.75,2.34,0.01190887,Low,0.401,0.146,0.186,0.068,Mild increase (p=0.022),Variable effect (p=0.022),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03845,rs686473,9,116735666,PICALM,Insertion,-,-,1.16,0.78,1.52,2.497e-05,Moderate,0.248,0.067,0.341,0.145,No significant pattern (p=0.048),Mild increase (p=0.015),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03846,rs738973,7,134563124,CR1,SNP (C/G),(C/,C,0.86,0.62,1.21,0.01569622,Moderate,0.078,0.554,0.16,0.008,Variable effect (p=0.036),Variable effect (p=0.019),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP03847,rs523121,3,52163542,CLU,SNP (A/T),(A/,A,1.03,0.82,1.34,0.0606606,Protective,0.036,0.278,0.016,0.47,No significant pattern (p=0.042),Significant increase (p=0.007),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03848,rs365163,7,26494681,PSEN2,SNP (A/T),(A/,A,0.35,0.1,0.58,0.01002356,Moderate,0.022,0.563,0.108,0.107,Mild decrease (p=0.033),Mild increase (p=0.023),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03849,rs185891,22,197370021,CR1,SNP (A/G),(A/,A,0.59,0.21,0.9,0.00055321,High,0.381,0.179,0.114,0.126,Significant increase (p=0.039),Variable effect (p=0.016),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03850,rs681507,12,28143790,APP,Insertion,-,-,1.02,0.79,1.3,0.06663491,Moderate,0.341,0.037,0.38,0.042,Mild decrease (p=0.04),Significant decrease (p=0.014),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP03851,rs160792,12,235543034,APOE,SNP (A/G),(A/,A,0.78,0.45,1.13,0.03881062,Low,0.097,0.119,0.044,0.54,Mild decrease (p=0.005),Significant decrease (p=0.031),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03852,rs735255,19,157607324,EPHA1,SNP (A/C),(A/,A,0.23,0.1,0.51,0.11181307,Low,0.435,0.115,0.003,0.248,Mild increase (p=0.019),Significant increase (p=0.019),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03853,rs860048,21,241203708,SORL1,Insertion,-,-,0.9,0.52,1.18,0.01826842,Low,0.062,0.271,0.113,0.354,Variable effect (p=0.035),Mild decrease (p=0.015),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03854,rs747430,1,99157903,PTK2B,SNP (A/T),(A/,A,0.53,0.21,0.74,0.02869499,High,0.32,0.186,0.069,0.225,Mild increase (p=0.012),Variable effect (p=0.023),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03855,rs818162,8,178902799,EPHA1,Deletion,-,-,1.3,0.95,1.55,0.01671079,Protective,0.001,0.083,0.451,0.264,Mild decrease (p=0.006),Variable effect (p=0.035),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03856,rs847079,16,181556879,APOE,Deletion,-,-,0.8,0.5,1.13,0.04151749,Moderate,0.75,0.006,0.008,0.036,Significant increase (p=0.041),Mild decrease (p=0.047),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03857,rs178907,2,118191500,CD2AP,Insertion,-,-,1.37,0.98,1.75,9.75e-06,Low,0.314,0.352,0.086,0.049,Mild decrease (p=0.009),Mild increase (p=0.003),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03858,rs714272,1,20844490,PTK2B,Deletion,-,-,0.6,0.36,0.95,0.01233517,High,0.309,0.046,0.055,0.39,Mild increase (p=0.03),Significant increase (p=0.017),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03859,rs299461,13,203426758,CR1,SNP (A/C),(A/,A,0.81,0.54,1.11,0.00034793,Moderate,0.037,0.295,0.411,0.057,No significant pattern (p=0.047),Mild increase (p=0.049),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03860,rs308579,11,232228624,TREM2,SNP (C/T),(C/,C,0.94,0.71,1.23,0.13033996,Low,0.094,0.012,0.358,0.336,No significant pattern (p=0.007),Significant increase (p=0.027),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03861,rs858827,11,137859372,PSEN2,SNP (A/T),(A/,A,1.4,1.19,1.64,0.03593299,Low,0.072,0.152,0.571,0.004,Mild increase (p=0.009),Mild increase (p=0.031),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03862,rs287116,7,30507357,PTK2B,SNP (G/T),(G/,G,0.38,0.16,0.63,0.0509737,Moderate,0.58,0.015,0.187,0.019,Significant increase (p=0.031),Variable effect (p=0.017),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03863,rs823523,7,20509061,APOE,SNP (C/G),(C/,C,1.42,1.22,1.8,0.00059316,High,0.639,0.037,0.078,0.046,Variable effect (p=0.039),Significant increase (p=0.035),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03864,rs661073,4,32996214,CD2AP,SNP (G/T),(G/,G,1.37,0.98,1.74,0.01546116,Moderate,0.145,0.29,0.226,0.139,No significant pattern (p=0.045),Mild increase (p=0.043),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP03865,rs319734,10,146270589,PTK2B,SNP (C/T),(C/,C,1.06,0.71,1.32,0.00791776,Low,0.013,0.129,0.354,0.304,Mild decrease (p=0.03),Variable effect (p=0.008),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03866,rs187041,20,162068068,CLU,SNP (A/T),(A/,A,0.72,0.34,1.09,0.0067915,Moderate,0.025,0.573,0.09,0.113,No significant pattern (p=0.025),Mild decrease (p=0.042),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03867,rs459007,11,229854058,EPHA1,SNP (G/T),(G/,G,0.85,0.62,1.09,0.00575132,Moderate,0.227,0.006,0.181,0.387,Significant increase (p=0.021),Significant increase (p=0.024),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP03868,rs704421,13,46905803,APOE,SNP (G/T),(G/,G,1.41,1.14,1.79,0.03378371,Low,0.317,0.182,0.282,0.018,No significant pattern (p=0.021),Mild decrease (p=0.002),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03869,rs519547,19,209844147,SORL1,Insertion,-,-,1.02,0.67,1.26,0.00015242,Low,0.049,0.487,0.229,0.035,No significant pattern (p=0.016),Significant increase (p=0.017),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03870,rs789201,3,141824471,PTK2B,SNP (A/C),(A/,A,0.57,0.2,0.95,0.00832887,High,0.321,0.035,0.052,0.392,Variable effect (p=0.027),Variable effect (p=0.014),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP03871,rs460086,11,3042028,BIN1,Deletion,-,-,1.37,1.12,1.69,0.02630005,Moderate,0.657,0.032,0.028,0.083,Mild increase (p=0.004),Significant increase (p=0.038),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03872,rs709557,6,54371024,MS4A6A,SNP (G/T),(G/,G,1.1,0.87,1.33,0.01440616,Moderate,0.2,0.011,0.234,0.354,Mild decrease (p=0.013),Significant decrease (p=0.026),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03873,rs927856,12,189613571,ABCA7,Deletion,-,-,1.6,1.32,1.9,0.03196574,Low,0.54,0.031,0.104,0.125,Variable effect (p=0.013),No significant pattern (p=0.003),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03874,rs184892,7,11761516,EPHA1,SNP (A/C),(A/,A,1.0,0.62,1.2,0.19694116,High,0.171,0.399,0.047,0.183,Variable effect (p=0.002),Significant increase (p=0.025),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03875,rs589345,7,3427293,APOE,SNP (C/T),(C/,C,1.09,0.87,1.43,0.01965512,Low,0.037,0.251,0.111,0.4,No significant pattern (p=0.005),Significant decrease (p=0.036),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP03876,rs320512,7,211338797,APP,SNP (A/T),(A/,A,1.12,0.78,1.4,0.12377977,Low,0.093,0.227,0.378,0.102,Significant decrease (p=0.018),Mild decrease (p=0.016),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03877,rs967600,5,6088849,CD33,Deletion,-,-,1.09,0.84,1.4,0.0238013,Moderate,0.136,0.179,0.16,0.324,Significant decrease (p=0.033),Significant increase (p=0.048),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03878,rs138971,1,70702930,SORL1,Insertion,-,-,0.42,0.2,0.81,0.01839519,High,0.155,0.033,0.267,0.345,Variable effect (p=0.046),Variable effect (p=0.039),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03879,rs315689,18,52986745,PTK2B,SNP (G/T),(G/,G,0.83,0.5,1.03,0.00357876,High,0.137,0.261,0.174,0.227,Variable effect (p=0.007),Mild decrease (p=0.026),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03880,rs176204,6,161492618,CR1,SNP (C/T),(C/,C,0.96,0.65,1.2,0.02023254,Protective,0.104,0.132,0.06,0.504,Mild decrease (p=0.048),No significant pattern (p=0.024),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03881,rs202515,8,133460852,CLU,Insertion,-,-,0.38,0.1,0.61,0.01394612,Moderate,0.177,0.276,0.108,0.239,No significant pattern (p=0.003),Significant decrease (p=0.034),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP03882,rs724697,21,112865207,CD2AP,SNP (A/C),(A/,A,1.23,0.94,1.47,0.0317817,High,0.038,0.123,0.171,0.468,Significant decrease (p=0.005),Significant decrease (p=0.04),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03883,rs217368,14,120211575,PSEN2,SNP (G/T),(G/,G,0.94,0.64,1.24,0.03298271,Moderate,0.278,0.281,0.072,0.168,Significant decrease (p=0.036),Variable effect (p=0.003),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03884,rs577290,11,13504614,CD2AP,SNP (G/T),(G/,G,1.98,1.76,2.29,0.04664386,High,0.065,0.395,0.249,0.091,Significant decrease (p=0.003),Mild decrease (p=0.017),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03885,rs693173,21,215054988,SORL1,Deletion,-,-,2.15,1.94,2.38,0.01824122,High,0.079,0.471,0.116,0.134,Variable effect (p=0.027),Significant decrease (p=0.027),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03886,rs246769,20,196770021,BIN1,SNP (A/T),(A/,A,1.95,1.61,2.32,0.04363184,Moderate,0.016,0.202,0.11,0.472,No significant pattern (p=0.028),Mild decrease (p=0.011),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03887,rs178554,1,123606423,PTK2B,SNP (A/C),(A/,A,1.99,1.7,2.31,0.16042751,High,0.225,0.22,0.285,0.071,Significant increase (p=0.022),Significant increase (p=0.014),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03888,rs978078,15,21260173,APOE,Insertion,-,-,0.72,0.4,0.96,0.00517951,Moderate,0.213,0.361,0.174,0.052,Variable effect (p=0.031),Mild increase (p=0.004),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03889,rs232360,13,221481575,PICALM,Deletion,-,-,1.05,0.78,1.43,0.06212523,Moderate,0.182,0.163,0.043,0.411,Significant increase (p=0.02),Mild increase (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03890,rs957861,17,246765381,CLU,SNP (A/T),(A/,A,1.16,0.95,1.38,0.05641831,Unknown,0.079,0.224,0.109,0.389,Significant increase (p=0.041),No significant pattern (p=0.042),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP03891,rs160026,9,95662118,APOE,SNP (A/C),(A/,A,0.75,0.54,1.13,0.00945892,Protective,0.18,0.489,0.11,0.021,Variable effect (p=0.021),Mild increase (p=0.013),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03892,rs996907,17,208040948,CD2AP,SNP (A/T),(A/,A,1.86,1.51,2.24,0.06446228,High,0.097,0.597,0.002,0.104,Mild increase (p=0.044),Significant increase (p=0.029),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03893,rs402117,5,191684628,CR1,SNP (A/T),(A/,A,0.87,0.62,1.22,0.05375326,High,0.435,0.145,0.216,0.004,Mild decrease (p=0.021),Significant increase (p=0.02),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03894,rs974548,1,51265710,PTK2B,SNP (A/C),(A/,A,1.09,0.82,1.34,0.00322319,Protective,0.055,0.388,0.004,0.353,Variable effect (p=0.044),Variable effect (p=0.02),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP03895,rs316858,13,79950852,APP,SNP (A/C),(A/,A,1.52,1.24,1.87,0.04008631,Protective,0.24,0.105,0.294,0.161,Significant decrease (p=0.033),Mild decrease (p=0.021),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03896,rs246103,3,146391693,APP,SNP (A/T),(A/,A,1.06,0.67,1.34,0.01617614,High,0.017,0.282,0.016,0.485,Mild increase (p=0.031),Significant decrease (p=0.021),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03897,rs219676,12,15557609,PSEN2,SNP (G/T),(G/,G,1.51,1.24,1.77,0.07087797,Moderate,0.464,0.158,0.068,0.11,Significant increase (p=0.019),Mild decrease (p=0.03),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03898,rs273792,13,43941808,SORL1,SNP (A/T),(A/,A,0.94,0.72,1.2,0.02837795,High,0.019,0.042,0.2,0.538,Significant decrease (p=0.007),Mild decrease (p=0.028),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03899,rs747601,13,150618789,APP,SNP (A/T),(A/,A,0.71,0.51,0.92,0.00308096,Low,0.101,0.068,0.085,0.546,Mild increase (p=0.026),No significant pattern (p=0.019),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03900,rs469117,21,71717878,CD2AP,SNP (A/C),(A/,A,1.15,0.82,1.48,0.14691178,Low,0.161,0.061,0.019,0.559,Mild decrease (p=0.01),Variable effect (p=0.025),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP03901,rs378916,6,159761533,CD33,SNP (C/G),(C/,C,0.66,0.36,0.93,0.07206373,Moderate,0.08,0.274,0.123,0.323,Mild decrease (p=0.045),Significant decrease (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP03902,rs363380,16,146937762,CD2AP,SNP (G/T),(G/,G,0.37,0.1,0.75,0.01927725,Protective,0.14,0.033,0.09,0.537,Mild decrease (p=0.012),Mild decrease (p=0.049),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP03903,rs421276,22,234770513,CR1,SNP (A/T),(A/,A,0.91,0.65,1.15,0.00968565,Moderate,0.407,0.174,0.13,0.09,No significant pattern (p=0.037),No significant pattern (p=0.007),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03904,rs828815,3,211435059,BIN1,SNP (G/T),(G/,G,0.5,0.22,0.78,0.01569958,High,0.448,0.055,0.227,0.07,Mild decrease (p=0.039),Mild increase (p=0.023),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03905,rs524169,9,139779515,EPHA1,SNP (G/T),(G/,G,0.82,0.49,1.19,0.00366199,High,0.097,0.012,0.239,0.452,Variable effect (p=0.034),Significant increase (p=0.036),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03906,rs560370,17,4799597,MS4A6A,Insertion,-,-,2.99,2.72,3.31,0.06071903,Low,0.062,0.288,0.207,0.243,Mild decrease (p=0.047),No significant pattern (p=0.047),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP03907,rs236482,13,48703043,EPHA1,SNP (C/G),(C/,C,0.88,0.58,1.15,0.02282891,High,0.195,0.056,0.074,0.475,No significant pattern (p=0.002),Mild decrease (p=0.035),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP03908,rs729762,15,92558469,CD33,Deletion,-,-,1.36,1.05,1.71,0.02892198,High,0.11,0.329,0.151,0.21,Mild decrease (p=0.026),No significant pattern (p=0.009),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03909,rs669001,22,190771020,CLU,SNP (A/T),(A/,A,0.54,0.21,0.82,0.03722261,Low,0.254,0.017,0.295,0.234,No significant pattern (p=0.01),No significant pattern (p=0.046),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03910,rs282605,5,208642102,PSEN2,Insertion,-,-,0.79,0.58,1.07,0.04228789,Protective,0.198,0.233,0.275,0.094,Mild increase (p=0.007),Variable effect (p=0.007),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03911,rs576061,22,167055493,APP,Insertion,-,-,0.48,0.2,0.7,0.00498998,Low,0.079,0.289,0.34,0.092,Significant increase (p=0.003),Significant decrease (p=0.016),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP03912,rs715579,10,247483289,SORL1,Deletion,-,-,1.56,1.32,1.81,0.02510937,High,0.182,0.524,0.06,0.033,Variable effect (p=0.038),Significant decrease (p=0.036),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP03913,rs303531,19,202274459,PTK2B,SNP (G/T),(G/,G,0.68,0.38,0.95,0.00657998,Moderate,0.012,0.209,0.336,0.243,Significant decrease (p=0.011),Significant increase (p=0.043),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03914,rs606018,8,210642576,CD2AP,Deletion,-,-,0.62,0.3,1.0,0.06856896,High,0.138,0.184,0.322,0.156,Variable effect (p=0.025),Mild increase (p=0.014),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03915,rs582011,1,131111049,MS4A6A,Deletion,-,-,1.06,0.84,1.4,0.01450294,Moderate,0.092,0.098,0.043,0.567,Mild decrease (p=0.01),Variable effect (p=0.04),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03916,rs972240,16,233666581,CD2AP,SNP (C/T),(C/,C,0.37,0.16,0.59,0.00139897,High,0.127,0.367,0.165,0.141,Significant increase (p=0.029),Significant increase (p=0.021),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03917,rs359351,7,165800719,APP,SNP (A/T),(A/,A,1.88,1.67,2.1,0.13540245,Low,0.028,0.067,0.142,0.563,Mild increase (p=0.042),Significant decrease (p=0.037),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03918,rs342236,5,101861808,APOE,Insertion,-,-,1.2,0.8,1.45,0.07252271,Unknown,0.102,0.203,0.432,0.062,No significant pattern (p=0.009),Mild increase (p=0.014),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03919,rs427873,13,150821044,TREM2,SNP (A/C),(A/,A,1.55,1.3,1.9,0.01738536,Low,0.248,0.114,0.136,0.302,No significant pattern (p=0.025),Variable effect (p=0.049),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP03920,rs326334,17,237535700,PTK2B,Deletion,-,-,0.49,0.26,0.85,0.01158904,Moderate,0.236,0.113,0.021,0.431,Mild increase (p=0.021),Mild decrease (p=0.033),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP03921,rs627534,19,227343624,APP,Deletion,-,-,0.98,0.66,1.23,0.00415061,Low,0.053,0.026,0.208,0.514,Significant increase (p=0.005),Significant decrease (p=0.026),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03922,rs938075,20,188343654,BIN1,SNP (C/G),(C/,C,0.34,0.1,0.73,0.05816118,Moderate,0.343,0.183,0.111,0.162,Mild decrease (p=0.023),Mild decrease (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03923,rs157675,20,225436578,MS4A6A,SNP (C/T),(C/,C,0.78,0.51,1.05,0.02914594,High,0.384,0.087,0.311,0.018,Significant decrease (p=0.033),Mild decrease (p=0.037),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP03924,rs369976,12,150556239,PSEN2,SNP (C/T),(C/,C,0.9,0.52,1.17,0.00649235,Moderate,0.032,0.662,0.008,0.099,Significant increase (p=0.028),Variable effect (p=0.046),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03925,rs753576,19,174206023,CD33,SNP (G/T),(G/,G,1.19,0.8,1.54,0.04265345,Moderate,0.098,0.065,0.555,0.081,Significant decrease (p=0.016),Mild decrease (p=0.009),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP03926,rs745281,11,15884995,PTK2B,SNP (G/T),(G/,G,1.08,0.83,1.43,0.00280301,Moderate,0.139,0.381,0.22,0.06,Mild decrease (p=0.017),No significant pattern (p=0.029),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP03927,rs199301,11,67317035,MS4A6A,Deletion,-,-,1.19,0.92,1.54,0.01248193,Moderate,0.236,0.404,0.059,0.101,Significant increase (p=0.029),Mild decrease (p=0.003),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03928,rs180670,12,17065066,CD2AP,SNP (C/G),(C/,C,1.03,0.75,1.27,0.05796585,Moderate,0.058,0.127,0.529,0.086,Significant decrease (p=0.002),Significant decrease (p=0.036),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03929,rs135362,17,41169070,TREM2,SNP (G/T),(G/,G,0.67,0.35,0.89,0.0179295,Moderate,0.306,0.025,0.353,0.116,Significant increase (p=0.011),Significant decrease (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03930,rs363073,18,63801163,TREM2,SNP (C/T),(C/,C,0.58,0.35,0.83,0.00591067,Moderate,0.163,0.117,0.174,0.346,Mild decrease (p=0.004),Mild increase (p=0.048),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03931,rs551911,5,118760864,CD33,SNP (A/G),(A/,A,1.09,0.71,1.38,0.02031953,Low,0.628,0.002,0.03,0.139,Significant increase (p=0.041),Mild decrease (p=0.046),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP03932,rs955673,9,75762020,CLU,SNP (G/T),(G/,G,0.69,0.4,0.92,0.02419201,Moderate,0.063,0.078,0.651,0.007,Variable effect (p=0.026),Mild decrease (p=0.016),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP03933,rs180830,3,20002847,APP,Deletion,-,-,2.18,1.86,2.44,0.04015196,Low,0.322,0.198,0.116,0.164,Significant decrease (p=0.025),Significant decrease (p=0.02),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP03934,rs322384,8,155427350,APP,Deletion,-,-,1.92,1.58,2.14,0.00726327,Moderate,0.342,0.308,0.13,0.02,Mild decrease (p=0.006),No significant pattern (p=0.034),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03935,rs862675,4,134892891,APP,SNP (C/T),(C/,C,0.91,0.58,1.11,0.06178998,Moderate,0.455,0.059,0.049,0.237,Significant increase (p=0.022),Variable effect (p=0.019),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP03936,rs123809,10,235718457,APP,SNP (A/G),(A/,A,1.3,0.95,1.51,0.04281584,Moderate,0.59,0.042,0.104,0.065,Significant increase (p=0.045),Mild increase (p=0.03),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03937,rs954044,9,147787248,MS4A6A,Insertion,-,-,0.8,0.57,1.17,0.00429688,High,0.026,0.312,0.186,0.275,Significant increase (p=0.031),Mild increase (p=0.024),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03938,rs283416,15,124314663,PICALM,SNP (C/T),(C/,C,1.14,0.79,1.44,0.01592051,Unknown,0.057,0.508,0.154,0.08,Significant increase (p=0.038),Significant decrease (p=0.033),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03939,rs802712,9,233387637,APP,SNP (G/T),(G/,G,0.73,0.5,1.12,0.02698015,High,0.041,0.082,0.35,0.327,No significant pattern (p=0.019),Mild decrease (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP03940,rs153079,20,57143963,SORL1,SNP (C/G),(C/,C,0.85,0.56,1.24,0.00945123,Moderate,0.075,0.289,0.337,0.099,Mild decrease (p=0.013),Significant increase (p=0.01),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03941,rs120005,11,72002643,CR1,SNP (A/T),(A/,A,1.29,1.01,1.51,0.0458068,High,0.227,0.132,0.298,0.144,Mild increase (p=0.043),Mild increase (p=0.045),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP03942,rs413686,4,118648798,CLU,Insertion,-,-,0.8,0.45,1.11,0.08821222,High,0.032,0.026,0.618,0.124,Significant increase (p=0.006),Significant decrease (p=0.025),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03943,rs899531,22,153497444,BIN1,SNP (G/T),(G/,G,0.58,0.36,0.79,0.05923622,Moderate,0.145,0.119,0.478,0.058,Mild decrease (p=0.023),Variable effect (p=0.028),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03944,rs846563,14,194357739,PICALM,Deletion,-,-,1.55,1.31,1.89,0.01829209,Low,0.304,0.098,0.116,0.282,Significant increase (p=0.006),Variable effect (p=0.036),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP03945,rs703656,1,146411967,BIN1,SNP (C/T),(C/,C,0.81,0.43,1.18,0.01247955,Protective,0.167,0.246,0.033,0.354,Variable effect (p=0.006),Mild decrease (p=0.035),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03946,rs499874,17,143438777,PSEN2,Insertion,-,-,1.05,0.79,1.25,0.03821928,Moderate,0.335,0.041,0.224,0.2,Significant decrease (p=0.036),No significant pattern (p=0.049),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03947,rs729904,12,120059066,EPHA1,SNP (G/T),(G/,G,0.91,0.7,1.26,0.06252151,Moderate,0.112,0.132,0.217,0.338,Mild increase (p=0.026),Variable effect (p=0.032),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03948,rs283478,15,116554596,CD2AP,SNP (A/T),(A/,A,0.83,0.49,1.22,0.00307449,Moderate,0.076,0.408,0.076,0.24,No significant pattern (p=0.049),Mild increase (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03949,rs124717,8,147585725,APOE,Deletion,-,-,1.02,0.76,1.28,0.04011275,Low,0.38,0.206,0.094,0.121,Mild decrease (p=0.024),No significant pattern (p=0.046),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP03950,rs552501,17,15301257,BIN1,SNP (A/G),(A/,A,1.65,1.4,1.97,0.07203389,High,0.155,0.47,0.164,0.011,No significant pattern (p=0.026),Mild increase (p=0.009),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP03951,rs733062,14,242721050,PICALM,Deletion,-,-,0.9,0.69,1.26,0.06582587,Low,0.019,0.062,0.55,0.169,Variable effect (p=0.024),Significant increase (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03952,rs722067,17,246638761,CLU,SNP (C/G),(C/,C,0.98,0.66,1.33,0.04386601,Low,0.437,0.222,0.038,0.103,Significant decrease (p=0.009),Mild decrease (p=0.034),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03953,rs484060,21,183764966,ABCA7,SNP (A/T),(A/,A,0.84,0.55,1.09,0.02648451,Moderate,0.058,0.142,0.148,0.453,Mild decrease (p=0.007),Significant increase (p=0.041),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP03954,rs990554,13,191064321,BIN1,SNP (A/C),(A/,A,1.53,1.32,1.8,0.00913623,Low,0.118,0.048,0.389,0.245,Significant decrease (p=0.013),Significant increase (p=0.02),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03955,rs568838,3,87819731,APOE,SNP (C/G),(C/,C,0.43,0.11,0.67,0.00398452,High,0.087,0.268,0.183,0.262,Significant increase (p=0.049),Variable effect (p=0.029),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03956,rs971755,21,18887708,PSEN2,Insertion,-,-,1.03,0.8,1.33,0.01014633,Moderate,0.067,0.273,0.068,0.392,Variable effect (p=0.044),Mild decrease (p=0.033),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03957,rs117710,3,218905626,ABCA7,SNP (C/T),(C/,C,1.3,1.09,1.61,0.01760533,Low,0.51,0.179,0.101,0.01,Mild increase (p=0.039),Variable effect (p=0.047),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP03958,rs812117,11,115010340,MS4A6A,SNP (C/G),(C/,C,2.79,2.56,3.08,0.00451533,Moderate,0.175,0.194,0.078,0.353,Significant decrease (p=0.011),Mild increase (p=0.019),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP03959,rs934893,18,149007938,MS4A6A,SNP (A/T),(A/,A,0.59,0.32,0.91,0.05350561,Protective,0.447,0.072,0.253,0.027,Significant increase (p=0.015),Variable effect (p=0.012),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP03960,rs354697,14,66054134,TREM2,Deletion,-,-,2.21,1.9,2.58,0.04126597,Unknown,0.111,0.036,0.211,0.442,Significant increase (p=0.008),Significant increase (p=0.038),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03961,rs441862,3,191247770,PTK2B,Deletion,-,-,1.13,0.78,1.39,0.0335037,Low,0.382,0.232,0.17,0.016,Significant increase (p=0.03),Mild decrease (p=0.009),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03962,rs745577,2,33599201,EPHA1,SNP (C/T),(C/,C,0.85,0.62,1.23,0.02020214,Moderate,0.192,0.073,0.173,0.362,Significant decrease (p=0.044),Significant increase (p=0.002),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP03963,rs776009,5,231322138,PTK2B,SNP (A/T),(A/,A,0.68,0.41,1.08,0.08504787,Low,0.036,0.402,0.36,0.003,No significant pattern (p=0.049),Mild increase (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03964,rs653545,4,238005293,PTK2B,SNP (A/C),(A/,A,0.95,0.57,1.33,0.00315727,Moderate,0.3,0.342,0.11,0.048,No significant pattern (p=0.028),Significant increase (p=0.031),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP03965,rs727868,17,73183366,SORL1,Deletion,-,-,0.75,0.45,1.14,0.00126667,Moderate,0.194,0.277,0.032,0.297,Significant decrease (p=0.029),No significant pattern (p=0.003),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03966,rs346953,9,150190404,PSEN2,Deletion,-,-,0.79,0.45,1.06,0.04498286,High,0.318,0.301,0.069,0.112,Significant decrease (p=0.025),Mild decrease (p=0.02),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP03967,rs489224,15,134960659,APP,SNP (C/G),(C/,C,0.77,0.42,1.08,0.060515,Low,0.36,0.131,0.021,0.287,Mild decrease (p=0.018),Mild increase (p=0.016),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP03968,rs318196,8,210449942,APOE,SNP (A/T),(A/,A,0.56,0.29,0.8,0.01526662,High,0.33,0.407,0.045,0.018,Variable effect (p=0.043),Mild increase (p=0.028),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP03969,rs660134,21,167324452,BIN1,Deletion,-,-,1.26,0.93,1.51,0.01213479,Protective,0.074,0.058,0.51,0.157,No significant pattern (p=0.027),Variable effect (p=0.048),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03970,rs524434,2,214858935,BIN1,Deletion,-,-,1.55,1.31,1.83,0.01640514,Moderate,0.244,0.113,0.322,0.121,Mild increase (p=0.004),Significant decrease (p=0.02),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03971,rs316955,5,248106649,CLU,Insertion,-,-,0.37,0.1,0.64,0.0228711,High,0.132,0.348,0.304,0.017,Mild decrease (p=0.03),Significant decrease (p=0.023),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP03972,rs884462,3,82987095,PSEN2,SNP (A/T),(A/,A,1.47,1.23,1.72,0.01475083,Low,0.019,0.545,0.012,0.223,Significant decrease (p=0.025),No significant pattern (p=0.007),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP03973,rs512771,16,98751726,APOE,SNP (C/T),(C/,C,1.42,1.2,1.65,0.06294726,Protective,0.167,0.135,0.438,0.06,Mild decrease (p=0.02),Significant decrease (p=0.016),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP03974,rs403833,2,72148769,PTK2B,Insertion,-,-,0.59,0.27,0.94,0.0099708,High,0.361,0.022,0.109,0.307,Significant decrease (p=0.002),Variable effect (p=0.04),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP03975,rs941430,6,154764255,PSEN2,SNP (C/T),(C/,C,0.61,0.29,0.96,0.06304589,Moderate,0.104,0.427,0.005,0.264,Variable effect (p=0.004),Mild decrease (p=0.037),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP03976,rs296197,4,146468835,APOE,SNP (A/C),(A/,A,1.52,1.25,1.75,0.04725515,Low,0.098,0.09,0.529,0.083,Variable effect (p=0.022),No significant pattern (p=0.03),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP03977,rs140337,1,229101892,PSEN2,SNP (A/C),(A/,A,1.44,1.05,1.7,0.0126024,High,0.216,0.283,0.099,0.203,Significant increase (p=0.011),Mild decrease (p=0.049),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP03978,rs401157,20,93819638,APOE,Deletion,-,-,0.94,0.71,1.31,0.00912887,Protective,0.214,0.166,0.263,0.156,Mild increase (p=0.013),Variable effect (p=0.013),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP03979,rs302102,11,88713408,APOE,SNP (A/T),(A/,A,0.48,0.26,0.78,0.00590499,Moderate,0.038,0.135,0.549,0.078,Variable effect (p=0.042),Variable effect (p=0.043),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP03980,rs538753,15,27926128,CR1,Deletion,-,-,0.37,0.1,0.67,0.01738397,Low,0.025,0.002,0.178,0.595,Significant increase (p=0.048),No significant pattern (p=0.007),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03981,rs918181,2,241154030,ABCA7,SNP (A/T),(A/,A,1.13,0.74,1.46,0.0075168,Protective,0.137,0.004,0.108,0.551,Significant decrease (p=0.047),Significant increase (p=0.024),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP03982,rs433473,15,157009228,PICALM,Insertion,-,-,1.45,1.07,1.68,0.01628592,Moderate,0.059,0.129,0.245,0.368,Significant decrease (p=0.041),Significant increase (p=0.042),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP03983,rs764428,21,151561134,MS4A6A,SNP (A/T),(A/,A,2.12,1.79,2.48,0.00648386,High,0.237,0.273,0.034,0.256,Variable effect (p=0.046),Significant increase (p=0.015),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP03984,rs281428,19,94650104,EPHA1,SNP (A/C),(A/,A,0.57,0.29,0.79,0.05438171,High,0.104,0.084,0.599,0.012,Variable effect (p=0.011),Variable effect (p=0.023),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03985,rs605381,5,108903322,PTK2B,SNP (A/C),(A/,A,1.22,1.02,1.57,0.00956495,Protective,0.041,0.722,0.008,0.03,Variable effect (p=0.043),Significant increase (p=0.028),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP03986,rs706825,1,214445312,PICALM,SNP (A/C),(A/,A,2.44,2.11,2.71,0.00687746,High,0.117,0.0,0.559,0.124,Significant decrease (p=0.032),Significant increase (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03987,rs229944,16,200970197,SORL1,Insertion,-,-,1.39,1.03,1.7,0.00080426,Protective,0.295,0.072,0.028,0.405,Mild increase (p=0.023),Significant increase (p=0.01),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP03988,rs237552,15,73747118,SORL1,Insertion,-,-,0.65,0.27,0.95,0.04266637,High,0.444,0.027,0.213,0.116,Variable effect (p=0.034),Mild increase (p=0.034),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP03989,rs354347,19,143055574,APOE,Deletion,-,-,1.01,0.79,1.31,0.05153237,High,0.093,0.407,0.067,0.234,Variable effect (p=0.033),Mild increase (p=0.029),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP03990,rs242614,13,209760904,APP,Insertion,-,-,0.62,0.3,0.87,0.00260393,Moderate,0.036,0.258,0.449,0.058,Significant decrease (p=0.046),Significant increase (p=0.033),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP03991,rs447942,17,34058186,ABCA7,SNP (A/C),(A/,A,0.54,0.14,0.92,0.04885319,Moderate,0.329,0.239,0.085,0.148,No significant pattern (p=0.006),Variable effect (p=0.013),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP03992,rs701723,19,65607235,APOE,SNP (A/T),(A/,A,1.2,0.95,1.52,0.00433149,Moderate,0.019,0.064,0.281,0.437,Mild increase (p=0.024),Mild decrease (p=0.044),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP03993,rs323761,8,137452215,PICALM,SNP (G/T),(G/,G,0.58,0.24,0.87,0.07013198,High,0.394,0.1,0.169,0.136,Mild decrease (p=0.034),Variable effect (p=0.012),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP03994,rs381488,19,36773625,SORL1,SNP (G/T),(G/,G,2.4,2.19,2.76,0.08442662,Protective,0.04,0.261,0.426,0.073,Mild increase (p=0.023),Mild decrease (p=0.019),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP03995,rs785774,14,3431705,MS4A6A,SNP (A/G),(A/,A,0.24,0.1,0.62,0.00752843,High,0.17,0.098,0.116,0.416,Mild decrease (p=0.025),Mild increase (p=0.04),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP03996,rs370034,13,149152345,CR1,SNP (C/G),(C/,C,1.45,1.1,1.81,0.02612005,High,0.365,0.135,0.139,0.161,Significant decrease (p=0.029),Mild increase (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP03997,rs933679,22,248510848,CLU,SNP (A/T),(A/,A,0.79,0.39,1.16,0.01876762,High,0.003,0.186,0.215,0.397,Significant increase (p=0.036),No significant pattern (p=0.037),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP03998,rs303331,10,36424281,CR1,SNP (C/T),(C/,C,0.92,0.6,1.31,0.02026613,Moderate,0.295,0.178,0.054,0.273,Significant decrease (p=0.042),Mild increase (p=0.02),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP03999,rs910618,18,84321200,CR1,SNP (A/G),(A/,A,1.0,0.65,1.37,0.03934118,Moderate,0.038,0.398,0.106,0.258,Variable effect (p=0.044),Mild increase (p=0.05),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04000,rs447704,22,47845955,CR1,Insertion,-,-,0.51,0.11,0.77,0.01044266,Low,0.083,0.283,0.083,0.351,Mild increase (p=0.016),No significant pattern (p=0.01),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04001,rs391152,10,214950958,BIN1,SNP (A/T),(A/,A,0.67,0.27,1.07,0.00162681,Moderate,0.172,0.315,0.071,0.242,Mild decrease (p=0.042),No significant pattern (p=0.022),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04002,rs283806,6,140291127,PSEN2,Insertion,-,-,0.94,0.63,1.22,0.01619634,Protective,0.187,0.354,0.113,0.146,No significant pattern (p=0.03),Variable effect (p=0.033),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP04003,rs764972,17,19257258,ABCA7,SNP (C/T),(C/,C,0.9,0.57,1.23,0.01822012,Moderate,0.022,0.73,0.001,0.047,No significant pattern (p=0.031),No significant pattern (p=0.007),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04004,rs714941,21,43675202,CR1,SNP (G/T),(G/,G,0.82,0.56,1.04,0.02593371,High,0.031,0.165,0.08,0.524,Variable effect (p=0.037),Mild increase (p=0.011),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP04005,rs257913,6,238100857,PSEN2,Insertion,-,-,2.0,1.74,2.24,0.01244688,Low,0.2,0.24,0.264,0.096,Significant increase (p=0.026),Significant increase (p=0.042),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP04006,rs981304,12,66772537,ABCA7,SNP (A/G),(A/,A,0.95,0.58,1.24,0.05484456,Unknown,0.03,0.116,0.106,0.548,No significant pattern (p=0.011),Significant decrease (p=0.019),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04007,rs144828,19,74294441,TREM2,Deletion,-,-,1.04,0.76,1.33,0.01055299,Moderate,0.238,0.28,0.08,0.203,Mild increase (p=0.047),Significant decrease (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04008,rs764646,5,194247129,ABCA7,SNP (A/G),(A/,A,0.68,0.3,1.04,0.02779259,Moderate,0.34,0.305,0.105,0.049,Variable effect (p=0.039),Significant decrease (p=0.023),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04009,rs529106,9,60906470,CR1,SNP (G/T),(G/,G,1.22,0.95,1.56,0.01185289,High,0.394,0.161,0.005,0.239,Mild increase (p=0.025),Significant increase (p=0.045),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP04010,rs314506,9,75751648,CR1,SNP (A/C),(A/,A,0.25,0.1,0.55,0.03477342,High,0.15,0.043,0.078,0.529,Mild decrease (p=0.008),Significant increase (p=0.002),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP04011,rs480475,15,124644440,MS4A6A,SNP (A/C),(A/,A,0.53,0.17,0.88,0.02751611,High,0.072,0.25,0.282,0.196,Significant decrease (p=0.023),Mild decrease (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04012,rs876047,7,188048726,MS4A6A,SNP (A/G),(A/,A,1.06,0.85,1.29,0.01005048,Moderate,0.659,0.014,0.094,0.033,No significant pattern (p=0.004),Significant increase (p=0.01),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04013,rs218059,12,96247984,MS4A6A,SNP (C/G),(C/,C,1.03,0.75,1.38,0.00926437,Protective,0.117,0.345,0.073,0.266,Variable effect (p=0.036),Significant increase (p=0.043),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04014,rs397048,22,222334388,TREM2,SNP (A/C),(A/,A,0.7,0.46,1.05,0.01564546,Moderate,0.036,0.018,0.348,0.397,No significant pattern (p=0.011),No significant pattern (p=0.037),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04015,rs173116,18,220860787,SORL1,SNP (C/G),(C/,C,2.44,2.21,2.74,0.0339264,Protective,0.309,0.014,0.081,0.396,Significant decrease (p=0.045),Significant increase (p=0.03),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04016,rs272809,1,37747242,APP,Deletion,-,-,1.04,0.67,1.29,0.02807096,Low,0.445,0.09,0.085,0.18,Significant decrease (p=0.046),Mild increase (p=0.018),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04017,rs755206,2,206626147,BIN1,Insertion,-,-,0.87,0.62,1.21,0.00537222,Protective,0.383,0.03,0.058,0.328,Mild increase (p=0.023),Variable effect (p=0.027),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04018,rs537374,18,231717873,ABCA7,SNP (G/T),(G/,G,0.83,0.47,1.19,0.02201178,Low,0.38,0.056,0.36,0.003,Mild increase (p=0.046),Variable effect (p=0.001),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04019,rs918030,12,140743005,TREM2,Deletion,-,-,0.58,0.24,0.88,0.00498171,Protective,0.235,0.394,0.066,0.105,Mild decrease (p=0.037),Significant increase (p=0.026),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP04020,rs836043,4,3796037,APP,SNP (A/G),(A/,A,0.99,0.64,1.23,0.03074818,High,0.082,0.111,0.177,0.431,Mild decrease (p=0.001),Significant decrease (p=0.031),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04021,rs457292,11,187718040,CR1,SNP (A/G),(A/,A,0.87,0.63,1.15,0.00744485,Unknown,0.051,0.137,0.413,0.199,Mild decrease (p=0.012),Mild increase (p=0.017),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP04022,rs965553,19,141192299,CR1,Insertion,-,-,1.91,1.69,2.23,0.03242433,Unknown,0.001,0.436,0.295,0.068,Significant increase (p=0.028),Mild increase (p=0.037),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04023,rs903345,11,10741796,ABCA7,SNP (A/G),(A/,A,0.71,0.34,1.03,0.07493065,Unknown,0.007,0.103,0.647,0.043,Variable effect (p=0.025),Significant decrease (p=0.036),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP04024,rs743584,7,127568884,PICALM,Deletion,-,-,1.12,0.87,1.35,0.01828261,Protective,0.194,0.081,0.348,0.177,No significant pattern (p=0.047),Mild increase (p=0.017),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04025,rs912166,11,3149978,CD33,SNP (C/G),(C/,C,0.77,0.48,1.12,0.09817281,Protective,0.028,0.003,0.232,0.537,No significant pattern (p=0.041),Significant decrease (p=0.015),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04026,rs242245,13,45471076,APP,Insertion,-,-,1.14,0.77,1.44,0.00148536,Protective,0.079,0.192,0.351,0.178,Significant decrease (p=0.017),No significant pattern (p=0.007),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP04027,rs113429,14,187288358,APOE,SNP (C/G),(C/,C,1.38,1.05,1.6,0.05855066,High,0.173,0.137,0.404,0.086,Variable effect (p=0.045),Significant decrease (p=0.032),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04028,rs112794,7,28650579,BIN1,Deletion,-,-,0.7,0.47,0.95,0.01516153,Moderate,0.507,0.088,0.182,0.024,Significant decrease (p=0.032),Mild decrease (p=0.024),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04029,rs683446,18,216028990,ABCA7,SNP (C/G),(C/,C,0.69,0.42,0.99,0.0296452,Moderate,0.511,0.118,0.102,0.069,Mild decrease (p=0.03),Significant decrease (p=0.049),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04030,rs772864,17,194542940,CLU,SNP (G/T),(G/,G,0.98,0.61,1.37,0.01347804,Unknown,0.312,0.077,0.39,0.021,Significant decrease (p=0.047),No significant pattern (p=0.006),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04031,rs255805,16,197222110,BIN1,SNP (C/T),(C/,C,1.28,1.03,1.53,0.0574903,Moderate,0.097,0.163,0.018,0.523,Mild increase (p=0.038),Variable effect (p=0.024),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04032,rs636549,18,172698264,PICALM,SNP (A/G),(A/,A,0.81,0.5,1.12,0.05105999,Moderate,0.126,0.543,0.082,0.049,Variable effect (p=0.049),Significant decrease (p=0.03),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04033,rs806727,15,114437710,MS4A6A,SNP (C/G),(C/,C,0.37,0.1,0.74,0.02119514,High,0.305,0.153,0.121,0.22,Mild decrease (p=0.037),Variable effect (p=0.018),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04034,rs499904,14,16020081,CD2AP,Deletion,-,-,0.92,0.55,1.16,0.01519096,Moderate,0.303,0.027,0.379,0.091,Mild decrease (p=0.048),Mild increase (p=0.037),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP04035,rs487225,17,43279337,ABCA7,Insertion,-,-,1.13,0.93,1.33,0.14470425,Unknown,0.229,0.107,0.288,0.177,Variable effect (p=0.037),Mild increase (p=0.041),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04036,rs791877,10,200189825,CLU,Insertion,-,-,0.63,0.29,0.89,0.02094693,Low,0.11,0.12,0.212,0.357,Significant increase (p=0.02),Mild decrease (p=0.046),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04037,rs876873,15,133950002,ABCA7,Deletion,-,-,0.29,0.1,0.63,0.0707893,High,0.236,0.087,0.092,0.386,No significant pattern (p=0.04),Mild increase (p=0.039),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04038,rs372098,8,189085447,APP,SNP (C/G),(C/,C,1.27,1.05,1.48,0.01394214,High,0.012,0.062,0.522,0.204,Mild decrease (p=0.048),Mild decrease (p=0.03),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04039,rs816054,6,183195929,CLU,SNP (G/T),(G/,G,1.75,1.43,2.03,0.0149037,High,0.014,0.543,0.241,0.003,Mild increase (p=0.027),Significant decrease (p=0.018),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04040,rs411436,11,191599117,CD33,Insertion,-,-,1.07,0.81,1.35,0.04373942,High,0.566,0.027,0.078,0.13,Variable effect (p=0.017),Variable effect (p=0.028),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04041,rs497137,14,88747411,CD2AP,Insertion,-,-,0.99,0.74,1.27,0.00640307,Moderate,0.472,0.08,0.067,0.182,Variable effect (p=0.038),Mild decrease (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP04042,rs139898,1,86537004,EPHA1,SNP (C/T),(C/,C,1.35,1.07,1.73,0.00807945,Moderate,0.062,0.166,0.201,0.372,Mild increase (p=0.007),No significant pattern (p=0.036),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04043,rs787481,11,82039165,PICALM,Insertion,-,-,1.32,1.09,1.69,0.03802968,Moderate,0.312,0.249,0.138,0.102,Mild decrease (p=0.034),Variable effect (p=0.01),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04044,rs154303,12,104380225,CR1,SNP (A/T),(A/,A,1.31,0.98,1.68,0.05027521,High,0.184,0.336,0.111,0.17,Mild decrease (p=0.009),Significant increase (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04045,rs926204,13,235780581,APOE,SNP (C/G),(C/,C,0.69,0.43,1.03,0.00045271,High,0.111,0.134,0.467,0.087,Mild decrease (p=0.005),Significant increase (p=0.045),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04046,rs832797,2,242238749,PSEN2,SNP (G/T),(G/,G,0.73,0.49,0.97,0.00170894,Unknown,0.517,0.104,0.05,0.129,No significant pattern (p=0.032),Significant increase (p=0.039),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04047,rs662811,11,78588423,ABCA7,Insertion,-,-,1.32,1.11,1.7,0.02333639,High,0.202,0.082,0.025,0.491,Significant decrease (p=0.015),Mild increase (p=0.017),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04048,rs628109,1,196897557,APOE,SNP (C/G),(C/,C,0.8,0.55,1.01,0.03845484,Moderate,0.07,0.097,0.504,0.129,Mild increase (p=0.022),Variable effect (p=0.037),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04049,rs281538,6,39897307,SORL1,Insertion,-,-,1.24,0.94,1.49,0.01041826,Low,0.26,0.208,0.071,0.261,No significant pattern (p=0.039),Significant decrease (p=0.032),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP04050,rs265485,8,165482478,APOE,SNP (A/C),(A/,A,1.0,0.72,1.25,0.01469142,High,0.211,0.092,0.045,0.452,Variable effect (p=0.035),No significant pattern (p=0.043),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04051,rs323487,8,128407767,PTK2B,SNP (A/C),(A/,A,1.1,0.77,1.4,0.00730891,Moderate,0.08,0.322,0.363,0.035,Mild increase (p=0.013),Significant decrease (p=0.007),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04052,rs619086,12,161651576,PTK2B,SNP (A/T),(A/,A,0.65,0.45,0.9,0.03141712,High,0.137,0.025,0.095,0.544,No significant pattern (p=0.003),No significant pattern (p=0.039),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04053,rs158733,10,77315328,CLU,Insertion,-,-,1.54,1.23,1.77,0.01197421,Low,0.133,0.093,0.471,0.103,No significant pattern (p=0.027),Significant increase (p=0.023),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04054,rs132497,18,178210352,TREM2,SNP (A/T),(A/,A,1.17,0.89,1.5,0.01153118,Moderate,0.126,0.171,0.11,0.394,Variable effect (p=0.005),Mild decrease (p=0.014),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP04055,rs973004,20,12483975,ABCA7,SNP (C/G),(C/,C,1.01,0.69,1.32,0.02619221,High,0.216,0.238,0.052,0.295,Mild decrease (p=0.031),Mild decrease (p=0.007),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP04056,rs933640,8,77174312,PSEN2,SNP (A/C),(A/,A,0.38,0.1,0.62,0.02453354,High,0.204,0.268,0.013,0.315,Variable effect (p=0.047),No significant pattern (p=0.04),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04057,rs756985,5,33756778,APP,SNP (A/T),(A/,A,0.71,0.49,0.97,0.00459351,Low,0.499,0.122,0.174,0.005,Variable effect (p=0.031),Significant decrease (p=0.014),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP04058,rs545901,5,208571958,APP,SNP (A/C),(A/,A,1.15,0.87,1.47,0.09405376,Low,0.095,0.381,0.306,0.017,Mild increase (p=0.015),Variable effect (p=0.012),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04059,rs507980,8,29008941,TREM2,Deletion,-,-,0.35,0.1,0.71,0.01080468,Moderate,0.031,0.238,0.125,0.406,No significant pattern (p=0.03),No significant pattern (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04060,rs998320,14,65951943,TREM2,Insertion,-,-,1.74,1.42,2.13,0.01210311,Protective,0.003,0.356,0.196,0.245,Mild decrease (p=0.013),Significant decrease (p=0.048),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04061,rs278867,20,188256872,CLU,SNP (A/G),(A/,A,0.61,0.24,0.89,0.0567116,Moderate,0.025,0.537,0.211,0.027,Significant decrease (p=0.032),Mild increase (p=0.017),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP04062,rs564327,12,7909875,CR1,SNP (A/G),(A/,A,0.58,0.28,0.82,0.02155996,High,0.072,0.124,0.083,0.521,Mild decrease (p=0.05),Variable effect (p=0.012),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04063,rs945733,12,148426784,BIN1,SNP (A/G),(A/,A,0.59,0.24,0.86,0.01137487,High,0.608,0.047,0.051,0.094,No significant pattern (p=0.007),Mild decrease (p=0.02),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP04064,rs189014,22,68227247,BIN1,Deletion,-,-,1.81,1.53,2.06,0.00916355,Protective,0.004,0.049,0.242,0.505,Significant decrease (p=0.038),Variable effect (p=0.008),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04065,rs374407,14,129669763,EPHA1,Insertion,-,-,1.42,1.1,1.71,0.00576991,Moderate,0.137,0.148,0.396,0.12,Mild increase (p=0.043),Mild increase (p=0.032),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04066,rs965252,16,114344259,BIN1,Deletion,-,-,1.4,1.07,1.65,0.02406173,Moderate,0.183,0.232,0.082,0.303,Variable effect (p=0.041),Mild decrease (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04067,rs488582,7,224549909,CD33,Insertion,-,-,1.14,0.87,1.37,0.01700328,Low,0.388,0.262,0.054,0.095,Mild decrease (p=0.045),No significant pattern (p=0.043),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04068,rs202359,16,127117547,APP,SNP (A/T),(A/,A,0.49,0.14,0.89,0.05383059,High,0.5,0.001,0.072,0.227,Variable effect (p=0.019),Mild increase (p=0.02),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04069,rs325245,16,19097940,CD2AP,SNP (A/C),(A/,A,1.35,1.0,1.67,0.02027698,High,0.001,0.143,0.162,0.494,Significant decrease (p=0.048),Significant increase (p=0.029),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04070,rs685039,6,32037853,MS4A6A,SNP (G/T),(G/,G,0.73,0.35,1.03,0.05541405,Moderate,0.152,0.051,0.057,0.541,No significant pattern (p=0.033),Significant decrease (p=0.048),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04071,rs990425,9,113417689,CLU,SNP (C/G),(C/,C,0.52,0.13,0.73,0.0078207,Moderate,0.131,0.207,0.27,0.192,Mild decrease (p=0.011),Variable effect (p=0.027),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04072,rs179723,19,21870008,PSEN2,Deletion,-,-,0.87,0.59,1.25,0.04131493,Low,0.065,0.498,0.027,0.21,Variable effect (p=0.012),Significant decrease (p=0.001),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04073,rs576863,8,89918395,SORL1,Deletion,-,-,1.09,0.76,1.37,0.04064852,Moderate,0.123,0.245,0.112,0.32,No significant pattern (p=0.044),No significant pattern (p=0.013),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04074,rs231586,14,135034811,CR1,SNP (A/G),(A/,A,0.75,0.37,1.05,0.02347671,Low,0.219,0.407,0.045,0.128,No significant pattern (p=0.033),No significant pattern (p=0.004),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04075,rs633697,16,133755400,PSEN2,SNP (A/T),(A/,A,0.9,0.62,1.19,0.08996889,High,0.006,0.241,0.553,0.001,Significant decrease (p=0.031),Significant decrease (p=0.007),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04076,rs232183,9,220747789,PTK2B,SNP (A/T),(A/,A,1.08,0.8,1.45,0.04080889,Moderate,0.131,0.269,0.041,0.359,Significant decrease (p=0.012),Mild increase (p=0.023),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04077,rs627100,22,120741728,PSEN2,SNP (C/G),(C/,C,1.13,0.93,1.53,0.04035253,Low,0.148,0.147,0.36,0.145,No significant pattern (p=0.025),Mild increase (p=0.035),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04078,rs510183,16,37202849,PSEN2,Insertion,-,-,0.95,0.68,1.18,0.0105001,High,0.123,0.346,0.123,0.208,Variable effect (p=0.003),Mild decrease (p=0.037),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP04079,rs571093,2,195801128,CR1,SNP (G/T),(G/,G,0.46,0.1,0.72,0.02313086,High,0.126,0.608,0.028,0.039,Significant increase (p=0.037),Mild decrease (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04080,rs170966,7,184220182,PICALM,Insertion,-,-,2.0,1.68,2.24,0.01972042,Moderate,0.15,0.334,0.177,0.139,No significant pattern (p=0.024),Mild increase (p=0.046),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04081,rs847620,18,215883933,PICALM,Insertion,-,-,1.36,1.09,1.73,0.05869402,High,0.062,0.141,0.502,0.094,Variable effect (p=0.033),Variable effect (p=0.023),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04082,rs799279,7,214314565,CD2AP,SNP (A/C),(A/,A,0.32,0.1,0.57,0.00553763,Moderate,0.189,0.562,0.027,0.022,Significant decrease (p=0.023),Mild increase (p=0.016),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04083,rs423621,17,175412057,PTK2B,SNP (A/G),(A/,A,0.99,0.76,1.38,0.02883291,Moderate,0.159,0.195,0.188,0.257,Mild increase (p=0.032),Significant increase (p=0.033),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP04084,rs348924,16,64893715,PTK2B,SNP (C/G),(C/,C,1.14,0.79,1.4,0.02065473,High,0.197,0.21,0.182,0.211,Variable effect (p=0.011),Significant increase (p=0.025),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04085,rs612082,10,55991147,CR1,SNP (A/T),(A/,A,0.96,0.74,1.21,0.03811379,High,0.372,0.323,0.026,0.079,Variable effect (p=0.032),Significant increase (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04086,rs638448,12,16815041,APOE,Insertion,-,-,1.24,1.04,1.61,0.0232071,Protective,0.526,0.032,0.104,0.138,Mild decrease (p=0.01),Significant decrease (p=0.015),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04087,rs478981,9,246366422,PSEN2,SNP (A/C),(A/,A,1.44,1.14,1.66,0.02389609,Protective,0.051,0.085,0.403,0.26,Significant decrease (p=0.042),Variable effect (p=0.026),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04088,rs261810,19,151676299,ABCA7,Deletion,-,-,0.75,0.55,1.14,0.00384344,High,0.02,0.148,0.585,0.047,No significant pattern (p=0.042),Mild decrease (p=0.027),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04089,rs963996,7,48138368,BIN1,Insertion,-,-,1.22,1.0,1.45,0.04832896,High,0.405,0.269,0.072,0.055,Mild decrease (p=0.005),Variable effect (p=0.002),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP04090,rs851912,20,57792088,TREM2,SNP (G/T),(G/,G,1.33,1.07,1.65,0.00848538,Moderate,0.107,0.61,0.034,0.048,Significant increase (p=0.042),Mild increase (p=0.003),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04091,rs268688,6,159219592,PSEN2,Deletion,-,-,0.87,0.5,1.15,0.01451155,Low,0.032,0.676,0.064,0.029,Mild increase (p=0.012),Mild increase (p=0.017),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04092,rs129498,6,198525435,PSEN2,SNP (A/C),(A/,A,0.29,0.1,0.67,0.01254022,Moderate,0.502,0.154,0.022,0.122,Variable effect (p=0.001),Significant increase (p=0.023),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04093,rs128057,20,188442667,BIN1,SNP (A/C),(A/,A,0.58,0.21,0.86,0.1248789,Protective,0.202,0.044,0.315,0.238,Mild increase (p=0.044),No significant pattern (p=0.032),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04094,rs188392,5,31952973,APOE,SNP (C/T),(C/,C,1.91,1.67,2.24,0.02140083,Moderate,0.296,0.175,0.088,0.241,Mild increase (p=0.046),Mild decrease (p=0.022),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04095,rs101264,12,211741191,MS4A6A,SNP (A/G),(A/,A,1.44,1.12,1.77,0.04531875,Moderate,0.13,0.184,0.316,0.17,Mild decrease (p=0.016),No significant pattern (p=0.027),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04096,rs599975,13,51388347,SORL1,Deletion,-,-,2.52,2.15,2.72,0.03160367,Moderate,0.309,0.012,0.208,0.272,Significant decrease (p=0.035),Significant increase (p=0.002),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04097,rs689877,10,98560497,CR1,SNP (G/T),(G/,G,1.94,1.7,2.3,0.06839286,Moderate,0.269,0.182,0.075,0.274,Significant decrease (p=0.049),No significant pattern (p=0.027),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04098,rs409372,11,11596883,CR1,Deletion,-,-,1.88,1.52,2.26,0.01610543,High,0.144,0.222,0.13,0.305,Mild decrease (p=0.021),No significant pattern (p=0.02),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04099,rs604990,10,234298656,PICALM,Insertion,-,-,0.46,0.1,0.76,0.04268216,High,0.228,0.016,0.34,0.217,Variable effect (p=0.049),No significant pattern (p=0.042),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04100,rs154859,2,168657475,PSEN2,Insertion,-,-,0.84,0.56,1.16,0.02157926,Low,0.034,0.439,0.297,0.03,Mild increase (p=0.009),Significant increase (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04101,rs709806,4,121152783,EPHA1,SNP (C/G),(C/,C,0.7,0.45,0.91,0.02737148,Moderate,0.013,0.567,0.174,0.045,Mild decrease (p=0.046),Significant increase (p=0.025),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04102,rs633109,10,148113005,APOE,SNP (G/T),(G/,G,0.8,0.49,1.03,0.03636496,Moderate,0.111,0.148,0.228,0.313,Variable effect (p=0.022),Significant decrease (p=0.034),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04103,rs437856,13,162965403,MS4A6A,SNP (C/T),(C/,C,1.58,1.37,1.87,0.00565647,High,0.001,0.321,0.107,0.37,Mild increase (p=0.04),Significant increase (p=0.035),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04104,rs897461,3,120208588,PSEN2,Deletion,-,-,1.45,1.07,1.71,0.14273764,Moderate,0.081,0.227,0.293,0.2,Mild decrease (p=0.028),No significant pattern (p=0.023),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04105,rs337496,20,45814344,CD2AP,SNP (A/T),(A/,A,1.32,0.96,1.59,0.04046721,High,0.235,0.05,0.317,0.197,Significant increase (p=0.023),No significant pattern (p=0.008),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP04106,rs374607,14,116234069,CLU,SNP (C/G),(C/,C,1.52,1.28,1.78,0.04988551,Low,0.273,0.211,0.039,0.277,No significant pattern (p=0.024),Mild decrease (p=0.047),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04107,rs446798,7,245313087,CR1,SNP (C/T),(C/,C,0.89,0.64,1.19,0.07242283,High,0.062,0.68,0.021,0.036,Significant increase (p=0.009),Mild increase (p=0.046),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04108,rs390705,18,71439415,CD2AP,Insertion,-,-,0.82,0.57,1.07,0.00174539,Moderate,0.18,0.463,0.127,0.03,Significant increase (p=0.006),Mild decrease (p=0.044),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP04109,rs421636,12,167541133,CD33,SNP (G/T),(G/,G,2.01,1.66,2.24,0.00943898,Low,0.493,0.086,0.137,0.084,Significant decrease (p=0.041),No significant pattern (p=0.023),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04110,rs444538,10,91698632,EPHA1,SNP (A/T),(A/,A,0.49,0.25,0.73,0.00738555,Moderate,0.313,0.136,0.328,0.023,Mild decrease (p=0.027),Significant decrease (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04111,rs779150,1,88176300,APOE,SNP (C/T),(C/,C,0.6,0.37,0.93,0.11135683,High,0.336,0.195,0.113,0.156,Mild increase (p=0.021),Mild increase (p=0.015),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04112,rs671489,10,165755772,PSEN2,SNP (C/T),(C/,C,0.85,0.59,1.18,0.00335405,High,0.23,0.003,0.491,0.076,No significant pattern (p=0.017),Significant decrease (p=0.015),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP04113,rs499722,10,131165958,BIN1,Deletion,-,-,0.89,0.6,1.1,0.00026984,High,0.23,0.122,0.192,0.257,Mild increase (p=0.026),Significant increase (p=0.02),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04114,rs727243,8,80598578,APOE,SNP (A/C),(A/,A,0.89,0.58,1.11,0.02418457,High,0.189,0.213,0.155,0.243,Mild decrease (p=0.007),Significant increase (p=0.041),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04115,rs428674,16,1117232,CLU,SNP (G/T),(G/,G,0.57,0.18,0.96,0.01729089,High,0.346,0.007,0.414,0.033,Mild increase (p=0.002),Significant decrease (p=0.042),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04116,rs509080,7,141757233,CD33,SNP (A/C),(A/,A,0.6,0.23,0.86,0.09612767,Moderate,0.233,0.344,0.219,0.005,Mild increase (p=0.02),Mild increase (p=0.027),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04117,rs456275,8,114340821,CD33,SNP (A/G),(A/,A,0.53,0.3,0.86,0.03107659,Protective,0.08,0.004,0.048,0.668,Significant increase (p=0.007),No significant pattern (p=0.019),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP04118,rs886303,17,228953990,MS4A6A,Insertion,-,-,1.59,1.31,1.8,0.07430714,High,0.364,0.202,0.15,0.084,Mild increase (p=0.04),Mild increase (p=0.043),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04119,rs479716,11,205742293,ABCA7,SNP (G/T),(G/,G,0.38,0.1,0.59,0.07193458,Low,0.222,0.339,0.238,0.001,Variable effect (p=0.011),No significant pattern (p=0.007),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04120,rs256062,21,207656126,TREM2,SNP (A/C),(A/,A,1.02,0.66,1.4,0.00536947,Low,0.276,0.119,0.191,0.213,Significant increase (p=0.024),No significant pattern (p=0.02),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04121,rs765382,11,161284164,APOE,SNP (A/T),(A/,A,0.75,0.36,1.07,0.01071939,Low,0.008,0.142,0.242,0.409,No significant pattern (p=0.043),Variable effect (p=0.025),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04122,rs927963,14,46341939,CR1,SNP (A/T),(A/,A,1.25,0.95,1.45,0.02196404,Low,0.141,0.235,0.144,0.28,Significant increase (p=0.043),Significant decrease (p=0.008),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04123,rs204979,19,25763609,PSEN2,Deletion,-,-,0.48,0.23,0.73,0.04387443,Moderate,0.482,0.192,0.013,0.112,Significant decrease (p=0.043),Mild decrease (p=0.028),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04124,rs255272,12,192910934,CR1,SNP (A/C),(A/,A,1.46,1.19,1.8,0.06459468,Low,0.328,0.013,0.229,0.23,Significant decrease (p=0.048),Mild increase (p=0.015),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04125,rs621248,19,226530696,CLU,SNP (G/T),(G/,G,0.82,0.48,1.19,0.02016973,High,0.063,0.618,0.019,0.1,Mild increase (p=0.026),Mild increase (p=0.024),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04126,rs351199,16,202247960,PSEN2,SNP (A/T),(A/,A,1.35,1.11,1.66,0.02800966,Moderate,0.296,0.11,0.018,0.375,Mild increase (p=0.035),Variable effect (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04127,rs322470,14,108386041,PICALM,SNP (C/T),(C/,C,1.79,1.53,2.15,0.00545084,Moderate,0.028,0.168,0.585,0.018,Significant increase (p=0.048),Significant decrease (p=0.004),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP04128,rs753907,12,174958841,SORL1,SNP (C/T),(C/,C,0.57,0.18,0.86,0.0090243,Protective,0.265,0.407,0.04,0.088,Mild decrease (p=0.048),Significant decrease (p=0.045),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP04129,rs734392,20,43146356,CD33,SNP (C/T),(C/,C,1.46,1.24,1.77,0.03316447,Moderate,0.379,0.07,0.24,0.111,Significant increase (p=0.01),Significant increase (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04130,rs812454,4,201394163,CD33,Insertion,-,-,1.08,0.78,1.37,0.1062497,High,0.014,0.084,0.644,0.059,Mild increase (p=0.046),Mild decrease (p=0.05),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04131,rs845671,10,56816041,CLU,SNP (A/T),(A/,A,7.0,6.64,7.25,0.01871664,Moderate,0.111,0.258,0.334,0.098,Significant increase (p=0.044),Variable effect (p=0.023),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04132,rs373257,18,44482902,CLU,Insertion,-,-,1.6,1.37,1.81,0.00485697,Low,0.418,0.047,0.263,0.071,Significant increase (p=0.046),Variable effect (p=0.028),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04133,rs658837,9,99199859,BIN1,SNP (C/G),(C/,C,2.08,1.7,2.33,0.0093158,Low,0.45,0.25,0.095,0.005,Significant decrease (p=0.05),Significant increase (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04134,rs191647,18,122671396,ABCA7,SNP (C/T),(C/,C,0.52,0.2,0.85,0.0043112,Moderate,0.292,0.367,0.131,0.011,Mild decrease (p=0.039),Significant decrease (p=0.042),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04135,rs140858,19,40852279,CD2AP,Deletion,-,-,0.32,0.1,0.58,0.00767684,Low,0.197,0.34,0.088,0.175,Mild decrease (p=0.005),Significant decrease (p=0.04),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04136,rs875462,20,51637487,PSEN2,SNP (A/T),(A/,A,1.35,0.96,1.66,0.15455245,Moderate,0.075,0.062,0.296,0.368,Mild increase (p=0.039),Mild decrease (p=0.023),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04137,rs540496,19,84230812,ABCA7,SNP (A/T),(A/,A,1.07,0.78,1.32,0.05874688,Low,0.014,0.16,0.575,0.052,No significant pattern (p=0.034),Significant decrease (p=0.04),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04138,rs809971,13,115526727,APOE,SNP (C/T),(C/,C,0.77,0.52,1.03,0.02602643,Low,0.215,0.138,0.335,0.112,Significant decrease (p=0.013),Variable effect (p=0.03),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04139,rs275517,22,166631570,CD33,Deletion,-,-,2.75,2.38,3.09,0.02460108,Moderate,0.09,0.145,0.162,0.404,Variable effect (p=0.044),Mild decrease (p=0.039),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP04140,rs544018,5,152022084,SORL1,SNP (A/G),(A/,A,0.42,0.13,0.67,0.04817849,Protective,0.393,0.03,0.237,0.14,Mild increase (p=0.016),Significant decrease (p=0.013),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04141,rs110179,10,73480926,BIN1,Insertion,-,-,1.53,1.14,1.89,0.05365531,Unknown,0.639,0.133,0.027,0.002,Mild increase (p=0.035),Significant decrease (p=0.026),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04142,rs606970,18,177629733,EPHA1,Insertion,-,-,0.24,0.1,0.56,0.00965467,Low,0.011,0.343,0.102,0.344,Significant increase (p=0.044),Significant increase (p=0.028),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04143,rs325088,10,165222485,MS4A6A,SNP (A/G),(A/,A,1.28,1.05,1.65,0.09037805,Moderate,0.195,0.465,0.124,0.016,Variable effect (p=0.045),No significant pattern (p=0.023),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04144,rs112169,18,103697468,APP,SNP (C/G),(C/,C,1.53,1.33,1.92,0.04862233,High,0.327,0.253,0.158,0.063,Mild decrease (p=0.036),Significant decrease (p=0.011),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP04145,rs243930,18,11717042,ABCA7,SNP (C/G),(C/,C,1.07,0.82,1.46,0.05973544,Low,0.287,0.057,0.297,0.159,Variable effect (p=0.006),Mild decrease (p=0.044),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP04146,rs282869,13,47524222,PSEN2,Deletion,-,-,1.59,1.3,1.87,0.01084952,Unknown,0.375,0.224,0.167,0.034,Significant increase (p=0.038),Significant increase (p=0.036),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04147,rs345733,13,220724716,EPHA1,Deletion,-,-,1.31,1.09,1.65,0.00978323,Moderate,0.458,0.115,0.099,0.128,Variable effect (p=0.027),Mild increase (p=0.041),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04148,rs622831,15,177220507,SORL1,SNP (A/G),(A/,A,0.63,0.27,0.97,0.03309387,Low,0.189,0.038,0.144,0.429,Significant decrease (p=0.05),Mild increase (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04149,rs451722,15,50413445,APOE,SNP (A/C),(A/,A,1.0,0.65,1.36,0.02145131,Moderate,0.126,0.042,0.565,0.067,Mild increase (p=0.043),Mild decrease (p=0.05),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04150,rs486185,13,198859058,EPHA1,Deletion,-,-,0.77,0.51,1.07,0.02454115,Moderate,0.052,0.641,0.107,0.001,Mild increase (p=0.04),Significant decrease (p=0.02),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP04151,rs796773,16,12493643,ABCA7,Insertion,-,-,0.96,0.59,1.29,0.01278426,Low,0.136,0.261,0.285,0.117,Significant decrease (p=0.021),Mild decrease (p=0.048),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP04152,rs223810,6,146816220,BIN1,Insertion,-,-,1.27,0.87,1.6,0.0593043,Moderate,0.004,0.152,0.459,0.185,Variable effect (p=0.005),Significant increase (p=0.008),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04153,rs527588,3,116531449,PICALM,SNP (A/T),(A/,A,1.25,0.89,1.6,0.04587374,Moderate,0.368,0.338,0.004,0.089,Variable effect (p=0.015),Mild increase (p=0.005),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04154,rs320022,3,74717915,MS4A6A,SNP (A/G),(A/,A,0.84,0.53,1.2,0.01603758,High,0.231,0.31,0.08,0.179,Variable effect (p=0.048),Mild increase (p=0.012),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04155,rs983798,8,189249153,SORL1,SNP (G/T),(G/,G,0.77,0.54,1.14,0.00916934,High,0.507,0.023,0.175,0.095,Mild increase (p=0.037),Variable effect (p=0.034),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04156,rs977257,19,68822467,SORL1,SNP (A/G),(A/,A,1.82,1.53,2.16,0.01132498,Moderate,0.018,0.565,0.18,0.037,Significant increase (p=0.017),Mild decrease (p=0.007),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04157,rs887137,14,209411826,MS4A6A,SNP (C/G),(C/,C,1.42,1.1,1.78,0.05282515,Low,0.075,0.463,0.011,0.251,Mild increase (p=0.042),Significant decrease (p=0.029),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04158,rs503968,8,38911276,CD33,SNP (A/C),(A/,A,0.75,0.54,1.09,0.1299849,Moderate,0.274,0.074,0.316,0.136,Significant decrease (p=0.008),Variable effect (p=0.038),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04159,rs830645,21,162560809,EPHA1,SNP (A/T),(A/,A,1.27,0.9,1.5,0.09076495,High,0.335,0.02,0.202,0.243,Mild decrease (p=0.006),Significant decrease (p=0.044),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04160,rs426136,14,226428945,APOE,SNP (C/G),(C/,C,1.6,1.37,1.92,0.01892392,Moderate,0.205,0.061,0.326,0.208,Mild increase (p=0.024),Mild increase (p=0.029),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04161,rs767353,1,186012695,CLU,SNP (A/C),(A/,A,0.66,0.31,1.01,0.16062108,Moderate,0.05,0.505,0.13,0.114,Significant decrease (p=0.045),Variable effect (p=0.007),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04162,rs834907,15,79441401,ABCA7,Deletion,-,-,1.1,0.83,1.3,0.05748011,Moderate,0.304,0.167,0.325,0.003,Mild increase (p=0.043),Variable effect (p=0.039),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04163,rs376717,6,1147834,EPHA1,SNP (A/T),(A/,A,1.37,0.99,1.76,0.00471627,Protective,0.15,0.235,0.176,0.239,Significant increase (p=0.002),No significant pattern (p=0.043),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04164,rs160604,4,34071398,ABCA7,SNP (A/T),(A/,A,0.5,0.17,0.72,0.05040483,Low,0.072,0.467,0.019,0.243,Mild decrease (p=0.025),Variable effect (p=0.004),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04165,rs504590,5,139100818,CD33,SNP (A/G),(A/,A,0.69,0.44,1.01,0.03098378,High,0.496,0.133,0.004,0.167,Significant increase (p=0.01),No significant pattern (p=0.007),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04166,rs979152,16,48135803,EPHA1,SNP (A/C),(A/,A,0.32,0.1,0.62,0.00681188,Unknown,0.355,0.002,0.326,0.117,Significant increase (p=0.001),Mild decrease (p=0.025),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP04167,rs157471,7,138594015,APP,Insertion,-,-,0.5,0.29,0.74,0.01939793,Moderate,0.201,0.223,0.178,0.198,Mild increase (p=0.006),No significant pattern (p=0.048),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04168,rs830804,3,76206875,BIN1,SNP (G/T),(G/,G,1.45,1.19,1.69,0.03786122,High,0.231,0.05,0.3,0.219,No significant pattern (p=0.007),Mild increase (p=0.019),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04169,rs505908,10,223259380,APP,SNP (G/T),(G/,G,0.32,0.1,0.59,0.00964712,High,0.26,0.359,0.011,0.17,Significant increase (p=0.036),Significant decrease (p=0.01),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP04170,rs568339,12,89218080,PTK2B,Deletion,-,-,0.61,0.21,0.91,0.02957438,Moderate,0.514,0.177,0.053,0.055,Mild increase (p=0.027),Mild increase (p=0.02),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP04171,rs147681,14,145016670,PSEN2,Deletion,-,-,1.77,1.52,1.98,0.00260619,Moderate,0.147,0.05,0.215,0.388,Significant decrease (p=0.026),Mild increase (p=0.039),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04172,rs852216,17,135718374,APOE,Insertion,-,-,1.7,1.31,1.91,0.01979754,Low,0.118,0.016,0.457,0.209,Significant increase (p=0.02),No significant pattern (p=0.006),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP04173,rs149035,2,187209351,SORL1,SNP (A/G),(A/,A,1.2,0.8,1.41,0.01483087,Moderate,0.15,0.036,0.278,0.336,Significant increase (p=0.037),Significant increase (p=0.018),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP04174,rs293780,1,101556508,CD33,SNP (G/T),(G/,G,0.65,0.42,0.88,0.02687903,High,0.032,0.199,0.464,0.105,Significant increase (p=0.043),Significant decrease (p=0.049),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04175,rs944333,21,144794267,PSEN2,Deletion,-,-,1.69,1.44,1.95,0.02340158,High,0.307,0.252,0.129,0.112,Significant decrease (p=0.021),Mild decrease (p=0.016),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04176,rs865755,14,177791059,APOE,SNP (A/C),(A/,A,0.86,0.65,1.19,0.00527164,Moderate,0.301,0.199,0.075,0.226,Mild decrease (p=0.021),No significant pattern (p=0.006),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04177,rs375126,4,142570267,MS4A6A,SNP (G/T),(G/,G,0.23,0.1,0.53,0.03701203,Unknown,0.365,0.161,0.13,0.144,Variable effect (p=0.01),Mild increase (p=0.01),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04178,rs735259,16,188233304,EPHA1,Insertion,-,-,0.81,0.5,1.19,0.01726087,Moderate,0.257,0.195,0.025,0.323,Mild increase (p=0.035),Significant decrease (p=0.042),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04179,rs160627,17,187168851,PSEN2,SNP (A/T),(A/,A,0.51,0.25,0.77,0.0069534,High,0.086,0.304,0.082,0.329,No significant pattern (p=0.031),Mild decrease (p=0.026),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04180,rs359628,18,103700838,CR1,SNP (A/T),(A/,A,1.58,1.28,1.79,0.01955174,High,0.536,0.115,0.049,0.1,Variable effect (p=0.039),Variable effect (p=0.003),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP04181,rs157350,6,123436531,CLU,SNP (A/T),(A/,A,0.68,0.45,0.9,0.03285781,Protective,0.172,0.009,0.436,0.183,Significant decrease (p=0.05),Significant increase (p=0.037),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04182,rs205669,11,128140708,EPHA1,SNP (A/G),(A/,A,0.39,0.16,0.71,0.09626712,Moderate,0.18,0.432,0.166,0.022,Significant increase (p=0.023),Significant increase (p=0.008),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04183,rs209281,15,68498369,CR1,Deletion,-,-,0.81,0.44,1.05,0.04886719,High,0.572,0.042,0.053,0.134,Variable effect (p=0.007),Variable effect (p=0.037),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04184,rs704264,8,51952126,APP,SNP (A/C),(A/,A,1.14,0.88,1.41,0.00613684,Unknown,0.601,0.072,0.1,0.027,Significant increase (p=0.004),Mild increase (p=0.031),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04185,rs321055,9,89847801,APP,Deletion,-,-,1.04,0.74,1.36,0.01950105,High,0.141,0.231,0.101,0.327,Variable effect (p=0.025),Significant decrease (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04186,rs602417,3,38945714,CD2AP,SNP (C/T),(C/,C,1.63,1.33,1.92,0.00250873,Moderate,0.741,0.003,0.024,0.032,Significant increase (p=0.028),No significant pattern (p=0.021),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP04187,rs585772,13,132410952,APP,SNP (G/T),(G/,G,1.53,1.3,1.92,0.01986493,Moderate,0.171,0.025,0.454,0.151,Significant increase (p=0.003),No significant pattern (p=0.038),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04188,rs205279,1,197677921,CD33,SNP (A/C),(A/,A,0.34,0.1,0.66,0.04245505,High,0.029,0.26,0.362,0.149,Significant decrease (p=0.012),No significant pattern (p=0.005),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04189,rs799533,5,76876300,TREM2,SNP (G/T),(G/,G,0.94,0.56,1.28,0.03206506,Low,0.318,0.099,0.3,0.083,Significant decrease (p=0.008),Mild decrease (p=0.021),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04190,rs942818,20,161087634,PICALM,SNP (C/T),(C/,C,0.57,0.27,0.96,0.0420725,Moderate,0.185,0.286,0.078,0.251,Significant decrease (p=0.027),No significant pattern (p=0.04),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04191,rs297160,12,238218566,TREM2,Deletion,-,-,1.2,0.99,1.43,0.03122251,Unknown,0.547,0.112,0.129,0.012,Significant increase (p=0.047),Significant decrease (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP04192,rs309822,3,34985584,APOE,SNP (A/T),(A/,A,0.33,0.1,0.67,0.00227458,Moderate,0.367,0.397,0.034,0.002,No significant pattern (p=0.042),Significant increase (p=0.012),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04193,rs504719,20,155806426,ABCA7,Insertion,-,-,1.13,0.73,1.47,0.00986028,High,0.082,0.645,0.058,0.014,Mild increase (p=0.017),No significant pattern (p=0.016),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04194,rs595747,22,131923430,PTK2B,Deletion,-,-,0.92,0.63,1.18,0.00770863,High,0.017,0.647,0.026,0.111,Significant decrease (p=0.05),Mild decrease (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04195,rs854202,22,237834224,APOE,Insertion,-,-,1.76,1.49,2.07,0.00463318,High,0.014,0.312,0.28,0.194,Mild increase (p=0.006),Mild decrease (p=0.026),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04196,rs938044,7,217457363,PSEN2,Insertion,-,-,0.62,0.32,0.85,0.06794531,Unknown,0.144,0.172,0.112,0.372,Mild decrease (p=0.031),Significant increase (p=0.025),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04197,rs425987,21,23975199,APOE,Deletion,-,-,1.19,0.98,1.53,0.06602707,High,0.146,0.141,0.099,0.413,Variable effect (p=0.016),Mild increase (p=0.04),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04198,rs980312,19,206711785,CD2AP,SNP (A/T),(A/,A,0.66,0.26,1.04,0.03764517,High,0.194,0.078,0.238,0.29,Mild increase (p=0.038),Mild increase (p=0.019),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04199,rs151021,10,113079806,CD33,Deletion,-,-,1.98,1.68,2.35,0.04945875,High,0.047,0.453,0.028,0.272,Significant increase (p=0.044),Significant decrease (p=0.004),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04200,rs952606,22,98796885,TREM2,SNP (A/C),(A/,A,0.77,0.37,1.07,0.0495726,High,0.064,0.463,0.174,0.099,Significant decrease (p=0.049),Significant decrease (p=0.023),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04201,rs733682,14,24650235,ABCA7,SNP (A/G),(A/,A,0.94,0.56,1.24,0.020274,Protective,0.335,0.018,0.285,0.162,Significant increase (p=0.031),Mild decrease (p=0.001),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP04202,rs214396,17,113404580,APP,Insertion,-,-,1.73,1.44,2.06,0.03595034,Moderate,0.023,0.519,0.153,0.104,Variable effect (p=0.046),Variable effect (p=0.011),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04203,rs502501,9,18447707,EPHA1,SNP (G/T),(G/,G,1.05,0.75,1.44,0.04077259,Protective,0.072,0.144,0.208,0.376,Significant decrease (p=0.046),Significant increase (p=0.011),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP04204,rs421084,18,183513927,BIN1,SNP (A/C),(A/,A,1.42,1.08,1.73,0.06322968,Moderate,0.065,0.427,0.072,0.236,Significant decrease (p=0.017),Significant decrease (p=0.035),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04205,rs396650,12,232643145,APOE,SNP (A/C),(A/,A,1.37,1.05,1.6,0.09201302,Low,0.019,0.067,0.35,0.364,No significant pattern (p=0.018),Significant decrease (p=0.031),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04206,rs491765,5,75119753,CD2AP,SNP (G/T),(G/,G,1.14,0.76,1.51,0.00341335,High,0.06,0.213,0.175,0.351,Significant increase (p=0.027),Variable effect (p=0.043),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP04207,rs536956,6,126169570,MS4A6A,SNP (C/T),(C/,C,0.85,0.54,1.12,0.0343614,High,0.016,0.104,0.621,0.059,Variable effect (p=0.035),Mild decrease (p=0.042),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04208,rs402833,11,56216849,PTK2B,SNP (A/C),(A/,A,0.97,0.68,1.23,0.04688508,Protective,0.107,0.057,0.566,0.07,Significant increase (p=0.019),Significant decrease (p=0.013),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04209,rs849719,11,142806281,APP,SNP (A/C),(A/,A,1.27,1.06,1.56,0.02798012,Moderate,0.201,0.29,0.128,0.181,Mild increase (p=0.006),Mild increase (p=0.035),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04210,rs268217,18,223447670,PICALM,SNP (A/G),(A/,A,1.59,1.22,1.85,0.00421635,Moderate,0.025,0.199,0.235,0.341,Mild decrease (p=0.019),Mild increase (p=0.012),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04211,rs638200,6,86699058,EPHA1,SNP (A/C),(A/,A,0.66,0.35,1.01,0.04754927,Unknown,0.223,0.452,0.07,0.054,Significant increase (p=0.041),Mild decrease (p=0.026),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP04212,rs570106,6,212127846,ABCA7,SNP (G/T),(G/,G,0.97,0.58,1.25,0.00386046,High,0.08,0.339,0.154,0.226,Significant decrease (p=0.043),Mild decrease (p=0.01),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04213,rs287565,18,93331864,PICALM,SNP (C/G),(C/,C,1.52,1.15,1.9,0.00922718,Low,0.614,0.022,0.139,0.024,Variable effect (p=0.049),Mild decrease (p=0.009),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP04214,rs798386,14,169783574,APP,Insertion,-,-,0.85,0.6,1.21,0.02644471,High,0.161,0.452,0.095,0.092,Mild increase (p=0.041),Variable effect (p=0.029),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04215,rs677388,5,118641411,PTK2B,SNP (C/G),(C/,C,0.17,0.1,0.52,0.0630007,Moderate,0.223,0.252,0.002,0.323,Significant decrease (p=0.011),Significant decrease (p=0.034),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP04216,rs426963,4,245629253,MS4A6A,SNP (C/G),(C/,C,0.55,0.16,0.75,0.02583745,High,0.211,0.117,0.265,0.207,Variable effect (p=0.005),Significant increase (p=0.011),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP04217,rs992744,14,245526398,CR1,SNP (G/T),(G/,G,1.13,0.75,1.49,0.00270681,Moderate,0.052,0.073,0.621,0.054,Mild increase (p=0.012),Variable effect (p=0.03),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04218,rs607212,1,116240678,PTK2B,Insertion,-,-,0.97,0.6,1.18,0.02530295,High,0.064,0.163,0.132,0.442,Mild increase (p=0.035),Mild increase (p=0.027),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP04219,rs542878,10,186309049,APOE,SNP (A/G),(A/,A,0.43,0.1,0.71,0.02726598,Moderate,0.36,0.094,0.185,0.161,Mild decrease (p=0.027),No significant pattern (p=0.032),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP04220,rs474278,21,205001091,BIN1,SNP (A/T),(A/,A,0.68,0.44,0.94,0.12694511,Moderate,0.015,0.168,0.024,0.593,No significant pattern (p=0.045),No significant pattern (p=0.019),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04221,rs720561,5,139139958,SORL1,SNP (A/G),(A/,A,0.37,0.16,0.73,0.00764207,Low,0.306,0.312,0.142,0.04,Significant increase (p=0.033),No significant pattern (p=0.027),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04222,rs237586,4,16481121,CLU,Deletion,-,-,0.99,0.73,1.34,0.00536829,Low,0.211,0.305,0.009,0.275,Significant decrease (p=0.041),Significant increase (p=0.039),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04223,rs443046,8,124380613,SORL1,Insertion,-,-,1.49,1.14,1.86,0.05331072,Moderate,0.496,0.083,0.183,0.038,Mild decrease (p=0.046),No significant pattern (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04224,rs390305,3,124383637,CD2AP,SNP (C/G),(C/,C,0.87,0.6,1.16,0.01029584,Protective,0.038,0.161,0.28,0.321,No significant pattern (p=0.003),Significant decrease (p=0.046),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04225,rs682722,19,223291338,ABCA7,Insertion,-,-,1.47,1.13,1.83,0.01284259,Moderate,0.056,0.161,0.415,0.168,Mild increase (p=0.035),Significant increase (p=0.031),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04226,rs947269,3,3096336,PICALM,SNP (A/T),(A/,A,0.43,0.1,0.65,0.0794474,Protective,0.01,0.294,0.387,0.109,Significant decrease (p=0.005),Variable effect (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP04227,rs338150,2,108228399,ABCA7,SNP (G/T),(G/,G,0.61,0.31,0.9,0.01801765,Low,0.475,0.16,0.094,0.071,Significant decrease (p=0.02),No significant pattern (p=0.014),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04228,rs200670,15,52272279,APP,SNP (A/G),(A/,A,1.95,1.6,2.3,0.00582216,Moderate,0.015,0.284,0.079,0.423,Variable effect (p=0.009),Significant decrease (p=0.031),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP04229,rs638364,8,203993159,MS4A6A,SNP (C/T),(C/,C,1.01,0.79,1.35,0.06629851,Low,0.3,0.366,0.085,0.049,Significant increase (p=0.013),Significant increase (p=0.009),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP04230,rs332365,13,62478909,ABCA7,SNP (A/C),(A/,A,1.04,0.82,1.3,0.00533772,High,0.31,0.058,0.398,0.034,Mild increase (p=0.029),Variable effect (p=0.043),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP04231,rs964829,12,30174520,PSEN2,SNP (C/T),(C/,C,1.45,1.12,1.85,0.05536644,Low,0.146,0.095,0.09,0.469,Significant decrease (p=0.013),Mild decrease (p=0.013),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04232,rs721785,6,39711122,TREM2,Insertion,-,-,1.37,1.15,1.76,0.01880481,High,0.036,0.174,0.104,0.486,Variable effect (p=0.017),Significant decrease (p=0.042),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04233,rs335184,3,85482542,PSEN2,Deletion,-,-,0.82,0.51,1.17,0.05767414,Moderate,0.024,0.368,0.034,0.374,Mild increase (p=0.003),Significant increase (p=0.011),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP04234,rs790772,4,63428520,PICALM,SNP (C/G),(C/,C,0.33,0.1,0.67,0.01235371,Low,0.498,0.02,0.191,0.092,Significant increase (p=0.008),Significant increase (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04235,rs184084,10,110821848,PSEN2,SNP (A/G),(A/,A,0.8,0.48,1.12,0.03879762,Low,0.115,0.032,0.127,0.526,Mild decrease (p=0.021),Mild increase (p=0.012),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04236,rs778414,5,203707706,CR1,SNP (G/T),(G/,G,0.91,0.59,1.19,0.02316893,Protective,0.045,0.47,0.283,0.002,Significant decrease (p=0.037),Mild decrease (p=0.015),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04237,rs415744,9,19489637,ABCA7,Deletion,-,-,1.46,1.11,1.69,0.03258364,High,0.097,0.145,0.551,0.007,No significant pattern (p=0.049),Significant increase (p=0.009),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04238,rs155941,15,178681877,CD33,Deletion,-,-,2.06,1.66,2.35,0.04301045,Moderate,0.376,0.006,0.006,0.413,Significant increase (p=0.043),Mild decrease (p=0.014),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP04239,rs281772,4,94978677,APP,SNP (G/T),(G/,G,0.77,0.44,1.07,0.04450685,Moderate,0.04,0.548,0.187,0.026,Mild increase (p=0.007),Mild decrease (p=0.01),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04240,rs678988,6,42272613,EPHA1,SNP (A/G),(A/,A,1.67,1.36,1.94,0.02241631,Moderate,0.251,0.073,0.339,0.136,Mild increase (p=0.009),Significant increase (p=0.023),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04241,rs249274,10,120785198,MS4A6A,SNP (G/T),(G/,G,0.42,0.15,0.75,0.007192,Moderate,0.226,0.14,0.287,0.146,Variable effect (p=0.003),Variable effect (p=0.01),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04242,rs578926,16,204540767,CD2AP,SNP (A/C),(A/,A,2.01,1.68,2.21,0.00889122,Low,0.049,0.418,0.067,0.267,Significant increase (p=0.005),Mild increase (p=0.035),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP04243,rs322891,11,4649162,TREM2,SNP (G/T),(G/,G,0.9,0.61,1.12,0.03783477,Protective,0.059,0.212,0.473,0.055,Mild decrease (p=0.016),No significant pattern (p=0.022),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04244,rs766571,12,25736340,PTK2B,SNP (C/T),(C/,C,1.93,1.64,2.28,0.00707776,Moderate,0.181,0.279,0.245,0.095,Variable effect (p=0.019),Mild increase (p=0.031),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP04245,rs461417,21,25064308,APP,Deletion,-,-,1.49,1.1,1.82,0.02299298,Moderate,0.287,0.324,0.171,0.017,Significant increase (p=0.018),Significant decrease (p=0.003),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP04246,rs793260,9,188209334,CD33,SNP (C/T),(C/,C,1.63,1.34,1.98,0.01915795,Low,0.024,0.242,0.018,0.516,Mild increase (p=0.026),Significant increase (p=0.039),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04247,rs715727,12,140113063,BIN1,SNP (C/G),(C/,C,0.86,0.53,1.23,0.02465934,Unknown,0.182,0.257,0.131,0.23,Variable effect (p=0.021),Significant increase (p=0.03),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04248,rs139253,1,7231346,TREM2,SNP (A/C),(A/,A,0.82,0.57,1.16,0.03994069,Moderate,0.138,0.426,0.21,0.026,Mild increase (p=0.008),Significant increase (p=0.03),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04249,rs109889,4,200288054,MS4A6A,SNP (G/T),(G/,G,1.79,1.46,2.1,0.06705397,High,0.478,0.167,0.035,0.12,No significant pattern (p=0.022),No significant pattern (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04250,rs108526,10,27360507,SORL1,SNP (G/T),(G/,G,1.17,0.89,1.41,0.03077624,High,0.089,0.486,0.06,0.165,Significant decrease (p=0.005),Significant increase (p=0.021),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04251,rs445755,19,167861800,EPHA1,Deletion,-,-,1.14,0.86,1.53,0.04633341,High,0.438,0.001,0.175,0.187,No significant pattern (p=0.048),Significant decrease (p=0.036),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04252,rs145505,14,161113352,EPHA1,Insertion,-,-,0.94,0.55,1.26,0.05380004,Unknown,0.279,0.063,0.391,0.066,Mild increase (p=0.015),Mild increase (p=0.015),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04253,rs995794,18,158842608,TREM2,Deletion,-,-,0.74,0.43,1.03,0.0347014,Protective,0.14,0.299,0.264,0.097,Mild decrease (p=0.022),Significant decrease (p=0.034),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04254,rs639482,7,205426498,APOE,SNP (G/T),(G/,G,1.76,1.51,2.16,0.00431764,Low,0.1,0.235,0.157,0.308,Significant decrease (p=0.043),Variable effect (p=0.037),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04255,rs598649,5,169832916,PICALM,SNP (A/C),(A/,A,1.31,1.03,1.69,0.01359577,High,0.332,0.159,0.132,0.176,Significant increase (p=0.028),Significant decrease (p=0.044),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04256,rs993636,19,117781722,ABCA7,SNP (A/C),(A/,A,1.29,0.91,1.59,0.00431178,Moderate,0.061,0.05,0.047,0.642,Variable effect (p=0.003),Variable effect (p=0.009),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04257,rs279427,2,106467866,CD33,Deletion,-,-,1.32,1.06,1.68,0.0870259,Protective,0.165,0.592,0.029,0.014,No significant pattern (p=0.033),Mild decrease (p=0.022),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04258,rs111443,7,148539427,CLU,SNP (C/G),(C/,C,2.0,1.67,2.24,0.05684972,Moderate,0.19,0.178,0.112,0.321,No significant pattern (p=0.039),Mild decrease (p=0.041),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04259,rs848118,2,120166028,APOE,SNP (A/T),(A/,A,1.04,0.67,1.39,0.10803746,Moderate,0.019,0.402,0.123,0.256,Mild decrease (p=0.024),No significant pattern (p=0.032),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04260,rs498520,5,222432078,EPHA1,SNP (G/T),(G/,G,1.78,1.5,2.03,0.00539876,Moderate,0.044,0.137,0.197,0.422,Mild increase (p=0.046),Variable effect (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04261,rs103339,3,19343393,APP,Deletion,-,-,1.57,1.2,1.86,0.04129849,High,0.501,0.062,0.089,0.148,Mild decrease (p=0.043),Significant decrease (p=0.005),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04262,rs332094,20,98539054,CD33,SNP (A/G),(A/,A,1.18,0.81,1.39,0.08562456,Moderate,0.327,0.07,0.235,0.168,Significant increase (p=0.025),Significant increase (p=0.009),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04263,rs531317,17,207510579,CD2AP,SNP (A/C),(A/,A,0.29,0.1,0.63,0.00546084,Protective,0.079,0.129,0.506,0.087,No significant pattern (p=0.041),No significant pattern (p=0.001),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04264,rs147369,7,119293941,CD2AP,Deletion,-,-,0.79,0.4,1.09,0.08106442,Low,0.083,0.444,0.082,0.191,Significant decrease (p=0.023),Mild increase (p=0.017),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04265,rs958573,12,69743981,CR1,Deletion,-,-,1.12,0.8,1.47,0.04455051,Moderate,0.045,0.115,0.441,0.199,Significant increase (p=0.009),No significant pattern (p=0.022),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP04266,rs735707,14,226377221,APOE,SNP (C/T),(C/,C,1.39,1.15,1.76,0.1078102,Low,0.031,0.049,0.086,0.634,Significant increase (p=0.007),Significant increase (p=0.013),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04267,rs303198,20,161917359,EPHA1,SNP (A/C),(A/,A,1.25,1.04,1.6,0.08340917,High,0.105,0.104,0.306,0.285,Significant increase (p=0.023),Variable effect (p=0.007),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04268,rs446235,6,112615352,ABCA7,SNP (G/T),(G/,G,1.29,1.05,1.62,0.02655712,Low,0.216,0.119,0.274,0.19,Significant increase (p=0.035),Mild increase (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP04269,rs304452,14,93609384,PICALM,Deletion,-,-,1.78,1.52,2.13,0.02112392,Moderate,0.001,0.559,0.167,0.073,Mild decrease (p=0.003),Variable effect (p=0.031),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04270,rs216401,4,94226062,BIN1,SNP (A/T),(A/,A,0.54,0.16,0.93,0.03947698,Moderate,0.189,0.082,0.271,0.257,Mild decrease (p=0.04),Mild increase (p=0.016),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04271,rs628390,1,196631721,MS4A6A,Deletion,-,-,0.45,0.22,0.69,0.00330069,Moderate,0.238,0.294,0.01,0.258,No significant pattern (p=0.016),Significant decrease (p=0.025),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04272,rs909525,1,91101386,CR1,SNP (A/C),(A/,A,0.78,0.55,1.02,0.03190517,High,0.161,0.439,0.189,0.01,Significant decrease (p=0.044),No significant pattern (p=0.013),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04273,rs455714,5,48834290,PTK2B,SNP (C/G),(C/,C,0.4,0.15,0.62,0.0297235,High,0.418,0.007,0.188,0.187,Significant decrease (p=0.029),Mild decrease (p=0.036),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04274,rs346287,3,210016485,TREM2,Insertion,-,-,1.66,1.39,1.93,0.0207383,Low,0.164,0.414,0.213,0.008,Significant increase (p=0.011),Significant decrease (p=0.032),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP04275,rs605469,6,77418121,BIN1,SNP (A/C),(A/,A,1.24,0.87,1.62,0.02071601,Protective,0.561,0.048,0.007,0.184,Significant increase (p=0.041),Variable effect (p=0.02),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04276,rs597006,18,201812193,CLU,SNP (G/T),(G/,G,1.76,1.48,1.96,0.03200253,High,0.178,0.329,0.086,0.206,Mild decrease (p=0.006),Variable effect (p=0.011),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04277,rs250258,4,208801463,APP,SNP (A/T),(A/,A,0.86,0.53,1.19,0.00207682,Low,0.203,0.058,0.409,0.13,No significant pattern (p=0.041),Significant decrease (p=0.044),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP04278,rs660506,18,67570368,PICALM,SNP (C/T),(C/,C,1.12,0.91,1.44,0.04153326,High,0.004,0.505,0.031,0.259,Mild increase (p=0.026),Significant increase (p=0.03),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04279,rs440807,3,79164149,APP,SNP (C/G),(C/,C,1.05,0.7,1.39,0.00929277,High,0.376,0.214,0.091,0.12,Significant increase (p=0.049),Variable effect (p=0.045),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04280,rs953754,11,190758276,PICALM,SNP (A/C),(A/,A,0.76,0.49,1.0,0.03894444,High,0.023,0.359,0.047,0.37,Variable effect (p=0.03),Mild decrease (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04281,rs921393,16,49327837,CR1,Insertion,-,-,0.42,0.1,0.77,0.01190089,High,0.049,0.117,0.182,0.452,Significant increase (p=0.04),Mild increase (p=0.003),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04282,rs774852,2,147229404,MS4A6A,Insertion,-,-,0.96,0.57,1.32,0.03210424,High,0.099,0.158,0.153,0.39,Variable effect (p=0.033),Significant increase (p=0.03),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04283,rs852772,18,104120282,TREM2,SNP (A/G),(A/,A,0.76,0.42,1.11,0.08037106,Moderate,0.098,0.372,0.185,0.145,No significant pattern (p=0.037),Variable effect (p=0.041),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP04284,rs231896,18,23626035,EPHA1,Deletion,-,-,0.7,0.32,0.92,0.04864801,Protective,0.017,0.102,0.523,0.159,Mild decrease (p=0.001),No significant pattern (p=0.039),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04285,rs989647,17,242178321,TREM2,SNP (G/T),(G/,G,0.73,0.51,1.07,0.01331856,High,0.266,0.207,0.278,0.049,Variable effect (p=0.019),No significant pattern (p=0.012),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04286,rs842943,17,45917664,APP,SNP (G/T),(G/,G,2.48,2.23,2.82,0.02190856,High,0.181,0.171,0.038,0.411,No significant pattern (p=0.025),Significant decrease (p=0.009),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04287,rs296505,19,153737819,MS4A6A,SNP (A/G),(A/,A,1.39,1.17,1.77,0.04946597,High,0.612,0.029,0.065,0.095,Mild increase (p=0.025),Variable effect (p=0.044),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04288,rs376505,6,129581275,CD33,Deletion,-,-,1.7,1.49,2.09,0.02708172,Moderate,0.008,0.031,0.54,0.221,Mild decrease (p=0.016),Variable effect (p=0.019),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04289,rs163596,5,40332152,CR1,Deletion,-,-,1.63,1.41,2.01,0.0402172,Moderate,0.065,0.06,0.082,0.593,Mild decrease (p=0.002),Mild increase (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP04290,rs572452,8,195071611,CR1,SNP (A/C),(A/,A,2.93,2.64,3.14,0.03894012,Moderate,0.379,0.336,0.031,0.054,Mild decrease (p=0.011),Mild decrease (p=0.047),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04291,rs430537,10,125738045,MS4A6A,SNP (C/T),(C/,C,0.69,0.39,0.98,0.02202848,Moderate,0.082,0.144,0.387,0.187,Mild increase (p=0.038),No significant pattern (p=0.035),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04292,rs683535,6,248031772,CD33,SNP (A/T),(A/,A,2.14,1.85,2.41,0.06699728,Protective,0.002,0.083,0.133,0.582,Mild increase (p=0.016),Variable effect (p=0.013),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04293,rs567247,2,94975715,PSEN2,Insertion,-,-,0.66,0.4,0.99,0.1185954,High,0.043,0.257,0.418,0.082,Significant decrease (p=0.012),Mild decrease (p=0.034),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04294,rs898169,8,81383482,CD33,SNP (C/T),(C/,C,0.71,0.48,0.94,0.13124238,High,0.414,0.135,0.237,0.015,Mild increase (p=0.013),Significant increase (p=0.04),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04295,rs855400,1,196196756,PICALM,SNP (A/G),(A/,A,0.98,0.72,1.24,0.13578644,Unknown,0.087,0.471,0.081,0.161,Mild decrease (p=0.012),Significant increase (p=0.035),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP04296,rs567235,12,208003729,TREM2,SNP (G/T),(G/,G,1.57,1.36,1.94,0.1070839,High,0.662,0.009,0.11,0.019,Mild increase (p=0.019),Significant increase (p=0.041),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04297,rs592195,15,209101929,APOE,SNP (A/T),(A/,A,0.4,0.15,0.67,0.00308535,Moderate,0.476,0.168,0.039,0.117,Significant increase (p=0.017),Mild increase (p=0.048),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04298,rs350102,9,183504205,CD2AP,Insertion,-,-,0.81,0.59,1.19,0.03515283,Moderate,0.29,0.049,0.184,0.277,Mild decrease (p=0.002),Mild decrease (p=0.011),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04299,rs918256,20,169953133,CLU,SNP (C/G),(C/,C,0.91,0.7,1.24,0.01447138,Protective,0.183,0.036,0.235,0.345,Significant increase (p=0.002),No significant pattern (p=0.026),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP04300,rs533396,10,194620483,CD33,SNP (C/T),(C/,C,0.36,0.1,0.63,0.00637982,Protective,0.45,0.081,0.267,0.002,Significant increase (p=0.011),Significant decrease (p=0.047),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04301,rs331314,17,154561731,EPHA1,SNP (A/T),(A/,A,1.03,0.74,1.37,0.00619725,High,0.004,0.209,0.019,0.568,Significant decrease (p=0.049),No significant pattern (p=0.032),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04302,rs838285,14,37469807,CD2AP,Insertion,-,-,0.87,0.52,1.25,0.00507006,Low,0.041,0.045,0.669,0.046,No significant pattern (p=0.026),Significant decrease (p=0.019),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04303,rs599810,13,19893644,PTK2B,SNP (A/C),(A/,A,0.81,0.52,1.16,0.01993909,High,0.408,0.16,0.087,0.145,Significant increase (p=0.018),Variable effect (p=0.032),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04304,rs599766,10,245696497,CD33,Deletion,-,-,1.05,0.76,1.33,0.09364397,Moderate,0.128,0.126,0.4,0.145,Significant increase (p=0.027),Variable effect (p=0.015),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP04305,rs750712,10,202073172,CLU,SNP (A/C),(A/,A,0.69,0.47,1.0,0.02734363,Moderate,0.02,0.191,0.464,0.125,Significant decrease (p=0.015),Significant decrease (p=0.034),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04306,rs143242,12,173426347,CLU,SNP (C/G),(C/,C,0.72,0.37,1.03,0.0253693,High,0.171,0.249,0.304,0.076,Variable effect (p=0.021),No significant pattern (p=0.007),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04307,rs366171,19,78209587,TREM2,SNP (A/T),(A/,A,2.36,2.07,2.6,0.01036894,Moderate,0.105,0.327,0.041,0.327,Significant decrease (p=0.05),Mild decrease (p=0.023),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04308,rs906452,18,50810284,BIN1,SNP (A/T),(A/,A,0.95,0.69,1.15,0.00853001,Moderate,0.029,0.526,0.126,0.119,Significant decrease (p=0.019),Mild decrease (p=0.037),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP04309,rs189654,17,216987268,CD2AP,Insertion,-,-,0.76,0.45,1.13,0.00145507,Unknown,0.154,0.206,0.033,0.406,Significant decrease (p=0.025),Variable effect (p=0.017),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04310,rs923553,21,158658583,TREM2,SNP (A/C),(A/,A,2.67,2.36,2.97,0.09008461,High,0.027,0.311,0.252,0.209,No significant pattern (p=0.019),Variable effect (p=0.02),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP04311,rs192964,5,219579227,APP,Deletion,-,-,1.13,0.81,1.41,0.03003113,Low,0.089,0.045,0.284,0.382,No significant pattern (p=0.038),Significant decrease (p=0.036),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP04312,rs745698,22,172953608,EPHA1,SNP (C/T),(C/,C,1.0,0.69,1.34,0.04873029,Low,0.065,0.362,0.219,0.154,Mild increase (p=0.027),Mild decrease (p=0.037),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04313,rs363786,21,110771915,CLU,SNP (C/T),(C/,C,5.16,4.95,5.38,0.00982092,Low,0.071,0.346,0.358,0.025,Significant increase (p=0.032),Significant increase (p=0.042),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04314,rs134366,13,78977797,CLU,SNP (A/T),(A/,A,1.73,1.38,2.0,0.03556794,Low,0.084,0.117,0.238,0.361,Variable effect (p=0.012),No significant pattern (p=0.037),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP04315,rs763534,7,69455621,CD33,SNP (G/T),(G/,G,1.0,0.62,1.26,0.06025174,Moderate,0.107,0.091,0.393,0.209,Variable effect (p=0.027),No significant pattern (p=0.027),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04316,rs620204,19,10581292,CD33,Deletion,-,-,1.0,0.65,1.24,0.0227377,Protective,0.001,0.102,0.635,0.062,Mild decrease (p=0.033),Significant increase (p=0.041),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04317,rs981351,14,126846199,CD2AP,SNP (C/T),(C/,C,0.51,0.25,0.79,0.01062623,High,0.218,0.267,0.031,0.284,Variable effect (p=0.022),No significant pattern (p=0.015),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04318,rs848584,18,105823634,ABCA7,Insertion,-,-,0.61,0.26,0.91,0.03539565,High,0.108,0.001,0.301,0.39,Significant decrease (p=0.012),Mild increase (p=0.024),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04319,rs603247,2,148558687,EPHA1,SNP (A/G),(A/,A,1.41,1.12,1.72,0.02676917,Moderate,0.251,0.452,0.079,0.018,Significant increase (p=0.025),Mild increase (p=0.004),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04320,rs100344,3,211382032,EPHA1,SNP (C/G),(C/,C,0.88,0.54,1.22,0.02714266,Low,0.075,0.292,0.086,0.347,Significant decrease (p=0.029),Significant increase (p=0.011),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP04321,rs356041,18,156211489,APP,SNP (G/T),(G/,G,1.65,1.35,1.98,0.03936712,Protective,0.012,0.216,0.264,0.308,No significant pattern (p=0.035),Significant increase (p=0.04),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04322,rs231363,9,26071400,MS4A6A,SNP (A/G),(A/,A,3.48,3.2,3.87,0.01803777,Low,0.235,0.138,0.024,0.402,Mild decrease (p=0.007),No significant pattern (p=0.05),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP04323,rs938314,21,58408719,TREM2,SNP (C/T),(C/,C,0.5,0.17,0.82,0.08441952,Moderate,0.218,0.13,0.433,0.019,Significant decrease (p=0.016),No significant pattern (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04324,rs107862,4,208178272,CLU,SNP (A/G),(A/,A,0.9,0.54,1.24,0.01075312,High,0.015,0.125,0.595,0.065,Mild decrease (p=0.011),Mild increase (p=0.04),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP04325,rs700924,15,40458947,CR1,Deletion,-,-,1.13,0.84,1.34,0.01979495,Moderate,0.272,0.37,0.151,0.006,Significant decrease (p=0.016),Variable effect (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04326,rs257846,3,53964634,CD2AP,Deletion,-,-,0.62,0.31,0.97,0.1019407,Low,0.123,0.176,0.486,0.016,Variable effect (p=0.023),Mild increase (p=0.05),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04327,rs378243,18,2978646,ABCA7,Deletion,-,-,1.68,1.34,2.01,0.0190604,High,0.107,0.058,0.553,0.082,Mild increase (p=0.038),Mild decrease (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04328,rs141333,4,233437690,EPHA1,SNP (C/T),(C/,C,0.49,0.1,0.85,0.01227319,High,0.17,0.405,0.076,0.149,Mild increase (p=0.032),Mild increase (p=0.023),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04329,rs686389,8,237812236,CLU,SNP (A/C),(A/,A,0.53,0.23,0.86,0.00703763,Moderate,0.298,0.012,0.281,0.209,Significant decrease (p=0.026),Mild decrease (p=0.043),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04330,rs297542,20,124676711,PSEN2,SNP (A/C),(A/,A,0.92,0.52,1.2,0.00512776,High,0.328,0.134,0.05,0.288,No significant pattern (p=0.015),Mild decrease (p=0.02),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04331,rs449803,4,126031827,CD33,Deletion,-,-,0.96,0.58,1.3,0.00017537,High,0.023,0.105,0.11,0.562,Variable effect (p=0.034),Mild increase (p=0.029),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04332,rs480098,10,159714761,MS4A6A,SNP (C/T),(C/,C,1.28,1.02,1.59,0.0170994,Protective,0.278,0.33,0.075,0.117,Mild increase (p=0.029),Mild decrease (p=0.038),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04333,rs110973,5,101005211,CR1,Deletion,-,-,1.82,1.59,2.04,0.06141405,Low,0.242,0.342,0.173,0.042,Variable effect (p=0.027),Mild decrease (p=0.037),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP04334,rs233521,19,91829279,APP,SNP (C/G),(C/,C,0.67,0.37,1.01,0.02006206,High,0.138,0.129,0.12,0.413,Variable effect (p=0.021),Mild increase (p=0.032),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04335,rs681564,2,58875254,PICALM,SNP (C/T),(C/,C,1.73,1.38,2.08,0.02833065,Protective,0.149,0.256,0.302,0.094,Significant increase (p=0.04),Significant decrease (p=0.025),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04336,rs116507,1,144465233,CD2AP,SNP (C/T),(C/,C,0.69,0.4,1.03,0.00693256,High,0.037,0.326,0.051,0.386,Variable effect (p=0.01),Variable effect (p=0.037),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04337,rs126800,15,1653639,CD33,SNP (A/C),(A/,A,0.93,0.54,1.23,0.10749924,Low,0.187,0.276,0.198,0.139,Significant decrease (p=0.022),Significant increase (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP04338,rs217613,7,183337861,BIN1,SNP (C/T),(C/,C,1.33,1.11,1.53,0.05614723,Unknown,0.016,0.141,0.251,0.392,Significant increase (p=0.041),Significant decrease (p=0.034),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04339,rs494865,14,61909857,TREM2,Deletion,-,-,0.68,0.29,0.95,0.01926915,High,0.304,0.037,0.205,0.253,Significant decrease (p=0.012),No significant pattern (p=0.023),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04340,rs199669,1,68576173,ABCA7,Insertion,-,-,1.03,0.83,1.32,0.09249339,Low,0.011,0.026,0.76,0.003,No significant pattern (p=0.035),Mild increase (p=0.005),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04341,rs356059,15,24987977,PSEN2,SNP (A/C),(A/,A,0.77,0.44,1.09,0.0293115,Low,0.008,0.277,0.056,0.459,Significant increase (p=0.009),Significant decrease (p=0.004),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP04342,rs679187,22,77285868,BIN1,SNP (C/T),(C/,C,0.31,0.1,0.68,0.02779488,High,0.284,0.406,0.087,0.023,Mild increase (p=0.046),Variable effect (p=0.033),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04343,rs487550,17,56898999,MS4A6A,SNP (G/T),(G/,G,0.84,0.56,1.15,0.06534999,Moderate,0.594,0.137,0.008,0.06,Mild increase (p=0.008),No significant pattern (p=0.047),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04344,rs393945,13,69623221,MS4A6A,SNP (C/G),(C/,C,0.41,0.1,0.68,0.01430432,Moderate,0.141,0.106,0.508,0.045,Variable effect (p=0.012),No significant pattern (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04345,rs823877,15,146349213,CD33,SNP (G/T),(G/,G,1.06,0.85,1.39,0.1018079,Low,0.144,0.023,0.104,0.53,No significant pattern (p=0.027),Mild decrease (p=0.038),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04346,rs505010,2,165894343,PSEN2,SNP (A/G),(A/,A,0.4,0.1,0.61,0.03569717,Moderate,0.307,0.085,0.045,0.363,Mild decrease (p=0.035),Mild decrease (p=0.02),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04347,rs980338,17,126687075,APOE,SNP (A/C),(A/,A,2.04,1.79,2.41,0.09111899,Moderate,0.019,0.344,0.131,0.306,Significant increase (p=0.047),No significant pattern (p=0.039),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04348,rs647586,15,238880776,TREM2,SNP (C/G),(C/,C,1.1,0.73,1.31,0.02250065,High,0.006,0.206,0.424,0.163,Significant decrease (p=0.027),Significant increase (p=0.019),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04349,rs702478,10,139928793,PICALM,Deletion,-,-,2.49,2.26,2.81,0.07956029,Moderate,0.146,0.226,0.147,0.281,Variable effect (p=0.004),Mild decrease (p=0.032),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04350,rs550151,17,41851113,SORL1,SNP (G/T),(G/,G,0.8,0.57,1.04,0.01594436,Moderate,0.048,0.548,0.187,0.017,Significant increase (p=0.012),No significant pattern (p=0.023),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04351,rs235745,3,115566631,CD2AP,SNP (A/G),(A/,A,1.15,0.83,1.54,0.0217187,High,0.185,0.053,0.032,0.531,Variable effect (p=0.047),Variable effect (p=0.017),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04352,rs732243,18,131736757,APP,SNP (C/G),(C/,C,1.28,1.04,1.64,0.02812816,High,0.142,0.411,0.207,0.041,Variable effect (p=0.012),Significant decrease (p=0.036),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04353,rs156086,18,228403952,ABCA7,SNP (G/T),(G/,G,0.36,0.13,0.7,0.00335134,Low,0.148,0.293,0.082,0.278,Significant increase (p=0.009),Significant increase (p=0.006),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04354,rs611289,13,48066608,CLU,Deletion,-,-,0.82,0.46,1.16,0.01066767,Moderate,0.002,0.095,0.222,0.481,Variable effect (p=0.014),Significant increase (p=0.047),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04355,rs194383,22,239703958,APOE,SNP (A/T),(A/,A,1.51,1.21,1.78,0.01479637,High,0.171,0.153,0.201,0.275,Significant decrease (p=0.031),Variable effect (p=0.003),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04356,rs257352,1,235482800,EPHA1,SNP (A/G),(A/,A,1.55,1.19,1.87,0.04444194,High,0.157,0.598,0.039,0.005,Variable effect (p=0.025),Variable effect (p=0.043),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04357,rs321813,9,105440245,PICALM,SNP (A/G),(A/,A,0.63,0.39,1.0,0.09153578,Low,0.563,0.005,0.104,0.129,Variable effect (p=0.018),Variable effect (p=0.006),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP04358,rs848947,15,88476603,CR1,SNP (C/T),(C/,C,1.43,1.08,1.64,0.05262983,Moderate,0.275,0.156,0.059,0.31,Mild increase (p=0.019),Significant decrease (p=0.039),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04359,rs344042,3,187425096,ABCA7,SNP (C/T),(C/,C,1.75,1.35,2.06,0.09005669,Low,0.565,0.099,0.099,0.036,Mild increase (p=0.02),No significant pattern (p=0.033),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04360,rs138447,2,185247135,BIN1,SNP (A/T),(A/,A,1.71,1.36,2.01,0.04282222,Protective,0.057,0.002,0.267,0.474,Variable effect (p=0.033),Mild decrease (p=0.05),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04361,rs284700,2,24129429,APP,Deletion,-,-,0.42,0.12,0.76,0.04594513,Moderate,0.099,0.133,0.386,0.182,Variable effect (p=0.018),Mild decrease (p=0.017),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04362,rs759260,4,219248530,TREM2,Insertion,-,-,0.83,0.5,1.09,0.00922729,Moderate,0.262,0.261,0.015,0.262,Variable effect (p=0.024),Mild decrease (p=0.035),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04363,rs931751,2,144719932,SORL1,SNP (A/T),(A/,A,1.43,1.05,1.75,0.01904426,High,0.124,0.076,0.349,0.25,Mild increase (p=0.033),Significant decrease (p=0.002),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04364,rs913154,17,89669165,ABCA7,SNP (A/G),(A/,A,0.55,0.29,0.93,0.00367429,High,0.139,0.521,0.087,0.053,No significant pattern (p=0.044),Significant decrease (p=0.023),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04365,rs931975,11,228804198,CR1,SNP (C/T),(C/,C,0.99,0.69,1.22,0.0043724,Moderate,0.086,0.506,0.209,0.0,Significant increase (p=0.038),No significant pattern (p=0.004),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04366,rs544860,1,213016585,SORL1,SNP (A/G),(A/,A,1.28,0.93,1.49,0.02328611,Moderate,0.163,0.091,0.451,0.095,Variable effect (p=0.045),Mild increase (p=0.014),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP04367,rs465380,6,101875367,BIN1,Insertion,-,-,0.65,0.28,0.87,0.03401387,High,0.177,0.029,0.098,0.495,Mild increase (p=0.032),Mild decrease (p=0.042),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04368,rs421196,7,224412018,PSEN2,Deletion,-,-,1.53,1.16,1.92,0.03041754,Unknown,0.335,0.011,0.315,0.139,Mild decrease (p=0.022),Variable effect (p=0.02),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04369,rs868926,7,143549369,PSEN2,SNP (A/C),(A/,A,0.79,0.4,1.02,0.02698752,High,0.155,0.374,0.156,0.114,Mild increase (p=0.048),Variable effect (p=0.024),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP04370,rs315196,12,34071030,APOE,SNP (A/C),(A/,A,1.49,1.18,1.71,0.04785213,High,0.302,0.163,0.155,0.179,Mild decrease (p=0.044),No significant pattern (p=0.004),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04371,rs832071,8,204535696,CLU,SNP (A/T),(A/,A,0.89,0.57,1.2,0.0157627,Low,0.058,0.732,0.009,0.001,No significant pattern (p=0.022),Variable effect (p=0.02),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04372,rs930654,2,168734900,SORL1,SNP (A/G),(A/,A,0.66,0.41,1.04,0.01877078,High,0.324,0.263,0.058,0.155,Mild increase (p=0.005),Variable effect (p=0.035),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04373,rs890595,20,138417039,PTK2B,SNP (A/T),(A/,A,0.57,0.2,0.95,0.04098361,High,0.145,0.356,0.09,0.208,Significant decrease (p=0.045),Mild decrease (p=0.028),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04374,rs792145,10,93821603,TREM2,SNP (C/G),(C/,C,1.98,1.7,2.22,0.01879434,Low,0.221,0.111,0.249,0.22,No significant pattern (p=0.018),Variable effect (p=0.004),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04375,rs299730,3,86253321,APP,SNP (C/G),(C/,C,0.89,0.58,1.13,0.04902068,Moderate,0.271,0.306,0.132,0.091,Mild decrease (p=0.002),Mild decrease (p=0.032),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04376,rs182163,4,195386293,CD33,SNP (A/T),(A/,A,1.5,1.16,1.81,0.00655907,Moderate,0.421,0.176,0.056,0.147,Significant increase (p=0.031),Significant decrease (p=0.035),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04377,rs662643,12,49551889,CD2AP,SNP (A/G),(A/,A,3.62,3.33,3.85,0.03170063,Moderate,0.185,0.46,0.111,0.044,Variable effect (p=0.002),Significant increase (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04378,rs872386,9,212230949,ABCA7,SNP (C/G),(C/,C,0.83,0.5,1.17,0.04156436,High,0.011,0.051,0.695,0.042,Significant decrease (p=0.032),Significant decrease (p=0.007),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04379,rs414608,15,244433662,APOE,SNP (A/C),(A/,A,1.5,1.24,1.89,0.01388087,Low,0.258,0.412,0.019,0.111,Mild increase (p=0.049),Variable effect (p=0.022),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP04380,rs556616,9,221351681,EPHA1,SNP (G/T),(G/,G,0.89,0.57,1.27,0.020341,Protective,0.003,0.247,0.103,0.447,No significant pattern (p=0.041),No significant pattern (p=0.035),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04381,rs632671,15,30063435,MS4A6A,SNP (A/T),(A/,A,0.63,0.23,0.83,0.0678238,Moderate,0.239,0.184,0.067,0.31,Mild increase (p=0.006),Significant decrease (p=0.004),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04382,rs334831,14,206306045,BIN1,SNP (A/T),(A/,A,1.14,0.8,1.49,0.00180741,High,0.279,0.136,0.12,0.265,Significant increase (p=0.046),No significant pattern (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP04383,rs926936,7,121640095,BIN1,Deletion,-,-,0.96,0.75,1.21,0.00484811,High,0.007,0.364,0.343,0.086,Mild increase (p=0.008),Significant decrease (p=0.047),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04384,rs682116,17,174148701,PSEN2,Deletion,-,-,1.78,1.57,2.15,0.00350495,High,0.16,0.599,0.02,0.021,Significant decrease (p=0.038),No significant pattern (p=0.036),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04385,rs549261,2,93188283,APP,SNP (G/T),(G/,G,0.94,0.72,1.33,0.04795983,Low,0.053,0.503,0.076,0.169,Mild decrease (p=0.024),Mild decrease (p=0.047),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP04386,rs218574,15,146740960,EPHA1,SNP (G/T),(G/,G,1.23,0.96,1.59,0.02958463,Low,0.165,0.058,0.16,0.417,Mild increase (p=0.047),Variable effect (p=0.038),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP04387,rs959021,18,116737809,ABCA7,SNP (A/G),(A/,A,1.31,0.92,1.6,0.00133766,High,0.008,0.18,0.057,0.555,Mild decrease (p=0.021),Mild decrease (p=0.048),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04388,rs446011,3,78570133,CLU,Deletion,-,-,1.08,0.85,1.28,0.00210218,Moderate,0.327,0.155,0.043,0.275,Variable effect (p=0.004),Variable effect (p=0.035),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04389,rs509095,13,230481906,PSEN2,SNP (C/G),(C/,C,1.27,0.94,1.54,0.12190727,Unknown,0.146,0.031,0.295,0.328,Variable effect (p=0.026),Variable effect (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04390,rs955142,12,200823562,TREM2,SNP (A/T),(A/,A,0.56,0.26,0.82,0.03505393,Moderate,0.046,0.061,0.051,0.642,No significant pattern (p=0.021),Significant decrease (p=0.021),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04391,rs385889,14,132605527,TREM2,Deletion,-,-,0.65,0.37,0.88,0.032262,High,0.328,0.144,0.315,0.013,Variable effect (p=0.048),Mild decrease (p=0.026),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP04392,rs875834,22,178282085,TREM2,Insertion,-,-,0.7,0.47,1.09,0.02393923,High,0.042,0.042,0.194,0.522,Significant decrease (p=0.003),Mild decrease (p=0.038),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04393,rs383183,17,127096286,PSEN2,SNP (G/T),(G/,G,0.41,0.12,0.69,0.03418494,Moderate,0.417,0.072,0.181,0.13,Mild decrease (p=0.039),Mild increase (p=0.022),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04394,rs652725,10,14302732,PSEN2,SNP (A/T),(A/,A,0.56,0.33,0.9,0.00505001,Low,0.098,0.526,0.109,0.067,Mild increase (p=0.009),No significant pattern (p=0.047),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04395,rs789714,13,141238482,EPHA1,SNP (A/T),(A/,A,1.14,0.86,1.5,0.02249973,High,0.047,0.238,0.444,0.071,No significant pattern (p=0.032),Significant increase (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04396,rs610689,10,211608536,CR1,Insertion,-,-,1.89,1.5,2.2,0.01364506,Protective,0.447,0.201,0.093,0.059,No significant pattern (p=0.046),Significant increase (p=0.025),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04397,rs426080,19,133868163,APP,SNP (A/T),(A/,A,1.59,1.22,1.87,0.00051356,Low,0.094,0.188,0.276,0.241,Mild decrease (p=0.026),Significant increase (p=0.031),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04398,rs994435,7,109211002,BIN1,SNP (G/T),(G/,G,2.41,2.12,2.62,0.00885844,Protective,0.04,0.561,0.199,0.0,No significant pattern (p=0.037),Variable effect (p=0.017),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04399,rs578874,7,42569732,CD2AP,SNP (C/G),(C/,C,0.4,0.1,0.77,0.0189893,High,0.117,0.013,0.268,0.401,Mild increase (p=0.002),Variable effect (p=0.012),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04400,rs636976,11,26082516,PSEN2,SNP (A/G),(A/,A,1.35,1.06,1.61,0.0096375,Moderate,0.109,0.273,0.137,0.282,Significant increase (p=0.014),No significant pattern (p=0.046),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04401,rs683720,22,150593818,PTK2B,SNP (C/T),(C/,C,0.98,0.7,1.31,0.08440225,Moderate,0.368,0.307,0.015,0.111,Mild increase (p=0.007),No significant pattern (p=0.037),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP04402,rs636410,6,63790901,CLU,SNP (A/C),(A/,A,0.69,0.47,1.06,0.03203465,Moderate,0.003,0.042,0.43,0.325,Mild decrease (p=0.008),Mild increase (p=0.041),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04403,rs180417,15,123158323,BIN1,Deletion,-,-,0.88,0.56,1.17,0.00013382,Low,0.022,0.567,0.075,0.136,Significant decrease (p=0.043),Mild decrease (p=0.031),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP04404,rs913661,8,246813491,PICALM,SNP (G/T),(G/,G,0.69,0.47,1.04,0.01609784,Moderate,0.187,0.176,0.208,0.229,Mild decrease (p=0.028),Significant increase (p=0.022),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04405,rs198435,17,151870161,APOE,SNP (A/T),(A/,A,1.1,0.87,1.44,0.04215208,Moderate,0.026,0.081,0.065,0.628,Significant increase (p=0.046),Mild decrease (p=0.048),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04406,rs946004,6,141390388,APP,SNP (C/G),(C/,C,0.39,0.19,0.79,0.00069742,Moderate,0.028,0.421,0.337,0.014,Mild increase (p=0.025),No significant pattern (p=0.04),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04407,rs854562,14,214068181,CD33,SNP (A/C),(A/,A,0.89,0.58,1.16,0.05029999,High,0.109,0.142,0.189,0.36,Mild decrease (p=0.016),Mild increase (p=0.03),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04408,rs458695,11,43669817,CR1,SNP (A/C),(A/,A,2.06,1.66,2.36,0.04601157,Low,0.323,0.093,0.238,0.146,Mild increase (p=0.029),Significant decrease (p=0.024),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04409,rs133490,14,102593167,PSEN2,SNP (C/T),(C/,C,0.83,0.45,1.12,0.0065905,High,0.159,0.012,0.627,0.002,Significant increase (p=0.042),Mild decrease (p=0.041),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04410,rs683321,9,171834141,APP,SNP (G/T),(G/,G,3.42,3.18,3.64,0.03250833,Low,0.393,0.099,0.214,0.093,Mild decrease (p=0.045),Significant increase (p=0.032),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04411,rs498281,22,6858025,CR1,SNP (A/T),(A/,A,0.63,0.37,1.01,0.05023744,Protective,0.511,0.209,0.072,0.008,No significant pattern (p=0.022),Significant decrease (p=0.039),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04412,rs867874,6,194874737,EPHA1,SNP (C/G),(C/,C,0.57,0.36,0.85,0.10876586,Moderate,0.076,0.077,0.114,0.533,Variable effect (p=0.015),Variable effect (p=0.007),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP04413,rs910037,11,99944084,MS4A6A,SNP (C/G),(C/,C,0.87,0.51,1.2,0.02124892,Moderate,0.474,0.195,0.065,0.065,Variable effect (p=0.033),No significant pattern (p=0.038),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04414,rs835154,12,133296715,CD33,SNP (G/T),(G/,G,2.13,1.84,2.42,0.00479639,High,0.206,0.345,0.065,0.184,Mild decrease (p=0.041),No significant pattern (p=0.002),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04415,rs719753,3,54510598,BIN1,SNP (G/T),(G/,G,1.17,0.79,1.51,0.01291948,Moderate,0.406,0.146,0.106,0.142,Mild decrease (p=0.023),No significant pattern (p=0.025),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04416,rs207756,6,140017075,APP,SNP (A/C),(A/,A,1.13,0.86,1.47,0.02227265,Moderate,0.273,0.327,0.037,0.162,Significant decrease (p=0.012),Mild increase (p=0.026),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP04417,rs500693,14,226000018,BIN1,SNP (A/C),(A/,A,1.96,1.63,2.17,0.0480609,Moderate,0.165,0.388,0.143,0.104,Significant decrease (p=0.028),No significant pattern (p=0.038),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04418,rs419641,22,69803186,CD33,SNP (A/T),(A/,A,0.96,0.74,1.35,0.03100388,Protective,0.14,0.332,0.305,0.023,Mild decrease (p=0.047),Significant increase (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04419,rs478061,10,123430620,BIN1,SNP (G/T),(G/,G,0.93,0.54,1.27,0.00393293,High,0.44,0.199,0.037,0.125,Mild decrease (p=0.037),Variable effect (p=0.01),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04420,rs971401,4,19843664,MS4A6A,Deletion,-,-,2.09,1.88,2.34,0.05038552,High,0.284,0.431,0.082,0.003,Variable effect (p=0.034),Variable effect (p=0.011),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04421,rs690637,11,31865596,CR1,SNP (A/T),(A/,A,0.96,0.6,1.25,0.00270066,High,0.136,0.153,0.134,0.377,Mild decrease (p=0.005),Variable effect (p=0.014),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04422,rs537547,9,242744223,TREM2,SNP (A/G),(A/,A,1.34,1.09,1.6,0.00413789,Moderate,0.071,0.08,0.25,0.399,Significant decrease (p=0.018),Mild decrease (p=0.029),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04423,rs533340,14,199821324,PSEN2,SNP (A/C),(A/,A,1.3,0.98,1.51,0.01135905,Moderate,0.166,0.346,0.148,0.14,Mild decrease (p=0.002),Significant decrease (p=0.002),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP04424,rs215514,11,55226513,CR1,Deletion,-,-,0.48,0.26,0.81,0.0041391,Protective,0.134,0.081,0.522,0.062,Significant decrease (p=0.018),Mild decrease (p=0.043),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04425,rs350840,11,208917866,SORL1,SNP (A/G),(A/,A,1.01,0.7,1.3,0.01963385,Moderate,0.215,0.25,0.184,0.151,No significant pattern (p=0.03),Variable effect (p=0.037),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP04426,rs161886,13,24353980,BIN1,SNP (A/C),(A/,A,0.44,0.1,0.65,0.0008245,Protective,0.254,0.388,0.155,0.003,Significant increase (p=0.008),Mild decrease (p=0.017),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04427,rs512570,8,86046004,PTK2B,SNP (A/G),(A/,A,1.12,0.74,1.48,0.05479796,High,0.296,0.305,0.192,0.007,Mild decrease (p=0.023),Significant increase (p=0.005),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04428,rs844934,1,141016821,CLU,SNP (A/T),(A/,A,0.66,0.3,0.88,0.02365615,High,0.086,0.642,0.049,0.023,Variable effect (p=0.038),Variable effect (p=0.042),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04429,rs288428,22,59479111,SORL1,SNP (A/G),(A/,A,1.68,1.45,2.0,0.02018268,Moderate,0.084,0.275,0.297,0.144,Significant decrease (p=0.034),No significant pattern (p=0.003),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04430,rs951835,16,61548370,APOE,SNP (C/T),(C/,C,0.81,0.43,1.07,0.02287639,Moderate,0.012,0.301,0.104,0.383,Mild increase (p=0.023),Mild decrease (p=0.034),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04431,rs474074,19,20631517,BIN1,Deletion,-,-,0.98,0.58,1.3,0.04462742,Moderate,0.211,0.246,0.105,0.239,Mild increase (p=0.021),Significant decrease (p=0.005),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04432,rs263576,12,92824359,PTK2B,Deletion,-,-,0.37,0.1,0.6,0.03111817,Moderate,0.185,0.175,0.357,0.083,Mild increase (p=0.01),Significant decrease (p=0.048),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04433,rs132807,17,240237364,PSEN2,SNP (A/T),(A/,A,1.9,1.51,2.22,0.00723292,Protective,0.698,0.009,0.057,0.036,No significant pattern (p=0.015),Significant increase (p=0.036),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04434,rs418845,7,208007151,PTK2B,SNP (C/G),(C/,C,1.07,0.78,1.31,0.01707896,Moderate,0.106,0.303,0.057,0.334,Significant increase (p=0.005),Mild increase (p=0.048),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP04435,rs557672,19,119313342,CD2AP,Deletion,-,-,1.74,1.52,1.94,0.03459679,Low,0.096,0.25,0.406,0.048,Significant decrease (p=0.033),Significant increase (p=0.039),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04436,rs204480,9,205927510,EPHA1,Deletion,-,-,0.49,0.19,0.86,0.09697884,Moderate,0.253,0.182,0.33,0.035,Significant decrease (p=0.025),Significant decrease (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04437,rs639193,13,24852672,APOE,SNP (G/T),(G/,G,0.93,0.68,1.15,0.0301184,Protective,0.054,0.461,0.065,0.221,Variable effect (p=0.016),Variable effect (p=0.025),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04438,rs636845,17,13429841,ABCA7,SNP (C/G),(C/,C,0.97,0.76,1.21,0.00518276,Moderate,0.26,0.283,0.036,0.221,No significant pattern (p=0.024),Variable effect (p=0.014),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04439,rs848465,21,133191474,PTK2B,Deletion,-,-,1.8,1.4,2.15,9.552e-05,Moderate,0.199,0.035,0.2,0.366,Significant increase (p=0.032),Mild decrease (p=0.025),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04440,rs334869,9,48741955,ABCA7,Deletion,-,-,1.65,1.44,1.94,0.05835665,High,0.1,0.343,0.305,0.051,No significant pattern (p=0.021),Mild increase (p=0.009),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04441,rs232230,21,6316698,TREM2,SNP (G/T),(G/,G,1.65,1.42,1.97,0.00580286,Unknown,0.067,0.212,0.432,0.089,Significant decrease (p=0.031),Variable effect (p=0.045),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04442,rs780637,5,13555645,MS4A6A,Insertion,-,-,0.84,0.56,1.18,0.00418455,High,0.18,0.388,0.038,0.195,Mild increase (p=0.002),Mild decrease (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04443,rs279873,18,128763251,CD2AP,Deletion,-,-,0.99,0.78,1.26,0.00412955,Moderate,0.065,0.292,0.263,0.18,Significant increase (p=0.036),Significant increase (p=0.044),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04444,rs964828,6,197196739,CLU,Deletion,-,-,1.05,0.76,1.3,0.05818379,Unknown,0.179,0.125,0.163,0.333,Significant increase (p=0.047),Significant increase (p=0.041),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04445,rs561049,1,89382847,MS4A6A,Insertion,-,-,0.8,0.4,1.03,0.0621855,Moderate,0.052,0.226,0.252,0.271,Mild increase (p=0.003),Mild decrease (p=0.028),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04446,rs977368,12,76667062,APOE,SNP (A/G),(A/,A,0.59,0.33,0.96,0.00268634,Moderate,0.002,0.068,0.4,0.33,No significant pattern (p=0.009),No significant pattern (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04447,rs203797,5,237582612,BIN1,SNP (A/G),(A/,A,1.74,1.53,1.99,0.01057371,High,0.218,0.049,0.194,0.339,No significant pattern (p=0.034),Mild decrease (p=0.014),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04448,rs846951,9,102873803,BIN1,SNP (C/T),(C/,C,0.86,0.5,1.22,0.01043743,Moderate,0.115,0.392,0.058,0.236,Mild increase (p=0.049),Significant increase (p=0.01),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04449,rs310942,4,247898503,CLU,Insertion,-,-,0.9,0.52,1.24,0.04441134,Moderate,0.069,0.282,0.363,0.086,Mild decrease (p=0.036),Mild increase (p=0.007),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04450,rs517681,4,152711736,CR1,SNP (A/G),(A/,A,0.41,0.16,0.64,0.071212,High,0.389,0.242,0.099,0.07,Mild increase (p=0.023),Variable effect (p=0.004),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04451,rs331003,20,170573787,PTK2B,SNP (C/T),(C/,C,1.5,1.11,1.73,0.01947467,Low,0.441,0.011,0.21,0.138,No significant pattern (p=0.03),No significant pattern (p=0.002),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04452,rs722888,12,97171164,CD2AP,SNP (C/G),(C/,C,0.77,0.38,1.08,0.03711635,Unknown,0.297,0.147,0.301,0.055,Variable effect (p=0.024),Significant decrease (p=0.006),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04453,rs726895,4,10370638,ABCA7,Deletion,-,-,1.75,1.51,2.11,0.01440001,Moderate,0.435,0.008,0.031,0.326,Significant increase (p=0.007),Significant decrease (p=0.015),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04454,rs650119,5,116326379,CD33,SNP (C/T),(C/,C,1.96,1.59,2.32,0.03176813,High,0.186,0.481,0.103,0.03,Significant decrease (p=0.031),Mild decrease (p=0.002),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04455,rs928892,2,66997148,TREM2,SNP (A/T),(A/,A,1.17,0.94,1.48,0.02303772,Low,0.22,0.319,0.2,0.061,Mild increase (p=0.003),Variable effect (p=0.009),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04456,rs314667,22,167992583,SORL1,SNP (A/C),(A/,A,0.88,0.6,1.22,0.03966616,Moderate,0.248,0.196,0.352,0.004,Significant decrease (p=0.041),Variable effect (p=0.05),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP04457,rs594752,1,240487234,APOE,SNP (G/T),(G/,G,0.67,0.3,0.99,0.08463161,Moderate,0.223,0.28,0.238,0.059,Mild increase (p=0.004),Mild increase (p=0.032),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04458,rs154306,13,76205803,CLU,SNP (C/T),(C/,C,0.61,0.34,1.0,0.02814151,High,0.034,0.028,0.652,0.086,Variable effect (p=0.015),No significant pattern (p=0.02),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP04459,rs902761,6,219293027,ABCA7,SNP (A/T),(A/,A,1.21,0.83,1.59,0.0071149,High,0.266,0.134,0.119,0.281,No significant pattern (p=0.02),Significant increase (p=0.009),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04460,rs922959,22,163290825,APP,SNP (A/C),(A/,A,1.1,0.77,1.49,0.05677283,Low,0.041,0.119,0.18,0.46,Mild increase (p=0.039),Significant decrease (p=0.035),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04461,rs468998,14,210922280,EPHA1,SNP (C/G),(C/,C,0.64,0.25,0.95,0.01013684,Moderate,0.215,0.014,0.153,0.418,Mild increase (p=0.041),Variable effect (p=0.02),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04462,rs347973,12,117240963,PICALM,Insertion,-,-,1.22,0.87,1.51,0.02613305,Moderate,0.613,0.096,0.044,0.047,No significant pattern (p=0.031),Significant increase (p=0.042),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04463,rs666685,8,146320655,APP,SNP (A/C),(A/,A,0.42,0.1,0.8,0.02412713,High,0.018,0.411,0.182,0.189,Variable effect (p=0.037),Significant increase (p=0.02),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04464,rs597965,21,25543692,CD2AP,SNP (A/C),(A/,A,0.6,0.25,0.81,0.06427652,Moderate,0.173,0.032,0.305,0.29,Mild decrease (p=0.007),Significant decrease (p=0.004),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04465,rs205357,4,12247659,MS4A6A,SNP (G/T),(G/,G,1.47,1.14,1.72,0.1373947,High,0.271,0.266,0.255,0.007,Mild increase (p=0.015),Significant increase (p=0.011),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04466,rs275692,21,236237890,APP,SNP (A/G),(A/,A,0.94,0.61,1.3,0.13218518,Moderate,0.083,0.192,0.08,0.446,Mild decrease (p=0.02),Mild increase (p=0.041),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04467,rs468959,4,155503191,PSEN2,Insertion,-,-,2.49,2.21,2.82,0.01916152,High,0.363,0.193,0.075,0.168,Significant increase (p=0.025),Mild decrease (p=0.034),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04468,rs474398,22,120107347,EPHA1,SNP (G/T),(G/,G,0.79,0.43,1.12,0.00548938,Moderate,0.169,0.396,0.187,0.048,Significant increase (p=0.025),Variable effect (p=0.033),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04469,rs808091,18,45347564,EPHA1,SNP (G/T),(G/,G,0.62,0.37,0.91,0.00159973,Moderate,0.267,0.253,0.204,0.076,Variable effect (p=0.015),Mild increase (p=0.005),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP04470,rs676781,13,54897550,TREM2,SNP (C/G),(C/,C,1.44,1.18,1.75,0.01329981,High,0.301,0.091,0.035,0.374,Significant decrease (p=0.025),No significant pattern (p=0.004),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04471,rs931376,13,189695599,BIN1,SNP (C/G),(C/,C,0.41,0.16,0.65,0.03211714,Low,0.123,0.039,0.392,0.246,Mild decrease (p=0.023),Mild decrease (p=0.028),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04472,rs758566,13,166503607,TREM2,SNP (A/G),(A/,A,0.61,0.35,0.88,0.02383172,Moderate,0.419,0.097,0.018,0.266,Significant decrease (p=0.016),Significant increase (p=0.008),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04473,rs790086,13,9962431,SORL1,SNP (A/T),(A/,A,2.16,1.87,2.54,0.01887656,Moderate,0.109,0.601,0.052,0.037,Significant increase (p=0.046),Significant decrease (p=0.049),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP04474,rs449932,1,86268375,APOE,SNP (C/G),(C/,C,1.12,0.86,1.41,0.01264647,Moderate,0.395,0.285,0.086,0.034,Mild increase (p=0.028),Mild decrease (p=0.027),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04475,rs476901,16,90721567,APOE,Deletion,-,-,0.4,0.13,0.69,0.01038218,Low,0.093,0.231,0.233,0.243,Variable effect (p=0.027),Mild decrease (p=0.009),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP04476,rs940709,20,38027774,BIN1,SNP (C/G),(C/,C,0.84,0.5,1.09,0.09101576,Protective,0.142,0.178,0.196,0.284,Significant decrease (p=0.003),No significant pattern (p=0.024),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04477,rs615099,21,11176101,CD33,SNP (G/T),(G/,G,0.8,0.52,1.2,0.01869785,High,0.121,0.172,0.484,0.022,Significant increase (p=0.044),Mild decrease (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04478,rs775463,17,22268892,CD33,SNP (A/G),(A/,A,1.41,1.03,1.74,0.04508863,High,0.319,0.268,0.193,0.021,Mild decrease (p=0.016),Mild decrease (p=0.034),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04479,rs873506,6,9222750,TREM2,SNP (C/G),(C/,C,0.88,0.49,1.11,0.0111754,Moderate,0.237,0.02,0.371,0.172,No significant pattern (p=0.02),Significant increase (p=0.046),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04480,rs517784,15,115317135,TREM2,SNP (G/T),(G/,G,0.87,0.52,1.13,0.04078019,Protective,0.055,0.104,0.552,0.09,No significant pattern (p=0.002),Significant decrease (p=0.043),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04481,rs729985,9,78312696,MS4A6A,SNP (C/T),(C/,C,1.4,1.18,1.74,0.01571321,High,0.079,0.228,0.474,0.019,No significant pattern (p=0.024),Mild increase (p=0.048),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04482,rs877076,18,109976503,CD2AP,SNP (A/C),(A/,A,1.38,0.98,1.63,0.02164386,Protective,0.033,0.206,0.521,0.04,Mild increase (p=0.03),No significant pattern (p=0.003),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04483,rs513591,21,221410465,BIN1,Deletion,-,-,1.05,0.76,1.39,0.05408377,High,0.093,0.614,0.079,0.014,Mild decrease (p=0.044),Significant increase (p=0.04),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04484,rs477870,17,163037363,APP,SNP (A/T),(A/,A,0.37,0.1,0.74,0.02644441,Moderate,0.262,0.122,0.382,0.034,Significant increase (p=0.031),No significant pattern (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04485,rs534179,13,39540714,SORL1,SNP (A/G),(A/,A,1.3,1.07,1.66,0.02164391,High,0.314,0.231,0.222,0.033,No significant pattern (p=0.016),Mild increase (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP04486,rs157489,14,130333651,PTK2B,SNP (A/T),(A/,A,0.99,0.63,1.39,0.02428619,Low,0.04,0.102,0.23,0.428,Significant decrease (p=0.01),Mild increase (p=0.047),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP04487,rs132468,2,80357463,BIN1,SNP (G/T),(G/,G,0.77,0.48,1.03,0.02373369,Moderate,0.061,0.254,0.394,0.091,Variable effect (p=0.006),Mild increase (p=0.024),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04488,rs198882,3,156307985,APOE,SNP (A/T),(A/,A,0.79,0.51,1.08,0.00586444,Moderate,0.03,0.398,0.342,0.03,Mild increase (p=0.023),Mild increase (p=0.036),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04489,rs165095,15,130578828,ABCA7,Deletion,-,-,1.11,0.85,1.47,0.01545985,High,0.202,0.16,0.246,0.192,Variable effect (p=0.038),Mild increase (p=0.042),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04490,rs319055,16,244289761,EPHA1,Insertion,-,-,0.53,0.32,0.81,0.00052236,High,0.611,0.109,0.065,0.015,No significant pattern (p=0.037),Significant decrease (p=0.043),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04491,rs929498,8,6027590,CLU,SNP (A/C),(A/,A,0.26,0.1,0.53,0.05557944,Moderate,0.003,0.11,0.01,0.677,Mild decrease (p=0.009),Variable effect (p=0.037),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04492,rs381065,17,167861234,CR1,SNP (A/G),(A/,A,1.22,0.84,1.44,0.00413878,Moderate,0.324,0.032,0.011,0.433,Significant decrease (p=0.042),Variable effect (p=0.015),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04493,rs462284,14,47992292,SORL1,SNP (C/G),(C/,C,3.32,3.02,3.61,0.05183874,High,0.21,0.332,0.108,0.15,Mild decrease (p=0.015),Mild increase (p=0.016),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04494,rs937254,21,63759682,BIN1,SNP (C/T),(C/,C,1.07,0.77,1.31,0.0332174,Low,0.167,0.071,0.299,0.262,Variable effect (p=0.017),Mild increase (p=0.022),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04495,rs452088,18,120779647,CLU,Insertion,-,-,1.0,0.71,1.27,0.01887612,High,0.013,0.668,0.045,0.073,Significant decrease (p=0.025),Mild increase (p=0.04),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP04496,rs228839,12,171940450,PSEN2,SNP (C/G),(C/,C,1.54,1.22,1.89,0.00017715,Moderate,0.08,0.162,0.239,0.319,Variable effect (p=0.022),Significant increase (p=0.02),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04497,rs101165,5,205443111,APOE,Insertion,-,-,2.15,1.81,2.52,0.03049347,Moderate,0.008,0.423,0.339,0.03,Significant increase (p=0.009),Mild decrease (p=0.047),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04498,rs999792,16,225565522,CLU,Insertion,-,-,1.0,0.75,1.34,0.02624483,High,0.354,0.122,0.06,0.263,Mild decrease (p=0.028),Mild increase (p=0.009),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04499,rs894209,5,8777619,BIN1,SNP (C/T),(C/,C,1.29,1.0,1.54,0.03223643,High,0.048,0.169,0.457,0.126,Mild decrease (p=0.036),Mild increase (p=0.043),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04500,rs614846,9,131863964,CD33,Insertion,-,-,1.56,1.23,1.8,0.06341572,Protective,0.063,0.106,0.422,0.209,No significant pattern (p=0.036),Mild decrease (p=0.035),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04501,rs352899,17,168105536,SORL1,SNP (A/T),(A/,A,0.99,0.66,1.23,0.01218418,Moderate,0.072,0.199,0.302,0.227,Mild decrease (p=0.007),Mild increase (p=0.042),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04502,rs189723,8,247424603,TREM2,SNP (G/T),(G/,G,0.82,0.57,1.17,0.04885324,High,0.193,0.068,0.137,0.401,Variable effect (p=0.03),Mild increase (p=0.035),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04503,rs227618,6,160627480,PICALM,SNP (A/C),(A/,A,1.3,1.01,1.58,0.01296123,High,0.012,0.029,0.73,0.029,Mild decrease (p=0.022),No significant pattern (p=0.024),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04504,rs223302,17,183954354,PTK2B,Deletion,-,-,0.63,0.29,0.85,0.04739672,High,0.29,0.124,0.246,0.14,Mild increase (p=0.009),Significant decrease (p=0.038),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04505,rs323426,14,195337215,APOE,Insertion,-,-,1.13,0.73,1.4,0.03094791,Moderate,0.224,0.131,0.089,0.356,Significant decrease (p=0.008),No significant pattern (p=0.004),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04506,rs198714,15,154827092,EPHA1,SNP (C/G),(C/,C,2.48,2.23,2.77,0.05573018,Moderate,0.209,0.002,0.07,0.518,Significant decrease (p=0.01),Significant decrease (p=0.048),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04507,rs883739,15,218786495,SORL1,SNP (A/T),(A/,A,1.82,1.48,2.21,0.00262044,High,0.39,0.16,0.136,0.114,Mild decrease (p=0.027),Variable effect (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04508,rs904593,21,223658853,SORL1,SNP (C/T),(C/,C,0.73,0.45,1.1,0.0047142,Protective,0.205,0.489,0.066,0.04,Significant increase (p=0.042),No significant pattern (p=0.009),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04509,rs876391,12,162389088,CLU,SNP (A/C),(A/,A,0.9,0.54,1.21,0.00128117,Protective,0.366,0.046,0.081,0.307,Mild decrease (p=0.013),Variable effect (p=0.005),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04510,rs349390,17,91892238,TREM2,Deletion,-,-,2.01,1.76,2.29,0.00581951,Moderate,0.073,0.386,0.024,0.317,Mild increase (p=0.018),Significant increase (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04511,rs725716,18,2117149,SORL1,SNP (G/T),(G/,G,1.06,0.82,1.35,0.06615726,Protective,0.341,0.197,0.156,0.105,Significant decrease (p=0.033),Significant decrease (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04512,rs664038,7,164154705,CD33,SNP (G/T),(G/,G,1.24,0.84,1.47,0.00770227,Unknown,0.1,0.002,0.594,0.104,Significant decrease (p=0.028),Mild increase (p=0.007),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04513,rs430611,8,67516301,EPHA1,SNP (A/C),(A/,A,0.7,0.47,1.07,0.05590691,Low,0.478,0.094,0.137,0.091,Variable effect (p=0.033),No significant pattern (p=0.01),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04514,rs224570,13,27342460,MS4A6A,SNP (C/T),(C/,C,1.27,0.91,1.61,0.00078489,Moderate,0.058,0.058,0.372,0.312,Significant increase (p=0.008),Significant increase (p=0.048),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04515,rs749886,21,197814766,CLU,SNP (A/C),(A/,A,3.2,2.95,3.47,0.10760901,Low,0.049,0.32,0.009,0.422,Significant decrease (p=0.048),Mild increase (p=0.016),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04516,rs401357,21,71552702,CR1,Deletion,-,-,1.07,0.84,1.46,0.00257141,High,0.115,0.627,0.018,0.039,Significant increase (p=0.004),No significant pattern (p=0.025),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04517,rs238694,2,7650054,APP,SNP (A/G),(A/,A,1.77,1.55,2.05,0.01224863,Moderate,0.033,0.036,0.626,0.105,Mild increase (p=0.008),Significant decrease (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04518,rs260962,13,203733843,EPHA1,Insertion,-,-,1.02,0.68,1.41,0.01675709,High,0.075,0.035,0.064,0.625,Significant decrease (p=0.006),Significant decrease (p=0.043),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04519,rs428783,19,105038765,EPHA1,Deletion,-,-,1.52,1.27,1.81,0.0919273,Moderate,0.192,0.523,0.021,0.064,Significant decrease (p=0.006),No significant pattern (p=0.023),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04520,rs211965,19,149774135,APOE,SNP (C/T),(C/,C,2.03,1.78,2.39,0.05671622,Moderate,0.008,0.277,0.048,0.467,Mild increase (p=0.004),Variable effect (p=0.043),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04521,rs619379,16,130427402,MS4A6A,Insertion,-,-,0.65,0.39,0.98,0.00309741,Moderate,0.148,0.436,0.096,0.12,Mild decrease (p=0.027),Mild increase (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04522,rs729473,16,233242888,PSEN2,SNP (A/C),(A/,A,1.17,0.94,1.53,0.0153106,Protective,0.622,0.101,0.031,0.046,Significant decrease (p=0.027),Variable effect (p=0.042),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04523,rs773828,21,241513281,PSEN2,SNP (A/G),(A/,A,1.4,1.0,1.79,0.05354181,Unknown,0.019,0.015,0.272,0.495,Mild decrease (p=0.033),Significant increase (p=0.014),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP04524,rs881266,21,100812872,TREM2,SNP (C/T),(C/,C,3.1,2.72,3.34,0.00083444,Low,0.168,0.378,0.024,0.229,Mild decrease (p=0.023),No significant pattern (p=0.007),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04525,rs922510,2,134185077,PICALM,SNP (C/T),(C/,C,1.09,0.8,1.4,0.02824575,High,0.145,0.299,0.185,0.171,No significant pattern (p=0.016),No significant pattern (p=0.042),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04526,rs398571,3,171092017,PICALM,SNP (C/T),(C/,C,0.95,0.58,1.19,0.00311595,High,0.174,0.256,0.234,0.136,No significant pattern (p=0.038),Significant decrease (p=0.006),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04527,rs172354,20,212473336,ABCA7,Deletion,-,-,1.61,1.31,1.89,0.05531515,Moderate,0.197,0.022,0.317,0.264,Mild increase (p=0.044),Mild decrease (p=0.049),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04528,rs938080,21,9327207,TREM2,SNP (A/G),(A/,A,0.92,0.69,1.17,0.02315264,Low,0.041,0.132,0.526,0.101,Significant increase (p=0.003),No significant pattern (p=0.015),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04529,rs588652,15,132883362,CR1,SNP (A/T),(A/,A,1.11,0.73,1.47,0.02961611,Low,0.019,0.19,0.395,0.196,No significant pattern (p=0.036),Mild increase (p=0.033),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04530,rs176865,4,196229056,CLU,SNP (A/G),(A/,A,0.89,0.51,1.22,0.00022876,Moderate,0.017,0.299,0.048,0.437,Mild increase (p=0.034),Significant decrease (p=0.048),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04531,rs524473,21,222095456,CD33,SNP (A/G),(A/,A,1.0,0.64,1.24,0.05359988,Moderate,0.026,0.398,0.159,0.217,Significant increase (p=0.004),No significant pattern (p=0.019),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04532,rs637481,11,22636005,PSEN2,SNP (A/C),(A/,A,0.69,0.44,0.94,0.07705138,Moderate,0.155,0.119,0.207,0.319,Variable effect (p=0.048),Mild decrease (p=0.04),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04533,rs843136,5,144207711,PTK2B,SNP (A/T),(A/,A,0.78,0.53,1.12,0.00308532,High,0.195,0.393,0.197,0.015,Mild increase (p=0.019),Mild increase (p=0.045),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04534,rs303135,4,217303284,EPHA1,SNP (A/T),(A/,A,0.55,0.27,0.92,0.02924532,Moderate,0.237,0.109,0.125,0.329,Mild increase (p=0.025),No significant pattern (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04535,rs620346,18,181583502,APOE,Insertion,-,-,0.89,0.67,1.21,0.02090438,Low,0.617,0.036,0.113,0.034,No significant pattern (p=0.033),Variable effect (p=0.02),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04536,rs122971,5,155747429,ABCA7,SNP (A/C),(A/,A,0.82,0.54,1.05,0.07725288,High,0.015,0.122,0.596,0.067,No significant pattern (p=0.009),Significant decrease (p=0.013),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04537,rs760022,2,161592357,CLU,SNP (A/T),(A/,A,2.06,1.74,2.37,0.03040359,Protective,0.05,0.637,0.067,0.046,Significant increase (p=0.003),Variable effect (p=0.008),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04538,rs970123,2,60363038,MS4A6A,SNP (G/T),(G/,G,1.48,1.09,1.8,0.00851447,High,0.128,0.492,0.013,0.167,No significant pattern (p=0.042),Mild decrease (p=0.003),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04539,rs191477,12,60162423,CD33,SNP (C/G),(C/,C,0.48,0.21,0.72,0.08532899,Moderate,0.077,0.417,0.069,0.237,No significant pattern (p=0.041),Significant decrease (p=0.031),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04540,rs119444,16,16251957,TREM2,SNP (C/G),(C/,C,2.4,2.12,2.77,0.02034267,Unknown,0.077,0.153,0.012,0.559,Mild increase (p=0.027),Mild decrease (p=0.042),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP04541,rs441407,22,205419342,APP,Deletion,-,-,0.89,0.61,1.16,0.01970124,Low,0.2,0.168,0.139,0.293,Variable effect (p=0.049),Mild increase (p=0.002),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04542,rs748276,22,17166549,APP,SNP (C/G),(C/,C,0.53,0.14,0.78,0.00244609,Moderate,0.071,0.154,0.097,0.478,Mild decrease (p=0.047),No significant pattern (p=0.022),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04543,rs249862,19,38173194,SORL1,SNP (A/C),(A/,A,0.68,0.31,1.0,0.02169575,Low,0.087,0.162,0.494,0.057,Significant increase (p=0.001),Significant decrease (p=0.027),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04544,rs834847,16,80095575,CD2AP,SNP (A/C),(A/,A,1.0,0.68,1.32,0.03890094,Moderate,0.093,0.304,0.403,0.0,Significant increase (p=0.027),Significant decrease (p=0.024),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04545,rs204103,16,107155645,PICALM,SNP (A/C),(A/,A,0.72,0.46,0.96,0.04405579,High,0.06,0.495,0.098,0.147,Significant decrease (p=0.043),Mild increase (p=0.042),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04546,rs963439,22,47776413,PSEN2,Insertion,-,-,0.75,0.51,0.98,0.14822025,High,0.318,0.077,0.107,0.298,No significant pattern (p=0.015),Significant decrease (p=0.019),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04547,rs283167,6,62358503,CD33,SNP (C/G),(C/,C,0.36,0.1,0.61,0.00407423,Moderate,0.226,0.171,0.114,0.29,Significant increase (p=0.037),Significant increase (p=0.009),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP04548,rs234966,4,181318334,ABCA7,Deletion,-,-,1.0,0.66,1.22,0.00462667,High,0.31,0.04,0.145,0.306,Mild increase (p=0.049),No significant pattern (p=0.048),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP04549,rs468596,14,159680981,PSEN2,SNP (C/T),(C/,C,1.03,0.78,1.38,0.00059484,Moderate,0.231,0.156,0.259,0.155,No significant pattern (p=0.012),Significant increase (p=0.049),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04550,rs541468,13,244097064,TREM2,SNP (G/T),(G/,G,0.68,0.4,1.07,0.0054556,Moderate,0.222,0.218,0.083,0.277,No significant pattern (p=0.017),Mild decrease (p=0.025),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04551,rs950597,10,113770587,CD2AP,SNP (C/G),(C/,C,1.12,0.73,1.35,0.01675299,High,0.177,0.536,0.031,0.057,Significant increase (p=0.044),Mild increase (p=0.018),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04552,rs332943,1,144645933,PSEN2,SNP (A/G),(A/,A,1.29,0.94,1.57,0.03238807,Moderate,0.479,0.012,0.004,0.305,Variable effect (p=0.026),No significant pattern (p=0.005),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP04553,rs931827,14,108655744,ABCA7,SNP (C/T),(C/,C,0.78,0.51,1.01,0.02016437,Low,0.218,0.022,0.521,0.039,Significant decrease (p=0.044),Mild increase (p=0.028),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04554,rs396373,11,115840880,PSEN2,SNP (A/T),(A/,A,0.55,0.3,0.78,0.01323687,Moderate,0.042,0.139,0.45,0.169,Significant increase (p=0.024),Variable effect (p=0.045),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04555,rs282679,20,130372726,PICALM,Deletion,-,-,0.66,0.43,0.95,0.03326011,High,0.372,0.005,0.198,0.224,Significant decrease (p=0.002),Significant increase (p=0.024),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04556,rs833455,17,206653079,BIN1,SNP (C/G),(C/,C,0.57,0.29,0.85,0.02467441,Unknown,0.031,0.08,0.566,0.123,Variable effect (p=0.007),No significant pattern (p=0.028),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04557,rs455999,21,233728642,PSEN2,SNP (A/G),(A/,A,1.38,0.99,1.77,0.01219618,Protective,0.206,0.395,0.147,0.052,Significant decrease (p=0.002),Variable effect (p=0.043),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP04558,rs480782,20,77536810,PSEN2,SNP (A/C),(A/,A,0.73,0.48,1.02,0.00601068,Moderate,0.082,0.354,0.207,0.157,Significant increase (p=0.016),Mild increase (p=0.035),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04559,rs340460,12,233988020,BIN1,SNP (A/G),(A/,A,1.38,1.08,1.61,0.03101245,Protective,0.42,0.099,0.152,0.129,Variable effect (p=0.033),Significant decrease (p=0.045),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04560,rs693264,6,69407378,APOE,SNP (A/C),(A/,A,0.85,0.6,1.15,0.02276148,Low,0.061,0.119,0.046,0.574,Significant increase (p=0.004),Mild increase (p=0.016),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04561,rs567397,12,240582120,PICALM,SNP (G/T),(G/,G,0.89,0.57,1.26,0.02382001,Moderate,0.114,0.003,0.527,0.156,Significant decrease (p=0.003),Significant increase (p=0.048),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04562,rs546883,12,72541736,CD2AP,SNP (C/T),(C/,C,0.71,0.36,0.97,0.01980409,High,0.279,0.411,0.028,0.082,No significant pattern (p=0.049),Mild increase (p=0.007),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP04563,rs955720,11,52021501,APOE,SNP (C/T),(C/,C,1.74,1.51,2.06,0.0036421,Moderate,0.184,0.003,0.022,0.591,Mild decrease (p=0.048),No significant pattern (p=0.027),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP04564,rs653472,17,142696994,PICALM,SNP (G/T),(G/,G,1.31,1.02,1.61,0.00067403,Moderate,0.509,0.016,0.266,0.009,No significant pattern (p=0.043),Mild increase (p=0.01),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04565,rs472105,1,237372347,CR1,Insertion,-,-,0.66,0.33,1.05,0.11386332,High,0.108,0.224,0.429,0.039,Significant increase (p=0.042),No significant pattern (p=0.019),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04566,rs477745,12,20012099,PSEN2,SNP (A/T),(A/,A,2.84,2.6,3.05,0.03275063,Low,0.05,0.025,0.241,0.484,Significant increase (p=0.001),Significant decrease (p=0.018),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP04567,rs595867,11,172330349,EPHA1,SNP (C/G),(C/,C,0.77,0.53,0.98,0.02501251,Moderate,0.084,0.224,0.105,0.387,Mild decrease (p=0.015),Variable effect (p=0.003),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04568,rs954623,10,199362258,CD33,SNP (A/G),(A/,A,1.27,0.97,1.56,0.03052495,Low,0.165,0.443,0.069,0.124,Variable effect (p=0.037),No significant pattern (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04569,rs876775,3,241172540,PSEN2,SNP (A/T),(A/,A,0.95,0.68,1.17,0.00293731,Moderate,0.148,0.011,0.431,0.209,Mild decrease (p=0.004),No significant pattern (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04570,rs686668,15,123862267,SORL1,SNP (C/T),(C/,C,0.76,0.41,1.09,0.01734395,Unknown,0.027,0.482,0.237,0.054,Mild decrease (p=0.033),Mild decrease (p=0.043),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04571,rs900498,22,231594118,EPHA1,SNP (A/G),(A/,A,3.84,3.56,4.24,0.02765696,Protective,0.285,0.422,0.006,0.087,Mild decrease (p=0.048),Significant decrease (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP04572,rs572635,15,83478798,CR1,SNP (A/G),(A/,A,0.85,0.61,1.21,0.02187272,High,0.045,0.613,0.08,0.062,Mild decrease (p=0.03),Significant increase (p=0.039),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04573,rs616578,3,214334724,APP,Deletion,-,-,1.41,1.09,1.63,0.00683458,High,0.084,0.146,0.467,0.103,Mild increase (p=0.049),Mild increase (p=0.002),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04574,rs432735,19,133009414,EPHA1,SNP (A/G),(A/,A,1.65,1.44,1.86,0.03135984,Unknown,0.015,0.613,0.098,0.074,Mild decrease (p=0.045),No significant pattern (p=0.028),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04575,rs444448,8,97987925,ABCA7,Deletion,-,-,0.92,0.71,1.31,0.04243839,Unknown,0.068,0.159,0.567,0.005,Mild increase (p=0.005),No significant pattern (p=0.013),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04576,rs668856,12,39066076,APOE,SNP (A/G),(A/,A,0.48,0.19,0.78,0.01162243,Moderate,0.198,0.277,0.246,0.08,Significant increase (p=0.045),Variable effect (p=0.045),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04577,rs946808,1,83686451,CLU,Deletion,-,-,1.58,1.28,1.98,0.01614646,High,0.007,0.278,0.101,0.413,Significant decrease (p=0.049),Mild decrease (p=0.021),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04578,rs810962,16,173253876,MS4A6A,SNP (G/T),(G/,G,0.71,0.46,1.05,0.07763852,Protective,0.169,0.093,0.107,0.431,Variable effect (p=0.04),Significant decrease (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04579,rs593780,11,1741419,ABCA7,SNP (C/T),(C/,C,1.07,0.86,1.37,0.02114968,High,0.245,0.16,0.179,0.217,No significant pattern (p=0.008),Significant increase (p=0.018),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04580,rs462579,8,56274175,CD2AP,Deletion,-,-,0.77,0.44,1.07,0.06766688,Low,0.303,0.022,0.179,0.295,Significant increase (p=0.017),Variable effect (p=0.032),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04581,rs933907,17,8736683,MS4A6A,SNP (A/G),(A/,A,1.23,0.99,1.49,0.03870665,Unknown,0.134,0.343,0.004,0.319,Mild decrease (p=0.037),No significant pattern (p=0.008),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04582,rs489622,13,226405315,SORL1,SNP (C/G),(C/,C,1.04,0.71,1.33,0.00476992,Moderate,0.255,0.092,0.038,0.414,Mild increase (p=0.002),Significant increase (p=0.037),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04583,rs653201,9,100310372,CR1,SNP (A/C),(A/,A,0.7,0.37,1.06,0.03352406,Moderate,0.1,0.296,0.038,0.366,Significant decrease (p=0.049),Mild decrease (p=0.011),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04584,rs309629,8,148738700,TREM2,SNP (A/G),(A/,A,1.09,0.78,1.36,0.00956577,Low,0.426,0.085,0.065,0.223,Mild increase (p=0.006),Significant increase (p=0.039),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04585,rs853685,4,26578118,MS4A6A,SNP (A/C),(A/,A,1.24,0.99,1.52,0.01209162,High,0.525,0.033,0.182,0.059,Mild increase (p=0.02),Mild increase (p=0.035),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP04586,rs339383,10,16390184,EPHA1,SNP (A/G),(A/,A,1.81,1.49,2.03,0.01613881,Low,0.025,0.048,0.355,0.372,Variable effect (p=0.016),Mild increase (p=0.018),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04587,rs538187,4,88942363,CLU,SNP (A/T),(A/,A,0.99,0.63,1.37,0.00321983,Moderate,0.213,0.154,0.115,0.319,Variable effect (p=0.032),Significant decrease (p=0.05),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04588,rs287858,22,204407175,BIN1,SNP (C/G),(C/,C,1.77,1.55,2.02,0.02416164,Moderate,0.28,0.227,0.212,0.081,Significant increase (p=0.027),Variable effect (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04589,rs986372,16,171764383,APP,SNP (A/G),(A/,A,1.08,0.81,1.46,0.12847443,Moderate,0.147,0.315,0.301,0.037,Significant increase (p=0.033),Mild increase (p=0.031),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04590,rs252588,16,217313469,CD33,Insertion,-,-,0.57,0.33,0.85,0.06446238,High,0.455,0.04,0.228,0.078,Variable effect (p=0.042),Mild decrease (p=0.022),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP04591,rs376876,7,157475237,TREM2,SNP (C/G),(C/,C,0.93,0.64,1.17,0.03303869,Low,0.153,0.051,0.194,0.402,Significant increase (p=0.029),Mild decrease (p=0.036),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04592,rs467752,6,23698475,TREM2,SNP (C/G),(C/,C,1.57,1.18,1.94,0.05375146,Moderate,0.06,0.24,0.143,0.357,Significant decrease (p=0.011),Significant increase (p=0.043),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04593,rs133177,9,160939106,SORL1,SNP (A/C),(A/,A,1.78,1.45,2.06,0.05783059,Moderate,0.181,0.173,0.415,0.031,Significant decrease (p=0.033),Significant increase (p=0.047),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04594,rs832139,15,169359050,CD33,Deletion,-,-,0.64,0.32,0.93,0.04342274,Moderate,0.296,0.321,0.035,0.149,Mild decrease (p=0.021),Mild increase (p=0.011),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04595,rs492289,3,161678734,CD2AP,Insertion,-,-,0.42,0.13,0.68,0.00230523,Low,0.165,0.007,0.627,0.001,Significant increase (p=0.002),Variable effect (p=0.044),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04596,rs671067,21,219178589,CLU,SNP (A/C),(A/,A,1.25,1.0,1.49,0.14796943,Moderate,0.25,0.361,0.047,0.142,Mild increase (p=0.037),Significant increase (p=0.01),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04597,rs522602,17,201776942,PTK2B,SNP (A/T),(A/,A,0.96,0.58,1.27,0.00994009,Moderate,0.02,0.039,0.014,0.727,No significant pattern (p=0.049),No significant pattern (p=0.023),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04598,rs996924,13,150292254,APOE,SNP (G/T),(G/,G,1.16,0.96,1.5,0.10568765,Low,0.004,0.286,0.208,0.301,No significant pattern (p=0.011),Mild decrease (p=0.003),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04599,rs372722,22,57993784,TREM2,SNP (A/T),(A/,A,1.5,1.27,1.78,0.02575288,High,0.013,0.066,0.053,0.667,Significant decrease (p=0.012),Mild increase (p=0.049),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP04600,rs467803,1,82827022,TREM2,SNP (C/T),(C/,C,0.86,0.51,1.15,0.02873316,High,0.353,0.164,0.274,0.009,Significant decrease (p=0.037),No significant pattern (p=0.043),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04601,rs283547,16,151454660,MS4A6A,SNP (C/T),(C/,C,1.71,1.45,2.0,0.0047546,High,0.195,0.326,0.203,0.076,No significant pattern (p=0.026),Variable effect (p=0.006),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04602,rs417148,14,75042837,SORL1,SNP (G/T),(G/,G,0.91,0.58,1.25,0.01231983,Moderate,0.076,0.038,0.248,0.437,Significant decrease (p=0.045),Mild decrease (p=0.009),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP04603,rs611313,2,78512370,SORL1,SNP (C/G),(C/,C,1.16,0.88,1.46,0.03585857,Moderate,0.231,0.057,0.057,0.455,Significant decrease (p=0.004),Significant increase (p=0.045),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04604,rs718560,7,151994288,ABCA7,SNP (C/G),(C/,C,1.45,1.05,1.71,0.02891097,Moderate,0.158,0.495,0.007,0.14,Mild increase (p=0.011),Mild decrease (p=0.028),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP04605,rs383078,9,204050145,CLU,SNP (A/C),(A/,A,1.55,1.31,1.95,0.01595858,Moderate,0.163,0.07,0.532,0.035,Mild decrease (p=0.021),Significant increase (p=0.03),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04606,rs117676,21,38996144,APP,SNP (A/T),(A/,A,0.67,0.3,0.92,0.08751397,High,0.157,0.451,0.147,0.045,Mild decrease (p=0.017),Significant increase (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04607,rs539238,21,225252817,TREM2,SNP (A/T),(A/,A,1.39,1.05,1.6,0.01708457,Moderate,0.095,0.193,0.382,0.131,Mild increase (p=0.048),Significant decrease (p=0.029),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04608,rs997064,12,10016056,CD2AP,SNP (A/C),(A/,A,1.18,0.92,1.51,0.02512934,Low,0.164,0.054,0.438,0.144,Mild decrease (p=0.017),Significant increase (p=0.002),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP04609,rs867946,17,112084432,CD33,Deletion,-,-,0.99,0.61,1.36,0.01910484,Low,0.048,0.104,0.412,0.236,No significant pattern (p=0.013),Significant decrease (p=0.027),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04610,rs804225,9,106091683,PSEN2,SNP (C/T),(C/,C,1.36,1.1,1.74,0.08323731,High,0.072,0.487,0.104,0.136,Significant decrease (p=0.044),Variable effect (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04611,rs721487,3,151772756,PICALM,SNP (A/G),(A/,A,1.44,1.07,1.71,0.02078293,High,0.147,0.059,0.574,0.02,Significant increase (p=0.009),Variable effect (p=0.034),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04612,rs803882,20,102205411,TREM2,SNP (C/T),(C/,C,1.13,0.77,1.38,0.04663319,High,0.646,0.083,0.026,0.045,Significant increase (p=0.008),Significant increase (p=0.044),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04613,rs105849,5,139989079,BIN1,Deletion,-,-,0.92,0.68,1.21,0.03739427,Moderate,0.518,0.026,0.201,0.055,Mild increase (p=0.023),Mild increase (p=0.025),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04614,rs304918,17,218590052,PICALM,SNP (A/C),(A/,A,1.23,0.88,1.43,0.09429619,Moderate,0.158,0.131,0.238,0.273,No significant pattern (p=0.021),Mild increase (p=0.011),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04615,rs795152,15,243754222,EPHA1,SNP (C/T),(C/,C,0.99,0.74,1.32,0.04116431,Low,0.162,0.41,0.061,0.166,Significant decrease (p=0.009),Significant increase (p=0.004),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04616,rs624084,4,41161952,PSEN2,SNP (C/T),(C/,C,0.58,0.37,0.91,0.0647523,Low,0.359,0.343,0.082,0.016,Mild increase (p=0.045),Significant increase (p=0.013),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04617,rs787065,4,188746844,CR1,SNP (C/T),(C/,C,0.55,0.22,0.92,0.03673266,Moderate,0.19,0.02,0.256,0.335,Variable effect (p=0.003),Significant decrease (p=0.031),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04618,rs403839,11,196399372,MS4A6A,SNP (A/C),(A/,A,2.02,1.71,2.41,0.03512119,Low,0.299,0.248,0.153,0.099,Mild increase (p=0.025),Significant increase (p=0.043),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04619,rs504009,3,105297003,BIN1,SNP (A/G),(A/,A,0.39,0.1,0.62,0.01532182,Low,0.3,0.031,0.283,0.186,Significant increase (p=0.002),Significant decrease (p=0.016),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04620,rs230562,5,68690471,CD33,SNP (A/C),(A/,A,1.05,0.69,1.27,0.02426129,High,0.043,0.395,0.279,0.082,Significant increase (p=0.018),Significant increase (p=0.014),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04621,rs193426,18,29431268,SORL1,Insertion,-,-,1.54,1.18,1.86,0.06597922,Protective,0.119,0.038,0.634,0.009,Significant increase (p=0.046),Mild decrease (p=0.039),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04622,rs234562,7,104344310,CLU,SNP (A/C),(A/,A,2.2,1.96,2.51,0.02072871,Protective,0.324,0.186,0.06,0.231,Significant decrease (p=0.04),Variable effect (p=0.046),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04623,rs744644,13,129424043,APOE,SNP (C/G),(C/,C,0.39,0.16,0.78,0.01834158,Low,0.416,0.072,0.049,0.262,Significant increase (p=0.005),Mild decrease (p=0.026),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04624,rs288853,20,96460782,CD2AP,Insertion,-,-,1.48,1.25,1.81,0.07859687,Moderate,0.427,0.115,0.058,0.2,Variable effect (p=0.022),Mild increase (p=0.028),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04625,rs916319,6,79557862,PSEN2,SNP (C/G),(C/,C,1.65,1.25,1.87,0.01632058,High,0.334,0.154,0.03,0.282,Significant increase (p=0.035),No significant pattern (p=0.046),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04626,rs166534,10,65144363,CD2AP,SNP (C/G),(C/,C,1.7,1.45,1.99,0.00821625,Protective,0.208,0.553,0.021,0.018,Variable effect (p=0.017),Mild increase (p=0.043),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04627,rs171595,10,6120039,SORL1,SNP (C/G),(C/,C,0.91,0.64,1.14,0.02404577,Moderate,0.187,0.031,0.442,0.14,Mild increase (p=0.036),Significant increase (p=0.022),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04628,rs789209,12,117834142,APP,SNP (A/G),(A/,A,0.78,0.43,1.17,0.00977374,Protective,0.62,0.071,0.033,0.076,Mild decrease (p=0.027),Variable effect (p=0.02),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04629,rs541535,13,89512103,EPHA1,SNP (A/G),(A/,A,1.46,1.15,1.77,0.03293379,Protective,0.11,0.312,0.07,0.308,No significant pattern (p=0.009),Mild decrease (p=0.016),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04630,rs140131,12,219507643,CD33,SNP (C/G),(C/,C,1.29,0.97,1.56,0.00899533,Moderate,0.494,0.088,0.14,0.078,Significant decrease (p=0.033),Mild decrease (p=0.049),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04631,rs637721,19,101591972,PTK2B,SNP (G/T),(G/,G,1.8,1.48,2.19,0.0252673,Moderate,0.116,0.524,0.012,0.147,Significant decrease (p=0.027),No significant pattern (p=0.04),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04632,rs639093,21,156681713,BIN1,SNP (C/G),(C/,C,0.87,0.51,1.2,0.00558065,Low,0.002,0.297,0.442,0.059,Mild increase (p=0.046),Mild increase (p=0.016),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04633,rs307651,4,122195117,PSEN2,Insertion,-,-,0.41,0.18,0.75,0.00072951,Moderate,0.049,0.133,0.097,0.52,Mild decrease (p=0.044),Mild decrease (p=0.032),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04634,rs650451,12,171990338,CD33,SNP (G/T),(G/,G,0.88,0.64,1.21,0.01687449,High,0.021,0.069,0.043,0.666,Variable effect (p=0.049),No significant pattern (p=0.026),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04635,rs167170,13,121511242,CR1,Insertion,-,-,0.48,0.21,0.8,0.11210659,High,0.002,0.423,0.239,0.136,Mild decrease (p=0.004),No significant pattern (p=0.001),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04636,rs143043,22,208836287,APOE,SNP (G/T),(G/,G,0.66,0.3,0.99,0.04078117,Moderate,0.082,0.167,0.26,0.291,Mild increase (p=0.048),Significant decrease (p=0.01),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04637,rs189174,20,148317824,ABCA7,Deletion,-,-,1.09,0.73,1.38,0.01803772,Moderate,0.337,0.007,0.401,0.056,Significant increase (p=0.046),Significant decrease (p=0.021),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04638,rs980094,10,137790821,BIN1,SNP (G/T),(G/,G,1.15,0.76,1.48,0.02171258,Protective,0.165,0.376,0.135,0.124,Significant increase (p=0.05),Mild increase (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04639,rs492979,13,203504559,ABCA7,SNP (C/G),(C/,C,0.65,0.31,0.92,0.06027879,Protective,0.134,0.02,0.525,0.122,Mild increase (p=0.004),No significant pattern (p=0.012),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04640,rs288777,8,139252269,CD2AP,Insertion,-,-,0.9,0.7,1.27,0.00547864,High,0.462,0.044,0.194,0.099,Significant increase (p=0.001),Variable effect (p=0.029),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04641,rs717375,9,163827352,APP,SNP (C/G),(C/,C,0.59,0.23,0.83,0.0232407,High,0.186,0.114,0.018,0.481,Mild increase (p=0.05),Mild increase (p=0.026),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04642,rs845564,7,14642202,BIN1,SNP (A/C),(A/,A,0.76,0.39,1.12,0.00473735,Moderate,0.304,0.069,0.39,0.037,Significant decrease (p=0.024),Mild increase (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04643,rs197173,21,218297330,MS4A6A,SNP (A/C),(A/,A,1.23,0.92,1.44,0.04891665,Moderate,0.007,0.021,0.259,0.514,No significant pattern (p=0.025),Variable effect (p=0.011),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04644,rs150152,10,227464811,CLU,Deletion,-,-,0.96,0.72,1.3,0.01963695,Moderate,0.023,0.183,0.273,0.321,Variable effect (p=0.049),Variable effect (p=0.03),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04645,rs269727,3,187043954,PSEN2,SNP (A/C),(A/,A,0.82,0.58,1.17,0.08137908,Moderate,0.005,0.413,0.32,0.063,No significant pattern (p=0.049),Mild increase (p=0.006),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04646,rs511020,2,76604692,PICALM,Deletion,-,-,1.33,0.96,1.62,0.0090885,Low,0.238,0.292,0.002,0.268,Significant increase (p=0.002),Significant increase (p=0.027),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04647,rs218458,21,112512940,CR1,SNP (A/T),(A/,A,1.75,1.37,2.12,0.01889225,High,0.108,0.288,0.321,0.084,Mild increase (p=0.031),No significant pattern (p=0.018),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04648,rs633595,1,132495437,PTK2B,SNP (A/T),(A/,A,1.12,0.92,1.44,0.08214706,Low,0.204,0.05,0.245,0.301,Mild increase (p=0.008),No significant pattern (p=0.003),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04649,rs434929,20,92561403,CR1,SNP (G/T),(G/,G,0.85,0.64,1.18,0.00943115,High,0.113,0.139,0.233,0.316,Significant increase (p=0.004),No significant pattern (p=0.003),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04650,rs374145,19,189473992,PTK2B,SNP (A/G),(A/,A,0.82,0.5,1.2,0.01525566,High,0.036,0.31,0.398,0.055,Mild increase (p=0.002),No significant pattern (p=0.035),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04651,rs160970,9,181792701,ABCA7,Deletion,-,-,0.87,0.67,1.22,0.11859545,Moderate,0.224,0.296,0.07,0.21,Significant increase (p=0.01),Mild increase (p=0.003),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04652,rs526468,16,148251211,CD33,SNP (G/T),(G/,G,1.24,0.87,1.53,0.01284412,High,0.075,0.204,0.507,0.014,Significant decrease (p=0.004),Mild increase (p=0.022),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04653,rs299876,7,194410038,PICALM,Deletion,-,-,1.93,1.72,2.19,0.00870939,Moderate,0.027,0.617,0.018,0.138,Mild increase (p=0.041),Significant decrease (p=0.039),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP04654,rs330305,12,236883026,EPHA1,Deletion,-,-,1.08,0.85,1.47,0.01548255,High,0.275,0.294,0.04,0.19,Mild decrease (p=0.019),Significant decrease (p=0.034),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04655,rs190723,17,29612663,PICALM,SNP (C/G),(C/,C,0.76,0.51,1.02,0.0022837,Moderate,0.649,0.008,0.052,0.091,Mild decrease (p=0.042),No significant pattern (p=0.011),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04656,rs233554,5,43660506,EPHA1,Insertion,-,-,0.39,0.1,0.62,0.00062606,High,0.058,0.064,0.357,0.321,Significant decrease (p=0.037),Variable effect (p=0.032),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP04657,rs483771,18,51644846,CLU,Insertion,-,-,0.69,0.48,0.92,0.01758625,High,0.128,0.116,0.002,0.554,Variable effect (p=0.006),Significant increase (p=0.025),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP04658,rs604920,6,23159105,APP,Insertion,-,-,0.87,0.48,1.17,0.027089,Moderate,0.206,0.32,0.135,0.139,Significant increase (p=0.02),No significant pattern (p=0.013),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04659,rs634487,1,156172270,CD33,Insertion,-,-,0.46,0.1,0.8,0.04238503,Moderate,0.006,0.011,0.521,0.262,Mild increase (p=0.03),Significant increase (p=0.027),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP04660,rs283421,1,104576933,CD2AP,SNP (A/C),(A/,A,0.7,0.4,1.0,0.05800703,Unknown,0.05,0.353,0.111,0.286,Mild increase (p=0.027),Mild increase (p=0.019),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04661,rs795617,2,167993989,SORL1,Insertion,-,-,0.47,0.18,0.85,0.01016695,Moderate,0.103,0.089,0.375,0.233,No significant pattern (p=0.01),Variable effect (p=0.016),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04662,rs308507,1,111552788,PSEN2,SNP (A/G),(A/,A,2.74,2.35,3.07,0.03056503,Moderate,0.006,0.313,0.269,0.211,Significant decrease (p=0.017),Mild decrease (p=0.04),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04663,rs235990,22,240315622,PICALM,SNP (C/T),(C/,C,1.11,0.72,1.44,0.00205178,Moderate,0.399,0.17,0.065,0.166,No significant pattern (p=0.019),Mild increase (p=0.037),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04664,rs704931,17,19707694,CR1,SNP (C/G),(C/,C,1.75,1.38,1.97,0.04578368,Moderate,0.224,0.025,0.233,0.317,No significant pattern (p=0.012),Mild decrease (p=0.043),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04665,rs308436,11,189732272,APP,SNP (A/G),(A/,A,0.5,0.23,0.73,0.1031153,Protective,0.125,0.468,0.085,0.122,No significant pattern (p=0.029),Variable effect (p=0.049),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04666,rs672168,21,247905656,APP,SNP (G/T),(G/,G,1.01,0.71,1.26,0.01903596,Moderate,0.059,0.473,0.001,0.267,Variable effect (p=0.037),No significant pattern (p=0.032),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04667,rs712351,16,49901515,TREM2,SNP (A/G),(A/,A,0.99,0.73,1.38,0.03911703,Moderate,0.066,0.063,0.029,0.642,Significant decrease (p=0.04),Significant increase (p=0.006),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04668,rs197198,8,176421484,APP,SNP (A/T),(A/,A,2.3,2.0,2.69,0.0180072,High,0.286,0.231,0.081,0.202,Mild increase (p=0.026),Variable effect (p=0.004),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04669,rs870992,7,162434741,BIN1,SNP (A/G),(A/,A,2.37,2.16,2.69,0.03790725,Moderate,0.351,0.14,0.249,0.06,Significant decrease (p=0.036),No significant pattern (p=0.024),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04670,rs294306,15,171783223,CD2AP,SNP (A/C),(A/,A,1.1,0.77,1.35,0.04581315,Moderate,0.127,0.182,0.289,0.202,Significant decrease (p=0.046),Significant decrease (p=0.035),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04671,rs620321,3,16353540,CR1,SNP (A/C),(A/,A,1.31,0.99,1.69,0.02930981,High,0.026,0.082,0.028,0.664,Variable effect (p=0.041),Variable effect (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04672,rs146667,14,33290972,PSEN2,Deletion,-,-,0.39,0.1,0.74,0.02100623,High,0.109,0.284,0.149,0.258,Variable effect (p=0.011),Mild increase (p=0.046),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04673,rs811446,9,225231781,PSEN2,SNP (A/C),(A/,A,1.18,0.89,1.51,0.05877595,Low,0.087,0.142,0.216,0.354,Significant decrease (p=0.002),Variable effect (p=0.016),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04674,rs159978,7,147282216,EPHA1,Deletion,-,-,1.19,0.97,1.49,0.06163058,High,0.561,0.028,0.134,0.077,Variable effect (p=0.029),Significant increase (p=0.004),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04675,rs762730,11,47629628,SORL1,SNP (C/G),(C/,C,0.45,0.24,0.82,0.03155214,High,0.148,0.078,0.411,0.163,Mild decrease (p=0.035),Variable effect (p=0.011),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04676,rs155828,1,52510522,ABCA7,SNP (A/G),(A/,A,0.82,0.48,1.11,0.02224465,High,0.087,0.119,0.448,0.145,Variable effect (p=0.011),Significant increase (p=0.03),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04677,rs764879,14,85548566,CR1,Deletion,-,-,0.68,0.41,0.95,0.03615435,High,0.608,0.135,0.006,0.051,Mild decrease (p=0.049),Significant decrease (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04678,rs361021,10,243338285,APP,SNP (C/T),(C/,C,0.63,0.37,0.86,0.02084386,Protective,0.251,0.1,0.364,0.086,Mild increase (p=0.022),Mild decrease (p=0.042),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04679,rs279708,4,121370180,MS4A6A,SNP (A/C),(A/,A,0.88,0.52,1.25,0.05993447,High,0.477,0.002,0.284,0.038,Mild decrease (p=0.01),Mild decrease (p=0.017),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04680,rs907412,10,217040084,APP,SNP (C/T),(C/,C,1.28,1.08,1.52,0.03174033,Moderate,0.267,0.374,0.048,0.111,Significant decrease (p=0.017),Mild decrease (p=0.042),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04681,rs913496,18,170195082,APOE,SNP (A/T),(A/,A,1.12,0.75,1.44,0.03325111,Low,0.221,0.125,0.307,0.147,No significant pattern (p=0.019),Variable effect (p=0.017),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04682,rs197575,1,230032842,APP,Insertion,-,-,0.35,0.1,0.75,0.00951913,Moderate,0.153,0.128,0.198,0.321,Mild increase (p=0.02),No significant pattern (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04683,rs460833,10,17344434,ABCA7,SNP (C/T),(C/,C,0.8,0.44,1.09,0.05326006,Moderate,0.054,0.259,0.051,0.436,Mild decrease (p=0.028),No significant pattern (p=0.001),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04684,rs701231,9,75921715,ABCA7,SNP (C/T),(C/,C,1.39,1.04,1.64,0.12067428,Moderate,0.201,0.404,0.039,0.157,Variable effect (p=0.008),Variable effect (p=0.03),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04685,rs542834,6,204078269,PSEN2,Deletion,-,-,0.56,0.22,0.78,0.01244131,Moderate,0.103,0.228,0.4,0.069,Mild decrease (p=0.03),Significant decrease (p=0.024),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04686,rs909521,14,27008735,CR1,SNP (G/T),(G/,G,0.5,0.27,0.72,0.01917524,Moderate,0.223,0.165,0.18,0.232,Variable effect (p=0.015),Mild increase (p=0.015),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04687,rs384668,2,201841003,APP,SNP (G/T),(G/,G,0.39,0.1,0.68,0.00832325,Low,0.286,0.203,0.118,0.193,Mild decrease (p=0.004),Variable effect (p=0.014),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04688,rs757931,19,37501122,PTK2B,SNP (C/G),(C/,C,1.14,0.86,1.48,0.00400731,Moderate,0.398,0.002,0.151,0.249,Significant decrease (p=0.039),Mild decrease (p=0.024),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP04689,rs660191,5,201872388,APP,Deletion,-,-,0.51,0.27,0.87,0.0121032,Protective,0.234,0.246,0.21,0.109,Mild increase (p=0.02),Significant increase (p=0.029),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP04690,rs950086,20,233637176,ABCA7,SNP (A/G),(A/,A,1.23,0.96,1.57,0.0037485,Moderate,0.183,0.382,0.075,0.161,Variable effect (p=0.022),Significant increase (p=0.012),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04691,rs826254,20,150309710,CD2AP,SNP (A/T),(A/,A,1.43,1.12,1.79,0.00707377,High,0.054,0.24,0.046,0.46,Significant decrease (p=0.045),Significant increase (p=0.002),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04692,rs174570,2,173359383,CLU,SNP (A/T),(A/,A,1.07,0.78,1.34,0.01280623,Low,0.378,0.025,0.211,0.186,Significant increase (p=0.041),No significant pattern (p=0.019),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04693,rs348886,7,84606196,SORL1,SNP (C/G),(C/,C,0.38,0.11,0.62,0.08920057,Moderate,0.336,0.182,0.151,0.132,Mild decrease (p=0.04),Significant increase (p=0.044),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04694,rs241420,18,155131560,SORL1,SNP (A/G),(A/,A,0.84,0.51,1.11,0.0737495,Low,0.169,0.051,0.497,0.083,Significant decrease (p=0.016),Mild decrease (p=0.024),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04695,rs611714,10,174545562,APOE,SNP (G/T),(G/,G,1.47,1.21,1.72,0.13832833,Low,0.096,0.422,0.026,0.256,Significant increase (p=0.045),No significant pattern (p=0.028),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04696,rs284660,8,216855940,CR1,SNP (C/G),(C/,C,0.55,0.18,0.91,0.00345171,Low,0.586,0.088,0.021,0.105,No significant pattern (p=0.035),Mild decrease (p=0.049),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04697,rs255243,7,77239900,APOE,SNP (A/T),(A/,A,1.6,1.23,1.97,0.03652252,Moderate,0.222,0.12,0.267,0.191,Mild decrease (p=0.04),Significant decrease (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04698,rs146008,1,209356312,APP,SNP (A/C),(A/,A,0.56,0.18,0.87,0.06966134,Low,0.635,0.002,0.097,0.066,Mild decrease (p=0.015),Mild decrease (p=0.03),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04699,rs464788,14,61763222,TREM2,SNP (C/T),(C/,C,0.94,0.64,1.32,0.02733301,Moderate,0.013,0.157,0.401,0.229,Variable effect (p=0.021),Significant increase (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04700,rs763746,7,245300800,CD33,SNP (A/C),(A/,A,0.55,0.21,0.9,0.00113147,Moderate,0.234,0.36,0.164,0.041,No significant pattern (p=0.025),Mild decrease (p=0.033),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04701,rs518795,15,148368126,TREM2,SNP (C/G),(C/,C,2.41,2.1,2.74,0.01565234,High,0.069,0.169,0.315,0.247,Mild decrease (p=0.037),Mild decrease (p=0.046),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04702,rs673453,3,48904348,SORL1,SNP (C/T),(C/,C,0.53,0.32,0.86,0.01951283,High,0.146,0.254,0.261,0.139,Significant increase (p=0.038),Mild decrease (p=0.007),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04703,rs570516,10,235206351,EPHA1,SNP (A/C),(A/,A,0.76,0.42,0.98,0.03872119,High,0.19,0.324,0.171,0.115,No significant pattern (p=0.018),Variable effect (p=0.049),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP04704,rs128774,20,138103828,BIN1,SNP (C/G),(C/,C,0.9,0.58,1.21,0.03321179,Low,0.068,0.54,0.121,0.071,Variable effect (p=0.044),No significant pattern (p=0.014),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04705,rs240159,14,146759644,ABCA7,SNP (A/T),(A/,A,0.68,0.31,0.94,0.03246707,Moderate,0.085,0.078,0.16,0.477,Significant increase (p=0.034),Significant increase (p=0.048),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04706,rs446163,9,82692478,MS4A6A,Insertion,-,-,1.05,0.78,1.28,0.09815923,Moderate,0.088,0.016,0.269,0.427,Variable effect (p=0.031),Variable effect (p=0.02),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04707,rs704162,21,194771607,PTK2B,SNP (A/T),(A/,A,0.95,0.73,1.16,0.02555083,High,0.279,0.137,0.211,0.172,Mild decrease (p=0.003),Variable effect (p=0.013),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04708,rs954113,16,205873253,ABCA7,SNP (C/T),(C/,C,0.52,0.26,0.78,0.06682067,Moderate,0.167,0.125,0.003,0.505,Significant increase (p=0.046),No significant pattern (p=0.047),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04709,rs231830,7,125157692,BIN1,Deletion,-,-,0.58,0.23,0.79,0.01139122,Protective,0.044,0.19,0.478,0.089,Mild increase (p=0.002),Mild decrease (p=0.026),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04710,rs322731,5,66579580,BIN1,SNP (A/G),(A/,A,1.52,1.15,1.89,0.00786692,Moderate,0.019,0.258,0.141,0.382,Mild decrease (p=0.029),Mild decrease (p=0.025),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP04711,rs619907,9,123527286,TREM2,SNP (C/T),(C/,C,2.12,1.76,2.38,0.02254309,Moderate,0.205,0.287,0.201,0.108,No significant pattern (p=0.034),Significant decrease (p=0.029),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP04712,rs296362,21,82172450,BIN1,SNP (A/C),(A/,A,0.78,0.55,1.04,0.03124795,High,0.448,0.098,0.128,0.125,No significant pattern (p=0.048),Significant decrease (p=0.004),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04713,rs906391,20,138214266,EPHA1,SNP (A/G),(A/,A,0.55,0.26,0.8,0.04012794,Moderate,0.022,0.196,0.53,0.052,Significant increase (p=0.022),Mild increase (p=0.013),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP04714,rs949161,11,140857106,ABCA7,SNP (A/T),(A/,A,0.69,0.37,1.04,0.02392455,High,0.18,0.218,0.258,0.145,Significant decrease (p=0.049),Mild decrease (p=0.001),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04715,rs506685,8,93716924,APOE,SNP (C/T),(C/,C,0.5,0.21,0.85,0.06482141,Low,0.053,0.01,0.141,0.595,Mild decrease (p=0.041),Mild decrease (p=0.041),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04716,rs620761,17,73429498,ABCA7,SNP (A/C),(A/,A,0.79,0.43,1.18,0.00212842,Low,0.228,0.065,0.45,0.057,Variable effect (p=0.015),Significant increase (p=0.011),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04717,rs954099,18,224091036,APP,Deletion,-,-,1.12,0.83,1.49,0.02953513,Moderate,0.317,0.064,0.211,0.208,Mild decrease (p=0.027),Variable effect (p=0.031),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04718,rs757269,3,4416631,EPHA1,SNP (C/G),(C/,C,1.11,0.82,1.5,0.06242008,Moderate,0.392,0.127,0.179,0.101,No significant pattern (p=0.039),Variable effect (p=0.048),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04719,rs751785,20,141127301,CR1,SNP (C/G),(C/,C,0.57,0.34,0.9,0.00911833,Low,0.143,0.392,0.004,0.261,Significant increase (p=0.014),Mild decrease (p=0.024),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04720,rs159507,16,67677547,SORL1,SNP (C/T),(C/,C,1.75,1.51,1.98,0.0175088,Moderate,0.146,0.051,0.461,0.142,Variable effect (p=0.027),Variable effect (p=0.039),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04721,rs776657,11,73502281,APP,SNP (A/C),(A/,A,1.25,0.95,1.5,0.01697621,Moderate,0.407,0.215,0.045,0.133,Mild increase (p=0.025),Mild decrease (p=0.049),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04722,rs828519,22,81193976,CLU,Deletion,-,-,0.93,0.58,1.32,0.00047821,Low,0.121,0.277,0.169,0.232,No significant pattern (p=0.044),No significant pattern (p=0.013),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP04723,rs383532,20,58605128,ABCA7,SNP (A/C),(A/,A,3.57,3.21,3.79,0.02388422,High,0.527,0.141,0.012,0.119,Significant decrease (p=0.048),No significant pattern (p=0.015),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP04724,rs525926,1,110566311,ABCA7,SNP (A/G),(A/,A,1.04,0.75,1.32,0.011752,Low,0.099,0.391,0.09,0.22,Mild decrease (p=0.01),Mild decrease (p=0.043),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04725,rs908677,4,225343971,MS4A6A,SNP (C/T),(C/,C,1.45,1.14,1.67,0.01477981,Unknown,0.138,0.115,0.501,0.047,Mild decrease (p=0.013),Significant decrease (p=0.036),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04726,rs803811,1,126013806,APP,SNP (A/G),(A/,A,2.39,2.14,2.73,0.01499045,Moderate,0.338,0.144,0.113,0.205,Significant increase (p=0.03),No significant pattern (p=0.008),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04727,rs620250,13,188203115,PICALM,SNP (C/T),(C/,C,0.97,0.73,1.25,0.00101347,High,0.036,0.307,0.455,0.002,Mild decrease (p=0.022),Significant decrease (p=0.023),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04728,rs183157,12,36910703,PSEN2,Deletion,-,-,0.74,0.44,1.1,0.02045167,Moderate,0.194,0.037,0.019,0.55,Mild increase (p=0.038),Significant increase (p=0.034),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP04729,rs119645,18,142093725,APOE,SNP (A/G),(A/,A,1.14,0.88,1.43,0.01497035,High,0.104,0.541,0.135,0.02,Significant increase (p=0.034),No significant pattern (p=0.02),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04730,rs771973,16,187398477,PSEN2,SNP (A/T),(A/,A,1.13,0.92,1.5,0.05392128,Unknown,0.176,0.265,0.313,0.046,Mild decrease (p=0.004),Significant increase (p=0.043),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04731,rs342451,22,58430640,APP,SNP (C/G),(C/,C,1.36,0.97,1.58,0.03388188,Moderate,0.214,0.362,0.164,0.061,Mild decrease (p=0.031),Mild decrease (p=0.027),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04732,rs689759,12,113322855,PTK2B,SNP (A/C),(A/,A,1.2,0.85,1.56,0.0420353,Moderate,0.015,0.123,0.264,0.397,Significant decrease (p=0.007),Significant decrease (p=0.046),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04733,rs464708,6,49651330,ABCA7,SNP (C/G),(C/,C,1.24,0.94,1.47,0.02557781,Moderate,0.237,0.252,0.128,0.184,No significant pattern (p=0.027),No significant pattern (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04734,rs371085,10,222493497,ABCA7,SNP (G/T),(G/,G,0.69,0.3,0.92,0.02150719,High,0.038,0.324,0.002,0.435,Variable effect (p=0.042),Variable effect (p=0.014),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04735,rs131654,5,164517668,CD2AP,Deletion,-,-,0.26,0.1,0.57,0.0052729,High,0.58,0.156,0.053,0.012,Significant increase (p=0.004),Significant decrease (p=0.024),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04736,rs583783,15,33382117,BIN1,Insertion,-,-,1.46,1.15,1.8,0.02170616,High,0.54,0.05,0.052,0.159,Significant decrease (p=0.02),Mild increase (p=0.028),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04737,rs601745,13,141650493,APOE,SNP (A/G),(A/,A,1.47,1.1,1.7,0.0178279,Low,0.04,0.119,0.15,0.491,Significant decrease (p=0.043),No significant pattern (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04738,rs185978,14,163746153,CD2AP,SNP (C/G),(C/,C,1.22,0.93,1.61,0.01781496,High,0.012,0.011,0.53,0.248,Mild increase (p=0.031),No significant pattern (p=0.042),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04739,rs891667,5,127669557,SORL1,SNP (A/C),(A/,A,0.73,0.45,1.13,0.03845858,Moderate,0.049,0.132,0.22,0.398,Significant increase (p=0.002),No significant pattern (p=0.021),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04740,rs190988,8,67239775,PTK2B,SNP (G/T),(G/,G,1.69,1.48,2.08,0.00584906,High,0.023,0.095,0.679,0.004,No significant pattern (p=0.041),Significant increase (p=0.023),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04741,rs664164,10,20450191,CR1,SNP (G/T),(G/,G,0.93,0.62,1.2,0.01358994,Protective,0.072,0.425,0.215,0.089,Significant increase (p=0.03),Mild decrease (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04742,rs894576,16,104518056,CR1,SNP (A/T),(A/,A,1.93,1.54,2.25,0.00216564,Moderate,0.157,0.09,0.318,0.235,No significant pattern (p=0.029),Significant decrease (p=0.016),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP04743,rs724674,4,38106399,APP,SNP (A/C),(A/,A,0.74,0.44,1.1,0.03577457,High,0.566,0.175,0.002,0.057,Variable effect (p=0.021),Variable effect (p=0.011),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04744,rs715119,20,157286997,PSEN2,Insertion,-,-,0.82,0.54,1.07,0.01624946,High,0.269,0.454,0.001,0.076,Significant decrease (p=0.046),Mild increase (p=0.049),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04745,rs273430,5,94636862,TREM2,SNP (A/C),(A/,A,0.37,0.14,0.71,0.04409356,Protective,0.071,0.683,0.007,0.039,Mild decrease (p=0.041),Mild decrease (p=0.039),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04746,rs128182,18,86300513,TREM2,SNP (C/T),(C/,C,1.49,1.22,1.71,0.01595911,High,0.039,0.041,0.268,0.453,Mild increase (p=0.033),No significant pattern (p=0.017),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP04747,rs249036,15,238853571,APP,SNP (A/C),(A/,A,0.54,0.19,0.79,0.02158137,Low,0.179,0.028,0.05,0.544,Mild decrease (p=0.01),Significant increase (p=0.05),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP04748,rs602858,13,30980368,BIN1,SNP (C/G),(C/,C,1.93,1.61,2.27,0.12586294,Moderate,0.424,0.18,0.193,0.004,Mild decrease (p=0.048),No significant pattern (p=0.039),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP04749,rs545734,14,54836409,CD33,SNP (C/T),(C/,C,1.0,0.79,1.28,0.00234079,High,0.373,0.015,0.293,0.12,Mild increase (p=0.01),Mild decrease (p=0.016),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04750,rs940833,5,39352739,PICALM,SNP (A/T),(A/,A,1.03,0.67,1.29,0.05964986,High,0.06,0.127,0.503,0.109,Significant decrease (p=0.048),Mild increase (p=0.004),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP04751,rs558354,12,122707056,SORL1,SNP (G/T),(G/,G,0.74,0.47,1.08,0.02447288,Protective,0.278,0.249,0.114,0.159,Mild decrease (p=0.019),Mild increase (p=0.003),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04752,rs473359,14,22192533,APOE,SNP (A/C),(A/,A,0.96,0.76,1.35,0.0269771,Low,0.22,0.249,0.068,0.263,Mild decrease (p=0.008),Mild increase (p=0.022),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP04753,rs833460,18,234728708,EPHA1,Insertion,-,-,1.46,1.2,1.78,0.01018798,High,0.54,0.072,0.161,0.027,Significant decrease (p=0.01),Variable effect (p=0.019),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP04754,rs260325,15,236762808,ABCA7,Insertion,-,-,0.68,0.37,0.98,0.00586697,High,0.033,0.458,0.024,0.285,Mild increase (p=0.003),Variable effect (p=0.033),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04755,rs101313,8,192573310,MS4A6A,SNP (A/T),(A/,A,1.23,0.87,1.56,0.01248126,Unknown,0.052,0.619,0.086,0.043,Variable effect (p=0.006),Mild increase (p=0.036),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04756,rs479411,8,109842509,CR1,Deletion,-,-,1.19,0.98,1.58,0.05286526,High,0.062,0.096,0.281,0.361,Significant increase (p=0.028),No significant pattern (p=0.019),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04757,rs813025,15,189656841,CD2AP,SNP (G/T),(G/,G,0.99,0.72,1.23,0.02121764,Low,0.112,0.05,0.23,0.408,Mild increase (p=0.042),No significant pattern (p=0.042),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP04758,rs751713,15,71247162,PSEN2,Insertion,-,-,0.97,0.67,1.18,0.01787038,High,0.063,0.104,0.268,0.365,Significant increase (p=0.048),Mild increase (p=0.006),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP04759,rs595698,9,139207425,PSEN2,SNP (G/T),(G/,G,1.27,0.95,1.55,0.00165966,Moderate,0.181,0.371,0.177,0.07,Mild decrease (p=0.022),Significant decrease (p=0.009),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP04760,rs293232,15,52821392,BIN1,Insertion,-,-,0.54,0.27,0.75,0.00530753,Moderate,0.211,0.155,0.348,0.086,Significant decrease (p=0.033),No significant pattern (p=0.01),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP04761,rs193997,9,115563227,CD33,SNP (C/G),(C/,C,0.66,0.3,0.99,0.00582531,High,0.205,0.019,0.04,0.536,Significant decrease (p=0.013),Variable effect (p=0.037),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP04762,rs876033,11,64758603,SORL1,SNP (A/G),(A/,A,0.83,0.53,1.08,0.00247022,Low,0.357,0.345,0.015,0.083,Mild increase (p=0.006),Mild increase (p=0.042),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04763,rs148281,6,22698196,PSEN2,SNP (G/T),(G/,G,0.69,0.42,0.92,0.00632171,High,0.082,0.57,0.072,0.075,Mild increase (p=0.034),Significant increase (p=0.028),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04764,rs391371,21,186106393,TREM2,SNP (A/G),(A/,A,0.92,0.55,1.19,0.01341343,High,0.048,0.34,0.103,0.309,Mild increase (p=0.023),Mild decrease (p=0.01),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04765,rs261887,9,107857136,TREM2,SNP (C/G),(C/,C,1.14,0.83,1.41,0.02207813,High,0.146,0.111,0.348,0.195,No significant pattern (p=0.021),No significant pattern (p=0.048),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04766,rs703226,12,8302758,PICALM,SNP (A/C),(A/,A,0.42,0.1,0.64,0.12440459,High,0.019,0.529,0.008,0.244,Variable effect (p=0.003),Mild decrease (p=0.021),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP04767,rs330586,1,204945243,APOE,SNP (A/C),(A/,A,0.73,0.35,0.97,0.00206223,High,0.37,0.033,0.051,0.346,Significant decrease (p=0.023),Significant increase (p=0.019),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP04768,rs549930,17,188518613,EPHA1,SNP (C/G),(C/,C,1.34,1.06,1.67,0.06928554,Protective,0.539,0.001,0.04,0.22,Significant increase (p=0.004),Mild increase (p=0.041),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP04769,rs555755,6,238007592,TREM2,SNP (C/G),(C/,C,1.1,0.87,1.46,0.09654518,High,0.023,0.021,0.6,0.156,Mild decrease (p=0.032),No significant pattern (p=0.035),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04770,rs258724,22,116810025,EPHA1,Insertion,-,-,1.01,0.77,1.34,0.00045064,Moderate,0.092,0.07,0.506,0.132,Significant decrease (p=0.03),No significant pattern (p=0.01),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04771,rs243590,2,22545993,SORL1,SNP (C/T),(C/,C,0.73,0.37,1.04,0.05027177,Moderate,0.34,0.011,0.103,0.346,Variable effect (p=0.033),Mild decrease (p=0.025),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04772,rs247831,19,210174975,CD33,Insertion,-,-,1.21,0.94,1.58,0.00706648,Unknown,0.196,0.028,0.374,0.202,Significant decrease (p=0.037),Mild increase (p=0.008),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04773,rs536146,14,12679639,BIN1,Insertion,-,-,2.3,2.01,2.64,0.03015691,Moderate,0.186,0.22,0.143,0.251,Significant decrease (p=0.02),Variable effect (p=0.02),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04774,rs657280,20,246650666,TREM2,SNP (A/T),(A/,A,1.13,0.91,1.42,0.05731449,High,0.561,0.015,0.191,0.033,No significant pattern (p=0.03),Mild increase (p=0.017),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04775,rs281104,2,87330136,CR1,Insertion,-,-,2.29,1.94,2.51,0.07034073,Low,0.465,0.229,0.042,0.064,Variable effect (p=0.033),Variable effect (p=0.019),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04776,rs119073,6,134041844,CD2AP,Deletion,-,-,0.95,0.67,1.27,0.0263345,Low,0.012,0.163,0.397,0.228,Variable effect (p=0.046),Significant decrease (p=0.009),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04777,rs451531,5,192590910,CLU,Insertion,-,-,1.13,0.85,1.38,0.01263985,High,0.301,0.229,0.254,0.016,Significant increase (p=0.043),Variable effect (p=0.043),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP04778,rs557511,15,190828309,PTK2B,SNP (A/T),(A/,A,0.64,0.38,0.88,0.03580788,Moderate,0.021,0.183,0.276,0.32,Mild decrease (p=0.014),Mild decrease (p=0.035),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04779,rs143315,5,216245611,TREM2,Insertion,-,-,1.66,1.38,2.05,0.03948637,High,0.054,0.142,0.208,0.396,Significant decrease (p=0.035),Mild decrease (p=0.021),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP04780,rs406107,14,101195881,PSEN2,SNP (A/T),(A/,A,1.01,0.68,1.35,0.00206769,Moderate,0.597,0.088,0.054,0.061,Variable effect (p=0.009),Significant decrease (p=0.012),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP04781,rs786797,15,97037094,MS4A6A,SNP (A/T),(A/,A,2.06,1.76,2.45,0.06981571,Moderate,0.054,0.159,0.173,0.414,Significant decrease (p=0.018),Significant increase (p=0.015),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04782,rs276674,16,209037860,CD2AP,SNP (G/T),(G/,G,0.68,0.44,0.95,0.02984616,Protective,0.524,0.174,0.017,0.085,Variable effect (p=0.032),Variable effect (p=0.027),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04783,rs411688,18,240904687,CD2AP,SNP (A/G),(A/,A,1.29,0.95,1.51,0.08494179,Moderate,0.087,0.435,0.25,0.028,Significant decrease (p=0.032),Significant increase (p=0.001),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP04784,rs804433,20,90137393,CR1,SNP (A/G),(A/,A,1.43,1.12,1.73,0.00136501,Moderate,0.245,0.12,0.339,0.096,Mild increase (p=0.028),Variable effect (p=0.049),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04785,rs755401,6,204268975,APP,SNP (A/G),(A/,A,1.11,0.86,1.38,0.01866613,Moderate,0.332,0.26,0.104,0.105,Significant decrease (p=0.004),Mild increase (p=0.023),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04786,rs652531,16,15643360,MS4A6A,SNP (G/T),(G/,G,1.05,0.67,1.25,0.03031534,Moderate,0.368,0.02,0.118,0.294,Significant decrease (p=0.026),Significant increase (p=0.048),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04787,rs706497,1,26680234,PICALM,SNP (C/T),(C/,C,0.71,0.42,1.04,0.01187625,High,0.269,0.135,0.103,0.292,Mild increase (p=0.044),No significant pattern (p=0.014),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP04788,rs980914,5,207595418,PSEN2,SNP (A/C),(A/,A,1.24,0.98,1.64,0.00386021,High,0.193,0.11,0.209,0.288,Significant increase (p=0.047),No significant pattern (p=0.005),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04789,rs339720,8,5324672,CD2AP,SNP (A/C),(A/,A,0.81,0.54,1.15,0.00709333,Moderate,0.126,0.157,0.094,0.422,Mild decrease (p=0.037),Mild decrease (p=0.004),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04790,rs962745,18,163921402,TREM2,SNP (C/G),(C/,C,0.28,0.1,0.48,0.03754401,High,0.079,0.007,0.08,0.634,Mild increase (p=0.022),Significant decrease (p=0.05),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04791,rs397642,3,234083241,APOE,Deletion,-,-,0.93,0.6,1.23,0.04437382,Unknown,0.012,0.696,0.01,0.082,No significant pattern (p=0.025),No significant pattern (p=0.035),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP04792,rs969265,8,152726419,TREM2,SNP (C/G),(C/,C,0.51,0.12,0.84,0.01844728,Low,0.188,0.205,0.345,0.062,Mild decrease (p=0.049),Mild increase (p=0.042),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04793,rs848388,12,219984857,TREM2,SNP (A/T),(A/,A,1.57,1.36,1.9,0.07707206,Low,0.202,0.079,0.15,0.369,Significant decrease (p=0.049),Variable effect (p=0.034),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04794,rs686088,22,90698291,CR1,SNP (G/T),(G/,G,1.83,1.6,2.06,0.0184013,Moderate,0.307,0.068,0.267,0.158,Mild increase (p=0.015),Mild increase (p=0.048),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04795,rs609803,5,104721512,ABCA7,SNP (A/C),(A/,A,1.42,1.17,1.63,0.04685038,High,0.033,0.54,0.047,0.181,Variable effect (p=0.021),Mild increase (p=0.013),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04796,rs617896,6,47566679,CR1,SNP (C/G),(C/,C,0.53,0.22,0.75,0.02344205,Low,0.239,0.274,0.085,0.201,Mild increase (p=0.019),Variable effect (p=0.013),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP04797,rs196586,12,28206852,SORL1,Insertion,-,-,0.86,0.61,1.19,0.001402,Moderate,0.23,0.022,0.079,0.469,Mild increase (p=0.032),Mild increase (p=0.026),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04798,rs309191,18,8706371,PSEN2,SNP (G/T),(G/,G,0.77,0.48,1.06,0.01490079,Unknown,0.094,0.111,0.521,0.074,Mild decrease (p=0.039),Mild decrease (p=0.014),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04799,rs884160,3,197778590,CLU,SNP (C/T),(C/,C,1.88,1.54,2.23,0.12178453,Moderate,0.214,0.262,0.217,0.108,No significant pattern (p=0.043),Variable effect (p=0.036),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04800,rs202009,9,17266471,CD2AP,SNP (A/G),(A/,A,1.29,0.92,1.53,0.00427996,Protective,0.084,0.478,0.224,0.014,Mild decrease (p=0.036),Variable effect (p=0.017),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04801,rs335649,5,47028695,CD2AP,SNP (C/T),(C/,C,0.51,0.14,0.8,0.03293087,Moderate,0.46,0.046,0.147,0.147,Mild increase (p=0.04),Mild increase (p=0.024),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04802,rs744951,8,29263903,TREM2,SNP (C/G),(C/,C,0.91,0.57,1.22,0.01271429,Moderate,0.021,0.042,0.248,0.489,Significant increase (p=0.029),Variable effect (p=0.041),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04803,rs245719,18,155174902,CR1,SNP (A/G),(A/,A,0.65,0.42,0.9,0.02597126,High,0.043,0.056,0.462,0.239,Variable effect (p=0.026),Significant decrease (p=0.045),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04804,rs981201,11,139888763,MS4A6A,SNP (A/G),(A/,A,1.39,1.17,1.78,0.00792857,Low,0.042,0.479,0.042,0.237,Mild decrease (p=0.021),Variable effect (p=0.008),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04805,rs391989,8,150024986,BIN1,SNP (A/T),(A/,A,0.48,0.26,0.69,0.01129633,Moderate,0.086,0.319,0.174,0.222,Significant increase (p=0.04),No significant pattern (p=0.036),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04806,rs268689,6,56626234,CR1,SNP (A/T),(A/,A,2.62,2.24,2.94,0.00631907,Moderate,0.273,0.215,0.175,0.137,Significant increase (p=0.031),Mild decrease (p=0.001),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP04807,rs636456,13,181450386,EPHA1,SNP (C/G),(C/,C,0.98,0.72,1.28,0.02220882,Moderate,0.245,0.071,0.347,0.137,Variable effect (p=0.035),Variable effect (p=0.021),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04808,rs935154,1,127047319,PSEN2,Deletion,-,-,2.74,2.43,3.01,0.01385858,Moderate,0.091,0.246,0.254,0.209,Mild increase (p=0.01),Significant decrease (p=0.05),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP04809,rs607488,8,172323309,PTK2B,Deletion,-,-,0.79,0.59,1.07,0.00109629,Moderate,0.034,0.569,0.082,0.115,Mild increase (p=0.032),Significant increase (p=0.027),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04810,rs368729,7,50342394,CLU,SNP (C/T),(C/,C,1.73,1.45,1.96,0.015585,High,0.413,0.164,0.127,0.095,Variable effect (p=0.036),Mild decrease (p=0.014),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04811,rs580984,10,25570759,CLU,SNP (C/G),(C/,C,0.84,0.48,1.21,0.00188483,High,0.443,0.07,0.012,0.275,No significant pattern (p=0.014),Significant decrease (p=0.047),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP04812,rs745899,22,220564332,APP,SNP (C/G),(C/,C,1.07,0.81,1.39,0.0614436,High,0.124,0.315,0.089,0.273,Mild increase (p=0.039),Significant decrease (p=0.035),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04813,rs496993,19,133764559,CD2AP,SNP (G/T),(G/,G,1.02,0.71,1.33,0.05182478,Moderate,0.181,0.43,0.14,0.049,Mild decrease (p=0.028),Mild decrease (p=0.028),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04814,rs939562,14,67251407,CD2AP,Insertion,-,-,0.69,0.4,0.9,0.00666889,Unknown,0.033,0.511,0.001,0.256,No significant pattern (p=0.006),No significant pattern (p=0.015),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04815,rs681274,1,164948481,CD2AP,SNP (A/C),(A/,A,1.15,0.75,1.43,0.0516821,High,0.075,0.244,0.409,0.071,No significant pattern (p=0.011),No significant pattern (p=0.03),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04816,rs550010,10,131608333,PICALM,SNP (A/C),(A/,A,0.5,0.17,0.79,0.01383169,Moderate,0.287,0.113,0.146,0.254,Variable effect (p=0.018),Significant decrease (p=0.003),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04817,rs254970,5,145670846,PTK2B,SNP (A/T),(A/,A,0.56,0.26,0.86,0.09380752,Moderate,0.025,0.035,0.629,0.111,Mild decrease (p=0.041),Mild decrease (p=0.043),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04818,rs589661,3,160803494,CLU,Deletion,-,-,0.4,0.1,0.75,0.03452009,Moderate,0.13,0.169,0.151,0.35,Mild decrease (p=0.028),No significant pattern (p=0.02),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04819,rs718723,11,126372651,MS4A6A,SNP (C/G),(C/,C,0.95,0.57,1.31,0.03788251,Moderate,0.064,0.201,0.424,0.111,Significant decrease (p=0.044),No significant pattern (p=0.045),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04820,rs688192,17,17087349,CD33,Deletion,-,-,0.9,0.53,1.2,0.03535983,Low,0.145,0.039,0.131,0.485,Variable effect (p=0.034),Significant increase (p=0.041),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04821,rs117748,22,182590315,TREM2,SNP (A/T),(A/,A,1.1,0.72,1.46,0.02061587,Moderate,0.043,0.192,0.439,0.125,Mild decrease (p=0.04),Variable effect (p=0.03),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04822,rs958993,8,14240573,TREM2,SNP (C/G),(C/,C,1.14,0.83,1.42,0.06056424,Unknown,0.13,0.584,0.075,0.012,No significant pattern (p=0.019),Significant decrease (p=0.028),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04823,rs213118,8,126296471,CLU,Insertion,-,-,0.54,0.21,0.77,0.06657561,Moderate,0.087,0.007,0.653,0.053,Mild increase (p=0.03),No significant pattern (p=0.049),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04824,rs649434,14,165735165,ABCA7,SNP (A/C),(A/,A,0.8,0.56,1.02,0.00644934,Low,0.101,0.162,0.16,0.377,Significant decrease (p=0.04),No significant pattern (p=0.012),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04825,rs707577,14,194070341,APP,Deletion,-,-,0.63,0.39,1.01,0.01414753,Moderate,0.175,0.091,0.012,0.522,Mild increase (p=0.026),Significant increase (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP04826,rs715762,10,158715746,CR1,SNP (A/C),(A/,A,1.61,1.24,1.96,0.01065001,Moderate,0.123,0.478,0.011,0.188,No significant pattern (p=0.013),Significant increase (p=0.002),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04827,rs455932,19,114077716,CD2AP,SNP (C/T),(C/,C,1.13,0.85,1.49,0.02297982,Low,0.068,0.032,0.337,0.363,Variable effect (p=0.006),Significant increase (p=0.044),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04828,rs791532,4,103218849,PICALM,SNP (A/C),(A/,A,1.21,0.83,1.51,0.08936359,Protective,0.082,0.35,0.32,0.047,Mild decrease (p=0.012),No significant pattern (p=0.015),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04829,rs124689,3,89340831,SORL1,SNP (A/C),(A/,A,1.19,0.9,1.54,0.02314527,High,0.188,0.414,0.175,0.023,No significant pattern (p=0.029),Significant decrease (p=0.041),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP04830,rs509313,7,247601916,EPHA1,SNP (C/G),(C/,C,1.56,1.26,1.9,0.07500334,High,0.135,0.128,0.434,0.103,Mild decrease (p=0.029),No significant pattern (p=0.009),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04831,rs553370,10,55974332,CLU,SNP (A/T),(A/,A,0.88,0.66,1.15,0.00068869,Low,0.072,0.601,0.055,0.071,Significant increase (p=0.025),No significant pattern (p=0.008),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04832,rs400409,5,16027508,APOE,Insertion,-,-,2.52,2.31,2.92,0.03307529,Protective,0.262,0.343,0.004,0.191,Significant increase (p=0.002),Mild increase (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04833,rs230178,18,199901429,CD2AP,SNP (G/T),(G/,G,1.54,1.26,1.94,0.01414211,High,0.096,0.053,0.512,0.139,Mild increase (p=0.017),No significant pattern (p=0.038),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP04834,rs532869,12,144206206,TREM2,Insertion,-,-,0.91,0.57,1.26,0.00025318,High,0.101,0.6,0.061,0.038,Significant decrease (p=0.039),No significant pattern (p=0.031),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04835,rs607897,2,93731371,ABCA7,Deletion,-,-,1.52,1.24,1.91,0.02882986,Moderate,0.198,0.353,0.162,0.086,Mild increase (p=0.029),Mild decrease (p=0.037),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04836,rs665046,9,49372791,MS4A6A,Deletion,-,-,1.67,1.38,1.87,0.01391219,High,0.194,0.145,0.012,0.449,No significant pattern (p=0.027),Significant increase (p=0.003),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04837,rs688270,22,227601536,PTK2B,SNP (C/T),(C/,C,1.17,0.86,1.47,0.01052343,Low,0.496,0.033,0.075,0.195,Significant increase (p=0.02),Mild increase (p=0.043),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04838,rs715972,15,140789773,PSEN2,Deletion,-,-,1.12,0.9,1.44,0.01850287,High,0.454,0.042,0.174,0.129,Mild decrease (p=0.007),Significant increase (p=0.006),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04839,rs737251,18,170611880,APOE,SNP (G/T),(G/,G,2.07,1.67,2.31,0.00342647,High,0.155,0.18,0.095,0.37,Mild decrease (p=0.022),Variable effect (p=0.042),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP04840,rs632467,11,134100955,EPHA1,SNP (C/T),(C/,C,1.47,1.14,1.86,0.01444248,High,0.164,0.25,0.048,0.338,Significant increase (p=0.017),No significant pattern (p=0.038),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04841,rs799293,20,211602716,TREM2,Insertion,-,-,1.25,0.99,1.45,0.05752695,Unknown,0.359,0.07,0.008,0.363,Significant decrease (p=0.039),Significant decrease (p=0.033),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04842,rs727153,12,159134432,CD33,SNP (G/T),(G/,G,1.95,1.75,2.18,0.02679323,High,0.486,0.112,0.166,0.036,Significant increase (p=0.038),Mild increase (p=0.018),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP04843,rs989918,8,18579965,PSEN2,SNP (C/T),(C/,C,0.19,0.1,0.55,0.04653945,High,0.05,0.235,0.454,0.061,No significant pattern (p=0.008),Significant increase (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04844,rs603386,5,161712164,CR1,SNP (A/T),(A/,A,1.45,1.23,1.67,0.00965394,Moderate,0.225,0.368,0.198,0.009,Mild decrease (p=0.005),Significant decrease (p=0.019),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP04845,rs904110,6,16014731,CLU,Deletion,-,-,1.22,0.98,1.57,0.0091053,Moderate,0.078,0.559,0.053,0.11,Mild increase (p=0.007),Significant decrease (p=0.037),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04846,rs762325,1,114833502,MS4A6A,SNP (A/G),(A/,A,3.02,2.67,3.3,0.01683499,Low,0.028,0.244,0.262,0.266,Variable effect (p=0.021),Significant decrease (p=0.027),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04847,rs118223,10,97269937,CR1,SNP (C/T),(C/,C,0.86,0.47,1.2,0.04275992,Moderate,0.002,0.073,0.658,0.067,Significant decrease (p=0.043),Mild increase (p=0.016),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04848,rs152884,8,95918001,CD2AP,Deletion,-,-,0.44,0.22,0.69,0.00020027,Low,0.679,0.04,0.078,0.003,No significant pattern (p=0.025),Mild decrease (p=0.02),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04849,rs640196,20,190337117,TREM2,Insertion,-,-,0.86,0.58,1.23,0.10123111,Moderate,0.298,0.008,0.123,0.372,No significant pattern (p=0.023),Significant decrease (p=0.033),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP04850,rs532958,8,19740139,APP,SNP (A/C),(A/,A,1.04,0.69,1.34,0.02123601,Moderate,0.004,0.008,0.407,0.381,Variable effect (p=0.047),No significant pattern (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP04851,rs217053,15,166333613,ABCA7,Deletion,-,-,1.06,0.83,1.3,0.00451126,Low,0.116,0.202,0.438,0.044,Mild decrease (p=0.049),Mild decrease (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP04852,rs997329,11,160633912,APP,Insertion,-,-,0.65,0.33,0.98,0.02332172,High,0.33,0.077,0.344,0.049,Significant decrease (p=0.031),Significant increase (p=0.015),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04853,rs717790,5,78854881,SORL1,SNP (C/T),(C/,C,1.36,1.12,1.63,0.00223646,Protective,0.07,0.099,0.411,0.22,Significant decrease (p=0.009),Significant increase (p=0.044),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04854,rs226750,6,54571458,APOE,SNP (C/T),(C/,C,0.83,0.45,1.11,0.0492781,High,0.054,0.154,0.393,0.199,Variable effect (p=0.03),Significant increase (p=0.03),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04855,rs341360,16,51485713,PSEN2,SNP (G/T),(G/,G,0.79,0.55,1.06,0.01268758,High,0.369,0.275,0.075,0.081,Mild increase (p=0.048),Significant increase (p=0.013),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04856,rs931484,12,201601979,PTK2B,SNP (G/T),(G/,G,0.74,0.47,1.13,0.03429154,Low,0.639,0.124,0.019,0.018,Significant decrease (p=0.007),Significant increase (p=0.004),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04857,rs557913,21,92430240,BIN1,Insertion,-,-,1.1,0.89,1.47,0.0383365,High,0.064,0.566,0.043,0.127,Mild increase (p=0.049),Variable effect (p=0.024),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04858,rs663786,16,3008821,TREM2,SNP (A/C),(A/,A,0.87,0.58,1.21,0.01310742,Low,0.466,0.174,0.056,0.104,Mild increase (p=0.006),Variable effect (p=0.005),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04859,rs626713,19,182361452,MS4A6A,SNP (A/G),(A/,A,0.72,0.51,1.05,0.02433091,Low,0.114,0.054,0.226,0.406,No significant pattern (p=0.028),Mild increase (p=0.032),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04860,rs890152,14,71453380,PTK2B,SNP (G/T),(G/,G,0.94,0.68,1.2,0.05150933,High,0.122,0.144,0.124,0.411,No significant pattern (p=0.019),Mild increase (p=0.04),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP04861,rs938971,5,7759233,PICALM,SNP (G/T),(G/,G,1.78,1.41,2.17,0.0179503,High,0.224,0.467,0.016,0.094,No significant pattern (p=0.033),Significant increase (p=0.014),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04862,rs802817,15,183701999,CR1,SNP (C/G),(C/,C,1.34,0.98,1.73,0.05628835,Protective,0.377,0.213,0.068,0.142,Variable effect (p=0.002),Variable effect (p=0.003),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04863,rs324009,5,57324187,BIN1,Insertion,-,-,1.29,0.92,1.65,0.03336282,Moderate,0.578,0.098,0.029,0.095,Significant increase (p=0.004),No significant pattern (p=0.032),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04864,rs352536,10,141385917,CLU,SNP (A/C),(A/,A,0.76,0.51,1.01,0.16375631,High,0.265,0.173,0.143,0.219,No significant pattern (p=0.021),Mild decrease (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04865,rs345178,14,209099684,BIN1,Deletion,-,-,0.77,0.51,1.13,0.0004658,Moderate,0.239,0.134,0.243,0.184,Mild increase (p=0.048),No significant pattern (p=0.049),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04866,rs378920,3,58165716,APOE,SNP (A/T),(A/,A,0.83,0.46,1.18,0.00078158,Low,0.13,0.441,0.119,0.111,Significant decrease (p=0.042),Significant increase (p=0.022),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP04867,rs319537,20,5446886,PTK2B,SNP (A/G),(A/,A,1.08,0.86,1.44,0.00324637,Protective,0.121,0.067,0.586,0.026,Significant decrease (p=0.049),Variable effect (p=0.03),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04868,rs914465,14,208848587,EPHA1,Deletion,-,-,0.84,0.44,1.15,0.00951262,Moderate,0.248,0.063,0.068,0.421,Variable effect (p=0.043),Variable effect (p=0.003),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04869,rs378419,22,99483423,CLU,SNP (C/G),(C/,C,0.57,0.37,0.78,0.01546956,Protective,0.143,0.077,0.428,0.152,Significant increase (p=0.013),Significant decrease (p=0.041),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04870,rs679583,7,21077007,BIN1,SNP (A/G),(A/,A,0.77,0.53,1.07,0.0257238,High,0.044,0.1,0.65,0.006,Variable effect (p=0.041),Significant decrease (p=0.003),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04871,rs531450,18,15007231,APOE,SNP (A/C),(A/,A,0.88,0.67,1.19,0.00468036,Low,0.293,0.24,0.255,0.012,Significant decrease (p=0.049),Mild increase (p=0.029),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04872,rs876862,5,53887258,TREM2,SNP (A/C),(A/,A,1.04,0.81,1.35,0.00521724,Low,0.135,0.251,0.144,0.271,Mild decrease (p=0.044),Significant decrease (p=0.025),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04873,rs581287,16,173410948,PSEN2,SNP (C/T),(C/,C,1.47,1.16,1.84,0.10242256,Low,0.013,0.11,0.431,0.246,Mild increase (p=0.002),Mild increase (p=0.045),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04874,rs239383,15,221898839,PSEN2,Insertion,-,-,1.39,1.12,1.75,0.03496017,Moderate,0.081,0.073,0.436,0.21,No significant pattern (p=0.015),Mild decrease (p=0.037),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04875,rs592178,6,19362784,BIN1,SNP (A/T),(A/,A,2.16,1.89,2.39,0.02588258,Moderate,0.251,0.172,0.135,0.242,Significant increase (p=0.014),Mild decrease (p=0.009),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP04876,rs209385,6,18144672,CR1,Insertion,-,-,1.41,1.15,1.72,0.03809056,High,0.41,0.108,0.128,0.154,Variable effect (p=0.009),Variable effect (p=0.03),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04877,rs125542,10,130355895,MS4A6A,Insertion,-,-,1.21,0.98,1.55,0.07105871,High,0.238,0.029,0.467,0.066,No significant pattern (p=0.005),Mild increase (p=0.044),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP04878,rs977003,12,185041054,PICALM,SNP (A/T),(A/,A,0.74,0.49,1.09,0.0642405,Low,0.196,0.275,0.216,0.113,Mild increase (p=0.013),Significant increase (p=0.008),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04879,rs255004,18,109782236,CR1,SNP (G/T),(G/,G,0.73,0.47,1.0,0.03031327,Moderate,0.012,0.19,0.203,0.395,Mild increase (p=0.013),Significant increase (p=0.001),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04880,rs616912,15,221803277,PSEN2,SNP (G/T),(G/,G,2.06,1.67,2.27,0.0152154,High,0.229,0.204,0.257,0.11,Mild decrease (p=0.047),Variable effect (p=0.038),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04881,rs166006,3,19012063,ABCA7,Insertion,-,-,1.78,1.45,2.07,0.03346046,Moderate,0.083,0.002,0.103,0.612,Mild decrease (p=0.044),Variable effect (p=0.026),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04882,rs761723,6,234253379,ABCA7,SNP (A/C),(A/,A,1.28,1.03,1.63,0.01237044,High,0.087,0.141,0.15,0.422,Variable effect (p=0.028),Variable effect (p=0.008),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP04883,rs808568,14,133478037,APOE,SNP (A/G),(A/,A,1.1,0.86,1.4,0.05377203,Low,0.196,0.346,0.205,0.053,Mild decrease (p=0.032),Variable effect (p=0.032),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04884,rs940232,15,176931432,CD2AP,Insertion,-,-,0.56,0.33,0.89,0.03188758,Moderate,0.01,0.625,0.071,0.094,No significant pattern (p=0.02),Mild decrease (p=0.009),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04885,rs969260,4,211750224,CD33,Deletion,-,-,1.01,0.68,1.37,0.0100519,Moderate,0.111,0.148,0.436,0.104,Significant decrease (p=0.032),Significant increase (p=0.047),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04886,rs467906,22,240265096,ABCA7,SNP (A/G),(A/,A,0.6,0.22,0.83,0.14408364,Protective,0.026,0.08,0.605,0.09,Mild decrease (p=0.034),No significant pattern (p=0.014),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04887,rs132458,9,173278284,CD33,SNP (G/T),(G/,G,0.59,0.21,0.84,0.02271793,Moderate,0.013,0.177,0.493,0.117,Mild increase (p=0.027),Variable effect (p=0.042),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04888,rs512069,16,136425876,CR1,SNP (C/T),(C/,C,0.86,0.63,1.17,0.00209238,Moderate,0.058,0.351,0.302,0.089,Significant decrease (p=0.028),Significant increase (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP04889,rs481001,15,224666327,ABCA7,SNP (A/T),(A/,A,1.99,1.67,2.36,0.00852217,Moderate,0.304,0.347,0.139,0.009,Mild decrease (p=0.012),Significant decrease (p=0.048),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP04890,rs653227,20,89672385,CD33,SNP (A/G),(A/,A,1.06,0.73,1.45,0.03856149,Protective,0.221,0.237,0.015,0.327,Mild increase (p=0.019),Significant decrease (p=0.005),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP04891,rs228900,3,16828799,BIN1,SNP (A/C),(A/,A,0.84,0.62,1.14,0.08232546,Moderate,0.255,0.236,0.037,0.272,Significant increase (p=0.049),Significant increase (p=0.024),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04892,rs196041,13,179203897,ABCA7,SNP (A/T),(A/,A,0.94,0.64,1.28,0.00805758,Moderate,0.244,0.449,0.043,0.064,No significant pattern (p=0.019),Mild increase (p=0.028),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04893,rs149812,4,105555980,APP,Insertion,-,-,0.83,0.48,1.19,0.08929867,Moderate,0.13,0.136,0.047,0.488,Significant increase (p=0.032),Mild increase (p=0.006),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP04894,rs916443,11,180360788,EPHA1,SNP (G/T),(G/,G,0.92,0.67,1.27,0.03334696,Protective,0.156,0.0,0.43,0.214,Mild increase (p=0.027),Significant decrease (p=0.008),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04895,rs173618,6,35541376,CD33,Insertion,-,-,1.63,1.37,1.88,0.04341293,High,0.116,0.225,0.103,0.357,Mild increase (p=0.027),Mild increase (p=0.023),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04896,rs601429,10,75218732,SORL1,SNP (C/G),(C/,C,0.67,0.45,0.91,0.12750457,High,0.081,0.066,0.291,0.362,Significant increase (p=0.046),Mild increase (p=0.02),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04897,rs915907,21,241134310,PICALM,SNP (A/G),(A/,A,1.9,1.65,2.23,0.0107961,Protective,0.083,0.34,0.186,0.192,No significant pattern (p=0.038),No significant pattern (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04898,rs140440,7,188316423,PTK2B,SNP (C/T),(C/,C,0.77,0.57,1.17,0.03572422,High,0.201,0.436,0.137,0.026,Mild decrease (p=0.042),Significant increase (p=0.016),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04899,rs108439,20,107077589,CR1,SNP (C/T),(C/,C,1.77,1.54,2.15,0.01169535,High,0.117,0.431,0.081,0.171,No significant pattern (p=0.046),Variable effect (p=0.028),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP04900,rs517005,15,156119336,APP,SNP (G/T),(G/,G,0.9,0.58,1.25,0.00600143,High,0.099,0.135,0.235,0.331,Variable effect (p=0.015),Variable effect (p=0.01),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04901,rs461137,12,76866497,BIN1,Deletion,-,-,0.87,0.57,1.23,0.00477201,Protective,0.668,0.027,0.072,0.033,Mild decrease (p=0.032),Significant decrease (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP04902,rs299427,4,217193914,BIN1,SNP (G/T),(G/,G,2.08,1.87,2.44,0.09247287,High,0.021,0.382,0.102,0.295,Variable effect (p=0.03),Mild decrease (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04903,rs582088,14,49044656,SORL1,SNP (C/T),(C/,C,2.28,1.95,2.61,0.03497999,Moderate,0.034,0.234,0.204,0.327,Variable effect (p=0.003),Significant decrease (p=0.037),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04904,rs799402,15,78591954,TREM2,SNP (C/G),(C/,C,0.69,0.32,0.99,0.04790052,Unknown,0.121,0.354,0.019,0.306,Variable effect (p=0.036),Significant increase (p=0.009),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04905,rs205197,11,248692719,MS4A6A,Insertion,-,-,1.35,1.12,1.67,0.00459632,Protective,0.05,0.216,0.345,0.189,Significant decrease (p=0.002),Significant decrease (p=0.013),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04906,rs711257,19,158712415,SORL1,Deletion,-,-,1.13,0.75,1.47,0.02370349,Moderate,0.09,0.247,0.063,0.399,No significant pattern (p=0.03),Mild decrease (p=0.022),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04907,rs904983,12,186272769,CD33,Deletion,-,-,0.62,0.26,0.91,0.01129154,High,0.05,0.308,0.314,0.127,Mild decrease (p=0.042),Variable effect (p=0.024),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04908,rs434665,6,14879334,BIN1,SNP (A/C),(A/,A,1.07,0.76,1.42,0.00559816,Moderate,0.063,0.433,0.239,0.065,Significant increase (p=0.04),Mild decrease (p=0.042),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04909,rs664817,7,109865414,SORL1,SNP (A/C),(A/,A,0.93,0.68,1.33,0.10606875,High,0.019,0.138,0.551,0.092,Mild increase (p=0.034),Significant decrease (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04910,rs187501,16,134990662,PICALM,SNP (A/T),(A/,A,1.04,0.8,1.37,0.01602764,Moderate,0.418,0.343,0.011,0.028,Significant increase (p=0.012),Mild increase (p=0.033),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04911,rs141406,15,44068630,CR1,SNP (C/G),(C/,C,1.72,1.34,2.05,0.0865283,High,0.042,0.099,0.146,0.512,Significant increase (p=0.031),No significant pattern (p=0.043),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP04912,rs365620,17,57966660,TREM2,SNP (A/G),(A/,A,1.08,0.71,1.34,0.01300972,Moderate,0.077,0.188,0.355,0.181,Significant increase (p=0.048),Variable effect (p=0.003),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04913,rs724935,11,42238205,CD33,Deletion,-,-,1.19,0.96,1.5,0.0442447,Moderate,0.032,0.293,0.302,0.172,Significant decrease (p=0.031),Significant decrease (p=0.029),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04914,rs163757,7,134374064,APOE,SNP (C/G),(C/,C,1.74,1.5,2.1,0.00079968,High,0.209,0.291,0.191,0.11,Mild increase (p=0.027),Significant increase (p=0.005),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP04915,rs575263,5,180367509,EPHA1,SNP (C/G),(C/,C,1.05,0.66,1.28,0.01376755,Moderate,0.434,0.148,0.158,0.06,Mild increase (p=0.045),No significant pattern (p=0.05),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04916,rs906477,12,28569773,CD33,Deletion,-,-,0.79,0.47,1.12,0.1137764,Moderate,0.252,0.519,0.019,0.01,No significant pattern (p=0.008),Significant decrease (p=0.043),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04917,rs687754,14,158309609,MS4A6A,SNP (C/T),(C/,C,0.77,0.4,0.99,0.16683623,Low,0.183,0.023,0.358,0.236,Variable effect (p=0.01),No significant pattern (p=0.012),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04918,rs368787,15,178261280,APOE,SNP (C/G),(C/,C,1.19,0.94,1.55,0.01132165,Moderate,0.419,0.059,0.117,0.205,Significant increase (p=0.045),Significant increase (p=0.01),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04919,rs531747,11,165031296,APP,SNP (C/T),(C/,C,1.55,1.2,1.76,0.05344696,Low,0.055,0.151,0.321,0.272,Mild decrease (p=0.023),Mild decrease (p=0.021),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP04920,rs746633,10,127024174,EPHA1,SNP (A/T),(A/,A,1.23,0.86,1.46,0.06263725,Protective,0.155,0.458,0.144,0.042,Variable effect (p=0.037),Mild increase (p=0.016),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04921,rs640245,1,178565788,CD33,Insertion,-,-,0.97,0.59,1.21,0.00345232,Low,0.212,0.466,0.092,0.03,Significant decrease (p=0.045),Mild decrease (p=0.001),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP04922,rs374025,2,150934750,CR1,Insertion,-,-,1.15,0.78,1.43,0.10253414,High,0.052,0.231,0.514,0.003,Mild increase (p=0.029),Mild decrease (p=0.023),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP04923,rs637218,16,187574045,PSEN2,SNP (C/G),(C/,C,1.67,1.28,1.91,0.00837924,Protective,0.166,0.208,0.376,0.05,Mild increase (p=0.039),Mild decrease (p=0.02),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04924,rs986011,21,244531029,EPHA1,SNP (A/G),(A/,A,0.84,0.59,1.2,0.03048213,Low,0.07,0.27,0.325,0.135,Mild increase (p=0.05),Variable effect (p=0.021),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04925,rs241818,11,4021186,TREM2,SNP (C/T),(C/,C,0.75,0.41,0.97,0.13869383,High,0.08,0.128,0.406,0.186,No significant pattern (p=0.029),Mild increase (p=0.036),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04926,rs227014,18,73659110,MS4A6A,Insertion,-,-,1.81,1.58,2.02,0.00899379,High,0.04,0.363,0.255,0.142,Variable effect (p=0.021),Variable effect (p=0.025),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04927,rs196089,14,231297248,EPHA1,Insertion,-,-,0.62,0.23,1.01,0.01901261,High,0.031,0.212,0.542,0.014,Mild increase (p=0.039),Variable effect (p=0.016),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04928,rs661587,12,16183845,PSEN2,SNP (C/T),(C/,C,1.45,1.14,1.77,0.05036846,Low,0.171,0.02,0.285,0.325,Significant decrease (p=0.025),Significant increase (p=0.027),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04929,rs631396,10,122665244,APOE,SNP (A/G),(A/,A,1.76,1.39,2.0,0.04001596,Low,0.256,0.032,0.123,0.389,Significant decrease (p=0.015),Significant decrease (p=0.017),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04930,rs268851,15,197692610,ABCA7,SNP (A/T),(A/,A,0.55,0.23,0.8,0.00510618,Moderate,0.177,0.086,0.199,0.338,Mild decrease (p=0.021),No significant pattern (p=0.015),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP04931,rs370352,19,12379436,CD2AP,SNP (A/C),(A/,A,1.35,1.02,1.6,0.0089667,Moderate,0.328,0.227,0.098,0.147,Mild decrease (p=0.024),Significant decrease (p=0.004),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP04932,rs718682,22,161840841,TREM2,Insertion,-,-,1.01,0.61,1.34,0.00616515,Low,0.213,0.529,0.038,0.02,Mild increase (p=0.029),Variable effect (p=0.022),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP04933,rs836273,4,97562325,CD33,Deletion,-,-,1.01,0.78,1.36,0.02446028,Moderate,0.278,0.118,0.271,0.134,Mild increase (p=0.037),Variable effect (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04934,rs528112,11,191580362,MS4A6A,Deletion,-,-,0.89,0.6,1.28,0.05638032,High,0.131,0.27,0.157,0.242,Mild increase (p=0.035),Significant decrease (p=0.007),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP04935,rs956369,21,248520768,CD33,SNP (C/G),(C/,C,1.46,1.06,1.67,0.00536299,High,0.206,0.052,0.374,0.168,Mild decrease (p=0.001),Variable effect (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP04936,rs665322,15,85282444,CD2AP,Insertion,-,-,2.28,1.97,2.67,0.02824875,High,0.376,0.114,0.037,0.273,Variable effect (p=0.029),Mild decrease (p=0.043),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04937,rs369011,16,78228981,PSEN2,SNP (A/C),(A/,A,0.7,0.41,0.91,0.05362133,Moderate,0.081,0.396,0.322,0.001,No significant pattern (p=0.008),No significant pattern (p=0.025),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04938,rs998258,19,115139616,PICALM,Deletion,-,-,0.85,0.5,1.21,0.00499705,Low,0.043,0.38,0.303,0.073,Significant increase (p=0.03),Variable effect (p=0.006),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04939,rs823653,11,13178921,TREM2,Insertion,-,-,3.69,3.42,3.94,0.01193004,High,0.016,0.442,0.137,0.206,Mild increase (p=0.015),Mild increase (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04940,rs310919,2,77848326,CD33,SNP (C/T),(C/,C,1.39,1.19,1.72,0.09782887,Protective,0.076,0.416,0.027,0.281,Mild increase (p=0.015),Significant increase (p=0.009),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04941,rs108205,20,185002063,CD2AP,Insertion,-,-,0.96,0.63,1.31,0.00675739,Low,0.072,0.116,0.182,0.43,Significant decrease (p=0.012),Significant increase (p=0.028),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04942,rs307852,3,194068138,PSEN2,SNP (A/T),(A/,A,0.54,0.21,0.83,0.04506056,Moderate,0.298,0.074,0.26,0.168,Significant increase (p=0.025),No significant pattern (p=0.011),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04943,rs714275,11,123611898,TREM2,SNP (A/C),(A/,A,2.4,2.15,2.66,0.01765521,Moderate,0.017,0.353,0.159,0.271,Significant decrease (p=0.017),Significant increase (p=0.047),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04944,rs477135,18,67085167,TREM2,SNP (A/C),(A/,A,1.06,0.68,1.33,0.0452696,High,0.226,0.121,0.291,0.161,Variable effect (p=0.017),Mild increase (p=0.023),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04945,rs177476,9,124561341,PSEN2,SNP (A/C),(A/,A,0.96,0.57,1.25,0.01430131,Moderate,0.421,0.119,0.005,0.254,Mild increase (p=0.007),Mild increase (p=0.046),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04946,rs283870,10,224543770,PICALM,SNP (C/G),(C/,C,1.26,0.96,1.53,0.13841024,Moderate,0.304,0.261,0.168,0.067,Significant decrease (p=0.029),Variable effect (p=0.001),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP04947,rs356542,7,141146151,APP,Insertion,-,-,1.5,1.29,1.8,0.0386791,High,0.083,0.193,0.061,0.464,Variable effect (p=0.039),Significant decrease (p=0.004),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04948,rs225949,14,33173393,EPHA1,SNP (C/G),(C/,C,1.07,0.71,1.41,0.04495248,Low,0.137,0.452,0.156,0.055,Significant decrease (p=0.04),No significant pattern (p=0.011),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP04949,rs735057,11,161018732,CD2AP,SNP (A/T),(A/,A,1.24,0.98,1.64,0.01754264,Moderate,0.276,0.298,0.061,0.165,No significant pattern (p=0.047),Mild decrease (p=0.025),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04950,rs123987,15,125649119,SORL1,Deletion,-,-,0.42,0.21,0.77,0.00804755,High,0.321,0.16,0.224,0.095,Significant decrease (p=0.012),Significant increase (p=0.044),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04951,rs154148,15,87361847,CR1,SNP (C/T),(C/,C,2.22,1.89,2.43,0.0302658,Low,0.122,0.258,0.196,0.224,Significant decrease (p=0.01),Significant decrease (p=0.044),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04952,rs746131,22,40389207,TREM2,SNP (A/G),(A/,A,0.89,0.55,1.25,0.02648792,Moderate,0.107,0.139,0.392,0.163,Significant decrease (p=0.035),Significant increase (p=0.049),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP04953,rs945986,3,229220269,MS4A6A,SNP (G/T),(G/,G,1.61,1.23,2.0,0.01011667,High,0.238,0.211,0.121,0.229,Mild decrease (p=0.006),Mild decrease (p=0.03),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04954,rs897669,22,3293902,TREM2,SNP (A/G),(A/,A,0.74,0.49,0.95,0.02449131,Moderate,0.075,0.571,0.091,0.063,No significant pattern (p=0.031),Mild decrease (p=0.023),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP04955,rs965201,1,15995425,SORL1,SNP (A/G),(A/,A,0.94,0.62,1.14,0.03033485,Low,0.258,0.424,0.0,0.118,Significant decrease (p=0.003),No significant pattern (p=0.031),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP04956,rs184170,3,11719073,BIN1,SNP (A/G),(A/,A,0.71,0.34,1.02,0.01892355,Moderate,0.159,0.033,0.265,0.343,Mild decrease (p=0.01),Significant decrease (p=0.031),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP04957,rs398035,11,154275786,EPHA1,Insertion,-,-,1.06,0.74,1.33,0.01710454,Low,0.455,0.026,0.193,0.125,No significant pattern (p=0.044),Variable effect (p=0.032),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP04958,rs449414,17,134839578,APOE,SNP (C/T),(C/,C,0.74,0.35,1.03,0.00655266,High,0.258,0.275,0.019,0.249,Mild increase (p=0.001),Variable effect (p=0.012),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04959,rs234362,16,96923015,CD2AP,SNP (C/T),(C/,C,1.16,0.86,1.53,0.00218174,High,0.157,0.49,0.037,0.116,Variable effect (p=0.018),Mild increase (p=0.021),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04960,rs576672,9,218717632,CLU,Insertion,-,-,2.14,1.75,2.46,0.02371892,Moderate,0.061,0.022,0.136,0.581,Significant increase (p=0.031),Variable effect (p=0.025),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04961,rs499895,16,22521943,APOE,Insertion,-,-,1.78,1.45,2.1,0.14025015,Unknown,0.194,0.441,0.125,0.04,Significant decrease (p=0.024),Variable effect (p=0.03),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04962,rs142953,18,147969737,EPHA1,SNP (A/C),(A/,A,0.86,0.57,1.24,0.0589716,Protective,0.183,0.233,0.182,0.202,Variable effect (p=0.019),Mild decrease (p=0.03),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP04963,rs753887,5,168564270,BIN1,SNP (C/T),(C/,C,1.26,0.94,1.5,0.03236992,Low,0.54,0.001,0.242,0.017,Significant decrease (p=0.043),No significant pattern (p=0.049),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP04964,rs489016,10,196199605,PSEN2,SNP (A/G),(A/,A,1.71,1.47,2.01,0.08050824,Low,0.108,0.079,0.277,0.337,Significant decrease (p=0.004),Significant increase (p=0.004),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP04965,rs357536,15,13147767,EPHA1,SNP (A/T),(A/,A,0.54,0.32,0.77,0.05659429,Moderate,0.135,0.148,0.199,0.317,Mild increase (p=0.044),Variable effect (p=0.045),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP04966,rs851676,13,150726773,CLU,SNP (C/G),(C/,C,0.44,0.18,0.68,0.17458325,Low,0.039,0.02,0.272,0.468,Significant increase (p=0.002),No significant pattern (p=0.023),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP04967,rs228591,9,248692669,TREM2,SNP (G/T),(G/,G,1.44,1.07,1.74,0.01760351,Moderate,0.137,0.065,0.047,0.551,Mild decrease (p=0.024),Significant increase (p=0.016),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP04968,rs537688,8,96235947,SORL1,SNP (A/T),(A/,A,1.56,1.32,1.86,0.04396414,Protective,0.14,0.031,0.263,0.366,No significant pattern (p=0.008),Significant decrease (p=0.019),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP04969,rs888046,10,21577412,APP,SNP (G/T),(G/,G,0.69,0.4,1.04,0.01196598,High,0.077,0.501,0.214,0.008,Variable effect (p=0.013),Mild decrease (p=0.019),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP04970,rs832966,19,21714751,CLU,SNP (C/T),(C/,C,1.51,1.27,1.89,0.00848626,Low,0.046,0.015,0.355,0.384,Mild increase (p=0.025),Significant decrease (p=0.019),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04971,rs166602,21,224292720,SORL1,SNP (A/T),(A/,A,0.83,0.44,1.09,0.01224494,High,0.418,0.067,0.077,0.238,Significant decrease (p=0.029),Variable effect (p=0.012),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP04972,rs861977,19,123769072,PTK2B,SNP (C/T),(C/,C,2.24,2.01,2.52,0.01487201,Low,0.161,0.105,0.37,0.164,Mild increase (p=0.048),Mild increase (p=0.012),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04973,rs421562,6,127989408,CD2AP,SNP (A/T),(A/,A,0.88,0.51,1.11,0.01801745,Low,0.082,0.003,0.613,0.102,Significant increase (p=0.004),Mild increase (p=0.014),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP04974,rs862375,15,15602636,CR1,SNP (A/G),(A/,A,1.49,1.22,1.85,0.01923541,Moderate,0.22,0.171,0.195,0.214,No significant pattern (p=0.022),Significant increase (p=0.004),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP04975,rs339693,16,79767573,ABCA7,SNP (G/T),(G/,G,1.16,0.83,1.38,0.07140537,Moderate,0.143,0.297,0.037,0.323,No significant pattern (p=0.023),Mild decrease (p=0.012),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04976,rs998709,19,68730749,APP,SNP (C/G),(C/,C,0.96,0.75,1.16,0.05799677,High,0.141,0.107,0.16,0.393,Significant increase (p=0.035),Mild increase (p=0.007),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP04977,rs904839,21,224725683,CR1,SNP (C/G),(C/,C,0.63,0.38,0.98,0.01025625,Moderate,0.35,0.149,0.02,0.281,Mild decrease (p=0.008),Mild increase (p=0.019),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP04978,rs365040,10,16297423,EPHA1,SNP (A/C),(A/,A,2.63,2.26,3.02,0.00581035,High,0.087,0.445,0.266,0.003,Mild decrease (p=0.035),Variable effect (p=0.026),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP04979,rs933721,2,158805359,MS4A6A,SNP (A/G),(A/,A,1.21,0.97,1.54,0.02268047,Moderate,0.172,0.368,0.028,0.233,Significant increase (p=0.039),Variable effect (p=0.004),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04980,rs734551,9,1310998,EPHA1,SNP (A/T),(A/,A,1.66,1.28,2.01,0.02940472,Protective,0.233,0.08,0.399,0.088,Significant increase (p=0.033),Mild decrease (p=0.026),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04981,rs131557,3,29204821,MS4A6A,SNP (A/G),(A/,A,1.38,1.09,1.58,0.00463684,Moderate,0.192,0.005,0.511,0.092,Mild increase (p=0.026),Variable effect (p=0.04),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP04982,rs706340,2,29700022,APOE,SNP (C/T),(C/,C,1.78,1.39,2.12,0.05920651,Moderate,0.1,0.481,0.083,0.136,No significant pattern (p=0.008),No significant pattern (p=0.028),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04983,rs536669,12,226681472,CLU,SNP (A/G),(A/,A,0.98,0.66,1.33,0.02752611,Unknown,0.0,0.017,0.417,0.366,No significant pattern (p=0.034),No significant pattern (p=0.045),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP04984,rs205101,20,180273649,MS4A6A,Deletion,-,-,1.48,1.21,1.82,0.01129123,Moderate,0.05,0.094,0.199,0.458,Variable effect (p=0.019),Mild decrease (p=0.012),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP04985,rs749245,20,134827632,PTK2B,SNP (G/T),(G/,G,1.48,1.09,1.8,0.00847229,High,0.097,0.024,0.444,0.234,No significant pattern (p=0.008),Significant increase (p=0.016),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04986,rs423215,21,130979776,APP,SNP (C/G),(C/,C,1.62,1.28,1.93,0.01467387,High,0.025,0.074,0.379,0.323,Mild increase (p=0.016),No significant pattern (p=0.046),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP04987,rs558210,12,218520926,ABCA7,SNP (A/G),(A/,A,0.67,0.42,1.04,0.0452349,Low,0.485,0.062,0.195,0.058,No significant pattern (p=0.021),Significant increase (p=0.015),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04988,rs939542,4,65453944,MS4A6A,SNP (A/C),(A/,A,1.71,1.47,2.0,0.04924675,Moderate,0.091,0.298,0.367,0.044,No significant pattern (p=0.048),Significant increase (p=0.003),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP04989,rs237866,17,7215407,CR1,SNP (C/T),(C/,C,1.55,1.26,1.82,0.04241736,Moderate,0.324,0.015,0.293,0.167,Variable effect (p=0.006),Significant increase (p=0.019),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP04990,rs221716,12,211372624,PTK2B,Deletion,-,-,1.79,1.46,2.04,0.12898258,Moderate,0.096,0.153,0.392,0.159,Significant increase (p=0.014),Variable effect (p=0.022),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP04991,rs584991,20,31790864,CLU,SNP (A/G),(A/,A,2.0,1.74,2.32,0.03705474,Moderate,0.061,0.003,0.699,0.036,Significant increase (p=0.024),Mild increase (p=0.022),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP04992,rs117315,10,77823485,CLU,SNP (A/G),(A/,A,1.04,0.82,1.4,0.00493887,High,0.065,0.506,0.227,0.002,Significant increase (p=0.019),Mild decrease (p=0.037),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP04993,rs565897,18,18281829,CLU,SNP (C/T),(C/,C,0.78,0.54,1.1,0.04146297,Low,0.342,0.013,0.115,0.329,Mild decrease (p=0.041),Significant decrease (p=0.002),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP04994,rs305871,17,220433676,TREM2,SNP (A/G),(A/,A,0.75,0.35,0.95,0.0056113,Moderate,0.066,0.128,0.509,0.097,Mild increase (p=0.023),Variable effect (p=0.003),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP04995,rs517233,15,22918520,PTK2B,Deletion,-,-,0.55,0.27,0.8,0.00545703,Moderate,0.009,0.173,0.085,0.532,No significant pattern (p=0.049),Significant decrease (p=0.017),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP04996,rs381298,17,120956461,APOE,SNP (G/T),(G/,G,0.69,0.34,1.01,0.02210939,Protective,0.23,0.086,0.229,0.255,Variable effect (p=0.02),No significant pattern (p=0.031),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP04997,rs338832,9,27096490,CR1,Insertion,-,-,0.99,0.62,1.27,0.00015961,High,0.002,0.151,0.127,0.52,Significant increase (p=0.014),Significant increase (p=0.017),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP04998,rs339977,1,227041683,PSEN2,SNP (A/G),(A/,A,1.98,1.77,2.29,0.0464878,Low,0.05,0.087,0.356,0.307,Significant decrease (p=0.036),Mild increase (p=0.007),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP04999,rs917784,13,215674729,CD33,SNP (A/G),(A/,A,1.75,1.35,2.02,0.00279382,Low,0.007,0.087,0.21,0.496,Significant decrease (p=0.039),Mild decrease (p=0.03),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05000,rs800333,14,228484716,CD33,Insertion,-,-,1.82,1.55,2.04,0.01213565,High,0.562,0.14,0.066,0.032,Significant decrease (p=0.047),Mild increase (p=0.044),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05001,rs129795,8,40076859,BIN1,SNP (A/T),(A/,A,0.87,0.63,1.21,0.02596278,High,0.029,0.273,0.272,0.226,Significant increase (p=0.04),Mild decrease (p=0.014),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05002,rs834987,7,102091934,TREM2,SNP (C/G),(C/,C,0.75,0.52,1.05,0.00278147,Unknown,0.134,0.339,0.242,0.085,Significant decrease (p=0.032),Mild decrease (p=0.006),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05003,rs378382,20,102886011,EPHA1,SNP (G/T),(G/,G,1.36,1.09,1.61,0.01990319,High,0.171,0.047,0.352,0.231,No significant pattern (p=0.047),Mild increase (p=0.031),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05004,rs656027,18,199052444,PICALM,SNP (C/G),(C/,C,0.98,0.63,1.2,0.09280493,High,0.657,0.074,0.045,0.024,Variable effect (p=0.019),Mild decrease (p=0.013),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05005,rs888574,9,232996536,MS4A6A,Insertion,-,-,1.98,1.73,2.3,0.02079718,High,0.137,0.199,0.146,0.318,Mild increase (p=0.027),Mild decrease (p=0.046),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05006,rs274535,13,167035866,MS4A6A,SNP (A/G),(A/,A,1.47,1.27,1.68,0.09352983,Moderate,0.09,0.093,0.324,0.293,Mild decrease (p=0.027),Mild decrease (p=0.002),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05007,rs282594,15,202301280,CLU,SNP (C/G),(C/,C,0.48,0.18,0.86,0.01750554,High,0.227,0.264,0.028,0.281,Mild increase (p=0.023),Variable effect (p=0.037),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05008,rs735294,21,182846313,CR1,Insertion,-,-,0.75,0.54,1.11,0.01329798,Moderate,0.045,0.191,0.132,0.432,Significant increase (p=0.004),No significant pattern (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05009,rs358703,3,209181263,APP,SNP (A/G),(A/,A,0.76,0.5,1.05,0.08240627,Low,0.246,0.088,0.059,0.407,Significant decrease (p=0.041),Mild decrease (p=0.038),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05010,rs925063,21,51043672,ABCA7,SNP (C/G),(C/,C,0.96,0.61,1.35,0.01055865,Low,0.267,0.067,0.385,0.082,Significant increase (p=0.032),No significant pattern (p=0.045),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05011,rs430711,13,107881383,PTK2B,SNP (A/C),(A/,A,1.52,1.13,1.73,0.17166632,Protective,0.138,0.38,0.21,0.072,Variable effect (p=0.047),Mild increase (p=0.006),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05012,rs874739,12,12412227,APOE,SNP (A/G),(A/,A,1.07,0.82,1.4,0.03673413,Moderate,0.013,0.15,0.624,0.014,No significant pattern (p=0.023),Mild decrease (p=0.033),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05013,rs119001,10,20775342,APOE,SNP (A/T),(A/,A,0.62,0.29,0.85,0.02411875,High,0.114,0.117,0.192,0.378,Significant decrease (p=0.016),Significant increase (p=0.026),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP05014,rs894315,6,206315658,PTK2B,SNP (G/T),(G/,G,0.55,0.21,0.87,0.03663099,Protective,0.008,0.076,0.352,0.364,Variable effect (p=0.043),Significant decrease (p=0.034),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05015,rs243453,7,28625419,APOE,Deletion,-,-,0.41,0.1,0.78,0.05487286,High,0.05,0.049,0.423,0.278,Significant increase (p=0.041),Variable effect (p=0.016),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05016,rs926014,8,204770172,ABCA7,SNP (A/G),(A/,A,1.08,0.8,1.35,0.05683217,Moderate,0.161,0.189,0.273,0.177,No significant pattern (p=0.014),Variable effect (p=0.045),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05017,rs135876,9,85346978,CLU,Deletion,-,-,1.19,0.9,1.49,0.07019333,Low,0.277,0.219,0.118,0.187,Significant decrease (p=0.035),Significant increase (p=0.038),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05018,rs624455,22,44971168,APOE,Deletion,-,-,0.56,0.16,0.81,0.06192356,Moderate,0.065,0.437,0.227,0.071,Significant increase (p=0.017),Significant decrease (p=0.045),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05019,rs233291,5,127540160,TREM2,SNP (A/T),(A/,A,0.6,0.22,0.9,0.00106442,Moderate,0.396,0.104,0.045,0.255,Significant increase (p=0.042),Mild increase (p=0.047),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05020,rs640182,15,37439546,MS4A6A,SNP (A/T),(A/,A,1.68,1.36,2.05,0.02694078,Moderate,0.075,0.331,0.134,0.261,Variable effect (p=0.012),No significant pattern (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05021,rs662425,14,217258375,ABCA7,SNP (A/C),(A/,A,0.59,0.28,0.83,0.02376632,Moderate,0.405,0.062,0.112,0.221,Variable effect (p=0.036),Variable effect (p=0.021),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05022,rs216060,4,62487911,TREM2,Insertion,-,-,2.89,2.57,3.26,0.01999929,Unknown,0.098,0.114,0.564,0.024,Mild decrease (p=0.034),Variable effect (p=0.035),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP05023,rs212423,15,223211475,EPHA1,SNP (C/T),(C/,C,0.91,0.53,1.26,0.03572644,High,0.014,0.042,0.003,0.74,Significant increase (p=0.043),Significant decrease (p=0.004),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05024,rs221316,9,36882606,PTK2B,SNP (A/G),(A/,A,1.22,0.92,1.52,0.001744,High,0.181,0.146,0.472,0.001,Mild increase (p=0.006),Variable effect (p=0.015),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP05025,rs651145,1,189129725,PTK2B,SNP (C/T),(C/,C,1.14,0.8,1.43,0.00680919,Moderate,0.107,0.344,0.052,0.297,Significant increase (p=0.037),Mild increase (p=0.041),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05026,rs821254,3,17265158,APOE,SNP (G/T),(G/,G,1.11,0.8,1.42,0.01184105,High,0.248,0.12,0.391,0.041,Mild increase (p=0.049),Significant increase (p=0.006),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP05027,rs473435,10,135647144,CR1,Insertion,-,-,0.81,0.6,1.16,0.03274027,Unknown,0.186,0.387,0.081,0.145,Mild increase (p=0.047),Variable effect (p=0.002),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP05028,rs925985,20,207482256,CD33,Insertion,-,-,1.17,0.95,1.52,0.00620071,Moderate,0.11,0.487,0.09,0.112,Mild decrease (p=0.016),Mild increase (p=0.026),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05029,rs733589,6,244285135,PICALM,SNP (A/G),(A/,A,1.18,0.8,1.53,0.0108603,High,0.09,0.024,0.543,0.144,Significant decrease (p=0.012),Mild increase (p=0.05),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05030,rs159879,8,215983241,CLU,Insertion,-,-,1.92,1.66,2.24,0.01094545,High,0.51,0.239,0.05,0.001,Variable effect (p=0.003),No significant pattern (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05031,rs985500,6,5095421,CD2AP,Insertion,-,-,1.06,0.71,1.39,0.05026188,Moderate,0.241,0.284,0.125,0.15,Significant increase (p=0.004),Mild decrease (p=0.047),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05032,rs244201,4,106246689,APP,Insertion,-,-,0.55,0.17,0.83,0.13714332,Moderate,0.426,0.035,0.054,0.286,Significant increase (p=0.009),Variable effect (p=0.034),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05033,rs546840,18,155500928,APP,SNP (A/G),(A/,A,0.95,0.72,1.32,0.00723904,Unknown,0.289,0.075,0.022,0.414,Significant decrease (p=0.022),Mild decrease (p=0.046),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP05034,rs699691,4,141628494,SORL1,SNP (A/C),(A/,A,2.44,2.08,2.77,0.00173459,High,0.2,0.352,0.15,0.097,Significant increase (p=0.049),Mild decrease (p=0.013),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05035,rs260918,3,127172236,ABCA7,SNP (A/T),(A/,A,0.65,0.26,0.96,0.04597239,Moderate,0.037,0.644,0.055,0.064,No significant pattern (p=0.023),Mild increase (p=0.039),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP05036,rs527885,2,17465120,BIN1,SNP (C/G),(C/,C,1.68,1.46,1.98,0.00123873,Moderate,0.187,0.196,0.321,0.096,No significant pattern (p=0.009),Significant increase (p=0.004),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05037,rs408303,1,165372837,EPHA1,SNP (A/T),(A/,A,0.56,0.28,0.88,0.10472158,Protective,0.048,0.256,0.367,0.13,Mild decrease (p=0.036),Mild decrease (p=0.014),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05038,rs364186,12,4401742,TREM2,SNP (A/C),(A/,A,1.63,1.39,1.88,0.0619209,Protective,0.041,0.097,0.309,0.352,Mild decrease (p=0.043),No significant pattern (p=0.022),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05039,rs833915,10,241024741,CD2AP,Deletion,-,-,0.95,0.61,1.17,0.04480654,Moderate,0.17,0.238,0.139,0.253,Mild decrease (p=0.036),Mild increase (p=0.02),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05040,rs428404,8,169832519,PSEN2,SNP (G/T),(G/,G,2.64,2.44,2.91,0.06824857,Moderate,0.243,0.422,0.074,0.06,Significant increase (p=0.025),Mild decrease (p=0.015),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05041,rs886111,2,60405263,MS4A6A,SNP (A/T),(A/,A,1.07,0.72,1.39,0.01985297,Moderate,0.222,0.01,0.189,0.379,Mild increase (p=0.015),Mild increase (p=0.024),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05042,rs701353,4,40377015,SORL1,SNP (A/T),(A/,A,0.46,0.15,0.82,0.04158337,Low,0.731,0.01,0.021,0.038,Significant decrease (p=0.023),Variable effect (p=0.027),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05043,rs467263,20,111850814,ABCA7,SNP (A/G),(A/,A,0.28,0.1,0.49,0.00809394,Moderate,0.113,0.069,0.528,0.09,Significant decrease (p=0.026),Significant decrease (p=0.004),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05044,rs233072,13,169998947,MS4A6A,SNP (C/T),(C/,C,1.67,1.32,2.05,0.05848636,Protective,0.259,0.002,0.202,0.336,Significant decrease (p=0.046),Variable effect (p=0.003),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05045,rs320414,18,22217599,SORL1,SNP (C/T),(C/,C,1.54,1.17,1.76,0.06162047,Moderate,0.369,0.234,0.048,0.149,Mild decrease (p=0.048),No significant pattern (p=0.001),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP05046,rs893228,18,218795560,CR1,SNP (A/C),(A/,A,1.55,1.25,1.9,0.13211153,Moderate,0.054,0.241,0.403,0.102,Significant decrease (p=0.033),No significant pattern (p=0.039),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05047,rs900667,15,241972874,MS4A6A,Deletion,-,-,1.69,1.39,1.97,0.06734892,High,0.384,0.205,0.049,0.162,Mild decrease (p=0.004),Significant decrease (p=0.004),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05048,rs347361,18,182194534,PICALM,Deletion,-,-,0.59,0.2,0.87,0.01281488,High,0.206,0.17,0.403,0.021,Variable effect (p=0.01),Significant increase (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05049,rs425257,21,3971424,BIN1,SNP (C/T),(C/,C,0.75,0.49,1.04,0.09532488,Moderate,0.157,0.362,0.105,0.176,Significant increase (p=0.032),No significant pattern (p=0.044),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05050,rs268591,8,151569335,PTK2B,SNP (G/T),(G/,G,1.14,0.75,1.47,0.0091151,Protective,0.383,0.084,0.319,0.014,Significant decrease (p=0.046),Variable effect (p=0.033),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP05051,rs948763,14,240945074,TREM2,SNP (A/C),(A/,A,1.56,1.33,1.88,0.04501937,Moderate,0.153,0.359,0.265,0.023,Significant increase (p=0.04),No significant pattern (p=0.038),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP05052,rs956742,13,111867979,BIN1,SNP (A/C),(A/,A,0.99,0.67,1.28,0.05655859,Low,0.132,0.231,0.031,0.406,No significant pattern (p=0.037),Significant increase (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05053,rs741422,6,237833748,TREM2,SNP (G/T),(G/,G,1.15,0.82,1.44,0.0184679,Moderate,0.027,0.134,0.195,0.444,Mild decrease (p=0.011),No significant pattern (p=0.034),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05054,rs746903,6,112771072,CLU,Deletion,-,-,2.16,1.95,2.45,0.0376683,Protective,0.034,0.348,0.139,0.279,Variable effect (p=0.02),Significant decrease (p=0.008),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05055,rs113238,21,203389764,APP,Insertion,-,-,0.94,0.71,1.22,0.01011252,High,0.452,0.013,0.226,0.108,Variable effect (p=0.04),Mild decrease (p=0.003),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05056,rs592524,19,29214992,PICALM,SNP (A/G),(A/,A,0.89,0.5,1.17,0.0215847,Moderate,0.162,0.007,0.05,0.581,Mild increase (p=0.024),Variable effect (p=0.031),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05057,rs292669,3,9900541,BIN1,SNP (G/T),(G/,G,2.17,1.87,2.56,0.03441782,Low,0.011,0.054,0.128,0.608,Variable effect (p=0.017),No significant pattern (p=0.022),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05058,rs644474,8,108575929,CD33,SNP (C/G),(C/,C,3.19,2.97,3.41,0.15209746,Low,0.241,0.054,0.411,0.094,Significant increase (p=0.015),Mild decrease (p=0.036),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05059,rs230704,8,104140195,CR1,Deletion,-,-,0.84,0.55,1.08,0.00138542,Moderate,0.313,0.179,0.291,0.016,Mild increase (p=0.002),Significant increase (p=0.003),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP05060,rs885350,19,134310004,BIN1,Deletion,-,-,1.38,1.1,1.68,0.00529125,High,0.07,0.277,0.042,0.411,Mild increase (p=0.021),Variable effect (p=0.018),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05061,rs780738,8,104261111,PTK2B,SNP (G/T),(G/,G,0.43,0.2,0.7,0.03536175,Moderate,0.19,0.042,0.419,0.149,No significant pattern (p=0.014),Variable effect (p=0.045),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05062,rs159445,7,168592703,SORL1,SNP (A/C),(A/,A,1.11,0.77,1.39,0.02980975,Low,0.185,0.35,0.124,0.142,Significant decrease (p=0.01),No significant pattern (p=0.032),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05063,rs617503,16,173370941,PTK2B,Insertion,-,-,0.67,0.34,0.92,0.04618819,Unknown,0.126,0.248,0.162,0.264,Mild decrease (p=0.02),Mild increase (p=0.043),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05064,rs990064,5,17713259,PSEN2,SNP (G/T),(G/,G,0.51,0.26,0.84,0.04228633,Low,0.403,0.002,0.381,0.015,Significant increase (p=0.022),Significant increase (p=0.015),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05065,rs706112,4,110806075,CD2AP,SNP (G/T),(G/,G,0.58,0.29,0.98,0.09018321,Protective,0.292,0.224,0.173,0.111,Mild decrease (p=0.015),Significant increase (p=0.02),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05066,rs343473,9,77566201,TREM2,SNP (A/T),(A/,A,0.78,0.49,1.03,0.09961707,Moderate,0.063,0.069,0.53,0.138,Significant decrease (p=0.021),Variable effect (p=0.044),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05067,rs963684,18,182629479,EPHA1,Deletion,-,-,1.04,0.68,1.33,0.03216709,Moderate,0.147,0.199,0.011,0.443,Significant increase (p=0.04),Mild increase (p=0.013),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP05068,rs940003,10,141737132,CR1,SNP (C/T),(C/,C,0.97,0.7,1.19,0.08585574,Moderate,0.263,0.105,0.415,0.016,Significant increase (p=0.027),Significant decrease (p=0.017),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP05069,rs698769,11,30618754,CD2AP,SNP (C/G),(C/,C,1.04,0.7,1.35,0.11157054,High,0.095,0.25,0.129,0.326,Mild increase (p=0.048),Mild increase (p=0.024),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05070,rs843710,6,248236450,BIN1,SNP (A/T),(A/,A,0.68,0.29,0.94,0.00735359,High,0.228,0.223,0.041,0.308,Significant decrease (p=0.032),Variable effect (p=0.007),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05071,rs862477,20,174608584,APP,SNP (G/T),(G/,G,1.02,0.68,1.39,0.04162867,High,0.203,0.4,0.114,0.083,Mild decrease (p=0.015),Mild decrease (p=0.037),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05072,rs884204,10,205518069,EPHA1,SNP (C/T),(C/,C,1.74,1.46,2.01,0.0233656,Protective,0.522,0.055,0.208,0.015,Variable effect (p=0.044),No significant pattern (p=0.023),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05073,rs896582,3,6823009,EPHA1,SNP (A/T),(A/,A,0.62,0.3,0.85,0.00627704,High,0.095,0.087,0.003,0.615,Mild decrease (p=0.009),Variable effect (p=0.032),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05074,rs825462,18,80505216,CD33,Deletion,-,-,2.02,1.74,2.24,0.01198555,Moderate,0.01,0.03,0.613,0.147,Significant decrease (p=0.018),Significant increase (p=0.038),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP05075,rs474815,6,200106616,BIN1,Deletion,-,-,2.39,2.0,2.74,0.00726314,Moderate,0.181,0.365,0.124,0.129,Mild decrease (p=0.033),Mild decrease (p=0.049),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP05076,rs260414,19,65214921,PICALM,Insertion,-,-,0.89,0.6,1.22,0.00691306,Protective,0.067,0.094,0.027,0.612,Mild decrease (p=0.046),Mild decrease (p=0.023),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05077,rs379622,7,170264815,PSEN2,SNP (A/G),(A/,A,0.21,0.1,0.45,0.0511003,Moderate,0.213,0.195,0.061,0.331,Mild decrease (p=0.014),Significant increase (p=0.038),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05078,rs371722,5,210575712,PSEN2,Insertion,-,-,0.61,0.25,1.0,0.01525793,Moderate,0.14,0.536,0.036,0.088,Significant decrease (p=0.026),Mild increase (p=0.033),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP05079,rs373404,20,158594025,CLU,SNP (C/G),(C/,C,0.51,0.14,0.78,0.0704966,Low,0.379,0.156,0.121,0.143,Significant decrease (p=0.013),Mild decrease (p=0.045),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05080,rs580661,19,3658081,CLU,Insertion,-,-,0.9,0.54,1.2,0.00604141,Low,0.302,0.406,0.053,0.038,Mild decrease (p=0.01),Variable effect (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05081,rs787926,19,182308127,PSEN2,SNP (C/T),(C/,C,1.29,1.08,1.54,0.0068862,Low,0.275,0.022,0.297,0.206,Significant decrease (p=0.044),Significant increase (p=0.034),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05082,rs653427,21,231707789,PTK2B,SNP (C/G),(C/,C,0.63,0.28,0.97,0.10720256,Moderate,0.512,0.046,0.116,0.126,Mild increase (p=0.031),Mild increase (p=0.038),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP05083,rs980214,1,243077534,APOE,Insertion,-,-,1.43,1.15,1.78,0.00279596,Moderate,0.595,0.054,0.023,0.128,No significant pattern (p=0.012),No significant pattern (p=0.022),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05084,rs379234,9,67282528,PICALM,SNP (C/G),(C/,C,0.7,0.36,1.06,0.0317993,Moderate,0.069,0.261,0.437,0.033,Significant decrease (p=0.015),Significant decrease (p=0.018),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05085,rs968846,9,165854263,CLU,SNP (A/G),(A/,A,0.65,0.43,0.97,0.06217146,Moderate,0.271,0.088,0.07,0.37,Significant decrease (p=0.04),Mild decrease (p=0.026),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05086,rs888218,5,66977711,ABCA7,SNP (A/T),(A/,A,0.6,0.37,0.85,0.07881629,Moderate,0.09,0.039,0.392,0.279,Mild increase (p=0.023),No significant pattern (p=0.016),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05087,rs114119,16,215471384,EPHA1,SNP (G/T),(G/,G,0.51,0.2,0.89,0.03683443,Protective,0.061,0.154,0.272,0.314,Variable effect (p=0.045),Mild decrease (p=0.05),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05088,rs177250,13,82624574,CD2AP,SNP (A/G),(A/,A,0.39,0.13,0.71,0.0552128,Moderate,0.185,0.149,0.078,0.389,Variable effect (p=0.023),No significant pattern (p=0.039),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP05089,rs805695,17,5439285,APP,SNP (G/T),(G/,G,0.61,0.36,0.93,0.00314485,High,0.361,0.273,0.134,0.032,No significant pattern (p=0.039),Variable effect (p=0.025),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05090,rs791978,6,231706296,BIN1,SNP (A/C),(A/,A,1.65,1.41,2.0,0.01498709,Moderate,0.124,0.152,0.219,0.305,Mild increase (p=0.04),Variable effect (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP05091,rs272221,19,120806822,CD33,SNP (A/G),(A/,A,0.68,0.28,1.07,0.00014734,High,0.241,0.013,0.37,0.176,No significant pattern (p=0.049),No significant pattern (p=0.036),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP05092,rs115908,20,237208362,APP,SNP (C/G),(C/,C,1.19,0.82,1.56,0.02545402,Protective,0.183,0.009,0.564,0.044,No significant pattern (p=0.001),Variable effect (p=0.045),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05093,rs967317,9,2473216,MS4A6A,SNP (A/G),(A/,A,0.57,0.28,0.87,0.09164507,Low,0.081,0.291,0.231,0.197,No significant pattern (p=0.041),Variable effect (p=0.047),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP05094,rs229881,1,108510004,APP,Deletion,-,-,0.55,0.25,0.84,0.03336783,Moderate,0.036,0.421,0.055,0.288,Variable effect (p=0.015),Significant decrease (p=0.016),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05095,rs278489,18,163353799,PICALM,Deletion,-,-,0.8,0.58,1.11,0.00439979,Moderate,0.214,0.181,0.006,0.399,Significant decrease (p=0.001),Mild decrease (p=0.046),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05096,rs814963,19,88490594,APP,SNP (G/T),(G/,G,0.99,0.77,1.28,0.02218688,High,0.379,0.178,0.193,0.05,Mild decrease (p=0.021),Mild increase (p=0.024),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05097,rs730688,4,116680374,CD2AP,SNP (A/G),(A/,A,0.89,0.6,1.18,0.00180775,Moderate,0.027,0.483,0.289,0.001,Mild decrease (p=0.013),Mild increase (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP05098,rs377912,2,192408887,APOE,SNP (C/T),(C/,C,0.48,0.1,0.88,0.00319404,Moderate,0.254,0.009,0.268,0.269,Significant decrease (p=0.016),Mild decrease (p=0.019),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05099,rs954936,14,193824367,PICALM,Deletion,-,-,0.8,0.55,1.17,0.00249662,Moderate,0.134,0.096,0.371,0.2,Variable effect (p=0.039),Mild decrease (p=0.013),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05100,rs652542,20,47175619,CD2AP,SNP (A/C),(A/,A,1.42,1.17,1.65,0.00377692,Low,0.462,0.103,0.204,0.031,Mild increase (p=0.034),Significant increase (p=0.019),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05101,rs976181,7,217986396,PSEN2,SNP (G/T),(G/,G,1.3,1.09,1.55,0.00330413,Moderate,0.116,0.225,0.245,0.214,Mild decrease (p=0.01),Mild decrease (p=0.026),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05102,rs394889,8,52273020,CR1,Deletion,-,-,0.6,0.2,0.88,0.02888036,Moderate,0.091,0.162,0.28,0.268,Significant decrease (p=0.032),Significant decrease (p=0.034),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05103,rs195756,19,159808851,APP,SNP (G/T),(G/,G,1.32,1.05,1.54,0.04598529,Low,0.127,0.093,0.146,0.434,Significant decrease (p=0.039),Significant increase (p=0.009),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05104,rs882351,15,55984971,APP,SNP (C/G),(C/,C,2.17,1.9,2.39,0.06698027,Low,0.108,0.067,0.413,0.212,Significant increase (p=0.014),Variable effect (p=0.015),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP05105,rs579478,14,173447642,CR1,Insertion,-,-,1.66,1.31,1.96,0.08735687,Moderate,0.118,0.338,0.265,0.079,Significant decrease (p=0.018),No significant pattern (p=0.036),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05106,rs504730,22,45529140,PTK2B,SNP (A/G),(A/,A,0.73,0.35,0.97,0.04008596,Low,0.171,0.036,0.557,0.036,Variable effect (p=0.039),Variable effect (p=0.031),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP05107,rs894669,5,77792477,CR1,Insertion,-,-,2.06,1.74,2.34,0.0342705,Moderate,0.395,0.021,0.315,0.069,No significant pattern (p=0.019),Significant decrease (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05108,rs610450,6,105489116,CD2AP,SNP (C/T),(C/,C,1.82,1.58,2.04,0.04092744,Low,0.023,0.502,0.068,0.207,Mild increase (p=0.034),No significant pattern (p=0.04),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05109,rs637653,5,97003555,APOE,SNP (A/C),(A/,A,0.54,0.24,0.85,0.02305317,High,0.635,0.006,0.024,0.135,Mild increase (p=0.015),Significant increase (p=0.01),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05110,rs372383,14,115851523,ABCA7,SNP (C/T),(C/,C,1.29,0.9,1.6,0.01990582,Protective,0.067,0.313,0.101,0.319,Significant increase (p=0.036),Significant increase (p=0.023),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05111,rs931754,17,37862577,CD33,Insertion,-,-,1.0,0.7,1.35,0.05021385,Moderate,0.207,0.393,0.04,0.16,Significant decrease (p=0.022),Significant decrease (p=0.015),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05112,rs568868,14,197784171,CD33,SNP (A/G),(A/,A,2.17,1.83,2.47,0.07067623,Low,0.132,0.086,0.556,0.026,Mild decrease (p=0.011),Significant increase (p=0.034),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05113,rs300466,20,47048797,APOE,Deletion,-,-,1.35,1.15,1.58,0.04544126,Moderate,0.4,0.111,0.057,0.233,Mild decrease (p=0.024),Mild increase (p=0.043),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05114,rs402237,11,38249904,CD33,SNP (A/C),(A/,A,0.31,0.1,0.71,0.0096459,Moderate,0.673,0.04,0.009,0.077,Variable effect (p=0.048),Significant increase (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05115,rs683168,7,64177377,SORL1,Insertion,-,-,0.69,0.33,0.96,0.04309121,High,0.029,0.239,0.093,0.439,No significant pattern (p=0.011),Significant increase (p=0.041),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05116,rs173616,1,49983320,EPHA1,SNP (G/T),(G/,G,0.75,0.37,1.04,0.00763503,Low,0.12,0.338,0.324,0.018,Variable effect (p=0.009),No significant pattern (p=0.012),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05117,rs329450,11,160142208,CR1,SNP (A/G),(A/,A,1.06,0.82,1.46,0.04728589,Low,0.158,0.143,0.477,0.023,Mild increase (p=0.028),Significant increase (p=0.017),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP05118,rs196316,3,22330758,EPHA1,SNP (C/G),(C/,C,0.67,0.42,0.93,0.01616698,High,0.003,0.038,0.657,0.102,No significant pattern (p=0.029),Mild increase (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05119,rs348893,10,115143459,MS4A6A,SNP (A/T),(A/,A,0.89,0.57,1.15,0.01729233,Moderate,0.426,0.282,0.036,0.056,No significant pattern (p=0.035),Significant increase (p=0.031),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP05120,rs473149,1,218439545,ABCA7,SNP (A/C),(A/,A,0.57,0.18,0.84,0.06736425,High,0.032,0.625,0.119,0.024,Mild increase (p=0.034),Significant decrease (p=0.034),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05121,rs699130,10,102942951,CD2AP,SNP (A/G),(A/,A,1.4,1.2,1.78,0.00426402,High,0.635,0.026,0.116,0.023,Mild increase (p=0.016),Variable effect (p=0.004),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05122,rs875392,13,186997928,EPHA1,Deletion,-,-,0.71,0.51,0.93,0.01126354,Low,0.05,0.29,0.098,0.362,Variable effect (p=0.024),Mild increase (p=0.006),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05123,rs936802,16,24353743,CD33,SNP (C/G),(C/,C,1.55,1.27,1.95,0.00678133,Moderate,0.004,0.355,0.293,0.148,Mild increase (p=0.005),No significant pattern (p=0.01),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05124,rs152926,5,24343923,APP,SNP (A/C),(A/,A,0.4,0.1,0.7,0.04499223,High,0.013,0.614,0.012,0.161,Significant decrease (p=0.038),Mild increase (p=0.041),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05125,rs500020,21,240551554,BIN1,SNP (C/T),(C/,C,0.85,0.53,1.18,0.02448164,High,0.171,0.071,0.376,0.182,No significant pattern (p=0.049),Mild decrease (p=0.031),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05126,rs193056,14,108048974,SORL1,SNP (A/G),(A/,A,0.67,0.42,0.98,0.03192826,Protective,0.056,0.163,0.28,0.302,Variable effect (p=0.038),Mild increase (p=0.044),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP05127,rs438117,21,102904731,BIN1,SNP (A/C),(A/,A,0.94,0.67,1.16,0.00859186,Unknown,0.093,0.04,0.592,0.075,Mild decrease (p=0.045),Mild increase (p=0.013),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05128,rs131417,10,98263362,APOE,SNP (C/T),(C/,C,0.66,0.41,1.04,0.00530795,Low,0.297,0.334,0.13,0.039,Variable effect (p=0.044),Mild increase (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05129,rs730625,18,29368132,PSEN2,SNP (A/G),(A/,A,1.7,1.36,1.91,0.01601561,High,0.187,0.142,0.36,0.112,Variable effect (p=0.036),Significant decrease (p=0.025),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05130,rs416472,8,58193336,CLU,SNP (G/T),(G/,G,1.02,0.65,1.4,0.01243284,High,0.092,0.622,0.043,0.042,Variable effect (p=0.029),Significant decrease (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05131,rs235226,6,60219152,PICALM,SNP (C/G),(C/,C,1.23,0.89,1.56,0.0069217,Protective,0.013,0.532,0.183,0.072,Mild increase (p=0.021),Mild increase (p=0.006),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05132,rs809435,19,245875612,CLU,SNP (G/T),(G/,G,0.35,0.1,0.7,0.0003452,Moderate,0.041,0.408,0.008,0.343,Significant decrease (p=0.031),Significant decrease (p=0.041),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP05133,rs155881,4,74098870,PTK2B,SNP (C/T),(C/,C,2.29,2.04,2.68,0.00265993,Moderate,0.437,0.106,0.001,0.256,Significant decrease (p=0.026),Mild increase (p=0.027),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05134,rs885665,12,121255345,CLU,SNP (A/G),(A/,A,1.39,1.01,1.64,0.07972329,Low,0.054,0.032,0.166,0.549,Variable effect (p=0.042),Variable effect (p=0.038),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP05135,rs689893,20,229020260,CD33,SNP (A/C),(A/,A,0.58,0.23,0.98,0.02729645,Unknown,0.014,0.171,0.276,0.339,No significant pattern (p=0.002),Mild increase (p=0.022),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP05136,rs962813,1,46785889,TREM2,SNP (A/T),(A/,A,1.52,1.23,1.86,0.09421335,Moderate,0.316,0.249,0.091,0.144,Mild decrease (p=0.018),Significant decrease (p=0.046),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP05137,rs443366,16,192802889,PICALM,SNP (C/G),(C/,C,0.55,0.16,0.91,0.01297295,High,0.133,0.101,0.091,0.475,No significant pattern (p=0.024),No significant pattern (p=0.027),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05138,rs585091,12,52073335,MS4A6A,SNP (C/T),(C/,C,0.99,0.77,1.2,0.00448536,Moderate,0.354,0.388,0.003,0.055,Mild decrease (p=0.025),Significant decrease (p=0.04),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05139,rs708444,3,234719329,TREM2,SNP (C/G),(C/,C,1.61,1.35,1.93,0.00433704,High,0.031,0.066,0.152,0.551,Variable effect (p=0.048),Significant increase (p=0.027),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05140,rs834596,21,103514826,APOE,SNP (C/T),(C/,C,1.46,1.15,1.78,0.02622682,Moderate,0.072,0.081,0.208,0.439,Variable effect (p=0.049),No significant pattern (p=0.003),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05141,rs361230,6,70761017,BIN1,SNP (A/C),(A/,A,1.21,0.92,1.45,0.02500221,Low,0.021,0.128,0.62,0.031,Mild increase (p=0.005),Mild decrease (p=0.012),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05142,rs729829,8,136045456,PSEN2,SNP (G/T),(G/,G,0.91,0.56,1.31,0.01324465,High,0.173,0.007,0.176,0.444,No significant pattern (p=0.028),Variable effect (p=0.039),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP05143,rs134057,20,133381976,ABCA7,SNP (A/C),(A/,A,1.11,0.76,1.34,0.03440887,High,0.14,0.134,0.275,0.251,Mild decrease (p=0.038),Significant decrease (p=0.041),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05144,rs129750,5,80615795,PTK2B,SNP (A/C),(A/,A,2.04,1.75,2.34,0.14171821,High,0.028,0.573,0.03,0.168,Mild increase (p=0.012),Mild increase (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05145,rs185240,7,196223709,APOE,Insertion,-,-,0.42,0.1,0.77,0.00947627,Moderate,0.016,0.2,0.181,0.404,Mild increase (p=0.048),Significant decrease (p=0.026),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP05146,rs192278,21,190049397,BIN1,SNP (C/T),(C/,C,0.53,0.31,0.81,0.06279166,Protective,0.054,0.511,0.052,0.183,Significant decrease (p=0.018),Mild increase (p=0.019),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05147,rs544110,10,171356769,CLU,SNP (A/T),(A/,A,1.14,0.93,1.4,0.05697139,High,0.173,0.121,0.471,0.035,Mild decrease (p=0.026),Mild decrease (p=0.003),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05148,rs823872,17,164758106,CR1,SNP (C/G),(C/,C,0.73,0.5,1.08,0.07522727,Protective,0.063,0.025,0.039,0.673,Significant increase (p=0.036),Mild increase (p=0.033),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05149,rs435078,22,125832313,TREM2,SNP (G/T),(G/,G,1.83,1.46,2.11,0.02939691,Moderate,0.188,0.375,0.146,0.091,Variable effect (p=0.005),Mild increase (p=0.036),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05150,rs510571,11,66269874,CR1,SNP (A/T),(A/,A,1.37,1.14,1.58,0.01003812,Protective,0.056,0.619,0.119,0.006,No significant pattern (p=0.02),No significant pattern (p=0.036),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP05151,rs155885,14,20278473,ABCA7,Deletion,-,-,0.34,0.1,0.61,0.01047974,Protective,0.134,0.393,0.047,0.226,No significant pattern (p=0.024),No significant pattern (p=0.041),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05152,rs271310,13,92802298,EPHA1,SNP (A/T),(A/,A,0.43,0.2,0.7,0.03490894,Moderate,0.151,0.077,0.57,0.002,No significant pattern (p=0.014),Mild increase (p=0.015),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05153,rs835043,13,244966784,BIN1,SNP (A/G),(A/,A,1.2,0.81,1.43,0.00559794,High,0.379,0.015,0.274,0.132,Variable effect (p=0.026),Significant decrease (p=0.025),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05154,rs833794,16,89312843,CLU,Insertion,-,-,1.98,1.7,2.28,0.02936403,Low,0.211,0.296,0.07,0.223,Significant increase (p=0.027),Variable effect (p=0.041),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05155,rs250470,6,145593661,CD33,SNP (C/T),(C/,C,0.79,0.59,1.03,0.03552289,Moderate,0.21,0.046,0.265,0.279,Significant decrease (p=0.029),Mild increase (p=0.021),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05156,rs131239,1,189539193,PICALM,Deletion,-,-,0.38,0.15,0.76,0.01556652,Moderate,0.008,0.165,0.224,0.404,Variable effect (p=0.028),Mild decrease (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05157,rs825506,17,176787409,MS4A6A,SNP (A/G),(A/,A,0.63,0.36,0.96,0.0070055,High,0.007,0.303,0.489,0.001,Mild increase (p=0.015),Significant decrease (p=0.045),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05158,rs480280,3,55038104,EPHA1,SNP (G/T),(G/,G,0.42,0.1,0.79,0.02137645,High,0.256,0.102,0.011,0.432,Significant increase (p=0.038),Variable effect (p=0.021),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05159,rs663854,1,51080756,APP,SNP (A/G),(A/,A,0.59,0.39,0.88,0.00272653,Moderate,0.419,0.236,0.011,0.135,Mild decrease (p=0.035),Mild decrease (p=0.009),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05160,rs195049,13,79473452,SORL1,Insertion,-,-,1.11,0.78,1.31,0.0429523,Moderate,0.015,0.501,0.046,0.238,Mild decrease (p=0.04),No significant pattern (p=0.01),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05161,rs903334,18,10708435,CLU,SNP (A/G),(A/,A,0.82,0.55,1.21,0.01939528,High,0.232,0.019,0.345,0.204,No significant pattern (p=0.005),Variable effect (p=0.05),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05162,rs440272,22,232364590,MS4A6A,SNP (A/G),(A/,A,1.34,1.0,1.58,0.00301716,Moderate,0.114,0.207,0.425,0.053,No significant pattern (p=0.038),Variable effect (p=0.033),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP05163,rs824932,15,168204396,MS4A6A,Insertion,-,-,0.75,0.45,1.0,0.1046484,Moderate,0.247,0.283,0.103,0.167,Mild decrease (p=0.012),Significant increase (p=0.029),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05164,rs241559,8,6401305,ABCA7,SNP (C/T),(C/,C,0.52,0.27,0.76,0.09097927,Unknown,0.09,0.132,0.573,0.005,Significant increase (p=0.033),Variable effect (p=0.048),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP05165,rs790839,4,76815918,SORL1,SNP (C/G),(C/,C,1.36,1.13,1.63,0.06536603,Low,0.422,0.105,0.23,0.043,Mild increase (p=0.022),Significant decrease (p=0.002),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP05166,rs221193,6,17172665,BIN1,SNP (A/G),(A/,A,2.92,2.58,3.19,0.04807441,High,0.463,0.154,0.129,0.053,Significant decrease (p=0.002),No significant pattern (p=0.025),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05167,rs596694,10,18450367,CD2AP,Insertion,-,-,0.61,0.36,0.98,0.09667471,High,0.229,0.029,0.048,0.494,Variable effect (p=0.026),No significant pattern (p=0.048),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05168,rs303742,12,78678806,MS4A6A,SNP (A/C),(A/,A,0.7,0.42,0.96,0.08461746,Moderate,0.167,0.294,0.019,0.32,Significant decrease (p=0.028),Mild increase (p=0.049),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05169,rs812197,15,6690072,APP,SNP (A/C),(A/,A,0.8,0.51,1.05,0.0224598,High,0.435,0.051,0.137,0.178,Mild increase (p=0.04),Variable effect (p=0.028),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP05170,rs304985,14,189913260,ABCA7,Insertion,-,-,0.85,0.57,1.24,0.0190199,Moderate,0.456,0.105,0.041,0.198,Mild increase (p=0.05),Mild decrease (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05171,rs538086,8,33687288,APOE,SNP (A/T),(A/,A,1.1,0.78,1.45,0.03660809,Low,0.58,0.167,0.005,0.048,Mild decrease (p=0.004),Mild increase (p=0.017),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP05172,rs637187,15,151171274,CLU,SNP (A/G),(A/,A,1.13,0.77,1.41,7.933e-05,High,0.309,0.104,0.274,0.113,Significant increase (p=0.039),Variable effect (p=0.031),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05173,rs138520,7,207730421,TREM2,SNP (G/T),(G/,G,3.18,2.92,3.45,0.09288905,Low,0.187,0.247,0.22,0.146,Significant increase (p=0.002),Mild decrease (p=0.032),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05174,rs799198,17,211386464,EPHA1,Insertion,-,-,0.74,0.41,1.13,0.03980434,Moderate,0.449,0.031,0.255,0.065,Variable effect (p=0.022),Mild decrease (p=0.046),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05175,rs110272,21,77512135,APP,SNP (A/G),(A/,A,1.01,0.69,1.27,0.05351011,Protective,0.233,0.185,0.28,0.101,Significant decrease (p=0.04),Mild decrease (p=0.034),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05176,rs734645,17,124876920,BIN1,Insertion,-,-,1.45,1.25,1.74,0.00170652,Moderate,0.13,0.292,0.3,0.077,Mild decrease (p=0.011),Variable effect (p=0.022),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05177,rs668679,13,75801723,SORL1,SNP (A/T),(A/,A,1.4,1.08,1.78,0.0397785,High,0.343,0.136,0.308,0.014,No significant pattern (p=0.049),No significant pattern (p=0.022),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05178,rs805196,10,73196466,CR1,SNP (G/T),(G/,G,0.81,0.56,1.12,0.0120676,High,0.198,0.221,0.013,0.367,Significant increase (p=0.02),Mild decrease (p=0.049),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05179,rs124728,8,33469486,CD33,Deletion,-,-,1.54,1.29,1.75,0.02683459,Protective,0.156,0.116,0.101,0.427,Mild decrease (p=0.015),No significant pattern (p=0.027),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05180,rs985363,21,205514925,CR1,Insertion,-,-,0.81,0.44,1.08,0.02240911,High,0.163,0.193,0.362,0.082,Mild increase (p=0.034),Variable effect (p=0.03),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05181,rs447336,21,65214473,PSEN2,SNP (A/T),(A/,A,0.83,0.63,1.15,0.02777062,Moderate,0.285,0.23,0.006,0.28,Mild decrease (p=0.016),Mild decrease (p=0.031),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05182,rs441787,12,219226657,EPHA1,SNP (A/T),(A/,A,0.71,0.4,0.99,0.0137742,High,0.021,0.113,0.394,0.272,Mild increase (p=0.027),No significant pattern (p=0.008),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05183,rs651564,17,108552562,CD33,SNP (A/C),(A/,A,1.25,0.99,1.6,0.00683333,High,0.147,0.041,0.318,0.294,Significant decrease (p=0.016),No significant pattern (p=0.033),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05184,rs612967,7,220338382,CD33,SNP (A/C),(A/,A,0.76,0.5,1.06,0.03417346,High,0.122,0.112,0.113,0.452,Significant decrease (p=0.019),No significant pattern (p=0.02),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05185,rs431708,19,79111743,CD2AP,SNP (C/G),(C/,C,0.98,0.78,1.26,0.0313843,Low,0.052,0.302,0.056,0.39,No significant pattern (p=0.025),Variable effect (p=0.03),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05186,rs789548,6,233377053,SORL1,SNP (A/G),(A/,A,0.61,0.22,0.89,0.05663487,Moderate,0.319,0.151,0.117,0.213,Variable effect (p=0.024),Mild increase (p=0.013),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05187,rs149561,16,29553573,BIN1,SNP (C/T),(C/,C,0.88,0.49,1.26,0.046891,High,0.258,0.094,0.034,0.415,Significant decrease (p=0.025),Significant decrease (p=0.047),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05188,rs739538,13,58013966,SORL1,Deletion,-,-,0.88,0.66,1.18,0.0293337,Low,0.142,0.11,0.079,0.47,Mild decrease (p=0.047),Mild decrease (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05189,rs217055,6,100139996,BIN1,SNP (A/C),(A/,A,0.66,0.4,1.04,0.00168374,Moderate,0.109,0.038,0.473,0.18,Significant decrease (p=0.011),Mild increase (p=0.041),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05190,rs777680,6,161961923,APOE,Insertion,-,-,1.16,0.8,1.48,0.00158321,High,0.175,0.093,0.198,0.335,Significant increase (p=0.014),No significant pattern (p=0.035),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05191,rs948916,14,205816996,MS4A6A,SNP (C/G),(C/,C,1.46,1.16,1.7,0.00307687,High,0.524,0.054,0.184,0.039,Significant increase (p=0.039),Significant decrease (p=0.043),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05192,rs254971,9,13615703,PSEN2,SNP (G/T),(G/,G,0.4,0.1,0.68,0.08944736,Protective,0.052,0.263,0.001,0.485,Significant decrease (p=0.031),No significant pattern (p=0.022),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05193,rs414467,12,194334991,APP,SNP (C/T),(C/,C,1.05,0.66,1.4,0.00660604,Low,0.24,0.163,0.138,0.259,Significant decrease (p=0.01),Significant decrease (p=0.034),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP05194,rs527026,12,193897624,CD33,SNP (G/T),(G/,G,1.27,1.07,1.6,0.02503029,Moderate,0.108,0.441,0.243,0.009,Significant decrease (p=0.048),Variable effect (p=0.016),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05195,rs534882,14,25785469,CR1,Deletion,-,-,2.45,2.21,2.66,0.02126364,Protective,0.36,0.141,0.096,0.203,Significant decrease (p=0.047),Significant increase (p=0.034),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05196,rs684653,7,192587666,BIN1,SNP (C/G),(C/,C,1.19,0.92,1.43,0.02900106,Low,0.316,0.238,0.016,0.23,Significant increase (p=0.036),No significant pattern (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05197,rs157713,7,63086287,APOE,Insertion,-,-,1.12,0.83,1.32,0.1111688,Unknown,0.228,0.202,0.329,0.04,Significant decrease (p=0.036),Mild decrease (p=0.042),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05198,rs255459,1,64921952,SORL1,SNP (A/G),(A/,A,0.67,0.44,1.05,0.00263277,Unknown,0.123,0.173,0.439,0.065,No significant pattern (p=0.048),Significant increase (p=0.026),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05199,rs790738,2,107257872,ABCA7,Insertion,-,-,1.21,0.96,1.56,0.01777587,Moderate,0.032,0.198,0.283,0.286,Mild increase (p=0.04),No significant pattern (p=0.031),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05200,rs610364,4,36200573,ABCA7,SNP (A/C),(A/,A,1.2,0.9,1.44,0.03727697,Moderate,0.655,0.001,0.13,0.014,No significant pattern (p=0.017),Significant decrease (p=0.017),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05201,rs942575,3,211171091,PTK2B,Deletion,-,-,0.91,0.58,1.21,0.03810658,High,0.234,0.082,0.133,0.351,Mild decrease (p=0.039),Significant decrease (p=0.005),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05202,rs523163,15,160796475,APOE,SNP (A/G),(A/,A,0.98,0.63,1.19,0.02020975,Protective,0.192,0.276,0.185,0.147,Variable effect (p=0.005),Mild decrease (p=0.039),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05203,rs296655,21,22983026,CD2AP,SNP (A/C),(A/,A,1.99,1.65,2.28,0.05054915,High,0.122,0.016,0.406,0.256,Mild increase (p=0.032),Significant increase (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05204,rs988256,12,93542802,PICALM,SNP (A/G),(A/,A,0.95,0.6,1.31,0.06816876,High,0.2,0.027,0.497,0.076,Mild increase (p=0.002),Significant decrease (p=0.034),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05205,rs641658,19,51825369,PTK2B,SNP (A/T),(A/,A,0.6,0.32,0.94,0.01692557,Protective,0.068,0.152,0.357,0.223,Significant decrease (p=0.021),Mild decrease (p=0.047),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05206,rs398595,10,79517935,PTK2B,SNP (A/G),(A/,A,0.83,0.56,1.03,0.02420893,High,0.163,0.186,0.084,0.367,Significant decrease (p=0.017),Variable effect (p=0.013),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05207,rs258557,21,47474557,CLU,SNP (A/G),(A/,A,1.13,0.91,1.34,0.02393933,Moderate,0.1,0.405,0.023,0.273,No significant pattern (p=0.048),Significant increase (p=0.036),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05208,rs541786,5,88758883,CD2AP,SNP (A/G),(A/,A,0.58,0.3,0.91,0.04393103,High,0.053,0.134,0.229,0.384,Significant increase (p=0.037),Significant decrease (p=0.001),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05209,rs689512,18,98262771,PSEN2,Insertion,-,-,1.56,1.33,1.92,0.05372202,Low,0.229,0.061,0.06,0.45,Significant decrease (p=0.015),Significant increase (p=0.039),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05210,rs553505,4,123157502,TREM2,SNP (A/G),(A/,A,0.98,0.64,1.29,0.05149307,Moderate,0.108,0.145,0.248,0.3,No significant pattern (p=0.009),Significant increase (p=0.034),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP05211,rs252102,7,202376787,EPHA1,SNP (C/T),(C/,C,1.53,1.28,1.93,0.00264848,Moderate,0.002,0.606,0.107,0.085,No significant pattern (p=0.046),Significant increase (p=0.022),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05212,rs208886,1,35838806,BIN1,SNP (C/G),(C/,C,2.26,1.9,2.62,0.01022864,Moderate,0.069,0.1,0.331,0.3,Significant decrease (p=0.015),Mild decrease (p=0.017),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05213,rs427870,18,133583034,PTK2B,SNP (C/G),(C/,C,1.12,0.81,1.33,0.06951404,High,0.253,0.127,0.072,0.348,No significant pattern (p=0.042),Significant decrease (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05214,rs326698,6,69955525,CLU,SNP (A/G),(A/,A,2.16,1.91,2.53,0.01078304,High,0.147,0.017,0.625,0.011,Mild increase (p=0.041),Significant increase (p=0.017),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05215,rs617215,22,160075929,PSEN2,SNP (A/G),(A/,A,1.67,1.29,1.91,0.05228264,Protective,0.288,0.232,0.198,0.083,Variable effect (p=0.041),Mild decrease (p=0.023),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05216,rs255447,22,120179395,CD33,Insertion,-,-,0.29,0.1,0.64,0.03873801,Moderate,0.35,0.14,0.273,0.038,Mild increase (p=0.035),Significant decrease (p=0.047),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05217,rs234488,1,71909355,CLU,SNP (A/T),(A/,A,1.37,1.09,1.71,0.08990063,Protective,0.124,0.303,0.342,0.032,Mild increase (p=0.003),Mild decrease (p=0.03),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP05218,rs714224,3,183162724,PICALM,SNP (A/C),(A/,A,0.66,0.31,0.98,0.03992483,Low,0.17,0.509,0.063,0.058,No significant pattern (p=0.036),No significant pattern (p=0.04),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05219,rs813319,14,85695912,CLU,Insertion,-,-,2.79,2.41,3.1,0.00846068,Unknown,0.228,0.111,0.102,0.358,Mild increase (p=0.048),Significant increase (p=0.02),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05220,rs540310,18,202889377,APOE,SNP (C/T),(C/,C,1.46,1.19,1.73,0.05170156,Moderate,0.077,0.061,0.363,0.299,Mild increase (p=0.031),Significant decrease (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05221,rs281852,15,35151589,EPHA1,SNP (A/T),(A/,A,1.47,1.12,1.74,0.02793288,Low,0.118,0.442,0.087,0.153,Significant decrease (p=0.027),Variable effect (p=0.025),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05222,rs957783,16,151524948,SORL1,SNP (G/T),(G/,G,1.82,1.53,2.19,0.16560645,Protective,0.078,0.282,0.388,0.052,Mild decrease (p=0.007),Significant increase (p=0.032),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05223,rs608711,10,191652601,BIN1,SNP (C/T),(C/,C,0.69,0.42,1.05,0.05517885,Low,0.087,0.429,0.022,0.262,Significant increase (p=0.038),Significant decrease (p=0.043),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05224,rs159943,3,148058706,PTK2B,SNP (A/C),(A/,A,0.66,0.39,1.01,0.04240807,Moderate,0.058,0.421,0.227,0.094,Significant increase (p=0.008),Mild increase (p=0.046),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05225,rs137833,8,222503833,PICALM,SNP (A/G),(A/,A,1.7,1.41,2.1,0.00278372,Low,0.091,0.284,0.025,0.399,Significant increase (p=0.005),Significant decrease (p=0.019),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05226,rs959741,15,228176162,CD33,SNP (A/G),(A/,A,0.4,0.1,0.61,0.0024924,Unknown,0.431,0.003,0.104,0.262,Significant increase (p=0.037),Mild decrease (p=0.035),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05227,rs679635,9,223885747,PICALM,SNP (A/T),(A/,A,1.41,1.06,1.64,0.01402804,Moderate,0.483,0.024,0.29,0.003,Significant decrease (p=0.019),No significant pattern (p=0.04),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05228,rs201674,6,118071293,SORL1,SNP (C/G),(C/,C,1.17,0.96,1.44,0.0070348,Protective,0.283,0.027,0.149,0.341,No significant pattern (p=0.045),Variable effect (p=0.005),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05229,rs470512,11,29382362,ABCA7,SNP (A/T),(A/,A,1.12,0.74,1.33,0.02212195,Moderate,0.46,0.118,0.152,0.07,Mild increase (p=0.009),Significant increase (p=0.01),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05230,rs808590,7,162070586,SORL1,SNP (A/T),(A/,A,0.69,0.43,0.97,0.03901484,High,0.288,0.006,0.422,0.085,Mild decrease (p=0.032),Mild decrease (p=0.002),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05231,rs121045,3,12363459,CR1,SNP (A/T),(A/,A,1.25,0.9,1.58,0.03650239,High,0.27,0.016,0.262,0.253,No significant pattern (p=0.013),Mild increase (p=0.043),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05232,rs361642,18,135086702,BIN1,SNP (C/G),(C/,C,0.63,0.4,0.9,0.00170039,Moderate,0.008,0.322,0.317,0.152,Significant decrease (p=0.039),Variable effect (p=0.015),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05233,rs381235,4,211706238,BIN1,SNP (A/T),(A/,A,0.97,0.63,1.28,0.01418742,Moderate,0.122,0.035,0.162,0.481,No significant pattern (p=0.007),Mild increase (p=0.016),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05234,rs442469,21,179443533,PICALM,SNP (C/T),(C/,C,1.25,0.92,1.48,0.01293465,Moderate,0.341,0.292,0.022,0.145,No significant pattern (p=0.01),Mild increase (p=0.016),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05235,rs249503,18,169090952,CD2AP,SNP (C/T),(C/,C,1.27,1.07,1.6,0.00290632,Moderate,0.19,0.475,0.072,0.063,Mild increase (p=0.045),Variable effect (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05236,rs603150,9,58551677,MS4A6A,SNP (A/G),(A/,A,0.73,0.35,1.1,0.00970866,Protective,0.524,0.247,0.012,0.017,Mild increase (p=0.02),Significant increase (p=0.044),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05237,rs177015,4,100684613,PICALM,SNP (A/C),(A/,A,1.67,1.27,2.0,0.01189813,High,0.226,0.194,0.017,0.363,No significant pattern (p=0.028),Significant decrease (p=0.043),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05238,rs347424,16,120439593,CD2AP,SNP (G/T),(G/,G,1.91,1.55,2.3,0.08539783,Moderate,0.443,0.083,0.076,0.199,No significant pattern (p=0.016),Significant increase (p=0.038),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05239,rs451584,6,225945534,PSEN2,SNP (C/G),(C/,C,0.3,0.1,0.55,0.06619044,Unknown,0.182,0.13,0.333,0.155,No significant pattern (p=0.049),Significant increase (p=0.02),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05240,rs112750,16,243889593,CR1,SNP (C/G),(C/,C,1.08,0.86,1.3,0.01606407,High,0.124,0.047,0.336,0.294,Variable effect (p=0.023),No significant pattern (p=0.037),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP05241,rs635052,9,29373119,PICALM,SNP (A/C),(A/,A,1.51,1.3,1.86,0.01660341,Low,0.294,0.089,0.125,0.292,Significant decrease (p=0.028),Significant decrease (p=0.023),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05242,rs268095,14,187189182,BIN1,SNP (A/C),(A/,A,1.27,0.88,1.51,0.00286339,Low,0.544,0.13,0.103,0.023,Mild increase (p=0.023),Mild increase (p=0.019),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05243,rs451687,10,112950368,CD2AP,SNP (G/T),(G/,G,1.26,0.88,1.54,0.11324332,Moderate,0.007,0.404,0.218,0.171,Significant decrease (p=0.035),Significant decrease (p=0.034),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05244,rs828720,22,96761343,PSEN2,SNP (C/G),(C/,C,1.08,0.83,1.33,0.02567733,Moderate,0.203,0.239,0.217,0.141,Significant decrease (p=0.035),Mild decrease (p=0.02),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP05245,rs170082,17,140921097,SORL1,Insertion,-,-,0.48,0.18,0.87,0.03031763,High,0.217,0.405,0.068,0.109,Significant decrease (p=0.038),Mild increase (p=0.03),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05246,rs877169,20,50299264,ABCA7,Deletion,-,-,0.69,0.32,0.92,0.01217623,Moderate,0.063,0.507,0.005,0.225,Significant decrease (p=0.019),Variable effect (p=0.026),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05247,rs366997,22,110472826,ABCA7,SNP (A/C),(A/,A,0.84,0.59,1.06,0.02598654,Moderate,0.276,0.253,0.07,0.201,No significant pattern (p=0.041),Variable effect (p=0.023),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05248,rs784810,14,28953585,EPHA1,SNP (A/C),(A/,A,0.75,0.52,1.08,0.02790672,High,0.095,0.513,0.105,0.087,Significant increase (p=0.04),Significant decrease (p=0.04),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05249,rs178169,11,243819498,CD2AP,SNP (G/T),(G/,G,0.84,0.5,1.05,0.08328986,Moderate,0.434,0.063,0.155,0.148,No significant pattern (p=0.033),Significant increase (p=0.016),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05250,rs827084,5,77474333,CLU,SNP (G/T),(G/,G,1.42,1.05,1.64,0.06210364,Low,0.126,0.03,0.478,0.166,No significant pattern (p=0.044),Significant increase (p=0.021),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05251,rs244057,8,238779211,EPHA1,Insertion,-,-,0.94,0.56,1.22,0.0302816,Moderate,0.137,0.068,0.06,0.535,Mild increase (p=0.03),Significant decrease (p=0.015),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05252,rs729631,5,208340213,PTK2B,SNP (C/G),(C/,C,1.2,0.97,1.5,0.02742819,Protective,0.264,0.09,0.428,0.018,Significant decrease (p=0.027),Variable effect (p=0.045),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05253,rs946330,15,31829660,PTK2B,Insertion,-,-,1.04,0.7,1.36,0.0246376,Low,0.051,0.383,0.098,0.268,No significant pattern (p=0.031),Variable effect (p=0.013),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05254,rs601569,5,31098994,APOE,SNP (C/G),(C/,C,2.09,1.73,2.32,0.0283048,Unknown,0.055,0.093,0.336,0.317,Significant decrease (p=0.028),Mild decrease (p=0.021),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05255,rs699906,8,100839039,TREM2,SNP (G/T),(G/,G,1.47,1.26,1.85,0.03138703,Moderate,0.034,0.162,0.006,0.599,Significant decrease (p=0.041),No significant pattern (p=0.045),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05256,rs127403,11,63755256,APOE,Insertion,-,-,1.02,0.66,1.41,0.01889675,Low,0.329,0.307,0.057,0.106,Mild increase (p=0.003),No significant pattern (p=0.015),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05257,rs320560,5,112873893,SORL1,SNP (A/C),(A/,A,0.9,0.58,1.23,0.01756281,Low,0.071,0.376,0.097,0.256,Mild increase (p=0.024),Significant increase (p=0.013),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05258,rs473700,4,11028673,APP,SNP (C/G),(C/,C,1.65,1.4,1.9,0.01741765,Moderate,0.516,0.026,0.105,0.153,No significant pattern (p=0.003),Significant decrease (p=0.008),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05259,rs182166,3,11811813,CR1,Insertion,-,-,0.5,0.18,0.86,0.04236031,High,0.207,0.337,0.048,0.208,Significant decrease (p=0.047),Mild increase (p=0.048),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05260,rs481698,4,176772362,CLU,SNP (A/T),(A/,A,1.5,1.15,1.82,0.00605465,Unknown,0.257,0.224,0.305,0.014,Significant increase (p=0.048),Mild increase (p=0.048),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05261,rs544473,22,238423612,PICALM,SNP (G/T),(G/,G,0.52,0.22,0.77,0.00014246,Moderate,0.275,0.201,0.01,0.314,Significant increase (p=0.018),No significant pattern (p=0.035),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05262,rs429729,18,87609837,CD33,SNP (A/T),(A/,A,1.24,1.0,1.51,0.02186085,High,0.254,0.021,0.18,0.345,Variable effect (p=0.017),No significant pattern (p=0.036),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05263,rs221785,16,226957384,PICALM,SNP (A/T),(A/,A,0.66,0.28,1.01,0.00649468,Unknown,0.03,0.159,0.276,0.335,Significant decrease (p=0.022),Mild decrease (p=0.041),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05264,rs829454,12,176471297,TREM2,SNP (C/G),(C/,C,0.72,0.46,1.09,0.0290308,Moderate,0.231,0.024,0.502,0.043,Mild increase (p=0.011),Mild decrease (p=0.019),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP05265,rs686675,1,74485817,CR1,SNP (A/G),(A/,A,1.17,0.94,1.38,0.02574973,Low,0.015,0.48,0.302,0.003,Significant decrease (p=0.049),No significant pattern (p=0.015),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP05266,rs804632,22,40230763,CD33,SNP (A/T),(A/,A,0.33,0.1,0.65,0.06981957,Moderate,0.284,0.293,0.062,0.161,Mild increase (p=0.011),No significant pattern (p=0.006),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05267,rs514679,21,57630455,CR1,SNP (C/G),(C/,C,2.26,2.02,2.61,0.03195024,Low,0.005,0.179,0.466,0.151,Significant decrease (p=0.035),No significant pattern (p=0.039),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP05268,rs189424,7,104186102,APP,SNP (A/T),(A/,A,1.0,0.63,1.32,0.00015829,Low,0.1,0.066,0.43,0.204,Significant decrease (p=0.05),Variable effect (p=0.04),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05269,rs985471,2,144929796,PTK2B,SNP (A/T),(A/,A,0.51,0.28,0.82,0.04153153,High,0.161,0.36,0.198,0.081,Significant decrease (p=0.029),No significant pattern (p=0.05),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05270,rs932920,11,9670894,BIN1,SNP (A/G),(A/,A,1.71,1.32,2.01,0.03471912,Moderate,0.095,0.073,0.052,0.58,Mild increase (p=0.021),Mild decrease (p=0.044),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05271,rs186789,11,85681772,PSEN2,SNP (A/G),(A/,A,0.65,0.42,0.88,0.01406674,Protective,0.302,0.232,0.095,0.171,Significant decrease (p=0.016),Significant increase (p=0.039),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05272,rs828762,11,136161382,PTK2B,SNP (A/T),(A/,A,1.07,0.76,1.46,0.0234327,High,0.096,0.142,0.035,0.528,Significant increase (p=0.035),No significant pattern (p=0.043),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP05273,rs216228,1,58496428,TREM2,SNP (C/T),(C/,C,1.36,1.08,1.58,0.06344938,High,0.028,0.183,0.186,0.403,Variable effect (p=0.006),Mild increase (p=0.033),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP05274,rs367209,17,74496188,TREM2,Deletion,-,-,1.11,0.78,1.43,0.01833056,Low,0.081,0.263,0.092,0.365,Mild decrease (p=0.005),No significant pattern (p=0.033),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05275,rs131819,3,51124674,PICALM,SNP (A/C),(A/,A,2.42,2.03,2.77,0.03208569,High,0.216,0.151,0.317,0.116,Significant decrease (p=0.04),Significant increase (p=0.03),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05276,rs903785,10,31477694,APOE,Insertion,-,-,1.82,1.44,2.21,0.00945829,High,0.368,0.2,0.008,0.223,Mild increase (p=0.023),Significant increase (p=0.038),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05277,rs549416,18,38749157,PSEN2,SNP (A/G),(A/,A,1.22,0.91,1.54,0.01760399,Low,0.261,0.23,0.11,0.199,Variable effect (p=0.014),Significant decrease (p=0.041),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05278,rs385879,8,30572256,APP,Deletion,-,-,0.85,0.63,1.06,0.01184331,High,0.018,0.274,0.349,0.159,Mild increase (p=0.035),Mild increase (p=0.015),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05279,rs827249,1,188156015,APP,SNP (G/T),(G/,G,0.54,0.27,0.84,0.00995981,High,0.525,0.128,0.004,0.143,Significant decrease (p=0.01),Variable effect (p=0.035),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05280,rs260671,2,107927129,CR1,Insertion,-,-,0.98,0.59,1.26,0.09140027,High,0.04,0.139,0.244,0.377,Mild increase (p=0.011),Mild increase (p=0.007),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05281,rs268391,1,73951866,MS4A6A,SNP (A/T),(A/,A,1.08,0.75,1.37,0.00557041,Low,0.09,0.065,0.545,0.1,Significant decrease (p=0.004),Variable effect (p=0.004),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05282,rs557023,9,94830706,MS4A6A,Insertion,-,-,0.95,0.69,1.34,0.00868192,High,0.215,0.082,0.409,0.095,Significant increase (p=0.027),No significant pattern (p=0.024),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP05283,rs710743,14,86703978,PSEN2,SNP (A/C),(A/,A,1.13,0.89,1.43,0.01339746,High,0.059,0.156,0.094,0.491,No significant pattern (p=0.039),Significant decrease (p=0.004),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05284,rs239239,14,79456373,ABCA7,Insertion,-,-,4.07,3.83,4.4,0.03390479,Moderate,0.057,0.086,0.317,0.339,Variable effect (p=0.036),No significant pattern (p=0.033),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05285,rs330081,10,16197842,EPHA1,SNP (A/T),(A/,A,0.78,0.48,1.18,0.08639002,Moderate,0.311,0.207,0.248,0.034,Significant decrease (p=0.009),Variable effect (p=0.047),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP05286,rs244791,8,60191559,CR1,SNP (A/T),(A/,A,1.34,1.08,1.55,0.01504041,Low,0.171,0.172,0.383,0.074,Significant increase (p=0.048),Significant increase (p=0.015),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05287,rs995372,4,160408697,CD33,Insertion,-,-,2.61,2.31,2.99,0.07518619,Unknown,0.471,0.038,0.003,0.287,Mild decrease (p=0.015),Variable effect (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05288,rs669379,2,10970470,SORL1,SNP (A/T),(A/,A,1.42,1.08,1.73,0.06606508,Protective,0.064,0.04,0.277,0.419,Significant decrease (p=0.045),Significant increase (p=0.006),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05289,rs520320,7,76276490,TREM2,SNP (C/G),(C/,C,0.44,0.24,0.72,0.03227622,Low,0.431,0.158,0.095,0.115,Variable effect (p=0.041),Mild increase (p=0.005),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05290,rs993231,4,58685182,PICALM,SNP (G/T),(G/,G,0.71,0.51,1.04,0.0438632,Low,0.3,0.168,0.151,0.181,Mild decrease (p=0.03),Variable effect (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05291,rs633379,16,34576538,APP,Insertion,-,-,0.35,0.14,0.61,0.02345933,High,0.027,0.119,0.229,0.425,Significant increase (p=0.014),Variable effect (p=0.034),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05292,rs500689,19,157413190,APP,SNP (G/T),(G/,G,0.99,0.59,1.34,0.0105283,Low,0.3,0.374,0.125,0.001,Mild decrease (p=0.018),Mild increase (p=0.047),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05293,rs360374,6,82410092,PSEN2,Insertion,-,-,0.83,0.6,1.12,0.00465879,High,0.073,0.007,0.245,0.474,Significant increase (p=0.028),Significant increase (p=0.01),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05294,rs378627,22,133167105,CD2AP,SNP (A/T),(A/,A,1.3,0.9,1.58,0.02837632,Moderate,0.04,0.008,0.038,0.714,Mild increase (p=0.027),No significant pattern (p=0.031),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05295,rs519510,15,200471384,BIN1,Deletion,-,-,0.75,0.39,1.06,0.01230744,High,0.009,0.404,0.183,0.205,Variable effect (p=0.029),Mild increase (p=0.024),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05296,rs539732,16,79077250,CD2AP,SNP (A/G),(A/,A,2.25,2.03,2.62,0.02254859,High,0.09,0.61,0.016,0.084,Variable effect (p=0.035),Significant increase (p=0.047),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05297,rs256296,17,111937037,CD2AP,SNP (G/T),(G/,G,0.77,0.4,1.14,0.0155354,Moderate,0.356,0.106,0.097,0.24,Mild decrease (p=0.02),Mild decrease (p=0.001),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05298,rs826012,17,82382053,PSEN2,SNP (C/G),(C/,C,0.84,0.52,1.22,0.02811278,High,0.196,0.368,0.108,0.128,Mild decrease (p=0.044),Variable effect (p=0.027),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05299,rs382509,16,36198742,EPHA1,SNP (A/C),(A/,A,1.38,1.03,1.75,0.00093287,Moderate,0.293,0.099,0.407,0.0,Significant decrease (p=0.047),Significant decrease (p=0.014),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05300,rs886558,22,154272842,CD33,SNP (A/G),(A/,A,0.62,0.32,0.82,0.01991693,Low,0.034,0.173,0.15,0.443,Mild decrease (p=0.025),No significant pattern (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP05301,rs707922,5,246718804,EPHA1,SNP (C/T),(C/,C,0.59,0.21,0.91,0.02976575,Unknown,0.136,0.074,0.214,0.376,Mild decrease (p=0.018),Mild decrease (p=0.028),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05302,rs921143,14,194141964,CD33,Insertion,-,-,0.72,0.36,1.02,0.02286046,Moderate,0.22,0.122,0.08,0.378,Mild increase (p=0.037),Mild decrease (p=0.017),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05303,rs870352,3,223711205,CD2AP,SNP (G/T),(G/,G,2.1,1.74,2.47,0.01647938,High,0.058,0.088,0.312,0.342,Significant decrease (p=0.037),Significant decrease (p=0.021),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05304,rs245511,17,55294919,PTK2B,Insertion,-,-,0.47,0.27,0.83,0.02936979,Moderate,0.175,0.087,0.469,0.069,No significant pattern (p=0.043),Significant increase (p=0.01),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05305,rs547544,9,217713714,APP,Deletion,-,-,0.93,0.62,1.14,8.642e-05,Moderate,0.298,0.106,0.2,0.196,Variable effect (p=0.044),Significant increase (p=0.033),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05306,rs513712,4,236081019,MS4A6A,SNP (C/G),(C/,C,0.63,0.26,0.97,0.00495531,High,0.059,0.336,0.402,0.002,Variable effect (p=0.029),Mild increase (p=0.039),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05307,rs304257,4,203380991,CR1,SNP (A/T),(A/,A,1.77,1.37,1.98,0.06900844,Moderate,0.509,0.077,0.186,0.028,Mild increase (p=0.001),Significant decrease (p=0.038),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05308,rs976103,22,118488634,ABCA7,SNP (A/G),(A/,A,0.56,0.27,0.84,0.01029344,High,0.48,0.005,0.099,0.216,Mild decrease (p=0.029),Mild decrease (p=0.011),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05309,rs443654,4,41269224,APP,SNP (C/G),(C/,C,0.9,0.66,1.16,0.00749215,Low,0.335,0.062,0.378,0.025,Mild decrease (p=0.002),Mild increase (p=0.019),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05310,rs462444,8,223639387,PICALM,SNP (A/T),(A/,A,0.83,0.58,1.13,0.05570673,Moderate,0.066,0.168,0.189,0.377,No significant pattern (p=0.04),No significant pattern (p=0.041),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05311,rs217558,6,189672213,EPHA1,SNP (C/T),(C/,C,1.23,0.91,1.44,0.05120475,Moderate,0.123,0.269,0.22,0.188,Significant decrease (p=0.025),Significant decrease (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05312,rs788841,17,5111276,CLU,SNP (A/G),(A/,A,1.51,1.31,1.83,0.01812855,High,0.15,0.509,0.091,0.05,Mild decrease (p=0.028),No significant pattern (p=0.028),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05313,rs672756,8,42493879,TREM2,SNP (A/G),(A/,A,0.67,0.47,0.94,0.05718998,Moderate,0.141,0.218,0.019,0.422,Mild increase (p=0.018),No significant pattern (p=0.01),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05314,rs235415,1,143715042,BIN1,Insertion,-,-,0.72,0.44,1.0,0.02863602,High,0.145,0.065,0.117,0.474,Mild increase (p=0.045),Mild decrease (p=0.014),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05315,rs452856,16,87083722,BIN1,SNP (A/C),(A/,A,0.92,0.66,1.31,0.01759019,High,0.022,0.671,0.051,0.055,Mild decrease (p=0.04),Significant increase (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05316,rs322417,16,13762206,APOE,Insertion,-,-,0.76,0.49,1.09,0.01856108,Moderate,0.089,0.07,0.157,0.484,Mild increase (p=0.011),Mild decrease (p=0.034),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05317,rs716440,4,151483997,CR1,Deletion,-,-,1.39,1.14,1.59,0.0566473,Low,0.308,0.244,0.246,0.002,Mild decrease (p=0.041),Significant increase (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05318,rs482745,12,179164775,ABCA7,Insertion,-,-,1.15,0.93,1.48,0.01952526,Low,0.411,0.147,0.062,0.18,Significant increase (p=0.032),Significant decrease (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP05319,rs408348,8,80608095,ABCA7,SNP (G/T),(G/,G,0.67,0.46,0.89,0.05747523,High,0.277,0.195,0.294,0.035,No significant pattern (p=0.035),No significant pattern (p=0.039),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP05320,rs361977,22,68672103,ABCA7,SNP (A/G),(A/,A,1.06,0.73,1.35,0.02815646,Low,0.367,0.238,0.168,0.026,Mild decrease (p=0.015),No significant pattern (p=0.028),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05321,rs327102,20,154594569,APP,Deletion,-,-,0.81,0.48,1.02,0.08605187,Low,0.251,0.281,0.216,0.052,Mild increase (p=0.04),Variable effect (p=0.012),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05322,rs787654,11,217249656,SORL1,SNP (A/C),(A/,A,0.76,0.45,1.04,0.09377002,Protective,0.338,0.047,0.362,0.053,Variable effect (p=0.041),Significant decrease (p=0.021),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05323,rs845699,19,43407215,MS4A6A,SNP (A/G),(A/,A,0.49,0.16,0.8,0.02515639,High,0.071,0.047,0.412,0.271,No significant pattern (p=0.024),Variable effect (p=0.038),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05324,rs762617,22,53828761,APOE,SNP (A/C),(A/,A,0.7,0.43,0.91,0.03563928,Moderate,0.153,0.006,0.414,0.227,Mild decrease (p=0.029),Mild decrease (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05325,rs705500,19,96994957,CR1,SNP (G/T),(G/,G,1.35,1.0,1.72,0.05554565,Moderate,0.29,0.032,0.2,0.277,Significant decrease (p=0.044),Significant increase (p=0.038),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05326,rs300172,11,16868657,CD33,Insertion,-,-,1.34,1.05,1.63,0.02582557,Moderate,0.019,0.124,0.528,0.13,Significant increase (p=0.039),Variable effect (p=0.017),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP05327,rs580614,9,142394452,CD2AP,SNP (C/G),(C/,C,0.85,0.5,1.13,0.02513517,Moderate,0.433,0.06,0.181,0.126,Significant increase (p=0.022),Significant decrease (p=0.042),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP05328,rs512970,19,156210670,CR1,SNP (A/G),(A/,A,0.73,0.52,0.93,0.00257013,Low,0.513,0.243,0.007,0.038,Significant increase (p=0.032),Significant increase (p=0.021),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05329,rs424197,5,133084433,CR1,SNP (C/T),(C/,C,0.67,0.44,0.99,0.0096951,Unknown,0.085,0.172,0.319,0.223,Mild decrease (p=0.016),Variable effect (p=0.017),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05330,rs584853,9,82397682,SORL1,SNP (C/G),(C/,C,1.69,1.3,1.95,0.01515572,Unknown,0.221,0.335,0.11,0.134,Mild decrease (p=0.025),Variable effect (p=0.002),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05331,rs232394,20,127836463,CD33,SNP (A/G),(A/,A,0.95,0.57,1.22,0.03472248,Moderate,0.468,0.005,0.038,0.289,Significant decrease (p=0.036),Significant increase (p=0.004),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05332,rs988519,3,97807944,BIN1,SNP (A/G),(A/,A,1.61,1.38,1.97,0.01191164,Low,0.009,0.144,0.576,0.071,Variable effect (p=0.039),Mild decrease (p=0.019),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05333,rs200405,8,16580184,MS4A6A,Deletion,-,-,0.28,0.1,0.66,0.01597378,High,0.125,0.232,0.148,0.295,Variable effect (p=0.003),Significant increase (p=0.02),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05334,rs197515,4,204915450,SORL1,SNP (A/G),(A/,A,0.79,0.39,1.12,0.10064633,Moderate,0.126,0.553,0.095,0.026,Significant increase (p=0.046),Mild decrease (p=0.031),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05335,rs509384,17,216756180,ABCA7,Insertion,-,-,0.94,0.69,1.23,0.0524014,Moderate,0.256,0.377,0.105,0.061,Significant decrease (p=0.03),Mild increase (p=0.041),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05336,rs995111,18,235035016,SORL1,SNP (A/T),(A/,A,0.92,0.72,1.25,0.0439755,Protective,0.169,0.159,0.338,0.134,Mild increase (p=0.009),Mild increase (p=0.039),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05337,rs867584,5,32022390,BIN1,SNP (C/T),(C/,C,0.63,0.34,0.99,0.04309548,High,0.372,0.06,0.345,0.023,Variable effect (p=0.024),Significant increase (p=0.034),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05338,rs181878,18,109513403,CLU,SNP (A/C),(A/,A,0.68,0.44,1.01,0.01036218,Moderate,0.055,0.416,0.001,0.328,Variable effect (p=0.023),Mild decrease (p=0.002),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP05339,rs492560,19,51211918,CR1,SNP (A/T),(A/,A,0.8,0.42,1.04,0.04363155,High,0.105,0.371,0.211,0.113,Mild increase (p=0.034),Variable effect (p=0.042),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP05340,rs617676,13,173082047,BIN1,SNP (A/C),(A/,A,2.67,2.34,2.98,0.00187308,Low,0.069,0.144,0.124,0.463,Mild increase (p=0.013),No significant pattern (p=0.048),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP05341,rs136159,6,135974922,PICALM,SNP (C/G),(C/,C,1.02,0.67,1.4,0.09814877,Moderate,0.357,0.254,0.035,0.155,Significant increase (p=0.028),Variable effect (p=0.042),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05342,rs620295,1,27035144,CD2AP,SNP (G/T),(G/,G,2.09,1.71,2.48,0.02467406,Moderate,0.544,0.059,0.125,0.072,Variable effect (p=0.033),No significant pattern (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05343,rs901970,18,99717367,ABCA7,SNP (C/T),(C/,C,1.07,0.81,1.43,0.05160646,Moderate,0.043,0.11,0.258,0.388,Significant decrease (p=0.027),Mild decrease (p=0.043),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05344,rs374508,5,44666306,MS4A6A,SNP (G/T),(G/,G,1.44,1.04,1.71,0.00452824,Unknown,0.274,0.094,0.372,0.06,Variable effect (p=0.037),Mild increase (p=0.034),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05345,rs575055,9,184260009,SORL1,SNP (C/G),(C/,C,1.76,1.51,2.11,0.00938209,Low,0.011,0.568,0.081,0.14,Significant decrease (p=0.037),Significant increase (p=0.03),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP05346,rs928641,18,116639245,BIN1,SNP (C/T),(C/,C,1.1,0.81,1.42,0.01965931,High,0.476,0.025,0.024,0.276,Variable effect (p=0.014),Mild decrease (p=0.046),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05347,rs115312,11,139226169,ABCA7,Deletion,-,-,1.32,0.99,1.67,0.00128718,High,0.369,0.16,0.004,0.268,Mild increase (p=0.024),Variable effect (p=0.001),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05348,rs261630,11,20588979,ABCA7,SNP (C/G),(C/,C,1.33,1.01,1.64,0.02226987,Low,0.453,0.109,0.138,0.1,No significant pattern (p=0.04),Mild decrease (p=0.034),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05349,rs522372,18,231388301,CD33,SNP (G/T),(G/,G,1.24,0.84,1.6,0.0080708,Moderate,0.312,0.119,0.256,0.113,Mild decrease (p=0.032),No significant pattern (p=0.035),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05350,rs678699,12,139218285,CR1,SNP (A/T),(A/,A,1.02,0.64,1.34,0.00926084,High,0.127,0.043,0.499,0.131,Significant decrease (p=0.004),Mild decrease (p=0.031),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP05351,rs124696,4,44916749,EPHA1,SNP (C/G),(C/,C,0.73,0.41,0.93,0.02709703,Low,0.07,0.045,0.256,0.429,Variable effect (p=0.007),Mild decrease (p=0.045),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05352,rs341243,21,242194948,BIN1,SNP (A/T),(A/,A,0.55,0.27,0.79,0.0746415,Moderate,0.136,0.118,0.363,0.182,Significant increase (p=0.023),Significant decrease (p=0.025),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP05353,rs113282,7,123652163,EPHA1,SNP (C/T),(C/,C,0.49,0.27,0.89,0.00195702,High,0.139,0.259,0.383,0.019,Mild increase (p=0.041),Mild increase (p=0.031),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05354,rs282220,3,77851505,ABCA7,SNP (A/G),(A/,A,0.85,0.53,1.07,0.02172847,High,0.07,0.271,0.281,0.177,Significant increase (p=0.04),No significant pattern (p=0.03),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05355,rs442244,16,99353322,MS4A6A,Deletion,-,-,1.16,0.77,1.39,0.0485103,Moderate,0.134,0.321,0.301,0.043,Mild increase (p=0.016),Variable effect (p=0.006),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05356,rs310471,3,89519418,CD33,SNP (A/G),(A/,A,0.38,0.1,0.74,0.03681748,Moderate,0.151,0.004,0.091,0.553,Significant decrease (p=0.039),Significant increase (p=0.049),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05357,rs621753,2,89114494,CLU,SNP (A/G),(A/,A,1.02,0.62,1.35,0.03524281,High,0.262,0.163,0.182,0.193,Mild increase (p=0.005),Mild decrease (p=0.005),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05358,rs281103,6,248517526,PTK2B,Insertion,-,-,1.55,1.32,1.85,0.01186881,Low,0.122,0.114,0.478,0.086,Significant decrease (p=0.006),No significant pattern (p=0.042),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP05359,rs337621,12,83305479,CD33,SNP (A/C),(A/,A,1.15,0.95,1.51,0.00204921,Moderate,0.179,0.271,0.047,0.303,Variable effect (p=0.03),Mild decrease (p=0.011),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP05360,rs329355,8,21440002,ABCA7,Deletion,-,-,1.3,1.1,1.51,0.01032614,High,0.425,0.046,0.118,0.211,Significant increase (p=0.025),Variable effect (p=0.038),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05361,rs156238,15,176099632,MS4A6A,SNP (A/C),(A/,A,0.57,0.3,0.86,0.05430916,Low,0.143,0.307,0.253,0.098,No significant pattern (p=0.029),Significant decrease (p=0.041),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05362,rs374987,15,3527702,PSEN2,SNP (C/G),(C/,C,1.72,1.34,1.95,0.01515638,High,0.167,0.049,0.26,0.324,Mild increase (p=0.005),Variable effect (p=0.027),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05363,rs307203,18,216810280,CD2AP,SNP (C/T),(C/,C,2.14,1.76,2.52,0.0001511,Moderate,0.292,0.211,0.267,0.03,Mild increase (p=0.046),Significant increase (p=0.027),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05364,rs387649,18,179623638,APP,Deletion,-,-,0.61,0.35,0.88,0.03955032,Moderate,0.03,0.086,0.413,0.27,Significant increase (p=0.031),Significant increase (p=0.012),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05365,rs849734,21,62927715,CLU,SNP (A/C),(A/,A,1.74,1.54,2.1,0.03222395,High,0.036,0.008,0.519,0.237,Variable effect (p=0.048),Significant increase (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05366,rs179567,18,208814125,APP,SNP (C/G),(C/,C,2.48,2.26,2.74,0.10911795,Low,0.186,0.021,0.503,0.09,Variable effect (p=0.021),Mild decrease (p=0.007),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05367,rs906313,19,129210837,MS4A6A,SNP (A/T),(A/,A,1.7,1.5,1.92,0.00290348,Low,0.249,0.335,0.156,0.06,Significant decrease (p=0.028),Significant decrease (p=0.01),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05368,rs641343,1,142585381,EPHA1,Insertion,-,-,0.99,0.61,1.22,0.00012464,Protective,0.039,0.142,0.608,0.011,Mild increase (p=0.04),Significant decrease (p=0.009),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05369,rs665893,3,85429150,PICALM,Insertion,-,-,0.97,0.68,1.34,0.02699968,Moderate,0.176,0.42,0.057,0.147,No significant pattern (p=0.009),No significant pattern (p=0.029),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP05370,rs195650,15,160062057,PSEN2,SNP (C/G),(C/,C,1.48,1.2,1.83,0.0237089,Low,0.27,0.05,0.034,0.446,Significant increase (p=0.041),Mild decrease (p=0.027),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05371,rs264942,16,155359096,BIN1,SNP (A/T),(A/,A,0.67,0.37,0.93,0.00294334,Low,0.221,0.095,0.1,0.384,Variable effect (p=0.023),Mild increase (p=0.023),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05372,rs872073,17,101332877,APP,SNP (A/G),(A/,A,0.68,0.32,0.9,0.04412737,Moderate,0.11,0.092,0.219,0.378,Significant increase (p=0.03),Variable effect (p=0.047),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05373,rs675726,19,218893326,APOE,SNP (A/G),(A/,A,1.06,0.77,1.36,0.04450496,Moderate,0.204,0.141,0.152,0.302,Mild decrease (p=0.017),Significant decrease (p=0.036),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05374,rs693529,4,82759066,ABCA7,SNP (A/C),(A/,A,2.07,1.69,2.44,0.05767228,High,0.148,0.098,0.423,0.131,Mild increase (p=0.023),Mild decrease (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05375,rs561933,2,132475897,APOE,SNP (C/G),(C/,C,1.01,0.72,1.23,0.07456805,High,0.595,0.014,0.123,0.067,No significant pattern (p=0.029),Significant decrease (p=0.025),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05376,rs999031,12,120124089,CD2AP,SNP (A/C),(A/,A,1.96,1.61,2.19,0.00876162,Protective,0.002,0.506,0.128,0.164,Significant increase (p=0.002),No significant pattern (p=0.028),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP05377,rs184480,11,160505768,CD2AP,SNP (C/T),(C/,C,1.56,1.33,1.91,0.01947767,High,0.277,0.009,0.103,0.411,Significant decrease (p=0.032),Mild increase (p=0.024),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05378,rs371150,10,47221253,CD33,SNP (A/C),(A/,A,1.07,0.85,1.27,0.01195345,Moderate,0.073,0.315,0.176,0.236,No significant pattern (p=0.018),Significant decrease (p=0.015),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05379,rs532961,19,97546794,ABCA7,SNP (C/G),(C/,C,1.28,1.03,1.51,0.01488927,Low,0.204,0.075,0.447,0.074,Variable effect (p=0.048),Mild increase (p=0.049),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05380,rs549698,14,145518583,APP,SNP (A/T),(A/,A,0.8,0.56,1.19,0.10835824,High,0.007,0.27,0.083,0.439,Significant increase (p=0.041),Mild increase (p=0.011),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05381,rs698851,13,222683728,BIN1,SNP (A/C),(A/,A,1.6,1.4,1.87,0.07007498,High,0.03,0.508,0.245,0.018,Significant increase (p=0.034),Mild decrease (p=0.035),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05382,rs161173,10,48805720,CLU,Deletion,-,-,1.1,0.81,1.45,0.05026863,High,0.218,0.233,0.239,0.11,Mild decrease (p=0.015),Mild decrease (p=0.034),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05383,rs440321,20,151120774,CD2AP,SNP (C/G),(C/,C,1.3,0.92,1.53,0.02128812,Unknown,0.028,0.248,0.475,0.049,No significant pattern (p=0.035),Variable effect (p=0.023),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05384,rs515524,6,71364925,EPHA1,SNP (C/G),(C/,C,0.55,0.28,0.79,0.00580578,Low,0.136,0.039,0.227,0.399,Mild increase (p=0.031),Mild decrease (p=0.03),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05385,rs134317,20,161239736,EPHA1,SNP (C/G),(C/,C,2.06,1.77,2.42,0.0772428,Moderate,0.407,0.233,0.045,0.115,Significant increase (p=0.044),Mild decrease (p=0.05),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05386,rs672374,10,177165246,PICALM,SNP (A/T),(A/,A,2.08,1.83,2.44,0.05725074,Protective,0.364,0.033,0.03,0.372,Mild increase (p=0.05),Variable effect (p=0.035),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05387,rs111459,6,10550694,CR1,SNP (A/C),(A/,A,1.94,1.72,2.19,0.01660756,Moderate,0.089,0.004,0.45,0.257,Significant decrease (p=0.037),Significant decrease (p=0.047),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05388,rs213040,4,52391724,PTK2B,SNP (C/T),(C/,C,0.47,0.1,0.83,0.03183821,Moderate,0.492,0.07,0.179,0.059,Mild decrease (p=0.034),Significant increase (p=0.05),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05389,rs767673,8,94513172,BIN1,SNP (G/T),(G/,G,1.6,1.24,1.88,0.00798088,High,0.037,0.049,0.152,0.561,Variable effect (p=0.039),Significant increase (p=0.019),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05390,rs309546,7,190205189,PICALM,Deletion,-,-,0.73,0.36,0.95,0.02047109,High,0.054,0.423,0.068,0.255,Mild increase (p=0.01),No significant pattern (p=0.048),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05391,rs238782,4,110066098,PTK2B,SNP (A/T),(A/,A,1.49,1.26,1.84,0.06950467,Moderate,0.019,0.129,0.408,0.244,Mild increase (p=0.027),Variable effect (p=0.047),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05392,rs667816,16,186767783,TREM2,SNP (A/C),(A/,A,0.78,0.51,1.06,0.01979972,Moderate,0.254,0.336,0.019,0.191,No significant pattern (p=0.016),Significant increase (p=0.013),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05393,rs814988,12,217624328,CR1,SNP (A/T),(A/,A,1.42,1.22,1.73,0.0217339,Moderate,0.229,0.247,0.127,0.197,Significant decrease (p=0.041),Significant decrease (p=0.005),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05394,rs418776,22,56803013,CLU,SNP (A/C),(A/,A,0.65,0.28,0.86,0.01090245,High,0.012,0.326,0.157,0.304,Significant increase (p=0.002),No significant pattern (p=0.016),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05395,rs496883,12,120601788,CD2AP,Deletion,-,-,0.44,0.17,0.7,0.00641398,High,0.005,0.012,0.301,0.482,Mild decrease (p=0.013),Mild increase (p=0.008),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05396,rs354410,4,224042272,PICALM,SNP (G/T),(G/,G,1.31,1.11,1.6,0.04432017,High,0.114,0.172,0.39,0.124,Significant decrease (p=0.023),Variable effect (p=0.01),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05397,rs717013,14,25710168,PTK2B,SNP (C/G),(C/,C,1.1,0.86,1.34,0.00272575,Moderate,0.034,0.405,0.025,0.337,Mild decrease (p=0.023),No significant pattern (p=0.049),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP05398,rs919389,13,162156382,CLU,SNP (A/T),(A/,A,2.56,2.17,2.95,0.02205676,Low,0.043,0.054,0.1,0.603,Significant decrease (p=0.046),No significant pattern (p=0.005),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05399,rs607157,7,73461326,PTK2B,SNP (G/T),(G/,G,0.6,0.36,0.88,0.01920073,High,0.045,0.265,0.272,0.218,Mild increase (p=0.019),Variable effect (p=0.012),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP05400,rs831938,4,20024802,TREM2,SNP (A/T),(A/,A,0.85,0.61,1.19,0.00686317,Unknown,0.081,0.032,0.261,0.427,Mild decrease (p=0.037),Significant decrease (p=0.035),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05401,rs962537,13,64115312,PTK2B,SNP (G/T),(G/,G,0.4,0.1,0.74,0.01685417,Moderate,0.211,0.019,0.055,0.515,No significant pattern (p=0.033),Variable effect (p=0.035),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05402,rs874405,11,188492209,CLU,SNP (A/G),(A/,A,0.55,0.17,0.87,0.03875194,Low,0.456,0.042,0.032,0.271,No significant pattern (p=0.031),Mild decrease (p=0.02),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP05403,rs706513,13,165205594,APP,SNP (C/T),(C/,C,1.49,1.27,1.86,0.02768842,High,0.121,0.134,0.274,0.272,Mild decrease (p=0.037),Significant increase (p=0.003),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05404,rs493008,5,158737796,APP,SNP (G/T),(G/,G,1.07,0.71,1.37,0.01928765,Low,0.045,0.034,0.062,0.658,Significant decrease (p=0.049),Mild decrease (p=0.002),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05405,rs579507,17,136228046,SORL1,SNP (C/T),(C/,C,1.21,0.85,1.57,0.00279815,Moderate,0.2,0.451,0.04,0.109,Mild decrease (p=0.005),Mild increase (p=0.008),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05406,rs624027,19,79299847,MS4A6A,SNP (A/T),(A/,A,0.69,0.33,1.01,0.01765531,Moderate,0.039,0.091,0.097,0.573,Significant decrease (p=0.023),Mild increase (p=0.035),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05407,rs534165,21,140304247,ABCA7,SNP (C/T),(C/,C,1.27,0.9,1.53,0.00171505,High,0.426,0.1,0.187,0.088,No significant pattern (p=0.018),Variable effect (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05408,rs148387,15,40124242,APP,SNP (A/G),(A/,A,0.36,0.1,0.64,0.11313155,High,0.178,0.042,0.042,0.538,Significant decrease (p=0.033),No significant pattern (p=0.008),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05409,rs493301,5,102071906,EPHA1,SNP (A/C),(A/,A,1.91,1.58,2.19,0.01411412,Unknown,0.064,0.06,0.622,0.055,Variable effect (p=0.027),Significant decrease (p=0.027),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP05410,rs854057,18,92413740,MS4A6A,SNP (C/G),(C/,C,0.94,0.7,1.18,0.05954544,Moderate,0.069,0.041,0.022,0.667,No significant pattern (p=0.02),Significant increase (p=0.028),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05411,rs548288,13,248244350,MS4A6A,SNP (C/T),(C/,C,0.67,0.34,0.94,0.00840723,Unknown,0.208,0.198,0.384,0.01,Variable effect (p=0.017),Variable effect (p=0.027),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05412,rs371336,1,125338170,CD2AP,Deletion,-,-,0.85,0.52,1.16,0.00487073,Moderate,0.039,0.106,0.102,0.553,Significant increase (p=0.013),Significant increase (p=0.032),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05413,rs874372,21,35353435,PTK2B,SNP (C/G),(C/,C,1.45,1.11,1.67,0.02894516,Protective,0.582,0.064,0.002,0.152,Variable effect (p=0.018),Mild decrease (p=0.007),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05414,rs796552,19,19401755,APOE,Insertion,-,-,0.52,0.21,0.82,0.10436519,Moderate,0.3,0.135,0.166,0.198,Variable effect (p=0.013),Significant decrease (p=0.02),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05415,rs779455,16,112369536,APOE,SNP (C/T),(C/,C,1.07,0.74,1.36,0.00423569,High,0.125,0.064,0.575,0.037,Variable effect (p=0.006),Mild increase (p=0.046),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05416,rs352445,22,7147909,PICALM,SNP (A/C),(A/,A,0.6,0.24,0.83,0.01049611,Protective,0.194,0.036,0.346,0.224,Significant increase (p=0.005),Variable effect (p=0.019),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05417,rs995449,14,170926835,TREM2,SNP (A/C),(A/,A,0.93,0.59,1.23,0.02483571,High,0.147,0.442,0.137,0.074,No significant pattern (p=0.034),Significant decrease (p=0.025),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05418,rs772754,11,101563189,MS4A6A,Insertion,-,-,1.61,1.41,1.9,0.05652054,Moderate,0.043,0.171,0.004,0.582,Mild increase (p=0.032),Variable effect (p=0.007),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP05419,rs676889,15,158734546,SORL1,Deletion,-,-,1.81,1.48,2.04,0.05393773,High,0.266,0.167,0.181,0.186,Variable effect (p=0.009),Variable effect (p=0.029),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP05420,rs697944,8,192322186,EPHA1,SNP (C/T),(C/,C,0.47,0.14,0.77,0.08647407,Moderate,0.229,0.168,0.227,0.176,Significant decrease (p=0.007),No significant pattern (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05421,rs208795,13,90963200,PICALM,SNP (G/T),(G/,G,0.4,0.1,0.71,0.07274816,Unknown,0.112,0.314,0.076,0.299,Mild decrease (p=0.035),Mild increase (p=0.016),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05422,rs175982,11,154131944,TREM2,SNP (C/G),(C/,C,0.96,0.67,1.35,0.0624587,High,0.163,0.391,0.196,0.05,Significant decrease (p=0.032),Significant increase (p=0.003),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05423,rs683981,11,172475590,TREM2,SNP (G/T),(G/,G,0.76,0.52,1.02,0.00628582,High,0.088,0.085,0.236,0.391,Significant decrease (p=0.043),Mild increase (p=0.013),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05424,rs685495,12,163034083,CLU,SNP (C/G),(C/,C,0.57,0.21,0.88,0.01174533,Unknown,0.481,0.19,0.016,0.113,Significant increase (p=0.033),Mild increase (p=0.04),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05425,rs306668,15,102765545,CD33,SNP (G/T),(G/,G,0.9,0.65,1.13,0.02980994,Moderate,0.207,0.279,0.162,0.151,Mild increase (p=0.009),No significant pattern (p=0.027),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05426,rs395312,20,199843095,CD2AP,Deletion,-,-,0.81,0.5,1.09,0.00394993,High,0.195,0.508,0.027,0.07,Mild decrease (p=0.016),Mild increase (p=0.014),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05427,rs232554,20,123850792,ABCA7,SNP (A/G),(A/,A,1.23,0.96,1.48,0.07873275,Low,0.032,0.438,0.307,0.023,Significant increase (p=0.041),Variable effect (p=0.028),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05428,rs311938,22,62081263,PTK2B,SNP (A/T),(A/,A,1.95,1.72,2.22,0.0617194,Moderate,0.222,0.051,0.18,0.347,Significant increase (p=0.003),Significant decrease (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05429,rs712513,9,68876665,PICALM,SNP (A/T),(A/,A,0.85,0.45,1.15,0.00619737,Low,0.013,0.331,0.301,0.155,Significant increase (p=0.015),No significant pattern (p=0.017),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05430,rs773674,6,191298378,CLU,SNP (C/T),(C/,C,0.99,0.76,1.34,0.02027714,Low,0.01,0.05,0.18,0.56,Mild increase (p=0.019),Mild increase (p=0.048),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05431,rs216590,18,14504203,ABCA7,SNP (G/T),(G/,G,0.64,0.31,0.98,0.00195582,High,0.158,0.327,0.216,0.099,Significant increase (p=0.028),Mild increase (p=0.041),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP05432,rs865907,13,239588190,SORL1,SNP (C/T),(C/,C,2.03,1.67,2.36,0.00708226,High,0.19,0.25,0.038,0.322,Significant increase (p=0.034),Significant decrease (p=0.014),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP05433,rs753132,20,246024881,APP,SNP (C/T),(C/,C,0.95,0.58,1.33,0.0753063,Moderate,0.164,0.278,0.348,0.011,Significant decrease (p=0.038),Mild decrease (p=0.01),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05434,rs291062,14,192441987,ABCA7,SNP (C/G),(C/,C,0.94,0.72,1.2,0.04814814,Protective,0.19,0.379,0.177,0.054,Significant decrease (p=0.038),Mild decrease (p=0.042),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05435,rs285535,14,94108901,PICALM,SNP (C/G),(C/,C,1.16,0.77,1.42,0.01585479,High,0.054,0.14,0.52,0.087,Mild decrease (p=0.038),Variable effect (p=0.029),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05436,rs325218,20,165218458,PTK2B,SNP (A/T),(A/,A,0.52,0.19,0.77,0.02770237,High,0.325,0.385,0.036,0.053,Mild increase (p=0.03),Mild decrease (p=0.044),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05437,rs561304,18,111207512,APOE,SNP (A/G),(A/,A,1.54,1.27,1.83,0.12564171,Moderate,0.344,0.022,0.364,0.07,Variable effect (p=0.015),Variable effect (p=0.004),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05438,rs339982,15,242489517,APP,SNP (A/T),(A/,A,2.83,2.56,3.04,0.04650506,Protective,0.076,0.264,0.076,0.384,Significant decrease (p=0.014),Significant decrease (p=0.029),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP05439,rs399546,6,57316478,PICALM,SNP (A/T),(A/,A,1.47,1.24,1.76,0.06985181,High,0.276,0.285,0.047,0.192,Variable effect (p=0.032),No significant pattern (p=0.02),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05440,rs802013,22,248690983,ABCA7,Insertion,-,-,3.33,3.02,3.54,0.04844377,Protective,0.112,0.457,0.184,0.047,Mild increase (p=0.047),Variable effect (p=0.006),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05441,rs266211,21,126382371,MS4A6A,SNP (C/T),(C/,C,1.57,1.35,1.85,0.01131222,High,0.377,0.02,0.36,0.042,Significant decrease (p=0.038),Mild increase (p=0.017),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP05442,rs535218,21,54312714,APOE,SNP (C/G),(C/,C,1.1,0.8,1.37,0.0526681,Moderate,0.155,0.345,0.117,0.184,Mild decrease (p=0.041),Significant decrease (p=0.043),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP05443,rs143487,17,136921326,PICALM,SNP (G/T),(G/,G,1.12,0.88,1.34,0.09287883,Moderate,0.245,0.409,0.128,0.019,Mild increase (p=0.026),Significant increase (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05444,rs608090,8,237224290,CD2AP,SNP (G/T),(G/,G,1.92,1.58,2.17,0.00427686,Protective,0.154,0.135,0.254,0.258,Mild increase (p=0.049),Significant decrease (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05445,rs224092,16,170287837,CD2AP,SNP (G/T),(G/,G,0.62,0.22,0.93,0.00474677,High,0.434,0.08,0.22,0.067,Variable effect (p=0.025),No significant pattern (p=0.005),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05446,rs286231,12,89898292,TREM2,Deletion,-,-,0.64,0.28,0.85,0.00032953,High,0.301,0.283,0.109,0.107,No significant pattern (p=0.025),No significant pattern (p=0.041),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05447,rs900448,3,183119294,PTK2B,Deletion,-,-,1.04,0.73,1.29,0.00742118,Low,0.044,0.17,0.199,0.387,Mild decrease (p=0.044),Mild increase (p=0.021),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05448,rs263901,4,177627457,CD33,SNP (G/T),(G/,G,0.61,0.35,0.81,0.02000605,Moderate,0.032,0.316,0.044,0.407,Significant increase (p=0.027),Significant increase (p=0.037),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05449,rs413944,1,103743742,EPHA1,Insertion,-,-,0.73,0.47,1.11,0.11444802,Low,0.006,0.309,0.121,0.363,Mild increase (p=0.047),Variable effect (p=0.041),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP05450,rs286124,21,179734317,APOE,SNP (A/G),(A/,A,1.13,0.82,1.47,0.07560258,High,0.392,0.065,0.123,0.22,No significant pattern (p=0.027),Significant increase (p=0.031),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05451,rs315722,16,185219912,CD33,Insertion,-,-,1.27,0.95,1.49,0.00238103,Moderate,0.43,0.056,0.201,0.113,Significant increase (p=0.028),No significant pattern (p=0.026),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP05452,rs348365,3,56304696,TREM2,Insertion,-,-,0.89,0.56,1.12,0.01978718,Protective,0.023,0.106,0.228,0.443,Significant decrease (p=0.031),Significant decrease (p=0.036),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP05453,rs116135,18,119452575,PSEN2,SNP (C/T),(C/,C,1.07,0.84,1.41,0.02451316,Protective,0.214,0.322,0.217,0.046,Significant increase (p=0.015),Significant increase (p=0.02),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05454,rs307928,2,101284729,PTK2B,SNP (A/G),(A/,A,0.52,0.27,0.78,0.0448439,Moderate,0.188,0.202,0.162,0.247,Mild increase (p=0.031),Variable effect (p=0.02),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05455,rs744794,22,117062150,CLU,Insertion,-,-,1.09,0.87,1.31,0.00650056,Low,0.435,0.047,0.243,0.075,Significant increase (p=0.017),Mild increase (p=0.015),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05456,rs371003,22,106034411,EPHA1,Deletion,-,-,0.42,0.1,0.75,0.02680207,High,0.188,0.075,0.3,0.237,Variable effect (p=0.001),Variable effect (p=0.014),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05457,rs357838,2,193622176,CD33,SNP (G/T),(G/,G,1.99,1.72,2.29,0.00968296,Low,0.006,0.35,0.125,0.319,Mild decrease (p=0.018),No significant pattern (p=0.049),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05458,rs727393,13,169077925,CLU,SNP (A/T),(A/,A,1.16,0.86,1.47,0.00068948,Moderate,0.53,0.191,0.041,0.038,Variable effect (p=0.006),Mild increase (p=0.045),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05459,rs435645,4,13865004,APP,SNP (A/C),(A/,A,0.81,0.57,1.08,0.05064449,Moderate,0.166,0.098,0.151,0.385,Mild decrease (p=0.043),Mild increase (p=0.006),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05460,rs840485,22,214695389,ABCA7,SNP (C/T),(C/,C,0.37,0.1,0.74,0.02421692,Moderate,0.405,0.018,0.159,0.217,Variable effect (p=0.049),Significant increase (p=0.022),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05461,rs965856,6,142653292,MS4A6A,SNP (A/G),(A/,A,0.77,0.55,1.03,0.0532061,Low,0.044,0.442,0.305,0.009,Variable effect (p=0.025),Mild increase (p=0.004),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05462,rs443802,16,144444042,BIN1,SNP (C/G),(C/,C,0.48,0.24,0.74,0.04011618,Protective,0.452,0.299,0.044,0.005,Variable effect (p=0.025),Variable effect (p=0.03),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05463,rs106420,9,188029500,APOE,SNP (A/G),(A/,A,1.84,1.5,2.11,0.02120756,Moderate,0.507,0.126,0.04,0.127,Mild decrease (p=0.046),Variable effect (p=0.013),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05464,rs283665,18,229197422,CR1,Deletion,-,-,0.93,0.64,1.17,0.04421909,Low,0.399,0.011,0.039,0.351,Significant increase (p=0.014),No significant pattern (p=0.041),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05465,rs891018,14,90720535,APP,SNP (C/T),(C/,C,0.93,0.57,1.24,0.01339432,High,0.068,0.104,0.133,0.495,Significant increase (p=0.011),Significant increase (p=0.02),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05466,rs919008,9,130771018,BIN1,SNP (A/C),(A/,A,1.06,0.85,1.34,0.0615484,High,0.476,0.096,0.036,0.191,Mild decrease (p=0.013),Variable effect (p=0.024),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP05467,rs864812,11,241742187,MS4A6A,Insertion,-,-,1.16,0.8,1.55,0.04646992,High,0.006,0.419,0.167,0.208,Significant decrease (p=0.001),Variable effect (p=0.032),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05468,rs440058,2,80822932,CR1,SNP (A/C),(A/,A,0.99,0.76,1.22,0.01197007,High,0.029,0.218,0.126,0.428,No significant pattern (p=0.006),No significant pattern (p=0.049),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05469,rs804563,4,37031334,EPHA1,SNP (C/T),(C/,C,1.56,1.18,1.89,0.05069659,Moderate,0.139,0.457,0.156,0.048,Mild decrease (p=0.025),Variable effect (p=0.014),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05470,rs668077,1,114276534,APP,SNP (A/C),(A/,A,1.31,1.06,1.69,0.00250705,Low,0.538,0.008,0.147,0.107,Variable effect (p=0.05),No significant pattern (p=0.049),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05471,rs567463,14,63178957,TREM2,SNP (C/G),(C/,C,0.38,0.1,0.66,0.01249629,High,0.384,0.13,0.128,0.159,Mild decrease (p=0.049),Variable effect (p=0.026),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05472,rs686360,10,154871516,PTK2B,SNP (A/C),(A/,A,0.73,0.43,1.06,0.01614155,Low,0.206,0.071,0.381,0.141,Significant decrease (p=0.025),Significant increase (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05473,rs120867,5,195158727,PSEN2,SNP (G/T),(G/,G,1.62,1.28,1.87,0.02112591,Moderate,0.541,0.054,0.108,0.097,Mild increase (p=0.003),Mild increase (p=0.016),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05474,rs323667,15,95220464,CLU,SNP (A/G),(A/,A,1.28,0.95,1.6,0.10776356,Low,0.089,0.391,0.061,0.259,Significant decrease (p=0.006),Mild decrease (p=0.004),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05475,rs819739,10,49328677,SORL1,SNP (A/C),(A/,A,1.51,1.27,1.84,0.0282184,Moderate,0.065,0.179,0.542,0.015,Mild decrease (p=0.003),Significant decrease (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05476,rs425038,17,191700095,CD33,SNP (G/T),(G/,G,0.33,0.1,0.69,0.09418883,Low,0.013,0.092,0.43,0.265,Mild increase (p=0.025),Variable effect (p=0.009),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05477,rs841938,21,243815701,APP,SNP (G/T),(G/,G,1.0,0.77,1.26,0.09994217,Low,0.498,0.051,0.012,0.238,Mild decrease (p=0.043),Significant decrease (p=0.002),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05478,rs904415,5,109548423,PICALM,Deletion,-,-,0.34,0.1,0.54,0.05245639,High,0.361,0.05,0.157,0.232,Mild increase (p=0.05),Mild increase (p=0.043),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05479,rs688967,18,34284478,CD2AP,Insertion,-,-,0.77,0.45,1.1,0.00104038,High,0.197,0.294,0.078,0.231,Mild increase (p=0.017),Significant increase (p=0.005),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05480,rs606803,8,235865184,PSEN2,Insertion,-,-,1.46,1.06,1.67,0.09154351,Moderate,0.069,0.095,0.577,0.059,Variable effect (p=0.034),Mild decrease (p=0.005),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05481,rs625105,12,202493199,CD33,SNP (C/T),(C/,C,1.29,1.07,1.54,0.08708279,Low,0.21,0.006,0.153,0.431,No significant pattern (p=0.012),Significant increase (p=0.011),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05482,rs646371,3,111454380,TREM2,SNP (A/G),(A/,A,1.01,0.72,1.27,0.00101338,Unknown,0.058,0.002,0.477,0.263,Significant increase (p=0.001),Mild decrease (p=0.039),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05483,rs522916,20,5084606,TREM2,Deletion,-,-,1.03,0.76,1.4,0.01843207,Low,0.309,0.102,0.228,0.162,Mild increase (p=0.028),Significant decrease (p=0.038),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05484,rs558635,22,213579152,TREM2,SNP (A/G),(A/,A,1.35,0.95,1.65,0.03277364,Moderate,0.106,0.118,0.157,0.419,Mild decrease (p=0.014),No significant pattern (p=0.004),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05485,rs887302,5,2685667,SORL1,Insertion,-,-,0.99,0.78,1.3,0.00359441,High,0.033,0.54,0.194,0.032,Mild decrease (p=0.039),Variable effect (p=0.044),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP05486,rs574063,6,39033245,CR1,SNP (C/G),(C/,C,0.59,0.2,0.86,0.10913651,Moderate,0.491,0.038,0.154,0.117,Significant increase (p=0.013),Mild decrease (p=0.038),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05487,rs475583,11,34714980,CD2AP,SNP (G/T),(G/,G,1.54,1.2,1.77,0.00671482,High,0.17,0.386,0.084,0.161,Significant increase (p=0.025),Significant increase (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP05488,rs265510,18,219173404,CD33,SNP (C/G),(C/,C,1.36,1.0,1.76,0.02319919,Moderate,0.198,0.059,0.532,0.011,Significant increase (p=0.038),Significant increase (p=0.045),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05489,rs106166,4,46983144,CD33,SNP (A/G),(A/,A,1.73,1.53,2.08,0.04380621,High,0.419,0.194,0.107,0.081,Mild increase (p=0.026),Variable effect (p=0.009),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05490,rs235279,20,28626553,BIN1,Deletion,-,-,0.81,0.5,1.04,0.06912383,Protective,0.273,0.224,0.066,0.238,Significant decrease (p=0.018),Significant decrease (p=0.028),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05491,rs924200,22,233035230,CR1,Insertion,-,-,1.79,1.51,2.07,0.015871,High,0.166,0.51,0.075,0.049,Variable effect (p=0.013),Variable effect (p=0.02),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05492,rs436758,4,89740885,TREM2,SNP (A/T),(A/,A,0.75,0.36,1.0,0.02551414,Moderate,0.041,0.559,0.136,0.063,Significant decrease (p=0.023),Significant increase (p=0.026),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05493,rs261938,18,44054021,PICALM,SNP (A/G),(A/,A,1.59,1.2,1.88,0.06636177,High,0.268,0.296,0.068,0.168,Mild increase (p=0.036),No significant pattern (p=0.048),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05494,rs950995,14,33928324,TREM2,SNP (A/G),(A/,A,0.77,0.41,0.98,0.02090269,Protective,0.048,0.095,0.137,0.52,Variable effect (p=0.038),Significant decrease (p=0.004),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP05495,rs922483,14,34209505,CD33,SNP (A/T),(A/,A,0.61,0.3,0.95,0.02987187,High,0.152,0.442,0.173,0.034,Mild decrease (p=0.017),Variable effect (p=0.023),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05496,rs648622,14,248532225,MS4A6A,SNP (C/T),(C/,C,0.24,0.1,0.61,0.11105076,Moderate,0.014,0.055,0.417,0.313,Mild increase (p=0.011),No significant pattern (p=0.003),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05497,rs212197,10,62829292,PTK2B,SNP (A/C),(A/,A,1.25,0.87,1.48,0.05008374,Moderate,0.291,0.084,0.266,0.159,Significant decrease (p=0.034),Mild increase (p=0.001),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05498,rs463203,10,178256954,PTK2B,SNP (A/G),(A/,A,1.22,1.0,1.49,0.04578851,Low,0.244,0.428,0.061,0.067,Mild decrease (p=0.043),Significant decrease (p=0.02),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05499,rs421037,22,187684153,PICALM,Deletion,-,-,0.33,0.1,0.64,0.03474508,Protective,0.412,0.0,0.168,0.22,Mild increase (p=0.037),Significant increase (p=0.024),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP05500,rs853753,22,226286253,PICALM,Insertion,-,-,1.09,0.73,1.42,0.03072341,Protective,0.429,0.136,0.193,0.043,Significant decrease (p=0.002),Mild decrease (p=0.005),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05501,rs898570,20,192966457,APOE,SNP (A/G),(A/,A,0.73,0.35,1.03,0.04809594,High,0.333,0.353,0.08,0.034,Mild increase (p=0.05),Significant decrease (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05502,rs776232,2,149578697,PICALM,SNP (C/T),(C/,C,2.97,2.67,3.2,0.08013494,Protective,0.294,0.06,0.154,0.292,Mild decrease (p=0.036),No significant pattern (p=0.015),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP05503,rs897734,21,100475972,EPHA1,SNP (C/T),(C/,C,1.16,0.91,1.45,0.01952123,High,0.293,0.05,0.158,0.3,Significant decrease (p=0.014),No significant pattern (p=0.012),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05504,rs333555,6,74383672,CD33,SNP (A/G),(A/,A,2.25,2.03,2.49,0.00102431,Moderate,0.083,0.525,0.027,0.165,No significant pattern (p=0.023),No significant pattern (p=0.009),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05505,rs681375,10,198099363,PTK2B,SNP (A/C),(A/,A,0.67,0.31,0.93,0.01025261,Moderate,0.265,0.436,0.038,0.061,No significant pattern (p=0.036),Significant increase (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05506,rs510737,9,146160319,APOE,SNP (C/T),(C/,C,1.71,1.47,1.94,0.02149881,Moderate,0.151,0.422,0.175,0.053,Mild decrease (p=0.006),Significant increase (p=0.001),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05507,rs461301,1,104122517,PICALM,Insertion,-,-,1.68,1.45,1.99,0.01533733,High,0.047,0.532,0.13,0.091,Mild decrease (p=0.022),Variable effect (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05508,rs421717,6,84878855,PTK2B,SNP (A/C),(A/,A,1.18,0.89,1.52,0.03907041,Low,0.111,0.041,0.182,0.466,Mild increase (p=0.022),Mild decrease (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05509,rs932192,5,71170432,BIN1,SNP (A/C),(A/,A,0.71,0.34,1.04,0.04508176,Protective,0.322,0.081,0.259,0.138,No significant pattern (p=0.048),Mild decrease (p=0.015),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05510,rs870463,19,203893144,CD33,SNP (C/G),(C/,C,1.35,1.08,1.63,0.01121067,Moderate,0.164,0.144,0.456,0.035,Significant decrease (p=0.04),Mild increase (p=0.046),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05511,rs881378,8,195906242,ABCA7,SNP (C/G),(C/,C,4.23,3.88,4.48,0.00039526,Low,0.176,0.294,0.018,0.311,Significant increase (p=0.047),No significant pattern (p=0.002),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP05512,rs997699,14,65245899,BIN1,SNP (A/G),(A/,A,1.42,1.03,1.65,0.00128561,High,0.527,0.157,0.053,0.063,Mild increase (p=0.04),Mild increase (p=0.001),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05513,rs254662,11,234049678,TREM2,Deletion,-,-,1.26,1.03,1.48,0.03442013,Moderate,0.044,0.41,0.339,0.007,Significant increase (p=0.02),Variable effect (p=0.021),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP05514,rs787600,1,186090012,BIN1,SNP (C/T),(C/,C,0.38,0.1,0.69,0.1242446,Moderate,0.38,0.028,0.055,0.337,Mild increase (p=0.038),Mild increase (p=0.013),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05515,rs881424,22,23188751,CD33,SNP (C/G),(C/,C,0.75,0.48,1.07,0.05421909,Protective,0.09,0.295,0.307,0.108,Variable effect (p=0.02),No significant pattern (p=0.001),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05516,rs539311,11,177824551,APOE,SNP (G/T),(G/,G,0.77,0.52,1.05,0.01676987,Protective,0.024,0.65,0.048,0.078,Variable effect (p=0.05),Significant increase (p=0.033),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05517,rs167275,15,18725881,APP,SNP (A/G),(A/,A,1.17,0.82,1.54,0.05573637,High,0.043,0.223,0.275,0.26,Significant decrease (p=0.007),Variable effect (p=0.037),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05518,rs729705,15,8433755,SORL1,SNP (C/T),(C/,C,1.89,1.64,2.27,0.05508745,Moderate,0.004,0.22,0.117,0.459,Variable effect (p=0.039),Mild decrease (p=0.016),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05519,rs479839,19,150601326,PICALM,Insertion,-,-,0.59,0.34,0.88,0.0044568,Protective,0.41,0.353,0.028,0.008,No significant pattern (p=0.017),Significant increase (p=0.041),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05520,rs107593,3,142856675,PSEN2,SNP (A/T),(A/,A,1.22,1.02,1.6,0.02750214,Low,0.04,0.209,0.174,0.377,Variable effect (p=0.019),Significant decrease (p=0.039),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05521,rs929718,8,179581975,MS4A6A,SNP (C/G),(C/,C,2.24,1.94,2.47,0.02761163,Unknown,0.103,0.28,0.02,0.397,Mild increase (p=0.035),Variable effect (p=0.035),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05522,rs639517,15,106055765,SORL1,SNP (A/T),(A/,A,0.7,0.47,0.97,0.09465824,Moderate,0.321,0.159,0.05,0.27,Significant decrease (p=0.01),Significant increase (p=0.049),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05523,rs292223,10,151193560,CLU,SNP (A/G),(A/,A,0.85,0.56,1.08,0.03259314,High,0.111,0.293,0.263,0.133,Mild increase (p=0.002),Significant increase (p=0.018),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05524,rs660515,10,5520550,APOE,SNP (A/T),(A/,A,1.15,0.83,1.51,0.03302122,Moderate,0.044,0.001,0.168,0.587,Significant increase (p=0.044),Significant decrease (p=0.027),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP05525,rs436046,18,21523658,CD2AP,SNP (C/T),(C/,C,0.94,0.54,1.31,0.024186,High,0.051,0.268,0.212,0.269,Variable effect (p=0.008),Mild increase (p=0.007),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP05526,rs394802,1,114265634,PSEN2,Insertion,-,-,1.0,0.77,1.26,0.00116147,Low,0.338,0.05,0.402,0.01,Significant increase (p=0.015),Mild increase (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05527,rs681608,7,178446369,PTK2B,SNP (A/G),(A/,A,0.59,0.29,0.88,0.06297351,Moderate,0.293,0.234,0.065,0.207,Variable effect (p=0.039),Variable effect (p=0.009),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05528,rs440863,18,47525514,APP,SNP (C/G),(C/,C,2.45,2.09,2.82,0.00350964,Low,0.255,0.014,0.191,0.34,Significant decrease (p=0.037),Significant decrease (p=0.047),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05529,rs901875,7,96684622,CR1,SNP (C/G),(C/,C,0.54,0.22,0.83,0.05941295,Moderate,0.242,0.111,0.19,0.257,Variable effect (p=0.04),Significant decrease (p=0.045),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05530,rs754632,7,199446710,PSEN2,SNP (C/T),(C/,C,0.79,0.51,1.08,0.01419918,Moderate,0.517,0.178,0.078,0.027,Significant decrease (p=0.047),Mild increase (p=0.023),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05531,rs794090,15,234213568,APP,Deletion,-,-,0.65,0.35,1.03,0.01766571,Moderate,0.098,0.475,0.005,0.222,Significant decrease (p=0.038),Mild decrease (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP05532,rs960273,12,195758635,CLU,SNP (C/T),(C/,C,0.99,0.63,1.39,0.01142205,High,0.226,0.324,0.211,0.039,Significant increase (p=0.017),Variable effect (p=0.033),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05533,rs999294,21,123418812,CR1,Deletion,-,-,0.69,0.3,1.06,0.00246736,High,0.318,0.235,0.046,0.201,Mild increase (p=0.013),No significant pattern (p=0.041),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05534,rs588236,14,133174009,ABCA7,SNP (C/T),(C/,C,0.79,0.39,1.05,0.07992081,Low,0.423,0.048,0.099,0.23,Significant decrease (p=0.013),Mild increase (p=0.044),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05535,rs652646,1,65478132,MS4A6A,Deletion,-,-,0.56,0.3,0.82,0.00894566,Moderate,0.044,0.472,0.255,0.03,No significant pattern (p=0.004),Significant increase (p=0.024),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP05536,rs383366,2,55814417,APP,Deletion,-,-,0.76,0.44,1.08,0.00057545,Moderate,0.026,0.086,0.16,0.527,Mild increase (p=0.044),Significant increase (p=0.03),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05537,rs267414,1,222615238,CLU,SNP (A/G),(A/,A,0.86,0.63,1.23,0.02648484,Moderate,0.343,0.038,0.215,0.204,Mild increase (p=0.012),Mild decrease (p=0.014),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05538,rs426246,17,45343432,CLU,Deletion,-,-,1.57,1.32,1.94,0.0300365,Moderate,0.286,0.118,0.137,0.259,Significant decrease (p=0.021),Mild increase (p=0.016),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05539,rs857343,2,204137337,APP,SNP (C/T),(C/,C,0.95,0.7,1.21,0.06736132,Moderate,0.358,0.304,0.038,0.1,Significant increase (p=0.043),Mild increase (p=0.035),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05540,rs153320,10,180462989,CR1,SNP (A/G),(A/,A,0.91,0.65,1.24,0.00969187,Moderate,0.001,0.538,0.034,0.227,Significant decrease (p=0.015),Significant decrease (p=0.024),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05541,rs976656,11,179756774,TREM2,Insertion,-,-,1.18,0.97,1.48,0.01641279,High,0.088,0.394,0.02,0.297,Mild decrease (p=0.033),Significant increase (p=0.025),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05542,rs994743,12,199174599,MS4A6A,SNP (A/T),(A/,A,2.67,2.3,3.01,0.03657342,Protective,0.014,0.038,0.498,0.25,No significant pattern (p=0.036),No significant pattern (p=0.04),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05543,rs431899,11,244384131,ABCA7,SNP (G/T),(G/,G,1.28,0.98,1.57,0.01664029,High,0.034,0.243,0.365,0.158,Mild increase (p=0.018),Significant decrease (p=0.016),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05544,rs750793,4,191737452,APP,Deletion,-,-,0.66,0.35,0.98,0.00352491,High,0.441,0.071,0.029,0.259,Variable effect (p=0.014),Significant increase (p=0.023),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05545,rs635733,7,63070435,EPHA1,SNP (A/T),(A/,A,1.02,0.72,1.27,0.06436346,Moderate,0.502,0.166,0.064,0.068,Mild decrease (p=0.04),Significant decrease (p=0.032),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05546,rs619940,4,114720606,CLU,SNP (G/T),(G/,G,0.51,0.26,0.75,0.02594562,Moderate,0.374,0.175,0.154,0.096,No significant pattern (p=0.019),Significant decrease (p=0.007),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05547,rs107459,10,42955004,ABCA7,SNP (G/T),(G/,G,1.99,1.74,2.24,0.04473471,Moderate,0.051,0.454,0.061,0.233,No significant pattern (p=0.016),Significant decrease (p=0.009),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05548,rs854786,10,121059923,PICALM,SNP (G/T),(G/,G,2.59,2.28,2.9,0.01514227,High,0.465,0.273,0.046,0.015,Significant decrease (p=0.037),Mild decrease (p=0.025),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05549,rs368099,6,230611080,CD2AP,SNP (G/T),(G/,G,0.62,0.32,0.99,0.02606945,Low,0.376,0.041,0.238,0.145,Significant decrease (p=0.05),Mild decrease (p=0.005),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05550,rs561456,20,64651605,TREM2,SNP (A/C),(A/,A,0.65,0.31,0.87,0.0653198,Moderate,0.102,0.023,0.498,0.177,No significant pattern (p=0.024),No significant pattern (p=0.035),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05551,rs240289,16,141114883,SORL1,SNP (A/G),(A/,A,1.36,1.05,1.69,0.01130531,Low,0.326,0.443,0.027,0.003,Significant decrease (p=0.006),Significant increase (p=0.046),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05552,rs413361,1,240553075,TREM2,SNP (A/C),(A/,A,1.42,1.12,1.76,0.02594901,Low,0.074,0.203,0.433,0.091,Mild decrease (p=0.044),Mild increase (p=0.024),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05553,rs741028,17,5025881,CD33,Insertion,-,-,1.62,1.39,1.85,0.04675146,Moderate,0.368,0.084,0.031,0.317,No significant pattern (p=0.039),Mild increase (p=0.032),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05554,rs899327,21,96230395,CD2AP,SNP (G/T),(G/,G,1.1,0.72,1.45,0.05960749,High,0.285,0.117,0.169,0.228,Significant increase (p=0.03),Significant decrease (p=0.036),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05555,rs563519,4,99159006,CD2AP,Deletion,-,-,2.53,2.3,2.8,0.00715984,Low,0.35,0.358,0.026,0.067,Significant decrease (p=0.01),Variable effect (p=0.022),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05556,rs485451,15,69638998,PICALM,SNP (A/G),(A/,A,1.13,0.77,1.38,0.0241999,High,0.003,0.144,0.254,0.4,Variable effect (p=0.015),Mild increase (p=0.026),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05557,rs960330,22,35622343,PTK2B,Insertion,-,-,0.91,0.65,1.13,0.0291441,Moderate,0.062,0.045,0.21,0.483,No significant pattern (p=0.003),Significant increase (p=0.024),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP05558,rs466989,20,2354124,CLU,Deletion,-,-,1.88,1.61,2.1,0.00584382,Moderate,0.105,0.056,0.366,0.273,No significant pattern (p=0.013),Significant increase (p=0.024),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05559,rs626951,18,32780509,MS4A6A,Deletion,-,-,1.33,0.96,1.6,0.03550522,Protective,0.102,0.024,0.512,0.162,Mild decrease (p=0.008),Significant increase (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP05560,rs356958,14,151056620,PICALM,Insertion,-,-,0.47,0.15,0.85,0.04749654,High,0.243,0.3,0.168,0.089,Significant increase (p=0.02),Significant increase (p=0.036),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05561,rs891311,16,212624063,EPHA1,SNP (C/G),(C/,C,1.68,1.35,1.96,0.03680999,Moderate,0.346,0.097,0.178,0.18,Mild increase (p=0.045),Significant increase (p=0.032),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05562,rs825998,12,121308207,CD33,SNP (A/C),(A/,A,2.49,2.15,2.83,0.06760923,High,0.083,0.234,0.169,0.313,Variable effect (p=0.019),Variable effect (p=0.03),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05563,rs123580,9,75960000,PICALM,SNP (A/G),(A/,A,0.77,0.55,1.16,0.01036445,Moderate,0.02,0.373,0.239,0.168,Variable effect (p=0.042),Mild increase (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05564,rs368182,11,96443581,PTK2B,SNP (A/C),(A/,A,1.63,1.24,2.02,0.04082142,Low,0.165,0.343,0.067,0.226,Significant decrease (p=0.018),Significant decrease (p=0.03),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP05565,rs927473,20,156670947,SORL1,Deletion,-,-,0.44,0.15,0.64,0.00850742,Unknown,0.302,0.177,0.21,0.111,Significant decrease (p=0.002),Mild increase (p=0.023),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP05566,rs387966,4,144545485,CR1,SNP (A/C),(A/,A,1.18,0.96,1.52,0.00033028,High,0.141,0.445,0.113,0.101,Mild increase (p=0.011),Significant decrease (p=0.02),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP05567,rs734640,12,193895895,CR1,SNP (C/T),(C/,C,0.55,0.15,0.78,0.01251511,Unknown,0.247,0.021,0.21,0.322,Mild decrease (p=0.019),Significant decrease (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05568,rs813215,2,239338754,APOE,SNP (A/C),(A/,A,2.31,2.04,2.62,0.04069189,Moderate,0.569,0.142,0.078,0.011,No significant pattern (p=0.031),Significant increase (p=0.036),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP05569,rs565289,7,118599563,BIN1,SNP (C/G),(C/,C,1.21,0.94,1.44,0.03750419,Moderate,0.137,0.32,0.004,0.339,Variable effect (p=0.04),Mild decrease (p=0.004),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05570,rs350836,13,126664610,PTK2B,Insertion,-,-,1.42,1.09,1.7,0.00533032,Low,0.008,0.696,0.067,0.029,Significant decrease (p=0.005),Mild increase (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05571,rs441735,12,201296242,PSEN2,Insertion,-,-,0.91,0.63,1.18,0.00518661,Moderate,0.523,0.043,0.122,0.112,No significant pattern (p=0.029),Significant decrease (p=0.001),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP05572,rs897092,9,15505658,BIN1,SNP (G/T),(G/,G,1.4,1.17,1.74,0.00177716,Moderate,0.085,0.183,0.255,0.277,Significant decrease (p=0.035),Mild increase (p=0.024),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP05573,rs869394,20,33773617,PSEN2,SNP (C/G),(C/,C,1.21,0.89,1.56,0.07874391,Low,0.338,0.279,0.099,0.084,No significant pattern (p=0.032),Mild increase (p=0.033),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05574,rs865141,8,207140033,ABCA7,SNP (A/T),(A/,A,0.53,0.22,0.91,0.01424395,Moderate,0.13,0.022,0.448,0.2,Mild increase (p=0.02),Mild increase (p=0.006),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05575,rs877453,15,86823603,CD2AP,Insertion,-,-,1.58,1.29,1.92,0.02138297,Unknown,0.004,0.098,0.38,0.318,Significant increase (p=0.035),Significant increase (p=0.007),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05576,rs695121,2,51693361,TREM2,Deletion,-,-,1.17,0.91,1.54,0.03366715,Protective,0.139,0.131,0.094,0.436,Significant increase (p=0.009),Mild increase (p=0.017),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05577,rs815825,9,55479357,TREM2,SNP (G/T),(G/,G,0.65,0.41,1.01,0.00305204,High,0.118,0.269,0.199,0.214,Significant decrease (p=0.039),No significant pattern (p=0.049),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP05578,rs517681,3,248951288,PSEN2,Deletion,-,-,0.96,0.6,1.19,0.03947813,High,0.104,0.393,0.076,0.228,Significant increase (p=0.026),Significant increase (p=0.013),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05579,rs390773,4,119579620,CD33,SNP (A/C),(A/,A,1.5,1.18,1.73,0.08322663,Moderate,0.097,0.196,0.353,0.154,Significant increase (p=0.026),Significant increase (p=0.048),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05580,rs884984,8,40406363,SORL1,SNP (A/C),(A/,A,0.82,0.59,1.1,0.02818696,Moderate,0.302,0.142,0.131,0.226,Significant decrease (p=0.016),Mild increase (p=0.002),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05581,rs566922,5,20285220,MS4A6A,Deletion,-,-,1.02,0.72,1.38,0.00130799,Low,0.298,0.326,0.11,0.066,Mild decrease (p=0.047),Significant increase (p=0.007),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05582,rs951596,4,214891013,APOE,SNP (G/T),(G/,G,0.86,0.63,1.19,0.01716342,Unknown,0.058,0.001,0.548,0.193,Mild increase (p=0.029),Significant increase (p=0.001),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05583,rs744945,22,228870485,ABCA7,SNP (A/C),(A/,A,1.06,0.85,1.39,0.02161037,High,0.334,0.357,0.009,0.1,Variable effect (p=0.015),Significant decrease (p=0.027),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05584,rs302389,9,152448925,ABCA7,SNP (A/G),(A/,A,0.27,0.1,0.6,0.00772455,Moderate,0.356,0.132,0.121,0.191,Significant decrease (p=0.041),Significant decrease (p=0.022),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05585,rs624135,12,117257078,CR1,SNP (C/G),(C/,C,1.31,1.11,1.68,0.02856344,Moderate,0.364,0.121,0.006,0.309,Variable effect (p=0.045),Mild decrease (p=0.013),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05586,rs945341,10,15307544,CLU,SNP (C/T),(C/,C,0.72,0.44,1.0,0.04312984,Moderate,0.226,0.074,0.356,0.144,Mild decrease (p=0.011),Variable effect (p=0.048),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05587,rs879138,12,8053481,ABCA7,SNP (A/C),(A/,A,2.79,2.58,3.02,0.06320052,High,0.458,0.136,0.038,0.168,Mild decrease (p=0.045),No significant pattern (p=0.017),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05588,rs282254,13,73494380,EPHA1,SNP (C/T),(C/,C,0.97,0.69,1.29,0.0075565,Moderate,0.067,0.44,0.193,0.1,Significant decrease (p=0.022),Mild decrease (p=0.029),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05589,rs763168,2,1538561,APOE,SNP (C/T),(C/,C,0.73,0.53,0.98,0.03906843,High,0.054,0.281,0.34,0.125,Mild increase (p=0.007),Mild decrease (p=0.038),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05590,rs878322,11,78163846,PSEN2,SNP (A/G),(A/,A,0.5,0.14,0.82,0.01178017,Moderate,0.159,0.311,0.299,0.032,No significant pattern (p=0.004),Mild increase (p=0.034),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05591,rs803125,21,201982603,CR1,SNP (A/C),(A/,A,0.76,0.4,1.16,0.03173132,Moderate,0.065,0.403,0.248,0.084,Mild decrease (p=0.033),No significant pattern (p=0.005),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05592,rs101078,20,66942016,EPHA1,SNP (C/T),(C/,C,0.7,0.31,0.93,0.0357823,Protective,0.007,0.057,0.13,0.605,No significant pattern (p=0.03),Mild decrease (p=0.033),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05593,rs202040,8,116773828,PICALM,SNP (C/T),(C/,C,2.18,1.83,2.41,0.0089843,Low,0.144,0.551,0.036,0.07,Variable effect (p=0.033),Significant increase (p=0.006),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05594,rs215982,12,43561030,PICALM,SNP (G/T),(G/,G,0.62,0.36,0.96,0.04157571,Protective,0.126,0.046,0.125,0.503,Mild increase (p=0.032),No significant pattern (p=0.036),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05595,rs510552,7,186846619,CD33,SNP (A/C),(A/,A,0.69,0.41,1.06,0.0312546,High,0.307,0.393,0.01,0.091,Significant increase (p=0.049),Mild decrease (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP05596,rs944676,4,118038541,CD33,SNP (A/G),(A/,A,0.93,0.71,1.22,0.02632053,Moderate,0.203,0.096,0.136,0.365,Significant decrease (p=0.037),No significant pattern (p=0.049),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05597,rs185808,18,157957593,PTK2B,SNP (A/T),(A/,A,1.13,0.79,1.34,0.00139683,Low,0.024,0.05,0.072,0.654,Variable effect (p=0.026),Mild decrease (p=0.043),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05598,rs434273,5,189768137,TREM2,SNP (C/G),(C/,C,1.26,1.02,1.62,0.05316804,Unknown,0.277,0.314,0.016,0.193,Significant decrease (p=0.013),Significant decrease (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05599,rs867919,18,209155953,CR1,Insertion,-,-,0.67,0.4,0.88,0.03486503,Low,0.08,0.081,0.214,0.425,Mild decrease (p=0.028),Mild increase (p=0.008),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05600,rs522848,15,111092222,EPHA1,SNP (C/G),(C/,C,0.74,0.36,1.08,0.0093589,Moderate,0.165,0.142,0.23,0.262,Variable effect (p=0.004),Mild decrease (p=0.012),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05601,rs914507,15,233747142,CLU,SNP (C/G),(C/,C,0.79,0.58,1.07,0.06600708,Low,0.362,0.218,0.18,0.039,Variable effect (p=0.036),Mild increase (p=0.05),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05602,rs960612,11,134614055,SORL1,SNP (A/G),(A/,A,0.92,0.66,1.18,0.00686862,Low,0.309,0.153,0.206,0.132,Variable effect (p=0.028),Mild decrease (p=0.026),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP05603,rs749613,13,47600941,APOE,SNP (G/T),(G/,G,1.14,0.77,1.45,0.0203763,High,0.365,0.074,0.01,0.351,Mild decrease (p=0.05),No significant pattern (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05604,rs966593,6,72724947,TREM2,SNP (C/G),(C/,C,0.48,0.17,0.7,0.00099626,Moderate,0.084,0.185,0.057,0.474,Variable effect (p=0.042),Variable effect (p=0.006),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05605,rs571471,3,175494895,EPHA1,Deletion,-,-,0.75,0.53,0.99,0.04758679,High,0.05,0.277,0.335,0.138,Significant decrease (p=0.012),Significant decrease (p=0.003),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05606,rs570724,17,157433770,CR1,SNP (A/G),(A/,A,0.58,0.26,0.84,0.05738431,Moderate,0.475,0.135,0.099,0.092,Mild increase (p=0.043),Variable effect (p=0.009),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05607,rs649685,10,35882160,CR1,SNP (C/G),(C/,C,1.05,0.71,1.42,0.05871548,Unknown,0.223,0.279,0.278,0.02,Significant decrease (p=0.044),Mild decrease (p=0.003),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05608,rs233155,6,197127237,EPHA1,SNP (C/T),(C/,C,0.72,0.35,1.04,0.04443371,Moderate,0.098,0.081,0.295,0.326,No significant pattern (p=0.033),Mild decrease (p=0.042),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP05609,rs366193,10,39580211,MS4A6A,SNP (A/C),(A/,A,1.08,0.72,1.34,0.03569978,Low,0.025,0.61,0.046,0.118,Variable effect (p=0.049),Mild increase (p=0.022),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP05610,rs766161,20,230333141,ABCA7,SNP (C/T),(C/,C,0.62,0.35,0.92,0.0476388,High,0.213,0.444,0.056,0.087,No significant pattern (p=0.002),Significant increase (p=0.028),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05611,rs630533,12,183837313,CR1,SNP (A/T),(A/,A,0.32,0.1,0.63,0.00992702,Protective,0.186,0.154,0.023,0.436,Mild increase (p=0.016),Significant decrease (p=0.036),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05612,rs198680,3,46206481,EPHA1,SNP (A/G),(A/,A,0.71,0.31,1.03,0.08911738,High,0.258,0.089,0.151,0.302,Mild decrease (p=0.004),No significant pattern (p=0.031),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05613,rs631672,8,97238906,TREM2,SNP (A/T),(A/,A,0.59,0.22,0.94,0.01931636,High,0.02,0.101,0.545,0.135,No significant pattern (p=0.016),No significant pattern (p=0.033),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05614,rs637383,13,38806763,CR1,SNP (C/G),(C/,C,1.49,1.28,1.84,0.01541472,Low,0.137,0.393,0.069,0.202,Mild decrease (p=0.006),Significant increase (p=0.024),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05615,rs613204,5,127933269,APOE,SNP (G/T),(G/,G,1.1,0.75,1.4,0.0313452,High,0.192,0.277,0.241,0.09,Significant increase (p=0.046),Mild decrease (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05616,rs297847,19,180057122,PICALM,SNP (A/T),(A/,A,1.59,1.21,1.83,0.00963547,Low,0.176,0.12,0.437,0.067,Significant decrease (p=0.01),Mild decrease (p=0.047),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05617,rs516370,13,25533831,CD33,Insertion,-,-,0.55,0.18,0.8,0.02131567,Protective,0.186,0.492,0.06,0.062,No significant pattern (p=0.042),Mild decrease (p=0.049),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05618,rs443215,3,156640741,CLU,Deletion,-,-,1.92,1.53,2.21,0.17010866,Moderate,0.096,0.539,0.158,0.006,No significant pattern (p=0.046),Mild decrease (p=0.026),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP05619,rs116460,11,72019115,SORL1,SNP (C/G),(C/,C,0.69,0.44,0.94,0.02583203,Moderate,0.595,0.012,0.041,0.152,Significant decrease (p=0.01),Mild decrease (p=0.011),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05620,rs419026,18,75741931,BIN1,Deletion,-,-,1.23,0.96,1.58,0.00748215,High,0.045,0.369,0.141,0.245,Variable effect (p=0.023),No significant pattern (p=0.012),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05621,rs733966,1,25580984,BIN1,SNP (C/G),(C/,C,0.87,0.5,1.09,0.00876775,Moderate,0.652,0.047,0.019,0.082,Significant decrease (p=0.013),Variable effect (p=0.022),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05622,rs343117,22,172050771,SORL1,SNP (A/T),(A/,A,1.52,1.22,1.87,0.05732044,Protective,0.089,0.33,0.254,0.127,Mild increase (p=0.005),Mild decrease (p=0.049),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05623,rs367557,6,27805841,APP,Insertion,-,-,2.84,2.56,3.08,0.00616292,High,0.079,0.362,0.201,0.158,Mild decrease (p=0.012),Mild increase (p=0.038),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05624,rs705458,8,60055506,CD2AP,Deletion,-,-,0.86,0.59,1.25,0.002709,Unknown,0.102,0.268,0.419,0.011,No significant pattern (p=0.013),Variable effect (p=0.003),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05625,rs808774,15,172535238,CLU,SNP (A/G),(A/,A,0.84,0.64,1.16,0.07994345,Moderate,0.002,0.37,0.158,0.27,Significant increase (p=0.024),Mild increase (p=0.008),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05626,rs625542,14,116199084,TREM2,SNP (A/C),(A/,A,1.36,1.01,1.65,0.07568277,High,0.158,0.53,0.003,0.109,Significant decrease (p=0.034),No significant pattern (p=0.024),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05627,rs831403,21,70238293,APP,SNP (A/G),(A/,A,2.17,1.81,2.55,0.02541837,Moderate,0.348,0.08,0.092,0.28,Significant decrease (p=0.024),Mild decrease (p=0.032),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05628,rs322103,2,212528478,CD33,Deletion,-,-,0.35,0.1,0.59,0.00377916,Moderate,0.038,0.478,0.158,0.126,Mild decrease (p=0.019),Mild decrease (p=0.017),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05629,rs529204,10,118132078,CLU,SNP (G/T),(G/,G,1.03,0.67,1.35,0.00946814,Moderate,0.392,0.125,0.014,0.269,Mild decrease (p=0.016),Mild increase (p=0.003),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05630,rs738675,14,35207937,PTK2B,SNP (A/C),(A/,A,1.38,1.09,1.63,0.00113586,Low,0.044,0.215,0.127,0.413,Variable effect (p=0.025),No significant pattern (p=0.03),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05631,rs172661,16,127456594,CD33,Insertion,-,-,2.61,2.4,2.89,0.03693324,High,0.114,0.419,0.022,0.246,Mild decrease (p=0.014),No significant pattern (p=0.043),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP05632,rs944139,13,156130578,MS4A6A,SNP (C/G),(C/,C,1.1,0.81,1.46,0.00351463,Moderate,0.091,0.095,0.549,0.065,Variable effect (p=0.024),Mild increase (p=0.012),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05633,rs847292,1,225385373,MS4A6A,SNP (A/G),(A/,A,1.35,0.96,1.69,0.01132948,High,0.315,0.319,0.014,0.152,Significant increase (p=0.015),Mild decrease (p=0.029),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05634,rs842446,17,70432499,SORL1,SNP (A/C),(A/,A,0.88,0.66,1.22,0.00558775,High,0.248,0.321,0.18,0.051,Mild decrease (p=0.011),No significant pattern (p=0.041),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05635,rs378823,3,60358467,PICALM,Deletion,-,-,1.63,1.38,1.98,0.04380087,Unknown,0.041,0.056,0.465,0.238,No significant pattern (p=0.034),Mild decrease (p=0.012),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05636,rs323000,12,138227233,SORL1,SNP (C/G),(C/,C,1.3,0.98,1.58,0.00509937,Unknown,0.022,0.0,0.466,0.311,Mild decrease (p=0.01),Mild increase (p=0.014),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP05637,rs660698,1,10169447,PTK2B,SNP (A/T),(A/,A,0.76,0.4,1.14,0.00147033,High,0.406,0.049,0.186,0.159,Variable effect (p=0.004),Mild increase (p=0.006),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05638,rs695734,7,206316773,PSEN2,SNP (A/T),(A/,A,0.6,0.38,0.95,0.03040307,Moderate,0.239,0.053,0.444,0.063,Variable effect (p=0.031),Significant decrease (p=0.047),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP05639,rs453814,22,166630074,CLU,Deletion,-,-,0.62,0.37,0.96,0.00107655,Unknown,0.028,0.166,0.181,0.425,Significant increase (p=0.047),Variable effect (p=0.031),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05640,rs421834,21,99616680,PTK2B,Insertion,-,-,0.9,0.68,1.26,0.03574853,Low,0.141,0.021,0.612,0.026,Mild increase (p=0.023),Significant decrease (p=0.034),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05641,rs345406,18,45665801,APP,SNP (A/T),(A/,A,1.31,1.03,1.7,0.06197113,Moderate,0.325,0.303,0.14,0.031,Mild decrease (p=0.041),Significant decrease (p=0.033),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05642,rs249570,18,132523194,APOE,SNP (A/G),(A/,A,2.75,2.51,3.1,0.00361871,High,0.024,0.089,0.029,0.659,Significant decrease (p=0.013),Mild increase (p=0.017),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05643,rs154828,18,241271056,APOE,SNP (A/T),(A/,A,0.66,0.33,0.9,0.02847364,Moderate,0.077,0.433,0.172,0.118,Significant increase (p=0.024),Mild increase (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05644,rs112481,2,120803166,APP,SNP (C/G),(C/,C,0.58,0.31,0.91,0.00785376,Low,0.332,0.005,0.228,0.235,Mild decrease (p=0.017),Mild increase (p=0.035),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05645,rs629032,1,170819185,ABCA7,SNP (C/G),(C/,C,2.75,2.36,3.09,0.11795755,Protective,0.328,0.192,0.063,0.217,No significant pattern (p=0.027),Significant decrease (p=0.031),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05646,rs693493,20,99520125,CLU,SNP (A/G),(A/,A,0.25,0.1,0.51,0.00302569,Moderate,0.187,0.318,0.116,0.18,No significant pattern (p=0.011),Significant decrease (p=0.02),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05647,rs763740,17,187855592,EPHA1,SNP (G/T),(G/,G,2.41,2.15,2.75,0.09146054,Low,0.267,0.135,0.216,0.182,Variable effect (p=0.035),Significant increase (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05648,rs698977,15,172147597,CR1,SNP (G/T),(G/,G,1.66,1.44,2.03,0.03461332,Moderate,0.04,0.061,0.219,0.481,Mild increase (p=0.009),Mild decrease (p=0.027),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP05649,rs216017,20,88246707,SORL1,SNP (C/G),(C/,C,1.43,1.15,1.73,0.05387602,Moderate,0.487,0.082,0.039,0.191,Mild increase (p=0.046),No significant pattern (p=0.032),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP05650,rs458371,1,13672434,EPHA1,Insertion,-,-,1.44,1.23,1.81,0.00482704,Low,0.252,0.148,0.251,0.15,No significant pattern (p=0.042),Variable effect (p=0.048),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05651,rs481084,12,88263208,BIN1,Deletion,-,-,0.56,0.33,0.77,0.02891732,High,0.578,0.115,0.009,0.097,Variable effect (p=0.007),Significant increase (p=0.046),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05652,rs858721,16,200309737,TREM2,SNP (C/G),(C/,C,0.71,0.49,0.97,0.0381745,Moderate,0.033,0.045,0.025,0.697,No significant pattern (p=0.013),Significant increase (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05653,rs634768,11,10325758,CLU,SNP (G/T),(G/,G,0.74,0.45,0.98,0.02778338,Moderate,0.109,0.322,0.326,0.044,Significant decrease (p=0.008),Mild decrease (p=0.022),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP05654,rs374465,6,102299939,MS4A6A,SNP (A/C),(A/,A,0.43,0.1,0.67,0.03558499,High,0.04,0.069,0.079,0.612,No significant pattern (p=0.007),Significant decrease (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP05655,rs716161,10,41850956,PICALM,SNP (A/T),(A/,A,0.61,0.28,0.84,0.03630978,High,0.307,0.046,0.339,0.108,Significant decrease (p=0.004),No significant pattern (p=0.004),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05656,rs356273,21,82614250,PSEN2,SNP (C/G),(C/,C,1.76,1.38,2.03,0.09574856,High,0.201,0.264,0.225,0.109,Mild increase (p=0.007),Mild decrease (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05657,rs502074,14,122769469,CD2AP,SNP (G/T),(G/,G,1.47,1.2,1.73,0.04830391,Low,0.056,0.372,0.244,0.129,Significant decrease (p=0.03),No significant pattern (p=0.015),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05658,rs922347,2,8536957,CD33,SNP (A/G),(A/,A,0.72,0.34,1.04,0.04660987,Unknown,0.423,0.12,0.194,0.063,Mild increase (p=0.045),No significant pattern (p=0.03),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05659,rs185989,2,32197766,APP,SNP (A/T),(A/,A,0.96,0.67,1.22,0.18196518,High,0.259,0.144,0.03,0.367,No significant pattern (p=0.02),Variable effect (p=0.003),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP05660,rs647134,10,20293482,ABCA7,SNP (C/T),(C/,C,0.61,0.35,0.9,0.00126675,Protective,0.278,0.066,0.189,0.267,Mild increase (p=0.049),Variable effect (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05661,rs757937,7,224134997,BIN1,SNP (C/G),(C/,C,1.49,1.11,1.87,0.07732606,Moderate,0.209,0.051,0.044,0.495,Mild increase (p=0.027),Variable effect (p=0.01),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05662,rs914394,17,226643480,BIN1,SNP (C/G),(C/,C,1.05,0.84,1.4,0.01343657,Moderate,0.367,0.308,0.047,0.078,Mild increase (p=0.009),Significant increase (p=0.041),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05663,rs909301,9,98151446,PTK2B,SNP (C/G),(C/,C,3.08,2.82,3.37,0.139575,Moderate,0.02,0.011,0.345,0.424,No significant pattern (p=0.015),Significant decrease (p=0.021),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05664,rs583625,14,103719554,PTK2B,SNP (A/C),(A/,A,1.08,0.83,1.37,0.03525141,Moderate,0.071,0.007,0.102,0.619,Mild increase (p=0.035),Significant decrease (p=0.005),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05665,rs647228,16,90305211,MS4A6A,SNP (C/T),(C/,C,1.16,0.85,1.52,0.02925808,Protective,0.257,0.329,0.128,0.086,Mild decrease (p=0.035),Mild decrease (p=0.039),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05666,rs637127,21,99004105,BIN1,SNP (G/T),(G/,G,1.16,0.95,1.44,0.00928367,Unknown,0.49,0.093,0.125,0.093,Mild increase (p=0.003),No significant pattern (p=0.005),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05667,rs803848,13,127198132,SORL1,SNP (A/C),(A/,A,2.22,2.0,2.48,0.01298425,Low,0.048,0.071,0.582,0.099,Variable effect (p=0.027),Mild decrease (p=0.016),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05668,rs869976,6,111316797,PSEN2,SNP (C/G),(C/,C,1.21,0.84,1.48,0.0079973,Moderate,0.294,0.102,0.297,0.107,Significant decrease (p=0.012),Variable effect (p=0.036),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05669,rs748414,1,74192251,MS4A6A,Deletion,-,-,1.05,0.73,1.26,0.02008562,Moderate,0.04,0.112,0.018,0.629,Significant increase (p=0.014),Mild increase (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05670,rs586991,6,215356469,CD2AP,Deletion,-,-,1.19,0.85,1.5,0.01265795,Unknown,0.314,0.095,0.011,0.381,Mild increase (p=0.011),Mild decrease (p=0.028),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05671,rs725108,2,184060299,BIN1,SNP (G/T),(G/,G,2.99,2.75,3.32,0.03685016,Low,0.116,0.483,0.149,0.052,No significant pattern (p=0.017),Significant increase (p=0.009),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05672,rs821199,4,173118992,CR1,Insertion,-,-,1.09,0.86,1.37,0.0310341,High,0.08,0.176,0.518,0.025,Significant increase (p=0.019),Variable effect (p=0.034),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05673,rs892409,6,99847038,PICALM,SNP (C/T),(C/,C,0.79,0.57,1.0,0.01378616,High,0.109,0.468,0.206,0.017,Mild decrease (p=0.023),Mild decrease (p=0.005),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP05674,rs975840,18,104339019,MS4A6A,SNP (C/G),(C/,C,0.42,0.1,0.8,0.00205303,Moderate,0.004,0.308,0.166,0.323,Mild decrease (p=0.017),Significant decrease (p=0.025),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP05675,rs435175,10,43289875,CD33,SNP (G/T),(G/,G,0.59,0.22,0.94,0.02232359,Protective,0.294,0.151,0.286,0.069,Significant increase (p=0.029),Mild increase (p=0.037),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05676,rs837178,3,40635836,APOE,SNP (A/G),(A/,A,1.72,1.48,1.99,0.0091861,Low,0.058,0.225,0.115,0.402,Significant increase (p=0.003),Significant decrease (p=0.004),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05677,rs488377,18,182094443,APOE,SNP (A/C),(A/,A,1.51,1.24,1.89,0.00652764,Low,0.266,0.422,0.061,0.05,Mild increase (p=0.043),Mild increase (p=0.013),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05678,rs985660,7,145011025,CD33,SNP (C/G),(C/,C,1.11,0.84,1.36,0.01862478,Low,0.007,0.052,0.101,0.64,Variable effect (p=0.002),Significant decrease (p=0.029),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05679,rs382239,13,8631871,APOE,Insertion,-,-,0.66,0.33,0.93,0.0762335,High,0.258,0.089,0.189,0.264,Variable effect (p=0.001),No significant pattern (p=0.023),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05680,rs172833,9,84214139,PSEN2,SNP (A/T),(A/,A,0.98,0.71,1.22,0.08985141,Moderate,0.347,0.061,0.16,0.232,Mild decrease (p=0.041),No significant pattern (p=0.037),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05681,rs165660,13,184513216,BIN1,SNP (G/T),(G/,G,2.0,1.77,2.3,0.00442169,Moderate,0.157,0.296,0.325,0.021,Mild increase (p=0.012),Mild increase (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05682,rs268489,12,135152637,BIN1,SNP (G/T),(G/,G,1.79,1.51,2.14,0.01899322,Moderate,0.16,0.14,0.095,0.405,Mild decrease (p=0.031),Variable effect (p=0.049),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP05683,rs332326,11,4637284,APP,SNP (C/G),(C/,C,1.71,1.39,1.96,0.00049044,Low,0.309,0.189,0.183,0.119,Significant decrease (p=0.027),Mild decrease (p=0.012),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05684,rs642669,7,32119743,CD33,Insertion,-,-,0.94,0.62,1.31,0.00415965,Moderate,0.238,0.175,0.116,0.271,Variable effect (p=0.029),Mild decrease (p=0.041),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05685,rs257872,5,194757503,ABCA7,SNP (C/T),(C/,C,1.26,0.89,1.63,0.04311639,Protective,0.372,0.051,0.029,0.348,Mild increase (p=0.043),Mild decrease (p=0.022),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05686,rs914282,2,216821823,PSEN2,SNP (A/G),(A/,A,2.19,1.86,2.46,0.01469694,Moderate,0.306,0.171,0.284,0.039,Significant decrease (p=0.022),Mild decrease (p=0.043),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05687,rs722874,18,179273028,CLU,SNP (G/T),(G/,G,1.04,0.7,1.43,0.08119525,High,0.462,0.006,0.234,0.098,Significant increase (p=0.025),No significant pattern (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP05688,rs813559,14,155761300,MS4A6A,SNP (A/T),(A/,A,1.84,1.47,2.09,0.02607228,Unknown,0.116,0.015,0.461,0.207,Mild increase (p=0.008),Significant increase (p=0.003),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05689,rs939984,16,209015545,PSEN2,Insertion,-,-,0.55,0.25,0.93,0.03285678,Protective,0.112,0.255,0.427,0.007,Significant decrease (p=0.025),Variable effect (p=0.002),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05690,rs464278,22,222934908,ABCA7,SNP (C/G),(C/,C,1.55,1.32,1.77,0.0417864,Low,0.185,0.312,0.087,0.215,Significant increase (p=0.003),No significant pattern (p=0.027),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05691,rs251820,11,147359197,BIN1,Deletion,-,-,1.18,0.9,1.47,0.02272508,Moderate,0.049,0.003,0.622,0.126,Significant increase (p=0.031),Mild increase (p=0.004),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05692,rs659828,5,135203656,CD2AP,SNP (C/T),(C/,C,1.12,0.89,1.44,0.02298377,High,0.33,0.338,0.114,0.019,Variable effect (p=0.006),Mild decrease (p=0.025),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05693,rs327856,5,122570870,TREM2,SNP (A/G),(A/,A,0.43,0.1,0.82,0.03706467,High,0.434,0.058,0.118,0.189,No significant pattern (p=0.046),Significant decrease (p=0.016),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05694,rs565448,20,92245447,APOE,SNP (A/T),(A/,A,1.24,1.02,1.57,0.1396808,Moderate,0.209,0.027,0.447,0.117,Variable effect (p=0.011),Mild decrease (p=0.05),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05695,rs820453,21,154836760,CR1,SNP (A/C),(A/,A,0.67,0.39,1.05,0.05475322,High,0.147,0.219,0.056,0.378,Significant increase (p=0.022),Significant increase (p=0.018),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05696,rs348160,8,120932231,BIN1,SNP (A/T),(A/,A,1.34,0.99,1.69,0.1006067,Low,0.019,0.072,0.537,0.172,No significant pattern (p=0.033),Mild decrease (p=0.024),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05697,rs139166,7,117200366,TREM2,SNP (G/T),(G/,G,0.75,0.55,1.05,0.00429548,Moderate,0.243,0.214,0.158,0.185,Significant increase (p=0.021),No significant pattern (p=0.012),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05698,rs207492,4,125776101,PTK2B,SNP (C/G),(C/,C,0.8,0.54,1.0,0.02750741,Low,0.271,0.191,0.002,0.335,No significant pattern (p=0.012),Significant decrease (p=0.046),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05699,rs750944,10,35132006,CLU,SNP (G/T),(G/,G,0.59,0.22,0.89,0.04213368,High,0.016,0.269,0.432,0.083,Variable effect (p=0.001),Variable effect (p=0.046),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05700,rs615617,21,10574873,CD33,SNP (G/T),(G/,G,1.78,1.54,2.02,0.03134331,High,0.199,0.027,0.558,0.017,Significant decrease (p=0.036),Variable effect (p=0.022),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05701,rs410066,5,133801207,APP,SNP (A/T),(A/,A,1.47,1.08,1.68,0.02380935,High,0.309,0.178,0.256,0.057,Mild decrease (p=0.033),No significant pattern (p=0.044),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05702,rs463447,15,201496273,EPHA1,Insertion,-,-,0.88,0.58,1.21,0.00332908,Moderate,0.438,0.115,0.134,0.114,Mild decrease (p=0.002),Variable effect (p=0.018),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP05703,rs200673,17,201029483,SORL1,Insertion,-,-,0.79,0.43,1.04,0.04466521,Unknown,0.209,0.29,0.253,0.048,No significant pattern (p=0.041),Variable effect (p=0.021),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05704,rs165369,7,229825138,SORL1,Insertion,-,-,1.54,1.18,1.93,0.0071705,Low,0.524,0.17,0.074,0.032,Significant increase (p=0.017),Mild increase (p=0.002),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP05705,rs913782,22,165698045,PTK2B,SNP (C/G),(C/,C,0.86,0.57,1.24,0.01997255,Moderate,0.159,0.002,0.538,0.102,Mild decrease (p=0.028),No significant pattern (p=0.02),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05706,rs449399,21,26158345,CD2AP,Deletion,-,-,0.88,0.65,1.16,0.03802989,High,0.229,0.048,0.137,0.385,Variable effect (p=0.043),Mild decrease (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP05707,rs481755,18,106870470,CLU,SNP (A/T),(A/,A,1.51,1.12,1.83,0.1148973,High,0.006,0.162,0.043,0.588,No significant pattern (p=0.038),No significant pattern (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP05708,rs357191,19,188244336,APP,SNP (A/G),(A/,A,1.78,1.51,2.09,0.00827536,Low,0.057,0.181,0.548,0.014,Variable effect (p=0.01),No significant pattern (p=0.007),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05709,rs963699,6,113799065,PICALM,Deletion,-,-,0.85,0.61,1.09,0.01153679,Low,0.007,0.011,0.701,0.08,Significant increase (p=0.032),No significant pattern (p=0.022),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP05710,rs953712,19,63062017,CD2AP,SNP (G/T),(G/,G,0.71,0.51,1.06,0.04069731,Moderate,0.276,0.044,0.061,0.419,Significant increase (p=0.037),No significant pattern (p=0.026),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05711,rs454079,2,176484893,CD33,SNP (C/T),(C/,C,1.28,1.01,1.49,0.06528855,Moderate,0.012,0.005,0.749,0.033,Significant increase (p=0.028),Variable effect (p=0.014),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05712,rs313808,1,35195581,BIN1,SNP (A/G),(A/,A,1.54,1.27,1.89,0.0068018,High,0.326,0.039,0.044,0.391,Significant decrease (p=0.046),Significant decrease (p=0.026),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05713,rs553820,12,120493934,CD33,Insertion,-,-,2.79,2.46,3.16,0.05726022,High,0.568,0.001,0.2,0.032,Mild increase (p=0.044),Mild decrease (p=0.032),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05714,rs762127,10,167902030,ABCA7,Insertion,-,-,1.53,1.25,1.83,0.07173581,Low,0.217,0.151,0.025,0.407,Significant decrease (p=0.039),Significant decrease (p=0.041),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05715,rs154856,4,12285160,ABCA7,SNP (G/T),(G/,G,1.66,1.42,2.0,0.00456221,Protective,0.068,0.366,0.14,0.226,Mild decrease (p=0.048),Significant increase (p=0.012),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05716,rs510255,22,42000079,CR1,SNP (C/G),(C/,C,2.19,1.96,2.41,0.00035504,High,0.466,0.228,0.058,0.047,Significant increase (p=0.022),Mild increase (p=0.043),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05717,rs545027,15,110015358,CD33,SNP (A/G),(A/,A,0.88,0.5,1.09,0.03865661,High,0.172,0.034,0.115,0.48,Significant increase (p=0.026),Mild increase (p=0.004),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05718,rs670905,15,62896171,CD2AP,SNP (A/T),(A/,A,0.41,0.1,0.74,0.01502505,Low,0.619,0.011,0.078,0.092,Significant decrease (p=0.027),Significant decrease (p=0.007),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05719,rs630611,7,134348833,BIN1,SNP (C/T),(C/,C,0.61,0.36,0.99,0.02347382,Moderate,0.095,0.064,0.417,0.224,Significant decrease (p=0.021),No significant pattern (p=0.039),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05720,rs405430,2,236802444,EPHA1,Insertion,-,-,2.15,1.81,2.39,0.06057583,Moderate,0.379,0.164,0.225,0.033,Variable effect (p=0.023),Variable effect (p=0.013),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05721,rs746989,15,211455626,APP,Deletion,-,-,1.3,1.04,1.61,0.03855594,High,0.107,0.187,0.206,0.3,Mild decrease (p=0.029),Significant increase (p=0.038),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05722,rs290268,11,67661530,APP,Deletion,-,-,0.58,0.18,0.98,0.0166811,Low,0.145,0.126,0.074,0.454,No significant pattern (p=0.021),Significant decrease (p=0.004),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP05723,rs455524,7,105991814,PICALM,SNP (C/T),(C/,C,0.88,0.52,1.28,0.05757941,Moderate,0.249,0.179,0.296,0.075,Mild increase (p=0.048),Mild increase (p=0.043),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05724,rs975576,21,176657646,CR1,SNP (C/G),(C/,C,1.12,0.9,1.45,0.02162041,Moderate,0.122,0.061,0.445,0.172,Mild decrease (p=0.038),Significant increase (p=0.039),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05725,rs620266,5,102819170,PICALM,Insertion,-,-,0.4,0.14,0.66,0.06186764,Moderate,0.095,0.548,0.088,0.069,Mild increase (p=0.007),Mild decrease (p=0.009),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP05726,rs199180,12,194146660,ABCA7,SNP (G/T),(G/,G,0.92,0.52,1.22,0.02101864,Unknown,0.053,0.364,0.302,0.081,Significant increase (p=0.039),Significant decrease (p=0.021),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05727,rs354353,3,27411455,EPHA1,SNP (A/C),(A/,A,1.33,1.08,1.54,0.00761673,Moderate,0.397,0.189,0.02,0.194,No significant pattern (p=0.004),Significant increase (p=0.004),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05728,rs670171,3,209479888,EPHA1,SNP (G/T),(G/,G,0.72,0.37,1.0,0.00625472,Moderate,0.172,0.079,0.466,0.083,Mild increase (p=0.005),Variable effect (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05729,rs404823,9,117472617,CD33,Insertion,-,-,0.5,0.15,0.75,0.00193552,Unknown,0.02,0.232,0.115,0.432,Significant decrease (p=0.028),Mild increase (p=0.031),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05730,rs781396,3,140621718,APOE,SNP (A/T),(A/,A,1.01,0.63,1.28,0.02393892,Protective,0.116,0.576,0.053,0.055,Significant increase (p=0.008),Variable effect (p=0.009),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05731,rs278205,14,203903710,CR1,Deletion,-,-,1.14,0.88,1.5,0.0393397,Moderate,0.015,0.418,0.176,0.191,Mild decrease (p=0.024),No significant pattern (p=0.004),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05732,rs967528,10,20269028,CR1,Deletion,-,-,0.43,0.19,0.67,0.02494266,Low,0.214,0.341,0.024,0.221,Significant increase (p=0.028),Mild increase (p=0.01),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05733,rs897905,14,138535257,PTK2B,SNP (C/G),(C/,C,1.87,1.64,2.24,0.04671125,Moderate,0.041,0.099,0.071,0.59,Significant increase (p=0.046),Variable effect (p=0.014),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05734,rs546395,5,224840564,CLU,SNP (C/T),(C/,C,0.48,0.13,0.71,0.05656396,Low,0.595,0.087,0.003,0.115,Mild decrease (p=0.017),Mild decrease (p=0.037),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP05735,rs687176,1,246515741,CD2AP,SNP (C/G),(C/,C,0.87,0.54,1.15,0.06982525,High,0.324,0.119,0.248,0.11,No significant pattern (p=0.05),Significant decrease (p=0.012),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP05736,rs927893,20,96865918,PSEN2,SNP (C/G),(C/,C,1.9,1.52,2.14,0.03774052,Moderate,0.118,0.045,0.457,0.18,Mild increase (p=0.034),Significant decrease (p=0.026),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05737,rs675832,4,45575061,CR1,SNP (C/G),(C/,C,1.24,0.98,1.5,0.03700782,Moderate,0.505,0.163,0.121,0.011,Mild decrease (p=0.013),Mild decrease (p=0.029),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05738,rs970881,1,148997695,CR1,SNP (A/G),(A/,A,0.46,0.1,0.75,0.00959583,Moderate,0.201,0.04,0.268,0.291,No significant pattern (p=0.03),Mild increase (p=0.034),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05739,rs548987,18,34573218,TREM2,SNP (A/G),(A/,A,0.54,0.34,0.77,0.03168675,Moderate,0.093,0.493,0.004,0.21,No significant pattern (p=0.048),Mild decrease (p=0.042),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05740,rs119007,14,38773775,EPHA1,Deletion,-,-,0.58,0.22,0.85,0.0015092,Low,0.628,0.084,0.06,0.028,Significant decrease (p=0.001),No significant pattern (p=0.02),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05741,rs797742,15,142273883,PSEN2,SNP (A/C),(A/,A,0.92,0.69,1.21,0.03981942,High,0.307,0.125,0.273,0.095,Significant decrease (p=0.012),Significant increase (p=0.015),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP05742,rs741410,20,145862659,CD2AP,Insertion,-,-,1.59,1.26,1.94,0.01615167,Unknown,0.023,0.596,0.02,0.161,Mild increase (p=0.041),No significant pattern (p=0.033),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05743,rs345425,9,10239884,TREM2,Deletion,-,-,1.05,0.79,1.4,0.02425324,Moderate,0.144,0.215,0.327,0.115,Variable effect (p=0.024),Significant decrease (p=0.017),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05744,rs939456,15,30407217,APOE,SNP (A/G),(A/,A,0.85,0.55,1.08,0.03125204,Low,0.165,0.284,0.207,0.143,No significant pattern (p=0.003),Significant decrease (p=0.04),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05745,rs122336,22,47969175,TREM2,SNP (C/T),(C/,C,0.74,0.5,0.95,0.0200902,Moderate,0.466,0.019,0.052,0.263,No significant pattern (p=0.043),Mild decrease (p=0.009),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP05746,rs812802,6,96133318,PICALM,Insertion,-,-,1.93,1.55,2.25,0.00635311,High,0.506,0.112,0.122,0.06,Mild increase (p=0.021),Significant decrease (p=0.023),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05747,rs751565,8,129041246,EPHA1,SNP (A/T),(A/,A,0.64,0.26,0.98,0.00623194,Low,0.177,0.341,0.132,0.15,Significant decrease (p=0.001),Mild increase (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05748,rs874265,9,139846240,APP,SNP (G/T),(G/,G,2.14,1.9,2.54,0.05968917,Unknown,0.066,0.299,0.394,0.041,Significant decrease (p=0.004),Mild increase (p=0.025),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05749,rs316791,11,202866195,PSEN2,Insertion,-,-,0.67,0.3,0.89,0.01816856,High,0.198,0.226,0.058,0.318,Mild increase (p=0.018),Mild increase (p=0.015),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05750,rs429110,10,47474522,CD2AP,SNP (A/T),(A/,A,0.29,0.1,0.52,0.08224709,High,0.333,0.41,0.002,0.055,No significant pattern (p=0.018),Variable effect (p=0.01),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP05751,rs739046,5,177796052,TREM2,Deletion,-,-,1.78,1.41,2.05,0.06052275,Unknown,0.113,0.256,0.05,0.381,Variable effect (p=0.033),Significant decrease (p=0.018),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05752,rs396310,13,81400259,CR1,SNP (A/T),(A/,A,0.58,0.27,0.9,0.00127501,Moderate,0.498,0.23,0.069,0.003,Mild decrease (p=0.046),No significant pattern (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05753,rs666333,16,90143400,CD2AP,SNP (A/T),(A/,A,0.58,0.31,0.84,0.02949195,Moderate,0.296,0.093,0.324,0.087,Significant increase (p=0.029),Significant increase (p=0.018),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05754,rs430182,6,201064885,SORL1,SNP (A/C),(A/,A,0.81,0.48,1.01,0.03011073,Protective,0.216,0.011,0.192,0.381,Variable effect (p=0.027),Mild decrease (p=0.046),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05755,rs574079,3,129482127,BIN1,SNP (C/G),(C/,C,1.12,0.81,1.37,0.05501106,Protective,0.146,0.178,0.13,0.347,Mild decrease (p=0.028),Significant increase (p=0.04),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05756,rs671556,8,231396904,ABCA7,SNP (A/G),(A/,A,0.41,0.16,0.61,0.00383884,High,0.386,0.232,0.16,0.022,No significant pattern (p=0.018),Mild decrease (p=0.044),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05757,rs990583,7,181491559,PTK2B,SNP (A/C),(A/,A,0.84,0.52,1.1,0.03395297,Moderate,0.09,0.334,0.196,0.181,Significant increase (p=0.032),Mild decrease (p=0.025),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05758,rs238237,1,10282790,CR1,SNP (A/T),(A/,A,2.09,1.85,2.4,0.00014777,High,0.167,0.149,0.192,0.291,Mild increase (p=0.012),Significant decrease (p=0.042),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05759,rs765036,9,191710820,CLU,SNP (A/G),(A/,A,1.96,1.59,2.2,0.05868744,Unknown,0.062,0.324,0.365,0.048,Mild increase (p=0.05),Mild increase (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP05760,rs392926,1,74167734,EPHA1,SNP (C/T),(C/,C,2.07,1.74,2.29,0.02907651,High,0.036,0.483,0.214,0.067,No significant pattern (p=0.002),Mild decrease (p=0.046),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP05761,rs423954,6,18856582,CD2AP,SNP (A/C),(A/,A,1.04,0.69,1.25,0.00272417,Moderate,0.144,0.238,0.24,0.178,Significant decrease (p=0.037),Mild decrease (p=0.041),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP05762,rs467281,22,119682928,MS4A6A,SNP (A/T),(A/,A,2.11,1.74,2.31,0.0857611,Low,0.181,0.068,0.512,0.039,Mild increase (p=0.029),Variable effect (p=0.035),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05763,rs706237,9,47886195,CLU,SNP (G/T),(G/,G,0.7,0.36,1.04,0.00825352,Protective,0.32,0.115,0.232,0.133,No significant pattern (p=0.04),Mild increase (p=0.025),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05764,rs514517,8,76153719,CD2AP,Insertion,-,-,0.87,0.56,1.26,0.0991438,High,0.341,0.392,0.045,0.021,Mild decrease (p=0.008),Variable effect (p=0.031),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05765,rs482664,11,204035470,APP,SNP (A/G),(A/,A,0.56,0.17,0.89,0.01126712,Moderate,0.068,0.038,0.292,0.402,Significant decrease (p=0.021),No significant pattern (p=0.035),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP05766,rs315178,16,165773259,PSEN2,SNP (A/T),(A/,A,1.96,1.76,2.29,0.00633832,Moderate,0.217,0.136,0.325,0.123,Significant decrease (p=0.032),Significant increase (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP05767,rs958996,20,99413587,CR1,Insertion,-,-,1.68,1.45,1.88,0.10516493,Moderate,0.258,0.5,0.013,0.028,Mild decrease (p=0.021),No significant pattern (p=0.029),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05768,rs956879,14,158407001,BIN1,SNP (A/T),(A/,A,0.55,0.22,0.83,0.01504451,Moderate,0.247,0.105,0.079,0.369,Variable effect (p=0.007),Variable effect (p=0.037),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05769,rs720011,3,41862290,BIN1,SNP (G/T),(G/,G,0.93,0.72,1.17,0.04985678,Low,0.447,0.096,0.143,0.113,Variable effect (p=0.024),No significant pattern (p=0.004),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05770,rs400227,12,247021901,PTK2B,Insertion,-,-,1.47,1.07,1.67,0.00643784,Protective,0.181,0.143,0.304,0.172,Mild increase (p=0.015),Variable effect (p=0.048),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP05771,rs886608,17,115155594,SORL1,SNP (G/T),(G/,G,1.83,1.45,2.18,0.00347168,Unknown,0.299,0.065,0.103,0.334,No significant pattern (p=0.004),Variable effect (p=0.028),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05772,rs807464,5,144008060,TREM2,Insertion,-,-,1.15,0.82,1.41,0.05642002,High,0.114,0.132,0.463,0.091,Variable effect (p=0.002),Significant decrease (p=0.015),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05773,rs892467,11,190325099,CD2AP,SNP (C/T),(C/,C,0.42,0.15,0.74,0.02309682,Low,0.033,0.25,0.478,0.039,Mild increase (p=0.035),Significant decrease (p=0.021),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05774,rs509346,6,248119926,BIN1,Insertion,-,-,2.14,1.86,2.43,0.00959667,Moderate,0.292,0.007,0.032,0.468,Mild increase (p=0.018),Mild decrease (p=0.016),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP05775,rs186437,16,137477442,CD33,SNP (A/T),(A/,A,0.52,0.2,0.84,0.08214988,Low,0.007,0.21,0.37,0.214,Mild decrease (p=0.003),Mild decrease (p=0.017),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP05776,rs542713,8,20265559,PTK2B,SNP (G/T),(G/,G,0.81,0.58,1.2,0.08014339,Moderate,0.03,0.295,0.269,0.206,Mild decrease (p=0.029),No significant pattern (p=0.038),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05777,rs850113,1,30121533,CLU,Insertion,-,-,1.86,1.57,2.21,0.01540859,High,0.065,0.319,0.111,0.305,Significant decrease (p=0.008),Significant decrease (p=0.034),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05778,rs502188,4,137683360,PTK2B,SNP (C/G),(C/,C,0.46,0.1,0.76,0.02038118,Low,0.122,0.088,0.529,0.06,No significant pattern (p=0.007),Mild increase (p=0.026),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05779,rs296859,10,132615484,BIN1,SNP (A/C),(A/,A,0.86,0.57,1.21,0.01484232,High,0.286,0.019,0.181,0.314,Significant decrease (p=0.012),Significant decrease (p=0.035),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP05780,rs639219,11,123661065,ABCA7,SNP (A/C),(A/,A,0.81,0.56,1.08,0.04141165,Low,0.438,0.233,0.119,0.01,Significant increase (p=0.011),Significant decrease (p=0.016),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05781,rs215383,19,14582335,APOE,SNP (G/T),(G/,G,0.58,0.21,0.95,0.05794413,Moderate,0.123,0.002,0.464,0.212,Significant increase (p=0.003),Variable effect (p=0.016),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05782,rs256194,12,124948231,CLU,SNP (G/T),(G/,G,1.66,1.37,1.9,0.08956745,High,0.215,0.19,0.177,0.217,Significant decrease (p=0.016),Significant increase (p=0.028),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05783,rs792501,10,80542409,MS4A6A,SNP (A/T),(A/,A,0.17,0.1,0.49,0.0320271,Low,0.201,0.126,0.306,0.167,Significant increase (p=0.023),Significant increase (p=0.039),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05784,rs930773,17,134278402,EPHA1,SNP (A/T),(A/,A,1.02,0.67,1.28,0.02545966,Moderate,0.241,0.338,0.121,0.099,Mild increase (p=0.015),No significant pattern (p=0.022),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05785,rs657168,21,104684605,PICALM,SNP (C/G),(C/,C,0.57,0.34,0.77,0.02606349,High,0.009,0.173,0.556,0.062,Significant increase (p=0.009),Significant increase (p=0.04),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05786,rs607041,18,154535834,MS4A6A,Insertion,-,-,0.85,0.47,1.22,0.0344154,Moderate,0.419,0.235,0.113,0.032,No significant pattern (p=0.034),No significant pattern (p=0.035),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05787,rs150031,13,183880862,EPHA1,SNP (G/T),(G/,G,0.86,0.6,1.22,0.00319127,Protective,0.464,0.067,0.031,0.238,No significant pattern (p=0.028),No significant pattern (p=0.03),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP05788,rs347294,16,116807653,BIN1,Deletion,-,-,0.86,0.58,1.19,0.0293443,Low,0.183,0.098,0.288,0.231,Significant decrease (p=0.008),Significant decrease (p=0.034),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05789,rs793431,11,227963836,EPHA1,SNP (G/T),(G/,G,0.63,0.33,0.94,0.03215207,Moderate,0.199,0.514,0.034,0.052,Variable effect (p=0.026),No significant pattern (p=0.019),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05790,rs433021,11,40792064,CR1,SNP (A/T),(A/,A,0.99,0.61,1.33,0.07984042,Moderate,0.252,0.218,0.176,0.154,Mild decrease (p=0.033),Mild decrease (p=0.026),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05791,rs241779,16,103145686,PSEN2,SNP (A/T),(A/,A,1.1,0.86,1.4,0.03246407,Unknown,0.16,0.539,0.08,0.021,Variable effect (p=0.044),Mild decrease (p=0.021),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05792,rs648960,14,135479916,SORL1,SNP (A/G),(A/,A,2.24,1.86,2.57,0.04165659,Protective,0.137,0.023,0.55,0.09,No significant pattern (p=0.043),Significant decrease (p=0.005),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05793,rs147760,22,137985772,BIN1,SNP (C/G),(C/,C,1.92,1.53,2.3,0.03330526,Protective,0.137,0.267,0.009,0.387,No significant pattern (p=0.05),Significant increase (p=0.023),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05794,rs508922,17,53868660,PICALM,SNP (G/T),(G/,G,0.58,0.35,0.85,0.02283978,Low,0.432,0.154,0.213,0.002,Significant increase (p=0.006),Mild increase (p=0.01),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05795,rs162958,11,152197277,BIN1,Insertion,-,-,0.49,0.12,0.83,0.04568739,High,0.032,0.518,0.005,0.245,Mild increase (p=0.014),Variable effect (p=0.018),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05796,rs870201,12,213982492,BIN1,Deletion,-,-,1.56,1.18,1.96,0.01514649,Protective,0.18,0.179,0.174,0.267,Significant decrease (p=0.024),Significant increase (p=0.035),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05797,rs877663,6,124661048,PSEN2,SNP (A/T),(A/,A,1.72,1.38,2.02,0.03404727,Low,0.165,0.177,0.237,0.221,Mild decrease (p=0.05),Significant decrease (p=0.031),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05798,rs648874,20,169907781,PICALM,SNP (G/T),(G/,G,2.57,2.3,2.91,0.05928544,High,0.386,0.097,0.023,0.294,Mild decrease (p=0.045),Variable effect (p=0.027),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05799,rs420605,8,203531219,CD33,Insertion,-,-,0.85,0.49,1.25,0.00875936,Moderate,0.249,0.35,0.082,0.12,Mild decrease (p=0.01),Significant decrease (p=0.003),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05800,rs278803,16,57876387,TREM2,SNP (C/G),(C/,C,1.59,1.24,1.81,0.03797734,Low,0.218,0.499,0.018,0.065,Mild increase (p=0.002),Significant increase (p=0.047),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05801,rs314654,21,78629320,BIN1,SNP (A/G),(A/,A,0.39,0.1,0.7,0.01866714,High,0.174,0.174,0.055,0.397,Significant decrease (p=0.024),Significant increase (p=0.048),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05802,rs240650,1,227470882,MS4A6A,SNP (A/C),(A/,A,1.0,0.65,1.28,0.03104202,Protective,0.099,0.202,0.161,0.338,Mild decrease (p=0.014),No significant pattern (p=0.048),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05803,rs470074,11,119354351,APOE,SNP (C/T),(C/,C,1.11,0.82,1.46,0.02636243,Moderate,0.134,0.322,0.111,0.233,Mild decrease (p=0.049),Mild increase (p=0.033),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05804,rs106114,4,126007934,ABCA7,SNP (G/T),(G/,G,0.91,0.68,1.13,0.00780547,Moderate,0.179,0.04,0.242,0.339,Significant decrease (p=0.004),No significant pattern (p=0.041),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05805,rs810552,15,150222835,ABCA7,Deletion,-,-,2.46,2.13,2.83,0.06072071,Protective,0.224,0.131,0.197,0.248,Variable effect (p=0.042),Mild decrease (p=0.024),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05806,rs974821,8,164317851,PTK2B,SNP (C/G),(C/,C,0.95,0.63,1.35,0.04011756,High,0.387,0.127,0.165,0.121,Mild decrease (p=0.035),Variable effect (p=0.045),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05807,rs725250,17,192185950,MS4A6A,Insertion,-,-,1.57,1.17,1.89,0.01865544,Moderate,0.069,0.117,0.399,0.215,Significant increase (p=0.04),Significant decrease (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05808,rs487065,20,120906551,MS4A6A,SNP (A/G),(A/,A,2.19,1.93,2.41,0.00873264,Moderate,0.149,0.01,0.328,0.313,No significant pattern (p=0.029),Significant increase (p=0.04),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP05809,rs855863,14,30828541,TREM2,SNP (A/G),(A/,A,0.42,0.17,0.81,0.0217512,Protective,0.569,0.0,0.141,0.089,Significant increase (p=0.009),Mild increase (p=0.013),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05810,rs197867,10,56578687,MS4A6A,SNP (A/G),(A/,A,1.68,1.44,2.03,0.01563164,Moderate,0.434,0.019,0.115,0.232,Variable effect (p=0.034),Mild increase (p=0.035),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP05811,rs764947,14,170590981,PICALM,Deletion,-,-,0.89,0.63,1.21,0.05374474,Moderate,0.052,0.41,0.195,0.143,No significant pattern (p=0.001),Variable effect (p=0.042),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP05812,rs105546,13,34805252,PTK2B,SNP (C/G),(C/,C,1.4,1.15,1.69,0.01160195,Moderate,0.045,0.086,0.075,0.595,Variable effect (p=0.03),Significant decrease (p=0.026),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05813,rs377309,3,22292383,MS4A6A,SNP (A/C),(A/,A,0.58,0.3,0.8,0.00354142,Moderate,0.299,0.258,0.083,0.161,No significant pattern (p=0.005),Variable effect (p=0.044),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05814,rs862250,7,80886369,BIN1,SNP (G/T),(G/,G,2.14,1.76,2.44,0.09590175,Moderate,0.116,0.385,0.295,0.004,Variable effect (p=0.032),Significant decrease (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05815,rs575917,17,85678063,CD33,Deletion,-,-,2.25,1.85,2.48,0.0244781,High,0.076,0.304,0.409,0.011,Variable effect (p=0.009),Significant increase (p=0.038),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05816,rs591009,13,186824317,APOE,SNP (G/T),(G/,G,0.5,0.22,0.8,0.05904789,Moderate,0.041,0.071,0.559,0.129,Significant decrease (p=0.039),Mild decrease (p=0.038),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05817,rs656455,4,216204938,APOE,SNP (C/T),(C/,C,1.02,0.68,1.23,0.06488131,Protective,0.109,0.271,0.35,0.07,Significant increase (p=0.019),Variable effect (p=0.045),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05818,rs511609,12,138106142,CD2AP,SNP (A/T),(A/,A,1.19,0.96,1.4,0.04372879,High,0.129,0.224,0.183,0.264,Mild decrease (p=0.029),Variable effect (p=0.043),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05819,rs936204,3,146245813,CD2AP,Deletion,-,-,0.68,0.42,0.92,0.02583253,Low,0.006,0.16,0.292,0.342,No significant pattern (p=0.009),Mild increase (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05820,rs309873,2,228427553,BIN1,Insertion,-,-,1.81,1.57,2.14,0.02114049,Moderate,0.166,0.537,0.085,0.012,Significant decrease (p=0.016),Mild increase (p=0.04),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05821,rs677400,11,39655295,APP,SNP (A/T),(A/,A,0.61,0.32,0.84,0.09147852,Low,0.031,0.029,0.41,0.33,Mild decrease (p=0.044),Variable effect (p=0.049),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05822,rs794747,18,235774552,MS4A6A,SNP (G/T),(G/,G,1.46,1.09,1.77,0.01186773,Unknown,0.454,0.187,0.031,0.129,Significant increase (p=0.01),Variable effect (p=0.024),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05823,rs379673,13,135377679,PICALM,Deletion,-,-,0.32,0.1,0.57,0.04923085,Low,0.064,0.165,0.498,0.073,Significant decrease (p=0.009),Mild increase (p=0.016),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05824,rs323686,8,199680911,BIN1,SNP (A/G),(A/,A,1.24,1.0,1.62,0.01720291,Moderate,0.446,0.015,0.019,0.321,Variable effect (p=0.049),Mild decrease (p=0.022),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05825,rs590301,14,132728188,EPHA1,SNP (C/T),(C/,C,1.06,0.85,1.45,0.00272442,Protective,0.192,0.385,0.03,0.193,Mild decrease (p=0.032),Significant increase (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05826,rs280629,19,184308903,EPHA1,SNP (G/T),(G/,G,1.6,1.36,1.89,0.02026393,High,0.128,0.369,0.066,0.237,Significant decrease (p=0.049),Mild decrease (p=0.041),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05827,rs503018,19,221634436,PSEN2,SNP (C/G),(C/,C,1.89,1.53,2.24,0.00784699,Low,0.246,0.372,0.063,0.12,Significant decrease (p=0.007),No significant pattern (p=0.04),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05828,rs549321,3,95160201,APOE,SNP (A/G),(A/,A,0.72,0.32,1.06,0.04295036,Protective,0.012,0.204,0.091,0.493,Mild decrease (p=0.016),No significant pattern (p=0.037),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05829,rs674562,9,247302795,CD2AP,Deletion,-,-,1.14,0.79,1.4,0.04218999,Low,0.01,0.082,0.236,0.472,Variable effect (p=0.008),Mild increase (p=0.015),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05830,rs617253,10,88049074,EPHA1,Insertion,-,-,0.9,0.5,1.23,0.04968927,Low,0.105,0.469,0.092,0.134,Mild increase (p=0.017),Variable effect (p=0.027),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05831,rs473044,13,218313129,APP,SNP (A/C),(A/,A,4.27,3.91,4.53,0.05730984,Low,0.151,0.019,0.548,0.082,Significant decrease (p=0.004),Mild decrease (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP05832,rs612233,4,64120739,MS4A6A,SNP (C/G),(C/,C,0.97,0.74,1.17,0.00430106,Protective,0.007,0.454,0.299,0.04,Significant increase (p=0.036),Significant decrease (p=0.006),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05833,rs186080,5,54477068,BIN1,Deletion,-,-,1.44,1.09,1.78,0.00621102,Low,0.333,0.055,0.214,0.198,Variable effect (p=0.018),Mild decrease (p=0.004),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05834,rs250757,1,166402663,CD33,SNP (A/G),(A/,A,0.89,0.57,1.11,0.05521681,Moderate,0.393,0.241,0.091,0.076,Mild decrease (p=0.037),Significant increase (p=0.042),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05835,rs949108,10,5732399,EPHA1,SNP (C/T),(C/,C,3.39,3.0,3.73,0.05962878,Moderate,0.28,0.354,0.085,0.081,Variable effect (p=0.002),Mild increase (p=0.009),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05836,rs412926,11,122713473,MS4A6A,SNP (C/T),(C/,C,1.4,1.04,1.8,0.00622209,Moderate,0.085,0.299,0.224,0.192,No significant pattern (p=0.03),No significant pattern (p=0.019),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05837,rs639205,9,229005581,CR1,SNP (A/G),(A/,A,0.45,0.1,0.69,0.04839459,Protective,0.424,0.025,0.335,0.016,No significant pattern (p=0.002),No significant pattern (p=0.006),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05838,rs130603,10,110493714,APOE,SNP (A/G),(A/,A,1.47,1.1,1.79,0.08203624,Low,0.019,0.391,0.039,0.351,No significant pattern (p=0.009),Variable effect (p=0.014),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05839,rs456987,7,186206240,EPHA1,SNP (A/G),(A/,A,0.65,0.45,0.88,0.04815523,High,0.043,0.026,0.438,0.293,Mild decrease (p=0.021),Mild increase (p=0.002),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05840,rs225959,5,36757366,APP,SNP (C/T),(C/,C,1.36,1.08,1.7,0.00789871,High,0.027,0.556,0.035,0.182,Mild decrease (p=0.007),No significant pattern (p=0.015),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05841,rs553175,1,51418330,PICALM,SNP (G/T),(G/,G,0.88,0.52,1.23,0.00562874,High,0.269,0.041,0.477,0.013,Significant increase (p=0.003),Mild decrease (p=0.035),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05842,rs579049,12,49868879,SORL1,SNP (G/T),(G/,G,0.95,0.75,1.35,0.0105151,High,0.129,0.244,0.339,0.088,No significant pattern (p=0.01),Mild decrease (p=0.043),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP05843,rs458140,13,67042320,ABCA7,SNP (A/C),(A/,A,0.72,0.39,1.02,0.03333497,Unknown,0.065,0.376,0.025,0.335,Variable effect (p=0.031),Mild decrease (p=0.011),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05844,rs157405,9,93480510,PSEN2,SNP (G/T),(G/,G,1.23,0.86,1.44,0.01990082,Moderate,0.011,0.483,0.045,0.261,Mild decrease (p=0.015),No significant pattern (p=0.004),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05845,rs841237,15,233181558,MS4A6A,SNP (G/T),(G/,G,0.33,0.1,0.72,0.04150339,High,0.592,0.047,0.032,0.128,No significant pattern (p=0.013),Variable effect (p=0.022),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05846,rs359411,4,75319040,EPHA1,SNP (C/T),(C/,C,1.6,1.28,1.88,0.02055623,Low,0.063,0.384,0.217,0.137,Mild increase (p=0.002),Significant increase (p=0.012),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05847,rs346689,7,225543844,CR1,SNP (C/T),(C/,C,0.61,0.35,0.87,0.0586073,High,0.097,0.515,0.146,0.042,Mild decrease (p=0.045),No significant pattern (p=0.006),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05848,rs537631,8,154140240,APP,SNP (A/C),(A/,A,0.57,0.3,0.91,0.03382347,Unknown,0.575,0.037,0.004,0.185,No significant pattern (p=0.02),Variable effect (p=0.003),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP05849,rs596266,12,234076689,APP,SNP (A/C),(A/,A,2.51,2.26,2.86,0.13485764,Protective,0.066,0.685,0.013,0.036,Mild decrease (p=0.027),Significant decrease (p=0.003),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05850,rs787826,8,231140478,CLU,SNP (A/T),(A/,A,0.56,0.21,0.81,0.0211732,High,0.022,0.239,0.255,0.284,Variable effect (p=0.017),Mild decrease (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05851,rs898036,9,184136748,APP,SNP (C/T),(C/,C,0.87,0.53,1.12,0.06923849,Moderate,0.359,0.05,0.327,0.064,Mild increase (p=0.041),No significant pattern (p=0.049),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05852,rs678030,13,61443798,PICALM,SNP (A/T),(A/,A,0.56,0.21,0.78,0.00849997,High,0.086,0.041,0.355,0.319,Mild decrease (p=0.004),No significant pattern (p=0.032),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05853,rs325920,9,160374940,MS4A6A,SNP (A/G),(A/,A,1.19,0.85,1.42,0.00834635,Moderate,0.205,0.089,0.378,0.128,Mild increase (p=0.018),Variable effect (p=0.02),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP05854,rs860014,5,244411823,APP,SNP (G/T),(G/,G,2.48,2.26,2.88,0.06183658,High,0.087,0.09,0.446,0.178,No significant pattern (p=0.025),Mild decrease (p=0.03),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05855,rs638054,14,93017234,MS4A6A,SNP (G/T),(G/,G,1.72,1.43,2.02,0.01329382,Low,0.035,0.031,0.613,0.121,Mild increase (p=0.006),Mild increase (p=0.004),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP05856,rs719886,22,219551397,CR1,SNP (A/G),(A/,A,0.46,0.14,0.86,0.07715518,High,0.023,0.057,0.524,0.196,No significant pattern (p=0.024),Mild increase (p=0.018),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05857,rs493603,18,152069561,CR1,SNP (A/T),(A/,A,1.93,1.59,2.28,0.08388971,Low,0.491,0.231,0.052,0.026,Variable effect (p=0.017),Mild increase (p=0.008),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP05858,rs645605,22,181109040,CD2AP,Deletion,-,-,0.8,0.47,1.05,0.04352601,Moderate,0.209,0.253,0.196,0.142,Mild decrease (p=0.029),No significant pattern (p=0.021),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP05859,rs594304,12,113972154,SORL1,SNP (A/C),(A/,A,0.79,0.39,1.14,0.0039239,Moderate,0.037,0.028,0.637,0.098,Mild increase (p=0.022),Variable effect (p=0.015),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05860,rs986217,7,198106047,PICALM,SNP (A/G),(A/,A,1.98,1.65,2.25,0.12452965,Moderate,0.298,0.014,0.278,0.209,Significant increase (p=0.044),Significant decrease (p=0.044),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05861,rs971158,2,136670774,CD33,SNP (C/G),(C/,C,1.51,1.22,1.87,0.03711547,Low,0.03,0.176,0.364,0.23,Mild increase (p=0.029),Mild decrease (p=0.034),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05862,rs449998,11,178687634,MS4A6A,SNP (A/G),(A/,A,0.86,0.56,1.16,0.02448914,High,0.206,0.17,0.269,0.154,Mild increase (p=0.001),No significant pattern (p=0.027),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP05863,rs708786,2,87617817,EPHA1,Deletion,-,-,1.01,0.66,1.31,0.01679883,High,0.34,0.154,0.042,0.264,No significant pattern (p=0.006),No significant pattern (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05864,rs648759,10,111286008,CLU,SNP (G/T),(G/,G,2.56,2.24,2.77,0.008037,High,0.004,0.201,0.381,0.213,Significant increase (p=0.037),Mild decrease (p=0.006),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05865,rs624666,18,210878241,PICALM,SNP (C/T),(C/,C,1.03,0.82,1.38,0.01169632,Moderate,0.179,0.109,0.268,0.244,Mild increase (p=0.037),No significant pattern (p=0.022),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05866,rs455619,14,212543027,ABCA7,SNP (G/T),(G/,G,1.06,0.83,1.43,0.02307929,Moderate,0.05,0.088,0.074,0.589,Mild increase (p=0.041),Significant decrease (p=0.02),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05867,rs544169,12,182294666,EPHA1,SNP (A/G),(A/,A,1.49,1.12,1.79,0.01547885,Protective,0.526,0.005,0.119,0.15,Significant decrease (p=0.008),Mild decrease (p=0.037),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP05868,rs217245,13,210671193,PTK2B,SNP (A/T),(A/,A,0.58,0.37,0.85,0.14011886,Protective,0.066,0.396,0.166,0.172,Mild decrease (p=0.049),Significant increase (p=0.014),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05869,rs965581,22,237186267,PTK2B,SNP (C/G),(C/,C,2.26,1.98,2.57,0.08120526,High,0.352,0.228,0.151,0.069,Mild decrease (p=0.043),Mild decrease (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05870,rs584493,11,217697537,APOE,SNP (G/T),(G/,G,1.3,1.09,1.62,0.05880498,Low,0.222,0.483,0.004,0.092,Variable effect (p=0.03),No significant pattern (p=0.021),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP05871,rs962368,6,130518475,CR1,SNP (C/T),(C/,C,1.05,0.77,1.32,0.00609484,Low,0.167,0.148,0.402,0.083,Variable effect (p=0.005),Mild increase (p=0.029),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05872,rs974821,7,133004974,CR1,SNP (C/G),(C/,C,0.6,0.26,0.94,0.00137432,Low,0.073,0.597,0.124,0.005,Variable effect (p=0.02),Variable effect (p=0.038),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05873,rs823839,12,67474605,SORL1,SNP (A/G),(A/,A,1.42,1.06,1.73,0.04470507,High,0.562,0.002,0.061,0.175,Variable effect (p=0.01),Mild increase (p=0.044),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP05874,rs102528,16,97115218,BIN1,SNP (C/T),(C/,C,0.76,0.41,1.02,0.03675492,High,0.214,0.164,0.083,0.339,Mild increase (p=0.004),Mild increase (p=0.003),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05875,rs314553,1,41330351,EPHA1,SNP (A/G),(A/,A,1.33,0.96,1.7,0.00104929,Moderate,0.135,0.405,0.088,0.172,Significant increase (p=0.044),Mild decrease (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05876,rs446579,8,67349289,PICALM,Deletion,-,-,3.63,3.39,3.94,0.00221916,Low,0.088,0.323,0.336,0.053,Variable effect (p=0.043),Mild increase (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP05877,rs742626,5,7535107,CD33,SNP (A/T),(A/,A,0.48,0.26,0.73,0.00955672,High,0.147,0.536,0.074,0.043,Mild decrease (p=0.031),Variable effect (p=0.041),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05878,rs685330,22,25637563,PICALM,SNP (C/G),(C/,C,1.44,1.21,1.83,0.0004623,Protective,0.053,0.224,0.173,0.35,Significant decrease (p=0.008),Variable effect (p=0.007),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05879,rs784666,8,31791884,TREM2,Insertion,-,-,1.09,0.76,1.35,0.05289329,Moderate,0.365,0.136,0.214,0.085,Significant decrease (p=0.037),Mild decrease (p=0.013),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05880,rs106341,21,172371029,APP,SNP (A/G),(A/,A,0.81,0.52,1.13,0.03297145,High,0.063,0.027,0.545,0.166,Significant increase (p=0.01),Mild decrease (p=0.002),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05881,rs973836,9,40829694,CD33,SNP (C/T),(C/,C,1.58,1.24,1.86,0.00602991,Protective,0.325,0.249,0.002,0.224,Mild decrease (p=0.037),No significant pattern (p=0.016),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05882,rs267661,11,66851811,TREM2,SNP (A/G),(A/,A,1.0,0.71,1.27,0.03684478,High,0.398,0.195,0.11,0.097,Mild increase (p=0.025),No significant pattern (p=0.021),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05883,rs327278,13,246040558,CLU,SNP (A/C),(A/,A,1.13,0.77,1.4,0.01416945,High,0.068,0.349,0.02,0.363,No significant pattern (p=0.016),Mild increase (p=0.021),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05884,rs566040,15,231961722,PICALM,Deletion,-,-,0.73,0.51,1.04,0.03429447,High,0.472,0.216,0.015,0.097,Variable effect (p=0.046),Significant increase (p=0.009),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP05885,rs975128,5,33041366,PICALM,SNP (C/G),(C/,C,0.69,0.35,0.91,0.00467046,Protective,0.061,0.025,0.434,0.28,Significant decrease (p=0.02),Mild increase (p=0.01),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05886,rs255892,15,123869843,PTK2B,SNP (A/T),(A/,A,0.46,0.22,0.84,0.08785689,Moderate,0.163,0.196,0.436,0.005,Variable effect (p=0.007),Significant increase (p=0.025),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05887,rs983443,21,70739106,ABCA7,Deletion,-,-,0.47,0.13,0.87,0.04995112,High,0.082,0.083,0.584,0.05,Significant increase (p=0.033),Variable effect (p=0.041),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP05888,rs632065,7,127013104,CR1,SNP (A/T),(A/,A,1.25,1.01,1.58,0.01211391,High,0.238,0.179,0.182,0.201,Variable effect (p=0.006),Significant increase (p=0.009),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05889,rs926993,14,186818075,PSEN2,SNP (C/G),(C/,C,0.64,0.35,1.03,0.02522725,Moderate,0.087,0.157,0.35,0.206,Mild decrease (p=0.007),Mild increase (p=0.048),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05890,rs198887,5,125440129,CD2AP,SNP (A/G),(A/,A,1.12,0.85,1.38,0.02731425,High,0.147,0.456,0.011,0.185,Mild decrease (p=0.026),Mild increase (p=0.048),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP05891,rs653029,10,189192401,TREM2,SNP (G/T),(G/,G,1.54,1.32,1.81,0.1066099,High,0.292,0.094,0.402,0.012,Significant increase (p=0.029),Mild decrease (p=0.013),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05892,rs137396,13,105729749,BIN1,SNP (A/C),(A/,A,0.71,0.45,0.97,0.0365889,High,0.576,0.004,0.099,0.121,No significant pattern (p=0.018),Mild increase (p=0.019),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05893,rs441270,8,242397810,PTK2B,Insertion,-,-,0.68,0.41,0.92,0.02970017,Moderate,0.156,0.23,0.033,0.382,Significant increase (p=0.024),Variable effect (p=0.013),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05894,rs101800,19,98504116,PTK2B,SNP (C/T),(C/,C,1.44,1.12,1.74,0.05036153,Moderate,0.017,0.47,0.105,0.208,Variable effect (p=0.046),Variable effect (p=0.01),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05895,rs942673,15,57833529,APOE,SNP (G/T),(G/,G,0.63,0.38,1.02,0.02406496,Low,0.474,0.177,0.083,0.065,Mild decrease (p=0.037),No significant pattern (p=0.019),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05896,rs738616,8,220487588,ABCA7,SNP (C/G),(C/,C,2.39,2.04,2.72,0.00987842,Protective,0.065,0.001,0.547,0.187,Significant increase (p=0.025),Mild decrease (p=0.035),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05897,rs339029,14,29256068,PTK2B,Insertion,-,-,0.3,0.1,0.61,0.00401344,Moderate,0.35,0.19,0.2,0.059,Variable effect (p=0.031),No significant pattern (p=0.008),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05898,rs212112,2,60999373,APP,SNP (A/C),(A/,A,0.43,0.1,0.75,0.01188828,Low,0.214,0.138,0.087,0.362,Significant decrease (p=0.04),Variable effect (p=0.026),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05899,rs547527,19,219583310,EPHA1,SNP (A/C),(A/,A,2.06,1.75,2.44,0.02886144,High,0.279,0.063,0.346,0.112,Mild decrease (p=0.035),Variable effect (p=0.036),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05900,rs297863,22,204265321,APOE,SNP (A/G),(A/,A,0.66,0.3,0.96,0.00011914,Moderate,0.054,0.162,0.001,0.583,Variable effect (p=0.035),Significant increase (p=0.038),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP05901,rs162640,12,142269121,CR1,SNP (G/T),(G/,G,1.32,1.04,1.72,0.03915451,Low,0.012,0.397,0.336,0.055,Variable effect (p=0.043),Significant increase (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05902,rs176161,18,148140144,APP,SNP (A/G),(A/,A,0.38,0.1,0.7,0.00581628,High,0.183,0.225,0.124,0.267,Significant decrease (p=0.036),Significant increase (p=0.025),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP05903,rs943966,17,243772559,PSEN2,Insertion,-,-,1.45,1.08,1.7,0.00845551,High,0.021,0.692,0.026,0.062,Significant decrease (p=0.045),Significant decrease (p=0.013),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05904,rs336835,4,148099171,CD33,Insertion,-,-,0.44,0.1,0.66,0.03130295,Protective,0.495,0.148,0.042,0.115,Significant increase (p=0.03),Mild decrease (p=0.035),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP05905,rs338789,9,113257759,CD33,SNP (A/T),(A/,A,1.51,1.21,1.77,0.05905728,High,0.466,0.136,0.0,0.198,Significant decrease (p=0.047),Mild increase (p=0.049),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05906,rs610072,3,82643277,ABCA7,SNP (A/C),(A/,A,0.58,0.2,0.87,0.0692219,High,0.234,0.385,0.181,0.001,No significant pattern (p=0.001),No significant pattern (p=0.017),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP05907,rs730686,12,65051982,TREM2,SNP (C/G),(C/,C,2.61,2.4,2.83,0.02837271,High,0.087,0.196,0.296,0.221,Variable effect (p=0.036),Significant increase (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05908,rs355131,5,104075736,BIN1,SNP (A/T),(A/,A,0.56,0.18,0.77,0.0010056,Low,0.243,0.064,0.276,0.218,Variable effect (p=0.01),Variable effect (p=0.05),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP05909,rs436163,8,81588093,APP,Insertion,-,-,1.89,1.52,2.28,0.02013647,Moderate,0.019,0.036,0.512,0.232,Mild decrease (p=0.037),Mild decrease (p=0.033),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05910,rs304321,14,61922485,SORL1,SNP (A/T),(A/,A,1.27,1.01,1.48,0.01013261,Moderate,0.181,0.087,0.072,0.46,Significant decrease (p=0.023),Significant increase (p=0.043),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP05911,rs166526,16,121514078,PTK2B,SNP (A/C),(A/,A,1.38,1.09,1.69,0.06142646,Moderate,0.36,0.186,0.109,0.145,No significant pattern (p=0.049),Mild decrease (p=0.048),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP05912,rs176220,5,231036888,SORL1,SNP (C/G),(C/,C,0.55,0.19,0.86,0.00754943,High,0.168,0.193,0.199,0.24,Significant increase (p=0.022),Mild decrease (p=0.026),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP05913,rs600568,2,41166376,PICALM,Deletion,-,-,2.61,2.25,2.99,0.01875846,Moderate,0.357,0.376,0.047,0.019,Significant increase (p=0.008),Mild decrease (p=0.01),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05914,rs537980,2,192924713,EPHA1,Insertion,-,-,0.72,0.51,1.08,0.03503495,Protective,0.448,0.115,0.221,0.016,No significant pattern (p=0.046),Mild decrease (p=0.048),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05915,rs417328,20,79576391,PICALM,SNP (A/C),(A/,A,3.48,3.27,3.79,0.00086234,Low,0.066,0.618,0.027,0.089,Significant decrease (p=0.025),No significant pattern (p=0.038),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05916,rs354374,5,11160439,SORL1,Insertion,-,-,0.58,0.19,0.82,0.04515636,Protective,0.047,0.016,0.28,0.457,No significant pattern (p=0.044),Significant increase (p=0.028),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP05917,rs180181,1,156074182,SORL1,SNP (C/G),(C/,C,0.74,0.39,1.07,0.03520159,Low,0.018,0.282,0.098,0.401,No significant pattern (p=0.04),Significant increase (p=0.007),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP05918,rs810536,12,115834939,CR1,SNP (C/T),(C/,C,2.25,1.89,2.65,0.00276098,High,0.43,0.185,0.047,0.139,Significant decrease (p=0.04),No significant pattern (p=0.026),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP05919,rs833788,5,138088850,MS4A6A,SNP (A/T),(A/,A,0.61,0.34,0.83,0.00856782,Moderate,0.061,0.349,0.215,0.175,Mild increase (p=0.042),Significant decrease (p=0.05),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP05920,rs482595,17,197907956,CR1,SNP (C/T),(C/,C,0.63,0.3,0.92,0.02716823,High,0.003,0.239,0.442,0.116,Significant increase (p=0.013),Mild increase (p=0.028),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP05921,rs320754,1,181303877,TREM2,SNP (G/T),(G/,G,1.3,1.08,1.53,0.06909559,Protective,0.1,0.061,0.301,0.338,Variable effect (p=0.032),No significant pattern (p=0.015),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP05922,rs377989,14,12319405,ABCA7,Deletion,-,-,0.84,0.61,1.21,0.06564548,Moderate,0.303,0.206,0.127,0.164,Significant decrease (p=0.049),Variable effect (p=0.025),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05923,rs111442,9,1768177,CR1,SNP (A/C),(A/,A,0.59,0.21,0.85,0.00174928,Low,0.059,0.326,0.027,0.387,Mild decrease (p=0.009),Significant decrease (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05924,rs723707,1,223941599,PICALM,SNP (A/G),(A/,A,0.55,0.21,0.8,0.03522216,High,0.063,0.312,0.312,0.113,Significant increase (p=0.023),Variable effect (p=0.023),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05925,rs381942,10,119341720,MS4A6A,SNP (C/T),(C/,C,1.64,1.34,1.97,0.05919759,Low,0.1,0.264,0.028,0.409,Significant decrease (p=0.031),Significant increase (p=0.026),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05926,rs984163,20,162666329,APOE,SNP (G/T),(G/,G,3.66,3.32,3.94,0.08466448,Protective,0.126,0.454,0.041,0.178,Mild decrease (p=0.002),No significant pattern (p=0.037),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05927,rs263544,16,95238718,CD33,SNP (C/T),(C/,C,1.41,1.11,1.74,0.0026298,High,0.384,0.109,0.277,0.03,Mild decrease (p=0.045),Significant increase (p=0.024),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP05928,rs112951,10,113585491,APP,Deletion,-,-,0.57,0.34,0.85,0.01553477,Moderate,0.052,0.686,0.037,0.025,Variable effect (p=0.028),No significant pattern (p=0.031),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP05929,rs430389,21,163632615,BIN1,SNP (C/G),(C/,C,0.65,0.28,1.01,0.05389643,Low,0.167,0.546,0.023,0.064,Variable effect (p=0.03),No significant pattern (p=0.003),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05930,rs986260,19,131208981,CD2AP,Deletion,-,-,0.95,0.57,1.33,0.01011682,Moderate,0.279,0.162,0.31,0.049,Significant increase (p=0.025),Significant decrease (p=0.049),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP05931,rs343989,11,55321321,CD33,SNP (C/T),(C/,C,0.62,0.3,0.94,0.01216484,Moderate,0.103,0.321,0.182,0.195,Variable effect (p=0.036),Mild decrease (p=0.006),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05932,rs694335,4,204755069,CD33,Insertion,-,-,1.01,0.7,1.32,0.05678648,Moderate,0.244,0.339,0.156,0.061,Significant decrease (p=0.002),Significant increase (p=0.017),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05933,rs841565,6,168896677,CLU,Insertion,-,-,1.48,1.26,1.75,0.00749822,Moderate,0.03,0.675,0.039,0.056,Significant increase (p=0.023),No significant pattern (p=0.015),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP05934,rs575442,21,56437688,TREM2,SNP (A/G),(A/,A,1.49,1.15,1.74,0.00637872,Low,0.103,0.218,0.033,0.447,Mild decrease (p=0.049),No significant pattern (p=0.005),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05935,rs893472,21,37466320,APOE,SNP (A/G),(A/,A,0.59,0.21,0.82,0.01503905,Moderate,0.096,0.048,0.185,0.471,Significant increase (p=0.04),Mild increase (p=0.009),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05936,rs684574,22,84919118,BIN1,Insertion,-,-,0.52,0.26,0.74,0.00074193,Protective,0.037,0.428,0.102,0.233,No significant pattern (p=0.024),Variable effect (p=0.025),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP05937,rs652228,4,209102526,MS4A6A,SNP (C/T),(C/,C,1.16,0.76,1.39,0.00537297,Moderate,0.472,0.086,0.179,0.062,Significant decrease (p=0.03),Mild increase (p=0.016),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05938,rs793780,16,120944920,EPHA1,SNP (C/T),(C/,C,2.27,2.02,2.59,0.04174704,Moderate,0.262,0.338,0.081,0.12,Variable effect (p=0.029),Significant increase (p=0.021),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05939,rs100564,12,198831532,ABCA7,SNP (A/T),(A/,A,0.67,0.36,0.98,0.03455246,High,0.026,0.236,0.218,0.32,Significant decrease (p=0.015),Significant increase (p=0.035),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP05940,rs294803,7,28570156,CR1,SNP (A/T),(A/,A,1.13,0.9,1.36,0.00167445,Low,0.401,0.166,0.212,0.02,Significant increase (p=0.048),Significant decrease (p=0.048),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05941,rs319867,19,139001802,PICALM,SNP (C/G),(C/,C,1.4,1.07,1.64,0.01711395,Moderate,0.341,0.15,0.15,0.16,Variable effect (p=0.04),Significant increase (p=0.024),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05942,rs822921,16,73651013,PTK2B,Insertion,-,-,1.58,1.22,1.82,0.01288504,Protective,0.389,0.351,0.011,0.049,Mild increase (p=0.037),Significant increase (p=0.028),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05943,rs605900,7,116953152,BIN1,SNP (C/T),(C/,C,0.8,0.44,1.06,0.01347345,Protective,0.094,0.054,0.558,0.094,No significant pattern (p=0.04),Variable effect (p=0.035),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05944,rs807456,12,19072294,BIN1,SNP (A/C),(A/,A,1.31,0.99,1.65,0.06171001,High,0.135,0.437,0.075,0.153,Significant decrease (p=0.047),Mild increase (p=0.011),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05945,rs327512,5,180327059,EPHA1,SNP (A/G),(A/,A,0.25,0.1,0.55,0.10243948,High,0.506,0.085,0.073,0.136,Mild decrease (p=0.028),Mild decrease (p=0.015),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP05946,rs957808,13,16470880,SORL1,SNP (G/T),(G/,G,1.45,1.23,1.77,0.00873757,Moderate,0.193,0.079,0.115,0.413,Mild increase (p=0.008),No significant pattern (p=0.01),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05947,rs534141,20,125536196,CD2AP,SNP (A/C),(A/,A,0.24,0.1,0.53,0.02554491,Low,0.03,0.701,0.051,0.018,No significant pattern (p=0.023),Variable effect (p=0.036),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP05948,rs693352,3,79590032,ABCA7,Deletion,-,-,0.84,0.63,1.14,0.13007645,Moderate,0.197,0.099,0.277,0.228,Significant decrease (p=0.031),No significant pattern (p=0.001),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP05949,rs560313,13,107229442,CR1,SNP (A/C),(A/,A,0.64,0.3,0.86,0.01702745,High,0.073,0.375,0.192,0.159,Significant increase (p=0.037),Mild increase (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05950,rs504014,20,189924840,CR1,SNP (A/T),(A/,A,1.29,1.05,1.49,0.1032002,High,0.164,0.457,0.116,0.063,Variable effect (p=0.018),Variable effect (p=0.016),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP05951,rs457534,19,119448820,CD2AP,Insertion,-,-,1.25,1.03,1.59,0.03872356,High,0.29,0.109,0.275,0.126,Mild increase (p=0.035),Significant increase (p=0.049),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP05952,rs706366,9,183978341,APP,SNP (G/T),(G/,G,1.81,1.56,2.15,0.01064952,Protective,0.032,0.266,0.098,0.404,No significant pattern (p=0.008),No significant pattern (p=0.038),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05953,rs370251,21,171881269,EPHA1,SNP (C/G),(C/,C,2.03,1.82,2.42,0.06640405,High,0.439,0.115,0.066,0.179,Variable effect (p=0.028),Mild decrease (p=0.029),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05954,rs471226,22,184466063,APOE,SNP (A/G),(A/,A,0.76,0.37,1.01,0.08247185,Moderate,0.179,0.294,0.071,0.257,Significant decrease (p=0.004),No significant pattern (p=0.04),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP05955,rs579824,9,45992330,PTK2B,SNP (G/T),(G/,G,2.18,1.84,2.39,0.0069252,High,0.142,0.122,0.111,0.425,Mild increase (p=0.039),Variable effect (p=0.042),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP05956,rs563875,5,118602330,APOE,SNP (A/C),(A/,A,0.97,0.6,1.25,0.0449831,Protective,0.057,0.58,0.022,0.141,Mild decrease (p=0.013),Significant decrease (p=0.015),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05957,rs190929,7,11516784,CD2AP,Deletion,-,-,1.35,0.99,1.68,0.05334069,Low,0.312,0.193,0.14,0.156,Mild increase (p=0.033),Mild increase (p=0.023),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05958,rs282963,7,85343937,CD2AP,Deletion,-,-,0.47,0.21,0.82,0.04785323,Moderate,0.182,0.281,0.274,0.063,No significant pattern (p=0.032),Significant increase (p=0.042),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP05959,rs370106,16,2851828,CD2AP,Insertion,-,-,3.19,2.82,3.54,0.0134047,Low,0.651,0.037,0.04,0.072,Variable effect (p=0.041),Significant decrease (p=0.047),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP05960,rs232512,1,109317518,CD33,SNP (A/T),(A/,A,1.18,0.89,1.49,0.016473,High,0.407,0.176,0.03,0.187,Variable effect (p=0.021),Variable effect (p=0.042),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05961,rs927381,2,171666568,MS4A6A,SNP (C/T),(C/,C,1.28,0.99,1.52,0.00239412,Low,0.156,0.274,0.164,0.206,Significant decrease (p=0.04),No significant pattern (p=0.02),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP05962,rs200568,11,246232913,MS4A6A,Deletion,-,-,1.57,1.27,1.85,0.02501892,Low,0.109,0.068,0.137,0.486,Significant decrease (p=0.01),Mild decrease (p=0.01),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05963,rs936452,20,224178451,CD33,Deletion,-,-,0.82,0.57,1.16,0.07491013,Low,0.099,0.229,0.163,0.309,No significant pattern (p=0.013),Significant decrease (p=0.019),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05964,rs923936,12,56944464,BIN1,SNP (C/G),(C/,C,1.5,1.16,1.77,0.00710005,Moderate,0.179,0.281,0.15,0.191,Mild decrease (p=0.036),Variable effect (p=0.046),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP05965,rs415028,15,21382054,CD33,SNP (A/T),(A/,A,1.73,1.42,1.99,0.0046302,Low,0.148,0.311,0.292,0.049,Mild decrease (p=0.005),Mild decrease (p=0.02),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP05966,rs400640,14,160324502,TREM2,SNP (C/T),(C/,C,1.49,1.24,1.7,0.0263463,Moderate,0.04,0.351,0.19,0.218,Variable effect (p=0.008),Significant decrease (p=0.027),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05967,rs598623,14,115855352,CR1,SNP (A/T),(A/,A,1.55,1.34,1.94,0.00264245,Moderate,0.251,0.151,0.089,0.309,Significant decrease (p=0.015),Mild increase (p=0.03),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP05968,rs254898,19,43174088,CLU,Deletion,-,-,1.42,1.08,1.72,0.06183418,Low,0.175,0.315,0.195,0.116,Significant decrease (p=0.004),No significant pattern (p=0.003),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05969,rs131494,1,20606644,CD2AP,SNP (G/T),(G/,G,1.3,0.9,1.52,0.00076587,Protective,0.753,0.023,0.013,0.011,Significant increase (p=0.032),No significant pattern (p=0.047),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05970,rs329547,10,225741745,CR1,SNP (A/C),(A/,A,0.46,0.1,0.76,0.01562755,Moderate,0.245,0.203,0.182,0.171,Variable effect (p=0.027),Mild increase (p=0.022),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP05971,rs258853,3,122580940,CD33,SNP (C/G),(C/,C,0.77,0.4,1.02,0.010579,Moderate,0.063,0.142,0.074,0.52,Variable effect (p=0.018),Variable effect (p=0.01),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05972,rs546445,21,144360485,BIN1,SNP (C/G),(C/,C,0.94,0.62,1.27,0.03641408,High,0.198,0.293,0.143,0.165,Mild decrease (p=0.018),Mild decrease (p=0.003),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05973,rs986676,20,151189774,SORL1,SNP (C/G),(C/,C,0.58,0.23,0.88,0.0052124,High,0.046,0.445,0.011,0.298,Variable effect (p=0.016),No significant pattern (p=0.027),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP05974,rs461226,16,45386251,CLU,Insertion,-,-,1.9,1.52,2.19,0.06843182,Moderate,0.141,0.569,0.021,0.069,Significant decrease (p=0.036),Variable effect (p=0.036),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05975,rs808223,18,71549224,PICALM,Deletion,-,-,2.43,2.06,2.75,0.0016266,Moderate,0.199,0.317,0.13,0.155,Mild increase (p=0.016),Mild increase (p=0.033),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP05976,rs676677,6,151235046,APOE,Insertion,-,-,1.27,0.96,1.52,0.10624908,Moderate,0.33,0.1,0.137,0.232,Mild decrease (p=0.013),Mild increase (p=0.033),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP05977,rs209585,19,68131148,PTK2B,SNP (C/T),(C/,C,1.37,1.04,1.59,0.01681751,High,0.052,0.003,0.439,0.306,Mild increase (p=0.003),Significant decrease (p=0.036),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP05978,rs980229,10,237288011,PSEN2,Deletion,-,-,0.34,0.1,0.64,0.00915334,Moderate,0.182,0.421,0.048,0.149,Mild decrease (p=0.046),Significant increase (p=0.024),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05979,rs162736,11,224197826,PICALM,SNP (G/T),(G/,G,1.12,0.8,1.44,0.00475673,Moderate,0.183,0.108,0.4,0.109,Significant increase (p=0.013),Mild decrease (p=0.024),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05980,rs266273,20,135364995,CLU,Insertion,-,-,1.2,0.98,1.43,0.02458702,Moderate,0.084,0.214,0.27,0.232,Significant decrease (p=0.037),No significant pattern (p=0.013),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05981,rs892587,12,194440018,PICALM,SNP (A/G),(A/,A,0.58,0.38,0.94,0.0213072,High,0.188,0.157,0.095,0.36,Significant decrease (p=0.011),No significant pattern (p=0.007),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP05982,rs410950,16,135254574,MS4A6A,SNP (A/G),(A/,A,0.41,0.1,0.73,0.00786287,Low,0.117,0.268,0.345,0.07,No significant pattern (p=0.001),Variable effect (p=0.045),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP05983,rs242139,16,206038095,BIN1,SNP (A/T),(A/,A,1.24,0.95,1.58,0.01149012,Unknown,0.117,0.288,0.039,0.357,Mild decrease (p=0.015),Significant increase (p=0.047),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP05984,rs312935,3,43480718,CD2AP,SNP (C/G),(C/,C,0.53,0.33,0.91,0.03695535,High,0.303,0.441,0.019,0.036,Significant decrease (p=0.025),Variable effect (p=0.006),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP05985,rs125992,10,115471463,EPHA1,SNP (A/G),(A/,A,0.8,0.57,1.19,0.01127825,Moderate,0.373,0.071,0.079,0.278,No significant pattern (p=0.002),Significant increase (p=0.007),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP05986,rs615340,22,179444562,MS4A6A,SNP (A/G),(A/,A,0.63,0.42,0.93,0.05285005,Low,0.091,0.184,0.131,0.394,Significant increase (p=0.014),Variable effect (p=0.028),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP05987,rs837685,15,189691509,BIN1,SNP (A/C),(A/,A,1.38,1.09,1.65,0.01283403,Protective,0.427,0.155,0.011,0.208,Variable effect (p=0.021),No significant pattern (p=0.05),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP05988,rs522211,11,61377130,APOE,SNP (A/G),(A/,A,0.2,0.1,0.59,0.07032278,Protective,0.056,0.015,0.339,0.39,Significant decrease (p=0.044),Mild increase (p=0.042),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP05989,rs910496,15,211874592,APOE,SNP (G/T),(G/,G,0.75,0.43,1.04,0.00124206,Protective,0.112,0.116,0.332,0.239,No significant pattern (p=0.037),Mild decrease (p=0.009),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP05990,rs266637,6,148440159,CR1,SNP (G/T),(G/,G,1.28,1.04,1.53,0.00289843,Low,0.36,0.213,0.166,0.061,No significant pattern (p=0.006),Significant increase (p=0.037),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP05991,rs697922,5,165143839,ABCA7,Deletion,-,-,0.45,0.1,0.67,0.01999279,Low,0.319,0.042,0.017,0.422,Mild decrease (p=0.008),No significant pattern (p=0.038),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP05992,rs201059,3,239878827,CD33,SNP (A/C),(A/,A,0.72,0.51,0.98,0.08242115,High,0.584,0.003,0.098,0.115,Significant increase (p=0.041),Significant decrease (p=0.043),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP05993,rs674042,7,218213015,CLU,SNP (A/T),(A/,A,0.71,0.32,1.11,0.02894685,High,0.289,0.42,0.059,0.032,No significant pattern (p=0.028),Variable effect (p=0.049),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05994,rs770721,8,12861155,APOE,SNP (A/G),(A/,A,2.05,1.79,2.38,0.00316418,Protective,0.476,0.011,0.0,0.313,Mild increase (p=0.021),Significant decrease (p=0.004),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP05995,rs367555,13,245062648,CD2AP,Insertion,-,-,0.97,0.59,1.24,0.00069173,High,0.134,0.524,0.061,0.081,Mild decrease (p=0.026),Significant decrease (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP05996,rs271048,18,199312055,EPHA1,SNP (A/T),(A/,A,1.98,1.66,2.26,0.02557381,Moderate,0.362,0.213,0.1,0.126,No significant pattern (p=0.021),Mild increase (p=0.036),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP05997,rs254523,20,171382544,PSEN2,Deletion,-,-,0.46,0.1,0.69,0.03454306,Moderate,0.181,0.373,0.059,0.187,Variable effect (p=0.035),Significant increase (p=0.034),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP05998,rs534852,10,123775093,ABCA7,Deletion,-,-,0.62,0.25,0.87,0.00570401,Moderate,0.188,0.255,0.136,0.221,Significant increase (p=0.014),No significant pattern (p=0.031),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP05999,rs124216,6,11154400,SORL1,SNP (A/T),(A/,A,1.04,0.75,1.26,0.03235478,Protective,0.342,0.22,0.028,0.209,Significant decrease (p=0.022),Mild decrease (p=0.039),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06000,rs687312,6,25370494,CD33,SNP (G/T),(G/,G,0.82,0.57,1.14,0.0064233,Low,0.427,0.098,0.12,0.154,Significant decrease (p=0.025),Mild increase (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06001,rs583292,21,92581046,ABCA7,SNP (G/T),(G/,G,1.62,1.35,1.88,0.008473,Moderate,0.039,0.353,0.334,0.074,Significant decrease (p=0.018),Mild increase (p=0.028),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06002,rs961573,20,22580106,CD2AP,SNP (C/T),(C/,C,1.28,0.92,1.53,0.00251904,High,0.119,0.058,0.417,0.206,Significant increase (p=0.049),No significant pattern (p=0.012),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06003,rs731652,3,153586905,EPHA1,Insertion,-,-,1.26,0.99,1.56,0.02211935,Moderate,0.031,0.163,0.535,0.072,Variable effect (p=0.013),Significant increase (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06004,rs709966,13,34243802,CR1,SNP (A/G),(A/,A,1.04,0.73,1.42,0.01010186,Moderate,0.347,0.259,0.025,0.169,Mild decrease (p=0.004),Mild increase (p=0.04),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06005,rs779531,4,41512118,PSEN2,SNP (C/G),(C/,C,0.63,0.28,0.92,0.00197479,Protective,0.047,0.149,0.37,0.235,Significant increase (p=0.037),Significant decrease (p=0.042),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06006,rs424882,14,122315917,CD33,SNP (A/C),(A/,A,1.58,1.21,1.84,0.0207658,Low,0.417,0.19,0.08,0.114,Significant decrease (p=0.034),Variable effect (p=0.006),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06007,rs799162,8,102578533,PTK2B,SNP (A/T),(A/,A,0.35,0.14,0.67,0.00336232,Unknown,0.259,0.402,0.03,0.109,No significant pattern (p=0.049),Variable effect (p=0.025),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP06008,rs910950,18,161848795,PSEN2,SNP (A/T),(A/,A,1.19,0.94,1.44,0.03930481,Protective,0.056,0.55,0.03,0.163,Variable effect (p=0.028),Significant decrease (p=0.002),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06009,rs205135,9,145962893,ABCA7,Insertion,-,-,1.59,1.26,1.92,0.01990192,Protective,0.117,0.299,0.085,0.299,Significant increase (p=0.026),Significant increase (p=0.034),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06010,rs283546,18,64719944,EPHA1,SNP (C/G),(C/,C,0.61,0.23,0.82,0.01011898,High,0.09,0.314,0.276,0.12,Mild increase (p=0.031),Mild increase (p=0.019),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06011,rs941447,3,45273504,PICALM,Deletion,-,-,1.25,0.89,1.58,0.0283475,Low,0.004,0.007,0.194,0.596,Significant decrease (p=0.026),Mild increase (p=0.016),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06012,rs362658,11,112581887,MS4A6A,SNP (A/G),(A/,A,0.7,0.45,1.06,0.01984165,High,0.301,0.029,0.436,0.034,Significant decrease (p=0.004),Significant increase (p=0.004),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06013,rs628739,15,103223340,CD33,SNP (A/G),(A/,A,1.1,0.88,1.35,0.00762739,Moderate,0.066,0.354,0.124,0.256,Significant decrease (p=0.021),No significant pattern (p=0.016),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06014,rs968368,19,153696468,PTK2B,SNP (C/G),(C/,C,0.7,0.45,1.07,0.0363414,High,0.208,0.47,0.103,0.019,Mild increase (p=0.047),No significant pattern (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06015,rs985656,7,64118130,PSEN2,SNP (G/T),(G/,G,0.7,0.35,0.91,0.03152753,Protective,0.393,0.006,0.215,0.186,Variable effect (p=0.048),Mild decrease (p=0.034),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP06016,rs729807,11,36303411,CD2AP,SNP (G/T),(G/,G,0.52,0.28,0.76,0.0012515,Protective,0.177,0.018,0.603,0.001,Variable effect (p=0.004),No significant pattern (p=0.025),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06017,rs593319,3,71274768,CD2AP,Insertion,-,-,1.73,1.35,2.04,0.01122976,High,0.331,0.156,0.166,0.146,Significant increase (p=0.02),Significant decrease (p=0.041),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06018,rs443715,16,214137859,TREM2,SNP (A/T),(A/,A,0.6,0.25,0.89,0.03570006,Low,0.704,0.052,0.027,0.016,Mild increase (p=0.012),Mild increase (p=0.021),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06019,rs714588,4,168448315,APP,Insertion,-,-,0.46,0.14,0.74,0.15893138,Moderate,0.213,0.053,0.097,0.438,Mild decrease (p=0.041),Significant decrease (p=0.023),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06020,rs711581,7,72322620,PSEN2,SNP (A/G),(A/,A,1.09,0.71,1.39,0.01739733,Moderate,0.183,0.125,0.09,0.403,Variable effect (p=0.048),Mild increase (p=0.011),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06021,rs607332,22,144880983,CR1,SNP (G/T),(G/,G,0.65,0.41,0.95,0.01789634,Moderate,0.383,0.086,0.012,0.318,Mild increase (p=0.019),No significant pattern (p=0.007),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06022,rs446958,15,188422296,PICALM,SNP (G/T),(G/,G,1.76,1.43,2.12,0.02510633,Moderate,0.086,0.001,0.311,0.402,Significant increase (p=0.033),No significant pattern (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06023,rs672323,13,173361229,BIN1,SNP (A/C),(A/,A,1.29,1.02,1.6,0.01623507,High,0.314,0.443,0.019,0.024,Significant decrease (p=0.002),No significant pattern (p=0.001),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06024,rs692388,6,247561632,BIN1,SNP (A/T),(A/,A,1.38,1.15,1.67,0.00260124,Low,0.049,0.125,0.198,0.428,Significant decrease (p=0.043),Significant decrease (p=0.002),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06025,rs351711,6,126135333,TREM2,SNP (A/G),(A/,A,1.21,0.9,1.55,0.02203637,Low,0.047,0.19,0.084,0.479,Significant decrease (p=0.041),No significant pattern (p=0.018),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP06026,rs616226,3,187045992,PICALM,SNP (A/C),(A/,A,0.36,0.1,0.56,0.05636993,Protective,0.003,0.31,0.478,0.009,Mild decrease (p=0.039),No significant pattern (p=0.033),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06027,rs647813,16,246257816,CLU,Insertion,-,-,2.3,1.93,2.67,0.00920528,High,0.296,0.077,0.065,0.362,Mild decrease (p=0.021),Mild decrease (p=0.046),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06028,rs640757,15,163565742,TREM2,SNP (G/T),(G/,G,0.69,0.35,0.92,0.01640387,High,0.27,0.117,0.106,0.307,Mild increase (p=0.024),Significant increase (p=0.039),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06029,rs593600,4,241562198,PICALM,SNP (A/C),(A/,A,1.25,0.96,1.63,0.0200726,Moderate,0.11,0.105,0.241,0.344,No significant pattern (p=0.005),Variable effect (p=0.012),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP06030,rs246139,8,86644161,PICALM,Insertion,-,-,0.87,0.62,1.15,0.00599765,Protective,0.019,0.489,0.194,0.099,Mild increase (p=0.037),No significant pattern (p=0.011),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06031,rs916026,22,91397044,PTK2B,Deletion,-,-,1.55,1.3,1.78,0.00266399,Moderate,0.085,0.218,0.277,0.22,Significant decrease (p=0.025),Variable effect (p=0.039),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06032,rs193117,12,226525551,PTK2B,SNP (C/G),(C/,C,0.77,0.43,1.15,0.08331751,Moderate,0.013,0.255,0.145,0.387,Mild increase (p=0.018),Mild increase (p=0.007),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP06033,rs890791,5,36161156,MS4A6A,SNP (A/C),(A/,A,1.54,1.33,1.75,0.00126537,Protective,0.587,0.0,0.095,0.118,Mild increase (p=0.01),Mild increase (p=0.046),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06034,rs216167,19,150402427,TREM2,SNP (A/G),(A/,A,0.56,0.33,0.83,0.0116484,Moderate,0.067,0.011,0.056,0.665,Significant increase (p=0.048),No significant pattern (p=0.008),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06035,rs401943,20,36030306,EPHA1,Deletion,-,-,2.67,2.44,2.9,0.00805142,High,0.06,0.066,0.399,0.275,Mild increase (p=0.019),Variable effect (p=0.046),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP06036,rs115694,10,86427016,ABCA7,Deletion,-,-,0.74,0.42,1.1,0.00240169,Low,0.074,0.177,0.294,0.256,No significant pattern (p=0.044),Mild increase (p=0.03),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06037,rs198284,7,164666078,SORL1,Insertion,-,-,2.2,2.0,2.58,0.02197251,Low,0.164,0.016,0.579,0.041,Significant decrease (p=0.004),Variable effect (p=0.021),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06038,rs922513,3,74029381,CR1,Deletion,-,-,0.79,0.39,1.17,0.01900213,Protective,0.364,0.253,0.081,0.101,No significant pattern (p=0.048),No significant pattern (p=0.036),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06039,rs661072,10,214452123,SORL1,SNP (A/G),(A/,A,1.56,1.21,1.96,0.00967874,Moderate,0.043,0.04,0.309,0.409,Variable effect (p=0.012),Mild increase (p=0.018),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06040,rs493696,6,248059023,MS4A6A,SNP (G/T),(G/,G,0.38,0.1,0.74,0.03121504,High,0.53,0.049,0.055,0.165,No significant pattern (p=0.024),No significant pattern (p=0.003),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06041,rs246562,16,245826355,CD33,SNP (A/G),(A/,A,0.51,0.11,0.84,0.01344692,Moderate,0.172,0.147,0.463,0.018,Mild decrease (p=0.037),Significant decrease (p=0.032),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06042,rs768101,8,10537411,APOE,SNP (C/T),(C/,C,0.99,0.63,1.25,0.00173489,Low,0.117,0.125,0.305,0.253,Mild decrease (p=0.007),Mild decrease (p=0.044),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06043,rs204599,11,226151336,PTK2B,Deletion,-,-,2.49,2.27,2.85,0.0321581,High,0.043,0.388,0.363,0.006,Variable effect (p=0.041),No significant pattern (p=0.01),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06044,rs666346,11,243619877,BIN1,SNP (A/G),(A/,A,1.03,0.79,1.35,0.03392507,Low,0.376,0.06,0.27,0.094,Significant decrease (p=0.034),Variable effect (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP06045,rs504685,9,136726584,MS4A6A,SNP (A/C),(A/,A,0.55,0.25,0.81,0.07253569,Low,0.004,0.036,0.523,0.238,Mild decrease (p=0.007),Variable effect (p=0.048),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06046,rs898787,4,35390761,PSEN2,SNP (C/G),(C/,C,0.77,0.5,0.99,0.08098221,High,0.129,0.306,0.082,0.283,Mild increase (p=0.024),Mild decrease (p=0.014),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06047,rs483811,2,207463891,TREM2,SNP (A/T),(A/,A,0.73,0.44,1.07,0.07620667,Low,0.154,0.15,0.327,0.169,Mild increase (p=0.042),Variable effect (p=0.01),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06048,rs236332,18,223646904,CD33,Insertion,-,-,1.69,1.38,1.99,0.00560609,Moderate,0.119,0.535,0.13,0.016,Variable effect (p=0.031),Mild decrease (p=0.024),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06049,rs983354,2,62750266,PTK2B,SNP (A/G),(A/,A,0.74,0.46,0.99,0.01278232,Low,0.036,0.362,0.006,0.395,Mild increase (p=0.049),No significant pattern (p=0.016),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06050,rs163324,10,98150456,APOE,Deletion,-,-,1.62,1.38,1.86,0.05454402,Moderate,0.277,0.426,0.016,0.081,Significant increase (p=0.046),Mild increase (p=0.05),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP06051,rs277286,14,29054747,MS4A6A,SNP (A/G),(A/,A,1.25,0.96,1.65,0.03241084,High,0.033,0.037,0.064,0.666,Mild increase (p=0.032),Mild decrease (p=0.023),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06052,rs536441,2,116182796,BIN1,SNP (A/T),(A/,A,0.81,0.53,1.18,0.00058121,Unknown,0.476,0.026,0.082,0.216,Mild increase (p=0.01),Significant decrease (p=0.007),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06053,rs641275,21,186228530,EPHA1,SNP (A/G),(A/,A,0.83,0.55,1.11,0.06476033,Moderate,0.405,0.054,0.319,0.022,Variable effect (p=0.048),Significant increase (p=0.031),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06054,rs444624,12,58787024,CR1,SNP (C/G),(C/,C,3.45,3.13,3.76,0.02303448,Moderate,0.183,0.061,0.063,0.493,Mild decrease (p=0.036),Variable effect (p=0.05),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP06055,rs240590,15,202756233,CLU,SNP (A/G),(A/,A,1.09,0.78,1.35,0.00030915,High,0.123,0.127,0.095,0.456,No significant pattern (p=0.004),Mild increase (p=0.04),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06056,rs305425,1,196220418,TREM2,SNP (G/T),(G/,G,2.13,1.75,2.36,0.02916251,High,0.045,0.116,0.306,0.334,Mild decrease (p=0.004),Mild increase (p=0.006),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06057,rs842462,5,198663679,PTK2B,Insertion,-,-,1.48,1.08,1.81,0.00104435,High,0.047,0.137,0.239,0.378,Mild decrease (p=0.043),Significant decrease (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06058,rs512770,9,210856287,CLU,SNP (G/T),(G/,G,1.04,0.73,1.27,0.09254743,Protective,0.248,0.146,0.022,0.384,Variable effect (p=0.021),Mild decrease (p=0.039),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06059,rs727863,20,128369330,APOE,SNP (A/C),(A/,A,1.8,1.53,2.06,0.02654193,Moderate,0.11,0.232,0.324,0.134,No significant pattern (p=0.045),Variable effect (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06060,rs236480,5,66102886,PICALM,SNP (A/G),(A/,A,0.59,0.29,0.8,0.01241324,Moderate,0.191,0.387,0.012,0.21,Significant decrease (p=0.014),Significant increase (p=0.012),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06061,rs799599,17,51587096,BIN1,Insertion,-,-,1.35,0.99,1.62,0.05980707,Low,0.024,0.366,0.092,0.319,No significant pattern (p=0.037),Mild decrease (p=0.013),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06062,rs388095,7,101872079,SORL1,Insertion,-,-,0.64,0.32,0.96,0.01142435,Moderate,0.385,0.14,0.111,0.165,Significant decrease (p=0.043),Variable effect (p=0.015),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06063,rs757129,13,195095183,CD33,SNP (C/G),(C/,C,0.79,0.55,1.0,0.04414721,High,0.216,0.191,0.228,0.165,Mild increase (p=0.004),Mild increase (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06064,rs276678,11,29206464,APOE,Deletion,-,-,1.84,1.57,2.22,0.00340386,Moderate,0.417,0.047,0.127,0.209,Mild decrease (p=0.004),Mild increase (p=0.015),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06065,rs145434,15,220228821,CD33,SNP (A/C),(A/,A,0.68,0.32,1.0,0.17289397,Low,0.001,0.31,0.239,0.249,Significant decrease (p=0.05),Significant increase (p=0.046),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06066,rs455644,17,39396791,EPHA1,Deletion,-,-,0.7,0.32,0.93,0.048005,High,0.422,0.208,0.033,0.137,No significant pattern (p=0.03),Significant increase (p=0.027),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06067,rs773602,21,246226254,EPHA1,SNP (C/G),(C/,C,1.17,0.78,1.47,0.080074,Low,0.127,0.023,0.222,0.428,Significant decrease (p=0.035),Variable effect (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06068,rs466540,9,22216948,BIN1,Insertion,-,-,1.45,1.17,1.78,0.00794699,High,0.026,0.082,0.678,0.014,Mild decrease (p=0.035),No significant pattern (p=0.015),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06069,rs360850,19,239693115,APOE,SNP (A/T),(A/,A,1.3,0.94,1.65,0.02346655,Moderate,0.267,0.051,0.207,0.276,Significant increase (p=0.022),Variable effect (p=0.024),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP06070,rs483657,12,52886346,APOE,SNP (A/C),(A/,A,0.69,0.46,0.96,0.03123257,Low,0.074,0.116,0.178,0.433,Variable effect (p=0.008),No significant pattern (p=0.014),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06071,rs832205,11,6353090,CD33,SNP (G/T),(G/,G,0.69,0.29,1.02,0.06764126,Low,0.222,0.373,0.113,0.092,Mild increase (p=0.029),Significant decrease (p=0.028),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP06072,rs882164,16,122885707,MS4A6A,SNP (A/G),(A/,A,0.73,0.51,1.01,0.02833504,High,0.438,0.22,0.11,0.032,No significant pattern (p=0.006),Variable effect (p=0.034),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06073,rs774061,18,74228013,CR1,SNP (G/T),(G/,G,1.24,1.03,1.6,0.03432814,Moderate,0.207,0.404,0.075,0.114,Variable effect (p=0.004),Mild decrease (p=0.016),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06074,rs938162,19,228311363,PTK2B,SNP (C/T),(C/,C,1.21,0.81,1.45,0.00210868,Moderate,0.395,0.134,0.165,0.106,Mild increase (p=0.01),Mild decrease (p=0.039),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP06075,rs849898,4,33129970,ABCA7,SNP (G/T),(G/,G,1.26,1.05,1.64,0.02608995,High,0.063,0.293,0.422,0.022,Variable effect (p=0.011),Variable effect (p=0.019),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06076,rs549227,18,25956003,BIN1,SNP (C/T),(C/,C,1.07,0.73,1.34,0.00028307,Low,0.156,0.251,0.297,0.096,Mild increase (p=0.025),Significant decrease (p=0.007),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06077,rs298311,22,91158569,PSEN2,SNP (A/C),(A/,A,0.8,0.58,1.03,0.11162925,Moderate,0.385,0.244,0.072,0.099,No significant pattern (p=0.037),Variable effect (p=0.031),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06078,rs182572,15,2650302,CR1,Insertion,-,-,0.79,0.47,1.01,0.05800867,High,0.073,0.159,0.522,0.046,Significant decrease (p=0.014),Significant decrease (p=0.022),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06079,rs440647,16,190036083,EPHA1,SNP (A/T),(A/,A,0.88,0.51,1.13,0.02833306,Moderate,0.41,0.023,0.263,0.105,No significant pattern (p=0.02),Significant decrease (p=0.041),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06080,rs521234,13,84058807,PICALM,SNP (A/C),(A/,A,1.53,1.31,1.8,0.04911163,Moderate,0.264,0.391,0.075,0.069,Significant increase (p=0.006),No significant pattern (p=0.029),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP06081,rs516122,21,53677047,EPHA1,SNP (C/T),(C/,C,1.28,0.96,1.62,0.01765539,Protective,0.318,0.23,0.229,0.023,Variable effect (p=0.004),Mild increase (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06082,rs970684,13,88761723,ABCA7,Deletion,-,-,2.29,1.97,2.56,0.01183244,Moderate,0.006,0.292,0.36,0.142,Variable effect (p=0.028),Significant decrease (p=0.01),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06083,rs763633,11,84430011,TREM2,Insertion,-,-,1.33,0.98,1.6,0.02630889,Moderate,0.491,0.013,0.152,0.144,Mild increase (p=0.035),Variable effect (p=0.048),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06084,rs349509,18,1225847,MS4A6A,SNP (A/G),(A/,A,1.09,0.77,1.29,0.13218642,High,0.34,0.097,0.125,0.238,Mild increase (p=0.003),Significant increase (p=0.033),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06085,rs476904,11,33938586,EPHA1,SNP (A/T),(A/,A,0.96,0.69,1.22,0.05233865,Low,0.565,0.035,0.021,0.178,Mild increase (p=0.015),Significant decrease (p=0.008),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06086,rs327986,19,160181602,APP,Insertion,-,-,1.31,0.97,1.64,0.07996059,Moderate,0.075,0.275,0.252,0.198,Mild decrease (p=0.006),Significant increase (p=0.012),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP06087,rs681694,7,224833974,CD33,Insertion,-,-,1.57,1.35,1.88,0.07655218,High,0.378,0.315,0.014,0.093,Significant increase (p=0.022),No significant pattern (p=0.018),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06088,rs912874,15,181824284,CD33,SNP (C/G),(C/,C,0.66,0.32,0.97,0.01686777,High,0.063,0.689,0.023,0.025,Mild decrease (p=0.042),Significant increase (p=0.046),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06089,rs134142,17,55567997,APP,Insertion,-,-,1.96,1.76,2.25,0.0053967,High,0.348,0.054,0.14,0.257,Variable effect (p=0.013),Significant increase (p=0.04),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06090,rs187758,14,41161210,CR1,SNP (A/C),(A/,A,0.69,0.34,0.95,0.0091146,High,0.286,0.007,0.094,0.413,Significant decrease (p=0.034),Significant increase (p=0.039),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP06091,rs219882,5,128069255,PSEN2,SNP (G/T),(G/,G,2.44,2.18,2.81,0.01897678,Moderate,0.631,0.018,0.118,0.033,Mild increase (p=0.041),Significant decrease (p=0.035),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06092,rs857714,14,238280355,CLU,Insertion,-,-,0.68,0.46,0.95,0.03521758,Moderate,0.031,0.074,0.556,0.138,Mild increase (p=0.046),No significant pattern (p=0.032),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06093,rs103340,4,189644356,BIN1,SNP (C/T),(C/,C,2.98,2.68,3.35,0.02786688,Moderate,0.105,0.155,0.103,0.437,Significant decrease (p=0.007),Mild increase (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP06094,rs495383,20,16335205,CR1,Insertion,-,-,0.63,0.27,0.98,0.00138349,High,0.056,0.205,0.227,0.312,Mild decrease (p=0.023),No significant pattern (p=0.03),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06095,rs237279,9,164276364,PTK2B,SNP (C/G),(C/,C,1.38,1.13,1.73,0.20872978,High,0.084,0.127,0.492,0.098,Mild decrease (p=0.03),Significant increase (p=0.012),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06096,rs104806,14,53083114,CD2AP,SNP (A/C),(A/,A,0.73,0.46,1.07,0.01741946,Protective,0.017,0.169,0.536,0.079,Mild decrease (p=0.014),Variable effect (p=0.029),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06097,rs835012,1,114041688,CLU,SNP (A/G),(A/,A,1.43,1.16,1.7,0.05421398,High,0.141,0.022,0.59,0.047,Significant increase (p=0.028),Mild increase (p=0.013),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06098,rs222278,9,46962238,CD2AP,SNP (G/T),(G/,G,0.81,0.43,1.04,0.05834847,Protective,0.044,0.137,0.329,0.29,Variable effect (p=0.049),Mild decrease (p=0.024),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06099,rs717931,9,247399321,APOE,SNP (C/T),(C/,C,1.93,1.65,2.25,0.03063028,Moderate,0.406,0.035,0.151,0.208,Significant decrease (p=0.019),Significant increase (p=0.003),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06100,rs650096,5,124510269,PSEN2,Deletion,-,-,0.38,0.14,0.58,0.00082498,High,0.186,0.196,0.167,0.252,Mild increase (p=0.042),Mild decrease (p=0.015),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06101,rs530710,12,194904206,BIN1,Deletion,-,-,1.12,0.81,1.5,0.00089718,Moderate,0.029,0.713,0.042,0.016,Mild decrease (p=0.016),No significant pattern (p=0.048),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06102,rs706630,6,70438593,BIN1,SNP (G/T),(G/,G,1.04,0.64,1.33,0.06228376,Protective,0.115,0.118,0.43,0.138,Mild decrease (p=0.039),Significant increase (p=0.005),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06103,rs565920,9,171014961,BIN1,SNP (A/C),(A/,A,0.79,0.52,1.11,0.01416824,Low,0.156,0.336,0.202,0.107,Variable effect (p=0.035),Mild decrease (p=0.019),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06104,rs609463,10,1386997,CR1,SNP (A/G),(A/,A,1.17,0.83,1.57,0.04548556,Low,0.23,0.295,0.141,0.134,Variable effect (p=0.036),Mild decrease (p=0.01),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06105,rs257857,3,16441399,EPHA1,SNP (G/T),(G/,G,0.73,0.37,1.12,0.07143178,Moderate,0.688,0.028,0.005,0.079,Mild decrease (p=0.033),Mild decrease (p=0.05),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06106,rs372667,9,61887870,ABCA7,SNP (A/C),(A/,A,1.68,1.44,1.9,0.04117112,High,0.041,0.608,0.072,0.078,Significant decrease (p=0.027),No significant pattern (p=0.022),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06107,rs361959,10,225721821,ABCA7,Deletion,-,-,0.55,0.34,0.79,0.00216003,Moderate,0.128,0.17,0.28,0.222,Significant increase (p=0.014),No significant pattern (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06108,rs881969,4,15633214,SORL1,Insertion,-,-,0.56,0.19,0.8,0.07068521,High,0.153,0.157,0.25,0.239,Significant increase (p=0.042),Mild increase (p=0.017),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06109,rs348914,21,173426479,CLU,SNP (C/T),(C/,C,0.75,0.41,1.09,0.0489218,Low,0.029,0.306,0.435,0.03,Mild increase (p=0.004),Significant decrease (p=0.036),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06110,rs674490,16,159850627,PICALM,SNP (G/T),(G/,G,0.57,0.34,0.88,0.00613039,Low,0.183,0.285,0.161,0.172,Significant decrease (p=0.049),Mild increase (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP06111,rs859292,16,12587722,SORL1,SNP (A/C),(A/,A,1.14,0.88,1.41,0.00025411,High,0.072,0.051,0.25,0.428,No significant pattern (p=0.043),Variable effect (p=0.01),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP06112,rs501180,5,151803036,MS4A6A,SNP (A/C),(A/,A,2.26,1.99,2.64,0.03808287,Moderate,0.085,0.482,0.191,0.042,Mild increase (p=0.007),No significant pattern (p=0.017),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP06113,rs137559,1,239813988,PICALM,SNP (C/G),(C/,C,1.42,1.03,1.72,0.00742135,Low,0.245,0.033,0.239,0.282,Mild increase (p=0.014),Mild decrease (p=0.045),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06114,rs106929,17,181040958,CD33,SNP (G/T),(G/,G,1.01,0.74,1.32,0.02252062,Moderate,0.018,0.309,0.347,0.125,Significant increase (p=0.04),Mild increase (p=0.027),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06115,rs247519,7,176801331,PTK2B,SNP (A/G),(A/,A,2.14,1.79,2.43,0.01832048,Protective,0.457,0.07,0.097,0.175,Variable effect (p=0.002),Significant increase (p=0.038),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06116,rs942146,12,33275567,EPHA1,SNP (C/T),(C/,C,0.84,0.46,1.18,0.0345604,Low,0.028,0.037,0.093,0.642,No significant pattern (p=0.032),No significant pattern (p=0.046),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06117,rs288612,21,112412859,CLU,Insertion,-,-,1.5,1.14,1.87,0.04414434,Moderate,0.197,0.213,0.352,0.039,Variable effect (p=0.003),Significant decrease (p=0.038),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06118,rs111778,1,25017603,ABCA7,Deletion,-,-,0.83,0.53,1.1,0.04567327,High,0.067,0.146,0.04,0.547,No significant pattern (p=0.013),Significant decrease (p=0.034),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06119,rs112738,1,70673782,APP,SNP (C/T),(C/,C,1.27,0.9,1.57,0.06481228,High,0.102,0.088,0.164,0.446,Significant decrease (p=0.004),No significant pattern (p=0.041),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06120,rs805599,7,12414778,TREM2,Insertion,-,-,0.73,0.41,0.97,0.01004239,Moderate,0.133,0.142,0.506,0.019,Significant decrease (p=0.009),Mild increase (p=0.024),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06121,rs831006,21,51275805,APP,SNP (A/G),(A/,A,2.51,2.2,2.72,0.05869138,High,0.48,0.059,0.064,0.197,Significant increase (p=0.002),Mild increase (p=0.004),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06122,rs529088,14,160650521,EPHA1,SNP (C/T),(C/,C,1.46,1.23,1.72,0.06597865,Low,0.067,0.083,0.413,0.237,Variable effect (p=0.024),Variable effect (p=0.041),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06123,rs772651,7,94440156,PSEN2,SNP (G/T),(G/,G,1.32,0.92,1.63,0.00717646,High,0.051,0.027,0.372,0.35,No significant pattern (p=0.013),Mild decrease (p=0.046),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP06124,rs303700,1,159130410,BIN1,SNP (C/T),(C/,C,1.48,1.27,1.81,0.01148564,Moderate,0.243,0.063,0.088,0.406,Variable effect (p=0.028),No significant pattern (p=0.02),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06125,rs463283,22,144319753,CR1,SNP (A/T),(A/,A,1.42,1.03,1.72,0.00213491,High,0.29,0.086,0.039,0.386,No significant pattern (p=0.04),Variable effect (p=0.009),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06126,rs516136,2,231129909,MS4A6A,SNP (G/T),(G/,G,1.27,0.9,1.5,0.01056085,Moderate,0.072,0.101,0.405,0.222,Mild decrease (p=0.038),Significant increase (p=0.05),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06127,rs910943,1,144791234,BIN1,Deletion,-,-,1.0,0.8,1.4,0.02249182,Unknown,0.174,0.038,0.351,0.237,Significant increase (p=0.013),No significant pattern (p=0.001),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06128,rs164595,22,140310036,PICALM,SNP (A/T),(A/,A,0.92,0.57,1.14,0.04212768,High,0.616,0.074,0.072,0.038,Variable effect (p=0.018),Significant decrease (p=0.048),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06129,rs748267,14,200596519,ABCA7,SNP (C/T),(C/,C,2.16,1.83,2.5,0.01994796,Moderate,0.067,0.165,0.509,0.06,Significant decrease (p=0.027),Mild decrease (p=0.039),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06130,rs719720,22,139750098,EPHA1,SNP (G/T),(G/,G,0.54,0.22,0.85,0.01332949,Moderate,0.233,0.184,0.22,0.162,Variable effect (p=0.013),No significant pattern (p=0.029),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP06131,rs349100,21,1670926,PICALM,Insertion,-,-,0.67,0.28,1.03,0.1368213,Moderate,0.157,0.289,0.055,0.299,Variable effect (p=0.005),Significant decrease (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06132,rs299735,22,124656270,CR1,Insertion,-,-,1.04,0.73,1.28,0.02156086,Low,0.123,0.152,0.508,0.016,Significant decrease (p=0.008),Significant decrease (p=0.042),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06133,rs516880,7,34427700,CD33,SNP (A/T),(A/,A,0.57,0.3,0.91,0.00298409,Unknown,0.216,0.312,0.198,0.073,No significant pattern (p=0.019),Mild decrease (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06134,rs641451,14,153074777,SORL1,SNP (A/C),(A/,A,0.77,0.45,0.98,0.00934685,High,0.482,0.031,0.247,0.04,Variable effect (p=0.008),Mild increase (p=0.004),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06135,rs172235,15,189944723,BIN1,SNP (C/G),(C/,C,0.56,0.35,0.95,0.00515394,Low,0.164,0.446,0.045,0.145,Mild decrease (p=0.009),Mild increase (p=0.045),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06136,rs358226,9,140078683,BIN1,SNP (C/T),(C/,C,1.52,1.22,1.79,0.05626668,High,0.132,0.423,0.142,0.103,Significant decrease (p=0.008),Significant increase (p=0.03),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06137,rs360106,9,169279656,CR1,Deletion,-,-,0.37,0.16,0.6,0.03439119,Protective,0.421,0.224,0.134,0.021,Variable effect (p=0.015),Mild decrease (p=0.049),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06138,rs749465,20,220038365,CD2AP,SNP (A/G),(A/,A,1.37,1.16,1.65,0.02901957,High,0.084,0.444,0.105,0.167,Significant increase (p=0.048),No significant pattern (p=0.041),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06139,rs936246,15,115516470,PTK2B,SNP (A/G),(A/,A,1.52,1.31,1.85,0.00796927,Moderate,0.388,0.081,0.121,0.21,Mild increase (p=0.041),Mild increase (p=0.047),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP06140,rs336639,9,203520372,PTK2B,SNP (C/G),(C/,C,0.72,0.51,1.1,0.05207237,Moderate,0.036,0.006,0.076,0.683,Significant decrease (p=0.024),Variable effect (p=0.006),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06141,rs625310,21,180802865,CLU,SNP (A/T),(A/,A,0.47,0.19,0.68,0.06519895,High,0.12,0.108,0.127,0.445,Mild decrease (p=0.012),Variable effect (p=0.05),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP06142,rs666795,11,65836607,CR1,SNP (A/C),(A/,A,1.38,1.11,1.6,0.01364448,Moderate,0.164,0.072,0.214,0.35,Mild increase (p=0.012),Mild decrease (p=0.017),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP06143,rs223243,19,235694929,CLU,SNP (C/T),(C/,C,0.47,0.18,0.73,0.04335774,Protective,0.282,0.471,0.034,0.013,No significant pattern (p=0.026),Variable effect (p=0.013),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP06144,rs211635,21,65805227,APP,SNP (A/G),(A/,A,0.93,0.65,1.21,0.02285841,Moderate,0.031,0.468,0.24,0.062,Variable effect (p=0.019),No significant pattern (p=0.034),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP06145,rs456168,6,97186642,PTK2B,SNP (A/C),(A/,A,0.39,0.11,0.66,0.02261326,Moderate,0.064,0.407,0.065,0.263,Variable effect (p=0.005),No significant pattern (p=0.031),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06146,rs590771,12,137500300,CR1,Insertion,-,-,0.8,0.42,1.19,0.00217371,Moderate,0.105,0.247,0.316,0.131,Significant decrease (p=0.032),Variable effect (p=0.011),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06147,rs901335,11,13974923,PICALM,Deletion,-,-,0.99,0.73,1.33,0.03116991,Protective,0.123,0.145,0.069,0.463,Mild increase (p=0.025),Mild increase (p=0.033),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06148,rs209850,22,64683958,ABCA7,SNP (A/G),(A/,A,0.97,0.58,1.34,0.00565697,Low,0.595,0.032,0.056,0.117,Significant decrease (p=0.007),Significant decrease (p=0.025),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP06149,rs761752,19,199268951,EPHA1,SNP (G/T),(G/,G,1.54,1.18,1.76,0.03479,Low,0.246,0.005,0.202,0.347,No significant pattern (p=0.048),Significant increase (p=0.017),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06150,rs782803,9,162546868,ABCA7,SNP (A/T),(A/,A,2.06,1.82,2.31,0.07661244,Unknown,0.142,0.506,0.012,0.14,Mild decrease (p=0.004),Significant decrease (p=0.007),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06151,rs445838,10,15572881,CLU,SNP (G/T),(G/,G,0.76,0.46,1.11,0.0672305,High,0.223,0.42,0.031,0.126,Significant decrease (p=0.037),Significant increase (p=0.009),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06152,rs289298,18,143873643,APP,Insertion,-,-,1.9,1.56,2.16,0.02607265,High,0.216,0.013,0.478,0.094,Variable effect (p=0.001),Mild increase (p=0.009),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06153,rs234481,14,180193517,CD2AP,SNP (C/T),(C/,C,2.36,2.12,2.64,0.07138033,High,0.228,0.097,0.072,0.404,Mild decrease (p=0.015),Variable effect (p=0.014),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06154,rs942703,14,145014413,CLU,Insertion,-,-,0.92,0.54,1.2,0.01743181,Moderate,0.034,0.447,0.271,0.048,Mild decrease (p=0.048),No significant pattern (p=0.025),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06155,rs366195,16,200561360,PTK2B,SNP (C/G),(C/,C,0.34,0.1,0.58,0.01791965,High,0.063,0.002,0.398,0.336,Significant increase (p=0.023),Significant decrease (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06156,rs622185,19,174639642,APOE,Insertion,-,-,0.87,0.61,1.13,0.01414836,Unknown,0.133,0.047,0.42,0.2,Significant decrease (p=0.044),Mild decrease (p=0.01),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06157,rs545082,21,199686321,PSEN2,Insertion,-,-,1.2,0.91,1.46,0.00784517,Moderate,0.175,0.303,0.212,0.11,Variable effect (p=0.008),Significant decrease (p=0.012),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06158,rs721496,13,154823424,CD33,SNP (G/T),(G/,G,1.49,1.18,1.83,0.00987726,Moderate,0.615,0.029,0.131,0.025,Significant increase (p=0.007),Mild decrease (p=0.043),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06159,rs313318,15,57066590,PICALM,SNP (A/T),(A/,A,0.73,0.49,0.96,0.02068892,Low,0.256,0.077,0.068,0.398,Significant decrease (p=0.002),Variable effect (p=0.038),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06160,rs359591,21,247080742,APOE,SNP (G/T),(G/,G,0.54,0.21,0.85,0.00087526,Moderate,0.021,0.604,0.097,0.078,Variable effect (p=0.021),Significant decrease (p=0.043),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06161,rs382027,18,118312800,ABCA7,SNP (C/T),(C/,C,2.07,1.75,2.41,0.04127898,Moderate,0.41,0.111,0.155,0.124,Significant increase (p=0.004),Significant decrease (p=0.038),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP06162,rs288871,5,119340003,PSEN2,SNP (C/T),(C/,C,0.54,0.33,0.81,0.00317755,High,0.089,0.269,0.253,0.189,Mild decrease (p=0.04),Significant decrease (p=0.025),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP06163,rs262602,6,47719683,SORL1,SNP (G/T),(G/,G,1.21,0.93,1.5,0.0365998,Low,0.265,0.054,0.0,0.48,No significant pattern (p=0.032),Significant increase (p=0.006),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP06164,rs797764,20,76160976,PICALM,Deletion,-,-,0.85,0.63,1.14,0.00994312,Protective,0.078,0.596,0.124,0.002,Variable effect (p=0.034),No significant pattern (p=0.028),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06165,rs705505,13,141437806,PICALM,SNP (C/T),(C/,C,1.15,0.78,1.35,0.02782239,High,0.172,0.016,0.014,0.597,Significant increase (p=0.003),Significant decrease (p=0.042),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06166,rs445505,8,133751410,CLU,Deletion,-,-,3.96,3.75,4.29,0.0119307,High,0.487,0.01,0.026,0.277,Mild increase (p=0.028),No significant pattern (p=0.023),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06167,rs975693,5,121208203,PSEN2,SNP (A/T),(A/,A,1.1,0.72,1.33,0.02460963,Low,0.122,0.004,0.237,0.437,Significant decrease (p=0.024),Significant increase (p=0.05),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06168,rs495978,8,227205613,SORL1,SNP (A/G),(A/,A,0.45,0.19,0.85,0.04789191,Unknown,0.386,0.376,0.002,0.036,No significant pattern (p=0.012),Mild decrease (p=0.024),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06169,rs867372,18,179295429,ABCA7,SNP (A/G),(A/,A,0.68,0.33,0.93,0.02339922,Moderate,0.228,0.243,0.045,0.284,Significant decrease (p=0.018),No significant pattern (p=0.032),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06170,rs629030,7,134600700,APP,SNP (A/C),(A/,A,1.8,1.53,2.02,0.07188896,Low,0.322,0.25,0.082,0.146,Mild decrease (p=0.01),Variable effect (p=0.024),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP06171,rs658617,10,115812074,CD33,SNP (A/G),(A/,A,1.27,0.89,1.63,0.00436831,Moderate,0.145,0.035,0.532,0.088,Mild increase (p=0.043),Mild increase (p=0.005),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06172,rs725753,11,136469061,TREM2,SNP (G/T),(G/,G,1.18,0.91,1.46,0.04631398,Moderate,0.232,0.001,0.037,0.53,No significant pattern (p=0.038),Variable effect (p=0.004),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06173,rs136273,2,146034630,CD33,SNP (A/T),(A/,A,0.94,0.64,1.23,0.05438418,High,0.07,0.413,0.014,0.304,Mild increase (p=0.035),Significant decrease (p=0.016),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06174,rs204458,8,60170386,ABCA7,SNP (A/C),(A/,A,1.22,0.84,1.57,0.00608892,Moderate,0.027,0.347,0.423,0.003,Variable effect (p=0.039),No significant pattern (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06175,rs667399,11,154771742,CLU,SNP (A/C),(A/,A,1.08,0.72,1.41,0.01824135,High,0.495,0.205,0.001,0.099,Mild increase (p=0.004),Variable effect (p=0.042),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06176,rs270563,5,57652528,ABCA7,Deletion,-,-,0.65,0.3,1.04,9.965e-05,Low,0.279,0.076,0.421,0.024,Mild increase (p=0.01),No significant pattern (p=0.001),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06177,rs578445,9,158550078,BIN1,SNP (G/T),(G/,G,1.16,0.91,1.53,0.01279663,Low,0.108,0.071,0.326,0.295,Significant increase (p=0.039),Significant increase (p=0.046),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06178,rs772331,14,162575846,CLU,SNP (A/C),(A/,A,2.58,2.31,2.9,0.00511557,Protective,0.312,0.291,0.191,0.006,Mild decrease (p=0.02),Significant decrease (p=0.036),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06179,rs452177,2,213686623,BIN1,Insertion,-,-,0.95,0.57,1.34,0.04290059,Low,0.339,0.138,0.257,0.066,No significant pattern (p=0.019),No significant pattern (p=0.012),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06180,rs905243,7,177697845,CD33,SNP (C/T),(C/,C,0.85,0.5,1.14,0.01233403,Low,0.272,0.076,0.36,0.091,Significant increase (p=0.02),Significant decrease (p=0.025),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06181,rs649216,1,185768983,CR1,Insertion,-,-,2.38,2.06,2.68,0.05172152,Moderate,0.303,0.025,0.388,0.085,Mild increase (p=0.015),Mild decrease (p=0.017),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06182,rs105587,17,106413734,PTK2B,SNP (A/G),(A/,A,1.16,0.81,1.5,0.0118009,High,0.407,0.069,0.192,0.132,Variable effect (p=0.036),Significant decrease (p=0.048),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP06183,rs811828,22,159310314,EPHA1,Deletion,-,-,0.72,0.51,1.09,0.00288771,Protective,0.143,0.041,0.058,0.558,Variable effect (p=0.027),No significant pattern (p=0.038),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06184,rs761197,16,170449171,PTK2B,SNP (C/G),(C/,C,0.54,0.16,0.8,0.08188986,Unknown,0.433,0.351,0.015,0.001,Variable effect (p=0.009),Variable effect (p=0.041),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06185,rs829590,19,104421486,PICALM,SNP (A/C),(A/,A,1.28,1.06,1.49,0.01010204,Low,0.502,0.177,0.073,0.047,Mild increase (p=0.019),No significant pattern (p=0.015),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP06186,rs762869,2,105819247,TREM2,Deletion,-,-,0.54,0.18,0.78,0.01843829,Moderate,0.285,0.101,0.253,0.16,Mild increase (p=0.014),Significant decrease (p=0.011),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06187,rs358745,9,30081426,PICALM,SNP (G/T),(G/,G,3.53,3.26,3.83,0.00180419,High,0.338,0.045,0.277,0.139,Significant decrease (p=0.025),Significant decrease (p=0.008),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06188,rs186915,5,26952955,CLU,SNP (G/T),(G/,G,0.91,0.54,1.11,0.00680067,Low,0.156,0.511,0.065,0.068,Significant increase (p=0.041),Variable effect (p=0.021),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06189,rs267267,22,139443728,CLU,Insertion,-,-,0.78,0.43,1.07,0.02382949,High,0.23,0.235,0.315,0.02,No significant pattern (p=0.046),Significant increase (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06190,rs175566,22,27056499,APOE,SNP (A/C),(A/,A,1.37,1.13,1.63,0.00567885,Protective,0.275,0.157,0.08,0.288,Mild decrease (p=0.046),No significant pattern (p=0.034),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06191,rs138763,9,214884926,CR1,SNP (A/T),(A/,A,2.06,1.79,2.43,0.03028299,Unknown,0.339,0.004,0.129,0.327,Mild increase (p=0.026),Mild increase (p=0.045),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06192,rs964260,18,202761675,BIN1,SNP (A/G),(A/,A,0.6,0.22,0.94,0.0060407,High,0.429,0.34,0.024,0.008,No significant pattern (p=0.007),Mild increase (p=0.043),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06193,rs881278,1,49380053,MS4A6A,Insertion,-,-,1.38,1.16,1.65,0.02511543,Low,0.103,0.588,0.103,0.006,Mild decrease (p=0.028),Significant increase (p=0.05),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06194,rs310966,8,55603595,CD33,SNP (A/C),(A/,A,1.22,0.95,1.57,0.01982816,Protective,0.038,0.182,0.297,0.282,Significant decrease (p=0.013),Significant decrease (p=0.016),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06195,rs525154,3,86776939,CLU,SNP (C/T),(C/,C,1.06,0.81,1.26,0.03830103,Moderate,0.043,0.252,0.468,0.037,Variable effect (p=0.028),No significant pattern (p=0.006),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06196,rs436946,11,8381012,APP,SNP (A/G),(A/,A,0.68,0.33,1.04,0.00142619,High,0.158,0.211,0.104,0.328,Mild decrease (p=0.014),Variable effect (p=0.032),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06197,rs893433,15,218277524,CR1,SNP (G/T),(G/,G,0.75,0.38,1.1,0.0160931,Low,0.233,0.064,0.042,0.461,No significant pattern (p=0.018),Mild decrease (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP06198,rs251317,12,114575647,BIN1,SNP (G/T),(G/,G,1.94,1.74,2.25,0.02056283,Low,0.055,0.101,0.39,0.253,Mild increase (p=0.023),Mild increase (p=0.02),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06199,rs469964,20,85743114,CD2AP,SNP (A/G),(A/,A,0.79,0.53,1.09,0.0231629,Protective,0.171,0.023,0.102,0.503,Mild increase (p=0.033),Mild decrease (p=0.037),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06200,rs463500,18,134130717,APP,SNP (A/C),(A/,A,1.58,1.31,1.94,0.01346665,Protective,0.288,0.046,0.242,0.224,Significant decrease (p=0.014),Mild increase (p=0.036),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06201,rs675064,16,41274974,PICALM,SNP (C/T),(C/,C,1.32,1.09,1.6,0.00854875,High,0.153,0.161,0.247,0.239,Mild decrease (p=0.048),Mild decrease (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06202,rs447887,1,159011760,PSEN2,SNP (A/T),(A/,A,1.27,1.03,1.48,0.01922288,Low,0.005,0.476,0.296,0.023,Mild increase (p=0.004),Mild increase (p=0.008),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06203,rs807616,1,135273195,APOE,SNP (A/T),(A/,A,0.79,0.5,1.0,0.06587144,Low,0.404,0.222,0.173,0.001,Significant increase (p=0.006),Significant decrease (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06204,rs822477,20,42534060,PSEN2,Insertion,-,-,1.39,1.08,1.78,0.01034095,Moderate,0.25,0.056,0.005,0.489,Significant decrease (p=0.034),No significant pattern (p=0.019),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06205,rs134069,9,208153066,SORL1,SNP (A/T),(A/,A,1.29,0.96,1.59,0.1317305,High,0.071,0.095,0.07,0.564,Significant decrease (p=0.01),Variable effect (p=0.04),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06206,rs402499,17,246757001,CLU,SNP (C/G),(C/,C,1.31,0.92,1.64,0.02879251,Moderate,0.047,0.635,0.078,0.04,Variable effect (p=0.014),Mild decrease (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06207,rs119161,4,210837871,CD2AP,SNP (G/T),(G/,G,1.02,0.74,1.34,0.04710171,High,0.068,0.319,0.041,0.373,Variable effect (p=0.015),Variable effect (p=0.049),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06208,rs657135,13,164921382,MS4A6A,Deletion,-,-,0.98,0.7,1.19,0.02999348,Low,0.492,0.099,0.131,0.078,No significant pattern (p=0.038),Mild increase (p=0.012),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06209,rs210173,1,59353523,MS4A6A,Insertion,-,-,2.6,2.29,2.9,0.09200968,High,0.211,0.304,0.172,0.113,Mild decrease (p=0.035),No significant pattern (p=0.028),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06210,rs112750,12,105566173,APP,Insertion,-,-,0.87,0.51,1.07,0.11413156,Moderate,0.155,0.097,0.471,0.076,Mild increase (p=0.013),Mild increase (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP06211,rs180063,5,3821744,APP,SNP (A/G),(A/,A,0.53,0.22,0.84,0.16865553,High,0.118,0.167,0.33,0.185,Variable effect (p=0.022),Mild decrease (p=0.029),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06212,rs294802,13,37710701,CD2AP,SNP (G/T),(G/,G,0.58,0.22,0.86,0.04520045,Moderate,0.123,0.098,0.242,0.337,No significant pattern (p=0.033),Mild increase (p=0.023),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06213,rs851953,19,126614831,CR1,SNP (G/T),(G/,G,0.84,0.46,1.18,0.01443771,Moderate,0.232,0.135,0.187,0.247,Significant decrease (p=0.046),Significant decrease (p=0.009),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06214,rs235836,6,58138749,PSEN2,SNP (A/G),(A/,A,0.79,0.41,1.15,0.04908151,High,0.02,0.089,0.024,0.667,Mild decrease (p=0.007),Mild decrease (p=0.011),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06215,rs643857,2,142584709,TREM2,Insertion,-,-,0.3,0.1,0.51,0.03445439,Moderate,0.219,0.158,0.311,0.111,Significant increase (p=0.044),Significant decrease (p=0.019),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06216,rs498580,22,226632493,EPHA1,Insertion,-,-,1.17,0.92,1.48,0.00047288,Moderate,0.416,0.015,0.273,0.096,Significant increase (p=0.014),Mild decrease (p=0.012),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06217,rs284180,21,156565742,CD33,SNP (C/T),(C/,C,0.23,0.1,0.46,0.00048912,Unknown,0.162,0.363,0.002,0.273,Variable effect (p=0.018),Mild increase (p=0.034),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06218,rs555233,15,205727096,EPHA1,SNP (A/G),(A/,A,0.62,0.25,0.93,0.02228023,Protective,0.015,0.274,0.234,0.278,Variable effect (p=0.04),Significant decrease (p=0.039),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06219,rs423277,21,185865512,MS4A6A,Deletion,-,-,0.6,0.35,0.82,0.00422109,Low,0.419,0.069,0.088,0.224,Significant decrease (p=0.044),Significant decrease (p=0.045),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06220,rs170272,5,122601945,BIN1,SNP (G/T),(G/,G,1.5,1.11,1.78,0.06856157,Unknown,0.036,0.002,0.241,0.521,Variable effect (p=0.009),No significant pattern (p=0.038),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06221,rs777269,14,8696731,PICALM,SNP (A/G),(A/,A,1.09,0.85,1.45,0.00662849,Moderate,0.481,0.166,0.089,0.064,Mild decrease (p=0.019),Variable effect (p=0.039),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06222,rs176606,5,92937484,APP,SNP (C/G),(C/,C,1.95,1.69,2.33,0.01989238,Moderate,0.03,0.078,0.432,0.261,Mild decrease (p=0.023),Mild increase (p=0.042),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06223,rs822631,19,131591622,TREM2,SNP (G/T),(G/,G,0.88,0.65,1.26,0.02659036,Moderate,0.046,0.447,0.078,0.23,No significant pattern (p=0.011),No significant pattern (p=0.043),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06224,rs388591,21,217251020,APOE,SNP (A/C),(A/,A,1.24,0.9,1.62,0.01025792,Low,0.209,0.499,0.015,0.076,Mild increase (p=0.026),No significant pattern (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06225,rs322725,22,198142065,CR1,SNP (C/T),(C/,C,1.52,1.3,1.85,0.02768754,High,0.468,0.332,0.0,0.0,No significant pattern (p=0.028),No significant pattern (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06226,rs702355,19,96780124,BIN1,SNP (C/T),(C/,C,0.79,0.52,1.08,0.03409723,Protective,0.038,0.146,0.29,0.326,No significant pattern (p=0.043),Mild increase (p=0.039),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06227,rs265702,10,54722507,CLU,Insertion,-,-,0.78,0.56,1.05,0.00075247,Moderate,0.012,0.265,0.285,0.239,Mild decrease (p=0.032),Mild decrease (p=0.008),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06228,rs662853,4,143380363,CD33,SNP (G/T),(G/,G,0.94,0.65,1.23,0.0549913,High,0.331,0.219,0.125,0.126,No significant pattern (p=0.002),Significant decrease (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06229,rs100371,7,45119221,CD2AP,SNP (A/G),(A/,A,2.08,1.75,2.45,0.02177599,High,0.025,0.306,0.315,0.154,Variable effect (p=0.033),No significant pattern (p=0.022),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06230,rs694383,10,18532374,CLU,Insertion,-,-,0.75,0.41,1.02,0.00860317,High,0.025,0.198,0.011,0.566,Mild increase (p=0.049),Significant increase (p=0.021),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP06231,rs731667,10,20311591,ABCA7,SNP (G/T),(G/,G,1.3,0.98,1.56,0.01397786,Low,0.331,0.208,0.072,0.189,No significant pattern (p=0.036),Variable effect (p=0.011),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06232,rs966351,3,226664841,MS4A6A,SNP (A/G),(A/,A,2.19,1.98,2.41,0.00733107,Moderate,0.128,0.008,0.618,0.045,No significant pattern (p=0.028),Mild decrease (p=0.014),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06233,rs885862,14,86994074,EPHA1,SNP (C/G),(C/,C,0.76,0.43,1.04,0.03655187,High,0.367,0.13,0.182,0.121,Mild decrease (p=0.035),Significant increase (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06234,rs523844,17,190532105,MS4A6A,Insertion,-,-,1.4,1.01,1.69,0.01981241,Low,0.019,0.031,0.383,0.366,Variable effect (p=0.016),Significant increase (p=0.047),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06235,rs372992,18,46399454,PTK2B,SNP (A/C),(A/,A,1.54,1.24,1.89,0.00150171,High,0.393,0.059,0.036,0.312,Mild increase (p=0.033),Mild decrease (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06236,rs796512,7,40012973,CLU,SNP (C/G),(C/,C,1.53,1.27,1.78,0.02881018,Moderate,0.331,0.095,0.027,0.347,Mild decrease (p=0.006),Mild increase (p=0.046),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06237,rs687209,13,189663835,PSEN2,SNP (C/T),(C/,C,1.0,0.79,1.24,0.02382815,Moderate,0.115,0.621,0.024,0.04,Mild decrease (p=0.02),Significant decrease (p=0.022),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06238,rs371064,7,4688772,SORL1,Insertion,-,-,0.99,0.65,1.2,0.00927541,Low,0.358,0.026,0.372,0.044,Significant decrease (p=0.002),No significant pattern (p=0.006),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06239,rs636263,2,185063606,PICALM,SNP (C/G),(C/,C,1.94,1.66,2.16,0.01505954,Moderate,0.033,0.078,0.313,0.376,No significant pattern (p=0.005),Significant decrease (p=0.033),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06240,rs996540,16,101176958,CLU,SNP (A/T),(A/,A,0.67,0.45,0.87,0.00750211,Moderate,0.245,0.497,0.017,0.041,Mild decrease (p=0.032),Mild decrease (p=0.029),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06241,rs753119,11,24511593,TREM2,SNP (A/C),(A/,A,1.28,1.01,1.6,0.02911135,Low,0.19,0.293,0.295,0.022,Mild increase (p=0.05),Significant decrease (p=0.014),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06242,rs772690,3,84505150,TREM2,Insertion,-,-,1.04,0.75,1.31,0.16514676,Low,0.259,0.532,0.0,0.008,Mild increase (p=0.03),Mild decrease (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06243,rs759332,1,111253469,CR1,SNP (A/G),(A/,A,0.49,0.11,0.87,0.00306764,Moderate,0.021,0.557,0.086,0.136,Mild decrease (p=0.019),No significant pattern (p=0.025),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP06244,rs773690,13,49262458,CLU,SNP (A/T),(A/,A,0.92,0.67,1.2,0.00218362,Moderate,0.476,0.296,0.013,0.016,Mild increase (p=0.008),No significant pattern (p=0.017),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06245,rs323872,6,15949979,PTK2B,SNP (G/T),(G/,G,1.52,1.16,1.82,0.01644615,Protective,0.627,0.017,0.079,0.076,No significant pattern (p=0.036),Variable effect (p=0.005),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06246,rs583062,5,234516899,APP,SNP (A/C),(A/,A,1.25,0.99,1.6,0.01090299,High,0.39,0.117,0.048,0.245,No significant pattern (p=0.016),Mild decrease (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06247,rs187549,22,88306308,CD2AP,SNP (C/T),(C/,C,1.11,0.75,1.44,0.00227892,High,0.455,0.023,0.105,0.217,No significant pattern (p=0.018),Mild increase (p=0.044),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06248,rs949682,17,124991352,PICALM,SNP (C/G),(C/,C,1.16,0.93,1.43,0.02708633,Low,0.278,0.363,0.156,0.004,Significant decrease (p=0.022),No significant pattern (p=0.014),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06249,rs286862,6,222505443,PTK2B,SNP (C/G),(C/,C,1.81,1.5,2.19,0.02759577,Moderate,0.07,0.171,0.287,0.272,Variable effect (p=0.03),No significant pattern (p=0.04),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06250,rs313515,14,227788489,BIN1,SNP (C/G),(C/,C,0.21,0.1,0.44,0.02869641,Moderate,0.125,0.122,0.54,0.013,Significant decrease (p=0.033),No significant pattern (p=0.005),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06251,rs470266,3,52301840,CD2AP,SNP (G/T),(G/,G,0.43,0.16,0.7,0.00771908,Moderate,0.037,0.045,0.305,0.413,Variable effect (p=0.044),Significant decrease (p=0.025),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06252,rs562182,20,215950387,PICALM,SNP (C/G),(C/,C,1.05,0.71,1.36,0.01212239,High,0.097,0.151,0.477,0.074,Significant decrease (p=0.033),No significant pattern (p=0.033),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06253,rs966548,15,56432480,BIN1,SNP (A/C),(A/,A,0.88,0.53,1.16,0.05360945,High,0.556,0.04,0.112,0.093,Mild decrease (p=0.028),Significant increase (p=0.045),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP06254,rs703779,17,132379203,PICALM,SNP (A/C),(A/,A,0.6,0.34,0.87,0.0043219,Low,0.363,0.141,0.241,0.055,Mild increase (p=0.05),Variable effect (p=0.002),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06255,rs283829,4,37661177,PSEN2,SNP (C/G),(C/,C,0.75,0.41,1.02,0.00440883,High,0.481,0.021,0.029,0.269,Variable effect (p=0.036),No significant pattern (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06256,rs437303,5,183539716,PICALM,SNP (C/G),(C/,C,0.35,0.1,0.56,0.00076102,Unknown,0.205,0.001,0.159,0.436,Mild decrease (p=0.021),Mild increase (p=0.046),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06257,rs111268,20,92519573,CR1,SNP (A/C),(A/,A,1.24,0.85,1.52,0.06705552,High,0.23,0.173,0.066,0.331,Variable effect (p=0.013),Variable effect (p=0.027),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06258,rs433581,9,237444887,CD2AP,SNP (C/T),(C/,C,1.42,1.04,1.76,0.06177193,Moderate,0.21,0.078,0.196,0.317,Variable effect (p=0.043),No significant pattern (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06259,rs576207,21,93356717,CD2AP,SNP (A/T),(A/,A,1.88,1.68,2.25,0.0115141,High,0.081,0.032,0.559,0.128,Significant increase (p=0.016),Variable effect (p=0.008),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06260,rs559312,17,149480813,APOE,Deletion,-,-,1.26,0.99,1.5,0.02551425,Low,0.059,0.024,0.702,0.016,Variable effect (p=0.012),Significant increase (p=0.003),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06261,rs811076,9,84555522,SORL1,SNP (G/T),(G/,G,3.28,2.99,3.62,0.01831224,Protective,0.01,0.36,0.249,0.181,Mild increase (p=0.033),Significant decrease (p=0.009),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06262,rs857924,13,208799388,MS4A6A,SNP (G/T),(G/,G,1.49,1.18,1.74,0.07950883,Unknown,0.388,0.181,0.21,0.021,Significant decrease (p=0.023),Significant increase (p=0.004),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06263,rs719557,1,92807202,ABCA7,SNP (G/T),(G/,G,0.62,0.38,0.91,0.03694693,Moderate,0.395,0.169,0.22,0.016,Mild decrease (p=0.008),Significant decrease (p=0.046),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06264,rs974537,19,50709458,SORL1,SNP (A/T),(A/,A,0.69,0.45,1.03,0.04236574,High,0.058,0.003,0.361,0.378,Variable effect (p=0.001),Mild increase (p=0.033),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06265,rs710397,1,143855477,APOE,SNP (C/T),(C/,C,0.93,0.56,1.22,0.01883054,Moderate,0.211,0.17,0.058,0.362,Significant increase (p=0.041),Mild increase (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06266,rs405902,21,99055708,PSEN2,SNP (G/T),(G/,G,0.97,0.75,1.34,0.10902964,Low,0.375,0.177,0.037,0.211,Variable effect (p=0.045),Mild decrease (p=0.002),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06267,rs576603,3,44735053,CD33,Insertion,-,-,1.28,1.04,1.48,0.01146531,High,0.154,0.187,0.305,0.154,Significant decrease (p=0.012),No significant pattern (p=0.027),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06268,rs617900,9,32773040,CLU,SNP (A/C),(A/,A,0.79,0.5,1.01,0.00600391,Moderate,0.097,0.213,0.286,0.204,Mild increase (p=0.014),No significant pattern (p=0.013),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06269,rs602782,7,119979027,CD2AP,Deletion,-,-,1.28,0.95,1.59,0.01227053,Moderate,0.546,0.1,0.137,0.017,Mild increase (p=0.023),Significant increase (p=0.026),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06270,rs664048,17,2777955,PICALM,SNP (G/T),(G/,G,0.58,0.26,0.86,0.02940601,Moderate,0.019,0.274,0.091,0.416,Mild increase (p=0.045),Variable effect (p=0.025),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP06271,rs566168,13,240825305,CD33,Deletion,-,-,0.77,0.52,1.02,0.0111099,Low,0.002,0.358,0.173,0.267,Significant increase (p=0.002),Significant decrease (p=0.036),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06272,rs269167,8,134097347,CD2AP,SNP (G/T),(G/,G,0.77,0.49,1.07,0.0469682,Moderate,0.317,0.061,0.119,0.303,Variable effect (p=0.013),Mild increase (p=0.045),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06273,rs390404,3,116073984,CR1,SNP (C/G),(C/,C,1.59,1.25,1.93,0.00585518,Moderate,0.201,0.029,0.559,0.011,Significant decrease (p=0.009),Mild decrease (p=0.026),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06274,rs595529,16,198693284,CR1,SNP (A/G),(A/,A,1.22,0.91,1.49,0.02014598,High,0.088,0.126,0.528,0.057,Significant decrease (p=0.034),Mild increase (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06275,rs886649,20,240674962,CLU,SNP (A/C),(A/,A,0.92,0.64,1.26,0.01573143,Low,0.058,0.112,0.396,0.235,Mild increase (p=0.023),No significant pattern (p=0.01),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP06276,rs150270,5,141980527,MS4A6A,SNP (A/C),(A/,A,0.47,0.11,0.73,0.10253959,High,0.332,0.238,0.197,0.034,Significant decrease (p=0.035),Significant increase (p=0.017),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06277,rs763523,8,217403579,CLU,SNP (C/T),(C/,C,1.12,0.83,1.41,0.13912765,High,0.045,0.366,0.223,0.166,No significant pattern (p=0.019),No significant pattern (p=0.047),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06278,rs128554,21,35417917,ABCA7,Insertion,-,-,1.32,0.94,1.62,0.04283943,Low,0.199,0.384,0.05,0.167,Variable effect (p=0.038),Significant decrease (p=0.038),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06279,rs852841,5,182468109,BIN1,SNP (C/G),(C/,C,0.82,0.46,1.04,0.00428704,Low,0.29,0.219,0.218,0.073,Significant increase (p=0.011),Mild decrease (p=0.005),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06280,rs293637,15,199640776,PTK2B,SNP (C/G),(C/,C,0.34,0.13,0.63,0.17389729,Moderate,0.107,0.347,0.203,0.143,No significant pattern (p=0.043),Significant decrease (p=0.014),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06281,rs641251,9,205506286,CLU,Insertion,-,-,3.04,2.66,3.25,0.01563858,High,0.322,0.016,0.301,0.16,Mild decrease (p=0.002),Variable effect (p=0.027),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06282,rs504254,1,239667612,EPHA1,SNP (C/T),(C/,C,1.65,1.36,1.93,0.02785587,Unknown,0.197,0.068,0.322,0.213,Mild decrease (p=0.039),Variable effect (p=0.032),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06283,rs874884,15,35135860,CR1,SNP (G/T),(G/,G,1.09,0.7,1.31,0.00678226,High,0.31,0.248,0.033,0.21,Significant increase (p=0.047),No significant pattern (p=0.009),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06284,rs529243,18,143307944,CD2AP,SNP (C/G),(C/,C,0.7,0.3,1.08,0.01911463,Moderate,0.003,0.541,0.238,0.018,No significant pattern (p=0.048),Significant increase (p=0.009),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06285,rs257544,11,42874158,PTK2B,SNP (A/C),(A/,A,0.25,0.1,0.49,0.00148471,Moderate,0.109,0.15,0.439,0.102,Significant increase (p=0.023),Significant decrease (p=0.037),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06286,rs972706,22,168573845,SORL1,SNP (G/T),(G/,G,0.85,0.59,1.19,0.08688201,Moderate,0.235,0.482,0.014,0.069,Significant increase (p=0.034),No significant pattern (p=0.001),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06287,rs295852,22,86341475,APP,SNP (G/T),(G/,G,0.3,0.1,0.51,0.01534013,High,0.077,0.045,0.006,0.673,Mild increase (p=0.028),Variable effect (p=0.026),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP06288,rs180291,10,177575592,CR1,SNP (G/T),(G/,G,1.25,0.95,1.56,0.00132233,Protective,0.198,0.068,0.231,0.304,Significant increase (p=0.04),Significant increase (p=0.037),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06289,rs717298,11,23786061,CD2AP,SNP (A/T),(A/,A,0.47,0.16,0.83,0.03317189,Unknown,0.28,0.383,0.093,0.044,Significant increase (p=0.004),Variable effect (p=0.015),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06290,rs549840,21,46542261,CLU,SNP (A/C),(A/,A,0.38,0.1,0.7,0.0004132,Low,0.047,0.167,0.586,0.0,Mild increase (p=0.039),Mild increase (p=0.026),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06291,rs482920,7,32158094,PTK2B,SNP (A/G),(A/,A,1.3,1.04,1.56,0.00952619,Protective,0.243,0.076,0.407,0.074,Mild increase (p=0.035),Mild increase (p=0.013),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06292,rs355625,22,76981997,CD2AP,SNP (A/T),(A/,A,1.19,0.91,1.46,0.10199962,High,0.434,0.062,0.055,0.249,Mild decrease (p=0.002),Significant decrease (p=0.016),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06293,rs973813,7,10112199,ABCA7,SNP (C/G),(C/,C,1.26,1.04,1.65,0.01687581,High,0.254,0.308,0.067,0.171,Variable effect (p=0.031),Significant decrease (p=0.04),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06294,rs738502,16,160047181,TREM2,Deletion,-,-,1.8,1.58,2.07,0.14691189,High,0.266,0.28,0.236,0.018,Significant decrease (p=0.006),No significant pattern (p=0.027),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06295,rs853882,4,231204745,SORL1,Insertion,-,-,5.23,4.86,5.51,0.01072911,Moderate,0.161,0.364,0.215,0.061,Mild increase (p=0.024),Mild increase (p=0.015),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP06296,rs323337,12,79824224,CLU,SNP (G/T),(G/,G,0.78,0.39,1.13,0.01221553,Low,0.171,0.172,0.312,0.146,Mild decrease (p=0.046),Mild decrease (p=0.042),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06297,rs308336,11,187311832,ABCA7,SNP (C/T),(C/,C,1.0,0.62,1.38,0.01554955,Moderate,0.217,0.336,0.094,0.154,Significant decrease (p=0.033),Mild decrease (p=0.049),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06298,rs205005,7,201688945,PTK2B,SNP (A/C),(A/,A,0.7,0.49,1.04,0.10906791,High,0.18,0.099,0.401,0.12,Significant decrease (p=0.004),Significant decrease (p=0.006),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06299,rs911071,3,26950879,MS4A6A,SNP (A/G),(A/,A,2.27,2.01,2.52,0.00376786,Moderate,0.443,0.166,0.009,0.181,Variable effect (p=0.014),Variable effect (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP06300,rs803808,15,109364919,CLU,SNP (G/T),(G/,G,1.26,0.92,1.53,0.09168227,Moderate,0.128,0.41,0.234,0.028,Significant increase (p=0.045),Variable effect (p=0.027),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06301,rs956521,22,129318314,EPHA1,SNP (G/T),(G/,G,0.85,0.56,1.1,0.00344042,Moderate,0.124,0.362,0.017,0.297,Variable effect (p=0.047),Variable effect (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06302,rs995306,15,55290343,CD33,SNP (C/G),(C/,C,0.44,0.19,0.68,0.01887087,Moderate,0.111,0.42,0.107,0.162,Significant increase (p=0.021),Significant decrease (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP06303,rs462138,16,142736933,ABCA7,SNP (C/G),(C/,C,0.98,0.7,1.25,0.00357742,Low,0.073,0.23,0.374,0.123,Significant increase (p=0.015),Mild increase (p=0.004),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06304,rs945019,1,229920380,CD33,SNP (A/G),(A/,A,0.75,0.43,1.04,0.01867126,Moderate,0.001,0.393,0.021,0.386,Mild increase (p=0.046),Mild increase (p=0.003),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06305,rs198957,18,189704640,APP,SNP (G/T),(G/,G,1.94,1.55,2.3,0.02661117,High,0.252,0.317,0.066,0.165,Variable effect (p=0.013),Significant decrease (p=0.016),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP06306,rs494166,11,16329841,CLU,Insertion,-,-,1.03,0.64,1.24,0.03301428,Unknown,0.173,0.199,0.248,0.18,No significant pattern (p=0.046),Variable effect (p=0.034),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06307,rs853494,16,245877276,EPHA1,Insertion,-,-,0.58,0.32,0.88,0.02394649,High,0.055,0.157,0.275,0.313,Significant increase (p=0.023),No significant pattern (p=0.044),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06308,rs421956,2,22757753,PSEN2,SNP (A/T),(A/,A,2.05,1.66,2.39,0.01599236,Unknown,0.244,0.248,0.045,0.262,Mild increase (p=0.001),Mild decrease (p=0.016),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06309,rs476136,6,104047637,CD33,SNP (G/T),(G/,G,1.07,0.68,1.28,0.01931199,Protective,0.142,0.356,0.192,0.11,Variable effect (p=0.026),Mild decrease (p=0.046),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06310,rs982883,22,18124685,BIN1,SNP (G/T),(G/,G,0.39,0.13,0.62,0.0367727,Low,0.261,0.003,0.215,0.32,Mild increase (p=0.026),No significant pattern (p=0.026),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06311,rs320984,17,159100067,PICALM,SNP (A/C),(A/,A,1.15,0.86,1.47,0.0375224,High,0.004,0.274,0.412,0.109,Significant increase (p=0.022),Mild decrease (p=0.04),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06312,rs217131,3,174271478,BIN1,Insertion,-,-,0.75,0.38,0.95,0.01408875,Moderate,0.292,0.064,0.404,0.04,No significant pattern (p=0.048),Significant decrease (p=0.046),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06313,rs920738,22,101126384,PSEN2,Deletion,-,-,0.46,0.1,0.82,0.0079954,Low,0.377,0.149,0.166,0.108,Mild increase (p=0.037),Mild decrease (p=0.042),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP06314,rs305569,19,127062041,CD2AP,SNP (C/T),(C/,C,1.93,1.65,2.29,0.00239811,High,0.055,0.123,0.202,0.42,Mild increase (p=0.035),Mild increase (p=0.001),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06315,rs263394,10,56460909,SORL1,Insertion,-,-,0.77,0.37,1.08,0.01167792,Low,0.311,0.21,0.2,0.079,Significant increase (p=0.045),Significant increase (p=0.005),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06316,rs372062,18,168056370,PSEN2,Insertion,-,-,1.72,1.4,2.04,0.01945225,Moderate,0.353,0.008,0.273,0.165,Significant increase (p=0.049),Significant increase (p=0.001),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06317,rs238334,12,73853272,PTK2B,SNP (A/C),(A/,A,1.69,1.34,1.89,0.04365695,Protective,0.269,0.121,0.371,0.039,No significant pattern (p=0.017),Variable effect (p=0.041),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP06318,rs626257,1,7872454,PICALM,SNP (A/C),(A/,A,1.4,1.19,1.66,0.02997513,High,0.301,0.118,0.078,0.303,Mild decrease (p=0.031),No significant pattern (p=0.041),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06319,rs945803,21,179741636,ABCA7,Deletion,-,-,2.85,2.55,3.08,0.13835832,Moderate,0.457,0.074,0.178,0.091,Variable effect (p=0.017),Mild decrease (p=0.026),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06320,rs219807,21,236402226,PTK2B,SNP (G/T),(G/,G,1.37,1.04,1.61,0.11169058,High,0.211,0.439,0.142,0.007,No significant pattern (p=0.025),Significant decrease (p=0.032),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06321,rs615756,6,172155529,MS4A6A,Deletion,-,-,0.86,0.51,1.24,0.01266481,Low,0.277,0.073,0.145,0.305,No significant pattern (p=0.003),No significant pattern (p=0.044),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06322,rs555270,1,114579530,TREM2,SNP (C/T),(C/,C,0.81,0.53,1.05,0.15640709,Moderate,0.107,0.238,0.124,0.332,Variable effect (p=0.026),Significant increase (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06323,rs910196,2,157135531,MS4A6A,Deletion,-,-,1.55,1.16,1.78,0.08190922,Low,0.061,0.062,0.589,0.088,Significant decrease (p=0.022),Mild increase (p=0.034),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP06324,rs855030,12,117191708,PTK2B,SNP (G/T),(G/,G,0.48,0.1,0.75,0.09441572,Low,0.289,0.302,0.14,0.069,Variable effect (p=0.043),Mild decrease (p=0.027),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06325,rs150734,3,44424888,CR1,SNP (C/G),(C/,C,0.67,0.33,0.87,0.00220621,Moderate,0.007,0.024,0.637,0.132,Significant decrease (p=0.042),No significant pattern (p=0.017),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06326,rs661547,11,203367377,ABCA7,SNP (A/C),(A/,A,0.59,0.36,0.81,0.0130569,Moderate,0.077,0.48,0.139,0.104,No significant pattern (p=0.016),Variable effect (p=0.043),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP06327,rs239563,7,247983263,ABCA7,SNP (A/G),(A/,A,1.01,0.7,1.37,0.0142297,High,0.084,0.255,0.298,0.163,Significant decrease (p=0.033),No significant pattern (p=0.01),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06328,rs790461,4,149726604,TREM2,SNP (A/G),(A/,A,0.38,0.17,0.75,0.06648747,High,0.316,0.234,0.086,0.164,Mild decrease (p=0.004),Significant decrease (p=0.019),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06329,rs702133,20,227712289,CLU,Deletion,-,-,0.98,0.69,1.25,0.02204715,Protective,0.066,0.064,0.277,0.392,Significant decrease (p=0.02),Mild increase (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06330,rs596039,14,78988867,MS4A6A,Insertion,-,-,1.63,1.3,1.84,0.0234377,Moderate,0.469,0.003,0.004,0.323,Significant increase (p=0.022),Mild decrease (p=0.004),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06331,rs939011,9,240013533,APP,SNP (C/T),(C/,C,0.89,0.58,1.16,0.02858741,High,0.558,0.165,0.038,0.039,Variable effect (p=0.034),Significant increase (p=0.01),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06332,rs463769,16,92816693,CR1,SNP (C/G),(C/,C,0.76,0.43,1.02,0.06599553,High,0.401,0.121,0.068,0.21,No significant pattern (p=0.018),Significant decrease (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06333,rs595713,17,132004580,PICALM,Insertion,-,-,1.06,0.75,1.42,0.01974443,Low,0.277,0.072,0.057,0.394,Significant increase (p=0.035),Mild decrease (p=0.03),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06334,rs912272,14,67691472,PICALM,SNP (A/T),(A/,A,0.99,0.67,1.24,0.03275773,Moderate,0.484,0.028,0.263,0.025,Mild increase (p=0.045),Mild increase (p=0.037),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06335,rs463731,16,32078351,PSEN2,SNP (A/G),(A/,A,1.3,1.0,1.59,0.00305774,Low,0.497,0.226,0.017,0.061,Significant decrease (p=0.005),Mild decrease (p=0.023),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06336,rs741314,8,28489887,PSEN2,SNP (C/G),(C/,C,2.37,2.08,2.74,0.06203678,High,0.229,0.28,0.155,0.136,No significant pattern (p=0.011),Mild decrease (p=0.02),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06337,rs171590,21,37945958,PICALM,SNP (C/G),(C/,C,0.79,0.44,1.0,0.02337306,Low,0.187,0.474,0.039,0.099,No significant pattern (p=0.021),Variable effect (p=0.049),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06338,rs122934,2,176236055,TREM2,SNP (G/T),(G/,G,0.88,0.64,1.15,0.01228151,High,0.005,0.098,0.328,0.369,Variable effect (p=0.037),Mild decrease (p=0.024),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06339,rs234863,10,104559468,CR1,SNP (A/T),(A/,A,0.5,0.14,0.79,0.0687636,Moderate,0.221,0.466,0.012,0.101,Significant decrease (p=0.02),Significant decrease (p=0.036),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06340,rs581296,17,58444031,SORL1,SNP (G/T),(G/,G,1.07,0.81,1.38,0.02722325,High,0.39,0.284,0.013,0.113,Significant increase (p=0.039),Variable effect (p=0.047),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP06341,rs104206,8,81197134,CD33,SNP (G/T),(G/,G,1.35,1.13,1.64,0.00177832,Low,0.105,0.317,0.246,0.132,Mild increase (p=0.045),No significant pattern (p=0.046),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06342,rs412308,9,138634531,PTK2B,SNP (C/G),(C/,C,0.65,0.35,1.04,0.01456411,High,0.231,0.192,0.335,0.042,Significant increase (p=0.014),Mild decrease (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06343,rs130235,7,44856933,EPHA1,SNP (C/T),(C/,C,1.43,1.22,1.82,0.00477617,Low,0.08,0.148,0.224,0.349,Variable effect (p=0.004),Significant decrease (p=0.046),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06344,rs998778,12,237575736,CR1,Deletion,-,-,2.27,2.04,2.55,0.0375896,High,0.059,0.017,0.374,0.351,Significant increase (p=0.046),Mild decrease (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP06345,rs529983,9,82760980,PTK2B,SNP (A/G),(A/,A,0.67,0.31,0.93,0.00084646,Low,0.251,0.061,0.209,0.279,Mild decrease (p=0.008),Mild decrease (p=0.045),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06346,rs771257,16,86251304,PSEN2,Deletion,-,-,1.03,0.64,1.23,0.00331929,Moderate,0.007,0.133,0.55,0.109,Mild decrease (p=0.008),No significant pattern (p=0.033),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06347,rs784139,15,38159863,PICALM,SNP (C/T),(C/,C,1.18,0.93,1.53,0.01353467,Moderate,0.416,0.252,0.012,0.12,No significant pattern (p=0.016),Mild increase (p=0.041),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06348,rs457253,7,233993005,APP,SNP (A/T),(A/,A,0.72,0.4,0.94,0.12037746,Protective,0.161,0.235,0.4,0.005,Significant decrease (p=0.031),Mild increase (p=0.002),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06349,rs702175,11,146082268,EPHA1,SNP (A/T),(A/,A,2.37,2.09,2.6,0.11917031,Unknown,0.247,0.152,0.387,0.014,Mild increase (p=0.049),Significant increase (p=0.016),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06350,rs757217,10,130628601,BIN1,SNP (A/T),(A/,A,0.7,0.38,0.94,0.00282953,High,0.175,0.004,0.607,0.014,Mild decrease (p=0.041),Significant increase (p=0.006),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06351,rs349233,9,2896364,APP,Insertion,-,-,1.83,1.56,2.17,0.03635056,Low,0.128,0.055,0.579,0.038,No significant pattern (p=0.044),No significant pattern (p=0.035),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06352,rs746498,10,209766511,SORL1,Insertion,-,-,1.01,0.66,1.28,0.01158788,Moderate,0.125,0.119,0.333,0.224,Mild increase (p=0.018),Significant decrease (p=0.015),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06353,rs606812,7,206406256,MS4A6A,SNP (A/G),(A/,A,0.51,0.22,0.9,0.06565648,Moderate,0.219,0.173,0.038,0.37,Mild increase (p=0.01),Variable effect (p=0.036),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06354,rs221746,2,234135157,EPHA1,SNP (A/C),(A/,A,2.68,2.34,2.96,0.02586876,Moderate,0.023,0.31,0.457,0.01,Significant decrease (p=0.019),Mild decrease (p=0.042),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06355,rs902765,18,20735578,EPHA1,Deletion,-,-,0.83,0.63,1.17,0.01763407,High,0.405,0.153,0.141,0.101,Mild increase (p=0.024),Variable effect (p=0.038),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06356,rs986894,4,236439767,TREM2,SNP (A/T),(A/,A,0.49,0.28,0.77,0.01106266,Moderate,0.048,0.111,0.357,0.284,No significant pattern (p=0.029),Variable effect (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP06357,rs199979,7,145272579,EPHA1,Insertion,-,-,1.02,0.8,1.37,0.01094636,Unknown,0.275,0.21,0.277,0.038,Mild decrease (p=0.049),Variable effect (p=0.04),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06358,rs862480,21,83551145,CD2AP,Insertion,-,-,0.52,0.27,0.84,0.10042222,Protective,0.004,0.476,0.19,0.131,Mild decrease (p=0.037),No significant pattern (p=0.016),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06359,rs308268,22,58967049,CD2AP,SNP (A/C),(A/,A,0.44,0.1,0.8,0.05939914,Low,0.204,0.151,0.394,0.052,Variable effect (p=0.046),Significant decrease (p=0.027),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06360,rs468121,11,237643809,CD2AP,SNP (G/T),(G/,G,1.54,1.22,1.76,0.06500778,Moderate,0.006,0.443,0.276,0.075,Mild increase (p=0.04),Significant increase (p=0.048),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06361,rs708008,5,196238101,APOE,SNP (C/G),(C/,C,0.85,0.48,1.22,0.05413796,Moderate,0.083,0.648,0.054,0.015,Mild increase (p=0.05),Mild increase (p=0.018),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06362,rs736671,4,84810513,APOE,Deletion,-,-,1.21,0.84,1.58,0.04914059,Protective,0.443,0.103,0.185,0.069,Mild decrease (p=0.039),No significant pattern (p=0.044),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06363,rs492121,21,60395002,MS4A6A,Deletion,-,-,0.79,0.41,1.09,0.06409399,Moderate,0.417,0.099,0.084,0.2,Significant decrease (p=0.016),Significant increase (p=0.036),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06364,rs550701,5,22582941,PTK2B,SNP (G/T),(G/,G,1.72,1.41,1.95,0.00992384,Moderate,0.275,0.049,0.026,0.45,Variable effect (p=0.007),Significant decrease (p=0.008),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06365,rs971644,21,138877111,PSEN2,SNP (C/T),(C/,C,0.84,0.46,1.12,0.00984212,High,0.051,0.148,0.248,0.353,Significant increase (p=0.02),Mild decrease (p=0.023),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06366,rs686380,14,221057655,BIN1,SNP (G/T),(G/,G,1.23,0.92,1.54,0.01743177,Moderate,0.232,0.397,0.101,0.07,Mild increase (p=0.006),Mild decrease (p=0.044),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06367,rs649891,21,115929247,APP,Insertion,-,-,0.61,0.22,0.85,0.01596179,Moderate,0.018,0.17,0.308,0.304,Variable effect (p=0.022),Mild increase (p=0.002),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP06368,rs448525,15,151020243,EPHA1,SNP (A/T),(A/,A,2.87,2.48,3.17,0.01139583,Low,0.131,0.191,0.088,0.389,Mild increase (p=0.019),Significant increase (p=0.014),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06369,rs249808,8,154999310,ABCA7,Deletion,-,-,1.06,0.82,1.45,0.00568092,High,0.37,0.079,0.242,0.11,Significant increase (p=0.026),Mild increase (p=0.019),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06370,rs639444,18,10217546,CD33,Insertion,-,-,1.72,1.35,2.01,0.00985102,High,0.126,0.265,0.393,0.017,Significant increase (p=0.011),Significant decrease (p=0.033),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP06371,rs714104,10,176549408,CLU,SNP (C/G),(C/,C,0.56,0.31,0.89,0.12150911,Moderate,0.138,0.052,0.379,0.231,Significant increase (p=0.038),No significant pattern (p=0.026),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06372,rs661840,4,168854768,MS4A6A,SNP (A/C),(A/,A,0.71,0.38,1.08,0.00231836,Moderate,0.1,0.406,0.244,0.049,Mild decrease (p=0.047),Significant decrease (p=0.028),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06373,rs853439,11,198659374,ABCA7,SNP (C/T),(C/,C,0.97,0.75,1.35,0.00906686,Low,0.165,0.405,0.138,0.091,Mild decrease (p=0.042),Significant increase (p=0.002),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP06374,rs549248,4,39773655,ABCA7,SNP (A/G),(A/,A,1.43,1.16,1.81,0.01249656,Low,0.111,0.466,0.155,0.068,Significant increase (p=0.007),Mild decrease (p=0.035),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP06375,rs270126,5,115260841,TREM2,SNP (A/G),(A/,A,1.17,0.88,1.56,0.03152531,Moderate,0.323,0.334,0.02,0.122,Significant increase (p=0.009),Significant increase (p=0.011),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06376,rs494363,19,198967464,SORL1,SNP (G/T),(G/,G,1.64,1.42,1.94,0.02476202,High,0.242,0.379,0.009,0.17,Mild increase (p=0.021),No significant pattern (p=0.015),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06377,rs358730,22,15856158,APOE,SNP (A/C),(A/,A,0.8,0.56,1.14,0.02917479,High,0.002,0.216,0.399,0.183,Significant decrease (p=0.034),Significant decrease (p=0.004),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06378,rs540624,4,91734321,APOE,SNP (A/T),(A/,A,0.9,0.63,1.26,0.0275861,Moderate,0.342,0.069,0.324,0.065,Significant increase (p=0.023),Mild decrease (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06379,rs919930,15,189311541,TREM2,SNP (A/G),(A/,A,0.6,0.38,0.96,0.08650379,High,0.361,0.249,0.126,0.064,Mild decrease (p=0.003),No significant pattern (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06380,rs991594,1,110838863,EPHA1,SNP (G/T),(G/,G,0.92,0.57,1.29,0.03120772,Moderate,0.267,0.208,0.125,0.2,Mild decrease (p=0.046),No significant pattern (p=0.011),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP06381,rs773966,10,22547526,APP,SNP (A/T),(A/,A,1.17,0.95,1.51,0.08838239,Moderate,0.036,0.416,0.083,0.264,Variable effect (p=0.002),Significant increase (p=0.006),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06382,rs899231,2,127270998,EPHA1,Insertion,-,-,0.8,0.55,1.04,0.0503275,Low,0.009,0.277,0.439,0.075,Significant increase (p=0.019),No significant pattern (p=0.023),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06383,rs402354,3,91578821,EPHA1,SNP (C/G),(C/,C,1.59,1.28,1.85,0.0221797,High,0.019,0.336,0.431,0.014,Mild increase (p=0.006),Significant decrease (p=0.037),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06384,rs637752,18,105513724,PSEN2,Insertion,-,-,0.67,0.3,0.91,0.00307644,High,0.184,0.328,0.105,0.184,Mild increase (p=0.027),Significant decrease (p=0.042),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06385,rs606909,8,133744596,CD2AP,SNP (A/G),(A/,A,1.26,1.02,1.62,0.02435182,Protective,0.01,0.425,0.305,0.06,Mild decrease (p=0.036),No significant pattern (p=0.016),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP06386,rs524804,16,52404487,CR1,SNP (A/G),(A/,A,2.25,1.98,2.46,0.07224401,Moderate,0.383,0.164,0.055,0.198,Significant decrease (p=0.048),Mild decrease (p=0.024),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06387,rs651268,15,191005275,TREM2,SNP (G/T),(G/,G,0.76,0.55,1.0,0.01878085,Moderate,0.098,0.523,0.016,0.163,Significant increase (p=0.02),Significant decrease (p=0.002),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP06388,rs666701,10,18975837,APP,SNP (A/G),(A/,A,0.28,0.1,0.53,0.01864457,Low,0.448,0.037,0.005,0.31,Variable effect (p=0.018),Variable effect (p=0.03),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06389,rs322731,8,184888461,CD2AP,SNP (A/C),(A/,A,1.33,0.97,1.62,0.00535978,High,0.573,0.088,0.005,0.134,Variable effect (p=0.008),Significant increase (p=0.045),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06390,rs144779,20,176340666,PTK2B,SNP (C/T),(C/,C,1.13,0.79,1.44,0.11868261,Low,0.058,0.051,0.495,0.196,Significant increase (p=0.013),Significant decrease (p=0.03),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06391,rs504436,1,176763047,CD33,Insertion,-,-,0.62,0.41,0.85,0.01075363,High,0.18,0.061,0.412,0.147,Significant decrease (p=0.048),Significant decrease (p=0.02),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06392,rs249947,20,76970440,PSEN2,SNP (C/T),(C/,C,0.61,0.26,0.96,0.00104164,Protective,0.035,0.182,0.549,0.034,No significant pattern (p=0.019),Significant increase (p=0.018),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06393,rs662246,2,29248192,EPHA1,SNP (A/T),(A/,A,0.53,0.18,0.89,0.02976052,Unknown,0.085,0.172,0.211,0.332,Significant increase (p=0.042),Significant increase (p=0.009),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06394,rs972585,8,45354624,MS4A6A,SNP (C/G),(C/,C,0.71,0.47,1.01,0.03588982,Moderate,0.052,0.344,0.149,0.254,Mild increase (p=0.014),Mild decrease (p=0.01),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06395,rs450046,15,166758886,PSEN2,Deletion,-,-,0.65,0.39,0.99,0.02832666,Moderate,0.099,0.175,0.02,0.506,Significant increase (p=0.025),No significant pattern (p=0.019),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06396,rs869940,19,58669943,PICALM,SNP (A/G),(A/,A,1.5,1.16,1.74,0.01640633,Moderate,0.17,0.298,0.018,0.315,Significant increase (p=0.026),Mild increase (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP06397,rs963569,13,70839614,APOE,SNP (A/G),(A/,A,2.28,1.92,2.62,0.06184388,Protective,0.301,0.061,0.132,0.307,No significant pattern (p=0.035),Mild increase (p=0.011),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06398,rs672224,3,52374302,PSEN2,SNP (A/T),(A/,A,1.57,1.24,1.83,0.03032409,Moderate,0.122,0.043,0.063,0.572,Significant increase (p=0.047),Variable effect (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06399,rs431040,1,194174840,APP,Insertion,-,-,0.52,0.28,0.74,0.01486161,Moderate,0.128,0.568,0.044,0.06,No significant pattern (p=0.01),Mild decrease (p=0.007),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06400,rs229100,2,186681724,CD2AP,Insertion,-,-,1.12,0.74,1.5,0.00253536,Moderate,0.072,0.212,0.068,0.447,Variable effect (p=0.041),Variable effect (p=0.019),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06401,rs139429,19,96572503,CD33,SNP (C/T),(C/,C,0.98,0.64,1.27,0.00262062,Moderate,0.235,0.257,0.133,0.175,Significant increase (p=0.043),Mild decrease (p=0.039),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06402,rs492601,20,146708723,PSEN2,SNP (A/T),(A/,A,0.77,0.48,1.1,0.0302006,Low,0.07,0.379,0.108,0.243,Significant increase (p=0.005),Mild decrease (p=0.036),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06403,rs100339,1,233120055,BIN1,SNP (A/C),(A/,A,1.34,1.03,1.68,0.02423653,Low,0.02,0.197,0.291,0.292,Significant increase (p=0.043),Mild decrease (p=0.03),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06404,rs305559,14,13914945,CLU,SNP (A/G),(A/,A,1.09,0.7,1.39,0.02156799,Low,0.419,0.004,0.024,0.352,Significant decrease (p=0.046),Significant increase (p=0.028),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06405,rs176049,9,201276896,PTK2B,SNP (C/T),(C/,C,1.26,0.94,1.52,0.03570095,Low,0.287,0.162,0.261,0.09,Mild decrease (p=0.047),Significant increase (p=0.047),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06406,rs820209,10,33887592,CLU,Insertion,-,-,0.88,0.49,1.22,0.08357541,Moderate,0.259,0.051,0.161,0.329,Significant increase (p=0.03),Significant decrease (p=0.012),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP06407,rs223260,18,160118598,APOE,SNP (C/T),(C/,C,0.74,0.4,1.03,0.00996871,Protective,0.125,0.25,0.147,0.278,Significant decrease (p=0.016),Mild increase (p=0.028),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06408,rs888914,16,105073230,MS4A6A,Insertion,-,-,0.66,0.27,1.05,0.00236572,Moderate,0.043,0.22,0.472,0.066,Significant decrease (p=0.025),Significant decrease (p=0.016),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP06409,rs423901,8,52298844,CLU,Deletion,-,-,0.96,0.73,1.24,0.06128666,Low,0.183,0.349,0.108,0.16,Significant decrease (p=0.011),Mild decrease (p=0.021),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06410,rs993404,13,13826825,PTK2B,SNP (A/C),(A/,A,1.51,1.13,1.83,0.0161999,Low,0.211,0.129,0.277,0.183,Mild increase (p=0.046),Variable effect (p=0.016),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06411,rs893960,8,215163171,TREM2,SNP (A/G),(A/,A,1.31,1.03,1.54,0.04466252,Protective,0.137,0.198,0.335,0.13,Significant increase (p=0.007),Mild decrease (p=0.024),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06412,rs415067,22,82348868,PTK2B,SNP (A/T),(A/,A,1.18,0.86,1.56,0.01532881,High,0.107,0.151,0.215,0.328,Significant decrease (p=0.02),Mild increase (p=0.025),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06413,rs634067,7,2066562,SORL1,SNP (A/C),(A/,A,0.86,0.54,1.2,0.07112989,Moderate,0.135,0.491,0.173,0.001,Variable effect (p=0.023),Significant decrease (p=0.01),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06414,rs269672,20,16236915,ABCA7,SNP (A/C),(A/,A,1.23,0.92,1.51,0.01012359,Moderate,0.109,0.113,0.125,0.453,Significant increase (p=0.034),Significant decrease (p=0.034),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06415,rs309188,17,44072027,PICALM,Deletion,-,-,1.62,1.34,1.86,0.00161305,Moderate,0.017,0.36,0.196,0.228,No significant pattern (p=0.026),No significant pattern (p=0.026),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06416,rs206450,2,69621965,SORL1,SNP (A/G),(A/,A,1.44,1.19,1.71,0.03813306,Low,0.026,0.118,0.496,0.16,Mild decrease (p=0.007),Significant decrease (p=0.034),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06417,rs655615,16,154235243,CLU,SNP (A/G),(A/,A,2.98,2.62,3.33,0.0076427,High,0.196,0.119,0.243,0.242,No significant pattern (p=0.046),Significant decrease (p=0.009),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06418,rs229667,4,55737861,APOE,SNP (C/T),(C/,C,1.72,1.36,2.02,0.01963076,Unknown,0.402,0.122,0.194,0.082,Significant decrease (p=0.015),Significant increase (p=0.029),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06419,rs174026,18,8274993,PSEN2,SNP (A/C),(A/,A,1.1,0.7,1.45,0.08966936,Low,0.459,0.04,0.073,0.227,No significant pattern (p=0.04),Mild decrease (p=0.026),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06420,rs871167,17,121938800,MS4A6A,SNP (A/G),(A/,A,0.47,0.11,0.71,5.65e-06,High,0.028,0.282,0.402,0.089,Mild increase (p=0.006),Mild decrease (p=0.019),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06421,rs446514,4,89209920,CLU,SNP (G/T),(G/,G,2.08,1.85,2.42,0.01616846,Protective,0.163,0.034,0.216,0.388,Significant increase (p=0.02),Significant increase (p=0.047),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06422,rs104518,6,55944452,APP,SNP (A/G),(A/,A,0.38,0.1,0.6,0.01140001,High,0.101,0.022,0.233,0.444,Significant increase (p=0.048),No significant pattern (p=0.013),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06423,rs788250,10,130202274,APOE,Deletion,-,-,0.63,0.37,1.01,0.00234605,High,0.306,0.112,0.379,0.003,Mild increase (p=0.022),Mild increase (p=0.012),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06424,rs956492,21,97738455,APP,SNP (A/G),(A/,A,0.91,0.69,1.12,0.05007931,Moderate,0.065,0.285,0.308,0.142,No significant pattern (p=0.035),Significant increase (p=0.017),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06425,rs692334,16,68991243,TREM2,SNP (A/C),(A/,A,1.03,0.79,1.25,0.01423697,Low,0.426,0.17,0.108,0.096,Variable effect (p=0.006),Mild decrease (p=0.028),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06426,rs200876,22,228163280,PTK2B,SNP (A/C),(A/,A,0.9,0.58,1.27,0.00071765,Moderate,0.465,0.037,0.064,0.235,Mild increase (p=0.023),Significant increase (p=0.013),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06427,rs547813,2,81874222,PSEN2,SNP (C/T),(C/,C,0.96,0.62,1.23,0.01450134,Low,0.275,0.31,0.159,0.056,Variable effect (p=0.029),No significant pattern (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06428,rs135278,20,131200930,CR1,SNP (A/T),(A/,A,1.31,1.09,1.6,0.00884751,Low,0.304,0.054,0.091,0.35,Significant increase (p=0.049),No significant pattern (p=0.04),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06429,rs251555,20,164763096,TREM2,Deletion,-,-,0.98,0.61,1.31,0.00923833,Moderate,0.461,0.029,0.048,0.262,Variable effect (p=0.019),No significant pattern (p=0.014),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06430,rs853749,21,33936378,APP,SNP (C/G),(C/,C,0.65,0.32,1.0,0.0831794,Moderate,0.059,0.293,0.423,0.025,Mild decrease (p=0.026),Mild increase (p=0.039),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06431,rs414040,16,150295195,PTK2B,SNP (G/T),(G/,G,0.68,0.41,0.97,0.00516608,Low,0.483,0.161,0.117,0.04,Variable effect (p=0.006),Significant increase (p=0.041),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP06432,rs313374,18,77224704,PSEN2,SNP (C/G),(C/,C,1.61,1.25,2.0,0.07285002,Low,0.039,0.354,0.146,0.261,Mild decrease (p=0.022),No significant pattern (p=0.035),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06433,rs684091,18,158738979,APOE,SNP (A/G),(A/,A,0.7,0.36,0.92,0.02837702,Low,0.042,0.355,0.274,0.129,No significant pattern (p=0.041),Mild increase (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06434,rs157644,4,63925964,EPHA1,SNP (C/G),(C/,C,1.73,1.5,1.96,5.64e-06,Protective,0.244,0.205,0.193,0.158,Mild increase (p=0.045),No significant pattern (p=0.026),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06435,rs890504,15,175350072,BIN1,SNP (A/C),(A/,A,0.48,0.11,0.71,0.05577078,Moderate,0.131,0.05,0.132,0.488,Significant increase (p=0.002),Significant decrease (p=0.043),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06436,rs992092,15,6586340,BIN1,SNP (C/T),(C/,C,0.88,0.63,1.23,0.02457311,Moderate,0.687,0.023,0.038,0.052,Mild increase (p=0.022),Mild increase (p=0.046),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06437,rs740958,1,220054519,CD2AP,SNP (A/G),(A/,A,0.9,0.55,1.1,0.07781833,Moderate,0.267,0.162,0.33,0.042,No significant pattern (p=0.047),Variable effect (p=0.006),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06438,rs513154,1,226908271,MS4A6A,SNP (C/G),(C/,C,1.3,0.93,1.65,0.10663854,Low,0.219,0.224,0.184,0.172,Significant decrease (p=0.004),Significant increase (p=0.025),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06439,rs246405,20,137186132,CD2AP,SNP (C/G),(C/,C,2.1,1.76,2.4,0.0281307,Low,0.294,0.123,0.187,0.197,Mild decrease (p=0.038),Mild decrease (p=0.038),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06440,rs998196,1,37391710,TREM2,SNP (C/T),(C/,C,1.94,1.62,2.22,0.02490955,Protective,0.286,0.299,0.031,0.183,No significant pattern (p=0.015),Significant increase (p=0.009),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06441,rs632906,8,218560843,ABCA7,SNP (A/G),(A/,A,0.94,0.6,1.32,0.00624165,Unknown,0.114,0.174,0.115,0.397,Variable effect (p=0.004),Mild decrease (p=0.013),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06442,rs295143,5,20355016,ABCA7,SNP (A/T),(A/,A,1.04,0.65,1.38,0.00555013,Unknown,0.17,0.457,0.1,0.072,Variable effect (p=0.034),Variable effect (p=0.025),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06443,rs487689,3,101153799,EPHA1,SNP (C/G),(C/,C,1.34,1.11,1.67,0.02286198,Moderate,0.162,0.538,0.06,0.04,Mild increase (p=0.017),Variable effect (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06444,rs262422,22,55502468,PSEN2,SNP (G/T),(G/,G,1.4,1.07,1.72,0.01138109,Moderate,0.16,0.079,0.423,0.138,Significant decrease (p=0.04),Mild decrease (p=0.037),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06445,rs486864,4,157283270,EPHA1,SNP (A/T),(A/,A,0.9,0.61,1.24,0.09048202,Moderate,0.061,0.042,0.403,0.294,Significant decrease (p=0.035),Variable effect (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06446,rs163694,21,224337190,CR1,SNP (C/T),(C/,C,0.7,0.4,0.93,0.00843646,High,0.242,0.302,0.181,0.075,Significant increase (p=0.039),Mild decrease (p=0.003),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06447,rs894711,9,89593823,CLU,SNP (C/T),(C/,C,1.06,0.68,1.3,0.06291353,Protective,0.193,0.188,0.41,0.008,Mild increase (p=0.042),Variable effect (p=0.002),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06448,rs999935,3,135107751,BIN1,Deletion,-,-,0.66,0.31,0.88,0.07350452,Protective,0.06,0.189,0.55,0.0,Significant decrease (p=0.02),Mild decrease (p=0.04),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06449,rs409561,18,72617332,SORL1,SNP (C/G),(C/,C,0.74,0.52,0.96,0.14977276,Unknown,0.306,0.016,0.336,0.142,Significant decrease (p=0.025),Significant decrease (p=0.01),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06450,rs587307,5,193631419,PICALM,SNP (C/T),(C/,C,1.2,0.97,1.49,0.03349301,Moderate,0.014,0.26,0.11,0.416,Mild increase (p=0.005),Significant decrease (p=0.033),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06451,rs944440,13,32965316,EPHA1,SNP (A/G),(A/,A,1.11,0.74,1.4,0.0543013,Low,0.204,0.047,0.02,0.528,Mild decrease (p=0.008),Variable effect (p=0.003),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06452,rs658228,18,231515244,TREM2,SNP (A/C),(A/,A,1.45,1.2,1.71,0.09509764,Moderate,0.072,0.075,0.222,0.431,Mild increase (p=0.011),Mild increase (p=0.014),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06453,rs616198,9,98212956,PICALM,Insertion,-,-,0.89,0.67,1.2,0.00781368,Moderate,0.389,0.007,0.357,0.047,Mild increase (p=0.007),Mild decrease (p=0.005),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06454,rs312320,4,64236627,CR1,Deletion,-,-,1.39,1.14,1.7,0.01691086,High,0.37,0.059,0.069,0.301,Mild decrease (p=0.007),Mild increase (p=0.048),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP06455,rs450476,10,158469993,CLU,SNP (A/T),(A/,A,1.89,1.61,2.24,0.00560306,High,0.133,0.225,0.265,0.177,Mild increase (p=0.024),Significant decrease (p=0.027),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP06456,rs420589,17,107712941,MS4A6A,SNP (A/C),(A/,A,1.08,0.73,1.33,0.02893262,Moderate,0.183,0.281,0.316,0.02,Mild decrease (p=0.003),Significant increase (p=0.033),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP06457,rs910933,21,133445667,TREM2,Deletion,-,-,1.35,1.12,1.64,0.1087503,Moderate,0.095,0.147,0.535,0.024,Significant increase (p=0.011),Mild decrease (p=0.037),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06458,rs438623,11,18332786,APP,SNP (A/C),(A/,A,0.69,0.41,0.94,0.06730186,High,0.271,0.036,0.201,0.292,Mild decrease (p=0.001),No significant pattern (p=0.023),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06459,rs402328,6,242576267,TREM2,SNP (A/G),(A/,A,0.82,0.62,1.16,0.0571246,Low,0.297,0.195,0.146,0.162,Significant decrease (p=0.021),Mild increase (p=0.006),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP06460,rs265104,4,21161080,PTK2B,SNP (A/G),(A/,A,0.95,0.56,1.31,0.07717282,Moderate,0.361,0.048,0.276,0.114,No significant pattern (p=0.019),Significant increase (p=0.007),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06461,rs283534,1,144215885,PTK2B,SNP (A/G),(A/,A,0.92,0.67,1.29,0.00766637,Moderate,0.456,0.124,0.075,0.146,No significant pattern (p=0.016),Significant decrease (p=0.035),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06462,rs825221,2,186795026,MS4A6A,Insertion,-,-,0.94,0.68,1.26,0.11992582,High,0.242,0.255,0.087,0.216,Mild increase (p=0.041),Variable effect (p=0.032),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06463,rs875291,18,110643316,PICALM,Deletion,-,-,1.48,1.19,1.73,0.01516721,Protective,0.342,0.05,0.354,0.054,Mild decrease (p=0.011),Significant decrease (p=0.026),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06464,rs750295,21,230973125,ABCA7,SNP (A/C),(A/,A,0.71,0.34,1.09,0.00976969,Protective,0.086,0.043,0.641,0.031,Mild decrease (p=0.048),No significant pattern (p=0.024),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06465,rs626215,14,105491693,APP,SNP (C/T),(C/,C,0.86,0.53,1.18,0.0786082,High,0.229,0.022,0.127,0.422,Mild decrease (p=0.022),Mild increase (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06466,rs696128,7,208858292,TREM2,SNP (C/T),(C/,C,0.47,0.18,0.76,0.02964785,Moderate,0.432,0.27,0.09,0.008,Variable effect (p=0.005),Variable effect (p=0.024),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06467,rs444464,12,183486004,CD2AP,Insertion,-,-,1.37,1.16,1.77,0.00787101,Low,0.266,0.019,0.407,0.107,Mild decrease (p=0.045),Significant increase (p=0.026),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06468,rs938277,13,236161208,EPHA1,SNP (C/T),(C/,C,0.56,0.29,0.89,0.11254859,High,0.187,0.285,0.316,0.013,Mild increase (p=0.048),Significant increase (p=0.039),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06469,rs337222,2,101943422,CD2AP,SNP (G/T),(G/,G,1.56,1.16,1.76,0.01053173,High,0.127,0.165,0.346,0.163,Mild increase (p=0.008),Mild increase (p=0.034),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06470,rs576468,12,149328806,CD2AP,SNP (A/C),(A/,A,1.64,1.31,2.04,0.04369729,High,0.453,0.14,0.14,0.068,Significant decrease (p=0.023),Variable effect (p=0.006),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP06471,rs754551,6,78958891,APOE,SNP (A/G),(A/,A,0.68,0.3,1.05,0.00769784,High,0.108,0.425,0.172,0.096,Mild increase (p=0.036),Mild decrease (p=0.003),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP06472,rs286740,11,234226325,BIN1,Deletion,-,-,0.77,0.44,1.09,0.00194561,Moderate,0.015,0.361,0.187,0.237,Significant increase (p=0.029),Variable effect (p=0.015),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP06473,rs819474,8,242226231,CD33,SNP (G/T),(G/,G,1.08,0.78,1.4,0.00328128,Low,0.134,0.202,0.154,0.311,Variable effect (p=0.033),No significant pattern (p=0.008),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP06474,rs391634,19,177453395,CD33,SNP (A/C),(A/,A,0.68,0.41,0.98,0.00227158,Protective,0.128,0.24,0.43,0.002,Variable effect (p=0.03),Mild increase (p=0.01),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP06475,rs172243,2,219299522,APOE,SNP (G/T),(G/,G,1.32,1.08,1.54,0.00235869,High,0.264,0.062,0.172,0.302,Variable effect (p=0.021),No significant pattern (p=0.021),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06476,rs536920,8,200909548,CD2AP,SNP (C/G),(C/,C,0.36,0.1,0.76,0.08061537,Low,0.38,0.045,0.005,0.369,Significant increase (p=0.02),Significant decrease (p=0.046),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06477,rs109972,2,213754309,PTK2B,SNP (C/G),(C/,C,0.74,0.42,1.11,0.04380703,Low,0.143,0.283,0.106,0.268,Significant increase (p=0.032),Significant decrease (p=0.034),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06478,rs832659,22,133789571,CD33,SNP (G/T),(G/,G,1.41,1.16,1.75,0.01664095,High,0.063,0.291,0.118,0.327,Variable effect (p=0.041),Mild increase (p=0.025),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06479,rs140713,17,88459969,MS4A6A,SNP (C/G),(C/,C,1.55,1.21,1.89,0.04076146,Moderate,0.204,0.004,0.293,0.299,Mild decrease (p=0.038),Mild increase (p=0.032),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP06480,rs971122,4,5071522,EPHA1,Deletion,-,-,0.64,0.26,0.91,0.08161115,Moderate,0.034,0.047,0.268,0.451,Mild decrease (p=0.044),Significant decrease (p=0.002),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06481,rs919815,13,173720818,ABCA7,SNP (C/G),(C/,C,0.81,0.6,1.12,0.00196044,Low,0.509,0.154,0.039,0.098,No significant pattern (p=0.011),Mild increase (p=0.03),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06482,rs502285,2,226690238,APP,SNP (C/G),(C/,C,3.41,3.05,3.71,0.0337132,High,0.33,0.008,0.276,0.186,Mild decrease (p=0.018),Significant increase (p=0.019),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06483,rs998311,18,165098567,PICALM,SNP (C/T),(C/,C,0.61,0.22,0.85,0.01911539,High,0.408,0.031,0.255,0.107,Mild decrease (p=0.009),Mild increase (p=0.041),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06484,rs371150,22,238303849,EPHA1,Insertion,-,-,2.86,2.62,3.21,0.15415765,Low,0.119,0.11,0.214,0.357,Significant decrease (p=0.044),Variable effect (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06485,rs503540,7,105566574,CLU,Insertion,-,-,0.38,0.1,0.66,0.08697707,Protective,0.058,0.094,0.335,0.313,Significant increase (p=0.002),Variable effect (p=0.016),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06486,rs121049,17,52701984,CLU,SNP (G/T),(G/,G,0.24,0.1,0.55,0.01712778,High,0.068,0.159,0.533,0.04,Variable effect (p=0.017),Variable effect (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06487,rs646797,21,167174159,PICALM,SNP (A/T),(A/,A,1.33,1.1,1.6,0.04683281,High,0.069,0.213,0.361,0.157,Mild decrease (p=0.037),Mild increase (p=0.041),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06488,rs833057,2,10517407,CD2AP,Insertion,-,-,1.74,1.35,2.12,0.05533956,Moderate,0.011,0.445,0.083,0.261,Variable effect (p=0.012),Mild increase (p=0.041),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06489,rs565484,19,166236179,CLU,SNP (G/T),(G/,G,0.77,0.52,1.01,0.00823259,Unknown,0.127,0.434,0.231,0.008,Mild increase (p=0.004),Variable effect (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06490,rs684642,5,184123321,BIN1,SNP (A/C),(A/,A,0.99,0.71,1.3,0.00537116,High,0.229,0.317,0.025,0.228,Variable effect (p=0.019),Significant increase (p=0.037),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06491,rs673326,5,90642459,PSEN2,SNP (A/T),(A/,A,0.39,0.1,0.67,0.13070702,Low,0.013,0.187,0.263,0.337,Significant increase (p=0.027),No significant pattern (p=0.001),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06492,rs112714,1,167555695,PSEN2,SNP (A/G),(A/,A,1.15,0.8,1.39,0.00145804,Moderate,0.08,0.007,0.537,0.176,Significant increase (p=0.018),No significant pattern (p=0.02),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06493,rs288447,14,123283588,CD33,SNP (A/T),(A/,A,4.1,3.88,4.39,0.02565725,High,0.032,0.501,0.134,0.134,No significant pattern (p=0.028),Mild decrease (p=0.03),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06494,rs584485,21,226824897,SORL1,SNP (A/G),(A/,A,3.49,3.22,3.88,0.03629211,Unknown,0.159,0.325,0.179,0.137,Variable effect (p=0.041),Mild decrease (p=0.023),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06495,rs320885,21,17852915,EPHA1,Insertion,-,-,0.68,0.35,0.93,0.10144237,Moderate,0.144,0.168,0.368,0.121,Mild increase (p=0.035),Mild increase (p=0.035),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06496,rs652814,9,55634566,PSEN2,SNP (A/G),(A/,A,1.02,0.66,1.26,0.03372435,Moderate,0.314,0.009,0.459,0.017,Significant increase (p=0.023),Mild increase (p=0.031),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06497,rs972570,2,228959501,EPHA1,SNP (C/G),(C/,C,1.42,1.07,1.71,0.04469744,Unknown,0.034,0.144,0.07,0.552,Significant increase (p=0.046),Significant increase (p=0.016),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06498,rs321018,18,173389873,BIN1,Insertion,-,-,1.19,0.85,1.41,0.02534862,High,0.004,0.069,0.658,0.068,Significant decrease (p=0.038),No significant pattern (p=0.005),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06499,rs344542,11,13875433,SORL1,SNP (A/T),(A/,A,0.73,0.44,0.95,0.02243199,Low,0.606,0.086,0.028,0.079,Significant decrease (p=0.007),No significant pattern (p=0.025),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06500,rs101678,20,63337991,CD2AP,SNP (C/T),(C/,C,1.7,1.37,2.03,0.0265067,High,0.001,0.003,0.549,0.248,Mild increase (p=0.023),Variable effect (p=0.005),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06501,rs723878,3,148556949,TREM2,SNP (A/C),(A/,A,0.87,0.59,1.12,0.0124766,Moderate,0.607,0.008,0.087,0.098,Variable effect (p=0.031),Significant decrease (p=0.041),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06502,rs793125,17,200479068,APOE,SNP (A/T),(A/,A,0.31,0.1,0.69,0.02423439,Protective,0.349,0.056,0.259,0.135,Mild decrease (p=0.006),Significant increase (p=0.013),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP06503,rs348609,11,216890229,SORL1,Deletion,-,-,0.45,0.25,0.67,0.03655951,Protective,0.337,0.107,0.162,0.193,No significant pattern (p=0.048),Variable effect (p=0.029),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06504,rs321666,13,213922721,MS4A6A,SNP (A/G),(A/,A,0.3,0.1,0.64,0.02719033,High,0.304,0.134,0.169,0.193,Variable effect (p=0.012),Significant increase (p=0.036),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06505,rs876779,10,66332562,APOE,Deletion,-,-,1.56,1.16,1.89,0.06698341,Low,0.167,0.54,0.039,0.054,Variable effect (p=0.041),No significant pattern (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06506,rs284654,9,82784494,CLU,SNP (C/T),(C/,C,0.65,0.4,0.93,0.01902314,High,0.131,0.043,0.499,0.127,Mild increase (p=0.028),Mild increase (p=0.028),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06507,rs870026,22,227115597,PICALM,Deletion,-,-,0.95,0.56,1.31,0.01976663,Moderate,0.023,0.602,0.01,0.164,No significant pattern (p=0.039),Variable effect (p=0.019),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06508,rs219642,14,60987332,CR1,SNP (C/T),(C/,C,1.11,0.76,1.32,0.02945571,High,0.036,0.054,0.429,0.28,Variable effect (p=0.035),No significant pattern (p=0.034),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06509,rs806143,10,164045882,CR1,SNP (C/T),(C/,C,1.34,1.0,1.72,0.10202925,High,0.387,0.124,0.092,0.197,Mild decrease (p=0.036),Significant increase (p=0.03),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06510,rs590425,17,78608484,CLU,SNP (G/T),(G/,G,1.94,1.63,2.25,0.06295086,Low,0.247,0.333,0.006,0.213,Significant decrease (p=0.008),Significant increase (p=0.022),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06511,rs407350,12,222248342,PSEN2,SNP (A/T),(A/,A,0.85,0.63,1.15,0.01231702,Moderate,0.246,0.006,0.437,0.111,Significant decrease (p=0.023),No significant pattern (p=0.017),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06512,rs696374,19,219756682,APOE,Insertion,-,-,0.33,0.1,0.61,0.06105853,Low,0.323,0.323,0.05,0.103,Significant decrease (p=0.023),Significant decrease (p=0.038),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06513,rs112994,17,221256118,PSEN2,SNP (A/C),(A/,A,0.78,0.58,1.05,0.06096511,Protective,0.042,0.262,0.189,0.307,Mild increase (p=0.007),No significant pattern (p=0.006),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06514,rs136794,5,227248757,BIN1,SNP (A/G),(A/,A,1.17,0.9,1.43,0.03795349,Low,0.099,0.027,0.007,0.666,Significant increase (p=0.024),Significant increase (p=0.047),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06515,rs925246,19,101377761,CD33,SNP (A/G),(A/,A,1.75,1.44,2.07,0.09417036,Low,0.001,0.265,0.307,0.227,Mild decrease (p=0.05),Significant decrease (p=0.023),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06516,rs424922,17,64749946,MS4A6A,SNP (G/T),(G/,G,1.14,0.83,1.43,0.00263143,Moderate,0.134,0.073,0.29,0.303,Significant decrease (p=0.024),No significant pattern (p=0.015),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06517,rs693548,16,80179716,PTK2B,SNP (A/G),(A/,A,1.73,1.39,2.07,0.01301068,High,0.342,0.121,0.247,0.089,Significant decrease (p=0.043),Mild decrease (p=0.049),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06518,rs202164,20,128606285,BIN1,SNP (A/T),(A/,A,2.97,2.77,3.35,0.00741328,High,0.065,0.249,0.392,0.094,Mild decrease (p=0.04),Mild increase (p=0.037),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06519,rs825989,4,134940467,PICALM,SNP (A/C),(A/,A,2.59,2.34,2.83,0.02733994,Moderate,0.151,0.153,0.269,0.227,Mild increase (p=0.016),Mild decrease (p=0.009),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06520,rs266478,1,92398867,CD2AP,SNP (A/C),(A/,A,1.38,1.11,1.77,0.01899418,Moderate,0.425,0.015,0.0,0.36,Significant decrease (p=0.031),No significant pattern (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06521,rs297916,18,94986037,EPHA1,Insertion,-,-,0.88,0.61,1.24,0.24457065,Moderate,0.013,0.237,0.218,0.332,Mild decrease (p=0.002),No significant pattern (p=0.021),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06522,rs113184,10,23971768,PTK2B,SNP (A/C),(A/,A,0.86,0.66,1.12,0.00599104,Protective,0.015,0.496,0.108,0.181,No significant pattern (p=0.032),Mild decrease (p=0.012),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06523,rs574263,17,83653592,MS4A6A,SNP (A/C),(A/,A,0.5,0.14,0.75,0.00402575,Moderate,0.23,0.165,0.126,0.279,Mild decrease (p=0.026),Variable effect (p=0.026),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06524,rs765035,9,50783565,CR1,SNP (A/T),(A/,A,1.1,0.72,1.46,0.00414847,Moderate,0.101,0.063,0.326,0.31,Mild decrease (p=0.039),Significant decrease (p=0.02),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06525,rs926898,21,142665889,PTK2B,SNP (C/G),(C/,C,0.67,0.35,1.07,0.00285979,Moderate,0.23,0.303,0.249,0.019,Mild decrease (p=0.04),No significant pattern (p=0.005),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06526,rs493785,22,158374025,PSEN2,Insertion,-,-,1.03,0.68,1.35,0.04483518,High,0.247,0.214,0.105,0.234,Mild decrease (p=0.014),Mild decrease (p=0.039),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06527,rs498566,1,67747126,CLU,SNP (A/G),(A/,A,0.54,0.24,0.76,0.00945287,High,0.115,0.397,0.172,0.116,Mild decrease (p=0.005),Mild decrease (p=0.028),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06528,rs101743,21,222612830,MS4A6A,Insertion,-,-,0.8,0.4,1.06,0.05276719,High,0.158,0.378,0.073,0.191,Variable effect (p=0.046),Significant increase (p=0.01),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06529,rs663060,15,112048555,TREM2,Deletion,-,-,0.8,0.41,1.02,0.02939239,High,0.458,0.23,0.092,0.019,Significant decrease (p=0.004),Mild increase (p=0.037),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06530,rs975767,20,44758139,APOE,SNP (A/T),(A/,A,0.54,0.22,0.77,0.01923103,Moderate,0.189,0.087,0.349,0.175,Significant decrease (p=0.012),Mild decrease (p=0.006),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06531,rs154784,15,115136205,BIN1,Deletion,-,-,0.53,0.14,0.77,0.00100013,Moderate,0.049,0.074,0.546,0.131,Significant increase (p=0.032),Mild decrease (p=0.039),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06532,rs345005,5,59524774,MS4A6A,SNP (C/T),(C/,C,0.45,0.23,0.71,0.00871167,High,0.174,0.25,0.363,0.013,Significant increase (p=0.012),Mild decrease (p=0.015),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06533,rs515692,8,4133395,ABCA7,SNP (C/G),(C/,C,0.59,0.27,0.96,0.07257673,Unknown,0.548,0.032,0.038,0.182,Significant decrease (p=0.03),Significant decrease (p=0.045),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP06534,rs465424,16,81674577,PSEN2,SNP (G/T),(G/,G,1.27,0.92,1.66,0.00104863,High,0.511,0.074,0.075,0.14,Mild increase (p=0.028),Mild increase (p=0.002),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06535,rs911723,6,53873473,PSEN2,Insertion,-,-,0.58,0.2,0.98,0.00316519,Unknown,0.081,0.431,0.123,0.164,Significant decrease (p=0.024),Mild increase (p=0.012),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06536,rs547782,22,9044462,PSEN2,SNP (A/T),(A/,A,0.94,0.72,1.21,0.00821145,High,0.272,0.057,0.079,0.393,Significant increase (p=0.013),Variable effect (p=0.015),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06537,rs809916,22,109077268,EPHA1,SNP (G/T),(G/,G,1.04,0.8,1.41,0.01785153,Protective,0.088,0.13,0.285,0.297,Significant increase (p=0.041),Variable effect (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06538,rs958011,22,35316456,APOE,Insertion,-,-,0.65,0.43,0.88,0.02877296,Unknown,0.416,0.024,0.157,0.203,No significant pattern (p=0.011),No significant pattern (p=0.018),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP06539,rs848920,10,248768618,PSEN2,SNP (G/T),(G/,G,1.06,0.81,1.42,0.03455085,Moderate,0.083,0.182,0.247,0.288,Mild increase (p=0.013),No significant pattern (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06540,rs674927,20,67641825,TREM2,Insertion,-,-,1.92,1.7,2.19,0.0310379,High,0.428,0.108,0.071,0.192,No significant pattern (p=0.019),Mild increase (p=0.047),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP06541,rs705652,4,129012885,EPHA1,SNP (G/T),(G/,G,2.18,1.82,2.41,0.0985524,Protective,0.066,0.217,0.231,0.285,Significant decrease (p=0.012),Variable effect (p=0.028),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06542,rs759825,9,226720921,APOE,SNP (C/T),(C/,C,0.66,0.37,0.95,0.02653596,Moderate,0.504,0.011,0.065,0.22,Variable effect (p=0.007),Significant increase (p=0.024),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06543,rs435664,2,112478351,CR1,SNP (C/G),(C/,C,1.17,0.82,1.39,0.03935869,High,0.035,0.048,0.55,0.167,Mild increase (p=0.043),No significant pattern (p=0.017),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06544,rs491283,9,66933072,CLU,SNP (A/G),(A/,A,0.55,0.34,0.8,0.00114739,High,0.13,0.014,0.304,0.352,No significant pattern (p=0.003),Significant increase (p=0.006),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP06545,rs142704,20,68761375,BIN1,SNP (C/G),(C/,C,0.82,0.42,1.13,0.09123797,Moderate,0.001,0.198,0.18,0.421,Variable effect (p=0.016),Significant increase (p=0.046),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06546,rs131278,2,235214304,CLU,SNP (G/T),(G/,G,0.49,0.26,0.82,0.03103404,Moderate,0.182,0.346,0.062,0.211,Significant decrease (p=0.012),Mild increase (p=0.006),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP06547,rs465845,14,134089996,CLU,Insertion,-,-,1.22,0.92,1.57,0.00467227,Moderate,0.101,0.032,0.195,0.472,Mild increase (p=0.049),Significant decrease (p=0.002),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06548,rs647583,12,211958125,BIN1,SNP (C/T),(C/,C,0.22,0.1,0.47,0.04566576,High,0.152,0.176,0.178,0.295,No significant pattern (p=0.019),Variable effect (p=0.033),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06549,rs533160,21,23782612,PTK2B,Insertion,-,-,0.55,0.26,0.87,0.01996317,High,0.073,0.485,0.117,0.125,Variable effect (p=0.006),No significant pattern (p=0.043),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06550,rs438053,19,3473060,APOE,Deletion,-,-,0.6,0.36,0.96,0.02964688,High,0.425,0.213,0.142,0.02,Variable effect (p=0.03),No significant pattern (p=0.016),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP06551,rs723336,22,152455742,SORL1,SNP (G/T),(G/,G,2.13,1.74,2.52,0.06466114,Moderate,0.125,0.292,0.065,0.317,Mild increase (p=0.009),Significant increase (p=0.033),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06552,rs366368,8,103784850,EPHA1,Deletion,-,-,1.38,1.11,1.69,0.04592324,Moderate,0.346,0.181,0.253,0.019,No significant pattern (p=0.045),Significant increase (p=0.041),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06553,rs825048,5,31734788,EPHA1,SNP (C/T),(C/,C,0.59,0.39,0.83,0.04511019,Low,0.008,0.051,0.493,0.248,No significant pattern (p=0.035),Mild decrease (p=0.034),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06554,rs508318,9,41401910,APOE,SNP (A/T),(A/,A,1.25,0.98,1.63,0.09409326,High,0.009,0.415,0.227,0.15,Mild decrease (p=0.007),Mild decrease (p=0.032),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06555,rs164266,19,239741996,APP,Insertion,-,-,2.41,2.09,2.76,0.05529816,Moderate,0.006,0.417,0.278,0.099,Variable effect (p=0.005),Significant decrease (p=0.044),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06556,rs572444,11,99536162,APOE,Deletion,-,-,0.93,0.62,1.14,0.03153754,Unknown,0.044,0.049,0.607,0.101,No significant pattern (p=0.023),No significant pattern (p=0.011),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06557,rs334322,18,47699384,PTK2B,Deletion,-,-,0.93,0.64,1.3,0.03746976,Low,0.312,0.222,0.167,0.099,No significant pattern (p=0.041),Significant increase (p=0.019),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06558,rs329210,7,91931185,TREM2,Insertion,-,-,2.64,2.41,2.85,0.00335824,High,0.071,0.206,0.269,0.253,No significant pattern (p=0.022),Mild increase (p=0.018),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP06559,rs427783,17,204605409,PICALM,Deletion,-,-,1.06,0.85,1.46,0.06355369,Protective,0.604,0.003,0.015,0.177,Variable effect (p=0.008),No significant pattern (p=0.014),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06560,rs219343,1,237812213,APP,SNP (G/T),(G/,G,0.79,0.46,1.12,0.02222983,High,0.25,0.354,0.061,0.135,Variable effect (p=0.038),No significant pattern (p=0.05),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06561,rs538758,8,180838537,CR1,SNP (A/C),(A/,A,0.67,0.45,0.98,0.02330736,High,0.299,0.027,0.102,0.373,Variable effect (p=0.024),No significant pattern (p=0.02),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06562,rs990825,12,239481664,PICALM,SNP (G/T),(G/,G,0.23,0.1,0.5,0.01177911,Unknown,0.045,0.065,0.615,0.075,Mild decrease (p=0.008),Mild decrease (p=0.013),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06563,rs294743,22,101006429,PTK2B,SNP (A/G),(A/,A,0.98,0.68,1.18,0.00137173,High,0.0,0.393,0.296,0.111,No significant pattern (p=0.044),Significant increase (p=0.029),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06564,rs145158,10,24435996,PSEN2,Insertion,-,-,1.77,1.42,2.12,0.04233705,Moderate,0.013,0.496,0.092,0.2,No significant pattern (p=0.022),Variable effect (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06565,rs441941,15,62505603,CLU,SNP (C/T),(C/,C,0.43,0.1,0.64,0.08042819,Moderate,0.012,0.021,0.08,0.688,Mild decrease (p=0.04),Significant decrease (p=0.028),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06566,rs587010,7,79753908,PICALM,SNP (C/G),(C/,C,1.28,0.96,1.49,0.00171616,Moderate,0.032,0.596,0.147,0.026,No significant pattern (p=0.019),Variable effect (p=0.006),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06567,rs631099,12,192083696,ABCA7,SNP (A/G),(A/,A,1.35,1.06,1.7,0.06184568,Moderate,0.305,0.187,0.266,0.042,Significant increase (p=0.02),Significant increase (p=0.04),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06568,rs805671,6,38659139,APP,SNP (G/T),(G/,G,0.98,0.7,1.21,0.00833914,Moderate,0.242,0.079,0.244,0.236,Mild increase (p=0.004),Significant increase (p=0.016),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06569,rs857246,16,192569108,SORL1,SNP (A/C),(A/,A,1.18,0.87,1.39,0.0749454,Moderate,0.067,0.143,0.263,0.327,Significant decrease (p=0.03),Mild decrease (p=0.013),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP06570,rs392523,19,198105475,CD2AP,Insertion,-,-,0.43,0.17,0.67,0.02063288,Moderate,0.069,0.216,0.239,0.277,Mild decrease (p=0.003),No significant pattern (p=0.023),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP06571,rs965021,10,201961793,TREM2,Insertion,-,-,0.79,0.53,1.04,0.0820504,Moderate,0.082,0.222,0.093,0.403,Significant decrease (p=0.032),Mild increase (p=0.007),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06572,rs915060,14,152651646,CLU,SNP (A/C),(A/,A,1.08,0.7,1.31,0.08856361,Protective,0.08,0.001,0.545,0.174,Significant increase (p=0.02),Mild increase (p=0.035),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP06573,rs870550,17,43048990,CD33,SNP (C/T),(C/,C,0.99,0.62,1.19,0.02115785,Moderate,0.2,0.003,0.477,0.12,Significant decrease (p=0.047),Significant decrease (p=0.016),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06574,rs511935,22,228373433,APP,Deletion,-,-,0.83,0.55,1.22,0.05600668,High,0.511,0.168,0.055,0.066,Variable effect (p=0.034),No significant pattern (p=0.017),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP06575,rs529548,18,214179997,EPHA1,SNP (C/T),(C/,C,1.33,1.01,1.57,0.02276388,Moderate,0.013,0.592,0.068,0.128,Variable effect (p=0.019),No significant pattern (p=0.006),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06576,rs356875,18,50719332,PTK2B,SNP (A/T),(A/,A,1.32,0.96,1.66,0.02451755,Low,0.043,0.218,0.46,0.079,Variable effect (p=0.016),Significant increase (p=0.02),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06577,rs401328,3,128328586,APP,SNP (G/T),(G/,G,1.64,1.25,2.04,0.07682224,Unknown,0.206,0.115,0.045,0.433,Significant decrease (p=0.032),Significant increase (p=0.017),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06578,rs942115,4,127660052,CR1,Insertion,-,-,0.68,0.41,0.93,0.00046259,Moderate,0.563,0.186,0.006,0.045,No significant pattern (p=0.03),Mild increase (p=0.004),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06579,rs654210,6,135086697,PSEN2,SNP (G/T),(G/,G,1.26,0.95,1.52,0.00269149,Moderate,0.425,0.085,0.202,0.089,Variable effect (p=0.036),No significant pattern (p=0.011),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06580,rs504416,4,20980388,BIN1,SNP (C/G),(C/,C,0.75,0.54,1.14,0.0090456,Moderate,0.317,0.097,0.364,0.022,Mild increase (p=0.038),Mild increase (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06581,rs955634,6,33616085,CD33,SNP (A/T),(A/,A,1.63,1.4,1.97,0.00010064,Moderate,0.142,0.273,0.175,0.209,Significant decrease (p=0.038),No significant pattern (p=0.003),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP06582,rs156929,21,63441038,PSEN2,SNP (A/G),(A/,A,1.24,0.9,1.54,0.04010944,Moderate,0.114,0.218,0.421,0.047,No significant pattern (p=0.028),Variable effect (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06583,rs266940,2,142604193,ABCA7,SNP (A/G),(A/,A,0.81,0.51,1.19,0.01343784,Low,0.242,0.224,0.061,0.273,Significant decrease (p=0.007),Variable effect (p=0.024),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06584,rs430551,7,128395874,APP,SNP (A/G),(A/,A,1.08,0.88,1.32,0.03416048,Moderate,0.086,0.279,0.365,0.069,No significant pattern (p=0.031),No significant pattern (p=0.001),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06585,rs722392,17,207401419,TREM2,Deletion,-,-,1.03,0.69,1.35,0.01111563,Low,0.44,0.152,0.051,0.158,No significant pattern (p=0.036),Mild increase (p=0.032),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06586,rs753225,8,221323825,PSEN2,SNP (C/G),(C/,C,0.86,0.48,1.24,0.09754261,Moderate,0.076,0.207,0.341,0.176,Significant increase (p=0.022),Significant increase (p=0.005),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06587,rs928031,5,99527462,CD33,Insertion,-,-,1.61,1.38,1.81,0.01772741,Low,0.399,0.005,0.331,0.065,No significant pattern (p=0.044),Mild decrease (p=0.012),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06588,rs297211,16,175724325,CR1,SNP (C/G),(C/,C,0.58,0.26,0.82,0.02946844,Moderate,0.013,0.031,0.731,0.024,Variable effect (p=0.041),Significant decrease (p=0.019),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06589,rs456651,22,224669676,MS4A6A,Deletion,-,-,1.09,0.72,1.36,0.0494188,Moderate,0.207,0.312,0.072,0.208,Mild decrease (p=0.044),Mild decrease (p=0.016),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06590,rs907261,16,148461263,EPHA1,SNP (A/T),(A/,A,0.38,0.18,0.71,0.01625638,High,0.11,0.222,0.251,0.217,Significant decrease (p=0.039),Significant decrease (p=0.018),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06591,rs711638,12,157688764,PTK2B,SNP (G/T),(G/,G,1.9,1.69,2.15,0.01711123,Protective,0.163,0.025,0.541,0.071,Mild increase (p=0.007),Significant increase (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06592,rs446202,6,248905792,CR1,SNP (A/C),(A/,A,0.92,0.53,1.16,0.0100533,Moderate,0.163,0.322,0.141,0.175,Variable effect (p=0.028),Mild increase (p=0.036),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06593,rs442351,8,61133631,CR1,Deletion,-,-,1.24,0.94,1.48,0.00408154,Moderate,0.168,0.107,0.04,0.485,Mild increase (p=0.033),Significant decrease (p=0.026),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06594,rs421801,14,181470550,APOE,SNP (C/T),(C/,C,1.51,1.15,1.9,0.00343585,Low,0.074,0.169,0.041,0.515,Significant increase (p=0.043),No significant pattern (p=0.038),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06595,rs235148,20,176777588,BIN1,SNP (C/G),(C/,C,0.45,0.14,0.84,0.0167725,High,0.203,0.331,0.19,0.076,Mild decrease (p=0.047),Significant increase (p=0.047),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06596,rs502307,4,221204238,CD2AP,SNP (G/T),(G/,G,0.32,0.1,0.57,0.10220772,Protective,0.034,0.038,0.496,0.231,Mild decrease (p=0.031),Mild decrease (p=0.018),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06597,rs245156,13,48957148,PSEN2,SNP (A/C),(A/,A,0.94,0.67,1.26,0.00334862,Low,0.235,0.084,0.345,0.136,No significant pattern (p=0.009),Significant increase (p=0.01),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06598,rs981792,3,239717169,PSEN2,SNP (C/G),(C/,C,1.97,1.57,2.24,0.04600647,Low,0.345,0.033,0.273,0.15,Variable effect (p=0.027),Significant increase (p=0.034),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06599,rs659278,6,83555913,ABCA7,SNP (A/G),(A/,A,1.15,0.89,1.54,0.02546126,Protective,0.479,0.213,0.1,0.008,Variable effect (p=0.026),Significant decrease (p=0.015),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06600,rs892348,5,33828625,CR1,SNP (A/C),(A/,A,1.17,0.84,1.39,0.02932007,High,0.445,0.303,0.048,0.004,Significant decrease (p=0.022),Mild decrease (p=0.014),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06601,rs734224,18,245781710,PTK2B,Insertion,-,-,0.39,0.1,0.76,0.03649327,Moderate,0.23,0.418,0.058,0.094,Mild increase (p=0.035),Mild decrease (p=0.036),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP06602,rs461342,12,78788695,CD33,SNP (A/T),(A/,A,0.88,0.57,1.17,0.05922267,Moderate,0.22,0.079,0.056,0.445,Variable effect (p=0.006),Variable effect (p=0.009),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP06603,rs183844,6,234156192,BIN1,Insertion,-,-,3.09,2.83,3.44,0.05295821,High,0.194,0.108,0.496,0.002,Significant increase (p=0.023),Variable effect (p=0.012),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06604,rs417887,11,142937413,PICALM,Insertion,-,-,1.32,0.99,1.66,0.05832183,Moderate,0.548,0.001,0.119,0.131,No significant pattern (p=0.038),No significant pattern (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06605,rs665525,7,9546979,ABCA7,Insertion,-,-,1.71,1.39,2.02,0.01543438,Low,0.264,0.387,0.138,0.012,Significant decrease (p=0.011),Significant decrease (p=0.013),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06606,rs226792,13,9409008,CLU,SNP (A/T),(A/,A,0.85,0.51,1.15,0.00192153,Moderate,0.241,0.025,0.23,0.304,Variable effect (p=0.039),Variable effect (p=0.004),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP06607,rs857897,22,105179606,PTK2B,SNP (C/G),(C/,C,1.26,1.02,1.52,3.056e-05,Moderate,0.017,0.701,0.019,0.063,No significant pattern (p=0.042),Variable effect (p=0.013),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06608,rs128907,14,7508308,CR1,SNP (G/T),(G/,G,0.75,0.47,1.01,0.07539877,Moderate,0.111,0.457,0.163,0.07,Mild decrease (p=0.019),Significant decrease (p=0.03),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06609,rs856482,8,230209650,APP,SNP (C/G),(C/,C,1.55,1.19,1.78,0.0174639,High,0.181,0.039,0.06,0.52,Significant decrease (p=0.037),Significant decrease (p=0.018),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06610,rs100955,14,101252280,MS4A6A,SNP (C/G),(C/,C,1.88,1.48,2.1,0.09969949,Low,0.058,0.692,0.026,0.025,Variable effect (p=0.042),No significant pattern (p=0.032),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06611,rs451950,9,138678350,CLU,SNP (C/T),(C/,C,0.81,0.45,1.11,0.0156954,Low,0.447,0.069,0.268,0.016,Variable effect (p=0.004),Mild decrease (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06612,rs891577,7,111878196,CR1,SNP (G/T),(G/,G,0.52,0.14,0.88,0.01452429,High,0.552,0.084,0.034,0.13,Variable effect (p=0.023),Significant decrease (p=0.035),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06613,rs154013,11,210160766,MS4A6A,SNP (C/G),(C/,C,0.49,0.23,0.76,0.00946537,Moderate,0.23,0.376,0.081,0.113,Variable effect (p=0.042),Significant increase (p=0.009),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06614,rs639187,7,80631138,APP,SNP (C/G),(C/,C,2.58,2.35,2.89,0.04316041,Low,0.151,0.396,0.059,0.195,Significant increase (p=0.027),Mild increase (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06615,rs765803,13,62983217,APP,SNP (G/T),(G/,G,0.72,0.5,1.07,0.05053822,High,0.051,0.193,0.246,0.31,Significant increase (p=0.004),Mild decrease (p=0.004),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06616,rs687455,7,13940400,CR1,Deletion,-,-,0.7,0.46,1.05,0.07741612,Moderate,0.043,0.011,0.742,0.003,Significant increase (p=0.008),Significant decrease (p=0.04),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06617,rs553773,2,136791167,PTK2B,SNP (A/T),(A/,A,0.88,0.66,1.25,0.03522335,Moderate,0.134,0.177,0.087,0.402,No significant pattern (p=0.022),Significant increase (p=0.023),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06618,rs821446,14,111403380,ABCA7,SNP (A/T),(A/,A,0.52,0.16,0.88,0.01248908,Moderate,0.245,0.138,0.118,0.298,Significant increase (p=0.048),Mild increase (p=0.011),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP06619,rs678234,16,86100791,PICALM,SNP (A/T),(A/,A,0.79,0.57,1.13,0.02000606,Moderate,0.263,0.162,0.253,0.122,Significant decrease (p=0.027),Mild increase (p=0.006),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP06620,rs868674,19,245406958,PSEN2,SNP (G/T),(G/,G,1.03,0.71,1.24,0.0040073,Moderate,0.062,0.452,0.24,0.046,Mild increase (p=0.007),No significant pattern (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06621,rs283031,1,35277126,APOE,SNP (A/G),(A/,A,0.74,0.34,0.97,0.03181538,High,0.034,0.261,0.3,0.205,Significant increase (p=0.045),No significant pattern (p=0.045),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP06622,rs303667,19,237918070,BIN1,SNP (A/T),(A/,A,0.89,0.53,1.21,0.00635751,Moderate,0.02,0.149,0.012,0.619,Significant increase (p=0.046),Variable effect (p=0.014),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06623,rs387876,6,54882542,BIN1,Deletion,-,-,2.15,1.89,2.37,0.01495606,Moderate,0.055,0.227,0.473,0.045,Mild increase (p=0.01),Significant decrease (p=0.039),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06624,rs974651,16,55561717,EPHA1,SNP (G/T),(G/,G,1.17,0.82,1.39,0.00360313,Protective,0.183,0.426,0.016,0.176,Mild decrease (p=0.013),Variable effect (p=0.027),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06625,rs452671,7,137921391,PSEN2,SNP (G/T),(G/,G,1.97,1.62,2.23,0.06637497,Low,0.033,0.009,0.392,0.366,Significant increase (p=0.017),Mild increase (p=0.025),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06626,rs118305,18,133265449,APP,SNP (G/T),(G/,G,0.46,0.26,0.72,0.011801,Unknown,0.204,0.063,0.036,0.497,Mild decrease (p=0.025),No significant pattern (p=0.015),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06627,rs219768,5,125923525,CR1,SNP (A/T),(A/,A,0.45,0.13,0.82,0.0272447,Protective,0.091,0.105,0.468,0.135,Significant decrease (p=0.041),Significant increase (p=0.021),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06628,rs215713,18,85694353,MS4A6A,Deletion,-,-,0.94,0.69,1.22,0.07564364,Low,0.019,0.295,0.261,0.225,Variable effect (p=0.02),No significant pattern (p=0.036),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06629,rs438851,10,42828181,APP,SNP (A/C),(A/,A,0.66,0.34,0.96,0.00636074,Unknown,0.137,0.203,0.082,0.378,Mild decrease (p=0.01),No significant pattern (p=0.032),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06630,rs332596,2,66868921,EPHA1,SNP (C/T),(C/,C,1.29,0.96,1.56,0.03737036,Moderate,0.065,0.265,0.098,0.372,Mild decrease (p=0.016),Mild decrease (p=0.012),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06631,rs155806,22,238752300,EPHA1,Deletion,-,-,1.66,1.43,1.95,0.01746876,Moderate,0.183,0.228,0.283,0.107,No significant pattern (p=0.023),No significant pattern (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06632,rs869303,2,105953498,CD2AP,SNP (A/G),(A/,A,1.27,0.98,1.49,0.02130475,Moderate,0.002,0.513,0.01,0.275,Significant decrease (p=0.027),Significant increase (p=0.019),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06633,rs726517,16,182845386,CD2AP,SNP (C/T),(C/,C,0.59,0.22,0.86,0.05792991,High,0.47,0.219,0.009,0.103,Significant increase (p=0.03),Significant decrease (p=0.001),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP06634,rs888919,1,190444298,PTK2B,SNP (C/G),(C/,C,1.03,0.72,1.26,0.01235375,Unknown,0.077,0.264,0.008,0.451,Significant increase (p=0.039),Mild decrease (p=0.042),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06635,rs771454,18,188849126,CD33,Deletion,-,-,0.96,0.72,1.29,0.06453109,High,0.34,0.136,0.092,0.232,Variable effect (p=0.023),Variable effect (p=0.039),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06636,rs235374,13,157804162,APOE,Deletion,-,-,0.87,0.63,1.2,0.04151339,Protective,0.21,0.252,0.234,0.104,No significant pattern (p=0.033),Mild increase (p=0.046),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP06637,rs455262,17,211414741,TREM2,SNP (A/T),(A/,A,1.93,1.62,2.17,0.05835726,Unknown,0.27,0.457,0.053,0.02,Significant increase (p=0.047),Significant increase (p=0.002),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06638,rs491379,21,26253664,PTK2B,SNP (C/T),(C/,C,1.77,1.51,2.12,0.07226149,Low,0.064,0.001,0.282,0.452,Variable effect (p=0.017),Mild increase (p=0.004),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06639,rs464035,3,237761794,CR1,SNP (A/C),(A/,A,0.76,0.46,1.16,0.03353495,Low,0.236,0.212,0.085,0.267,Mild decrease (p=0.04),Mild increase (p=0.002),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06640,rs797725,11,89713564,CD2AP,Deletion,-,-,1.44,1.17,1.78,0.04951226,Low,0.228,0.297,0.07,0.205,No significant pattern (p=0.035),Mild increase (p=0.024),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06641,rs536344,8,76750338,BIN1,SNP (C/T),(C/,C,1.08,0.73,1.32,0.03793097,Low,0.671,0.06,0.048,0.022,Significant decrease (p=0.046),Mild increase (p=0.015),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06642,rs581902,19,75465711,PICALM,SNP (A/G),(A/,A,1.1,0.73,1.46,0.0364024,High,0.089,0.454,0.108,0.148,No significant pattern (p=0.038),No significant pattern (p=0.025),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06643,rs982367,18,177783761,SORL1,SNP (C/T),(C/,C,1.15,0.93,1.52,0.05143222,Moderate,0.163,0.056,0.519,0.062,Variable effect (p=0.048),Significant decrease (p=0.032),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06644,rs911007,11,49193728,APP,SNP (C/T),(C/,C,1.6,1.31,1.81,0.07881877,Moderate,0.278,0.29,0.121,0.112,No significant pattern (p=0.037),Variable effect (p=0.032),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06645,rs639275,15,52286416,MS4A6A,SNP (A/C),(A/,A,0.84,0.54,1.19,0.00691398,Low,0.4,0.198,0.017,0.185,Variable effect (p=0.005),Significant increase (p=0.047),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06646,rs400097,14,83231991,ABCA7,Insertion,-,-,0.93,0.54,1.33,0.07500573,Moderate,0.099,0.453,0.234,0.014,Mild increase (p=0.038),Mild decrease (p=0.007),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06647,rs169976,20,233585394,CD2AP,SNP (A/T),(A/,A,0.62,0.31,1.0,0.19304772,Moderate,0.258,0.089,0.029,0.424,No significant pattern (p=0.026),Significant decrease (p=0.012),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06648,rs941638,12,198543238,TREM2,SNP (G/T),(G/,G,0.96,0.58,1.17,0.02949886,High,0.054,0.024,0.212,0.511,Significant decrease (p=0.024),Significant increase (p=0.024),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06649,rs568778,6,191072054,CD2AP,SNP (A/T),(A/,A,1.08,0.8,1.38,0.00743555,Unknown,0.517,0.167,0.028,0.088,Significant increase (p=0.003),No significant pattern (p=0.003),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06650,rs371742,20,217243116,TREM2,SNP (C/G),(C/,C,1.2,0.94,1.43,0.06508045,Moderate,0.084,0.116,0.545,0.056,Mild decrease (p=0.024),Mild increase (p=0.027),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06651,rs109539,21,170644945,MS4A6A,Deletion,-,-,0.99,0.79,1.37,0.01531387,Moderate,0.104,0.461,0.053,0.182,Significant decrease (p=0.004),Variable effect (p=0.024),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06652,rs607990,1,18565680,ABCA7,SNP (C/G),(C/,C,1.02,0.65,1.22,0.05331046,Moderate,0.217,0.006,0.361,0.216,Variable effect (p=0.049),No significant pattern (p=0.027),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06653,rs968738,16,232456550,PICALM,SNP (A/T),(A/,A,0.35,0.1,0.57,0.02955815,High,0.243,0.247,0.13,0.18,Significant decrease (p=0.001),Mild increase (p=0.049),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06654,rs760741,8,93798224,APP,SNP (C/G),(C/,C,0.34,0.1,0.62,0.01159357,Moderate,0.185,0.357,0.023,0.236,Significant decrease (p=0.025),No significant pattern (p=0.036),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06655,rs866384,5,192125286,ABCA7,Deletion,-,-,2.93,2.72,3.28,0.00194908,Moderate,0.103,0.024,0.527,0.146,Significant increase (p=0.04),Significant decrease (p=0.01),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP06656,rs880201,7,247112746,CR1,SNP (G/T),(G/,G,0.67,0.35,0.92,0.00458822,High,0.311,0.269,0.18,0.04,No significant pattern (p=0.021),Significant increase (p=0.042),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06657,rs995091,3,177037370,MS4A6A,SNP (A/C),(A/,A,2.12,1.8,2.45,0.01157001,Unknown,0.301,0.42,0.074,0.005,Variable effect (p=0.028),Mild decrease (p=0.024),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06658,rs724062,18,141606736,SORL1,SNP (A/G),(A/,A,0.7,0.3,1.06,0.00651695,Moderate,0.07,0.443,0.255,0.032,No significant pattern (p=0.04),Variable effect (p=0.036),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06659,rs386577,19,203531951,TREM2,SNP (A/G),(A/,A,1.41,1.08,1.79,0.01979393,High,0.187,0.06,0.299,0.254,No significant pattern (p=0.022),Significant decrease (p=0.016),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06660,rs232637,11,137072184,MS4A6A,SNP (A/C),(A/,A,1.4,1.14,1.6,0.03301434,High,0.028,0.109,0.031,0.632,Mild decrease (p=0.033),No significant pattern (p=0.048),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06661,rs776513,19,51531032,SORL1,SNP (C/G),(C/,C,0.69,0.48,1.05,0.01972497,Low,0.56,0.016,0.052,0.172,Significant decrease (p=0.02),No significant pattern (p=0.046),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP06662,rs560457,6,94826978,CR1,Deletion,-,-,0.67,0.35,0.96,0.02055574,High,0.284,0.088,0.202,0.226,Variable effect (p=0.042),Mild decrease (p=0.049),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06663,rs325645,1,66767466,CD33,SNP (A/C),(A/,A,1.31,1.01,1.62,0.04151602,High,0.535,0.013,0.133,0.119,Significant decrease (p=0.05),No significant pattern (p=0.002),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06664,rs463654,14,204083485,CD33,Deletion,-,-,2.49,2.11,2.72,0.01110975,Low,0.184,0.061,0.188,0.367,Mild decrease (p=0.014),Mild decrease (p=0.019),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06665,rs833379,22,238825938,CD2AP,SNP (C/G),(C/,C,0.48,0.16,0.73,0.002282,Low,0.397,0.167,0.071,0.164,Mild increase (p=0.012),Significant decrease (p=0.047),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06666,rs467347,22,239650505,ABCA7,SNP (A/T),(A/,A,0.79,0.45,1.08,0.08101596,Protective,0.23,0.385,0.074,0.111,Mild decrease (p=0.021),Variable effect (p=0.045),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06667,rs275113,14,210407626,CLU,SNP (A/T),(A/,A,0.64,0.35,0.96,0.00298427,High,0.235,0.073,0.205,0.287,Mild decrease (p=0.025),Mild increase (p=0.031),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06668,rs228557,9,84753189,PTK2B,Deletion,-,-,1.42,1.06,1.66,0.00789665,Low,0.231,0.153,0.007,0.408,Significant decrease (p=0.016),Significant increase (p=0.021),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06669,rs177983,16,176648617,APOE,SNP (A/C),(A/,A,1.11,0.91,1.34,0.0194226,Low,0.1,0.272,0.419,0.009,Variable effect (p=0.034),No significant pattern (p=0.049),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06670,rs172885,9,30660133,PICALM,Deletion,-,-,0.97,0.64,1.36,0.03258449,Moderate,0.365,0.06,0.084,0.291,Mild increase (p=0.034),Mild increase (p=0.044),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP06671,rs615748,8,27719645,CD2AP,SNP (A/G),(A/,A,0.7,0.4,0.94,0.01153765,Low,0.05,0.031,0.634,0.085,Significant decrease (p=0.045),Significant decrease (p=0.035),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06672,rs781054,17,64303264,CLU,Deletion,-,-,0.95,0.57,1.23,0.01343868,High,0.091,0.295,0.39,0.024,Mild increase (p=0.038),Significant decrease (p=0.015),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06673,rs288551,11,99791889,PTK2B,SNP (A/C),(A/,A,1.18,0.87,1.56,0.02691121,Moderate,0.667,0.125,0.001,0.007,Mild decrease (p=0.021),No significant pattern (p=0.038),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06674,rs604113,2,32821384,PTK2B,SNP (A/T),(A/,A,2.32,2.01,2.69,0.0584879,Low,0.069,0.075,0.174,0.482,Mild decrease (p=0.038),Mild decrease (p=0.034),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06675,rs599116,19,6692216,SORL1,SNP (A/T),(A/,A,0.95,0.71,1.17,0.02887285,Protective,0.191,0.27,0.326,0.013,Variable effect (p=0.03),Significant decrease (p=0.023),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06676,rs393859,19,2078157,CR1,SNP (C/G),(C/,C,1.29,0.95,1.62,0.02447985,Moderate,0.152,0.337,0.178,0.134,Significant decrease (p=0.011),Mild decrease (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06677,rs346860,3,92146763,TREM2,Insertion,-,-,1.81,1.55,2.08,0.00445313,Low,0.049,0.631,0.033,0.087,Mild increase (p=0.021),No significant pattern (p=0.018),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP06678,rs321237,5,223033995,CD33,SNP (C/G),(C/,C,0.63,0.42,0.91,0.02107213,Low,0.017,0.205,0.462,0.116,Variable effect (p=0.045),Significant decrease (p=0.038),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06679,rs767902,10,77118510,EPHA1,Deletion,-,-,0.74,0.52,0.96,0.04027829,Low,0.05,0.555,0.168,0.027,Variable effect (p=0.008),Variable effect (p=0.039),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06680,rs913218,5,43653197,MS4A6A,Insertion,-,-,0.87,0.58,1.24,0.06773355,Low,0.086,0.378,0.091,0.244,No significant pattern (p=0.015),Significant decrease (p=0.043),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06681,rs316997,10,135758431,ABCA7,SNP (A/G),(A/,A,1.3,0.9,1.55,0.01379877,Moderate,0.264,0.353,0.13,0.053,Mild decrease (p=0.024),Variable effect (p=0.047),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP06682,rs260510,12,217119521,PICALM,SNP (C/T),(C/,C,2.12,1.78,2.5,0.05158853,Protective,0.322,0.153,0.129,0.196,Variable effect (p=0.016),No significant pattern (p=0.003),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06683,rs503217,3,116339984,CR1,SNP (G/T),(G/,G,0.56,0.27,0.89,0.00637128,Low,0.12,0.084,0.224,0.373,Significant increase (p=0.041),Mild increase (p=0.036),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06684,rs683522,22,236912353,APP,SNP (A/C),(A/,A,0.52,0.23,0.83,0.0298501,High,0.059,0.038,0.261,0.442,Significant increase (p=0.023),Mild decrease (p=0.042),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP06685,rs626979,19,79513019,SORL1,Deletion,-,-,1.54,1.17,1.85,0.01263274,High,0.139,0.022,0.285,0.354,Variable effect (p=0.029),Significant decrease (p=0.046),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06686,rs839026,3,16284920,CR1,SNP (C/G),(C/,C,1.12,0.91,1.35,0.04324768,Moderate,0.291,0.177,0.085,0.247,Variable effect (p=0.035),Mild decrease (p=0.012),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06687,rs485570,12,127754129,ABCA7,SNP (C/T),(C/,C,1.26,0.92,1.62,0.00089209,High,0.567,0.006,0.039,0.188,Variable effect (p=0.031),No significant pattern (p=0.01),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06688,rs957739,8,133690199,PTK2B,SNP (A/T),(A/,A,0.72,0.46,0.95,0.007702,Protective,0.079,0.159,0.255,0.307,Mild decrease (p=0.002),Mild increase (p=0.038),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06689,rs136661,10,34259002,APOE,SNP (C/G),(C/,C,1.29,0.95,1.59,0.08992169,Protective,0.133,0.409,0.252,0.006,No significant pattern (p=0.025),Variable effect (p=0.046),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06690,rs387988,18,45578596,BIN1,SNP (A/G),(A/,A,0.66,0.39,0.87,0.03551671,High,0.227,0.295,0.197,0.081,No significant pattern (p=0.035),Significant decrease (p=0.008),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06691,rs662673,6,64324371,APP,SNP (C/G),(C/,C,0.45,0.14,0.81,0.00251311,Moderate,0.521,0.24,0.005,0.034,Mild increase (p=0.018),Mild increase (p=0.028),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06692,rs820075,19,196510634,BIN1,SNP (A/G),(A/,A,0.62,0.24,0.97,0.01804363,Protective,0.595,0.023,0.015,0.166,Significant decrease (p=0.024),Significant decrease (p=0.015),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06693,rs576547,5,3935207,APP,Deletion,-,-,1.33,1.0,1.59,0.01914363,Protective,0.403,0.048,0.267,0.083,No significant pattern (p=0.027),Mild decrease (p=0.009),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06694,rs505713,12,116125892,CLU,Insertion,-,-,1.32,1.12,1.68,0.0534895,Low,0.604,0.009,0.126,0.061,Mild increase (p=0.032),Significant decrease (p=0.003),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06695,rs814791,4,135481138,EPHA1,SNP (A/T),(A/,A,0.92,0.62,1.24,0.10723571,Protective,0.153,0.327,0.002,0.318,Variable effect (p=0.014),Significant decrease (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06696,rs284929,15,26228022,CD33,SNP (A/T),(A/,A,0.63,0.25,0.87,0.02555238,High,0.448,0.251,0.039,0.062,Significant decrease (p=0.037),Variable effect (p=0.046),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06697,rs310501,5,94139975,CR1,SNP (G/T),(G/,G,0.58,0.37,0.82,0.02552085,Low,0.134,0.32,0.072,0.274,Variable effect (p=0.025),Mild decrease (p=0.042),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06698,rs832370,20,67311499,ABCA7,SNP (C/T),(C/,C,1.67,1.32,2.05,0.06320046,Moderate,0.045,0.208,0.366,0.182,No significant pattern (p=0.03),No significant pattern (p=0.004),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06699,rs795728,10,95558196,EPHA1,SNP (G/T),(G/,G,0.73,0.5,0.94,0.11930775,Low,0.342,0.102,0.181,0.174,Variable effect (p=0.048),Mild decrease (p=0.045),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06700,rs414857,8,196393246,EPHA1,SNP (C/T),(C/,C,1.08,0.86,1.4,0.0342373,Low,0.001,0.246,0.206,0.347,Significant decrease (p=0.01),Mild increase (p=0.043),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06701,rs734194,1,123303043,TREM2,SNP (G/T),(G/,G,0.56,0.35,0.87,0.00848377,Moderate,0.486,0.264,0.027,0.023,Significant increase (p=0.038),Significant decrease (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06702,rs207938,13,246470969,BIN1,SNP (C/T),(C/,C,0.55,0.27,0.83,0.00466921,Low,0.572,0.002,0.135,0.091,Mild decrease (p=0.03),Significant decrease (p=0.03),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06703,rs861631,13,199343440,TREM2,Deletion,-,-,0.77,0.52,1.17,0.00492815,Protective,0.024,0.566,0.176,0.034,Mild decrease (p=0.024),Variable effect (p=0.038),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP06704,rs895291,7,173484934,APOE,SNP (A/G),(A/,A,1.3,1.08,1.5,0.02099763,Low,0.415,0.337,0.017,0.032,No significant pattern (p=0.009),Mild decrease (p=0.031),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06705,rs456282,7,208045412,CD33,SNP (C/T),(C/,C,1.17,0.96,1.57,0.04450617,High,0.227,0.431,0.087,0.056,Significant increase (p=0.049),Significant decrease (p=0.018),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06706,rs389264,7,92289591,ABCA7,Deletion,-,-,0.87,0.63,1.22,0.00083528,Moderate,0.284,0.289,0.159,0.069,Mild increase (p=0.002),Significant increase (p=0.012),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06707,rs827521,15,28953619,APOE,SNP (A/T),(A/,A,1.02,0.72,1.25,0.02325326,Moderate,0.428,0.044,0.029,0.299,Mild decrease (p=0.009),No significant pattern (p=0.042),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06708,rs494364,3,207868520,PICALM,Deletion,-,-,1.01,0.67,1.23,0.03198213,High,0.105,0.25,0.165,0.28,Mild increase (p=0.029),Variable effect (p=0.018),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06709,rs324788,10,82578771,TREM2,Insertion,-,-,0.83,0.5,1.22,0.07077704,Moderate,0.001,0.23,0.529,0.04,No significant pattern (p=0.017),Significant increase (p=0.033),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP06710,rs660345,10,39338856,SORL1,Deletion,-,-,1.4,1.04,1.79,0.01335064,Protective,0.062,0.156,0.426,0.157,Variable effect (p=0.017),Mild increase (p=0.025),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06711,rs551837,17,136147481,CR1,SNP (A/C),(A/,A,1.25,0.92,1.49,0.03513624,High,0.187,0.225,0.162,0.226,Mild increase (p=0.036),Significant increase (p=0.043),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06712,rs630433,17,106086127,APP,SNP (G/T),(G/,G,0.92,0.57,1.24,0.03458842,Unknown,0.21,0.168,0.075,0.346,Mild increase (p=0.018),Mild decrease (p=0.019),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06713,rs717916,2,236404713,APOE,Insertion,-,-,0.74,0.45,1.0,0.05692417,Moderate,0.236,0.457,0.04,0.067,Variable effect (p=0.035),Significant increase (p=0.018),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06714,rs416881,12,125522177,BIN1,SNP (A/C),(A/,A,0.51,0.26,0.86,0.01557,Moderate,0.128,0.05,0.156,0.466,Significant decrease (p=0.015),Significant decrease (p=0.019),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06715,rs603812,20,79092277,CD33,Insertion,-,-,0.96,0.58,1.32,0.03298035,Moderate,0.078,0.001,0.134,0.588,Variable effect (p=0.042),Significant increase (p=0.034),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06716,rs811906,4,18560484,CD33,SNP (A/T),(A/,A,1.3,0.95,1.57,0.10142659,Moderate,0.162,0.124,0.059,0.455,Significant increase (p=0.014),Mild decrease (p=0.04),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06717,rs189177,13,56480089,CR1,SNP (G/T),(G/,G,0.53,0.15,0.84,0.03323418,Moderate,0.064,0.349,0.278,0.109,Significant decrease (p=0.049),Variable effect (p=0.032),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06718,rs339527,14,182000431,MS4A6A,SNP (A/G),(A/,A,1.01,0.77,1.37,0.05163716,Low,0.296,0.106,0.288,0.11,Mild decrease (p=0.045),Significant decrease (p=0.014),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06719,rs393875,3,199630699,CR1,Deletion,-,-,1.44,1.14,1.75,0.0071798,Moderate,0.461,0.031,0.176,0.132,Mild decrease (p=0.036),Significant decrease (p=0.024),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06720,rs595589,18,125893746,EPHA1,Deletion,-,-,1.43,1.04,1.71,0.00664414,Low,0.041,0.032,0.295,0.432,Mild decrease (p=0.019),Significant increase (p=0.024),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06721,rs597805,9,170183853,PTK2B,SNP (C/T),(C/,C,1.09,0.69,1.47,0.05640279,Unknown,0.264,0.336,0.115,0.085,Mild increase (p=0.041),Significant increase (p=0.044),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06722,rs208256,17,131785013,ABCA7,SNP (A/C),(A/,A,0.87,0.57,1.27,0.00681976,Low,0.292,0.002,0.453,0.053,Mild increase (p=0.033),Mild decrease (p=0.01),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06723,rs349255,3,221918719,EPHA1,SNP (C/T),(C/,C,0.95,0.63,1.25,0.00488005,Moderate,0.004,0.498,0.063,0.234,No significant pattern (p=0.03),Significant decrease (p=0.029),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06724,rs782611,18,228638152,BIN1,Insertion,-,-,0.99,0.6,1.3,0.01863257,Moderate,0.24,0.184,0.287,0.089,Mild increase (p=0.021),Mild decrease (p=0.01),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06725,rs120619,15,111502319,CD2AP,SNP (C/T),(C/,C,1.98,1.67,2.28,0.0054644,High,0.016,0.038,0.611,0.135,Mild increase (p=0.029),Significant decrease (p=0.019),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06726,rs396440,17,134375641,PTK2B,Insertion,-,-,1.09,0.73,1.36,0.01952158,Protective,0.205,0.083,0.361,0.151,Significant decrease (p=0.046),Significant decrease (p=0.039),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06727,rs729614,19,45803220,APOE,Deletion,-,-,1.63,1.31,1.89,0.0014103,High,0.136,0.073,0.441,0.149,Mild increase (p=0.005),Significant increase (p=0.044),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06728,rs324324,15,177210667,CLU,Insertion,-,-,0.6,0.23,0.81,0.02633764,Low,0.522,0.001,0.146,0.132,Significant decrease (p=0.01),Significant decrease (p=0.028),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06729,rs628891,8,38487260,EPHA1,SNP (A/T),(A/,A,1.34,1.02,1.74,0.09391619,Moderate,0.222,0.191,0.372,0.015,Significant decrease (p=0.011),No significant pattern (p=0.01),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06730,rs535622,8,105713443,MS4A6A,SNP (C/T),(C/,C,3.65,3.26,3.94,0.01679706,Moderate,0.233,0.319,0.074,0.173,Mild decrease (p=0.021),Mild increase (p=0.021),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP06731,rs981276,12,217955572,APP,SNP (A/C),(A/,A,0.94,0.59,1.17,0.04070418,Low,0.009,0.324,0.403,0.065,Significant increase (p=0.023),Mild decrease (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06732,rs926927,19,31345380,SORL1,Insertion,-,-,0.96,0.75,1.31,0.02890281,High,0.257,0.302,0.043,0.198,Significant decrease (p=0.02),Variable effect (p=0.024),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06733,rs570329,22,121280563,APOE,Deletion,-,-,1.66,1.28,1.87,0.0303515,Low,0.006,0.01,0.498,0.286,Variable effect (p=0.007),Mild decrease (p=0.012),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP06734,rs331271,6,238746185,CD2AP,SNP (A/T),(A/,A,0.66,0.38,1.05,0.0070934,Moderate,0.224,0.243,0.083,0.251,Mild increase (p=0.023),Significant decrease (p=0.03),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06735,rs386655,20,50553269,TREM2,SNP (A/C),(A/,A,1.84,1.51,2.17,0.02345443,Low,0.113,0.527,0.058,0.101,Mild increase (p=0.041),Significant increase (p=0.001),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06736,rs368903,10,158388090,TREM2,Insertion,-,-,1.08,0.85,1.44,0.00762786,High,0.006,0.271,0.079,0.445,Mild increase (p=0.022),Significant increase (p=0.047),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06737,rs768354,15,186646224,CR1,SNP (C/T),(C/,C,1.56,1.2,1.76,0.03913339,Unknown,0.393,0.179,0.097,0.131,Mild decrease (p=0.039),Variable effect (p=0.045),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06738,rs791629,17,9334630,BIN1,SNP (A/C),(A/,A,2.19,1.86,2.52,0.0105614,Moderate,0.262,0.175,0.296,0.066,No significant pattern (p=0.024),No significant pattern (p=0.04),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06739,rs883470,22,181082135,APP,SNP (A/T),(A/,A,0.71,0.42,1.06,0.00463075,Moderate,0.011,0.484,0.163,0.142,Mild increase (p=0.007),No significant pattern (p=0.015),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06740,rs282473,3,45406407,MS4A6A,SNP (A/T),(A/,A,1.41,1.08,1.66,0.02176955,Low,0.552,0.039,0.181,0.027,Significant increase (p=0.003),Mild decrease (p=0.022),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06741,rs378042,5,161106497,CR1,SNP (A/T),(A/,A,0.73,0.35,1.08,0.00926134,Moderate,0.297,0.417,0.05,0.036,No significant pattern (p=0.004),Significant increase (p=0.029),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06742,rs558249,9,60281111,APOE,Deletion,-,-,0.75,0.42,1.1,0.02874444,High,0.032,0.376,0.185,0.207,Mild increase (p=0.012),Significant increase (p=0.043),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06743,rs482778,21,202864019,BIN1,Deletion,-,-,1.64,1.35,1.87,0.00673977,Moderate,0.017,0.241,0.275,0.266,Variable effect (p=0.015),Variable effect (p=0.041),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06744,rs225774,18,84600656,TREM2,Insertion,-,-,0.48,0.18,0.76,0.04895379,High,0.26,0.127,0.277,0.137,Significant increase (p=0.03),Variable effect (p=0.009),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06745,rs210116,13,218554074,CLU,SNP (C/G),(C/,C,1.32,1.09,1.7,0.00181185,Moderate,0.2,0.076,0.012,0.512,Mild decrease (p=0.047),Mild increase (p=0.038),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06746,rs600732,6,150004329,APOE,SNP (A/C),(A/,A,1.47,1.11,1.74,0.00462094,Low,0.57,0.06,0.123,0.047,Significant decrease (p=0.048),Mild decrease (p=0.037),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06747,rs879132,12,197304570,APOE,SNP (G/T),(G/,G,1.05,0.69,1.32,0.04726878,Unknown,0.576,0.17,0.039,0.015,Significant increase (p=0.018),No significant pattern (p=0.041),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06748,rs615043,16,214930000,EPHA1,SNP (A/T),(A/,A,0.58,0.23,0.95,0.04572027,Low,0.259,0.36,0.131,0.051,Mild decrease (p=0.039),Mild decrease (p=0.017),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06749,rs562563,5,248608752,ABCA7,SNP (C/G),(C/,C,1.11,0.83,1.49,0.00220913,High,0.465,0.21,0.047,0.078,Significant decrease (p=0.044),Significant decrease (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06750,rs924771,10,26491352,CD2AP,SNP (A/T),(A/,A,0.8,0.46,1.18,0.04348941,Moderate,0.079,0.187,0.134,0.4,Mild decrease (p=0.012),No significant pattern (p=0.023),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06751,rs326274,7,130260282,CR1,Insertion,-,-,0.77,0.54,1.05,0.00494472,Moderate,0.226,0.208,0.11,0.256,Mild decrease (p=0.012),No significant pattern (p=0.038),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06752,rs634555,15,229040124,PICALM,SNP (C/G),(C/,C,0.42,0.1,0.81,0.01845832,Low,0.246,0.217,0.303,0.035,Significant increase (p=0.044),Significant increase (p=0.008),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06753,rs199649,8,112111075,CR1,SNP (A/G),(A/,A,1.45,1.14,1.83,0.0330208,Moderate,0.218,0.048,0.198,0.336,Significant increase (p=0.048),Variable effect (p=0.008),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06754,rs641162,10,129664981,TREM2,SNP (A/C),(A/,A,0.69,0.31,0.93,0.01505301,High,0.146,0.038,0.284,0.332,Mild increase (p=0.036),Significant increase (p=0.031),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06755,rs503161,13,160542629,SORL1,SNP (G/T),(G/,G,0.86,0.49,1.24,0.02044501,Unknown,0.213,0.172,0.32,0.095,No significant pattern (p=0.021),Mild decrease (p=0.027),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06756,rs326157,12,41115968,CD2AP,SNP (G/T),(G/,G,0.6,0.34,0.89,0.00043078,Low,0.078,0.051,0.579,0.092,Significant decrease (p=0.047),Significant decrease (p=0.014),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06757,rs253021,10,68098477,PSEN2,SNP (A/G),(A/,A,1.02,0.75,1.34,0.09852881,Moderate,0.104,0.063,0.346,0.287,Significant increase (p=0.009),Variable effect (p=0.008),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06758,rs109535,13,131130332,APP,Insertion,-,-,0.85,0.49,1.16,0.02232536,Moderate,0.108,0.073,0.145,0.475,Mild increase (p=0.017),Variable effect (p=0.016),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP06759,rs644275,21,238253953,BIN1,Deletion,-,-,0.86,0.51,1.23,0.01719915,High,0.079,0.281,0.128,0.312,No significant pattern (p=0.006),Mild increase (p=0.031),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06760,rs939739,17,159656211,MS4A6A,Insertion,-,-,0.38,0.15,0.65,0.01124036,Moderate,0.302,0.239,0.003,0.256,Variable effect (p=0.037),Variable effect (p=0.046),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06761,rs121472,8,151191054,MS4A6A,SNP (C/T),(C/,C,1.47,1.26,1.8,0.01689401,Unknown,0.009,0.312,0.063,0.417,Variable effect (p=0.014),Significant increase (p=0.002),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06762,rs218520,19,216705065,BIN1,SNP (A/G),(A/,A,0.61,0.35,0.94,0.00483331,High,0.369,0.116,0.308,0.007,Mild increase (p=0.042),Mild increase (p=0.022),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06763,rs736568,13,160511591,CLU,SNP (G/T),(G/,G,1.29,0.95,1.53,0.08182257,High,0.423,0.043,0.226,0.108,Significant decrease (p=0.02),Mild decrease (p=0.029),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06764,rs599785,8,209680600,MS4A6A,SNP (A/T),(A/,A,0.55,0.35,0.84,0.04473156,High,0.033,0.26,0.441,0.066,No significant pattern (p=0.01),Mild increase (p=0.014),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06765,rs586188,5,78839476,APOE,Deletion,-,-,2.03,1.74,2.31,0.03425147,Moderate,0.028,0.262,0.267,0.242,Mild decrease (p=0.026),No significant pattern (p=0.003),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06766,rs264801,8,188807905,CLU,SNP (C/T),(C/,C,1.14,0.8,1.46,0.00904585,High,0.245,0.031,0.382,0.142,No significant pattern (p=0.02),Variable effect (p=0.025),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06767,rs707849,6,180199744,PTK2B,SNP (A/G),(A/,A,1.61,1.22,1.84,0.00365676,High,0.033,0.322,0.194,0.251,Significant increase (p=0.042),No significant pattern (p=0.036),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06768,rs194084,22,132325611,TREM2,Insertion,-,-,2.15,1.84,2.42,0.04498888,Low,0.1,0.355,0.127,0.219,Variable effect (p=0.004),Mild increase (p=0.008),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06769,rs154141,19,4732879,APP,SNP (A/T),(A/,A,1.59,1.22,1.86,0.00139484,High,0.425,0.045,0.085,0.245,Significant increase (p=0.035),Mild decrease (p=0.047),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06770,rs847438,1,192200044,EPHA1,Deletion,-,-,0.57,0.37,0.89,0.13327824,High,0.03,0.079,0.149,0.542,Significant decrease (p=0.021),Significant increase (p=0.002),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06771,rs941022,6,149253191,CD33,SNP (A/G),(A/,A,1.52,1.16,1.81,0.02806852,Moderate,0.201,0.12,0.291,0.187,Mild increase (p=0.005),Variable effect (p=0.002),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06772,rs499103,13,121999853,APP,SNP (G/T),(G/,G,1.81,1.52,2.18,0.00704295,Protective,0.023,0.279,0.487,0.011,Significant decrease (p=0.003),Mild decrease (p=0.038),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06773,rs807025,20,35221814,MS4A6A,Insertion,-,-,1.13,0.82,1.49,0.05352326,Moderate,0.113,0.002,0.344,0.342,No significant pattern (p=0.002),No significant pattern (p=0.005),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06774,rs527485,1,104180952,PTK2B,Insertion,-,-,1.72,1.43,2.06,0.00740837,Low,0.126,0.41,0.036,0.228,Significant increase (p=0.029),Mild increase (p=0.017),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06775,rs788002,3,175695240,CD2AP,SNP (C/T),(C/,C,0.74,0.49,0.98,0.00015383,Unknown,0.036,0.036,0.038,0.689,Mild increase (p=0.023),Significant decrease (p=0.015),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06776,rs481367,3,214804770,EPHA1,SNP (A/C),(A/,A,0.47,0.15,0.8,0.03871981,Protective,0.512,0.11,0.116,0.062,No significant pattern (p=0.015),Variable effect (p=0.025),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP06777,rs148397,16,193459842,CD2AP,SNP (A/G),(A/,A,1.02,0.76,1.4,0.07303141,Moderate,0.121,0.035,0.539,0.106,No significant pattern (p=0.037),Significant increase (p=0.026),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP06778,rs301123,13,247313477,ABCA7,SNP (G/T),(G/,G,2.91,2.55,3.19,0.03634063,Protective,0.038,0.431,0.219,0.111,Variable effect (p=0.025),Significant increase (p=0.008),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06779,rs926834,14,82741326,CLU,SNP (C/T),(C/,C,0.49,0.28,0.83,0.04021899,High,0.126,0.295,0.236,0.143,Significant decrease (p=0.032),No significant pattern (p=0.048),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06780,rs462168,8,162393511,APOE,SNP (A/T),(A/,A,1.16,0.77,1.49,0.01034723,Protective,0.02,0.232,0.526,0.022,Significant increase (p=0.045),Mild decrease (p=0.006),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06781,rs784308,5,6927321,APOE,SNP (G/T),(G/,G,0.35,0.1,0.66,0.01563078,Low,0.109,0.357,0.201,0.133,Mild decrease (p=0.028),Significant increase (p=0.033),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06782,rs566866,20,199926312,CR1,SNP (A/G),(A/,A,1.89,1.53,2.27,0.01130847,High,0.154,0.026,0.374,0.246,Mild increase (p=0.004),Mild decrease (p=0.043),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06783,rs538256,4,106858045,PSEN2,Insertion,-,-,1.06,0.7,1.34,0.00348668,Low,0.235,0.157,0.004,0.404,Mild increase (p=0.012),Significant increase (p=0.029),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06784,rs627533,17,3898949,APOE,SNP (G/T),(G/,G,0.73,0.47,1.02,0.01095713,Low,0.116,0.077,0.085,0.522,Mild increase (p=0.034),Variable effect (p=0.04),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP06785,rs980599,18,210061825,APP,Deletion,-,-,0.57,0.3,0.85,0.01732344,High,0.149,0.062,0.522,0.067,Significant increase (p=0.042),Significant decrease (p=0.032),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06786,rs499842,9,63848887,MS4A6A,SNP (C/G),(C/,C,0.93,0.56,1.19,0.01405152,High,0.075,0.236,0.263,0.226,No significant pattern (p=0.041),Mild decrease (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06787,rs679911,11,103159095,ABCA7,Insertion,-,-,0.81,0.49,1.03,0.00558311,Protective,0.138,0.34,0.268,0.053,Mild decrease (p=0.02),Significant decrease (p=0.009),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06788,rs187957,13,204330119,EPHA1,SNP (A/T),(A/,A,1.3,0.98,1.66,0.04258733,Low,0.124,0.64,0.022,0.014,No significant pattern (p=0.04),Variable effect (p=0.001),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06789,rs760965,16,102671187,APOE,SNP (G/T),(G/,G,1.02,0.7,1.3,0.01568315,Low,0.113,0.183,0.072,0.431,Mild increase (p=0.043),Mild increase (p=0.044),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06790,rs600551,19,30034168,EPHA1,Insertion,-,-,1.38,1.08,1.66,0.00135657,Moderate,0.151,0.004,0.427,0.219,Significant decrease (p=0.043),Significant increase (p=0.048),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06791,rs820260,3,143157793,MS4A6A,SNP (G/T),(G/,G,0.84,0.47,1.04,0.03659365,Protective,0.18,0.328,0.104,0.188,Significant decrease (p=0.007),Significant increase (p=0.018),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06792,rs737426,18,119980934,BIN1,SNP (C/T),(C/,C,0.64,0.4,0.88,0.0907203,Protective,0.058,0.43,0.11,0.202,Variable effect (p=0.022),Significant increase (p=0.032),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06793,rs554333,15,182845129,BIN1,SNP (A/C),(A/,A,0.84,0.51,1.24,0.01475174,Moderate,0.146,0.23,0.189,0.235,Variable effect (p=0.05),Significant increase (p=0.025),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06794,rs444947,21,214031292,CD33,Deletion,-,-,1.85,1.54,2.09,0.01911289,Low,0.342,0.33,0.096,0.032,No significant pattern (p=0.005),Significant decrease (p=0.012),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06795,rs375967,18,52771404,EPHA1,SNP (A/G),(A/,A,1.2,0.91,1.5,0.02996913,Protective,0.509,0.104,0.038,0.149,Mild decrease (p=0.005),Significant increase (p=0.013),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06796,rs624805,7,141880497,CD2AP,Insertion,-,-,1.42,1.03,1.8,0.04312208,Moderate,0.12,0.1,0.165,0.416,Significant decrease (p=0.031),Significant increase (p=0.012),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06797,rs245644,15,57586623,TREM2,SNP (C/T),(C/,C,2.74,2.41,3.07,0.03092303,High,0.071,0.455,0.129,0.145,Mild increase (p=0.045),Significant increase (p=0.039),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06798,rs529576,5,196589329,MS4A6A,Deletion,-,-,0.88,0.52,1.19,0.07619613,Moderate,0.422,0.157,0.117,0.104,Significant decrease (p=0.048),No significant pattern (p=0.006),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06799,rs846806,10,238251920,PICALM,SNP (A/T),(A/,A,1.06,0.73,1.41,0.20756176,High,0.172,0.249,0.101,0.277,No significant pattern (p=0.02),Significant decrease (p=0.006),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06800,rs232540,16,23595871,BIN1,SNP (C/T),(C/,C,1.12,0.81,1.33,0.02736525,Low,0.424,0.022,0.085,0.268,Variable effect (p=0.012),Significant increase (p=0.022),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06801,rs151776,10,229897298,CD33,SNP (G/T),(G/,G,1.64,1.25,1.91,0.01056724,Moderate,0.001,0.312,0.361,0.127,Mild decrease (p=0.039),Variable effect (p=0.047),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06802,rs423028,20,26076533,CLU,SNP (C/G),(C/,C,1.04,0.7,1.44,0.02854218,Moderate,0.28,0.086,0.313,0.122,Significant decrease (p=0.005),Mild decrease (p=0.041),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06803,rs533231,13,110147020,PICALM,SNP (A/T),(A/,A,0.53,0.2,0.9,0.00891006,Low,0.374,0.106,0.302,0.019,Variable effect (p=0.025),Mild decrease (p=0.044),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06804,rs929518,13,146597049,PICALM,SNP (C/T),(C/,C,2.15,1.76,2.42,0.0093487,High,0.186,0.259,0.315,0.039,No significant pattern (p=0.032),Significant increase (p=0.044),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06805,rs290550,10,116890352,CLU,Insertion,-,-,1.87,1.52,2.1,0.06188239,High,0.178,0.076,0.487,0.059,No significant pattern (p=0.014),No significant pattern (p=0.045),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06806,rs597880,11,21043187,SORL1,SNP (A/T),(A/,A,0.57,0.37,0.77,0.02229943,Moderate,0.135,0.039,0.451,0.175,Mild decrease (p=0.022),Significant increase (p=0.002),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06807,rs650000,13,172608872,APOE,SNP (C/T),(C/,C,1.21,0.9,1.46,0.08381931,Low,0.185,0.131,0.138,0.346,Significant decrease (p=0.048),Significant decrease (p=0.042),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP06808,rs310830,16,4444365,PTK2B,SNP (A/G),(A/,A,0.66,0.41,0.95,0.1259338,Moderate,0.007,0.191,0.096,0.506,Variable effect (p=0.026),No significant pattern (p=0.027),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06809,rs242104,7,209414365,CR1,SNP (A/T),(A/,A,0.58,0.26,0.87,0.05272913,Moderate,0.202,0.22,0.208,0.171,Mild increase (p=0.04),No significant pattern (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06810,rs846326,10,74139990,CD2AP,SNP (G/T),(G/,G,1.29,1.08,1.62,0.00821821,High,0.026,0.497,0.099,0.178,No significant pattern (p=0.045),No significant pattern (p=0.005),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP06811,rs366521,8,53232973,ABCA7,SNP (C/T),(C/,C,2.27,2.06,2.6,0.00149325,Low,0.154,0.285,0.296,0.066,Variable effect (p=0.029),Significant decrease (p=0.014),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06812,rs582507,6,57985002,MS4A6A,SNP (A/T),(A/,A,1.14,0.88,1.51,0.04951902,High,0.012,0.063,0.617,0.107,Mild increase (p=0.05),Mild decrease (p=0.029),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06813,rs527450,7,155501287,CLU,SNP (G/T),(G/,G,0.82,0.47,1.18,0.01093518,Moderate,0.403,0.056,0.255,0.087,Mild decrease (p=0.015),Significant increase (p=0.005),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06814,rs256986,18,116240690,EPHA1,SNP (A/C),(A/,A,1.11,0.89,1.48,0.0015824,Moderate,0.451,0.228,0.033,0.088,Significant decrease (p=0.016),Mild increase (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06815,rs573303,21,242057156,PICALM,SNP (A/T),(A/,A,1.37,1.05,1.76,0.03335333,High,0.098,0.081,0.262,0.359,Significant increase (p=0.03),Mild decrease (p=0.012),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06816,rs504826,4,114718377,PSEN2,Deletion,-,-,1.56,1.28,1.78,0.06966522,Moderate,0.258,0.424,0.075,0.043,Significant decrease (p=0.035),Variable effect (p=0.047),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06817,rs395464,10,103313181,APOE,SNP (A/G),(A/,A,0.9,0.5,1.11,0.02258939,High,0.059,0.549,0.152,0.04,Mild decrease (p=0.036),No significant pattern (p=0.031),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP06818,rs986046,16,21068008,CD33,SNP (A/G),(A/,A,1.25,0.93,1.47,0.0654589,High,0.1,0.41,0.063,0.227,No significant pattern (p=0.047),Mild decrease (p=0.029),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06819,rs715172,4,143153377,BIN1,SNP (A/G),(A/,A,0.79,0.47,1.07,0.11197332,Protective,0.251,0.057,0.475,0.017,Variable effect (p=0.001),Mild increase (p=0.043),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06820,rs771502,4,150581867,APP,SNP (C/T),(C/,C,0.59,0.21,0.97,0.00023182,Low,0.261,0.002,0.405,0.133,Significant increase (p=0.037),Mild decrease (p=0.033),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP06821,rs911390,7,223320135,PICALM,SNP (A/C),(A/,A,1.0,0.71,1.22,0.14353172,Low,0.417,0.009,0.284,0.09,Significant increase (p=0.047),Significant increase (p=0.022),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06822,rs698928,9,4830863,BIN1,SNP (C/T),(C/,C,1.05,0.81,1.25,0.00712381,High,0.02,0.085,0.638,0.057,Significant decrease (p=0.04),No significant pattern (p=0.009),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06823,rs660913,4,70406783,APP,Insertion,-,-,0.7,0.39,1.02,0.00439539,Moderate,0.313,0.14,0.303,0.045,No significant pattern (p=0.011),No significant pattern (p=0.036),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06824,rs170689,13,47545187,CD33,Deletion,-,-,1.54,1.17,1.91,0.06901741,High,0.472,0.164,0.054,0.11,Mild decrease (p=0.007),Significant increase (p=0.005),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06825,rs360192,8,222310043,PICALM,SNP (C/T),(C/,C,0.69,0.48,1.04,0.01909258,Moderate,0.096,0.138,0.229,0.337,Significant increase (p=0.044),Significant increase (p=0.022),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06826,rs891698,3,71747925,PICALM,SNP (A/G),(A/,A,0.56,0.17,0.89,0.02071097,Moderate,0.429,0.05,0.264,0.057,Mild decrease (p=0.011),Mild increase (p=0.035),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06827,rs668042,19,140712044,CD2AP,Insertion,-,-,1.16,0.82,1.53,0.12693342,Moderate,0.285,0.145,0.018,0.352,Significant increase (p=0.02),Significant decrease (p=0.016),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06828,rs392732,9,238100320,CD33,Insertion,-,-,1.43,1.21,1.77,0.0186926,Low,0.558,0.133,0.086,0.023,Significant increase (p=0.041),Mild decrease (p=0.029),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06829,rs942840,3,57589716,PICALM,SNP (A/G),(A/,A,0.47,0.14,0.84,0.15002469,Moderate,0.115,0.329,0.229,0.127,No significant pattern (p=0.016),Variable effect (p=0.036),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06830,rs582692,2,241144363,CD33,SNP (A/G),(A/,A,0.75,0.53,1.12,0.00994229,Low,0.016,0.266,0.012,0.505,Significant increase (p=0.034),Variable effect (p=0.028),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06831,rs834954,14,44089234,BIN1,SNP (A/T),(A/,A,0.99,0.65,1.26,0.06982989,Moderate,0.325,0.063,0.3,0.111,Variable effect (p=0.048),Mild increase (p=0.045),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06832,rs849122,16,55607863,MS4A6A,Insertion,-,-,0.3,0.1,0.62,0.01855742,Moderate,0.057,0.167,0.016,0.56,Mild decrease (p=0.037),Mild increase (p=0.043),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06833,rs270664,15,92377466,BIN1,SNP (A/C),(A/,A,0.56,0.19,0.93,0.01781931,Moderate,0.129,0.46,0.164,0.047,Variable effect (p=0.033),Mild increase (p=0.034),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06834,rs704602,19,235300274,ABCA7,SNP (A/T),(A/,A,0.66,0.34,0.92,0.08687838,Low,0.327,0.288,0.047,0.138,No significant pattern (p=0.022),Mild increase (p=0.041),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06835,rs874520,15,202641364,APOE,SNP (A/T),(A/,A,1.25,1.05,1.61,0.00416313,High,0.295,0.046,0.103,0.355,No significant pattern (p=0.013),No significant pattern (p=0.048),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06836,rs353280,19,3404990,PTK2B,SNP (C/T),(C/,C,1.16,0.78,1.52,0.00466889,Low,0.261,0.284,0.202,0.053,Mild increase (p=0.029),Significant increase (p=0.028),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06837,rs446213,13,218772655,EPHA1,SNP (G/T),(G/,G,0.57,0.22,0.83,0.03754041,Moderate,0.507,0.174,0.097,0.022,Significant increase (p=0.027),Mild decrease (p=0.031),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06838,rs879306,16,26559427,CD2AP,SNP (A/C),(A/,A,1.49,1.28,1.82,0.00190535,High,0.383,0.0,0.306,0.111,No significant pattern (p=0.005),Mild decrease (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP06839,rs144521,17,123718510,PICALM,SNP (A/C),(A/,A,0.84,0.52,1.16,0.05056331,High,0.053,0.266,0.396,0.086,Significant increase (p=0.006),Significant decrease (p=0.048),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06840,rs243367,15,187891756,EPHA1,SNP (A/T),(A/,A,0.66,0.44,0.99,0.01591368,Moderate,0.077,0.293,0.28,0.151,No significant pattern (p=0.011),Significant decrease (p=0.027),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06841,rs139696,2,131589328,ABCA7,SNP (C/G),(C/,C,1.41,1.19,1.61,0.0246749,Low,0.033,0.075,0.51,0.182,Variable effect (p=0.02),Significant decrease (p=0.044),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06842,rs577250,16,45846759,CR1,SNP (G/T),(G/,G,0.55,0.29,0.87,0.01895384,Low,0.105,0.134,0.216,0.346,Significant decrease (p=0.008),Significant decrease (p=0.016),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06843,rs202635,6,167898337,APOE,Deletion,-,-,0.4,0.17,0.62,0.09702898,Moderate,0.009,0.017,0.349,0.425,Variable effect (p=0.018),Variable effect (p=0.003),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06844,rs561630,12,175662683,SORL1,SNP (A/T),(A/,A,4.03,3.64,4.38,0.01574081,Unknown,0.479,0.006,0.072,0.243,Variable effect (p=0.04),Mild decrease (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06845,rs240868,13,178500817,EPHA1,Deletion,-,-,0.9,0.51,1.12,0.03127839,Moderate,0.253,0.123,0.147,0.277,Significant increase (p=0.043),Mild decrease (p=0.047),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP06846,rs722683,12,219246721,EPHA1,SNP (A/T),(A/,A,1.02,0.72,1.34,0.02657351,Low,0.451,0.179,0.024,0.146,No significant pattern (p=0.046),Variable effect (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP06847,rs119145,20,87482975,BIN1,SNP (C/G),(C/,C,1.08,0.78,1.41,0.04058685,High,0.213,0.269,0.158,0.16,Variable effect (p=0.021),Mild increase (p=0.026),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06848,rs302889,21,234808465,CLU,SNP (A/T),(A/,A,2.59,2.36,2.91,0.01828801,Moderate,0.112,0.522,0.023,0.143,Mild decrease (p=0.025),Mild increase (p=0.041),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP06849,rs158493,15,150742224,PTK2B,SNP (A/T),(A/,A,0.54,0.32,0.9,0.01620267,Protective,0.055,0.204,0.14,0.401,Variable effect (p=0.014),Mild increase (p=0.046),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06850,rs863012,1,246660692,SORL1,SNP (C/G),(C/,C,1.6,1.3,1.81,0.0340233,Protective,0.403,0.011,0.246,0.14,Significant decrease (p=0.022),Variable effect (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06851,rs888732,11,100196419,PICALM,Deletion,-,-,0.3,0.1,0.54,0.0052628,Low,0.441,0.015,0.197,0.147,Significant decrease (p=0.026),Mild increase (p=0.004),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06852,rs654540,5,118219831,ABCA7,SNP (A/T),(A/,A,0.69,0.35,1.02,0.04654223,Protective,0.225,0.347,0.078,0.15,Significant increase (p=0.04),No significant pattern (p=0.042),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06853,rs488288,22,204083388,ABCA7,SNP (A/C),(A/,A,1.6,1.29,1.91,0.0247555,Protective,0.045,0.304,0.278,0.174,Significant decrease (p=0.047),Mild increase (p=0.02),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06854,rs176978,6,233407847,PICALM,SNP (A/G),(A/,A,1.31,1.05,1.53,0.01536125,High,0.331,0.02,0.079,0.369,Significant increase (p=0.01),Significant increase (p=0.044),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06855,rs468726,8,248562212,PICALM,Deletion,-,-,0.43,0.11,0.74,0.04239827,High,0.156,0.325,0.13,0.189,Variable effect (p=0.041),Significant decrease (p=0.045),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06856,rs594175,22,212229783,CD33,SNP (A/G),(A/,A,2.79,2.46,3.14,0.01586484,Unknown,0.171,0.078,0.076,0.475,Significant increase (p=0.016),No significant pattern (p=0.032),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06857,rs550693,1,166324203,MS4A6A,SNP (G/T),(G/,G,0.32,0.12,0.72,0.020551,High,0.233,0.033,0.17,0.364,No significant pattern (p=0.042),Significant increase (p=0.03),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06858,rs410895,19,64581624,ABCA7,SNP (A/T),(A/,A,0.96,0.74,1.24,0.00818264,Moderate,0.063,0.064,0.485,0.189,Variable effect (p=0.043),Variable effect (p=0.023),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP06859,rs729328,11,126325288,MS4A6A,SNP (A/G),(A/,A,1.06,0.66,1.27,0.10189987,Low,0.322,0.113,0.316,0.049,No significant pattern (p=0.041),Significant decrease (p=0.038),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06860,rs466315,10,37229198,ABCA7,SNP (C/G),(C/,C,2.07,1.83,2.43,0.00971222,Moderate,0.04,0.438,0.001,0.321,Variable effect (p=0.035),Variable effect (p=0.046),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06861,rs239478,22,10331369,SORL1,SNP (A/T),(A/,A,1.4,1.18,1.65,0.00501783,Protective,0.011,0.213,0.418,0.158,No significant pattern (p=0.011),Significant decrease (p=0.032),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06862,rs474579,12,1333590,CD33,SNP (A/T),(A/,A,0.89,0.6,1.11,0.00668356,Moderate,0.008,0.291,0.352,0.149,Significant increase (p=0.009),Mild increase (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06863,rs402156,14,3503539,BIN1,SNP (C/G),(C/,C,0.73,0.42,0.95,0.00374066,Moderate,0.226,0.172,0.318,0.084,No significant pattern (p=0.004),Mild decrease (p=0.037),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06864,rs213991,13,11408132,TREM2,SNP (C/T),(C/,C,1.81,1.42,2.15,0.06944367,Low,0.203,0.106,0.382,0.109,Significant decrease (p=0.016),Significant decrease (p=0.043),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06865,rs951687,5,157508986,PTK2B,SNP (A/T),(A/,A,0.58,0.26,0.97,0.02270512,High,0.087,0.077,0.099,0.537,Mild increase (p=0.047),Significant increase (p=0.017),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06866,rs141356,7,55645560,SORL1,SNP (C/T),(C/,C,0.84,0.53,1.1,0.01619474,Moderate,0.373,0.11,0.255,0.062,No significant pattern (p=0.003),No significant pattern (p=0.047),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP06867,rs577076,18,40751900,PTK2B,SNP (C/T),(C/,C,1.54,1.17,1.78,0.00800914,Low,0.129,0.14,0.23,0.301,Mild increase (p=0.037),Mild increase (p=0.037),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06868,rs915479,1,22773496,CD2AP,SNP (C/G),(C/,C,0.51,0.23,0.82,0.02420825,Protective,0.166,0.266,0.366,0.002,Mild increase (p=0.015),Variable effect (p=0.002),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP06869,rs457753,15,131443172,CR1,SNP (C/T),(C/,C,0.82,0.61,1.07,0.00054155,Low,0.033,0.166,0.165,0.436,Significant decrease (p=0.045),Significant decrease (p=0.042),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06870,rs432004,8,47997659,PTK2B,SNP (G/T),(G/,G,1.51,1.2,1.76,0.02445255,High,0.141,0.281,0.097,0.281,Variable effect (p=0.032),Mild decrease (p=0.015),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06871,rs572787,20,63161335,EPHA1,Insertion,-,-,0.86,0.5,1.14,0.02646689,Protective,0.331,0.101,0.248,0.12,No significant pattern (p=0.023),Significant increase (p=0.02),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06872,rs199758,11,100819169,CD33,Deletion,-,-,1.52,1.28,1.9,0.06121463,Moderate,0.505,0.132,0.019,0.144,Mild increase (p=0.023),No significant pattern (p=0.002),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06873,rs344133,5,199828337,MS4A6A,SNP (A/C),(A/,A,1.01,0.68,1.31,0.02881234,Low,0.086,0.469,0.163,0.082,Significant decrease (p=0.036),Variable effect (p=0.015),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06874,rs768053,16,226070419,EPHA1,SNP (G/T),(G/,G,0.89,0.49,1.16,0.0090455,Unknown,0.335,0.106,0.114,0.245,Mild increase (p=0.05),Mild increase (p=0.022),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06875,rs839530,20,218222755,CLU,Deletion,-,-,1.27,0.88,1.61,0.01696905,Unknown,0.059,0.214,0.005,0.523,Mild increase (p=0.041),Mild decrease (p=0.016),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06876,rs111817,22,191772500,CD33,SNP (C/G),(C/,C,0.78,0.42,1.03,0.0006891,High,0.109,0.24,0.343,0.107,Variable effect (p=0.022),Significant increase (p=0.004),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06877,rs950467,12,247348748,PSEN2,SNP (A/G),(A/,A,0.71,0.31,1.1,0.03060458,Protective,0.096,0.201,0.007,0.496,Variable effect (p=0.023),Significant decrease (p=0.007),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP06878,rs418730,22,44742871,APOE,SNP (A/C),(A/,A,1.27,1.03,1.51,0.00103127,High,0.365,0.092,0.323,0.02,Mild increase (p=0.046),Mild decrease (p=0.023),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06879,rs645810,8,148194517,APOE,Insertion,-,-,2.17,1.8,2.52,0.00924291,Protective,0.17,0.377,0.079,0.174,Significant increase (p=0.043),Mild increase (p=0.032),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06880,rs206107,3,212029778,APOE,SNP (C/G),(C/,C,1.7,1.41,1.93,0.00856531,High,0.391,0.361,0.024,0.023,Significant increase (p=0.031),Mild increase (p=0.01),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP06881,rs609698,4,38176022,APP,SNP (A/C),(A/,A,1.24,0.94,1.48,0.01190664,Moderate,0.019,0.167,0.226,0.388,Mild increase (p=0.04),Significant increase (p=0.018),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP06882,rs295826,4,208951495,CR1,SNP (A/T),(A/,A,1.11,0.81,1.47,0.03708049,Protective,0.01,0.051,0.345,0.395,Significant increase (p=0.05),Significant decrease (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06883,rs667778,2,114586997,PTK2B,SNP (G/T),(G/,G,0.79,0.45,1.05,0.01950926,High,0.436,0.218,0.035,0.11,No significant pattern (p=0.046),Mild decrease (p=0.025),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06884,rs427763,14,56126569,CR1,SNP (C/T),(C/,C,0.57,0.27,0.81,0.03823391,Moderate,0.094,0.051,0.15,0.504,Mild increase (p=0.031),No significant pattern (p=0.019),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06885,rs302256,21,194604805,ABCA7,SNP (C/G),(C/,C,0.91,0.63,1.14,0.00769209,High,0.355,0.16,0.181,0.104,Mild increase (p=0.017),Significant decrease (p=0.01),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP06886,rs852005,4,167794890,BIN1,SNP (A/G),(A/,A,0.67,0.31,0.87,0.09759865,High,0.063,0.529,0.155,0.053,Mild increase (p=0.009),Significant increase (p=0.003),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06887,rs190034,15,84168911,CR1,Insertion,-,-,1.28,1.01,1.65,0.00608786,Protective,0.251,0.099,0.377,0.072,Mild decrease (p=0.009),Significant increase (p=0.028),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP06888,rs767284,1,12732446,SORL1,Insertion,-,-,0.43,0.1,0.7,0.0783831,Moderate,0.256,0.168,0.284,0.092,Significant increase (p=0.01),Significant increase (p=0.002),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06889,rs962038,14,126871286,PTK2B,SNP (A/C),(A/,A,0.57,0.2,0.82,0.02699146,Protective,0.069,0.169,0.305,0.257,Variable effect (p=0.041),Mild increase (p=0.047),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP06890,rs100036,1,103896865,CR1,SNP (A/G),(A/,A,1.38,1.14,1.59,0.00731515,High,0.113,0.058,0.363,0.267,Mild increase (p=0.018),Mild decrease (p=0.004),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06891,rs644958,7,248396034,CD33,SNP (G/T),(G/,G,1.99,1.69,2.25,0.02254332,Moderate,0.167,0.53,0.081,0.022,Mild increase (p=0.027),No significant pattern (p=0.04),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06892,rs437088,14,232593323,BIN1,SNP (A/C),(A/,A,1.4,1.18,1.79,0.04830707,High,0.443,0.061,0.143,0.153,Variable effect (p=0.031),Significant increase (p=0.015),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP06893,rs439712,12,83213254,APP,SNP (C/T),(C/,C,1.26,0.86,1.49,0.00038233,Low,0.05,0.495,0.035,0.22,Mild increase (p=0.001),No significant pattern (p=0.041),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06894,rs521607,6,15499432,PICALM,Insertion,-,-,1.05,0.7,1.42,0.0766561,Low,0.16,0.316,0.26,0.065,Significant increase (p=0.031),No significant pattern (p=0.009),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06895,rs109004,16,206823499,PICALM,SNP (A/C),(A/,A,0.79,0.49,1.04,0.00972798,Protective,0.04,0.205,0.431,0.124,Significant decrease (p=0.048),No significant pattern (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06896,rs945980,3,39555964,CR1,SNP (C/T),(C/,C,1.7,1.37,2.07,0.01188804,Low,0.142,0.312,0.27,0.076,Mild increase (p=0.044),Mild decrease (p=0.002),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06897,rs376823,8,118471653,EPHA1,Insertion,-,-,1.05,0.67,1.41,0.01119233,High,0.167,0.105,0.023,0.505,Significant increase (p=0.039),No significant pattern (p=0.028),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06898,rs771631,1,160353744,PTK2B,SNP (A/T),(A/,A,1.71,1.45,2.03,0.01830806,Moderate,0.173,0.129,0.29,0.208,Mild increase (p=0.043),No significant pattern (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP06899,rs270814,10,98901188,MS4A6A,SNP (A/T),(A/,A,0.86,0.55,1.1,0.01819509,Moderate,0.169,0.281,0.319,0.031,Mild increase (p=0.02),Significant decrease (p=0.031),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06900,rs332099,7,110403672,ABCA7,Deletion,-,-,0.85,0.55,1.18,0.04763241,High,0.324,0.106,0.331,0.038,Significant decrease (p=0.022),Mild decrease (p=0.033),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06901,rs895162,10,179897195,EPHA1,SNP (C/G),(C/,C,1.18,0.83,1.49,0.03681832,Low,0.064,0.185,0.289,0.262,Mild increase (p=0.041),No significant pattern (p=0.027),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06902,rs399539,21,118669632,TREM2,Insertion,-,-,0.54,0.15,0.8,0.01476023,Low,0.268,0.24,0.087,0.205,Variable effect (p=0.025),Significant increase (p=0.039),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP06903,rs962024,19,200975324,ABCA7,SNP (A/T),(A/,A,1.58,1.28,1.82,0.02276675,High,0.097,0.05,0.417,0.236,Mild decrease (p=0.015),Mild decrease (p=0.039),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06904,rs407822,14,124770532,SORL1,SNP (C/G),(C/,C,0.82,0.57,1.1,0.05034572,Moderate,0.073,0.157,0.541,0.028,No significant pattern (p=0.003),Mild decrease (p=0.014),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06905,rs332259,8,63760257,PICALM,SNP (C/T),(C/,C,0.69,0.4,1.03,0.00808046,Low,0.266,0.071,0.126,0.337,Significant increase (p=0.015),Variable effect (p=0.031),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06906,rs989998,9,152368850,MS4A6A,Deletion,-,-,2.82,2.47,3.21,0.00828273,High,0.372,0.061,0.044,0.323,Significant decrease (p=0.026),No significant pattern (p=0.03),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP06907,rs512975,15,29156800,APOE,Insertion,-,-,0.19,0.1,0.44,0.0029411,Protective,0.09,0.158,0.456,0.095,Mild decrease (p=0.039),No significant pattern (p=0.019),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06908,rs635478,8,28000299,CD33,Deletion,-,-,1.21,0.94,1.59,0.1083106,Low,0.322,0.014,0.065,0.399,Mild increase (p=0.021),Mild increase (p=0.029),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06909,rs616212,7,106856577,CD2AP,SNP (A/G),(A/,A,0.82,0.52,1.21,0.00238117,Protective,0.127,0.252,0.146,0.275,Mild increase (p=0.024),No significant pattern (p=0.045),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06910,rs945518,1,130629952,TREM2,SNP (C/T),(C/,C,0.76,0.52,1.0,0.02636109,Protective,0.06,0.195,0.391,0.153,No significant pattern (p=0.019),Variable effect (p=0.021),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06911,rs375759,16,239642132,PICALM,Deletion,-,-,0.96,0.63,1.34,0.04084379,Protective,0.299,0.005,0.42,0.076,Variable effect (p=0.049),Mild increase (p=0.031),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP06912,rs573735,19,136435656,ABCA7,Insertion,-,-,1.54,1.27,1.93,0.00171711,Low,0.441,0.109,0.029,0.221,Significant increase (p=0.002),No significant pattern (p=0.042),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06913,rs987318,7,110507825,PSEN2,SNP (A/G),(A/,A,0.77,0.53,0.98,0.04884365,Moderate,0.084,0.34,0.144,0.232,Mild decrease (p=0.042),Variable effect (p=0.041),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06914,rs226748,18,172106117,CD2AP,SNP (A/T),(A/,A,0.39,0.1,0.76,0.0466983,High,0.544,0.021,0.076,0.159,Mild increase (p=0.01),Mild increase (p=0.036),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06915,rs689962,15,72690748,TREM2,SNP (A/G),(A/,A,0.5,0.17,0.81,0.01709417,Low,0.121,0.007,0.145,0.528,Significant decrease (p=0.026),Significant increase (p=0.041),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06916,rs840552,18,30276858,PTK2B,SNP (C/G),(C/,C,0.41,0.17,0.67,0.01882143,Low,0.224,0.133,0.01,0.433,Significant increase (p=0.038),Significant increase (p=0.047),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP06917,rs575145,17,229631404,EPHA1,Deletion,-,-,0.85,0.62,1.13,0.04400049,Moderate,0.017,0.047,0.075,0.661,No significant pattern (p=0.002),Significant decrease (p=0.049),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06918,rs609646,6,245779621,TREM2,Deletion,-,-,0.39,0.1,0.69,0.02068431,Low,0.478,0.197,0.01,0.115,No significant pattern (p=0.008),Variable effect (p=0.014),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP06919,rs480919,20,122361040,PSEN2,SNP (G/T),(G/,G,0.88,0.67,1.08,0.0339843,High,0.421,0.032,0.317,0.03,Mild decrease (p=0.027),Significant decrease (p=0.042),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP06920,rs333612,4,218561360,EPHA1,SNP (C/G),(C/,C,1.17,0.94,1.44,0.03320548,Moderate,0.712,0.0,0.07,0.018,No significant pattern (p=0.034),Significant increase (p=0.023),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP06921,rs430062,9,202926389,PTK2B,SNP (A/G),(A/,A,1.69,1.35,1.92,0.01923884,Unknown,0.069,0.238,0.099,0.394,No significant pattern (p=0.005),Variable effect (p=0.019),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06922,rs729276,2,84814120,APOE,Insertion,-,-,0.58,0.28,0.94,0.00241947,Moderate,0.094,0.248,0.372,0.086,Significant decrease (p=0.023),Significant increase (p=0.004),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06923,rs791197,9,44508034,TREM2,SNP (A/T),(A/,A,1.34,1.06,1.66,0.01468448,Low,0.563,0.07,0.089,0.078,Mild increase (p=0.007),Mild decrease (p=0.014),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06924,rs628142,3,220048314,SORL1,Deletion,-,-,0.28,0.1,0.55,0.01373863,Protective,0.022,0.137,0.297,0.345,Significant decrease (p=0.042),Variable effect (p=0.007),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06925,rs496878,13,97301219,SORL1,SNP (C/T),(C/,C,1.22,0.87,1.59,0.01074058,Low,0.203,0.14,0.139,0.318,Mild decrease (p=0.036),Significant decrease (p=0.036),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06926,rs669628,14,96313234,PSEN2,SNP (G/T),(G/,G,1.49,1.2,1.88,0.01259916,Low,0.003,0.49,0.239,0.067,Variable effect (p=0.013),Variable effect (p=0.001),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06927,rs414604,11,123307180,ABCA7,Deletion,-,-,2.24,1.9,2.59,0.05033926,Low,0.209,0.213,0.072,0.306,Mild increase (p=0.012),Mild increase (p=0.029),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06928,rs123567,5,70769625,CLU,SNP (C/G),(C/,C,0.93,0.53,1.19,0.01137318,Moderate,0.241,0.367,0.065,0.128,Variable effect (p=0.017),Significant increase (p=0.041),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06929,rs391549,7,60902620,APOE,SNP (A/G),(A/,A,2.03,1.69,2.33,0.02757022,Low,0.226,0.177,0.063,0.334,Mild increase (p=0.047),Significant decrease (p=0.026),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06930,rs209114,8,33246758,CR1,SNP (A/C),(A/,A,0.52,0.28,0.91,0.00030499,Unknown,0.556,0.028,0.114,0.101,Mild decrease (p=0.04),Mild increase (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06931,rs203753,1,70799963,CR1,SNP (G/T),(G/,G,1.12,0.78,1.42,0.0561707,Moderate,0.198,0.339,0.081,0.182,Significant decrease (p=0.015),No significant pattern (p=0.024),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06932,rs394052,11,6677272,CR1,SNP (A/C),(A/,A,2.27,1.96,2.63,0.05375187,High,0.001,0.175,0.599,0.025,Significant increase (p=0.024),No significant pattern (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06933,rs161447,11,247082078,TREM2,SNP (A/C),(A/,A,1.01,0.77,1.32,0.00206911,High,0.484,0.25,0.015,0.052,No significant pattern (p=0.014),Significant increase (p=0.012),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06934,rs272005,15,191994090,EPHA1,Deletion,-,-,0.63,0.39,0.85,0.00024579,Moderate,0.23,0.014,0.347,0.208,Variable effect (p=0.032),Mild decrease (p=0.021),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06935,rs989460,14,9554885,CD33,SNP (G/T),(G/,G,0.77,0.49,1.03,0.05356554,Low,0.169,0.32,0.121,0.19,Mild decrease (p=0.011),Significant increase (p=0.007),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06936,rs656761,22,160734307,APP,SNP (G/T),(G/,G,0.43,0.15,0.73,0.00093137,High,0.001,0.293,0.257,0.25,Significant increase (p=0.029),No significant pattern (p=0.032),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP06937,rs685321,12,201199056,TREM2,SNP (A/C),(A/,A,0.93,0.7,1.17,0.00217087,Moderate,0.15,0.159,0.354,0.136,Mild increase (p=0.034),Significant increase (p=0.019),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP06938,rs111513,4,90143093,APOE,Insertion,-,-,1.62,1.38,1.97,0.0257968,Protective,0.216,0.025,0.118,0.441,No significant pattern (p=0.047),Significant increase (p=0.009),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06939,rs552706,13,247458391,EPHA1,SNP (A/T),(A/,A,1.21,0.9,1.48,0.00929179,Moderate,0.068,0.251,0.005,0.476,Mild decrease (p=0.032),Significant decrease (p=0.022),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP06940,rs928458,4,21538347,TREM2,SNP (C/T),(C/,C,0.83,0.6,1.06,0.00093904,Moderate,0.463,0.082,0.123,0.132,Mild increase (p=0.041),Variable effect (p=0.046),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06941,rs831862,6,196639316,TREM2,Deletion,-,-,0.39,0.1,0.69,0.00777629,Moderate,0.257,0.433,0.009,0.101,Significant decrease (p=0.03),No significant pattern (p=0.024),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06942,rs388366,2,215408580,BIN1,SNP (A/G),(A/,A,0.83,0.59,1.1,0.00402025,Moderate,0.027,0.078,0.407,0.288,Mild decrease (p=0.02),No significant pattern (p=0.028),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06943,rs526463,17,109777978,APP,SNP (A/G),(A/,A,0.58,0.25,0.85,0.01197962,Low,0.343,0.03,0.065,0.362,Mild decrease (p=0.043),Significant decrease (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06944,rs384916,21,82591247,APOE,SNP (A/T),(A/,A,1.21,0.92,1.54,0.01711728,Protective,0.161,0.23,0.008,0.401,Significant increase (p=0.02),Mild decrease (p=0.036),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP06945,rs986604,18,154809022,SORL1,SNP (C/G),(C/,C,1.36,1.13,1.71,0.00373245,High,0.409,0.257,0.054,0.079,Mild decrease (p=0.032),No significant pattern (p=0.038),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06946,rs100014,2,84261835,CR1,SNP (A/C),(A/,A,1.28,1.02,1.55,0.01372055,Low,0.246,0.063,0.282,0.209,Mild increase (p=0.02),Significant increase (p=0.026),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06947,rs277094,11,187040089,SORL1,Insertion,-,-,2.18,1.88,2.56,0.0766402,Moderate,0.12,0.221,0.339,0.12,Variable effect (p=0.019),Mild decrease (p=0.02),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP06948,rs130499,5,73631148,CD2AP,Insertion,-,-,1.0,0.67,1.27,0.05158087,Moderate,0.193,0.332,0.268,0.007,Mild increase (p=0.037),Mild decrease (p=0.017),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP06949,rs459769,7,179366398,APP,SNP (A/G),(A/,A,0.77,0.55,1.09,5.466e-05,Moderate,0.086,0.208,0.455,0.052,Mild increase (p=0.013),Significant decrease (p=0.04),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP06950,rs719800,11,181509458,APOE,Deletion,-,-,0.71,0.35,1.1,0.13915714,High,0.042,0.099,0.374,0.285,No significant pattern (p=0.014),Mild decrease (p=0.011),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06951,rs868750,13,161940242,CR1,Deletion,-,-,1.73,1.4,2.12,0.04032623,Moderate,0.104,0.317,0.334,0.045,Significant increase (p=0.023),Mild increase (p=0.003),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06952,rs673775,15,231121688,CLU,SNP (A/C),(A/,A,0.47,0.17,0.81,0.00915222,Unknown,0.032,0.151,0.563,0.054,Mild decrease (p=0.028),Mild increase (p=0.05),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP06953,rs858719,1,54058715,CLU,SNP (A/T),(A/,A,2.23,1.9,2.6,0.048359,Low,0.332,0.02,0.149,0.299,Variable effect (p=0.006),Significant increase (p=0.018),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06954,rs337012,9,6941578,ABCA7,SNP (A/T),(A/,A,1.97,1.66,2.22,0.00604053,High,0.409,0.172,0.146,0.073,Significant increase (p=0.034),Variable effect (p=0.046),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06955,rs873684,22,238666093,CLU,SNP (A/C),(A/,A,0.41,0.12,0.79,0.02894001,High,0.07,0.048,0.312,0.371,Significant increase (p=0.021),Significant increase (p=0.033),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06956,rs558606,18,197981150,EPHA1,Insertion,-,-,0.6,0.36,0.89,0.01706033,Low,0.074,0.24,0.344,0.141,No significant pattern (p=0.007),No significant pattern (p=0.019),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06957,rs730803,12,135013656,EPHA1,SNP (A/C),(A/,A,0.74,0.52,1.04,0.00761449,High,0.054,0.229,0.208,0.308,Significant decrease (p=0.041),Significant increase (p=0.005),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06958,rs276776,20,196448118,SORL1,SNP (G/T),(G/,G,1.0,0.76,1.26,0.03275132,Unknown,0.059,0.301,0.265,0.175,Mild decrease (p=0.038),No significant pattern (p=0.04),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06959,rs543563,20,35387172,MS4A6A,SNP (A/T),(A/,A,1.2,0.85,1.6,0.04960858,Moderate,0.148,0.513,0.133,0.006,Mild increase (p=0.028),No significant pattern (p=0.047),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06960,rs508425,18,1154190,CR1,SNP (A/T),(A/,A,2.47,2.09,2.76,0.01661029,Moderate,0.508,0.018,0.263,0.012,Mild increase (p=0.008),Mild increase (p=0.03),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06961,rs560074,2,88199064,APP,SNP (A/T),(A/,A,3.29,2.93,3.66,0.00585557,Moderate,0.008,0.482,0.052,0.257,Mild decrease (p=0.043),Mild decrease (p=0.014),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP06962,rs824134,15,58982686,ABCA7,SNP (A/G),(A/,A,2.08,1.81,2.45,0.03626543,Moderate,0.076,0.115,0.212,0.398,No significant pattern (p=0.048),Mild decrease (p=0.038),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP06963,rs955710,7,195915648,SORL1,SNP (C/T),(C/,C,0.73,0.39,0.93,0.00918522,Low,0.639,0.014,0.049,0.098,Significant increase (p=0.049),No significant pattern (p=0.016),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06964,rs418595,2,196101999,EPHA1,SNP (C/G),(C/,C,1.32,1.08,1.52,0.00559587,Protective,0.011,0.355,0.177,0.257,No significant pattern (p=0.03),Mild decrease (p=0.025),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP06965,rs815955,10,86310186,APP,SNP (A/C),(A/,A,0.76,0.36,1.14,0.01095939,Moderate,0.029,0.224,0.061,0.486,Variable effect (p=0.027),Mild increase (p=0.035),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP06966,rs884026,11,148657163,CD33,SNP (C/T),(C/,C,1.12,0.77,1.39,0.00956609,Low,0.182,0.052,0.146,0.421,Significant increase (p=0.034),Variable effect (p=0.047),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP06967,rs285402,13,194094831,CD2AP,Deletion,-,-,0.95,0.7,1.33,0.05681698,Low,0.224,0.112,0.252,0.212,Significant increase (p=0.015),Mild decrease (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06968,rs672267,18,244077772,EPHA1,SNP (A/C),(A/,A,1.01,0.75,1.23,0.01503336,Moderate,0.408,0.187,0.078,0.127,Mild decrease (p=0.05),Variable effect (p=0.037),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP06969,rs469212,1,146852882,CR1,SNP (C/T),(C/,C,0.38,0.1,0.64,0.04186582,High,0.377,0.112,0.143,0.168,No significant pattern (p=0.03),Mild decrease (p=0.037),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06970,rs153901,21,3249160,CR1,SNP (C/G),(C/,C,0.82,0.62,1.15,0.07570869,Low,0.106,0.047,0.412,0.235,No significant pattern (p=0.045),Significant decrease (p=0.042),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06971,rs696697,1,246399008,CLU,Deletion,-,-,0.68,0.34,0.98,0.02801855,Moderate,0.093,0.636,0.06,0.011,Mild decrease (p=0.046),Mild increase (p=0.022),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06972,rs179480,8,192167387,ABCA7,SNP (C/T),(C/,C,2.18,1.8,2.48,0.0096078,Moderate,0.097,0.026,0.112,0.565,Mild decrease (p=0.024),Mild increase (p=0.011),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP06973,rs972535,4,178167848,APP,Deletion,-,-,0.81,0.52,1.08,0.00659692,Low,0.017,0.296,0.387,0.1,Significant increase (p=0.04),No significant pattern (p=0.049),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP06974,rs795364,15,74299549,CR1,SNP (C/G),(C/,C,1.46,1.25,1.8,0.01848148,High,0.143,0.1,0.009,0.548,Significant decrease (p=0.045),Mild increase (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP06975,rs850408,1,191431969,TREM2,Insertion,-,-,1.22,0.92,1.47,0.00964443,Moderate,0.024,0.097,0.602,0.077,Mild increase (p=0.049),Significant decrease (p=0.017),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06976,rs291301,8,205628420,APOE,Insertion,-,-,0.53,0.28,0.79,0.01977256,Protective,0.136,0.299,0.035,0.331,Significant increase (p=0.025),No significant pattern (p=0.049),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06977,rs498453,6,219132482,PTK2B,SNP (A/C),(A/,A,0.92,0.54,1.18,0.03958439,Protective,0.224,0.062,0.065,0.449,Significant decrease (p=0.032),Significant decrease (p=0.02),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP06978,rs911636,19,91242407,CD2AP,SNP (G/T),(G/,G,1.64,1.34,1.88,0.04043229,Moderate,0.745,0.011,0.033,0.011,No significant pattern (p=0.046),Significant decrease (p=0.047),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP06979,rs403959,5,216814656,BIN1,SNP (C/G),(C/,C,3.09,2.73,3.46,0.09713431,Moderate,0.09,0.181,0.417,0.112,Significant increase (p=0.015),Significant decrease (p=0.02),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP06980,rs437101,20,41620500,PICALM,Insertion,-,-,1.08,0.83,1.39,0.00526154,High,0.015,0.391,0.17,0.225,No significant pattern (p=0.017),Significant decrease (p=0.003),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP06981,rs928736,3,88608472,CD2AP,SNP (A/G),(A/,A,0.59,0.22,0.84,0.00253966,High,0.137,0.556,0.061,0.046,No significant pattern (p=0.042),Variable effect (p=0.048),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP06982,rs126825,15,7324470,MS4A6A,Deletion,-,-,1.2,0.97,1.5,0.00942918,Moderate,0.005,0.316,0.087,0.392,Significant increase (p=0.027),Mild decrease (p=0.049),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP06983,rs591017,19,152489985,CD2AP,SNP (A/C),(A/,A,0.7,0.33,0.99,0.0232007,Moderate,0.075,0.269,0.315,0.141,Mild decrease (p=0.014),Significant decrease (p=0.025),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06984,rs640798,22,13405830,BIN1,SNP (C/T),(C/,C,0.84,0.58,1.18,0.00589335,High,0.013,0.04,0.327,0.419,No significant pattern (p=0.049),Variable effect (p=0.031),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP06985,rs812579,4,152271254,SORL1,Insertion,-,-,0.5,0.3,0.87,0.03544761,Low,0.291,0.007,0.393,0.109,Variable effect (p=0.038),Significant increase (p=0.029),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06986,rs895530,11,230319390,MS4A6A,SNP (C/T),(C/,C,1.36,1.06,1.67,0.03964907,Low,0.099,0.517,0.179,0.006,Significant increase (p=0.049),No significant pattern (p=0.024),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP06987,rs629496,18,33984488,BIN1,Deletion,-,-,1.23,0.91,1.5,0.00997641,Moderate,0.019,0.257,0.293,0.23,Mild increase (p=0.009),Significant increase (p=0.039),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP06988,rs586124,17,36079309,CD33,SNP (A/G),(A/,A,0.83,0.56,1.06,0.07740318,Protective,0.001,0.501,0.29,0.008,Significant increase (p=0.041),Mild increase (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP06989,rs564334,14,136071267,MS4A6A,SNP (C/T),(C/,C,2.57,2.3,2.96,0.0009553,High,0.032,0.546,0.031,0.19,Significant increase (p=0.012),Mild increase (p=0.047),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP06990,rs527322,22,240608100,PICALM,SNP (G/T),(G/,G,1.23,1.03,1.46,0.00353644,Protective,0.272,0.401,0.077,0.051,No significant pattern (p=0.025),Significant decrease (p=0.042),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP06991,rs396884,12,66883110,PTK2B,SNP (G/T),(G/,G,0.54,0.22,0.78,0.018908,Moderate,0.183,0.235,0.121,0.261,Mild increase (p=0.021),Mild increase (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP06992,rs873151,13,234621543,PSEN2,SNP (A/G),(A/,A,1.16,0.79,1.43,0.06247139,Moderate,0.16,0.161,0.258,0.221,Mild increase (p=0.038),Mild decrease (p=0.041),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP06993,rs612606,13,143459986,EPHA1,Insertion,-,-,0.49,0.14,0.76,0.02421722,High,0.343,0.331,0.1,0.026,Significant increase (p=0.048),Mild decrease (p=0.046),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP06994,rs389533,10,242463790,PSEN2,SNP (G/T),(G/,G,1.6,1.27,1.94,0.02190271,High,0.059,0.235,0.498,0.008,Mild decrease (p=0.041),Significant increase (p=0.043),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP06995,rs233471,3,200148884,CD2AP,SNP (G/T),(G/,G,3.31,3.08,3.67,0.02100932,High,0.198,0.154,0.363,0.085,Significant decrease (p=0.042),Mild decrease (p=0.013),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP06996,rs236991,2,13091648,PSEN2,Deletion,-,-,0.3,0.1,0.52,0.01342781,Moderate,0.062,0.296,0.33,0.112,Variable effect (p=0.025),Significant increase (p=0.046),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06997,rs785913,21,8591358,CD2AP,Insertion,-,-,2.01,1.71,2.23,0.03674549,Unknown,0.446,0.041,0.166,0.147,Mild decrease (p=0.025),Mild decrease (p=0.007),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06998,rs920758,12,37211843,APOE,SNP (C/G),(C/,C,1.48,1.11,1.83,0.04940894,Moderate,0.351,0.26,0.001,0.188,No significant pattern (p=0.043),Significant increase (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP06999,rs749450,20,95821378,CD33,Insertion,-,-,1.57,1.19,1.83,0.07097983,Low,0.054,0.358,0.25,0.138,Variable effect (p=0.039),Significant decrease (p=0.015),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07000,rs327616,2,99784451,APOE,SNP (C/T),(C/,C,0.57,0.19,0.83,0.04269233,Moderate,0.191,0.274,0.043,0.292,Mild increase (p=0.006),Mild decrease (p=0.035),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07001,rs733308,7,247694904,APP,SNP (C/G),(C/,C,0.69,0.44,1.04,0.06960958,High,0.336,0.135,0.328,0.001,Significant increase (p=0.007),Significant decrease (p=0.028),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07002,rs168051,18,139412184,PSEN2,SNP (G/T),(G/,G,1.04,0.82,1.37,0.01805079,High,0.12,0.512,0.009,0.159,Mild increase (p=0.001),Mild decrease (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07003,rs769940,20,132349869,PTK2B,SNP (A/G),(A/,A,0.84,0.49,1.05,0.00677427,Low,0.105,0.094,0.358,0.244,Significant increase (p=0.028),Significant increase (p=0.024),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07004,rs544280,8,6827984,SORL1,SNP (A/C),(A/,A,1.05,0.7,1.31,0.04070651,High,0.246,0.123,0.416,0.015,Mild increase (p=0.008),Mild increase (p=0.037),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07005,rs474426,4,178950366,PTK2B,SNP (C/T),(C/,C,0.82,0.48,1.03,3.989e-05,Low,0.412,0.035,0.202,0.151,Mild decrease (p=0.017),Significant decrease (p=0.006),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07006,rs719317,5,155381459,APOE,Deletion,-,-,0.45,0.1,0.79,0.11965592,High,0.33,0.209,0.252,0.01,Significant increase (p=0.023),Significant increase (p=0.004),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07007,rs140410,16,82382746,CD33,SNP (G/T),(G/,G,1.41,1.1,1.81,0.06483267,Moderate,0.451,0.026,0.125,0.199,No significant pattern (p=0.047),Variable effect (p=0.009),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07008,rs792414,4,238763953,APOE,Insertion,-,-,1.31,0.92,1.68,0.09833249,Moderate,0.463,0.079,0.106,0.153,Mild decrease (p=0.021),Mild increase (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07009,rs304836,1,11300895,PSEN2,SNP (G/T),(G/,G,1.03,0.78,1.25,0.05417109,Moderate,0.394,0.307,0.011,0.088,Mild decrease (p=0.014),Mild decrease (p=0.027),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07010,rs955768,18,72098754,TREM2,SNP (A/C),(A/,A,2.03,1.7,2.4,0.01685202,Moderate,0.086,0.127,0.255,0.332,Significant increase (p=0.02),Significant increase (p=0.043),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07011,rs308983,14,102240097,CD33,SNP (A/G),(A/,A,1.08,0.84,1.32,0.00664108,Unknown,0.161,0.207,0.181,0.252,Mild increase (p=0.018),Variable effect (p=0.047),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07012,rs556737,22,220842816,SORL1,SNP (G/T),(G/,G,1.51,1.13,1.85,0.02375658,Low,0.525,0.164,0.02,0.092,Mild decrease (p=0.008),Mild increase (p=0.007),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07013,rs471575,6,113683697,CD33,SNP (G/T),(G/,G,1.79,1.49,2.16,0.05377781,High,0.396,0.287,0.076,0.041,Mild increase (p=0.004),Significant increase (p=0.041),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07014,rs849194,4,18337382,BIN1,SNP (C/T),(C/,C,0.87,0.63,1.16,0.10176322,Low,0.014,0.056,0.255,0.475,Mild increase (p=0.024),No significant pattern (p=0.012),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07015,rs466695,19,130150757,APP,SNP (G/T),(G/,G,0.99,0.59,1.38,0.05449103,Moderate,0.038,0.09,0.09,0.581,Significant increase (p=0.002),Mild decrease (p=0.007),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07016,rs548176,14,235563380,PICALM,SNP (A/G),(A/,A,0.41,0.17,0.62,0.00626178,Low,0.607,0.009,0.031,0.153,No significant pattern (p=0.025),Variable effect (p=0.035),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07017,rs575057,10,78881021,CD2AP,SNP (A/C),(A/,A,1.57,1.28,1.9,0.00326408,High,0.447,0.03,0.202,0.121,Significant decrease (p=0.017),Mild decrease (p=0.031),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07018,rs481347,19,245068421,APP,SNP (C/T),(C/,C,0.75,0.5,1.06,0.01563317,Protective,0.037,0.29,0.313,0.16,Variable effect (p=0.01),Variable effect (p=0.009),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07019,rs110428,11,89090509,BIN1,SNP (C/G),(C/,C,0.59,0.2,0.87,0.01462862,Moderate,0.303,0.312,0.127,0.058,Significant increase (p=0.029),Significant decrease (p=0.036),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07020,rs595825,1,217842834,SORL1,SNP (A/G),(A/,A,0.65,0.42,1.05,0.00746879,Protective,0.071,0.121,0.239,0.37,Significant decrease (p=0.007),Variable effect (p=0.026),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07021,rs900985,5,7550173,EPHA1,Deletion,-,-,1.15,0.85,1.54,0.06089519,Moderate,0.376,0.014,0.074,0.336,No significant pattern (p=0.046),Significant increase (p=0.04),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07022,rs875453,10,196075871,CD2AP,SNP (A/C),(A/,A,1.47,1.12,1.7,0.08072783,Moderate,0.041,0.529,0.229,0.0,Mild increase (p=0.001),Significant decrease (p=0.031),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07023,rs894722,2,173428684,SORL1,SNP (C/T),(C/,C,1.01,0.62,1.25,0.00539159,High,0.066,0.3,0.113,0.322,Significant decrease (p=0.036),No significant pattern (p=0.047),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07024,rs512819,11,48555689,CLU,SNP (A/C),(A/,A,2.47,2.13,2.78,0.08643988,Moderate,0.306,0.167,0.126,0.202,Mild decrease (p=0.014),Variable effect (p=0.004),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07025,rs693309,15,174171054,CD33,SNP (A/C),(A/,A,1.07,0.67,1.29,0.0518882,Low,0.083,0.184,0.017,0.515,No significant pattern (p=0.05),No significant pattern (p=0.026),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07026,rs370034,5,197874382,BIN1,SNP (G/T),(G/,G,1.11,0.88,1.49,0.00305882,Low,0.217,0.073,0.077,0.432,No significant pattern (p=0.005),Mild increase (p=0.012),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07027,rs486097,5,221402804,TREM2,SNP (A/C),(A/,A,1.7,1.5,2.04,0.0016019,Moderate,0.125,0.27,0.209,0.196,Significant decrease (p=0.011),No significant pattern (p=0.033),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07028,rs634697,4,76485773,CLU,Deletion,-,-,1.1,0.84,1.38,0.03501663,Moderate,0.039,0.257,0.485,0.018,Mild decrease (p=0.043),Mild decrease (p=0.04),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07029,rs983798,11,236238678,CR1,SNP (C/G),(C/,C,2.0,1.67,2.35,0.08614833,Low,0.245,0.046,0.403,0.106,No significant pattern (p=0.015),Mild decrease (p=0.035),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP07030,rs988556,7,196495965,PICALM,SNP (C/G),(C/,C,2.05,1.66,2.42,0.00421453,High,0.328,0.141,0.235,0.096,Mild increase (p=0.031),Mild increase (p=0.012),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07031,rs472074,9,74741095,APOE,SNP (C/G),(C/,C,1.61,1.38,1.86,0.00098697,Moderate,0.014,0.417,0.328,0.042,Mild increase (p=0.036),No significant pattern (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP07032,rs431007,5,214743638,MS4A6A,SNP (C/T),(C/,C,1.12,0.84,1.49,0.00047584,Moderate,0.295,0.083,0.093,0.329,Significant decrease (p=0.01),Mild decrease (p=0.024),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07033,rs526304,4,115928300,CD2AP,SNP (A/T),(A/,A,0.97,0.67,1.2,0.0388604,Unknown,0.159,0.009,0.428,0.203,Mild decrease (p=0.045),No significant pattern (p=0.006),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07034,rs395995,13,14382650,ABCA7,SNP (A/G),(A/,A,1.44,1.18,1.73,0.01633282,Moderate,0.023,0.022,0.553,0.202,Significant decrease (p=0.013),No significant pattern (p=0.024),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07035,rs809644,10,78536601,PICALM,SNP (A/T),(A/,A,0.72,0.37,1.01,0.01095542,Unknown,0.14,0.04,0.249,0.371,Mild increase (p=0.004),Significant decrease (p=0.036),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07036,rs281026,21,130418299,SORL1,SNP (G/T),(G/,G,0.76,0.46,1.04,0.04606224,Low,0.099,0.221,0.17,0.31,Mild increase (p=0.017),Variable effect (p=0.046),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07037,rs704390,7,192299445,BIN1,SNP (A/G),(A/,A,1.49,1.19,1.86,0.00153688,High,0.576,0.128,0.053,0.042,No significant pattern (p=0.017),Mild increase (p=0.046),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07038,rs174441,8,194600876,PICALM,SNP (A/T),(A/,A,1.72,1.36,2.06,0.01465693,Moderate,0.021,0.101,0.127,0.551,Variable effect (p=0.05),Variable effect (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07039,rs894607,12,54395608,CD2AP,Insertion,-,-,1.34,1.1,1.66,0.09635508,High,0.301,0.12,0.262,0.116,Mild increase (p=0.033),No significant pattern (p=0.039),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07040,rs668343,18,111965137,PTK2B,Insertion,-,-,0.81,0.45,1.18,0.01050312,High,0.178,0.492,0.073,0.057,Significant increase (p=0.042),Mild decrease (p=0.025),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07041,rs225015,5,182081394,APOE,SNP (G/T),(G/,G,0.88,0.57,1.18,0.07419115,High,0.171,0.122,0.052,0.456,Significant increase (p=0.045),Variable effect (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07042,rs792252,6,97306338,MS4A6A,SNP (G/T),(G/,G,2.86,2.48,3.19,0.11148154,Protective,0.127,0.503,0.115,0.055,Mild decrease (p=0.027),Significant decrease (p=0.028),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07043,rs263140,9,95840932,PSEN2,SNP (C/G),(C/,C,0.6,0.34,0.8,0.01970093,High,0.289,0.072,0.195,0.245,Mild decrease (p=0.015),Significant decrease (p=0.034),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07044,rs518804,3,35559335,APOE,SNP (C/T),(C/,C,1.77,1.51,2.04,0.0105017,Moderate,0.072,0.295,0.0,0.432,Mild increase (p=0.036),Significant decrease (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07045,rs518082,20,194808565,APP,SNP (A/T),(A/,A,1.49,1.25,1.78,0.03197641,Low,0.056,0.492,0.234,0.018,Significant increase (p=0.036),No significant pattern (p=0.022),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07046,rs678237,17,23493389,PTK2B,SNP (A/C),(A/,A,0.66,0.42,1.02,0.0061244,Moderate,0.122,0.244,0.117,0.317,Significant decrease (p=0.045),Significant decrease (p=0.004),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07047,rs718608,8,157810008,CLU,SNP (C/T),(C/,C,0.78,0.47,1.1,0.00983271,Low,0.317,0.244,0.12,0.119,No significant pattern (p=0.008),Variable effect (p=0.049),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07048,rs140361,19,214170973,BIN1,SNP (A/T),(A/,A,1.17,0.89,1.54,0.04883454,Low,0.124,0.146,0.038,0.493,Variable effect (p=0.023),No significant pattern (p=0.042),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07049,rs972973,5,67103674,APOE,SNP (A/G),(A/,A,1.93,1.72,2.25,0.01556729,Moderate,0.301,0.242,0.106,0.152,Significant decrease (p=0.038),Mild decrease (p=0.005),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07050,rs936278,2,204102340,PSEN2,Insertion,-,-,1.07,0.81,1.43,0.00435588,Moderate,0.035,0.045,0.704,0.016,Mild increase (p=0.03),Mild increase (p=0.008),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07051,rs870076,14,98914961,PSEN2,SNP (G/T),(G/,G,1.23,0.89,1.58,0.05753508,High,0.555,0.141,0.103,0.0,Variable effect (p=0.019),Significant decrease (p=0.024),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07052,rs937167,14,24143647,PSEN2,SNP (A/G),(A/,A,0.65,0.32,0.89,0.08626684,High,0.18,0.003,0.46,0.157,Significant decrease (p=0.014),Significant increase (p=0.033),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07053,rs723378,11,79047448,CLU,SNP (A/G),(A/,A,0.78,0.51,1.02,0.08885531,High,0.127,0.398,0.068,0.207,Significant increase (p=0.007),Variable effect (p=0.035),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07054,rs515647,13,20303992,ABCA7,Insertion,-,-,0.43,0.1,0.68,0.02204572,High,0.401,0.071,0.022,0.306,Mild increase (p=0.018),Mild increase (p=0.002),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07055,rs481772,4,164793650,PICALM,Deletion,-,-,1.47,1.12,1.78,0.02320295,Moderate,0.459,0.163,0.008,0.17,Significant increase (p=0.017),Mild decrease (p=0.039),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07056,rs680492,5,247835362,PTK2B,SNP (A/G),(A/,A,2.09,1.75,2.32,0.04516248,Low,0.155,0.13,0.133,0.382,Significant decrease (p=0.024),Significant increase (p=0.037),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07057,rs918037,3,19146906,CD33,SNP (A/T),(A/,A,0.35,0.1,0.64,0.07044231,High,0.432,0.017,0.299,0.052,No significant pattern (p=0.046),No significant pattern (p=0.008),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07058,rs574434,10,222037547,CLU,SNP (A/T),(A/,A,1.23,1.01,1.52,0.07135113,High,0.175,0.427,0.08,0.118,No significant pattern (p=0.012),Significant increase (p=0.033),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07059,rs548139,1,188906253,TREM2,SNP (A/T),(A/,A,0.8,0.56,1.08,0.05075183,Unknown,0.223,0.023,0.365,0.189,No significant pattern (p=0.025),Variable effect (p=0.036),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07060,rs455537,6,165717864,ABCA7,SNP (A/C),(A/,A,0.8,0.52,1.14,0.07086802,Moderate,0.272,0.208,0.285,0.035,Significant decrease (p=0.047),Significant increase (p=0.028),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP07061,rs168263,10,209651571,CR1,Deletion,-,-,1.07,0.74,1.42,0.02391964,Protective,0.234,0.498,0.001,0.066,No significant pattern (p=0.019),Mild increase (p=0.018),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07062,rs584728,3,142123288,CD33,SNP (C/T),(C/,C,1.62,1.41,1.87,0.04982815,Low,0.071,0.059,0.144,0.526,Significant increase (p=0.009),No significant pattern (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07063,rs173828,12,6489447,PICALM,SNP (C/G),(C/,C,0.96,0.76,1.27,0.05142551,High,0.325,0.279,0.088,0.108,Mild decrease (p=0.04),Significant increase (p=0.015),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07064,rs854104,3,162255222,SORL1,SNP (G/T),(G/,G,0.38,0.14,0.67,0.04590909,High,0.407,0.262,0.079,0.052,Mild decrease (p=0.029),Mild decrease (p=0.046),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP07065,rs479560,10,88352968,PSEN2,Insertion,-,-,1.05,0.8,1.37,0.02067348,Low,0.225,0.352,0.197,0.027,Mild increase (p=0.022),Variable effect (p=0.016),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07066,rs487776,6,222094195,BIN1,Insertion,-,-,0.63,0.42,0.97,0.05073628,Moderate,0.076,0.149,0.139,0.435,Mild increase (p=0.044),Variable effect (p=0.012),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07067,rs954228,6,55410707,PSEN2,SNP (A/G),(A/,A,0.59,0.2,0.97,0.03736657,Low,0.075,0.124,0.274,0.327,Mild decrease (p=0.026),Variable effect (p=0.031),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07068,rs939129,9,38558527,SORL1,SNP (C/T),(C/,C,1.16,0.79,1.56,0.00937487,Low,0.231,0.367,0.092,0.111,Mild increase (p=0.044),No significant pattern (p=0.039),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07069,rs516732,8,232772102,TREM2,SNP (C/T),(C/,C,0.62,0.36,0.91,0.00525888,High,0.246,0.102,0.304,0.147,Mild increase (p=0.044),Mild decrease (p=0.028),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07070,rs885175,4,181295792,CD2AP,Insertion,-,-,1.9,1.64,2.19,0.00680066,Moderate,0.233,0.005,0.263,0.298,Mild decrease (p=0.04),No significant pattern (p=0.048),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07071,rs663127,4,45831449,EPHA1,SNP (G/T),(G/,G,0.99,0.76,1.23,0.02459797,High,0.175,0.372,0.06,0.192,Significant increase (p=0.033),Significant increase (p=0.018),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07072,rs906857,5,197017474,MS4A6A,SNP (C/T),(C/,C,0.84,0.63,1.19,0.00589514,Unknown,0.059,0.194,0.34,0.206,No significant pattern (p=0.039),Variable effect (p=0.023),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP07073,rs360697,17,83967877,PTK2B,SNP (A/G),(A/,A,1.25,1.04,1.63,0.07101376,Low,0.298,0.321,0.151,0.03,Variable effect (p=0.009),Mild increase (p=0.031),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07074,rs630934,1,144031704,APOE,SNP (A/C),(A/,A,1.27,1.01,1.54,0.22819549,Moderate,0.082,0.086,0.279,0.352,Significant decrease (p=0.046),Variable effect (p=0.017),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07075,rs267032,11,168352114,TREM2,SNP (C/G),(C/,C,1.01,0.78,1.24,0.02692617,High,0.077,0.212,0.254,0.257,Significant increase (p=0.019),No significant pattern (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07076,rs276393,17,197524916,APP,SNP (G/T),(G/,G,0.66,0.29,1.01,0.03459451,Low,0.077,0.464,0.02,0.239,Mild increase (p=0.046),Variable effect (p=0.01),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07077,rs187362,9,119544807,ABCA7,SNP (A/C),(A/,A,0.78,0.51,1.06,0.0018713,Moderate,0.207,0.098,0.123,0.372,Mild increase (p=0.023),Mild decrease (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07078,rs594446,15,136717895,TREM2,SNP (A/C),(A/,A,1.14,0.83,1.53,0.01261881,Unknown,0.034,0.021,0.138,0.608,Significant increase (p=0.045),Mild increase (p=0.003),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07079,rs894668,2,46772323,CD2AP,SNP (A/T),(A/,A,1.16,0.89,1.52,0.07149443,Moderate,0.319,0.014,0.447,0.02,Significant decrease (p=0.022),Mild increase (p=0.027),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07080,rs582085,20,77691892,CD33,SNP (A/C),(A/,A,1.25,0.96,1.56,0.05079747,High,0.225,0.174,0.231,0.17,Significant increase (p=0.002),No significant pattern (p=0.045),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07081,rs388179,2,196863539,TREM2,SNP (C/G),(C/,C,0.56,0.2,0.86,0.07329951,High,0.004,0.04,0.679,0.077,Mild increase (p=0.04),Mild decrease (p=0.009),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07082,rs755726,7,149105807,CR1,SNP (C/G),(C/,C,0.76,0.5,1.0,0.02543522,Low,0.281,0.233,0.177,0.109,No significant pattern (p=0.012),Mild increase (p=0.014),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07083,rs180054,21,237353061,TREM2,SNP (A/C),(A/,A,0.56,0.25,0.95,0.01507845,Low,0.124,0.431,0.234,0.011,No significant pattern (p=0.037),Mild decrease (p=0.032),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07084,rs538543,18,104217805,CLU,Insertion,-,-,0.47,0.15,0.71,0.03033458,Moderate,0.223,0.166,0.075,0.336,Mild decrease (p=0.047),Significant decrease (p=0.015),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07085,rs479898,15,17651495,EPHA1,Deletion,-,-,1.3,0.93,1.67,0.02425264,Protective,0.143,0.018,0.423,0.216,Significant increase (p=0.046),Mild increase (p=0.01),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07086,rs427976,15,18632674,ABCA7,SNP (C/G),(C/,C,1.18,0.97,1.57,0.00505889,High,0.572,0.163,0.046,0.018,Significant decrease (p=0.018),Significant decrease (p=0.032),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07087,rs232166,21,22114990,BIN1,SNP (G/T),(G/,G,1.11,0.9,1.43,0.00254449,Low,0.052,0.01,0.128,0.61,Significant increase (p=0.01),No significant pattern (p=0.001),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07088,rs747418,17,94934428,APOE,SNP (C/T),(C/,C,0.78,0.46,1.02,0.01766768,Unknown,0.103,0.159,0.398,0.14,No significant pattern (p=0.018),Significant increase (p=0.028),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07089,rs696960,18,235910065,APP,SNP (C/G),(C/,C,1.16,0.95,1.44,0.05200535,Unknown,0.003,0.024,0.687,0.086,No significant pattern (p=0.008),No significant pattern (p=0.036),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07090,rs824036,8,66992352,ABCA7,SNP (C/T),(C/,C,0.41,0.1,0.63,0.03939927,Moderate,0.221,0.188,0.332,0.059,Significant decrease (p=0.034),Significant decrease (p=0.019),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07091,rs774357,21,83188048,CLU,SNP (G/T),(G/,G,0.87,0.48,1.14,0.00377338,Moderate,0.413,0.113,0.083,0.19,Significant increase (p=0.021),No significant pattern (p=0.019),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07092,rs439079,3,23737412,MS4A6A,SNP (A/G),(A/,A,0.32,0.1,0.67,0.09526268,Moderate,0.059,0.141,0.284,0.316,Significant decrease (p=0.004),Mild decrease (p=0.045),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07093,rs251504,4,3950438,APOE,SNP (C/G),(C/,C,1.08,0.87,1.45,0.0277899,High,0.234,0.043,0.379,0.144,Mild increase (p=0.002),Mild decrease (p=0.037),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07094,rs738316,1,156346749,BIN1,SNP (A/T),(A/,A,1.61,1.35,1.95,0.0307968,Moderate,0.051,0.205,0.015,0.529,Mild increase (p=0.007),Significant decrease (p=0.043),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07095,rs636752,10,223002608,EPHA1,SNP (A/T),(A/,A,2.37,2.0,2.65,0.06095964,Moderate,0.079,0.388,0.195,0.139,Mild increase (p=0.031),No significant pattern (p=0.031),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07096,rs368795,10,203481508,EPHA1,SNP (A/T),(A/,A,0.69,0.42,1.08,0.02416025,Low,0.262,0.189,0.018,0.33,No significant pattern (p=0.034),Significant decrease (p=0.009),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07097,rs416355,10,80806514,APP,SNP (A/G),(A/,A,1.48,1.2,1.75,0.05811788,High,0.006,0.57,0.046,0.178,Variable effect (p=0.05),No significant pattern (p=0.029),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07098,rs541740,4,32308191,MS4A6A,Deletion,-,-,2.95,2.73,3.3,0.03861377,Moderate,0.278,0.032,0.365,0.125,Mild decrease (p=0.011),No significant pattern (p=0.033),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07099,rs717775,8,32060652,CD33,SNP (G/T),(G/,G,0.96,0.61,1.2,0.03331929,Moderate,0.137,0.028,0.469,0.167,Significant increase (p=0.032),Mild decrease (p=0.019),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07100,rs856233,13,104769638,PICALM,SNP (C/G),(C/,C,2.14,1.91,2.45,0.02467551,Low,0.407,0.13,0.051,0.212,No significant pattern (p=0.043),No significant pattern (p=0.027),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07101,rs508160,5,172626605,PICALM,Deletion,-,-,1.94,1.71,2.28,0.01024049,Low,0.338,0.088,0.024,0.35,Mild decrease (p=0.008),Variable effect (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07102,rs620016,15,88891980,TREM2,Deletion,-,-,1.74,1.38,2.06,0.00509819,Protective,0.256,0.012,0.439,0.092,Significant decrease (p=0.025),No significant pattern (p=0.03),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07103,rs549275,9,82875254,PSEN2,Deletion,-,-,1.65,1.34,1.97,0.14127357,Low,0.011,0.405,0.358,0.026,Mild decrease (p=0.045),Variable effect (p=0.034),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP07104,rs505783,16,23306473,ABCA7,SNP (A/C),(A/,A,0.65,0.26,0.91,0.04054984,Unknown,0.216,0.089,0.459,0.035,Significant decrease (p=0.017),Significant decrease (p=0.009),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07105,rs701531,7,59794510,SORL1,SNP (C/G),(C/,C,0.74,0.44,1.04,0.03252141,Moderate,0.13,0.211,0.443,0.016,Mild increase (p=0.04),Variable effect (p=0.021),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07106,rs923006,18,31936309,ABCA7,SNP (A/T),(A/,A,1.17,0.9,1.46,0.01908763,Low,0.104,0.037,0.573,0.086,No significant pattern (p=0.023),Mild decrease (p=0.011),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07107,rs619639,14,196343824,CD2AP,Insertion,-,-,1.12,0.79,1.41,0.01565427,Moderate,0.091,0.284,0.113,0.312,No significant pattern (p=0.045),No significant pattern (p=0.044),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07108,rs393782,7,69835582,BIN1,SNP (A/C),(A/,A,1.56,1.26,1.84,0.04042871,Low,0.088,0.232,0.075,0.405,Significant increase (p=0.028),No significant pattern (p=0.029),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07109,rs822816,11,14254968,TREM2,Deletion,-,-,1.45,1.19,1.68,0.04750849,High,0.197,0.093,0.203,0.307,No significant pattern (p=0.026),Mild increase (p=0.026),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07110,rs499090,3,160861127,TREM2,SNP (C/T),(C/,C,2.62,2.26,2.98,0.01165084,High,0.421,0.222,0.005,0.152,Significant increase (p=0.032),No significant pattern (p=0.025),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07111,rs297457,10,115537146,PSEN2,SNP (A/T),(A/,A,1.49,1.21,1.74,0.03007554,Moderate,0.121,0.161,0.127,0.391,No significant pattern (p=0.001),Significant decrease (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07112,rs595027,11,204183085,BIN1,Deletion,-,-,0.61,0.36,0.95,0.00274992,High,0.145,0.163,0.419,0.074,Mild decrease (p=0.031),Mild decrease (p=0.014),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP07113,rs534419,9,218882690,CD2AP,Insertion,-,-,0.91,0.69,1.26,0.05137688,High,0.097,0.215,0.214,0.274,No significant pattern (p=0.034),No significant pattern (p=0.015),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07114,rs685036,18,43136653,CD33,SNP (A/G),(A/,A,2.0,1.74,2.23,0.03036762,Protective,0.015,0.146,0.018,0.621,No significant pattern (p=0.033),Variable effect (p=0.021),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07115,rs302693,18,110762705,ABCA7,Deletion,-,-,0.9,0.66,1.22,0.0069057,Moderate,0.005,0.223,0.426,0.146,Significant decrease (p=0.034),Mild increase (p=0.006),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07116,rs161511,2,194050099,CR1,Deletion,-,-,0.41,0.1,0.66,0.01869804,High,0.002,0.293,0.026,0.479,Mild decrease (p=0.014),Variable effect (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07117,rs994895,9,99086683,BIN1,SNP (A/T),(A/,A,1.71,1.46,1.96,0.01011699,Moderate,0.121,0.047,0.112,0.519,Mild increase (p=0.006),Variable effect (p=0.048),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07118,rs417957,5,31360629,BIN1,SNP (A/C),(A/,A,0.84,0.48,1.16,0.02606393,Moderate,0.039,0.461,0.276,0.024,Significant increase (p=0.002),Significant increase (p=0.009),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07119,rs713805,18,136131853,CD2AP,SNP (A/C),(A/,A,0.32,0.1,0.66,0.00995944,High,0.063,0.426,0.109,0.201,Significant decrease (p=0.02),Mild decrease (p=0.019),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07120,rs832288,22,89932735,CD2AP,SNP (A/G),(A/,A,0.96,0.72,1.17,0.03086112,Low,0.32,0.179,0.074,0.228,Mild increase (p=0.008),Significant decrease (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP07121,rs111435,21,115288748,PICALM,SNP (A/C),(A/,A,1.69,1.44,1.95,0.01312709,Low,0.236,0.188,0.291,0.085,Mild increase (p=0.031),Significant increase (p=0.049),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07122,rs665535,8,236686566,MS4A6A,SNP (A/G),(A/,A,0.75,0.45,1.08,0.02788955,Moderate,0.434,0.162,0.181,0.022,Significant decrease (p=0.003),Significant increase (p=0.008),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07123,rs774340,17,80539415,TREM2,SNP (A/G),(A/,A,0.98,0.75,1.21,0.02657468,High,0.166,0.182,0.373,0.079,Significant increase (p=0.043),Significant increase (p=0.018),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07124,rs802461,16,123975243,APP,Insertion,-,-,1.7,1.31,1.94,0.01845944,Low,0.0,0.443,0.115,0.241,No significant pattern (p=0.012),Variable effect (p=0.007),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07125,rs492464,6,211209474,BIN1,Insertion,-,-,0.96,0.75,1.2,0.00898788,Moderate,0.033,0.17,0.01,0.586,No significant pattern (p=0.025),Mild increase (p=0.027),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07126,rs987190,19,221039071,SORL1,SNP (C/G),(C/,C,1.06,0.72,1.42,0.02157576,Moderate,0.104,0.003,0.402,0.291,Mild decrease (p=0.036),No significant pattern (p=0.023),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP07127,rs437643,10,224467936,EPHA1,Deletion,-,-,0.49,0.26,0.84,0.00815025,Protective,0.312,0.259,0.116,0.113,Significant decrease (p=0.023),Mild decrease (p=0.019),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07128,rs260714,3,147095889,PTK2B,SNP (A/C),(A/,A,0.51,0.27,0.78,0.00167169,Moderate,0.242,0.148,0.397,0.014,Mild decrease (p=0.015),Variable effect (p=0.021),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07129,rs607484,10,214701990,MS4A6A,SNP (A/C),(A/,A,0.69,0.38,1.07,0.01258797,Moderate,0.188,0.113,0.049,0.449,No significant pattern (p=0.025),Mild increase (p=0.029),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07130,rs850724,8,133953076,TREM2,Insertion,-,-,1.75,1.46,2.04,0.01207563,Unknown,0.144,0.072,0.39,0.195,Variable effect (p=0.029),No significant pattern (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07131,rs963809,1,104281383,SORL1,SNP (C/T),(C/,C,1.26,0.95,1.65,0.00477844,High,0.04,0.514,0.209,0.037,Significant increase (p=0.045),Mild decrease (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07132,rs220750,9,91793102,PSEN2,SNP (C/G),(C/,C,1.46,1.22,1.78,0.0129055,High,0.009,0.141,0.423,0.227,No significant pattern (p=0.017),Mild decrease (p=0.033),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07133,rs701591,17,64049590,CD2AP,SNP (C/T),(C/,C,1.11,0.9,1.45,0.11696479,Moderate,0.081,0.138,0.143,0.438,Mild decrease (p=0.035),Significant increase (p=0.003),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07134,rs134991,1,5445026,ABCA7,SNP (A/G),(A/,A,1.09,0.76,1.4,0.03122846,Low,0.134,0.02,0.603,0.042,Variable effect (p=0.009),No significant pattern (p=0.034),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07135,rs461244,7,128217651,PICALM,SNP (A/G),(A/,A,0.66,0.4,1.05,0.06142101,High,0.202,0.232,0.015,0.35,Mild increase (p=0.017),Mild decrease (p=0.004),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP07136,rs554804,17,43074202,PSEN2,SNP (C/G),(C/,C,1.66,1.39,1.95,0.1069444,High,0.172,0.232,0.16,0.237,No significant pattern (p=0.018),No significant pattern (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07137,rs712463,16,112507719,APP,SNP (A/G),(A/,A,0.64,0.4,0.98,0.03673954,Moderate,0.113,0.21,0.159,0.317,Variable effect (p=0.039),No significant pattern (p=0.026),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP07138,rs228424,10,86552819,APOE,Insertion,-,-,0.74,0.48,1.04,0.00303998,Low,0.033,0.537,0.11,0.119,Mild increase (p=0.039),Mild increase (p=0.015),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07139,rs900059,2,236093164,APP,SNP (C/T),(C/,C,1.22,0.96,1.43,0.04548622,Moderate,0.197,0.107,0.227,0.269,Significant increase (p=0.005),Mild decrease (p=0.034),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07140,rs688136,6,20065218,PTK2B,SNP (G/T),(G/,G,1.39,1.14,1.7,0.04241918,Low,0.145,0.064,0.465,0.126,Mild decrease (p=0.029),Significant increase (p=0.026),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP07141,rs551308,18,129971997,APOE,SNP (C/T),(C/,C,0.97,0.68,1.34,0.04931841,Protective,0.036,0.029,0.224,0.511,Mild decrease (p=0.006),No significant pattern (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07142,rs402616,8,5538743,CLU,SNP (A/T),(A/,A,0.68,0.37,0.98,0.00914956,High,0.065,0.554,0.113,0.067,Significant increase (p=0.026),No significant pattern (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP07143,rs902236,18,64511539,APP,SNP (C/G),(C/,C,1.36,1.07,1.69,0.01034017,Unknown,0.213,0.329,0.14,0.118,Significant decrease (p=0.039),Mild increase (p=0.003),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07144,rs669442,5,146553524,PICALM,Deletion,-,-,0.66,0.32,1.0,0.02281998,Moderate,0.432,0.042,0.112,0.215,Mild increase (p=0.011),Significant increase (p=0.037),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07145,rs745889,17,83107298,PICALM,SNP (A/C),(A/,A,1.72,1.34,2.11,0.01582658,Low,0.075,0.005,0.301,0.419,No significant pattern (p=0.007),Variable effect (p=0.015),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP07146,rs472036,1,7731950,BIN1,Deletion,-,-,0.83,0.54,1.2,0.00963011,Moderate,0.002,0.201,0.16,0.437,Mild decrease (p=0.023),Significant decrease (p=0.05),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07147,rs381707,9,35767182,CR1,Insertion,-,-,3.95,3.59,4.21,0.08896979,High,0.001,0.405,0.215,0.178,No significant pattern (p=0.025),No significant pattern (p=0.011),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07148,rs520318,15,14796457,MS4A6A,SNP (C/T),(C/,C,1.21,0.83,1.56,0.07959854,High,0.043,0.128,0.479,0.15,Variable effect (p=0.04),Mild increase (p=0.042),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07149,rs193518,10,39688136,ABCA7,SNP (A/C),(A/,A,0.95,0.68,1.29,0.01442659,High,0.199,0.159,0.427,0.015,Significant decrease (p=0.038),Variable effect (p=0.023),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07150,rs861341,15,128785343,PSEN2,SNP (C/G),(C/,C,1.12,0.77,1.32,0.00053199,Moderate,0.321,0.392,0.003,0.084,Mild increase (p=0.043),Mild increase (p=0.017),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07151,rs653563,18,97368659,PICALM,SNP (A/G),(A/,A,1.18,0.87,1.51,0.02346862,Low,0.291,0.285,0.156,0.068,Mild decrease (p=0.022),No significant pattern (p=0.003),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07152,rs637408,12,244529803,EPHA1,SNP (C/T),(C/,C,0.67,0.29,1.05,0.02997053,High,0.01,0.594,0.033,0.163,No significant pattern (p=0.025),Mild increase (p=0.007),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07153,rs100420,6,50570958,BIN1,SNP (C/T),(C/,C,1.32,1.0,1.63,0.03986424,Low,0.247,0.267,0.17,0.116,Significant increase (p=0.027),Significant increase (p=0.03),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07154,rs659121,3,31702882,PSEN2,Deletion,-,-,0.87,0.63,1.22,0.05072334,Low,0.353,0.056,0.255,0.136,Significant decrease (p=0.04),Variable effect (p=0.045),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07155,rs507021,18,49541789,TREM2,SNP (G/T),(G/,G,1.14,0.92,1.49,0.0336943,Unknown,0.245,0.356,0.152,0.047,No significant pattern (p=0.034),No significant pattern (p=0.027),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07156,rs807079,4,127257701,TREM2,SNP (C/G),(C/,C,0.92,0.6,1.2,0.01572047,High,0.282,0.353,0.124,0.04,Mild decrease (p=0.027),Significant increase (p=0.041),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07157,rs394097,13,25419389,MS4A6A,SNP (A/G),(A/,A,0.96,0.72,1.19,0.0271853,Low,0.322,0.053,0.201,0.225,Mild increase (p=0.03),Variable effect (p=0.021),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07158,rs601089,8,61726565,CD2AP,SNP (C/G),(C/,C,1.57,1.25,1.79,0.07188863,Protective,0.265,0.478,0.017,0.039,Mild increase (p=0.007),Significant increase (p=0.007),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07159,rs758258,17,128153797,CD33,SNP (A/G),(A/,A,1.41,1.04,1.76,0.13478194,High,0.164,0.134,0.3,0.203,Mild decrease (p=0.018),Mild increase (p=0.013),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07160,rs263583,6,181986211,SORL1,SNP (A/T),(A/,A,1.09,0.75,1.35,0.00025708,Moderate,0.506,0.135,0.024,0.135,Significant increase (p=0.012),Significant decrease (p=0.04),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07161,rs740535,4,132653744,PTK2B,SNP (C/T),(C/,C,1.09,0.77,1.3,0.02427237,Unknown,0.329,0.043,0.264,0.164,Mild increase (p=0.015),Significant increase (p=0.021),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07162,rs738544,22,15593591,ABCA7,Insertion,-,-,1.35,0.98,1.65,0.01794981,Low,0.037,0.398,0.177,0.189,Mild decrease (p=0.049),Mild increase (p=0.039),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07163,rs122042,20,194628716,PSEN2,SNP (C/T),(C/,C,0.6,0.36,0.92,0.01448061,Moderate,0.063,0.093,0.344,0.3,No significant pattern (p=0.002),Significant increase (p=0.046),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07164,rs125733,8,109376488,CLU,Insertion,-,-,1.05,0.73,1.32,0.0414998,Moderate,0.139,0.242,0.017,0.402,Significant decrease (p=0.005),Variable effect (p=0.005),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07165,rs187674,15,215433521,PSEN2,SNP (A/C),(A/,A,1.48,1.11,1.73,0.07643281,Moderate,0.053,0.363,0.275,0.109,Mild decrease (p=0.007),Variable effect (p=0.022),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07166,rs754572,15,185690894,PICALM,SNP (C/G),(C/,C,0.88,0.5,1.15,0.02576889,Moderate,0.111,0.309,0.289,0.092,Variable effect (p=0.039),No significant pattern (p=0.017),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07167,rs545622,17,115316941,APP,Deletion,-,-,0.75,0.4,1.11,0.04515288,Low,0.283,0.091,0.019,0.407,No significant pattern (p=0.044),Variable effect (p=0.035),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07168,rs213281,7,241098555,SORL1,Insertion,-,-,0.72,0.46,1.1,0.08544435,Protective,0.58,0.009,0.016,0.195,Mild increase (p=0.045),Significant increase (p=0.01),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07169,rs712355,3,144691497,MS4A6A,SNP (G/T),(G/,G,0.69,0.41,0.91,0.01891789,Low,0.192,0.07,0.316,0.223,No significant pattern (p=0.013),Mild decrease (p=0.016),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07170,rs901749,14,162950576,TREM2,Deletion,-,-,0.86,0.56,1.09,0.07075455,Protective,0.32,0.159,0.3,0.021,Variable effect (p=0.019),Significant increase (p=0.014),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07171,rs916394,22,2204568,PICALM,Insertion,-,-,0.9,0.56,1.22,0.02622092,Moderate,0.198,0.523,0.052,0.026,Significant increase (p=0.016),Mild increase (p=0.04),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP07172,rs552551,10,122976109,APP,SNP (G/T),(G/,G,1.53,1.26,1.89,0.0276753,Moderate,0.004,0.233,0.244,0.319,Significant decrease (p=0.025),No significant pattern (p=0.032),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP07173,rs276553,21,247736349,PICALM,SNP (G/T),(G/,G,0.89,0.54,1.15,0.04230432,High,0.08,0.084,0.081,0.554,Mild decrease (p=0.049),Significant increase (p=0.033),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07174,rs722538,17,214423198,APOE,SNP (A/G),(A/,A,0.47,0.24,0.84,0.00474771,High,0.015,0.244,0.019,0.521,Variable effect (p=0.012),Significant decrease (p=0.042),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07175,rs641780,21,245366198,CLU,SNP (G/T),(G/,G,0.95,0.7,1.18,0.00780803,Unknown,0.065,0.559,0.002,0.174,Significant increase (p=0.038),No significant pattern (p=0.046),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07176,rs834234,3,171567201,MS4A6A,Insertion,-,-,1.15,0.84,1.36,0.00188495,High,0.12,0.506,0.004,0.169,Mild decrease (p=0.024),Mild increase (p=0.012),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07177,rs780936,3,101776710,PSEN2,SNP (A/T),(A/,A,1.9,1.54,2.24,0.03764503,High,0.009,0.292,0.491,0.009,Significant decrease (p=0.027),Variable effect (p=0.02),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07178,rs572390,15,77379466,APP,SNP (A/C),(A/,A,1.27,0.92,1.51,0.00550301,High,0.07,0.425,0.014,0.291,Mild decrease (p=0.046),Significant decrease (p=0.012),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07179,rs563490,3,192461597,PSEN2,SNP (A/G),(A/,A,1.16,0.93,1.47,0.00238628,High,0.162,0.222,0.339,0.077,Significant increase (p=0.008),Mild increase (p=0.027),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07180,rs869401,17,116717778,CD2AP,SNP (A/C),(A/,A,1.25,0.93,1.54,0.00082,Low,0.038,0.189,0.442,0.131,Variable effect (p=0.047),Significant increase (p=0.029),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07181,rs125790,12,15453777,CD33,Deletion,-,-,1.62,1.38,1.98,0.00297853,Moderate,0.148,0.095,0.35,0.207,Significant decrease (p=0.023),Significant increase (p=0.047),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07182,rs953631,7,141194683,CD2AP,SNP (A/T),(A/,A,0.39,0.1,0.75,0.03763703,Moderate,0.367,0.132,0.192,0.108,Significant increase (p=0.005),Significant decrease (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP07183,rs468177,1,99040840,SORL1,SNP (G/T),(G/,G,1.05,0.85,1.35,0.00933629,Moderate,0.043,0.144,0.516,0.097,Variable effect (p=0.044),Mild increase (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07184,rs979873,1,176523088,PICALM,SNP (G/T),(G/,G,0.72,0.44,0.99,0.04717583,High,0.011,0.134,0.451,0.203,Variable effect (p=0.012),Significant increase (p=0.023),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07185,rs938489,19,75137068,MS4A6A,SNP (C/G),(C/,C,0.69,0.47,1.06,0.08040671,High,0.465,0.11,0.095,0.13,Significant increase (p=0.029),No significant pattern (p=0.036),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP07186,rs671391,7,168465139,SORL1,SNP (C/T),(C/,C,1.33,1.11,1.68,0.02612179,Low,0.196,0.194,0.119,0.292,Significant decrease (p=0.045),Significant increase (p=0.05),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07187,rs424133,7,47613386,CD2AP,Deletion,-,-,0.63,0.23,0.97,0.01255783,High,0.177,0.412,0.063,0.147,Significant increase (p=0.008),Significant decrease (p=0.019),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07188,rs426345,11,154731775,EPHA1,SNP (G/T),(G/,G,0.87,0.53,1.18,0.01313192,High,0.016,0.537,0.016,0.231,Significant decrease (p=0.029),Variable effect (p=0.035),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP07189,rs529731,3,248815068,SORL1,SNP (A/T),(A/,A,1.06,0.67,1.43,0.07312356,Protective,0.247,0.133,0.353,0.067,Mild decrease (p=0.024),Mild decrease (p=0.004),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07190,rs836167,5,99430934,PICALM,SNP (G/T),(G/,G,1.09,0.86,1.3,0.0029455,High,0.17,0.179,0.018,0.433,No significant pattern (p=0.01),Mild increase (p=0.03),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07191,rs140037,5,121408939,APOE,SNP (C/G),(C/,C,1.05,0.71,1.38,0.02693025,High,0.019,0.077,0.631,0.074,Significant increase (p=0.035),No significant pattern (p=0.013),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07192,rs928142,9,89128967,BIN1,SNP (C/T),(C/,C,1.05,0.76,1.44,0.03543259,Moderate,0.284,0.301,0.21,0.005,Significant increase (p=0.034),No significant pattern (p=0.016),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07193,rs405178,8,66142499,APP,SNP (G/T),(G/,G,0.9,0.63,1.27,0.00206775,Moderate,0.182,0.301,0.195,0.121,Significant decrease (p=0.036),No significant pattern (p=0.027),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07194,rs303689,9,160735138,MS4A6A,SNP (A/T),(A/,A,1.02,0.64,1.39,0.00952731,Protective,0.023,0.005,0.373,0.399,Mild increase (p=0.011),No significant pattern (p=0.028),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07195,rs187392,4,84546155,CD33,SNP (G/T),(G/,G,0.72,0.35,0.94,0.0153341,Moderate,0.202,0.275,0.264,0.059,Mild increase (p=0.012),Significant decrease (p=0.008),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP07196,rs931376,8,150849537,BIN1,SNP (A/T),(A/,A,0.54,0.19,0.92,0.01347587,Low,0.163,0.022,0.247,0.368,No significant pattern (p=0.008),Significant increase (p=0.003),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07197,rs676369,16,21253796,MS4A6A,SNP (A/G),(A/,A,1.56,1.24,1.95,0.05223794,Unknown,0.286,0.08,0.091,0.344,Mild increase (p=0.006),Significant increase (p=0.036),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07198,rs164059,14,204540595,PTK2B,SNP (C/T),(C/,C,1.88,1.49,2.24,0.00247882,Moderate,0.064,0.232,0.165,0.34,Variable effect (p=0.004),No significant pattern (p=0.026),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07199,rs487830,12,85325314,SORL1,SNP (A/T),(A/,A,0.88,0.56,1.1,0.01884678,High,0.089,0.161,0.544,0.006,Significant decrease (p=0.044),Mild decrease (p=0.013),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07200,rs101378,18,127611475,ABCA7,SNP (C/G),(C/,C,0.75,0.43,1.14,0.01846554,High,0.289,0.199,0.054,0.258,Variable effect (p=0.025),Mild increase (p=0.011),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07201,rs802574,11,20812604,MS4A6A,SNP (A/C),(A/,A,1.03,0.64,1.4,0.02304935,Low,0.51,0.187,0.028,0.075,No significant pattern (p=0.011),Mild decrease (p=0.026),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07202,rs234885,22,102590864,TREM2,SNP (A/C),(A/,A,2.16,1.95,2.39,0.03704408,Moderate,0.05,0.005,0.554,0.19,Significant decrease (p=0.035),Mild decrease (p=0.027),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP07203,rs852510,16,100656109,SORL1,SNP (A/C),(A/,A,1.82,1.62,2.03,0.01850986,Moderate,0.479,0.011,0.019,0.291,Mild decrease (p=0.031),Mild decrease (p=0.041),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07204,rs281294,22,83510032,PTK2B,SNP (C/T),(C/,C,1.65,1.32,2.05,0.03059629,Moderate,0.029,0.17,0.312,0.289,Mild decrease (p=0.026),Variable effect (p=0.022),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07205,rs853001,19,22158756,ABCA7,SNP (A/T),(A/,A,1.12,0.81,1.51,0.00122158,High,0.101,0.108,0.19,0.402,Mild increase (p=0.001),Mild increase (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07206,rs836662,4,30988902,CR1,SNP (A/C),(A/,A,0.79,0.52,1.11,0.0148214,Moderate,0.045,0.077,0.398,0.281,Significant increase (p=0.029),Mild increase (p=0.002),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07207,rs197569,7,79129741,APOE,Deletion,-,-,0.91,0.69,1.17,0.00134891,High,0.411,0.14,0.037,0.212,Variable effect (p=0.018),No significant pattern (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07208,rs881919,16,206066659,CLU,SNP (A/C),(A/,A,1.4,1.17,1.67,0.00013746,High,0.311,0.153,0.305,0.031,Mild increase (p=0.012),Significant decrease (p=0.014),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07209,rs430761,3,54153864,TREM2,SNP (A/G),(A/,A,0.68,0.3,0.92,0.00029273,High,0.098,0.386,0.289,0.027,Mild increase (p=0.039),Significant increase (p=0.021),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07210,rs440613,14,235942934,PICALM,Deletion,-,-,1.41,1.2,1.76,0.00972887,Moderate,0.059,0.176,0.267,0.298,Mild increase (p=0.033),Mild increase (p=0.006),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07211,rs875155,17,232011362,PICALM,SNP (A/G),(A/,A,0.47,0.26,0.74,0.00631937,Moderate,0.12,0.058,0.269,0.352,No significant pattern (p=0.01),Mild increase (p=0.05),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07212,rs601749,3,42706438,CD2AP,Deletion,-,-,0.77,0.56,1.01,0.02253279,Protective,0.306,0.288,0.181,0.025,Variable effect (p=0.035),No significant pattern (p=0.033),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07213,rs648585,7,14519171,SORL1,SNP (C/T),(C/,C,0.71,0.36,0.94,0.02441554,High,0.125,0.414,0.257,0.005,Mild decrease (p=0.017),No significant pattern (p=0.006),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07214,rs247673,14,46215213,APP,SNP (C/T),(C/,C,1.11,0.9,1.42,0.02519625,High,0.291,0.192,0.24,0.077,Variable effect (p=0.03),Significant decrease (p=0.006),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07215,rs165023,22,136225878,ABCA7,SNP (A/T),(A/,A,1.04,0.67,1.28,0.08917521,Moderate,0.038,0.167,0.163,0.433,Significant increase (p=0.034),Variable effect (p=0.048),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07216,rs594566,14,48729452,ABCA7,Deletion,-,-,0.86,0.56,1.08,0.14374838,Moderate,0.199,0.306,0.205,0.089,Mild increase (p=0.038),No significant pattern (p=0.021),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07217,rs227058,8,11016274,BIN1,Insertion,-,-,0.98,0.64,1.37,0.03337626,Low,0.027,0.127,0.308,0.338,Mild increase (p=0.045),No significant pattern (p=0.026),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07218,rs942942,16,106314598,PICALM,SNP (G/T),(G/,G,1.76,1.52,2.12,0.00137783,Unknown,0.083,0.057,0.066,0.594,Mild increase (p=0.019),Significant increase (p=0.045),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07219,rs723553,5,13864082,PTK2B,Deletion,-,-,2.11,1.77,2.44,0.00289286,High,0.133,0.308,0.083,0.276,Mild increase (p=0.021),Significant decrease (p=0.014),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07220,rs784887,7,95854833,TREM2,SNP (C/G),(C/,C,0.92,0.61,1.16,0.08084296,Protective,0.036,0.435,0.22,0.109,Mild decrease (p=0.04),Significant decrease (p=0.02),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07221,rs392656,11,183679036,TREM2,SNP (A/C),(A/,A,1.41,1.09,1.69,0.06035587,High,0.052,0.339,0.0,0.408,Mild decrease (p=0.004),Significant increase (p=0.01),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP07222,rs465569,7,231257597,CD33,Deletion,-,-,0.86,0.53,1.11,0.00805478,Low,0.005,0.046,0.299,0.45,Significant increase (p=0.033),Significant increase (p=0.01),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07223,rs486373,6,209620152,TREM2,SNP (A/G),(A/,A,1.37,0.97,1.59,0.00327716,Protective,0.269,0.057,0.045,0.429,Significant decrease (p=0.014),Significant increase (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07224,rs516980,11,55950181,APP,SNP (A/G),(A/,A,0.59,0.29,0.82,0.01300329,Protective,0.459,0.216,0.071,0.055,Variable effect (p=0.042),Mild increase (p=0.035),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07225,rs829329,19,81952050,PTK2B,SNP (C/G),(C/,C,0.53,0.21,0.91,0.01280363,High,0.003,0.166,0.249,0.382,Significant decrease (p=0.021),Variable effect (p=0.029),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07226,rs641236,9,220101917,PICALM,SNP (A/T),(A/,A,0.85,0.48,1.08,0.03065735,Low,0.366,0.055,0.144,0.236,No significant pattern (p=0.034),Mild increase (p=0.025),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07227,rs463421,22,197027147,CD2AP,SNP (C/G),(C/,C,3.15,2.85,3.52,0.01406887,Low,0.012,0.159,0.282,0.346,No significant pattern (p=0.011),Mild increase (p=0.014),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07228,rs446464,10,157497544,CR1,Insertion,-,-,0.69,0.46,0.89,0.001023,Protective,0.002,0.044,0.209,0.545,Significant increase (p=0.047),Variable effect (p=0.04),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07229,rs135298,3,235543670,MS4A6A,SNP (A/G),(A/,A,0.65,0.26,1.0,0.0658234,Low,0.078,0.026,0.357,0.339,Significant increase (p=0.035),Significant decrease (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07230,rs739323,2,23564837,MS4A6A,SNP (C/T),(C/,C,1.3,1.03,1.59,0.03010118,High,0.096,0.306,0.124,0.273,Significant increase (p=0.04),Significant decrease (p=0.002),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP07231,rs663096,3,186560254,PICALM,SNP (A/G),(A/,A,1.43,1.16,1.69,0.03225631,Moderate,0.146,0.186,0.341,0.127,Mild decrease (p=0.005),Variable effect (p=0.003),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07232,rs421051,9,35810990,SORL1,Deletion,-,-,1.19,0.83,1.58,0.04636577,Protective,0.019,0.009,0.552,0.22,Variable effect (p=0.01),Variable effect (p=0.019),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07233,rs535308,8,80573841,APP,Deletion,-,-,0.73,0.38,0.94,0.05801803,Unknown,0.403,0.019,0.139,0.239,Variable effect (p=0.003),No significant pattern (p=0.039),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07234,rs958754,19,20469715,APOE,SNP (A/C),(A/,A,1.14,0.8,1.5,0.03923991,Moderate,0.189,0.008,0.095,0.508,Significant decrease (p=0.003),No significant pattern (p=0.037),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP07235,rs896934,21,40604690,SORL1,SNP (C/G),(C/,C,0.46,0.1,0.69,0.00851134,Moderate,0.43,0.03,0.251,0.089,Mild decrease (p=0.004),Significant decrease (p=0.023),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07236,rs167716,16,115598663,BIN1,SNP (C/T),(C/,C,4.13,3.73,4.5,0.06671748,Moderate,0.369,0.017,0.216,0.199,Mild increase (p=0.042),Significant increase (p=0.03),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07237,rs123198,18,21857777,CD33,SNP (A/T),(A/,A,0.78,0.51,1.13,0.05355271,High,0.127,0.007,0.641,0.024,Significant increase (p=0.01),No significant pattern (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP07238,rs632081,4,209373625,CR1,SNP (A/C),(A/,A,0.72,0.42,0.95,0.07307402,High,0.237,0.436,0.059,0.068,No significant pattern (p=0.012),Significant decrease (p=0.04),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07239,rs713318,10,222255922,CR1,Deletion,-,-,1.01,0.75,1.35,0.03346075,High,0.046,0.19,0.012,0.552,Mild decrease (p=0.002),Significant decrease (p=0.038),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07240,rs242185,8,201172126,BIN1,Insertion,-,-,1.05,0.72,1.44,0.04327902,High,0.147,0.298,0.33,0.025,Variable effect (p=0.024),Variable effect (p=0.02),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07241,rs837801,17,117808882,CD2AP,SNP (C/T),(C/,C,1.03,0.75,1.3,0.0013536,Moderate,0.02,0.121,0.635,0.024,No significant pattern (p=0.036),Mild decrease (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07242,rs278436,9,63545456,ABCA7,SNP (A/G),(A/,A,1.2,0.97,1.52,0.05772251,Protective,0.168,0.108,0.308,0.216,Mild decrease (p=0.033),Mild decrease (p=0.042),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07243,rs755435,2,129227032,EPHA1,SNP (G/T),(G/,G,1.53,1.25,1.9,0.02016129,Moderate,0.121,0.586,0.018,0.075,Mild increase (p=0.006),Significant increase (p=0.041),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07244,rs342170,5,93045461,CR1,SNP (C/G),(C/,C,0.85,0.58,1.22,0.03967474,Low,0.0,0.201,0.311,0.288,Significant increase (p=0.018),Mild increase (p=0.029),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07245,rs398775,15,94999859,EPHA1,SNP (C/T),(C/,C,2.86,2.59,3.2,0.02050112,High,0.053,0.112,0.16,0.475,Mild decrease (p=0.046),Significant increase (p=0.02),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP07246,rs589042,3,195766079,CD2AP,SNP (A/G),(A/,A,0.99,0.76,1.25,0.02757189,Unknown,0.289,0.13,0.31,0.071,No significant pattern (p=0.015),Significant increase (p=0.041),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07247,rs513442,7,165447489,SORL1,Deletion,-,-,1.7,1.44,2.0,0.01664193,High,0.052,0.171,0.547,0.03,No significant pattern (p=0.029),Variable effect (p=0.044),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07248,rs425247,19,34884116,CR1,SNP (A/T),(A/,A,0.65,0.27,1.02,0.01640524,Moderate,0.164,0.016,0.386,0.233,Variable effect (p=0.039),Significant increase (p=0.033),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07249,rs552021,10,138003469,MS4A6A,Insertion,-,-,0.5,0.11,0.84,0.03757093,High,0.064,0.486,0.184,0.065,Mild increase (p=0.029),Significant decrease (p=0.002),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07250,rs753279,16,158300564,MS4A6A,SNP (C/T),(C/,C,0.89,0.63,1.26,0.01062043,High,0.119,0.211,0.279,0.191,No significant pattern (p=0.037),Significant decrease (p=0.026),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07251,rs704961,10,16821619,SORL1,Deletion,-,-,1.29,0.94,1.53,0.00451574,Moderate,0.5,0.091,0.086,0.123,Variable effect (p=0.048),Mild increase (p=0.023),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07252,rs233956,17,23440076,MS4A6A,SNP (A/T),(A/,A,0.63,0.34,0.92,0.00761873,Low,0.021,0.331,0.407,0.041,No significant pattern (p=0.037),Significant decrease (p=0.041),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP07253,rs811385,21,143712111,CD2AP,SNP (C/T),(C/,C,0.43,0.1,0.73,0.04577789,High,0.01,0.528,0.178,0.084,Variable effect (p=0.002),No significant pattern (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP07254,rs823823,11,85835942,PSEN2,SNP (C/G),(C/,C,1.99,1.65,2.24,0.03856775,Unknown,0.127,0.314,0.352,0.007,Significant decrease (p=0.014),No significant pattern (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07255,rs258440,9,43951094,APP,SNP (A/T),(A/,A,1.5,1.24,1.71,0.02811471,Moderate,0.023,0.155,0.143,0.479,No significant pattern (p=0.012),Significant increase (p=0.006),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07256,rs530385,22,85768647,EPHA1,SNP (A/C),(A/,A,0.49,0.26,0.72,0.00220858,High,0.279,0.136,0.252,0.132,No significant pattern (p=0.02),Variable effect (p=0.025),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP07257,rs613937,11,132019307,CD2AP,SNP (C/G),(C/,C,0.57,0.25,0.84,0.06545358,High,0.104,0.165,0.144,0.387,Mild decrease (p=0.003),Significant decrease (p=0.017),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07258,rs600466,11,53924482,APOE,SNP (G/T),(G/,G,0.74,0.52,1.05,0.07693779,High,0.009,0.297,0.06,0.433,Significant increase (p=0.027),Variable effect (p=0.006),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07259,rs997489,18,150266590,MS4A6A,SNP (C/G),(C/,C,0.74,0.39,1.11,0.0090492,Moderate,0.139,0.179,0.295,0.188,Mild increase (p=0.041),Variable effect (p=0.049),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP07260,rs463799,5,1649416,ABCA7,SNP (A/T),(A/,A,1.6,1.36,1.81,0.01423946,Moderate,0.283,0.263,0.199,0.055,Variable effect (p=0.016),Mild increase (p=0.012),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07261,rs403850,5,103346220,CD2AP,SNP (A/G),(A/,A,1.19,0.91,1.5,0.01197456,High,0.105,0.063,0.036,0.597,Mild increase (p=0.023),Mild decrease (p=0.014),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07262,rs363034,14,107964094,EPHA1,Deletion,-,-,0.93,0.54,1.27,0.00034708,Moderate,0.03,0.315,0.403,0.051,Mild decrease (p=0.041),Mild increase (p=0.02),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP07263,rs335563,18,246988271,BIN1,SNP (C/G),(C/,C,0.88,0.58,1.18,0.00019879,High,0.399,0.136,0.232,0.034,Significant increase (p=0.014),Significant decrease (p=0.017),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP07264,rs476364,13,99486952,CLU,SNP (G/T),(G/,G,0.68,0.37,1.08,0.00850078,Low,0.058,0.167,0.27,0.305,Mild increase (p=0.018),Significant increase (p=0.003),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07265,rs246623,18,170362386,BIN1,SNP (C/G),(C/,C,0.91,0.57,1.24,0.00234441,Moderate,0.129,0.117,0.539,0.014,Significant decrease (p=0.004),Mild decrease (p=0.039),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07266,rs523803,2,173183882,ABCA7,SNP (A/T),(A/,A,0.75,0.46,1.08,0.05075448,Protective,0.124,0.193,0.268,0.216,Significant increase (p=0.048),Variable effect (p=0.003),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07267,rs484423,19,101808010,APOE,Insertion,-,-,1.42,1.08,1.64,0.00405421,Moderate,0.085,0.16,0.421,0.133,Mild decrease (p=0.026),No significant pattern (p=0.007),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07268,rs441592,11,39131526,APP,Insertion,-,-,1.55,1.28,1.87,0.02045272,High,0.184,0.207,0.273,0.136,Significant decrease (p=0.035),Variable effect (p=0.023),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07269,rs290080,17,110689208,CD33,SNP (A/C),(A/,A,0.82,0.6,1.15,0.02542383,Moderate,0.373,0.18,0.039,0.209,Significant decrease (p=0.038),Significant increase (p=0.012),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP07270,rs506837,12,14184844,CLU,Deletion,-,-,0.25,0.1,0.63,0.01320629,Protective,0.05,0.599,0.145,0.006,Mild increase (p=0.042),Mild increase (p=0.013),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07271,rs903389,17,240736386,APP,SNP (C/T),(C/,C,0.64,0.25,0.9,0.04947366,Moderate,0.015,0.048,0.392,0.345,Mild decrease (p=0.036),Significant decrease (p=0.02),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07272,rs749699,12,58761755,APOE,SNP (A/T),(A/,A,1.27,0.9,1.56,0.0717101,Moderate,0.149,0.426,0.149,0.077,No significant pattern (p=0.036),Significant increase (p=0.014),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07273,rs207668,13,207328410,CD2AP,SNP (C/G),(C/,C,1.15,0.88,1.49,0.03891139,High,0.098,0.045,0.429,0.229,Mild decrease (p=0.003),Significant decrease (p=0.006),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07274,rs634808,16,154012472,ABCA7,SNP (A/T),(A/,A,0.74,0.39,1.03,0.06362885,Moderate,0.112,0.014,0.138,0.536,No significant pattern (p=0.012),Significant decrease (p=0.045),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07275,rs790123,8,203332168,CD2AP,SNP (A/T),(A/,A,0.67,0.33,1.01,0.06916365,High,0.095,0.395,0.005,0.305,Significant decrease (p=0.037),Mild increase (p=0.03),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07276,rs882707,18,233527517,CLU,SNP (C/G),(C/,C,0.66,0.36,1.03,0.01615155,Low,0.056,0.06,0.109,0.575,No significant pattern (p=0.022),Variable effect (p=0.01),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07277,rs982630,22,64618618,TREM2,SNP (C/T),(C/,C,1.01,0.64,1.32,0.02132702,High,0.1,0.231,0.026,0.443,Mild decrease (p=0.024),Variable effect (p=0.007),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07278,rs213840,21,183840955,CLU,SNP (A/C),(A/,A,3.09,2.74,3.46,0.00445585,High,0.313,0.09,0.27,0.126,Significant increase (p=0.041),Significant increase (p=0.046),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP07279,rs715078,13,70766392,CD2AP,Deletion,-,-,0.84,0.49,1.08,0.02157226,High,0.224,0.355,0.179,0.042,No significant pattern (p=0.034),Mild decrease (p=0.039),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07280,rs768911,13,95379285,CLU,SNP (C/G),(C/,C,1.62,1.28,1.89,0.03965886,High,0.628,0.038,0.127,0.007,Significant decrease (p=0.049),Variable effect (p=0.029),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07281,rs433631,12,55604003,EPHA1,SNP (G/T),(G/,G,1.58,1.35,1.85,0.0027852,High,0.18,0.463,0.005,0.153,Significant decrease (p=0.043),Significant increase (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07282,rs169077,20,69359141,ABCA7,SNP (C/G),(C/,C,0.48,0.1,0.71,0.00108758,Low,0.094,0.432,0.197,0.077,No significant pattern (p=0.01),Significant decrease (p=0.034),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07283,rs847261,20,31578497,PSEN2,SNP (C/G),(C/,C,1.25,0.92,1.6,0.01092259,High,0.108,0.183,0.428,0.081,Mild decrease (p=0.024),Significant decrease (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07284,rs661902,22,245192775,PTK2B,SNP (A/G),(A/,A,0.7,0.3,0.96,0.0878127,Low,0.067,0.206,0.515,0.012,Significant decrease (p=0.008),No significant pattern (p=0.045),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07285,rs899330,5,108232049,CLU,SNP (G/T),(G/,G,1.23,0.85,1.56,0.0316509,Low,0.076,0.217,0.436,0.071,Significant increase (p=0.031),Significant increase (p=0.027),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07286,rs822260,3,139777722,CD33,SNP (A/T),(A/,A,2.0,1.75,2.38,0.01659362,Low,0.145,0.32,0.076,0.259,Variable effect (p=0.029),Mild decrease (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07287,rs643586,11,50987364,CD33,SNP (C/G),(C/,C,2.21,1.85,2.57,0.00635293,High,0.042,0.516,0.116,0.126,Significant decrease (p=0.031),Significant decrease (p=0.012),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07288,rs619752,21,159601493,MS4A6A,SNP (G/T),(G/,G,2.03,1.74,2.26,0.00207667,High,0.123,0.369,0.1,0.207,Variable effect (p=0.048),Variable effect (p=0.026),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07289,rs113907,4,119329259,MS4A6A,Deletion,-,-,1.41,1.07,1.61,0.02801121,High,0.027,0.203,0.566,0.004,Significant decrease (p=0.02),No significant pattern (p=0.033),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07290,rs106804,9,200608363,SORL1,SNP (C/G),(C/,C,0.56,0.31,0.85,0.02707098,High,0.276,0.189,0.088,0.247,Mild decrease (p=0.04),Significant increase (p=0.036),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07291,rs216516,22,156488744,TREM2,SNP (A/T),(A/,A,0.88,0.61,1.19,0.02007263,High,0.057,0.462,0.027,0.255,Significant increase (p=0.009),Mild decrease (p=0.011),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07292,rs249161,2,228203036,MS4A6A,SNP (C/T),(C/,C,0.77,0.56,1.16,0.00447692,Moderate,0.04,0.213,0.192,0.355,Mild decrease (p=0.018),Variable effect (p=0.028),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07293,rs206420,20,65902602,CD33,Deletion,-,-,1.48,1.14,1.73,0.10573014,Low,0.166,0.22,0.005,0.409,Mild decrease (p=0.026),Mild decrease (p=0.049),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07294,rs713099,6,165160389,APP,SNP (C/G),(C/,C,1.58,1.32,1.82,0.0891972,High,0.076,0.17,0.016,0.537,No significant pattern (p=0.015),No significant pattern (p=0.045),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP07295,rs405565,19,24819239,TREM2,SNP (A/T),(A/,A,1.56,1.36,1.81,0.02647307,Moderate,0.529,0.087,0.169,0.015,Significant decrease (p=0.017),Mild increase (p=0.001),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07296,rs732295,7,112788339,EPHA1,SNP (A/T),(A/,A,1.52,1.22,1.84,0.01181328,Moderate,0.048,0.049,0.385,0.318,Variable effect (p=0.042),Significant increase (p=0.035),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07297,rs700314,14,220406702,CLU,SNP (A/G),(A/,A,0.36,0.1,0.61,0.03595252,High,0.104,0.113,0.24,0.343,Significant increase (p=0.002),Significant decrease (p=0.013),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07298,rs979596,11,64738948,TREM2,Deletion,-,-,1.25,0.94,1.62,0.01428218,Protective,0.089,0.173,0.02,0.518,Variable effect (p=0.026),Mild increase (p=0.038),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07299,rs927346,11,156396039,CLU,SNP (A/G),(A/,A,0.79,0.48,1.02,0.01040507,High,0.058,0.058,0.565,0.118,Significant decrease (p=0.047),Mild increase (p=0.047),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07300,rs182943,22,233170515,SORL1,SNP (C/G),(C/,C,0.64,0.33,1.0,0.0120342,Moderate,0.432,0.042,0.091,0.235,Mild decrease (p=0.029),No significant pattern (p=0.017),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07301,rs386545,11,147950110,CD2AP,SNP (C/T),(C/,C,1.41,1.06,1.81,0.00581359,Low,0.017,0.122,0.574,0.087,Mild increase (p=0.049),No significant pattern (p=0.044),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07302,rs444122,13,178088399,CR1,Insertion,-,-,0.78,0.47,1.07,0.02470591,Low,0.053,0.5,0.232,0.015,Mild increase (p=0.05),Significant increase (p=0.004),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07303,rs753260,20,111447981,TREM2,SNP (A/G),(A/,A,1.29,1.07,1.5,0.01453865,Unknown,0.049,0.292,0.179,0.28,No significant pattern (p=0.01),Mild increase (p=0.033),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07304,rs789402,11,230835325,APOE,Deletion,-,-,0.69,0.31,1.08,0.02848194,Low,0.011,0.437,0.144,0.209,Mild increase (p=0.03),Mild increase (p=0.02),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07305,rs455890,12,193138858,CD33,Deletion,-,-,0.49,0.28,0.82,0.04379886,Moderate,0.296,0.013,0.24,0.251,Significant increase (p=0.002),Mild decrease (p=0.033),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07306,rs541724,16,137946750,PTK2B,SNP (C/T),(C/,C,1.14,0.82,1.36,0.00665252,High,0.107,0.463,0.21,0.02,Mild increase (p=0.01),No significant pattern (p=0.041),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07307,rs467702,18,38621323,CD33,SNP (A/C),(A/,A,1.12,0.87,1.4,0.13218015,High,0.254,0.009,0.043,0.494,Mild decrease (p=0.009),Variable effect (p=0.041),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07308,rs528304,5,62324603,MS4A6A,SNP (A/T),(A/,A,1.81,1.59,2.04,0.00276407,Low,0.11,0.224,0.044,0.423,Significant increase (p=0.049),No significant pattern (p=0.015),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07309,rs132243,3,203156426,PTK2B,Deletion,-,-,1.3,0.96,1.54,0.00421454,Moderate,0.191,0.164,0.26,0.185,Significant increase (p=0.047),Mild increase (p=0.012),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07310,rs239975,15,110256020,CR1,Insertion,-,-,1.3,1.07,1.6,0.03840856,Moderate,0.291,0.293,0.129,0.086,Variable effect (p=0.024),Variable effect (p=0.022),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP07311,rs318261,12,222463612,APP,SNP (C/T),(C/,C,1.36,1.09,1.76,0.0363814,Moderate,0.644,0.051,0.029,0.076,Significant decrease (p=0.025),Significant increase (p=0.016),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07312,rs574429,17,77842337,PSEN2,SNP (C/T),(C/,C,0.78,0.49,1.12,0.00236139,High,0.448,0.03,0.18,0.142,Significant decrease (p=0.017),Mild decrease (p=0.037),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07313,rs145313,3,146312036,CR1,SNP (C/G),(C/,C,1.33,1.07,1.59,0.00516478,Low,0.023,0.218,0.412,0.147,No significant pattern (p=0.005),Significant increase (p=0.012),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07314,rs458296,1,234093886,CR1,SNP (A/C),(A/,A,0.53,0.3,0.73,0.05746213,High,0.212,0.029,0.175,0.384,No significant pattern (p=0.035),Mild decrease (p=0.033),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07315,rs106911,8,236717339,ABCA7,SNP (C/T),(C/,C,1.17,0.95,1.54,0.05252808,Moderate,0.13,0.335,0.045,0.29,No significant pattern (p=0.048),Significant increase (p=0.039),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07316,rs580968,15,169465941,EPHA1,Insertion,-,-,0.99,0.6,1.31,0.02222772,High,0.189,0.483,0.08,0.047,Significant increase (p=0.011),Significant increase (p=0.039),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07317,rs759520,12,14081155,ABCA7,SNP (A/C),(A/,A,0.98,0.62,1.19,0.04053334,Unknown,0.292,0.065,0.392,0.051,Significant increase (p=0.013),No significant pattern (p=0.025),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07318,rs709451,9,219083404,CR1,SNP (A/G),(A/,A,2.03,1.8,2.4,0.10032379,Moderate,0.036,0.687,0.019,0.058,Significant increase (p=0.019),Significant increase (p=0.031),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP07319,rs553760,11,91928678,BIN1,SNP (A/G),(A/,A,1.05,0.68,1.28,0.00657323,High,0.117,0.094,0.326,0.263,No significant pattern (p=0.024),Variable effect (p=0.048),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07320,rs629322,9,108956092,CD2AP,Deletion,-,-,0.86,0.58,1.09,0.00732171,Moderate,0.071,0.696,0.006,0.026,Significant decrease (p=0.014),Significant increase (p=0.01),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07321,rs651335,16,82900964,APOE,Deletion,-,-,1.48,1.11,1.7,0.04412622,High,0.107,0.066,0.325,0.303,Variable effect (p=0.045),Significant decrease (p=0.016),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07322,rs415979,17,103597498,TREM2,SNP (C/T),(C/,C,1.35,1.1,1.66,0.09597467,Low,0.39,0.045,0.177,0.188,Mild decrease (p=0.01),No significant pattern (p=0.006),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07323,rs144956,18,103274665,EPHA1,Insertion,-,-,1.16,0.81,1.37,0.01521709,Moderate,0.046,0.356,0.294,0.104,Significant increase (p=0.047),Mild increase (p=0.026),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07324,rs596247,20,4612218,EPHA1,SNP (A/T),(A/,A,1.11,0.88,1.42,0.01543999,Low,0.426,0.119,0.137,0.117,Variable effect (p=0.024),Mild decrease (p=0.031),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07325,rs831207,8,151741897,PICALM,SNP (A/G),(A/,A,1.76,1.42,2.1,0.02556736,Protective,0.042,0.048,0.508,0.201,Variable effect (p=0.048),Variable effect (p=0.018),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07326,rs470762,22,64531293,APP,SNP (C/T),(C/,C,0.76,0.51,1.05,0.02101489,Moderate,0.256,0.116,0.258,0.17,No significant pattern (p=0.036),Mild increase (p=0.046),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07327,rs192591,18,237504882,SORL1,SNP (A/T),(A/,A,0.24,0.1,0.63,0.04746249,Moderate,0.183,0.041,0.462,0.114,No significant pattern (p=0.038),Significant decrease (p=0.001),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07328,rs982238,4,198527278,CLU,Insertion,-,-,1.32,1.1,1.61,0.02731995,Moderate,0.15,0.284,0.179,0.188,No significant pattern (p=0.001),Significant decrease (p=0.007),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07329,rs500019,10,53159746,CD2AP,SNP (C/T),(C/,C,0.7,0.46,0.99,0.04378338,Unknown,0.115,0.139,0.059,0.486,No significant pattern (p=0.006),Mild increase (p=0.025),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07330,rs878049,19,127130743,CD2AP,SNP (A/G),(A/,A,0.32,0.1,0.68,0.01196699,Moderate,0.077,0.31,0.066,0.347,Significant decrease (p=0.001),Significant decrease (p=0.026),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07331,rs170130,6,20091268,APOE,SNP (C/T),(C/,C,0.81,0.43,1.08,0.00507142,Moderate,0.27,0.146,0.128,0.256,Mild increase (p=0.034),Significant decrease (p=0.029),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07332,rs133679,6,14621347,CD33,SNP (G/T),(G/,G,0.73,0.41,1.02,0.05293608,Moderate,0.247,0.067,0.453,0.033,Mild decrease (p=0.046),Significant increase (p=0.041),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07333,rs962666,20,125254074,BIN1,SNP (A/C),(A/,A,0.77,0.55,1.09,0.0256761,Low,0.229,0.2,0.307,0.065,No significant pattern (p=0.04),Variable effect (p=0.014),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07334,rs290077,22,165077975,ABCA7,SNP (A/G),(A/,A,1.48,1.18,1.87,0.09587195,Moderate,0.043,0.176,0.276,0.305,Significant increase (p=0.009),Variable effect (p=0.02),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07335,rs229045,9,224434772,MS4A6A,SNP (G/T),(G/,G,0.47,0.17,0.84,0.00521877,High,0.093,0.406,0.081,0.22,Mild decrease (p=0.049),No significant pattern (p=0.017),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07336,rs798414,22,226373638,APP,SNP (A/C),(A/,A,2.46,2.15,2.68,0.00114072,High,0.497,0.229,0.014,0.061,No significant pattern (p=0.005),Significant decrease (p=0.005),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07337,rs645763,10,227501476,BIN1,SNP (G/T),(G/,G,1.5,1.24,1.74,0.06587789,Moderate,0.19,0.405,0.094,0.111,Significant decrease (p=0.014),Variable effect (p=0.035),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07338,rs272143,19,191819016,APP,SNP (A/C),(A/,A,0.3,0.1,0.59,0.01506454,High,0.065,0.023,0.237,0.475,Mild increase (p=0.019),Significant increase (p=0.02),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07339,rs250307,13,83049731,SORL1,SNP (A/C),(A/,A,1.85,1.56,2.11,0.0059772,Moderate,0.01,0.004,0.527,0.259,Significant increase (p=0.002),Mild decrease (p=0.042),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07340,rs610961,12,107289754,BIN1,Insertion,-,-,2.33,2.12,2.56,0.009304,Low,0.208,0.16,0.004,0.428,No significant pattern (p=0.006),Significant increase (p=0.01),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP07341,rs902693,8,119255807,PSEN2,SNP (C/T),(C/,C,0.62,0.32,0.87,0.01972094,High,0.049,0.293,0.073,0.384,Mild decrease (p=0.012),Mild decrease (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07342,rs883872,6,150269062,CLU,SNP (C/G),(C/,C,1.45,1.16,1.81,0.0378031,Low,0.277,0.142,0.052,0.329,Mild increase (p=0.012),Mild increase (p=0.016),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07343,rs399790,9,201254450,CD33,SNP (C/T),(C/,C,1.41,1.12,1.66,0.03126716,High,0.002,0.13,0.352,0.316,Significant increase (p=0.002),Significant decrease (p=0.01),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07344,rs228456,22,125526727,TREM2,SNP (A/C),(A/,A,1.77,1.46,2.15,0.00104773,High,0.349,0.121,0.246,0.084,Variable effect (p=0.048),Variable effect (p=0.016),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07345,rs476928,2,199603132,PICALM,Insertion,-,-,0.96,0.65,1.19,0.05253136,Moderate,0.663,0.048,0.061,0.028,Significant decrease (p=0.036),No significant pattern (p=0.011),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07346,rs469411,15,45538549,MS4A6A,SNP (C/G),(C/,C,2.74,2.39,3.07,0.0040293,High,0.351,0.096,0.08,0.273,Mild increase (p=0.033),No significant pattern (p=0.017),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07347,rs976963,7,49077237,CD33,SNP (C/G),(C/,C,0.23,0.1,0.63,0.00894788,Moderate,0.533,0.118,0.133,0.016,Mild increase (p=0.039),Significant increase (p=0.011),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07348,rs730539,11,155010876,PTK2B,SNP (G/T),(G/,G,0.59,0.37,0.84,0.05531234,Low,0.388,0.095,0.01,0.307,No significant pattern (p=0.008),Significant decrease (p=0.034),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07349,rs274104,21,54298517,APOE,Deletion,-,-,2.14,1.81,2.47,0.01229444,Moderate,0.047,0.392,0.064,0.297,No significant pattern (p=0.021),Variable effect (p=0.018),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07350,rs580607,4,115457434,CD2AP,SNP (A/T),(A/,A,0.5,0.21,0.87,0.00244369,High,0.264,0.363,0.13,0.043,Mild decrease (p=0.049),Variable effect (p=0.04),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07351,rs171416,10,41104374,EPHA1,SNP (A/G),(A/,A,1.28,1.0,1.57,0.00893235,Moderate,0.288,0.11,0.378,0.024,Mild increase (p=0.009),Variable effect (p=0.022),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07352,rs147013,20,89878308,PSEN2,SNP (C/T),(C/,C,0.95,0.68,1.25,0.00038397,Low,0.305,0.106,0.287,0.102,Mild decrease (p=0.022),Mild increase (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07353,rs448585,4,17629813,PICALM,SNP (A/C),(A/,A,1.26,0.96,1.63,0.00731008,High,0.172,0.071,0.022,0.535,Mild increase (p=0.009),Mild decrease (p=0.027),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07354,rs758345,13,215327941,EPHA1,SNP (C/G),(C/,C,0.7,0.42,1.1,0.02862253,Moderate,0.328,0.052,0.408,0.011,Significant increase (p=0.037),Mild decrease (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07355,rs568314,5,86684998,APP,SNP (C/T),(C/,C,0.45,0.18,0.76,0.00921616,Low,0.77,0.01,0.006,0.014,Mild increase (p=0.02),Significant decrease (p=0.04),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP07356,rs821685,13,64463179,SORL1,SNP (G/T),(G/,G,0.81,0.46,1.02,0.05773692,High,0.351,0.169,0.128,0.152,Variable effect (p=0.033),Variable effect (p=0.038),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07357,rs387512,20,229642120,APP,SNP (C/T),(C/,C,2.39,2.08,2.65,0.02857788,Moderate,0.323,0.103,0.064,0.309,Variable effect (p=0.046),Significant decrease (p=0.008),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07358,rs996131,3,57661830,ABCA7,SNP (A/C),(A/,A,0.8,0.5,1.04,0.02824772,Unknown,0.246,0.141,0.046,0.367,Mild increase (p=0.02),Significant decrease (p=0.038),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07359,rs186048,12,161000877,TREM2,SNP (G/T),(G/,G,0.98,0.74,1.29,0.08387966,Moderate,0.328,0.184,0.223,0.065,Variable effect (p=0.023),No significant pattern (p=0.037),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07360,rs333523,12,183349869,APP,SNP (A/G),(A/,A,0.94,0.7,1.24,0.03899072,Moderate,0.467,0.047,0.011,0.276,No significant pattern (p=0.014),Significant increase (p=0.035),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP07361,rs128869,17,78367733,PSEN2,Deletion,-,-,0.87,0.59,1.12,0.02443832,Moderate,0.305,0.035,0.093,0.367,Variable effect (p=0.027),No significant pattern (p=0.038),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07362,rs904232,21,169494787,MS4A6A,SNP (A/G),(A/,A,0.69,0.42,1.08,0.01811654,Low,0.134,0.314,0.081,0.271,Mild decrease (p=0.028),No significant pattern (p=0.047),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07363,rs765542,16,170100186,EPHA1,SNP (A/G),(A/,A,1.63,1.31,2.01,0.05630764,Moderate,0.512,0.093,0.139,0.057,No significant pattern (p=0.012),No significant pattern (p=0.002),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP07364,rs867013,12,196815465,PSEN2,SNP (C/G),(C/,C,0.54,0.26,0.76,0.00143086,Low,0.141,0.363,0.171,0.125,No significant pattern (p=0.017),Significant decrease (p=0.041),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07365,rs345217,19,180582109,SORL1,SNP (A/T),(A/,A,0.74,0.37,0.97,0.04834455,Low,0.019,0.536,0.213,0.033,Variable effect (p=0.03),Significant decrease (p=0.018),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07366,rs715837,12,128973089,PSEN2,SNP (C/T),(C/,C,0.92,0.7,1.13,0.04148951,High,0.331,0.175,0.045,0.248,Significant decrease (p=0.05),Significant increase (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07367,rs615647,17,206725570,CD2AP,SNP (G/T),(G/,G,0.67,0.35,1.02,0.03817743,Moderate,0.198,0.254,0.098,0.25,Mild decrease (p=0.023),Mild increase (p=0.04),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07368,rs858871,4,226769683,SORL1,SNP (G/T),(G/,G,1.37,1.02,1.66,0.02195459,Moderate,0.01,0.031,0.06,0.699,Significant increase (p=0.009),Significant increase (p=0.011),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07369,rs682817,2,155059183,APP,Deletion,-,-,0.71,0.37,1.08,0.01510435,Low,0.207,0.144,0.299,0.15,Significant increase (p=0.034),Mild increase (p=0.019),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07370,rs851872,15,228708419,CLU,SNP (A/G),(A/,A,0.56,0.2,0.78,0.01723604,Low,0.061,0.221,0.5,0.018,Mild decrease (p=0.018),Mild increase (p=0.008),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07371,rs431774,19,63769619,SORL1,SNP (G/T),(G/,G,1.71,1.46,1.93,0.07303948,High,0.27,0.067,0.121,0.342,Mild increase (p=0.028),No significant pattern (p=0.016),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP07372,rs899001,12,235692165,EPHA1,SNP (C/G),(C/,C,1.04,0.83,1.39,0.07745976,Moderate,0.08,0.4,0.164,0.156,Mild increase (p=0.028),Variable effect (p=0.02),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07373,rs390706,17,199539259,SORL1,SNP (A/G),(A/,A,0.99,0.7,1.37,0.00838969,Moderate,0.066,0.049,0.683,0.002,Variable effect (p=0.037),Mild increase (p=0.047),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07374,rs107517,11,126902679,ABCA7,Insertion,-,-,1.06,0.8,1.43,0.11401738,Moderate,0.085,0.05,0.013,0.651,Mild decrease (p=0.049),No significant pattern (p=0.002),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07375,rs920738,18,241262640,TREM2,Insertion,-,-,0.63,0.32,1.02,0.09775033,High,0.169,0.242,0.121,0.268,No significant pattern (p=0.034),Variable effect (p=0.01),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07376,rs738553,22,172194625,PTK2B,SNP (A/C),(A/,A,0.96,0.63,1.24,0.0396955,Protective,0.359,0.167,0.19,0.084,No significant pattern (p=0.048),Significant increase (p=0.003),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07377,rs963342,10,92571243,MS4A6A,Deletion,-,-,0.5,0.2,0.85,0.07733304,Moderate,0.014,0.391,0.201,0.194,Significant increase (p=0.048),Significant decrease (p=0.006),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07378,rs508332,17,5261816,CD2AP,SNP (C/T),(C/,C,0.87,0.63,1.17,0.04291768,Moderate,0.291,0.088,0.332,0.089,Variable effect (p=0.05),Mild increase (p=0.02),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07379,rs562660,10,54462364,APOE,SNP (G/T),(G/,G,0.72,0.38,1.03,0.01325608,High,0.173,0.043,0.526,0.058,Mild decrease (p=0.029),Significant increase (p=0.028),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP07380,rs548996,18,87480549,PSEN2,SNP (C/T),(C/,C,1.08,0.84,1.39,0.01901933,Unknown,0.252,0.032,0.116,0.401,No significant pattern (p=0.024),Mild increase (p=0.041),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07381,rs450629,18,210456871,BIN1,Deletion,-,-,0.64,0.33,0.88,0.02358608,Low,0.056,0.229,0.156,0.359,Significant decrease (p=0.006),Variable effect (p=0.007),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07382,rs302660,1,152959219,ABCA7,SNP (G/T),(G/,G,2.04,1.78,2.26,0.00013433,Low,0.362,0.026,0.405,0.007,Mild increase (p=0.031),Significant decrease (p=0.024),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07383,rs284977,14,21394702,SORL1,Insertion,-,-,2.06,1.76,2.41,9.147e-05,Protective,0.574,0.059,0.061,0.106,No significant pattern (p=0.041),No significant pattern (p=0.018),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07384,rs806396,17,198576248,CD2AP,Deletion,-,-,1.61,1.26,1.99,0.00044964,High,0.247,0.249,0.056,0.249,No significant pattern (p=0.006),Significant decrease (p=0.002),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP07385,rs153157,15,71310134,MS4A6A,SNP (G/T),(G/,G,0.54,0.22,0.75,0.02159677,Moderate,0.172,0.123,0.263,0.243,Mild increase (p=0.026),No significant pattern (p=0.029),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07386,rs749689,15,223256226,CD2AP,SNP (A/T),(A/,A,0.72,0.51,0.95,0.00895812,Moderate,0.009,0.467,0.002,0.322,Mild increase (p=0.05),Mild decrease (p=0.037),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP07387,rs992091,3,134056060,BIN1,SNP (A/C),(A/,A,0.43,0.2,0.81,0.00014207,Protective,0.027,0.033,0.193,0.547,Significant decrease (p=0.044),Mild increase (p=0.045),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07388,rs899094,9,202603674,CLU,SNP (G/T),(G/,G,1.28,0.95,1.52,0.00998651,Moderate,0.174,0.387,0.031,0.209,Mild increase (p=0.038),Significant increase (p=0.007),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07389,rs221441,10,20444035,EPHA1,SNP (A/T),(A/,A,1.06,0.67,1.46,0.02350196,Moderate,0.028,0.265,0.152,0.355,Significant increase (p=0.013),Mild increase (p=0.022),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07390,rs824740,17,230018094,APOE,SNP (C/T),(C/,C,1.6,1.35,1.81,0.00283051,Protective,0.475,0.285,0.039,0.001,Significant decrease (p=0.043),Significant increase (p=0.002),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07391,rs528167,17,91288264,APP,Insertion,-,-,1.23,0.91,1.46,0.09620407,Protective,0.104,0.092,0.317,0.288,No significant pattern (p=0.019),No significant pattern (p=0.048),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07392,rs297352,2,212600211,SORL1,SNP (C/G),(C/,C,0.97,0.68,1.31,0.03027329,High,0.313,0.159,0.08,0.248,Mild decrease (p=0.022),Mild increase (p=0.009),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07393,rs924114,22,81563523,CD2AP,SNP (C/T),(C/,C,1.02,0.66,1.4,0.01482259,Protective,0.217,0.385,0.0,0.198,Significant increase (p=0.021),Significant increase (p=0.007),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07394,rs372908,1,136084843,TREM2,SNP (G/T),(G/,G,1.02,0.78,1.31,0.00359186,Low,0.322,0.095,0.252,0.131,Mild decrease (p=0.041),Variable effect (p=0.019),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07395,rs211425,3,68715782,EPHA1,SNP (A/T),(A/,A,1.41,1.07,1.66,0.00702885,Moderate,0.18,0.002,0.498,0.12,Mild increase (p=0.004),Significant decrease (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP07396,rs367699,1,173350240,MS4A6A,SNP (A/C),(A/,A,0.68,0.36,0.97,0.00653198,Protective,0.03,0.005,0.345,0.42,No significant pattern (p=0.046),Variable effect (p=0.036),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07397,rs614164,9,190697186,MS4A6A,SNP (C/G),(C/,C,0.79,0.57,1.15,0.02485924,Moderate,0.206,0.049,0.198,0.347,Significant decrease (p=0.028),Mild increase (p=0.049),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP07398,rs396372,19,168540747,CR1,SNP (C/G),(C/,C,1.58,1.26,1.8,0.01230912,High,0.103,0.292,0.276,0.13,Mild decrease (p=0.023),Variable effect (p=0.021),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP07399,rs899666,1,202244878,APOE,SNP (A/C),(A/,A,0.87,0.65,1.26,0.01378855,Moderate,0.064,0.346,0.135,0.255,Variable effect (p=0.045),Significant decrease (p=0.039),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07400,rs601222,7,231788669,CD33,Insertion,-,-,0.8,0.57,1.18,0.03322573,High,0.414,0.233,0.075,0.078,Variable effect (p=0.042),Significant decrease (p=0.016),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07401,rs831408,14,242702822,TREM2,Insertion,-,-,2.07,1.76,2.38,0.00613269,High,0.151,0.228,0.233,0.188,Mild increase (p=0.028),Significant decrease (p=0.027),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07402,rs178594,16,138747919,CR1,Insertion,-,-,2.2,1.99,2.54,0.00042939,Low,0.146,0.322,0.294,0.038,Variable effect (p=0.033),Significant decrease (p=0.044),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP07403,rs218352,18,202279749,CD33,SNP (A/G),(A/,A,0.86,0.62,1.25,0.00315601,Moderate,0.209,0.209,0.375,0.008,Mild increase (p=0.023),No significant pattern (p=0.036),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07404,rs475884,16,74997307,PTK2B,SNP (A/C),(A/,A,3.23,2.9,3.63,0.01023353,Moderate,0.018,0.548,0.052,0.182,Mild increase (p=0.007),Mild increase (p=0.041),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP07405,rs486315,22,216395242,TREM2,SNP (A/G),(A/,A,0.94,0.69,1.27,0.00684402,High,0.452,0.207,0.088,0.054,Variable effect (p=0.044),No significant pattern (p=0.032),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07406,rs526806,9,68742265,MS4A6A,SNP (A/C),(A/,A,0.83,0.62,1.19,0.04327665,High,0.158,0.321,0.008,0.312,Mild increase (p=0.045),Mild decrease (p=0.005),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07407,rs894928,1,225055622,CLU,SNP (A/G),(A/,A,0.57,0.33,0.92,0.025085,Protective,0.226,0.088,0.094,0.393,Variable effect (p=0.026),Significant decrease (p=0.034),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07408,rs402301,11,70410635,CD33,Deletion,-,-,1.44,1.17,1.79,0.04689369,Moderate,0.084,0.286,0.405,0.025,Mild decrease (p=0.038),No significant pattern (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07409,rs800478,11,111924810,CD2AP,SNP (A/G),(A/,A,1.84,1.54,2.21,0.00293191,Low,0.13,0.257,0.041,0.372,Mild decrease (p=0.05),Mild decrease (p=0.012),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07410,rs841873,17,165452639,ABCA7,SNP (C/G),(C/,C,1.03,0.65,1.25,0.04025965,High,0.205,0.072,0.297,0.226,Significant increase (p=0.028),Significant decrease (p=0.005),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07411,rs436290,22,32863172,PTK2B,SNP (C/T),(C/,C,1.48,1.15,1.84,0.04343156,Moderate,0.127,0.231,0.211,0.231,Significant decrease (p=0.026),Variable effect (p=0.003),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07412,rs576918,2,20551038,PICALM,SNP (C/G),(C/,C,0.35,0.1,0.56,0.04182417,High,0.07,0.205,0.05,0.475,Mild decrease (p=0.034),No significant pattern (p=0.047),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07413,rs408290,10,186405888,CR1,SNP (A/T),(A/,A,1.02,0.77,1.25,0.02169978,Moderate,0.05,0.397,0.185,0.168,Significant increase (p=0.023),Significant decrease (p=0.028),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP07414,rs785112,3,50457555,EPHA1,SNP (C/T),(C/,C,0.81,0.58,1.02,0.05621868,Low,0.05,0.18,0.508,0.062,Mild increase (p=0.01),Variable effect (p=0.048),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07415,rs429520,3,120094121,CLU,Deletion,-,-,1.87,1.66,2.15,0.01811578,Moderate,0.036,0.385,0.128,0.251,Mild increase (p=0.04),Mild decrease (p=0.009),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07416,rs794191,20,165801876,CD2AP,SNP (G/T),(G/,G,2.22,1.98,2.55,0.05479596,Moderate,0.422,0.126,0.193,0.059,Significant increase (p=0.036),Significant decrease (p=0.024),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07417,rs618300,11,90205492,APOE,SNP (C/T),(C/,C,0.49,0.14,0.72,0.04131058,High,0.112,0.147,0.331,0.21,Mild decrease (p=0.001),Significant decrease (p=0.007),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07418,rs984685,4,118540288,PTK2B,SNP (A/G),(A/,A,1.95,1.63,2.19,0.00190835,Moderate,0.16,0.055,0.428,0.156,Significant increase (p=0.043),Mild decrease (p=0.039),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07419,rs581802,4,58746025,APOE,Insertion,-,-,1.64,1.3,2.03,0.00177574,Unknown,0.105,0.091,0.03,0.573,Significant decrease (p=0.031),No significant pattern (p=0.027),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07420,rs876980,8,12300195,CD2AP,SNP (A/C),(A/,A,1.18,0.95,1.55,0.00350768,High,0.002,0.077,0.433,0.288,Mild increase (p=0.037),Significant increase (p=0.017),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP07421,rs278991,19,142773234,APOE,SNP (C/G),(C/,C,0.62,0.27,0.83,0.04019321,Moderate,0.202,0.046,0.28,0.273,Significant decrease (p=0.012),Significant decrease (p=0.041),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07422,rs609563,16,248380061,CD33,SNP (C/G),(C/,C,1.15,0.84,1.37,0.00665458,Unknown,0.375,0.206,0.021,0.199,Mild increase (p=0.008),Variable effect (p=0.048),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07423,rs300663,19,225188110,ABCA7,SNP (A/C),(A/,A,1.04,0.78,1.4,0.03172885,High,0.438,0.234,0.104,0.024,Significant decrease (p=0.021),Significant increase (p=0.029),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07424,rs776124,21,2301129,PTK2B,Deletion,-,-,0.21,0.1,0.46,0.007486,Moderate,0.225,0.175,0.201,0.2,Significant increase (p=0.009),Variable effect (p=0.046),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07425,rs577903,17,79398292,PICALM,Insertion,-,-,2.13,1.8,2.47,0.03595699,High,0.113,0.363,0.262,0.062,No significant pattern (p=0.023),Significant increase (p=0.042),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07426,rs787796,22,43071907,APOE,Deletion,-,-,1.3,0.97,1.64,0.0727745,Protective,0.178,0.306,0.134,0.182,Variable effect (p=0.023),Mild decrease (p=0.033),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP07427,rs224635,1,123028230,PICALM,Deletion,-,-,0.71,0.44,0.93,0.02656351,Protective,0.144,0.181,0.275,0.2,Variable effect (p=0.035),Variable effect (p=0.015),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07428,rs857221,7,238365309,PICALM,SNP (G/T),(G/,G,1.33,1.12,1.56,0.03456632,Moderate,0.656,0.012,0.082,0.05,Significant decrease (p=0.048),Mild decrease (p=0.014),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07429,rs573797,2,116368836,PSEN2,SNP (A/G),(A/,A,0.79,0.59,1.13,0.02857821,Moderate,0.183,0.241,0.174,0.202,Variable effect (p=0.007),Variable effect (p=0.049),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07430,rs120976,18,101785031,APP,SNP (C/G),(C/,C,0.67,0.27,1.02,0.00401846,Moderate,0.645,0.049,0.093,0.014,No significant pattern (p=0.046),No significant pattern (p=0.004),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07431,rs770784,7,43205935,APP,SNP (G/T),(G/,G,1.09,0.86,1.32,0.04180762,High,0.364,0.194,0.23,0.012,Mild decrease (p=0.047),Significant increase (p=0.012),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07432,rs506073,20,26679580,ABCA7,SNP (A/C),(A/,A,1.0,0.77,1.36,0.00452534,High,0.052,0.267,0.292,0.188,Significant decrease (p=0.039),Variable effect (p=0.007),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07433,rs403302,17,150922301,PSEN2,SNP (C/G),(C/,C,1.36,1.16,1.75,0.00498702,Protective,0.234,0.095,0.452,0.02,No significant pattern (p=0.036),Significant decrease (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07434,rs276991,8,61817341,EPHA1,SNP (A/G),(A/,A,1.32,0.98,1.66,0.05247647,High,0.236,0.125,0.195,0.244,No significant pattern (p=0.002),No significant pattern (p=0.003),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07435,rs721057,18,225096987,BIN1,SNP (A/G),(A/,A,0.61,0.33,0.86,0.01657674,Moderate,0.073,0.007,0.685,0.036,Variable effect (p=0.04),Significant increase (p=0.028),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07436,rs947391,5,216209259,ABCA7,SNP (C/G),(C/,C,0.72,0.47,1.1,0.01931536,Protective,0.085,0.272,0.187,0.256,Mild increase (p=0.021),Significant decrease (p=0.003),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07437,rs399353,17,53258647,APOE,SNP (C/T),(C/,C,0.52,0.31,0.82,0.0331099,Low,0.314,0.016,0.086,0.384,Variable effect (p=0.024),Mild increase (p=0.008),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07438,rs443535,14,119763216,CD2AP,SNP (C/G),(C/,C,1.95,1.59,2.34,0.0708356,Low,0.124,0.465,0.1,0.111,Variable effect (p=0.023),Significant decrease (p=0.037),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP07439,rs547578,1,138806590,CD2AP,SNP (C/G),(C/,C,2.64,2.24,2.87,0.00287903,Protective,0.158,0.089,0.145,0.408,No significant pattern (p=0.034),Variable effect (p=0.036),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07440,rs403852,14,173173104,APOE,SNP (C/G),(C/,C,2.04,1.7,2.44,0.05188057,High,0.185,0.348,0.223,0.044,Significant increase (p=0.044),Mild decrease (p=0.033),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07441,rs280908,7,18515206,APOE,Deletion,-,-,1.51,1.24,1.81,0.03806055,Moderate,0.179,0.011,0.384,0.226,No significant pattern (p=0.008),Significant decrease (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07442,rs355799,22,148939294,CD2AP,SNP (A/G),(A/,A,1.92,1.57,2.19,0.0312556,Unknown,0.009,0.162,0.399,0.229,Variable effect (p=0.004),Significant decrease (p=0.032),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07443,rs431557,3,184696407,CR1,SNP (A/C),(A/,A,1.59,1.24,1.84,0.00911173,Moderate,0.177,0.314,0.192,0.117,Mild increase (p=0.025),Mild decrease (p=0.011),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP07444,rs436160,9,211674498,CD2AP,SNP (G/T),(G/,G,0.82,0.56,1.15,0.00589,High,0.098,0.471,0.033,0.199,Variable effect (p=0.045),Mild increase (p=0.03),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP07445,rs849005,1,22984852,TREM2,SNP (A/C),(A/,A,0.55,0.35,0.95,0.00314844,High,0.016,0.088,0.216,0.479,Mild decrease (p=0.044),Mild increase (p=0.005),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07446,rs838612,20,189553652,CLU,SNP (C/T),(C/,C,0.85,0.58,1.17,0.04326655,Low,0.1,0.121,0.339,0.24,Mild decrease (p=0.029),Mild decrease (p=0.043),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07447,rs220642,18,153615517,CR1,SNP (C/T),(C/,C,0.22,0.1,0.46,0.02546971,High,0.317,0.034,0.237,0.212,Variable effect (p=0.017),Significant decrease (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07448,rs298852,13,190416739,APOE,SNP (A/C),(A/,A,1.06,0.76,1.33,0.0142772,Protective,0.501,0.073,0.162,0.064,Variable effect (p=0.019),Significant increase (p=0.011),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07449,rs737069,22,110233552,PTK2B,SNP (C/G),(C/,C,0.93,0.57,1.14,0.01704619,High,0.015,0.473,0.056,0.256,Mild increase (p=0.008),Significant increase (p=0.011),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07450,rs771418,18,84563740,SORL1,SNP (G/T),(G/,G,1.04,0.79,1.44,0.07041701,Moderate,0.126,0.344,0.231,0.098,No significant pattern (p=0.036),Significant decrease (p=0.029),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07451,rs230444,7,24066191,CLU,SNP (C/G),(C/,C,2.06,1.84,2.37,0.00685247,High,0.315,0.18,0.035,0.27,Mild increase (p=0.021),Significant increase (p=0.035),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07452,rs470532,7,181456595,APOE,SNP (A/C),(A/,A,0.58,0.31,0.88,0.0002417,Moderate,0.128,0.05,0.224,0.398,Mild increase (p=0.045),Mild decrease (p=0.022),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07453,rs669241,8,71039810,PTK2B,SNP (A/G),(A/,A,0.65,0.31,0.94,0.02958333,High,0.21,0.153,0.092,0.345,Variable effect (p=0.049),Mild increase (p=0.014),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07454,rs383320,21,43533226,TREM2,SNP (A/G),(A/,A,1.52,1.17,1.9,0.01855609,High,0.283,0.281,0.228,0.008,No significant pattern (p=0.019),No significant pattern (p=0.008),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07455,rs151134,15,2444433,PICALM,SNP (C/G),(C/,C,2.33,2.06,2.56,0.04577875,High,0.619,0.036,0.049,0.095,Significant decrease (p=0.047),Variable effect (p=0.048),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07456,rs607168,12,56431285,APOE,SNP (C/T),(C/,C,0.65,0.29,1.01,0.00260621,Protective,0.263,0.334,0.155,0.049,No significant pattern (p=0.014),Variable effect (p=0.016),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07457,rs166723,18,108852753,MS4A6A,SNP (C/G),(C/,C,0.65,0.38,0.86,0.0245591,Low,0.117,0.3,0.194,0.189,Significant increase (p=0.041),Mild increase (p=0.043),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07458,rs113240,12,6221071,CLU,Deletion,-,-,0.54,0.29,0.75,0.007606,High,0.033,0.272,0.352,0.143,No significant pattern (p=0.004),Variable effect (p=0.012),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07459,rs997133,18,78312907,SORL1,SNP (C/T),(C/,C,0.55,0.17,0.78,0.01468236,High,0.003,0.326,0.4,0.071,Variable effect (p=0.014),Variable effect (p=0.01),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07460,rs122365,8,233866414,PTK2B,SNP (A/C),(A/,A,0.92,0.54,1.23,0.07792888,Low,0.383,0.072,0.144,0.201,No significant pattern (p=0.023),Significant increase (p=0.02),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07461,rs560116,7,42238976,CLU,SNP (C/G),(C/,C,1.73,1.47,2.0,0.01628879,Moderate,0.175,0.06,0.438,0.127,Variable effect (p=0.008),Mild decrease (p=0.042),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07462,rs863621,8,195207868,TREM2,SNP (C/G),(C/,C,1.98,1.72,2.28,0.00128724,Moderate,0.041,0.012,0.355,0.392,Significant decrease (p=0.023),Significant decrease (p=0.049),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07463,rs546521,5,130239034,PSEN2,Deletion,-,-,1.91,1.57,2.17,0.0699547,Moderate,0.166,0.214,0.092,0.328,Mild decrease (p=0.013),Significant increase (p=0.025),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07464,rs901235,15,243623752,TREM2,SNP (A/T),(A/,A,0.42,0.22,0.66,0.03765956,Unknown,0.427,0.165,0.075,0.132,Significant increase (p=0.045),No significant pattern (p=0.04),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07465,rs770373,4,82235745,PSEN2,SNP (G/T),(G/,G,4.09,3.81,4.39,0.00379215,High,0.19,0.374,0.106,0.13,Mild increase (p=0.03),No significant pattern (p=0.014),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07466,rs245747,7,152998510,SORL1,SNP (C/T),(C/,C,0.73,0.35,1.0,0.02279914,Protective,0.002,0.045,0.148,0.605,No significant pattern (p=0.026),Mild decrease (p=0.02),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07467,rs741271,22,193930686,PSEN2,SNP (G/T),(G/,G,1.03,0.73,1.3,0.06438485,High,0.598,0.056,0.143,0.003,No significant pattern (p=0.025),Significant increase (p=0.003),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07468,rs707112,18,120195300,PSEN2,SNP (A/G),(A/,A,0.69,0.38,1.01,0.01027195,High,0.012,0.22,0.019,0.55,Significant increase (p=0.046),Significant increase (p=0.01),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07469,rs628568,11,212310532,SORL1,SNP (C/G),(C/,C,1.51,1.24,1.81,0.00945683,Moderate,0.275,0.12,0.151,0.254,Mild increase (p=0.021),No significant pattern (p=0.032),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07470,rs737241,14,165522129,EPHA1,Insertion,-,-,0.79,0.5,1.06,0.00994069,Unknown,0.088,0.165,0.495,0.052,Variable effect (p=0.024),Mild decrease (p=0.005),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP07471,rs429630,2,196838672,APOE,SNP (C/G),(C/,C,1.45,1.21,1.72,0.01298793,Protective,0.147,0.573,0.046,0.034,Mild increase (p=0.041),Mild increase (p=0.034),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07472,rs552338,16,30891862,CR1,SNP (A/T),(A/,A,0.72,0.46,0.93,0.03544004,Moderate,0.017,0.49,0.004,0.289,Significant decrease (p=0.035),Variable effect (p=0.047),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07473,rs795536,6,77528301,PSEN2,SNP (C/G),(C/,C,0.76,0.54,1.09,0.00928604,High,0.36,0.059,0.147,0.234,Significant increase (p=0.006),No significant pattern (p=0.031),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07474,rs171685,8,43773949,APP,SNP (A/G),(A/,A,0.68,0.38,0.99,0.04371613,Low,0.309,0.001,0.349,0.14,Mild decrease (p=0.026),Mild decrease (p=0.045),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07475,rs591080,17,168700890,ABCA7,Deletion,-,-,2.03,1.69,2.26,0.00981381,High,0.078,0.085,0.073,0.563,Variable effect (p=0.003),Mild decrease (p=0.027),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07476,rs306379,10,54934634,PTK2B,SNP (C/G),(C/,C,0.63,0.39,0.85,0.01482336,High,0.033,0.342,0.204,0.221,Variable effect (p=0.003),Significant decrease (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07477,rs403095,1,22452277,APOE,Insertion,-,-,0.67,0.31,1.05,0.06072057,Protective,0.044,0.075,0.135,0.546,Significant decrease (p=0.009),Significant increase (p=0.034),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07478,rs813958,10,75550883,PTK2B,SNP (A/G),(A/,A,1.26,0.88,1.6,0.08855117,High,0.374,0.059,0.076,0.291,No significant pattern (p=0.044),Significant increase (p=0.027),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07479,rs691340,13,152883775,APOE,SNP (A/C),(A/,A,0.69,0.37,0.89,0.05317088,Low,0.074,0.528,0.181,0.018,Mild decrease (p=0.025),Mild increase (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07480,rs297846,9,98102741,ABCA7,Deletion,-,-,1.03,0.83,1.28,0.03752857,Moderate,0.299,0.003,0.463,0.035,No significant pattern (p=0.031),Mild increase (p=0.027),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07481,rs324309,19,189310573,APP,SNP (C/T),(C/,C,1.2,0.84,1.5,0.03105336,Low,0.223,0.023,0.15,0.404,Variable effect (p=0.033),Mild decrease (p=0.033),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07482,rs775396,20,99384406,MS4A6A,SNP (A/G),(A/,A,1.07,0.85,1.3,0.00162796,Moderate,0.311,0.164,0.143,0.182,Significant decrease (p=0.026),Mild increase (p=0.049),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP07483,rs140561,16,130817404,APP,SNP (A/T),(A/,A,1.42,1.18,1.81,0.00621701,High,0.009,0.142,0.446,0.203,Significant decrease (p=0.002),No significant pattern (p=0.038),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07484,rs214400,4,205502431,CD2AP,Deletion,-,-,0.68,0.32,0.95,0.08135259,Moderate,0.058,0.18,0.194,0.368,Significant decrease (p=0.016),Mild increase (p=0.003),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07485,rs977389,22,45840585,ABCA7,SNP (A/C),(A/,A,1.8,1.5,2.11,0.01615323,High,0.036,0.427,0.227,0.11,Mild increase (p=0.01),Significant decrease (p=0.005),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07486,rs175803,10,122492063,PICALM,SNP (G/T),(G/,G,0.74,0.46,1.04,0.00277028,Low,0.024,0.472,0.117,0.188,Mild increase (p=0.047),No significant pattern (p=0.049),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP07487,rs322428,17,82153522,BIN1,Insertion,-,-,2.19,1.88,2.47,0.0280897,Low,0.147,0.156,0.377,0.12,Mild decrease (p=0.05),Variable effect (p=0.022),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07488,rs737915,4,136681312,CD2AP,SNP (A/G),(A/,A,0.98,0.6,1.21,0.01415039,Moderate,0.051,0.379,0.21,0.159,Mild decrease (p=0.008),Mild increase (p=0.016),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07489,rs771832,11,208815604,SORL1,Insertion,-,-,3.47,3.21,3.85,0.03748254,High,0.321,0.142,0.312,0.025,Mild decrease (p=0.02),Mild decrease (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07490,rs367238,1,233960830,TREM2,SNP (C/T),(C/,C,1.9,1.55,2.25,0.0407762,Protective,0.255,0.149,0.05,0.346,No significant pattern (p=0.011),No significant pattern (p=0.046),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP07491,rs780148,8,158289189,BIN1,SNP (A/C),(A/,A,1.47,1.21,1.73,0.05486713,High,0.16,0.187,0.358,0.094,Significant decrease (p=0.037),Variable effect (p=0.003),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07492,rs464380,2,62005865,MS4A6A,SNP (C/G),(C/,C,0.97,0.71,1.31,0.01033819,Low,0.147,0.212,0.224,0.217,Significant increase (p=0.014),Mild decrease (p=0.015),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07493,rs877064,16,206744296,ABCA7,SNP (A/C),(A/,A,3.12,2.83,3.4,0.0227375,Protective,0.003,0.338,0.064,0.396,Significant decrease (p=0.02),Mild increase (p=0.028),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP07494,rs382874,4,146009456,PICALM,SNP (A/C),(A/,A,1.8,1.52,2.08,0.0022182,High,0.272,0.195,0.327,0.007,Mild decrease (p=0.045),Significant increase (p=0.007),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07495,rs532393,3,194002988,EPHA1,Insertion,-,-,2.19,1.89,2.55,0.0282157,High,0.149,0.075,0.163,0.412,Mild increase (p=0.046),Mild decrease (p=0.006),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07496,rs155923,9,159789436,SORL1,SNP (A/T),(A/,A,1.34,1.12,1.72,0.05639071,Moderate,0.219,0.263,0.044,0.273,No significant pattern (p=0.006),Significant increase (p=0.023),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP07497,rs845421,3,143782512,APOE,SNP (C/G),(C/,C,1.1,0.86,1.43,0.0151024,Moderate,0.635,0.041,0.049,0.075,No significant pattern (p=0.017),Variable effect (p=0.005),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07498,rs747527,20,91904495,SORL1,SNP (G/T),(G/,G,0.36,0.1,0.68,0.03286852,Unknown,0.543,0.035,0.033,0.19,Mild increase (p=0.02),Mild increase (p=0.05),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07499,rs518193,20,245777068,CLU,Insertion,-,-,2.08,1.7,2.38,0.02838516,High,0.649,0.003,0.116,0.032,Mild decrease (p=0.042),Mild decrease (p=0.045),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07500,rs303784,1,205837219,PICALM,Deletion,-,-,0.77,0.49,1.13,0.03303615,Low,0.589,0.002,0.056,0.154,Significant increase (p=0.022),Mild increase (p=0.005),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07501,rs184028,15,109030007,TREM2,SNP (A/C),(A/,A,0.86,0.64,1.06,0.00204345,High,0.1,0.168,0.221,0.312,Significant decrease (p=0.031),Significant decrease (p=0.008),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07502,rs667752,3,83897113,CR1,SNP (A/C),(A/,A,0.9,0.52,1.12,0.06933504,Moderate,0.023,0.519,0.185,0.073,Variable effect (p=0.004),Significant decrease (p=0.021),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07503,rs172248,17,218415228,PSEN2,SNP (A/G),(A/,A,0.89,0.55,1.15,0.00302918,High,0.255,0.105,0.372,0.068,No significant pattern (p=0.022),Significant decrease (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07504,rs903564,6,86122553,CD2AP,SNP (A/C),(A/,A,1.05,0.77,1.25,0.02418024,Moderate,0.051,0.011,0.613,0.125,Significant increase (p=0.032),Significant increase (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07505,rs307210,10,177926852,EPHA1,SNP (C/G),(C/,C,1.23,0.91,1.49,0.02293223,Low,0.311,0.433,0.007,0.049,Mild increase (p=0.046),Significant increase (p=0.003),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP07506,rs497952,4,132607223,MS4A6A,Insertion,-,-,1.62,1.27,1.9,0.12477346,Moderate,0.179,0.058,0.028,0.535,Mild decrease (p=0.01),Mild decrease (p=0.045),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07507,rs317775,5,9438441,PSEN2,SNP (C/T),(C/,C,0.95,0.67,1.2,0.00123851,Low,0.094,0.43,0.149,0.127,Variable effect (p=0.047),Variable effect (p=0.015),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07508,rs762840,2,71058605,APOE,SNP (A/G),(A/,A,0.84,0.61,1.08,0.00331612,High,0.08,0.011,0.378,0.332,Significant decrease (p=0.027),Significant increase (p=0.035),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07509,rs425293,6,73463151,CLU,Insertion,-,-,1.09,0.82,1.47,0.01157618,High,0.097,0.439,0.033,0.231,Significant decrease (p=0.027),Variable effect (p=0.023),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07510,rs542447,11,203255715,MS4A6A,Deletion,-,-,0.45,0.21,0.73,0.02672343,Moderate,0.129,0.075,0.444,0.151,No significant pattern (p=0.015),Significant increase (p=0.031),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07511,rs404026,11,83223349,TREM2,SNP (C/T),(C/,C,1.07,0.79,1.32,0.05614905,Moderate,0.093,0.03,0.229,0.447,Mild decrease (p=0.016),Variable effect (p=0.041),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07512,rs796968,22,7533425,BIN1,SNP (G/T),(G/,G,2.4,2.2,2.75,0.01031415,High,0.233,0.367,0.182,0.018,Mild decrease (p=0.018),Variable effect (p=0.036),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07513,rs959567,18,13340381,PTK2B,Deletion,-,-,3.63,3.39,3.84,0.08121343,Low,0.37,0.274,0.133,0.024,Mild decrease (p=0.045),Significant decrease (p=0.033),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07514,rs299908,8,22114152,CLU,SNP (A/C),(A/,A,1.43,1.03,1.77,0.02948224,Low,0.148,0.168,0.46,0.025,Significant decrease (p=0.025),Significant decrease (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07515,rs628558,2,189982863,TREM2,SNP (A/C),(A/,A,0.81,0.58,1.13,0.03146888,Moderate,0.058,0.239,0.486,0.017,No significant pattern (p=0.024),Variable effect (p=0.019),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP07516,rs585955,17,74119139,APP,Insertion,-,-,0.82,0.57,1.05,0.06330916,Moderate,0.455,0.166,0.04,0.14,Variable effect (p=0.007),Mild decrease (p=0.047),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07517,rs169878,6,75879624,PSEN2,SNP (C/T),(C/,C,0.4,0.1,0.62,0.00702131,Protective,0.021,0.265,0.053,0.461,Mild decrease (p=0.032),Significant decrease (p=0.005),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07518,rs285409,1,119379060,CR1,SNP (A/G),(A/,A,0.91,0.55,1.12,0.04009421,Moderate,0.066,0.677,0.005,0.053,Mild decrease (p=0.047),No significant pattern (p=0.005),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07519,rs231493,7,19937738,BIN1,Insertion,-,-,0.55,0.26,0.78,0.047973,High,0.22,0.23,0.198,0.152,Mild increase (p=0.036),Variable effect (p=0.036),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07520,rs534479,5,147378977,PSEN2,SNP (C/T),(C/,C,1.39,1.02,1.73,0.01777093,High,0.011,0.339,0.056,0.394,Variable effect (p=0.007),Mild increase (p=0.011),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07521,rs214041,3,58882049,APOE,SNP (A/C),(A/,A,1.14,0.85,1.35,0.00141576,Moderate,0.025,0.55,0.06,0.165,Significant decrease (p=0.029),Significant decrease (p=0.029),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07522,rs632584,7,75186558,CD33,Deletion,-,-,0.79,0.56,1.02,0.01339448,High,0.041,0.327,0.203,0.23,Variable effect (p=0.01),Significant increase (p=0.014),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07523,rs277548,19,47153702,CR1,SNP (A/T),(A/,A,1.13,0.82,1.38,0.07023146,High,0.254,0.104,0.168,0.274,No significant pattern (p=0.019),Mild increase (p=0.011),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07524,rs871429,6,145462162,MS4A6A,SNP (C/G),(C/,C,1.4,1.19,1.63,0.04002312,High,0.53,0.157,0.04,0.073,Significant decrease (p=0.01),Significant increase (p=0.025),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07525,rs765047,7,84626184,SORL1,SNP (A/T),(A/,A,1.4,1.04,1.75,0.02105003,Moderate,0.426,0.081,0.224,0.068,Significant decrease (p=0.043),Variable effect (p=0.012),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP07526,rs444934,7,51846075,EPHA1,SNP (G/T),(G/,G,1.52,1.22,1.79,0.03637754,High,0.245,0.063,0.418,0.074,Mild decrease (p=0.018),Mild decrease (p=0.047),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07527,rs321341,17,190791774,PTK2B,SNP (A/G),(A/,A,1.87,1.6,2.15,0.03321574,Protective,0.333,0.095,0.261,0.111,No significant pattern (p=0.044),Mild increase (p=0.014),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07528,rs431109,2,179512095,PSEN2,Deletion,-,-,0.5,0.12,0.81,0.07390319,High,0.348,0.0,0.443,0.009,Mild decrease (p=0.041),Significant decrease (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07529,rs732202,20,208339090,ABCA7,Insertion,-,-,1.49,1.17,1.85,0.05254767,Moderate,0.123,0.303,0.11,0.264,Mild decrease (p=0.014),Variable effect (p=0.023),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07530,rs654164,6,141274205,CR1,SNP (A/T),(A/,A,1.0,0.67,1.36,0.00404249,Moderate,0.08,0.088,0.183,0.449,Mild decrease (p=0.023),Significant increase (p=0.005),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07531,rs209702,12,163212943,TREM2,SNP (G/T),(G/,G,0.55,0.15,0.88,0.03360095,Moderate,0.032,0.177,0.238,0.352,Significant increase (p=0.029),No significant pattern (p=0.028),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07532,rs796298,12,72916007,MS4A6A,SNP (A/C),(A/,A,0.49,0.17,0.86,0.00726952,High,0.103,0.04,0.194,0.463,Significant decrease (p=0.036),Mild increase (p=0.035),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07533,rs416545,17,215375511,ABCA7,SNP (A/G),(A/,A,1.14,0.93,1.41,0.05761015,Moderate,0.168,0.078,0.257,0.297,Mild decrease (p=0.018),No significant pattern (p=0.038),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07534,rs820643,11,211667297,BIN1,SNP (C/G),(C/,C,0.54,0.21,0.77,0.00463713,Moderate,0.095,0.172,0.122,0.411,Mild decrease (p=0.029),No significant pattern (p=0.004),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07535,rs276074,5,106208067,CLU,SNP (C/G),(C/,C,1.49,1.22,1.72,0.04018342,Moderate,0.164,0.099,0.149,0.388,Significant increase (p=0.044),Mild decrease (p=0.031),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07536,rs148593,8,204538813,APOE,SNP (A/C),(A/,A,0.98,0.67,1.36,0.08174002,Moderate,0.393,0.05,0.283,0.074,Mild decrease (p=0.015),Significant increase (p=0.011),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07537,rs694806,5,188740588,APP,Deletion,-,-,0.91,0.58,1.24,0.03640977,Moderate,0.007,0.104,0.594,0.096,Variable effect (p=0.009),Significant increase (p=0.011),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07538,rs279035,11,85602445,CD33,Insertion,-,-,1.12,0.78,1.36,0.0009375,High,0.306,0.038,0.333,0.123,Variable effect (p=0.012),Mild increase (p=0.036),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07539,rs508055,22,101344370,TREM2,SNP (G/T),(G/,G,0.89,0.68,1.23,0.01321618,Low,0.357,0.315,0.12,0.008,Variable effect (p=0.008),No significant pattern (p=0.043),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07540,rs407308,8,137908474,BIN1,SNP (A/G),(A/,A,0.72,0.4,1.06,0.0026731,Moderate,0.064,0.324,0.387,0.025,Mild increase (p=0.026),Significant decrease (p=0.035),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07541,rs833135,9,111308058,TREM2,SNP (G/T),(G/,G,0.46,0.18,0.84,0.06757567,Low,0.043,0.49,0.217,0.05,Mild increase (p=0.004),Significant increase (p=0.003),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07542,rs621516,15,248809100,TREM2,Deletion,-,-,0.74,0.43,1.14,0.07982049,High,0.338,0.097,0.317,0.049,Significant increase (p=0.038),Significant decrease (p=0.033),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07543,rs838272,12,131802155,PICALM,Insertion,-,-,0.62,0.25,1.0,0.02910297,Moderate,0.279,0.065,0.42,0.036,Variable effect (p=0.007),Significant increase (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP07544,rs659832,11,96334814,CD33,SNP (A/T),(A/,A,1.4,1.18,1.69,0.00798112,High,0.0,0.094,0.37,0.336,Significant decrease (p=0.002),Variable effect (p=0.034),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07545,rs490040,7,43200235,SORL1,SNP (C/T),(C/,C,0.55,0.32,0.75,0.0406424,Moderate,0.017,0.228,0.27,0.285,No significant pattern (p=0.045),Mild increase (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07546,rs571506,12,21395499,SORL1,SNP (A/T),(A/,A,0.7,0.33,1.08,0.08212938,Moderate,0.016,0.229,0.052,0.503,Significant decrease (p=0.047),Mild decrease (p=0.025),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07547,rs484282,15,76639254,ABCA7,SNP (A/C),(A/,A,0.95,0.68,1.34,0.00831604,Low,0.198,0.145,0.25,0.207,No significant pattern (p=0.028),Mild increase (p=0.007),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07548,rs546857,10,221487581,CD33,SNP (C/G),(C/,C,0.73,0.36,1.12,0.00017042,Protective,0.666,0.055,0.028,0.051,Significant increase (p=0.008),No significant pattern (p=0.002),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07549,rs509510,17,72338177,ABCA7,SNP (C/G),(C/,C,1.32,0.99,1.54,0.0146248,High,0.027,0.2,0.494,0.079,No significant pattern (p=0.02),Mild decrease (p=0.022),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP07550,rs157596,3,81203236,APP,Deletion,-,-,0.58,0.37,0.95,0.06096132,Moderate,0.183,0.138,0.355,0.124,Significant increase (p=0.012),Mild decrease (p=0.025),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07551,rs599980,11,50181990,ABCA7,SNP (A/C),(A/,A,1.14,0.77,1.47,0.03980527,Moderate,0.19,0.263,0.089,0.258,Significant increase (p=0.009),Variable effect (p=0.034),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07552,rs663999,5,105302188,PTK2B,SNP (G/T),(G/,G,1.25,1.03,1.46,0.03215246,Unknown,0.463,0.31,0.024,0.004,Variable effect (p=0.002),No significant pattern (p=0.038),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07553,rs929935,13,187090014,APOE,Deletion,-,-,1.35,1.05,1.71,0.07065846,High,0.308,0.002,0.461,0.029,Variable effect (p=0.028),Variable effect (p=0.039),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07554,rs284558,4,63485692,PSEN2,SNP (A/C),(A/,A,1.87,1.65,2.25,0.01658152,Low,0.099,0.141,0.449,0.111,Variable effect (p=0.007),Mild decrease (p=0.011),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07555,rs842731,5,29441818,CD33,SNP (A/C),(A/,A,0.52,0.27,0.84,0.03257706,Low,0.128,0.496,0.131,0.045,No significant pattern (p=0.021),Mild decrease (p=0.034),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP07556,rs264388,8,223725695,APP,SNP (A/G),(A/,A,1.09,0.81,1.3,0.00615772,High,0.359,0.106,0.277,0.058,Variable effect (p=0.04),No significant pattern (p=0.05),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07557,rs485918,9,108445548,ABCA7,SNP (G/T),(G/,G,2.85,2.54,3.19,0.03444084,Moderate,0.143,0.599,0.037,0.021,Significant increase (p=0.02),Significant decrease (p=0.03),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07558,rs966937,10,129094155,ABCA7,SNP (A/T),(A/,A,1.59,1.29,1.84,0.08563555,Low,0.156,0.36,0.201,0.082,Mild increase (p=0.006),Variable effect (p=0.038),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07559,rs709170,21,163881350,ABCA7,SNP (C/G),(C/,C,0.72,0.42,1.01,0.00750484,High,0.202,0.359,0.053,0.186,Significant decrease (p=0.036),Significant increase (p=0.017),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP07560,rs362626,2,127195513,PICALM,SNP (A/T),(A/,A,1.2,0.9,1.46,0.00989644,Low,0.169,0.244,0.218,0.169,Significant increase (p=0.01),No significant pattern (p=0.002),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07561,rs102808,1,56028860,MS4A6A,Insertion,-,-,1.14,0.88,1.48,0.14635232,High,0.043,0.081,0.147,0.528,Variable effect (p=0.041),Variable effect (p=0.035),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07562,rs761154,17,161662742,EPHA1,SNP (G/T),(G/,G,0.7,0.47,1.08,0.01835384,Moderate,0.309,0.334,0.053,0.103,Significant decrease (p=0.018),Significant decrease (p=0.044),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07563,rs696595,11,161898746,CR1,Insertion,-,-,1.34,0.96,1.61,0.07811224,Moderate,0.144,0.361,0.169,0.126,Significant increase (p=0.028),Mild decrease (p=0.045),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07564,rs131738,20,136944775,CD33,SNP (C/T),(C/,C,1.47,1.17,1.79,0.09433721,Moderate,0.479,0.094,0.117,0.11,No significant pattern (p=0.008),Significant decrease (p=0.004),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07565,rs778669,13,155858508,CD33,SNP (C/T),(C/,C,0.61,0.29,0.95,0.01167598,High,0.077,0.68,0.012,0.031,Mild decrease (p=0.041),Significant increase (p=0.026),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07566,rs513697,3,133787267,SORL1,SNP (G/T),(G/,G,1.37,1.15,1.57,0.05827001,Moderate,0.207,0.265,0.261,0.067,Significant increase (p=0.044),No significant pattern (p=0.026),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07567,rs454565,10,54295181,TREM2,Deletion,-,-,0.98,0.63,1.23,0.11847197,Moderate,0.181,0.296,0.049,0.274,No significant pattern (p=0.03),Significant decrease (p=0.028),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07568,rs549884,10,198368053,APOE,SNP (A/C),(A/,A,2.6,2.35,2.91,0.00099191,High,0.591,0.04,0.002,0.166,Mild increase (p=0.002),No significant pattern (p=0.034),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07569,rs569378,13,202575197,ABCA7,Insertion,-,-,1.8,1.52,2.02,0.00783349,High,0.063,0.036,0.313,0.388,Significant increase (p=0.015),Significant increase (p=0.046),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07570,rs648163,21,55293497,EPHA1,Insertion,-,-,1.06,0.7,1.3,0.02150261,Low,0.068,0.198,0.086,0.448,Significant decrease (p=0.045),Significant increase (p=0.022),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07571,rs915223,5,72251006,CD2AP,SNP (A/T),(A/,A,1.41,1.15,1.68,0.00627357,Moderate,0.186,0.401,0.024,0.19,Significant increase (p=0.03),Significant decrease (p=0.046),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP07572,rs480015,5,83046232,BIN1,SNP (A/T),(A/,A,0.98,0.64,1.26,0.00554672,Moderate,0.033,0.338,0.051,0.377,Mild increase (p=0.024),Mild decrease (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07573,rs856645,21,144586584,PTK2B,SNP (G/T),(G/,G,0.58,0.37,0.86,0.02164004,Moderate,0.32,0.129,0.229,0.122,Mild decrease (p=0.021),Variable effect (p=0.039),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP07574,rs277852,8,143192075,APOE,Deletion,-,-,1.56,1.18,1.84,0.06218455,High,0.295,0.02,0.208,0.277,Significant decrease (p=0.011),Mild decrease (p=0.046),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07575,rs740768,2,80074718,MS4A6A,SNP (G/T),(G/,G,1.91,1.68,2.28,0.06008767,Moderate,0.069,0.093,0.265,0.374,Variable effect (p=0.009),Variable effect (p=0.037),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07576,rs680645,17,202663220,MS4A6A,SNP (C/T),(C/,C,0.65,0.42,0.98,0.06659124,Moderate,0.213,0.216,0.094,0.277,Mild decrease (p=0.015),Significant increase (p=0.05),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07577,rs249028,4,223436033,CLU,Insertion,-,-,1.77,1.45,2.14,0.02745282,High,0.404,0.152,0.092,0.151,Significant decrease (p=0.017),Significant increase (p=0.02),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07578,rs350565,18,224036256,MS4A6A,Insertion,-,-,1.06,0.81,1.27,0.00310288,Low,0.437,0.02,0.022,0.32,Mild increase (p=0.023),Mild increase (p=0.037),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07579,rs303141,19,200834721,BIN1,SNP (C/T),(C/,C,0.52,0.18,0.86,0.01118116,High,0.105,0.046,0.195,0.455,Variable effect (p=0.023),Variable effect (p=0.01),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07580,rs452477,7,49177022,EPHA1,SNP (A/T),(A/,A,0.72,0.35,0.92,0.02073289,Protective,0.267,0.212,0.057,0.264,Variable effect (p=0.026),Significant increase (p=0.014),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07581,rs492700,6,52271735,ABCA7,SNP (G/T),(G/,G,0.93,0.55,1.24,0.05457543,High,0.292,0.443,0.021,0.043,Significant decrease (p=0.014),No significant pattern (p=0.039),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07582,rs568137,8,211640087,PSEN2,SNP (A/C),(A/,A,1.26,1.05,1.5,0.054423,Protective,0.306,0.356,0.013,0.125,Significant decrease (p=0.048),No significant pattern (p=0.023),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07583,rs213547,7,84206971,APP,SNP (G/T),(G/,G,1.9,1.67,2.16,0.01813638,High,0.027,0.131,0.237,0.405,Mild increase (p=0.03),Variable effect (p=0.049),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07584,rs972033,5,185100446,CLU,Deletion,-,-,1.2,0.94,1.55,0.00753968,Moderate,0.057,0.357,0.181,0.205,No significant pattern (p=0.025),Mild decrease (p=0.037),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07585,rs708869,14,86823524,ABCA7,SNP (A/G),(A/,A,0.44,0.1,0.69,0.0056732,Moderate,0.397,0.109,0.277,0.017,Variable effect (p=0.042),Mild decrease (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07586,rs394984,10,26843470,PICALM,Deletion,-,-,0.87,0.57,1.24,0.03826402,Protective,0.321,0.077,0.278,0.125,Variable effect (p=0.035),Variable effect (p=0.027),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07587,rs766625,17,7046807,ABCA7,SNP (A/T),(A/,A,0.8,0.43,1.17,0.00751364,Low,0.451,0.076,0.145,0.129,Mild increase (p=0.035),No significant pattern (p=0.002),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07588,rs511085,3,58645642,CR1,SNP (A/C),(A/,A,0.54,0.19,0.9,0.07814516,Protective,0.388,0.067,0.161,0.184,Mild increase (p=0.037),Variable effect (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07589,rs696922,13,34565065,CD2AP,SNP (A/T),(A/,A,0.9,0.56,1.2,0.06607025,Moderate,0.212,0.136,0.159,0.292,Mild decrease (p=0.012),No significant pattern (p=0.023),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07590,rs220928,4,85634430,CLU,SNP (G/T),(G/,G,0.69,0.47,0.95,0.01417113,High,0.053,0.52,0.111,0.116,Variable effect (p=0.017),Mild decrease (p=0.027),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07591,rs793441,18,240527681,APOE,SNP (A/C),(A/,A,0.68,0.3,0.93,0.08284056,High,0.294,0.258,0.117,0.131,Significant increase (p=0.017),Significant decrease (p=0.004),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07592,rs756149,4,244456747,MS4A6A,SNP (A/G),(A/,A,0.99,0.71,1.31,0.06703979,High,0.3,0.327,0.148,0.025,Mild decrease (p=0.037),Variable effect (p=0.006),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07593,rs394098,4,25019947,CD2AP,Deletion,-,-,0.69,0.38,1.03,0.03789393,High,0.025,0.477,0.032,0.265,No significant pattern (p=0.019),Significant increase (p=0.015),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07594,rs709774,15,23760763,TREM2,SNP (G/T),(G/,G,1.03,0.65,1.42,0.00534735,Low,0.029,0.31,0.274,0.187,Variable effect (p=0.05),Significant increase (p=0.021),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07595,rs850869,10,180697328,EPHA1,Insertion,-,-,0.42,0.19,0.8,0.00594859,Moderate,0.027,0.091,0.281,0.401,Significant increase (p=0.02),Significant increase (p=0.034),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07596,rs366689,17,8231459,PSEN2,SNP (C/G),(C/,C,1.84,1.47,2.07,0.05655087,Low,0.262,0.234,0.215,0.089,Variable effect (p=0.022),No significant pattern (p=0.036),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07597,rs114614,4,34259281,CR1,Deletion,-,-,1.27,1.02,1.49,0.02879966,High,0.097,0.257,0.147,0.299,Mild increase (p=0.041),Significant increase (p=0.048),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07598,rs335121,8,56154773,CLU,SNP (C/G),(C/,C,0.52,0.22,0.85,0.03847938,Moderate,0.236,0.145,0.237,0.181,Mild increase (p=0.028),Significant increase (p=0.017),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07599,rs121862,21,149419901,MS4A6A,SNP (A/C),(A/,A,1.14,0.82,1.44,0.01465376,High,0.032,0.086,0.658,0.024,Variable effect (p=0.013),Significant decrease (p=0.015),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07600,rs967834,10,157857697,SORL1,SNP (C/T),(C/,C,3.66,3.37,4.01,0.08117619,Moderate,0.218,0.132,0.204,0.246,Mild decrease (p=0.011),Significant increase (p=0.02),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07601,rs812853,3,190909983,APP,Deletion,-,-,0.54,0.22,0.9,0.03395514,High,0.044,0.267,0.145,0.345,Significant decrease (p=0.046),Significant increase (p=0.032),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07602,rs336955,18,229927634,SORL1,SNP (A/T),(A/,A,0.52,0.27,0.74,0.02667594,Moderate,0.169,0.04,0.251,0.34,Significant decrease (p=0.02),Significant decrease (p=0.025),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07603,rs102360,15,34138616,APOE,SNP (A/C),(A/,A,1.13,0.89,1.46,0.05352352,Moderate,0.094,0.028,0.309,0.369,Significant decrease (p=0.044),Significant increase (p=0.033),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07604,rs267345,4,20705054,CD33,SNP (G/T),(G/,G,2.19,1.82,2.58,0.02199002,Unknown,0.006,0.269,0.488,0.036,Mild decrease (p=0.015),Variable effect (p=0.012),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP07605,rs160617,22,61688735,APOE,SNP (A/T),(A/,A,0.66,0.3,1.01,0.03293923,Protective,0.57,0.025,0.078,0.126,Variable effect (p=0.025),Mild increase (p=0.05),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07606,rs908271,3,142210832,CR1,SNP (C/T),(C/,C,2.91,2.57,3.14,0.00299836,Unknown,0.491,0.133,0.003,0.173,No significant pattern (p=0.049),Variable effect (p=0.018),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07607,rs887837,8,11761852,SORL1,Deletion,-,-,1.2,0.83,1.59,0.02259721,High,0.243,0.028,0.319,0.209,Variable effect (p=0.028),Mild decrease (p=0.013),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07608,rs563081,1,127860059,CLU,SNP (A/C),(A/,A,1.98,1.61,2.25,0.02155602,Moderate,0.631,0.114,0.037,0.018,Variable effect (p=0.044),Mild decrease (p=0.039),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP07609,rs359026,11,64209311,PSEN2,SNP (A/C),(A/,A,0.99,0.6,1.31,0.00627656,Moderate,0.37,0.014,0.413,0.003,Mild decrease (p=0.025),No significant pattern (p=0.017),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07610,rs118756,5,93900546,EPHA1,SNP (C/T),(C/,C,1.38,1.11,1.66,0.02329221,Low,0.132,0.187,0.366,0.115,Significant decrease (p=0.008),Significant increase (p=0.002),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07611,rs205311,7,107785751,CR1,SNP (C/T),(C/,C,1.13,0.84,1.45,0.07177384,Protective,0.054,0.042,0.411,0.293,Significant increase (p=0.028),Significant decrease (p=0.028),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07612,rs672137,11,178699270,TREM2,SNP (C/G),(C/,C,1.5,1.18,1.75,0.0107816,Low,0.176,0.166,0.389,0.069,Significant decrease (p=0.046),Significant decrease (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07613,rs452787,6,130750703,PICALM,Insertion,-,-,1.51,1.27,1.76,0.04473574,Protective,0.149,0.266,0.334,0.051,Significant increase (p=0.021),Significant decrease (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07614,rs800231,19,66492125,BIN1,SNP (A/G),(A/,A,0.64,0.26,0.85,0.00711643,Moderate,0.017,0.227,0.263,0.292,No significant pattern (p=0.005),Significant increase (p=0.016),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07615,rs620149,8,158810517,CD33,SNP (C/G),(C/,C,0.8,0.57,1.02,0.00702026,Unknown,0.111,0.405,0.083,0.202,Significant increase (p=0.006),No significant pattern (p=0.025),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07616,rs612438,21,85002381,ABCA7,SNP (A/T),(A/,A,1.64,1.39,1.92,0.03472684,Protective,0.111,0.558,0.011,0.12,No significant pattern (p=0.024),No significant pattern (p=0.034),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07617,rs864358,10,32420417,APOE,Insertion,-,-,1.47,1.11,1.82,0.06085683,Moderate,0.065,0.053,0.571,0.11,Significant decrease (p=0.032),Mild increase (p=0.019),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07618,rs764297,7,13836655,CR1,Insertion,-,-,1.95,1.7,2.16,0.11866215,Moderate,0.322,0.04,0.217,0.22,Mild decrease (p=0.021),Significant decrease (p=0.042),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07619,rs246028,11,7208609,BIN1,Deletion,-,-,0.66,0.3,0.99,0.01727296,Moderate,0.614,0.049,0.104,0.034,Mild increase (p=0.008),Variable effect (p=0.039),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07620,rs638038,3,2404428,CD33,SNP (A/G),(A/,A,0.59,0.2,0.96,0.07712162,High,0.161,0.05,0.312,0.276,Variable effect (p=0.032),No significant pattern (p=0.046),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07621,rs202508,19,37058969,PSEN2,SNP (A/T),(A/,A,0.74,0.46,0.99,0.01227185,Protective,0.143,0.132,0.08,0.444,No significant pattern (p=0.042),No significant pattern (p=0.006),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07622,rs433213,9,140964587,EPHA1,SNP (C/T),(C/,C,1.25,0.93,1.47,0.10810654,Unknown,0.179,0.067,0.235,0.319,Significant decrease (p=0.038),Mild decrease (p=0.037),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP07623,rs614553,12,124639530,TREM2,SNP (A/T),(A/,A,0.83,0.52,1.13,0.03939898,Low,0.182,0.059,0.469,0.089,Significant increase (p=0.046),Variable effect (p=0.042),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07624,rs629112,11,19269033,TREM2,SNP (A/C),(A/,A,1.61,1.3,2.01,0.00436149,Low,0.247,0.282,0.055,0.216,No significant pattern (p=0.046),Significant decrease (p=0.021),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07625,rs883945,6,238514934,PICALM,SNP (C/G),(C/,C,0.75,0.36,0.99,0.0538763,High,0.418,0.186,0.115,0.082,Mild increase (p=0.05),Variable effect (p=0.032),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07626,rs436315,15,147610918,EPHA1,SNP (A/C),(A/,A,0.88,0.61,1.25,0.04213429,High,0.071,0.336,0.366,0.028,Variable effect (p=0.005),Significant decrease (p=0.03),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP07627,rs226411,2,55611194,EPHA1,Deletion,-,-,1.69,1.35,1.94,0.03443197,Moderate,0.0,0.297,0.426,0.077,Significant increase (p=0.018),Significant increase (p=0.017),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07628,rs869804,7,208085732,MS4A6A,SNP (A/T),(A/,A,1.05,0.81,1.41,0.0175371,Moderate,0.149,0.017,0.39,0.244,Significant increase (p=0.032),Variable effect (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07629,rs194293,11,202455103,CD2AP,SNP (A/C),(A/,A,1.87,1.64,2.19,0.00094055,Protective,0.017,0.312,0.434,0.037,Mild decrease (p=0.047),Significant decrease (p=0.014),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07630,rs269823,11,33892149,PSEN2,Insertion,-,-,1.4,1.08,1.66,0.00740124,High,0.072,0.059,0.033,0.637,Significant increase (p=0.038),Mild increase (p=0.01),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP07631,rs296055,4,1467973,EPHA1,SNP (A/C),(A/,A,0.79,0.48,1.14,0.01543946,Moderate,0.31,0.238,0.029,0.224,No significant pattern (p=0.031),No significant pattern (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07632,rs716762,8,222361726,CD2AP,SNP (A/C),(A/,A,1.73,1.44,2.06,0.13307359,Moderate,0.028,0.007,0.193,0.572,Significant decrease (p=0.016),Mild decrease (p=0.049),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07633,rs385248,21,27967753,PTK2B,SNP (A/T),(A/,A,0.74,0.44,0.98,0.01356735,Moderate,0.022,0.207,0.17,0.401,Mild decrease (p=0.024),Variable effect (p=0.047),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07634,rs337068,10,224808031,CD2AP,SNP (A/G),(A/,A,0.65,0.3,0.9,0.0014459,Moderate,0.238,0.205,0.077,0.281,Variable effect (p=0.011),Significant decrease (p=0.028),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07635,rs244568,6,1515859,APOE,SNP (C/G),(C/,C,1.78,1.43,2.02,0.00924203,Low,0.023,0.02,0.458,0.299,Significant increase (p=0.018),Significant increase (p=0.039),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07636,rs780917,14,179213327,PSEN2,Deletion,-,-,0.77,0.5,1.1,0.04842677,Moderate,0.248,0.072,0.207,0.273,Variable effect (p=0.009),Variable effect (p=0.017),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07637,rs368447,17,187364596,BIN1,SNP (C/G),(C/,C,0.89,0.63,1.25,0.01489973,Moderate,0.346,0.052,0.375,0.026,Mild decrease (p=0.037),Variable effect (p=0.045),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07638,rs802787,17,55713378,CLU,SNP (A/T),(A/,A,0.97,0.68,1.33,0.08287067,Unknown,0.17,0.534,0.032,0.064,Variable effect (p=0.044),No significant pattern (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07639,rs614917,10,106362625,CLU,Insertion,-,-,1.8,1.46,2.01,0.04510383,Moderate,0.175,0.276,0.004,0.345,No significant pattern (p=0.007),Variable effect (p=0.023),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP07640,rs470484,18,66870107,TREM2,Insertion,-,-,0.59,0.2,0.8,0.07002601,Moderate,0.213,0.052,0.345,0.189,Significant increase (p=0.046),Significant decrease (p=0.04),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07641,rs557747,20,148254185,PICALM,Deletion,-,-,1.06,0.69,1.26,0.00644653,Moderate,0.011,0.022,0.289,0.478,No significant pattern (p=0.023),Significant increase (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07642,rs241727,18,129660464,ABCA7,SNP (A/C),(A/,A,1.59,1.27,1.82,0.03336441,Low,0.302,0.06,0.016,0.421,Significant increase (p=0.015),Mild decrease (p=0.048),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07643,rs749807,1,198904813,CLU,Insertion,-,-,0.61,0.28,0.89,0.00864335,High,0.051,0.338,0.074,0.337,No significant pattern (p=0.045),Variable effect (p=0.006),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07644,rs352891,15,62953502,EPHA1,Insertion,-,-,0.58,0.35,0.94,0.03281573,Moderate,0.1,0.329,0.101,0.271,Significant decrease (p=0.008),Significant decrease (p=0.012),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07645,rs649632,6,30146670,PSEN2,SNP (G/T),(G/,G,1.08,0.85,1.42,0.0260227,Moderate,0.261,0.178,0.327,0.034,Mild increase (p=0.003),Mild decrease (p=0.028),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07646,rs469088,10,244961001,BIN1,Deletion,-,-,1.87,1.53,2.27,0.0054848,Unknown,0.028,0.14,0.088,0.545,Significant increase (p=0.049),Variable effect (p=0.005),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP07647,rs331455,5,16351110,BIN1,SNP (A/C),(A/,A,1.64,1.25,1.98,0.00414386,High,0.583,0.025,0.089,0.103,Significant increase (p=0.021),Significant increase (p=0.002),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07648,rs139000,8,111128284,CR1,SNP (A/G),(A/,A,0.95,0.68,1.21,0.01660871,Moderate,0.458,0.143,0.038,0.162,Mild increase (p=0.042),Significant decrease (p=0.024),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07649,rs844962,15,180161127,TREM2,SNP (C/G),(C/,C,2.05,1.68,2.35,0.01485149,Moderate,0.214,0.082,0.023,0.481,Significant decrease (p=0.022),Significant increase (p=0.007),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07650,rs945386,22,35310910,ABCA7,SNP (A/C),(A/,A,0.84,0.51,1.06,0.02811827,Moderate,0.096,0.254,0.115,0.335,Significant increase (p=0.028),Significant increase (p=0.035),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07651,rs430456,18,62865661,PSEN2,Deletion,-,-,1.17,0.85,1.46,0.07985073,Moderate,0.334,0.034,0.37,0.062,Mild increase (p=0.033),Significant increase (p=0.038),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07652,rs240821,4,209199793,CR1,SNP (A/C),(A/,A,1.2,0.88,1.48,0.0460143,Low,0.16,0.301,0.047,0.292,Variable effect (p=0.038),Mild decrease (p=0.021),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07653,rs267362,10,180498789,CR1,SNP (C/T),(C/,C,1.06,0.74,1.31,0.09190712,Moderate,0.194,0.133,0.279,0.194,Significant increase (p=0.03),No significant pattern (p=0.035),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07654,rs969780,18,60160749,PTK2B,SNP (G/T),(G/,G,1.25,0.89,1.52,0.01674292,Unknown,0.149,0.227,0.076,0.349,Significant increase (p=0.013),Mild decrease (p=0.033),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07655,rs711676,1,126793086,CD33,Deletion,-,-,0.69,0.46,0.99,0.0655629,Low,0.01,0.123,0.535,0.132,Variable effect (p=0.033),Significant decrease (p=0.048),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07656,rs779161,7,234475650,TREM2,SNP (C/T),(C/,C,1.14,0.74,1.36,0.01774099,Protective,0.11,0.317,0.347,0.026,Mild increase (p=0.015),Mild increase (p=0.027),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07657,rs264743,16,215616126,PSEN2,SNP (C/G),(C/,C,1.7,1.32,1.92,0.02151521,Low,0.361,0.043,0.275,0.122,Mild decrease (p=0.029),Significant decrease (p=0.031),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07658,rs294604,12,231218255,EPHA1,SNP (G/T),(G/,G,1.0,0.62,1.37,0.03222354,Unknown,0.196,0.163,0.312,0.13,Variable effect (p=0.03),Mild decrease (p=0.029),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07659,rs308605,8,84370803,EPHA1,SNP (C/T),(C/,C,1.23,0.9,1.58,0.07653115,Moderate,0.258,0.108,0.183,0.25,Significant decrease (p=0.045),Mild decrease (p=0.022),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07660,rs758504,14,96678198,ABCA7,SNP (G/T),(G/,G,0.88,0.62,1.25,0.05527665,Unknown,0.296,0.191,0.045,0.267,Significant increase (p=0.01),Significant increase (p=0.02),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07661,rs360363,11,88661999,APP,SNP (A/C),(A/,A,1.09,0.85,1.35,0.0323619,Low,0.254,0.358,0.094,0.094,Variable effect (p=0.022),Significant decrease (p=0.035),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07662,rs470668,15,79228696,CLU,SNP (G/T),(G/,G,0.4,0.1,0.73,0.04168964,Low,0.132,0.352,0.036,0.279,No significant pattern (p=0.021),Variable effect (p=0.05),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07663,rs249065,14,4542814,PTK2B,Deletion,-,-,1.11,0.75,1.43,0.05997732,Low,0.177,0.076,0.41,0.137,Significant increase (p=0.039),Mild decrease (p=0.002),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07664,rs437955,12,75802777,PSEN2,SNP (A/T),(A/,A,2.37,2.14,2.66,0.09710507,Moderate,0.116,0.327,0.338,0.018,No significant pattern (p=0.026),No significant pattern (p=0.032),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07665,rs469383,6,109644554,APOE,SNP (C/T),(C/,C,0.99,0.68,1.19,0.05279414,Unknown,0.144,0.164,0.243,0.248,Significant decrease (p=0.018),Significant decrease (p=0.048),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07666,rs226074,17,85609971,MS4A6A,Deletion,-,-,0.53,0.23,0.9,0.06385428,Low,0.268,0.072,0.068,0.392,No significant pattern (p=0.036),No significant pattern (p=0.049),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07667,rs391484,16,246328315,PSEN2,SNP (G/T),(G/,G,1.68,1.37,2.0,2.379e-05,High,0.031,0.351,0.3,0.118,No significant pattern (p=0.017),Significant decrease (p=0.03),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP07668,rs987741,21,91688737,PICALM,SNP (C/G),(C/,C,0.74,0.35,1.11,0.01187803,Protective,0.248,0.008,0.36,0.184,Mild decrease (p=0.035),Variable effect (p=0.026),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07669,rs344363,1,46671674,APOE,SNP (C/T),(C/,C,0.8,0.42,1.15,0.08000262,High,0.173,0.229,0.333,0.065,Variable effect (p=0.033),No significant pattern (p=0.032),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP07670,rs288737,22,192608773,BIN1,Insertion,-,-,1.35,0.98,1.69,0.00113406,Low,0.055,0.193,0.194,0.358,Variable effect (p=0.002),Significant increase (p=0.003),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07671,rs856942,14,234395826,BIN1,SNP (C/T),(C/,C,1.05,0.81,1.43,0.05455092,Unknown,0.029,0.427,0.09,0.255,Significant increase (p=0.003),Variable effect (p=0.023),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP07672,rs636364,17,90135915,CLU,SNP (G/T),(G/,G,0.7,0.48,1.05,0.06978847,High,0.178,0.127,0.429,0.066,Variable effect (p=0.033),Mild increase (p=0.041),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07673,rs888856,18,96066321,CD2AP,SNP (A/T),(A/,A,1.28,0.93,1.57,0.01438626,Moderate,0.077,0.437,0.135,0.151,Mild increase (p=0.002),Variable effect (p=0.034),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07674,rs316626,15,63580824,CD33,SNP (A/G),(A/,A,1.58,1.28,1.92,0.00879353,Moderate,0.095,0.372,0.219,0.114,Mild decrease (p=0.045),Mild increase (p=0.015),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07675,rs641380,17,215070120,BIN1,SNP (C/G),(C/,C,1.76,1.52,2.09,0.00111456,Moderate,0.265,0.291,0.059,0.185,Variable effect (p=0.039),Significant decrease (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07676,rs583811,19,123216811,APP,SNP (G/T),(G/,G,0.8,0.58,1.13,0.01802902,Moderate,0.141,0.131,0.44,0.088,Mild increase (p=0.031),No significant pattern (p=0.023),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07677,rs851177,2,210397751,EPHA1,SNP (A/C),(A/,A,0.52,0.27,0.84,0.06173046,Moderate,0.234,0.452,0.111,0.003,No significant pattern (p=0.049),Significant decrease (p=0.029),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07678,rs405178,17,246038156,MS4A6A,SNP (C/G),(C/,C,0.49,0.22,0.86,0.01010969,Low,0.075,0.1,0.58,0.045,Mild decrease (p=0.006),Significant increase (p=0.02),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07679,rs175960,19,212941702,BIN1,SNP (G/T),(G/,G,0.99,0.7,1.32,0.0287739,High,0.194,0.107,0.381,0.117,No significant pattern (p=0.02),Mild decrease (p=0.035),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07680,rs334636,5,167918794,TREM2,SNP (A/C),(A/,A,0.88,0.58,1.18,0.03131262,Moderate,0.171,0.439,0.101,0.09,No significant pattern (p=0.036),Mild increase (p=0.019),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07681,rs837378,10,143243452,TREM2,SNP (C/T),(C/,C,2.01,1.65,2.29,0.04408716,Low,0.092,0.208,0.169,0.331,Significant increase (p=0.003),No significant pattern (p=0.028),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07682,rs600613,10,45534754,TREM2,Deletion,-,-,2.33,1.96,2.6,0.00059086,Moderate,0.102,0.415,0.226,0.057,Significant decrease (p=0.023),No significant pattern (p=0.002),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07683,rs254085,16,161006667,TREM2,SNP (A/T),(A/,A,3.17,2.95,3.37,0.10891119,Protective,0.086,0.109,0.214,0.39,Mild decrease (p=0.02),Significant decrease (p=0.017),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07684,rs746471,6,181141923,BIN1,SNP (A/G),(A/,A,1.0,0.65,1.33,0.03693919,Moderate,0.511,0.164,0.027,0.097,Significant increase (p=0.014),Variable effect (p=0.009),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07685,rs510180,16,165105986,CR1,SNP (G/T),(G/,G,1.03,0.66,1.28,0.00112568,High,0.374,0.336,0.073,0.017,No significant pattern (p=0.043),Significant increase (p=0.003),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07686,rs538327,17,106032429,CR1,SNP (C/G),(C/,C,1.05,0.8,1.26,0.00592904,Protective,0.201,0.216,0.176,0.207,Mild increase (p=0.022),No significant pattern (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP07687,rs324912,8,154440458,CR1,SNP (C/T),(C/,C,1.82,1.6,2.17,0.06656776,Low,0.041,0.082,0.359,0.318,Significant increase (p=0.032),Mild increase (p=0.03),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07688,rs827591,16,166100968,CD33,SNP (A/C),(A/,A,0.56,0.35,0.76,0.00363191,Protective,0.701,0.03,0.006,0.063,Significant decrease (p=0.003),Significant increase (p=0.039),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07689,rs323795,19,22178464,APOE,SNP (G/T),(G/,G,1.25,0.9,1.53,0.01785796,Low,0.089,0.01,0.102,0.598,Significant increase (p=0.042),Mild decrease (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07690,rs389634,7,47373916,BIN1,Deletion,-,-,0.68,0.37,1.01,0.00558525,Moderate,0.224,0.048,0.506,0.021,Significant decrease (p=0.005),Mild decrease (p=0.031),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07691,rs584316,10,120916908,PTK2B,Insertion,-,-,1.71,1.5,2.0,0.01172982,Protective,0.417,0.077,0.034,0.271,Mild increase (p=0.028),No significant pattern (p=0.046),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07692,rs439489,21,177100160,PSEN2,SNP (A/G),(A/,A,0.69,0.36,0.95,0.01758293,Low,0.422,0.06,0.219,0.098,Significant increase (p=0.018),No significant pattern (p=0.048),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07693,rs287056,6,33607350,CLU,Insertion,-,-,0.97,0.72,1.22,0.01851459,Moderate,0.2,0.52,0.074,0.006,Variable effect (p=0.048),Variable effect (p=0.046),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP07694,rs394786,5,215177218,MS4A6A,Deletion,-,-,0.73,0.43,1.06,0.05459325,Moderate,0.61,0.072,0.109,0.009,Significant increase (p=0.031),Mild increase (p=0.02),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07695,rs537291,4,58745676,SORL1,SNP (A/T),(A/,A,0.58,0.22,0.97,0.00141898,High,0.384,0.022,0.365,0.029,Mild decrease (p=0.013),Significant increase (p=0.044),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07696,rs855077,3,143549403,PSEN2,SNP (A/C),(A/,A,0.72,0.41,1.06,0.08234984,High,0.394,0.124,0.214,0.068,Variable effect (p=0.022),Variable effect (p=0.033),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07697,rs959972,2,68592380,CD33,SNP (C/G),(C/,C,2.62,2.29,3.0,0.06905186,High,0.099,0.237,0.281,0.183,Variable effect (p=0.009),Variable effect (p=0.017),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07698,rs732939,9,44775815,PICALM,SNP (C/T),(C/,C,1.12,0.84,1.46,0.08695132,Moderate,0.271,0.205,0.229,0.095,Variable effect (p=0.021),Mild decrease (p=0.039),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07699,rs929461,3,172800073,CD33,SNP (A/T),(A/,A,1.15,0.82,1.53,0.01292581,Low,0.102,0.062,0.61,0.026,No significant pattern (p=0.041),Mild decrease (p=0.022),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP07700,rs922853,21,195654483,BIN1,SNP (A/C),(A/,A,1.06,0.81,1.44,0.00428722,Protective,0.023,0.194,0.118,0.466,Variable effect (p=0.003),Mild decrease (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07701,rs821724,4,185515501,MS4A6A,Deletion,-,-,1.16,0.84,1.49,0.00381421,Low,0.003,0.234,0.454,0.108,Significant decrease (p=0.043),Significant increase (p=0.011),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07702,rs942969,1,64781753,TREM2,SNP (A/G),(A/,A,1.02,0.7,1.25,0.01340795,Low,0.295,0.136,0.11,0.258,Mild decrease (p=0.015),Mild decrease (p=0.03),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07703,rs231853,3,222768291,MS4A6A,SNP (C/G),(C/,C,1.0,0.64,1.4,0.07334415,High,0.511,0.155,0.088,0.046,Mild increase (p=0.003),Variable effect (p=0.017),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07704,rs822045,14,121274421,MS4A6A,Deletion,-,-,0.37,0.16,0.71,0.05014298,Low,0.159,0.214,0.144,0.283,Mild increase (p=0.028),Mild decrease (p=0.033),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP07705,rs939214,9,38303409,PICALM,Insertion,-,-,1.21,0.91,1.59,0.0233244,High,0.044,0.153,0.248,0.356,Mild decrease (p=0.047),Significant increase (p=0.023),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07706,rs457940,14,50053865,CD2AP,SNP (A/G),(A/,A,0.45,0.21,0.84,0.09876617,Moderate,0.108,0.237,0.413,0.042,Significant decrease (p=0.025),No significant pattern (p=0.025),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP07707,rs910047,10,7913090,PTK2B,SNP (A/T),(A/,A,0.52,0.32,0.74,0.00745144,High,0.029,0.076,0.486,0.209,Variable effect (p=0.019),Mild increase (p=0.01),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07708,rs240660,6,37866372,ABCA7,SNP (C/T),(C/,C,1.86,1.53,2.2,0.0431388,Low,0.3,0.069,0.104,0.327,Mild decrease (p=0.037),Significant decrease (p=0.012),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07709,rs554854,22,40755906,PTK2B,SNP (C/T),(C/,C,1.41,1.2,1.78,0.1385191,Protective,0.028,0.183,0.577,0.012,Variable effect (p=0.034),Variable effect (p=0.014),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07710,rs392765,14,145831297,PTK2B,Deletion,-,-,1.03,0.67,1.27,0.02715719,Protective,0.148,0.291,0.275,0.085,No significant pattern (p=0.039),Mild increase (p=0.008),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07711,rs787635,22,94450210,APP,SNP (A/T),(A/,A,0.92,0.67,1.16,0.0332954,Protective,0.43,0.137,0.069,0.163,Mild increase (p=0.022),Significant increase (p=0.021),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07712,rs436732,9,198488217,TREM2,SNP (A/G),(A/,A,0.94,0.59,1.25,0.03510196,High,0.103,0.412,0.146,0.139,Mild increase (p=0.01),Significant decrease (p=0.037),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07713,rs307362,11,135914127,BIN1,SNP (C/T),(C/,C,3.19,2.79,3.49,0.02606551,Moderate,0.055,0.002,0.124,0.619,Mild increase (p=0.036),Significant increase (p=0.036),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07714,rs161240,4,72093312,CR1,SNP (A/G),(A/,A,1.19,0.97,1.54,0.03595867,Moderate,0.483,0.232,0.021,0.064,Variable effect (p=0.027),Mild increase (p=0.029),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07715,rs287670,5,22675092,CR1,SNP (A/T),(A/,A,0.47,0.26,0.71,0.04034617,High,0.068,0.151,0.265,0.317,No significant pattern (p=0.029),Mild increase (p=0.018),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07716,rs102680,22,49271917,PSEN2,Insertion,-,-,2.08,1.69,2.43,0.01464605,Protective,0.398,0.172,0.018,0.212,Mild decrease (p=0.009),Mild increase (p=0.017),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP07717,rs864131,7,74158020,EPHA1,Deletion,-,-,1.05,0.83,1.29,0.00708127,Moderate,0.021,0.068,0.432,0.278,Mild decrease (p=0.035),Significant decrease (p=0.048),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07718,rs701447,1,199937292,CR1,SNP (C/T),(C/,C,1.17,0.97,1.51,0.11519799,High,0.262,0.111,0.187,0.24,Mild decrease (p=0.011),Mild increase (p=0.033),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07719,rs446650,12,197126512,CD2AP,Insertion,-,-,1.72,1.4,1.98,0.00024418,Protective,0.161,0.057,0.116,0.466,Significant decrease (p=0.016),Mild decrease (p=0.006),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07720,rs371656,16,160298116,CD33,SNP (A/C),(A/,A,1.48,1.13,1.81,0.01245444,Moderate,0.058,0.495,0.244,0.003,Mild decrease (p=0.045),Mild increase (p=0.012),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07721,rs789260,2,10962359,ABCA7,SNP (C/T),(C/,C,0.58,0.22,0.85,0.03284847,Unknown,0.312,0.207,0.018,0.263,No significant pattern (p=0.048),Mild decrease (p=0.04),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07722,rs761866,21,218692071,CLU,SNP (C/T),(C/,C,1.19,0.8,1.56,0.00447369,High,0.181,0.257,0.042,0.32,Mild decrease (p=0.011),No significant pattern (p=0.025),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07723,rs774218,4,64197734,TREM2,SNP (G/T),(G/,G,1.31,0.95,1.6,0.02905938,Protective,0.154,0.201,0.241,0.203,No significant pattern (p=0.033),No significant pattern (p=0.028),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07724,rs438530,1,38609446,PSEN2,Deletion,-,-,1.63,1.32,1.86,0.02575143,Moderate,0.525,0.202,0.063,0.01,Mild decrease (p=0.045),Significant increase (p=0.004),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07725,rs198281,9,1751722,CR1,SNP (A/T),(A/,A,0.88,0.55,1.13,0.00063926,High,0.321,0.213,0.222,0.043,Variable effect (p=0.04),Significant decrease (p=0.006),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07726,rs928944,2,63251128,PSEN2,SNP (A/T),(A/,A,0.66,0.4,0.89,0.01859876,Moderate,0.403,0.003,0.15,0.243,Variable effect (p=0.044),No significant pattern (p=0.037),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07727,rs897690,6,49892906,EPHA1,SNP (A/C),(A/,A,0.26,0.1,0.46,0.0325637,Protective,0.156,0.202,0.237,0.205,No significant pattern (p=0.017),Mild increase (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07728,rs946168,20,208852759,BIN1,SNP (A/T),(A/,A,1.76,1.39,2.01,0.03866032,Moderate,0.335,0.152,0.127,0.186,Variable effect (p=0.033),No significant pattern (p=0.047),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07729,rs359691,17,128305601,CD2AP,Insertion,-,-,2.42,2.07,2.7,0.1328443,Low,0.068,0.127,0.506,0.099,No significant pattern (p=0.042),Mild increase (p=0.017),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07730,rs888683,1,47069527,APOE,SNP (C/G),(C/,C,0.63,0.23,0.92,0.01319456,Protective,0.483,0.026,0.245,0.046,Significant increase (p=0.038),Mild increase (p=0.008),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07731,rs991747,17,152917787,MS4A6A,Deletion,-,-,0.65,0.44,0.99,0.06721794,High,0.078,0.304,0.24,0.177,No significant pattern (p=0.05),Mild increase (p=0.012),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07732,rs751856,4,130691679,APOE,SNP (C/G),(C/,C,0.91,0.53,1.15,0.0548564,Low,0.016,0.105,0.553,0.126,No significant pattern (p=0.003),Significant decrease (p=0.009),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07733,rs547580,20,185820931,PICALM,SNP (A/C),(A/,A,2.42,2.12,2.63,0.00029102,Moderate,0.165,0.061,0.536,0.038,Significant decrease (p=0.02),Mild increase (p=0.027),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07734,rs752700,20,233727347,EPHA1,SNP (A/C),(A/,A,0.99,0.61,1.21,0.02078887,Unknown,0.059,0.096,0.02,0.625,Variable effect (p=0.003),Variable effect (p=0.008),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP07735,rs576837,11,219764041,APOE,SNP (C/G),(C/,C,0.69,0.49,0.94,0.00490048,High,0.101,0.132,0.137,0.43,No significant pattern (p=0.045),Mild increase (p=0.002),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP07736,rs909706,16,208460341,ABCA7,SNP (C/G),(C/,C,1.21,0.82,1.47,0.07077936,Protective,0.055,0.448,0.1,0.196,Significant increase (p=0.05),Significant increase (p=0.044),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07737,rs301078,14,92717300,PTK2B,Deletion,-,-,2.56,2.33,2.91,0.07684312,Moderate,0.08,0.476,0.129,0.115,Significant increase (p=0.016),No significant pattern (p=0.008),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07738,rs942447,1,113367183,CD33,SNP (A/C),(A/,A,0.44,0.2,0.73,0.0352005,Low,0.492,0.0,0.173,0.135,Variable effect (p=0.032),Significant increase (p=0.026),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP07739,rs229130,19,153727680,CD2AP,Insertion,-,-,0.7,0.34,1.0,0.02484486,High,0.131,0.11,0.091,0.468,Variable effect (p=0.024),Mild increase (p=0.007),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP07740,rs947224,14,9529338,TREM2,SNP (C/T),(C/,C,0.36,0.1,0.73,0.00511469,Low,0.178,0.097,0.422,0.103,Variable effect (p=0.025),No significant pattern (p=0.004),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07741,rs213596,17,34033647,APP,SNP (C/T),(C/,C,1.35,0.98,1.56,0.00066453,Low,0.376,0.123,0.008,0.293,No significant pattern (p=0.025),Variable effect (p=0.032),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07742,rs575897,13,62424819,PICALM,SNP (A/G),(A/,A,0.75,0.42,0.97,0.05860208,Moderate,0.065,0.178,0.453,0.104,Mild decrease (p=0.047),Mild increase (p=0.045),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07743,rs299383,17,91394921,APP,SNP (A/T),(A/,A,1.58,1.2,1.96,0.0010401,Unknown,0.106,0.245,0.159,0.291,Mild decrease (p=0.003),Variable effect (p=0.031),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07744,rs293089,9,127049407,TREM2,Deletion,-,-,0.36,0.1,0.57,0.01309582,Moderate,0.189,0.413,0.119,0.079,No significant pattern (p=0.014),Variable effect (p=0.02),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07745,rs645006,6,167256726,BIN1,Insertion,-,-,1.03,0.8,1.38,0.00397075,Moderate,0.115,0.391,0.016,0.277,Mild increase (p=0.033),No significant pattern (p=0.04),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP07746,rs824055,6,95608194,EPHA1,SNP (A/G),(A/,A,1.56,1.31,1.88,0.01245466,Moderate,0.213,0.507,0.023,0.057,Variable effect (p=0.036),Mild increase (p=0.041),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07747,rs112474,15,231811217,CR1,SNP (A/G),(A/,A,2.08,1.78,2.47,0.00418948,High,0.088,0.332,0.166,0.213,Significant increase (p=0.031),Variable effect (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07748,rs913662,21,15702584,PTK2B,SNP (A/C),(A/,A,1.03,0.81,1.37,0.03085961,Moderate,0.302,0.26,0.147,0.091,Mild decrease (p=0.037),No significant pattern (p=0.037),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07749,rs952366,1,149009433,CD33,SNP (A/T),(A/,A,1.42,1.15,1.67,0.02379629,Low,0.013,0.199,0.498,0.091,Mild decrease (p=0.025),Mild increase (p=0.02),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07750,rs644068,8,137437494,APOE,SNP (C/T),(C/,C,2.22,1.93,2.49,0.04077793,Moderate,0.136,0.592,0.041,0.031,No significant pattern (p=0.005),Significant increase (p=0.05),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07751,rs555172,1,165902515,TREM2,SNP (A/C),(A/,A,0.81,0.42,1.03,0.00952445,Moderate,0.15,0.232,0.123,0.295,Significant increase (p=0.003),No significant pattern (p=0.027),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07752,rs997154,7,170548067,PICALM,Deletion,-,-,1.15,0.78,1.44,0.12582697,High,0.162,0.281,0.297,0.06,No significant pattern (p=0.045),Significant decrease (p=0.007),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07753,rs172496,5,199580540,CLU,SNP (A/C),(A/,A,0.95,0.72,1.27,0.03233965,Unknown,0.111,0.29,0.294,0.105,Significant decrease (p=0.02),No significant pattern (p=0.022),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07754,rs570701,14,189701675,PSEN2,Deletion,-,-,0.89,0.55,1.14,0.00672277,Moderate,0.287,0.001,0.393,0.119,Mild increase (p=0.007),Significant decrease (p=0.032),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07755,rs919716,17,51017530,APP,SNP (C/G),(C/,C,2.0,1.7,2.22,0.14817242,High,0.306,0.113,0.174,0.208,Significant decrease (p=0.039),Significant decrease (p=0.029),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07756,rs135591,11,127004011,TREM2,SNP (A/G),(A/,A,0.89,0.64,1.24,0.0694245,High,0.056,0.132,0.113,0.499,Mild decrease (p=0.009),Variable effect (p=0.026),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07757,rs273494,12,76327158,PSEN2,SNP (A/T),(A/,A,1.21,0.97,1.46,0.02334125,Moderate,0.004,0.028,0.303,0.465,Significant increase (p=0.035),Variable effect (p=0.009),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07758,rs958651,6,143069378,PSEN2,SNP (A/C),(A/,A,0.75,0.41,1.12,0.04716912,High,0.079,0.39,0.03,0.302,Significant decrease (p=0.047),Variable effect (p=0.031),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07759,rs914695,12,247521376,TREM2,SNP (A/T),(A/,A,1.29,1.08,1.65,0.03297822,Low,0.161,0.205,0.389,0.046,Significant increase (p=0.017),Variable effect (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07760,rs891098,10,130557197,APP,Insertion,-,-,0.43,0.13,0.64,0.00466025,Unknown,0.309,0.409,0.059,0.023,Mild increase (p=0.047),Variable effect (p=0.026),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07761,rs238718,3,152785448,CLU,Insertion,-,-,1.33,1.1,1.72,0.01009019,High,0.372,0.056,0.19,0.182,Variable effect (p=0.021),Mild increase (p=0.012),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07762,rs150006,19,166331003,PICALM,SNP (A/G),(A/,A,0.72,0.47,1.11,0.00019239,Low,0.242,0.155,0.296,0.107,No significant pattern (p=0.03),Mild increase (p=0.018),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07763,rs708166,18,79527878,CD2AP,SNP (C/T),(C/,C,0.94,0.57,1.3,0.02667592,Moderate,0.308,0.298,0.183,0.01,Significant decrease (p=0.044),Significant increase (p=0.027),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07764,rs834994,2,81429217,PICALM,Deletion,-,-,0.38,0.12,0.64,0.02035249,Moderate,0.487,0.104,0.02,0.189,Variable effect (p=0.035),Mild decrease (p=0.033),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07765,rs842255,20,2059697,ABCA7,SNP (A/C),(A/,A,1.51,1.14,1.85,0.05406046,Protective,0.132,0.355,0.075,0.238,No significant pattern (p=0.046),Mild decrease (p=0.003),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07766,rs593270,21,189157008,PTK2B,Deletion,-,-,0.36,0.1,0.7,0.08469884,Moderate,0.357,0.205,0.113,0.124,Variable effect (p=0.005),Significant increase (p=0.004),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07767,rs729813,20,217020508,TREM2,SNP (G/T),(G/,G,0.9,0.68,1.29,0.09419827,Low,0.586,0.069,0.036,0.108,Mild decrease (p=0.002),Significant increase (p=0.013),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07768,rs610509,7,208759614,ABCA7,SNP (A/T),(A/,A,0.69,0.42,0.91,0.01955613,Moderate,0.651,0.024,0.062,0.063,Significant decrease (p=0.041),Significant decrease (p=0.011),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07769,rs677735,6,141265365,PSEN2,SNP (G/T),(G/,G,1.31,1.1,1.65,0.02549793,Protective,0.378,0.077,0.015,0.33,Significant increase (p=0.025),No significant pattern (p=0.023),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07770,rs768983,5,37324217,MS4A6A,Deletion,-,-,0.64,0.36,0.94,0.13002005,High,0.567,0.031,0.194,0.008,Significant decrease (p=0.032),Significant increase (p=0.011),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07771,rs505051,5,67148233,APP,SNP (C/T),(C/,C,1.07,0.83,1.43,0.01728117,High,0.073,0.352,0.305,0.071,No significant pattern (p=0.025),Mild decrease (p=0.007),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07772,rs795812,13,172631030,PSEN2,Insertion,-,-,1.32,0.99,1.68,0.01959744,High,0.296,0.059,0.087,0.358,Significant increase (p=0.027),No significant pattern (p=0.032),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07773,rs845250,5,228651414,EPHA1,SNP (G/T),(G/,G,1.05,0.82,1.45,0.00453831,Low,0.031,0.02,0.381,0.369,Mild decrease (p=0.004),Mild increase (p=0.016),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07774,rs562796,7,216592676,CR1,SNP (C/G),(C/,C,0.41,0.14,0.63,0.01460144,High,0.133,0.046,0.493,0.128,Significant decrease (p=0.019),Significant increase (p=0.039),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07775,rs249182,5,155948437,EPHA1,SNP (C/T),(C/,C,1.08,0.87,1.44,0.00085114,Low,0.448,0.197,0.104,0.051,Significant decrease (p=0.041),Mild decrease (p=0.033),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07776,rs638382,14,73862429,CLU,SNP (C/T),(C/,C,0.55,0.19,0.89,0.00296873,High,0.399,0.086,0.203,0.111,Significant increase (p=0.027),Significant decrease (p=0.035),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07777,rs400535,19,118625629,ABCA7,SNP (A/G),(A/,A,0.89,0.52,1.27,0.00486663,Moderate,0.005,0.545,0.034,0.217,Significant increase (p=0.033),No significant pattern (p=0.024),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07778,rs498298,1,113566423,CR1,SNP (A/C),(A/,A,2.09,1.73,2.35,0.0367448,Protective,0.158,0.554,0.06,0.028,Significant decrease (p=0.044),Significant decrease (p=0.013),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07779,rs941513,1,119109932,PICALM,SNP (A/G),(A/,A,0.69,0.37,1.02,0.03216883,Moderate,0.099,0.061,0.405,0.235,Variable effect (p=0.041),Significant increase (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07780,rs900273,6,129853114,MS4A6A,SNP (A/T),(A/,A,0.65,0.32,1.01,0.0129165,High,0.015,0.502,0.232,0.051,Mild decrease (p=0.007),Mild decrease (p=0.01),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07781,rs679608,16,157393026,PSEN2,Deletion,-,-,1.49,1.1,1.69,0.00954954,High,0.173,0.163,0.3,0.164,Mild decrease (p=0.005),Mild decrease (p=0.025),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07782,rs575315,22,57040184,BIN1,SNP (A/G),(A/,A,1.75,1.54,1.96,0.04782789,Protective,0.027,0.434,0.042,0.297,Mild decrease (p=0.013),Variable effect (p=0.01),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07783,rs382372,17,14587599,CD2AP,SNP (A/T),(A/,A,1.61,1.39,1.99,0.01992375,Moderate,0.097,0.291,0.032,0.381,No significant pattern (p=0.004),Mild increase (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07784,rs974415,15,196679489,ABCA7,SNP (A/C),(A/,A,1.01,0.66,1.27,0.0021572,Low,0.236,0.231,0.154,0.179,Mild increase (p=0.039),No significant pattern (p=0.05),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07785,rs146302,7,187473808,BIN1,SNP (A/G),(A/,A,1.04,0.67,1.32,0.02372629,Protective,0.294,0.092,0.26,0.153,Significant decrease (p=0.048),Mild increase (p=0.018),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07786,rs562726,3,211245218,CD2AP,SNP (G/T),(G/,G,1.74,1.38,1.99,0.08305282,High,0.114,0.361,0.009,0.315,Significant increase (p=0.039),Mild decrease (p=0.031),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07787,rs438309,17,230890815,PTK2B,SNP (A/T),(A/,A,0.76,0.38,1.16,0.12795079,High,0.227,0.089,0.341,0.144,Significant decrease (p=0.044),No significant pattern (p=0.019),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07788,rs828117,1,16157024,MS4A6A,SNP (C/G),(C/,C,0.6,0.22,0.92,0.0034545,Moderate,0.226,0.104,0.033,0.437,Variable effect (p=0.008),Mild increase (p=0.003),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07789,rs917289,20,174417162,CD33,Deletion,-,-,0.79,0.46,1.01,0.0052442,Unknown,0.171,0.533,0.03,0.066,Significant increase (p=0.047),Variable effect (p=0.013),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07790,rs267425,22,2354198,MS4A6A,Insertion,-,-,0.88,0.55,1.25,0.15325046,Moderate,0.026,0.264,0.313,0.196,Significant decrease (p=0.018),Significant decrease (p=0.05),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP07791,rs973010,19,136210079,CR1,SNP (A/C),(A/,A,1.53,1.19,1.81,0.00685875,High,0.076,0.462,0.156,0.107,Variable effect (p=0.003),Mild increase (p=0.048),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP07792,rs378302,8,186530867,CD33,SNP (G/T),(G/,G,2.38,2.05,2.75,0.02357688,High,0.214,0.029,0.285,0.273,Variable effect (p=0.048),Variable effect (p=0.022),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07793,rs363046,17,17970949,PSEN2,SNP (C/G),(C/,C,1.42,1.12,1.66,0.00820189,Low,0.015,0.448,0.273,0.065,Significant decrease (p=0.014),Mild decrease (p=0.008),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP07794,rs954744,17,178582531,PSEN2,SNP (A/G),(A/,A,0.74,0.53,1.07,0.03703163,High,0.091,0.251,0.261,0.197,Significant decrease (p=0.041),Significant decrease (p=0.048),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07795,rs449499,8,239965539,CR1,SNP (A/T),(A/,A,1.01,0.8,1.27,0.02949584,Low,0.176,0.402,0.069,0.152,Mild increase (p=0.017),Mild decrease (p=0.016),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07796,rs177593,8,199144507,BIN1,SNP (A/T),(A/,A,1.53,1.17,1.77,0.10995271,Moderate,0.347,0.036,0.234,0.183,Mild decrease (p=0.009),Mild increase (p=0.021),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07797,rs222706,13,210643964,APP,SNP (G/T),(G/,G,1.03,0.67,1.23,0.00074002,Moderate,0.136,0.032,0.395,0.237,Variable effect (p=0.034),Variable effect (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP07798,rs625259,21,125022892,CD33,SNP (A/T),(A/,A,0.74,0.41,1.11,0.06617059,High,0.379,0.179,0.049,0.193,Variable effect (p=0.049),Significant decrease (p=0.003),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07799,rs667529,20,50627782,CD2AP,SNP (A/C),(A/,A,1.12,0.87,1.36,0.00157207,Moderate,0.5,0.149,0.108,0.043,Significant decrease (p=0.005),Mild decrease (p=0.028),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07800,rs660474,19,196032186,MS4A6A,Deletion,-,-,1.46,1.21,1.82,0.01793409,High,0.353,0.221,0.22,0.006,No significant pattern (p=0.016),Mild increase (p=0.035),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07801,rs415270,20,237027021,CD2AP,SNP (C/G),(C/,C,1.4,1.08,1.75,0.0025675,Moderate,0.209,0.171,0.265,0.155,No significant pattern (p=0.002),Significant increase (p=0.014),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP07802,rs143341,6,176573534,SORL1,SNP (A/C),(A/,A,1.51,1.12,1.81,0.02201924,High,0.122,0.294,0.024,0.36,Mild increase (p=0.009),Significant increase (p=0.011),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07803,rs933412,3,143347454,PSEN2,Insertion,-,-,1.05,0.84,1.26,0.0011631,Unknown,0.03,0.054,0.517,0.199,Mild decrease (p=0.031),Variable effect (p=0.03),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP07804,rs776648,10,238405727,PSEN2,SNP (A/G),(A/,A,0.56,0.24,0.91,0.04005593,Moderate,0.001,0.481,0.241,0.078,Mild increase (p=0.036),Variable effect (p=0.001),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07805,rs331710,3,85358321,CR1,SNP (C/T),(C/,C,0.46,0.25,0.71,5.19e-05,High,0.214,0.42,0.081,0.085,Significant decrease (p=0.015),Mild decrease (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07806,rs263907,11,232047014,PTK2B,SNP (A/T),(A/,A,1.46,1.11,1.7,0.00615253,Moderate,0.072,0.344,0.164,0.22,Mild increase (p=0.022),No significant pattern (p=0.004),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07807,rs296377,3,162172731,APP,Deletion,-,-,1.3,1.01,1.65,0.00487384,Moderate,0.151,0.074,0.146,0.429,Variable effect (p=0.015),No significant pattern (p=0.048),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07808,rs862569,21,121025392,EPHA1,SNP (C/T),(C/,C,1.2,0.99,1.49,0.00727747,High,0.025,0.563,0.183,0.028,Significant decrease (p=0.046),Variable effect (p=0.027),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07809,rs290996,7,32003467,CD2AP,Insertion,-,-,0.89,0.53,1.16,0.13192934,High,0.034,0.034,0.227,0.506,No significant pattern (p=0.021),Mild increase (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07810,rs920303,18,177608182,MS4A6A,Deletion,-,-,1.56,1.24,1.78,0.00310935,High,0.212,0.017,0.46,0.111,Mild decrease (p=0.007),Significant decrease (p=0.021),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07811,rs293632,16,62387510,MS4A6A,Insertion,-,-,0.48,0.23,0.7,0.0572054,Low,0.282,0.244,0.176,0.098,Variable effect (p=0.005),Significant decrease (p=0.047),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07812,rs360352,17,1435098,CR1,SNP (A/T),(A/,A,1.21,0.95,1.42,0.03442333,Moderate,0.14,0.292,0.08,0.288,Mild decrease (p=0.04),No significant pattern (p=0.044),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07813,rs372727,16,238836621,CD2AP,SNP (A/T),(A/,A,0.72,0.42,1.11,0.01770964,Low,0.278,0.453,0.042,0.026,Significant increase (p=0.044),No significant pattern (p=0.028),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07814,rs557473,8,105600843,MS4A6A,SNP (A/C),(A/,A,0.48,0.26,0.87,0.02222767,Low,0.041,0.258,0.099,0.402,Mild increase (p=0.022),Significant decrease (p=0.042),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07815,rs994612,5,137063323,CD33,SNP (C/G),(C/,C,0.99,0.71,1.33,0.00600949,Protective,0.243,0.036,0.246,0.274,Significant increase (p=0.001),Mild increase (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07816,rs268469,11,177059412,BIN1,SNP (A/C),(A/,A,0.85,0.57,1.06,0.03356688,High,0.432,0.145,0.095,0.127,Significant decrease (p=0.047),Significant increase (p=0.004),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07817,rs231659,4,8685678,CLU,SNP (G/T),(G/,G,1.56,1.27,1.82,0.01724751,Low,0.611,0.0,0.171,0.017,No significant pattern (p=0.008),Significant increase (p=0.043),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07818,rs569362,20,193645804,APP,Deletion,-,-,2.14,1.93,2.41,0.0236751,Unknown,0.085,0.098,0.387,0.23,Mild decrease (p=0.026),Significant increase (p=0.023),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07819,rs500651,17,38874985,EPHA1,SNP (C/G),(C/,C,1.87,1.49,2.08,0.05727505,Protective,0.544,0.202,0.036,0.017,Significant increase (p=0.034),Mild increase (p=0.046),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07820,rs700308,5,15257632,CLU,Deletion,-,-,1.25,1.02,1.56,0.02030692,Moderate,0.138,0.38,0.162,0.12,Significant decrease (p=0.002),Mild increase (p=0.012),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07821,rs439773,2,238827380,CLU,Deletion,-,-,1.47,1.08,1.73,0.01089141,Unknown,0.056,0.055,0.394,0.295,Mild increase (p=0.043),Variable effect (p=0.009),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07822,rs483743,8,185221435,CD33,SNP (A/T),(A/,A,0.77,0.43,1.08,0.0322359,Moderate,0.488,0.169,0.08,0.062,Variable effect (p=0.039),Significant increase (p=0.05),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP07823,rs684650,7,64402156,PICALM,SNP (A/G),(A/,A,1.07,0.73,1.4,0.00073294,Moderate,0.092,0.273,0.267,0.169,No significant pattern (p=0.023),Significant decrease (p=0.032),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07824,rs102563,22,183879680,APP,Deletion,-,-,0.8,0.47,1.09,0.03733265,Protective,0.05,0.578,0.082,0.09,Significant increase (p=0.043),Variable effect (p=0.016),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07825,rs284040,1,73785008,PICALM,SNP (A/T),(A/,A,0.78,0.39,1.15,0.02145879,High,0.163,0.011,0.198,0.429,Mild increase (p=0.041),Significant decrease (p=0.01),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07826,rs994482,1,74881421,CLU,SNP (A/G),(A/,A,2.26,2.06,2.57,0.01970056,High,0.34,0.161,0.081,0.218,Variable effect (p=0.016),Significant increase (p=0.027),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07827,rs484428,22,27200591,MS4A6A,SNP (A/C),(A/,A,1.29,0.94,1.57,0.03521357,Moderate,0.071,0.039,0.488,0.203,No significant pattern (p=0.034),Mild increase (p=0.046),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07828,rs737770,7,222291136,ABCA7,SNP (G/T),(G/,G,1.87,1.62,2.21,0.06147342,Low,0.505,0.232,0.044,0.02,Significant decrease (p=0.042),No significant pattern (p=0.008),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07829,rs201801,6,121795575,BIN1,SNP (A/C),(A/,A,1.59,1.35,1.86,0.04464888,Moderate,0.263,0.402,0.022,0.113,No significant pattern (p=0.038),Significant decrease (p=0.049),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07830,rs210481,14,157447838,CD33,SNP (C/T),(C/,C,0.57,0.19,0.83,0.04151887,Moderate,0.06,0.135,0.068,0.537,Mild increase (p=0.012),Mild decrease (p=0.007),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP07831,rs185050,2,26378357,EPHA1,SNP (A/C),(A/,A,0.36,0.14,0.73,0.00231917,Protective,0.258,0.088,0.438,0.015,No significant pattern (p=0.028),Variable effect (p=0.001),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07832,rs464867,10,122683541,CD33,SNP (C/G),(C/,C,0.31,0.1,0.65,0.02344777,Low,0.271,0.078,0.299,0.151,Mild increase (p=0.03),No significant pattern (p=0.048),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07833,rs233389,22,16991531,APP,Deletion,-,-,0.8,0.5,1.05,0.00643886,Moderate,0.206,0.2,0.353,0.041,No significant pattern (p=0.044),Mild decrease (p=0.003),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07834,rs953169,14,179697865,CD33,Deletion,-,-,1.17,0.86,1.51,0.0452655,Moderate,0.122,0.029,0.145,0.503,Significant increase (p=0.035),Significant decrease (p=0.015),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07835,rs488343,9,42864334,APP,Deletion,-,-,0.75,0.37,1.09,0.00540685,Moderate,0.092,0.23,0.411,0.067,Mild decrease (p=0.026),No significant pattern (p=0.011),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07836,rs258349,5,67210832,BIN1,SNP (C/T),(C/,C,1.43,1.05,1.72,0.00348576,High,0.111,0.24,0.045,0.404,Significant decrease (p=0.031),No significant pattern (p=0.002),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07837,rs768952,21,4300107,EPHA1,SNP (C/T),(C/,C,1.25,1.05,1.59,0.01641962,Moderate,0.213,0.059,0.007,0.521,Significant decrease (p=0.048),No significant pattern (p=0.035),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07838,rs930030,16,6421873,TREM2,SNP (A/G),(A/,A,0.61,0.38,1.01,0.00905394,Moderate,0.337,0.022,0.012,0.429,Variable effect (p=0.002),Variable effect (p=0.035),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07839,rs889536,22,201690707,APP,Insertion,-,-,1.68,1.29,1.95,0.00954486,High,0.105,0.243,0.037,0.415,Significant increase (p=0.013),Significant decrease (p=0.03),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07840,rs452548,17,17866013,CR1,SNP (C/T),(C/,C,0.84,0.59,1.11,0.01477255,Moderate,0.024,0.328,0.245,0.203,Mild increase (p=0.038),Significant increase (p=0.02),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07841,rs989851,21,74799652,PICALM,Insertion,-,-,1.41,1.02,1.71,0.00132446,High,0.09,0.08,0.219,0.412,Significant increase (p=0.009),Mild decrease (p=0.019),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07842,rs780106,8,247344263,MS4A6A,SNP (A/C),(A/,A,0.87,0.61,1.23,0.05100036,High,0.181,0.124,0.353,0.143,Significant increase (p=0.046),Mild increase (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07843,rs736632,7,120893519,PICALM,SNP (A/T),(A/,A,1.62,1.32,2.0,0.00543597,Moderate,0.007,0.174,0.317,0.302,Mild decrease (p=0.009),Significant increase (p=0.044),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07844,rs542397,2,149607137,CLU,SNP (G/T),(G/,G,0.98,0.7,1.28,0.02909635,Low,0.3,0.006,0.337,0.157,Significant decrease (p=0.02),Mild increase (p=0.01),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07845,rs406723,15,12875543,PTK2B,SNP (C/T),(C/,C,0.28,0.1,0.59,0.03214987,High,0.084,0.236,0.183,0.297,Mild decrease (p=0.001),Mild decrease (p=0.046),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07846,rs503675,17,232056320,APP,SNP (A/G),(A/,A,1.02,0.64,1.41,0.02076028,High,0.005,0.203,0.442,0.15,Significant decrease (p=0.019),Significant decrease (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07847,rs568468,18,120813008,PTK2B,SNP (A/C),(A/,A,0.52,0.18,0.92,0.04881511,Moderate,0.036,0.197,0.085,0.482,No significant pattern (p=0.016),Significant increase (p=0.032),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07848,rs884076,13,133960513,PSEN2,SNP (G/T),(G/,G,1.29,0.96,1.56,0.05111468,Moderate,0.102,0.138,0.123,0.437,Significant increase (p=0.013),Mild decrease (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07849,rs629962,20,142119586,SORL1,SNP (C/T),(C/,C,0.71,0.4,1.1,0.02124146,Protective,0.008,0.517,0.176,0.1,Significant increase (p=0.011),Significant decrease (p=0.038),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP07850,rs747587,13,87696121,MS4A6A,SNP (A/T),(A/,A,0.98,0.59,1.29,0.00445466,Moderate,0.107,0.341,0.07,0.282,No significant pattern (p=0.048),Variable effect (p=0.016),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP07851,rs860569,5,192428202,CR1,SNP (G/T),(G/,G,2.07,1.69,2.27,0.01370264,High,0.12,0.645,0.013,0.021,Mild increase (p=0.044),Significant decrease (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07852,rs142309,1,160800815,EPHA1,Insertion,-,-,0.59,0.3,0.85,0.020485,Low,0.009,0.633,0.005,0.153,Variable effect (p=0.047),Variable effect (p=0.013),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07853,rs598158,16,63215528,SORL1,SNP (G/T),(G/,G,0.75,0.51,0.98,0.00954226,Moderate,0.607,0.125,0.042,0.026,Variable effect (p=0.037),Significant decrease (p=0.006),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07854,rs731863,20,215955333,CLU,SNP (A/G),(A/,A,2.18,1.8,2.57,0.00378045,Low,0.121,0.175,0.286,0.218,Mild increase (p=0.012),Mild decrease (p=0.022),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07855,rs657897,16,10624072,PTK2B,Deletion,-,-,2.11,1.72,2.48,0.07128514,High,0.279,0.076,0.288,0.158,No significant pattern (p=0.009),Significant decrease (p=0.039),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07856,rs904853,15,168416963,BIN1,SNP (A/T),(A/,A,0.8,0.46,1.04,0.03456151,Low,0.091,0.108,0.185,0.416,No significant pattern (p=0.046),Significant decrease (p=0.003),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07857,rs533990,4,183362086,PTK2B,SNP (C/T),(C/,C,1.04,0.83,1.32,0.00565717,Moderate,0.376,0.308,0.051,0.065,Significant decrease (p=0.014),No significant pattern (p=0.002),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP07858,rs553436,21,184250696,PICALM,SNP (A/G),(A/,A,1.06,0.85,1.33,0.05554112,Unknown,0.042,0.21,0.385,0.163,Mild decrease (p=0.027),Mild increase (p=0.021),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07859,rs950952,8,200353372,SORL1,SNP (A/C),(A/,A,0.69,0.42,0.96,0.00625797,High,0.431,0.183,0.026,0.16,Significant increase (p=0.044),Significant increase (p=0.016),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07860,rs223234,21,96082814,APP,SNP (A/T),(A/,A,0.94,0.56,1.18,0.01741989,Moderate,0.179,0.278,0.324,0.018,Significant decrease (p=0.041),Significant decrease (p=0.032),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP07861,rs571543,8,78787454,CLU,SNP (C/T),(C/,C,1.13,0.77,1.37,0.02507637,Moderate,0.039,0.184,0.423,0.154,No significant pattern (p=0.032),Mild increase (p=0.002),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07862,rs446228,17,214335257,CD33,SNP (G/T),(G/,G,0.87,0.56,1.08,0.09562189,Moderate,0.197,0.094,0.039,0.471,Variable effect (p=0.011),Variable effect (p=0.007),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07863,rs767773,3,173368502,CR1,SNP (C/G),(C/,C,2.25,1.88,2.56,0.01645389,Low,0.3,0.101,0.131,0.268,Significant decrease (p=0.012),Significant increase (p=0.044),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP07864,rs793752,10,76712923,PTK2B,SNP (A/C),(A/,A,1.5,1.17,1.88,0.0042924,Moderate,0.381,0.221,0.165,0.032,No significant pattern (p=0.027),Variable effect (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07865,rs187696,8,19633643,SORL1,SNP (A/C),(A/,A,0.99,0.7,1.24,0.0604293,Moderate,0.402,0.067,0.123,0.208,Significant increase (p=0.006),Mild decrease (p=0.045),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07866,rs683482,17,104437599,PTK2B,Deletion,-,-,1.06,0.83,1.45,0.00027974,High,0.396,0.325,0.013,0.067,Significant decrease (p=0.043),Significant increase (p=0.015),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07867,rs979373,15,78281433,BIN1,SNP (C/T),(C/,C,1.35,0.95,1.71,0.00494371,Low,0.129,0.25,0.31,0.111,Variable effect (p=0.036),Significant increase (p=0.047),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07868,rs750601,12,167219777,PTK2B,Deletion,-,-,2.09,1.8,2.42,0.05081497,High,0.006,0.198,0.223,0.373,Significant decrease (p=0.049),No significant pattern (p=0.027),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07869,rs432443,16,220413363,MS4A6A,Deletion,-,-,1.53,1.26,1.78,0.06192426,High,0.199,0.095,0.067,0.439,Significant increase (p=0.005),Variable effect (p=0.016),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07870,rs175076,14,168337032,BIN1,Insertion,-,-,1.26,0.94,1.64,0.03462936,Moderate,0.468,0.18,0.124,0.028,Mild increase (p=0.048),Significant increase (p=0.022),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07871,rs750815,4,189480473,CLU,Deletion,-,-,1.23,0.91,1.53,0.00302011,Moderate,0.107,0.137,0.257,0.299,Significant decrease (p=0.015),Significant decrease (p=0.017),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07872,rs235446,18,32299486,CD33,SNP (G/T),(G/,G,1.61,1.32,1.91,0.04371143,High,0.178,0.263,0.151,0.208,Mild decrease (p=0.026),Mild decrease (p=0.014),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07873,rs120791,18,70506093,CD2AP,SNP (C/T),(C/,C,2.12,1.89,2.45,0.03745521,Low,0.061,0.363,0.235,0.141,Mild decrease (p=0.01),Significant increase (p=0.027),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07874,rs611786,13,186983852,APOE,Deletion,-,-,1.2,0.81,1.44,0.01141634,Moderate,0.102,0.541,0.078,0.079,Significant increase (p=0.004),Significant increase (p=0.008),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07875,rs299418,12,91673448,PSEN2,SNP (A/C),(A/,A,0.82,0.49,1.09,0.06573486,Moderate,0.25,0.023,0.038,0.489,Significant decrease (p=0.036),Mild decrease (p=0.005),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07876,rs518914,20,203037180,CD33,SNP (G/T),(G/,G,1.14,0.79,1.43,0.02945055,Moderate,0.045,0.211,0.518,0.025,Significant increase (p=0.037),Mild increase (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07877,rs792273,16,27433549,BIN1,Deletion,-,-,0.93,0.54,1.14,0.00557683,High,0.136,0.141,0.095,0.428,Mild increase (p=0.043),Mild increase (p=0.021),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07878,rs718007,10,222632855,SORL1,SNP (C/T),(C/,C,0.74,0.37,1.06,0.02646577,Protective,0.039,0.402,0.14,0.219,Significant decrease (p=0.013),Variable effect (p=0.017),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07879,rs316550,4,192433964,EPHA1,SNP (A/C),(A/,A,0.98,0.69,1.22,0.08201999,Moderate,0.126,0.194,0.08,0.4,Variable effect (p=0.04),Significant decrease (p=0.026),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07880,rs936156,10,10855822,PSEN2,Insertion,-,-,0.43,0.23,0.69,0.00523812,Low,0.625,0.152,0.01,0.013,Significant decrease (p=0.035),Variable effect (p=0.048),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07881,rs479859,7,69205761,MS4A6A,Deletion,-,-,2.65,2.41,2.88,0.0857831,Moderate,0.041,0.514,0.152,0.093,Significant decrease (p=0.026),Significant increase (p=0.009),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07882,rs893383,19,41534767,APP,Deletion,-,-,1.94,1.62,2.18,0.00049393,Moderate,0.567,0.012,0.016,0.206,Significant increase (p=0.032),Significant increase (p=0.021),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07883,rs357960,13,151121655,CD33,SNP (A/G),(A/,A,0.59,0.21,0.86,0.00428716,Protective,0.123,0.34,0.113,0.224,No significant pattern (p=0.022),Significant decrease (p=0.031),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07884,rs434875,20,22108532,EPHA1,SNP (A/C),(A/,A,0.22,0.1,0.49,0.01359059,Low,0.278,0.028,0.449,0.044,Significant increase (p=0.018),Variable effect (p=0.027),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07885,rs914361,1,119844155,CR1,SNP (C/T),(C/,C,1.6,1.22,1.95,0.01836622,Moderate,0.304,0.035,0.194,0.267,Variable effect (p=0.014),No significant pattern (p=0.011),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07886,rs545912,2,221074233,APOE,SNP (A/C),(A/,A,1.45,1.08,1.66,0.01947536,Moderate,0.25,0.26,0.246,0.044,Significant increase (p=0.022),Mild increase (p=0.041),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07887,rs336518,18,47217009,CLU,Deletion,-,-,0.46,0.25,0.7,0.0080308,High,0.481,0.018,0.058,0.243,Significant increase (p=0.047),Significant decrease (p=0.015),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07888,rs413925,15,139133221,PTK2B,SNP (A/C),(A/,A,1.6,1.39,1.81,0.00363911,Moderate,0.08,0.017,0.599,0.103,No significant pattern (p=0.029),Mild increase (p=0.004),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07889,rs355851,3,199100086,PSEN2,SNP (A/T),(A/,A,2.47,2.15,2.79,0.0146857,Low,0.3,0.027,0.02,0.454,Significant increase (p=0.008),No significant pattern (p=0.002),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP07890,rs392156,13,8228174,PTK2B,Deletion,-,-,1.23,0.99,1.45,0.06358134,Low,0.147,0.118,0.242,0.293,Variable effect (p=0.029),Mild increase (p=0.016),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07891,rs615829,4,82286371,PTK2B,SNP (C/G),(C/,C,0.95,0.7,1.19,0.01935786,Low,0.249,0.213,0.321,0.018,Variable effect (p=0.019),Mild decrease (p=0.007),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07892,rs416831,14,72049783,EPHA1,SNP (A/T),(A/,A,1.1,0.79,1.33,0.05352419,Protective,0.389,0.255,0.084,0.072,Variable effect (p=0.006),Significant decrease (p=0.018),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07893,rs573660,11,75582762,CLU,Deletion,-,-,1.09,0.69,1.44,0.00316999,High,0.112,0.457,0.217,0.015,Significant increase (p=0.023),Mild increase (p=0.032),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07894,rs515976,8,2483775,CD2AP,SNP (A/C),(A/,A,1.9,1.69,2.27,0.00950593,Low,0.304,0.062,0.097,0.337,Significant decrease (p=0.008),Significant decrease (p=0.002),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07895,rs281261,19,43520820,PICALM,SNP (C/G),(C/,C,2.17,1.8,2.5,0.02629289,High,0.019,0.04,0.402,0.339,No significant pattern (p=0.033),No significant pattern (p=0.04),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP07896,rs912448,1,129654398,PSEN2,SNP (C/T),(C/,C,0.52,0.13,0.74,0.03698632,High,0.326,0.044,0.085,0.344,Variable effect (p=0.029),Mild increase (p=0.044),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07897,rs902044,12,182255903,EPHA1,SNP (A/T),(A/,A,0.76,0.44,1.1,0.04032966,Moderate,0.155,0.489,0.101,0.055,No significant pattern (p=0.047),No significant pattern (p=0.029),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP07898,rs232649,8,40126563,CD2AP,SNP (A/T),(A/,A,0.33,0.1,0.59,0.03257148,High,0.155,0.454,0.154,0.037,Mild decrease (p=0.04),Variable effect (p=0.045),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07899,rs626877,8,243211797,APP,SNP (C/T),(C/,C,0.82,0.54,1.08,0.00589437,Low,0.113,0.131,0.102,0.455,Mild increase (p=0.04),Mild increase (p=0.039),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07900,rs363873,11,32639392,EPHA1,SNP (A/T),(A/,A,0.85,0.6,1.16,0.01231077,Protective,0.033,0.242,0.191,0.334,Significant increase (p=0.045),Mild decrease (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07901,rs702162,11,108413104,PICALM,SNP (C/G),(C/,C,0.77,0.55,1.13,0.11130483,Low,0.075,0.327,0.144,0.254,No significant pattern (p=0.045),Variable effect (p=0.034),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07902,rs606723,14,4925790,MS4A6A,SNP (A/G),(A/,A,1.75,1.44,2.11,0.02623134,Moderate,0.163,0.192,0.082,0.364,Mild increase (p=0.022),Significant increase (p=0.016),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07903,rs235700,11,79709037,APP,SNP (A/C),(A/,A,1.07,0.76,1.41,0.04886436,High,0.469,0.203,0.12,0.008,Significant increase (p=0.043),No significant pattern (p=0.004),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07904,rs169040,14,159450910,EPHA1,SNP (A/C),(A/,A,1.43,1.08,1.76,0.03873645,High,0.098,0.024,0.033,0.645,Mild decrease (p=0.006),Mild decrease (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07905,rs660947,22,194532145,CD33,SNP (A/G),(A/,A,0.7,0.33,0.91,0.00196569,Low,0.455,0.175,0.035,0.135,Significant decrease (p=0.017),No significant pattern (p=0.027),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07906,rs140864,1,120368300,EPHA1,SNP (A/T),(A/,A,1.39,1.08,1.77,0.00042453,Moderate,0.387,0.068,0.016,0.33,Variable effect (p=0.009),No significant pattern (p=0.032),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07907,rs980094,9,27449522,CR1,SNP (A/T),(A/,A,1.59,1.26,1.94,0.11874496,Moderate,0.273,0.308,0.055,0.163,Significant decrease (p=0.016),Significant increase (p=0.023),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07908,rs239189,17,32436151,PICALM,SNP (A/G),(A/,A,0.68,0.29,0.92,0.00016936,High,0.205,0.324,0.014,0.257,Significant increase (p=0.032),Mild decrease (p=0.036),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07909,rs880073,13,10406348,EPHA1,SNP (A/G),(A/,A,1.09,0.89,1.42,0.00729842,Moderate,0.425,0.161,0.156,0.058,Mild increase (p=0.048),Significant increase (p=0.004),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07910,rs279474,22,46420000,PTK2B,SNP (C/T),(C/,C,0.61,0.35,0.82,0.04463214,Moderate,0.103,0.244,0.047,0.406,Significant increase (p=0.021),Mild decrease (p=0.04),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07911,rs116004,15,46314827,APOE,Insertion,-,-,1.02,0.72,1.31,0.03290283,Low,0.237,0.064,0.264,0.235,Mild decrease (p=0.008),Significant increase (p=0.004),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07912,rs317312,10,13706553,PICALM,SNP (G/T),(G/,G,0.87,0.51,1.19,0.01287741,Unknown,0.239,0.099,0.449,0.013,Significant decrease (p=0.034),Significant increase (p=0.048),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07913,rs314361,5,225930217,ABCA7,Insertion,-,-,1.11,0.79,1.36,0.01753869,Moderate,0.253,0.481,0.065,0.001,Significant increase (p=0.048),No significant pattern (p=0.026),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07914,rs526797,11,236103158,PSEN2,SNP (A/C),(A/,A,0.52,0.18,0.73,0.13367398,Moderate,0.118,0.21,0.235,0.237,Mild increase (p=0.022),Significant increase (p=0.01),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07915,rs784971,19,72859623,EPHA1,SNP (A/G),(A/,A,0.35,0.13,0.75,0.01126451,Protective,0.179,0.14,0.032,0.449,Significant increase (p=0.049),Significant increase (p=0.01),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07916,rs591581,5,39525833,PTK2B,SNP (A/C),(A/,A,0.68,0.34,0.98,0.1220414,Moderate,0.15,0.385,0.057,0.207,Significant decrease (p=0.029),Mild increase (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP07917,rs453658,22,182500825,APP,SNP (C/G),(C/,C,1.39,1.01,1.73,0.06352695,High,0.165,0.32,0.248,0.068,Significant increase (p=0.002),Mild decrease (p=0.049),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07918,rs573420,10,200458132,APP,Deletion,-,-,1.57,1.2,1.96,0.03140512,High,0.236,0.42,0.045,0.099,Significant increase (p=0.018),Mild increase (p=0.015),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07919,rs561708,20,86780983,APOE,SNP (A/C),(A/,A,0.75,0.48,1.01,0.00393468,Protective,0.016,0.624,0.002,0.158,Mild decrease (p=0.041),Significant increase (p=0.041),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP07920,rs398154,4,109667883,CD2AP,SNP (C/G),(C/,C,0.64,0.4,0.94,0.03925256,Moderate,0.004,0.071,0.446,0.28,Mild increase (p=0.034),Variable effect (p=0.02),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07921,rs101561,8,116884360,CLU,SNP (A/G),(A/,A,1.06,0.71,1.32,0.06120939,Moderate,0.301,0.085,0.24,0.175,Significant decrease (p=0.003),Mild decrease (p=0.04),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07922,rs339309,12,154891330,MS4A6A,SNP (C/G),(C/,C,0.67,0.44,0.94,0.01474086,Moderate,0.081,0.264,0.215,0.24,Variable effect (p=0.038),No significant pattern (p=0.041),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP07923,rs621962,6,177510090,PSEN2,SNP (A/C),(A/,A,0.89,0.6,1.21,0.03131972,Moderate,0.387,0.167,0.11,0.135,Variable effect (p=0.023),Mild increase (p=0.013),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP07924,rs580799,18,186082092,TREM2,SNP (A/T),(A/,A,1.22,0.9,1.6,0.01658379,Low,0.311,0.101,0.168,0.22,Variable effect (p=0.039),Significant increase (p=0.006),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07925,rs888093,17,9646069,ABCA7,SNP (C/T),(C/,C,0.7,0.43,1.08,0.02496373,High,0.052,0.251,0.147,0.349,No significant pattern (p=0.023),Significant decrease (p=0.014),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP07926,rs685767,9,63771843,MS4A6A,SNP (A/C),(A/,A,1.1,0.78,1.41,0.00688309,Moderate,0.118,0.069,0.538,0.075,Mild increase (p=0.036),Variable effect (p=0.006),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07927,rs425604,19,52345873,ABCA7,SNP (A/T),(A/,A,0.52,0.31,0.88,0.06929007,Moderate,0.133,0.248,0.085,0.335,Mild increase (p=0.032),Significant increase (p=0.024),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP07928,rs740443,11,78214853,BIN1,SNP (C/G),(C/,C,0.89,0.51,1.11,0.01335736,High,0.237,0.031,0.411,0.122,Mild decrease (p=0.034),Mild increase (p=0.049),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07929,rs839460,11,87645625,CD33,SNP (A/G),(A/,A,1.49,1.28,1.77,0.07377804,Low,0.059,0.308,0.351,0.082,Significant decrease (p=0.023),Significant increase (p=0.019),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07930,rs474636,5,141668406,CD2AP,SNP (G/T),(G/,G,1.49,1.2,1.81,0.00529738,Moderate,0.483,0.019,0.194,0.103,Mild decrease (p=0.009),Significant increase (p=0.006),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07931,rs962431,20,9704565,APP,SNP (A/C),(A/,A,0.57,0.31,0.79,0.0024824,Unknown,0.274,0.262,0.158,0.106,Mild increase (p=0.014),Significant decrease (p=0.044),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07932,rs253704,5,30452412,PTK2B,SNP (C/G),(C/,C,0.35,0.1,0.71,0.01138424,Moderate,0.061,0.044,0.188,0.507,No significant pattern (p=0.005),Mild increase (p=0.029),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP07933,rs149529,2,117597633,APOE,SNP (G/T),(G/,G,0.94,0.63,1.27,0.03563574,Moderate,0.316,0.34,0.14,0.004,Significant increase (p=0.029),No significant pattern (p=0.039),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07934,rs602766,20,223227222,CD33,SNP (A/G),(A/,A,1.44,1.22,1.83,0.08260237,High,0.14,0.356,0.281,0.023,Significant increase (p=0.037),Mild decrease (p=0.038),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07935,rs259901,14,60072331,CR1,SNP (A/C),(A/,A,1.29,0.93,1.59,0.00310285,High,0.087,0.421,0.046,0.246,Significant increase (p=0.039),Mild increase (p=0.034),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07936,rs228799,20,92732906,CR1,SNP (C/G),(C/,C,1.32,0.94,1.71,0.0528436,High,0.125,0.226,0.448,0.001,Variable effect (p=0.03),Significant increase (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07937,rs794474,11,30470347,BIN1,SNP (A/G),(A/,A,0.84,0.62,1.16,0.07913475,High,0.481,0.023,0.053,0.244,Significant decrease (p=0.043),Variable effect (p=0.004),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07938,rs299086,20,60089447,TREM2,Deletion,-,-,0.82,0.61,1.19,0.03872711,Low,0.062,0.346,0.014,0.379,Significant decrease (p=0.031),Mild decrease (p=0.001),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07939,rs439165,12,202936104,CD33,Deletion,-,-,0.31,0.1,0.6,0.11280024,High,0.233,0.265,0.071,0.231,Significant increase (p=0.026),Significant decrease (p=0.034),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP07940,rs669599,4,13011121,CR1,Deletion,-,-,0.28,0.1,0.67,0.01465763,High,0.141,0.181,0.044,0.433,Mild increase (p=0.035),Mild increase (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07941,rs266475,12,201881309,PICALM,SNP (C/T),(C/,C,0.65,0.41,0.96,0.08697305,Low,0.013,0.368,0.127,0.292,Significant decrease (p=0.009),Variable effect (p=0.034),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP07942,rs319659,1,199620111,SORL1,SNP (G/T),(G/,G,1.26,0.87,1.61,0.11019181,Protective,0.064,0.185,0.294,0.257,Variable effect (p=0.005),Variable effect (p=0.022),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP07943,rs461720,2,206962750,CD2AP,SNP (A/G),(A/,A,0.53,0.31,0.81,0.01394291,High,0.381,0.129,0.103,0.188,Mild increase (p=0.01),Mild decrease (p=0.027),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07944,rs801152,3,225630670,PICALM,Insertion,-,-,1.29,0.97,1.61,0.02361346,High,0.208,0.061,0.22,0.31,Mild increase (p=0.021),Significant increase (p=0.022),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07945,rs200956,20,198691375,CD33,SNP (C/T),(C/,C,1.31,0.97,1.69,0.01084799,Moderate,0.423,0.097,0.117,0.163,Mild increase (p=0.049),Significant increase (p=0.023),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP07946,rs409311,21,189747063,APOE,SNP (C/G),(C/,C,1.18,0.83,1.53,0.0688947,Moderate,0.066,0.379,0.031,0.325,Mild increase (p=0.036),Variable effect (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP07947,rs687226,3,214050529,CD33,SNP (A/G),(A/,A,1.65,1.34,2.04,0.00869005,Moderate,0.211,0.266,0.178,0.144,Significant increase (p=0.023),No significant pattern (p=0.04),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP07948,rs331334,19,149646728,CD33,SNP (A/T),(A/,A,0.49,0.27,0.77,0.00019785,Moderate,0.084,0.482,0.041,0.192,Significant decrease (p=0.027),Significant decrease (p=0.018),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP07949,rs662723,9,41466691,TREM2,SNP (C/T),(C/,C,0.93,0.56,1.16,0.03753447,High,0.365,0.115,0.182,0.137,Variable effect (p=0.006),Mild decrease (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07950,rs142488,16,245203868,APP,SNP (A/G),(A/,A,0.62,0.29,0.91,0.02964239,Protective,0.264,0.004,0.429,0.103,Significant decrease (p=0.01),Significant increase (p=0.024),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07951,rs671906,19,209318041,PICALM,Deletion,-,-,0.92,0.58,1.24,0.03639391,Moderate,0.012,0.569,0.079,0.14,Mild increase (p=0.016),Mild decrease (p=0.042),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07952,rs585369,12,148058209,SORL1,Insertion,-,-,0.77,0.4,1.04,0.08592239,High,0.102,0.507,0.133,0.058,Mild decrease (p=0.017),Mild decrease (p=0.007),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07953,rs605842,22,56102344,CR1,SNP (A/C),(A/,A,0.58,0.21,0.9,0.02946382,Moderate,0.348,0.228,0.063,0.161,Mild increase (p=0.033),Mild increase (p=0.033),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07954,rs736157,19,143338735,PICALM,SNP (C/T),(C/,C,1.31,1.04,1.55,0.05475637,Protective,0.135,0.155,0.282,0.228,No significant pattern (p=0.003),Variable effect (p=0.016),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07955,rs547350,8,25944997,MS4A6A,Insertion,-,-,1.88,1.58,2.27,0.08041814,Moderate,0.209,0.107,0.296,0.188,Variable effect (p=0.02),Significant increase (p=0.033),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07956,rs421388,7,189425059,APOE,SNP (C/G),(C/,C,0.7,0.4,1.04,0.04850789,High,0.227,0.416,0.105,0.052,Significant decrease (p=0.039),No significant pattern (p=0.012),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP07957,rs343182,12,7907334,CD33,Deletion,-,-,1.55,1.25,1.91,0.07389042,Moderate,0.026,0.08,0.198,0.496,Significant increase (p=0.019),Mild increase (p=0.028),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP07958,rs671726,6,3358271,MS4A6A,SNP (A/G),(A/,A,1.07,0.77,1.44,0.02976652,High,0.08,0.118,0.024,0.578,No significant pattern (p=0.023),Significant increase (p=0.035),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07959,rs609614,17,153209637,APOE,SNP (A/T),(A/,A,0.58,0.2,0.87,0.00338958,High,0.052,0.656,0.057,0.035,Mild decrease (p=0.044),Variable effect (p=0.05),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07960,rs230706,7,97405340,MS4A6A,SNP (C/T),(C/,C,1.44,1.07,1.71,0.03851537,Moderate,0.37,0.06,0.013,0.357,No significant pattern (p=0.012),No significant pattern (p=0.02),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP07961,rs477688,16,95750151,TREM2,SNP (A/G),(A/,A,1.46,1.2,1.81,0.01186323,High,0.189,0.26,0.318,0.034,Mild increase (p=0.031),Variable effect (p=0.034),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07962,rs382024,14,85437943,PICALM,SNP (A/G),(A/,A,0.55,0.17,0.85,0.03242487,High,0.328,0.046,0.256,0.17,Variable effect (p=0.014),Significant increase (p=0.003),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07963,rs625412,7,190716993,BIN1,SNP (C/G),(C/,C,0.78,0.51,1.05,0.0286612,Low,0.047,0.558,0.089,0.106,Mild increase (p=0.031),Mild increase (p=0.036),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP07964,rs715189,15,51609058,APOE,SNP (G/T),(G/,G,2.33,1.96,2.68,0.02550415,Moderate,0.171,0.105,0.238,0.287,Mild decrease (p=0.015),Significant increase (p=0.016),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP07965,rs312963,22,172666970,APP,SNP (C/G),(C/,C,1.23,0.89,1.44,0.15367203,High,0.021,0.356,0.23,0.194,Significant increase (p=0.036),No significant pattern (p=0.045),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP07966,rs199585,10,99656430,BIN1,SNP (A/G),(A/,A,3.25,3.03,3.48,0.04346774,High,0.626,0.149,0.018,0.007,Mild decrease (p=0.024),No significant pattern (p=0.041),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP07967,rs796076,2,1632740,CLU,SNP (A/T),(A/,A,1.12,0.88,1.32,0.02764448,Moderate,0.243,0.045,0.196,0.316,Variable effect (p=0.005),Mild decrease (p=0.025),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP07968,rs902691,12,93166909,CD2AP,SNP (A/T),(A/,A,1.27,0.89,1.67,0.00841845,Low,0.237,0.118,0.007,0.437,Significant increase (p=0.012),Variable effect (p=0.021),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07969,rs418750,2,174835983,EPHA1,Insertion,-,-,1.13,0.89,1.41,0.10961698,Moderate,0.037,0.059,0.068,0.636,Mild increase (p=0.015),Variable effect (p=0.042),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP07970,rs508871,6,108995202,CD33,Insertion,-,-,1.26,1.04,1.63,0.08795736,Moderate,0.041,0.361,0.381,0.017,Variable effect (p=0.018),Significant increase (p=0.001),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07971,rs995827,16,112928804,APOE,SNP (A/C),(A/,A,0.54,0.22,0.75,0.0363299,Moderate,0.357,0.132,0.092,0.219,No significant pattern (p=0.012),Mild increase (p=0.018),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07972,rs296834,2,5890863,CR1,SNP (C/T),(C/,C,0.96,0.71,1.23,0.01453379,Moderate,0.013,0.52,0.076,0.19,No significant pattern (p=0.013),No significant pattern (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07973,rs935767,18,223447965,ABCA7,SNP (C/T),(C/,C,0.83,0.56,1.15,0.00427908,Moderate,0.046,0.326,0.256,0.173,Mild increase (p=0.002),Significant increase (p=0.028),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP07974,rs557369,14,77154150,PTK2B,SNP (C/G),(C/,C,1.45,1.21,1.74,0.03248452,Protective,0.036,0.31,0.215,0.239,Mild increase (p=0.04),Variable effect (p=0.02),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP07975,rs586930,20,5724140,PTK2B,Deletion,-,-,0.44,0.19,0.7,0.12205077,Moderate,0.387,0.159,0.227,0.028,Mild decrease (p=0.021),No significant pattern (p=0.017),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP07976,rs930665,17,5455828,MS4A6A,SNP (A/T),(A/,A,2.68,2.4,2.91,0.03957942,Low,0.257,0.123,0.335,0.084,No significant pattern (p=0.041),Significant increase (p=0.033),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP07977,rs161646,21,83042666,PICALM,SNP (A/C),(A/,A,0.51,0.18,0.73,0.03027564,High,0.131,0.091,0.169,0.41,Significant decrease (p=0.006),Variable effect (p=0.023),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07978,rs959018,11,2129311,APOE,SNP (C/G),(C/,C,1.02,0.73,1.23,0.08680633,Moderate,0.26,0.276,0.069,0.195,Variable effect (p=0.005),Variable effect (p=0.047),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07979,rs862470,2,114522377,CD33,SNP (A/G),(A/,A,0.91,0.66,1.21,0.00599951,Low,0.311,0.072,0.05,0.367,Significant decrease (p=0.009),Mild increase (p=0.001),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP07980,rs168544,1,204712263,CD2AP,SNP (G/T),(G/,G,1.97,1.71,2.19,0.04584743,Moderate,0.04,0.107,0.638,0.015,Mild increase (p=0.043),Mild decrease (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP07981,rs643179,11,221093844,APOE,SNP (G/T),(G/,G,0.47,0.24,0.82,0.01707044,High,0.17,0.167,0.161,0.302,Mild decrease (p=0.025),Variable effect (p=0.047),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP07982,rs441136,11,51213615,CR1,SNP (A/G),(A/,A,0.87,0.6,1.07,0.02805506,High,0.011,0.155,0.175,0.459,Mild decrease (p=0.01),Mild decrease (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP07983,rs132954,13,46177349,SORL1,Insertion,-,-,0.49,0.25,0.84,0.00031962,Low,0.349,0.004,0.098,0.349,Significant increase (p=0.006),Variable effect (p=0.046),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP07984,rs685161,14,94339097,TREM2,Deletion,-,-,0.82,0.55,1.16,0.01302627,Low,0.061,0.396,0.033,0.31,No significant pattern (p=0.025),Variable effect (p=0.025),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP07985,rs205296,10,45744953,APP,SNP (A/G),(A/,A,2.21,1.85,2.42,0.02009157,Low,0.139,0.027,0.322,0.312,Mild increase (p=0.011),Mild decrease (p=0.013),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP07986,rs630193,1,112028250,EPHA1,SNP (G/T),(G/,G,1.22,0.95,1.43,0.00383455,High,0.594,0.016,0.033,0.157,Mild increase (p=0.012),Mild decrease (p=0.027),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07987,rs695852,10,131656329,ABCA7,Insertion,-,-,0.44,0.13,0.66,0.02108491,Low,0.002,0.042,0.368,0.388,Mild decrease (p=0.05),Significant increase (p=0.022),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07988,rs302225,14,131680530,PSEN2,SNP (G/T),(G/,G,0.73,0.34,1.1,0.01333833,Unknown,0.175,0.03,0.151,0.445,Significant decrease (p=0.044),Significant decrease (p=0.047),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP07989,rs981969,12,208801096,CR1,SNP (A/C),(A/,A,1.65,1.43,1.99,0.00639795,Moderate,0.167,0.074,0.22,0.338,Variable effect (p=0.04),Mild increase (p=0.002),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07990,rs207638,10,89413329,PSEN2,Deletion,-,-,0.35,0.1,0.57,0.06950749,Moderate,0.145,0.114,0.237,0.303,Significant increase (p=0.034),Variable effect (p=0.017),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP07991,rs361292,16,154753910,ABCA7,SNP (C/G),(C/,C,0.34,0.1,0.65,0.01273046,Moderate,0.088,0.463,0.21,0.039,Mild increase (p=0.042),Variable effect (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07992,rs818666,4,68225443,PICALM,SNP (A/T),(A/,A,0.78,0.49,1.02,0.00771036,Low,0.25,0.089,0.304,0.157,Mild increase (p=0.045),Mild decrease (p=0.048),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP07993,rs590458,3,151028748,APP,SNP (A/G),(A/,A,1.25,0.93,1.64,0.02335984,Protective,0.155,0.017,0.135,0.493,Significant decrease (p=0.044),Significant decrease (p=0.004),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP07994,rs236016,9,41845816,PSEN2,SNP (C/G),(C/,C,3.11,2.88,3.36,0.02792057,Low,0.103,0.275,0.317,0.105,Mild decrease (p=0.016),Significant increase (p=0.017),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP07995,rs110867,16,237143216,PSEN2,SNP (C/G),(C/,C,0.55,0.2,0.94,0.03358075,Moderate,0.057,0.114,0.158,0.471,Significant increase (p=0.002),Mild decrease (p=0.043),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP07996,rs654194,7,106178876,APOE,SNP (C/G),(C/,C,0.64,0.25,0.88,0.08044227,Low,0.024,0.221,0.34,0.215,No significant pattern (p=0.015),Significant decrease (p=0.031),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP07997,rs413450,7,158964012,ABCA7,SNP (A/C),(A/,A,0.78,0.38,1.14,0.04731433,Unknown,0.41,0.111,0.091,0.188,Significant decrease (p=0.046),Mild decrease (p=0.009),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP07998,rs823224,20,24479852,CR1,SNP (C/G),(C/,C,0.71,0.32,0.97,0.00192793,High,0.164,0.151,0.168,0.317,Significant decrease (p=0.014),No significant pattern (p=0.021),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP07999,rs422544,20,4685511,CD2AP,Insertion,-,-,0.9,0.51,1.12,0.00761792,Low,0.601,0.141,0.052,0.007,Mild increase (p=0.035),Mild increase (p=0.041),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08000,rs517670,7,149833986,BIN1,Insertion,-,-,0.68,0.45,0.9,0.00229068,Protective,0.4,0.182,0.182,0.037,Mild decrease (p=0.004),Mild decrease (p=0.009),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP08001,rs521967,20,58468523,SORL1,SNP (C/G),(C/,C,0.86,0.65,1.08,0.06501736,Moderate,0.19,0.466,0.127,0.018,Variable effect (p=0.041),Variable effect (p=0.007),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08002,rs694419,8,22470998,CD33,Deletion,-,-,1.2,0.94,1.53,0.00285118,Moderate,0.01,0.598,0.012,0.18,No significant pattern (p=0.007),No significant pattern (p=0.007),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08003,rs520971,4,22317665,TREM2,Deletion,-,-,1.31,1.11,1.54,0.00897535,High,0.1,0.015,0.351,0.334,No significant pattern (p=0.032),Variable effect (p=0.012),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08004,rs340599,18,158712619,CLU,Insertion,-,-,0.93,0.57,1.26,0.02616792,High,0.291,0.35,0.05,0.109,Mild decrease (p=0.044),Mild decrease (p=0.038),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08005,rs698867,5,226163473,EPHA1,SNP (G/T),(G/,G,0.32,0.1,0.55,0.02549922,Moderate,0.018,0.233,0.127,0.422,Variable effect (p=0.012),Significant increase (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08006,rs428194,17,193370876,PSEN2,Deletion,-,-,1.2,0.85,1.47,0.05483599,Moderate,0.006,0.384,0.097,0.313,Mild decrease (p=0.008),Significant increase (p=0.004),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08007,rs937503,12,108458831,ABCA7,SNP (A/G),(A/,A,1.43,1.12,1.74,0.0148772,Moderate,0.066,0.247,0.433,0.054,Mild increase (p=0.015),Mild decrease (p=0.046),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08008,rs274755,9,152622828,EPHA1,Insertion,-,-,2.0,1.78,2.4,0.02080452,Low,0.518,0.121,0.046,0.115,Mild decrease (p=0.028),Significant increase (p=0.02),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08009,rs449247,20,102575525,SORL1,SNP (A/C),(A/,A,0.94,0.64,1.27,0.00617882,Moderate,0.022,0.378,0.314,0.085,Variable effect (p=0.024),No significant pattern (p=0.023),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08010,rs710591,2,219443465,EPHA1,SNP (A/T),(A/,A,0.5,0.15,0.72,0.02401539,Low,0.144,0.014,0.529,0.112,Mild increase (p=0.014),Significant decrease (p=0.024),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08011,rs645292,18,225408704,EPHA1,Deletion,-,-,2.1,1.86,2.4,0.02065798,Low,0.457,0.102,0.034,0.207,Significant increase (p=0.004),Significant decrease (p=0.021),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08012,rs359902,8,57832580,APP,SNP (C/G),(C/,C,1.3,0.97,1.63,0.00371368,Moderate,0.175,0.217,0.293,0.115,Variable effect (p=0.049),Mild increase (p=0.006),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08013,rs949899,21,226549070,TREM2,SNP (A/C),(A/,A,0.72,0.49,1.07,0.01428512,Moderate,0.022,0.211,0.324,0.243,Mild increase (p=0.018),Mild decrease (p=0.032),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08014,rs512808,16,141592034,ABCA7,SNP (A/T),(A/,A,0.45,0.17,0.79,0.02562537,Protective,0.468,0.09,0.161,0.081,Mild increase (p=0.029),Significant increase (p=0.045),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08015,rs531075,16,189686396,APOE,Insertion,-,-,1.83,1.58,2.06,0.11665067,Moderate,0.203,0.157,0.307,0.133,Significant decrease (p=0.017),Significant decrease (p=0.05),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08016,rs392155,12,188720955,CR1,SNP (G/T),(G/,G,0.78,0.4,1.07,0.0113212,High,0.167,0.047,0.167,0.419,Variable effect (p=0.001),Mild decrease (p=0.021),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08017,rs521594,13,156482269,APOE,Deletion,-,-,0.98,0.77,1.34,0.01107716,Moderate,0.045,0.141,0.6,0.014,Variable effect (p=0.02),Significant decrease (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08018,rs777237,2,193307915,BIN1,SNP (A/C),(A/,A,0.94,0.6,1.3,0.01991328,Moderate,0.034,0.224,0.033,0.509,Significant decrease (p=0.001),No significant pattern (p=0.028),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP08019,rs568452,12,183768182,APP,SNP (A/G),(A/,A,2.09,1.75,2.41,0.00382611,High,0.089,0.106,0.11,0.495,No significant pattern (p=0.044),Mild increase (p=0.013),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08020,rs425064,5,181823362,SORL1,Deletion,-,-,0.66,0.44,1.01,0.00200761,Moderate,0.484,0.004,0.157,0.155,No significant pattern (p=0.007),Variable effect (p=0.017),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08021,rs884092,8,177896674,MS4A6A,SNP (A/T),(A/,A,0.89,0.59,1.23,0.04917876,High,0.1,0.221,0.47,0.009,Significant decrease (p=0.04),Mild decrease (p=0.012),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08022,rs818014,4,15377588,CR1,Insertion,-,-,1.63,1.26,1.91,0.00484851,Moderate,0.121,0.296,0.348,0.035,Mild increase (p=0.038),Significant decrease (p=0.028),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08023,rs596679,12,237640075,APP,SNP (A/C),(A/,A,0.63,0.41,0.96,0.01397043,Low,0.35,0.258,0.121,0.071,Significant increase (p=0.043),Mild increase (p=0.042),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08024,rs920722,10,180907896,SORL1,SNP (A/G),(A/,A,0.77,0.42,0.98,0.07707951,Unknown,0.315,0.014,0.021,0.451,Mild increase (p=0.003),Significant decrease (p=0.024),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08025,rs833304,4,208457787,CD2AP,SNP (A/G),(A/,A,1.9,1.59,2.28,0.02789504,Moderate,0.74,0.014,0.021,0.025,Significant decrease (p=0.039),No significant pattern (p=0.019),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08026,rs320806,1,208662760,CLU,SNP (A/C),(A/,A,0.77,0.37,1.12,0.01831735,High,0.071,0.071,0.453,0.205,Mild decrease (p=0.044),Significant decrease (p=0.018),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP08027,rs952758,7,90115015,PTK2B,Insertion,-,-,1.41,1.15,1.78,0.01751257,Moderate,0.405,0.173,0.162,0.06,Significant increase (p=0.03),No significant pattern (p=0.05),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP08028,rs239378,1,128042408,CLU,SNP (G/T),(G/,G,1.39,1.03,1.66,0.03211873,High,0.053,0.562,0.054,0.131,Significant decrease (p=0.009),Significant decrease (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08029,rs931117,7,154739188,ABCA7,SNP (G/T),(G/,G,1.9,1.52,2.3,0.0082025,Low,0.029,0.198,0.402,0.17,Significant increase (p=0.035),Mild decrease (p=0.027),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08030,rs981240,19,76261462,CD2AP,SNP (C/T),(C/,C,0.66,0.42,0.88,0.07453428,Moderate,0.198,0.06,0.226,0.316,Mild decrease (p=0.011),Mild decrease (p=0.039),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP08031,rs195139,5,153136403,PICALM,SNP (C/G),(C/,C,1.95,1.69,2.2,0.00279799,Low,0.16,0.302,0.22,0.118,No significant pattern (p=0.036),Variable effect (p=0.009),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08032,rs198124,12,63241498,PSEN2,SNP (C/G),(C/,C,0.77,0.55,1.13,0.01107617,Unknown,0.215,0.018,0.17,0.398,No significant pattern (p=0.005),Significant increase (p=0.011),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08033,rs282329,15,99633291,APP,SNP (A/C),(A/,A,1.28,0.93,1.62,0.00953009,Moderate,0.21,0.359,0.103,0.128,Variable effect (p=0.044),Significant increase (p=0.044),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP08034,rs140908,22,219730690,CD2AP,SNP (G/T),(G/,G,1.02,0.79,1.3,0.02014532,Moderate,0.087,0.337,0.217,0.159,Mild decrease (p=0.029),Significant increase (p=0.038),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08035,rs373223,20,232721446,EPHA1,SNP (A/G),(A/,A,1.29,0.97,1.55,0.02902086,High,0.159,0.213,0.172,0.256,Significant increase (p=0.009),Significant increase (p=0.011),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08036,rs805279,3,87439775,EPHA1,SNP (A/T),(A/,A,0.55,0.22,0.83,0.00422088,Low,0.01,0.592,0.066,0.132,No significant pattern (p=0.046),Significant decrease (p=0.049),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08037,rs590978,7,102519872,TREM2,SNP (C/G),(C/,C,0.72,0.42,1.02,0.00769174,High,0.334,0.314,0.083,0.069,Significant decrease (p=0.018),Significant increase (p=0.017),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP08038,rs597271,2,211139827,ABCA7,Deletion,-,-,1.41,1.06,1.74,0.03398594,Protective,0.188,0.145,0.437,0.03,Variable effect (p=0.048),Significant increase (p=0.046),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08039,rs850753,13,73798781,TREM2,SNP (G/T),(G/,G,1.92,1.54,2.31,0.02344514,Unknown,0.247,0.254,0.187,0.113,Mild decrease (p=0.039),Significant increase (p=0.039),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08040,rs613099,11,245719708,CD2AP,SNP (A/C),(A/,A,0.74,0.37,1.11,0.03926208,Low,0.391,0.199,0.202,0.007,Mild increase (p=0.04),Significant decrease (p=0.029),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08041,rs413050,22,89734623,ABCA7,Deletion,-,-,0.46,0.12,0.7,0.04857244,High,0.249,0.222,0.221,0.108,Variable effect (p=0.001),Mild increase (p=0.035),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08042,rs528366,2,25536767,APP,SNP (C/T),(C/,C,0.76,0.38,1.07,0.09059635,High,0.477,0.245,0.002,0.076,No significant pattern (p=0.005),Significant increase (p=0.038),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08043,rs998635,20,39622119,EPHA1,SNP (A/G),(A/,A,2.82,2.44,3.07,0.01743554,Moderate,0.135,0.378,0.089,0.198,Significant increase (p=0.008),Mild increase (p=0.017),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08044,rs861065,2,44078195,PTK2B,SNP (C/G),(C/,C,0.89,0.54,1.11,0.02883998,Low,0.526,0.007,0.089,0.178,Mild decrease (p=0.032),Mild increase (p=0.021),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08045,rs569985,1,46495028,SORL1,Deletion,-,-,0.4,0.1,0.71,0.02432861,Low,0.189,0.273,0.004,0.333,Variable effect (p=0.007),Mild increase (p=0.01),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08046,rs439698,15,68029904,SORL1,SNP (C/G),(C/,C,1.46,1.08,1.67,0.00486276,Moderate,0.307,0.256,0.145,0.092,Mild decrease (p=0.015),Significant decrease (p=0.048),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08047,rs240606,17,46004094,APP,SNP (G/T),(G/,G,0.69,0.43,1.05,0.01361978,High,0.035,0.144,0.052,0.569,Mild decrease (p=0.035),No significant pattern (p=0.047),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08048,rs723493,9,90476366,APP,SNP (A/T),(A/,A,0.52,0.28,0.89,0.01023103,Moderate,0.663,0.042,0.092,0.004,No significant pattern (p=0.044),No significant pattern (p=0.027),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08049,rs273226,14,161328163,MS4A6A,SNP (C/T),(C/,C,1.91,1.59,2.14,0.05646587,Moderate,0.324,0.002,0.369,0.106,No significant pattern (p=0.049),Mild decrease (p=0.021),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08050,rs590531,16,49910975,EPHA1,Insertion,-,-,0.41,0.2,0.77,0.04126066,Protective,0.331,0.087,0.149,0.232,Significant increase (p=0.038),Significant increase (p=0.007),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08051,rs859096,20,145134096,CD2AP,SNP (G/T),(G/,G,0.49,0.18,0.79,0.00382578,High,0.369,0.088,0.143,0.199,Significant increase (p=0.04),Significant increase (p=0.024),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08052,rs244503,12,1986696,PSEN2,SNP (A/C),(A/,A,0.84,0.52,1.07,0.04597454,Moderate,0.2,0.379,0.014,0.206,Mild decrease (p=0.008),Significant decrease (p=0.042),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08053,rs685395,18,131716996,TREM2,SNP (A/C),(A/,A,1.24,1.01,1.58,0.09818201,Moderate,0.01,0.104,0.592,0.094,Mild decrease (p=0.043),Significant increase (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP08054,rs156466,4,100082239,PTK2B,Insertion,-,-,1.81,1.5,2.21,0.0811056,High,0.124,0.043,0.328,0.306,Mild increase (p=0.009),Variable effect (p=0.034),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08055,rs748253,15,105296057,BIN1,SNP (G/T),(G/,G,0.34,0.14,0.66,0.11033135,Moderate,0.185,0.055,0.464,0.096,Significant decrease (p=0.036),Significant decrease (p=0.035),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08056,rs839738,14,246489532,SORL1,Deletion,-,-,1.09,0.76,1.36,0.00312302,Moderate,0.39,0.075,0.239,0.096,Mild decrease (p=0.021),Significant increase (p=0.033),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08057,rs887640,22,157833565,BIN1,SNP (G/T),(G/,G,1.32,0.97,1.62,0.05509803,High,0.085,0.131,0.022,0.561,No significant pattern (p=0.029),Mild decrease (p=0.013),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08058,rs876009,1,14439539,APP,Deletion,-,-,1.01,0.81,1.33,0.00373377,Moderate,0.076,0.046,0.483,0.195,Significant decrease (p=0.039),Significant decrease (p=0.015),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08059,rs367112,1,144008619,BIN1,SNP (A/T),(A/,A,0.74,0.48,1.08,0.1211152,High,0.059,0.458,0.018,0.265,Significant decrease (p=0.011),Variable effect (p=0.045),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08060,rs492379,3,145142766,APOE,Insertion,-,-,1.02,0.72,1.35,0.09155268,Low,0.389,0.02,0.323,0.068,Mild increase (p=0.048),Mild increase (p=0.006),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08061,rs172136,15,232563277,CD2AP,Deletion,-,-,1.21,0.84,1.59,0.02516656,High,0.116,0.402,0.232,0.051,Significant increase (p=0.03),Significant increase (p=0.018),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08062,rs703308,10,194598105,BIN1,SNP (A/C),(A/,A,1.41,1.15,1.68,0.02023119,Moderate,0.176,0.432,0.013,0.179,Variable effect (p=0.037),Significant decrease (p=0.017),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08063,rs370140,6,165509855,CD2AP,SNP (A/T),(A/,A,1.18,0.92,1.48,0.01559944,Moderate,0.086,0.204,0.027,0.483,Variable effect (p=0.023),Variable effect (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08064,rs734877,12,53653024,TREM2,SNP (G/T),(G/,G,1.03,0.66,1.33,0.03591125,High,0.325,0.161,0.175,0.139,Significant increase (p=0.023),Variable effect (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08065,rs326986,19,40106172,PICALM,SNP (A/T),(A/,A,0.53,0.15,0.89,0.01648859,High,0.344,0.368,0.01,0.077,No significant pattern (p=0.025),Mild increase (p=0.001),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08066,rs637395,22,157224720,MS4A6A,SNP (A/T),(A/,A,0.39,0.18,0.61,0.03589089,High,0.358,0.155,0.033,0.254,Mild increase (p=0.015),No significant pattern (p=0.011),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08067,rs944907,22,109474902,PICALM,SNP (A/T),(A/,A,2.09,1.8,2.42,0.0051724,High,0.099,0.164,0.409,0.127,Significant increase (p=0.037),Significant increase (p=0.043),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08068,rs953658,22,44585791,MS4A6A,SNP (A/T),(A/,A,3.14,2.8,3.44,0.01764823,Low,0.126,0.265,0.119,0.29,Mild increase (p=0.029),Significant increase (p=0.026),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP08069,rs433193,3,145904354,SORL1,Insertion,-,-,0.52,0.14,0.81,0.04783187,High,0.213,0.26,0.141,0.186,Significant decrease (p=0.031),Significant decrease (p=0.002),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP08070,rs526517,20,172874830,ABCA7,Insertion,-,-,1.25,1.05,1.56,0.02605602,High,0.059,0.221,0.39,0.131,Mild increase (p=0.002),Significant increase (p=0.011),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08071,rs687475,5,14668310,TREM2,SNP (G/T),(G/,G,0.76,0.43,0.98,0.02143893,Unknown,0.027,0.204,0.472,0.097,Significant increase (p=0.035),Mild decrease (p=0.009),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08072,rs278907,9,137285119,ABCA7,SNP (A/C),(A/,A,2.12,1.9,2.46,0.00541785,Low,0.0,0.292,0.335,0.173,Significant increase (p=0.022),Variable effect (p=0.037),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP08073,rs247070,20,23983393,ABCA7,SNP (C/T),(C/,C,0.99,0.61,1.31,0.00344131,High,0.244,0.102,0.228,0.226,Mild increase (p=0.023),Significant decrease (p=0.017),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08074,rs590929,1,245666905,PSEN2,SNP (G/T),(G/,G,0.32,0.1,0.66,0.07352587,Moderate,0.142,0.081,0.384,0.193,Significant increase (p=0.035),Significant decrease (p=0.02),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08075,rs646933,22,69756504,MS4A6A,Deletion,-,-,0.43,0.2,0.81,0.03307983,High,0.131,0.168,0.01,0.491,Mild decrease (p=0.041),No significant pattern (p=0.009),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08076,rs534675,20,247901426,APP,SNP (A/T),(A/,A,1.08,0.86,1.48,0.07326009,Low,0.108,0.155,0.231,0.306,Mild decrease (p=0.012),Mild increase (p=0.005),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08077,rs895660,21,85163370,BIN1,Deletion,-,-,2.24,2.0,2.48,0.0631583,Moderate,0.071,0.137,0.398,0.194,Mild increase (p=0.047),Variable effect (p=0.042),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08078,rs152016,16,153725453,CLU,SNP (G/T),(G/,G,0.73,0.51,1.06,0.00212967,High,0.691,0.007,0.042,0.06,Significant decrease (p=0.045),Variable effect (p=0.013),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08079,rs502786,1,183514517,MS4A6A,SNP (C/G),(C/,C,0.76,0.48,1.13,0.01678066,High,0.271,0.181,0.041,0.308,Mild increase (p=0.03),Variable effect (p=0.022),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08080,rs428483,15,239710050,PSEN2,Deletion,-,-,1.57,1.27,1.79,0.06749566,Moderate,0.041,0.261,0.342,0.156,No significant pattern (p=0.039),Mild decrease (p=0.04),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08081,rs350084,11,26172743,PTK2B,SNP (G/T),(G/,G,1.47,1.24,1.7,0.05612278,Moderate,0.128,0.325,0.18,0.167,No significant pattern (p=0.045),Significant decrease (p=0.012),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08082,rs224810,2,77234786,ABCA7,Deletion,-,-,1.28,1.07,1.49,0.0093903,Low,0.51,0.014,0.011,0.265,Variable effect (p=0.017),Variable effect (p=0.009),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08083,rs235822,15,226710303,APOE,Insertion,-,-,1.3,1.03,1.64,0.0583665,Low,0.28,0.134,0.084,0.302,Variable effect (p=0.015),Variable effect (p=0.014),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08084,rs826849,17,36302766,CLU,Deletion,-,-,1.77,1.38,2.07,0.07923194,High,0.512,0.124,0.122,0.041,Variable effect (p=0.03),Significant increase (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08085,rs969467,5,145260836,PSEN2,SNP (A/C),(A/,A,0.74,0.47,1.02,0.02421534,Low,0.102,0.15,0.147,0.401,Mild increase (p=0.014),Significant increase (p=0.014),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08086,rs918020,5,128322889,BIN1,Insertion,-,-,0.8,0.49,1.12,0.02180226,Moderate,0.077,0.545,0.063,0.114,Mild decrease (p=0.047),Mild increase (p=0.035),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08087,rs951248,10,154803535,CD2AP,SNP (A/G),(A/,A,0.76,0.45,1.0,0.07303828,Low,0.002,0.127,0.444,0.227,Variable effect (p=0.029),Variable effect (p=0.039),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08088,rs687881,6,21426173,CD2AP,Deletion,-,-,0.69,0.3,1.07,0.07079489,Moderate,0.348,0.034,0.101,0.317,Significant decrease (p=0.032),Variable effect (p=0.021),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08089,rs319273,13,97757623,ABCA7,Insertion,-,-,1.54,1.23,1.75,0.01398468,Protective,0.112,0.123,0.151,0.415,Mild increase (p=0.044),Significant increase (p=0.014),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08090,rs280734,6,152738172,ABCA7,SNP (A/T),(A/,A,1.12,0.79,1.52,0.01827164,High,0.123,0.048,0.209,0.419,Variable effect (p=0.031),Significant increase (p=0.015),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP08091,rs773687,7,29512066,CD2AP,Insertion,-,-,0.56,0.22,0.92,0.04001067,Moderate,0.029,0.017,0.725,0.03,Significant increase (p=0.027),Mild increase (p=0.013),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP08092,rs986513,3,128665867,ABCA7,SNP (C/T),(C/,C,0.48,0.11,0.7,0.05179627,Moderate,0.091,0.275,0.398,0.036,Significant decrease (p=0.016),No significant pattern (p=0.047),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08093,rs381181,6,103068105,APP,SNP (A/T),(A/,A,1.13,0.84,1.37,0.07297037,Moderate,0.208,0.095,0.459,0.038,Variable effect (p=0.007),No significant pattern (p=0.032),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08094,rs230091,9,12455916,CLU,SNP (A/G),(A/,A,0.78,0.53,1.14,0.05934479,Low,0.26,0.016,0.19,0.334,Significant increase (p=0.048),No significant pattern (p=0.03),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08095,rs808119,14,147394124,EPHA1,SNP (A/C),(A/,A,0.91,0.52,1.14,0.01562122,High,0.487,0.086,0.21,0.017,Mild increase (p=0.034),Significant decrease (p=0.013),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP08096,rs177546,3,12076419,APP,SNP (G/T),(G/,G,0.88,0.58,1.2,0.00808987,Protective,0.106,0.249,0.236,0.21,No significant pattern (p=0.026),Significant increase (p=0.035),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08097,rs369129,22,149543739,PICALM,SNP (A/C),(A/,A,1.7,1.5,1.97,0.00785332,Low,0.077,0.252,0.251,0.22,Mild increase (p=0.017),Mild decrease (p=0.046),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08098,rs483681,18,72312532,BIN1,SNP (A/C),(A/,A,2.79,2.4,3.09,0.01832807,High,0.101,0.125,0.318,0.256,No significant pattern (p=0.026),Significant increase (p=0.016),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08099,rs431863,21,73001403,BIN1,Insertion,-,-,0.61,0.37,0.83,0.00391104,High,0.063,0.405,0.109,0.223,Mild increase (p=0.009),Mild increase (p=0.009),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08100,rs198096,16,103517763,CLU,SNP (A/C),(A/,A,0.65,0.41,1.02,0.04065889,High,0.171,0.357,0.067,0.205,Significant decrease (p=0.022),Mild decrease (p=0.02),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08101,rs558338,2,150556335,PSEN2,SNP (A/T),(A/,A,0.53,0.26,0.74,0.04232467,Unknown,0.037,0.298,0.33,0.134,Mild decrease (p=0.046),Significant increase (p=0.049),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08102,rs137871,22,225315170,CD2AP,SNP (C/T),(C/,C,2.43,2.16,2.78,0.04881881,Low,0.418,0.006,0.076,0.299,No significant pattern (p=0.044),Variable effect (p=0.023),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP08103,rs719457,17,214549147,CR1,SNP (A/T),(A/,A,0.99,0.66,1.26,0.04310106,Moderate,0.05,0.222,0.228,0.301,Mild decrease (p=0.003),Significant decrease (p=0.045),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08104,rs438481,22,89158744,ABCA7,SNP (A/T),(A/,A,0.82,0.57,1.16,0.00086066,Moderate,0.509,0.007,0.228,0.055,Mild decrease (p=0.004),Variable effect (p=0.023),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08105,rs779407,21,113171982,SORL1,SNP (A/G),(A/,A,0.99,0.72,1.37,0.04201014,Moderate,0.254,0.471,0.051,0.024,Mild increase (p=0.04),No significant pattern (p=0.018),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08106,rs346236,5,242263819,APP,SNP (A/C),(A/,A,0.98,0.62,1.18,0.00381532,Protective,0.191,0.318,0.075,0.216,No significant pattern (p=0.021),Mild increase (p=0.034),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08107,rs414953,18,65319322,APP,SNP (A/C),(A/,A,0.84,0.59,1.14,0.00020185,Unknown,0.333,0.375,0.065,0.027,Significant increase (p=0.028),Significant increase (p=0.033),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08108,rs614506,20,24197716,BIN1,SNP (A/C),(A/,A,0.71,0.49,1.08,0.01159141,Unknown,0.008,0.365,0.307,0.12,No significant pattern (p=0.015),Significant decrease (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08109,rs221705,10,164523300,APP,SNP (C/T),(C/,C,0.36,0.11,0.68,0.06291815,High,0.122,0.04,0.015,0.623,Mild decrease (p=0.008),Significant increase (p=0.025),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08110,rs602040,9,213201341,PSEN2,SNP (A/T),(A/,A,1.4,1.14,1.66,0.02859686,High,0.051,0.455,0.217,0.076,Significant increase (p=0.027),Significant increase (p=0.036),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08111,rs355969,8,9895386,ABCA7,SNP (A/C),(A/,A,0.5,0.28,0.84,0.03973404,Moderate,0.327,0.028,0.322,0.123,Mild increase (p=0.003),No significant pattern (p=0.039),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08112,rs285726,12,11501060,PSEN2,SNP (C/G),(C/,C,0.4,0.1,0.71,0.01917684,Moderate,0.38,0.063,0.32,0.038,Significant decrease (p=0.017),Significant decrease (p=0.016),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08113,rs305261,7,14070406,TREM2,SNP (A/G),(A/,A,0.75,0.41,1.13,0.03921523,Moderate,0.43,0.111,0.229,0.03,Significant increase (p=0.008),Variable effect (p=0.028),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08114,rs202980,14,52839760,MS4A6A,Insertion,-,-,0.43,0.15,0.82,0.0396095,Low,0.195,0.204,0.241,0.159,No significant pattern (p=0.035),No significant pattern (p=0.004),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08115,rs192982,4,38179850,APOE,SNP (A/T),(A/,A,0.8,0.55,1.14,0.05126634,Low,0.301,0.23,0.047,0.222,Significant increase (p=0.032),Variable effect (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08116,rs212275,22,3753285,APP,SNP (G/T),(G/,G,1.81,1.46,2.14,0.0426983,Moderate,0.651,0.065,0.031,0.054,Significant decrease (p=0.025),Mild decrease (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08117,rs802392,14,86877830,ABCA7,Insertion,-,-,1.13,0.81,1.5,0.03743354,Low,0.141,0.092,0.275,0.292,Mild increase (p=0.024),Variable effect (p=0.049),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08118,rs486719,12,71709239,CD33,SNP (A/G),(A/,A,0.66,0.29,1.0,0.03691243,Moderate,0.03,0.262,0.454,0.053,Mild decrease (p=0.003),Significant decrease (p=0.016),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08119,rs634393,8,121262309,APOE,SNP (A/T),(A/,A,1.64,1.34,2.01,0.02281772,Low,0.081,0.081,0.571,0.067,No significant pattern (p=0.023),No significant pattern (p=0.027),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP08120,rs239785,15,73710170,SORL1,SNP (A/G),(A/,A,0.73,0.4,1.11,0.00894628,Protective,0.006,0.147,0.079,0.568,No significant pattern (p=0.031),Significant decrease (p=0.01),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08121,rs299431,10,98433285,SORL1,SNP (A/C),(A/,A,0.72,0.38,0.94,0.00687913,High,0.5,0.004,0.117,0.179,Significant decrease (p=0.008),Variable effect (p=0.04),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08122,rs760582,16,186582658,CLU,Deletion,-,-,1.49,1.2,1.85,0.05958194,Low,0.013,0.356,0.299,0.133,Variable effect (p=0.016),No significant pattern (p=0.019),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08123,rs972236,18,145717769,PICALM,SNP (C/T),(C/,C,0.54,0.15,0.85,0.00748663,Low,0.183,0.208,0.275,0.134,Variable effect (p=0.011),Variable effect (p=0.005),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08124,rs663225,9,160283736,CD33,SNP (A/C),(A/,A,4.58,4.29,4.9,0.00480255,Protective,0.114,0.157,0.527,0.002,No significant pattern (p=0.03),Significant decrease (p=0.035),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08125,rs178966,10,45670859,BIN1,SNP (A/T),(A/,A,0.72,0.35,1.01,0.0088886,Moderate,0.514,0.088,0.007,0.191,Variable effect (p=0.043),Significant increase (p=0.007),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP08126,rs949987,8,43617563,APOE,SNP (A/G),(A/,A,1.0,0.65,1.34,0.00050834,Moderate,0.383,0.152,0.025,0.241,Significant decrease (p=0.037),Significant decrease (p=0.014),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP08127,rs858975,6,236723624,BIN1,Deletion,-,-,1.82,1.49,2.03,0.05864826,Low,0.176,0.287,0.311,0.026,Significant increase (p=0.024),Variable effect (p=0.044),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08128,rs313827,11,168758538,EPHA1,SNP (A/C),(A/,A,1.62,1.22,1.85,0.03562138,Low,0.033,0.289,0.364,0.115,Variable effect (p=0.028),Mild increase (p=0.049),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08129,rs968381,21,177006964,CD2AP,Insertion,-,-,0.86,0.47,1.19,0.03253679,High,0.081,0.301,0.334,0.084,Mild decrease (p=0.021),No significant pattern (p=0.012),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08130,rs586049,17,216645520,PICALM,SNP (C/T),(C/,C,1.13,0.8,1.4,0.01157258,Moderate,0.195,0.081,0.226,0.298,Mild increase (p=0.022),Mild decrease (p=0.008),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08131,rs886855,7,154654245,PSEN2,Insertion,-,-,2.83,2.62,3.09,0.03439442,High,0.321,0.014,0.385,0.081,Significant decrease (p=0.028),Mild decrease (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP08132,rs499785,6,72782284,EPHA1,SNP (A/G),(A/,A,0.47,0.12,0.84,0.05159705,Low,0.037,0.632,0.086,0.045,Variable effect (p=0.001),Mild increase (p=0.024),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08133,rs608026,22,144379298,EPHA1,SNP (A/G),(A/,A,1.29,0.95,1.65,0.04278724,High,0.302,0.185,0.25,0.063,Significant decrease (p=0.024),Variable effect (p=0.031),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08134,rs212037,10,32683854,CR1,Deletion,-,-,1.08,0.82,1.44,0.05025211,Moderate,0.066,0.081,0.603,0.05,Significant decrease (p=0.047),Significant decrease (p=0.026),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08135,rs732292,7,223974981,EPHA1,SNP (C/T),(C/,C,0.98,0.65,1.37,0.02296724,Moderate,0.022,0.094,0.468,0.215,Variable effect (p=0.012),No significant pattern (p=0.002),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP08136,rs208330,10,127434593,MS4A6A,SNP (A/T),(A/,A,0.89,0.6,1.21,0.06979182,High,0.181,0.115,0.405,0.098,Mild increase (p=0.041),Variable effect (p=0.002),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08137,rs741621,2,86983931,SORL1,SNP (C/T),(C/,C,0.77,0.38,1.05,0.00058171,Moderate,0.16,0.047,0.491,0.102,Significant decrease (p=0.033),Significant decrease (p=0.008),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08138,rs777617,2,155838848,PTK2B,SNP (A/G),(A/,A,0.59,0.33,0.88,0.00842991,Moderate,0.268,0.314,0.111,0.107,Mild increase (p=0.049),Significant decrease (p=0.025),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08139,rs587922,8,80904746,PTK2B,Deletion,-,-,1.12,0.88,1.42,0.07811003,High,0.102,0.057,0.25,0.391,Mild decrease (p=0.012),Variable effect (p=0.05),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08140,rs545570,6,129816387,MS4A6A,SNP (G/T),(G/,G,1.13,0.84,1.38,0.03014235,High,0.392,0.198,0.023,0.187,No significant pattern (p=0.007),Significant increase (p=0.048),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08141,rs335193,16,138772948,PICALM,SNP (A/G),(A/,A,1.72,1.44,1.98,0.06090121,High,0.266,0.119,0.011,0.405,Significant increase (p=0.006),Variable effect (p=0.012),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08142,rs515002,12,65292624,CR1,Insertion,-,-,1.85,1.5,2.1,0.10658242,Moderate,0.075,0.037,0.634,0.054,Mild decrease (p=0.025),Significant increase (p=0.018),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08143,rs653017,16,141439918,MS4A6A,SNP (A/C),(A/,A,1.53,1.3,1.76,0.07615626,Moderate,0.117,0.106,0.299,0.278,Significant increase (p=0.022),Mild decrease (p=0.026),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08144,rs710129,2,70254137,PTK2B,SNP (C/T),(C/,C,0.95,0.7,1.23,0.02829543,Moderate,0.235,0.304,0.036,0.226,No significant pattern (p=0.025),Mild increase (p=0.034),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP08145,rs146896,13,187456423,PICALM,SNP (G/T),(G/,G,1.32,1.1,1.71,0.00852091,Moderate,0.328,0.055,0.392,0.025,No significant pattern (p=0.043),Significant decrease (p=0.032),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08146,rs302351,9,157532408,CR1,SNP (A/C),(A/,A,2.62,2.4,2.92,0.01804513,Moderate,0.583,0.04,0.16,0.017,Variable effect (p=0.018),Significant increase (p=0.012),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP08147,rs666602,9,149212099,CD2AP,SNP (C/G),(C/,C,1.07,0.76,1.31,0.04420689,High,0.124,0.411,0.137,0.128,Variable effect (p=0.037),No significant pattern (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08148,rs425191,6,129173825,EPHA1,SNP (G/T),(G/,G,1.6,1.39,1.94,0.10464659,High,0.478,0.002,0.086,0.234,Mild increase (p=0.032),Significant increase (p=0.03),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08149,rs217571,6,209688788,TREM2,SNP (A/T),(A/,A,0.89,0.57,1.16,0.06461067,Low,0.01,0.0,0.096,0.694,Mild decrease (p=0.049),Mild decrease (p=0.018),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP08150,rs880630,20,44054478,ABCA7,SNP (G/T),(G/,G,2.06,1.82,2.28,0.01892343,Unknown,0.262,0.469,0.047,0.023,Mild increase (p=0.043),Significant increase (p=0.047),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08151,rs705243,3,122944628,PICALM,SNP (A/C),(A/,A,0.55,0.25,0.82,0.07285777,High,0.084,0.123,0.463,0.13,Significant increase (p=0.043),No significant pattern (p=0.011),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08152,rs205929,11,164182523,CLU,Deletion,-,-,0.47,0.26,0.72,0.01924779,Protective,0.248,0.27,0.142,0.14,Significant decrease (p=0.045),Variable effect (p=0.025),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08153,rs861409,6,150578211,PICALM,SNP (C/T),(C/,C,2.9,2.65,3.21,0.01095546,High,0.286,0.409,0.028,0.078,Significant increase (p=0.006),Variable effect (p=0.024),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08154,rs137743,10,118425488,CLU,SNP (A/G),(A/,A,1.27,1.03,1.52,0.06494538,Low,0.024,0.283,0.134,0.359,Significant decrease (p=0.032),Significant decrease (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08155,rs184616,14,199279993,APOE,SNP (A/C),(A/,A,1.8,1.45,2.13,0.01212512,High,0.488,0.054,0.027,0.231,Mild increase (p=0.047),Significant decrease (p=0.005),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08156,rs320381,2,69122494,EPHA1,SNP (A/C),(A/,A,1.07,0.74,1.44,0.0067462,Protective,0.31,0.069,0.161,0.259,Significant decrease (p=0.009),Significant increase (p=0.011),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08157,rs427809,20,44785489,SORL1,SNP (A/G),(A/,A,0.76,0.43,1.15,0.03325579,High,0.271,0.19,0.032,0.306,Mild increase (p=0.003),Mild decrease (p=0.036),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08158,rs422751,10,211542328,CD2AP,SNP (C/G),(C/,C,1.34,1.12,1.56,0.06719503,Moderate,0.178,0.114,0.38,0.128,Significant increase (p=0.022),Variable effect (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08159,rs883021,5,17089548,CD33,SNP (C/T),(C/,C,0.85,0.64,1.18,0.01899333,High,0.356,0.064,0.135,0.244,Mild increase (p=0.012),No significant pattern (p=0.016),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08160,rs619022,18,29569067,EPHA1,Deletion,-,-,0.8,0.5,1.11,0.02458191,High,0.002,0.196,0.352,0.25,Mild increase (p=0.034),Mild increase (p=0.022),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08161,rs894583,21,48638200,TREM2,SNP (A/T),(A/,A,0.78,0.47,1.1,0.00069111,Moderate,0.343,0.26,0.012,0.184,No significant pattern (p=0.01),Significant increase (p=0.01),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08162,rs288933,19,189035633,PICALM,SNP (C/T),(C/,C,0.5,0.19,0.73,0.07229468,High,0.217,0.041,0.333,0.21,Mild increase (p=0.018),No significant pattern (p=0.031),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08163,rs433889,14,170841501,PTK2B,SNP (A/G),(A/,A,0.44,0.1,0.77,0.00952661,Moderate,0.207,0.024,0.405,0.164,Variable effect (p=0.034),No significant pattern (p=0.028),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP08164,rs873018,18,169941141,MS4A6A,SNP (A/T),(A/,A,3.05,2.84,3.28,0.02821497,Unknown,0.064,0.287,0.005,0.444,Mild increase (p=0.046),Mild decrease (p=0.039),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08165,rs347300,5,123531506,CD2AP,Deletion,-,-,1.52,1.29,1.75,0.01166265,High,0.013,0.048,0.23,0.509,Mild increase (p=0.023),Variable effect (p=0.047),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08166,rs459918,3,8192869,PSEN2,SNP (A/T),(A/,A,1.06,0.78,1.28,0.01414766,Moderate,0.028,0.371,0.125,0.276,No significant pattern (p=0.031),Mild decrease (p=0.008),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08167,rs223997,21,66527805,CR1,SNP (A/C),(A/,A,1.11,0.86,1.49,0.04359682,Moderate,0.241,0.095,0.367,0.096,No significant pattern (p=0.044),Mild increase (p=0.037),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08168,rs274238,21,104619152,PSEN2,SNP (A/C),(A/,A,0.84,0.59,1.1,0.05963625,High,0.276,0.06,0.453,0.011,No significant pattern (p=0.04),Variable effect (p=0.025),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP08169,rs900204,21,102329653,APOE,SNP (A/G),(A/,A,0.57,0.32,0.86,0.02743384,High,0.092,0.033,0.078,0.596,Significant increase (p=0.035),Significant decrease (p=0.028),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP08170,rs585306,2,215306147,CLU,Deletion,-,-,1.08,0.76,1.36,0.04277556,Moderate,0.294,0.28,0.162,0.064,Mild increase (p=0.03),No significant pattern (p=0.024),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08171,rs980225,10,77575475,BIN1,SNP (C/T),(C/,C,1.28,1.02,1.6,0.00973818,Moderate,0.125,0.069,0.492,0.114,Mild decrease (p=0.01),Mild increase (p=0.042),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08172,rs527996,6,115461615,PTK2B,SNP (A/G),(A/,A,0.6,0.39,0.93,0.12944128,Protective,0.146,0.555,0.093,0.006,Mild increase (p=0.014),No significant pattern (p=0.043),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP08173,rs763158,20,13173962,APOE,SNP (A/T),(A/,A,1.4,1.1,1.76,0.03237562,High,0.039,0.549,0.086,0.127,Mild increase (p=0.049),Significant increase (p=0.004),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08174,rs697576,19,102806182,PTK2B,Deletion,-,-,1.53,1.14,1.92,0.00918237,High,0.005,0.08,0.7,0.015,No significant pattern (p=0.044),Significant decrease (p=0.045),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08175,rs121587,4,91290961,APP,SNP (C/T),(C/,C,0.51,0.11,0.91,0.00384971,Moderate,0.136,0.101,0.523,0.041,Significant decrease (p=0.04),Significant increase (p=0.013),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08176,rs996394,22,105833297,PICALM,SNP (A/G),(A/,A,1.52,1.18,1.86,0.11454745,High,0.027,0.001,0.141,0.63,Mild decrease (p=0.025),Mild decrease (p=0.025),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08177,rs227960,20,4118319,PICALM,SNP (C/G),(C/,C,0.63,0.37,1.0,0.06118612,Moderate,0.055,0.673,0.038,0.034,No significant pattern (p=0.029),Mild increase (p=0.005),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08178,rs684485,15,147589614,APOE,SNP (C/G),(C/,C,0.8,0.49,1.05,0.0284476,Protective,0.253,0.224,0.186,0.137,Mild increase (p=0.009),Mild decrease (p=0.001),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP08179,rs635413,11,95841429,CLU,SNP (G/T),(G/,G,2.08,1.79,2.38,0.00259774,Protective,0.044,0.41,0.322,0.024,Significant decrease (p=0.05),Mild decrease (p=0.033),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08180,rs331136,20,143645872,SORL1,Deletion,-,-,1.92,1.61,2.25,0.01553478,High,0.152,0.274,0.316,0.057,No significant pattern (p=0.034),Significant increase (p=0.008),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08181,rs761233,1,189524204,CD2AP,SNP (C/G),(C/,C,1.37,1.07,1.7,0.02685927,High,0.043,0.085,0.053,0.619,Significant increase (p=0.049),Mild decrease (p=0.011),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08182,rs558231,20,172150284,SORL1,SNP (G/T),(G/,G,0.84,0.51,1.07,0.0045147,Protective,0.194,0.078,0.174,0.355,Mild increase (p=0.026),Significant decrease (p=0.001),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08183,rs282931,1,106906165,EPHA1,Insertion,-,-,1.13,0.81,1.49,0.06334384,Moderate,0.138,0.081,0.207,0.375,Variable effect (p=0.035),Mild decrease (p=0.02),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08184,rs174457,13,103822965,CD2AP,Deletion,-,-,0.68,0.31,1.01,0.00271522,Moderate,0.103,0.23,0.066,0.4,Variable effect (p=0.034),Mild increase (p=0.035),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08185,rs410802,9,173104303,CD2AP,Deletion,-,-,0.75,0.44,1.15,0.02306345,Low,0.483,0.102,0.018,0.197,Variable effect (p=0.046),Mild increase (p=0.049),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08186,rs419988,1,150263075,PTK2B,Deletion,-,-,0.83,0.62,1.21,0.01928094,High,0.083,0.105,0.326,0.286,Mild decrease (p=0.017),Significant increase (p=0.03),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08187,rs748622,8,80775011,APOE,SNP (C/T),(C/,C,2.2,1.89,2.47,0.0386501,Moderate,0.374,0.296,0.058,0.073,No significant pattern (p=0.02),Significant increase (p=0.041),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08188,rs370660,4,111782441,CD33,SNP (G/T),(G/,G,0.62,0.28,0.89,0.05941604,Low,0.141,0.164,0.177,0.319,Mild increase (p=0.017),Mild increase (p=0.004),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08189,rs776750,20,52577627,EPHA1,SNP (A/C),(A/,A,2.34,2.04,2.54,0.00845891,Low,0.061,0.202,0.455,0.082,Mild increase (p=0.026),Significant decrease (p=0.045),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08190,rs590584,7,139908844,CD2AP,SNP (G/T),(G/,G,0.88,0.55,1.1,0.03640623,Low,0.147,0.392,0.162,0.099,Significant increase (p=0.007),Significant decrease (p=0.029),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08191,rs142948,6,118447267,APP,SNP (A/G),(A/,A,0.49,0.1,0.83,0.00421006,High,0.053,0.016,0.712,0.019,No significant pattern (p=0.015),Mild decrease (p=0.013),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08192,rs121333,3,60699547,SORL1,Deletion,-,-,0.7,0.4,1.0,0.00149006,Low,0.013,0.158,0.453,0.177,Variable effect (p=0.029),Significant decrease (p=0.019),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08193,rs821411,13,223178209,EPHA1,SNP (A/T),(A/,A,0.84,0.51,1.05,0.03121336,Moderate,0.445,0.242,0.067,0.046,Variable effect (p=0.02),Mild increase (p=0.024),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08194,rs409735,8,241712704,APP,Insertion,-,-,2.35,2.05,2.57,0.0414466,Low,0.223,0.431,0.105,0.042,Mild decrease (p=0.014),Mild decrease (p=0.029),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08195,rs123462,14,241040307,SORL1,SNP (G/T),(G/,G,0.73,0.41,1.0,0.09866161,High,0.248,0.252,0.152,0.148,No significant pattern (p=0.018),Mild decrease (p=0.044),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08196,rs645205,21,39178332,SORL1,SNP (C/T),(C/,C,1.41,1.13,1.72,0.0097243,Moderate,0.382,0.203,0.066,0.15,Variable effect (p=0.007),Significant increase (p=0.031),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08197,rs448187,14,125781407,PTK2B,SNP (A/T),(A/,A,0.77,0.52,1.15,0.04313779,Moderate,0.063,0.157,0.304,0.277,Mild decrease (p=0.019),No significant pattern (p=0.031),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08198,rs247701,8,144772891,PICALM,SNP (G/T),(G/,G,0.94,0.6,1.3,0.05047873,Low,0.023,0.231,0.148,0.398,Variable effect (p=0.038),Significant decrease (p=0.008),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08199,rs697980,17,148432309,BIN1,Deletion,-,-,0.65,0.41,0.9,0.00185244,High,0.392,0.075,0.095,0.238,No significant pattern (p=0.033),No significant pattern (p=0.002),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08200,rs387621,3,209856527,CLU,SNP (A/C),(A/,A,0.43,0.19,0.65,0.01176618,Low,0.052,0.285,0.118,0.345,Significant decrease (p=0.007),Significant decrease (p=0.03),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08201,rs794151,11,103521767,CD33,Insertion,-,-,0.54,0.25,0.79,0.00058441,Moderate,0.192,0.191,0.287,0.13,Significant increase (p=0.027),Significant decrease (p=0.011),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08202,rs151402,14,27863238,PSEN2,SNP (A/G),(A/,A,2.18,1.78,2.47,0.00411749,High,0.018,0.091,0.676,0.014,Significant increase (p=0.018),No significant pattern (p=0.015),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP08203,rs363388,16,176955029,BIN1,SNP (A/G),(A/,A,1.21,0.86,1.51,0.01054499,High,0.193,0.36,0.102,0.145,Significant decrease (p=0.007),Significant increase (p=0.016),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP08204,rs632292,18,118806595,CD2AP,SNP (A/G),(A/,A,0.54,0.33,0.91,0.01284119,Protective,0.195,0.592,0.01,0.003,Mild decrease (p=0.039),Variable effect (p=0.011),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08205,rs538044,15,143353078,PICALM,Deletion,-,-,0.88,0.55,1.14,0.03060884,Low,0.14,0.086,0.082,0.492,Variable effect (p=0.05),Mild increase (p=0.034),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP08206,rs359885,2,64184637,APP,SNP (G/T),(G/,G,1.31,1.1,1.56,0.02237844,Unknown,0.112,0.089,0.43,0.17,Variable effect (p=0.018),Mild increase (p=0.006),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08207,rs582507,18,75384557,APP,Deletion,-,-,1.07,0.68,1.3,0.03482362,Low,0.25,0.199,0.241,0.11,Variable effect (p=0.027),Variable effect (p=0.022),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08208,rs702201,8,173190608,MS4A6A,SNP (A/C),(A/,A,2.29,1.93,2.53,0.01224828,Low,0.247,0.037,0.228,0.288,Mild increase (p=0.05),No significant pattern (p=0.007),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08209,rs994272,14,90324045,CD33,SNP (C/G),(C/,C,1.62,1.36,1.91,0.04762732,Low,0.547,0.079,0.136,0.038,No significant pattern (p=0.037),No significant pattern (p=0.044),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08210,rs102995,10,62673138,SORL1,Insertion,-,-,1.69,1.31,1.92,0.01810433,Moderate,0.048,0.527,0.21,0.015,Significant decrease (p=0.008),Mild decrease (p=0.033),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08211,rs690846,14,14419621,CD2AP,SNP (G/T),(G/,G,1.14,0.92,1.49,0.01900883,Moderate,0.2,0.517,0.066,0.017,Mild increase (p=0.044),Mild increase (p=0.014),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08212,rs512245,11,166462346,PTK2B,SNP (A/C),(A/,A,2.75,2.47,3.13,0.00343632,High,0.326,0.12,0.135,0.219,Significant increase (p=0.028),Significant decrease (p=0.009),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08213,rs793807,1,220210619,APOE,Insertion,-,-,2.11,1.75,2.48,0.01630033,High,0.143,0.235,0.215,0.207,Variable effect (p=0.038),Mild increase (p=0.034),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08214,rs157307,10,35478089,APP,Deletion,-,-,2.2,1.94,2.57,0.01931769,Low,0.01,0.08,0.237,0.474,Significant increase (p=0.044),Mild increase (p=0.044),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08215,rs155055,5,181523896,APOE,SNP (G/T),(G/,G,2.72,2.32,3.08,0.0200961,Low,0.167,0.02,0.328,0.285,No significant pattern (p=0.015),No significant pattern (p=0.023),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08216,rs102600,13,202858465,PSEN2,SNP (A/C),(A/,A,2.08,1.75,2.35,0.01199333,Moderate,0.007,0.142,0.325,0.326,Significant decrease (p=0.036),Variable effect (p=0.008),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08217,rs294781,7,213823370,PICALM,SNP (C/T),(C/,C,1.08,0.79,1.29,0.01687713,Moderate,0.526,0.06,0.155,0.059,Variable effect (p=0.023),Mild decrease (p=0.032),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08218,rs991237,10,201523330,APP,SNP (G/T),(G/,G,1.03,0.76,1.29,0.08206667,Moderate,0.013,0.304,0.392,0.09,Significant decrease (p=0.037),Mild decrease (p=0.037),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08219,rs234355,3,15041067,PICALM,SNP (A/T),(A/,A,0.97,0.73,1.2,0.01599722,High,0.057,0.192,0.226,0.325,Mild decrease (p=0.041),Significant decrease (p=0.05),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08220,rs403647,11,73559606,CD2AP,SNP (A/T),(A/,A,1.58,1.32,1.98,0.12644764,Moderate,0.315,0.176,0.303,0.006,Mild increase (p=0.021),Mild increase (p=0.04),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP08221,rs352645,7,227607379,EPHA1,SNP (C/G),(C/,C,0.79,0.46,1.13,0.01530357,High,0.537,0.118,0.048,0.097,Mild decrease (p=0.038),No significant pattern (p=0.013),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08222,rs903734,13,109067460,CLU,SNP (C/T),(C/,C,0.55,0.23,0.9,0.03768607,Moderate,0.403,0.175,0.042,0.181,Mild increase (p=0.008),Variable effect (p=0.006),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08223,rs840399,14,135520802,CLU,SNP (A/G),(A/,A,0.91,0.59,1.24,0.00058127,Moderate,0.302,0.321,0.056,0.121,Significant decrease (p=0.043),Mild increase (p=0.035),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP08224,rs846393,12,245922376,SORL1,SNP (A/G),(A/,A,2.49,2.15,2.86,0.00418904,High,0.043,0.459,0.015,0.284,Significant decrease (p=0.042),Mild decrease (p=0.05),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08225,rs483604,5,12142052,CD2AP,Insertion,-,-,1.67,1.44,1.99,0.13513176,Moderate,0.246,0.112,0.191,0.251,No significant pattern (p=0.017),Variable effect (p=0.045),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08226,rs927852,22,168317186,CLU,Deletion,-,-,1.03,0.73,1.39,0.03757123,Protective,0.043,0.33,0.261,0.166,Significant increase (p=0.038),No significant pattern (p=0.008),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08227,rs903624,22,51638999,APP,SNP (C/T),(C/,C,0.68,0.46,0.92,0.0640662,Protective,0.064,0.066,0.223,0.447,Significant decrease (p=0.012),Mild increase (p=0.004),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08228,rs416645,13,56911180,EPHA1,SNP (C/G),(C/,C,1.33,1.05,1.65,0.06642357,High,0.342,0.09,0.353,0.016,Mild increase (p=0.006),Significant increase (p=0.027),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08229,rs789223,11,58609133,APOE,Insertion,-,-,1.38,1.07,1.71,0.01742601,High,0.082,0.071,0.115,0.532,Mild increase (p=0.027),Significant decrease (p=0.007),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08230,rs139620,5,111317492,EPHA1,SNP (A/T),(A/,A,0.5,0.11,0.73,0.02491793,High,0.044,0.148,0.397,0.211,Significant increase (p=0.01),No significant pattern (p=0.003),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08231,rs128446,2,95582884,PSEN2,Deletion,-,-,0.8,0.49,1.13,0.15749067,Unknown,0.279,0.137,0.332,0.051,Mild decrease (p=0.019),Significant increase (p=0.027),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP08232,rs576598,4,84172224,ABCA7,Deletion,-,-,0.55,0.34,0.83,0.03397496,Low,0.046,0.526,0.006,0.222,Mild increase (p=0.006),Mild decrease (p=0.03),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08233,rs732272,17,66107776,APP,Deletion,-,-,0.42,0.12,0.8,0.03671802,Moderate,0.026,0.309,0.062,0.403,Mild decrease (p=0.027),Mild decrease (p=0.027),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08234,rs886181,22,218660239,TREM2,SNP (C/T),(C/,C,0.75,0.45,1.03,0.0142155,High,0.118,0.036,0.38,0.266,Significant increase (p=0.028),Mild increase (p=0.048),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP08235,rs835391,7,19419747,BIN1,SNP (A/G),(A/,A,0.98,0.66,1.35,0.0460712,High,0.465,0.199,0.105,0.031,Mild increase (p=0.007),Variable effect (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08236,rs833217,1,90785000,MS4A6A,Insertion,-,-,1.06,0.78,1.31,0.02552017,Moderate,0.365,0.219,0.155,0.061,No significant pattern (p=0.02),Significant increase (p=0.014),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08237,rs893645,10,221587214,PTK2B,SNP (A/C),(A/,A,1.09,0.87,1.31,0.09025057,High,0.095,0.182,0.036,0.486,Mild decrease (p=0.015),Variable effect (p=0.016),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08238,rs320984,16,86564282,CR1,SNP (A/C),(A/,A,0.82,0.54,1.16,0.00393828,Low,0.147,0.264,0.058,0.331,Variable effect (p=0.046),Variable effect (p=0.014),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08239,rs348651,12,108038661,ABCA7,Deletion,-,-,1.86,1.55,2.18,0.05411225,High,0.251,0.034,0.014,0.501,Significant decrease (p=0.012),Variable effect (p=0.015),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08240,rs145271,16,112715809,CR1,SNP (G/T),(G/,G,2.19,1.97,2.56,0.02005517,Moderate,0.03,0.038,0.573,0.159,Mild decrease (p=0.029),Variable effect (p=0.047),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08241,rs400723,19,175186865,CLU,Insertion,-,-,1.05,0.7,1.37,0.04093026,High,0.026,0.023,0.344,0.406,Significant decrease (p=0.036),Significant increase (p=0.008),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP08242,rs201615,12,19312813,MS4A6A,SNP (A/C),(A/,A,0.5,0.17,0.89,0.01922876,High,0.135,0.22,0.364,0.081,Variable effect (p=0.029),Mild decrease (p=0.014),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08243,rs350282,11,210453489,ABCA7,SNP (A/C),(A/,A,1.87,1.58,2.18,0.05674984,High,0.096,0.452,0.225,0.027,Variable effect (p=0.045),Significant increase (p=0.004),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08244,rs318701,10,6483174,PSEN2,Deletion,-,-,1.94,1.64,2.32,0.01572518,Low,0.075,0.382,0.109,0.234,Mild increase (p=0.017),Significant decrease (p=0.016),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08245,rs424618,17,129017098,PTK2B,SNP (A/C),(A/,A,0.85,0.61,1.21,0.01424901,Moderate,0.025,0.336,0.236,0.203,Mild decrease (p=0.046),Significant decrease (p=0.026),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08246,rs240948,17,64228654,CD2AP,SNP (A/G),(A/,A,0.7,0.34,1.04,0.0395901,High,0.153,0.21,0.319,0.118,Mild decrease (p=0.029),No significant pattern (p=0.012),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08247,rs887130,6,123652584,APOE,SNP (C/G),(C/,C,1.04,0.81,1.36,0.00569108,Low,0.096,0.264,0.389,0.05,Mild decrease (p=0.021),Mild decrease (p=0.027),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP08248,rs388166,20,17614195,SORL1,SNP (G/T),(G/,G,1.58,1.29,1.8,0.0231417,High,0.515,0.005,0.032,0.247,No significant pattern (p=0.025),Significant decrease (p=0.026),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08249,rs755719,14,94011072,APP,SNP (G/T),(G/,G,0.74,0.46,1.05,0.00076652,Low,0.099,0.027,0.174,0.501,Mild decrease (p=0.018),No significant pattern (p=0.025),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08250,rs894382,2,137842845,SORL1,Insertion,-,-,0.78,0.44,1.06,0.07305162,Moderate,0.174,0.365,0.053,0.207,Significant decrease (p=0.011),Significant decrease (p=0.049),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08251,rs821295,9,121469034,SORL1,SNP (G/T),(G/,G,0.78,0.54,1.09,0.02276156,Moderate,0.01,0.186,0.314,0.29,Mild decrease (p=0.043),Mild decrease (p=0.029),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP08252,rs851769,8,230992194,CLU,SNP (A/C),(A/,A,1.06,0.67,1.36,0.0037913,Moderate,0.215,0.031,0.206,0.347,Significant increase (p=0.048),No significant pattern (p=0.023),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP08253,rs793265,21,130482492,BIN1,SNP (C/T),(C/,C,1.43,1.22,1.74,0.0201758,Low,0.005,0.651,0.101,0.044,No significant pattern (p=0.007),Mild decrease (p=0.008),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08254,rs516948,9,51578509,CD33,SNP (C/T),(C/,C,0.95,0.65,1.28,0.06169916,Moderate,0.41,0.171,0.155,0.064,Variable effect (p=0.026),Mild decrease (p=0.031),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08255,rs619879,5,180212866,PICALM,SNP (C/T),(C/,C,0.51,0.14,0.81,0.0499518,Moderate,0.158,0.228,0.114,0.3,Mild decrease (p=0.01),Variable effect (p=0.019),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08256,rs619952,22,127483053,EPHA1,SNP (A/C),(A/,A,1.9,1.53,2.25,0.01640824,Moderate,0.475,0.074,0.022,0.228,Variable effect (p=0.025),Mild increase (p=0.048),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08257,rs668059,14,51601279,MS4A6A,Deletion,-,-,0.52,0.26,0.83,0.00153443,Protective,0.007,0.15,0.257,0.385,No significant pattern (p=0.028),Variable effect (p=0.032),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08258,rs989227,13,69501583,TREM2,Deletion,-,-,0.6,0.21,0.92,0.00201076,Low,0.322,0.299,0.155,0.024,Significant increase (p=0.031),No significant pattern (p=0.044),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP08259,rs509369,5,121422790,PTK2B,SNP (C/G),(C/,C,1.82,1.49,2.04,0.02633151,Low,0.065,0.165,0.328,0.242,Mild decrease (p=0.017),Mild decrease (p=0.021),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP08260,rs325932,7,5585611,PTK2B,SNP (C/T),(C/,C,1.33,1.0,1.73,0.01044637,Moderate,0.418,0.335,0.027,0.02,Significant decrease (p=0.033),No significant pattern (p=0.011),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08261,rs416876,2,54595104,CLU,SNP (A/C),(A/,A,0.87,0.54,1.15,0.01323438,High,0.478,0.04,0.183,0.099,Mild decrease (p=0.049),Significant decrease (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08262,rs787939,20,19823717,CD33,SNP (G/T),(G/,G,0.91,0.7,1.3,0.06676765,Low,0.172,0.124,0.463,0.041,Significant decrease (p=0.005),Significant increase (p=0.034),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP08263,rs590520,22,69515042,PSEN2,SNP (C/T),(C/,C,0.91,0.7,1.29,0.02287174,High,0.005,0.474,0.098,0.223,Significant decrease (p=0.041),Variable effect (p=0.029),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08264,rs254476,20,102751677,CLU,SNP (A/T),(A/,A,0.56,0.31,0.82,0.01426154,Moderate,0.156,0.173,0.38,0.091,Significant decrease (p=0.035),Variable effect (p=0.014),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08265,rs591654,19,231848246,CD33,SNP (A/C),(A/,A,0.78,0.5,1.02,0.01466263,Low,0.148,0.084,0.039,0.529,Significant increase (p=0.049),Significant increase (p=0.036),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08266,rs283965,17,67822099,APP,SNP (A/T),(A/,A,0.92,0.52,1.24,0.00680449,High,0.242,0.348,0.119,0.091,Mild decrease (p=0.012),Significant increase (p=0.038),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08267,rs185264,17,209167243,CD2AP,SNP (A/G),(A/,A,0.58,0.18,0.95,0.01488242,Moderate,0.462,0.19,0.066,0.082,Significant increase (p=0.003),Significant increase (p=0.041),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08268,rs825433,22,137335544,PSEN2,SNP (A/C),(A/,A,1.96,1.69,2.24,0.00153242,High,0.096,0.457,0.24,0.007,Significant decrease (p=0.038),Significant increase (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08269,rs603801,9,49334642,APOE,Deletion,-,-,0.73,0.46,1.11,0.08238022,High,0.196,0.361,0.141,0.102,Significant decrease (p=0.048),Significant decrease (p=0.007),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08270,rs320563,14,193930956,PTK2B,SNP (C/T),(C/,C,1.23,1.01,1.61,0.04731978,Low,0.123,0.182,0.269,0.226,No significant pattern (p=0.016),No significant pattern (p=0.026),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08271,rs419189,17,102089565,CD2AP,SNP (C/T),(C/,C,0.39,0.1,0.63,0.05070653,Unknown,0.005,0.191,0.499,0.104,Variable effect (p=0.007),No significant pattern (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08272,rs158424,10,220799581,MS4A6A,SNP (A/G),(A/,A,0.51,0.21,0.78,0.04420507,High,0.37,0.201,0.164,0.065,Significant decrease (p=0.048),Significant decrease (p=0.002),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08273,rs499917,8,21466295,CR1,SNP (A/G),(A/,A,1.98,1.7,2.28,0.03055388,Moderate,0.007,0.269,0.502,0.023,Mild decrease (p=0.045),Variable effect (p=0.023),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP08274,rs809855,9,202818008,CD33,SNP (C/T),(C/,C,0.44,0.18,0.75,0.05037077,Protective,0.099,0.202,0.236,0.263,Mild decrease (p=0.035),Mild increase (p=0.022),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08275,rs634314,16,7773083,SORL1,Insertion,-,-,2.25,1.99,2.65,0.00388223,High,0.206,0.523,0.007,0.064,Mild increase (p=0.018),Significant decrease (p=0.032),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08276,rs415105,2,39533340,PSEN2,Insertion,-,-,0.78,0.52,1.0,0.01360351,Moderate,0.307,0.333,0.08,0.08,Mild decrease (p=0.007),Significant increase (p=0.004),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08277,rs152428,22,177231573,CR1,SNP (A/T),(A/,A,0.35,0.13,0.67,0.03115203,Protective,0.076,0.125,0.016,0.583,Variable effect (p=0.019),Mild increase (p=0.049),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08278,rs712834,12,194038986,APP,SNP (A/G),(A/,A,0.96,0.73,1.32,0.0296751,Unknown,0.055,0.348,0.155,0.241,No significant pattern (p=0.002),Mild increase (p=0.032),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08279,rs665008,5,162340113,EPHA1,SNP (A/G),(A/,A,1.38,1.12,1.75,0.00780416,Moderate,0.134,0.051,0.002,0.614,Variable effect (p=0.033),No significant pattern (p=0.03),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08280,rs352554,11,141671306,CD33,SNP (C/G),(C/,C,0.66,0.43,0.97,0.00875719,High,0.404,0.028,0.216,0.152,Variable effect (p=0.04),No significant pattern (p=0.015),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08281,rs489200,8,153730005,BIN1,SNP (C/T),(C/,C,1.39,1.08,1.61,0.00263497,High,0.069,0.415,0.187,0.129,Mild increase (p=0.029),Significant increase (p=0.003),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08282,rs236150,15,182483776,TREM2,SNP (A/G),(A/,A,1.64,1.4,1.89,0.00948139,High,0.073,0.273,0.421,0.034,Mild decrease (p=0.039),Mild increase (p=0.016),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08283,rs472203,7,77431789,CLU,SNP (A/C),(A/,A,0.64,0.29,0.87,0.00427751,Moderate,0.132,0.196,0.043,0.43,Variable effect (p=0.01),Significant increase (p=0.006),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08284,rs605694,11,26584655,CD33,SNP (A/T),(A/,A,1.17,0.95,1.43,0.00428905,Moderate,0.049,0.049,0.249,0.453,Mild increase (p=0.045),Significant decrease (p=0.018),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08285,rs304964,1,62186796,APP,Insertion,-,-,1.12,0.83,1.4,0.00825644,Low,0.592,0.119,0.041,0.048,Mild decrease (p=0.007),Variable effect (p=0.005),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08286,rs943956,8,193212617,TREM2,SNP (A/C),(A/,A,0.8,0.53,1.02,0.01728886,Low,0.073,0.107,0.229,0.391,Significant increase (p=0.049),No significant pattern (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08287,rs408510,17,67556667,TREM2,SNP (A/C),(A/,A,0.81,0.58,1.1,0.00484235,Unknown,0.245,0.039,0.064,0.452,Mild increase (p=0.048),Significant increase (p=0.002),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08288,rs214973,5,168791443,CD33,SNP (A/T),(A/,A,0.96,0.56,1.22,0.02567348,Low,0.061,0.09,0.583,0.066,Mild increase (p=0.025),Significant decrease (p=0.011),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08289,rs566195,13,25198480,BIN1,SNP (A/G),(A/,A,2.65,2.27,2.94,0.00732028,Unknown,0.127,0.21,0.349,0.114,Significant decrease (p=0.001),Significant decrease (p=0.014),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08290,rs229388,12,10636842,EPHA1,SNP (A/G),(A/,A,0.77,0.55,1.13,0.17696598,Moderate,0.053,0.296,0.356,0.094,No significant pattern (p=0.013),Mild decrease (p=0.026),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08291,rs128221,16,115072235,PICALM,SNP (C/T),(C/,C,0.71,0.39,1.02,0.01934479,Moderate,0.033,0.127,0.031,0.609,Mild decrease (p=0.012),Mild decrease (p=0.018),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08292,rs599348,3,147222621,ABCA7,SNP (A/G),(A/,A,0.93,0.68,1.15,0.00202342,Moderate,0.148,0.276,0.163,0.212,Mild increase (p=0.018),No significant pattern (p=0.035),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP08293,rs329863,17,160545882,CD33,SNP (A/G),(A/,A,1.09,0.82,1.35,0.02212564,High,0.489,0.118,0.136,0.057,No significant pattern (p=0.027),Significant decrease (p=0.038),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08294,rs242073,13,89360838,APOE,Insertion,-,-,1.34,1.04,1.66,0.10605833,Protective,0.008,0.253,0.133,0.406,Significant decrease (p=0.038),Significant increase (p=0.009),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08295,rs674153,7,1558842,CD33,SNP (G/T),(G/,G,0.59,0.25,0.8,0.01741196,Low,0.041,0.181,0.043,0.535,Mild decrease (p=0.021),Mild increase (p=0.007),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP08296,rs227297,8,145716297,CR1,SNP (A/G),(A/,A,2.91,2.64,3.24,0.03964718,High,0.0,0.068,0.631,0.101,Mild decrease (p=0.044),No significant pattern (p=0.006),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08297,rs717447,21,178173574,CD33,SNP (G/T),(G/,G,1.22,0.87,1.54,0.02455771,High,0.275,0.116,0.02,0.389,No significant pattern (p=0.035),Mild increase (p=0.009),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08298,rs732824,10,53841093,TREM2,Insertion,-,-,0.42,0.18,0.8,0.03930924,Low,0.139,0.092,0.036,0.533,Mild decrease (p=0.037),Mild increase (p=0.047),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08299,rs654095,13,17704283,CD2AP,SNP (A/T),(A/,A,1.34,0.97,1.7,0.01793108,Protective,0.373,0.247,0.04,0.139,Mild decrease (p=0.008),Variable effect (p=0.036),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08300,rs133219,12,78039761,CD2AP,SNP (C/T),(C/,C,0.76,0.49,1.07,0.06876821,Unknown,0.185,0.568,0.035,0.012,Variable effect (p=0.014),Variable effect (p=0.034),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08301,rs449151,10,183971293,CD2AP,Deletion,-,-,0.8,0.51,1.04,0.04726205,Low,0.265,0.128,0.106,0.301,Significant increase (p=0.005),Variable effect (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08302,rs386674,16,22162244,APP,SNP (C/G),(C/,C,0.49,0.28,0.82,0.03942898,Protective,0.137,0.32,0.067,0.276,No significant pattern (p=0.006),Mild increase (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08303,rs838725,10,10627468,CD2AP,SNP (C/T),(C/,C,0.46,0.22,0.8,0.036512,Protective,0.357,0.329,0.067,0.047,Mild decrease (p=0.046),Significant decrease (p=0.038),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08304,rs332616,18,128443351,APP,SNP (A/C),(A/,A,0.9,0.69,1.12,0.07529841,High,0.045,0.105,0.369,0.281,No significant pattern (p=0.006),No significant pattern (p=0.005),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08305,rs688711,22,162597003,EPHA1,SNP (C/T),(C/,C,0.81,0.5,1.03,0.03289199,Moderate,0.2,0.089,0.009,0.501,Significant decrease (p=0.049),Variable effect (p=0.031),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP08306,rs241123,1,233232663,MS4A6A,Insertion,-,-,0.3,0.1,0.53,0.02684949,Moderate,0.018,0.322,0.332,0.128,Mild increase (p=0.011),Variable effect (p=0.043),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08307,rs805779,2,206064849,CLU,Insertion,-,-,0.96,0.6,1.21,0.0155266,Low,0.018,0.196,0.29,0.297,Variable effect (p=0.045),Variable effect (p=0.011),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08308,rs400916,2,74971531,ABCA7,SNP (A/G),(A/,A,1.16,0.84,1.44,0.07483238,High,0.246,0.051,0.433,0.071,Significant increase (p=0.001),Significant decrease (p=0.009),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08309,rs824641,3,131607151,PSEN2,SNP (C/G),(C/,C,1.01,0.63,1.38,0.01089023,Unknown,0.053,0.499,0.218,0.03,Significant increase (p=0.009),Significant decrease (p=0.03),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08310,rs751816,6,183825918,APP,SNP (G/T),(G/,G,1.06,0.8,1.44,0.00648265,Moderate,0.049,0.361,0.11,0.279,Significant decrease (p=0.02),Mild decrease (p=0.049),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP08311,rs478476,6,117618162,CR1,SNP (C/T),(C/,C,0.36,0.13,0.64,0.02255935,High,0.104,0.277,0.388,0.032,Mild decrease (p=0.04),No significant pattern (p=0.04),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08312,rs745249,21,213463533,PSEN2,SNP (A/T),(A/,A,1.42,1.16,1.62,0.02995469,Low,0.035,0.415,0.226,0.125,Mild decrease (p=0.023),Mild increase (p=0.043),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP08313,rs777582,5,164282650,PTK2B,Insertion,-,-,0.97,0.6,1.23,0.00807326,Moderate,0.228,0.066,0.098,0.408,Mild decrease (p=0.005),Variable effect (p=0.038),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08314,rs308473,5,208927516,TREM2,SNP (A/T),(A/,A,1.18,0.98,1.39,0.07892627,High,0.301,0.058,0.219,0.222,Significant increase (p=0.032),No significant pattern (p=0.044),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP08315,rs716265,15,157025285,APP,Deletion,-,-,1.98,1.7,2.2,0.04604943,Moderate,0.246,0.135,0.135,0.283,Significant decrease (p=0.011),Mild increase (p=0.034),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08316,rs640318,17,124254592,CD33,SNP (C/G),(C/,C,0.7,0.32,0.94,0.00942905,Moderate,0.235,0.024,0.087,0.453,Significant increase (p=0.008),Mild increase (p=0.033),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08317,rs318784,12,3498486,PICALM,Deletion,-,-,0.46,0.12,0.75,0.00572145,Moderate,0.248,0.177,0.353,0.022,Significant decrease (p=0.039),Mild increase (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08318,rs712525,20,177710648,CR1,Insertion,-,-,1.59,1.31,1.84,0.00628283,Moderate,0.299,0.301,0.055,0.145,Mild increase (p=0.015),No significant pattern (p=0.017),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP08319,rs114570,22,52971112,ABCA7,SNP (A/C),(A/,A,1.07,0.71,1.33,0.00560513,High,0.017,0.224,0.322,0.238,No significant pattern (p=0.046),Mild decrease (p=0.027),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08320,rs279282,16,49445546,PICALM,Deletion,-,-,1.25,0.89,1.53,0.00012445,Protective,0.203,0.201,0.086,0.309,Variable effect (p=0.003),Mild decrease (p=0.031),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08321,rs399901,20,137463241,MS4A6A,SNP (G/T),(G/,G,0.97,0.73,1.22,0.0185818,Low,0.404,0.069,0.294,0.033,Mild decrease (p=0.03),Significant decrease (p=0.046),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08322,rs900187,15,24389409,PICALM,SNP (A/T),(A/,A,0.94,0.65,1.24,0.00057019,High,0.152,0.346,0.048,0.254,No significant pattern (p=0.032),Significant decrease (p=0.019),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08323,rs622447,14,132262510,PSEN2,Deletion,-,-,1.15,0.88,1.51,0.01262494,Moderate,0.228,0.076,0.071,0.425,Variable effect (p=0.022),Mild decrease (p=0.027),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP08324,rs181133,21,3663491,BIN1,SNP (G/T),(G/,G,0.72,0.52,0.93,0.06541643,High,0.148,0.161,0.487,0.005,Mild increase (p=0.048),No significant pattern (p=0.019),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08325,rs807811,16,189683037,CR1,SNP (C/G),(C/,C,2.51,2.16,2.71,0.01315559,Moderate,0.041,0.166,0.039,0.554,Mild decrease (p=0.013),Mild increase (p=0.03),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08326,rs590477,15,131556434,APP,SNP (A/T),(A/,A,0.68,0.31,0.95,0.08589243,Moderate,0.315,0.468,0.008,0.01,Mild decrease (p=0.019),No significant pattern (p=0.033),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP08327,rs949735,18,70023774,APP,Insertion,-,-,0.88,0.5,1.15,0.1226663,Moderate,0.058,0.003,0.654,0.086,No significant pattern (p=0.017),Significant increase (p=0.043),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08328,rs517396,21,211602198,PICALM,SNP (A/C),(A/,A,1.17,0.84,1.43,0.12540342,Low,0.167,0.002,0.204,0.426,Mild increase (p=0.023),Mild decrease (p=0.016),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08329,rs738377,10,47965694,APOE,SNP (C/T),(C/,C,0.67,0.38,1.02,0.01915567,Low,0.093,0.25,0.063,0.394,Mild decrease (p=0.028),Mild increase (p=0.027),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP08330,rs495283,19,240775059,BIN1,SNP (A/T),(A/,A,0.87,0.59,1.19,0.04328055,Moderate,0.098,0.243,0.243,0.217,Significant increase (p=0.026),Mild decrease (p=0.034),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP08331,rs104216,1,100499087,PSEN2,SNP (A/G),(A/,A,0.84,0.59,1.15,0.04855377,Protective,0.394,0.138,0.029,0.238,Mild increase (p=0.007),Significant decrease (p=0.037),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08332,rs526646,12,19213957,ABCA7,SNP (A/G),(A/,A,0.85,0.6,1.08,0.06579251,High,0.067,0.186,0.441,0.106,Mild decrease (p=0.044),No significant pattern (p=0.008),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP08333,rs360179,21,92761286,PSEN2,SNP (G/T),(G/,G,0.54,0.21,0.81,0.00824707,Moderate,0.538,0.134,0.031,0.098,Significant decrease (p=0.021),Mild increase (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08334,rs372474,16,1164199,CD33,SNP (A/T),(A/,A,1.95,1.55,2.29,0.04288425,Moderate,0.197,0.059,0.194,0.349,Variable effect (p=0.003),No significant pattern (p=0.009),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08335,rs416421,5,157065651,APP,SNP (C/G),(C/,C,1.59,1.35,1.89,0.08379684,Protective,0.101,0.228,0.049,0.421,No significant pattern (p=0.011),Mild decrease (p=0.021),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08336,rs710595,10,157039682,BIN1,Insertion,-,-,0.94,0.61,1.28,0.03839076,High,0.418,0.037,0.034,0.311,No significant pattern (p=0.03),Mild decrease (p=0.04),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08337,rs351486,6,180964138,CD2AP,SNP (A/T),(A/,A,0.71,0.4,1.0,0.00082898,Moderate,0.423,0.245,0.091,0.041,Significant decrease (p=0.047),Mild increase (p=0.019),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08338,rs279466,15,29590711,APP,SNP (C/G),(C/,C,1.19,0.93,1.44,0.00079254,High,0.144,0.092,0.424,0.14,Significant increase (p=0.039),Variable effect (p=0.016),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP08339,rs240577,14,195793540,PTK2B,SNP (A/G),(A/,A,0.83,0.48,1.13,0.02117268,Moderate,0.358,0.126,0.239,0.076,Significant increase (p=0.026),No significant pattern (p=0.004),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08340,rs953839,13,139301123,PICALM,SNP (C/G),(C/,C,1.91,1.62,2.19,0.05032565,Low,0.135,0.058,0.144,0.463,Significant increase (p=0.027),No significant pattern (p=0.002),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08341,rs587854,6,228530962,EPHA1,Insertion,-,-,0.85,0.51,1.11,0.07405092,High,0.473,0.277,0.007,0.043,Variable effect (p=0.045),Significant decrease (p=0.014),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08342,rs419685,4,226094097,SORL1,SNP (C/T),(C/,C,2.61,2.31,2.83,0.01187069,Moderate,0.009,0.154,0.382,0.255,No significant pattern (p=0.014),Mild increase (p=0.031),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08343,rs683481,13,198078009,MS4A6A,SNP (C/G),(C/,C,1.99,1.61,2.24,0.01639211,High,0.065,0.48,0.198,0.058,No significant pattern (p=0.007),Significant decrease (p=0.031),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08344,rs533883,21,110368808,MS4A6A,SNP (A/G),(A/,A,0.99,0.69,1.38,0.01289908,Moderate,0.375,0.02,0.33,0.076,Significant increase (p=0.048),Significant decrease (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08345,rs741881,18,21961939,CR1,SNP (A/T),(A/,A,1.06,0.74,1.38,0.04200466,Moderate,0.235,0.259,0.065,0.241,Mild decrease (p=0.036),No significant pattern (p=0.003),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08346,rs963907,4,162830118,CLU,SNP (C/T),(C/,C,0.46,0.1,0.81,0.01205016,Protective,0.361,0.044,0.361,0.035,Significant decrease (p=0.005),Variable effect (p=0.019),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08347,rs775733,16,137115280,APOE,Deletion,-,-,1.53,1.25,1.87,0.0147228,Moderate,0.014,0.013,0.41,0.363,Significant decrease (p=0.031),Significant decrease (p=0.04),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08348,rs334534,13,73660993,MS4A6A,SNP (A/G),(A/,A,1.53,1.27,1.73,0.006599,Protective,0.157,0.188,0.42,0.036,Significant increase (p=0.049),Mild increase (p=0.01),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP08349,rs428410,16,216959036,PTK2B,SNP (G/T),(G/,G,1.58,1.24,1.9,0.05133083,Moderate,0.087,0.196,0.425,0.092,Significant increase (p=0.029),Mild increase (p=0.011),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08350,rs322490,12,104026669,ABCA7,Deletion,-,-,1.03,0.82,1.34,0.04034183,Low,0.151,0.023,0.163,0.463,Variable effect (p=0.005),Significant decrease (p=0.033),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08351,rs364447,4,91043209,CLU,SNP (C/T),(C/,C,1.02,0.72,1.31,0.04813656,Moderate,0.126,0.306,0.24,0.128,Significant increase (p=0.047),Mild decrease (p=0.007),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08352,rs357518,5,188845708,CD33,Deletion,-,-,0.87,0.62,1.26,0.00084078,Low,0.065,0.411,0.012,0.313,Mild increase (p=0.05),Mild increase (p=0.037),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08353,rs259155,6,211565697,BIN1,Insertion,-,-,1.17,0.96,1.48,0.11376213,Low,0.196,0.435,0.055,0.115,Mild decrease (p=0.033),Mild decrease (p=0.009),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08354,rs222866,12,84692662,SORL1,Insertion,-,-,0.34,0.1,0.55,0.05431491,Unknown,0.076,0.53,0.134,0.06,Significant increase (p=0.019),Significant decrease (p=0.017),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08355,rs895310,12,173935335,CR1,SNP (A/T),(A/,A,1.87,1.66,2.2,0.00983657,Moderate,0.048,0.567,0.004,0.18,Variable effect (p=0.017),Mild increase (p=0.029),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08356,rs537677,19,153622954,SORL1,SNP (A/G),(A/,A,0.48,0.26,0.84,0.03435853,Low,0.095,0.434,0.257,0.014,Variable effect (p=0.034),No significant pattern (p=0.032),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08357,rs583296,6,39174631,ABCA7,Insertion,-,-,1.06,0.77,1.33,0.02834099,Protective,0.229,0.049,0.508,0.014,Significant increase (p=0.005),Significant increase (p=0.034),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08358,rs495184,20,151070395,CD2AP,SNP (A/G),(A/,A,0.7,0.35,1.03,0.09761657,Moderate,0.466,0.009,0.024,0.301,Mild decrease (p=0.016),No significant pattern (p=0.005),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP08359,rs336767,7,186359365,PICALM,SNP (C/G),(C/,C,1.61,1.4,1.85,0.02083626,Low,0.05,0.274,0.377,0.099,Significant increase (p=0.015),No significant pattern (p=0.024),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP08360,rs811223,15,30402842,PTK2B,SNP (A/T),(A/,A,1.96,1.67,2.18,0.00341194,Protective,0.38,0.346,0.041,0.033,Variable effect (p=0.013),Mild increase (p=0.01),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP08361,rs423397,20,185110037,MS4A6A,SNP (A/T),(A/,A,0.47,0.22,0.72,0.01000436,High,0.097,0.247,0.105,0.351,Mild increase (p=0.032),Significant decrease (p=0.019),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08362,rs830065,19,54542789,ABCA7,Insertion,-,-,1.48,1.13,1.82,0.07347481,High,0.209,0.004,0.203,0.384,Variable effect (p=0.048),Significant decrease (p=0.038),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08363,rs544429,15,164913212,PSEN2,Insertion,-,-,0.43,0.17,0.73,0.04246615,Low,0.48,0.026,0.008,0.285,Mild decrease (p=0.036),Mild increase (p=0.041),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP08364,rs690873,9,2569135,APOE,SNP (A/C),(A/,A,1.34,0.94,1.65,0.00321592,Low,0.362,0.078,0.245,0.114,Significant decrease (p=0.025),Mild increase (p=0.002),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08365,rs360531,10,21169283,MS4A6A,SNP (A/C),(A/,A,0.48,0.12,0.76,0.07633201,Moderate,0.259,0.273,0.165,0.103,Mild decrease (p=0.01),Mild increase (p=0.011),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08366,rs510671,17,42323984,CD2AP,SNP (A/C),(A/,A,1.03,0.82,1.34,0.10108492,Protective,0.085,0.202,0.206,0.306,No significant pattern (p=0.006),Significant decrease (p=0.033),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08367,rs744561,22,210681615,APOE,Insertion,-,-,0.27,0.1,0.57,0.00180343,Protective,0.222,0.272,0.131,0.175,Significant decrease (p=0.015),No significant pattern (p=0.035),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08368,rs272783,13,151409205,EPHA1,Deletion,-,-,0.28,0.1,0.62,0.03923368,High,0.186,0.188,0.18,0.246,Significant decrease (p=0.049),Significant increase (p=0.009),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08369,rs655221,22,111030669,CD33,Deletion,-,-,1.46,1.25,1.67,0.04872796,Moderate,0.188,0.006,0.073,0.533,Mild increase (p=0.021),Variable effect (p=0.007),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08370,rs607977,19,77604372,MS4A6A,SNP (A/C),(A/,A,0.96,0.72,1.2,0.01689028,Unknown,0.714,0.032,0.04,0.015,Significant decrease (p=0.012),Variable effect (p=0.01),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08371,rs248152,3,3902708,MS4A6A,SNP (C/G),(C/,C,1.02,0.78,1.34,0.02858489,High,0.172,0.156,0.301,0.171,Mild increase (p=0.048),Significant increase (p=0.04),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP08372,rs263624,15,95410046,BIN1,Deletion,-,-,0.66,0.4,0.91,0.06288799,Low,0.202,0.469,0.113,0.016,Mild increase (p=0.049),Significant decrease (p=0.015),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08373,rs126192,13,24283263,TREM2,SNP (C/G),(C/,C,1.8,1.52,2.11,0.00949484,Protective,0.082,0.077,0.228,0.413,Variable effect (p=0.041),No significant pattern (p=0.005),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08374,rs102356,6,5281191,CLU,SNP (A/C),(A/,A,2.27,1.88,2.54,0.04597,Low,0.157,0.053,0.578,0.012,Significant decrease (p=0.008),Mild decrease (p=0.034),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08375,rs604887,10,186921749,APP,SNP (A/T),(A/,A,1.62,1.28,1.9,0.07943136,High,0.093,0.057,0.171,0.479,Significant increase (p=0.023),Variable effect (p=0.044),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP08376,rs430402,19,141582947,CR1,Deletion,-,-,0.81,0.46,1.08,0.11970249,Moderate,0.052,0.148,0.509,0.091,Mild decrease (p=0.037),Significant increase (p=0.02),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08377,rs810696,18,182451111,SORL1,SNP (C/T),(C/,C,0.44,0.1,0.64,0.15315296,Low,0.322,0.182,0.019,0.276,Mild increase (p=0.011),Mild decrease (p=0.031),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08378,rs719568,16,75277638,TREM2,SNP (A/G),(A/,A,2.82,2.6,3.17,0.03309356,Low,0.397,0.267,0.132,0.004,No significant pattern (p=0.02),Significant decrease (p=0.005),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08379,rs774453,21,117928344,ABCA7,Deletion,-,-,0.78,0.39,1.07,0.04528357,Moderate,0.333,0.36,0.097,0.009,Variable effect (p=0.018),Mild decrease (p=0.018),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08380,rs629941,20,247313109,PSEN2,SNP (A/C),(A/,A,1.05,0.69,1.25,0.03549774,Protective,0.018,0.004,0.405,0.374,Mild decrease (p=0.021),Significant decrease (p=0.024),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08381,rs869031,5,22334955,APOE,Deletion,-,-,0.7,0.48,1.01,0.03721451,Protective,0.103,0.042,0.132,0.523,Mild increase (p=0.007),Variable effect (p=0.039),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08382,rs178921,9,187005390,CD2AP,SNP (A/T),(A/,A,0.82,0.45,1.19,0.02382395,Moderate,0.283,0.362,0.066,0.088,Mild increase (p=0.008),Mild increase (p=0.003),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP08383,rs183688,21,115502350,EPHA1,Insertion,-,-,0.94,0.64,1.17,0.0107691,Low,0.719,0.014,0.058,0.009,Significant decrease (p=0.035),Variable effect (p=0.038),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08384,rs961257,12,179441066,MS4A6A,Insertion,-,-,0.68,0.45,1.04,0.00570955,Low,0.022,0.57,0.052,0.155,Significant increase (p=0.025),Significant increase (p=0.015),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08385,rs479814,7,38264482,TREM2,Deletion,-,-,0.77,0.52,0.97,0.02689831,Low,0.057,0.352,0.196,0.195,Significant decrease (p=0.009),Variable effect (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08386,rs114527,11,207854015,PICALM,SNP (A/T),(A/,A,0.84,0.54,1.12,0.05609463,High,0.328,0.071,0.243,0.158,Variable effect (p=0.039),Variable effect (p=0.002),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08387,rs842751,4,155405595,CD2AP,SNP (C/T),(C/,C,1.38,1.08,1.65,0.04272851,Moderate,0.012,0.31,0.24,0.238,Significant increase (p=0.05),Significant increase (p=0.034),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08388,rs895118,19,104205458,CD2AP,SNP (A/C),(A/,A,1.56,1.32,1.93,0.0316712,Moderate,0.229,0.171,0.131,0.269,Mild increase (p=0.044),Mild increase (p=0.01),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08389,rs909764,19,170137353,CLU,SNP (C/G),(C/,C,1.77,1.38,2.11,0.0028835,Low,0.031,0.139,0.127,0.503,Significant increase (p=0.034),Variable effect (p=0.001),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08390,rs458654,8,78448689,PICALM,Insertion,-,-,0.77,0.55,1.03,0.01160036,High,0.034,0.327,0.076,0.363,Mild increase (p=0.032),No significant pattern (p=0.002),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP08391,rs931254,6,91925592,CR1,SNP (C/T),(C/,C,0.84,0.48,1.12,0.00856036,Moderate,0.208,0.183,0.141,0.268,Variable effect (p=0.011),Significant increase (p=0.049),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP08392,rs537825,18,110025319,PTK2B,SNP (A/G),(A/,A,0.88,0.54,1.1,0.02984928,Moderate,0.298,0.029,0.295,0.178,Mild decrease (p=0.046),No significant pattern (p=0.028),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08393,rs578534,19,73474282,SORL1,Insertion,-,-,0.51,0.19,0.75,0.008353,Protective,0.228,0.34,0.047,0.185,Mild decrease (p=0.033),Variable effect (p=0.025),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08394,rs703016,2,129454444,PSEN2,Deletion,-,-,2.03,1.7,2.3,0.01561691,Moderate,0.137,0.383,0.225,0.055,Variable effect (p=0.01),Variable effect (p=0.046),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP08395,rs919026,2,165835052,CD2AP,SNP (A/G),(A/,A,0.99,0.63,1.31,0.01448516,High,0.128,0.27,0.327,0.075,Mild decrease (p=0.014),No significant pattern (p=0.05),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08396,rs283697,1,72811021,CD33,SNP (C/G),(C/,C,1.87,1.61,2.15,0.0476653,High,0.192,0.222,0.136,0.25,Mild decrease (p=0.012),Significant increase (p=0.02),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08397,rs363732,6,51254073,CD33,SNP (C/G),(C/,C,0.4,0.1,0.76,0.02858579,Moderate,0.305,0.289,0.18,0.026,Significant decrease (p=0.005),Significant increase (p=0.014),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08398,rs571657,5,30606507,CD2AP,SNP (A/C),(A/,A,2.18,1.91,2.58,0.01639908,Protective,0.123,0.051,0.273,0.353,Significant decrease (p=0.028),Mild decrease (p=0.027),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08399,rs991697,7,248946112,PSEN2,Insertion,-,-,1.39,1.12,1.73,0.03494513,High,0.321,0.34,0.054,0.085,Significant increase (p=0.006),No significant pattern (p=0.043),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08400,rs333706,7,234844942,PTK2B,SNP (C/G),(C/,C,0.43,0.1,0.71,0.12033399,High,0.283,0.049,0.425,0.043,Variable effect (p=0.006),No significant pattern (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08401,rs131881,1,148725286,EPHA1,Deletion,-,-,1.22,1.0,1.59,7.252e-05,Protective,0.339,0.346,0.096,0.019,Mild decrease (p=0.01),Variable effect (p=0.046),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP08402,rs530900,19,187223142,MS4A6A,Insertion,-,-,0.34,0.1,0.55,0.00231479,High,0.253,0.078,0.275,0.194,Mild decrease (p=0.015),No significant pattern (p=0.02),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08403,rs795950,5,162902392,EPHA1,SNP (C/T),(C/,C,0.59,0.26,0.96,0.00615179,High,0.128,0.111,0.254,0.306,No significant pattern (p=0.019),Variable effect (p=0.038),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08404,rs619116,3,143780515,APP,SNP (G/T),(G/,G,1.07,0.74,1.38,0.01756187,Moderate,0.14,0.504,0.124,0.032,Significant decrease (p=0.048),Mild increase (p=0.035),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08405,rs423315,18,212221150,PSEN2,SNP (C/T),(C/,C,0.83,0.62,1.14,0.015932,High,0.395,0.076,0.002,0.327,No significant pattern (p=0.044),No significant pattern (p=0.009),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08406,rs608342,19,204479288,CD2AP,Deletion,-,-,0.41,0.19,0.67,0.05421424,High,0.148,0.216,0.056,0.38,No significant pattern (p=0.042),Significant decrease (p=0.013),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08407,rs609082,9,39116454,PTK2B,SNP (A/T),(A/,A,1.06,0.7,1.34,0.01816115,Moderate,0.14,0.397,0.081,0.182,Significant increase (p=0.037),Mild decrease (p=0.022),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08408,rs615990,1,21198716,CD33,SNP (A/C),(A/,A,1.01,0.65,1.28,0.00723676,High,0.019,0.253,0.288,0.24,Mild decrease (p=0.016),No significant pattern (p=0.05),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP08409,rs510186,8,6441772,CLU,SNP (A/T),(A/,A,0.98,0.61,1.28,0.04808203,High,0.283,0.12,0.316,0.081,Significant increase (p=0.031),Significant increase (p=0.031),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08410,rs643683,4,103433498,CD2AP,Insertion,-,-,0.29,0.1,0.6,0.01881471,High,0.287,0.045,0.074,0.393,Variable effect (p=0.05),No significant pattern (p=0.005),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08411,rs186885,12,75671266,PTK2B,SNP (G/T),(G/,G,1.14,0.86,1.4,0.00778091,High,0.031,0.122,0.463,0.184,Significant decrease (p=0.021),Mild increase (p=0.018),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP08412,rs903813,10,21115202,PSEN2,SNP (G/T),(G/,G,1.73,1.49,2.09,0.08711041,High,0.054,0.169,0.006,0.571,No significant pattern (p=0.048),Mild decrease (p=0.028),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08413,rs141976,4,150116769,TREM2,SNP (A/T),(A/,A,1.06,0.85,1.45,0.00917917,Moderate,0.248,0.054,0.375,0.123,No significant pattern (p=0.04),No significant pattern (p=0.034),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08414,rs542655,16,230229533,PTK2B,SNP (C/T),(C/,C,1.84,1.51,2.18,0.00946373,Low,0.101,0.124,0.284,0.291,Mild increase (p=0.044),Variable effect (p=0.044),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08415,rs626994,16,83436532,CD33,Insertion,-,-,0.39,0.12,0.67,0.04586932,High,0.062,0.577,0.134,0.026,No significant pattern (p=0.001),No significant pattern (p=0.009),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08416,rs998807,9,124964453,PICALM,SNP (A/G),(A/,A,1.08,0.88,1.34,0.00545597,Moderate,0.363,0.056,0.144,0.237,Significant decrease (p=0.031),Mild decrease (p=0.002),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP08417,rs169968,3,156512415,CD2AP,SNP (A/G),(A/,A,1.4,1.18,1.64,0.04670823,Low,0.02,0.135,0.312,0.332,Significant decrease (p=0.016),Variable effect (p=0.024),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08418,rs771569,5,211702065,EPHA1,SNP (A/C),(A/,A,1.17,0.81,1.54,0.00700154,Moderate,0.047,0.456,0.096,0.202,Significant decrease (p=0.039),Variable effect (p=0.019),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08419,rs786892,14,96708996,PTK2B,SNP (A/C),(A/,A,1.75,1.43,1.95,0.03798539,Moderate,0.288,0.275,0.146,0.091,Significant decrease (p=0.015),Significant increase (p=0.012),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08420,rs294691,18,101539966,APOE,SNP (A/C),(A/,A,0.57,0.36,0.91,0.03080838,Moderate,0.113,0.012,0.294,0.381,Significant increase (p=0.038),Mild decrease (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP08421,rs741567,12,101005340,MS4A6A,SNP (C/G),(C/,C,0.58,0.22,0.79,0.00969047,Unknown,0.55,0.105,0.098,0.046,Variable effect (p=0.029),No significant pattern (p=0.024),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP08422,rs112227,22,226138015,APOE,SNP (C/T),(C/,C,1.03,0.67,1.36,0.0921542,High,0.097,0.556,0.005,0.142,Significant increase (p=0.026),Mild increase (p=0.028),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08423,rs742460,4,50055563,CLU,SNP (A/T),(A/,A,1.35,1.1,1.75,0.01203636,Moderate,0.197,0.038,0.304,0.261,No significant pattern (p=0.046),Significant decrease (p=0.037),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08424,rs510281,1,38821079,CLU,SNP (A/T),(A/,A,0.51,0.22,0.9,0.03241755,High,0.298,0.45,0.033,0.018,Variable effect (p=0.029),Variable effect (p=0.029),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08425,rs553937,21,211232362,PSEN2,SNP (A/C),(A/,A,0.31,0.1,0.56,0.0137855,Moderate,0.28,0.205,0.011,0.305,Significant increase (p=0.039),Significant decrease (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08426,rs632249,6,193476766,APOE,SNP (A/C),(A/,A,0.85,0.64,1.22,0.00239785,Protective,0.029,0.157,0.456,0.158,No significant pattern (p=0.023),No significant pattern (p=0.039),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08427,rs681494,4,185816741,APOE,SNP (A/C),(A/,A,1.35,1.09,1.56,0.0195735,Low,0.696,0.043,0.013,0.048,Mild decrease (p=0.017),Mild decrease (p=0.041),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08428,rs467423,12,120984021,EPHA1,SNP (A/G),(A/,A,1.06,0.72,1.35,0.06446276,Moderate,0.079,0.511,0.003,0.208,Significant decrease (p=0.033),Significant increase (p=0.023),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08429,rs893149,9,222754139,APP,SNP (C/G),(C/,C,1.06,0.7,1.28,0.01684204,Unknown,0.051,0.094,0.247,0.409,Significant increase (p=0.023),Variable effect (p=0.028),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08430,rs576605,15,176259282,CLU,SNP (C/G),(C/,C,0.74,0.39,1.05,0.00439332,Moderate,0.503,0.118,0.042,0.137,Mild increase (p=0.034),Significant increase (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08431,rs508139,9,159684213,APP,SNP (C/T),(C/,C,0.48,0.16,0.78,0.09864824,Low,0.22,0.032,0.426,0.122,No significant pattern (p=0.029),No significant pattern (p=0.013),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08432,rs713486,22,94465433,EPHA1,SNP (A/G),(A/,A,0.39,0.1,0.76,0.05623917,Moderate,0.328,0.097,0.33,0.045,Significant increase (p=0.001),Mild decrease (p=0.014),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08433,rs104073,10,142572240,CD2AP,SNP (A/T),(A/,A,1.05,0.68,1.33,0.05990605,Protective,0.321,0.33,0.11,0.038,Mild decrease (p=0.016),Mild increase (p=0.007),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08434,rs495599,20,188912847,APOE,SNP (G/T),(G/,G,0.7,0.33,0.9,0.05861452,Moderate,0.251,0.189,0.234,0.126,Significant decrease (p=0.049),No significant pattern (p=0.005),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08435,rs875588,11,232522152,APP,Insertion,-,-,0.78,0.5,1.0,0.00774019,Protective,0.475,0.113,0.21,0.002,Significant decrease (p=0.018),No significant pattern (p=0.015),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08436,rs657928,20,66221771,BIN1,SNP (C/G),(C/,C,2.28,2.06,2.59,0.04239615,Moderate,0.443,0.146,0.15,0.062,Mild increase (p=0.015),Significant increase (p=0.009),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP08437,rs930267,21,146318969,PTK2B,SNP (G/T),(G/,G,0.67,0.33,0.95,0.01209017,Low,0.065,0.216,0.517,0.003,Mild increase (p=0.002),Significant decrease (p=0.008),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08438,rs372479,20,69538004,ABCA7,SNP (C/G),(C/,C,0.46,0.17,0.67,0.01310316,Low,0.173,0.072,0.25,0.305,Significant decrease (p=0.024),Mild decrease (p=0.033),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP08439,rs872657,22,100340102,PSEN2,SNP (A/T),(A/,A,0.53,0.29,0.76,0.01565737,Low,0.172,0.22,0.104,0.304,No significant pattern (p=0.021),Variable effect (p=0.045),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08440,rs182191,19,214015604,CLU,SNP (C/G),(C/,C,1.33,1.01,1.56,0.04531709,Moderate,0.228,0.043,0.241,0.288,Mild decrease (p=0.013),Variable effect (p=0.024),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08441,rs752257,20,52313542,APOE,SNP (C/G),(C/,C,1.41,1.09,1.69,0.03491599,Moderate,0.087,0.128,0.321,0.265,Mild increase (p=0.028),Variable effect (p=0.021),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08442,rs304718,12,47582917,MS4A6A,SNP (C/G),(C/,C,0.68,0.47,1.06,0.0198097,Moderate,0.293,0.108,0.161,0.238,Significant increase (p=0.021),Significant increase (p=0.014),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08443,rs720363,6,234491366,ABCA7,SNP (C/T),(C/,C,1.29,1.01,1.51,0.16249421,High,0.089,0.249,0.021,0.441,Variable effect (p=0.027),No significant pattern (p=0.009),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08444,rs190274,9,186837170,APOE,SNP (G/T),(G/,G,0.77,0.37,1.15,0.01243232,High,0.407,0.325,0.039,0.029,No significant pattern (p=0.04),Significant increase (p=0.023),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08445,rs944100,14,25242570,PICALM,SNP (G/T),(G/,G,1.24,0.87,1.5,0.00651477,Moderate,0.353,0.254,0.108,0.085,Significant decrease (p=0.021),Variable effect (p=0.035),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP08446,rs141018,5,129738181,PSEN2,SNP (C/T),(C/,C,1.17,0.86,1.38,0.01788625,High,0.187,0.001,0.405,0.207,Variable effect (p=0.043),Variable effect (p=0.02),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08447,rs925395,20,136022278,APP,SNP (G/T),(G/,G,2.19,1.87,2.49,0.02088449,Low,0.014,0.014,0.379,0.394,Mild increase (p=0.039),Significant decrease (p=0.007),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08448,rs468650,21,66906491,CR1,SNP (A/G),(A/,A,0.76,0.56,0.99,0.02648725,Protective,0.137,0.201,0.369,0.092,Significant increase (p=0.028),No significant pattern (p=0.034),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08449,rs311681,19,51860991,CR1,SNP (C/G),(C/,C,0.68,0.42,0.92,0.00386022,Moderate,0.437,0.331,0.027,0.004,Significant decrease (p=0.012),Mild decrease (p=0.001),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08450,rs963122,19,24361477,PSEN2,SNP (A/T),(A/,A,1.22,0.91,1.59,0.0154418,Moderate,0.002,0.081,0.318,0.399,Significant increase (p=0.007),Mild decrease (p=0.012),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08451,rs982351,11,164862765,PSEN2,SNP (G/T),(G/,G,1.8,1.4,2.13,0.02095492,Moderate,0.142,0.269,0.181,0.207,Variable effect (p=0.01),Mild decrease (p=0.015),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08452,rs191324,14,24766903,CD2AP,SNP (C/G),(C/,C,2.17,1.82,2.41,0.00714284,Moderate,0.009,0.446,0.158,0.187,Mild decrease (p=0.027),No significant pattern (p=0.007),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08453,rs837581,17,111133763,ABCA7,SNP (A/C),(A/,A,1.73,1.42,1.95,0.10751123,High,0.185,0.412,0.184,0.019,Mild decrease (p=0.004),Mild increase (p=0.036),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08454,rs841665,5,174005453,EPHA1,SNP (A/T),(A/,A,1.67,1.37,1.89,0.00361721,High,0.028,0.325,0.011,0.436,Variable effect (p=0.013),No significant pattern (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08455,rs769035,4,12145478,ABCA7,SNP (C/G),(C/,C,0.75,0.4,1.13,0.03204655,Low,0.19,0.048,0.409,0.153,Mild decrease (p=0.045),Significant decrease (p=0.015),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08456,rs732584,3,52400139,CR1,Insertion,-,-,0.44,0.17,0.76,0.00395145,Moderate,0.212,0.33,0.018,0.24,Variable effect (p=0.009),Significant increase (p=0.004),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08457,rs130293,1,124111803,PTK2B,SNP (A/G),(A/,A,1.94,1.65,2.16,0.00427278,Moderate,0.27,0.042,0.319,0.169,Variable effect (p=0.039),Significant decrease (p=0.024),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08458,rs562374,7,97846594,ABCA7,SNP (A/C),(A/,A,0.79,0.52,1.12,0.03051331,Protective,0.566,0.104,0.079,0.051,No significant pattern (p=0.008),Significant decrease (p=0.023),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP08459,rs820992,18,109517867,SORL1,Deletion,-,-,0.32,0.1,0.55,0.07762063,Moderate,0.178,0.105,0.279,0.239,No significant pattern (p=0.049),Significant increase (p=0.025),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08460,rs500339,4,220490683,PTK2B,SNP (G/T),(G/,G,1.71,1.36,1.91,0.0018465,Protective,0.503,0.095,0.087,0.115,Mild decrease (p=0.009),Variable effect (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08461,rs477930,19,87973487,CD2AP,Insertion,-,-,1.58,1.34,1.86,0.00741883,Moderate,0.343,0.143,0.182,0.132,Significant decrease (p=0.008),Mild decrease (p=0.047),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08462,rs702487,21,120402894,APP,Insertion,-,-,1.25,1.02,1.65,0.02136818,Low,0.004,0.279,0.156,0.36,Significant increase (p=0.014),No significant pattern (p=0.016),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08463,rs667797,13,191370623,SORL1,SNP (A/T),(A/,A,0.64,0.36,0.85,0.10725104,High,0.188,0.135,0.427,0.05,Significant increase (p=0.019),Significant decrease (p=0.011),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08464,rs250920,1,200397126,APP,Insertion,-,-,1.28,0.96,1.67,0.04757879,Low,0.197,0.039,0.537,0.027,Significant increase (p=0.044),Significant decrease (p=0.044),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08465,rs417259,15,192209892,CD33,SNP (A/T),(A/,A,0.51,0.28,0.85,0.01798441,Unknown,0.259,0.05,0.175,0.317,Significant decrease (p=0.03),Significant increase (p=0.048),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08466,rs970590,2,97152624,APOE,SNP (C/G),(C/,C,1.12,0.78,1.44,0.01349713,Low,0.001,0.157,0.632,0.01,Variable effect (p=0.039),Mild increase (p=0.026),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08467,rs575362,22,156905218,MS4A6A,Deletion,-,-,0.57,0.33,0.82,0.00557506,Low,0.07,0.169,0.415,0.146,Significant increase (p=0.016),Variable effect (p=0.013),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08468,rs997547,14,206177563,PTK2B,SNP (A/G),(A/,A,0.61,0.26,0.95,0.00429534,Moderate,0.186,0.057,0.01,0.548,Mild increase (p=0.024),No significant pattern (p=0.034),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08469,rs630272,10,90322031,TREM2,SNP (A/C),(A/,A,0.72,0.48,1.1,0.00741226,Moderate,0.159,0.022,0.437,0.182,Significant increase (p=0.017),Mild decrease (p=0.029),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08470,rs543641,10,104185568,APP,SNP (G/T),(G/,G,0.4,0.2,0.71,0.01255096,Protective,0.213,0.252,0.134,0.201,Variable effect (p=0.021),Variable effect (p=0.018),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08471,rs110553,22,38563066,BIN1,SNP (C/T),(C/,C,0.68,0.3,0.93,0.0029912,Moderate,0.004,0.426,0.109,0.261,Significant increase (p=0.013),No significant pattern (p=0.026),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08472,rs816684,16,217237784,ABCA7,Deletion,-,-,0.8,0.43,1.03,0.00043887,Moderate,0.31,0.206,0.196,0.088,No significant pattern (p=0.018),No significant pattern (p=0.049),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08473,rs286439,9,24579349,PICALM,Insertion,-,-,0.35,0.14,0.72,0.01050161,Moderate,0.008,0.695,0.089,0.009,Mild decrease (p=0.041),Mild increase (p=0.037),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP08474,rs997132,1,146224368,MS4A6A,SNP (C/T),(C/,C,0.92,0.64,1.27,0.01275464,High,0.256,0.146,0.293,0.104,Mild decrease (p=0.026),Significant increase (p=0.033),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP08475,rs716775,4,52366831,CD2AP,SNP (A/C),(A/,A,0.91,0.64,1.14,0.08654409,High,0.014,0.089,0.128,0.568,Significant decrease (p=0.023),Mild decrease (p=0.046),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08476,rs143898,17,55940516,PTK2B,SNP (A/T),(A/,A,0.42,0.22,0.65,0.00486879,High,0.192,0.021,0.173,0.414,Mild decrease (p=0.039),Significant decrease (p=0.002),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08477,rs997523,9,25587783,CR1,SNP (A/C),(A/,A,0.44,0.15,0.69,0.02294746,Moderate,0.333,0.352,0.084,0.032,Mild increase (p=0.033),No significant pattern (p=0.033),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08478,rs459996,20,75934066,APOE,SNP (A/G),(A/,A,0.76,0.54,1.01,0.06494493,Moderate,0.329,0.109,0.246,0.116,Significant decrease (p=0.048),Mild decrease (p=0.021),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08479,rs127134,21,72732760,APP,SNP (A/C),(A/,A,2.12,1.86,2.47,0.07740818,Moderate,0.248,0.212,0.027,0.313,Mild decrease (p=0.005),Significant decrease (p=0.023),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP08480,rs368602,10,212766836,SORL1,SNP (C/T),(C/,C,0.59,0.3,0.95,0.00934356,High,0.218,0.183,0.387,0.011,Mild increase (p=0.019),Mild decrease (p=0.048),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08481,rs985251,16,212569954,TREM2,SNP (A/G),(A/,A,0.64,0.28,1.03,0.0643787,Low,0.407,0.078,0.313,0.001,Mild increase (p=0.018),Variable effect (p=0.025),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08482,rs443257,6,79612558,PTK2B,Deletion,-,-,0.77,0.5,1.0,0.00330493,Moderate,0.025,0.028,0.658,0.089,Mild increase (p=0.036),Mild decrease (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08483,rs471539,17,34745748,BIN1,SNP (C/G),(C/,C,0.76,0.43,0.97,0.00969598,Moderate,0.284,0.082,0.147,0.287,Significant decrease (p=0.01),No significant pattern (p=0.003),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP08484,rs207038,20,191139246,PICALM,SNP (C/T),(C/,C,0.74,0.45,1.11,0.00328226,Low,0.412,0.032,0.117,0.239,Variable effect (p=0.026),Significant increase (p=0.007),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08485,rs380829,6,47487803,PICALM,Insertion,-,-,1.85,1.48,2.07,0.00528784,Moderate,0.515,0.036,0.166,0.083,No significant pattern (p=0.025),No significant pattern (p=0.026),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08486,rs511622,21,185343442,PTK2B,SNP (C/G),(C/,C,0.54,0.21,0.81,0.00335969,Low,0.324,0.12,0.312,0.044,Mild increase (p=0.036),Variable effect (p=0.027),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08487,rs635845,14,5235350,EPHA1,Insertion,-,-,0.9,0.55,1.25,0.01501023,Unknown,0.237,0.079,0.368,0.117,Mild increase (p=0.028),Variable effect (p=0.004),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP08488,rs281726,16,65259189,CD33,SNP (A/T),(A/,A,0.91,0.52,1.26,0.03487758,High,0.2,0.474,0.086,0.04,Significant increase (p=0.028),Mild decrease (p=0.043),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08489,rs997982,13,105599175,SORL1,SNP (G/T),(G/,G,2.14,1.86,2.36,0.13027931,Moderate,0.105,0.204,0.31,0.181,Mild increase (p=0.009),Significant decrease (p=0.001),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08490,rs899713,7,6705348,ABCA7,Insertion,-,-,0.95,0.59,1.18,0.01861424,High,0.327,0.021,0.154,0.298,Variable effect (p=0.024),Significant increase (p=0.004),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08491,rs876236,2,20532805,APOE,SNP (A/C),(A/,A,0.84,0.57,1.19,0.03825579,High,0.592,0.128,0.01,0.071,Variable effect (p=0.044),Variable effect (p=0.002),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08492,rs872355,6,134542917,MS4A6A,Deletion,-,-,0.75,0.52,1.05,0.05160202,High,0.032,0.272,0.007,0.489,No significant pattern (p=0.017),Significant decrease (p=0.028),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08493,rs763068,7,10940652,CD33,SNP (A/T),(A/,A,0.76,0.46,1.02,0.01116522,Protective,0.106,0.252,0.078,0.363,Variable effect (p=0.014),Mild increase (p=0.045),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08494,rs138401,8,180342870,BIN1,SNP (A/G),(A/,A,1.68,1.34,1.91,0.07166497,Moderate,0.138,0.048,0.469,0.144,Significant increase (p=0.035),Variable effect (p=0.025),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08495,rs732911,22,161497836,CD2AP,Deletion,-,-,1.51,1.22,1.87,0.01178769,Moderate,0.092,0.202,0.135,0.372,Mild decrease (p=0.008),Mild decrease (p=0.001),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08496,rs502810,2,153990026,APP,Insertion,-,-,0.81,0.45,1.07,0.05208537,High,0.087,0.245,0.094,0.374,Significant increase (p=0.045),No significant pattern (p=0.01),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08497,rs944448,15,209831370,BIN1,SNP (A/T),(A/,A,0.68,0.35,0.89,0.00225581,Protective,0.689,0.031,0.06,0.019,Mild decrease (p=0.025),Significant decrease (p=0.031),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08498,rs415764,4,84642930,CD33,Insertion,-,-,0.54,0.17,0.76,0.02270145,High,0.251,0.174,0.353,0.022,Mild increase (p=0.021),No significant pattern (p=0.036),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08499,rs193655,22,229537370,APOE,SNP (A/T),(A/,A,1.03,0.67,1.34,0.00220424,High,0.027,0.425,0.025,0.323,Variable effect (p=0.019),Mild decrease (p=0.017),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP08500,rs662381,9,81096349,BIN1,SNP (A/G),(A/,A,0.9,0.6,1.27,0.09168345,Moderate,0.234,0.039,0.152,0.375,Mild increase (p=0.03),Significant decrease (p=0.028),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08501,rs680067,13,46938272,APP,SNP (A/C),(A/,A,0.96,0.61,1.25,0.03884457,Low,0.168,0.292,0.211,0.129,Significant increase (p=0.04),No significant pattern (p=0.019),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08502,rs604080,4,236675885,CD2AP,SNP (A/G),(A/,A,0.57,0.21,0.88,0.00048187,Moderate,0.179,0.254,0.238,0.13,No significant pattern (p=0.02),Variable effect (p=0.043),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08503,rs858815,3,161330477,TREM2,SNP (A/T),(A/,A,0.93,0.61,1.23,0.00255397,Moderate,0.109,0.31,0.022,0.359,Significant increase (p=0.034),Significant increase (p=0.022),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08504,rs437576,18,243145222,TREM2,SNP (C/T),(C/,C,0.86,0.62,1.09,0.04715626,High,0.01,0.255,0.185,0.35,Mild increase (p=0.029),Mild increase (p=0.045),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08505,rs545472,1,107082822,ABCA7,Insertion,-,-,1.03,0.74,1.33,0.10316933,Moderate,0.354,0.311,0.096,0.039,Mild decrease (p=0.05),Mild increase (p=0.01),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08506,rs263455,7,136785590,APOE,SNP (A/C),(A/,A,1.61,1.3,1.97,0.06774191,Protective,0.278,0.209,0.048,0.265,Mild decrease (p=0.003),Mild increase (p=0.048),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP08507,rs147639,12,185426130,PTK2B,SNP (C/G),(C/,C,0.96,0.58,1.31,0.01656455,Moderate,0.484,0.136,0.004,0.176,Mild decrease (p=0.044),No significant pattern (p=0.032),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08508,rs274788,16,82422985,CLU,Insertion,-,-,0.92,0.59,1.18,0.01064556,Moderate,0.527,0.031,0.088,0.154,No significant pattern (p=0.002),Mild decrease (p=0.035),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08509,rs846016,16,33809629,CD2AP,Insertion,-,-,3.08,2.69,3.32,0.09031485,Moderate,0.276,0.024,0.468,0.031,No significant pattern (p=0.041),Mild increase (p=0.042),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08510,rs702130,1,124540075,CD2AP,SNP (A/T),(A/,A,1.63,1.26,1.86,0.01664863,Protective,0.224,0.04,0.047,0.489,Variable effect (p=0.033),Mild decrease (p=0.024),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08511,rs504701,5,89507740,PTK2B,SNP (A/T),(A/,A,1.14,0.94,1.51,0.03575472,Low,0.024,0.115,0.263,0.399,Variable effect (p=0.013),Mild increase (p=0.005),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08512,rs476190,21,162449472,PSEN2,SNP (A/G),(A/,A,0.81,0.57,1.11,0.05847657,Low,0.737,0.013,0.001,0.049,Significant decrease (p=0.043),Variable effect (p=0.018),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08513,rs990375,3,211245731,APP,SNP (A/T),(A/,A,1.62,1.24,1.95,0.00565904,Moderate,0.007,0.535,0.06,0.199,Significant decrease (p=0.044),Mild increase (p=0.003),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08514,rs890076,7,243200663,CR1,SNP (G/T),(G/,G,1.18,0.98,1.39,0.00175014,High,0.163,0.403,0.053,0.182,Mild decrease (p=0.039),Mild decrease (p=0.043),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP08515,rs736527,3,79823757,BIN1,SNP (G/T),(G/,G,1.44,1.04,1.71,0.07104047,High,0.226,0.305,0.153,0.115,Significant increase (p=0.048),Mild increase (p=0.013),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08516,rs829386,5,225239166,PSEN2,Deletion,-,-,0.29,0.1,0.55,0.00546226,High,0.179,0.228,0.094,0.3,Significant increase (p=0.014),Significant increase (p=0.028),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP08517,rs352809,13,106243527,APP,SNP (G/T),(G/,G,2.27,1.95,2.57,0.00350979,High,0.304,0.136,0.327,0.033,Significant increase (p=0.037),Significant increase (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP08518,rs742175,7,240565058,APOE,SNP (A/C),(A/,A,0.51,0.28,0.74,0.00736617,Moderate,0.051,0.219,0.281,0.25,Significant decrease (p=0.032),Significant increase (p=0.027),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08519,rs229156,20,19358567,MS4A6A,SNP (A/T),(A/,A,0.65,0.28,0.94,0.02703392,High,0.408,0.057,0.209,0.126,No significant pattern (p=0.009),No significant pattern (p=0.014),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08520,rs376767,16,78029256,EPHA1,SNP (G/T),(G/,G,0.41,0.21,0.63,0.03510685,Low,0.145,0.153,0.476,0.026,No significant pattern (p=0.007),Variable effect (p=0.021),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08521,rs615969,18,238805279,APOE,SNP (A/T),(A/,A,0.73,0.38,1.04,0.01855452,High,0.006,0.447,0.328,0.019,No significant pattern (p=0.002),Variable effect (p=0.012),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08522,rs674007,21,183723500,PSEN2,SNP (A/C),(A/,A,0.72,0.46,1.06,0.0325562,Moderate,0.067,0.312,0.021,0.4,Variable effect (p=0.036),Mild increase (p=0.034),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08523,rs279911,6,232382759,TREM2,SNP (C/T),(C/,C,0.82,0.59,1.08,0.01587324,High,0.239,0.134,0.066,0.361,Significant decrease (p=0.006),Mild increase (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08524,rs536353,14,96841820,PSEN2,Deletion,-,-,2.73,2.46,3.01,0.00066419,High,0.245,0.199,0.138,0.217,Mild decrease (p=0.047),No significant pattern (p=0.046),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08525,rs305117,7,29130358,PICALM,SNP (A/T),(A/,A,1.11,0.8,1.45,0.02511783,Unknown,0.472,0.07,0.11,0.148,Mild decrease (p=0.016),Mild decrease (p=0.033),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08526,rs164226,10,203237058,ABCA7,Insertion,-,-,0.93,0.66,1.31,0.01985565,High,0.463,0.164,0.011,0.162,Mild decrease (p=0.037),No significant pattern (p=0.003),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP08527,rs867076,22,222225010,CR1,SNP (G/T),(G/,G,0.57,0.34,0.78,0.06539285,High,0.027,0.016,0.107,0.65,Mild decrease (p=0.031),Mild decrease (p=0.017),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP08528,rs894004,10,228527412,ABCA7,SNP (C/T),(C/,C,0.92,0.56,1.21,0.00556803,Moderate,0.197,0.167,0.292,0.144,No significant pattern (p=0.01),Significant increase (p=0.011),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08529,rs250222,14,68539796,APP,SNP (A/C),(A/,A,0.68,0.3,0.98,0.04410751,High,0.052,0.386,0.051,0.311,No significant pattern (p=0.043),Mild decrease (p=0.037),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08530,rs217932,8,30383283,CD2AP,SNP (C/G),(C/,C,0.92,0.68,1.18,0.00926173,Moderate,0.439,0.036,0.263,0.063,Variable effect (p=0.015),Significant increase (p=0.039),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08531,rs106385,2,109485330,TREM2,Insertion,-,-,0.63,0.4,0.83,0.00197138,High,0.153,0.131,0.228,0.287,Significant increase (p=0.022),Mild decrease (p=0.048),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP08532,rs215797,15,23582698,APOE,SNP (A/G),(A/,A,1.52,1.15,1.9,0.0424349,High,0.216,0.429,0.078,0.076,Significant increase (p=0.038),Significant increase (p=0.049),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08533,rs807531,14,89759477,SORL1,SNP (G/T),(G/,G,0.94,0.65,1.24,0.0058808,Moderate,0.183,0.291,0.149,0.177,Significant decrease (p=0.006),Variable effect (p=0.023),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08534,rs546471,2,195244675,APOE,SNP (A/G),(A/,A,1.92,1.59,2.27,0.0502481,Moderate,0.183,0.234,0.31,0.073,Significant decrease (p=0.035),No significant pattern (p=0.024),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08535,rs825358,21,12367088,BIN1,SNP (A/C),(A/,A,4.51,4.29,4.8,0.01252134,High,0.202,0.078,0.128,0.392,Mild decrease (p=0.02),Significant decrease (p=0.039),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08536,rs313994,3,182803523,PSEN2,SNP (A/G),(A/,A,2.1,1.89,2.39,0.00548838,Moderate,0.074,0.46,0.202,0.064,Mild increase (p=0.024),No significant pattern (p=0.046),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08537,rs804816,21,106823839,CR1,SNP (G/T),(G/,G,1.4,1.2,1.66,0.03676782,High,0.298,0.202,0.043,0.257,No significant pattern (p=0.034),Significant increase (p=0.027),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08538,rs626486,5,248288383,CD33,Deletion,-,-,1.11,0.88,1.41,0.06097228,High,0.338,0.041,0.367,0.054,Mild decrease (p=0.047),Mild decrease (p=0.012),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP08539,rs668770,5,211365919,CLU,Insertion,-,-,0.89,0.54,1.26,0.01929105,Moderate,0.084,0.103,0.053,0.559,No significant pattern (p=0.038),Significant decrease (p=0.005),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08540,rs978964,7,147033704,SORL1,SNP (C/G),(C/,C,0.7,0.47,0.94,0.00705495,High,0.031,0.413,0.158,0.197,Mild increase (p=0.04),No significant pattern (p=0.021),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08541,rs587360,21,17321054,APOE,SNP (A/T),(A/,A,1.31,1.11,1.55,0.03522622,High,0.1,0.058,0.509,0.133,No significant pattern (p=0.012),Mild increase (p=0.002),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08542,rs640993,6,121191824,CLU,SNP (G/T),(G/,G,0.81,0.45,1.04,0.01722365,Low,0.06,0.193,0.107,0.44,No significant pattern (p=0.021),Significant decrease (p=0.002),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08543,rs371205,18,242931896,EPHA1,Insertion,-,-,1.2,0.86,1.52,0.00056511,Low,0.105,0.334,0.009,0.352,Significant increase (p=0.038),Mild decrease (p=0.019),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08544,rs405431,9,191500912,EPHA1,SNP (C/T),(C/,C,0.46,0.26,0.86,0.07116959,High,0.443,0.303,0.042,0.012,Significant decrease (p=0.04),Significant increase (p=0.043),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08545,rs962871,6,26214523,PSEN2,SNP (A/T),(A/,A,1.32,1.09,1.63,0.0087019,Moderate,0.3,0.059,0.368,0.072,Variable effect (p=0.048),No significant pattern (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08546,rs871130,12,213909885,CD33,SNP (A/G),(A/,A,1.82,1.58,2.1,0.00938666,Protective,0.439,0.005,0.105,0.251,Mild decrease (p=0.021),Significant decrease (p=0.001),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08547,rs327295,20,15387413,APP,SNP (A/C),(A/,A,1.01,0.7,1.36,0.01177267,High,0.044,0.514,0.199,0.043,No significant pattern (p=0.045),No significant pattern (p=0.04),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08548,rs771917,9,233484447,PTK2B,SNP (C/G),(C/,C,0.68,0.46,0.98,0.00598424,Low,0.029,0.473,0.031,0.268,Mild increase (p=0.031),Mild decrease (p=0.026),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08549,rs847493,1,52342832,MS4A6A,Insertion,-,-,1.86,1.48,2.23,0.00782255,Moderate,0.053,0.59,0.151,0.006,Mild increase (p=0.003),Significant increase (p=0.036),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08550,rs575345,14,40558335,PSEN2,Deletion,-,-,1.02,0.81,1.39,0.00105909,Moderate,0.085,0.253,0.257,0.205,Significant decrease (p=0.018),No significant pattern (p=0.002),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08551,rs378963,22,32984387,CD33,SNP (A/T),(A/,A,1.09,0.79,1.37,0.01527964,High,0.426,0.083,0.135,0.156,Mild decrease (p=0.032),Significant increase (p=0.048),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP08552,rs878706,14,17647086,APOE,SNP (C/T),(C/,C,1.32,1.06,1.59,0.03014067,Low,0.127,0.411,0.194,0.068,No significant pattern (p=0.033),Significant increase (p=0.005),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP08553,rs873734,22,220041840,PTK2B,SNP (C/T),(C/,C,1.57,1.21,1.79,0.0106089,Low,0.136,0.134,0.376,0.154,No significant pattern (p=0.02),Mild increase (p=0.042),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP08554,rs968976,1,146170138,MS4A6A,Insertion,-,-,0.99,0.62,1.25,0.04426754,Protective,0.575,0.095,0.004,0.126,Mild increase (p=0.005),Mild decrease (p=0.042),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08555,rs928509,14,12889494,PSEN2,SNP (G/T),(G/,G,1.29,0.97,1.52,0.01691776,Moderate,0.04,0.29,0.031,0.44,Mild decrease (p=0.003),No significant pattern (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08556,rs110583,16,172765453,PTK2B,Deletion,-,-,1.8,1.57,2.15,0.00798178,Low,0.045,0.035,0.356,0.364,Significant decrease (p=0.034),Mild increase (p=0.013),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP08557,rs503548,3,22352044,TREM2,SNP (A/C),(A/,A,1.28,1.0,1.6,0.02018389,Low,0.013,0.161,0.116,0.51,Mild increase (p=0.016),Mild increase (p=0.01),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08558,rs548430,8,36439820,MS4A6A,Deletion,-,-,1.8,1.54,2.11,0.03023261,Moderate,0.004,0.247,0.014,0.535,Significant increase (p=0.03),Mild decrease (p=0.043),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08559,rs575251,22,61446072,PSEN2,Insertion,-,-,1.42,1.08,1.8,0.052239,Moderate,0.149,0.258,0.055,0.338,Mild decrease (p=0.039),Significant decrease (p=0.004),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08560,rs778535,6,227767262,CD2AP,SNP (C/T),(C/,C,0.95,0.64,1.34,0.0284424,High,0.523,0.099,0.034,0.143,Mild decrease (p=0.013),Variable effect (p=0.043),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08561,rs755747,2,129010199,APP,SNP (G/T),(G/,G,0.72,0.49,0.95,0.17834361,High,0.031,0.126,0.147,0.496,Significant increase (p=0.043),Significant increase (p=0.009),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP08562,rs323439,22,36084821,TREM2,Deletion,-,-,1.9,1.52,2.24,0.08237945,Moderate,0.133,0.221,0.108,0.338,Significant decrease (p=0.04),Mild decrease (p=0.015),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08563,rs288234,3,166850478,TREM2,Deletion,-,-,1.39,1.13,1.74,0.00779539,High,0.292,0.244,0.261,0.003,Mild decrease (p=0.032),Mild increase (p=0.033),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP08564,rs162072,4,72891307,PSEN2,SNP (A/T),(A/,A,0.67,0.28,1.0,0.06660586,High,0.297,0.141,0.321,0.041,Variable effect (p=0.041),Mild decrease (p=0.041),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP08565,rs753352,3,93057865,APP,SNP (C/G),(C/,C,0.81,0.47,1.15,0.04261266,Moderate,0.4,0.091,0.081,0.229,Significant increase (p=0.006),Significant decrease (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08566,rs642494,11,33127877,CD2AP,SNP (A/T),(A/,A,1.35,1.09,1.63,0.01203504,Moderate,0.198,0.189,0.387,0.026,Variable effect (p=0.044),Mild increase (p=0.031),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08567,rs399495,3,36072433,APOE,SNP (C/T),(C/,C,1.63,1.28,1.85,0.02969102,Low,0.294,0.035,0.394,0.076,Variable effect (p=0.041),No significant pattern (p=0.016),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08568,rs852007,16,56239036,PTK2B,SNP (C/G),(C/,C,1.85,1.5,2.08,0.04803751,Moderate,0.428,0.039,0.048,0.286,Variable effect (p=0.018),Variable effect (p=0.045),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08569,rs672455,8,133633729,EPHA1,Deletion,-,-,1.18,0.8,1.43,0.03628177,High,0.418,0.32,0.017,0.045,Variable effect (p=0.046),Significant increase (p=0.04),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP08570,rs266437,13,7717356,BIN1,SNP (A/G),(A/,A,0.47,0.1,0.75,0.03326851,High,0.432,0.141,0.061,0.165,Significant increase (p=0.039),Mild decrease (p=0.023),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08571,rs389544,19,7144056,CLU,SNP (A/C),(A/,A,0.58,0.23,0.96,0.00526146,High,0.094,0.018,0.16,0.528,Variable effect (p=0.04),Mild decrease (p=0.008),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08572,rs734399,20,51131267,PSEN2,SNP (A/T),(A/,A,1.55,1.17,1.89,0.02975946,Moderate,0.38,0.263,0.004,0.152,Mild increase (p=0.036),Variable effect (p=0.048),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08573,rs557038,5,202354058,BIN1,Deletion,-,-,1.18,0.85,1.55,0.03372962,Moderate,0.0,0.201,0.28,0.318,No significant pattern (p=0.039),Mild decrease (p=0.043),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08574,rs269803,3,235971868,BIN1,SNP (A/G),(A/,A,1.81,1.42,2.21,0.12579839,High,0.196,0.18,0.272,0.153,Mild increase (p=0.007),Significant decrease (p=0.012),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP08575,rs605123,1,108174857,EPHA1,SNP (C/G),(C/,C,0.58,0.21,0.88,0.02341488,Low,0.177,0.324,0.1,0.2,No significant pattern (p=0.023),Mild increase (p=0.043),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP08576,rs646677,8,73186199,APOE,SNP (G/T),(G/,G,0.56,0.31,0.84,0.00607981,Low,0.439,0.222,0.122,0.017,Mild increase (p=0.013),Variable effect (p=0.047),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08577,rs544941,9,241984878,EPHA1,Insertion,-,-,1.8,1.47,2.01,0.09290785,High,0.071,0.611,0.018,0.099,No significant pattern (p=0.049),Mild decrease (p=0.017),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08578,rs938087,4,172238855,APP,SNP (A/C),(A/,A,1.16,0.94,1.53,0.00453132,High,0.215,0.041,0.364,0.18,Variable effect (p=0.046),Mild increase (p=0.039),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP08579,rs179604,17,8995758,SORL1,SNP (A/G),(A/,A,0.95,0.68,1.23,0.02030874,Low,0.074,0.605,0.111,0.01,Significant decrease (p=0.013),Significant decrease (p=0.024),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08580,rs773600,1,118606764,CD2AP,SNP (A/C),(A/,A,0.52,0.24,0.76,0.04527495,Low,0.077,0.274,0.168,0.281,Mild increase (p=0.046),No significant pattern (p=0.002),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08581,rs501608,18,189581077,EPHA1,SNP (A/T),(A/,A,1.28,1.07,1.6,0.01138803,High,0.048,0.318,0.32,0.114,Mild increase (p=0.018),Mild decrease (p=0.033),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08582,rs427127,2,17769350,CD2AP,SNP (C/T),(C/,C,3.51,3.18,3.88,0.01977127,Moderate,0.128,0.463,0.001,0.208,Variable effect (p=0.044),Significant increase (p=0.007),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08583,rs840020,19,208463860,PICALM,Insertion,-,-,2.31,1.92,2.53,0.02678221,Unknown,0.164,0.389,0.152,0.096,Mild decrease (p=0.026),Variable effect (p=0.018),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08584,rs606186,5,47998248,CD33,SNP (A/T),(A/,A,1.67,1.45,1.94,0.01347908,High,0.483,0.098,0.145,0.073,Significant decrease (p=0.007),Significant decrease (p=0.031),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08585,rs489133,14,246587621,PTK2B,SNP (G/T),(G/,G,1.18,0.95,1.52,0.03061941,Moderate,0.18,0.012,0.432,0.176,Mild increase (p=0.026),Variable effect (p=0.038),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08586,rs471268,1,187805954,APOE,SNP (G/T),(G/,G,1.86,1.59,2.25,0.02487095,Moderate,0.752,0.033,0.007,0.008,No significant pattern (p=0.012),Mild increase (p=0.004),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08587,rs571684,5,89635557,SORL1,SNP (A/T),(A/,A,0.34,0.1,0.71,0.05244104,Low,0.146,0.022,0.307,0.325,Mild decrease (p=0.013),Significant increase (p=0.023),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08588,rs613495,3,11521476,APP,SNP (G/T),(G/,G,1.04,0.77,1.41,0.00661679,Unknown,0.102,0.082,0.196,0.421,No significant pattern (p=0.041),No significant pattern (p=0.049),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP08589,rs198263,1,248637715,EPHA1,SNP (C/T),(C/,C,1.03,0.65,1.28,0.0498048,Moderate,0.55,0.16,0.086,0.005,Variable effect (p=0.034),No significant pattern (p=0.033),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08590,rs261904,2,106174097,CR1,SNP (C/G),(C/,C,0.66,0.34,0.88,0.02668979,Moderate,0.167,0.036,0.517,0.08,Variable effect (p=0.049),Mild increase (p=0.01),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08591,rs850745,16,14201530,CD2AP,SNP (G/T),(G/,G,1.84,1.5,2.21,0.00341721,High,0.174,0.067,0.324,0.235,Mild increase (p=0.043),Mild increase (p=0.038),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08592,rs154784,6,102471121,CD33,SNP (C/T),(C/,C,0.91,0.55,1.22,0.04670493,High,0.07,0.133,0.014,0.583,Mild decrease (p=0.016),Mild increase (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08593,rs931039,8,118852511,CLU,SNP (G/T),(G/,G,1.03,0.76,1.24,0.01966559,High,0.183,0.392,0.16,0.065,Mild decrease (p=0.035),Mild increase (p=0.045),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08594,rs568368,2,213132343,MS4A6A,SNP (A/C),(A/,A,0.44,0.19,0.68,0.06800685,High,0.219,0.237,0.107,0.237,Significant increase (p=0.048),No significant pattern (p=0.046),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08595,rs964853,11,229460965,EPHA1,SNP (A/T),(A/,A,0.36,0.12,0.59,0.03384593,Moderate,0.068,0.09,0.441,0.201,Significant increase (p=0.022),Mild decrease (p=0.045),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08596,rs460260,10,108484878,PTK2B,Deletion,-,-,0.83,0.45,1.16,0.03557686,Protective,0.171,0.225,0.288,0.116,Mild decrease (p=0.019),Mild decrease (p=0.042),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08597,rs106103,13,14245801,CR1,SNP (G/T),(G/,G,0.92,0.7,1.19,0.02389055,Low,0.039,0.074,0.216,0.471,Mild decrease (p=0.007),Mild decrease (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08598,rs240136,6,206503219,CD33,SNP (G/T),(G/,G,0.54,0.21,0.92,0.05961631,Protective,0.218,0.137,0.231,0.214,Mild decrease (p=0.035),Mild decrease (p=0.044),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08599,rs228911,3,8541771,EPHA1,Insertion,-,-,0.63,0.34,1.01,0.0306949,Low,0.51,0.071,0.027,0.192,No significant pattern (p=0.04),Significant decrease (p=0.041),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08600,rs960717,7,67956032,APP,SNP (G/T),(G/,G,1.76,1.54,2.0,0.0108267,Low,0.224,0.049,0.337,0.191,No significant pattern (p=0.017),Significant increase (p=0.037),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP08601,rs155776,9,219953887,CD33,SNP (A/C),(A/,A,1.14,0.9,1.34,0.13113457,Moderate,0.137,0.174,0.4,0.089,Significant decrease (p=0.012),Mild decrease (p=0.04),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08602,rs354956,22,214642885,MS4A6A,SNP (A/G),(A/,A,0.73,0.44,1.04,0.00202157,High,0.025,0.029,0.311,0.435,Variable effect (p=0.039),Significant increase (p=0.033),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08603,rs757079,2,210693201,CLU,Insertion,-,-,6.26,6.0,6.49,0.05330145,High,0.078,0.278,0.083,0.362,Variable effect (p=0.016),Significant decrease (p=0.029),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08604,rs433190,13,229518214,BIN1,SNP (A/T),(A/,A,1.89,1.64,2.17,0.02850605,Protective,0.381,0.063,0.148,0.208,Variable effect (p=0.02),Variable effect (p=0.029),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08605,rs373180,7,237876131,ABCA7,Insertion,-,-,0.29,0.1,0.51,0.10718047,Low,0.011,0.519,0.08,0.19,Significant decrease (p=0.048),Mild increase (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08606,rs979079,20,151258796,MS4A6A,SNP (G/T),(G/,G,0.83,0.61,1.05,0.02402008,Low,0.028,0.055,0.116,0.601,No significant pattern (p=0.019),Significant decrease (p=0.013),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08607,rs532132,15,63199971,PSEN2,SNP (C/T),(C/,C,0.85,0.61,1.06,0.00430283,Moderate,0.236,0.053,0.001,0.51,Mild decrease (p=0.025),Variable effect (p=0.018),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08608,rs912087,13,215790313,BIN1,SNP (G/T),(G/,G,1.39,1.01,1.73,0.06694379,High,0.228,0.088,0.235,0.249,Mild increase (p=0.026),Mild decrease (p=0.05),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08609,rs500051,15,8678393,SORL1,SNP (C/G),(C/,C,2.33,2.0,2.54,0.00366534,Moderate,0.024,0.279,0.448,0.049,Mild increase (p=0.011),No significant pattern (p=0.049),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08610,rs556664,1,241022088,APOE,SNP (A/T),(A/,A,0.89,0.66,1.16,0.04588188,Low,0.292,0.358,0.086,0.064,Variable effect (p=0.026),Variable effect (p=0.023),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP08611,rs526638,7,97921467,CR1,SNP (C/G),(C/,C,1.1,0.73,1.3,0.08040996,Low,0.071,0.282,0.395,0.052,Variable effect (p=0.029),Variable effect (p=0.049),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP08612,rs644562,11,156048874,CD2AP,SNP (A/T),(A/,A,0.48,0.16,0.74,0.06617519,High,0.544,0.096,0.15,0.01,No significant pattern (p=0.046),Significant decrease (p=0.015),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08613,rs108631,17,145697081,EPHA1,Deletion,-,-,0.68,0.48,1.05,0.02324634,High,0.034,0.362,0.388,0.016,Variable effect (p=0.015),Variable effect (p=0.043),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08614,rs949253,22,200603296,CD33,Deletion,-,-,2.03,1.77,2.29,0.05266239,High,0.079,0.22,0.103,0.398,Significant increase (p=0.048),No significant pattern (p=0.002),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08615,rs156455,17,169828216,CLU,SNP (A/T),(A/,A,1.48,1.21,1.79,0.05551151,High,0.321,0.182,0.134,0.164,No significant pattern (p=0.028),Significant decrease (p=0.044),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08616,rs789371,21,246734770,PICALM,SNP (C/T),(C/,C,0.74,0.35,1.13,0.00931317,Unknown,0.296,0.104,0.246,0.154,Significant increase (p=0.028),Variable effect (p=0.035),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08617,rs138220,22,53120103,PSEN2,SNP (A/C),(A/,A,1.12,0.74,1.41,0.00174167,Moderate,0.314,0.141,0.198,0.148,Mild decrease (p=0.049),No significant pattern (p=0.015),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08618,rs448119,7,107562480,CD2AP,SNP (C/T),(C/,C,1.07,0.8,1.37,0.03816029,High,0.274,0.034,0.164,0.328,No significant pattern (p=0.024),No significant pattern (p=0.035),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP08619,rs135959,17,153320940,CD33,SNP (G/T),(G/,G,0.97,0.64,1.37,0.02866179,Moderate,0.641,0.009,0.026,0.124,Significant decrease (p=0.039),Significant increase (p=0.024),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08620,rs347772,1,59457144,ABCA7,SNP (A/G),(A/,A,1.15,0.83,1.42,0.1784471,Moderate,0.487,0.093,0.22,0.0,Significant decrease (p=0.019),Significant decrease (p=0.033),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08621,rs562923,1,14386562,PICALM,SNP (A/T),(A/,A,1.22,0.92,1.53,0.03779501,Moderate,0.14,0.323,0.16,0.177,Significant increase (p=0.016),Significant decrease (p=0.027),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP08622,rs893235,4,15073255,APP,SNP (A/G),(A/,A,1.03,0.64,1.29,0.05736756,Moderate,0.218,0.409,0.122,0.05,Significant decrease (p=0.037),Significant decrease (p=0.026),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08623,rs225814,10,163261693,CR1,SNP (A/C),(A/,A,0.57,0.32,0.87,0.00819182,High,0.319,0.119,0.209,0.153,Significant increase (p=0.047),Significant increase (p=0.007),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08624,rs671369,9,85868036,PSEN2,SNP (C/T),(C/,C,0.74,0.37,1.04,0.00058208,Low,0.168,0.466,0.165,0.0,Mild increase (p=0.027),No significant pattern (p=0.041),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08625,rs653370,22,211284757,TREM2,SNP (C/G),(C/,C,0.88,0.5,1.19,0.04979109,Low,0.354,0.093,0.1,0.253,Significant increase (p=0.032),Mild decrease (p=0.02),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08626,rs633093,16,171285626,PTK2B,SNP (A/G),(A/,A,0.37,0.1,0.61,0.0021179,Protective,0.04,0.016,0.075,0.669,Significant decrease (p=0.001),No significant pattern (p=0.046),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08627,rs386960,14,215535552,APP,SNP (A/T),(A/,A,1.87,1.52,2.25,0.00603518,Moderate,0.307,0.419,0.031,0.042,Significant increase (p=0.034),Mild decrease (p=0.022),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08628,rs581289,20,243185839,APP,SNP (C/T),(C/,C,0.79,0.54,1.05,0.01124871,High,0.126,0.067,0.42,0.186,Mild increase (p=0.025),Mild increase (p=0.04),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08629,rs545046,5,114089912,BIN1,SNP (C/G),(C/,C,0.72,0.47,1.08,0.05214306,Unknown,0.031,0.186,0.452,0.13,Variable effect (p=0.037),No significant pattern (p=0.013),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08630,rs308484,3,184774350,CLU,SNP (A/C),(A/,A,1.06,0.72,1.37,0.00416197,Unknown,0.082,0.325,0.113,0.279,Mild decrease (p=0.023),Significant increase (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP08631,rs135801,3,137969096,CR1,Deletion,-,-,0.88,0.67,1.26,0.0117593,Low,0.05,0.413,0.235,0.103,Variable effect (p=0.013),Significant decrease (p=0.005),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP08632,rs443880,15,246687217,CR1,SNP (C/T),(C/,C,2.4,2.13,2.73,0.02224795,Unknown,0.261,0.099,0.394,0.045,Significant decrease (p=0.003),Variable effect (p=0.019),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08633,rs885313,20,231478824,BIN1,SNP (G/T),(G/,G,1.75,1.49,2.0,0.12104275,Low,0.056,0.123,0.178,0.443,Significant decrease (p=0.008),No significant pattern (p=0.023),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08634,rs646885,18,76611632,EPHA1,SNP (G/T),(G/,G,0.95,0.69,1.27,0.03826185,Moderate,0.058,0.595,0.059,0.088,No significant pattern (p=0.003),Significant increase (p=0.009),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08635,rs912017,15,29524132,CR1,SNP (A/T),(A/,A,0.78,0.41,1.12,0.009611,Low,0.307,0.022,0.255,0.217,Mild decrease (p=0.016),Significant decrease (p=0.006),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08636,rs990361,7,87631492,EPHA1,SNP (A/C),(A/,A,2.34,2.08,2.74,0.18953182,Protective,0.11,0.452,0.206,0.033,Significant decrease (p=0.023),Variable effect (p=0.002),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08637,rs325916,19,185213631,PTK2B,SNP (C/G),(C/,C,1.2,0.97,1.57,0.07642843,Moderate,0.355,0.155,0.108,0.182,Significant increase (p=0.006),Significant decrease (p=0.024),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08638,rs687648,16,141305066,APOE,SNP (G/T),(G/,G,1.09,0.77,1.32,0.0632969,Low,0.178,0.131,0.379,0.112,Significant decrease (p=0.022),Mild decrease (p=0.022),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP08639,rs194040,13,10010441,CLU,SNP (G/T),(G/,G,1.11,0.75,1.31,0.00680361,Moderate,0.535,0.107,0.046,0.112,No significant pattern (p=0.013),Significant increase (p=0.014),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08640,rs265154,13,164294806,PSEN2,SNP (C/G),(C/,C,0.59,0.3,0.98,0.02483957,Moderate,0.094,0.139,0.236,0.331,Variable effect (p=0.002),Mild decrease (p=0.015),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP08641,rs509160,4,167702849,ABCA7,SNP (C/T),(C/,C,0.77,0.4,1.09,0.04978174,Protective,0.27,0.303,0.188,0.039,Significant increase (p=0.01),Significant decrease (p=0.041),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08642,rs848865,21,207468125,TREM2,SNP (A/C),(A/,A,1.67,1.27,1.9,0.00765748,Protective,0.474,0.092,0.014,0.22,Mild decrease (p=0.043),No significant pattern (p=0.03),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP08643,rs677461,8,179886703,CR1,SNP (C/T),(C/,C,1.26,0.92,1.58,0.05010569,Low,0.527,0.021,0.002,0.249,No significant pattern (p=0.048),Mild increase (p=0.003),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08644,rs573395,20,76929238,APP,SNP (C/G),(C/,C,1.25,1.04,1.54,0.10009525,Moderate,0.016,0.544,0.237,0.003,Significant increase (p=0.01),Significant decrease (p=0.04),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08645,rs646264,1,184690585,TREM2,SNP (C/T),(C/,C,0.67,0.4,0.94,0.01796207,Low,0.007,0.635,0.116,0.042,Mild increase (p=0.044),Mild increase (p=0.02),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08646,rs162096,13,113218032,PTK2B,SNP (C/G),(C/,C,0.97,0.7,1.21,0.03582831,High,0.654,0.012,0.083,0.051,Significant increase (p=0.002),No significant pattern (p=0.039),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08647,rs293507,20,174112289,SORL1,SNP (A/T),(A/,A,1.57,1.34,1.78,0.03315416,High,0.094,0.235,0.241,0.23,Mild decrease (p=0.025),Mild decrease (p=0.026),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08648,rs884764,15,94209007,CLU,SNP (C/G),(C/,C,1.04,0.68,1.29,0.04751813,Moderate,0.066,0.016,0.567,0.151,Significant decrease (p=0.025),Mild increase (p=0.038),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08649,rs347512,20,87020139,EPHA1,Insertion,-,-,0.6,0.4,0.85,0.01054733,Moderate,0.057,0.116,0.19,0.437,Mild increase (p=0.043),Mild decrease (p=0.03),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08650,rs512059,20,65128326,TREM2,SNP (C/T),(C/,C,0.66,0.46,1.05,0.11058441,High,0.015,0.1,0.158,0.527,Mild decrease (p=0.041),Significant increase (p=0.028),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08651,rs442460,20,13807361,SORL1,SNP (A/T),(A/,A,2.57,2.32,2.96,0.0094812,High,0.095,0.255,0.261,0.189,Significant increase (p=0.004),Mild decrease (p=0.025),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08652,rs885802,4,85836854,APP,SNP (G/T),(G/,G,1.4,1.12,1.62,0.02165062,Moderate,0.045,0.109,0.374,0.271,Mild decrease (p=0.029),Significant increase (p=0.004),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP08653,rs860925,21,185389409,APOE,SNP (A/C),(A/,A,0.85,0.58,1.2,0.05505757,High,0.191,0.118,0.092,0.399,Significant increase (p=0.042),Significant increase (p=0.008),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08654,rs377471,11,4051943,APOE,SNP (C/T),(C/,C,0.57,0.26,0.79,0.00947519,Low,0.069,0.241,0.076,0.415,Significant increase (p=0.022),Mild increase (p=0.029),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08655,rs273407,9,113633844,TREM2,SNP (A/G),(A/,A,1.03,0.77,1.39,0.01547349,Moderate,0.094,0.089,0.315,0.302,Mild decrease (p=0.021),Significant decrease (p=0.046),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08656,rs626857,8,228225539,PTK2B,SNP (A/C),(A/,A,2.13,1.86,2.36,0.04223976,Moderate,0.084,0.285,0.063,0.367,Significant decrease (p=0.02),Mild decrease (p=0.039),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08657,rs955789,11,115110307,EPHA1,SNP (C/G),(C/,C,1.09,0.77,1.35,0.07688728,Moderate,0.004,0.237,0.266,0.293,Significant increase (p=0.04),Significant increase (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08658,rs363534,7,96586746,PSEN2,Deletion,-,-,0.78,0.39,1.09,0.07789062,High,0.378,0.06,0.032,0.331,Significant increase (p=0.006),Significant increase (p=0.003),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08659,rs872044,5,72371748,TREM2,SNP (A/G),(A/,A,2.29,1.98,2.6,0.01195818,Low,0.111,0.385,0.21,0.095,Significant decrease (p=0.002),Mild increase (p=0.031),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08660,rs986468,14,216624631,PSEN2,Insertion,-,-,2.05,1.82,2.35,0.03639563,High,0.131,0.155,0.348,0.167,Significant decrease (p=0.045),No significant pattern (p=0.036),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08661,rs304572,14,196907847,BIN1,SNP (A/T),(A/,A,0.82,0.6,1.19,0.00189357,Moderate,0.027,0.056,0.168,0.55,Significant increase (p=0.025),Significant decrease (p=0.004),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08662,rs670841,15,239653743,CLU,Deletion,-,-,0.45,0.1,0.74,0.0040831,High,0.146,0.016,0.263,0.375,Mild increase (p=0.001),Mild decrease (p=0.009),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08663,rs328845,20,4756919,BIN1,SNP (C/G),(C/,C,1.07,0.74,1.45,0.05629496,Unknown,0.424,0.007,0.156,0.212,No significant pattern (p=0.003),Variable effect (p=0.041),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08664,rs350566,20,227775161,CLU,Insertion,-,-,0.77,0.46,0.97,0.03080652,High,0.353,0.224,0.049,0.174,Significant increase (p=0.005),Significant increase (p=0.028),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08665,rs918903,21,16845583,PICALM,SNP (A/T),(A/,A,0.64,0.39,0.91,0.00512151,Low,0.156,0.247,0.174,0.223,Variable effect (p=0.048),Mild decrease (p=0.024),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP08666,rs895719,5,53379901,CD2AP,SNP (A/G),(A/,A,1.2,0.84,1.47,0.06905265,Unknown,0.205,0.173,0.276,0.145,Mild decrease (p=0.045),Significant decrease (p=0.009),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08667,rs707570,17,114462173,EPHA1,Deletion,-,-,1.91,1.59,2.21,0.0600495,High,0.088,0.574,0.13,0.008,Mild decrease (p=0.034),Significant increase (p=0.025),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08668,rs653684,19,119218538,APP,SNP (G/T),(G/,G,0.62,0.3,0.98,0.00738507,High,0.053,0.11,0.26,0.377,Significant increase (p=0.031),Variable effect (p=0.019),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08669,rs692685,10,121448770,CD33,Insertion,-,-,1.79,1.45,2.04,0.01659524,Protective,0.243,0.397,0.156,0.004,Significant increase (p=0.016),No significant pattern (p=0.016),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP08670,rs568772,15,23912838,CLU,Insertion,-,-,2.2,1.84,2.44,0.01533582,High,0.119,0.331,0.022,0.329,Mild decrease (p=0.011),No significant pattern (p=0.03),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08671,rs301056,19,133093945,ABCA7,SNP (C/T),(C/,C,1.06,0.86,1.32,0.00193282,Moderate,0.027,0.036,0.398,0.338,Significant decrease (p=0.017),Variable effect (p=0.024),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08672,rs343636,13,240225873,SORL1,Deletion,-,-,0.61,0.38,0.91,0.05537762,High,0.194,0.369,0.237,0.001,Mild increase (p=0.019),Mild decrease (p=0.031),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08673,rs411372,11,96921648,CD33,SNP (A/C),(A/,A,0.46,0.1,0.84,0.00457756,High,0.026,0.147,0.545,0.083,Mild increase (p=0.023),Variable effect (p=0.033),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08674,rs755297,3,117609124,PSEN2,SNP (A/G),(A/,A,1.08,0.82,1.47,0.04631989,Moderate,0.604,0.052,0.099,0.045,Significant increase (p=0.01),Significant decrease (p=0.016),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08675,rs679433,8,125049102,MS4A6A,SNP (A/G),(A/,A,0.74,0.45,1.06,0.01836364,High,0.124,0.179,0.054,0.443,No significant pattern (p=0.015),Mild increase (p=0.032),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP08676,rs631886,19,61102906,BIN1,SNP (C/T),(C/,C,1.83,1.56,2.19,0.00894241,Moderate,0.208,0.461,0.06,0.072,Significant decrease (p=0.037),Variable effect (p=0.006),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08677,rs324541,7,223149487,PICALM,SNP (A/T),(A/,A,1.02,0.71,1.35,0.05291788,High,0.118,0.118,0.538,0.025,No significant pattern (p=0.047),Significant increase (p=0.013),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08678,rs405341,4,222734538,CD33,SNP (G/T),(G/,G,1.17,0.94,1.42,0.0135112,Unknown,0.18,0.13,0.156,0.334,Variable effect (p=0.046),Variable effect (p=0.036),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08679,rs485539,22,43360903,BIN1,SNP (G/T),(G/,G,0.49,0.25,0.86,0.05607743,High,0.369,0.152,0.148,0.131,Mild decrease (p=0.013),Mild increase (p=0.025),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08680,rs897335,20,102049657,SORL1,Deletion,-,-,0.27,0.1,0.61,0.01484703,High,0.077,0.139,0.251,0.334,Mild increase (p=0.019),Mild decrease (p=0.027),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP08681,rs263871,8,134911599,CD33,SNP (A/T),(A/,A,1.55,1.25,1.83,0.01969209,Low,0.318,0.216,0.055,0.212,Significant increase (p=0.005),Mild increase (p=0.028),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08682,rs395847,11,242624572,PSEN2,Deletion,-,-,0.79,0.55,1.03,0.01516415,Low,0.119,0.207,0.016,0.459,Variable effect (p=0.044),Significant increase (p=0.027),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP08683,rs970029,1,95619657,CR1,Insertion,-,-,0.8,0.41,1.15,0.01586457,High,0.133,0.17,0.441,0.056,Mild decrease (p=0.04),Significant decrease (p=0.003),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP08684,rs650070,8,17276069,PTK2B,SNP (A/G),(A/,A,0.66,0.4,0.96,0.00552323,Protective,0.116,0.041,0.237,0.406,No significant pattern (p=0.028),Mild decrease (p=0.046),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP08685,rs445820,6,180961403,CD2AP,SNP (C/G),(C/,C,0.79,0.48,1.14,0.03086734,High,0.346,0.083,0.008,0.363,Mild decrease (p=0.025),No significant pattern (p=0.045),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08686,rs845751,8,209957255,CD2AP,SNP (C/G),(C/,C,1.28,1.05,1.61,0.03820164,High,0.049,0.155,0.158,0.438,Significant increase (p=0.012),Mild decrease (p=0.04),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08687,rs334543,5,90329147,BIN1,Deletion,-,-,2.36,1.98,2.61,0.02241774,Low,0.585,0.182,0.028,0.005,Significant decrease (p=0.037),No significant pattern (p=0.039),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP08688,rs292610,4,123132591,APP,SNP (C/G),(C/,C,1.13,0.89,1.47,0.01344702,High,0.203,0.469,0.097,0.031,Significant increase (p=0.039),Mild increase (p=0.025),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08689,rs333501,9,181304723,CR1,SNP (A/C),(A/,A,0.44,0.1,0.69,0.03737637,Moderate,0.144,0.243,0.122,0.291,Mild decrease (p=0.001),Mild increase (p=0.018),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08690,rs156539,8,36599569,CLU,SNP (A/T),(A/,A,2.42,2.19,2.74,0.0080633,High,0.098,0.046,0.236,0.42,No significant pattern (p=0.042),Variable effect (p=0.008),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08691,rs783397,14,223248889,CD33,SNP (A/G),(A/,A,1.53,1.31,1.81,0.06663255,Low,0.231,0.158,0.067,0.345,Significant increase (p=0.018),Significant decrease (p=0.03),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08692,rs806574,15,203836879,PTK2B,SNP (G/T),(G/,G,1.49,1.27,1.88,0.0351016,Moderate,0.007,0.284,0.496,0.013,Mild decrease (p=0.031),Mild decrease (p=0.007),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08693,rs832006,21,181591268,CD2AP,SNP (C/G),(C/,C,0.54,0.17,0.93,0.02021222,High,0.201,0.275,0.109,0.215,Mild decrease (p=0.049),Mild increase (p=0.002),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08694,rs277989,8,99756030,PICALM,Deletion,-,-,0.53,0.27,0.89,0.02117323,Moderate,0.046,0.344,0.117,0.293,Variable effect (p=0.049),Significant decrease (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08695,rs641792,11,239190497,CD2AP,Deletion,-,-,1.12,0.89,1.46,0.01000098,Moderate,0.521,0.176,0.023,0.081,Mild increase (p=0.023),Mild increase (p=0.043),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08696,rs855258,10,180255894,CR1,SNP (G/T),(G/,G,0.81,0.45,1.1,0.00604086,High,0.143,0.291,0.028,0.338,Variable effect (p=0.024),No significant pattern (p=0.035),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08697,rs498049,1,236131732,ABCA7,SNP (C/T),(C/,C,0.79,0.53,1.03,0.00596258,High,0.134,0.173,0.481,0.012,Mild decrease (p=0.042),Mild decrease (p=0.045),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08698,rs548851,2,159120985,CR1,SNP (A/G),(A/,A,0.29,0.1,0.52,0.0052885,Protective,0.118,0.591,0.039,0.052,Mild increase (p=0.037),Mild increase (p=0.039),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08699,rs497775,7,50191367,ABCA7,SNP (A/C),(A/,A,0.47,0.21,0.71,0.00789314,Low,0.439,0.052,0.202,0.106,Variable effect (p=0.004),No significant pattern (p=0.022),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08700,rs854093,13,4029404,PTK2B,SNP (A/C),(A/,A,1.62,1.33,1.98,0.07074009,High,0.055,0.041,0.274,0.43,Variable effect (p=0.021),Mild increase (p=0.008),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08701,rs906454,19,203928784,PICALM,SNP (A/C),(A/,A,0.85,0.5,1.19,0.00202801,Moderate,0.257,0.021,0.43,0.091,No significant pattern (p=0.011),Mild increase (p=0.041),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08702,rs791180,8,169724978,BIN1,SNP (A/C),(A/,A,1.26,0.94,1.6,0.01561437,High,0.367,0.006,0.266,0.16,Mild decrease (p=0.006),Significant decrease (p=0.021),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08703,rs628368,12,137668338,EPHA1,SNP (C/G),(C/,C,1.66,1.33,1.97,0.01962885,Moderate,0.271,0.019,0.49,0.021,Variable effect (p=0.042),Significant decrease (p=0.008),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08704,rs371139,1,60214133,CR1,SNP (C/G),(C/,C,0.74,0.53,1.12,0.00605262,Moderate,0.319,0.174,0.227,0.079,Significant increase (p=0.035),Mild decrease (p=0.011),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08705,rs188088,8,188110492,ABCA7,SNP (A/G),(A/,A,0.87,0.6,1.14,0.08869556,Unknown,0.297,0.273,0.045,0.184,Variable effect (p=0.044),Significant decrease (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08706,rs275344,13,171510420,PTK2B,Insertion,-,-,0.88,0.49,1.2,0.07129739,High,0.013,0.174,0.04,0.572,Mild decrease (p=0.025),Variable effect (p=0.044),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP08707,rs631161,14,236437350,EPHA1,SNP (G/T),(G/,G,0.89,0.55,1.27,0.00430759,High,0.194,0.033,0.364,0.209,No significant pattern (p=0.031),Mild increase (p=0.048),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08708,rs994167,16,16538430,APP,SNP (C/G),(C/,C,0.59,0.3,0.83,0.09091412,High,0.137,0.451,0.058,0.155,Significant increase (p=0.029),Significant decrease (p=0.039),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08709,rs312267,19,60227354,APOE,SNP (A/T),(A/,A,0.77,0.48,1.06,0.01585853,High,0.082,0.151,0.421,0.147,Variable effect (p=0.036),Significant increase (p=0.026),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP08710,rs246242,6,115449659,PTK2B,SNP (A/G),(A/,A,1.87,1.53,2.26,0.01579615,Moderate,0.299,0.107,0.364,0.03,Significant increase (p=0.036),Variable effect (p=0.049),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP08711,rs129618,4,118806643,CLU,Deletion,-,-,0.86,0.64,1.11,0.00230027,Moderate,0.37,0.299,0.117,0.014,Significant decrease (p=0.047),No significant pattern (p=0.035),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08712,rs725257,17,52487680,MS4A6A,Deletion,-,-,1.32,1.06,1.63,0.03028313,Moderate,0.095,0.652,0.011,0.043,Variable effect (p=0.013),Significant increase (p=0.023),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08713,rs358540,6,65984770,TREM2,SNP (G/T),(G/,G,2.01,1.67,2.31,0.0343559,Protective,0.286,0.313,0.005,0.196,Variable effect (p=0.04),No significant pattern (p=0.011),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08714,rs363972,3,186834828,ABCA7,SNP (A/G),(A/,A,0.89,0.51,1.22,0.01762514,High,0.003,0.623,0.023,0.151,Mild decrease (p=0.031),Significant decrease (p=0.028),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP08715,rs592067,9,236645147,EPHA1,SNP (A/G),(A/,A,1.5,1.19,1.71,0.02039215,High,0.378,0.012,0.322,0.088,Mild decrease (p=0.044),Variable effect (p=0.014),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08716,rs122743,10,118499863,TREM2,Insertion,-,-,2.52,2.26,2.75,0.01271936,High,0.415,0.342,0.04,0.003,No significant pattern (p=0.045),Mild decrease (p=0.004),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08717,rs190962,7,115935933,PTK2B,SNP (C/T),(C/,C,0.67,0.38,1.05,0.00196923,Protective,0.019,0.248,0.404,0.129,Significant increase (p=0.035),Significant decrease (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08718,rs911178,12,172831190,APP,SNP (C/G),(C/,C,1.14,0.93,1.35,0.02517221,High,0.031,0.218,0.545,0.007,No significant pattern (p=0.032),No significant pattern (p=0.049),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08719,rs971406,8,219772237,ABCA7,SNP (A/T),(A/,A,0.65,0.4,0.89,0.01329208,High,0.186,0.39,0.018,0.207,Mild decrease (p=0.023),Significant increase (p=0.01),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08720,rs896255,19,109721263,PICALM,Insertion,-,-,1.77,1.56,2.07,0.04647154,Protective,0.001,0.252,0.403,0.144,Mild increase (p=0.003),Significant increase (p=0.024),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08721,rs906689,4,207519578,CD2AP,Deletion,-,-,0.86,0.46,1.22,0.01272416,High,0.022,0.053,0.088,0.638,Variable effect (p=0.005),Significant increase (p=0.016),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08722,rs463490,14,60096961,PTK2B,SNP (A/C),(A/,A,0.75,0.49,1.03,0.00482727,Moderate,0.396,0.224,0.083,0.096,Mild increase (p=0.037),Significant decrease (p=0.026),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08723,rs989864,4,26778387,PSEN2,Deletion,-,-,1.76,1.54,1.99,0.01350393,Protective,0.357,0.054,0.193,0.196,No significant pattern (p=0.02),Significant increase (p=0.018),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08724,rs217691,9,180923975,BIN1,SNP (A/C),(A/,A,1.64,1.39,1.9,0.15876303,Moderate,0.225,0.083,0.084,0.409,Variable effect (p=0.019),No significant pattern (p=0.026),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP08725,rs695842,21,240910120,SORL1,SNP (A/T),(A/,A,0.97,0.62,1.34,0.0049707,High,0.077,0.056,0.24,0.427,Mild decrease (p=0.01),Significant decrease (p=0.03),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08726,rs517361,8,30203544,TREM2,Deletion,-,-,2.8,2.48,3.19,0.03568153,Unknown,0.304,0.243,0.032,0.221,No significant pattern (p=0.031),No significant pattern (p=0.018),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08727,rs651291,3,57817743,CD33,SNP (C/T),(C/,C,0.4,0.17,0.71,0.00541017,High,0.075,0.526,0.085,0.114,Significant increase (p=0.012),No significant pattern (p=0.021),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP08728,rs134359,6,47381103,MS4A6A,SNP (C/T),(C/,C,1.1,0.7,1.47,0.01445191,Moderate,0.077,0.251,0.212,0.26,Mild increase (p=0.017),Significant decrease (p=0.035),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08729,rs969734,15,197712292,TREM2,SNP (C/G),(C/,C,0.67,0.4,1.04,0.00140758,Moderate,0.091,0.44,0.141,0.128,Variable effect (p=0.02),Significant decrease (p=0.042),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP08730,rs747567,16,108079971,PTK2B,SNP (G/T),(G/,G,0.62,0.27,0.85,0.08008134,High,0.232,0.152,0.267,0.148,Mild decrease (p=0.045),Mild decrease (p=0.032),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP08731,rs489735,19,232559198,ABCA7,SNP (A/G),(A/,A,0.75,0.43,0.99,0.02018284,High,0.042,0.296,0.231,0.231,Significant increase (p=0.023),No significant pattern (p=0.034),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08732,rs573846,14,34347760,PSEN2,Deletion,-,-,1.44,1.15,1.76,0.00991757,Low,0.646,0.005,0.042,0.107,Mild increase (p=0.035),Variable effect (p=0.038),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08733,rs702538,1,222349592,SORL1,SNP (A/G),(A/,A,0.99,0.6,1.35,0.06308317,Low,0.06,0.196,0.16,0.384,No significant pattern (p=0.033),Mild decrease (p=0.033),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08734,rs929255,18,166322755,PTK2B,SNP (A/C),(A/,A,1.53,1.17,1.91,0.0257335,Moderate,0.099,0.106,0.167,0.428,Significant increase (p=0.048),Mild increase (p=0.033),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08735,rs892568,22,233397935,CD2AP,Insertion,-,-,0.84,0.49,1.2,0.01363321,Protective,0.086,0.304,0.388,0.022,Mild decrease (p=0.044),Variable effect (p=0.034),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08736,rs737366,20,198148045,CD33,SNP (A/C),(A/,A,0.89,0.68,1.12,0.03136236,Low,0.444,0.119,0.086,0.151,Variable effect (p=0.017),No significant pattern (p=0.03),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08737,rs984621,17,93441105,APOE,SNP (A/C),(A/,A,1.93,1.61,2.15,0.02556134,Moderate,0.027,0.267,0.39,0.116,Variable effect (p=0.036),Significant increase (p=0.031),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08738,rs581700,2,68655812,CD33,SNP (C/T),(C/,C,1.89,1.66,2.28,0.08618253,High,0.038,0.114,0.498,0.15,Significant increase (p=0.024),No significant pattern (p=0.009),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08739,rs754278,1,119400756,PTK2B,SNP (G/T),(G/,G,0.59,0.28,0.97,0.0407042,High,0.121,0.325,0.261,0.094,Significant increase (p=0.042),Mild increase (p=0.01),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08740,rs180021,17,78672303,EPHA1,Deletion,-,-,0.61,0.34,0.83,0.0127604,Moderate,0.026,0.543,0.06,0.171,Significant increase (p=0.047),No significant pattern (p=0.013),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08741,rs731638,17,100867094,ABCA7,SNP (G/T),(G/,G,0.93,0.54,1.18,0.01684102,Protective,0.075,0.074,0.083,0.568,Mild increase (p=0.025),Variable effect (p=0.009),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP08742,rs334545,20,107933787,CR1,SNP (G/T),(G/,G,1.19,0.94,1.59,0.02774142,Moderate,0.172,0.484,0.13,0.013,Significant decrease (p=0.036),Significant increase (p=0.006),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08743,rs454073,20,111363379,MS4A6A,Insertion,-,-,0.62,0.23,0.97,0.02238953,Low,0.273,0.208,0.127,0.192,Significant decrease (p=0.003),Mild decrease (p=0.003),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP08744,rs285860,2,128196498,CR1,Deletion,-,-,1.26,0.93,1.49,0.06900175,High,0.034,0.522,0.068,0.176,Significant decrease (p=0.006),Variable effect (p=0.016),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08745,rs343375,8,180917694,APOE,Insertion,-,-,0.6,0.31,1.0,0.03637245,Moderate,0.46,0.101,0.166,0.073,Significant decrease (p=0.043),Mild decrease (p=0.001),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08746,rs458455,19,208949787,MS4A6A,SNP (C/T),(C/,C,1.04,0.77,1.43,0.02102831,Protective,0.278,0.171,0.201,0.15,Mild decrease (p=0.008),Variable effect (p=0.011),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08747,rs430114,9,161510500,ABCA7,SNP (A/T),(A/,A,0.75,0.52,1.13,0.03539477,High,0.336,0.079,0.339,0.046,Mild decrease (p=0.048),Significant increase (p=0.021),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08748,rs619156,9,226406778,APOE,SNP (A/T),(A/,A,0.71,0.41,1.05,0.0214752,Moderate,0.123,0.347,0.073,0.258,Mild decrease (p=0.033),Significant increase (p=0.031),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08749,rs114855,18,137237302,APP,SNP (A/G),(A/,A,0.86,0.5,1.07,0.03605102,Moderate,0.02,0.066,0.335,0.379,Significant decrease (p=0.021),Mild decrease (p=0.034),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08750,rs863414,4,43908247,CD2AP,SNP (C/G),(C/,C,1.18,0.93,1.4,0.0297931,Moderate,0.166,0.119,0.224,0.291,Variable effect (p=0.015),Mild increase (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08751,rs379337,10,167746974,CD33,SNP (A/T),(A/,A,0.8,0.54,1.09,0.0175686,Moderate,0.354,0.082,0.087,0.277,Significant increase (p=0.035),Mild decrease (p=0.002),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08752,rs485534,8,214109409,PTK2B,SNP (A/T),(A/,A,0.97,0.77,1.26,0.01102706,Unknown,0.375,0.006,0.412,0.008,Mild increase (p=0.039),No significant pattern (p=0.009),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP08753,rs285686,22,164900263,PSEN2,SNP (A/T),(A/,A,0.66,0.45,1.0,0.13579437,High,0.238,0.32,0.236,0.006,Significant increase (p=0.006),Mild decrease (p=0.018),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08754,rs935867,5,197257092,PICALM,SNP (C/G),(C/,C,0.73,0.42,1.01,0.01074264,Moderate,0.154,0.303,0.14,0.203,Variable effect (p=0.045),No significant pattern (p=0.045),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08755,rs667074,14,119156200,APOE,SNP (C/G),(C/,C,0.41,0.19,0.63,0.00790719,High,0.068,0.193,0.141,0.398,Significant increase (p=0.017),Significant increase (p=0.016),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08756,rs381256,5,225824731,SORL1,SNP (C/G),(C/,C,0.61,0.32,0.84,0.01876111,Moderate,0.029,0.31,0.408,0.053,Mild increase (p=0.014),Variable effect (p=0.016),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08757,rs237562,16,120129360,EPHA1,SNP (G/T),(G/,G,0.48,0.19,0.79,0.02112377,Low,0.324,0.017,0.296,0.164,Variable effect (p=0.045),No significant pattern (p=0.032),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08758,rs547670,10,160521087,ABCA7,SNP (C/T),(C/,C,0.72,0.4,0.95,0.01894023,Low,0.125,0.366,0.223,0.086,Mild increase (p=0.01),Mild increase (p=0.019),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08759,rs594513,15,48326626,ABCA7,SNP (A/C),(A/,A,0.69,0.49,0.99,0.00647732,Protective,0.121,0.559,0.054,0.066,Mild increase (p=0.028),No significant pattern (p=0.043),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08760,rs323236,13,102694093,TREM2,Deletion,-,-,1.27,1.04,1.5,0.01340879,High,0.198,0.26,0.194,0.148,Significant decrease (p=0.044),Variable effect (p=0.042),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08761,rs565150,3,18966676,CR1,SNP (A/T),(A/,A,0.69,0.39,0.9,0.00081589,Protective,0.453,0.066,0.273,0.008,Significant decrease (p=0.03),Mild increase (p=0.007),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP08762,rs711705,8,243176330,CR1,SNP (A/T),(A/,A,1.98,1.6,2.2,0.01022259,High,0.141,0.29,0.23,0.139,Significant increase (p=0.02),Mild decrease (p=0.003),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08763,rs818065,12,210956682,CLU,Deletion,-,-,1.88,1.56,2.18,0.00366674,Moderate,0.256,0.285,0.018,0.242,Significant decrease (p=0.039),Significant increase (p=0.037),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08764,rs695988,17,219804713,TREM2,SNP (A/C),(A/,A,1.51,1.31,1.88,0.03266715,Moderate,0.101,0.577,0.049,0.072,No significant pattern (p=0.018),Significant increase (p=0.027),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP08765,rs242373,1,187452885,APP,SNP (A/T),(A/,A,0.75,0.36,1.0,0.01353124,Moderate,0.087,0.285,0.16,0.268,Variable effect (p=0.016),Mild increase (p=0.02),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08766,rs509936,3,12707525,CD33,SNP (A/T),(A/,A,1.16,0.95,1.42,0.02042216,Moderate,0.172,0.164,0.097,0.367,Mild increase (p=0.003),Variable effect (p=0.028),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08767,rs965674,19,177034196,ABCA7,SNP (C/T),(C/,C,0.78,0.43,1.11,0.00960628,Unknown,0.073,0.019,0.073,0.635,Mild decrease (p=0.013),Significant increase (p=0.037),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08768,rs456715,15,177546175,APOE,SNP (C/G),(C/,C,0.84,0.58,1.17,0.0086475,Low,0.058,0.051,0.19,0.501,Significant decrease (p=0.02),Mild decrease (p=0.015),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08769,rs710750,8,109938471,CD33,SNP (C/G),(C/,C,3.55,3.17,3.94,0.01003573,Moderate,0.113,0.188,0.15,0.348,No significant pattern (p=0.021),Variable effect (p=0.029),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08770,rs324554,11,119265912,CD33,SNP (C/T),(C/,C,0.87,0.49,1.14,0.1273879,High,0.225,0.557,0.003,0.015,Mild increase (p=0.012),Significant increase (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08771,rs323756,16,21924583,ABCA7,SNP (G/T),(G/,G,1.34,1.1,1.74,0.0020554,Moderate,0.005,0.199,0.195,0.401,No significant pattern (p=0.009),Significant increase (p=0.038),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP08772,rs656784,3,226336215,CLU,SNP (C/T),(C/,C,1.99,1.68,2.25,0.00107622,Moderate,0.257,0.072,0.168,0.303,Mild decrease (p=0.03),Significant decrease (p=0.038),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08773,rs634016,13,104317241,CLU,SNP (C/T),(C/,C,0.38,0.13,0.62,0.05020004,High,0.243,0.094,0.213,0.25,Significant increase (p=0.046),Significant increase (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP08774,rs284824,6,158955507,TREM2,SNP (C/G),(C/,C,0.5,0.28,0.79,0.12170805,High,0.109,0.376,0.077,0.237,Mild increase (p=0.005),No significant pattern (p=0.013),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08775,rs967332,18,107424670,CD2AP,SNP (A/C),(A/,A,2.87,2.55,3.16,0.01941533,High,0.005,0.272,0.378,0.145,Significant decrease (p=0.043),Mild decrease (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08776,rs937626,12,54756364,EPHA1,SNP (G/T),(G/,G,1.21,0.93,1.53,0.00873774,Low,0.03,0.135,0.061,0.574,No significant pattern (p=0.036),Mild decrease (p=0.024),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08777,rs139757,15,169780795,PTK2B,SNP (C/G),(C/,C,0.47,0.15,0.82,0.0441794,High,0.548,0.079,0.091,0.082,Significant decrease (p=0.01),Significant increase (p=0.008),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08778,rs617494,6,60357869,PTK2B,SNP (G/T),(G/,G,0.66,0.4,0.93,0.00195312,Moderate,0.537,0.194,0.066,0.003,Mild increase (p=0.041),Significant decrease (p=0.028),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08779,rs735997,11,200017639,CD33,SNP (A/G),(A/,A,2.36,1.99,2.63,0.0277274,High,0.275,0.009,0.412,0.104,No significant pattern (p=0.039),Mild increase (p=0.019),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08780,rs119270,15,142030473,CD33,SNP (C/T),(C/,C,0.99,0.67,1.34,0.04829946,Moderate,0.068,0.314,0.088,0.329,Variable effect (p=0.014),Significant decrease (p=0.041),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08781,rs597046,7,23234546,APP,Deletion,-,-,0.23,0.1,0.43,0.03042318,Moderate,0.029,0.156,0.146,0.469,No significant pattern (p=0.005),Mild decrease (p=0.036),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08782,rs516947,13,74297109,PTK2B,Deletion,-,-,0.54,0.25,0.88,0.02574494,Protective,0.25,0.156,0.338,0.056,Mild increase (p=0.003),Variable effect (p=0.032),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08783,rs570409,7,127223393,CD2AP,SNP (A/T),(A/,A,0.52,0.32,0.78,0.01157703,High,0.138,0.073,0.47,0.118,Mild decrease (p=0.029),No significant pattern (p=0.01),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08784,rs209837,15,245208130,PICALM,Insertion,-,-,1.01,0.65,1.38,0.00137174,Moderate,0.02,0.59,0.104,0.086,Mild increase (p=0.02),Significant increase (p=0.034),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP08785,rs398933,21,191546620,CLU,SNP (G/T),(G/,G,1.08,0.84,1.33,0.01326295,Low,0.484,0.263,0.034,0.02,No significant pattern (p=0.028),No significant pattern (p=0.042),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08786,rs843017,9,217704440,EPHA1,Insertion,-,-,2.03,1.78,2.3,0.02859861,Moderate,0.559,0.162,0.049,0.031,Significant decrease (p=0.024),Variable effect (p=0.043),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP08787,rs651981,18,204763650,CR1,SNP (C/G),(C/,C,0.43,0.1,0.76,0.01710766,Moderate,0.101,0.134,0.064,0.501,Variable effect (p=0.019),Mild decrease (p=0.009),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08788,rs762679,19,19426180,CR1,SNP (C/T),(C/,C,0.54,0.32,0.78,0.04248764,Low,0.039,0.029,0.084,0.648,Significant increase (p=0.024),Significant decrease (p=0.029),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08789,rs135447,18,113755882,PICALM,SNP (A/T),(A/,A,0.49,0.28,0.74,0.05438116,Moderate,0.288,0.065,0.074,0.373,Significant decrease (p=0.032),Significant increase (p=0.008),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08790,rs178752,22,41671125,APP,SNP (A/G),(A/,A,1.29,1.08,1.62,0.02146777,Low,0.304,0.002,0.188,0.305,Significant increase (p=0.026),No significant pattern (p=0.046),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP08791,rs299857,11,175970463,CR1,SNP (C/G),(C/,C,1.2,0.83,1.44,0.0014973,Low,0.133,0.244,0.139,0.284,Significant increase (p=0.034),Mild decrease (p=0.014),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08792,rs619313,11,35635526,CLU,SNP (G/T),(G/,G,1.28,1.06,1.61,0.02367801,Moderate,0.336,0.072,0.112,0.279,Mild increase (p=0.029),Variable effect (p=0.025),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08793,rs366514,14,208604994,SORL1,SNP (G/T),(G/,G,1.24,0.92,1.59,0.05198419,Moderate,0.554,0.03,0.034,0.182,Variable effect (p=0.024),Mild decrease (p=0.046),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08794,rs507003,12,189856046,PTK2B,SNP (G/T),(G/,G,0.7,0.32,0.94,0.02182164,Moderate,0.106,0.031,0.066,0.597,Significant increase (p=0.045),Mild decrease (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08795,rs775252,20,56725712,TREM2,Deletion,-,-,1.22,0.87,1.53,0.00984409,High,0.02,0.709,0.026,0.045,Mild decrease (p=0.002),No significant pattern (p=0.031),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP08796,rs593583,6,48591525,TREM2,SNP (A/C),(A/,A,0.92,0.7,1.18,0.00951257,High,0.293,0.076,0.111,0.321,Significant decrease (p=0.03),No significant pattern (p=0.013),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP08797,rs100310,2,77471856,PICALM,Insertion,-,-,1.03,0.67,1.33,0.00700677,Moderate,0.282,0.061,0.285,0.172,No significant pattern (p=0.034),Mild decrease (p=0.035),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08798,rs554482,9,190606363,CD2AP,SNP (C/T),(C/,C,1.18,0.98,1.57,0.01197744,Moderate,0.619,0.042,0.079,0.06,No significant pattern (p=0.046),Variable effect (p=0.014),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08799,rs735358,19,117631438,CD33,SNP (C/T),(C/,C,0.78,0.51,1.15,0.01322645,Unknown,0.41,0.244,0.138,0.008,Significant decrease (p=0.04),No significant pattern (p=0.013),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08800,rs112508,13,28922356,CD2AP,Insertion,-,-,1.56,1.25,1.95,0.06039154,Moderate,0.284,0.003,0.439,0.074,Significant increase (p=0.007),Significant increase (p=0.043),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08801,rs673098,3,240335650,PTK2B,SNP (C/T),(C/,C,0.62,0.3,0.92,0.0211655,Moderate,0.025,0.004,0.378,0.393,No significant pattern (p=0.003),Significant decrease (p=0.038),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08802,rs827114,19,85287978,PTK2B,Insertion,-,-,0.65,0.34,0.89,0.03089405,High,0.583,0.04,0.014,0.163,Mild decrease (p=0.029),Variable effect (p=0.044),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08803,rs479440,15,120292212,MS4A6A,SNP (C/T),(C/,C,0.82,0.6,1.08,0.03513197,Protective,0.248,0.128,0.387,0.036,No significant pattern (p=0.03),Variable effect (p=0.03),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08804,rs617672,2,6763771,SORL1,Insertion,-,-,0.59,0.19,0.95,0.07934988,High,0.009,0.29,0.125,0.376,No significant pattern (p=0.032),Significant decrease (p=0.048),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08805,rs159682,5,152228434,CLU,SNP (G/T),(G/,G,0.96,0.64,1.17,0.00129796,Protective,0.056,0.492,0.16,0.092,Variable effect (p=0.008),No significant pattern (p=0.043),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08806,rs262100,16,240144501,EPHA1,SNP (A/C),(A/,A,0.7,0.39,1.0,0.11293382,Low,0.107,0.04,0.62,0.033,Mild increase (p=0.04),Significant decrease (p=0.008),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08807,rs691018,1,144128085,PICALM,SNP (A/C),(A/,A,1.03,0.81,1.41,0.05510397,Moderate,0.07,0.558,0.007,0.165,Significant increase (p=0.017),Mild decrease (p=0.012),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08808,rs172907,14,198555596,CR1,Deletion,-,-,1.42,1.18,1.65,0.04102612,Protective,0.25,0.051,0.305,0.193,Mild decrease (p=0.021),No significant pattern (p=0.032),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08809,rs939672,9,111096336,CLU,Deletion,-,-,0.98,0.77,1.27,0.0010493,Protective,0.241,0.182,0.212,0.166,Significant decrease (p=0.011),Significant decrease (p=0.016),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08810,rs594854,17,92373785,ABCA7,SNP (C/T),(C/,C,0.47,0.1,0.78,0.02379697,High,0.018,0.161,0.4,0.221,Significant increase (p=0.023),Variable effect (p=0.019),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08811,rs589738,1,154816927,PTK2B,SNP (A/C),(A/,A,0.99,0.71,1.37,0.04631191,High,0.119,0.521,0.121,0.04,Mild decrease (p=0.036),Mild increase (p=0.023),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08812,rs377828,9,157940968,ABCA7,SNP (C/T),(C/,C,2.52,2.15,2.74,0.00553518,Moderate,0.204,0.376,0.125,0.095,Variable effect (p=0.04),Variable effect (p=0.041),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08813,rs204101,12,137190768,PTK2B,Deletion,-,-,0.94,0.61,1.32,0.00124177,Protective,0.19,0.005,0.08,0.526,Mild increase (p=0.021),Mild increase (p=0.035),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08814,rs683759,8,202796493,TREM2,Insertion,-,-,0.81,0.51,1.13,0.0214758,High,0.132,0.075,0.278,0.315,Significant decrease (p=0.026),Mild decrease (p=0.005),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08815,rs770724,12,31979794,PTK2B,Deletion,-,-,0.77,0.38,1.06,0.00452205,Protective,0.572,0.041,0.06,0.127,Significant increase (p=0.028),Mild increase (p=0.003),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08816,rs273020,13,97521594,SORL1,Deletion,-,-,1.45,1.21,1.79,0.00479362,Moderate,0.206,0.037,0.153,0.403,Significant decrease (p=0.013),Significant decrease (p=0.001),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08817,rs551655,17,192153937,SORL1,SNP (C/T),(C/,C,1.03,0.73,1.33,0.06817879,High,0.317,0.104,0.012,0.366,Significant decrease (p=0.014),Mild increase (p=0.043),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08818,rs155022,20,93734374,APOE,SNP (A/G),(A/,A,1.12,0.83,1.48,0.20384164,High,0.534,0.153,0.09,0.022,Significant increase (p=0.048),Mild decrease (p=0.021),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08819,rs277536,10,123470474,PSEN2,SNP (A/C),(A/,A,1.54,1.26,1.91,0.00497575,Unknown,0.295,0.109,0.051,0.345,Significant increase (p=0.028),Variable effect (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08820,rs126076,14,189069341,SORL1,SNP (G/T),(G/,G,0.79,0.41,1.11,0.02483032,High,0.118,0.088,0.293,0.301,Variable effect (p=0.048),Significant decrease (p=0.034),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP08821,rs955495,12,145604616,BIN1,SNP (C/G),(C/,C,0.99,0.67,1.35,0.06704592,Moderate,0.329,0.01,0.307,0.153,Variable effect (p=0.001),No significant pattern (p=0.018),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08822,rs883310,4,147429227,TREM2,SNP (A/T),(A/,A,1.92,1.56,2.3,0.00869108,Protective,0.079,0.698,0.022,0.002,Significant increase (p=0.049),Mild increase (p=0.009),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08823,rs742932,4,206875517,MS4A6A,SNP (C/T),(C/,C,1.1,0.77,1.37,0.0268958,Low,0.05,0.297,0.187,0.266,Significant decrease (p=0.04),Variable effect (p=0.041),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08824,rs824826,9,138756419,APP,SNP (A/G),(A/,A,1.48,1.25,1.86,0.01180196,Low,0.028,0.438,0.286,0.048,Mild increase (p=0.021),Mild decrease (p=0.048),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08825,rs389385,13,147314937,APOE,SNP (A/G),(A/,A,0.76,0.4,1.0,0.05787298,High,0.076,0.385,0.099,0.239,No significant pattern (p=0.034),Mild decrease (p=0.005),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08826,rs381390,5,83653562,CR1,SNP (C/T),(C/,C,2.26,2.04,2.54,0.00413565,Moderate,0.55,0.104,0.003,0.144,No significant pattern (p=0.003),Variable effect (p=0.005),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08827,rs824081,10,205525694,APP,SNP (A/T),(A/,A,0.86,0.46,1.12,0.03962528,Moderate,0.162,0.252,0.206,0.181,Variable effect (p=0.035),No significant pattern (p=0.001),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP08828,rs287933,13,122311102,APP,Deletion,-,-,1.05,0.8,1.31,0.00992087,Moderate,0.125,0.21,0.252,0.212,Variable effect (p=0.017),Mild increase (p=0.005),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP08829,rs830767,15,119876481,PSEN2,Deletion,-,-,0.22,0.1,0.56,0.00981988,Moderate,0.036,0.029,0.381,0.354,Significant increase (p=0.009),Mild increase (p=0.019),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08830,rs770710,15,243891811,TREM2,Deletion,-,-,1.8,1.56,2.05,0.02577972,Moderate,0.369,0.367,0.061,0.002,Mild decrease (p=0.044),No significant pattern (p=0.022),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08831,rs226863,9,126786400,PSEN2,SNP (C/G),(C/,C,1.78,1.43,2.01,0.04361285,Protective,0.132,0.189,0.322,0.157,No significant pattern (p=0.032),Variable effect (p=0.043),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08832,rs460849,10,36886399,SORL1,Deletion,-,-,1.75,1.52,2.05,0.01116962,Low,0.035,0.276,0.118,0.371,Variable effect (p=0.004),Mild increase (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08833,rs332635,19,148877650,PTK2B,SNP (A/T),(A/,A,1.55,1.34,1.75,0.01479825,High,0.085,0.428,0.222,0.064,Significant decrease (p=0.014),Significant decrease (p=0.034),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08834,rs739561,9,216536010,CR1,Deletion,-,-,0.52,0.2,0.77,0.06783178,High,0.117,0.148,0.445,0.09,No significant pattern (p=0.023),Significant decrease (p=0.031),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08835,rs783160,15,142992257,CD2AP,Insertion,-,-,0.75,0.49,1.03,0.04096958,Moderate,0.119,0.434,0.172,0.075,Variable effect (p=0.023),No significant pattern (p=0.025),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08836,rs229003,13,132611067,TREM2,SNP (A/T),(A/,A,0.68,0.32,0.9,0.00627821,Protective,0.082,0.329,0.257,0.131,Significant increase (p=0.015),Mild decrease (p=0.016),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08837,rs392756,14,247560952,TREM2,SNP (A/C),(A/,A,1.64,1.25,1.96,0.00149894,Protective,0.255,0.031,0.135,0.379,Significant increase (p=0.043),Variable effect (p=0.045),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP08838,rs272906,11,95503627,CD2AP,SNP (A/G),(A/,A,0.56,0.35,0.9,0.02092144,High,0.217,0.44,0.057,0.086,No significant pattern (p=0.014),Mild decrease (p=0.017),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08839,rs740539,12,133905264,APP,SNP (G/T),(G/,G,1.26,1.01,1.46,0.03728039,High,0.148,0.239,0.063,0.35,Mild increase (p=0.012),Significant decrease (p=0.05),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08840,rs823915,18,201492395,APP,SNP (C/T),(C/,C,0.89,0.66,1.19,0.00396171,Low,0.038,0.211,0.489,0.062,Significant decrease (p=0.04),Mild decrease (p=0.018),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP08841,rs882941,8,7402489,BIN1,SNP (C/G),(C/,C,0.35,0.1,0.75,0.00140574,High,0.156,0.036,0.598,0.01,Significant increase (p=0.013),Mild decrease (p=0.014),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08842,rs265473,22,230187917,BIN1,SNP (C/G),(C/,C,1.65,1.4,1.97,0.02953373,High,0.227,0.18,0.219,0.174,No significant pattern (p=0.039),Mild decrease (p=0.043),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08843,rs318531,7,229947358,EPHA1,SNP (G/T),(G/,G,1.64,1.4,1.89,0.05250982,Moderate,0.19,0.124,0.409,0.077,Variable effect (p=0.009),Mild decrease (p=0.009),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP08844,rs525945,22,83103150,APP,SNP (G/T),(G/,G,1.82,1.62,2.09,0.00724627,High,0.012,0.46,0.229,0.099,Significant increase (p=0.033),Significant increase (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08845,rs176676,3,45334780,TREM2,SNP (A/T),(A/,A,0.97,0.7,1.3,0.00399943,Unknown,0.453,0.261,0.004,0.082,Mild increase (p=0.014),Significant increase (p=0.015),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP08846,rs378022,15,234897809,APOE,SNP (A/T),(A/,A,0.44,0.1,0.83,0.03369975,Moderate,0.154,0.495,0.064,0.087,Significant decrease (p=0.029),Variable effect (p=0.022),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08847,rs203226,9,202569929,APP,SNP (A/C),(A/,A,1.64,1.26,1.97,0.00797102,Low,0.394,0.331,0.019,0.056,Significant decrease (p=0.009),No significant pattern (p=0.018),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08848,rs880451,7,184314178,CR1,Deletion,-,-,0.79,0.41,1.19,0.10807234,Moderate,0.144,0.313,0.09,0.253,No significant pattern (p=0.049),Variable effect (p=0.005),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP08849,rs819220,7,192363187,CLU,SNP (C/G),(C/,C,1.61,1.37,1.94,0.06255949,Protective,0.303,0.003,0.149,0.345,Significant decrease (p=0.036),Significant increase (p=0.044),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08850,rs580295,7,162108509,EPHA1,SNP (A/G),(A/,A,1.22,0.89,1.45,0.02507324,Moderate,0.083,0.04,0.473,0.204,Significant increase (p=0.046),No significant pattern (p=0.027),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08851,rs244333,13,90352650,PICALM,Insertion,-,-,1.01,0.79,1.32,0.04252454,High,0.27,0.136,0.391,0.003,Mild increase (p=0.045),Mild decrease (p=0.049),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08852,rs696867,12,145047740,CD33,SNP (A/T),(A/,A,1.01,0.72,1.4,0.07632189,Low,0.141,0.26,0.082,0.316,Significant increase (p=0.007),Mild increase (p=0.022),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08853,rs301402,5,181597547,APP,SNP (G/T),(G/,G,0.84,0.48,1.16,0.00348409,Low,0.188,0.208,0.233,0.172,No significant pattern (p=0.009),Mild increase (p=0.028),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08854,rs715786,5,166897479,CD2AP,SNP (A/T),(A/,A,1.0,0.65,1.35,0.0158537,High,0.17,0.367,0.027,0.236,Significant decrease (p=0.013),Mild increase (p=0.012),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08855,rs517299,22,100838527,CD2AP,Deletion,-,-,1.33,1.07,1.72,0.01471283,Moderate,0.316,0.139,0.055,0.29,Variable effect (p=0.002),Significant increase (p=0.042),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08856,rs139416,6,154488862,APP,Deletion,-,-,1.66,1.33,2.04,0.05406916,Moderate,0.377,0.085,0.246,0.092,Variable effect (p=0.033),No significant pattern (p=0.048),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08857,rs866710,20,152580231,CLU,SNP (A/C),(A/,A,0.68,0.31,1.01,0.01925474,Protective,0.025,0.507,0.172,0.096,Variable effect (p=0.017),Mild increase (p=0.038),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08858,rs519599,10,63439465,CLU,SNP (A/T),(A/,A,1.85,1.56,2.14,0.02928272,Moderate,0.703,0.03,0.037,0.03,Variable effect (p=0.021),Mild decrease (p=0.031),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP08859,rs439863,1,100845751,APOE,Deletion,-,-,0.85,0.54,1.12,0.06173173,Moderate,0.016,0.287,0.332,0.166,No significant pattern (p=0.007),Mild increase (p=0.01),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08860,rs811632,22,137469335,APOE,Insertion,-,-,2.41,2.07,2.67,0.05170696,Moderate,0.08,0.005,0.625,0.09,Variable effect (p=0.008),Mild increase (p=0.026),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08861,rs747602,8,121836099,BIN1,SNP (A/T),(A/,A,1.82,1.61,2.19,0.03861342,Moderate,0.179,0.471,0.07,0.081,Mild increase (p=0.002),Significant increase (p=0.015),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP08862,rs108765,22,45516116,MS4A6A,SNP (A/T),(A/,A,0.96,0.69,1.36,0.06724334,High,0.498,0.085,0.082,0.135,Variable effect (p=0.007),Variable effect (p=0.012),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08863,rs657356,3,52274235,CD2AP,SNP (C/G),(C/,C,0.4,0.1,0.71,0.0449177,Moderate,0.068,0.158,0.205,0.369,No significant pattern (p=0.005),Significant increase (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08864,rs815217,18,6783363,CR1,Insertion,-,-,1.67,1.43,1.95,0.0103543,Protective,0.046,0.14,0.456,0.158,No significant pattern (p=0.037),Mild decrease (p=0.044),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP08865,rs436052,22,46362534,CD33,SNP (C/T),(C/,C,4.88,4.59,5.16,0.00485861,Moderate,0.073,0.098,0.324,0.305,Variable effect (p=0.043),Mild increase (p=0.032),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08866,rs532096,11,59783179,BIN1,Insertion,-,-,0.97,0.67,1.2,0.00371521,Protective,0.108,0.087,0.419,0.186,Significant decrease (p=0.018),No significant pattern (p=0.011),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08867,rs547772,6,90777452,CR1,SNP (C/G),(C/,C,0.74,0.43,1.01,0.02457854,Moderate,0.422,0.096,0.236,0.046,Significant decrease (p=0.023),Mild increase (p=0.034),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08868,rs784049,10,167323519,CLU,SNP (A/T),(A/,A,0.94,0.55,1.24,0.11275804,Moderate,0.206,0.29,0.16,0.144,Variable effect (p=0.015),Mild increase (p=0.031),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08869,rs881843,12,51489566,MS4A6A,SNP (A/G),(A/,A,2.22,1.96,2.46,0.05927878,Protective,0.273,0.434,0.078,0.016,Mild decrease (p=0.009),Mild decrease (p=0.023),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08870,rs337886,9,163401042,PTK2B,SNP (A/T),(A/,A,0.64,0.32,0.93,0.08700832,Low,0.106,0.181,0.171,0.342,Variable effect (p=0.01),Variable effect (p=0.008),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08871,rs154973,10,109257961,EPHA1,SNP (C/G),(C/,C,0.68,0.46,1.01,0.01449296,High,0.14,0.046,0.228,0.386,No significant pattern (p=0.018),Significant decrease (p=0.014),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP08872,rs368709,7,216984662,PTK2B,SNP (A/C),(A/,A,0.82,0.43,1.12,0.04240575,High,0.025,0.303,0.314,0.159,Variable effect (p=0.043),No significant pattern (p=0.037),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP08873,rs855561,11,51378132,ABCA7,SNP (A/T),(A/,A,1.04,0.83,1.42,0.01835242,Low,0.532,0.077,0.147,0.044,No significant pattern (p=0.044),No significant pattern (p=0.048),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP08874,rs443798,11,160140848,CR1,SNP (A/C),(A/,A,1.66,1.38,1.99,0.02043976,High,0.228,0.401,0.038,0.133,Mild increase (p=0.013),No significant pattern (p=0.017),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08875,rs519633,11,41331530,CLU,SNP (A/C),(A/,A,1.21,0.85,1.45,0.01545708,High,0.38,0.129,0.126,0.165,Mild increase (p=0.015),Mild increase (p=0.024),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08876,rs218893,11,83578187,CD33,Deletion,-,-,0.44,0.22,0.67,0.09981863,High,0.392,0.008,0.377,0.023,No significant pattern (p=0.01),Mild increase (p=0.044),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP08877,rs248149,5,84686711,MS4A6A,SNP (A/T),(A/,A,1.2,0.96,1.57,0.00435042,Moderate,0.526,0.155,0.098,0.022,No significant pattern (p=0.006),No significant pattern (p=0.039),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08878,rs388339,6,9176511,BIN1,Deletion,-,-,1.55,1.23,1.82,0.00353375,High,0.315,0.328,0.112,0.045,Significant increase (p=0.014),Mild increase (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08879,rs520752,10,64175124,CD2AP,SNP (A/T),(A/,A,1.77,1.39,2.16,0.0461826,Low,0.525,0.164,0.006,0.105,No significant pattern (p=0.012),Significant increase (p=0.043),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08880,rs269124,22,166253515,PICALM,SNP (C/T),(C/,C,1.23,0.84,1.47,0.10460006,Moderate,0.326,0.272,0.1,0.102,Significant decrease (p=0.036),Significant decrease (p=0.006),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08881,rs535271,14,174582558,EPHA1,SNP (A/T),(A/,A,0.41,0.12,0.75,0.01332033,Moderate,0.486,0.048,0.126,0.14,Mild decrease (p=0.024),Mild decrease (p=0.046),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP08882,rs301093,17,187210097,SORL1,SNP (A/T),(A/,A,2.16,1.95,2.53,0.0400577,Moderate,0.057,0.102,0.576,0.065,Mild decrease (p=0.042),Mild increase (p=0.039),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08883,rs101047,17,214615924,ABCA7,Deletion,-,-,0.97,0.68,1.36,0.00901529,Low,0.391,0.086,0.216,0.106,Significant increase (p=0.006),Mild increase (p=0.021),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP08884,rs761945,12,67178224,TREM2,SNP (C/T),(C/,C,0.56,0.16,0.84,0.03025507,Low,0.2,0.279,0.234,0.087,Mild decrease (p=0.04),No significant pattern (p=0.047),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08885,rs973396,20,124373921,PTK2B,SNP (C/T),(C/,C,1.27,1.0,1.62,0.02616516,Moderate,0.119,0.158,0.347,0.176,Variable effect (p=0.016),No significant pattern (p=0.05),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08886,rs156850,6,202403847,MS4A6A,SNP (A/T),(A/,A,1.01,0.72,1.33,0.00431222,High,0.143,0.337,0.208,0.112,Significant increase (p=0.012),Variable effect (p=0.004),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08887,rs937795,9,156451158,BIN1,SNP (G/T),(G/,G,1.25,0.86,1.51,0.03194527,High,0.321,0.285,0.074,0.12,Mild increase (p=0.01),Variable effect (p=0.012),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP08888,rs285209,10,79178944,PICALM,SNP (A/G),(A/,A,1.05,0.7,1.32,0.02122424,Moderate,0.12,0.082,0.195,0.403,Mild increase (p=0.038),Variable effect (p=0.024),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08889,rs751451,11,149086176,APOE,SNP (C/G),(C/,C,0.99,0.67,1.21,0.00510997,High,0.04,0.148,0.327,0.285,Significant increase (p=0.031),No significant pattern (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08890,rs330646,17,131710173,CLU,SNP (A/C),(A/,A,0.32,0.1,0.63,0.00120435,Protective,0.066,0.165,0.38,0.189,Variable effect (p=0.023),Significant increase (p=0.018),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08891,rs714535,5,7333016,PSEN2,SNP (A/T),(A/,A,1.67,1.41,1.95,0.00679543,Moderate,0.444,0.012,0.338,0.006,Mild increase (p=0.026),Variable effect (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08892,rs793749,15,68603303,BIN1,SNP (A/T),(A/,A,0.75,0.51,1.06,0.02126878,Low,0.111,0.312,0.307,0.07,Mild increase (p=0.016),Mild decrease (p=0.027),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP08893,rs406355,6,181940929,ABCA7,SNP (A/C),(A/,A,0.93,0.7,1.14,0.044584,High,0.15,0.43,0.103,0.117,No significant pattern (p=0.041),Mild increase (p=0.017),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP08894,rs570906,18,213707008,PICALM,SNP (A/T),(A/,A,1.5,1.13,1.78,0.02187975,High,0.118,0.222,0.447,0.013,No significant pattern (p=0.023),Significant increase (p=0.001),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08895,rs810675,19,240566615,CD2AP,Insertion,-,-,1.03,0.8,1.33,0.06812291,Moderate,0.39,0.051,0.267,0.091,Mild decrease (p=0.011),Significant decrease (p=0.018),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08896,rs768465,22,124257801,CR1,SNP (A/T),(A/,A,1.41,1.09,1.8,6.13e-06,High,0.416,0.018,0.262,0.104,Mild increase (p=0.014),Significant decrease (p=0.029),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08897,rs239991,1,172042383,CD33,SNP (G/T),(G/,G,0.95,0.69,1.16,0.06139846,High,0.132,0.284,0.155,0.228,Mild increase (p=0.018),Significant decrease (p=0.002),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08898,rs741656,10,6692413,EPHA1,Deletion,-,-,0.24,0.1,0.54,0.0092611,Unknown,0.028,0.386,0.096,0.29,Significant decrease (p=0.022),Significant decrease (p=0.04),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP08899,rs864163,8,170332255,APP,SNP (A/G),(A/,A,1.94,1.56,2.31,0.07958294,Moderate,0.034,0.584,0.029,0.153,Significant increase (p=0.015),Significant decrease (p=0.025),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08900,rs472394,17,49927015,TREM2,Insertion,-,-,0.61,0.39,0.82,0.04814694,Low,0.575,0.044,0.11,0.071,Variable effect (p=0.026),Variable effect (p=0.012),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08901,rs313417,11,103053186,ABCA7,SNP (C/G),(C/,C,0.88,0.57,1.11,0.0401935,Protective,0.163,0.437,0.021,0.179,No significant pattern (p=0.005),Mild decrease (p=0.043),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP08902,rs455303,21,154625810,EPHA1,Insertion,-,-,1.27,0.97,1.5,0.00973022,High,0.568,0.122,0.054,0.056,Mild decrease (p=0.039),Variable effect (p=0.026),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08903,rs895300,10,35194359,SORL1,SNP (A/G),(A/,A,0.78,0.42,1.17,0.01398895,Moderate,0.087,0.58,0.081,0.052,Significant decrease (p=0.003),Significant decrease (p=0.024),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08904,rs728664,19,70849155,CD33,SNP (C/T),(C/,C,1.42,1.18,1.72,0.02185428,Low,0.13,0.071,0.569,0.031,Mild decrease (p=0.012),Mild decrease (p=0.041),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP08905,rs798825,12,63307315,CD33,SNP (A/G),(A/,A,0.95,0.62,1.25,0.00567156,Low,0.112,0.376,0.3,0.012,Mild increase (p=0.026),Mild increase (p=0.018),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08906,rs418776,12,238590308,PICALM,Insertion,-,-,0.34,0.11,0.7,0.01322798,High,0.023,0.163,0.293,0.321,Significant decrease (p=0.005),Significant decrease (p=0.045),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08907,rs452012,20,66328277,TREM2,SNP (A/G),(A/,A,1.37,1.05,1.66,0.04896333,Moderate,0.394,0.094,0.12,0.192,Significant increase (p=0.024),Significant decrease (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08908,rs727077,19,245303748,APP,SNP (C/G),(C/,C,0.63,0.3,0.85,0.08621547,Moderate,0.01,0.486,0.214,0.09,Mild decrease (p=0.023),Mild increase (p=0.011),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08909,rs703187,6,14477239,CD2AP,SNP (C/T),(C/,C,0.99,0.7,1.28,0.04348453,Protective,0.163,0.107,0.151,0.379,Mild decrease (p=0.008),Significant decrease (p=0.038),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08910,rs426045,22,3629511,PICALM,SNP (A/C),(A/,A,1.38,1.09,1.68,0.00985042,High,0.369,0.293,0.032,0.105,Variable effect (p=0.028),Significant increase (p=0.024),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08911,rs437077,9,18493391,APP,SNP (A/C),(A/,A,1.72,1.45,2.01,0.025972,Moderate,0.067,0.031,0.225,0.478,Variable effect (p=0.004),Significant increase (p=0.036),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08912,rs678150,16,82401561,EPHA1,SNP (A/G),(A/,A,0.44,0.17,0.67,0.13414624,Low,0.191,0.047,0.09,0.472,Significant increase (p=0.038),No significant pattern (p=0.048),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08913,rs807823,5,221927375,ABCA7,Insertion,-,-,0.87,0.51,1.2,0.00179445,Low,0.159,0.051,0.264,0.327,Mild increase (p=0.022),No significant pattern (p=0.009),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08914,rs426883,17,44306008,MS4A6A,SNP (A/T),(A/,A,0.69,0.3,1.02,0.05037382,High,0.111,0.063,0.33,0.296,Variable effect (p=0.014),No significant pattern (p=0.019),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08915,rs420812,19,74110874,PSEN2,SNP (C/T),(C/,C,0.62,0.38,0.96,0.00226947,High,0.249,0.358,0.161,0.032,No significant pattern (p=0.045),No significant pattern (p=0.035),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08916,rs165095,14,115040867,ABCA7,SNP (C/G),(C/,C,1.14,0.86,1.53,0.00348464,High,0.331,0.078,0.128,0.262,Mild decrease (p=0.03),Mild increase (p=0.044),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP08917,rs594877,10,181211302,TREM2,SNP (C/T),(C/,C,1.35,0.96,1.59,0.02324419,Moderate,0.047,0.507,0.149,0.097,Mild decrease (p=0.008),Significant increase (p=0.04),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08918,rs528631,5,48581981,BIN1,SNP (A/C),(A/,A,1.14,0.86,1.51,0.00373754,Moderate,0.01,0.401,0.125,0.263,Variable effect (p=0.048),Significant decrease (p=0.022),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08919,rs842965,1,2240898,CD33,Insertion,-,-,1.59,1.36,1.81,0.03113709,High,0.074,0.268,0.103,0.355,Variable effect (p=0.013),Variable effect (p=0.036),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP08920,rs319776,19,39931467,CD33,SNP (A/T),(A/,A,1.93,1.56,2.2,0.01397539,High,0.17,0.011,0.119,0.499,Significant decrease (p=0.019),Variable effect (p=0.023),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08921,rs343737,8,43747009,CLU,SNP (A/G),(A/,A,0.54,0.21,0.91,0.00116166,Low,0.1,0.517,0.067,0.117,Variable effect (p=0.044),Significant increase (p=0.011),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP08922,rs799937,18,227675707,CR1,SNP (A/G),(A/,A,0.32,0.1,0.56,0.01204302,High,0.089,0.166,0.059,0.486,Mild decrease (p=0.044),Mild decrease (p=0.048),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08923,rs876892,15,197095882,PICALM,Insertion,-,-,1.64,1.39,2.02,0.05836472,High,0.007,0.225,0.45,0.119,Significant increase (p=0.013),Significant decrease (p=0.023),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08924,rs923079,12,63271208,MS4A6A,SNP (C/T),(C/,C,1.26,0.89,1.64,0.0115608,High,0.72,0.014,0.046,0.02,Mild increase (p=0.038),Variable effect (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08925,rs842196,21,121442040,CLU,Insertion,-,-,0.99,0.62,1.26,0.10105519,Low,0.196,0.075,0.198,0.331,Variable effect (p=0.025),Mild increase (p=0.049),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP08926,rs697225,7,106857204,PSEN2,SNP (A/C),(A/,A,0.98,0.65,1.2,0.00063079,High,0.149,0.532,0.106,0.013,Variable effect (p=0.018),Significant increase (p=0.016),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP08927,rs473910,7,165963987,TREM2,Deletion,-,-,1.7,1.38,1.94,0.0751278,High,0.509,0.053,0.06,0.178,Variable effect (p=0.01),Variable effect (p=0.029),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08928,rs504508,5,163451947,MS4A6A,SNP (A/T),(A/,A,1.57,1.26,1.83,0.00761433,Moderate,0.002,0.041,0.14,0.616,Mild increase (p=0.033),Mild increase (p=0.037),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP08929,rs856247,15,74922739,MS4A6A,SNP (A/C),(A/,A,1.8,1.57,2.04,0.00665548,Moderate,0.081,0.399,0.123,0.197,Variable effect (p=0.019),Significant increase (p=0.018),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08930,rs459047,5,44460568,BIN1,SNP (A/T),(A/,A,1.72,1.52,2.03,0.03298495,Moderate,0.071,0.046,0.36,0.323,Significant increase (p=0.029),No significant pattern (p=0.017),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08931,rs544218,14,169407240,PTK2B,SNP (A/T),(A/,A,1.09,0.79,1.46,0.0026953,Moderate,0.017,0.429,0.027,0.327,Significant increase (p=0.047),Mild decrease (p=0.041),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08932,rs148207,14,15243474,CD33,Insertion,-,-,0.56,0.19,0.87,0.00968179,Low,0.117,0.235,0.258,0.189,Variable effect (p=0.01),Mild increase (p=0.022),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP08933,rs458970,14,97643970,CLU,Deletion,-,-,1.79,1.39,2.17,0.01429269,High,0.109,0.253,0.308,0.13,Mild decrease (p=0.008),Mild increase (p=0.028),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP08934,rs625805,4,151962533,CD2AP,Insertion,-,-,2.9,2.54,3.23,0.00252694,High,0.46,0.044,0.058,0.238,No significant pattern (p=0.047),No significant pattern (p=0.004),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP08935,rs501191,3,52388843,PTK2B,Deletion,-,-,0.73,0.35,1.01,0.0172187,Low,0.206,0.022,0.307,0.265,Mild increase (p=0.015),Mild decrease (p=0.024),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP08936,rs696406,8,236033310,TREM2,SNP (A/C),(A/,A,1.39,1.11,1.65,0.00015908,High,0.022,0.189,0.437,0.152,No significant pattern (p=0.038),Variable effect (p=0.05),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08937,rs807843,3,57171454,ABCA7,SNP (G/T),(G/,G,1.17,0.83,1.55,0.05726251,High,0.34,0.221,0.093,0.146,Mild increase (p=0.009),Mild decrease (p=0.025),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP08938,rs158490,8,83068340,CR1,Deletion,-,-,0.79,0.46,1.01,0.07541511,Moderate,0.292,0.115,0.271,0.122,Significant decrease (p=0.041),No significant pattern (p=0.02),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08939,rs597137,5,75241419,CR1,Deletion,-,-,0.96,0.68,1.26,0.00970808,Low,0.273,0.24,0.256,0.03,Variable effect (p=0.05),Variable effect (p=0.026),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP08940,rs408794,8,36002221,MS4A6A,SNP (C/G),(C/,C,0.79,0.57,1.11,0.03055868,Low,0.274,0.446,0.046,0.035,Significant decrease (p=0.007),Significant decrease (p=0.012),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08941,rs182560,9,100295136,CR1,SNP (A/C),(A/,A,1.52,1.13,1.78,0.0026796,Moderate,0.067,0.199,0.236,0.298,Mild decrease (p=0.024),Mild decrease (p=0.002),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08942,rs278093,6,26598000,CLU,SNP (C/T),(C/,C,0.83,0.56,1.12,0.00869216,Moderate,0.289,0.048,0.202,0.261,Mild decrease (p=0.021),No significant pattern (p=0.006),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP08943,rs995467,21,126917545,CR1,SNP (A/G),(A/,A,0.5,0.14,0.85,0.02239698,Moderate,0.229,0.052,0.263,0.257,Significant decrease (p=0.043),Mild increase (p=0.008),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08944,rs354182,2,20282441,SORL1,SNP (C/G),(C/,C,0.85,0.54,1.14,0.0309047,Low,0.18,0.087,0.399,0.133,Significant decrease (p=0.005),Mild decrease (p=0.02),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08945,rs327605,1,91560850,TREM2,Deletion,-,-,0.83,0.59,1.21,0.00711766,High,0.396,0.116,0.088,0.2,Mild decrease (p=0.018),Mild decrease (p=0.009),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP08946,rs120431,4,15421250,CR1,SNP (A/T),(A/,A,1.74,1.45,2.01,0.03952066,Moderate,0.288,0.092,0.106,0.314,Significant decrease (p=0.021),Significant increase (p=0.028),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08947,rs135474,9,73523976,PICALM,SNP (A/C),(A/,A,0.33,0.1,0.68,0.05233279,Moderate,0.51,0.134,0.092,0.065,Mild decrease (p=0.018),Significant increase (p=0.003),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP08948,rs652339,14,51413682,CD2AP,SNP (G/T),(G/,G,1.52,1.19,1.88,0.02915268,High,0.315,0.148,0.202,0.134,No significant pattern (p=0.034),Mild decrease (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP08949,rs507546,15,209823079,CD2AP,SNP (A/T),(A/,A,0.84,0.64,1.2,0.02055745,Low,0.165,0.346,0.2,0.089,No significant pattern (p=0.014),Significant decrease (p=0.024),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08950,rs471924,6,153674107,MS4A6A,SNP (A/G),(A/,A,1.28,0.92,1.53,0.03381078,Low,0.22,0.452,0.015,0.112,Significant increase (p=0.031),Mild decrease (p=0.007),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP08951,rs796118,13,172846959,PICALM,SNP (A/G),(A/,A,1.04,0.66,1.26,0.02706537,Moderate,0.22,0.411,0.121,0.048,Significant increase (p=0.043),Significant decrease (p=0.04),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP08952,rs986022,17,243033609,APP,SNP (G/T),(G/,G,0.5,0.27,0.78,0.01749136,Protective,0.097,0.096,0.218,0.39,Significant decrease (p=0.038),Variable effect (p=0.009),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP08953,rs705488,18,177450764,CD33,SNP (A/T),(A/,A,0.99,0.68,1.35,0.03289442,Protective,0.033,0.336,0.394,0.036,Mild increase (p=0.041),No significant pattern (p=0.007),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08954,rs920525,12,229100335,CR1,SNP (C/G),(C/,C,0.87,0.47,1.21,0.00726871,High,0.335,0.163,0.085,0.218,Variable effect (p=0.012),Significant decrease (p=0.044),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08955,rs891117,3,164314942,CD2AP,SNP (C/G),(C/,C,1.89,1.52,2.19,0.01946202,Low,0.027,0.576,0.179,0.018,Significant increase (p=0.01),Mild increase (p=0.032),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08956,rs217737,18,248139481,ABCA7,SNP (A/C),(A/,A,1.67,1.28,1.91,0.05818047,Low,0.166,0.363,0.242,0.029,Mild decrease (p=0.046),Significant decrease (p=0.04),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08957,rs874939,1,136453398,PTK2B,SNP (A/G),(A/,A,2.94,2.59,3.33,0.00673388,Moderate,0.235,0.249,0.007,0.309,Significant decrease (p=0.011),Variable effect (p=0.026),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP08958,rs871252,6,23842279,CD33,SNP (G/T),(G/,G,1.77,1.4,2.02,0.003707,Low,0.332,0.015,0.073,0.38,Significant increase (p=0.039),Mild decrease (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08959,rs955333,14,149817137,BIN1,SNP (A/T),(A/,A,0.72,0.33,1.0,0.02189919,Moderate,0.254,0.004,0.099,0.442,Significant increase (p=0.008),No significant pattern (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08960,rs881261,22,1465763,CD33,SNP (C/T),(C/,C,2.89,2.67,3.16,0.0485322,Low,0.007,0.175,0.047,0.57,Mild increase (p=0.042),Significant decrease (p=0.035),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP08961,rs329968,6,151134221,PSEN2,SNP (A/G),(A/,A,1.51,1.2,1.73,0.06905456,High,0.106,0.136,0.492,0.067,Significant decrease (p=0.012),Mild decrease (p=0.003),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08962,rs745371,1,116249157,CR1,SNP (A/T),(A/,A,1.14,0.9,1.35,0.002604,Low,0.337,0.009,0.258,0.196,No significant pattern (p=0.015),Mild decrease (p=0.03),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP08963,rs433747,16,74235338,MS4A6A,Deletion,-,-,0.98,0.76,1.22,0.0630733,Moderate,0.012,0.139,0.017,0.632,Mild increase (p=0.011),Mild increase (p=0.02),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP08964,rs474767,1,98979425,CD33,SNP (A/G),(A/,A,0.43,0.11,0.68,0.00815712,Low,0.053,0.038,0.08,0.629,Mild increase (p=0.028),No significant pattern (p=0.033),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP08965,rs123658,14,49677490,SORL1,SNP (A/G),(A/,A,0.41,0.13,0.62,0.06393504,Moderate,0.055,0.348,0.288,0.109,No significant pattern (p=0.011),No significant pattern (p=0.034),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08966,rs791899,4,11069151,APP,SNP (A/C),(A/,A,0.78,0.45,0.99,0.00766392,Moderate,0.044,0.258,0.4,0.098,Variable effect (p=0.003),Mild decrease (p=0.045),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP08967,rs956230,14,168398172,SORL1,SNP (A/T),(A/,A,1.06,0.84,1.32,0.01755913,Low,0.077,0.065,0.008,0.65,Significant increase (p=0.034),Variable effect (p=0.04),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP08968,rs626676,3,47207139,CD33,SNP (C/T),(C/,C,0.34,0.1,0.57,0.04273506,Moderate,0.307,0.02,0.244,0.229,Mild increase (p=0.004),No significant pattern (p=0.032),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08969,rs164314,14,133016483,PICALM,SNP (C/G),(C/,C,0.77,0.37,1.02,0.03250234,Moderate,0.042,0.017,0.114,0.626,Significant increase (p=0.028),Mild decrease (p=0.037),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP08970,rs286247,11,193569794,PICALM,SNP (A/G),(A/,A,1.57,1.35,1.78,0.01670239,Moderate,0.679,0.018,0.012,0.09,Mild increase (p=0.02),No significant pattern (p=0.013),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP08971,rs303015,22,187161207,PICALM,Deletion,-,-,0.53,0.21,0.78,0.0348322,Moderate,0.344,0.267,0.15,0.039,Significant increase (p=0.04),Mild decrease (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08972,rs547979,22,70574513,CD33,SNP (A/G),(A/,A,1.11,0.79,1.47,0.05526427,Moderate,0.024,0.195,0.033,0.547,Mild decrease (p=0.019),No significant pattern (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08973,rs574397,15,124596551,EPHA1,SNP (A/G),(A/,A,0.57,0.22,0.96,0.05014862,Low,0.139,0.008,0.149,0.503,Mild decrease (p=0.036),Significant decrease (p=0.016),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08974,rs746064,17,52143236,APP,SNP (A/G),(A/,A,1.07,0.8,1.36,0.0609791,High,0.012,0.201,0.495,0.091,Significant increase (p=0.002),No significant pattern (p=0.022),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP08975,rs620301,6,74444964,CR1,SNP (C/G),(C/,C,0.78,0.53,1.15,0.09180811,High,0.568,0.201,0.01,0.02,Significant increase (p=0.035),Mild increase (p=0.029),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP08976,rs467909,12,232426955,APOE,Insertion,-,-,0.86,0.47,1.09,0.01097362,Protective,0.191,0.285,0.207,0.116,Variable effect (p=0.012),Mild decrease (p=0.048),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP08977,rs980576,11,43760158,CD2AP,SNP (A/C),(A/,A,1.0,0.66,1.22,0.00305921,Low,0.068,0.135,0.395,0.201,Mild decrease (p=0.028),Significant increase (p=0.01),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08978,rs240449,8,187279789,SORL1,SNP (A/C),(A/,A,0.77,0.46,1.06,0.04554194,Low,0.365,0.022,0.231,0.182,Significant increase (p=0.006),Mild increase (p=0.034),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08979,rs358061,13,198746033,CD2AP,SNP (A/G),(A/,A,1.07,0.84,1.29,0.03015093,Low,0.035,0.311,0.129,0.325,Significant decrease (p=0.03),Variable effect (p=0.015),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP08980,rs351251,1,190720778,APOE,SNP (G/T),(G/,G,0.47,0.2,0.69,0.03940562,Low,0.328,0.141,0.129,0.202,No significant pattern (p=0.048),Mild increase (p=0.047),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP08981,rs104300,12,82549698,PTK2B,SNP (G/T),(G/,G,1.53,1.17,1.75,0.01583391,Moderate,0.163,0.04,0.528,0.069,Variable effect (p=0.018),Significant increase (p=0.036),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP08982,rs624132,15,121653513,ABCA7,SNP (A/T),(A/,A,1.0,0.72,1.21,0.00620375,High,0.213,0.022,0.562,0.003,Mild decrease (p=0.009),Mild decrease (p=0.013),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP08983,rs650765,1,120959611,CD33,SNP (A/G),(A/,A,0.7,0.37,0.94,0.00467784,Low,0.131,0.456,0.176,0.038,Significant increase (p=0.002),No significant pattern (p=0.004),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP08984,rs964558,13,149881008,EPHA1,SNP (C/T),(C/,C,1.13,0.82,1.42,0.003423,Moderate,0.509,0.131,0.104,0.056,Significant increase (p=0.007),Significant decrease (p=0.009),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP08985,rs718618,14,217742766,PTK2B,SNP (C/T),(C/,C,0.93,0.65,1.15,0.00571074,Moderate,0.267,0.436,0.0,0.097,No significant pattern (p=0.045),Significant increase (p=0.004),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP08986,rs642881,14,145591685,APP,SNP (C/T),(C/,C,2.41,2.05,2.79,0.01935784,High,0.199,0.151,0.092,0.359,Significant increase (p=0.038),Significant decrease (p=0.02),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP08987,rs573237,9,106627191,CR1,SNP (A/G),(A/,A,0.91,0.71,1.31,0.00541866,Low,0.143,0.141,0.018,0.498,Mild increase (p=0.038),Mild decrease (p=0.034),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP08988,rs910077,18,132609350,ABCA7,SNP (A/C),(A/,A,1.6,1.31,1.91,0.00473595,Protective,0.022,0.081,0.648,0.049,Significant decrease (p=0.033),Significant increase (p=0.017),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP08989,rs812727,3,191231342,SORL1,SNP (G/T),(G/,G,1.64,1.42,1.86,0.02675575,Moderate,0.044,0.021,0.292,0.442,Mild increase (p=0.023),No significant pattern (p=0.019),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08990,rs527514,8,231226646,MS4A6A,SNP (C/G),(C/,C,0.82,0.57,1.2,0.03146446,High,0.1,0.524,0.082,0.093,No significant pattern (p=0.021),Mild decrease (p=0.004),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP08991,rs793852,8,50691818,TREM2,SNP (C/G),(C/,C,0.77,0.53,1.01,0.04019348,Protective,0.245,0.232,0.305,0.019,Mild decrease (p=0.044),Mild increase (p=0.032),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08992,rs167341,6,127319759,CR1,SNP (C/T),(C/,C,0.99,0.6,1.26,0.00702776,High,0.252,0.331,0.129,0.088,Variable effect (p=0.041),Significant decrease (p=0.008),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP08993,rs831360,17,162947904,CD2AP,SNP (A/C),(A/,A,2.19,1.87,2.48,0.05380527,High,0.062,0.431,0.032,0.275,Mild decrease (p=0.023),Mild decrease (p=0.026),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP08994,rs600083,9,238852816,SORL1,SNP (G/T),(G/,G,1.57,1.31,1.79,0.00192606,Protective,0.473,0.018,0.18,0.13,Mild decrease (p=0.046),Mild decrease (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP08995,rs972247,17,179543963,SORL1,SNP (C/T),(C/,C,0.82,0.48,1.14,0.00844997,Protective,0.236,0.448,0.074,0.042,Mild decrease (p=0.004),No significant pattern (p=0.027),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP08996,rs699584,19,4010788,CD33,Insertion,-,-,1.42,1.05,1.8,0.07735947,High,0.065,0.488,0.057,0.19,Mild increase (p=0.013),Significant increase (p=0.038),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP08997,rs465073,3,153010536,EPHA1,SNP (A/G),(A/,A,2.45,2.06,2.69,0.00606571,Protective,0.188,0.45,0.16,0.002,No significant pattern (p=0.024),Significant increase (p=0.038),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP08998,rs823317,20,200353094,PSEN2,Deletion,-,-,0.59,0.36,0.87,0.00363115,Moderate,0.234,0.198,0.062,0.306,Significant decrease (p=0.011),No significant pattern (p=0.004),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP08999,rs586078,20,105597097,TREM2,SNP (C/G),(C/,C,2.04,1.83,2.36,0.09384577,High,0.324,0.104,0.248,0.124,No significant pattern (p=0.05),Significant increase (p=0.03),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09000,rs553995,15,64949703,EPHA1,SNP (G/T),(G/,G,0.83,0.43,1.14,0.04275333,Moderate,0.114,0.021,0.252,0.413,Mild increase (p=0.041),Variable effect (p=0.033),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP09001,rs760651,6,3523209,PTK2B,SNP (A/C),(A/,A,0.55,0.21,0.76,0.07844038,Low,0.255,0.082,0.368,0.095,Mild decrease (p=0.049),Mild decrease (p=0.028),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09002,rs433811,8,222563957,PTK2B,Deletion,-,-,0.42,0.1,0.68,0.00034032,Moderate,0.004,0.336,0.087,0.373,Significant decrease (p=0.033),Mild decrease (p=0.005),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09003,rs907998,8,97051065,CD33,SNP (C/G),(C/,C,1.1,0.76,1.47,0.05717633,High,0.347,0.118,0.072,0.262,No significant pattern (p=0.043),Significant decrease (p=0.038),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09004,rs106648,5,154854794,CR1,SNP (C/T),(C/,C,0.77,0.57,1.03,0.04269376,Unknown,0.394,0.22,0.067,0.119,Significant decrease (p=0.046),No significant pattern (p=0.001),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09005,rs546174,9,191879091,TREM2,SNP (G/T),(G/,G,1.15,0.91,1.44,0.01577941,Moderate,0.47,0.01,0.133,0.187,Variable effect (p=0.04),Mild increase (p=0.039),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09006,rs834981,16,225323899,CD33,Deletion,-,-,0.76,0.38,1.12,0.05570413,Moderate,0.161,0.269,0.081,0.289,Significant increase (p=0.038),Significant decrease (p=0.05),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09007,rs224275,15,151480379,PSEN2,Insertion,-,-,0.92,0.71,1.22,0.00899382,High,0.344,0.12,0.227,0.109,Mild increase (p=0.041),Variable effect (p=0.005),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09008,rs702140,3,216111603,APP,Insertion,-,-,1.19,0.97,1.48,0.02189771,Moderate,0.158,0.405,0.2,0.037,Variable effect (p=0.028),No significant pattern (p=0.031),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09009,rs182392,11,168953959,APP,Deletion,-,-,1.21,0.93,1.5,0.00498535,Low,0.199,0.384,0.134,0.083,Significant increase (p=0.014),Variable effect (p=0.044),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP09010,rs116309,5,34409795,CLU,SNP (G/T),(G/,G,1.16,0.91,1.45,0.01229586,Moderate,0.172,0.11,0.286,0.231,No significant pattern (p=0.011),Significant decrease (p=0.018),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09011,rs114167,7,108422395,PTK2B,SNP (A/T),(A/,A,1.8,1.59,2.04,0.00034056,High,0.117,0.219,0.296,0.167,Significant increase (p=0.028),Mild increase (p=0.04),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09012,rs719176,7,189995303,MS4A6A,Deletion,-,-,2.19,1.82,2.51,0.04936073,Moderate,0.365,0.05,0.158,0.227,Mild decrease (p=0.033),Significant increase (p=0.044),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09013,rs926954,10,40350389,CLU,SNP (A/C),(A/,A,0.47,0.19,0.79,0.04119169,Moderate,0.53,0.109,0.042,0.119,Significant decrease (p=0.014),Significant increase (p=0.014),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09014,rs552175,3,144412021,PTK2B,SNP (C/G),(C/,C,0.93,0.55,1.13,0.13107379,Moderate,0.033,0.14,0.458,0.168,No significant pattern (p=0.01),Significant decrease (p=0.042),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09015,rs559390,19,22684266,CR1,SNP (G/T),(G/,G,0.82,0.49,1.05,0.01825598,Low,0.141,0.483,0.055,0.122,Significant decrease (p=0.016),Variable effect (p=0.002),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09016,rs652435,20,178536508,PICALM,SNP (A/T),(A/,A,1.01,0.79,1.32,0.01919633,Moderate,0.42,0.12,0.027,0.232,Significant decrease (p=0.031),Significant increase (p=0.01),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09017,rs718323,9,14119730,PSEN2,SNP (C/G),(C/,C,1.17,0.83,1.57,0.06929461,Protective,0.169,0.193,0.41,0.027,Significant increase (p=0.019),Mild decrease (p=0.048),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09018,rs955779,7,94375764,APP,SNP (A/C),(A/,A,1.08,0.71,1.4,0.01490648,Moderate,0.238,0.056,0.088,0.418,Significant increase (p=0.043),Mild increase (p=0.009),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09019,rs942866,6,181628385,CD33,SNP (A/T),(A/,A,1.3,0.97,1.54,0.01894009,Low,0.154,0.237,0.393,0.016,Significant increase (p=0.036),Significant increase (p=0.021),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09020,rs470331,19,64994143,CD33,SNP (A/G),(A/,A,0.63,0.35,0.97,0.02731227,Moderate,0.208,0.072,0.504,0.016,Significant increase (p=0.038),Significant decrease (p=0.049),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09021,rs923107,8,39981887,PTK2B,Deletion,-,-,0.89,0.54,1.17,0.1296689,Unknown,0.606,0.106,0.074,0.013,Variable effect (p=0.04),Significant increase (p=0.002),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09022,rs431483,2,50353312,ABCA7,SNP (A/C),(A/,A,0.92,0.69,1.32,0.01110713,Low,0.27,0.178,0.03,0.322,Variable effect (p=0.015),Mild decrease (p=0.04),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09023,rs320442,4,27458258,SORL1,SNP (A/C),(A/,A,2.25,1.91,2.57,0.01955536,High,0.1,0.456,0.138,0.106,Mild increase (p=0.043),Mild increase (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09024,rs643416,15,2851549,SORL1,SNP (A/T),(A/,A,0.63,0.3,0.97,0.00626482,Protective,0.21,0.287,0.248,0.055,Mild decrease (p=0.023),Mild decrease (p=0.009),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09025,rs844149,20,100833618,PSEN2,Deletion,-,-,1.24,0.85,1.54,0.02328715,Low,0.059,0.359,0.238,0.144,No significant pattern (p=0.017),No significant pattern (p=0.004),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09026,rs223260,13,191123297,PTK2B,Insertion,-,-,1.0,0.79,1.22,0.00590872,Unknown,0.251,0.121,0.311,0.117,Mild increase (p=0.008),Mild increase (p=0.046),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09027,rs784488,3,167950845,PTK2B,Insertion,-,-,0.61,0.25,0.91,0.09523914,Moderate,0.067,0.234,0.232,0.268,Significant decrease (p=0.006),Variable effect (p=0.027),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09028,rs327709,6,218886671,EPHA1,Deletion,-,-,0.31,0.1,0.69,0.09459276,High,0.033,0.335,0.083,0.349,Significant increase (p=0.019),Variable effect (p=0.046),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09029,rs454355,8,204635931,CLU,SNP (C/T),(C/,C,2.57,2.34,2.89,0.02887311,High,0.082,0.231,0.406,0.081,Mild increase (p=0.039),Variable effect (p=0.049),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09030,rs805911,7,196004414,PICALM,Deletion,-,-,1.32,1.05,1.7,0.09274804,High,0.189,0.01,0.196,0.405,Significant increase (p=0.031),Variable effect (p=0.016),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09031,rs157866,19,55393269,MS4A6A,SNP (A/C),(A/,A,0.65,0.28,0.93,0.08135955,Moderate,0.028,0.369,0.231,0.173,Significant decrease (p=0.05),No significant pattern (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09032,rs422357,5,137819694,SORL1,SNP (C/T),(C/,C,1.78,1.55,1.98,0.00698741,Low,0.026,0.097,0.285,0.392,Variable effect (p=0.005),No significant pattern (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09033,rs557263,12,151349416,CD33,SNP (G/T),(G/,G,0.42,0.18,0.78,0.05933539,Moderate,0.055,0.026,0.585,0.133,Mild increase (p=0.022),Significant decrease (p=0.026),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09034,rs136272,14,132370853,CD33,SNP (C/T),(C/,C,1.46,1.1,1.69,0.03584897,High,0.558,0.145,0.096,0.001,Mild decrease (p=0.027),Variable effect (p=0.011),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP09035,rs729367,2,182774469,CR1,Deletion,-,-,0.97,0.61,1.21,0.04698713,Low,0.223,0.116,0.334,0.127,Variable effect (p=0.046),Variable effect (p=0.03),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09036,rs585685,16,68662272,CD33,Insertion,-,-,0.28,0.1,0.67,0.0200468,Low,0.173,0.289,0.254,0.085,Variable effect (p=0.008),Variable effect (p=0.038),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09037,rs871747,20,126958691,BIN1,SNP (A/C),(A/,A,1.11,0.85,1.35,0.00902447,High,0.092,0.107,0.019,0.583,Variable effect (p=0.008),Significant decrease (p=0.007),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP09038,rs333486,8,187681033,CR1,SNP (C/G),(C/,C,2.33,2.07,2.7,0.02845607,Moderate,0.068,0.559,0.094,0.079,Mild increase (p=0.017),Mild increase (p=0.039),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP09039,rs772450,22,199961150,APOE,SNP (G/T),(G/,G,1.45,1.2,1.65,0.02611297,Unknown,0.023,0.548,0.129,0.1,Mild increase (p=0.006),Significant decrease (p=0.047),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP09040,rs771720,11,248007523,PSEN2,SNP (A/G),(A/,A,1.9,1.61,2.16,0.03261442,Unknown,0.277,0.024,0.11,0.389,Mild increase (p=0.015),Significant decrease (p=0.043),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09041,rs912717,15,71728633,PSEN2,SNP (G/T),(G/,G,0.59,0.25,0.94,0.02092358,Low,0.238,0.47,0.077,0.016,Mild decrease (p=0.019),No significant pattern (p=0.042),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09042,rs165897,17,225092232,TREM2,SNP (G/T),(G/,G,1.56,1.25,1.76,0.0085982,Moderate,0.112,0.255,0.137,0.296,No significant pattern (p=0.034),No significant pattern (p=0.036),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09043,rs305014,17,192005335,EPHA1,Insertion,-,-,0.75,0.53,1.12,0.04639085,High,0.083,0.05,0.564,0.103,Significant decrease (p=0.049),Significant increase (p=0.043),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09044,rs933948,16,24723034,TREM2,SNP (A/G),(A/,A,1.86,1.61,2.23,0.00923303,High,0.005,0.591,0.007,0.197,Mild increase (p=0.008),Significant decrease (p=0.045),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09045,rs908201,9,138272029,MS4A6A,Deletion,-,-,0.98,0.74,1.35,0.02834499,Moderate,0.006,0.13,0.33,0.335,No significant pattern (p=0.03),Mild decrease (p=0.009),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09046,rs480052,13,144699547,MS4A6A,SNP (C/G),(C/,C,0.91,0.58,1.18,0.09580522,Unknown,0.038,0.164,0.523,0.075,Mild decrease (p=0.049),No significant pattern (p=0.037),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09047,rs238696,2,225918741,BIN1,Insertion,-,-,0.27,0.1,0.59,0.0604851,Moderate,0.23,0.01,0.056,0.505,Significant decrease (p=0.001),No significant pattern (p=0.012),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP09048,rs421738,17,209786701,PTK2B,SNP (A/C),(A/,A,1.75,1.54,2.11,0.00160698,Moderate,0.146,0.029,0.374,0.251,Significant decrease (p=0.011),No significant pattern (p=0.015),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09049,rs393535,3,132280661,APOE,SNP (G/T),(G/,G,1.45,1.23,1.82,0.01134932,Low,0.072,0.567,0.117,0.044,Significant increase (p=0.048),Significant decrease (p=0.019),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP09050,rs532892,12,234124663,CR1,SNP (A/T),(A/,A,0.8,0.48,1.09,0.0248849,Moderate,0.048,0.094,0.194,0.464,Mild increase (p=0.047),Variable effect (p=0.034),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09051,rs478365,18,172451414,CR1,SNP (C/G),(C/,C,1.3,0.92,1.67,0.08129629,High,0.009,0.336,0.393,0.062,Significant increase (p=0.003),Mild increase (p=0.046),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09052,rs177482,9,99845815,APP,SNP (A/G),(A/,A,1.97,1.58,2.26,0.00579301,Protective,0.396,0.137,0.083,0.184,Variable effect (p=0.006),Mild decrease (p=0.042),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09053,rs626029,6,143976515,PSEN2,SNP (C/T),(C/,C,0.84,0.53,1.14,0.00208069,High,0.124,0.142,0.042,0.492,Mild increase (p=0.042),Mild decrease (p=0.008),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09054,rs378928,6,98407966,CR1,SNP (C/G),(C/,C,0.54,0.34,0.86,0.05396368,Moderate,0.711,0.024,0.02,0.045,Significant increase (p=0.004),Significant increase (p=0.047),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09055,rs930353,12,178166516,CD2AP,SNP (A/G),(A/,A,0.82,0.57,1.15,0.03321646,High,0.302,0.436,0.015,0.047,Variable effect (p=0.037),Mild decrease (p=0.001),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09056,rs705193,19,53171356,CD33,Insertion,-,-,1.21,0.84,1.52,0.08669228,High,0.105,0.123,0.235,0.337,Significant decrease (p=0.003),Variable effect (p=0.024),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP09057,rs819256,3,142883184,PSEN2,SNP (C/G),(C/,C,0.47,0.11,0.75,0.00692253,Moderate,0.163,0.157,0.41,0.07,Mild increase (p=0.019),Mild increase (p=0.028),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP09058,rs786510,10,184080454,APOE,Insertion,-,-,1.55,1.21,1.8,0.01371959,High,0.105,0.257,0.159,0.279,Significant increase (p=0.013),Variable effect (p=0.038),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09059,rs346659,6,222850666,PICALM,SNP (C/T),(C/,C,1.56,1.24,1.77,0.0301698,Unknown,0.039,0.604,0.13,0.027,Significant decrease (p=0.023),Significant increase (p=0.021),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09060,rs513548,4,197610806,SORL1,SNP (A/C),(A/,A,1.34,1.08,1.67,0.01926403,Low,0.489,0.104,0.195,0.012,Significant decrease (p=0.041),Variable effect (p=0.023),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP09061,rs219092,20,2513998,CD33,SNP (C/G),(C/,C,1.09,0.8,1.39,0.04372677,High,0.623,0.063,0.083,0.031,Mild increase (p=0.017),Significant decrease (p=0.02),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09062,rs309735,15,74454332,TREM2,SNP (A/C),(A/,A,1.35,1.05,1.58,0.00485299,Moderate,0.047,0.237,0.443,0.074,Variable effect (p=0.046),No significant pattern (p=0.029),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09063,rs186856,10,47385333,BIN1,SNP (A/G),(A/,A,0.56,0.19,0.8,0.02960008,Moderate,0.142,0.063,0.313,0.282,Significant decrease (p=0.041),Significant decrease (p=0.036),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09064,rs268299,9,127495433,APOE,SNP (G/T),(G/,G,0.8,0.41,1.0,0.00802762,High,0.083,0.171,0.204,0.343,Significant decrease (p=0.039),Significant decrease (p=0.009),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09065,rs436688,4,234288746,CLU,SNP (C/T),(C/,C,1.73,1.47,1.98,0.04841559,High,0.44,0.04,0.315,0.004,Mild increase (p=0.026),Mild decrease (p=0.032),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09066,rs621063,21,26838589,TREM2,SNP (G/T),(G/,G,0.85,0.48,1.11,0.01746115,Moderate,0.155,0.253,0.139,0.253,Significant increase (p=0.031),Mild increase (p=0.05),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09067,rs797934,4,84844690,EPHA1,SNP (G/T),(G/,G,0.92,0.55,1.29,0.00805108,Low,0.339,0.277,0.171,0.013,Variable effect (p=0.04),Mild decrease (p=0.038),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09068,rs911799,14,89013909,ABCA7,SNP (A/G),(A/,A,0.49,0.14,0.77,0.00053873,Moderate,0.507,0.054,0.236,0.002,Significant increase (p=0.034),Mild decrease (p=0.026),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09069,rs405693,14,246459534,APP,SNP (G/T),(G/,G,0.8,0.41,1.15,0.11391228,Moderate,0.104,0.479,0.006,0.211,Mild decrease (p=0.017),Significant increase (p=0.022),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09070,rs823792,17,199398324,SORL1,SNP (A/T),(A/,A,1.3,0.92,1.65,0.06097159,Moderate,0.484,0.201,0.064,0.052,Variable effect (p=0.012),Variable effect (p=0.046),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09071,rs309868,20,36343738,APOE,SNP (C/T),(C/,C,0.51,0.12,0.72,0.00461774,Unknown,0.35,0.119,0.188,0.142,Significant increase (p=0.023),Mild increase (p=0.028),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09072,rs711819,19,34051458,CLU,SNP (C/T),(C/,C,1.14,0.8,1.38,0.03311751,Moderate,0.34,0.399,0.053,0.008,Significant decrease (p=0.037),Variable effect (p=0.05),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09073,rs980324,2,109734408,APP,SNP (G/T),(G/,G,0.55,0.27,0.9,0.00477892,Moderate,0.166,0.308,0.06,0.267,Significant decrease (p=0.036),Variable effect (p=0.027),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09074,rs917233,3,105977642,APP,Deletion,-,-,0.99,0.65,1.36,0.06181647,Moderate,0.074,0.146,0.012,0.568,Significant decrease (p=0.03),Mild increase (p=0.045),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09075,rs205183,10,16092859,EPHA1,SNP (A/T),(A/,A,0.73,0.46,1.08,0.00987642,High,0.073,0.43,0.096,0.201,Significant increase (p=0.005),Variable effect (p=0.044),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09076,rs233748,15,142142729,TREM2,SNP (C/G),(C/,C,0.39,0.16,0.74,0.06628244,Moderate,0.416,0.22,0.102,0.062,Mild increase (p=0.01),Variable effect (p=0.028),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09077,rs386166,18,112951197,CD2AP,SNP (A/C),(A/,A,0.75,0.4,1.08,0.10016261,Moderate,0.148,0.113,0.532,0.007,Mild decrease (p=0.023),No significant pattern (p=0.001),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09078,rs712122,1,147415854,CLU,Deletion,-,-,1.21,1.0,1.43,0.00277612,Low,0.154,0.424,0.148,0.074,Mild increase (p=0.007),Mild increase (p=0.021),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09079,rs169030,18,36503180,CR1,SNP (A/C),(A/,A,0.5,0.26,0.79,0.06151578,High,0.19,0.05,0.494,0.066,Significant increase (p=0.016),Significant decrease (p=0.013),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09080,rs128637,15,27067086,MS4A6A,SNP (A/G),(A/,A,1.16,0.86,1.41,0.06669152,Protective,0.429,0.0,0.337,0.034,Mild increase (p=0.033),Mild increase (p=0.012),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP09081,rs281847,8,152338303,BIN1,SNP (C/T),(C/,C,0.73,0.41,0.95,0.00233888,Protective,0.314,0.097,0.137,0.252,No significant pattern (p=0.025),Mild increase (p=0.031),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09082,rs917068,20,82203366,PICALM,SNP (A/C),(A/,A,0.83,0.57,1.11,0.00044031,High,0.312,0.079,0.163,0.246,Significant decrease (p=0.041),Significant decrease (p=0.002),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP09083,rs517000,11,59809520,PTK2B,SNP (A/T),(A/,A,1.01,0.7,1.24,0.17440052,Moderate,0.44,0.19,0.008,0.162,Variable effect (p=0.012),Significant decrease (p=0.031),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09084,rs594624,5,199137644,PICALM,Insertion,-,-,1.56,1.25,1.91,0.07170326,Low,0.346,0.055,0.31,0.09,Mild increase (p=0.018),No significant pattern (p=0.045),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09085,rs770085,22,68261438,BIN1,SNP (C/T),(C/,C,1.25,0.89,1.5,0.00843514,Protective,0.146,0.294,0.22,0.14,Mild decrease (p=0.016),No significant pattern (p=0.043),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09086,rs508072,9,202031982,MS4A6A,SNP (C/G),(C/,C,0.58,0.35,0.84,0.02676429,Unknown,0.028,0.504,0.152,0.116,No significant pattern (p=0.023),Mild increase (p=0.041),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09087,rs204590,11,33372201,ABCA7,SNP (A/C),(A/,A,0.92,0.54,1.29,0.01263853,Protective,0.122,0.004,0.134,0.54,Significant increase (p=0.049),Mild increase (p=0.012),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09088,rs941329,7,191568437,EPHA1,SNP (A/C),(A/,A,1.08,0.73,1.32,0.00010217,High,0.295,0.198,0.255,0.052,Mild decrease (p=0.04),No significant pattern (p=0.026),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09089,rs963321,16,204928065,MS4A6A,SNP (A/C),(A/,A,0.48,0.22,0.73,0.1040253,High,0.008,0.228,0.365,0.199,Significant decrease (p=0.044),Significant decrease (p=0.012),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09090,rs265713,15,236074338,PSEN2,SNP (C/T),(C/,C,1.54,1.16,1.89,0.06792033,Moderate,0.22,0.151,0.324,0.105,Mild decrease (p=0.038),Mild increase (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09091,rs960723,2,238892019,APP,SNP (A/G),(A/,A,1.74,1.49,2.13,0.06496324,High,0.336,0.03,0.431,0.002,Significant decrease (p=0.011),Mild decrease (p=0.042),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP09092,rs305393,22,150203900,PSEN2,Insertion,-,-,1.1,0.74,1.44,0.03472333,Moderate,0.16,0.003,0.336,0.302,Significant decrease (p=0.009),Mild decrease (p=0.043),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09093,rs589587,2,165018450,CR1,SNP (A/T),(A/,A,1.03,0.63,1.25,0.01493406,Moderate,0.378,0.349,0.02,0.053,Mild increase (p=0.016),Variable effect (p=0.019),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09094,rs208747,11,76423087,PICALM,SNP (A/C),(A/,A,1.18,0.89,1.51,0.07674937,Moderate,0.001,0.396,0.066,0.337,No significant pattern (p=0.033),Significant decrease (p=0.033),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09095,rs143961,6,233985400,MS4A6A,SNP (G/T),(G/,G,0.81,0.42,1.21,0.06302655,High,0.023,0.289,0.379,0.11,No significant pattern (p=0.034),Significant increase (p=0.042),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP09096,rs982669,22,142794493,SORL1,SNP (C/G),(C/,C,1.83,1.55,2.14,0.09046654,Protective,0.022,0.344,0.237,0.197,Significant decrease (p=0.024),No significant pattern (p=0.026),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09097,rs551301,1,169625575,MS4A6A,SNP (A/C),(A/,A,0.71,0.42,1.08,0.02615239,Low,0.404,0.115,0.223,0.057,Significant decrease (p=0.007),Significant decrease (p=0.017),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09098,rs773322,8,56438636,PICALM,SNP (A/C),(A/,A,1.09,0.81,1.48,0.00242969,High,0.357,0.114,0.313,0.016,Mild decrease (p=0.003),Significant decrease (p=0.038),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP09099,rs689266,17,107971943,BIN1,SNP (C/G),(C/,C,1.62,1.39,1.89,0.00615733,Protective,0.105,0.14,0.264,0.291,Variable effect (p=0.046),Significant increase (p=0.01),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09100,rs311346,17,25847358,CR1,SNP (A/T),(A/,A,2.47,2.27,2.7,0.01396335,Low,0.032,0.095,0.347,0.325,No significant pattern (p=0.013),No significant pattern (p=0.012),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09101,rs321808,6,15354992,CD33,SNP (A/T),(A/,A,0.43,0.1,0.79,0.01257287,Protective,0.157,0.385,0.186,0.071,Significant increase (p=0.028),Significant increase (p=0.034),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09102,rs440139,9,161339304,ABCA7,SNP (A/T),(A/,A,2.58,2.18,2.93,0.03803648,Moderate,0.121,0.572,0.016,0.091,Mild increase (p=0.016),Mild increase (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09103,rs791176,3,178178488,EPHA1,Insertion,-,-,1.2,0.87,1.4,0.02370981,High,0.167,0.052,0.227,0.354,Significant decrease (p=0.024),Mild increase (p=0.03),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09104,rs203616,12,43152641,TREM2,SNP (A/T),(A/,A,0.95,0.65,1.23,0.02216974,High,0.026,0.376,0.318,0.08,No significant pattern (p=0.023),Variable effect (p=0.022),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09105,rs452262,7,80195638,CD2AP,SNP (C/G),(C/,C,1.05,0.69,1.41,0.00188897,High,0.068,0.258,0.177,0.297,Mild decrease (p=0.023),No significant pattern (p=0.005),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP09106,rs273674,13,180723404,CLU,SNP (A/C),(A/,A,0.75,0.53,0.98,0.0447369,Low,0.015,0.22,0.438,0.127,Mild decrease (p=0.017),Significant increase (p=0.003),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09107,rs400955,14,176450669,TREM2,SNP (A/C),(A/,A,1.03,0.69,1.27,0.00267671,Moderate,0.336,0.09,0.125,0.25,Significant increase (p=0.006),Significant increase (p=0.034),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09108,rs203406,12,128140339,ABCA7,SNP (C/G),(C/,C,1.15,0.92,1.39,0.03150973,Low,0.233,0.218,0.15,0.198,No significant pattern (p=0.038),Significant decrease (p=0.026),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09109,rs693736,11,215383392,MS4A6A,SNP (A/G),(A/,A,2.95,2.62,3.28,0.10929228,High,0.232,0.25,0.082,0.236,Significant decrease (p=0.013),Mild decrease (p=0.048),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09110,rs360988,5,2948403,CLU,SNP (A/G),(A/,A,1.83,1.55,2.22,0.12042482,High,0.188,0.283,0.14,0.189,Variable effect (p=0.005),Mild increase (p=0.034),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09111,rs216417,15,230223056,CLU,SNP (A/C),(A/,A,0.77,0.46,1.12,0.04166526,High,0.075,0.036,0.518,0.171,Significant decrease (p=0.041),Mild decrease (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09112,rs305033,7,57538234,APP,SNP (A/T),(A/,A,0.72,0.36,1.08,0.01137754,High,0.209,0.068,0.172,0.351,Significant increase (p=0.008),No significant pattern (p=0.023),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09113,rs609543,9,20275523,SORL1,SNP (A/C),(A/,A,0.54,0.28,0.89,0.00357387,Moderate,0.144,0.072,0.362,0.222,Mild increase (p=0.02),Mild increase (p=0.021),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09114,rs242512,1,16419139,CD33,SNP (A/T),(A/,A,0.84,0.57,1.15,0.01171512,Moderate,0.258,0.296,0.231,0.015,Mild increase (p=0.028),Significant increase (p=0.028),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09115,rs115325,7,126881903,ABCA7,SNP (G/T),(G/,G,1.55,1.17,1.93,0.05263327,Moderate,0.021,0.33,0.305,0.144,Significant increase (p=0.027),Mild increase (p=0.031),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09116,rs683266,2,176204333,CD2AP,SNP (C/T),(C/,C,1.22,0.85,1.58,0.01259786,Moderate,0.45,0.047,0.151,0.152,Mild increase (p=0.043),Mild increase (p=0.025),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09117,rs877242,2,87363498,CLU,SNP (C/G),(C/,C,1.17,0.77,1.52,0.05906652,Low,0.21,0.044,0.095,0.451,Mild decrease (p=0.045),Mild increase (p=0.042),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09118,rs691132,10,115664043,APP,Deletion,-,-,0.68,0.34,0.93,0.00226312,Moderate,0.136,0.15,0.427,0.087,Significant decrease (p=0.048),Mild increase (p=0.03),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09119,rs105164,21,140202545,MS4A6A,SNP (C/G),(C/,C,0.73,0.41,1.09,0.01005482,Moderate,0.207,0.355,0.189,0.049,Mild decrease (p=0.001),Variable effect (p=0.009),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP09120,rs516269,4,57244857,TREM2,SNP (A/T),(A/,A,0.72,0.35,0.97,0.01561706,Low,0.191,0.119,0.28,0.211,Mild decrease (p=0.011),Significant increase (p=0.025),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09121,rs815236,11,32742904,TREM2,SNP (C/G),(C/,C,0.79,0.55,1.06,0.00946336,Low,0.046,0.297,0.17,0.287,Mild decrease (p=0.011),Variable effect (p=0.002),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09122,rs862690,17,88062721,CD2AP,Insertion,-,-,0.55,0.26,0.83,0.0025334,Protective,0.414,0.188,0.168,0.029,No significant pattern (p=0.029),Variable effect (p=0.023),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09123,rs542655,17,119852476,EPHA1,SNP (A/T),(A/,A,0.95,0.64,1.26,0.00630979,High,0.562,0.141,0.075,0.022,Significant increase (p=0.045),Significant decrease (p=0.03),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09124,rs106837,20,59384427,MS4A6A,SNP (C/T),(C/,C,1.06,0.85,1.37,0.06583502,Protective,0.069,0.554,0.117,0.059,No significant pattern (p=0.027),No significant pattern (p=0.031),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09125,rs182024,22,151037952,MS4A6A,SNP (A/T),(A/,A,1.26,0.87,1.54,0.05155699,Low,0.497,0.055,0.015,0.233,Significant increase (p=0.036),Significant decrease (p=0.04),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09126,rs524478,4,176787486,APOE,SNP (A/T),(A/,A,0.8,0.51,1.14,0.09220806,Moderate,0.053,0.326,0.01,0.412,No significant pattern (p=0.029),Significant decrease (p=0.039),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP09127,rs912576,3,4935957,CLU,SNP (G/T),(G/,G,0.97,0.75,1.24,0.03181519,Protective,0.243,0.247,0.141,0.168,Significant increase (p=0.014),Significant decrease (p=0.036),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09128,rs496207,8,64566122,CD33,SNP (A/T),(A/,A,1.88,1.64,2.26,0.00162935,High,0.32,0.012,0.263,0.205,Significant increase (p=0.025),Mild decrease (p=0.047),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09129,rs449190,9,155824161,MS4A6A,SNP (C/G),(C/,C,0.61,0.28,0.92,0.01416947,High,0.192,0.033,0.388,0.188,Variable effect (p=0.003),Mild decrease (p=0.041),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09130,rs573548,22,105353548,APOE,SNP (G/T),(G/,G,1.22,0.89,1.52,0.00090244,Moderate,0.113,0.139,0.273,0.275,Variable effect (p=0.029),Variable effect (p=0.021),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09131,rs762232,22,120755259,BIN1,SNP (A/G),(A/,A,0.75,0.49,1.05,0.00378545,Low,0.188,0.104,0.021,0.487,Mild increase (p=0.043),No significant pattern (p=0.002),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09132,rs357967,20,181011986,CLU,Deletion,-,-,1.04,0.69,1.4,0.03985818,Unknown,0.056,0.674,0.061,0.01,Significant decrease (p=0.004),Mild decrease (p=0.012),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09133,rs777477,18,55252799,APOE,Deletion,-,-,0.47,0.26,0.84,0.02400479,High,0.337,0.23,0.014,0.218,No significant pattern (p=0.036),No significant pattern (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP09134,rs168441,20,130517781,CR1,Deletion,-,-,1.1,0.72,1.49,0.00010667,High,0.074,0.066,0.032,0.628,Significant increase (p=0.041),Significant decrease (p=0.041),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09135,rs851497,11,167338792,CLU,SNP (A/T),(A/,A,0.57,0.28,0.95,0.05616697,Protective,0.35,0.196,0.066,0.188,No significant pattern (p=0.05),Significant decrease (p=0.015),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09136,rs500725,18,14417415,TREM2,SNP (G/T),(G/,G,0.54,0.32,0.8,0.02689429,Moderate,0.178,0.156,0.429,0.037,Significant decrease (p=0.027),Mild increase (p=0.044),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09137,rs638560,6,163349054,EPHA1,SNP (C/T),(C/,C,0.87,0.6,1.11,0.00465517,High,0.043,0.031,0.65,0.076,Mild increase (p=0.002),Significant increase (p=0.018),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09138,rs391838,2,241636163,BIN1,SNP (A/G),(A/,A,0.93,0.73,1.21,0.01105492,Moderate,0.261,0.324,0.136,0.079,Mild decrease (p=0.033),No significant pattern (p=0.039),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09139,rs936457,1,34843568,APOE,SNP (A/T),(A/,A,0.94,0.56,1.2,0.03091143,Moderate,0.199,0.248,0.089,0.263,Mild decrease (p=0.044),Significant increase (p=0.002),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09140,rs326694,7,198069360,PICALM,SNP (A/C),(A/,A,0.68,0.36,0.94,0.02076384,Low,0.367,0.155,0.135,0.143,Mild decrease (p=0.047),No significant pattern (p=0.012),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09141,rs109334,12,191358609,BIN1,SNP (A/C),(A/,A,2.01,1.74,2.3,0.00032228,High,0.233,0.015,0.374,0.178,Significant decrease (p=0.025),Mild increase (p=0.03),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09142,rs768560,3,23175279,BIN1,SNP (C/G),(C/,C,1.14,0.91,1.52,0.09341353,Moderate,0.054,0.284,0.143,0.32,Mild decrease (p=0.038),Significant increase (p=0.007),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09143,rs312058,5,167561679,PSEN2,SNP (A/T),(A/,A,0.42,0.11,0.8,0.05670196,Protective,0.397,0.018,0.106,0.279,Variable effect (p=0.005),Significant increase (p=0.009),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09144,rs786165,6,233645583,CD2AP,Insertion,-,-,0.52,0.13,0.8,0.01728571,Moderate,0.167,0.419,0.099,0.115,Significant decrease (p=0.047),Significant increase (p=0.008),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09145,rs214733,8,224527066,PTK2B,SNP (C/G),(C/,C,1.75,1.52,2.1,0.05392322,Low,0.035,0.516,0.233,0.016,Mild decrease (p=0.002),Mild increase (p=0.042),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09146,rs817500,16,219488250,BIN1,SNP (A/T),(A/,A,1.16,0.9,1.46,0.08823768,Low,0.126,0.483,0.189,0.002,Mild increase (p=0.013),Significant decrease (p=0.001),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09147,rs536137,6,26541757,TREM2,SNP (C/T),(C/,C,0.83,0.47,1.22,0.08066934,Moderate,0.275,0.115,0.171,0.239,Mild increase (p=0.017),Significant decrease (p=0.014),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09148,rs148539,5,211893127,PSEN2,SNP (C/T),(C/,C,1.44,1.07,1.83,0.0014723,High,0.132,0.023,0.012,0.633,Variable effect (p=0.003),Significant increase (p=0.04),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09149,rs298167,4,34296947,CLU,Deletion,-,-,0.85,0.45,1.06,0.08431913,Protective,0.008,0.235,0.103,0.454,Variable effect (p=0.038),Mild increase (p=0.007),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09150,rs162288,15,218416931,SORL1,Insertion,-,-,0.37,0.1,0.72,0.06971035,Unknown,0.015,0.371,0.017,0.397,Mild increase (p=0.039),No significant pattern (p=0.025),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09151,rs382626,16,239736864,MS4A6A,SNP (A/C),(A/,A,0.93,0.64,1.18,0.01748433,High,0.225,0.076,0.289,0.21,Mild increase (p=0.017),No significant pattern (p=0.002),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09152,rs978467,18,166452296,TREM2,SNP (C/T),(C/,C,0.88,0.65,1.26,0.00508279,High,0.391,0.026,0.334,0.048,Significant increase (p=0.01),No significant pattern (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09153,rs484470,12,126142269,TREM2,Deletion,-,-,1.12,0.74,1.49,0.01191177,Moderate,0.051,0.26,0.029,0.46,No significant pattern (p=0.015),Variable effect (p=0.035),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09154,rs265124,13,43670135,MS4A6A,SNP (A/G),(A/,A,0.41,0.11,0.76,0.03461194,High,0.014,0.285,0.481,0.02,Variable effect (p=0.026),Significant decrease (p=0.029),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09155,rs895661,7,176898361,PICALM,Insertion,-,-,1.7,1.41,2.0,0.02879414,Moderate,0.298,0.207,0.018,0.277,Variable effect (p=0.035),Significant decrease (p=0.016),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP09156,rs840407,7,151059160,APOE,SNP (A/G),(A/,A,0.71,0.49,1.02,0.02437796,High,0.166,0.177,0.034,0.424,Mild decrease (p=0.002),Variable effect (p=0.005),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP09157,rs336363,13,36126511,SORL1,SNP (C/G),(C/,C,0.83,0.61,1.2,0.01964698,Low,0.526,0.162,0.091,0.021,Mild decrease (p=0.014),Variable effect (p=0.024),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09158,rs764952,5,91111017,PSEN2,Deletion,-,-,0.84,0.54,1.11,0.00020753,Low,0.045,0.282,0.269,0.203,Mild increase (p=0.02),Mild increase (p=0.034),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09159,rs392552,15,21199546,SORL1,Insertion,-,-,0.24,0.1,0.55,0.0148768,Moderate,0.014,0.406,0.29,0.09,Significant increase (p=0.018),Variable effect (p=0.048),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09160,rs776825,7,117970690,CLU,Deletion,-,-,1.2,0.88,1.48,0.03046161,High,0.381,0.147,0.109,0.162,Significant increase (p=0.047),No significant pattern (p=0.035),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09161,rs744877,21,55792250,PTK2B,SNP (A/C),(A/,A,0.68,0.41,0.9,0.00281956,Moderate,0.333,0.123,0.279,0.065,Significant increase (p=0.003),Significant increase (p=0.006),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09162,rs638341,21,119035339,PSEN2,SNP (A/C),(A/,A,1.49,1.28,1.75,0.08338418,Protective,0.24,0.389,0.02,0.151,No significant pattern (p=0.018),Mild increase (p=0.029),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09163,rs203879,16,60923386,APOE,Insertion,-,-,1.6,1.37,1.98,0.00827018,Moderate,0.071,0.043,0.603,0.084,Significant increase (p=0.046),No significant pattern (p=0.036),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09164,rs355025,10,189473272,CD33,SNP (C/T),(C/,C,1.29,1.02,1.62,0.06959194,Low,0.153,0.18,0.154,0.314,Significant decrease (p=0.029),Mild increase (p=0.024),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09165,rs328550,22,190564748,APP,SNP (A/G),(A/,A,0.72,0.38,0.98,0.01306963,High,0.324,0.128,0.344,0.004,No significant pattern (p=0.033),Variable effect (p=0.039),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09166,rs949256,19,180435257,MS4A6A,SNP (A/G),(A/,A,3.19,2.97,3.46,0.04786925,Protective,0.527,0.049,0.2,0.024,No significant pattern (p=0.002),Mild increase (p=0.046),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP09167,rs777113,4,120996034,PTK2B,SNP (A/C),(A/,A,0.57,0.19,0.92,0.04394139,High,0.254,0.043,0.384,0.119,Variable effect (p=0.049),Significant decrease (p=0.035),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09168,rs631758,9,116434800,MS4A6A,SNP (A/C),(A/,A,0.65,0.44,0.86,0.01214748,Moderate,0.441,0.3,0.013,0.046,Mild increase (p=0.038),No significant pattern (p=0.008),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP09169,rs312398,15,122653540,PSEN2,SNP (C/G),(C/,C,1.48,1.11,1.71,0.00533146,Moderate,0.24,0.086,0.401,0.073,Mild decrease (p=0.032),Significant increase (p=0.02),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09170,rs139424,18,67834485,EPHA1,SNP (A/G),(A/,A,0.62,0.26,1.0,0.05334935,Moderate,0.256,0.227,0.103,0.213,No significant pattern (p=0.016),Variable effect (p=0.019),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09171,rs836041,8,189893176,CR1,SNP (C/G),(C/,C,1.06,0.75,1.36,0.0166904,Moderate,0.01,0.01,0.324,0.457,Significant increase (p=0.015),Variable effect (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09172,rs337808,7,125338439,CR1,Deletion,-,-,1.26,0.92,1.62,0.03934192,Moderate,0.298,0.102,0.388,0.012,Mild decrease (p=0.011),No significant pattern (p=0.015),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09173,rs554675,12,183405398,PICALM,SNP (A/C),(A/,A,1.98,1.6,2.29,0.03726471,Low,0.037,0.199,0.444,0.12,Variable effect (p=0.018),No significant pattern (p=0.027),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09174,rs730038,22,30901635,MS4A6A,SNP (C/T),(C/,C,0.53,0.16,0.92,0.00329717,Protective,0.244,0.035,0.36,0.162,Mild increase (p=0.043),Significant decrease (p=0.004),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09175,rs329407,6,220231288,CLU,SNP (A/T),(A/,A,0.54,0.3,0.91,0.01168689,Low,0.01,0.233,0.162,0.394,Variable effect (p=0.045),No significant pattern (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09176,rs897782,10,94214884,PSEN2,SNP (A/T),(A/,A,0.92,0.71,1.32,0.01598776,Unknown,0.428,0.137,0.178,0.057,Variable effect (p=0.025),Mild decrease (p=0.02),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09177,rs350314,18,156251624,EPHA1,SNP (G/T),(G/,G,0.68,0.35,0.93,0.02102264,Moderate,0.004,0.55,0.199,0.047,Mild decrease (p=0.01),Significant increase (p=0.007),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09178,rs356622,18,93533177,TREM2,SNP (A/T),(A/,A,2.05,1.72,2.29,0.06570934,Moderate,0.302,0.07,0.005,0.423,Variable effect (p=0.007),Significant decrease (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09179,rs890135,2,39823090,APP,Insertion,-,-,0.59,0.19,0.98,0.03839901,Protective,0.13,0.191,0.274,0.205,Mild decrease (p=0.025),Significant increase (p=0.007),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09180,rs972727,14,68260499,APP,SNP (A/T),(A/,A,1.75,1.47,2.04,0.00465638,Protective,0.009,0.416,0.011,0.364,Mild increase (p=0.028),No significant pattern (p=0.017),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09181,rs374235,1,87729629,PICALM,SNP (G/T),(G/,G,1.6,1.21,1.88,0.0037932,Low,0.498,0.089,0.092,0.121,Mild decrease (p=0.048),No significant pattern (p=0.013),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09182,rs766390,20,58987899,CD2AP,SNP (A/G),(A/,A,1.26,0.94,1.5,0.03709336,High,0.114,0.032,0.097,0.556,Mild decrease (p=0.001),No significant pattern (p=0.038),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09183,rs949180,16,24185827,SORL1,Deletion,-,-,0.76,0.53,0.99,0.01835894,High,0.056,0.036,0.16,0.547,Mild decrease (p=0.033),Variable effect (p=0.003),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP09184,rs323659,11,194500957,TREM2,SNP (A/G),(A/,A,0.28,0.1,0.64,0.03046435,Moderate,0.017,0.452,0.091,0.24,Variable effect (p=0.005),Mild increase (p=0.002),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09185,rs844379,19,60344865,APP,Deletion,-,-,0.41,0.1,0.8,0.0076352,Low,0.017,0.183,0.346,0.254,No significant pattern (p=0.012),Mild increase (p=0.014),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP09186,rs887515,10,170752750,ABCA7,SNP (C/G),(C/,C,0.69,0.34,1.06,0.00100509,High,0.031,0.48,0.041,0.248,Mild increase (p=0.018),No significant pattern (p=0.039),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09187,rs701786,22,220033671,SORL1,SNP (C/G),(C/,C,0.49,0.1,0.84,0.02478974,High,0.44,0.137,0.163,0.06,Significant decrease (p=0.046),Mild decrease (p=0.033),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP09188,rs592171,1,95472968,CR1,SNP (A/G),(A/,A,0.74,0.44,0.97,0.02784643,Moderate,0.176,0.022,0.239,0.363,Significant decrease (p=0.041),Variable effect (p=0.004),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09189,rs210231,20,234797517,CLU,SNP (A/G),(A/,A,0.54,0.27,0.89,0.0153814,Unknown,0.227,0.163,0.4,0.01,Significant increase (p=0.015),Variable effect (p=0.04),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09190,rs913722,20,200134009,CLU,Insertion,-,-,1.41,1.19,1.8,0.04200726,High,0.178,0.296,0.207,0.118,Mild increase (p=0.024),Mild increase (p=0.027),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP09191,rs872730,5,192080692,PTK2B,SNP (A/T),(A/,A,1.67,1.32,2.03,0.01946567,Low,0.133,0.53,0.1,0.037,Mild increase (p=0.002),Variable effect (p=0.023),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09192,rs599156,21,37323656,PTK2B,Insertion,-,-,1.61,1.31,1.88,0.0115689,Moderate,0.393,0.268,0.034,0.104,Significant increase (p=0.032),No significant pattern (p=0.033),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09193,rs673702,2,230203209,MS4A6A,Insertion,-,-,3.47,3.16,3.84,0.07890303,Moderate,0.02,0.014,0.35,0.417,No significant pattern (p=0.028),Mild decrease (p=0.016),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09194,rs938891,17,43278217,PICALM,SNP (A/T),(A/,A,1.14,0.81,1.37,0.05950223,Moderate,0.107,0.46,0.16,0.073,No significant pattern (p=0.037),Mild decrease (p=0.002),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09195,rs910838,6,27543843,PTK2B,Deletion,-,-,2.45,2.19,2.67,0.0464347,High,0.246,0.041,0.363,0.15,Mild decrease (p=0.042),Significant decrease (p=0.013),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09196,rs429960,21,243906654,SORL1,SNP (A/T),(A/,A,0.83,0.51,1.11,0.03925908,High,0.365,0.309,0.035,0.092,Significant increase (p=0.04),Significant increase (p=0.043),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09197,rs235045,7,157835148,BIN1,Deletion,-,-,0.81,0.5,1.19,0.0299509,Low,0.061,0.189,0.049,0.502,Mild decrease (p=0.009),Significant increase (p=0.046),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09198,rs717336,11,219975175,SORL1,SNP (C/T),(C/,C,0.73,0.38,1.05,0.03310821,Protective,0.048,0.26,0.427,0.065,No significant pattern (p=0.025),Mild increase (p=0.044),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09199,rs189767,15,241911373,SORL1,SNP (G/T),(G/,G,0.43,0.23,0.66,0.02780189,Low,0.177,0.139,0.341,0.142,No significant pattern (p=0.029),Mild decrease (p=0.017),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09200,rs613013,19,228935399,BIN1,SNP (A/T),(A/,A,0.56,0.29,0.87,0.10550434,Low,0.28,0.218,0.23,0.072,Mild decrease (p=0.029),Mild decrease (p=0.035),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09201,rs994060,8,227391353,APOE,SNP (C/T),(C/,C,0.94,0.62,1.21,0.01038965,Protective,0.289,0.255,0.169,0.087,Significant decrease (p=0.034),No significant pattern (p=0.01),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP09202,rs868607,17,241653661,PSEN2,SNP (A/T),(A/,A,0.9,0.52,1.2,0.12897171,Moderate,0.52,0.102,0.025,0.153,No significant pattern (p=0.032),Mild decrease (p=0.021),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09203,rs372538,4,47846595,BIN1,SNP (A/T),(A/,A,1.47,1.13,1.76,0.03808272,Moderate,0.132,0.272,0.153,0.243,Mild decrease (p=0.018),No significant pattern (p=0.021),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09204,rs958767,3,171019754,CR1,Deletion,-,-,1.43,1.13,1.64,0.06146557,Moderate,0.021,0.176,0.207,0.396,Significant increase (p=0.042),Mild decrease (p=0.004),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP09205,rs826362,9,245346167,EPHA1,SNP (C/T),(C/,C,1.29,1.05,1.66,0.01517129,Protective,0.105,0.015,0.397,0.282,Significant decrease (p=0.002),Variable effect (p=0.004),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09206,rs945453,16,61632440,ABCA7,SNP (A/C),(A/,A,0.73,0.34,1.03,0.14278025,Moderate,0.035,0.507,0.028,0.231,Variable effect (p=0.013),No significant pattern (p=0.002),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09207,rs693016,6,23831298,EPHA1,SNP (C/G),(C/,C,0.57,0.25,0.82,0.02812542,High,0.133,0.364,0.031,0.272,Significant decrease (p=0.047),Mild decrease (p=0.002),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP09208,rs619825,19,233522646,ABCA7,SNP (G/T),(G/,G,0.32,0.1,0.65,0.08814599,Moderate,0.219,0.031,0.053,0.497,Variable effect (p=0.029),No significant pattern (p=0.013),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09209,rs329814,15,191177569,BIN1,Insertion,-,-,1.88,1.66,2.11,0.02624281,High,0.334,0.205,0.14,0.121,Mild increase (p=0.049),Significant decrease (p=0.003),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09210,rs232509,11,19883703,CD33,SNP (C/G),(C/,C,1.56,1.31,1.86,0.05510256,Moderate,0.042,0.549,0.018,0.191,Significant increase (p=0.034),Mild decrease (p=0.038),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09211,rs240899,18,94787001,PICALM,SNP (A/C),(A/,A,1.32,1.01,1.67,0.03987181,Protective,0.186,0.129,0.083,0.401,Mild decrease (p=0.017),Variable effect (p=0.035),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP09212,rs245573,22,21269053,SORL1,SNP (C/T),(C/,C,1.44,1.15,1.68,0.01656984,High,0.335,0.313,0.022,0.13,Significant decrease (p=0.044),Mild decrease (p=0.006),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09213,rs585468,13,27488633,CR1,SNP (A/C),(A/,A,0.93,0.66,1.18,0.0159463,High,0.2,0.56,0.037,0.003,No significant pattern (p=0.011),Significant increase (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09214,rs511623,15,128791572,CD2AP,SNP (C/G),(C/,C,2.26,1.87,2.49,0.00254692,Low,0.428,0.275,0.003,0.094,No significant pattern (p=0.004),Variable effect (p=0.022),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09215,rs870276,14,15734820,TREM2,SNP (A/T),(A/,A,2.51,2.31,2.77,0.0325043,Low,0.426,0.016,0.032,0.326,Mild increase (p=0.045),Mild increase (p=0.015),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09216,rs423210,18,66162116,BIN1,Deletion,-,-,0.29,0.1,0.54,0.02115432,Low,0.222,0.243,0.129,0.206,Mild increase (p=0.009),Significant increase (p=0.002),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP09217,rs492880,11,208781419,CD33,Insertion,-,-,1.12,0.73,1.37,0.05000597,Low,0.093,0.151,0.333,0.223,Significant increase (p=0.02),No significant pattern (p=0.043),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09218,rs416855,12,210893831,MS4A6A,SNP (A/G),(A/,A,0.9,0.56,1.2,0.0429211,Unknown,0.166,0.313,0.249,0.072,Significant decrease (p=0.042),Significant decrease (p=0.026),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09219,rs240177,20,50215758,ABCA7,SNP (C/T),(C/,C,0.92,0.54,1.13,0.06876508,Moderate,0.155,0.094,0.454,0.097,Mild increase (p=0.03),Significant decrease (p=0.024),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09220,rs340968,1,95856199,CD2AP,SNP (A/G),(A/,A,0.57,0.32,0.95,0.00392283,Moderate,0.311,0.208,0.079,0.201,Significant decrease (p=0.016),Mild increase (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09221,rs870568,2,27218367,PTK2B,SNP (A/T),(A/,A,3.7,3.34,4.05,0.03710818,Protective,0.412,0.08,0.134,0.173,Significant decrease (p=0.019),Significant increase (p=0.016),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09222,rs701312,3,192940678,EPHA1,SNP (A/T),(A/,A,0.65,0.25,0.89,0.08213426,Protective,0.116,0.053,0.217,0.415,Significant decrease (p=0.035),Significant decrease (p=0.036),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09223,rs596938,1,138686665,MS4A6A,SNP (A/C),(A/,A,0.99,0.68,1.33,0.0117832,High,0.236,0.384,0.087,0.093,Significant increase (p=0.045),Significant decrease (p=0.017),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP09224,rs779341,7,244372157,CD33,SNP (A/C),(A/,A,1.52,1.2,1.82,0.13662185,Low,0.505,0.19,0.094,0.011,Mild increase (p=0.027),Significant decrease (p=0.023),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09225,rs530796,13,183645583,APP,SNP (A/T),(A/,A,1.78,1.54,2.12,0.01818961,Moderate,0.038,0.152,0.255,0.355,No significant pattern (p=0.046),No significant pattern (p=0.032),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09226,rs775182,15,106758520,CD2AP,SNP (A/G),(A/,A,1.29,1.07,1.58,0.06399611,Protective,0.039,0.319,0.151,0.291,Variable effect (p=0.017),Significant increase (p=0.043),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09227,rs486828,3,52687335,MS4A6A,SNP (C/T),(C/,C,2.65,2.31,2.91,0.01107768,Low,0.225,0.148,0.179,0.247,Significant increase (p=0.038),Significant increase (p=0.003),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09228,rs550743,7,57568604,CLU,SNP (A/T),(A/,A,0.64,0.38,0.95,0.01377983,Moderate,0.071,0.038,0.637,0.055,Mild increase (p=0.015),No significant pattern (p=0.011),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09229,rs180957,21,238332126,CD33,SNP (C/G),(C/,C,1.59,1.39,1.82,0.06894232,Protective,0.057,0.027,0.147,0.569,Significant increase (p=0.013),No significant pattern (p=0.016),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09230,rs812835,14,34286775,CR1,SNP (G/T),(G/,G,1.19,0.89,1.53,0.0009751,Unknown,0.189,0.271,0.042,0.297,Mild increase (p=0.021),Mild increase (p=0.026),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09231,rs265063,11,21967786,PSEN2,SNP (A/C),(A/,A,0.53,0.28,0.75,0.03171509,Moderate,0.13,0.241,0.149,0.28,Mild increase (p=0.049),Mild decrease (p=0.028),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09232,rs345968,3,242133716,SORL1,SNP (A/C),(A/,A,0.95,0.74,1.34,0.01410841,Low,0.041,0.138,0.315,0.306,Mild increase (p=0.003),Significant decrease (p=0.048),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09233,rs694075,12,238974350,EPHA1,Deletion,-,-,0.55,0.19,0.89,0.12647273,Moderate,0.536,0.15,0.062,0.052,Significant decrease (p=0.026),Significant increase (p=0.006),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09234,rs792122,14,121422212,MS4A6A,SNP (A/T),(A/,A,0.8,0.55,1.1,0.01162442,High,0.194,0.068,0.162,0.376,Significant increase (p=0.042),Significant decrease (p=0.011),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09235,rs542985,7,8329661,CD33,Deletion,-,-,2.78,2.58,3.01,0.02792417,Unknown,0.077,0.287,0.304,0.131,Significant increase (p=0.047),Significant increase (p=0.02),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09236,rs253312,21,13381530,APP,SNP (C/G),(C/,C,1.26,0.96,1.61,0.02801628,Unknown,0.183,0.19,0.267,0.159,Significant increase (p=0.023),Significant decrease (p=0.026),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09237,rs104831,7,100250911,PICALM,SNP (C/T),(C/,C,1.32,1.08,1.61,0.01454422,Moderate,0.125,0.066,0.323,0.287,Mild increase (p=0.009),Significant increase (p=0.041),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09238,rs646706,21,107608611,CD2AP,Insertion,-,-,0.74,0.37,1.11,0.01132097,Moderate,0.122,0.437,0.212,0.029,Variable effect (p=0.034),No significant pattern (p=0.016),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09239,rs187656,8,179823192,MS4A6A,SNP (A/C),(A/,A,0.71,0.42,1.08,0.04042813,Low,0.246,0.387,0.099,0.067,Variable effect (p=0.034),Mild increase (p=0.029),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09240,rs920023,10,126115469,CD2AP,SNP (A/T),(A/,A,0.63,0.33,0.98,0.07718341,Unknown,0.119,0.207,0.301,0.172,Significant decrease (p=0.031),Mild increase (p=0.03),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09241,rs684406,8,20759712,APOE,SNP (G/T),(G/,G,0.7,0.34,1.04,0.00094765,Moderate,0.059,0.346,0.391,0.004,Significant decrease (p=0.035),No significant pattern (p=0.025),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP09242,rs953070,7,155494876,PICALM,SNP (G/T),(G/,G,0.98,0.59,1.22,0.00488834,Moderate,0.298,0.085,0.305,0.112,Mild increase (p=0.045),Mild increase (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09243,rs213441,14,82147021,EPHA1,SNP (C/T),(C/,C,1.44,1.18,1.81,0.02227818,Low,0.127,0.592,0.017,0.064,Mild increase (p=0.041),Mild decrease (p=0.016),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09244,rs304152,2,148004993,CR1,SNP (G/T),(G/,G,0.4,0.18,0.76,0.04326191,Moderate,0.126,0.165,0.417,0.091,No significant pattern (p=0.009),Significant increase (p=0.048),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09245,rs889170,22,204564987,SORL1,SNP (A/C),(A/,A,0.65,0.33,0.95,0.00871664,High,0.249,0.047,0.362,0.142,Mild increase (p=0.01),Variable effect (p=0.009),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09246,rs438847,20,168158711,MS4A6A,Deletion,-,-,0.97,0.57,1.28,0.03702238,High,0.158,0.12,0.198,0.325,No significant pattern (p=0.04),No significant pattern (p=0.046),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09247,rs702285,21,159201704,SORL1,SNP (C/G),(C/,C,0.6,0.28,0.86,0.02199037,Low,0.344,0.03,0.223,0.203,Significant increase (p=0.031),Mild increase (p=0.027),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09248,rs685485,13,75654840,MS4A6A,Deletion,-,-,1.72,1.5,2.02,0.01478141,Moderate,0.157,0.016,0.219,0.408,Mild decrease (p=0.01),Variable effect (p=0.021),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09249,rs576663,19,96708368,CD2AP,Insertion,-,-,1.48,1.21,1.69,0.01638001,Moderate,0.117,0.295,0.188,0.2,Significant increase (p=0.042),Mild decrease (p=0.031),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09250,rs954037,21,34541574,BIN1,SNP (G/T),(G/,G,0.54,0.23,0.82,0.0285387,Low,0.045,0.247,0.224,0.285,Significant decrease (p=0.002),Significant decrease (p=0.012),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09251,rs414068,20,186757012,CR1,Insertion,-,-,0.34,0.1,0.7,0.03497349,Low,0.326,0.061,0.363,0.05,Variable effect (p=0.012),Significant decrease (p=0.02),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09252,rs596250,5,155878549,ABCA7,SNP (G/T),(G/,G,3.62,3.29,3.83,0.02483154,High,0.217,0.052,0.323,0.208,Mild decrease (p=0.048),Significant decrease (p=0.049),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09253,rs632765,13,120083505,CLU,Insertion,-,-,0.78,0.58,1.1,0.02476853,Moderate,0.255,0.025,0.245,0.275,No significant pattern (p=0.04),Mild decrease (p=0.003),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09254,rs395553,10,87547900,CD33,Insertion,-,-,1.06,0.71,1.44,0.00186805,Moderate,0.171,0.07,0.141,0.419,Mild decrease (p=0.008),Significant increase (p=0.016),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09255,rs923727,11,206867629,CD33,SNP (C/G),(C/,C,0.8,0.48,1.13,0.01188441,High,0.576,0.058,0.146,0.019,Significant decrease (p=0.047),Significant decrease (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09256,rs375710,9,100985805,ABCA7,SNP (C/T),(C/,C,2.19,1.98,2.45,0.01324137,Moderate,0.527,0.069,0.041,0.163,Significant decrease (p=0.013),Variable effect (p=0.008),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09257,rs633055,9,155118302,PTK2B,SNP (G/T),(G/,G,2.43,2.07,2.78,0.00977526,High,0.102,0.376,0.258,0.064,Variable effect (p=0.019),Variable effect (p=0.014),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09258,rs168534,19,4393048,APP,SNP (A/C),(A/,A,0.84,0.63,1.06,0.0704792,Moderate,0.121,0.022,0.454,0.203,Mild increase (p=0.016),Significant increase (p=0.009),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09259,rs482589,20,109004366,EPHA1,Deletion,-,-,0.68,0.36,0.94,0.00472165,Moderate,0.253,0.17,0.197,0.18,Significant increase (p=0.034),Mild increase (p=0.012),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP09260,rs116133,10,212930356,CLU,SNP (C/T),(C/,C,1.19,0.98,1.52,0.06373849,Low,0.101,0.443,0.25,0.006,No significant pattern (p=0.023),Mild increase (p=0.028),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09261,rs683912,18,174768976,EPHA1,SNP (C/G),(C/,C,0.86,0.46,1.12,0.01726569,Moderate,0.006,0.227,0.469,0.098,Mild decrease (p=0.001),Mild decrease (p=0.024),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09262,rs457123,8,79334489,EPHA1,SNP (G/T),(G/,G,1.11,0.75,1.33,0.01404608,High,0.657,0.076,0.04,0.027,Mild decrease (p=0.037),No significant pattern (p=0.044),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09263,rs233008,6,161184640,PSEN2,SNP (C/T),(C/,C,0.86,0.63,1.07,0.01769417,Moderate,0.427,0.015,0.353,0.005,Significant decrease (p=0.017),Significant decrease (p=0.009),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09264,rs444596,18,203823132,SORL1,SNP (C/G),(C/,C,0.97,0.59,1.36,0.00043927,Moderate,0.169,0.001,0.282,0.348,Variable effect (p=0.02),Mild decrease (p=0.006),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09265,rs479769,11,15335541,CLU,SNP (A/G),(A/,A,1.58,1.28,1.81,0.01769768,Moderate,0.078,0.169,0.462,0.091,Mild increase (p=0.017),Variable effect (p=0.014),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09266,rs699751,17,48904221,TREM2,SNP (A/G),(A/,A,1.16,0.89,1.44,0.0137514,Protective,0.599,0.091,0.048,0.062,Significant increase (p=0.003),Mild decrease (p=0.038),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09267,rs575343,15,19082226,PSEN2,SNP (A/T),(A/,A,1.83,1.44,2.23,0.00367282,Low,0.186,0.304,0.204,0.106,Significant decrease (p=0.024),Significant increase (p=0.034),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09268,rs959799,14,226711910,PTK2B,SNP (A/T),(A/,A,1.37,1.16,1.63,0.06491535,Low,0.186,0.363,0.114,0.137,Mild increase (p=0.012),Mild decrease (p=0.013),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP09269,rs812132,21,216065397,CD33,SNP (A/T),(A/,A,0.29,0.1,0.53,0.02122078,Low,0.049,0.085,0.387,0.278,Significant decrease (p=0.03),Mild increase (p=0.008),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09270,rs305686,15,129014725,SORL1,SNP (G/T),(G/,G,0.68,0.46,1.07,0.03312921,Moderate,0.245,0.064,0.294,0.197,No significant pattern (p=0.027),Mild increase (p=0.019),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09271,rs222636,8,215557465,BIN1,SNP (A/G),(A/,A,0.57,0.28,0.94,0.06142807,Moderate,0.364,0.232,0.163,0.041,Significant decrease (p=0.046),No significant pattern (p=0.025),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09272,rs463829,10,86721837,CD33,SNP (G/T),(G/,G,0.89,0.68,1.27,0.00043208,High,0.343,0.314,0.081,0.061,Significant increase (p=0.01),Significant increase (p=0.035),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09273,rs554253,11,65696545,SORL1,Insertion,-,-,0.8,0.5,1.15,0.07425956,High,0.28,0.216,0.092,0.211,Significant decrease (p=0.033),No significant pattern (p=0.015),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09274,rs999682,4,110610955,CD33,SNP (A/T),(A/,A,0.72,0.44,0.96,0.02897893,High,0.293,0.41,0.015,0.082,Mild decrease (p=0.015),Mild decrease (p=0.01),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09275,rs511463,17,40621308,APP,Deletion,-,-,0.99,0.68,1.35,0.01101061,Protective,0.004,0.604,0.016,0.176,Significant decrease (p=0.003),No significant pattern (p=0.022),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09276,rs989996,15,126079215,CD33,Deletion,-,-,0.95,0.72,1.32,0.00086106,Protective,0.119,0.376,0.204,0.102,Variable effect (p=0.004),Mild decrease (p=0.048),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09277,rs330754,10,116915846,CLU,SNP (A/C),(A/,A,0.69,0.48,0.91,0.04845796,Moderate,0.303,0.287,0.21,0.0,Mild decrease (p=0.035),No significant pattern (p=0.03),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP09278,rs182498,18,171475760,ABCA7,Deletion,-,-,1.31,1.0,1.68,0.17893328,Low,0.339,0.027,0.385,0.048,Mild decrease (p=0.01),Significant increase (p=0.03),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09279,rs837942,11,184813237,PSEN2,Insertion,-,-,0.98,0.76,1.23,0.00317332,Moderate,0.03,0.338,0.096,0.336,Significant increase (p=0.003),No significant pattern (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09280,rs300353,16,98581903,PSEN2,SNP (A/T),(A/,A,0.9,0.66,1.25,0.02310553,Moderate,0.009,0.632,0.12,0.04,Mild increase (p=0.032),Mild increase (p=0.038),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09281,rs184321,5,135663489,CD33,SNP (A/T),(A/,A,0.78,0.45,1.0,0.06184314,High,0.076,0.192,0.316,0.217,Significant increase (p=0.023),Variable effect (p=0.042),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09282,rs830709,5,110010034,PICALM,SNP (A/C),(A/,A,1.25,1.01,1.45,0.01941006,Moderate,0.046,0.146,0.604,0.004,Variable effect (p=0.043),Significant increase (p=0.04),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP09283,rs981567,1,172029950,PSEN2,SNP (A/C),(A/,A,0.85,0.59,1.18,0.03038568,Low,0.129,0.057,0.027,0.588,Variable effect (p=0.004),Significant decrease (p=0.036),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09284,rs414247,9,78516667,PICALM,SNP (A/C),(A/,A,1.11,0.91,1.36,0.12613774,Low,0.159,0.108,0.118,0.414,Mild decrease (p=0.009),Mild decrease (p=0.038),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09285,rs874326,5,32326776,CD2AP,Deletion,-,-,2.8,2.45,3.13,0.00824455,Moderate,0.357,0.263,0.024,0.156,Significant increase (p=0.044),Significant increase (p=0.028),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09286,rs112285,21,3760670,PTK2B,Insertion,-,-,0.72,0.41,0.94,0.00899755,Low,0.374,0.36,0.039,0.028,Mild decrease (p=0.047),Mild increase (p=0.008),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09287,rs822129,13,178951690,BIN1,SNP (A/T),(A/,A,1.17,0.82,1.55,0.00995297,Low,0.136,0.005,0.307,0.351,No significant pattern (p=0.047),Significant decrease (p=0.044),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09288,rs184998,9,229554991,CR1,SNP (A/C),(A/,A,0.8,0.46,1.19,0.02741146,Moderate,0.246,0.274,0.097,0.183,Mild increase (p=0.037),Variable effect (p=0.022),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09289,rs869038,7,203742695,PSEN2,SNP (C/T),(C/,C,0.75,0.54,0.95,0.00416951,High,0.036,0.096,0.146,0.522,Significant decrease (p=0.027),Mild increase (p=0.038),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09290,rs844570,21,232571151,CLU,Insertion,-,-,0.78,0.43,1.05,0.0426938,High,0.03,0.247,0.248,0.274,No significant pattern (p=0.002),No significant pattern (p=0.015),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09291,rs795213,5,55810162,BIN1,SNP (A/G),(A/,A,1.58,1.34,1.85,0.07079183,Moderate,0.242,0.067,0.311,0.181,Significant increase (p=0.037),Significant increase (p=0.026),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP09292,rs210376,9,241174706,PTK2B,Deletion,-,-,0.73,0.43,1.05,0.01608154,High,0.042,0.272,0.373,0.113,Significant increase (p=0.049),Variable effect (p=0.011),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09293,rs371643,16,164884777,MS4A6A,SNP (A/T),(A/,A,0.3,0.1,0.67,0.01840114,Moderate,0.021,0.09,0.268,0.421,Significant decrease (p=0.05),Variable effect (p=0.023),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09294,rs338553,5,135284048,PSEN2,SNP (G/T),(G/,G,1.43,1.1,1.65,0.00636533,High,0.208,0.356,0.012,0.224,Mild decrease (p=0.037),No significant pattern (p=0.016),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09295,rs708892,8,192597846,EPHA1,SNP (C/T),(C/,C,1.27,0.95,1.5,0.0909463,Moderate,0.303,0.208,0.166,0.123,Mild decrease (p=0.033),Variable effect (p=0.026),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09296,rs703766,14,105352119,TREM2,SNP (A/C),(A/,A,1.47,1.23,1.69,0.0113141,Moderate,0.074,0.228,0.26,0.238,Variable effect (p=0.032),Significant increase (p=0.012),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09297,rs216363,18,62750260,TREM2,Insertion,-,-,1.22,0.87,1.46,0.00651941,High,0.033,0.248,0.059,0.46,No significant pattern (p=0.049),Mild decrease (p=0.016),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP09298,rs686255,7,178601079,PTK2B,Deletion,-,-,0.37,0.13,0.6,0.00337117,High,0.473,0.036,0.214,0.077,Mild decrease (p=0.04),No significant pattern (p=0.033),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09299,rs474725,16,163785851,MS4A6A,SNP (C/G),(C/,C,0.82,0.43,1.05,0.08386312,High,0.284,0.027,0.287,0.202,Mild decrease (p=0.014),Mild increase (p=0.036),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP09300,rs340180,18,49403319,TREM2,SNP (G/T),(G/,G,0.81,0.54,1.04,0.02364414,Moderate,0.206,0.437,0.033,0.124,Variable effect (p=0.049),Significant decrease (p=0.016),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09301,rs244568,19,183603375,BIN1,SNP (A/G),(A/,A,1.89,1.61,2.27,0.02381704,High,0.417,0.06,0.255,0.068,Mild decrease (p=0.047),Variable effect (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP09302,rs171137,16,246380072,CR1,Deletion,-,-,0.96,0.71,1.3,0.17775813,High,0.199,0.233,0.23,0.138,Mild decrease (p=0.025),Significant increase (p=0.014),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09303,rs142231,10,248230634,CR1,SNP (A/T),(A/,A,1.07,0.86,1.37,0.010701,High,0.178,0.056,0.333,0.234,Significant increase (p=0.047),Variable effect (p=0.041),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09304,rs611219,3,247979826,BIN1,SNP (C/T),(C/,C,0.93,0.63,1.17,0.01920001,Low,0.32,0.018,0.185,0.277,Significant decrease (p=0.049),Variable effect (p=0.028),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09305,rs248864,21,233955522,CLU,SNP (A/G),(A/,A,0.83,0.46,1.12,0.01113659,Moderate,0.383,0.185,0.165,0.067,Significant increase (p=0.033),Mild decrease (p=0.05),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09306,rs281648,8,176964433,CD2AP,SNP (C/T),(C/,C,1.5,1.23,1.88,0.06944478,Moderate,0.185,0.253,0.21,0.152,Significant decrease (p=0.048),Variable effect (p=0.031),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP09307,rs801057,14,119453010,APP,Insertion,-,-,1.97,1.7,2.18,0.11380823,Moderate,0.401,0.109,0.227,0.064,No significant pattern (p=0.028),Mild increase (p=0.034),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09308,rs415043,6,98681646,PICALM,Deletion,-,-,0.68,0.46,0.96,0.09820014,Low,0.251,0.18,0.064,0.305,Mild increase (p=0.046),Variable effect (p=0.022),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP09309,rs188564,17,59032611,BIN1,SNP (A/T),(A/,A,0.41,0.1,0.65,0.04485829,High,0.015,0.434,0.014,0.337,Significant increase (p=0.022),No significant pattern (p=0.029),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP09310,rs442566,3,91996137,BIN1,Insertion,-,-,0.84,0.56,1.13,0.01252306,Moderate,0.176,0.049,0.045,0.529,Mild increase (p=0.018),Significant decrease (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09311,rs981100,13,228378684,TREM2,Deletion,-,-,0.96,0.62,1.17,0.00870832,High,0.014,0.607,0.029,0.15,Significant decrease (p=0.035),No significant pattern (p=0.036),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09312,rs287034,4,197132919,CLU,SNP (A/G),(A/,A,2.29,2.03,2.69,0.02645785,Low,0.199,0.028,0.228,0.346,Mild increase (p=0.014),Significant increase (p=0.017),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP09313,rs763516,4,162918024,PSEN2,SNP (G/T),(G/,G,1.1,0.73,1.35,0.04964162,Moderate,0.2,0.354,0.225,0.022,Mild decrease (p=0.042),No significant pattern (p=0.003),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09314,rs893005,1,24371922,PTK2B,SNP (G/T),(G/,G,1.01,0.71,1.34,0.02051163,Protective,0.438,0.283,0.006,0.074,Significant increase (p=0.016),Significant decrease (p=0.037),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP09315,rs996414,7,96677535,CD33,SNP (G/T),(G/,G,1.06,0.78,1.26,0.03642625,Moderate,0.169,0.246,0.276,0.109,Significant increase (p=0.035),No significant pattern (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09316,rs228156,5,141466919,BIN1,Deletion,-,-,1.54,1.14,1.75,0.00553184,Low,0.135,0.35,0.313,0.001,Significant decrease (p=0.005),Significant increase (p=0.036),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09317,rs141930,18,26795851,ABCA7,SNP (A/T),(A/,A,0.59,0.28,0.85,0.03323871,Protective,0.221,0.347,0.16,0.072,Mild decrease (p=0.046),Variable effect (p=0.024),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP09318,rs316365,19,209051705,PSEN2,Deletion,-,-,1.25,0.86,1.48,0.0030271,Moderate,0.552,0.01,0.026,0.211,Mild decrease (p=0.037),Mild decrease (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09319,rs936250,2,174456985,PICALM,SNP (G/T),(G/,G,1.23,1.03,1.44,0.00364046,Moderate,0.175,0.19,0.064,0.372,Mild decrease (p=0.034),Mild increase (p=0.042),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09320,rs502522,2,63172696,ABCA7,SNP (A/G),(A/,A,1.35,1.01,1.72,0.02331108,Moderate,0.036,0.324,0.414,0.026,Mild increase (p=0.003),No significant pattern (p=0.021),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09321,rs639667,19,145553197,MS4A6A,SNP (A/T),(A/,A,0.38,0.1,0.77,0.0006226,Moderate,0.022,0.032,0.011,0.735,Significant decrease (p=0.029),Significant decrease (p=0.017),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09322,rs287050,19,224345456,CLU,SNP (A/C),(A/,A,0.89,0.58,1.2,0.0323275,Low,0.275,0.195,0.105,0.225,Mild increase (p=0.039),Mild decrease (p=0.013),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09323,rs698143,20,125471855,CR1,SNP (A/C),(A/,A,1.08,0.74,1.43,0.01256694,Moderate,0.292,0.023,0.072,0.413,Mild decrease (p=0.045),Mild increase (p=0.022),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09324,rs523816,19,68836448,BIN1,Insertion,-,-,2.66,2.31,2.91,0.05859519,Protective,0.118,0.205,0.242,0.235,Variable effect (p=0.006),Mild decrease (p=0.03),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09325,rs301162,13,163184089,CD33,SNP (C/T),(C/,C,1.97,1.77,2.27,0.01194263,Moderate,0.437,0.028,0.304,0.031,Significant decrease (p=0.014),Mild decrease (p=0.038),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09326,rs667182,6,130437635,CLU,Insertion,-,-,1.51,1.23,1.88,0.00875969,Low,0.283,0.074,0.393,0.05,Variable effect (p=0.009),Variable effect (p=0.033),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09327,rs609513,17,102943967,PSEN2,SNP (A/G),(A/,A,0.49,0.21,0.72,0.0215717,High,0.077,0.094,0.199,0.43,Mild decrease (p=0.046),Variable effect (p=0.046),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09328,rs707434,15,33607051,CD33,SNP (A/G),(A/,A,1.21,0.9,1.43,0.03649574,High,0.26,0.241,0.284,0.015,Variable effect (p=0.047),Mild increase (p=0.01),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09329,rs633075,22,222725484,ABCA7,SNP (G/T),(G/,G,0.9,0.54,1.12,0.01779047,High,0.483,0.036,0.12,0.161,Mild decrease (p=0.04),Mild decrease (p=0.017),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09330,rs530523,9,113518453,BIN1,Deletion,-,-,2.41,2.17,2.77,0.02813646,Low,0.215,0.029,0.485,0.071,Significant decrease (p=0.003),Significant increase (p=0.008),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09331,rs430431,4,5389264,EPHA1,SNP (A/T),(A/,A,0.82,0.6,1.15,0.07034053,Low,0.091,0.038,0.505,0.165,Significant increase (p=0.007),Variable effect (p=0.041),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09332,rs504897,2,63235898,MS4A6A,SNP (G/T),(G/,G,2.48,2.28,2.73,0.04672232,High,0.031,0.594,0.042,0.133,Variable effect (p=0.027),Mild decrease (p=0.014),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09333,rs625623,1,231516564,PSEN2,Deletion,-,-,1.37,0.99,1.7,0.0260185,Moderate,0.356,0.035,0.148,0.261,Significant decrease (p=0.046),Significant increase (p=0.019),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09334,rs909033,14,106352628,APOE,SNP (C/T),(C/,C,1.59,1.25,1.97,0.00764025,Unknown,0.321,0.163,0.078,0.238,Significant increase (p=0.01),Mild decrease (p=0.048),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09335,rs605170,20,172643668,PSEN2,SNP (A/T),(A/,A,1.24,0.9,1.62,0.04526766,Low,0.209,0.068,0.336,0.187,Variable effect (p=0.037),Significant decrease (p=0.009),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09336,rs644759,1,150247111,TREM2,SNP (G/T),(G/,G,0.58,0.34,0.93,0.00589623,Moderate,0.042,0.032,0.481,0.245,No significant pattern (p=0.023),Significant decrease (p=0.019),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09337,rs757467,15,106505862,CR1,SNP (C/T),(C/,C,1.39,1.0,1.66,0.04269082,Unknown,0.28,0.069,0.38,0.07,Significant increase (p=0.017),Mild increase (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP09338,rs762287,22,131585333,CD2AP,SNP (A/T),(A/,A,0.98,0.6,1.27,0.0034473,Moderate,0.123,0.134,0.311,0.232,Significant increase (p=0.049),Variable effect (p=0.017),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP09339,rs719164,12,131267280,CD33,SNP (A/T),(A/,A,0.53,0.18,0.84,0.00467541,High,0.245,0.418,0.127,0.01,Mild decrease (p=0.012),Significant decrease (p=0.042),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09340,rs880480,19,61246372,APP,SNP (A/C),(A/,A,1.61,1.4,1.91,0.01256097,High,0.417,0.008,0.101,0.274,Variable effect (p=0.043),Significant decrease (p=0.018),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09341,rs277877,16,246941470,PTK2B,SNP (C/G),(C/,C,0.46,0.1,0.83,0.00254954,Moderate,0.086,0.38,0.29,0.045,Significant decrease (p=0.036),Significant increase (p=0.048),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP09342,rs857970,18,147818347,PSEN2,SNP (A/G),(A/,A,1.58,1.29,1.95,0.0240493,Protective,0.002,0.113,0.031,0.654,Mild decrease (p=0.032),Mild increase (p=0.02),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09343,rs891939,18,151188645,PSEN2,Deletion,-,-,1.06,0.73,1.34,0.00270427,Unknown,0.089,0.101,0.594,0.017,No significant pattern (p=0.044),Significant increase (p=0.01),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09344,rs771453,14,193788165,PICALM,SNP (A/T),(A/,A,0.59,0.23,0.97,0.01655155,High,0.237,0.219,0.134,0.21,No significant pattern (p=0.039),Significant increase (p=0.033),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09345,rs277517,17,166386351,APP,SNP (A/G),(A/,A,0.67,0.31,0.94,0.00173342,Moderate,0.044,0.512,0.179,0.065,Mild increase (p=0.016),Mild decrease (p=0.038),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09346,rs946894,16,167486327,CD2AP,SNP (G/T),(G/,G,0.5,0.23,0.84,0.01438347,Unknown,0.599,0.046,0.056,0.1,Mild decrease (p=0.045),Mild increase (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09347,rs803768,6,187751877,PSEN2,Insertion,-,-,1.85,1.49,2.24,0.0125791,Moderate,0.035,0.127,0.528,0.11,Mild decrease (p=0.043),Significant increase (p=0.009),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09348,rs591233,4,191405364,PSEN2,SNP (G/T),(G/,G,1.53,1.32,1.77,0.02295722,Protective,0.252,0.008,0.249,0.291,Significant increase (p=0.006),No significant pattern (p=0.006),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09349,rs760491,21,158122686,SORL1,SNP (C/T),(C/,C,0.79,0.58,1.06,0.02633268,High,0.039,0.626,0.031,0.104,Significant decrease (p=0.013),No significant pattern (p=0.007),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09350,rs997933,5,187537806,PICALM,SNP (A/G),(A/,A,2.17,1.86,2.54,0.02299632,Moderate,0.137,0.479,0.033,0.151,Significant increase (p=0.035),Mild increase (p=0.009),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09351,rs246510,1,229653347,PTK2B,SNP (C/T),(C/,C,0.71,0.44,1.04,0.06277381,Moderate,0.003,0.402,0.031,0.364,Mild decrease (p=0.042),Variable effect (p=0.023),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09352,rs151377,20,120634541,ABCA7,SNP (G/T),(G/,G,0.38,0.1,0.67,0.00261638,Moderate,0.085,0.113,0.561,0.041,Significant decrease (p=0.048),Significant increase (p=0.031),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09353,rs783437,9,84386586,MS4A6A,SNP (A/C),(A/,A,0.83,0.52,1.09,0.05598915,Moderate,0.003,0.203,0.162,0.432,Mild increase (p=0.029),Mild increase (p=0.004),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09354,rs686895,22,137332283,PSEN2,SNP (A/C),(A/,A,1.23,0.98,1.58,0.01581543,Moderate,0.05,0.023,0.571,0.157,Significant increase (p=0.008),Mild increase (p=0.01),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09355,rs944502,8,105839732,EPHA1,SNP (C/G),(C/,C,3.03,2.74,3.25,0.03415691,High,0.176,0.363,0.088,0.172,Significant decrease (p=0.037),Mild decrease (p=0.018),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09356,rs654518,11,127479978,CD33,SNP (C/G),(C/,C,1.29,0.95,1.61,0.02343871,High,0.06,0.379,0.111,0.25,Significant decrease (p=0.014),No significant pattern (p=0.019),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09357,rs493194,20,239823386,PSEN2,Deletion,-,-,1.67,1.46,1.98,0.04078824,Moderate,0.412,0.211,0.046,0.132,Variable effect (p=0.027),Variable effect (p=0.008),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09358,rs622569,4,104925339,APOE,SNP (A/C),(A/,A,1.93,1.59,2.33,0.00948062,Moderate,0.107,0.059,0.479,0.155,Mild decrease (p=0.023),Significant increase (p=0.016),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09359,rs316486,8,229129184,PSEN2,Deletion,-,-,0.64,0.36,0.92,0.00107153,High,0.022,0.212,0.219,0.347,Significant decrease (p=0.038),Significant increase (p=0.006),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP09360,rs983250,22,35102833,TREM2,SNP (G/T),(G/,G,1.05,0.67,1.38,0.03285067,Moderate,0.129,0.496,0.07,0.105,Significant increase (p=0.003),Variable effect (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09361,rs271972,22,163299266,SORL1,SNP (A/G),(A/,A,1.24,0.96,1.61,0.12675868,Moderate,0.363,0.005,0.328,0.104,Significant decrease (p=0.024),No significant pattern (p=0.034),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09362,rs832944,15,199780532,PICALM,SNP (A/C),(A/,A,1.19,0.8,1.47,0.02414793,High,0.022,0.318,0.096,0.364,Significant increase (p=0.015),Mild increase (p=0.024),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09363,rs771681,22,10120965,CR1,SNP (A/T),(A/,A,0.43,0.1,0.76,0.02673924,Moderate,0.019,0.258,0.308,0.215,Significant decrease (p=0.041),Mild increase (p=0.045),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09364,rs217387,21,51343681,CD2AP,SNP (A/T),(A/,A,1.09,0.86,1.32,0.03762228,Moderate,0.083,0.301,0.164,0.252,Mild decrease (p=0.038),Mild decrease (p=0.006),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09365,rs323592,10,224952717,CR1,SNP (G/T),(G/,G,0.64,0.41,0.9,0.0853618,Low,0.08,0.102,0.259,0.359,Variable effect (p=0.026),No significant pattern (p=0.008),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09366,rs942145,5,29391854,CD2AP,SNP (A/C),(A/,A,0.76,0.52,1.03,0.03554863,Moderate,0.446,0.247,0.027,0.08,Significant increase (p=0.004),No significant pattern (p=0.01),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09367,rs838945,17,26715959,CD33,Insertion,-,-,0.77,0.45,1.09,0.01851479,High,0.119,0.046,0.389,0.246,No significant pattern (p=0.04),No significant pattern (p=0.028),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09368,rs786515,5,166411141,MS4A6A,SNP (A/T),(A/,A,1.91,1.62,2.29,0.02861268,Moderate,0.01,0.145,0.219,0.425,Variable effect (p=0.042),Variable effect (p=0.009),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09369,rs776828,14,39109154,CLU,Insertion,-,-,1.01,0.67,1.25,0.06607205,High,0.256,0.048,0.159,0.337,Significant decrease (p=0.008),Mild decrease (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09370,rs305522,7,15202385,APOE,SNP (G/T),(G/,G,0.93,0.59,1.19,0.06761277,Protective,0.15,0.133,0.279,0.238,No significant pattern (p=0.026),Significant increase (p=0.01),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09371,rs453773,10,238264583,CR1,SNP (A/C),(A/,A,1.17,0.93,1.39,0.00246312,Low,0.259,0.306,0.12,0.116,Mild decrease (p=0.046),Significant decrease (p=0.032),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09372,rs940391,20,5130706,CR1,SNP (A/C),(A/,A,0.32,0.1,0.64,0.01001621,Protective,0.131,0.424,0.12,0.125,Mild decrease (p=0.006),No significant pattern (p=0.031),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09373,rs668855,8,34608407,APOE,SNP (G/T),(G/,G,1.14,0.93,1.46,0.0012301,High,0.256,0.188,0.002,0.353,No significant pattern (p=0.04),Significant decrease (p=0.032),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09374,rs735863,21,221241369,PTK2B,Insertion,-,-,0.67,0.37,1.07,0.0423169,Moderate,0.048,0.035,0.469,0.248,No significant pattern (p=0.025),Significant increase (p=0.01),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09375,rs195482,14,51597071,TREM2,SNP (A/C),(A/,A,0.41,0.21,0.66,0.0078319,High,0.087,0.308,0.384,0.021,Significant decrease (p=0.014),Variable effect (p=0.029),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09376,rs604833,12,218711794,PICALM,SNP (C/T),(C/,C,0.26,0.1,0.64,0.09723743,High,0.073,0.127,0.435,0.165,Mild decrease (p=0.045),No significant pattern (p=0.013),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09377,rs120137,14,192842675,CLU,SNP (G/T),(G/,G,0.53,0.17,0.77,0.06205246,Moderate,0.234,0.087,0.003,0.476,Significant decrease (p=0.002),Mild decrease (p=0.036),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09378,rs516811,5,173299103,CR1,Deletion,-,-,0.52,0.19,0.83,0.04445544,Moderate,0.056,0.062,0.499,0.183,Significant decrease (p=0.005),Significant decrease (p=0.008),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09379,rs507370,7,1422399,PICALM,Deletion,-,-,0.92,0.64,1.13,0.01931327,High,0.231,0.175,0.159,0.235,Mild decrease (p=0.011),No significant pattern (p=0.003),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09380,rs806801,10,25888631,PICALM,SNP (C/T),(C/,C,0.56,0.28,0.85,0.05120585,Moderate,0.121,0.181,0.289,0.209,Mild increase (p=0.027),No significant pattern (p=0.034),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09381,rs558142,21,38785966,MS4A6A,SNP (C/T),(C/,C,1.28,0.9,1.66,0.00421541,High,0.086,0.224,0.303,0.186,No significant pattern (p=0.024),Mild increase (p=0.03),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09382,rs751247,8,186866776,MS4A6A,SNP (A/G),(A/,A,0.43,0.22,0.64,0.00171566,Moderate,0.042,0.453,0.158,0.147,Significant increase (p=0.02),Mild decrease (p=0.048),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09383,rs279132,7,227867941,BIN1,Insertion,-,-,2.26,2.05,2.56,0.02161053,Low,0.162,0.159,0.172,0.306,Mild decrease (p=0.041),No significant pattern (p=0.049),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP09384,rs776675,13,136218261,PICALM,SNP (A/C),(A/,A,1.29,0.9,1.69,0.01207094,Protective,0.235,0.028,0.168,0.37,Variable effect (p=0.041),Significant increase (p=0.038),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09385,rs852000,21,113747042,ABCA7,Insertion,-,-,0.44,0.22,0.68,0.09300862,Moderate,0.021,0.136,0.072,0.572,Mild increase (p=0.044),Variable effect (p=0.039),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09386,rs430103,6,159234123,EPHA1,SNP (C/G),(C/,C,1.72,1.49,2.08,0.00305254,High,0.024,0.169,0.008,0.599,No significant pattern (p=0.02),Significant increase (p=0.016),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09387,rs415384,7,180746792,CLU,SNP (A/C),(A/,A,0.32,0.1,0.57,0.07655244,Low,0.39,0.267,0.101,0.041,Mild decrease (p=0.007),Mild increase (p=0.004),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09388,rs677090,10,182307233,ABCA7,SNP (G/T),(G/,G,0.81,0.49,1.14,0.01739574,High,0.009,0.058,0.539,0.194,Variable effect (p=0.02),No significant pattern (p=0.037),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09389,rs377049,6,139229816,APOE,SNP (A/G),(A/,A,0.64,0.35,0.99,0.02816632,Moderate,0.121,0.03,0.331,0.317,No significant pattern (p=0.035),No significant pattern (p=0.021),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09390,rs666983,15,36766660,APOE,SNP (A/G),(A/,A,0.52,0.26,0.74,0.1192721,Unknown,0.699,0.05,0.009,0.043,No significant pattern (p=0.025),Significant increase (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09391,rs371446,21,89321444,PTK2B,SNP (A/C),(A/,A,0.79,0.54,1.13,0.01100592,High,0.139,0.208,0.316,0.137,Significant increase (p=0.046),Variable effect (p=0.026),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09392,rs499710,17,187174787,SORL1,SNP (A/C),(A/,A,0.73,0.45,1.02,0.04316858,Moderate,0.38,0.211,0.026,0.184,Significant increase (p=0.014),Mild increase (p=0.013),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09393,rs975583,15,36416635,APP,Insertion,-,-,1.26,0.95,1.62,0.01920877,Moderate,0.549,0.048,0.088,0.115,Mild increase (p=0.046),Significant decrease (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09394,rs582339,19,109012074,MS4A6A,SNP (A/T),(A/,A,1.06,0.72,1.34,0.02430116,Moderate,0.031,0.422,0.012,0.335,Significant increase (p=0.035),Variable effect (p=0.035),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP09395,rs186794,15,93562844,MS4A6A,SNP (A/C),(A/,A,2.61,2.3,2.88,0.0347947,Low,0.16,0.051,0.491,0.098,Mild increase (p=0.027),Significant decrease (p=0.041),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09396,rs614044,22,179383651,PSEN2,SNP (A/C),(A/,A,2.42,2.11,2.72,0.02479293,Low,0.336,0.162,0.034,0.269,No significant pattern (p=0.011),Variable effect (p=0.027),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09397,rs534587,7,63173631,TREM2,SNP (C/T),(C/,C,0.79,0.41,1.01,0.02947468,Protective,0.078,0.481,0.105,0.135,Variable effect (p=0.043),Variable effect (p=0.038),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09398,rs284988,17,215977183,APP,SNP (C/T),(C/,C,1.21,0.83,1.42,0.03424119,Moderate,0.521,0.166,0.094,0.018,Mild decrease (p=0.016),No significant pattern (p=0.027),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09399,rs477676,15,109211811,MS4A6A,SNP (A/C),(A/,A,2.39,2.0,2.76,0.04543687,Moderate,0.212,0.032,0.454,0.102,Significant increase (p=0.022),Significant increase (p=0.041),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09400,rs589062,7,107671079,CR1,SNP (A/G),(A/,A,0.88,0.54,1.23,0.00554974,Protective,0.159,0.138,0.042,0.462,Significant decrease (p=0.013),Variable effect (p=0.033),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09401,rs247418,7,37264907,TREM2,SNP (G/T),(G/,G,1.77,1.46,2.12,0.01274183,High,0.106,0.148,0.456,0.09,Mild increase (p=0.038),Variable effect (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09402,rs266366,6,82503025,APOE,Insertion,-,-,2.08,1.76,2.47,0.06860956,High,0.394,0.008,0.142,0.256,No significant pattern (p=0.021),Mild decrease (p=0.025),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09403,rs392601,17,181018359,CR1,SNP (A/G),(A/,A,1.22,0.86,1.56,0.05554228,Unknown,0.055,0.307,0.23,0.208,Variable effect (p=0.031),Significant decrease (p=0.019),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09404,rs950251,17,224427664,APP,Insertion,-,-,1.42,1.07,1.78,0.03810657,Moderate,0.044,0.279,0.337,0.14,Significant increase (p=0.004),Mild increase (p=0.045),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP09405,rs666611,2,55165290,TREM2,SNP (A/T),(A/,A,1.55,1.25,1.87,0.00571914,High,0.355,0.061,0.317,0.067,Significant decrease (p=0.04),No significant pattern (p=0.011),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09406,rs143387,19,108553322,CD2AP,SNP (A/G),(A/,A,1.12,0.9,1.35,0.04787316,Low,0.109,0.404,0.228,0.059,Significant increase (p=0.034),Mild increase (p=0.041),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09407,rs186943,18,224747137,CR1,SNP (G/T),(G/,G,1.03,0.72,1.3,0.00879434,Low,0.173,0.209,0.117,0.3,No significant pattern (p=0.035),Significant decrease (p=0.034),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09408,rs178966,19,228325833,ABCA7,SNP (A/G),(A/,A,0.96,0.72,1.26,0.01138843,Low,0.04,0.215,0.155,0.391,Variable effect (p=0.004),Mild increase (p=0.025),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09409,rs756550,4,31451631,EPHA1,SNP (A/C),(A/,A,1.39,1.11,1.62,0.03357529,Moderate,0.552,0.112,0.125,0.011,Significant decrease (p=0.03),Mild increase (p=0.017),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09410,rs780369,16,207853079,PSEN2,SNP (C/T),(C/,C,0.95,0.56,1.26,0.03062267,High,0.234,0.217,0.0,0.348,Mild decrease (p=0.022),Mild increase (p=0.008),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09411,rs393765,20,80607940,ABCA7,SNP (A/G),(A/,A,0.82,0.51,1.11,0.01834752,Low,0.197,0.095,0.476,0.032,Variable effect (p=0.014),Significant decrease (p=0.015),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09412,rs466300,10,13252500,CD33,SNP (C/G),(C/,C,2.14,1.87,2.36,0.0556377,Unknown,0.095,0.019,0.451,0.235,Mild decrease (p=0.028),Variable effect (p=0.007),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP09413,rs484844,13,164188091,APP,Deletion,-,-,0.65,0.44,1.02,0.00122316,High,0.2,0.189,0.375,0.036,Variable effect (p=0.015),Variable effect (p=0.047),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09414,rs772944,22,222362291,EPHA1,SNP (A/C),(A/,A,0.64,0.28,0.97,0.01698601,Low,0.074,0.153,0.058,0.514,Significant increase (p=0.005),Mild increase (p=0.008),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09415,rs984591,3,117122542,CR1,SNP (A/C),(A/,A,1.83,1.53,2.2,0.13710099,High,0.315,0.062,0.193,0.229,Mild increase (p=0.019),Mild increase (p=0.003),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09416,rs691771,5,50345621,CD33,SNP (A/G),(A/,A,0.6,0.31,0.97,0.01918454,Moderate,0.052,0.065,0.475,0.207,No significant pattern (p=0.011),Variable effect (p=0.044),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP09417,rs415609,14,228110029,PICALM,SNP (C/G),(C/,C,0.66,0.32,0.87,0.01815111,High,0.094,0.417,0.045,0.245,Mild increase (p=0.035),Variable effect (p=0.04),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09418,rs416063,9,233398166,CD2AP,SNP (C/G),(C/,C,1.25,0.89,1.59,0.0228631,Moderate,0.23,0.239,0.228,0.103,No significant pattern (p=0.003),Mild increase (p=0.009),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09419,rs426997,15,205341235,CD2AP,SNP (A/G),(A/,A,1.02,0.82,1.35,0.02420296,Low,0.151,0.097,0.523,0.028,Variable effect (p=0.008),Variable effect (p=0.043),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP09420,rs706411,20,77366731,CR1,SNP (C/T),(C/,C,1.24,0.99,1.64,0.01894229,Low,0.141,0.316,0.092,0.252,Significant increase (p=0.01),Significant increase (p=0.035),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09421,rs428619,5,46808535,APP,Deletion,-,-,1.32,1.04,1.68,0.04214866,Moderate,0.186,0.232,0.299,0.083,Significant decrease (p=0.018),Significant decrease (p=0.031),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09422,rs547308,6,192362815,SORL1,SNP (C/T),(C/,C,0.6,0.25,0.9,0.21721711,High,0.08,0.223,0.111,0.386,Mild increase (p=0.038),Significant increase (p=0.026),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP09423,rs778475,13,7275826,CR1,SNP (A/T),(A/,A,0.91,0.53,1.17,0.00992364,Moderate,0.142,0.106,0.049,0.504,Significant decrease (p=0.047),Mild increase (p=0.025),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09424,rs283823,7,12368900,MS4A6A,Deletion,-,-,1.12,0.78,1.49,0.00521754,High,0.169,0.097,0.47,0.065,Mild increase (p=0.02),Mild decrease (p=0.028),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09425,rs108265,14,87015429,CLU,SNP (A/C),(A/,A,1.02,0.79,1.34,0.04014678,Moderate,0.008,0.058,0.153,0.581,Variable effect (p=0.049),Significant increase (p=0.024),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09426,rs882612,22,86944471,ABCA7,SNP (A/C),(A/,A,0.77,0.37,1.08,0.05473157,Unknown,0.192,0.055,0.413,0.139,No significant pattern (p=0.01),Significant increase (p=0.047),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09427,rs477697,18,80831778,ABCA7,Deletion,-,-,0.82,0.51,1.21,0.09888162,Moderate,0.462,0.033,0.188,0.117,Significant increase (p=0.018),Significant decrease (p=0.031),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09428,rs435575,1,43661691,PSEN2,Deletion,-,-,2.79,2.5,3.02,0.00664687,Protective,0.398,0.095,0.093,0.215,Significant increase (p=0.026),Mild decrease (p=0.045),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09429,rs407487,8,226569109,MS4A6A,SNP (A/G),(A/,A,1.19,0.85,1.4,0.00693189,Moderate,0.339,0.012,0.218,0.232,Significant decrease (p=0.038),Mild increase (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09430,rs845607,15,159806287,SORL1,SNP (A/T),(A/,A,1.52,1.17,1.72,0.02164314,Moderate,0.09,0.283,0.298,0.129,Mild decrease (p=0.043),Significant increase (p=0.02),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09431,rs619539,21,190698334,CLU,SNP (G/T),(G/,G,0.88,0.61,1.26,0.01339728,Low,0.097,0.007,0.009,0.686,No significant pattern (p=0.04),Mild decrease (p=0.032),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09432,rs303129,20,74431723,APP,SNP (A/T),(A/,A,1.33,1.07,1.65,0.02153212,Unknown,0.315,0.169,0.07,0.246,Significant decrease (p=0.043),Significant decrease (p=0.047),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09433,rs561312,19,140630818,CR1,SNP (C/T),(C/,C,1.26,1.05,1.66,0.1132159,Protective,0.262,0.03,0.197,0.311,Significant decrease (p=0.046),Significant decrease (p=0.019),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09434,rs498421,21,222900064,CR1,Insertion,-,-,0.89,0.6,1.16,0.00212544,Low,0.453,0.089,0.162,0.096,Mild increase (p=0.013),Variable effect (p=0.014),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09435,rs956770,7,152654378,APP,SNP (A/C),(A/,A,2.07,1.86,2.28,0.03218734,Low,0.084,0.066,0.305,0.345,Mild decrease (p=0.005),Mild increase (p=0.018),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09436,rs168049,5,144345464,TREM2,SNP (A/G),(A/,A,1.89,1.55,2.2,0.02479123,Low,0.07,0.1,0.321,0.309,Mild decrease (p=0.017),Mild decrease (p=0.013),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09437,rs319512,4,40194032,ABCA7,SNP (C/G),(C/,C,1.03,0.83,1.42,0.01405545,Moderate,0.251,0.055,0.426,0.068,Significant decrease (p=0.041),Mild decrease (p=0.033),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP09438,rs326011,3,167054633,CR1,SNP (C/T),(C/,C,2.83,2.59,3.22,0.07018474,High,0.12,0.041,0.133,0.506,Significant decrease (p=0.016),Mild decrease (p=0.037),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09439,rs677311,22,93503305,EPHA1,SNP (G/T),(G/,G,1.11,0.77,1.47,0.02841474,Moderate,0.341,0.077,0.098,0.284,Mild decrease (p=0.008),Significant decrease (p=0.045),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09440,rs967015,12,154747798,MS4A6A,SNP (G/T),(G/,G,1.58,1.34,1.97,0.04335153,Protective,0.123,0.288,0.204,0.184,Mild decrease (p=0.026),Significant decrease (p=0.039),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09441,rs778107,5,216586859,CLU,SNP (C/T),(C/,C,1.45,1.13,1.8,0.00039576,High,0.314,0.032,0.025,0.429,Significant increase (p=0.028),Significant increase (p=0.005),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09442,rs842627,1,147542459,CLU,Insertion,-,-,1.27,0.97,1.58,0.01827987,High,0.692,0.031,0.059,0.017,Mild increase (p=0.047),Significant increase (p=0.046),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09443,rs118227,1,52748065,ABCA7,SNP (A/C),(A/,A,2.28,1.98,2.67,0.00376389,Low,0.482,0.106,0.193,0.019,Significant decrease (p=0.027),No significant pattern (p=0.019),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP09444,rs128573,21,142326170,CR1,SNP (A/C),(A/,A,0.72,0.5,1.0,0.00656193,High,0.108,0.329,0.138,0.224,Significant increase (p=0.009),Mild increase (p=0.04),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09445,rs841455,17,158979790,SORL1,Deletion,-,-,0.64,0.33,0.96,0.00280426,Moderate,0.659,0.006,0.13,0.005,Significant decrease (p=0.049),No significant pattern (p=0.009),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09446,rs475456,14,109982227,PTK2B,SNP (C/T),(C/,C,0.8,0.47,1.04,0.01450792,Moderate,0.317,0.227,0.151,0.104,No significant pattern (p=0.01),Significant increase (p=0.003),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09447,rs244137,14,142793695,TREM2,Insertion,-,-,1.35,1.1,1.7,0.05376371,Moderate,0.265,0.145,0.303,0.087,Variable effect (p=0.019),Mild decrease (p=0.032),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09448,rs583189,2,73095502,PICALM,SNP (C/T),(C/,C,1.18,0.81,1.51,0.12558092,High,0.211,0.154,0.385,0.05,Variable effect (p=0.049),Mild decrease (p=0.014),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09449,rs707862,2,248842018,APOE,SNP (A/G),(A/,A,0.82,0.5,1.11,0.01774727,Unknown,0.228,0.178,0.387,0.007,Significant decrease (p=0.03),Significant decrease (p=0.041),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09450,rs261872,3,178426875,TREM2,Insertion,-,-,0.67,0.28,1.03,0.00065092,Low,0.014,0.078,0.03,0.678,Mild increase (p=0.025),Significant increase (p=0.047),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09451,rs238841,20,171643431,APOE,SNP (G/T),(G/,G,0.8,0.44,1.19,0.00075784,High,0.024,0.197,0.201,0.378,Mild decrease (p=0.046),Variable effect (p=0.027),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09452,rs302610,6,121461190,CLU,Insertion,-,-,0.56,0.27,0.79,0.03306201,High,0.371,0.012,0.351,0.066,Mild decrease (p=0.006),Significant decrease (p=0.013),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09453,rs603051,18,171216410,APOE,Insertion,-,-,1.05,0.79,1.39,0.01686694,Protective,0.178,0.236,0.17,0.216,Significant decrease (p=0.03),Mild decrease (p=0.037),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09454,rs529762,12,183609072,SORL1,Insertion,-,-,1.14,0.87,1.49,0.03565272,Low,0.029,0.195,0.515,0.061,Mild decrease (p=0.034),Significant decrease (p=0.001),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP09455,rs142762,16,52421796,PSEN2,SNP (C/T),(C/,C,0.41,0.1,0.78,0.02319872,High,0.071,0.548,0.113,0.068,Mild increase (p=0.008),Mild decrease (p=0.028),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09456,rs992481,16,242162141,EPHA1,SNP (C/T),(C/,C,0.6,0.21,0.87,0.05406334,Low,0.114,0.136,0.042,0.508,Mild increase (p=0.038),Mild decrease (p=0.036),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09457,rs134928,8,214558979,TREM2,SNP (C/G),(C/,C,1.5,1.26,1.7,0.0635383,Low,0.21,0.29,0.175,0.125,No significant pattern (p=0.002),Significant increase (p=0.042),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09458,rs868399,1,233567026,CD2AP,Insertion,-,-,0.44,0.17,0.8,0.08550678,Moderate,0.108,0.204,0.462,0.026,Significant decrease (p=0.012),Significant decrease (p=0.014),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09459,rs424706,19,95952630,ABCA7,SNP (A/C),(A/,A,1.41,1.16,1.79,0.00765635,Moderate,0.088,0.111,0.161,0.44,Significant increase (p=0.049),No significant pattern (p=0.025),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09460,rs961794,4,128943468,APP,Insertion,-,-,1.76,1.42,2.02,0.01282061,High,0.003,0.316,0.11,0.372,Variable effect (p=0.041),Mild decrease (p=0.007),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09461,rs494890,16,77174837,SORL1,SNP (A/C),(A/,A,0.98,0.74,1.22,0.03169,High,0.341,0.003,0.226,0.23,Significant decrease (p=0.018),Significant increase (p=0.015),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09462,rs122805,12,109221795,SORL1,Deletion,-,-,1.5,1.28,1.82,0.02443242,High,0.303,0.213,0.276,0.007,No significant pattern (p=0.015),Significant increase (p=0.037),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09463,rs613724,21,142183922,MS4A6A,SNP (A/C),(A/,A,0.8,0.41,1.09,0.07174602,High,0.504,0.162,0.017,0.116,Mild increase (p=0.025),No significant pattern (p=0.009),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09464,rs773653,17,15281115,ABCA7,Deletion,-,-,0.85,0.5,1.09,0.0101132,High,0.331,0.028,0.098,0.343,No significant pattern (p=0.02),Mild increase (p=0.009),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09465,rs536148,21,13157175,MS4A6A,SNP (G/T),(G/,G,1.67,1.4,1.96,0.06949103,Moderate,0.042,0.196,0.509,0.053,Significant decrease (p=0.016),No significant pattern (p=0.011),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09466,rs409864,15,119428332,EPHA1,Deletion,-,-,0.5,0.15,0.82,0.06391757,Moderate,0.112,0.006,0.398,0.284,No significant pattern (p=0.034),Significant decrease (p=0.009),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09467,rs366077,10,133777470,BIN1,SNP (A/T),(A/,A,0.93,0.66,1.18,0.05752328,Moderate,0.204,0.016,0.028,0.552,Mild increase (p=0.044),Mild increase (p=0.009),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09468,rs911938,14,134601316,APP,SNP (C/T),(C/,C,0.7,0.4,1.1,0.04502536,Low,0.44,0.089,0.263,0.007,Mild increase (p=0.008),Mild increase (p=0.039),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09469,rs554816,14,81581157,MS4A6A,SNP (A/T),(A/,A,1.31,1.05,1.65,0.06725653,Moderate,0.046,0.214,0.427,0.113,Mild decrease (p=0.012),Significant increase (p=0.02),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09470,rs816131,15,111313277,APOE,Insertion,-,-,0.68,0.42,0.88,0.0077244,Low,0.097,0.027,0.376,0.3,No significant pattern (p=0.045),Significant decrease (p=0.008),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09471,rs902573,10,197872690,CR1,Deletion,-,-,0.26,0.1,0.63,0.03024295,High,0.099,0.185,0.302,0.214,Significant increase (p=0.007),Significant decrease (p=0.045),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09472,rs740997,22,130575894,PTK2B,SNP (C/T),(C/,C,0.78,0.48,1.08,0.04025793,Moderate,0.078,0.408,0.244,0.071,Mild increase (p=0.037),Variable effect (p=0.044),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09473,rs499133,17,76365766,APP,Deletion,-,-,0.95,0.56,1.27,0.05499058,Moderate,0.073,0.063,0.603,0.061,No significant pattern (p=0.042),Significant increase (p=0.015),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09474,rs217625,9,124970943,CD2AP,SNP (A/G),(A/,A,1.01,0.78,1.33,0.03020815,High,0.333,0.274,0.018,0.175,Significant increase (p=0.031),Mild increase (p=0.039),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09475,rs777228,3,60667294,APOE,SNP (C/G),(C/,C,1.76,1.51,2.09,0.00649386,Moderate,0.147,0.349,0.096,0.208,No significant pattern (p=0.031),Variable effect (p=0.001),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09476,rs204151,14,23320619,CLU,Deletion,-,-,1.87,1.64,2.18,0.01579967,Low,0.429,0.056,0.266,0.049,Significant increase (p=0.009),Variable effect (p=0.033),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09477,rs795268,7,171818137,TREM2,SNP (A/G),(A/,A,1.67,1.29,1.94,0.03338995,Low,0.007,0.245,0.402,0.145,Mild increase (p=0.02),Mild increase (p=0.019),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09478,rs568342,18,51104523,SORL1,SNP (A/G),(A/,A,0.75,0.47,1.07,0.12071274,Moderate,0.064,0.428,0.026,0.282,Mild decrease (p=0.002),Mild increase (p=0.028),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09479,rs412295,16,241551458,APOE,Insertion,-,-,0.43,0.1,0.69,0.03501109,Moderate,0.299,0.224,0.019,0.257,Variable effect (p=0.035),No significant pattern (p=0.032),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09480,rs771624,22,171836509,EPHA1,SNP (C/G),(C/,C,0.96,0.73,1.31,0.01104828,Low,0.536,0.044,0.218,0.003,Significant decrease (p=0.011),Significant decrease (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09481,rs193800,9,195255542,SORL1,SNP (A/G),(A/,A,0.91,0.52,1.22,0.07296714,High,0.31,0.033,0.386,0.071,Significant decrease (p=0.002),Significant increase (p=0.029),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09482,rs630386,22,220350021,APOE,Insertion,-,-,0.37,0.13,0.71,0.02290081,High,0.195,0.331,0.004,0.27,Significant increase (p=0.029),No significant pattern (p=0.012),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09483,rs485118,3,228157009,APP,SNP (A/G),(A/,A,1.31,0.91,1.53,0.0371119,Low,0.349,0.346,0.09,0.015,Mild increase (p=0.043),No significant pattern (p=0.002),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09484,rs339177,12,78947558,CLU,SNP (A/T),(A/,A,0.74,0.41,1.12,0.03316816,High,0.187,0.348,0.018,0.247,Mild increase (p=0.023),Significant decrease (p=0.002),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP09485,rs166440,2,209430087,EPHA1,SNP (A/C),(A/,A,0.8,0.53,1.13,0.02699711,Moderate,0.093,0.126,0.374,0.207,Significant decrease (p=0.005),Variable effect (p=0.039),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09486,rs517914,15,228707583,TREM2,SNP (C/T),(C/,C,0.73,0.43,0.94,0.0074304,Low,0.062,0.16,0.562,0.016,No significant pattern (p=0.036),Mild increase (p=0.044),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09487,rs858327,3,123802230,PICALM,SNP (C/G),(C/,C,1.0,0.79,1.35,0.03882228,High,0.09,0.026,0.029,0.655,Mild increase (p=0.016),Significant decrease (p=0.044),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09488,rs360533,4,63836350,MS4A6A,SNP (G/T),(G/,G,0.58,0.34,0.8,0.01142586,High,0.314,0.267,0.164,0.055,Significant increase (p=0.01),Mild increase (p=0.049),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09489,rs618110,10,136905178,BIN1,SNP (A/T),(A/,A,0.63,0.27,0.95,0.06379984,Low,0.105,0.289,0.261,0.145,Significant increase (p=0.01),Significant decrease (p=0.016),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09490,rs678793,4,14517726,CR1,SNP (A/C),(A/,A,0.85,0.45,1.05,0.0095475,Low,0.055,0.39,0.18,0.175,Variable effect (p=0.006),Mild increase (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09491,rs261342,17,228705491,BIN1,Deletion,-,-,1.84,1.53,2.23,0.00511367,Moderate,0.19,0.342,0.147,0.121,Significant decrease (p=0.026),Variable effect (p=0.026),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09492,rs215016,2,135776831,TREM2,SNP (C/T),(C/,C,2.6,2.23,2.97,0.0608811,High,0.147,0.14,0.25,0.263,Mild decrease (p=0.049),Mild decrease (p=0.003),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09493,rs536980,12,19221448,CD2AP,Insertion,-,-,1.38,1.16,1.58,0.00628012,High,0.377,0.048,0.139,0.236,Significant decrease (p=0.036),Mild increase (p=0.035),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09494,rs243154,11,84496060,ABCA7,Insertion,-,-,1.88,1.65,2.14,0.07816524,High,0.21,0.09,0.126,0.374,No significant pattern (p=0.011),Significant increase (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP09495,rs843115,12,25815940,CLU,SNP (G/T),(G/,G,0.6,0.25,0.83,0.00136973,High,0.122,0.395,0.125,0.157,Mild increase (p=0.01),Mild increase (p=0.004),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09496,rs845827,9,90775236,CD2AP,SNP (A/G),(A/,A,1.32,0.98,1.65,0.00347138,Moderate,0.643,0.02,0.007,0.13,Variable effect (p=0.001),Significant increase (p=0.028),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09497,rs866731,3,155113409,PSEN2,SNP (C/T),(C/,C,1.09,0.76,1.45,0.0466617,Low,0.038,0.161,0.25,0.35,Significant increase (p=0.046),Significant decrease (p=0.014),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09498,rs528657,4,83137654,CR1,SNP (C/T),(C/,C,0.84,0.62,1.22,0.04305661,High,0.026,0.507,0.148,0.118,Variable effect (p=0.014),Variable effect (p=0.015),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09499,rs203062,3,238835357,PICALM,SNP (A/G),(A/,A,0.47,0.18,0.7,0.00443334,High,0.115,0.45,0.029,0.207,No significant pattern (p=0.018),Mild decrease (p=0.037),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09500,rs959837,5,75051911,SORL1,Insertion,-,-,1.18,0.8,1.44,0.00806763,High,0.173,0.238,0.258,0.131,Significant decrease (p=0.048),Significant increase (p=0.023),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09501,rs245527,5,156032498,MS4A6A,Deletion,-,-,1.61,1.23,1.87,0.05680593,Moderate,0.143,0.251,0.255,0.152,Significant increase (p=0.045),Significant increase (p=0.026),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09502,rs717753,22,210265453,APOE,Insertion,-,-,1.71,1.31,2.0,0.07155208,High,0.141,0.259,0.267,0.133,Mild increase (p=0.037),Significant decrease (p=0.049),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09503,rs571233,21,57145547,APOE,SNP (C/T),(C/,C,2.1,1.8,2.44,0.01465208,High,0.299,0.182,0.17,0.148,Significant increase (p=0.019),Mild increase (p=0.034),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09504,rs434072,18,204752776,APP,SNP (C/T),(C/,C,0.73,0.39,0.95,0.03925814,Low,0.153,0.051,0.412,0.184,Mild increase (p=0.002),Significant decrease (p=0.013),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09505,rs124929,2,150780260,PSEN2,SNP (A/C),(A/,A,1.5,1.19,1.78,0.00725299,Moderate,0.114,0.109,0.206,0.371,Mild decrease (p=0.02),Significant decrease (p=0.026),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09506,rs176083,16,197175508,PTK2B,SNP (A/T),(A/,A,1.42,1.14,1.72,0.04367171,Low,0.388,0.1,0.296,0.016,Mild decrease (p=0.006),Mild decrease (p=0.045),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09507,rs859156,12,48460817,ABCA7,SNP (A/C),(A/,A,0.64,0.31,0.88,0.06421992,Moderate,0.189,0.203,0.129,0.278,No significant pattern (p=0.048),Mild decrease (p=0.022),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09508,rs922352,2,176116581,CLU,SNP (G/T),(G/,G,0.94,0.62,1.29,0.00497949,Protective,0.062,0.051,0.648,0.039,Mild decrease (p=0.017),No significant pattern (p=0.01),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP09509,rs635360,6,204230137,ABCA7,SNP (A/C),(A/,A,0.7,0.39,0.9,0.02163375,Low,0.015,0.401,0.188,0.196,Mild decrease (p=0.047),Significant increase (p=0.028),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09510,rs365293,18,53720888,PTK2B,Deletion,-,-,1.53,1.32,1.78,0.00792783,Protective,0.11,0.071,0.356,0.263,Significant decrease (p=0.012),Variable effect (p=0.001),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09511,rs372135,14,14864964,ABCA7,Insertion,-,-,0.69,0.41,0.91,0.03540496,Moderate,0.184,0.283,0.174,0.159,Mild decrease (p=0.039),Significant decrease (p=0.007),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09512,rs195226,20,32608539,BIN1,SNP (G/T),(G/,G,0.77,0.43,1.11,0.0108885,High,0.01,0.067,0.63,0.093,No significant pattern (p=0.018),Variable effect (p=0.037),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP09513,rs579089,9,166858876,PSEN2,SNP (G/T),(G/,G,1.09,0.75,1.4,0.06941734,Moderate,0.321,0.111,0.019,0.349,Variable effect (p=0.029),Mild decrease (p=0.044),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09514,rs440023,19,41410605,BIN1,SNP (G/T),(G/,G,0.59,0.32,0.84,0.01540095,Protective,0.342,0.002,0.068,0.387,Mild decrease (p=0.012),Variable effect (p=0.021),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09515,rs254782,18,134320290,TREM2,SNP (A/G),(A/,A,0.64,0.24,0.92,0.01752183,High,0.183,0.405,0.052,0.159,Significant decrease (p=0.001),Variable effect (p=0.011),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09516,rs102350,5,161097031,SORL1,SNP (C/T),(C/,C,2.25,1.88,2.46,0.08591799,Moderate,0.153,0.408,0.208,0.032,Mild increase (p=0.025),Significant increase (p=0.018),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP09517,rs544481,15,203204869,PSEN2,SNP (A/T),(A/,A,0.94,0.7,1.33,0.02296735,Protective,0.507,0.099,0.078,0.117,Mild decrease (p=0.032),Significant decrease (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09518,rs623703,6,35606958,TREM2,SNP (C/T),(C/,C,0.93,0.56,1.2,0.03481945,High,0.372,0.011,0.092,0.325,Significant increase (p=0.012),No significant pattern (p=0.012),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09519,rs105350,21,192636978,CD2AP,Insertion,-,-,0.71,0.34,1.07,0.0218324,Low,0.036,0.624,0.024,0.116,Mild increase (p=0.018),Significant decrease (p=0.042),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09520,rs412556,11,136099902,SORL1,SNP (A/C),(A/,A,1.0,0.76,1.38,0.07886199,High,0.217,0.221,0.018,0.343,Significant decrease (p=0.002),Mild increase (p=0.046),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09521,rs768384,8,49145042,CLU,SNP (A/C),(A/,A,0.7,0.36,1.08,0.01433504,High,0.514,0.004,0.163,0.119,Significant increase (p=0.047),No significant pattern (p=0.002),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09522,rs149303,1,170402684,CD2AP,Deletion,-,-,0.98,0.73,1.28,0.04034525,Low,0.151,0.088,0.099,0.462,Mild increase (p=0.016),Significant increase (p=0.02),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09523,rs161599,20,95658405,BIN1,SNP (C/G),(C/,C,0.61,0.25,0.99,0.03000497,Protective,0.47,0.001,0.252,0.077,Significant increase (p=0.033),No significant pattern (p=0.038),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09524,rs548661,17,182361772,EPHA1,SNP (G/T),(G/,G,1.16,0.86,1.4,0.07821542,Moderate,0.197,0.188,0.361,0.054,Mild increase (p=0.01),Significant increase (p=0.044),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP09525,rs294795,6,67899586,CR1,Deletion,-,-,1.18,0.78,1.5,0.02366293,High,0.226,0.069,0.048,0.457,Significant decrease (p=0.03),Significant increase (p=0.042),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP09526,rs115688,19,169692812,PICALM,Deletion,-,-,1.01,0.71,1.23,0.00120715,Moderate,0.26,0.385,0.034,0.122,Significant increase (p=0.012),Variable effect (p=0.021),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09527,rs218660,8,109521349,ABCA7,SNP (C/T),(C/,C,1.07,0.69,1.43,0.04956644,Moderate,0.287,0.025,0.307,0.181,Significant decrease (p=0.009),Mild decrease (p=0.046),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP09528,rs607346,14,23208487,PICALM,Insertion,-,-,0.7,0.35,0.96,0.00481815,Unknown,0.501,0.141,0.095,0.063,Variable effect (p=0.036),Variable effect (p=0.048),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09529,rs464318,1,22687112,CD33,SNP (A/C),(A/,A,1.97,1.74,2.26,0.01440815,Moderate,0.185,0.046,0.446,0.124,Mild decrease (p=0.025),Significant decrease (p=0.01),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09530,rs431519,13,94291475,PTK2B,SNP (A/T),(A/,A,1.22,0.84,1.45,0.0152404,Moderate,0.014,0.041,0.455,0.29,Significant decrease (p=0.034),No significant pattern (p=0.021),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP09531,rs481012,7,171850594,PICALM,SNP (A/C),(A/,A,1.32,1.02,1.56,0.00812254,Unknown,0.392,0.039,0.201,0.167,Mild decrease (p=0.002),Significant increase (p=0.034),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09532,rs415640,10,219218331,BIN1,SNP (C/G),(C/,C,0.48,0.27,0.77,0.00417429,Moderate,0.353,0.237,0.039,0.171,Mild increase (p=0.05),Variable effect (p=0.006),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09533,rs168070,20,25690834,ABCA7,SNP (A/C),(A/,A,1.04,0.79,1.35,0.01868201,Protective,0.273,0.194,0.282,0.051,Mild decrease (p=0.03),Significant decrease (p=0.035),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09534,rs139385,3,51215669,CD2AP,Deletion,-,-,1.74,1.44,2.01,0.04053085,Low,0.368,0.017,0.319,0.096,Mild increase (p=0.038),Significant increase (p=0.002),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09535,rs451458,20,197562748,BIN1,SNP (A/C),(A/,A,1.19,0.93,1.43,0.00027245,Low,0.009,0.395,0.19,0.206,Variable effect (p=0.042),No significant pattern (p=0.05),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP09536,rs458632,11,178115287,APP,SNP (A/T),(A/,A,3.24,2.87,3.62,0.04265278,Moderate,0.215,0.123,0.086,0.377,Variable effect (p=0.019),Mild increase (p=0.035),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09537,rs931424,11,84564539,MS4A6A,Insertion,-,-,0.75,0.39,1.12,0.06792154,Low,0.107,0.509,0.105,0.079,Significant increase (p=0.03),No significant pattern (p=0.038),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09538,rs587326,6,216275413,APP,Insertion,-,-,1.88,1.55,2.16,0.06221727,High,0.191,0.523,0.073,0.013,Mild increase (p=0.047),No significant pattern (p=0.013),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09539,rs779239,9,142315108,APOE,SNP (C/T),(C/,C,0.73,0.38,0.94,0.06689955,High,0.245,0.002,0.306,0.247,Variable effect (p=0.024),No significant pattern (p=0.032),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP09540,rs419394,17,128325966,CLU,Deletion,-,-,0.8,0.43,1.09,0.0285822,Moderate,0.282,0.206,0.088,0.224,Mild increase (p=0.023),Significant increase (p=0.036),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09541,rs230961,15,32443486,CD33,SNP (A/T),(A/,A,0.73,0.36,1.06,0.06275473,Low,0.039,0.128,0.153,0.48,Mild increase (p=0.03),No significant pattern (p=0.009),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09542,rs956759,19,10431182,BIN1,SNP (A/T),(A/,A,0.97,0.58,1.22,0.00201784,Moderate,0.119,0.097,0.03,0.553,Variable effect (p=0.048),No significant pattern (p=0.041),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09543,rs528573,4,124003748,PTK2B,Deletion,-,-,0.71,0.44,0.95,0.06550069,Low,0.017,0.152,0.623,0.008,Significant increase (p=0.008),Significant decrease (p=0.01),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09544,rs774484,14,161752902,MS4A6A,SNP (C/G),(C/,C,1.11,0.75,1.4,0.0191004,High,0.244,0.115,0.091,0.35,Significant increase (p=0.031),No significant pattern (p=0.01),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09545,rs307488,20,13703843,PICALM,SNP (G/T),(G/,G,2.0,1.6,2.29,0.04465284,Moderate,0.332,0.033,0.067,0.368,Variable effect (p=0.049),Significant decrease (p=0.047),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09546,rs213524,18,48780623,APOE,SNP (A/T),(A/,A,1.47,1.08,1.84,0.01801531,High,0.069,0.191,0.414,0.126,Mild increase (p=0.012),Mild increase (p=0.023),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09547,rs124133,20,205186005,PICALM,SNP (C/T),(C/,C,0.82,0.48,1.07,0.12976362,High,0.003,0.434,0.273,0.09,Significant decrease (p=0.01),Significant increase (p=0.031),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09548,rs410867,3,221906768,PICALM,SNP (A/G),(A/,A,1.41,1.17,1.64,0.06467464,Moderate,0.151,0.057,0.516,0.076,Significant increase (p=0.007),Significant increase (p=0.035),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09549,rs574340,17,169396865,MS4A6A,Deletion,-,-,2.12,1.82,2.42,0.02534117,Moderate,0.291,0.157,0.204,0.148,No significant pattern (p=0.01),No significant pattern (p=0.049),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP09550,rs705946,21,211538699,APP,SNP (C/G),(C/,C,1.98,1.67,2.28,0.13247297,High,0.642,0.077,0.077,0.004,Significant increase (p=0.033),Mild increase (p=0.01),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09551,rs731302,7,44783149,BIN1,Deletion,-,-,0.75,0.47,1.07,0.07973356,Low,0.509,0.02,0.151,0.119,Significant decrease (p=0.017),Mild increase (p=0.045),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09552,rs660808,12,150893807,PTK2B,SNP (A/G),(A/,A,1.2,0.9,1.49,0.04741717,Low,0.142,0.464,0.011,0.182,Variable effect (p=0.007),Mild decrease (p=0.013),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09553,rs407498,8,35398520,MS4A6A,SNP (C/G),(C/,C,1.15,0.84,1.43,0.02954982,High,0.548,0.018,0.211,0.024,No significant pattern (p=0.039),No significant pattern (p=0.021),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09554,rs818072,22,48999720,CD2AP,SNP (A/T),(A/,A,1.86,1.5,2.17,0.0659427,Protective,0.038,0.429,0.323,0.01,No significant pattern (p=0.015),Significant increase (p=0.016),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09555,rs850312,17,17786598,TREM2,SNP (C/G),(C/,C,0.91,0.56,1.26,0.00811778,Moderate,0.092,0.192,0.445,0.071,No significant pattern (p=0.037),No significant pattern (p=0.011),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP09556,rs182029,2,58730811,CD33,SNP (A/G),(A/,A,2.17,1.81,2.48,0.08242282,Moderate,0.158,0.256,0.16,0.225,Significant decrease (p=0.021),Mild increase (p=0.029),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09557,rs910660,6,56718193,PICALM,SNP (C/G),(C/,C,0.77,0.44,1.02,0.00827783,Low,0.214,0.437,0.073,0.076,Variable effect (p=0.015),Significant decrease (p=0.01),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09558,rs491689,10,167917868,APOE,Insertion,-,-,2.74,2.47,3.06,0.04967819,High,0.196,0.441,0.089,0.074,Variable effect (p=0.032),Variable effect (p=0.032),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09559,rs435028,18,247364188,TREM2,SNP (A/C),(A/,A,0.48,0.26,0.83,0.07159494,Moderate,0.155,0.409,0.17,0.065,Mild increase (p=0.013),Significant decrease (p=0.03),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09560,rs349459,16,197419058,CR1,SNP (C/T),(C/,C,1.38,1.05,1.67,0.01405057,High,0.149,0.496,0.096,0.059,Mild decrease (p=0.047),Significant increase (p=0.049),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP09561,rs823597,5,202857521,PSEN2,SNP (A/G),(A/,A,0.95,0.57,1.19,0.0286798,High,0.039,0.214,0.083,0.464,Significant decrease (p=0.02),Significant increase (p=0.028),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09562,rs156372,11,105148108,CD33,SNP (A/C),(A/,A,1.19,0.87,1.52,0.00983879,High,0.154,0.216,0.107,0.323,Significant decrease (p=0.011),Mild decrease (p=0.046),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09563,rs259472,9,77088223,CR1,Insertion,-,-,0.45,0.18,0.71,0.00576486,Low,0.446,0.024,0.274,0.056,Significant decrease (p=0.016),Mild decrease (p=0.022),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09564,rs818053,5,69780155,SORL1,SNP (G/T),(G/,G,0.67,0.36,0.95,0.11888189,Moderate,0.079,0.289,0.387,0.045,Significant increase (p=0.038),Mild decrease (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP09565,rs230515,18,75187014,MS4A6A,SNP (A/T),(A/,A,1.49,1.21,1.75,0.0728198,Moderate,0.159,0.155,0.367,0.118,Significant decrease (p=0.029),No significant pattern (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09566,rs950257,22,5388809,PTK2B,SNP (C/T),(C/,C,0.95,0.61,1.29,0.01329729,Low,0.426,0.093,0.239,0.042,Significant increase (p=0.015),Mild decrease (p=0.032),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09567,rs237735,12,188348911,CLU,SNP (A/C),(A/,A,1.65,1.26,1.94,0.03853841,Moderate,0.059,0.274,0.192,0.275,Significant decrease (p=0.012),Mild decrease (p=0.043),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09568,rs651922,7,132709182,CD2AP,Insertion,-,-,1.01,0.72,1.38,0.1808002,Moderate,0.409,0.371,0.019,0.002,Variable effect (p=0.027),Significant decrease (p=0.04),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09569,rs383571,10,225563797,CLU,Deletion,-,-,1.04,0.66,1.32,0.00172719,High,0.002,0.539,0.067,0.192,Mild increase (p=0.023),Mild increase (p=0.023),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP09570,rs427447,11,75495432,PICALM,Deletion,-,-,0.6,0.37,0.94,0.03926683,Low,0.12,0.102,0.346,0.232,Mild increase (p=0.024),Mild decrease (p=0.024),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09571,rs526647,6,92072266,PTK2B,Deletion,-,-,1.17,0.82,1.52,0.01328969,Protective,0.071,0.304,0.35,0.076,Variable effect (p=0.04),Significant decrease (p=0.035),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09572,rs965404,5,4449766,CLU,SNP (C/T),(C/,C,1.45,1.22,1.76,0.02402521,Protective,0.224,0.079,0.126,0.372,Mild increase (p=0.034),Variable effect (p=0.047),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09573,rs217922,12,4307013,CD2AP,SNP (G/T),(G/,G,0.83,0.62,1.23,0.01014107,Low,0.075,0.517,0.194,0.014,Significant increase (p=0.042),Mild decrease (p=0.043),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09574,rs216586,21,220176815,CR1,SNP (G/T),(G/,G,1.08,0.81,1.28,0.00455714,Moderate,0.131,0.554,0.084,0.031,No significant pattern (p=0.021),Mild decrease (p=0.02),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09575,rs279443,4,133526497,MS4A6A,SNP (A/T),(A/,A,1.6,1.34,1.83,0.04141761,High,0.089,0.049,0.033,0.629,Significant decrease (p=0.031),Significant increase (p=0.03),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP09576,rs739582,8,174175761,EPHA1,Deletion,-,-,1.06,0.76,1.27,0.02181828,Unknown,0.349,0.176,0.112,0.163,Variable effect (p=0.043),Mild decrease (p=0.031),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09577,rs136811,14,199319952,APOE,SNP (G/T),(G/,G,2.02,1.78,2.42,0.00011607,High,0.432,0.027,0.273,0.068,Variable effect (p=0.036),Mild decrease (p=0.005),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP09578,rs882359,10,46938774,SORL1,SNP (C/T),(C/,C,2.3,1.99,2.67,0.01430261,Protective,0.106,0.347,0.062,0.286,Mild decrease (p=0.009),Variable effect (p=0.02),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP09579,rs996165,7,131406971,PICALM,Deletion,-,-,1.21,0.95,1.55,0.00485217,High,0.369,0.28,0.144,0.006,Significant decrease (p=0.015),No significant pattern (p=0.015),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09580,rs299685,22,24064377,PSEN2,Deletion,-,-,0.69,0.35,1.0,0.0233503,High,0.325,0.091,0.014,0.369,No significant pattern (p=0.025),Significant decrease (p=0.035),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09581,rs487415,8,171546716,CR1,SNP (A/G),(A/,A,1.47,1.23,1.84,0.02850864,Moderate,0.019,0.583,0.094,0.105,Mild increase (p=0.022),Mild decrease (p=0.04),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09582,rs553661,10,52794233,ABCA7,SNP (A/C),(A/,A,0.94,0.6,1.22,0.0345577,Unknown,0.032,0.283,0.173,0.312,Significant decrease (p=0.013),Variable effect (p=0.02),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09583,rs761768,1,189051287,CD2AP,SNP (A/T),(A/,A,1.17,0.88,1.42,0.01952911,Protective,0.179,0.027,0.408,0.187,Significant increase (p=0.034),Mild decrease (p=0.009),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09584,rs342904,8,164580606,CLU,Deletion,-,-,0.82,0.45,1.09,0.06012067,Moderate,0.22,0.151,0.084,0.345,No significant pattern (p=0.027),Variable effect (p=0.026),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09585,rs822446,7,52700653,CD33,SNP (A/G),(A/,A,1.08,0.7,1.33,0.00409918,Moderate,0.178,0.346,0.151,0.124,Variable effect (p=0.02),Mild decrease (p=0.04),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09586,rs227897,1,20178487,CR1,SNP (C/G),(C/,C,0.75,0.39,1.13,0.00318269,High,0.254,0.005,0.497,0.044,Significant decrease (p=0.012),No significant pattern (p=0.038),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09587,rs939355,19,151928940,CLU,SNP (C/T),(C/,C,0.76,0.39,1.11,0.01812787,Low,0.033,0.52,0.05,0.197,Significant increase (p=0.007),Significant increase (p=0.007),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09588,rs619393,13,56907351,BIN1,SNP (G/T),(G/,G,1.51,1.27,1.73,0.01923635,High,0.165,0.55,0.007,0.079,No significant pattern (p=0.018),Mild decrease (p=0.014),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09589,rs453910,15,181897334,CR1,Insertion,-,-,0.97,0.62,1.22,0.00229263,Moderate,0.127,0.161,0.226,0.286,Mild increase (p=0.029),No significant pattern (p=0.011),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09590,rs359520,15,16740506,CD2AP,SNP (C/G),(C/,C,0.65,0.37,0.86,0.04467184,Low,0.762,0.016,0.013,0.01,Variable effect (p=0.045),Mild decrease (p=0.016),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09591,rs994743,15,245058136,APP,SNP (A/T),(A/,A,1.75,1.55,2.13,0.01048358,Moderate,0.138,0.093,0.279,0.289,Variable effect (p=0.002),Significant decrease (p=0.008),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09592,rs560670,17,187033145,CR1,SNP (A/T),(A/,A,0.99,0.74,1.32,0.03468903,Protective,0.355,0.238,0.013,0.193,Mild increase (p=0.019),No significant pattern (p=0.026),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09593,rs135322,16,138420656,APOE,Insertion,-,-,0.79,0.58,1.0,0.0210867,Low,0.61,0.017,0.114,0.059,No significant pattern (p=0.028),Mild decrease (p=0.039),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09594,rs368496,10,238515089,CLU,SNP (A/T),(A/,A,2.36,2.14,2.58,0.08370274,Low,0.455,0.142,0.052,0.151,Significant decrease (p=0.046),Mild decrease (p=0.024),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09595,rs269248,22,72343988,APP,SNP (A/T),(A/,A,1.2,0.85,1.58,0.00917298,Low,0.018,0.256,0.52,0.006,Significant increase (p=0.026),No significant pattern (p=0.005),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09596,rs856236,12,11671208,SORL1,Insertion,-,-,1.07,0.81,1.45,0.00596206,Protective,0.047,0.163,0.262,0.329,Variable effect (p=0.041),Mild increase (p=0.05),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09597,rs828433,19,33948883,EPHA1,SNP (A/C),(A/,A,1.23,1.0,1.62,0.01434998,High,0.25,0.071,0.458,0.02,Mild increase (p=0.024),Variable effect (p=0.037),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09598,rs446465,9,81794761,ABCA7,Deletion,-,-,0.74,0.51,0.97,0.02641802,High,0.174,0.24,0.115,0.271,No significant pattern (p=0.045),Significant decrease (p=0.032),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09599,rs446046,1,17354892,SORL1,Insertion,-,-,0.4,0.2,0.63,0.0264411,Moderate,0.06,0.054,0.209,0.477,Significant increase (p=0.008),Significant decrease (p=0.018),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP09600,rs943043,3,175888239,TREM2,SNP (A/G),(A/,A,0.49,0.24,0.79,0.00277647,High,0.051,0.044,0.035,0.67,Significant decrease (p=0.006),Mild decrease (p=0.05),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09601,rs172643,10,148234255,SORL1,SNP (G/T),(G/,G,0.34,0.1,0.63,0.07134536,Unknown,0.454,0.15,0.153,0.043,Significant decrease (p=0.017),Mild decrease (p=0.016),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09602,rs373274,21,101883135,SORL1,SNP (C/G),(C/,C,0.63,0.26,0.94,0.01741002,High,0.072,0.094,0.468,0.166,Significant decrease (p=0.019),Mild increase (p=0.002),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09603,rs314120,14,93547041,MS4A6A,SNP (A/C),(A/,A,1.93,1.62,2.2,0.02085166,Moderate,0.204,0.08,0.006,0.511,No significant pattern (p=0.007),Mild increase (p=0.006),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP09604,rs719308,22,73809436,CD33,SNP (C/G),(C/,C,1.05,0.67,1.31,0.10705532,High,0.295,0.328,0.156,0.021,Mild decrease (p=0.021),Mild increase (p=0.03),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09605,rs944638,14,222495366,CD33,SNP (G/T),(G/,G,1.76,1.55,2.15,0.03501868,Moderate,0.615,0.037,0.066,0.082,Mild increase (p=0.045),Significant increase (p=0.033),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09606,rs593329,6,79852311,MS4A6A,Deletion,-,-,1.12,0.75,1.38,0.06621202,Protective,0.365,0.255,0.166,0.014,Significant increase (p=0.004),No significant pattern (p=0.031),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09607,rs956055,21,248641732,MS4A6A,SNP (A/C),(A/,A,0.53,0.2,0.85,0.00346617,Moderate,0.307,0.176,0.182,0.135,Significant increase (p=0.044),Variable effect (p=0.044),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP09608,rs691870,15,47355960,CD33,Deletion,-,-,0.41,0.12,0.77,0.05063998,Protective,0.57,0.046,0.052,0.132,No significant pattern (p=0.016),No significant pattern (p=0.029),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09609,rs269784,3,8478864,BIN1,SNP (A/C),(A/,A,1.21,0.96,1.56,0.03754649,Protective,0.475,0.117,0.023,0.186,No significant pattern (p=0.041),No significant pattern (p=0.049),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09610,rs920567,12,20992138,MS4A6A,SNP (A/G),(A/,A,0.52,0.22,0.85,0.03754646,Unknown,0.103,0.206,0.295,0.197,Significant increase (p=0.041),Significant increase (p=0.021),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP09611,rs680793,2,45281495,SORL1,SNP (A/G),(A/,A,1.92,1.58,2.32,0.00025713,Moderate,0.176,0.447,0.174,0.003,No significant pattern (p=0.006),Mild increase (p=0.039),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09612,rs206473,8,120855838,EPHA1,SNP (G/T),(G/,G,2.41,2.02,2.76,0.02312032,High,0.171,0.434,0.181,0.015,Mild decrease (p=0.002),Mild decrease (p=0.045),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09613,rs800073,11,60645054,PTK2B,SNP (A/T),(A/,A,1.48,1.28,1.7,0.05480876,Moderate,0.333,0.168,0.127,0.172,Variable effect (p=0.025),No significant pattern (p=0.006),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP09614,rs370768,21,144010079,CD2AP,SNP (C/G),(C/,C,1.0,0.75,1.32,0.01550615,Moderate,0.712,0.04,0.003,0.046,No significant pattern (p=0.032),Mild decrease (p=0.036),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09615,rs325136,11,203438312,ABCA7,SNP (C/T),(C/,C,0.75,0.37,1.04,0.01963469,Moderate,0.224,0.09,0.134,0.352,Variable effect (p=0.03),Significant decrease (p=0.031),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09616,rs149651,6,131080366,CD33,Insertion,-,-,0.99,0.62,1.28,0.01284199,Low,0.074,0.287,0.064,0.376,Mild decrease (p=0.043),No significant pattern (p=0.019),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09617,rs671137,1,236601313,EPHA1,SNP (A/G),(A/,A,1.39,1.0,1.63,0.00986745,High,0.544,0.082,0.074,0.101,Mild decrease (p=0.02),Mild increase (p=0.026),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09618,rs137337,3,166898259,MS4A6A,SNP (C/G),(C/,C,0.99,0.72,1.23,0.07830562,High,0.057,0.035,0.697,0.011,Variable effect (p=0.012),Mild increase (p=0.032),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09619,rs446246,20,36700931,CR1,SNP (C/T),(C/,C,0.66,0.42,0.91,0.04696448,High,0.231,0.32,0.094,0.155,Significant decrease (p=0.028),Mild increase (p=0.005),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09620,rs647577,5,219888943,CD2AP,SNP (C/T),(C/,C,0.93,0.66,1.32,0.08249591,Low,0.284,0.314,0.005,0.197,Variable effect (p=0.045),Significant increase (p=0.017),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09621,rs103243,6,158756902,TREM2,SNP (G/T),(G/,G,1.11,0.74,1.39,0.06372408,Protective,0.115,0.441,0.037,0.206,Mild decrease (p=0.013),Variable effect (p=0.033),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09622,rs873284,22,40986175,PICALM,SNP (G/T),(G/,G,0.72,0.43,0.94,0.02429468,Low,0.054,0.098,0.024,0.623,Variable effect (p=0.023),Significant decrease (p=0.008),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09623,rs324428,16,173619766,MS4A6A,SNP (A/G),(A/,A,1.87,1.55,2.08,0.01950204,Moderate,0.17,0.014,0.077,0.539,Significant decrease (p=0.02),Significant decrease (p=0.026),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09624,rs991332,5,130926913,CD33,SNP (A/C),(A/,A,1.37,1.1,1.67,0.01313649,High,0.106,0.004,0.037,0.654,Variable effect (p=0.049),Variable effect (p=0.045),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09625,rs601754,14,133283309,PICALM,SNP (C/G),(C/,C,0.73,0.5,1.09,0.00086759,High,0.2,0.073,0.45,0.078,Mild increase (p=0.026),No significant pattern (p=0.046),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09626,rs526231,16,147637015,EPHA1,Insertion,-,-,2.2,1.85,2.56,0.0085451,Low,0.527,0.015,0.236,0.022,Significant increase (p=0.021),Mild increase (p=0.041),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09627,rs586023,13,220286836,APP,SNP (G/T),(G/,G,1.76,1.52,2.08,0.07460166,High,0.028,0.024,0.643,0.104,Mild increase (p=0.036),Significant decrease (p=0.031),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09628,rs221029,1,125511914,BIN1,SNP (A/C),(A/,A,0.89,0.57,1.09,0.06225688,Moderate,0.067,0.145,0.534,0.055,Significant increase (p=0.035),Variable effect (p=0.038),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09629,rs922853,20,101359963,CD33,SNP (A/G),(A/,A,1.69,1.48,1.96,0.01648295,High,0.006,0.045,0.225,0.523,Significant increase (p=0.004),Mild increase (p=0.028),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09630,rs767313,13,161502318,BIN1,Deletion,-,-,0.68,0.31,0.94,0.04664004,High,0.272,0.025,0.307,0.196,Significant increase (p=0.025),Significant decrease (p=0.016),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09631,rs801047,15,73793760,PICALM,Insertion,-,-,0.92,0.59,1.23,0.06091584,Moderate,0.087,0.013,0.095,0.605,No significant pattern (p=0.04),Mild increase (p=0.02),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09632,rs743357,21,19503090,CLU,Insertion,-,-,1.28,1.03,1.67,0.08352699,High,0.149,0.016,0.511,0.125,Significant decrease (p=0.033),Mild increase (p=0.033),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09633,rs189262,5,119139675,APOE,SNP (A/T),(A/,A,1.51,1.23,1.75,0.03247269,Moderate,0.219,0.005,0.112,0.464,Significant increase (p=0.01),Variable effect (p=0.005),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09634,rs350478,16,201154040,PSEN2,Insertion,-,-,0.97,0.6,1.34,0.00688323,Low,0.157,0.307,0.137,0.2,No significant pattern (p=0.05),No significant pattern (p=0.022),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09635,rs496850,20,211101994,APOE,Insertion,-,-,1.23,0.88,1.52,0.02484598,Protective,0.338,0.272,0.023,0.167,No significant pattern (p=0.011),Mild increase (p=0.004),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09636,rs685287,12,234283386,PTK2B,SNP (G/T),(G/,G,1.82,1.56,2.21,0.02418305,Moderate,0.009,0.16,0.601,0.03,Mild increase (p=0.045),Mild decrease (p=0.021),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09637,rs189794,14,75751139,CLU,SNP (G/T),(G/,G,0.91,0.67,1.2,0.01379244,High,0.137,0.27,0.34,0.054,Significant increase (p=0.046),Significant increase (p=0.046),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09638,rs952005,5,136718126,CD2AP,Insertion,-,-,1.01,0.71,1.41,0.05831257,High,0.527,0.042,0.044,0.187,Mild increase (p=0.047),Significant decrease (p=0.017),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09639,rs799410,4,142494117,SORL1,SNP (C/T),(C/,C,2.33,1.96,2.54,0.01838019,Low,0.111,0.047,0.009,0.634,Significant increase (p=0.015),Mild increase (p=0.021),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09640,rs616514,22,204514784,CLU,SNP (C/G),(C/,C,0.85,0.52,1.08,0.00014963,Moderate,0.107,0.33,0.248,0.114,Mild decrease (p=0.032),Variable effect (p=0.048),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09641,rs356696,2,73465307,CR1,Deletion,-,-,2.14,1.86,2.38,0.03583563,Low,0.142,0.234,0.392,0.032,Significant increase (p=0.022),Significant decrease (p=0.023),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09642,rs194768,13,93231253,PICALM,SNP (G/T),(G/,G,1.95,1.63,2.19,0.02891911,High,0.281,0.207,0.31,0.001,Significant decrease (p=0.038),Significant increase (p=0.036),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09643,rs273798,21,166961093,BIN1,SNP (C/G),(C/,C,1.07,0.82,1.38,0.02204168,Moderate,0.256,0.165,0.249,0.13,Mild increase (p=0.015),Mild increase (p=0.017),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP09644,rs543717,8,202822678,PICALM,Deletion,-,-,1.72,1.35,2.1,0.04997105,Protective,0.193,0.093,0.486,0.028,Significant decrease (p=0.011),Significant increase (p=0.012),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09645,rs273591,9,170650292,ABCA7,SNP (C/G),(C/,C,0.92,0.54,1.27,0.03275618,Low,0.067,0.134,0.151,0.448,No significant pattern (p=0.019),Mild decrease (p=0.036),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09646,rs248476,17,192634986,CD33,SNP (A/G),(A/,A,0.61,0.23,0.92,0.04040154,Low,0.407,0.018,0.084,0.291,Variable effect (p=0.037),Variable effect (p=0.009),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09647,rs854488,19,230111822,ABCA7,SNP (A/C),(A/,A,1.95,1.67,2.25,0.01052327,Low,0.348,0.017,0.407,0.028,Significant decrease (p=0.018),Mild increase (p=0.03),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP09648,rs729554,1,188890489,CR1,Deletion,-,-,1.5,1.3,1.82,0.02609659,Low,0.244,0.021,0.529,0.006,Variable effect (p=0.037),Mild increase (p=0.05),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09649,rs542210,5,202222098,CD2AP,Insertion,-,-,1.64,1.25,1.87,0.0085415,Low,0.43,0.006,0.302,0.063,Mild decrease (p=0.033),Variable effect (p=0.016),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09650,rs688530,7,38020832,ABCA7,SNP (G/T),(G/,G,0.76,0.4,1.08,0.00192427,Low,0.354,0.179,0.168,0.099,Mild decrease (p=0.037),Significant increase (p=0.037),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09651,rs903916,15,138778911,PTK2B,SNP (A/T),(A/,A,1.11,0.89,1.36,0.0044882,Moderate,0.004,0.146,0.38,0.269,Significant increase (p=0.002),Mild increase (p=0.043),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09652,rs284202,8,66338921,CD33,SNP (A/T),(A/,A,1.52,1.21,1.84,0.06521406,Protective,0.076,0.344,0.355,0.024,Mild increase (p=0.028),Variable effect (p=0.046),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09653,rs943196,13,132700261,CD33,SNP (A/G),(A/,A,1.64,1.42,1.97,0.05239445,Low,0.126,0.342,0.261,0.071,Mild decrease (p=0.009),Mild increase (p=0.026),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09654,rs763921,8,30025765,MS4A6A,SNP (A/G),(A/,A,1.23,0.93,1.57,0.02254776,Moderate,0.444,0.144,0.191,0.02,Variable effect (p=0.044),Mild decrease (p=0.028),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09655,rs231767,20,72142591,EPHA1,SNP (A/T),(A/,A,0.61,0.24,0.98,0.0381369,Moderate,0.19,0.258,0.131,0.221,Variable effect (p=0.006),Variable effect (p=0.042),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09656,rs309093,6,132062604,PSEN2,SNP (A/C),(A/,A,1.05,0.72,1.38,0.01063896,Moderate,0.084,0.33,0.286,0.1,No significant pattern (p=0.008),No significant pattern (p=0.047),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09657,rs347293,19,23560464,CD33,SNP (G/T),(G/,G,0.74,0.38,1.02,0.01976917,Low,0.112,0.036,0.322,0.331,No significant pattern (p=0.043),Significant decrease (p=0.031),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09658,rs432777,16,226381145,BIN1,SNP (A/T),(A/,A,3.44,3.06,3.77,0.01385927,Protective,0.517,0.073,0.013,0.197,Mild decrease (p=0.041),Significant decrease (p=0.045),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09659,rs853348,21,129791472,CD33,Deletion,-,-,1.4,1.11,1.7,0.01201638,Protective,0.592,0.011,0.117,0.081,No significant pattern (p=0.025),Variable effect (p=0.029),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP09660,rs327095,13,85670583,CR1,SNP (C/T),(C/,C,1.94,1.66,2.15,0.0518118,Moderate,0.127,0.379,0.226,0.068,Mild decrease (p=0.049),Mild decrease (p=0.01),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09661,rs130003,14,129619672,MS4A6A,Deletion,-,-,1.43,1.15,1.82,0.00430199,Low,0.404,0.052,0.076,0.269,No significant pattern (p=0.022),Significant increase (p=0.048),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09662,rs195356,2,141304943,PTK2B,SNP (G/T),(G/,G,0.92,0.72,1.17,0.05414501,High,0.197,0.048,0.372,0.184,No significant pattern (p=0.009),Significant increase (p=0.037),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09663,rs125657,4,247309741,PSEN2,SNP (A/T),(A/,A,1.69,1.39,2.01,0.00988671,Moderate,0.073,0.083,0.437,0.206,Significant decrease (p=0.047),Significant increase (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09664,rs634625,18,205835200,MS4A6A,Insertion,-,-,1.27,1.06,1.48,0.08958261,Low,0.108,0.257,0.121,0.315,Variable effect (p=0.008),Mild decrease (p=0.011),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09665,rs826024,22,155391325,CR1,SNP (A/C),(A/,A,0.44,0.1,0.68,0.02057783,High,0.265,0.274,0.019,0.242,Significant decrease (p=0.049),Significant increase (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP09666,rs577522,20,213970726,APP,Deletion,-,-,1.02,0.8,1.34,0.00769923,Protective,0.117,0.057,0.511,0.115,Mild increase (p=0.006),No significant pattern (p=0.015),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09667,rs477387,15,243021752,BIN1,SNP (C/T),(C/,C,0.71,0.39,1.08,0.06914108,High,0.358,0.206,0.128,0.108,Significant increase (p=0.012),Mild increase (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09668,rs111707,17,31307776,PTK2B,SNP (A/C),(A/,A,0.79,0.41,1.03,0.00379659,High,0.066,0.272,0.394,0.068,Mild decrease (p=0.034),Significant decrease (p=0.025),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP09669,rs464492,7,145459558,BIN1,SNP (C/G),(C/,C,0.57,0.26,0.88,0.02679062,High,0.105,0.581,0.015,0.099,Variable effect (p=0.033),Significant increase (p=0.037),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09670,rs812760,3,160847826,PTK2B,Insertion,-,-,0.82,0.55,1.07,0.07307349,Moderate,0.104,0.533,0.07,0.093,Variable effect (p=0.032),Variable effect (p=0.006),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09671,rs593633,14,62615196,MS4A6A,Deletion,-,-,1.05,0.71,1.25,0.00973658,Low,0.201,0.337,0.042,0.22,Variable effect (p=0.016),Mild decrease (p=0.026),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09672,rs853480,20,80299194,CR1,SNP (G/T),(G/,G,0.69,0.38,0.98,0.02713338,Low,0.184,0.304,0.051,0.26,Significant increase (p=0.038),No significant pattern (p=0.004),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP09673,rs445087,19,157835031,TREM2,SNP (C/G),(C/,C,1.97,1.68,2.25,0.20404233,Low,0.181,0.409,0.035,0.175,Mild increase (p=0.01),Mild increase (p=0.036),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09674,rs120580,20,45362112,CLU,Insertion,-,-,1.15,0.87,1.36,0.09862386,High,0.065,0.528,0.184,0.023,Variable effect (p=0.01),Significant increase (p=0.004),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09675,rs175806,1,126680347,CD33,SNP (G/T),(G/,G,0.94,0.57,1.23,0.02951423,High,0.185,0.415,0.126,0.074,Mild increase (p=0.022),Mild increase (p=0.01),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09676,rs662662,19,90708649,APOE,SNP (A/T),(A/,A,0.52,0.15,0.78,0.01064012,High,0.256,0.092,0.437,0.015,Significant increase (p=0.011),Significant increase (p=0.005),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09677,rs568070,19,68203606,TREM2,Deletion,-,-,0.86,0.51,1.15,0.00943299,Low,0.307,0.091,0.208,0.194,Mild decrease (p=0.03),Significant increase (p=0.039),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09678,rs587963,9,52401242,CD2AP,SNP (A/C),(A/,A,0.95,0.71,1.18,0.0261908,Low,0.257,0.26,0.233,0.05,Mild increase (p=0.02),Mild increase (p=0.038),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP09679,rs623087,9,101670517,CD33,Insertion,-,-,0.43,0.17,0.68,0.00749,Unknown,0.049,0.357,0.109,0.285,No significant pattern (p=0.04),Mild increase (p=0.007),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP09680,rs964924,4,66237666,EPHA1,SNP (A/C),(A/,A,1.45,1.21,1.84,0.04479832,Moderate,0.239,0.11,0.262,0.188,Mild increase (p=0.029),Mild decrease (p=0.018),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09681,rs770635,8,131675879,PSEN2,Insertion,-,-,1.79,1.42,1.99,0.04714512,Moderate,0.412,0.151,0.188,0.049,Significant increase (p=0.029),Significant increase (p=0.043),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09682,rs175847,6,241470561,CR1,SNP (A/T),(A/,A,0.64,0.41,1.03,0.04013577,Low,0.465,0.282,0.002,0.051,No significant pattern (p=0.027),Significant increase (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09683,rs736060,7,120718498,TREM2,Deletion,-,-,1.05,0.75,1.34,0.08340287,Moderate,0.376,0.026,0.279,0.12,Variable effect (p=0.036),Significant decrease (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09684,rs919033,17,245495038,MS4A6A,Insertion,-,-,1.53,1.18,1.85,0.01510227,Moderate,0.352,0.193,0.092,0.163,Significant increase (p=0.033),Significant increase (p=0.042),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP09685,rs177956,9,67055459,CD33,SNP (A/G),(A/,A,1.14,0.85,1.41,0.07094977,High,0.427,0.02,0.028,0.325,No significant pattern (p=0.013),Significant increase (p=0.021),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09686,rs285552,22,129517372,MS4A6A,SNP (C/T),(C/,C,0.63,0.42,1.0,0.03501355,Moderate,0.123,0.15,0.423,0.104,Mild increase (p=0.005),Mild increase (p=0.045),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09687,rs564159,2,39724147,CR1,SNP (C/T),(C/,C,0.43,0.14,0.79,0.03933741,High,0.182,0.053,0.207,0.358,Mild decrease (p=0.003),No significant pattern (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09688,rs831471,21,165937516,EPHA1,Insertion,-,-,0.66,0.44,0.88,0.02268729,High,0.153,0.383,0.111,0.154,Significant increase (p=0.015),Variable effect (p=0.048),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09689,rs845149,4,195138118,BIN1,SNP (G/T),(G/,G,3.18,2.95,3.43,0.10288738,High,0.086,0.056,0.222,0.436,Mild decrease (p=0.032),Significant decrease (p=0.011),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09690,rs577620,6,142862255,TREM2,SNP (A/G),(A/,A,1.42,1.12,1.73,0.016471,Protective,0.012,0.478,0.041,0.268,Variable effect (p=0.004),Mild increase (p=0.04),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09691,rs926659,2,26262166,PSEN2,SNP (C/G),(C/,C,0.58,0.36,0.84,0.06763042,Moderate,0.098,0.058,0.617,0.027,Variable effect (p=0.002),Mild decrease (p=0.008),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP09692,rs103951,19,178972095,BIN1,SNP (G/T),(G/,G,0.61,0.34,0.87,0.0047112,Moderate,0.232,0.387,0.003,0.178,No significant pattern (p=0.036),Mild increase (p=0.025),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09693,rs622365,6,100998139,TREM2,SNP (A/G),(A/,A,1.7,1.34,1.94,0.01957159,Moderate,0.148,0.111,0.286,0.255,Variable effect (p=0.006),Variable effect (p=0.018),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09694,rs649100,2,56002847,PTK2B,Insertion,-,-,0.72,0.37,1.03,0.00054606,Unknown,0.103,0.45,0.033,0.214,Mild increase (p=0.009),Variable effect (p=0.008),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP09695,rs990705,22,6499927,SORL1,SNP (G/T),(G/,G,0.9,0.58,1.12,0.03227437,Protective,0.378,0.328,0.065,0.029,Significant increase (p=0.006),Mild decrease (p=0.006),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09696,rs513635,5,130860688,ABCA7,SNP (C/T),(C/,C,1.35,1.13,1.59,0.00512255,Low,0.049,0.18,0.167,0.403,Variable effect (p=0.006),Significant decrease (p=0.05),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09697,rs912502,6,72281379,APP,SNP (A/C),(A/,A,3.34,2.96,3.66,0.03986948,Moderate,0.064,0.164,0.525,0.047,No significant pattern (p=0.026),Variable effect (p=0.011),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09698,rs980677,13,108981699,CD33,SNP (A/T),(A/,A,1.42,1.07,1.75,0.0303865,Low,0.124,0.123,0.498,0.055,Significant decrease (p=0.015),No significant pattern (p=0.038),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09699,rs730713,22,244179173,PSEN2,SNP (C/T),(C/,C,2.27,2.04,2.54,0.083581,Moderate,0.288,0.054,0.126,0.333,Mild increase (p=0.021),Mild decrease (p=0.013),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09700,rs384874,2,222465740,MS4A6A,SNP (G/T),(G/,G,1.15,0.92,1.53,0.05725693,High,0.258,0.126,0.28,0.135,No significant pattern (p=0.044),Mild decrease (p=0.002),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09701,rs473026,19,241872753,BIN1,SNP (C/G),(C/,C,0.85,0.62,1.08,0.00109198,Low,0.08,0.374,0.085,0.261,Variable effect (p=0.042),Mild decrease (p=0.003),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09702,rs311950,17,196272126,CLU,SNP (G/T),(G/,G,0.72,0.49,0.97,0.01795048,Moderate,0.133,0.42,0.164,0.082,Mild increase (p=0.044),Mild decrease (p=0.046),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09703,rs705440,22,55825780,ABCA7,SNP (C/T),(C/,C,1.18,0.79,1.47,0.1058901,Unknown,0.135,0.192,0.386,0.086,Variable effect (p=0.006),Significant decrease (p=0.03),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09704,rs100020,21,8137581,PSEN2,Deletion,-,-,0.92,0.55,1.15,0.04153108,Moderate,0.163,0.105,0.181,0.351,Mild increase (p=0.025),Variable effect (p=0.026),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09705,rs526554,7,203369511,TREM2,SNP (A/T),(A/,A,0.81,0.59,1.15,0.00531994,Low,0.183,0.257,0.31,0.05,Significant decrease (p=0.025),Mild decrease (p=0.009),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09706,rs929064,14,18641126,SORL1,SNP (A/T),(A/,A,1.97,1.7,2.21,0.00181196,High,0.246,0.099,0.391,0.064,Mild increase (p=0.035),No significant pattern (p=0.048),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09707,rs789821,7,37498440,SORL1,SNP (A/G),(A/,A,1.08,0.85,1.3,0.02804567,High,0.125,0.252,0.138,0.286,Significant increase (p=0.02),Mild increase (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09708,rs107751,7,179104668,ABCA7,SNP (C/T),(C/,C,0.42,0.1,0.67,0.01919684,Moderate,0.033,0.17,0.333,0.264,Variable effect (p=0.023),Variable effect (p=0.029),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09709,rs973840,2,87070594,CR1,SNP (C/G),(C/,C,0.5,0.15,0.89,0.03891445,Moderate,0.142,0.014,0.32,0.325,No significant pattern (p=0.021),Mild increase (p=0.007),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09710,rs881258,10,204537161,CD2AP,Insertion,-,-,0.49,0.14,0.76,0.03379385,Moderate,0.226,0.172,0.088,0.314,Significant decrease (p=0.027),Significant increase (p=0.048),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09711,rs636105,21,61772641,CR1,SNP (C/G),(C/,C,0.81,0.53,1.09,0.00356689,High,0.538,0.015,0.048,0.198,Significant increase (p=0.025),Significant decrease (p=0.042),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09712,rs956996,21,76803944,PSEN2,Insertion,-,-,0.56,0.18,0.9,0.0014557,Moderate,0.428,0.183,0.007,0.183,Mild decrease (p=0.04),Mild increase (p=0.033),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09713,rs967491,14,213138679,SORL1,SNP (A/G),(A/,A,2.34,1.97,2.74,0.02527909,High,0.373,0.107,0.013,0.308,Variable effect (p=0.018),Mild increase (p=0.017),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09714,rs215868,1,157718955,CD33,SNP (A/G),(A/,A,0.76,0.38,0.99,0.03801582,High,0.111,0.367,0.055,0.267,No significant pattern (p=0.041),Mild increase (p=0.034),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09715,rs782906,20,160370227,PTK2B,Insertion,-,-,0.42,0.1,0.75,0.001427,High,0.074,0.015,0.091,0.619,Mild increase (p=0.004),Significant increase (p=0.045),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09716,rs382760,13,221384276,SORL1,SNP (C/G),(C/,C,1.34,1.04,1.54,0.00092184,Protective,0.2,0.291,0.225,0.084,Significant increase (p=0.05),Mild decrease (p=0.006),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09717,rs490761,14,56856237,CR1,Deletion,-,-,0.65,0.3,0.9,0.05274897,Moderate,0.558,0.011,0.217,0.014,No significant pattern (p=0.04),Mild increase (p=0.039),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09718,rs155299,11,13810475,PTK2B,SNP (A/G),(A/,A,0.47,0.1,0.77,0.02892601,High,0.384,0.055,0.228,0.134,No significant pattern (p=0.024),Variable effect (p=0.047),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09719,rs814282,10,56778731,ABCA7,SNP (G/T),(G/,G,0.22,0.1,0.44,0.02547302,High,0.237,0.185,0.369,0.008,No significant pattern (p=0.006),Mild decrease (p=0.031),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09720,rs774443,8,71793288,APOE,SNP (A/T),(A/,A,0.67,0.31,1.0,0.10538699,Low,0.119,0.025,0.457,0.199,Variable effect (p=0.033),Mild increase (p=0.002),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09721,rs943181,1,130813345,CR1,SNP (A/C),(A/,A,1.45,1.09,1.68,0.00500989,Protective,0.531,0.136,0.093,0.04,Mild decrease (p=0.007),Significant increase (p=0.007),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09722,rs780147,10,95188801,PSEN2,SNP (A/C),(A/,A,0.53,0.28,0.74,0.01725007,Moderate,0.281,0.137,0.158,0.224,Variable effect (p=0.048),Significant increase (p=0.035),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09723,rs219854,14,154192537,TREM2,SNP (C/G),(C/,C,0.78,0.39,1.0,0.02578852,High,0.264,0.108,0.017,0.411,Mild increase (p=0.011),Significant decrease (p=0.038),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP09724,rs726976,18,230662540,CD2AP,SNP (A/C),(A/,A,1.05,0.71,1.33,0.03182778,Unknown,0.408,0.055,0.234,0.104,Mild increase (p=0.004),Variable effect (p=0.026),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09725,rs854030,7,196654780,BIN1,SNP (A/C),(A/,A,3.58,3.24,3.91,0.01439929,High,0.059,0.038,0.624,0.078,No significant pattern (p=0.007),Variable effect (p=0.012),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09726,rs472258,18,239734698,MS4A6A,Insertion,-,-,1.41,1.02,1.73,0.00087801,Low,0.161,0.004,0.071,0.564,Mild increase (p=0.015),Significant increase (p=0.011),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP09727,rs142709,16,53899565,PICALM,SNP (C/G),(C/,C,2.29,2.03,2.52,0.03376149,Moderate,0.081,0.254,0.056,0.409,Significant decrease (p=0.005),Significant increase (p=0.014),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09728,rs356271,19,141090308,ABCA7,SNP (G/T),(G/,G,0.79,0.44,1.04,0.02641848,Moderate,0.416,0.013,0.244,0.126,Significant decrease (p=0.001),No significant pattern (p=0.023),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09729,rs360577,20,198113782,MS4A6A,Deletion,-,-,0.78,0.56,1.05,0.05699711,Low,0.09,0.253,0.359,0.098,Variable effect (p=0.048),Variable effect (p=0.008),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09730,rs263922,19,34132013,EPHA1,SNP (A/T),(A/,A,1.26,1.05,1.53,0.01151191,Low,0.27,0.271,0.144,0.114,Significant increase (p=0.041),Variable effect (p=0.047),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09731,rs935966,13,150243373,CD2AP,Insertion,-,-,0.64,0.25,0.87,0.02288136,High,0.021,0.197,0.004,0.577,No significant pattern (p=0.021),Mild increase (p=0.047),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP09732,rs929273,18,219579826,PSEN2,SNP (G/T),(G/,G,1.18,0.85,1.48,0.04937814,Moderate,0.378,0.066,0.153,0.202,No significant pattern (p=0.002),Mild decrease (p=0.023),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09733,rs374441,17,57645215,CR1,SNP (A/G),(A/,A,0.46,0.1,0.84,0.00709645,Protective,0.139,0.079,0.267,0.315,Mild decrease (p=0.047),Mild increase (p=0.033),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09734,rs294661,13,12801472,MS4A6A,Insertion,-,-,0.59,0.25,0.89,0.02419718,High,0.038,0.189,0.319,0.253,Mild decrease (p=0.026),Significant increase (p=0.013),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP09735,rs896009,9,178519742,CR1,SNP (C/G),(C/,C,1.48,1.19,1.85,0.00519737,Moderate,0.427,0.099,0.088,0.186,No significant pattern (p=0.034),Mild increase (p=0.005),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09736,rs842657,8,117920930,SORL1,SNP (A/G),(A/,A,1.88,1.57,2.21,0.01153205,Protective,0.034,0.288,0.342,0.135,No significant pattern (p=0.021),Variable effect (p=0.035),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09737,rs441108,4,54912625,PICALM,SNP (C/T),(C/,C,0.9,0.69,1.25,0.07058483,High,0.331,0.076,0.048,0.345,Significant increase (p=0.036),Mild increase (p=0.006),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09738,rs965579,14,61785015,APOE,Deletion,-,-,1.74,1.53,2.06,0.00040267,High,0.168,0.27,0.127,0.235,No significant pattern (p=0.023),Mild decrease (p=0.02),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09739,rs495926,11,126956469,CD33,Deletion,-,-,1.66,1.33,1.87,0.02098471,Moderate,0.096,0.245,0.139,0.32,Variable effect (p=0.005),Mild increase (p=0.029),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09740,rs357018,21,150312111,CD33,SNP (C/G),(C/,C,0.34,0.1,0.55,0.02501109,Low,0.404,0.129,0.204,0.063,Variable effect (p=0.043),Significant decrease (p=0.044),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09741,rs723295,16,170013836,CD33,SNP (C/T),(C/,C,0.74,0.45,1.04,0.03001268,High,0.186,0.287,0.244,0.083,Significant increase (p=0.018),Variable effect (p=0.018),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09742,rs444648,5,200477590,CD2AP,Deletion,-,-,1.45,1.16,1.78,0.00510859,Moderate,0.403,0.009,0.06,0.328,Significant decrease (p=0.05),No significant pattern (p=0.011),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP09743,rs670368,4,196776934,MS4A6A,SNP (G/T),(G/,G,1.45,1.13,1.7,0.17491022,High,0.017,0.614,0.008,0.16,Significant decrease (p=0.018),Variable effect (p=0.049),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09744,rs843062,4,71681252,CD33,SNP (C/T),(C/,C,0.89,0.6,1.12,0.00012971,Moderate,0.007,0.371,0.227,0.195,Significant increase (p=0.004),No significant pattern (p=0.012),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09745,rs790907,5,113881814,PTK2B,Insertion,-,-,0.82,0.61,1.09,0.03910436,Protective,0.55,0.04,0.003,0.207,Mild increase (p=0.002),Significant decrease (p=0.028),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09746,rs424620,20,181263885,EPHA1,Insertion,-,-,1.43,1.23,1.68,0.01394538,Moderate,0.132,0.019,0.378,0.271,Significant decrease (p=0.034),Variable effect (p=0.043),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09747,rs116745,11,55843336,CLU,Deletion,-,-,1.37,1.04,1.63,0.00243894,Low,0.246,0.093,0.018,0.443,Significant decrease (p=0.048),Significant increase (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09748,rs553976,9,36557504,SORL1,Deletion,-,-,0.64,0.26,0.96,0.09930664,Low,0.083,0.023,0.513,0.181,Variable effect (p=0.005),Mild increase (p=0.042),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09749,rs749303,11,201008283,CD2AP,SNP (G/T),(G/,G,0.55,0.28,0.8,0.01991656,High,0.277,0.279,0.037,0.207,Significant increase (p=0.022),Mild decrease (p=0.018),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09750,rs497282,3,149945934,SORL1,Insertion,-,-,2.11,1.88,2.42,0.04543837,Moderate,0.286,0.041,0.372,0.101,Significant increase (p=0.008),Significant decrease (p=0.024),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09751,rs241227,20,71047244,EPHA1,Deletion,-,-,0.37,0.1,0.59,0.00155441,High,0.085,0.023,0.64,0.052,Mild decrease (p=0.037),Variable effect (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09752,rs536882,20,102795920,CLU,SNP (A/G),(A/,A,1.6,1.33,1.9,0.07290023,Moderate,0.524,0.08,0.18,0.016,Mild decrease (p=0.027),Significant increase (p=0.042),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09753,rs813800,6,182924452,PTK2B,SNP (G/T),(G/,G,0.64,0.37,0.91,0.00331083,Low,0.03,0.035,0.021,0.713,Mild decrease (p=0.046),Mild increase (p=0.01),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP09754,rs444462,14,22928796,APOE,Insertion,-,-,0.88,0.53,1.22,0.09224441,Moderate,0.247,0.362,0.058,0.133,Variable effect (p=0.047),Variable effect (p=0.015),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09755,rs906889,17,171321363,MS4A6A,SNP (C/T),(C/,C,1.66,1.27,2.06,0.04195893,Moderate,0.142,0.164,0.03,0.464,Mild increase (p=0.011),Mild decrease (p=0.023),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09756,rs716119,14,108348160,CLU,SNP (A/G),(A/,A,1.13,0.93,1.52,0.04500213,Protective,0.05,0.222,0.005,0.523,Mild decrease (p=0.023),Significant decrease (p=0.029),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09757,rs791183,12,74854357,MS4A6A,SNP (C/G),(C/,C,0.82,0.62,1.14,0.00978166,High,0.325,0.061,0.114,0.3,Variable effect (p=0.038),Significant decrease (p=0.021),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP09758,rs344611,11,121781975,BIN1,SNP (A/C),(A/,A,0.7,0.37,1.09,0.03484763,Low,0.229,0.153,0.232,0.185,Variable effect (p=0.032),Variable effect (p=0.036),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09759,rs680044,16,209435250,TREM2,SNP (C/G),(C/,C,0.8,0.58,1.03,0.04193544,High,0.192,0.104,0.337,0.168,Variable effect (p=0.022),Significant decrease (p=0.008),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09760,rs701988,17,130434719,BIN1,SNP (C/T),(C/,C,0.96,0.73,1.34,0.00538608,Moderate,0.319,0.146,0.003,0.332,No significant pattern (p=0.038),Significant decrease (p=0.023),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09761,rs212581,9,235965098,EPHA1,Deletion,-,-,0.48,0.14,0.78,0.03578594,Moderate,0.485,0.156,0.135,0.024,Significant increase (p=0.02),Variable effect (p=0.003),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP09762,rs436009,15,171963099,APP,Deletion,-,-,0.68,0.38,0.92,0.002994,Protective,0.253,0.015,0.304,0.227,Variable effect (p=0.003),No significant pattern (p=0.046),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09763,rs737913,14,142548302,APOE,Insertion,-,-,0.51,0.22,0.77,0.00356046,Moderate,0.041,0.097,0.591,0.071,Significant decrease (p=0.005),Significant increase (p=0.049),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09764,rs354423,21,63883069,PICALM,SNP (A/G),(A/,A,0.97,0.7,1.23,0.00524174,Unknown,0.613,0.12,0.02,0.047,Mild decrease (p=0.005),Variable effect (p=0.016),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09765,rs704858,22,138256689,APP,SNP (A/G),(A/,A,2.83,2.53,3.05,0.04855342,High,0.054,0.036,0.49,0.219,Mild increase (p=0.007),Significant increase (p=0.027),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP09766,rs273349,10,95579249,PTK2B,SNP (A/T),(A/,A,1.46,1.2,1.75,0.00630152,Moderate,0.244,0.328,0.226,0.002,Mild decrease (p=0.024),Mild increase (p=0.045),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09767,rs596531,9,244454655,SORL1,SNP (A/G),(A/,A,0.79,0.54,1.17,0.00259054,Moderate,0.057,0.055,0.653,0.034,No significant pattern (p=0.041),Significant increase (p=0.029),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09768,rs133109,5,68061883,APP,SNP (C/T),(C/,C,0.95,0.67,1.29,0.00921749,Low,0.238,0.223,0.05,0.289,Significant decrease (p=0.003),Significant decrease (p=0.002),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09769,rs201615,2,157416164,TREM2,Insertion,-,-,1.47,1.22,1.77,0.04958533,Low,0.44,0.087,0.051,0.222,Mild increase (p=0.022),Mild increase (p=0.038),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09770,rs112313,13,40086190,CD2AP,SNP (C/G),(C/,C,1.1,0.89,1.38,0.02929041,Moderate,0.167,0.145,0.109,0.379,Significant increase (p=0.018),Significant decrease (p=0.026),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09771,rs806495,2,185492408,MS4A6A,Insertion,-,-,0.64,0.24,1.0,0.07650511,Protective,0.051,0.517,0.04,0.193,Significant increase (p=0.018),Variable effect (p=0.017),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09772,rs567455,1,70621184,SORL1,SNP (C/G),(C/,C,0.5,0.2,0.74,0.04321168,Moderate,0.118,0.07,0.406,0.206,Significant increase (p=0.008),Variable effect (p=0.041),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09773,rs850745,1,8492514,APOE,SNP (A/C),(A/,A,2.33,2.11,2.6,0.01092074,Moderate,0.349,0.006,0.212,0.233,Significant increase (p=0.036),Variable effect (p=0.049),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09774,rs240134,17,7698611,SORL1,SNP (A/T),(A/,A,1.54,1.2,1.77,0.05542573,Low,0.052,0.13,0.466,0.151,Significant decrease (p=0.006),Significant increase (p=0.011),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09775,rs674341,22,216249209,CD2AP,SNP (A/T),(A/,A,1.55,1.18,1.92,0.00757286,Low,0.044,0.247,0.448,0.061,Significant increase (p=0.014),Significant decrease (p=0.025),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09776,rs277529,8,142261198,CD33,SNP (G/T),(G/,G,1.27,0.91,1.59,0.03926615,High,0.091,0.112,0.144,0.453,No significant pattern (p=0.046),Variable effect (p=0.027),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09777,rs899109,9,196745612,SORL1,SNP (G/T),(G/,G,1.42,1.13,1.82,0.00086539,Unknown,0.28,0.102,0.219,0.199,Significant decrease (p=0.002),Variable effect (p=0.007),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09778,rs682471,14,207988575,TREM2,SNP (G/T),(G/,G,0.84,0.52,1.09,0.00521241,Low,0.06,0.005,0.051,0.684,No significant pattern (p=0.032),Mild decrease (p=0.026),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09779,rs993999,5,109246877,EPHA1,SNP (G/T),(G/,G,1.37,1.05,1.7,0.11585076,Protective,0.078,0.176,0.141,0.405,No significant pattern (p=0.014),Significant decrease (p=0.026),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09780,rs817863,12,52570093,CD33,SNP (G/T),(G/,G,2.63,2.33,2.88,0.00759133,High,0.005,0.6,0.157,0.037,Mild increase (p=0.006),Variable effect (p=0.023),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP09781,rs215715,11,123885796,EPHA1,Deletion,-,-,1.02,0.69,1.37,0.03965279,Low,0.139,0.127,0.051,0.483,Mild decrease (p=0.034),Significant increase (p=0.016),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09782,rs108996,2,34351788,PICALM,Insertion,-,-,0.74,0.39,1.01,0.004017,Moderate,0.107,0.383,0.132,0.178,Variable effect (p=0.024),Significant increase (p=0.038),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09783,rs319507,15,20881622,APOE,SNP (C/G),(C/,C,1.46,1.07,1.84,0.03258224,Low,0.056,0.12,0.118,0.505,Significant increase (p=0.031),No significant pattern (p=0.048),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Monitoring marker
AD-SNP09784,rs546015,13,28001928,PTK2B,SNP (G/T),(G/,G,0.89,0.65,1.15,0.02451044,High,0.317,0.123,0.272,0.088,Significant increase (p=0.015),Mild increase (p=0.033),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09785,rs933730,4,173854754,SORL1,SNP (C/G),(C/,C,0.94,0.58,1.23,0.03915213,High,0.059,0.291,0.205,0.245,Variable effect (p=0.006),Mild increase (p=0.028),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09786,rs655642,6,117479332,ABCA7,SNP (A/C),(A/,A,0.9,0.65,1.1,0.00940441,Low,0.085,0.192,0.025,0.498,Mild decrease (p=0.033),Significant decrease (p=0.036),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09787,rs313442,11,62846754,PICALM,SNP (A/C),(A/,A,2.79,2.46,3.07,0.05297095,Moderate,0.143,0.151,0.279,0.227,Mild increase (p=0.042),Significant decrease (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09788,rs260133,16,39399668,EPHA1,SNP (G/T),(G/,G,3.08,2.69,3.47,0.00736334,Protective,0.016,0.074,0.629,0.08,Significant decrease (p=0.036),Variable effect (p=0.044),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09789,rs888678,9,232459113,EPHA1,SNP (C/T),(C/,C,1.5,1.24,1.8,0.00388374,Moderate,0.138,0.365,0.203,0.094,Significant increase (p=0.024),Variable effect (p=0.026),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Unknown clinical significance
AD-SNP09790,rs350926,12,231361015,MS4A6A,Insertion,-,-,1.34,1.03,1.69,0.0296682,Protective,0.117,0.231,0.151,0.301,No significant pattern (p=0.043),Mild decrease (p=0.005),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09791,rs925737,15,119093675,SORL1,SNP (A/G),(A/,A,0.83,0.6,1.07,0.05169944,High,0.272,0.1,0.205,0.223,No significant pattern (p=0.035),Mild increase (p=0.043),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP09792,rs515986,10,164671665,PICALM,SNP (C/G),(C/,C,2.86,2.52,3.08,0.00136617,High,0.161,0.575,0.009,0.055,Mild increase (p=0.009),Significant decrease (p=0.041),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09793,rs823916,17,237781811,TREM2,Insertion,-,-,1.1,0.75,1.44,0.0068147,Moderate,0.163,0.167,0.254,0.216,Mild increase (p=0.016),No significant pattern (p=0.006),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09794,rs358019,15,88612888,PSEN2,SNP (G/T),(G/,G,1.23,0.83,1.53,0.05751281,Moderate,0.14,0.533,0.067,0.061,Variable effect (p=0.009),Significant increase (p=0.014),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09795,rs212211,4,44705004,PICALM,SNP (G/T),(G/,G,0.81,0.59,1.15,0.01289515,Moderate,0.128,0.145,0.385,0.143,Significant decrease (p=0.025),Variable effect (p=0.014),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP09796,rs123148,22,161396908,PICALM,SNP (C/T),(C/,C,0.95,0.59,1.17,0.09020377,Moderate,0.048,0.113,0.224,0.415,Significant decrease (p=0.042),Variable effect (p=0.017),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09797,rs759794,3,179539456,PICALM,Deletion,-,-,1.0,0.76,1.23,0.03513681,Low,0.317,0.148,0.255,0.08,Mild increase (p=0.012),Mild decrease (p=0.041),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP09798,rs964694,13,232833321,PTK2B,SNP (C/T),(C/,C,1.81,1.58,2.16,0.05751741,Unknown,0.46,0.287,0.018,0.035,Significant increase (p=0.005),Mild decrease (p=0.05),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09799,rs230348,17,9342199,MS4A6A,SNP (C/G),(C/,C,1.93,1.61,2.32,0.04303261,Low,0.113,0.155,0.248,0.284,Mild decrease (p=0.026),Variable effect (p=0.026),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09800,rs976749,7,64605124,SORL1,SNP (C/G),(C/,C,1.13,0.79,1.39,0.07207639,Low,0.108,0.329,0.002,0.361,Mild increase (p=0.03),No significant pattern (p=0.02),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09801,rs511740,5,236947848,TREM2,SNP (A/C),(A/,A,3.04,2.8,3.38,0.07055566,Moderate,0.221,0.141,0.233,0.205,No significant pattern (p=0.019),Mild decrease (p=0.027),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09802,rs727128,14,160851400,PSEN2,Deletion,-,-,1.8,1.44,2.04,0.08233156,Moderate,0.539,0.148,0.034,0.08,Mild increase (p=0.015),Significant decrease (p=0.025),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09803,rs124058,15,99182944,CLU,SNP (A/T),(A/,A,4.1,3.83,4.31,0.02369703,Unknown,0.598,0.149,0.028,0.025,Variable effect (p=0.032),Mild decrease (p=0.015),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09804,rs271526,3,205212369,CD2AP,SNP (G/T),(G/,G,1.13,0.76,1.45,0.01140639,High,0.03,0.347,0.315,0.109,No significant pattern (p=0.037),No significant pattern (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP09805,rs570890,10,220192222,APP,SNP (C/T),(C/,C,0.36,0.12,0.63,0.0625644,High,0.021,0.254,0.394,0.132,No significant pattern (p=0.02),Significant decrease (p=0.041),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09806,rs262500,22,109170291,PICALM,SNP (C/T),(C/,C,1.55,1.33,1.8,0.00477779,High,0.601,0.0,0.113,0.085,Variable effect (p=0.043),Significant decrease (p=0.015),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09807,rs738995,6,26585355,BIN1,SNP (A/C),(A/,A,1.16,0.9,1.47,0.00564346,High,0.131,0.015,0.122,0.533,No significant pattern (p=0.041),Significant increase (p=0.007),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09808,rs959630,15,6273846,CD2AP,Insertion,-,-,1.54,1.24,1.8,0.02312592,Unknown,0.436,0.102,0.244,0.018,No significant pattern (p=0.02),No significant pattern (p=0.04),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09809,rs568700,1,103898605,APOE,SNP (A/T),(A/,A,1.3,1.09,1.57,0.01357783,Moderate,0.113,0.223,0.04,0.424,Mild increase (p=0.028),Significant increase (p=0.044),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09810,rs774259,3,44332927,PSEN2,SNP (A/G),(A/,A,1.26,0.9,1.5,0.00735493,Low,0.384,0.004,0.324,0.088,No significant pattern (p=0.049),Significant increase (p=0.033),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09811,rs317696,15,74473802,BIN1,Deletion,-,-,0.65,0.36,1.04,0.00695266,High,0.167,0.426,0.01,0.197,Mild decrease (p=0.038),Variable effect (p=0.021),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09812,rs550844,1,98891381,ABCA7,SNP (A/T),(A/,A,0.57,0.17,0.96,0.00027777,Moderate,0.398,0.245,0.029,0.129,No significant pattern (p=0.028),Significant increase (p=0.02),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09813,rs717042,16,147094177,TREM2,SNP (C/G),(C/,C,1.36,1.11,1.69,0.05933768,High,0.321,0.038,0.163,0.278,Mild decrease (p=0.028),Mild increase (p=0.016),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09814,rs688461,18,114455881,CLU,SNP (A/G),(A/,A,1.07,0.8,1.32,0.03251762,Moderate,0.04,0.184,0.158,0.418,Significant increase (p=0.022),No significant pattern (p=0.005),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09815,rs478824,10,72798714,ABCA7,SNP (A/G),(A/,A,1.63,1.32,1.97,0.00600094,Low,0.169,0.324,0.105,0.203,Significant decrease (p=0.029),Mild decrease (p=0.017),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09816,rs492198,1,46982720,ABCA7,Insertion,-,-,1.16,0.84,1.46,0.01309325,Unknown,0.363,0.203,0.233,0.001,Mild decrease (p=0.03),Significant decrease (p=0.019),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Unknown clinical significance
AD-SNP09817,rs790193,4,12093268,TREM2,SNP (G/T),(G/,G,1.32,1.06,1.68,0.00798502,Low,0.196,0.025,0.378,0.201,Mild increase (p=0.021),No significant pattern (p=0.001),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09818,rs961315,21,100270578,PSEN2,SNP (G/T),(G/,G,0.96,0.67,1.16,0.01119975,Low,0.255,0.222,0.296,0.026,No significant pattern (p=0.044),Significant decrease (p=0.019),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09819,rs949916,15,238501244,CR1,Deletion,-,-,2.44,2.15,2.65,0.00295819,Low,0.324,0.109,0.227,0.14,No significant pattern (p=0.005),Significant decrease (p=0.015),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09820,rs557643,17,42716821,PSEN2,SNP (C/T),(C/,C,1.41,1.07,1.64,0.00228946,Moderate,0.162,0.615,0.018,0.005,Mild decrease (p=0.014),Variable effect (p=0.001),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09821,rs460974,20,130460122,BIN1,SNP (G/T),(G/,G,0.97,0.7,1.35,0.05081205,Moderate,0.327,0.323,0.111,0.039,Mild increase (p=0.016),Significant decrease (p=0.023),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09822,rs507750,14,92253197,PTK2B,SNP (C/G),(C/,C,0.89,0.55,1.14,0.02099761,Moderate,0.068,0.538,0.077,0.117,Variable effect (p=0.042),No significant pattern (p=0.011),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09823,rs381512,5,73448750,EPHA1,SNP (G/T),(G/,G,0.95,0.59,1.24,0.01283985,Protective,0.227,0.068,0.346,0.16,Significant increase (p=0.002),Mild increase (p=0.009),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09824,rs254417,9,123015668,SORL1,Insertion,-,-,0.97,0.76,1.29,0.0333475,Protective,0.036,0.01,0.714,0.041,No significant pattern (p=0.039),Significant decrease (p=0.008),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09825,rs670140,6,211097271,ABCA7,SNP (A/G),(A/,A,1.37,1.07,1.67,0.01776037,Moderate,0.339,0.24,0.005,0.215,Significant decrease (p=0.026),Mild increase (p=0.039),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP09826,rs236777,18,150797793,CLU,Insertion,-,-,1.72,1.37,2.0,0.02605607,Low,0.252,0.39,0.088,0.069,Significant increase (p=0.044),No significant pattern (p=0.031),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09827,rs806296,17,166756867,BIN1,SNP (A/G),(A/,A,0.43,0.14,0.76,0.0064328,Protective,0.005,0.184,0.405,0.206,Significant decrease (p=0.036),No significant pattern (p=0.011),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09828,rs912186,19,204675420,SORL1,SNP (A/C),(A/,A,0.39,0.18,0.68,0.02417795,Moderate,0.062,0.581,0.089,0.067,Significant increase (p=0.028),Mild increase (p=0.009),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP09829,rs812480,20,177709027,PSEN2,SNP (G/T),(G/,G,1.15,0.91,1.47,0.07635005,Moderate,0.082,0.356,0.354,0.008,Mild decrease (p=0.002),No significant pattern (p=0.003),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09830,rs112410,8,30473239,CD33,SNP (C/G),(C/,C,1.42,1.17,1.81,0.07932128,High,0.132,0.409,0.048,0.21,Significant increase (p=0.004),Variable effect (p=0.015),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09831,rs841011,11,185803873,SORL1,Deletion,-,-,0.48,0.12,0.87,0.01623729,Low,0.298,0.023,0.375,0.104,Significant decrease (p=0.04),No significant pattern (p=0.033),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09832,rs265723,8,176298295,SORL1,SNP (C/T),(C/,C,1.34,1.0,1.68,0.00302293,Protective,0.04,0.611,0.063,0.086,Mild decrease (p=0.043),Significant decrease (p=0.034),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09833,rs846074,19,44120168,CLU,SNP (A/G),(A/,A,1.46,1.07,1.84,0.00460238,Low,0.292,0.444,0.053,0.011,Significant decrease (p=0.009),Significant decrease (p=0.039),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09834,rs380049,16,30641271,APP,SNP (C/G),(C/,C,0.74,0.49,1.13,0.00433318,Unknown,0.205,0.019,0.442,0.134,Variable effect (p=0.044),Mild decrease (p=0.034),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09835,rs399406,21,159186109,CLU,Insertion,-,-,3.12,2.76,3.36,0.06779598,Protective,0.087,0.359,0.036,0.317,Mild increase (p=0.033),Mild increase (p=0.025),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09836,rs280816,8,227746504,EPHA1,Deletion,-,-,0.7,0.49,0.92,0.05418046,Low,0.158,0.063,0.078,0.501,Mild decrease (p=0.025),No significant pattern (p=0.016),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09837,rs271534,13,233677118,CD2AP,SNP (G/T),(G/,G,1.01,0.73,1.22,0.00594598,Moderate,0.266,0.022,0.381,0.131,Variable effect (p=0.028),Significant decrease (p=0.045),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09838,rs957115,2,216357110,APOE,Insertion,-,-,0.54,0.18,0.88,0.01994573,Moderate,0.076,0.383,0.145,0.196,Significant increase (p=0.042),Significant increase (p=0.02),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09839,rs241092,4,206785433,BIN1,SNP (A/T),(A/,A,1.5,1.26,1.88,0.00470564,Moderate,0.278,0.069,0.103,0.35,Significant decrease (p=0.044),Variable effect (p=0.018),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09840,rs245011,10,89114603,APP,SNP (G/T),(G/,G,1.62,1.3,1.94,0.00016079,Moderate,0.039,0.191,0.361,0.209,Significant decrease (p=0.033),Significant increase (p=0.011),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09841,rs141958,16,175401571,ABCA7,SNP (C/G),(C/,C,1.91,1.69,2.12,0.02540313,High,0.145,0.128,0.273,0.253,Significant increase (p=0.045),Significant decrease (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09842,rs651161,1,177602445,APOE,SNP (C/T),(C/,C,2.22,1.95,2.45,0.04839854,Moderate,0.057,0.019,0.359,0.365,Variable effect (p=0.028),Significant increase (p=0.029),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09843,rs132842,8,216937059,MS4A6A,SNP (G/T),(G/,G,0.97,0.72,1.17,0.02510747,High,0.046,0.244,0.154,0.355,Mild increase (p=0.031),Variable effect (p=0.04),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09844,rs462633,13,110909338,CLU,Insertion,-,-,1.01,0.72,1.26,0.017291,Protective,0.213,0.428,0.125,0.034,Mild increase (p=0.003),Mild decrease (p=0.034),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09845,rs172915,17,60114153,CD33,SNP (C/T),(C/,C,0.58,0.28,0.97,0.01638298,High,0.5,0.007,0.166,0.128,Significant increase (p=0.004),No significant pattern (p=0.028),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09846,rs676895,15,236903986,PSEN2,Deletion,-,-,0.55,0.17,0.75,0.03070456,Protective,0.232,0.293,0.023,0.253,Variable effect (p=0.029),No significant pattern (p=0.012),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP09847,rs440216,14,139259709,EPHA1,Deletion,-,-,1.36,1.14,1.58,0.01713088,Low,0.271,0.055,0.283,0.191,Significant increase (p=0.041),Significant decrease (p=0.031),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09848,rs825943,20,30596779,TREM2,SNP (C/T),(C/,C,0.36,0.1,0.61,0.02316395,Moderate,0.343,0.028,0.287,0.141,Significant increase (p=0.005),Variable effect (p=0.006),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09849,rs881979,18,172620897,MS4A6A,SNP (A/T),(A/,A,1.29,1.0,1.56,0.04620063,Moderate,0.011,0.211,0.44,0.137,Mild increase (p=0.047),Significant decrease (p=0.043),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09850,rs599429,11,11258576,PSEN2,SNP (A/C),(A/,A,1.2,0.85,1.49,0.02802682,Low,0.415,0.123,0.127,0.135,Significant decrease (p=0.038),No significant pattern (p=0.041),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09851,rs971789,1,233386540,CD2AP,SNP (A/G),(A/,A,0.89,0.65,1.15,0.0010081,High,0.321,0.023,0.041,0.415,Mild increase (p=0.045),No significant pattern (p=0.037),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09852,rs920628,7,182216581,CD33,SNP (C/G),(C/,C,1.06,0.77,1.33,0.01247634,Moderate,0.438,0.145,0.054,0.163,Mild increase (p=0.015),Significant decrease (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09853,rs883972,21,212051146,CD2AP,SNP (A/T),(A/,A,1.46,1.23,1.71,0.01037167,High,0.2,0.005,0.278,0.318,Significant increase (p=0.045),No significant pattern (p=0.05),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09854,rs731474,20,106146395,MS4A6A,Insertion,-,-,1.73,1.47,1.96,0.03688342,Moderate,0.423,0.164,0.173,0.04,Mild increase (p=0.006),No significant pattern (p=0.029),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP09855,rs885320,15,164640500,TREM2,Insertion,-,-,0.62,0.37,0.87,0.00049836,Low,0.105,0.571,0.075,0.049,Variable effect (p=0.018),Mild decrease (p=0.021),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09856,rs280482,21,160920708,PSEN2,SNP (A/C),(A/,A,0.8,0.6,1.18,0.07316884,Moderate,0.141,0.285,0.075,0.299,Significant increase (p=0.017),Significant increase (p=0.007),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP09857,rs131754,15,86325109,TREM2,SNP (A/G),(A/,A,1.34,1.12,1.57,0.06587423,Moderate,0.344,0.033,0.309,0.113,Significant decrease (p=0.003),Significant decrease (p=0.005),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09858,rs556243,9,196473549,SORL1,Insertion,-,-,0.88,0.6,1.11,0.00255459,Moderate,0.2,0.18,0.384,0.035,Variable effect (p=0.027),No significant pattern (p=0.021),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09859,rs287799,6,216912319,EPHA1,SNP (G/T),(G/,G,1.5,1.11,1.72,0.00521344,High,0.015,0.409,0.007,0.369,Mild decrease (p=0.017),Significant decrease (p=0.04),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09860,rs365178,8,2120252,CD33,Insertion,-,-,1.85,1.64,2.21,0.00090779,Unknown,0.124,0.077,0.593,0.006,Mild increase (p=0.03),Variable effect (p=0.035),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09861,rs163218,5,210556751,ABCA7,SNP (C/G),(C/,C,1.68,1.31,1.89,0.02311921,High,0.133,0.088,0.196,0.384,No significant pattern (p=0.04),Significant decrease (p=0.032),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP09862,rs920557,21,97558850,TREM2,Deletion,-,-,1.36,0.99,1.67,0.0008564,Protective,0.138,0.157,0.356,0.148,Significant increase (p=0.014),Significant increase (p=0.015),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP09863,rs284191,2,55802063,APOE,SNP (A/G),(A/,A,0.33,0.1,0.67,0.0168828,Low,0.124,0.336,0.322,0.019,Variable effect (p=0.018),Mild decrease (p=0.045),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09864,rs188637,7,189435920,APP,SNP (C/G),(C/,C,1.48,1.13,1.78,0.00679892,Moderate,0.175,0.106,0.418,0.101,No significant pattern (p=0.046),Significant decrease (p=0.02),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09865,rs233621,20,26400853,PSEN2,SNP (C/G),(C/,C,0.9,0.54,1.24,0.02311776,Moderate,0.005,0.339,0.393,0.064,Variable effect (p=0.001),Variable effect (p=0.022),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09866,rs456940,6,234678435,CR1,SNP (A/C),(A/,A,1.36,1.15,1.56,0.01961883,Moderate,0.376,0.245,0.121,0.059,Mild decrease (p=0.047),Mild increase (p=0.011),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP09867,rs913180,19,153717158,CD33,Deletion,-,-,0.83,0.48,1.04,0.01206153,Moderate,0.212,0.044,0.106,0.438,Mild increase (p=0.01),Mild decrease (p=0.028),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09868,rs700699,6,217219208,PTK2B,Deletion,-,-,0.41,0.1,0.79,0.01533751,Low,0.096,0.178,0.502,0.024,Significant decrease (p=0.018),No significant pattern (p=0.021),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09869,rs809163,21,59175934,MS4A6A,SNP (A/T),(A/,A,0.57,0.18,0.95,0.06347901,Moderate,0.108,0.167,0.315,0.211,Mild increase (p=0.024),No significant pattern (p=0.038),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09870,rs580440,4,44981623,PTK2B,Deletion,-,-,1.26,0.89,1.66,0.06956727,Low,0.121,0.282,0.33,0.068,Variable effect (p=0.037),No significant pattern (p=0.021),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09871,rs746960,12,215975364,PTK2B,Deletion,-,-,1.31,1.09,1.52,0.00591586,High,0.499,0.063,0.219,0.02,No significant pattern (p=0.027),Significant decrease (p=0.039),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09872,rs694172,22,142105701,SORL1,SNP (G/T),(G/,G,1.26,1.0,1.46,0.08133491,Protective,0.117,0.174,0.481,0.028,Mild decrease (p=0.007),Significant increase (p=0.032),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09873,rs636922,19,163287358,EPHA1,SNP (A/G),(A/,A,1.14,0.9,1.51,0.07251478,Low,0.123,0.219,0.419,0.038,Mild increase (p=0.022),Mild increase (p=0.027),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09874,rs507767,13,173865226,PTK2B,SNP (G/T),(G/,G,1.57,1.22,1.89,0.00427397,Moderate,0.135,0.128,0.218,0.32,Mild increase (p=0.021),Mild decrease (p=0.049),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09875,rs318955,8,198477173,BIN1,Deletion,-,-,0.72,0.4,1.08,0.12394779,High,0.003,0.208,0.154,0.435,Mild decrease (p=0.048),No significant pattern (p=0.033),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09876,rs728029,5,78092548,APP,SNP (A/G),(A/,A,2.88,2.54,3.13,0.0199355,Low,0.194,0.081,0.27,0.256,Mild increase (p=0.016),Mild increase (p=0.04),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09877,rs571001,9,171295831,EPHA1,SNP (A/C),(A/,A,1.33,0.96,1.6,0.01555307,Low,0.224,0.062,0.425,0.089,No significant pattern (p=0.022),Mild increase (p=0.049),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09878,rs278710,21,88885590,PICALM,SNP (G/T),(G/,G,1.45,1.15,1.78,0.01522672,Moderate,0.325,0.073,0.005,0.397,Variable effect (p=0.044),Significant decrease (p=0.007),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09879,rs734537,2,160006425,CR1,SNP (A/T),(A/,A,0.88,0.66,1.09,0.01085975,High,0.064,0.187,0.313,0.236,Significant decrease (p=0.005),Variable effect (p=0.004),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09880,rs775532,13,163435853,CLU,SNP (G/T),(G/,G,0.91,0.61,1.24,0.00647512,Moderate,0.172,0.27,0.236,0.122,Mild increase (p=0.026),Significant decrease (p=0.037),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09881,rs990437,1,52867012,APOE,SNP (C/T),(C/,C,0.82,0.48,1.09,0.03555697,Moderate,0.131,0.319,0.141,0.209,Mild increase (p=0.012),Significant decrease (p=0.027),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09882,rs492967,4,45492454,PTK2B,SNP (C/T),(C/,C,1.37,1.13,1.62,0.01907542,High,0.188,0.32,0.069,0.223,Mild decrease (p=0.016),Mild decrease (p=0.007),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP09883,rs930393,13,208318791,MS4A6A,SNP (C/T),(C/,C,1.77,1.51,2.02,0.0744335,Moderate,0.012,0.242,0.013,0.533,Mild decrease (p=0.004),Significant increase (p=0.047),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09884,rs129235,2,126078956,CR1,Insertion,-,-,0.6,0.34,0.87,0.03488027,Moderate,0.258,0.04,0.234,0.268,Significant increase (p=0.046),Significant increase (p=0.017),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09885,rs892550,21,13476520,TREM2,Deletion,-,-,0.69,0.46,0.97,0.00041555,High,0.176,0.031,0.314,0.279,Mild decrease (p=0.025),No significant pattern (p=0.003),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Biomarker for patient stratification
AD-SNP09886,rs769310,20,168289265,APOE,SNP (G/T),(G/,G,0.69,0.43,1.04,0.02784336,Moderate,0.037,0.077,0.04,0.645,No significant pattern (p=0.039),No significant pattern (p=0.006),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09887,rs128054,8,6942541,APOE,Insertion,-,-,1.0,0.72,1.4,0.00165412,Low,0.429,0.027,0.088,0.256,Significant increase (p=0.02),Significant increase (p=0.037),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09888,rs530585,15,127941553,PSEN2,SNP (G/T),(G/,G,0.42,0.1,0.71,0.02556723,Moderate,0.464,0.016,0.184,0.136,Variable effect (p=0.043),No significant pattern (p=0.027),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09889,rs719663,18,58092085,PTK2B,SNP (C/T),(C/,C,0.86,0.46,1.22,0.05711094,Protective,0.255,0.29,0.228,0.027,Significant decrease (p=0.032),No significant pattern (p=0.042),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09890,rs520510,14,68167478,CLU,Insertion,-,-,1.13,0.77,1.38,0.04591369,Unknown,0.017,0.359,0.424,0.0,Significant decrease (p=0.035),Variable effect (p=0.009),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09891,rs238279,14,226165874,MS4A6A,SNP (C/T),(C/,C,1.56,1.17,1.79,0.01404074,High,0.413,0.164,0.102,0.121,Significant increase (p=0.007),Significant increase (p=0.005),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP09892,rs612940,15,32414951,PSEN2,SNP (C/G),(C/,C,0.44,0.23,0.71,0.01769856,Low,0.06,0.068,0.304,0.368,Mild increase (p=0.049),Significant decrease (p=0.041),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09893,rs432048,10,196381764,TREM2,SNP (G/T),(G/,G,0.72,0.45,1.04,0.00656613,Low,0.402,0.073,0.18,0.146,Significant decrease (p=0.036),Mild increase (p=0.027),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Potential drug target
AD-SNP09894,rs354702,16,164137271,EPHA1,SNP (C/T),(C/,C,0.99,0.65,1.35,0.07606157,High,0.079,0.462,0.071,0.188,Mild increase (p=0.035),Significant increase (p=0.046),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09895,rs461703,12,220533319,APOE,Insertion,-,-,1.04,0.68,1.25,0.00526739,High,0.085,0.023,0.389,0.304,Variable effect (p=0.002),Significant decrease (p=0.012),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09896,rs458840,20,167493134,SORL1,Deletion,-,-,1.58,1.28,1.9,0.03000015,Moderate,0.19,0.35,0.026,0.233,No significant pattern (p=0.035),Significant decrease (p=0.019),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09897,rs571773,10,124083805,CD2AP,Deletion,-,-,1.54,1.21,1.85,0.0219248,High,0.049,0.102,0.061,0.588,Significant increase (p=0.036),Variable effect (p=0.007),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09898,rs498331,12,225616243,MS4A6A,SNP (A/T),(A/,A,1.24,1.0,1.49,0.02478973,High,0.115,0.368,0.197,0.12,No significant pattern (p=0.043),Variable effect (p=0.009),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP09899,rs133274,11,6498409,SORL1,Deletion,-,-,2.37,2.16,2.72,0.02156262,High,0.445,0.207,0.102,0.046,Significant decrease (p=0.025),No significant pattern (p=0.046),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09900,rs969122,5,198652854,ABCA7,SNP (A/T),(A/,A,1.18,0.83,1.45,0.00078727,Moderate,0.01,0.008,0.393,0.389,Significant decrease (p=0.015),Mild increase (p=0.023),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09901,rs425583,19,54604291,CR1,SNP (A/T),(A/,A,1.63,1.36,2.02,0.00589161,Low,0.324,0.027,0.004,0.445,No significant pattern (p=0.02),Significant increase (p=0.008),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09902,rs930271,11,162167378,CD2AP,Insertion,-,-,0.98,0.67,1.37,0.01060987,High,0.548,0.013,0.201,0.039,Variable effect (p=0.037),Mild decrease (p=0.028),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09903,rs203771,18,45341529,APP,SNP (A/C),(A/,A,0.71,0.47,1.0,0.00277295,Low,0.006,0.232,0.006,0.557,Significant decrease (p=0.036),Significant decrease (p=0.012),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09904,rs355880,17,62806877,CLU,SNP (G/T),(G/,G,1.56,1.32,1.77,0.00854692,High,0.247,0.181,0.07,0.303,Mild decrease (p=0.048),No significant pattern (p=0.035),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09905,rs491449,20,142778041,ABCA7,Insertion,-,-,1.03,0.74,1.25,0.00945209,High,0.054,0.09,0.35,0.307,Significant increase (p=0.008),Significant increase (p=0.033),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09906,rs369782,21,6638397,PTK2B,SNP (A/T),(A/,A,1.32,1.12,1.53,0.02950089,Low,0.313,0.088,0.06,0.339,No significant pattern (p=0.015),Significant increase (p=0.015),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09907,rs955982,15,3669543,CLU,SNP (G/T),(G/,G,0.8,0.54,1.1,0.04663201,Unknown,0.01,0.393,0.153,0.244,Mild increase (p=0.022),Mild decrease (p=0.046),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09908,rs639638,16,151435055,APOE,SNP (A/T),(A/,A,1.28,1.01,1.65,0.22067385,High,0.008,0.094,0.344,0.355,Variable effect (p=0.029),No significant pattern (p=0.031),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Unknown clinical significance
AD-SNP09909,rs884522,21,85441893,ABCA7,SNP (A/T),(A/,A,1.55,1.2,1.82,0.03969827,Low,0.303,0.42,0.052,0.025,No significant pattern (p=0.034),Significant increase (p=0.042),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09910,rs640676,18,177594915,CR1,Insertion,-,-,1.55,1.28,1.78,0.10810336,Low,0.59,0.045,0.108,0.057,No significant pattern (p=0.028),Variable effect (p=0.042),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP09911,rs374617,16,181047329,CR1,SNP (A/C),(A/,A,1.59,1.35,1.97,0.00914318,Low,0.057,0.237,0.08,0.426,Mild increase (p=0.01),Mild decrease (p=0.009),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09912,rs883691,15,210532227,ABCA7,SNP (A/C),(A/,A,2.13,1.91,2.42,0.02516074,High,0.461,0.009,0.132,0.198,Significant increase (p=0.047),Mild decrease (p=0.014),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Potential drug target
AD-SNP09913,rs284886,9,178578980,ABCA7,SNP (A/G),(A/,A,0.62,0.32,0.87,0.03114732,High,0.145,0.161,0.39,0.104,Variable effect (p=0.037),Mild decrease (p=0.009),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09914,rs468147,6,143668198,TREM2,Deletion,-,-,0.86,0.49,1.25,0.03123356,Unknown,0.214,0.12,0.29,0.176,Mild increase (p=0.013),Significant decrease (p=0.023),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09915,rs765340,1,234921495,ABCA7,Insertion,-,-,0.78,0.42,0.99,0.02918153,Low,0.057,0.038,0.566,0.138,Significant decrease (p=0.009),Variable effect (p=0.038),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09916,rs324206,9,129001847,PSEN2,SNP (A/G),(A/,A,1.77,1.45,2.16,0.00819406,High,0.011,0.109,0.018,0.662,Mild increase (p=0.001),Significant increase (p=0.02),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09917,rs378567,9,91604610,PTK2B,SNP (A/C),(A/,A,0.37,0.1,0.7,0.04448935,Unknown,0.085,0.061,0.355,0.299,Mild increase (p=0.003),Mild increase (p=0.024),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Monitoring marker
AD-SNP09918,rs274611,22,46884708,CLU,SNP (A/G),(A/,A,1.32,1.07,1.56,0.0557616,Protective,0.458,0.012,0.28,0.05,Significant decrease (p=0.013),Mild decrease (p=0.02),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09919,rs835709,20,82626921,PICALM,SNP (A/C),(A/,A,0.97,0.71,1.27,0.04411449,Protective,0.13,0.163,0.457,0.05,Significant decrease (p=0.037),Significant increase (p=0.049),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09920,rs223658,15,37320351,TREM2,Insertion,-,-,1.26,1.02,1.46,0.07592517,High,0.06,0.041,0.48,0.218,No significant pattern (p=0.003),Significant increase (p=0.039),Mild increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Potential drug target
AD-SNP09921,rs208867,8,45350132,SORL1,SNP (A/T),(A/,A,1.18,0.84,1.49,0.12086594,Protective,0.053,0.406,0.237,0.104,No significant pattern (p=0.017),Mild increase (p=0.024),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09922,rs427570,11,55293952,PTK2B,SNP (G/T),(G/,G,0.76,0.45,1.12,0.00497165,Protective,0.048,0.273,0.175,0.305,Significant increase (p=0.028),Mild increase (p=0.031),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09923,rs190039,10,49989300,CR1,Deletion,-,-,1.2,0.84,1.41,0.00143771,High,0.155,0.101,0.215,0.328,Variable effect (p=0.038),No significant pattern (p=0.025),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Monitoring marker
AD-SNP09924,rs289444,17,59880886,CLU,Insertion,-,-,0.78,0.55,1.05,0.03629334,Moderate,0.243,0.108,0.429,0.02,Mild increase (p=0.047),No significant pattern (p=0.003),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09925,rs628481,18,77049017,CLU,Insertion,-,-,0.92,0.68,1.32,0.01896736,Moderate,0.59,0.017,0.153,0.04,Significant increase (p=0.043),No significant pattern (p=0.039),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09926,rs563812,20,103494548,SORL1,SNP (A/C),(A/,A,1.55,1.22,1.85,0.00118779,Moderate,0.011,0.306,0.256,0.228,Significant increase (p=0.026),Significant increase (p=0.034),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09927,rs538084,16,97227930,BIN1,SNP (A/G),(A/,A,0.51,0.24,0.79,0.023409,Moderate,0.156,0.198,0.162,0.284,No significant pattern (p=0.023),Variable effect (p=0.032),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP09928,rs185328,10,154680528,BIN1,SNP (C/T),(C/,C,3.23,2.95,3.53,0.02022979,Low,0.133,0.134,0.271,0.262,Variable effect (p=0.029),No significant pattern (p=0.03),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09929,rs382631,17,58701117,CR1,SNP (A/G),(A/,A,1.62,1.36,1.87,0.06020217,Moderate,0.301,0.113,0.215,0.171,Significant increase (p=0.026),Significant increase (p=0.025),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP09930,rs247957,4,172875085,CLU,SNP (C/T),(C/,C,0.46,0.25,0.7,0.00573689,High,0.362,0.133,0.262,0.043,Variable effect (p=0.013),Mild decrease (p=0.016),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09931,rs931385,12,131612318,EPHA1,SNP (C/T),(C/,C,1.17,0.95,1.4,0.01021944,Unknown,0.052,0.111,0.07,0.566,Significant increase (p=0.039),No significant pattern (p=0.037),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Biomarker for patient stratification
AD-SNP09932,rs996871,18,221358881,PSEN2,SNP (C/T),(C/,C,3.2,2.88,3.55,0.06152033,High,0.454,0.013,0.298,0.035,Mild decrease (p=0.009),Mild increase (p=0.039),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Monitoring marker
AD-SNP09933,rs717857,8,97180844,CD33,SNP (A/C),(A/,A,0.32,0.1,0.58,0.11830437,High,0.482,0.21,0.048,0.06,Mild increase (p=0.035),Variable effect (p=0.037),No significant pattern,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP09934,rs322050,3,176744433,EPHA1,Insertion,-,-,0.66,0.29,1.01,0.07798411,Low,0.006,0.434,0.1,0.26,Mild decrease (p=0.006),No significant pattern (p=0.035),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Potential drug target
AD-SNP09935,rs280566,8,139175310,APP,SNP (A/C),(A/,A,0.56,0.23,0.78,0.01681275,Unknown,0.446,0.036,0.198,0.12,Significant increase (p=0.023),No significant pattern (p=0.028),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09936,rs873293,6,202587961,CD33,Insertion,-,-,1.45,1.23,1.76,0.05410965,High,0.265,0.335,0.181,0.019,Significant increase (p=0.026),No significant pattern (p=0.035),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09937,rs493106,14,142471632,CLU,SNP (C/T),(C/,C,0.78,0.55,1.08,0.08572556,High,0.194,0.125,0.342,0.138,Mild increase (p=0.011),Mild decrease (p=0.002),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09938,rs522119,10,226833489,CD33,SNP (A/T),(A/,A,0.47,0.22,0.7,0.03313653,Moderate,0.16,0.098,0.093,0.45,Significant decrease (p=0.043),Significant increase (p=0.04),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP09939,rs357886,14,224936129,CR1,SNP (C/G),(C/,C,1.35,1.12,1.65,0.05080535,Low,0.488,0.112,0.018,0.182,No significant pattern (p=0.025),Significant increase (p=0.042),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09940,rs685040,12,101956899,SORL1,Deletion,-,-,0.64,0.36,1.03,0.01148616,High,0.164,0.09,0.482,0.064,Mild increase (p=0.006),Mild decrease (p=0.004),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Monitoring marker
AD-SNP09941,rs664602,1,199518166,MS4A6A,SNP (G/T),(G/,G,0.93,0.54,1.18,0.01765295,High,0.063,0.218,0.245,0.274,Mild decrease (p=0.007),No significant pattern (p=0.028),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09942,rs147967,6,175452561,CD33,Insertion,-,-,0.79,0.58,1.09,0.01134817,Low,0.017,0.549,0.035,0.199,No significant pattern (p=0.021),Significant decrease (p=0.049),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP09943,rs188145,8,88098419,MS4A6A,Deletion,-,-,0.71,0.48,1.1,0.11269101,Unknown,0.059,0.092,0.416,0.233,Significant decrease (p=0.006),Mild increase (p=0.021),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Unknown clinical significance
AD-SNP09944,rs243280,18,94820995,SORL1,Deletion,-,-,2.09,1.8,2.49,0.04210396,High,0.104,0.003,0.34,0.353,Significant increase (p=0.013),Mild decrease (p=0.02),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Unknown clinical significance
AD-SNP09945,rs122509,10,172972637,PSEN2,SNP (G/T),(G/,G,2.48,2.13,2.83,0.02143178,Protective,0.197,0.032,0.459,0.111,Mild decrease (p=0.042),Variable effect (p=0.035),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09946,rs425069,17,144117448,CR1,SNP (C/G),(C/,C,1.06,0.67,1.45,0.01051022,Moderate,0.158,0.192,0.13,0.321,No significant pattern (p=0.034),Significant increase (p=0.013),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Biomarker for patient stratification
AD-SNP09947,rs689165,2,162326777,ABCA7,SNP (A/G),(A/,A,0.83,0.54,1.21,0.08023653,Moderate,0.308,0.157,0.21,0.125,No significant pattern (p=0.007),Mild increase (p=0.023),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Potential drug target
AD-SNP09948,rs802644,2,195879445,CR1,SNP (A/T),(A/,A,1.77,1.4,2.04,0.02245009,Moderate,0.095,0.447,0.173,0.085,Mild increase (p=0.012),Variable effect (p=0.043),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09949,rs339729,14,141767219,ABCA7,Insertion,-,-,0.65,0.32,1.01,0.05588445,Moderate,0.551,0.197,0.017,0.036,Significant decrease (p=0.017),Mild increase (p=0.012),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09950,rs591268,1,35702696,TREM2,SNP (A/G),(A/,A,0.68,0.29,1.0,0.07698061,Moderate,0.087,0.459,0.113,0.14,Significant increase (p=0.006),Significant increase (p=0.044),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Potential drug target
AD-SNP09951,rs719297,4,77335471,SORL1,SNP (G/T),(G/,G,1.78,1.53,2.0,0.01172458,Moderate,0.018,0.162,0.614,0.006,Significant increase (p=0.007),Mild increase (p=0.049),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09952,rs769051,12,158162809,EPHA1,Deletion,-,-,1.17,0.84,1.56,0.02787895,High,0.403,0.272,0.083,0.043,Mild increase (p=0.042),Significant decrease (p=0.045),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Unknown clinical significance
AD-SNP09953,rs431261,3,195913062,MS4A6A,Insertion,-,-,0.96,0.74,1.2,0.051842,Moderate,0.064,0.19,0.182,0.363,Significant increase (p=0.024),Variable effect (p=0.007),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Biomarker for patient stratification
AD-SNP09954,rs686154,22,192465277,ABCA7,SNP (G/T),(G/,G,1.18,0.89,1.45,0.01898905,High,0.019,0.624,0.103,0.053,Significant decrease (p=0.024),Mild decrease (p=0.047),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09955,rs195350,6,123903329,CLU,SNP (C/T),(C/,C,0.8,0.52,1.15,0.01165476,Low,0.097,0.028,0.195,0.479,Mild increase (p=0.01),Significant decrease (p=0.043),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09956,rs894384,9,99853768,MS4A6A,SNP (C/T),(C/,C,2.09,1.81,2.36,0.01510993,Low,0.186,0.499,0.091,0.025,Variable effect (p=0.04),Variable effect (p=0.042),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09957,rs980993,12,155895761,CD2AP,SNP (A/T),(A/,A,1.7,1.37,1.98,0.01615609,Moderate,0.221,0.03,0.038,0.511,Significant increase (p=0.029),Significant increase (p=0.049),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Slow,Biomarker for patient stratification
AD-SNP09958,rs684261,21,20137456,APP,SNP (C/G),(C/,C,1.83,1.48,2.21,0.08181322,High,0.246,0.264,0.036,0.254,Variable effect (p=0.039),Mild increase (p=0.003),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09959,rs360240,15,122935583,BIN1,Insertion,-,-,1.33,1.1,1.7,0.01211369,High,0.463,0.056,0.012,0.269,No significant pattern (p=0.015),Mild decrease (p=0.024),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09960,rs299134,6,61156684,APP,Insertion,-,-,0.52,0.18,0.73,0.03016447,Moderate,0.047,0.504,0.125,0.124,Significant decrease (p=0.028),Significant decrease (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Biomarker for patient stratification
AD-SNP09961,rs590282,18,247376578,EPHA1,Deletion,-,-,0.58,0.2,0.91,0.04588843,Moderate,0.143,0.035,0.117,0.505,Mild decrease (p=0.044),No significant pattern (p=0.043),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09962,rs113000,4,59439191,TREM2,Insertion,-,-,0.51,0.23,0.88,0.0002046,Low,0.16,0.062,0.478,0.1,Mild decrease (p=0.026),Significant increase (p=0.009),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09963,rs470307,6,210648732,ABCA7,Insertion,-,-,1.43,1.07,1.65,0.01478729,Moderate,0.05,0.344,0.355,0.05,No significant pattern (p=0.036),Mild increase (p=0.015),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09964,rs390810,4,79315444,TREM2,SNP (C/T),(C/,C,2.01,1.63,2.25,0.0054039,High,0.129,0.569,0.083,0.019,Significant increase (p=0.021),Mild decrease (p=0.005),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09965,rs790821,12,234765508,CR1,SNP (G/T),(G/,G,0.77,0.41,1.15,0.01539424,Low,0.649,0.006,0.046,0.099,Significant increase (p=0.019),Significant decrease (p=0.043),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Biomarker for patient stratification
AD-SNP09966,rs879443,20,165161028,BIN1,SNP (A/C),(A/,A,1.07,0.74,1.44,0.02926994,Moderate,0.177,0.282,0.122,0.219,Variable effect (p=0.011),Variable effect (p=0.035),Significant increase,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Potential drug target
AD-SNP09967,rs756580,7,3364007,CR1,SNP (G/T),(G/,G,0.95,0.68,1.27,0.02256482,High,0.068,0.031,0.23,0.471,Mild increase (p=0.046),Significant decrease (p=0.05),Significant increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Monitoring marker
AD-SNP09968,rs291381,4,58148231,MS4A6A,Insertion,-,-,0.89,0.65,1.1,0.0152107,Moderate,0.108,0.016,0.006,0.669,Mild increase (p=0.039),Significant decrease (p=0.049),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09969,rs928671,3,60200468,CD2AP,Deletion,-,-,0.8,0.54,1.16,0.00016622,Moderate,0.297,0.268,0.104,0.131,Variable effect (p=0.013),Significant decrease (p=0.043),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP09970,rs316301,1,236352229,MS4A6A,SNP (A/C),(A/,A,0.38,0.1,0.71,0.04652944,Low,0.36,0.046,0.0,0.394,Significant decrease (p=0.027),Mild increase (p=0.046),Mild decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09971,rs296299,16,144631411,CR1,Insertion,-,-,1.37,1.09,1.69,0.03487178,Moderate,0.395,0.376,0.02,0.009,Significant increase (p=0.009),Significant decrease (p=0.042),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
AD-SNP09972,rs309602,17,73151632,TREM2,SNP (A/G),(A/,A,1.14,0.76,1.46,0.07997061,Moderate,0.415,0.16,0.038,0.186,Mild decrease (p=0.04),Mild increase (p=0.04),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09973,rs384385,19,219359658,BIN1,Deletion,-,-,1.22,0.9,1.57,0.03790516,Moderate,0.509,0.035,0.072,0.184,Significant decrease (p=0.045),Variable effect (p=0.005),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Unknown clinical significance
AD-SNP09974,rs441617,4,141052304,CD2AP,SNP (C/G),(C/,C,1.88,1.61,2.13,0.05508852,Moderate,0.33,0.023,0.069,0.379,Variable effect (p=0.026),Mild decrease (p=0.049),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Monitoring marker
AD-SNP09975,rs439746,1,224689050,CR1,SNP (C/G),(C/,C,1.59,1.28,1.88,0.01640198,High,0.328,0.209,0.074,0.188,No significant pattern (p=0.041),Significant decrease (p=0.042),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Slow,Potential drug target
AD-SNP09976,rs399083,10,214631148,MS4A6A,SNP (C/T),(C/,C,0.97,0.61,1.35,0.04270555,Unknown,0.01,0.036,0.727,0.026,Mild decrease (p=0.004),Mild decrease (p=0.024),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Biomarker for patient stratification
AD-SNP09977,rs769618,21,23736550,APP,SNP (G/T),(G/,G,1.35,1.04,1.61,0.02074167,Moderate,0.391,0.065,0.338,0.007,Mild decrease (p=0.022),Mild increase (p=0.034),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Monitoring marker
AD-SNP09978,rs473064,8,95515233,CD2AP,SNP (A/T),(A/,A,0.94,0.6,1.21,0.07270066,High,0.127,0.143,0.459,0.072,Significant decrease (p=0.022),Significant increase (p=0.029),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09979,rs555050,3,91327714,PSEN2,SNP (A/G),(A/,A,4.21,3.93,4.61,0.021427,Moderate,0.152,0.177,0.149,0.322,Mild decrease (p=0.031),Mild increase (p=0.003),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09980,rs633091,20,89525144,PSEN2,Insertion,-,-,1.05,0.73,1.33,0.02970258,Moderate,0.213,0.092,0.081,0.413,Mild increase (p=0.021),Mild decrease (p=0.028),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Potential drug target
AD-SNP09981,rs599476,12,187365939,SORL1,SNP (C/G),(C/,C,0.77,0.37,1.03,0.07487776,High,0.391,0.016,0.077,0.316,Significant decrease (p=0.032),Mild increase (p=0.049),Significant decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09982,rs402513,11,180656833,ABCA7,SNP (A/G),(A/,A,0.94,0.64,1.31,0.11927192,Moderate,0.071,0.376,0.078,0.276,Mild increase (p=0.034),Variable effect (p=0.02),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Biomarker for patient stratification
AD-SNP09983,rs746801,19,113836729,PTK2B,SNP (A/C),(A/,A,1.05,0.73,1.31,0.00700603,Low,0.684,0.026,0.031,0.059,Significant increase (p=0.012),Significant increase (p=0.01),Significant increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Unknown clinical significance
AD-SNP09984,rs550636,13,90540298,CR1,SNP (C/T),(C/,C,1.12,0.72,1.43,0.02896644,Unknown,0.015,0.076,0.6,0.109,Mild increase (p=0.026),Significant decrease (p=0.034),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Unknown clinical significance
AD-SNP09985,rs616835,22,212460773,ABCA7,SNP (A/G),(A/,A,0.93,0.59,1.26,0.10891289,Unknown,0.249,0.313,0.199,0.038,Mild increase (p=0.041),Mild increase (p=0.036),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09986,rs792378,15,140949963,MS4A6A,SNP (C/T),(C/,C,1.1,0.83,1.35,0.01388296,Moderate,0.338,0.152,0.286,0.024,Mild decrease (p=0.04),No significant pattern (p=0.022),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09987,rs293258,9,63401661,CLU,SNP (A/C),(A/,A,0.28,0.1,0.63,0.03466237,High,0.017,0.072,0.183,0.528,Significant decrease (p=0.018),Mild decrease (p=0.032),Significant decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Rapid,Potential drug target
AD-SNP09988,rs174706,20,158938732,CLU,SNP (A/C),(A/,A,0.35,0.1,0.69,0.00280234,Moderate,0.223,0.061,0.213,0.304,Significant decrease (p=0.023),Mild decrease (p=0.037),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Biomarker for patient stratification
AD-SNP09989,rs337069,10,190252099,CD33,SNP (G/T),(G/,G,1.46,1.13,1.79,0.02837641,Moderate,0.52,0.186,0.093,0.001,Mild increase (p=0.01),Mild decrease (p=0.046),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Monitoring marker
AD-SNP09990,rs174563,21,85291018,EPHA1,Insertion,-,-,0.85,0.46,1.18,0.00196321,Moderate,0.015,0.441,0.258,0.086,Significant increase (p=0.045),Significant decrease (p=0.019),Mild decrease,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Negligible,Potential drug target
AD-SNP09991,rs879339,13,243466933,CR1,Deletion,-,-,1.13,0.88,1.43,0.00657411,Moderate,0.159,0.521,0.026,0.094,Mild decrease (p=0.024),Significant decrease (p=0.04),Mild increase,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09992,rs483126,4,151012240,BIN1,SNP (C/T),(C/,C,0.61,0.37,0.91,0.08930142,Moderate,0.192,0.097,0.025,0.485,Variable effect (p=0.001),Variable effect (p=0.049),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Moderate,Monitoring marker
AD-SNP09993,rs927481,15,245017192,PTK2B,SNP (C/G),(C/,C,0.76,0.5,1.15,0.00983594,Low,0.052,0.53,0.029,0.189,No significant pattern (p=0.031),Significant increase (p=0.028),Variable effect,Significant effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Moderate,Unknown clinical significance
AD-SNP09994,rs335229,4,244301184,TREM2,SNP (C/T),(C/,C,1.24,0.87,1.46,0.00526576,Low,0.206,0.328,0.045,0.222,Significant decrease (p=0.026),Mild decrease (p=0.03),No significant pattern,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Rapid,Biomarker for patient stratification
AD-SNP09995,rs148945,5,229664127,CD33,Insertion,-,-,0.71,0.49,0.98,0.11867646,High,0.098,0.297,0.138,0.267,Significant increase (p=0.026),Mild decrease (p=0.05),Mild decrease,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Moderate,Negligible,Unknown clinical significance
AD-SNP09996,rs515231,9,142409425,APOE,Deletion,-,-,1.14,0.93,1.49,0.01056611,Unknown,0.038,0.553,0.099,0.11,Variable effect (p=0.048),Variable effect (p=0.044),Mild increase,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Strong,Rapid,Monitoring marker
AD-SNP09997,rs174372,7,25390556,PSEN2,SNP (C/G),(C/,C,1.36,1.07,1.72,0.00423114,High,0.3,0.042,0.389,0.068,Significant decrease (p=0.006),Significant decrease (p=0.033),Variable effect,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Biomarker for patient stratification
AD-SNP09998,rs170579,3,92730674,SORL1,SNP (C/G),(C/,C,1.24,1.02,1.58,0.0109334,High,0.461,0.009,0.21,0.12,Mild decrease (p=0.033),No significant pattern (p=0.002),Variable effect,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Slow,Potential drug target
AD-SNP09999,rs505240,18,161125270,APOE,SNP (G/T),(G/,G,1.53,1.28,1.75,0.01430845,Moderate,0.173,0.378,0.094,0.155,Significant decrease (p=0.009),Mild increase (p=0.02),Significant decrease,Minimal effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Moderate,Monitoring marker
AD-SNP10000,rs784870,17,44750216,CD33,Deletion,-,-,0.41,0.21,0.76,0.07975652,Unknown,0.237,0.292,0.052,0.22,Significant decrease (p=0.018),No significant pattern (p=0.022),No significant pattern,Modest effect,Uncertain significance,Class 3 (Uncertain significance),Weak,Negligible,Unknown clinical significance
